PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Galal, WC; Pan, M; Kelman, Z; Hurwitz, J				Galal, Wiebke Chemnitz; Pan, Miao; Kelman, Zvi; Hurwitz, Jerard			Characterization of DNA Primase Complex Isolated from the Archaeon, Thermococcus kodakaraensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFOLOBUS-SOLFATARICUS; BIOCHEMICAL-CHARACTERIZATION; HETERODIMERIC PRIMASE; REPLICATION FORK; RNA; POLYMERASES; IDENTIFICATION; DOMAIN	In most organisms, DNA replication is initiated by DNA primases, which synthesize primers that are elongated by DNA polymerases. In this study, we describe the isolation and biochemical characterization of the DNA primase complex and its subunits from the archaeon Thermococcus kodakaraensis. The T. kodakaraensis DNA primase complex is a heterodimer containing stoichiometric levels of the p41 and p46 subunits. The catalytic activity of the complex resides within the p41 subunit. We show that the complex supports both DNA and RNA synthesis, whereas the p41 subunit alone marginally produces RNA and synthesizes DNA chains that are longer than those formed by the complex. We report that the T. kodakaraensis primase complex preferentially interacts with dNTP rather than ribonucleoside triphosphates and initiates RNA as well as DNA chains de novo. The latter findings indicate that the archaeal primase complex, in contrast to the eukaryote homolog, can initiate DNA chain synthesis in the absence of ribonucleoside triphosphates. DNA primers formed by the archaeal complex can be elongated extensively by the T. kodakaraensis DNA polymerase (Pol) B, whereas DNA primers formed by the p41 catalytic subunit alone were not. Supplementation of reactions containing the p41 subunit with the p46 subunit leads to PolB-catalyzed DNA synthesis. We also established a rolling circle reaction using a primed 200-nucleotide circle as the substrate. In the presence of the T. kodakaraensis minichromosome maintenance (MCM) 3'-> 35' DNA helicase, PolB, replication factor C, and proliferating cell nuclear antigen, long leading strands (>10 kb) are produced. Supplementation of such reactions with the DNA primase complex supported lagging strand formation as well.	[Galal, Wiebke Chemnitz; Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Pan, Miao; Kelman, Zvi] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Kelman, Zvi] Natl Inst Stand & Technol, Rockville, MD 20850 USA	Memorial Sloan Kettering Cancer Center; National Institute of Standards & Technology (NIST) - USA	Hurwitz, J (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	j-hurwitz@ski.mskcc.org	Pan, Miao/E-7346-2012		National Institutes of Health [GH034559]; National Science Foundation [MCB-0815646]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported, in whole or in part, by National Institutes of Health Grant GH034559 (to J. H.). This work was also supported by National Science Foundation Grant MCB-0815646 (to Z. K.).	Beck K, 2007, NUCLEIC ACIDS RES, V35, P5635, DOI 10.1093/nar/gkm625; Bocquier AA, 2001, CURR BIOL, V11, P452, DOI 10.1016/S0960-9822(01)00119-1; CONAWAY RC, 1982, P NATL ACAD SCI-BIOL, V79, P2523, DOI 10.1073/pnas.79.8.2523; De Falco M, 2004, NUCLEIC ACIDS RES, V32, P5223, DOI 10.1093/nar/gkh865; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Galal WC, 2012, J BIOL CHEM, V287, P16220, DOI 10.1074/jbc.M111.338160; JOSSE J, 1961, J BIOL CHEM, V236, P864; Kasiviswanathan R, 2004, J BIOL CHEM, V279, P28358, DOI 10.1074/jbc.M403202200; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Ladner JE, 2011, P NATL ACAD SCI USA, V108, P2711, DOI 10.1073/pnas.1019179108; Lao-Sirieix SH, 2005, TRENDS GENET, V21, P568, DOI 10.1016/j.tig.2005.07.010; Lao-Sirieix SH, 2004, J MOL BIOL, V344, P1251, DOI 10.1016/j.jmb.2004.10.018; Le Breton M, 2007, J MOL BIOL, V374, P1172, DOI 10.1016/j.jmb.2007.10.015; Li Z, 2010, MBIO, V1, DOI 10.1128/mBio.00221-10; Liu LD, 2001, J BIOL CHEM, V276, P45484, DOI 10.1074/jbc.M106391200; MAITRA U, 1965, P NATL ACAD SCI USA, V54, P815, DOI 10.1073/pnas.54.3.815; Matsunaga F, 2003, EMBO REP, V4, P154, DOI 10.1038/sj.embor.embor732; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Norais C, 2007, PLOS GENET, V3, P729, DOI 10.1371/journal.pgen.0030077; Pan M, 2011, NUCLEIC ACIDS RES, V39, P9671, DOI 10.1093/nar/gkr624; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Walter P, 2006, MOL MICROBIOL, V62, P1076, DOI 10.1111/j.1365-2958.2006.05393.x; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200	28	25	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16209	16219		10.1074/jbc.M111.338145	http://dx.doi.org/10.1074/jbc.M111.338145			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22351771	Green Published, hybrid			2022-12-25	WOS:000304030900013
J	Tome, CML; Palma, E; Ferluga, S; Lowther, WT; Hantgan, R; Wykosky, J; Debinski, W				Tome, Carla M. Lema; Palma, Enzo; Ferluga, Sara; Lowther, W. Todd; Hantgan, Roy; Wykosky, Jill; Debinski, Waldemar			Structural and Functional Characterization of Monomeric EphrinA1 Binding Site to EphA2 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; GLIOBLASTOMA-MULTIFORME; LIGAND-BINDING; TUMOR-CELLS; IN-VITRO; CANCER; EXPRESSION; ACTIVATION; OVEREXPRESSION; PATHWAY	The EphA2 receptor is overexpressed in glioblastoma multiforme and has been to shown to contribute to cell transformation, tumor initiation, progression, and maintenance. EphrinA1 (eA1) is a preferred ligand for the receptor. Treatment with monomeric eA1, the form of eA1 found in the extracellular environment, causes receptor phosphorylation, internalization, and down-regulation with subsequent anti-tumor effects. Here, we investigated the structure-function relationship of a monomeric eA1 focusing on its G-H loop ((108)FQRFTPFTLGKEFKE(123)G), a highly conserved region among eAs that mediates binding to their receptors. Alanine substitution mutants of the G-H loop amino acids were transfected into U-251 MG glioblastoma multiforme cells, and functional activity of each mutant in conditioned media was assessed by EphA2 down-regulation, ERK and AKT activation and cellular response assays. Alanine substitutions at positions Pro-113 Thr-115, Gly-117, Glu-122, and also Gln-109 enhanced the EphA2 receptor down-regulation and decreased p-ERK and p-AKT. Substitution mutants of eA1 at positions Phe-108, Arg-110, Phe-111, Thr-112, Phe-114, Leu-116, Lys-118, Glu-119, and Phe-120 had a deleterious effect on EphA2 down-regulation when compared with eA1-WT. Mutants at positions Phe-108, Lys-18, Lys-121, Gly-123 retained similar properties to eA1-WT. Recombinant eA1-R110A, -T115A, -G117A, and -F120A have been found to exhibit the same characteristics as the ligands contained in the conditioned media mainly due to the differences in their binding to the receptor. Thus, we have identified variants of eA1 that possess either superagonistic or antagonistic properties. These new findings will be important in the understanding of the receptor/ligand interactions and in further design of anti-cancer therapies targeting the eA/EphA system.	[Tome, Carla M. Lema; Palma, Enzo; Ferluga, Sara; Wykosky, Jill; Debinski, Waldemar] Wake Forest Sch Med, Dept Neurosurg, Brain Tumor Ctr Excellence, Winston Salem, NC 27157 USA; [Lowther, W. Todd] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Hantgan, Roy] Wake Forest Sch Med, Dept Biochem & Mol Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University	Debinski, W (corresponding author), Wake Forest Sch Med, Dept Neurosurg, Brain Tumor Ctr Excellence, Med Ctr Blvd, Winston Salem, NC 27157 USA.	debinski@wakehealth.edu		Ferluga, Sara/0000-0002-6151-5492	National Institutes of Health [CA 74145]; Brain Tumor Center of Excellence; North Carolina Biotechnology Center [2006-IDG-1004]; NATIONAL CANCER INSTITUTE [R01CA074145, T32CA113267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Tumor Center of Excellence; North Carolina Biotechnology Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 74145 (NCI; to W. D.). This work was supported by the Brain Tumor Center of Excellence (to W. D.) and Institutional Development Grant 2006-IDG-1004 from the North Carolina Biotechnology Center (to R. H.).	Beauchamp A, 2012, SEMIN CELL DEV BIOL, V23, P109, DOI 10.1016/j.semcdb.2011.10.019; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V320, P1096, DOI 10.1016/j.bbrc.2004.06.054; Fritsche-Guenther R, 2010, HISTOPATHOLOGY, V57, P836, DOI 10.1111/j.1365-2559.2010.03713.x; Guo H, 2006, CANCER RES, V66, P7050, DOI 10.1158/0008-5472.CAN-06-0004; Hantgan RR, 2010, BIOCHEMISTRY-US, V49, P9217, DOI 10.1021/bi1009858; Hantgan RR, 2009, BIOCHEMISTRY-US, V48, P8355, DOI 10.1021/bi900475k; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Kataoka H, 2004, CANCER SCI, V95, P136, DOI 10.1111/j.1349-7006.2004.tb03194.x; Kinch MS, 2003, CLIN EXP METASTAS, V20, P59, DOI 10.1023/A:1022546620495; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Li X, 2007, TUMOR BIOL, V28, P165, DOI 10.1159/000103010; Liu FH, 2006, CANCER RES, V66, P10815, DOI 10.1158/0008-5472.CAN-06-1408; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Mudali SV, 2006, CLIN EXP METASTAS, V23, P357, DOI 10.1007/s10585-006-9045-7; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Nakamura R, 2005, CANCER SCI, V96, P42, DOI 10.1111/j.1349-7006.2005.00007.x; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pratt RL, 2002, ONCOGENE, V21, P7690, DOI 10.1038/sj.onc.1205758; Qin HN, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-2; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; SHAO HN, 1995, J BIOL CHEM, V270, P5636, DOI 10.1074/jbc.270.10.5636; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Walker-Daniels J, 2003, AM J PATHOL, V162, P1037, DOI 10.1016/S0002-9440(10)63899-0; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Wang LF, 2008, ONCOL REP, V19, P151; Wimmer-Kleikamp SH, 2005, IUBMB LIFE, V57, P421, DOI 10.1080/15216540500138337; Wu QH, 2004, PATHOL ONCOL RES, V10, P26, DOI 10.1007/BF02893405; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Wykosky J, 2008, ONCOGENE, V27, P7260, DOI 10.1038/onc.2008.328; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Yang NY, 2011, CELL SIGNAL, V23, P201, DOI 10.1016/j.cellsig.2010.09.004; Zelinski DP, 2001, CANCER RES, V61, P2301; Zeng GY, 2003, AM J PATHOL, V163, P2271, DOI 10.1016/S0002-9440(10)63584-5	48	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14012	14022		10.1074/jbc.M111.311670	http://dx.doi.org/10.1074/jbc.M111.311670			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22362770	hybrid, Green Published			2022-12-25	WOS:000303996300056
J	Seldin, MM; Peterson, JM; Byerly, MS; Wei, ZK; Wong, GW				Seldin, Marcus M.; Peterson, Jonathan M.; Byerly, Mardi S.; Wei, Zhikui; Wong, G. William			Myonectin (CTRP15), a Novel Myokine That Links Skeletal Muscle to Systemic Lipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; INSULIN-RESISTANCE; ENDOCRINE ORGAN; ADIPOSE-TISSUE; PROTEIN; FAMILY; IDENTIFICATION; EXPRESSION; GLUCOSE; GENE	Skeletal muscle plays important roles in whole-body glucose and fatty acid metabolism. However, muscle also secretes cytokines and growth factors (collectively termed myokines) that can potentially act in an autocrine, a paracrine, and/or an endocrine manner to modulate metabolic, inflammatory, and other processes. Here, we report the identification and characterization of myonectin, a novel myokine belonging to the C1q/TNF-related protein (CTRP) family. Myonectin transcript was highly induced in differentiated myotubes and predominantly expressed by skeletal muscle. Circulating levels of myonectin were tightly regulated by the metabolic state; fasting suppressed, but refeeding dramatically increased, its mRNA and serum levels. Although mRNA and circulating levels of myonectin were reduced in a diet-induced obese state, voluntary exercise increased its expression and circulating levels. Accordingly, myonectin transcript was up-regulated by compounds (forskolin, epinephrine, ionomycin) that raise cellular cAMP or calcium levels. In vitro, secreted myonectin forms disulfide-linked oligomers, and when co-expressed, forms heteromeric complexes with other members of the C1q/TNF-related protein family. In mice, recombinant myonectin administration reduced circulating levels of free fatty acids without altering adipose tissue lipolysis. Consistent with this, myonectin promoted fatty acid uptake in cultured adipocytes and hepatocytes, in part by up-regulating the expression of genes (CD36, FATP1, Fabp1, and Fabp4) that promote lipid uptake. Collectively, these results suggest that myonectin links skeletal muscle to lipid homeostasis in liver and adipose tissue in response to alterations in energy state, revealing a novel myonectin-mediated metabolic circuit.	[Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wong, G. William/0000-0002-5286-6506; Wei, Zhikui/0000-0002-2311-9800	National Institutes of Health [DK084171, T32DK007751]; American Heart Association [SDG2260721, PRE3790034]; National Institutes of Health National Research Service [F32DK084607]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171, F32DK084607, T32DK007751, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	* This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.). This work was also supported in part by American Heart Association Grant SDG2260721 (to G. W. W.).; <SUP>1</SUP> Supported by National Institutes of Health National Research Service Award F32DK084607. Present address: Dept. of Health Sciences, School of Public Health, East Tennessee State University, Johnson City, TN 37614.; <SUP>2</SUP> Supported by National Institutes of Health Training Grant T32DK007751.; <SUP>3</SUP> Supported by American Heart Association Fellowship PRE3790034.	Briggs DB, 2009, BIOCHEMISTRY-US, V48, P12345, DOI 10.1021/bi9015555; Broholm C, 2011, J APPL PHYSIOL, V111, P251, DOI 10.1152/japplphysiol.01399.2010; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Haugen F, 2010, AM J PHYSIOL-CELL PH, V298, pC807, DOI 10.1152/ajpcell.00094.2009; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Lim S, 2012, J CLIN ENDOCR METAB, V97, pE88, DOI 10.1210/jc.2011-1743; Lok S, 2000, BIOL REPROD, V62, P1593, DOI 10.1095/biolreprod62.6.1593; Mashimo J, 1997, CANCER LETT, V113, P213, DOI 10.1016/S0304-3835(97)04700-9; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; Nishizawa H, 2004, J BIOL CHEM, V279, P19391, DOI 10.1074/jbc.C400066200; Norheim F, 2011, AM J PHYSIOL-ENDOC M, V301, pE1013, DOI 10.1152/ajpendo.00326.2011; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Park SY, 2009, J BIOL CHEM, V284, P27780, DOI 10.1074/jbc.M109.005611; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2009, J APPL PHYSIOL, V107, P1006, DOI 10.1152/japplphysiol.00734.2009; Petersen KF, 2002, AM J CARDIOL, V90, p11G; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; Quinn LS, 2009, AM J PHYSIOL-ENDOC M, V296, pE191, DOI 10.1152/ajpendo.90506.2008; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Rasmussen BB, 1999, ANNU REV NUTR, V19, P463, DOI 10.1146/annurev.nutr.19.1.463; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; Steensberg A, 2001, AM J PHYSIOL-CELL PH, V281, pC1001; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Wang H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207779; Wasserman DH, 2005, CLIN EXP PHARMACOL P, V32, P319, DOI 10.1111/j.1440-1681.2005.04191.x; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zeng L, 2010, J BIOL CHEM, V285, P36060, DOI 10.1074/jbc.M110.160879	46	248	273	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11968	11980		10.1074/jbc.M111.336834	http://dx.doi.org/10.1074/jbc.M111.336834			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351773	Green Published, hybrid			2022-12-25	WOS:000302782200035
J	Ueki, T; Leang, C; Inoue, K; Lovley, DR				Ueki, Toshiyuki; Leang, Ching; Inoue, Kengo; Lovley, Derek R.			Identification of Multicomponent Histidine-Aspartate Phosphorelay System Controlling Flagellar and Motility Gene Expression in Geobacter Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SUBSURFACE ENVIRONMENTS; PSEUDOMONAS-AERUGINOSA; SP-NOV; SULFURREDUCENS; GENOME; REDUCTION; IRON; MICROORGANISM; CHEMOTAXIS	Geobacter species play an important role in the natural bio-geochemical cycles of aquatic sediments and subsurface environments as well as in subsurface bioremediation by oxidizing organic compounds with the reduction of insoluble Fe(III) oxides. Flagellum-based motility is considered to be critical for Geobacter species to locate fresh sources of Fe(III) oxides. Functional and comparative genomic approaches, coupled with genetic and biochemical methods, identified key regulators for flagellar gene expression in Geobacter species. A master transcriptional regulator, designated FgrM, is a member of the enhancer-binding protein family. The fgrM gene in the most studied strain of Geobacter species, Geobacter sulfurreducens strain DL-1, is truncated by a transposase gene, preventing flagellar biosynthesis. Integrating a functional FgrM homolog restored flagellar biosynthesis and motility in G. sulfurreducens DL-1 and enhanced the ability to reduce insoluble Fe(III) oxide. Interrupting the fgrM gene in G. sulfurreducens strain KN400, which is motile, removed the capacity for flagellar production and inhibited Fe(III) oxide reduction. FgrM, which is also a response regulator of the two-component His-Asp phosphorelay system, was phosphorylated by histidine kinase GHK4, which was essential for flagellar production and motility. GHK4, which is a hybrid kinase with a receiver domain at the N terminus, was phosphorylated by another histidine kinase, GHK3. Therefore, the multicomponent His-Asp phosphorelay system appears to control flagellar gene expression in Geobacter species.	[Ueki, Toshiyuki] Univ Massachusetts, Dept Microbiol, Morrill Sci Ctr 4 N, Amherst, MA 01003 USA; [Inoue, Kengo] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki 8891692, Japan	University of Massachusetts System; University of Massachusetts Amherst; University of Miyazaki	Ueki, T (corresponding author), Univ Massachusetts, Dept Microbiol, Morrill Sci Ctr 4 N, 639 N Pleasant St, Amherst, MA 01003 USA.	tueki@microbio.umass.edu		Inoue, Kengo/0000-0002-9680-8359	Office of Science (Biological and Environmental Research), United States Department of Energy [DE-FC02-02ER63446, DE-SC0004080]	Office of Science (Biological and Environmental Research), United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Grants DE-FC02-02ER63446 and DE-SC0004080 from the Office of Science (Biological and Environmental Research), United States Department of Energy.	Aklujkar M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-490; Aklujkar M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-109; Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Arora SK, 1997, J BACTERIOL, V179, P5574, DOI 10.1128/jb.179.17.5574-5581.1997; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Childers SE, 2002, NATURE, V416, P767, DOI 10.1038/416767a; Coppi MV, 2001, APPL ENVIRON MICROB, V67, P3180, DOI 10.1128/AEM.67.7.3180-3187.2001; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Esteve-Nunez A, 2008, ENVIRON MICROBIOL, V10, P497, DOI 10.1111/j.1462-2920.2007.01470.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Holmes DE, 2004, INT J SYST EVOL MICR, V54, P1591, DOI 10.1099/ijs.0.02958-0; Leang C, 2010, APPL ENVIRON MICROB, V76, P4080, DOI 10.1128/AEM.00023-10; Leang C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-331; Lonergan DJ, 1996, J BACTERIOL, V178, P2402, DOI 10.1128/jb.178.8.2402-2408.1996; Lovley DR, 2008, GEOBIOLOGY, V6, P225, DOI 10.1111/j.1472-4669.2008.00148.x; Lovley DR, 2011, ADV MICROB PHYSIOL, V59, P1, DOI 10.1016/B978-0-12-387661-4.00004-5; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Mahadevan R, 2011, NAT REV MICROBIOL, V9, P39, DOI 10.1038/nrmicro2456; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Miller J.H., 1972, EXPT MOL GENETICS; Nagarajan H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010922; Prouty MG, 2001, MOL MICROBIOL, V39, P1595, DOI 10.1046/j.1365-2958.2001.02348.x; Reguera G, 2006, APPL ENVIRON MICROB, V72, P7345, DOI 10.1128/AEM.01444-06; SANDLER SJ, 1994, J BACTERIOL, V176, P3661, DOI 10.1128/JB.176.12.3661-3672.1994; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Taylor BL, 2007, MOL MICROBIOL, V65, P1415, DOI 10.1111/j.1365-2958.2007.05889.x; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tran HT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-471; Ueki T, 2002, J BIOL CHEM, V277, P6170, DOI 10.1074/jbc.M110155200; Ueki T, 2010, NUCLEIC ACIDS RES, V38, P7485, DOI 10.1093/nar/gkq652; Ueki T, 2010, NUCLEIC ACIDS RES, V38, P810, DOI 10.1093/nar/gkp1085; Wigneshweraraj S, 2008, MOL MICROBIOL, V68, P538, DOI 10.1111/j.1365-2958.2008.06181.x; Yi HN, 2009, BIOSENS BIOELECTRON, V24, P3498, DOI 10.1016/j.bios.2009.05.004	41	18	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10958	10966		10.1074/jbc.M112.345041	http://dx.doi.org/10.1074/jbc.M112.345041			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22362768	Green Published, hybrid			2022-12-25	WOS:000302780100024
J	Akinsola, AK; Ota, MOC; Enwere, GC; Okoko, BJ; Zaman, SMA; Saaka, M; Nsekpong, ED; Odutola, AA; Greenwood, BM; Cutts, FT; Adegbola, RA				Akinsola, Adebayo K.; Ota, Martin O. C.; Enwere, Godwin C.; Okoko, Brown J.; Zaman, Syed M. A.; Saaka, Mark; Nsekpong, Ekpedeme D.; Odutola, Aderonke A.; Greenwood, Brian M.; Cutts, Felicity T.; Adegbola, Richard A.			Pneumococcal Antibody Concentrations and Carriage of Pneumococci more than 3 Years after Infant Immunization with a Pneumococcal Conjugate Vaccine	PLOS ONE			English	Article							INFLUENZAE TYPE-B; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; INVASIVE-DISEASE; CHILDREN; IMMUNOGENICITY; SEROTYPE; EFFICACY; GAMBIA; TRIAL	Background: A 9-valent pneumococcal conjugate vaccine (PCV-9), given in a 3-dose schedule, protected Gambian children against pneumococcal disease and reduced nasopharyngeal carriage of pneumococci of vaccine serotypes. We have studied the effect of a booster or delayed primary dose of 7-valent conjugate vaccine (PCV-7) on antibody and nasopharyngeal carriage of pneumococci 3-4 years after primary vaccination. Methodology/Principal Findings: We recruited a subsample of children who had received 3 doses of either PCV-9 or placebo (controls) into this follow-up study. Pre- and post-PCV-7 pneumococcal antibody concentrations to the 9 serotypes in PCV-9 and nasopharyngeal carriage of pneumococci were determined before and at intervals up to 18 months post-PCV7. We enrolled 282 children at a median age of 45 months (range, 38-52 months); 138 had received 3 doses of PCV-9 in infancy and 144 were controls. Before receiving PCV-7, a high proportion of children had antibody concentrations > 0.35 mu g/mL to most of the serotypes in PCV-9 (average of 75% in the PCV-9 and 66% in the control group respectively). The geometric mean antibody concentrations in the vaccinated group were significantly higher compared to controls for serotypes 6B, 14, and 23F. Antibody concentrations were significantly increased to serotypes in the PCV-7 vaccine both 6-8 weeks and 16-18 months after PCV-7. Antibodies to serotypes 6B, 9V and 23F were higher in the PCV-9 group than in the control group 6-8 weeks after PCV-7, but only the 6B difference was sustained at 16-18 months. There was no significant difference in nasopharyngeal carriage between the two groups. Conclusions/Significance: Pneumococcal antibody concentrations in Gambian children were high 34-48 months after a 3-dose primary infant vaccination series of PCV-9 for serotypes other than serotypes 1 and 18C, and were significantly higher than in control children for 3 of the 9 serotypes. Antibody concentrations increased after PCV-7 and remained raised for at least 18 months.	[Akinsola, Adebayo K.; Ota, Martin O. C.; Enwere, Godwin C.; Okoko, Brown J.; Zaman, Syed M. A.; Saaka, Mark; Nsekpong, Ekpedeme D.; Odutola, Aderonke A.; Adegbola, Richard A.] MRC, Gambia Unit, Banjul, Gambia; [Greenwood, Brian M.; Cutts, Felicity T.] London Sch Hyg & Trop Med, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Akinsola, AK (corresponding author), MRC, Gambia Unit, Banjul, Gambia.	radegbola@hotmail.com			UK Medical Research Council; MRC [MC_UP_A900_1122, MC_U190071468] Funding Source: UKRI; Medical Research Council [MC_UP_A900_1122, MC_U190071468] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2005, J INFECT DIS, V192, P367, DOI 10.1086/431679; Goetghebuer T, 2000, TROP MED INT HEALTH, V5, P207, DOI 10.1046/j.1365-3156.2000.00535.x; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Heath PT, 2002, ARCH DIS CHILD, V86, P396, DOI 10.1136/adc.86.6.396; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Madhi SA, 2007, VACCINE, V25, P2451, DOI 10.1016/j.vaccine.2006.09.019; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Miernyk KM, 2000, CLIN INFECT DIS, V31, P34, DOI 10.1086/313907; Mulholland EK, 1999, PEDIATR INFECT DIS J, V18, pS35, DOI 10.1097/00006454-199910001-00007; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obaro SK, 2000, PEDIATR INFECT DIS J, V19, P463, DOI 10.1097/00006454-200005000-00014; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; ODempsey TJD, 1996, PEDIATR INFECT DIS J, V15, P431, DOI 10.1097/00006454-199605000-00010; Ota MO, 2011, VACCINE, V29, P2999, DOI 10.1016/j.vaccine.2011.01.098; Palmer A, 1999, J TROP PEDIATRICS, V45, P51, DOI 10.1093/tropej/45.1.51; Russell FM, 2010, CLIN VACCINE IMMUNOL, V17, P1970, DOI 10.1128/CVI.00117-10; Saaka M, 2008, VACCINE, V26, P3719, DOI 10.1016/j.vaccine.2008.04.066; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Trotter CL, 2008, VACCINE, V26, P4434, DOI 10.1016/j.vaccine.2008.05.073; Usen S, 1998, PEDIATR INFECT DIS J, V17, P23, DOI 10.1097/00006454-199801000-00006; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	32	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31050	10.1371/journal.pone.0031050	http://dx.doi.org/10.1371/journal.pone.0031050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363544	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000302871500025
J	Alshatwi, AA; Shafi, G; Hasan, TN; Syed, NA; Al-Hazzani, AA; Alsaif, MA; Alsaif, AA				Alshatwi, Ali A.; Shafi, Gowhar; Hasan, Tarique N.; Syed, Naveed Ahmed; Al-Hazzani, Amal A.; Alsaif, Mohammed A.; Alsaif, Abdulaziz A.			Differential Expression Profile and Genetic Variants of MicroRNAs Sequences in Breast Cancer Patients	PLOS ONE			English	Article							DISEASES; PROGNOSIS; DIAGNOSIS; MIRNAS; RISK; SNP	The technology available for cancer diagnosis and prognosis is not yet satisfactory at the molecular level, and requires further improvements. Micro RNAs (miRNAs) have been recently reported as useful biomarkers in diseases including cancer. We performed a miRNA expression profiling study using peripheral blood from breast cancer patients to detect and identify characteristic patterns. A total of 100 breast cancer patients and 89 healthy patients were recruited for miRNA genotyping and expression profiling. We found that hs-miR-196a2 in premenopausal patients, and hs-miR-499, hs-miR-146a and hs-miR-196a2 postmenopausal patients, may discriminate breast cancer patients from healthy individuals. In addition, we found a significant association between two microRNA polymorphisms (hs-miR-196a2 and hs-miR-499) and breast cancer risk. However, no significant association between the hs-miR-146a gene and breast cancer risk was found. In summary, the study demonstrates that peripheral blood miRNAs and their expression and genotypic profiles can be developed as biomarkers for early diagnosis and prognosis of breast cancer.	[Alshatwi, Ali A.; Shafi, Gowhar; Hasan, Tarique N.; Syed, Naveed Ahmed] King Saud Univ, MCBRL, Dept Food Sci & Nutr, Coll Food & Agr Sci, Riyadh, Saudi Arabia; [Al-Hazzani, Amal A.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia; [Alsaif, Mohammed A.] King Saud Univ, Coll Appl Med Sci, Riyadh 11451, Saudi Arabia; [Alsaif, Abdulaziz A.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia	King Saud University; King Saud University; King Saud University; King Saud University	Alshatwi, AA (corresponding author), King Saud Univ, MCBRL, Dept Food Sci & Nutr, Coll Food & Agr Sci, Riyadh, Saudi Arabia.	alialshatwi@gmail.com	Alshatwi, Ali/E-5271-2014; Syed, Naveed/K-2318-2012	Alshatwi, Ali/0000-0002-2441-553X; Noorul Hasan, Tarique/0000-0002-7744-9637	National Plan for Sciences and Technology, King Saud University, Riyadh, Saudi Arabia [09-BIO675-02]	National Plan for Sciences and Technology, King Saud University, Riyadh, Saudi Arabia	The authors would like to acknowledge National Plan for Sciences and Technology, King Saud University, Riyadh, Saudi Arabia (Project No. 09-BIO675-02), for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshatwi AA, 2011, FUND CLIN PHARM, DOI [10.1111/j.1472-8206.2011.00939, DOI 10.1111/J.1472-8206.2011.00939]; Aumiller V, 2008, BBA-GENE REGUL MECH, V1779, P692, DOI 10.1016/j.bbagrm.2008.04.008; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carissimi C, 2009, AUTOIMMUN REV, V8, P520, DOI 10.1016/j.autrev.2009.01.008; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Elkum N, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-222; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Li LC, 2008, RNA BIOL, V5, P61, DOI 10.4161/rna.5.2.5989; Maqbool Z, 2008, SAUDI MED J, V29, P507; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mocellin S, 2009, MINI-REV MED CHEM, V9, P70, DOI 10.2174/138955709787001802; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Ruijs MW, 2007, FAM CANCER, V6, P311; Shafi G, 2010, CAN J NEUROL SCI, V37, P177, DOI 10.1017/S0317167100009902; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	28	62	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30049	10.1371/journal.pone.0030049	http://dx.doi.org/10.1371/journal.pone.0030049			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363415	Green Submitted, Green Published, gold			2022-12-25	WOS:000302871500005
J	Erent, M; Drummond, DR; Cross, RA				Erent, Muriel; Drummond, Douglas R.; Cross, Robert A.			S. pombe Kinesins-8 Promote Both Nucleation and Catastrophe of Microtubules	PLOS ONE			English	Article							SINGLE-HEADED KINESIN; FISSION YEAST; INTERPHASE MICROTUBULES; DYNAMIC INSTABILITY; SCHIZOSACCHAROMYCES-POMBE; MITOTIC SPINDLE; MOTOR PROTEINS; CHROMOSOME CONGRESSION; LENGTH; MOVEMENT	The skinesins-8 were originally thought to be microtubule depolymerases, but are now emerging as more versatile catalysts of microtubule dynamics. We show here that S. pombe Klp5-436 and Klp6-440 are non-processive plus-end-directed motors whose in vitro velocities on S. pombe microtubules at 7 and 23 nm s(-1) are too slow to keep pace with the growing tips of dynamic interphase microtubules in living S. pombe. In vitro, Klp5 and 6 dimers exhibit a hitherto-undescribed combination of strong enhancement of microtubule nucleation with no effect on growth rate or catastrophe frequency. By contrast in vivo, both Klp5 and Klp6 promote microtubule catastrophe at cell ends whilst Klp6 also increases the number of interphase microtubule arrays (IMAs). Our data support a model in which Klp5/6 bind tightly to free tubulin heterodimers, strongly promoting the nucleation of new microtubules, and then continue to land as a tubulin-motor complex on the tips of growing microtubules, with the motors then dissociating after a few seconds residence on the lattice. In vivo, we predict that only at cell ends, when growing microtubule tips become lodged and their growth slows down, will Klp5/6 motor activity succeed in tracking growing microtubule tips. This mechanism would allow Klp5/6 to detect the arrival of microtubule tips at cells ends and to amplify the intrinsic tendency for microtubules to catastrophise in compression at cell ends. Our evidence identifies Klp5 and 6 as spatial regulators of microtubule dynamics that enhance both microtubule nucleation at the cell centre and microtubule catastrophe at the cell ends.	[Erent, Muriel; Drummond, Douglas R.; Cross, Robert A.] Univ Warwick, Ctr Mechanochem Cell Biol, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of Warwick	Erent, M (corresponding author), Univ Warwick, Ctr Mechanochem Cell Biol, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	D.Drummond@mechanochemistry.org	Cross, Robert A/F-1798-2011	Cross, Robert A/0000-0002-0004-7832; Drummond, Douglas/0000-0003-4155-3747	Marie Curie Cancer Care; Medical Research Council [G0200542]; MRC [G0200542] Funding Source: UKRI	Marie Curie Cancer Care; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Marie Curie Cancer Care (www.mariecurie.org.uk), Medical Research Council ( www.mrc.ac.uk, Grant G0200542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Carter NJ, 2006, CELL BIOL LAB HDB, P371; Catarinella M, 2009, ANGEW CHEM INT EDIT, V48, P9072, DOI 10.1002/anie.200904510; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041; Crevel IMTC, 1997, J MOL BIOL, V273, P160, DOI 10.1006/jmbi.1997.1319; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Drummond DR, 2011, METHODS MOL BIOL, V777, P29, DOI 10.1007/978-1-61779-252-6_3; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Drummond DR, 2011, SEM CELL DEV BIOL; Du YQ, 2010, CURR BIOL, V20, P374, DOI 10.1016/j.cub.2009.12.049; Foethke D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.76; Friel CT, 2011, EMBO J; Gandhi R, 2004, MOL BIOL CELL, V15, P121, DOI 10.1091/mbc.E03-05-0342; Garcia MA, 2002, EMBO J, V21, P6015, DOI 10.1093/emboj/cdf611; Garcia MA, 2002, CURR BIOL, V12, P610, DOI 10.1016/S0960-9822(02)00761-3; Gatt MK, 2005, J CELL SCI, V118, P2671, DOI 10.1242/jcs.02410; GELLES J, 1995, BIOPHYS J, V68, pS276; Gelles J, 1995, BIOPHYS J, V68, p282S; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Grissom PM, 2009, MOL BIOL CELL, V20, P963, DOI 10.1091/mbc.E08-09-0979; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020; HOHEISEL JD, 1993, CELL, V73, P109, DOI 10.1016/0092-8674(93)90164-L; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Huang Y, 2009, CELL CYCLE, V8, P2643, DOI 10.4161/cc.8.16.9366; HUNT AJ, 1993, P NATL ACAD SCI USA, V90, P11653, DOI 10.1073/pnas.90.24.11653; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Kamei T, 2005, BIOPHYS J, V88, P2068, DOI 10.1529/biophysj.104.049759; LOCKHART A, 1994, EMBO J, V13, P751, DOI 10.1002/j.1460-2075.1994.tb06317.x; Mayr MI, 2007, CURR BIOL, V17, P488, DOI 10.1016/j.cub.2007.02.036; Meadows JC, 2011, DEV CELL, V20, P739, DOI 10.1016/j.devcel.2011.05.008; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mizukami T, 1993, Tanpakushitsu Kakusan Koso, V38, P677; Newton CN, 2002, J BIOL CHEM, V277, P42456, DOI 10.1074/jbc.M207134200; Pereira AJ, 1997, J CELL BIOL, V136, P1081, DOI 10.1083/jcb.136.5.1081; Peters C, 2010, EMBO J, V29, P3437, DOI 10.1038/emboj.2010.220; Sagolla MJ, 2003, J CELL SCI, V116, P4891, DOI 10.1242/jcs.00796; Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761; Savoian MS, 2010, J CELL SCI, V123, P767, DOI 10.1242/jcs.055905; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Stout JR, 2011, MOL BIOL CELL, V22, P3070, DOI 10.1091/mbc.E11-04-0363; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Stumpff J, 2011, MOL CELL, V43, P764, DOI 10.1016/j.molcel.2011.07.022; Su XL, 2011, MOL CELL, V43, P751, DOI 10.1016/j.molcel.2011.06.027; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; Tanenbaum ME, 2011, CURR BIOL, V21, P1356, DOI 10.1016/j.cub.2011.07.017; Tanenbaum ME, 2009, CURR BIOL, V19, P1703, DOI 10.1016/j.cub.2009.08.027; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Tran PT, 1999, BIOL BULL, V197, P262, DOI 10.2307/1542640; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Unsworth A, 2008, MOL BIOL CELL, V19, P5104, DOI 10.1091/mbc.E08-02-0224; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang HF, 2010, CYTOSKELETON, V67, P715, DOI 10.1002/cm.20482; Warburg O., 1942, BIOCHEM Z, V310, P384; Wargacki MM, 2010, CELL CYCLE, V9, P2581, DOI 10.4161/cc.9.13.12076; Waterman-Storer C, 1998, CURRENT PROTOCOLS CE; Weaver LN, 2011, CURRENT BIOL CB; West RR, 2008, CELL MOTIL CYTOSKEL, V65, P626, DOI 10.1002/cm.20289; West RR, 2002, J CELL SCI, V115, P931; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	78	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30738	10.1371/journal.pone.0030738	http://dx.doi.org/10.1371/journal.pone.0030738			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363481	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500015
J	Blaise, S; Kneib, M; Rousseau, A; Gambino, F; Chenard, MP; Messadeq, N; Muckenstrum, M; Alpy, F; Tomasetto, C; Humeau, Y; Rio, MC				Blaise, Sebastien; Kneib, Marie; Rousseau, Adrien; Gambino, Frederic; Chenard, Marie-Pierre; Messadeq, Nadia; Muckenstrum, Martine; Alpy, Fabien; Tomasetto, Catherine; Humeau, Yann; Rio, Marie-Christine			In Vivo Evidence That TRAF4 Is Required for Central Nervous System Myelin Homeostasis	PLOS ONE			English	Article							NECROSIS-FACTOR-RECEPTOR; CEREBELLAR PURKINJE-CELLS; TRAF4-DEFICIENT MICE; MOTOR COORDINATION; DEFICIENCY LEADS; MUTANT MICE; FAMILY; MOUSE; PROTEIN; INHIBITION	Tumor Necrosis Factor Receptor-Associated Factors (TRAFs) are major signal transducers for the TNF and interleukin-1/Toll-like receptor superfamilies. However, TRAF4 does not fit the paradigm of TRAF function in immune and inflammatory responses. Its physiological and molecular functions remain poorly understood. Behavorial analyses show that TRAF4-deficient mice (TRAF4-KO) exhibit altered locomotion coordination typical of ataxia. TRAF4-KO central nervous system (CNS) ultrastructure shows strong myelin perturbation including disorganized layers and disturbances in paranode organization. TRAF4 was previously reported to be expressed by CNS neurons. Using primary cell culture, we now show that TRAF4 is also expressed by oligodendrocytes, at all stages of their differentiation. Moreover, histology and electron microscopy show degeneration of a high number of Purkinje cells in TRAF4-KO mice, that was confirmed by increased expression of the Bax pro-apoptotic marker (immunofluorescence), TUNEL analysis, and caspase-3 activation and PARP1 cleavage (western blotting). Consistent with this phenotype, MAG and NogoA, two myelin-induced neurite outgrowth inhibitors, and their neuron partners, NgR and p75NTR were overexpressed (Q-RT-PCR and western blotting). The strong increased phosphorylation of Rock2, a RhoA downstream target, indicated that the NgR/p75NTR/RhoA signaling pathway, known to induce actin cytoskeleton rearrangement that favors axon regeneration inhibition and neuron apoptosis, is activated in the absence of TRAF4 (western blotting). Altogether, these results provide conclusive evidence for the pivotal contribution of TRAF4 to myelination and to cerebellar homeostasis, and link the loss of TRAF4 function to demyelinating or neurodegenerative diseases.	[Blaise, Sebastien; Rousseau, Adrien; Messadeq, Nadia; Alpy, Fabien; Tomasetto, Catherine; Rio, Marie-Christine] Univ Strasbourg, Ctr Natl Rech Sci,Inst Natl Sante & Rech Med, Funct Genom & Canc Dept,UMR7104, Inst Genet & Biol Mol & Cellulaire,U964, Illkirch Graffenstaden, France; [Kneib, Marie; Gambino, Frederic; Humeau, Yann] Ctr Natl Rech Sci, UPR3212, Strasbourg, France; [Chenard, Marie-Pierre; Muckenstrum, Martine] Ctr Hosp Univ Hautepierre, Dept Pathol, Strasbourg, France; Univ Reims, Reims, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Strasbourg; Universite de Reims Champagne-Ardenne	Blaise, S (corresponding author), Univ Reims, Ctr Natl Rech Sci, UMR6237, Reims, France.	rio@igbmc.fr	BLAISE, Sebastien/AAS-1022-2020; Alpy, Fabien/H-8941-2016; Alpy, Fabien/ABD-5893-2020; Chenard, Marie-Pierre/O-2373-2016; Tomasetto, Catherine Laure/J-2783-2014	BLAISE, Sebastien/0000-0003-3012-1500; Alpy, Fabien/0000-0002-0526-0720; Alpy, Fabien/0000-0002-0526-0720; Tomasetto, Catherine Laure/0000-0002-1811-5848; gambino, frederic/0000-0002-2981-5030; Rousseau, Adrien/0000-0001-8130-5380	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; l'Agence Nationale pour la Recherche; Hopital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer; Ligue Nationale Francaise contre le Cancer; Comites du Haut-Rhin et du Bas-Rhin; Institut National du Cancer; Fond National pour la Sante [ACI 2007]	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); l'Agence Nationale pour la Recherche(French National Research Agency (ANR)); Hopital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Francaise contre le Cancer(Ligue nationale contre le cancer); Comites du Haut-Rhin et du Bas-Rhin; Institut National du Cancer(Institut National du Cancer (INCA) France); Fond National pour la Sante	This work was supported by funds from the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, l'Agence Nationale pour la Recherche, the Hopital Universitaire de Strasbourg, the Association pour la Recherche sur le Cancer, the Ligue Nationale Francaise contre le Cancer (Equipe labellisee LIGUE 2010) and the Comites du Haut-Rhin et du Bas-Rhin, the Institut National du Cancer, Fond National pour la Sante ACI 2007 Canceropole Grand-Est. SB was recipient of an Institut National du Cancer fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy EM, 2006, BRAIN CELL BIOL, V35, P137, DOI 10.1007/s11068-007-9014-3; Ariel M, 2009, CEREBELLUM, V8, P463, DOI 10.1007/s12311-009-0123-7; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Buchet D, 2009, NEUROSCI LETT, V456, P112, DOI 10.1016/j.neulet.2008.09.086; Budel S, 2008, J NEUROSCI, V28, P13161, DOI 10.1523/JNEUROSCI.3828-08.2008; Camilleri-Broet S, 2007, ONCOGENE, V26, P142, DOI 10.1038/sj.onc.1209762; Cherfils-Vicini J, 2008, IMMUNOLOGY, V124, P562, DOI 10.1111/j.1365-2567.2008.02810.x; Christianson JA, 2007, NEUROSCIENCE, V145, P303, DOI 10.1016/j.neuroscience.2006.11.064; Chung JY, 2002, J CELL SCI, V115, P679; Contet C, 2006, NEUROPSYCHOPHARMACOL, V31, P1733, DOI 10.1038/sj.npp.1300934; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Deiss V, 2000, NEUROSCIENCE, V95, P903; Dupuis L, 2008, P NATL ACAD SCI USA, V105, P740, DOI 10.1073/pnas.0703842105; Esparza EM, 2004, CELL MOL LIFE SCI, V61, P3087, DOI 10.1007/s00018-004-4417-0; Gambino F, 2009, EUR J NEUROSCI, V30, P1476, DOI 10.1111/j.1460-9568.2009.06975.x; Gao WC, 2006, J NEUROSCI, V26, P8377, DOI 10.1523/JNEUROSCI.2434-06.2006; Garwicz M, 2002, BRAIN RES REV, V40, P152, DOI 10.1016/S0165-0173(02)00198-4; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Grusser-Cornehls U, 2001, PROG NEUROBIOL, V63, P489, DOI 10.1016/S0301-0082(00)00024-1; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Heitz S, 2008, DEV NEUROBIOL, V68, P332, DOI 10.1002/dneu.20555; Hoeger H, 2000, LIFE SCI, V66, P947, DOI 10.1016/S0024-3205(99)00678-5; Huber AB, 2002, J NEUROSCI, V22, P3553; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Kalkan T, 2009, MOL BIOL CELL, V20, P3436, DOI 10.1091/mbc.E08-03-0325; Kedinger V, 2005, GENE EXPR PATTERNS, V5, P545, DOI 10.1016/j.modgep.2004.10.011; Kedinger V, 2007, ADV EXP MED BIOL, V597, P60; Kedinger V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003518; Lalonde R, 2007, BRAIN RES, V1140, P51, DOI 10.1016/j.brainres.2006.01.031; Lee M, 2001, J NEUROSCI, V21, P3849, DOI 10.1523/JNEUROSCI.21-11-03849.2001; Lee PR, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.004.2009; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; Liu HZ, 1999, CURR BIOL, V9, P101, DOI 10.1016/S0960-9822(99)80023-2; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Masson R, 1998, MECH DEVELOP, V71, P187, DOI 10.1016/S0925-4773(97)00192-5; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Motrescu ER, 2008, ONCOGENE, V27, P6347, DOI 10.1038/onc.2008.218; NORMAN DJ, 1995, DEVELOPMENT, V121, P1183; Pietrobon D, 2010, J PHYSIOL-LONDON, V588, P1871, DOI 10.1113/jphysiol.2010.188003; Preiss A, 2001, MECH DEVELOP, V100, P109, DOI 10.1016/S0925-4773(00)00506-2; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; Regnier CH, 2002, P NATL ACAD SCI USA, V99, P5585, DOI 10.1073/pnas.052124799; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Rousseau Adrien, 2011, Cancers (Basel), V3, P2734, DOI 10.3390/cancers3022734; Shiels H, 2000, AM J PATHOL, V157, P679, DOI 10.1016/S0002-9440(10)64578-6; Simons M, 2006, J CELL SCI, V119, P4381, DOI 10.1242/jcs.03242; Spencer T, 2003, CURR OPIN NEUROBIOL, V13, P133, DOI 10.1016/S0959-4388(03)00012-6; Takeshita F, 2005, EUR J IMMUNOL, V35, P2477, DOI 10.1002/eji.200526151; Teigler A, 2009, HUM MOL GENET, V18, P1897, DOI 10.1093/hmg/ddp110; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Thaxton C, 2009, RESULTS PROBL CELL D, V48, P1, DOI 10.1007/400_2009_3; Timmann D, 2008, CEREBELLUM, V7, P602, DOI 10.1007/s12311-008-0066-4; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Wajant H, 1998, J MOL EVOL, V47, P656, DOI 10.1007/PL00006423; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Xie F, 2008, EXP NEUROL, V209, P302, DOI 10.1016/j.expneurol.2007.07.005; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202	67	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30917	10.1371/journal.pone.0030917	http://dx.doi.org/10.1371/journal.pone.0030917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363515	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600089
J	Hosono, K; Ishigami, C; Takahashi, M; Park, DH; Hirami, Y; Nakanishi, H; Ueno, S; Yokoi, T; Hikoya, A; Fujita, T; Zhao, Y; Nishina, S; Shin, JP; Kim, IT; Yamamoto, S; Azuma, N; Terasaki, H; Sato, M; Kondo, M; Minoshima, S; Hotta, Y				Hosono, Katsuhiro; Ishigami, Chie; Takahashi, Masayo; Park, Dong Ho; Hirami, Yasuhiko; Nakanishi, Hiroshi; Ueno, Shinji; Yokoi, Tadashi; Hikoya, Akiko; Fujita, Taichi; Zhao, Yang; Nishina, Sachiko; Shin, Jae Pil; Kim, In Taek; Yamamoto, Shuichi; Azuma, Noriyuki; Terasaki, Hiroko; Sato, Miho; Kondo, Mineo; Minoshima, Shinsei; Hotta, Yoshihiro			Two Novel Mutations in the EYS Gene Are Possible Major Causes of Autosomal Recessive Retinitis Pigmentosa in the Japanese Population	PLOS ONE			English	Article							USH2A GENE; IDENTIFICATION; ORTHOLOG; FREQUENT	Retinitis pigmentosa (RP) is a highly heterogeneous genetic disease including autosomal recessive (ar), autosomal dominant (ad), and X-linked inheritance. Recently, arRP has been associated with mutations in EYS (Eyes shut homolog), which is a major causative gene for this disease. This study was conducted to determine the spectrum and frequency of EYS mutations in 100 Japanese arRP patients. To determine the prevalence of EYS mutations, all EYS exons were screened for mutations by polymerase chain reaction amplification, and sequence analysis was performed. We detected 67 sequence alterations in EYS, of which 21 were novel. Of these, 7 were very likely pathogenic mutations, 6 were possible pathogenic mutations, and 54 were predicted non-pathogenic sequence alterations. The minimum observed prevalence of distinct EYS mutations in our study was 18% (18/100, comprising 9 patients with 2 very likely pathogenic mutations and the remaining 9 with only one such mutation). Among these mutations, 2 novel truncating mutations, c.4957_4958insA (p.S1653KfsX2) and c.8868C>A (p.Y2956X), were identified in 16 patients and accounted for 57.1% (20/35 alleles) of the mutated alleles. Although these 2 truncating mutations were not detected in Japanese patients with adRP or Leber's congenital amaurosis, we detected them in Korean arRP patients. Similar to Japanese arRP results, the c.4957_4958insA mutation was more frequently detected than the c.8868C>.A mutation. The 18% estimated prevalence of very likely pathogenic mutations in our study suggests a major involvement of EYS in the pathogenesis of arRP in the Japanese population. Mutation spectrum of EYS in 100 Japanese patients, including 13 distinct very likely and possible pathogenic mutations, was largely different from the previously reported spectrum in patients from non-Asian populations. Screening for c. 4957_4958insA and c.8868C>A mutations in the EYS gene may therefore be very effective for the genetic testing and counseling of RP patients in Japan.	[Hosono, Katsuhiro; Hikoya, Akiko; Fujita, Taichi; Zhao, Yang; Sato, Miho; Hotta, Yoshihiro] Hamamatsu Univ Sch Med, Dept Ophthalmol, Hamamatsu, Shizuoka, Japan; [Ishigami, Chie; Takahashi, Masayo] RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan; [Park, Dong Ho; Shin, Jae Pil; Kim, In Taek] Kyungpook Natl Univ Hosp, Dept Ophthalmol, Taegu, South Korea; [Hirami, Yasuhiko] Inst Biomed Res & Innovat Hosp, Dept Ophthalmol, Kobe, Hyogo, Japan; [Nakanishi, Hiroshi] Hamamatsu Univ Sch Med, Dept Otolaryngol, Hamamatsu, Shizuoka, Japan; [Ueno, Shinji; Terasaki, Hiroko; Kondo, Mineo] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan; [Yokoi, Tadashi; Nishina, Sachiko; Azuma, Noriyuki] Natl Ctr Child Hlth & Dev, Dept Ophthalmol, Tokyo, Japan; [Yokoi, Tadashi; Nishina, Sachiko; Azuma, Noriyuki] Natl Ctr Child Hlth & Dev, Cell Biol Lab, Tokyo, Japan; [Zhao, Yang; Minoshima, Shinsei] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Dept Photomed Genom, Basic Med Photon Lab, Hamamatsu, Shizuoka, Japan; [Yamamoto, Shuichi] Chiba Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Chiba, Japan	Hamamatsu University School of Medicine; RIKEN; Kyungpook National University; Kyungpook National University Hospital; Institute for Biomedical Research & Innovation (IBRI); Hamamatsu University School of Medicine; Nagoya University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Hamamatsu University School of Medicine; Chiba University	Hosono, K (corresponding author), Hamamatsu Univ Sch Med, Dept Ophthalmol, Hamamatsu, Shizuoka, Japan.	hosono@hama-med.ac.jp	Ueno, Shinji/M-5063-2014; Terasaki, Hiroko/M-5054-2014; Hotta, Yoshihiro/O-5115-2019	Hotta, Yoshihiro/0000-0003-4052-5066; Minoshima, Satoshi/0000-0002-0043-3047	Ministry of Health, Labour and Welfare (Research on Measures for Intractable Diseases); Japan Society for the Promotion of Science [23592561, 23791975]; Grants-in-Aid for Scientific Research [22390327, 23592562, 23592603, 24659770] Funding Source: KAKEN	Ministry of Health, Labour and Welfare (Research on Measures for Intractable Diseases)(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research grants from the Ministry of Health, Labour and Welfare (Research on Measures for Intractable Diseases) and from the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research (C) 23592561 and Grant-in Aid for Young Scientists (B) 23791975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Abd El-Aziz MM, 2010, INVEST OPHTH VIS SCI, V51, P4266, DOI 10.1167/iovs.09-5109; Audo I, 2010, HUM MUTAT, V31, pE1406, DOI 10.1002/humu.21249; Bandah-Rozenfeld D, 2010, INVEST OPHTH VIS SCI, V51, P4387, DOI 10.1167/iovs.09-4732; Barragan I, 2010, HUM MUTAT, V31, pE1772, DOI 10.1002/humu.21334; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Dreyer B, 2001, AM J HUM GENET, V69, P228, DOI 10.1086/321269; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hayakawa M, 1997, JPN J OPHTHALMOL, V41, P1, DOI 10.1016/S0021-5155(96)00018-4; HOTTA Y, 1992, Nippon Ganka Gakkai Zasshi, V96, P237; Huang YK, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-121; Jin ZB, 2008, J MED GENET, V45, P465, DOI 10.1136/jmg.2007.056416; Khan MI, 2010, MOL VIS, V16, P2753; Littink KW, 2010, OPHTHALMOLOGY, V117, P2026, DOI 10.1016/j.ophtha.2010.01.040; Pieras JI, 2011, INVEST OPHTH VIS SCI, V52, P5625, DOI 10.1167/iovs.11-7292; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Seyedahmadia BJ, 2004, EXP EYE RES, V79, P167, DOI 10.1016/j.exer.2004.03.005	17	74	77	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31036	10.1371/journal.pone.0031036	http://dx.doi.org/10.1371/journal.pone.0031036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363543	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600103
J	Suzue, T; Hoshikawa, Y; Nishihara, S; Fujikawa, A; Miyatake, N; Sakano, N; Yoda, T; Yoshioka, A; Hirao, T				Suzue, Takeshi; Hoshikawa, Yoichi; Nishihara, Shuzo; Fujikawa, Ai; Miyatake, Nobuyuki; Sakano, Noriko; Yoda, Takeshi; Yoshioka, Akira; Hirao, Tomohiro			The New School Absentees Reporting System for Pandemic Influenza A/H1N1 2009 Infection in Japan	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE SYSTEM; NEW-YORK-CITY; DISEASE SURVEILLANCE	Objective: To evaluate the new Japanese School Absentees Reporting System for Infectious Disease (SARSID) for pandemic influenza A/H1N1 2009 infection in comparison with the National epidemiological Surveillance of Infectious Disease (NESID). Methods: We used data of 53,223 students (97.7%) in Takamatsu city Japan. Data regarding school absentees in SARSID was compared with that in NESID from Oct 13, 2009 to Jan 12, 2010. Results: Similar trends were observed both in SARSID and NESID. However, the epidemic trend for influenza in SARSID was thought to be more sensitive than that in NESID. Conclusion: The epidemic trend for influenza among school-aged children could be easily and rapidly assessed by SARSID compared to NESID. SARSID might be useful for detecting the epidemic trend of influenza.	[Suzue, Takeshi; Yoda, Takeshi; Yoshioka, Akira; Hirao, Tomohiro] Kagawa Univ, Fac Med, Dept Publ Hlth, Takamatsu, Kagawa 760, Japan; [Hoshikawa, Yoichi; Nishihara, Shuzo] Kagawa Prefectural Govt, Fac Med, Dept Hlth & Welf, Kagawa, Japan; [Fujikawa, Ai] Takamatsu City Publ Hlth Ctr, Kagawa, Japan; [Miyatake, Nobuyuki; Sakano, Noriko] Kagawa Univ, Fac Med, Dept Hyg, Takamatsu, Kagawa 760, Japan	Kagawa University; Kagawa University	Suzue, T (corresponding author), Kagawa Univ, Fac Med, Dept Publ Hlth, Takamatsu, Kagawa 760, Japan.	suzue@med.kagawa-u.ac.jp	Yoda, Takeshi/AAW-5384-2021	Yoda, Takeshi/0000-0001-6950-5056	Kagawa University	Kagawa University	This research was supported in part by a research grant from the Kagawa University fund of regional contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Besculides M, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-105; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Doroshenko Alexander, 2005, MMWR Suppl, V54, P117; Greenko J, 2003, J URBAN HEALTH, V80, pI50; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Kamigaki T, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1139; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; Lazarus R, 2002, EMERG INFECT DIS, V8, P753, DOI 10.3201/eid0808.020239; Ohkusa Yasushi, 2005, MMWR Suppl, V54, P47; Ohta A, 2007, J EPIDEMIOL, V17, pS14, DOI 10.2188/jea.17.S14; Schmidt WP, 2010, EURO SURVEILL, V15; Sugiura H, 2010, EPIDEMIOL INFECT, V13, P1; Taniguchi K, 2007, J EPIDEMIOL, V17, pS3, DOI 10.2188/jea.17.S3; World Health Organization, 2009, INFL LIK ILL US MEX; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18	15	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30639	10.1371/journal.pone.0030639	http://dx.doi.org/10.1371/journal.pone.0030639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363458	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600045
J	Duan, QL; Wang, XX; Gong, W; Ni, L; Chen, C; He, XX; Chen, FQ; Yang, L; Wang, PH; Wang, DW				Duan, Quanlu; Wang, Xingxu; Gong, Wei; Ni, Li; Chen, Chen; He, Xingxing; Chen, Fuqiong; Yang, Lei; Wang, Peihua; Wang, Dao Wen			ER Stress Negatively Modulates the Expression of the miR-199a/214 Cluster to Regulates Tumor Survival and Progression in Human Hepatocellular Cancer	PLOS ONE			English	Article							NF-KAPPA-B; UNFOLDED PROTEIN RESPONSE; MICRORNA EXPRESSION; OVARIAN-CANCER; SUPPRESSES TUMORIGENICITY; ANTICANCER STRATEGY; CELL-PROLIFERATION; CARCINOMA CELLS; RECEPTOR-ALPHA; TARGETING PTEN	Background: Recent studies have emphasized causative links between microRNAs (miRNAs) deregulation and tumor development. In hepatocellular carcinoma (HCC), more and more miRNAs were identified as diagnostic and prognostic cancer biomarkers, as well as additional therapeutic tools. This study aimed to investigate the functional significance and regulatory mechanism of the miR-199a2/214 cluster in HCC progression. Methods and Findings: In this study, we showed that miR-214, as well as miR-199a-3p and miR-199a-5p levels were significantly reduced in the majority of examined 23 HCC tissues and HepG2 and SMMC-7721 cell lines, compared with their nontumor counterparts. To further explore the role of miR-214 in hepatocarcinogenesis, we disclosed that the ER stress-induced pro-survival factor XBP-1 is a target of miR-214 by using western blot assay and luciferase reporter assay. Re-expression of miR-214 in HCC cell lines (HepG2 and SMMC-7721) inhibited proliferation and induced apoptosis. Furthermore, ectopic expression of miR-214 dramatically suppressed the ability of HCC cells to form colonies in vitro and to develop tumors in a subcutaneous xenotransplantation model of the BALB/c athymic nude mice. Moreover, reintroduction of XBP-1s attenuated miR-214-mediated suppression of HCC cells proliferation, colony and tumor formation. To further understand the mechanism of the miR-199a/214 cluster down-expression in HCC, we found that thapsigargin (TG) and tunicamycin (TM) or hypoxia-induced unfolded protein response (UPR) suppresses the expression of the miR-199a/214 cluster in HCC cells. By promoter analysis of the miR-199a2/214 gene, we conjectured NFkB as a potential negative regulator. We further found that UPR and LPS-induced NF kappa B activation suppressed miR-199a2/214 transcription, and this suppression was reversed by NF kappa B inhibition in HCC cells. Conclusions: Our study suggest that modulation of miR-214 levels may provide a new therapeutic approach for cancer treatment and revealed that UPR may offer a new explanation for why the miR-199a/214 cluster were down-regulated in the progression in HCC.	[Duan, Quanlu; Wang, Xingxu; Gong, Wei; Ni, Li; Chen, Chen; Chen, Fuqiong; Yang, Lei; Wang, Peihua; Wang, Dao Wen] Huazhong Univ Sci & Technol, Dept Internal Med, Wuhan 430074, Peoples R China; [Duan, Quanlu; Wang, Xingxu; Gong, Wei; Ni, Li; Chen, Chen; Chen, Fuqiong; Yang, Lei; Wang, Peihua; Wang, Dao Wen] Huazhong Univ Sci & Technol, Gene Therapy Ctr, Wuhan 430074, Peoples R China; [He, Xingxing] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Liver Dis, Tongji Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Duan, QL (corresponding author), Huazhong Univ Sci & Technol, Dept Internal Med, Wuhan 430074, Peoples R China.	cyc.chenchen@gmail.com; dwwang@tjh.tjmu.edu.cn	, Chen/R-4321-2019; Wang, Xingxu/AAF-4769-2020	Wang, Dao Wen/0000-0002-9774-3980	National Natural Science Foundation of China [30930039, 81000097, 30770882]; National Basic Research Program of China (973 Program) [2007CB512004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by grants from the National Natural Science Foundation of China (No. 30930039, 81000097 and 30770882), and National Basic Research Program of China (973 Program No. 2007CB512004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Culver C, 2010, MOL CELL BIOL, V30, P4901, DOI 10.1128/MCB.00409-10; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Ding H, 2010, CIRC RES, V106, P1145, DOI 10.1161/CIRCRESAHA.109.215616; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Git A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2109; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gramantieri L, 2009, CLIN CANCER RES, V15, P5073, DOI 10.1158/1078-0432.CCR-09-0092; Guo J, 2004, CLIN CANCER RES, V10, P3333, DOI 10.1158/1078-0432.CCR-03-0366; Harmey JH, 2002, INT J CANCER, V101, P415, DOI 10.1002/ijc.10632; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Jindra PT, 2010, J IMMUNOL, V185, P990, DOI 10.4049/jimmunol.1000793; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Liu LP, 2010, CANCER INVEST, V28, P443, DOI 10.3109/07357900903405959; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029; Liu XD, 2010, MOL BIOL REP, V37, P2235, DOI 10.1007/s11033-009-9710-4; Nana-Sinkam SP, 2011, TRANSL RES, V157, P216, DOI 10.1016/j.trsl.2011.01.013; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Qiang R, 2011, INT J BIOCHEM CELL B, V43, P632, DOI 10.1016/j.biocel.2011.01.002; Qiao L, 2006, HUM GENE THER, V17, P280, DOI 10.1089/hum.2006.17.280; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Shen QL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-227; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wu N., 2011, FEBS J; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yeung ML, 2011, PHARM RES-DORDR, V28, P3043, DOI 10.1007/s11095-011-0526-2; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Zhang S, 2011, ONCOGENE IN PRESS; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108	62	113	118	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31518	10.1371/journal.pone.0031518	http://dx.doi.org/10.1371/journal.pone.0031518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359598	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200067
J	Hirotsu, N; Wada, K; Oshitani, H				Hirotsu, Nobuo; Wada, Koji; Oshitani, Hitoshi			Risk Factors of Household Transmission of Pandemic (H1N1) 2009 among Patients Treated with Antivirals: A Prospective Study at a Primary Clinic in Japan	PLOS ONE			English	Article							INFLUENZA-A H1N1; SECONDARY ATTACK RATES; VIRUS-INFECTION; UNITED-STATES; OSELTAMIVIR; CONTACTS; THERAPY; ILLNESS	Background: Household transmission of influenza can affect the daily lives of patients and their families and be a trigger for community transmission, thus it is necessary to take precautions to prevent household transmission. We aimed to determine the risks of household transmission of pandemic (H1N1) 2009 influenza virus from an index patient who visited a primary clinic and was treated with antiviral drugs. Methods: We followed up all the patients who were diagnosed with influenza A by rapid diagnostic test with a questionnaire or interview from July 2009 to April 2010. Secondary cases were defined as patients visiting the clinic or other clinics and being positive for influenza A by rapid diagnostic test within 7 days of onset of an index patient. Logistic regression analysis was used to explore the association between household transmission and the studied variables. Results: We recruited 591 index patients and 1629 household contacts. The crude secondary attack rate was 7.3% [95% confidence interval (CI): 6.1-8.7]. Age of index patients (0-6 years old: odds ratio 2.56; 95% CI: 1.31-4.01; 7-12 years old: 2.44, 1.31-3.72; 30-39 years old 3.88; 2.09-5.21; 40 years old or more 2.76; 1.17-4.53) and number of household members with five or more (3.09, 2.11-4.07), medication started >= 48 hours from the onset of fever (2.38, 1.17-3.87) were significantly associated with household transmission. Conclusions: Household transmission was associated with index patients aged <= 12 years old and adults >= 30 years with children, with more than five persons in the household, and medication initiated >= 48 hours from the onset of fever among the population, in which, antiviral treatment was given to all patients. We need to warn patients at high risk of household transmission to take additional precautions.	[Hirotsu, Nobuo] Hirotsu Clin, Kawasaki, Kanagawa, Japan; [Wada, Koji] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 228, Japan; [Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan	Kitasato University; Tohoku University	Hirotsu, N (corresponding author), Hirotsu Clin, Kawasaki, Kanagawa, Japan.	kwada-sgy@umin.ac.jp	Oshitani, Hitoshi/AAE-4349-2019		Ministry of Health; Labour and Welfare	Ministry of Health; Labour and Welfare	This study was funded by a research project for emerging and re-emerging infectious diseases, Ministry of Health, This work was supported by Labour and Welfare (H23-Emerging infectious diseases-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carcione D, 2011, EUROSURVEILLANCE, V16, P32; Carrat F, 2002, ARCH INTERN MED, V162, P1842, DOI 10.1001/archinte.162.16.1842; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Goldstein E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-211; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; Hama R, 2007, BMJ-BRIT MED J, V335, P59, DOI 10.1136/bmj.39262.448877.BE; Hayward A, 2010, CLIN INFECT DIS, V50, P715, DOI 10.1086/650459; Hirotsu N, 2007, INTRAFAMILIAL TRANSM, P54; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Jefferson T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub4; Kamigaki T, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1139; Komiya N, 2010, J INFECTION, V61, P284, DOI 10.1016/j.jinf.2010.06.019; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Looker C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013702; Loustalot F, 2011, CLIN INFECT DIS, V52, pS146, DOI 10.1093/cid/ciq057; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; National Institute of Infectious Diseaes Japan, 2009, REP SURV ANT INFL CA; National Institute of Infectious Diseaes Japan, 2009, CURR SIT PAND INFL H, VNational Institute of Infectious Diseaes, Japan; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; Nishiura H, 2011, J INT MED RES, V39, P619, DOI 10.1177/147323001103900231; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Pebody RG, 2011, EMERG INFECT DIS, V17, P990, DOI [10.3201/eid1706.101161, 10.3201/eid/1706.101161]; Savage R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-234; Simmerman JM, 2010, CLIN INFECT DIS, V51, P1053, DOI 10.1086/656581; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; Wada K, 2010, INFLUENZA OTHER RESP, V4, P179, DOI 10.1111/j.1750-2659.2010.00143.x; Yang Y, 2010, PLOS ONE, V5; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	36	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31519	10.1371/journal.pone.0031519	http://dx.doi.org/10.1371/journal.pone.0031519			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359599	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200068
J	Ziebarth, JD; Cook, MN; Wang, XS; Williams, RW; Lu, L; Cui, Y				Ziebarth, Jesse D.; Cook, Melloni N.; Wang, Xusheng; Williams, Robert W.; Lu, Lu; Cui, Yan			Treatment- and Population-Dependent Activity Patterns of Behavioral and Expression QTLs	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INBRED MOUSE STRAINS; ETHANOL SENSITIVITY; GENE-EXPRESSION; ALCOHOL DEPENDENCE; SYSTEMS GENETICS; MESSENGER-RNA; BRAIN; STRESS; NETWORKS	Genetic control of gene expression and higher-order phenotypes is almost invariably dependent on environment and experimental conditions. We use two families of recombinant inbred strains of mice (LXS and BXD) to study treatment-and genotype-dependent control of hippocampal gene expression and behavioral phenotypes. We analyzed responses to all combinations of two experimental perturbations, ethanol and restraint stress, in both families, allowing for comparisons across 8 combinations of treatment and population. We introduce the concept of QTL activity patterns to characterize how associations between genomic loci and traits vary across treatments. We identified several significant behavioral QTLs and many expression QTLs (eQTLs). The behavioral QTLs are highly dependent on treatment and population. We classified eQTLs into three groups: cis-eQTLs (expression variation that maps to within 5 Mb of the cognate gene), syntenic trans-eQTLs (the gene and the QTL are on the same chromosome but not within 5 Mb), and non-syntenic trans-eQTLs (the gene and the QTL are on different chromosomes). We found that most non-syntenic trans-eQTLs were treatment-specific whereas both classes of syntenic eQTLs were more conserved across treatments. We also found there was a correlation between regions along the genome enriched for eQTLs and SNPs that were conserved across the LXS and BXD families. Genes with eQTLs that co-localized with the behavioral QTLs and displayed similar QTL activity patterns were identified as potential candidate genes associated with the phenotypes, yielding identification of novel genes as well as genes that have been previously associated with responses to ethanol.	[Ziebarth, Jesse D.; Williams, Robert W.; Cui, Yan] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN USA; [Ziebarth, Jesse D.; Cui, Yan] Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, Memphis, TN USA; [Cook, Melloni N.] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA; [Wang, Xusheng; Williams, Robert W.; Lu, Lu] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, Memphis, TN USA; [Lu, Lu] Nantong Univ, Jiangsu Key Lab Neuroregenert, Nantong, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Tennessee System; University of Tennessee Health Science Center; Nantong University	Ziebarth, JD (corresponding author), Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN USA.	lulu@uthsc.edu; ycui2@uthsc.edu	lu, lu/HGA-0894-2022; lu, lu/HII-7530-2022; Williams, Robert W./H-8789-2016	Williams, Robert W./0000-0001-8924-4447; Cui, Yan/0000-0002-7577-6845	University of Tennessee Center for Integrative and Translational Genomics; NIH [U01 AA014425, AA013499, AA017590]; Department of Defense [W81XHW-05-01-0227]; National Natural Science Foundation of China [30771200, 30971591]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662, U01AA017590, U01AA013499, U01AA014425] Funding Source: NIH RePORTER	University of Tennessee Center for Integrative and Translational Genomics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by The University of Tennessee Center for Integrative and Translational Genomics; NIH Grants U01 AA014425, AA013499, AA017590; a Department of Defense grant W81XHW-05-01-0227; and National Natural Science Foundation of China Grants 30771200 and 30971591. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Bardag-Gorce F, 2009, ALCOHOL CLIN EXP RES, V33, P684, DOI 10.1111/j.1530-0277.2008.00885.x; Bennett B, 2008, GENES BRAIN BEHAV, V7, P659, DOI 10.1111/j.1601-183X.2008.00403.x; Bennett B, 2002, ALCOHOL CLIN EXP RES, V26, P149, DOI 10.1111/j.1530-0277.2002.tb02519.x; Bennett B, 2006, J PHARMACOL EXP THER, V319, P299, DOI 10.1124/jpet.106.103572; Blednov YA, 2005, BEHAV BRAIN RES, V165, P110, DOI 10.1016/j.bbr.2005.06.026; Bousios S, 2001, J STEROID BIOCHEM, V78, P401, DOI 10.1016/S0960-0760(01)00123-6; Brady KT, 1999, ALCOHOL RES HEALTH, V23, P263; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Briand LA, 2010, BRAIN RES, V1314, P219, DOI 10.1016/j.brainres.2009.11.002; Browman KE, 2000, ALCOHOL CLIN EXP RES, V24, P17, DOI 10.1111/j.1530-0277.2000.tb04547.x; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Damodaran S, 2006, EUR J PHARMACOL, V547, P75, DOI 10.1016/j.ejphar.2006.08.005; Darbandi-Tonkabon R, 2004, J PHARMACOL EXP THER, V308, P502, DOI 10.1124/jpet.103.058123; DEVOR EJ, 1989, ANNU REV GENET, V23, P19, DOI 10.1146/annurev.ge.23.120189.000315; Downing C, 2006, ALCOHOL CLIN EXP RES, V30, P1111, DOI 10.1111/j.1530-0277.2006.00137.x; Edenberg HJ, 2006, HUM MOL GENET, V15, P1539, DOI 10.1093/hmg/ddl073; Ehlers CL, 2010, ADDICT BIOL, V15, P185, DOI 10.1111/j.1369-1600.2009.00195.x; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Grubb SC, 2009, NUCLEIC ACIDS RES, V37, pD720, DOI 10.1093/nar/gkn778; Guo AY, 2009, NUCLEIC ACIDS RES, V37, pD840, DOI 10.1093/nar/gkn816; Hitzemann R, 2004, ALCOHOL CLIN EXP RES, V28; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Jacobson LH, 2007, BEHAV GENET, V37, P171, DOI 10.1007/s10519-006-9106-3; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kirby A, 2010, GENETICS, V185, P1081, DOI 10.1534/genetics.110.115014; Li Y, 2008, TRENDS GENET, V24, P518, DOI 10.1016/j.tig.2008.08.001; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu H, 2011, NUTR NEUROSCI, V14, P80, DOI 10.1179/1476830511Y.0000000004; Malmanger B, 2006, MAMM GENOME, V17, P1193, DOI 10.1007/s00335-006-0070-2; MCCLEARN G. E., 1970, Contributions to behavior-genetic analysis., P3; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Petrie J, 2001, ALCOHOL CLIN EXP RES, V25, P819, DOI 10.1097/00000374-200106000-00005; Prescott CA, 2006, MOL PSYCHIATR, V11, P603, DOI 10.1038/sj.mp.4001811; Quigley D, 2009, NAT REV GENET, V10, P651, DOI 10.1038/nrg2617; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Ryabinin AE, 1998, PSYCHOPHARMACOLOGY, V139, P34, DOI 10.1007/s002130050687; Ryabinin AE, 1997, MOL PSYCHIATR, V2, P32, DOI 10.1038/sj.mp.4000206; Sayette MA, 1999, ALCOHOL RES HEALTH, V23, P250; Schmidt MV, 2007, BRAIN RES, V1174, P1, DOI 10.1016/j.brainres.2007.08.023; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Song M, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/545176; Strutz-Seebohm N, 2005, J PHYSIOL-LONDON, V565, P381, DOI 10.1113/jphysiol.2004.079582; Thome J, 2001, BIOL PSYCHIAT, V50, P809, DOI 10.1016/S0006-3223(01)01229-X; Treadwell JA, 2004, NEUROCHEM RES, V29, P357, DOI 10.1023/B:NERE.0000013738.06437.a6; Ueyama T, 1997, NEUROSCI RES, V28, P103, DOI 10.1016/S0168-0102(97)00030-8; van Nas A, 2010, GENETICS, V185, P1059, DOI 10.1534/genetics.110.116087; Wang XS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-O7; Williams RW, 2004, MAMM GENOME, V15, P637, DOI 10.1007/s00335-004-2380-6; Winkler A, 1999, MOL BRAIN RES, V72, P166, DOI 10.1016/S0169-328X(99)00218-1; Yau JLW, 2001, NEUROSCI LETT, V309, P141, DOI 10.1016/S0304-3940(01)02054-7; Yore MA, 2010, NEUROSCIENCE, V169, P1017, DOI 10.1016/j.neuroscience.2010.05.053; Yun SJ, 2002, NEUROSCI LETT, V318, P85, DOI 10.1016/S0304-3940(01)02492-2; Zhou Y, 2010, BRAIN RES, V1314, P235, DOI 10.1016/j.brainres.2009.11.015; Ziebarth JD, 2010, BIOM SCI ENG C BSEC, V2010, P1; ZOELLER RT, 1994, MOL BRAIN RES, V24, P185; Zuo LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026726	63	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31805	10.1371/journal.pone.0031805	http://dx.doi.org/10.1371/journal.pone.0031805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359631	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200100
J	Gamper, AM; Choi, S; Matsumoto, Y; Banerjee, D; Tomkinson, AE; Bakkenist, CJ				Gamper, Armin M.; Choi, Serah; Matsumoto, Yoshihiro; Banerjee, Dibyendu; Tomkinson, Alan E.; Bakkenist, Christopher J.			ATM Protein Physically and Functionally Interacts with Proliferating Cell Nuclear Antigen to Regulate DNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATAXIA-TELANGIECTASIA; REPLICATION FORK; HUMAN PCNA; KINASE; REPAIR; POLYMERASE; DAMAGE; PHOSPHORYLATION; INHIBITION; ACTIVATION	Ataxia telangiectasia (A-T) is a pleiotropic disease, with a characteristic hypersensitivity to ionizing radiation that is caused by biallelic mutations in A-T mutated (ATM), a gene encoding a protein kinase critical for the induction of cellular responses to DNA damage, particularly to DNA double strand breaks. Along known characteristic of A-T cells is their ability to synthesize DNA even in the presence of ionizing radiation-induced DNA damage, a phenomenon termed radioresistant DNA synthesis. We previously reported that ATM kinase inhibition, but not ATM protein disruption, blocks sister chromatid exchange following DNA damage. We now show that ATM kinase inhibition, but not ATM protein disruption, also inhibits DNA synthesis. Investigating a potential physical interaction of ATM with the DNA replication machinery, we found that ATM co-precipitates with proliferating cell nuclear antigen (PCNA) from cellular extracts. Using bacterially purified ATM truncation mutants and in vitro translated PCNA, we showed that the interaction is direct and mediated by the C terminus of ATM. Indeed, a 20-amino acid region close to the kinase domain is sufficient for strong binding to PCNA. This binding is specific to ATM, because the homologous regions of other PIKK members, including the closely related kinase A-T and Rad3-related (ATR), did not bind PCNA. ATM was found to bind two regions in PCNA. To examine the functional significance of the interaction between ATM and PCNA, we tested the ability of ATM to stimulate DNA synthesis by DNA polymerase delta, which is implicated in both DNA replication and DNA repair processes. ATM was observed to stimulate DNA polymerase activity in a PCNA-dependent manner.	[Gamper, Armin M.; Choi, Serah; Bakkenist, Christopher J.] Univ Pittsburgh, Dept Radiat Oncol, Pittsburgh, PA 15213 USA; [Bakkenist, Christopher J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Matsumoto, Yoshihiro; Banerjee, Dibyendu; Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Matsumoto, Yoshihiro; Banerjee, Dibyendu; Tomkinson, Alan E.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of New Mexico; University of New Mexico	Bakkenist, CJ (corresponding author), Univ Pittsburgh, Sch Med, Hillman Canc Ctr, Dept Radiat Oncol, Res Pavilion,Suite 2-6,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	bakkenistcj@upmc.edu	Banerjee, Dibyendu/Y-4652-2019	Matsumoto, Yoshihiro/0000-0001-6580-7188; Banerjee, Dibyendu/0000-0003-4244-9714; Gamper, Armin/0000-0002-6003-0768	National Institutes of Health [CA148644, GM57479, P30CA047904]; Frieda G. and Saul F. Shapira Breast Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA148644, P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frieda G. and Saul F. Shapira Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA148644 (to C. J. B.), GM57479 (to A. E. T.), and P30CA047904. This work was also supported by the Frieda G. and Saul F. Shapira Breast Cancer Research Program.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Choi S, 2010, CELL CYCLE, V9, P4052, DOI 10.4161/cc.9.20.13471; COHEN MM, 1980, CYTOGENET CELL GENET, V28, P24, DOI 10.1159/000131508; CORNFORTH MN, 1985, SCIENCE, V227, P1589, DOI 10.1126/science.3975628; Fazlieva R, 2009, NUCLEIC ACIDS RES, V37, P2854, DOI 10.1093/nar/gkp155; Fox JT, 2011, FEBS LETT, V585, P2780, DOI 10.1016/j.febslet.2011.05.053; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; de Saro FJL, 2009, CURR GENOMICS, V10, P206, DOI 10.2174/138920209788185234; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; MURNANE JP, 1982, P NATL ACAD SCI-BIOL, V79, P1960, DOI 10.1073/pnas.79.6.1960; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; White JS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000758	35	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12445	12454		10.1074/jbc.M112.352310	http://dx.doi.org/10.1074/jbc.M112.352310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22362778	hybrid, Green Published			2022-12-25	WOS:000302782200084
J	Sawant, A; Chanda, D; Isayeva, T; Tsuladze, G; Garvey, WT; Ponnazhagan, S				Sawant, Anandi; Chanda, Diptiman; Isayeva, Tatyana; Tsuladze, George; Garvey, W. T.; Ponnazhagan, Selvarangan			Noggin Is Novel Inducer of Mesenchymal Stem Cell Adipogenesis IMPLICATIONS FOR BONE HEALTH AND OBESITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE DIFFERENTIATION; MORPHOGENETIC PROTEINS; SIGNALING PATHWAY; RETINOIC ACID; CYCLIC-AMP; TGF-BETA; MARROW; GROWTH; EXPRESSION; RECEPTOR	Noggin is a glycosylated-secreted protein known so far for its inhibitory effects on bone morphogenetic protein (BMP) signaling by sequestering the BMP ligand. We report here for the first time a novel mechanism by which noggin directly induces adipogenesis of mesenchymal stem cells independently of major human adipogenic signals through C/EBP delta, C/EBP alpha and peroxisome proliferator-activated receptor-gamma. Evaluation of a possible mechanism for noggin-induced adipogenesis of mesenchymal stem cells identified the role of Pax-1 in mediating such differentiation. The relevance of elevated noggin levels in obesity was confirmed in a preclinical, immunocompetent mouse model of spontaneous obesity and in human patients with higher body mass index. These data clearly provide a novel role for noggin in inducing adipogenesis and possibly obesity and further indicates the potential of noggin as a therapeutic target to control obesity.	[Ponnazhagan, Selvarangan] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Garvey, W. T.] Univ Alabama, Dept Nutr Sci, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ponnazhagan, S (corresponding author), Univ Alabama, Dept Pathol, 701 19th St S,LHRB 505, Birmingham, AL 35294 USA.	pons@uab.edu			National Institutes of Health [AR050251, AR060948, DK083562, DK038765]; University of Alabama at Birmingham Diabetes Research and Training Center [P60 DK079626]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060948, R01AR050251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038765, R01DK038765, R01DK083562, P60DK079626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Diabetes Research and Training Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050251, AR060948 (to S. P.), DK083562 (to W. T. G.), and DK038765 (to W. T. G.). This work was also supported by the University of Alabama at Birmingham Diabetes Research and Training Center Grant P60 DK079626 (to W. T. G.).	Barness LA, 2007, AM J MED GENET A, V143A, P3016, DOI 10.1002/ajmg.a.32035; Beraldo FH, 2005, J CELL BIOL, V170, P551, DOI 10.1083/jcb.200505117; Bredella MA, 2011, OBESITY, V19, P49, DOI 10.1038/oby.2010.106; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Choi KS, 2011, ARCH PHARM RES, V34, P599, DOI 10.1007/s12272-011-0410-y; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; DiPaola CP, 2005, J ORTHOP RES, V23, P1112, DOI 10.1016/j.orthres.2005.03.008; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Holecki M, 2010, POL ARCH MED WEWN, V120, P361, DOI 10.20452/pamw.969; Kajkenova O, 1997, J BONE MINER RES, V12, P1772, DOI 10.1359/jbmr.1997.12.11.1772; Kim JS, 2010, ARTHRITIS RHEUM-US, V62, P3706, DOI 10.1002/art.27733; Lee JS, 2011, BIOCHEM BIOPH RES CO, V409, P550, DOI 10.1016/j.bbrc.2011.05.042; Magni P, 2010, CURR MOL MED, V10, P522; Marchildon F, 2010, J BIOL CHEM, V285, P13274, DOI 10.1074/jbc.M109.054536; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; MonsoroBurq AH, 1996, DEVELOPMENT, V122, P3607; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Rodriguez JP, 2008, CURR STEM CELL RES T, V3, P208, DOI 10.2174/157488808785740325; Ryden M, 2003, BIOCHEM BIOPH RES CO, V311, P391, DOI 10.1016/j.bbrc.2003.10.010; Takada I, 2009, EXPERT OPIN THER TAR, V13, P593, DOI [10.1517/14728220902915310 , 10.1517/14728220902915310]; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; van Harmelen V, 2002, DIABETES, V51, P2029, DOI 10.2337/diabetes.51.7.2029; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; Wang LA, 2010, CELL PHYSIOL BIOCHEM, V26, P1093, DOI 10.1159/000323987; Warden CH, 2004, MAMM GENOME, V15, P460, DOI 10.1007/s00335-004-2353-9; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Yan Q, 2007, J BIOL CHEM, V282, P13954, DOI 10.1074/jbc.M611476200; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540; Yu WH, 2008, MOL CELL BIOCHEM, V310, P11, DOI 10.1007/s11010-007-9661-9	38	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12241	12249		10.1074/jbc.M111.293613	http://dx.doi.org/10.1074/jbc.M111.293613			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351751	Green Published, hybrid			2022-12-25	WOS:000302782200065
J	Shanmugam, A; Rajoria, S; George, AL; Mittelman, A; Suriano, R; Tiwari, RK				Shanmugam, Arulkumaran; Rajoria, Shilpi; George, Andrea L.; Mittelman, Abraham; Suriano, Robert; Tiwari, Raj K.			Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; CELL RESPONSES; ENDOTOXIN; INFLAMMATION; LIGANDS; SEPSIS	Background: Adjuvants serve as catalysts of the innate immune response by initiating a localized site of inflammation that is mitigated by the interactions between antigens and toll like receptor (TLR) proteins. Currently, the majority of vaccines are formulated with aluminum based adjuvants, which are associated with various side effects. In an effort to develop a new class of adjuvants, agonists of TLR proteins, such as bacterial products, would be natural candidates. Lipopolysaccharide (LPS), a major structural component of gram negative bacteria cell walls, induces the systemic inflammation observed in septic shock by interacting with TLR-4. The use of synthetic peptides of LPS or TLR-4 agonists, which mimic the interaction between TLR-4 and LPS, can potentially regulate cellular signal transduction pathways such that a localized inflammatory response is achieved similar to that generated by adjuvants. Methodology/Principal Findings: We report the identification and activity of several peptides isolated using phage display combinatorial peptide technology, which functionally mimicked LPS. The activity of the LPS-TLR-4 interaction was assessed by NF-kappa B nuclear translocation analyses in HEK-BLUE (TM)-4 cells, a cell culture model that expresses only TLR-4, and the murine macrophage cell line, RAW264.7. Furthermore, the LPS peptide mimics were capable of inducing inflammatory cytokine secretion from RAW264.7 cells. Lastly, ELISA analysis of serum from vaccinated BALB/c mice revealed that the LPS peptide mimics act as a functional adjuvant. Conclusions/Significance: Our data demonstrate the identification of synthetic peptides that mimic LPS by interacting with TLR-4. This LPS mimotope-TLR-4 interaction will allow for the development and use of these peptides as a new class of adjuvants, namely TLR-4 agonists.	[Shanmugam, Arulkumaran; Rajoria, Shilpi; George, Andrea L.; Mittelman, Abraham; Suriano, Robert; Tiwari, Raj K.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA	New York Medical College	Shanmugam, A (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	robert_suriano@nymc.edu; raj_tiwari@nymc.edu			Applied Vaccine Therapeutics, LLC; National Institute of Health [RO1CA131946]; NATIONAL CANCER INSTITUTE [R01CA131946] Funding Source: NIH RePORTER	Applied Vaccine Therapeutics, LLC; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by: Applied Vaccine Therapeutics, LLC and National Institute of Health grant RO1CA131946 (RKT).	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Beveridge TJ, 2001, BIOTECH HISTOCHEM, V76, P111, DOI 10.1080/714028139; Bochud PY, 2003, BMJ-BRIT MED J, V326, P262, DOI 10.1136/bmj.326.7383.262; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; Douagi I, 2009, J IMMUNOL, V182, P1991, DOI 10.4049/jimmunol.0802257; Ellett JD, 2010, J IMMUNOL, V184, P5849, DOI 10.4049/jimmunol.0902024; Hack CE, 1997, ADV IMMUNOL, V66, P101, DOI 10.1016/S0065-2776(08)60597-0; Harris J, 2010, EUR J IMMUNOL, V40, P634, DOI 10.1002/eji.200940172; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hou YC, 2003, J IMMUNOL, V170, P4373, DOI 10.4049/jimmunol.170.8.4373; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Leung JYK, 2008, CELL MOL LIFE SCI, V65, P2732, DOI 10.1007/s00018-008-8184-1; Means TK, 2000, LIFE SCI, V68, P241, DOI 10.1016/S0024-3205(00)00939-5; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; SASSE KC, 1995, CRIT CARE MED, V23, P1040, DOI 10.1097/00003246-199506000-00008; Schijns VEJC, 2000, CURR OPIN IMMUNOL, V12, P456, DOI 10.1016/S0952-7915(00)00120-5; SCHNEERSON R, 1991, J IMMUNOL, V147, P2136; Shanmugam A, 2011, CELL STRESS CHAPERON, V16, P225, DOI 10.1007/s12192-010-0234-6; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Stoll LL, 2006, CURR PHARM DESIGN, V12, P4229, DOI 10.2174/138161206778743501; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wilson-Welder JH, 2009, J PHARM SCI-US, V98, P1278, DOI 10.1002/jps.21523	32	82	87	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30839	10.1371/journal.pone.0030839	http://dx.doi.org/10.1371/journal.pone.0030839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363498	Green Submitted, gold, Green Published			2022-12-25	WOS:000302871500019
J	Watt, RG; Tsakos, G; de Oliveira, C; Hamer, M				Watt, Richard G.; Tsakos, Georgios; de Oliveira, Cesar; Hamer, Mark			Tooth Loss and Cardiovascular Disease Mortality Risk - Results from the Scottish Health Survey	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PERIODONTAL-DISEASE; MYOCARDIAL-INFARCTION; ORAL INFECTIONS; OLDER-PEOPLE; COHORT; STROKE; TEETH; EPIDEMIOLOGY; ASSOCIATIONS	Background: Tooth loss is associated with increased cardiovascular disease (CVD) mortality risk. This association may however be due to residual confounding. We aimed to assess whether tooth loss is associated with specific CVD mortality endpoints in a national population sample adjusting for potential confounders. Methods and Results: We used a prospective cohort design and data from the Scottish Health Survey. We combined data from surveys in 1995, 1998, 2003 and linked this to mortality records. Dental status was classified through self-reports as natural teeth only, natural teeth and dentures, and no natural teeth (edentate). Cox proportional hazards models were used to estimate risk of CVD mortality by dental status adjusting for potential confounders. The sample consisted of 12871 participants. They were followed for 8.0 (SD: 3.3) years. During 103173 person-years, there were 1480 cases of all-cause mortality, 498 of CVD, and 515 of cancer. After adjusting for demographic, socio-economic, behavioural and health status, edentate subjects had significantly higher risk of all-cause (HR, 1.30; 95% CI, 1.12,1.50) and CVD mortality (HR, 1.49; 95% CI, 1.16,1.92) compared to subjects with natural teeth only. Dental status was not significantly associated with cancer mortality in fully adjusted analysis. Further analysis for CVD mortality showed that in the fully adjusted model, edentate subjects had 2.97 (95% CI, 1.46, 6.05) times higher risk for stroke-related mortality. Conclusions: In a national population sample of Scottish adults, being edentate was an independent predictor of total CVD mortality, although this was mainly driven by fatal stroke events.	[Watt, Richard G.; Tsakos, Georgios; de Oliveira, Cesar; Hamer, Mark] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London	Watt, RG (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	r.watt@ucl.ac.uk	de Oliveira, Cesar/B-5251-2019; Hamer, Mark/AAJ-6814-2021; Hamer, Mark/C-1602-2008	Hamer, Mark/0000-0002-8726-7992; Hamer, Mark/0000-0002-8726-7992; Tsakos, Georgios/0000-0002-5086-235X; Watt, Richard/0000-0001-6229-8584; De Oliveira, Cesar/0000-0002-4099-4762				Abnet CC, 2005, INT J EPIDEMIOL, V34, P467, DOI 10.1093/ije/dyh375; [Anonymous], 2009, ANN REPORT CHIEF MED; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251.49515.c214656957, DOI 10.1161/01.HYP.0000107251.49515.C214656957]; Choe H, 2009, ATHEROSCLEROSIS, V203, P550, DOI 10.1016/j.atherosclerosis.2008.07.017; de Oliveira C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2451; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Desvarieux M, 2003, STROKE, V34, P2120, DOI 10.1161/01.STR.0000085086.50957.22; Fukai K, 2007, GERIATR GERONTOL INT, V7, P341, DOI 10.1111/j.1447-0594.2007.00422.x; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Heitmann BL, 2008, PREV MED, V47, P156, DOI 10.1016/j.ypmed.2008.04.007; Holmlund A, 2010, J PERIODONTOL, V81, P870, DOI 10.1902/jop.2010.090680; Hujoel PP, 2002, PERIODONTOL 2000, V30, P51, DOI 10.1034/j.1600-0757.2002.03005.x; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Joshipura K J, 1998, Ann Periodontol, V3, P175, DOI 10.1902/annals.1998.3.1.175; KLOCK KS, 1991, COMMUNITY DENT ORAL, V19, P336, DOI 10.1111/j.1600-0528.1991.tb00183.x; KWEIDER M, 1993, SCOT MED J, V38, P73, DOI 10.1177/003693309303800304; Li Q, 2010, DIABETOLOGIA, V53, P2320, DOI 10.1007/s00125-010-1862-1; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; Mann JI, 2002, LANCET, V360, P783, DOI 10.1016/S0140-6736(02)09901-4; Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2; Nowjack-Raymer RE, 2003, J DENT RES, V82, P123, DOI 10.1177/154405910308200209; OSLER W, 1908, MODERN MED ITS THEOR; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38; Sheiham A, 2001, PUBLIC HEALTH NUTR, V4, P797, DOI 10.1079/PHN2000116; Simons Leon A, 2009, Heart Lung Circ, V18, P330, DOI 10.1016/j.hlc.2009.05.001; Slots J, 2001, INT DENT J, V51, P417, DOI 10.1002/j.1875-595X.2001.tb00854.x; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Spahr A, 2006, ARCH INTERN MED, V166, P554, DOI 10.1001/archinte.166.5.554; Steele JG, 2000, BRIT DENT J, V189, P598, DOI 10.1038/sj.bdj.4800840a; Tu YK, 2007, HEART, V93, P1098, DOI 10.1136/hrt.2006.097410; Valtonen VV, 1999, AM HEART J, V138, pS431, DOI 10.1016/S0002-8703(99)70269-3; Wilhelmsen L, 2005, EUR HEART J, V26, P1916, DOI 10.1093/eurheartj/ehi412; Wu TJ, 2000, ARCH INTERN MED, V160, P2749, DOI 10.1001/archinte.160.18.2749	35	67	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30797	10.1371/journal.pone.0030797	http://dx.doi.org/10.1371/journal.pone.0030797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363491	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500018
J	Abad-Grau, MM; Medina-Medina, N; Montes-Soldado, R; Matesanz, F; Bafna, V				Abad-Grau, Mara M.; Medina-Medina, Nuria; Montes-Soldado, Rosana; Matesanz, Fuencisla; Bafna, Vineet			Sample Reproducibility of Genetic Association Using Different Multimarker TDTs in Genome-Wide Association Studies: Characterization and a New Approach	PLOS ONE			English	Article							TRANSMISSION/DISEQUILIBRIUM TEST; MULTIPLE-SCLEROSIS; HAPLOTYPE SIMILARITY; TESTS; MODEL; RISK; MS	Multimarker Transmission/Disequilibrium Tests (TDTs) are very robust association tests to population admixture and structure which may be used to identify susceptibility loci in genome-wide association studies. Multimarker TDTs using several markers may increase power by capturing high-degree associations. However, there is also a risk of spurious associations and power reduction due to the increase in degrees of freedom. In this study we show that associations found by tests built on simple null hypotheses are highly reproducible in a second independent data set regardless the number of markers. As a test exhibiting this feature to its maximum, we introduce the multimarker 2-Groups TDT (mTDT(2G)), a test which under the hypothesis of no linkage, asymptotically follows a chi(2) distribution with 1 degree of freedom regardless the number of markers. The statistic requires the division of parental haplotypes into two groups: disease susceptibility and disease protective haplotype groups. We assessed the test behavior by performing an extensive simulation study as well as a real-data study using several data sets of two complex diseases. We show that mTDT(2G) test is highly efficient and it achieves the highest power among all the tests used, even when the null hypothesis is tested in a second independent data set. Therefore, mTDT(2G) turns out to be a very promising multimarker TDT to perform genome-wide searches for disease susceptibility loci that may be used as a preprocessing step in the construction of more accurate genetic models to predict individual susceptibility to complex diseases.	[Abad-Grau, Mara M.; Medina-Medina, Nuria; Montes-Soldado, Rosana] Univ Granada, ETS Ingn Informat & Telecomunicac CITIC, Dept Lenguajes & Sistemas Informat, Granada, Spain; [Matesanz, Fuencisla] CSIC, Inst Parasitologa & Biomed Lopez Neyra, Granada, Spain; [Bafna, Vineet] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); University of California System; University of California San Diego	Abad-Grau, MM (corresponding author), Univ Granada, ETS Ingn Informat & Telecomunicac CITIC, Dept Lenguajes & Sistemas Informat, Granada, Spain.	mabad@ugr.es	Soldado, Rosana Montes/AAT-7222-2021; Bafna, Vineet/AAY-8111-2020; Matesanz, Fuencisla/F-3715-2016; Medina, Nuria Medina/B-1743-2012; Montes, Rosana/C-2434-2012; Abad Grau, María del Mar/B-2172-2012	Soldado, Rosana Montes/0000-0002-0183-044X; Bafna, Vineet/0000-0002-5810-6241; Matesanz, Fuencisla/0000-0002-9429-1819; Medina, Nuria Medina/0000-0002-6013-732X; Montes, Rosana/0000-0002-0183-044X; Abad Grau, María del Mar/0000-0001-8470-9719	Spanish Research Program [TIN2007-67418-C03-03, PIA12009-07]; Health Research Fund FEDER [PI081636]; Andalusian Research Program [P08-TIC-03717]; European Regional Development Fund	Spanish Research Program(Spanish Government); Health Research Fund FEDER; Andalusian Research Program; European Regional Development Fund(European Commission)	The authors have been partially supported by the Spanish Research Program under projects TIN2007-67418-C03-03 and PIA12009-07, by the Health Research Fund FEDER (PI081636), by the Andalusian Research Program under project P08-TIC-03717, and by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Grau MM, 2010, HUM GENET, V128, P325, DOI 10.1007/s00439-010-0854-z; Abecasis GR, 2001, AM J HUM GENET, V69, P198; Alcina A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004137; Betensky RA, 2000, ANN HUM GENET, V64, P567, DOI 10.1046/j.1469-1809.2000.6460567.x; Bickeboller H, 1995, GENET EPIDEMIOL, V12, P865, DOI 10.1002/gepi.1370120656; Bourgain C, 2001, AM J HUM GENET, V68, P154, DOI 10.1086/316933; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Fan RZ, 2001, ADV APPL STAT, V1, P277; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gregory J, 2007, NAT GENET, V39, P1053; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Hellenthal G, 2007, BIOINFORMATICS, V23, P520, DOI 10.1093/bioinformatics/btl622; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jager PD, 2008, P NATL ACAD SCI USA, V106, P5264; Kaplan NL, 1997, AM J HUM GENET, V60, P691; Kristjansdottir G, 2008, J MED GENET, V45, P362, DOI 10.1136/jmg.2007.055012; Lam JC, 2000, AM J HUM GENET, V66, P659, DOI 10.1086/302756; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Marchini J, 2005, NAT GENET, V39, P906; Matesanz F, 2007, J NEUROL, V254, P682, DOI 10.1007/s00415-006-0416-4; Montes R, 2009, LECT NOTES COMPUT SC, V5518, P1097, DOI 10.1007/978-3-642-02481-8_166; Ott J., 1999, ANAL HUMAN GENETIC L; Ramagopalan SV, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-10; Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Seltman H, 2001, AM J HUM GENET, V68, P223; Sevon P, 2006, IEEE ACM T COMPUT BI, V3, P174, DOI 10.1109/TCBB.2006.28; Sham P, 1997, AM J HUM GENET, V61, P774; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Tang R, 2009, ANN HUM GENET, V73, P631, DOI 10.1111/j.1469-1809.2009.00543.x; Tzeng JY, 2003, AM J HUM GENET, V72, P891, DOI 10.1086/373881; Yu K, 2005, GENET EPIDEMIOL, V29, P323, DOI 10.1002/gepi.20102; Yu K, 2004, GENET EPIDEMIOL, V27, P182, DOI 10.1002/gepi.20022; Zhang SL, 2003, AM J HUM GENET, V73, P566, DOI 10.1086/378205; Zhao JY, 2007, HUM GENET, V121, P357, DOI 10.1007/s00439-007-0322-6; Zoledziewska M, 2007, GENES IMMUN, V10, P15	44	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e29613	10.1371/journal.pone.0029613	http://dx.doi.org/10.1371/journal.pone.0029613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363405	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600007
J	Fujii, T; Albarede, F				Fujii, Toshiyuki; Albarede, Francis			Ab Initio Calculation of the Zn Isotope Effect in Phosphates, Citrates, and Malates and Applications to Plants and Soil	PLOS ONE			English	Article							HYPERACCUMULATOR ARABIDOPSIS-HALLERI; ORTHOPHOSPHATE SOLUTIONS; ZINC; FRACTIONATION; PH; EQUILIBRIA; COMPLEXES; DENSITY; ROOT	Stable Zn isotopes are fractionated in roots and leaves of plants. Analyses demonstrate that the heavy Zn isotopes are enriched in the root system of plants with respect to shoots and leaves as well as the host soil, but the fractionation mechanisms remain unclear. Here we show that the origin of this isotope fractionation is due to a chemical isotope effect upon complexation by Zn malates and citrates in the aerial parts and by phosphates in the roots. We calculated the Zn isotope effect in aqueous citrates, malates, and phosphates by ab initio methods. For pH <5, the Zn isotopic compositions of the various parts of the plants are expected to be similar to those of groundwater. In the neutral to alkaline region, the calculations correctly predict that Zn-66 is enriched over Zn-64 in roots, which concentrate phosphates, with respect to leaves, which concentrate malates and citrates, by about one permil. It is proposed that Zn isotope fractionation represents a useful tracer of Zn availability and mobility in soils.	[Fujii, Toshiyuki] Kyoto Univ, Inst Res Reactor, Osaka 59004, Japan; [Albarede, Francis] Ecole Normale Super Lyon, F-69364 Lyon, France	Kyoto University; Ecole Normale Superieure de Lyon (ENS de LYON)	Fujii, T (corresponding author), Kyoto Univ, Inst Res Reactor, Osaka 59004, Japan.	tosiyuki@rri.kyoto-u.ac.jp	Fujii, Toshiyuki/AAD-1450-2019; Albarede, Francis/A-8871-2011	Albarede, Francis/0000-0003-1994-1428				Arnold T, 2008, ANAL BIOANAL CHEM, V398, P3115; Aucour AM, 2011, ENVIRON SCI TECHNOL, V45, P9212, DOI 10.1021/es200874x; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BERNER RA, 1973, EARTH PLANET SC LETT, V18, P77, DOI 10.1016/0012-821X(73)90037-X; BERTHON G, 1987, AGENTS ACTIONS, V22, P231, DOI 10.1007/BF02009051; Bibikova TN, 1998, DEVELOPMENT, V125, P2925; BIGELEISEN J, 1947, J CHEM PHYS, V15, P261, DOI 10.1063/1.1746492; Black JR, 2011, GEOCHIM COSMOCHIM AC, V75, P769, DOI 10.1016/j.gca.2010.11.019; CAPONE S, 1986, TALANTA, V33, P763, DOI 10.1016/0039-9140(86)80184-9; CHILDS CW, 1970, INORG CHEM, V9, P2465, DOI 10.1021/ic50093a017; Fasano JM, 2001, PLANT CELL, V13, P907, DOI 10.1105/tpc.13.4.907; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fujii T, 2011, GEOCHIM COSMOCHIM AC, V75, P7632, DOI 10.1016/j.gca.2011.09.036; Fujii T, 2010, J PHYS CHEM A, V114, P2543, DOI 10.1021/jp908642f; IULIANO M, 1994, ANN CHIM-ROME, V84, P187; Kent DB, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004841; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Magini M, 1988, XRAY DIFFRACTION ION; Makar GKR, 1976, J CHEM SOC DA, V11, P1016; Marechal CN, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000029; Millam J., GAUSSVIEW VERSION 5; Moynier F, 2009, CHEM GEOL, V267, P125, DOI 10.1016/j.chemgeo.2008.09.017; Peel K, 2009, LIMNOL OCEANOGR, V54, P1699, DOI 10.4319/lo.2009.54.5.1699; Rulisek L, 1999, J PHYS CHEM A, V103, P1634, DOI 10.1021/jp983540f; Sarret G, 2002, PLANT PHYSIOL, V130, P1815, DOI 10.1104/pp.007799; Stevenson FJ, 1999, CYCLES SOIL CARBON N; Swanson SJ, 2011, ANNU REV PLANT BIOL, V62, P273, DOI 10.1146/annurev-arplant-042110-103832; UPCHURCH JB, 1974, ENVIRON SCI TECHNOL, V8, P56, DOI 10.1021/es60086a002; UREY HC, 1947, J CHEM SOC, P562, DOI 10.1039/jr9470000562; Viers J, 2007, CHEM GEOL, V239, P124, DOI 10.1016/j.chemgeo.2007.01.005; Weiss DJ, 2005, NEW PHYTOL, V165, P703, DOI 10.1111/j.1469-8137.2004.01307.x	31	59	60	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30726	10.1371/journal.pone.0030726	http://dx.doi.org/10.1371/journal.pone.0030726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363478	Green Published, gold			2022-12-25	WOS:000302853600061
J	Kamat, A; Misra, V; Cassol, E; Ancuta, P; Yan, ZY; Li, C; Morgello, S; Gabuzda, D				Kamat, Anupa; Misra, Vikas; Cassol, Edana; Ancuta, Petronela; Yan, Zhenyu; Li, Cheng; Morgello, Susan; Gabuzda, Dana			A Plasma Biomarker Signature of Immune Activation in HIV Patients on Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; HEPATITIS-C-VIRUS; T-CELL-ACTIVATION; NATURAL-KILLER-CELLS; DISEASE PROGRESSION; INTERFERON-GAMMA; MICROBIAL TRANSLOCATION; SIGMA-1 RECEPTORS; DENDRITIC CELLS; CRACK-COCAINE	Background: Immune activation is a strong predictor of disease progression in HIV infection. Combinatorial plasma biomarker signatures that represent surrogate markers of immune activation in both viremic and aviremic HIV patients on combination antiretroviral therapy (cART) have not been defined. Here, we identify a plasma inflammatory biomarker signature that distinguishes between both viremic and aviremic HIV patients on cART and healthy controls and examine relationships of this signature to markers of disease progression. Methods: Multiplex profiling and ELISA were used to detect 15 cytokines/chemokines, soluble IL-2R (sIL-2R), and soluble CD14 (sCD14) in plasma from 57 HIV patients with CD4 nadir <300 cells/mu l and 29 healthy controls. Supervised and unsupervised analyses were used to identify biomarkers explaining variance between groups defined by HIV status or drug abuse. Relationships between biomarkers and disease markers were examined by Spearman correlation. Results: The majority (91%) of HIV subjects were on cART, with 38% having undetectable viral loads (VL). Hierarchical clustering identified a biomarker cluster in plasma consisting of two interferon-stimulated gene products (CXCL9 and CXCL10), T cell activation marker (sIL-2R), and monocyte activation marker (sCD14) that distinguished both viremic and aviremic HIV patients on cART from controls (p<0.0001) and were top-ranked in variables important in projection plots. IL-12 and CCL4 were also elevated in viremic and aviremic patients compared to controls (p<0.05). IL-12 correlated with IFN alpha, IFN gamma, CXCL9, and sIL-2R (p<0.05). CXCL10 correlated positively with plasma VL and percentage of CD16+ monocytes, and inversely with CD4 count (p = 0.001, <0.0001, and 0.04, respectively). Conclusion: A plasma inflammatory biomarker signature consisting of CXCL9, CXCL10, sIL-2R, and sCD14 may be useful as a surrogate marker to monitor immune activation in both viremic and aviremic HIV patients on cART during disease progression and therapeutic responses.	[Kamat, Anupa; Misra, Vikas; Cassol, Edana; Gabuzda, Dana] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Kamat, Anupa; Cassol, Edana; Gabuzda, Dana] Harvard Univ, Sch Med, Boston, MA USA; [Ancuta, Petronela] Univ Montreal, Dept Microbiol & Immunol, Fac Med, CHUM Res Ctr, Montreal, PQ H3C 3J7, Canada; [Yan, Zhenyu; Li, Cheng] Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA; [Morgello, Susan] Mt Sinai Med Ctr, New York, NY 10029 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Universite de Montreal; Harvard University; Dana-Farber Cancer Institute; Icahn School of Medicine at Mount Sinai	Kamat, A (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	dana_gabuzda@dfci.harvard.edu	Cassol, Edana/Z-6301-2019		National Institutes of Health [DA30985, DA28994, U01MH083501, R24MH59724, U01MH083506, R24MH59745, U01MH083507, R24 NS45491, 5U01MH083500, NS38841, U01MH083545, N01MH32002]; Canadian Institutes of Health Research (CIHR); Fonds de la Recherche en Sante Quebec (FRSQ); CNS HIV Antiretroviral Therapy Effects Research (CHARTER) [N01MH22005]; Harvard Center for AIDS Research and Dana-Farber Cancer Institute/Harvard Center for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [N01MH022005, R24MH059745, P30MH062512, U01MH083507, U01MH083501, R24MH059724, U01MH083506, U01MH083545, U01MH083500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS045491, R24NS038841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030985, DP1DA028994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); CNS HIV Antiretroviral Therapy Effects Research (CHARTER); Harvard Center for AIDS Research and Dana-Farber Cancer Institute/Harvard Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants DA30985 and DA28994 to Dr. Gabuzda. Dr. Cassol was supported by a fellowship award from Canadian Institutes of Health Research (CIHR). Dr. Ancuta was supported by a Salary Award from Fonds de la Recherche en Sante Quebec (FRSQ). National NeuroAIDS Tissue Consortium (NNTC) sites were supported by National Institutes of Health Grants U01MH083501, R24MH59724, U01MH083506, R24MH59745, U01MH083507, R24 NS45491, 5U01MH083500, NS38841, U01MH083545, and N01MH32002. CNS HIV Antiretroviral Therapy Effects Research (CHARTER) was supported by N01MH22005. Core facilities were supported by the Harvard Center for AIDS Research and Dana-Farber Cancer Institute/Harvard Center for Cancer Research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison RD, 2009, J INFECT DIS, V200, P619, DOI 10.1086/600107; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anthony KB, 2003, JAIDS-J ACQ IMM DEF, V33, P125, DOI 10.1097/00126334-200306010-00002; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Arico E, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-67; Aukrust P, 1999, J INFECT DIS, V179, P74, DOI 10.1086/314572; Barqasho B, 2009, HIV MED, V10, P94, DOI 10.1111/j.1468-1293.2008.00657.x; Baum MK, 2009, JAIDS-J ACQ IMM DEF, V50, P93, DOI 10.1097/QAI.0b013e3181900129; Berres ML, 2011, HEPATOLOGY, V53, P596, DOI 10.1002/hep.24098; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Boasso A, 2008, CLIN IMMUNOL, V126, P235, DOI 10.1016/j.clim.2007.08.015; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Byrnes AA, 2008, J LEUKOCYTE BIOL, V84, P1447, DOI 10.1189/jlb.0708438; Carrico AW, 2008, BRAIN BEHAV IMMUN, V22, P1257, DOI 10.1016/j.bbi.2008.07.010; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Catalfamo M, 2011, J IMMUNOL, V186, P2106, DOI 10.4049/jimmunol.1002000; Catalfamo M, 2008, P NATL ACAD SCI USA, V105, P19851, DOI 10.1073/pnas.0810032105; Cook JA, 2008, AIDS, V22, P1355, DOI 10.1097/QAD.0b013e32830507f2; d'Ettorre G, 2006, IMMUNOL LETT, V103, P192, DOI 10.1016/j.imlet.2005.10.001; d'Ettorre G, 2011, AIDS RES HUM RETROVI; Dandekar Satya, 2007, Curr HIV/AIDS Rep, V4, P10, DOI 10.1007/s11904-007-0002-0; Deeks SG, 2004, J CLIN INVEST, V113, P808, DOI 10.1172/JCI200421318; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Eberly MD, 2009, J IMMUNOL, V182, P1439, DOI 10.4049/jimmunol.182.3.1439; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fischer-Smith T, 2008, AIDS RES HUM RETROV, V24, P417, DOI 10.1089/aid.2007.0193; Forcina G, 2004, CYTOKINE, V25, P283, DOI 10.1016/j.cyto.2003.12.004; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Gan XH, 1998, CLIN IMMUNOL IMMUNOP, V89, P181, DOI 10.1006/clin.1998.4607; Gonzalez VD, 2010, CLIN IMMUNOL, V135, P12, DOI 10.1016/j.clim.2009.12.005; Han JY, 2009, JAIDS-J ACQ IMM DEF, V52, P553, DOI 10.1097/QAI.0b013e3181c1d4fe; Hardy GAD, 2009, BLOOD, V113, P5497, DOI 10.1182/blood-2008-11-190231; Hasin DS, 1996, AM J PSYCHIAT, V153, P1195; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kalayjian RC, 2010, J INFECT DIS, V201, P1796, DOI 10.1086/652750; Keating SM, 2011, AIDS, V25, P1823, DOI 10.1097/QAD.0b013e3283489d1f; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Lehmann C, 2008, JAIDS-J ACQ IMM DEF, V48, P522, DOI 10.1097/QAI.0b013e31817f97cf; Manches O, 2008, J CLIN INVEST, V118, P3431, DOI 10.1172/JCI34823; Mohty AM, 2010, IMMUNOBIOLOGY, V215, P113, DOI 10.1016/j.imbio.2009.03.008; Mueller YM, 2008, J IMMUNOL, V180, P350, DOI 10.4049/jimmunol.180.1.350; Mueller YM, 2010, EUR CYTOKINE NETW, V21, P219, DOI 10.1684/ecn.2010.0198; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; Neely GG, 2004, J IMMUNOL, V172, P4225, DOI 10.4049/jimmunol.172.7.4225; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Ortiz Alexandra M, 2009, Curr Infect Dis Rep, V11, P239, DOI 10.1007/s11908-009-0035-1; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Reiberger T, 2008, ANTIVIR THER, V13, P969; Rempel H, 2010, AIDS, V24, P1415, DOI 10.1097/QAD.0b013e32833ac623; Rios-Olivares E, 2006, DRUG ALCOHOL DEPEN, V85, P236, DOI 10.1016/j.drugalcdep.2006.05.013; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rodriguez AR, 2007, J GEN VIROL, V88, P641, DOI 10.1099/vir.0.82154-0; Roe B, 2007, J INFECT DIS, V196, P1053, DOI 10.1086/520935; Roth MD, 2005, J LEUKOCYTE BIOL, V78, P1198, DOI 10.1189/jlb.0405219; Ruckert R, 2009, IMMUNOLOGY, V126, P63, DOI 10.1111/j.1365-2567.2008.02878.x; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sarkar S, 2003, J MED PRIMATOL, V32, P247, DOI 10.1034/j.1600-0684.2003.00031.x; Schmidt B, 2005, VIROLOGY, V343, P256, DOI 10.1016/j.virol.2005.09.059; Schroecksnadel K, 2007, CURR DRUG METAB, V8, P225, DOI 10.2174/138920007780362608; Stuart JWTC, 2000, J ACQ IMMUN DEF SYND, V25, P203, DOI 10.1097/00126334-200011010-00001; Stylianou E, 2000, CLIN EXP IMMUNOL, V119, P479, DOI 10.1046/j.1365-2249.2000.01144.x; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Tan DBA, 2011, CLIN IMMUNOL, V139, P115, DOI 10.1016/j.clim.2011.02.015; Tarkowski M., 2011, AIDS RES HUM RETROVI; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Tilton JC, 2006, J VIROL, V80, P11486, DOI 10.1128/JVI.00324-06; Torti C, 2004, VIRAL IMMUNOL, V17, P279, DOI 10.1089/0882824041310630; Vrisekoop N, 2008, J IMMUNOL, V181, P1573, DOI 10.4049/jimmunol.181.2.1573; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zeremski M, 2007, JAIDS-J ACQ IMM DEF, V45, P262; Zeremski M, 2011, J INFECT DIS, V204, P832, DOI 10.1093/infdis/jir424	75	91	92	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30881	10.1371/journal.pone.0030881	http://dx.doi.org/10.1371/journal.pone.0030881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363505	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600080
J	Meisel, C; Kuehn, C				Meisel, Christian; Kuehn, Christian			Scaling Effects and Spatio-Temporal Multilevel Dynamics in Epileptic Seizures	PLOS ONE			English	Article							SPIKE-WAVE DISCHARGES; HOMOCLINIC ORBITS; STABILITY LOSS; TIME; BRAIN; PHASE; SYNCHRONIZATION; PREDICTION; OSCILLATIONS; PERSISTENCE	Epileptic seizures are one of the most well-known dysfunctions of the nervous system. During a seizure, a highly synchronized behavior of neural activity is observed that can cause symptoms ranging from mild sensual malfunctions to the complete loss of body control. In this paper, we aim to contribute towards a better understanding of the dynamical systems phenomena that cause seizures. Based on data analysis and modelling, seizure dynamics can be identified to possess multiple spatial scales and on each spatial scale also multiple time scales. At each scale, we reach several novel insights. On the smallest spatial scale we consider single model neurons and investigate early-warning signs of spiking. This introduces the theory of critical transitions to excitable systems. For clusters of neurons (or neuronal regions) we use patient data and find oscillatory behavior and new scaling laws near the seizure onset. These scalings lead to substantiate the conjecture obtained from mean-field models that a Hopf bifurcation could be involved near seizure onset. On the largest spatial scale we introduce a measure based on phase-locking intervals and wavelets into seizure modelling. It is used to resolve synchronization between different regions in the brain and identifies time-shifted scaling laws at different wavelet scales. We also compare our wavelet-based multiscale approach with maximum linear cross-correlation and mean-phase coherence measures.	[Meisel, Christian; Kuehn, Christian] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Meisel, Christian] Univ Clin Carl Gustav Carus, Dept Neurol, Dresden, Germany	Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Meisel, C (corresponding author), Max Planck Inst Phys Komplexer Syst, Dresden, Germany.	meisel@mpipks-dresden.mpg.de	Kuehn, Christian/H-3950-2014	Kuehn, Christian/0000-0002-7063-6173; Meisel, Christian/0000-0003-2984-5480				Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; BAK P, 1995, P NATL ACAD SCI USA, V92, P6689, DOI 10.1073/pnas.92.15.6689; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Berglund N, 2009, STOCHASTIC METHODS N, V2, P65; Berglund N, 2006, PROB APPL S; Bosnyakova D, 2007, CLIN NEUROPHYSIOL, V118, P1736, DOI 10.1016/j.clinph.2007.04.013; Bosnyakova D, 2006, J NEUROSCI METH, V154, P80, DOI 10.1016/j.jneumeth.2005.12.006; Breakspear M, 2006, CEREB CORTEX, V16, P1296, DOI 10.1093/cercor/bhj072; Breakspear M, 2005, PHILOS T R SOC B, V360, P1051, DOI 10.1098/rstb.2005.1643; Bullmore ET, 2003, STAT METHODS MED RES, V12, P375, DOI 10.1191/0962280203sm339ra; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; Chavez M, 2003, IEEE T BIO-MED ENG, V50, P571, DOI 10.1109/TBME.2003.810696; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Desroches M, 2012, SIAM REV IN PRESS; DeVille REL, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031105; Ermentrout GB, 2010, MATH FDN NEUROSCIENC; Feldwisch-Drentrup H, 2010, EPILEPSIA, V51, P1598, DOI 10.1111/j.1528-1167.2009.02497.x; FitzHugh R., 1955, B MATH BIOPHYS, V17, P257, DOI [10.1007/BF02477753, DOI 10.1007/BF02477753, 10.1007/bf02477753]; Freidlin M.I., 2012, RANDOM PERTURBATIONS, V3rd ed.; Gardiner C., 2009, STOCHASTIC METHODS; GASPARD P, 1987, J STAT PHYS, V48, P151, DOI 10.1007/BF01010405; Grasman J., 1987, ASYMPTOTIC METHODS R; Guckenheimer J, 2003, NONLINEAR DYNAMICS AND CHAOS: WHERE DO WE GO FROM HERE?, P1; Guckenheimer J, 2009, DISCRETE CONT DYN-S, V2, P851, DOI 10.3934/dcdss.2009.2.851; Guckenheimer J, 2009, SIAM J APPL DYN SYST, V8, P854, DOI 10.1137/080741999; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Ihle M, 2011, COMPUT METH PROG BIO; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Jost J, 2006, PARTIAL DIFFERENTIAL; Kalitzin SN, 2010, EPILEPSY BEHAV, V17, P310, DOI 10.1016/j.yebeh.2009.12.023; Kapiris PG, 2005, EUROPHYS LETT, V69, P657, DOI 10.1209/epl/i2004-10383-2; Keener J., 2008, MATH PHYSL, V1; KELSO JAS, 1992, PHYS LETT A, V169, P134, DOI 10.1016/0375-9601(92)90583-8; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Kuehn C., 2011, ARXIV11012908, P1; Kuehn C, 2011, PHYSICA D, V240, P1020, DOI 10.1016/j.physd.2011.02.012; Kuhnert MT, 2010, CHAOS, V20, DOI 10.1063/1.3504998; Kuznetsov Yu. A., 2004, ELEMENTS APPL BIFURC, Vthird; Lehnertz K, 2009, J NEUROSCI METH, V183, P42, DOI 10.1016/j.jneumeth.2009.05.015; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Lindner B, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.022901; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Lindner B, 1999, PHYS REV E, V60, P7270, DOI 10.1103/PhysRevE.60.7270; Litt B, 2002, LANCET NEUROL, V1, P22, DOI 10.1016/S1474-4422(02)00003-0; LU Y.-C., 1976, SINGULARITY THEORY I; Marten F, 2009, PHILOS T R SOC A, V367, P1145, DOI 10.1098/rsta.2008.0255; Meisel C, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061917; Mishchenko E. F., 1980, DIFFERENTIAL EQUATIO; Molaee-Ardekani B, 2010, NEUROIMAGE, V52, P1109, DOI 10.1016/j.neuroimage.2009.12.049; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Mormann F, 2003, EPILEPSY RES, V53, P173, DOI 10.1016/S0920-1211(03)00002-0; Mormann F, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021912; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Muratov CB, 2005, PHYSICA D, V210, P227, DOI 10.1016/j.physd.2005.07.014; Muratov CB, 2008, CHAOS, V18, DOI 10.1063/1.2779852; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; NEISHTADT AI, 1987, DIFF EQUAT+, V23, P1385; NEISHTADT AI, 1988, DIFF EQUAT+, V24, P171; Osorio I, 2002, EPILEPSIA, V43, P1522, DOI 10.1046/j.1528-1157.2002.11102.x; Osorio I, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021919; Perc M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016207; Percival D., 2000, CA ST PR MA; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Richardson MP, 2011, PROG BIOPHYS MOL BIO, V105, P5, DOI 10.1016/j.pbiomolbio.2010.09.019; Robinson PA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041924; Rocsoreanu C., 2000, FITZHUGH NAGUMO MODE; Rodrigues S, 2010, BIOL CYBERN, V102, P145, DOI 10.1007/s00422-009-0357-y; Rodrigues S, 2009, J COMPUT NEUROSCI, V27, P507, DOI 10.1007/s10827-009-0166-2; Rosenblum MG, 1997, PHYS REV LETT, V78, P4193, DOI 10.1103/PhysRevLett.78.4193; Rubin J, 2007, BIOL CYBERN, V97, P5, DOI 10.1007/s00422-007-0153-5; Sagues F, 2007, REV MOD PHYS, V79, P829, DOI 10.1103/RevModPhys.79.829; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schelter B, 2006, CHAOS, V16, DOI 10.1063/1.2137623; Schelter B, SEIZURE PREDICITION; Shusterman V, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061911; Strogatz S., 2000, NONLINEAR DYNAMICS C; Subasi A, 2005, EXPERT SYST APPL, V29, P343, DOI 10.1016/j.eswa.2005.04.007; Suffczynski P, 2006, IEEE T BIO-MED ENG, V53, P524, DOI 10.1109/TBME.2005.869800; Suffczynski P, 2004, NEUROSCIENCE, V126, P467, DOI 10.1016/j.neuroscience.2004.03.014; Suffczynski P, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051917; Taylor P, 2011, J COMPUT NEUROSCI, P1; Van der Pol B., 1920, RADIO REV, V1, P701; van Luijtelaar G, 2011, CLIN NEUROPHYSIOL, V122, P687, DOI 10.1016/j.clinph.2010.10.038; Volman V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020572; Wendling F, 2003, BRAIN, V126, P1449, DOI 10.1093/brain/awg144; Wendling Fabrice, 2008, Expert Rev Neurother, V8, P889, DOI 10.1586/14737175.8.6.889; Whitcher B, 2005, SIGNAL PROCESS, V85, P2065, DOI 10.1016/j.sigpro.2005.07.002; Wiggins S., 2003, INTRO APPL NONLINEAR, DOI 10.1007/b97481	95	49	49	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30371	10.1371/journal.pone.0030371	http://dx.doi.org/10.1371/journal.pone.0030371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363431	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600025
J	Xue, LJ; Zhang, JJ; Xue, HW				Xue, Liang-Jiao; Zhang, Jing-Jing; Xue, Hong-Wei			Genome-Wide Analysis of the Complex Transcriptional Networks of Rice Developing Seeds	PLOS ONE			English	Article							GENE-EXPRESSION; ENDOSPERM DEVELOPMENT; ARABIDOPSIS-THALIANA; TEMPERATURE STRESS; FREEZING TOLERANCE; IDENTIFICATION; REGULATOR; INSIGHTS; DATABASE; PROTEIN	Background: The development of rice (Oryza sativa) seed is closely associated with assimilates storage and plant yield, and is fine controlled by complex regulatory networks. Exhaustive transcriptome analysis of developing rice embryo and endosperm will help to characterize the genes possibly involved in the regulation of seed development and provide clues of yield and quality improvement. Principal Findings: Our analysis showed that genes involved in metabolism regulation, hormone response and cellular organization processes are predominantly expressed during rice development. Interestingly, 191 transcription factor (TF)-encoding genes are predominantly expressed in seed and 59 TFs are regulated during seed development, some of which are homologs of seed-specific TFs or regulators of Arabidopsis seed development. Gene co-expression network analysis showed these TFs associated with multiple cellular and metabolism pathways, indicating a complex regulation of rice seed development. Further, by employing a cold-resistant cultivar Hanfeng (HF), genome-wide analyses of seed transcriptome at normal and low temperature reveal that rice seed is sensitive to low temperature at early stage and many genes associated with seed development are down-regulated by low temperature, indicating that the delayed development of rice seed by low temperature is mainly caused by the inhibition of the development-related genes. The transcriptional response of seed and seedling to low temperature is different, and the differential expressions of genes in signaling and metabolism pathways may contribute to the chilling tolerance of HF during seed development. Conclusions: These results provide informative clues and will significantly improve the understanding of rice seed development regulation and the mechanism of cold response in rice seed.	[Xue, Liang-Jiao; Zhang, Jing-Jing; Xue, Hong-Wei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xue, HW (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	hwxue@sibs.ac.cn	Xue, Liangjiao/F-3554-2016; Xue, Liangjiao/AAE-7123-2022; Xue, Liang-Jiao/N-3675-2014	Xue, Liangjiao/0000-0003-1766-5298; Xue, Liang-Jiao/0000-0003-1766-5298	Chinese Academy of Sciences [KSCX2-YW-N-058]; Shanghai Institutes for Biological Sciences [SIBS2008004]	Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences)	This study was supported by Chinese Academy of Sciences (KSCX2-YW-N-058) and Shanghai Institutes for Biological Sciences (SIBS2008004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Agarwal P, 2011, BIOESSAYS, V33, P189, DOI 10.1002/bies.201000107; Attia KA, 2009, CURR ISSUES MOL BIOL, V11, pI29, DOI 10.21775/cimb.011.i29; Benjamini Y, 2001, ANN STAT, V29, P1165; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Druka Arnis, 2006, Functional & Integrative Genomics, V6, P202, DOI 10.1007/s10142-006-0025-4; Duan K, 2005, PLANT MOL BIOL, V57, P785, DOI 10.1007/s11103-005-1803-4; Ducruet JM, 2007, PHOTOSYNTH RES, V93, P159, DOI 10.1007/s11120-007-9132-x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Forestan C, 2010, PLANT PHYSIOL, V152, P1373, DOI 10.1104/pp.109.150193; Fu FF, 2010, PLANT PHYSIOL, V154, P927, DOI 10.1104/pp.110.159517; Gao G, 2006, BIOINFORMATICS, V22, P1286, DOI 10.1093/bioinformatics/btl107; Ge XM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-114; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; HATTORI T, 1994, PLANT MOL BIOL, V24, P805, DOI 10.1007/BF00029862; Hieber AD, 2000, BBA-PROTEIN STRUCT M, V1482, P84, DOI 10.1016/S0167-4838(00)00141-2; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hobo T, 1999, P NATL ACAD SCI USA, V96, P15348, DOI 10.1073/pnas.96.26.15348; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; IZAWA T, 1994, PLANT CELL, V6, P1277, DOI 10.1105/tpc.6.9.1277; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Kerk NM, 2003, PLANT PHYSIOL, V132, P27, DOI 10.1104/pp.102.018127; Kim CK, 2011, J APPL GENET, V52, P161, DOI 10.1007/s13353-011-0027-3; Kondou Y, 2008, PLANT PHYSIOL, V147, P1924, DOI 10.1104/pp.108.118364; Kurata N, 2005, PLANT CELL PHYSIOL, V46, P48, DOI 10.1093/pcp/pci506; Laudencia-Chingcuanco DL, 2007, PLANT MOL BIOL, V63, P651, DOI 10.1007/s11103-006-9114-y; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee JM, 2002, FUNCT INTEGR GENOMIC, V2, P13, DOI 10.1007/s10142-002-0046-6; Liu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-730; Liu XH, 2008, GENOMICS, V91, P378, DOI 10.1016/j.ygeno.2007.12.002; Long TA, 2006, CURR OPIN CELL BIOL, V18, P710, DOI 10.1016/j.ceb.2006.09.004; Matsuda F, 2005, BIOSCI BIOTECH BIOCH, V69, P778, DOI 10.1271/bbb.69.778; Nagasaki H, 2007, P NATL ACAD SCI USA, V104, P14867, DOI 10.1073/pnas.0704339104; Nakase M, 1997, PLANT MOL BIOL, V33, P513, DOI 10.1023/A:1005784717782; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Onai K, 2005, GENES CELLS, V10, P963, DOI 10.1111/j.1365-2443.2005.00892.x; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Roxrud I, 2007, PLANT CELL PHYSIOL, V48, P471, DOI 10.1093/pcp/pcm016; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; SATAKE T, 1970, Proceedings of the Crop Science Society of Japan, V39, P468; Sato T, 1996, MOL GEN GENET, V251, P13; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Sazuka T, 2009, PLANT J, V60, P227, DOI 10.1111/j.1365-313X.2009.03952.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Sun XD, 2010, CURR OPIN PLANT BIOL, V13, P611, DOI 10.1016/j.pbi.2010.08.009; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; Tu QC, 2008, J INTEGR PLANT BIOL, V50, P1078, DOI 10.1111/j.1744-7909.2008.00714.x; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xue H, 2007, CURR OPIN PLANT BIOL, V10, P483, DOI 10.1016/j.pbi.2007.07.003; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yang HJ, 2002, PLANT MOL BIOL, V50, P379, DOI 10.1023/A:1019859612791; Young TE, 2000, PLANT MOL BIOL, V44, P283, DOI 10.1023/A:1026588408152; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zhu T, 2003, PLANT BIOTECHNOL J, V1, P59, DOI 10.1046/j.1467-7652.2003.00006.x	60	66	69	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31081	10.1371/journal.pone.0031081	http://dx.doi.org/10.1371/journal.pone.0031081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363552	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600109
J	Chambers, AL; Brownlee, PM; Durley, SC; Beacham, T; Kent, NA; Downs, JA				Chambers, Anna L.; Brownlee, Peter M.; Durley, Samuel C.; Beacham, Tracey; Kent, Nicholas A.; Downs, Jessica A.			The Two Different Isoforms of the RSC Chromatin Remodeling Complex Play Distinct Roles in DNA Damage Responses	PLOS ONE			English	Article							STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; CHECKPOINT; GENE; ADAPTATION; INDUCTION	The RSC chromatin remodeling complex has been implicated in contributing to DNA double-strand break (DSB) repair in a number of studies. Both survival and levels of H2A phosphorylation in response to damage are reduced in the absence of RSC. Importantly, there is evidence for two isoforms of this complex, defined by the presence of either Rsc1 or Rsc2. Here, we investigated whether the two isoforms of RSC provide distinct contributions to DNA damage responses. First, we established that the two isoforms of RSC differ in the presence of Rsc1 or Rsc2 but otherwise have the same subunit composition. We found that both rsc1 and rsc2 mutant strains have intact DNA damage-induced checkpoint activity and transcriptional induction. In addition, both strains show reduced non-homologous end joining activity and have a similar spectrum of DSB repair junctions, suggesting perhaps that the two complexes provide the same functions. However, the hypersensitivity of a rsc1 strain cannot be complemented with an extra copy of RSC2, and likewise, the hypersensitivity of the rsc2 strain remains unchanged when an additional copy of RSC1 is present, indicating that the two proteins are unable to functionally compensate for one another in DNA damage responses. Rsc1, but not Rsc2, is required for nucleosome sliding flanking a DNA DSB. Interestingly, while swapping the domains from Rsc1 into the Rsc2 protein does not compromise hypersensitivity to DNA damage suggesting they are functionally interchangeable, the BAH domain from Rsc1 confers upon Rsc2 the ability to remodel chromatin at a DNA break. These data demonstrate that, despite the similarity between Rsc1 and Rsc2, the two different isoforms of RSC provide distinct functions in DNA damage responses, and that at least part of the functional specificity is dictated by the BAH domains.	[Chambers, Anna L.; Brownlee, Peter M.; Downs, Jessica A.] Univ Sussex, Med Res Council Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Durley, Samuel C.; Beacham, Tracey; Kent, Nicholas A.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales	University of Sussex; Cardiff University	Chambers, AL (corresponding author), Univ Sussex, Med Res Council Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	j.a.downs@sussex.ac.uk	Kent, Nicholas/A-4503-2010	Kent, Nicholas/0000-0002-4114-1307; Beacham, Tracey/0000-0001-5552-2330; Downs, Jessica/0000-0002-6600-849X; Durley, Samuel/0000-0002-1316-2426; Chambers, Anna/0000-0001-8133-6240	Cancer Research UK [CEA C7905/A10269]; BBSRC [BB/F012810/1]; Biotechnology and Biological Sciences Research Council [BB/F012810/1] Funding Source: researchfish; Medical Research Council [G0801130B] Funding Source: researchfish; Worldwide Cancer Research [12-1118] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research	ALC, PMB, and JAD are supported by Cancer Research UK CEA C7905/A10269. NAK is supported by BBSRC grant BB/F012810/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Bungard D, 2004, EUKARYOT CELL, V3, P910, DOI 10.1128/EC.3.4.910-918.2004; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Horikawa I, 2002, DNA SEQUENCE, V13, P211, DOI 10.1080/1042517021000021590; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Kent NA, 2007, J BIOL CHEM, V282, P27693, DOI 10.1074/jbc.M704707200; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Liang B, 2007, CURR BIOL, V17, P1432, DOI 10.1016/j.cub.2007.07.035; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Paques F, 1998, MOL CELL BIOL, V18, P2045, DOI 10.1128/MCB.18.4.2045; Rossio V, 2010, J CELL BIOL, V191, P981, DOI 10.1083/jcb.201007025; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shim EY, 2005, MOL CELL BIOL, V25, P3934, DOI 10.1128/MCB.25.10.3934-3944.2005; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276	24	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32016	10.1371/journal.pone.0032016	http://dx.doi.org/10.1371/journal.pone.0032016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359657	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200126
J	De Cian, A; Praly, E; Ding, FY; Singh, V; Lavelle, C; Le Cam, E; Croquette, V; Pietrement, O; Bensimon, D				De Cian, Anne; Praly, Elise; Ding, Fangyuan; Singh, Vijender; Lavelle, Christophe; Le Cam, Eric; Croquette, Vincent; Pietrement, Olivier; Bensimon, David			ATP-Independent Cooperative Binding of Yeast Isw1a to Bare and Nucleosomal DNA	PLOS ONE			English	Article							SINGLE-MOLECULE; RNA-POLYMERASE; REAL-TIME; CHROMATIN; TRANSLOCATION; MECHANISM; PROTEIN; SWI/SNF; GENE; RSC	Among chromatin remodeling factors, the ISWI family displays a nucleosome-enhanced ATPase activity coupled to DNA translocation. While these enzymes are known to bind to DNA, their activity has not been fully characterized. Here we use TEM imaging and single molecule manipulation to investigate the interaction between DNA and yeast Isw1a. We show that Isw1a displays a highly cooperative ATP-independent binding to and bridging between DNA segments. Under appropriate tension, rare single nucleation events can sometimes be observed and loop DNA with a regular step. These nucleation events are often followed by binding of successive complexes bridging between nearby DNA segments in a zipper-like fashion, as confirmed by TEM observations. On nucleosomal substrates, we show that the specific ATP-dependent remodeling activity occurs in the context of cooperative Isw1a complexes bridging extranucleosomal DNA. Our results are interpreted in the context of the recently published partial structure of Isw1a and support its acting as a "protein ruler'' (with possibly more than one tick).	[De Cian, Anne; Le Cam, Eric; Pietrement, Olivier] CNRS, UMR 8126, Villejuif, France; [De Cian, Anne; Le Cam, Eric; Pietrement, Olivier] Univ Paris 11, Villejuif, France; [Praly, Elise; Ding, Fangyuan; Croquette, Vincent; Bensimon, David] Ecole Normale Super, CNRS, Lab Phys Stat, UMR 8550, Paris, France; [Singh, Vijender] Univ Dundee, Wellcome Trust Bioctr, Dundee, Scotland; [Lavelle, Christophe] CNRS, UMR 7196, INSERM, U565, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; University of Dundee; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Museum National d'Histoire Naturelle (MNHN)	De Cian, A (corresponding author), CNRS, UMR 8126, Villejuif, France.	olivier.pietrement@igr.fr; david@lps.ens.fr	Lavelle, Christophe/F-2377-2013; Ding, Fangyuan/I-4787-2014; Bensimon, David/E-7768-2015; PIETREMENT, Olivier/T-2555-2017	Bensimon, David/0000-0003-1971-9907; Le cam, Eric/0000-0002-6832-6117; PIETREMENT, Olivier/0000-0002-0018-7202; Ding, Fangyuan/0000-0003-0118-5441; DE CIAN, Anne/0000-0002-1737-2543; Croquette, Vincent/0000-0003-1400-0039	Association pour la Recherche sur le Cancer; Ministry of Instruction and Research; Region Ile-de-France; Wellcome Trust; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [06PCV0005 PCV FaRC]	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ministry of Instruction and Research; Region Ile-de-France(Region Ile-de-France); Wellcome Trust(Wellcome Trust); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	ADC was funded by the Association pour la Recherche sur le Cancer, and EP was funded by the Ministry of Instruction and Research. OP and ELC acknowledge support from the Region Ile-de-France in the framework of C'nano-IdF. VS acknowledges support from the Wellcome Trust. VC, DB, CL, OP, and ELC acknowledge support from the Centre National de la Recherche Scientifique and the Agence Nationale de la Recherche (no06PCV0005 PCV FaRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beloin C, 2003, J BIOL CHEM, V278, P5333, DOI 10.1074/jbc.M207489200; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Charvin G, 2005, BIOPHYS J, V89, P384, DOI 10.1529/biophysj.105.060202; Charvin G, 2003, P NATL ACAD SCI USA, V100, P9820, DOI 10.1073/pnas.1631550100; Chin J, 2004, METHOD ENZYMOL, V376, P3; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dame RT, 2006, NATURE, V444, P387, DOI 10.1038/nature05283; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dirscherl SS, 2004, BIOCHEM CELL BIOL, V82, P482, DOI 10.1139/O04-044; Dupaigne P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003643; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gangaraju VK, 2007, MOL CELL BIOL, V27, P3217, DOI 10.1128/MCB.01731-06; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; JULICHER F, 1995, PHYS REV LETT, V75, P2618, DOI 10.1103/PhysRevLett.75.2618; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lavelle C, 2009, BIOCHEM CELL BIOL, V87, P307, DOI 10.1139/O08-123; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; MANNING GS, 1985, CELL BIOPHYS, V7, P57, DOI 10.1007/BF02788639; McBryant SJ, 2006, CHROMOSOME RES, V14, P39, DOI 10.1007/s10577-006-1025-x; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Neuman KC, 2009, P NATL ACAD SCI USA, V106, P6986, DOI 10.1073/pnas.0900574106; Okada M, 1998, MOL CELL BIOL, V18, P2455, DOI 10.1128/MCB.18.5.2455; Pinskaya M, 2009, MOL CELL BIOL, V29, P2419, DOI 10.1128/MCB.01050-08; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Pusarla RH, 2005, FEBS J, V272, P5149, DOI 10.1111/j.1742-4658.2005.04930.x; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Rippe K, 2007, P NATL ACAD SCI USA, V104, P15635, DOI 10.1073/pnas.0702430104; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Shukla MS, 2010, P NATL ACAD SCI USA, V107, P1936, DOI 10.1073/pnas.0904497107; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Strick TR, 2003, REP PROG PHYS, V66, P1, DOI 10.1088/0034-4885/66/1/201; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; van der Heijden T, 2008, MOL CELL, V30, P530, DOI 10.1016/j.molcel.2008.03.010; van Vugt JJFA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006345; Varga-Weisz PD, 2006, CURR OPIN GENET DEV, V16, P151, DOI 10.1016/j.gde.2006.02.006; Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Wiggins PA, 2009, BIOPHYS J, V97, P1997, DOI 10.1016/j.bpj.2009.06.051; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	51	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31845	10.1371/journal.pone.0031845	http://dx.doi.org/10.1371/journal.pone.0031845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359636	Green Published, gold			2022-12-25	WOS:000302796200105
J	Kempf, M; Bakour, S; Flaudrops, C; Berrazeg, M; Brunel, JM; Drissi, M; Mesli, E; Touati, A; Rolain, JM				Kempf, Marie; Bakour, Sofiane; Flaudrops, Christophe; Berrazeg, Meryem; Brunel, Jean-Michel; Drissi, Mourad; Mesli, Esma; Touati, Abdelaziz; Rolain, Jean-Marc			Rapid Detection of Carbapenem Resistance in Acinetobacter baumannii Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry	PLOS ONE			English	Article							IDENTIFICATION; BACTERIA; EPIDEMIOLOGY; HOSPITALS; IMIPENEM; COLISTIN; GENES	Rapid detection of carbapenem-resistant Acinetobacter baumannii strains is critical and will benefit patient care by optimizing antibiotic therapies and preventing outbreaks. Herein we describe the development and successful application of a mass spectrometry profile generated by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) that utilized the imipenem antibiotic for the detection of carbapenem resistance in a large series of A. baumannii clinical isolates from France and Algeria. A total of 106 A. baumannii strains including 63 well-characterized carbapenemase-producing and 43 non-carbapenemase-producing strains, as well as 43 control strains (7 carbapenem-resistant and 36 carbapenem-sensitive strains) were studied. After an incubation of bacteria with imipenem for up to 4 h, the mixture was centrifuged and the supernatant analyzed by MALDI-TOF MS. The presence and absence of peaks representing imipenem and its natural metabolite was analyzed. The result was interpreted as positive for carbapenemase production if the specific peak for imipenem at 300.0 m/z disappeared during the incubation time and if the peak of the natural metabolite at 254.0 m/z increased as measured by the area under the curves leading to a ratio between the peak for imipenem and its metabolite being <0.5. This assay, which was applied to the large series of A. baumannii clinical isolates, showed a sensitivity of 100.0% and a specificity of 100.0%. Our study is the first to demonstrate that this quick and simple assay can be used as a routine tool as a point-of-care method for the identification of A. baumannii carbapenemase-producers in an effort to prevent outbreaks and the spread of uncontrollable superbugs.	[Kempf, Marie; Bakour, Sofiane; Flaudrops, Christophe; Berrazeg, Meryem; Brunel, Jean-Michel; Rolain, Jean-Marc] Aix Marseille Univ, URMITE, CNRS,Fac Med & Pharm, IRD,INSERM,UMR 6236, Marseille, France; [Bakour, Sofiane; Touati, Abdelaziz] Univ A MIRA Bejaia, Dept Microbiol, FSNV, Bejaia, Algeria; [Drissi, Mourad; Mesli, Esma] Univ Abou Bekr Belkaid Tlemcen, Lab Antibiot Antifong Physicochim Synth & Act Bio, Tilimsen, Algeria	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Universite de Bejaia; Universite Abou Bekr Belkaid	Kempf, M (corresponding author), Aix Marseille Univ, URMITE, CNRS,Fac Med & Pharm, IRD,INSERM,UMR 6236, Marseille, France.	jean-marc.rolain@univmed.fr	TOUATI, Abdelaziz/N-5759-2016; Rolain, Jean-Marc/Y-3788-2019; Bakour, Sofiane/I-3528-2019	TOUATI, Abdelaziz/0000-0002-7479-2456; Rolain, Jean-Marc/0000-0002-2402-4467; bakour, sofiane/0000-0002-3436-7391; jean michel, brunel/0000-0002-9355-8980; KEMPF, Marie/0000-0002-2943-7500	CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was partly funded by CNRS. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnin RA, 2011, CLIN MICROBIOL INFEC, V17, P1524, DOI 10.1111/j.1469-0691.2011.03622.x; Burckhardt I, 2011, J CLIN MICROBIOL, V49, P3321, DOI 10.1128/JCM.00287-11; Coelho JM, 2006, J CLIN MICROBIOL, V44, P3623, DOI 10.1128/JCM.00699-06; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Gogou V, 2011, J ANTIMICROB CHEMOTH, V66, P2767, DOI 10.1093/jac/dkr390; He C, 2011, INT J ANTIMICROB AG, V38, P257, DOI 10.1016/j.ijantimicag.2011.04.015; Hrabak J, 2011, J CLIN MICROBIOL, V49, P3222, DOI 10.1128/JCM.00984-11; Karah N, 2011, MICROB DRUG RESIST, V17, P545, DOI 10.1089/mdr.2011.0089; Kempf M, 2012, INT J ANTIMICROB AG, V39, P105, DOI 10.1016/j.ijantimicag.2011.10.004; Kusradze I, 2011, INT J ANTIMICROB AG, V38, P164, DOI 10.1016/j.ijantimicag.2011.03.021; Lee K, 2003, J CLIN MICROBIOL, V41, P4623, DOI 10.1128/JCM.41.10.4623-4629.2003; Markelz AE, 2011, ANTIMICROB AGENTS CH, V55, P4707, DOI 10.1128/AAC.00112-11; Mezzatesta ML, 2012, CLIN MICROBIOL INFEC, V18, P160, DOI 10.1111/j.1469-0691.2011.03527.x; Michalopoulos AS, 2005, CLIN MICROBIOL INFEC, V11, P115, DOI 10.1111/j.1469-0691.2004.01043.x; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Nordmann P, 2011, J ANTIMICROB CHEMOTH, V66, P1070, DOI 10.1093/jac/dkr056; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Rolain JM, 2011, J INFECT DIS, V204, P1146, DOI 10.1093/infdis/jir475; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; SWANSON DJ, 1986, ANTIMICROB AGENTS CH, V29, P936, DOI 10.1128/AAC.29.5.936; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; Vitorino R, 2011, METHODS MOL BIOL, V790, P31, DOI 10.1007/978-1-61779-319-6_3; Zarrilli Raffaele, 2009, J Infect Dev Ctries, V3, P335, DOI 10.3855/jidc.240	25	111	124	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31676	10.1371/journal.pone.0031676	http://dx.doi.org/10.1371/journal.pone.0031676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359616	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200085
J	van der Tol, A; Van Biesen, W; Van Laecke, S; Bogaerts, K; De Lombaert, K; Warrinnier, H; Vanholder, R				van der Tol, Arjan; Van Biesen, Wim; Van Laecke, Steven; Bogaerts, Kris; De Lombaert, Koen; Warrinnier, Hans; Vanholder, Raymond			Statin Use and the Presence of Microalbuminuria. Results from the ERICABEL Trial: A Non-Interventional Epidemiological Cohort Study	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; URINARY ALBUMIN EXCRETION; NORD-TRONDELAG HEALTH; CARDIOVASCULAR EVENTS; RENAL-DISEASE; ROSUVASTATIN; ATORVASTATIN; METAANALYSIS; CHOLESTEROL; SIMVASTATIN	Background: Microalbuminuria (MAU) is considered as a predictor or marker of cardiovascular and renal events. Statins are widely prescribed to reduce cardiovascular risk and to slow down progression of kidney disease. But statins may also generate tubular MAU. The current observational study evaluated the impact of statin use on the interpretation of MAU as a predictor or marker of cardiovascular or renal disease. Methodology/Principal Findings: We used cross-sectional data of ERICABEL, a cohort with 1,076 hypertensive patients. MAU was defined as albuminuria >= 20 mg/l. A propensity score was created to correct for "bias by indication" to receive a statin. As expected, subjects using statins vs. no statins had more cardiovascular risk factors, pointing to bias by indication. Statin users were more likely to have MAU (OR: 2.01, 95%CI: 1.34-3.01). The association between statin use and MAU remained significant after adjusting for the propensity to receive a statin based on cardiovascular risk factors (OR: 1.82, 95%CI: 1.14-2.91). Next to statin use, only diabetes (OR: 1.92, 95%CI: 1.00-3.66) and smoking (OR: 1.49, 95%CI: 0.99-2.26) were associated with MAU. Conclusions: Use of statins is independently associated with MAU, even after adjusting for bias by indication to receive a statin. In the hypothesis that this MAU is of tubular origin, statin use can result in incorrect labeling of subjects as having a predictor or marker of cardiovascular or renal risk. In addition, statin use affected the association of established cardiovascular risk factors with MAU, blurring the interpretation of multivariable analyses.	[van der Tol, Arjan; Van Biesen, Wim; Van Laecke, Steven; Vanholder, Raymond] Univ Hosp Ghent, Div Renal, Dept Internal Med, Ghent, Belgium; [Bogaerts, Kris] Interuniv Ctr Biostat & Stat Bioinformat, Louvain, Belgium; [De Lombaert, Koen; Warrinnier, Hans] Hoffman La Roche Ltd, Brussels, Belgium	Ghent University; Ghent University Hospital	van der Tol, A (corresponding author), Univ Hosp Ghent, Div Renal, Dept Internal Med, Ghent, Belgium.	Arjan.vandertol@ugent.be		Bogaerts, Kris/0000-0003-0188-8665; Van Laecke, Steven/0000-0001-7628-8491	F. Hoffmann-La Roche Ltd.	F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	The funder of this study was F. Hoffmann-La Roche Ltd. The funder had a role in data collection because the ERICABEL study was initiated by F. Hoffmann-La Roche Ltd. The funder had no other role in the study design, analysis, decision to publish, or preparation of the manuscript.	Atthobari J, 2006, NEPHROL DIAL TRANSPL, V21, P3106, DOI 10.1093/ndt/gfl244; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barnieh L, 2011, J NEPHROLOGY; Bigazzi R, 1998, J HYPERTENS, V16, P1325, DOI 10.1097/00004872-199816090-00014; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Corna D, 2007, AM J NEPHROL, V27, P630, DOI 10.1159/000108359; DESLYPERE JP, 1990, LANCET, V336, P1453, DOI 10.1016/0140-6736(90)93164-K; Douglas K, 2006, ANN INTERN MED, V145, P117, DOI 10.7326/0003-4819-145-2-200607180-00009; Frank EH, 2009, HMISC HARRELL MISCER; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Hallan H, 2003, SCAND J UROL NEPHROL, V37, P151, DOI 10.1080/00365590310008901; Heinze G., 2011, EUROPEAN HEART J; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Klausen KP, 2005, HYPERTENSION, V46, P33, DOI 10.1161/01.HYP.0000169153.78459.50; Knight SF, 2010, AM J PHYSIOL-RENAL, V298, pF86, DOI 10.1152/ajprenal.00351.2009; Kostapanos MS, 2007, J CARDIOVASC PHARM T, V12, P292, DOI 10.1177/1074248407306676; Luo Zhehui, 2010, Med Care Res Rev, V67, P528, DOI 10.1177/1077558710361486; Mogensen CE, 1999, DIABETOLOGIA, V42, P263, DOI 10.1007/s001250051151; Park JK, 2009, J HYPERTENS, V27, P599, DOI 10.1097/HJH.0b013e32831ef369; Pollock CA, 2007, CURR OPIN NEPHROL HY, V16, P359, DOI 10.1097/MNH.0b013e3281eb9059; Romundstad S, 2003, AM J KIDNEY DIS, V42, P466, DOI 10.1016/S0272-6386(03)00742-X; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 2004, MULTIPLE IMPUTATION; Rutter MK, 2011, DIABETIC MED, V28, P100, DOI 10.1111/j.1464-5491.2010.03139.x; Sandhu S, 2006, J AM SOC NEPHROL, V17, P2006, DOI 10.1681/ASN.2006010012; Sidaway JE, 2004, J AM SOC NEPHROL, V15, P2258, DOI 10.1097/01.ASN.0000138236.82706.EE; Sorof J, 2006, DIABETES RES CLIN PR, V72, P81, DOI 10.1016/j.diabres.2005.09.004; Van der Tol A, 2011, ACTA CLIN BELG, V66, P171; van der Tol A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013328; van Zyl-Smit R, 2004, NEPHROL DIAL TRANSPL, V19, P3176, DOI 10.1093/ndt/gfh474; Verhulst A, 2004, J AM SOC NEPHROL, V15, P2249, DOI 10.1097/01.ASN.0000136778.32499.05; Wolfe SM, 2004, LANCET, V363, P2189, DOI 10.1016/S0140-6736(04)16513-6	33	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31639	10.1371/journal.pone.0031639	http://dx.doi.org/10.1371/journal.pone.0031639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359611	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200080
J	Inoue, S; Patil, R; Portilla-Arias, J; Ding, H; Konda, B; Espinoza, A; Mongayt, D; Markman, JL; Elramsisy, A; Phillips, HW; Black, KL; Holler, E; Ljubimova, JY				Inoue, Satoshi; Patil, Rameshwar; Portilla-Arias, Jose; Ding, Hui; Konda, Bindu; Espinoza, Andres; Mongayt, Dmitriy; Markman, Janet L.; Elramsisy, Adam; Phillips, H. Westley; Black, Keith L.; Holler, Eggehard; Ljubimova, Julia Y.			Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TUMOR-CELLS; POLYMALIC ACID; IN-VITRO; ANTIBODY; ANTISENSE; LIPOSOMES; DELIVERY; TRANSFERRIN; APOPTOSIS	Treatment options for triple negative breast cancer (TNBC) are generally limited to cytotoxic chemotherapy. Recently, anti-epidermal growth factor receptor (EGFR) therapy has been introduced for TNBC patients. We engineered a novel nanobioconjugate based on a poly(beta-L-malic acid) (PMLA) nanoplatform for TNBC treatment. The nanobioconjugate carries anti-tumor nucleosome-specific monoclonal antibody (mAb) 2C5 to target breast cancer cells, anti-mouse transferrin receptor (TfR) antibody for drug delivery through the host endothelial system, and Morpholino antisense oligonucleotide (AON) to inhibit EGFR synthesis. The nanobioconjugates variants were: (1) P (BioPolymer) with AON, 2C5 and anti-TfR for tumor endothelial and cancer cell targeting, and EGFR suppression (P/AON/2C5/TfR), and (2) P with AON and 2C5 (P/AON/2C5). Controls included (3) P with 2C5 but without AON (P/2C5), (4) PBS, and (5) P with PEG and leucine ester (LOEt) for endosomal escape (P/mPEG/LOEt). Drugs were injected intravenously to MDA-MB-468 TNBC bearing mice. Tissue accumulation of injected nanobioconjugates labeled with Alexa Fluor 680 was examined by Xenogen IVIS 200 (live imaging) and confocal microscopy of tissue sections. Levels of EGFR, phosphorylated and total Akt in tumor samples were detected by western blotting. In vitro western blot showed that the leading nanobioconjugate P/AON/2C5/TfR inhibited EGFR synthesis significantly better than naked AON. In vivo imaging revealed that 2C5 increased drug-tumor accumulation. Significant tumor growth inhibition was observed in mice treated with the lead nanobioconjugate (1) [P = 0.03 vs. controls; P<0.05 vs. nanobioconjugate variant (2)]. Lead nanobioconjugate (1) also showed stronger inhibition of EGFR expression and Akt phosphorylation than other treatments. Treatment of TNBC with the new nanobioconjugate results in tumor growth arrest by inhibiting EGFR and its downstream signaling intermediate, phosphorylated Akt. The nanobioconjugate represents a new generation of nanodrugs for treatment of TNBC.	[Inoue, Satoshi; Patil, Rameshwar; Portilla-Arias, Jose; Ding, Hui; Konda, Bindu; Espinoza, Andres; Markman, Janet L.; Elramsisy, Adam; Phillips, H. Westley; Black, Keith L.; Holler, Eggehard; Ljubimova, Julia Y.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Mongayt, Dmitriy] Northeastern Univ, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA	Cedars Sinai Medical Center; Northeastern University	Inoue, S (corresponding author), Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA.	ljubimovaj@cshs.org	Holler, Eggehard Josef/H-7408-2014; PORTILLA-ARIAS, JOSE/C-3223-2008	Holler, Eggehard Josef/0000-0001-8582-2190; PORTILLA-ARIAS, JOSE/0000-0003-1105-1842; Markman, Janet/0000-0003-4691-2964; Black, Keith/0000-0002-0546-4934	National Institutes of Health [R01 CA123495, R01 CA CA136841]; Winnick Family Foundation [M01 RR00425]; NATIONAL CANCER INSTITUTE [R01CA136841, R01CA123495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winnick Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Institutes of Health (R01 CA123495 and R01 CA CA136841) to JYL and the Winnick Family Foundation(M01 RR00425) to JYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Agrawal A, 2005, ENDOCR-RELAT CANCER, V12, pS135, DOI 10.1677/erc.1.01059; Atkinson RL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001447; Baselga J, 2005, J CLIN ONCOL, V23, P5323, DOI 10.1200/JCO.2005.08.326; Baselga J, 2002, ONCOLOGIST, V7, P2; Bevers TB, 2009, J NATL COMPR CANC NE, V7, P1060, DOI 10.6004/jnccn.2009.0070; BRAUD C, 1992, POLYM BULL, V29, P177, DOI 10.1007/BF00558054; BUSCH RK, 1994, CANCER LETT, V86, P151, DOI 10.1016/0304-3835(94)90073-6; Chandna P, 2010, PHARM RES-DORDR, V27, P2296, DOI 10.1007/s11095-010-0235-2; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Ding H, 2010, P NATL ACAD SCI USA, V107, P18143, DOI 10.1073/pnas.1003919107; El Bayoumil T, 2009, CLIN CANCER RES, V15, P1973, DOI 10.1158/1078-0432.CCR-08-2392; Elbayoumi TA, 2008, INT J PHARMACEUT, V357, P272, DOI 10.1016/j.ijpharm.2008.01.041; Elbayoumi TA, 2007, J LIPOSOME RES, V17, P1, DOI 10.1080/08982100601186474; Flynn JF, 2009, J ONCOL, V2009, DOI 10.1155/2009/526963; Fujita M, 2007, J CONTROL RELEASE, V122, P356, DOI 10.1016/j.jconrel.2007.05.032; Fujita Manabu, 2006, Angiogenesis, V9, P183, DOI 10.1007/s10456-006-9046-9; Gasslmaier B, 1997, EUR J BIOCHEM, V250, P308, DOI 10.1111/j.1432-1033.1997.0308a.x; Gasslmaier B, 2000, EUR J BIOCHEM, V267, P5101, DOI 10.1046/j.1432-1327.2000.01573.x; Gupta B, 2005, J DRUG TARGET, V13, P337, DOI 10.1080/10611860500286239; Herbst RS, 2006, J CLIN ONCOL, V24, P190, DOI 10.1200/JCO.2005.04.8678; Huang SM, 2004, CANCER RES, V64, P5355, DOI 10.1158/0008-5472.CAN-04-0562; Inoue S, 2005, MOL THER, V12, P707, DOI 10.1016/j.ymthe.2005.05.015; Inoue S, 2011, CANCER RES, V71, P1454, DOI 10.1158/0008-5472.CAN-10-3093; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kallergi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2149; Kang CS, 2006, CANCER GENE THER, V13, P530, DOI 10.1038/sj.cgt.7700932; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Lee BS, 2006, BIOCONJUGATE CHEM, V17, P317, DOI 10.1021/bc0502457; Liu D, 2010, MED ONCOL; Liu X, 2008, CANCER GENE THER, V15, P126, DOI 10.1038/sj.cgt.7701111; Ljubimova JY, 2008, NANOMEDICINE-UK, V3, P247, DOI 10.2217/17435889.3.2.247; Ljubimova JY, 2008, CHEM-BIOL INTERACT, V171, P195, DOI 10.1016/j.cbi.2007.01.015; Lorenz MR, 2006, BIOMATERIALS, V27, P2820, DOI 10.1016/j.biomaterials.2005.12.022; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; Modi S, 2006, CLIN BREAST CANCER, V7, P270, DOI 10.3816/CBC.2006.n.040; Nahta R, 2007, MOL CANCER THER, V6, P667, DOI 10.1158/1535-7163.MCT-06-0423; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Sekhon HS, 2008, LUNG CANCER, V60, P347, DOI 10.1016/j.lungcan.2007.10.028; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; VANRENSWOUDE J, 1982, P NATL ACAD SCI-BIOL, V79, P6186; Vert M., 2002, BIOPOLYMERS A, V3a, P75; Wilhelm C, 2003, BIOMATERIALS, V24, P1001, DOI 10.1016/S0142-9612(02)00440-4; Wu B, 2010, GENE THER, V17, P132, DOI 10.1038/gt.2009.120; Xia CQ, 2001, PHARM RES-DORDR, V18, P191, DOI 10.1023/A:1011032502097	47	41	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31070	10.1371/journal.pone.0031070	http://dx.doi.org/10.1371/journal.pone.0031070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355336	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300036
J	Maxwell, BA; Xu, CL; Suo, ZC				Maxwell, Brian A.; Xu, Cuiling; Suo, Zucai			DNA Lesion Alters Global Conformational Dynamics of Y-family DNA Polymerase during Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFOLOBUS-SOLFATARICUS P2; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; FIDELITY; REPLICATION; DPO4; BYPASS; BETA; TRANSITIONS; MECHANISM	A major product of oxidative damage to DNA, 8-oxo-7,8-dihydro-2'-deoxyguanine (8-oxoG), can lead to genomic mutations if it is bypassed unfaithfully by DNA polymerases in vivo. However, our pre-steady-state kinetic studies show that DNA polymerase IV (Dpo4), a prototype Y-family enzyme from Sulfolobus solfataricus, can bypass 8-oxoG both efficiently and faithfully. For the first time, our stopped-flow FRET studies revealed that a DNA polymerase altered its synchronized global conformational dynamics in response to a DNA lesion. Relative to nucleotide incorporation into undamaged DNA, three of the four domains of Dpo4 undertook different conformational transitions during 8-oxoG bypass and the subsequent extension step. Moreover, the rapid translocation of Dpo4 along DNA induced by nucleotide binding was significantly hindered by the interactions between the embedded 8-oxoG and Dpo4 during the extension step. These results unprecedentedly demonstrate that a Y-family DNA polymerase employs different global conformational dynamics when replicating undamaged and damaged DNA.	[Maxwell, Brian A.; Xu, Cuiling; Suo, Zucai] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Maxwell, Brian A.; Suo, Zucai] Ohio State Univ, Biophys Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Suo, ZC (corresponding author), Ohio State Univ, Dept Biochem, 484 W 12th Ave, Columbus, OH 43210 USA.	suo.3@osu.edu		Maxwell, Brian/0000-0002-0177-3991	National Science Foundation [MCB-0447899, MCB-0960961]; Div Of Molecular and Cellular Bioscience [0960961] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Career Award MCB-0447899 and Grant MCB-0960961 (to Z. S.).	Boudsocq F, 2004, J BIOL CHEM, V279, P32932, DOI 10.1074/jbc.M405249200; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Irimia A, 2010, ACTA CRYSTALLOGR F, V66, P1013, DOI 10.1107/S1744309110029374; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Rechkoblit O, 2009, STRUCTURE, V17, P725, DOI 10.1016/j.str.2009.03.011; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Silverstein TD, 2010, STRUCTURE, V18, P1463, DOI 10.1016/j.str.2010.08.019; Wang YL, 2006, PROTEIN SCI, V15, P135, DOI 10.1110/ps.051726906; Wong JH, 2008, J MOL BIOL, V379, P317, DOI 10.1016/j.jmb.2008.03.038; Xu CL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000225; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zhang LK, 2009, BIOCHEMISTRY-US, V48, P7492, DOI 10.1021/bi900532w	25	20	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13040	13047		10.1074/jbc.M112.345835	http://dx.doi.org/10.1074/jbc.M112.345835			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362779	hybrid, Green Published			2022-12-25	WOS:000302903700042
J	Schaper, W; Bentrop, J; Ustinova, J; Blume, L; Kats, E; Tiralongo, J; Weinhold, B; Bastmeyer, M; Munster-Kuhnel, AK				Schaper, Wiebke; Bentrop, Joachim; Ustinova, Jana; Blume, Linda; Kats, Elina; Tiralongo, Joe; Weinhold, Birgit; Bastmeyer, Martin; Muenster-Kuehnel, Anja-K.			Identification and Biochemical Characterization of Two Functional CMP-Sialic Acid Synthetases in Danio rerio	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; GENOME DUPLICATION; MOLECULAR-CLONING; POLYSIALIC ACID; EXPRESSION; EVOLUTION; PROTEIN; GENES; SIALYLATION; UTILIZES	Sialic acids (Sia) form the nonreducing end of the bulk of cell surface-expressed glycoconjugates. They are, therefore, major elements in intercellular communication processes. The addition of Sia to glycoconjugates requires metabolic activation to CMP-Sia, catalyzed by CMP-Sia synthetase (CMAS). This highly conserved enzyme is located in the cell nucleus in all vertebrates investigated to date, but its nuclear function remains elusive. Here, we describe the identification and characterization of two Cmas enzymes in Danio rerio (dreCmas), one of which is exclusively localized in the cytosol. We show that the two cmas genes most likely originated from the third whole genome duplication, which occurred at the base of teleost radiation. cmas paralogues were maintained in fishes of the Otocephala clade, whereas one copy got subsequently lost in Euteleostei (e.g. rainbow trout). In zebrafish, the two genes exhibited a distinct spatial expression pattern. The products of these genes (dreCmas1 and dreCmas2) diverged not only with respect to subcellular localization but also in substrate specificity. Nuclear dreCmas1 favored N-acetylneuraminic acid, whereas the cytosolic dreCmas2 showed highest affinity for 5-deaminoneuraminic acid. The subcellular localization was confirmed for the endogenous enzymes in fractionated zebrafish lysates. Nuclear entry of dreCmas1 was mediated by a bipartite nuclear localization signal, which seemed irrelevant for other enzymatic functions. With the current demonstration that in zebrafish two subfunctionalized cmas paralogues co-exist, we introduce a novel and unique model to detail the roles that CMAS has in the nucleus and in the sialylation pathways of animal cells.	[Schaper, Wiebke; Blume, Linda; Kats, Elina; Weinhold, Birgit; Muenster-Kuehnel, Anja-K.] Hannover Med Sch MHH, Inst Cellular Chem, D-30625 Hannover, Germany; [Bentrop, Joachim; Ustinova, Jana; Bastmeyer, Martin] KIT, Inst Zool 1, D-76131 Karlsruhe, Germany; [Tiralongo, Joe] Griffith Univ, Inst Glyc, Southport, Qld 4222, Australia	Hannover Medical School; Helmholtz Association; Karlsruhe Institute of Technology; Griffith University	Munster-Kuhnel, AK (corresponding author), Hannover Med Sch MHH, Inst Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	muenster.anja@mh-hannover.de	Bastmeyer, Martin/H-9342-2013	Bastmeyer, Martin/0000-0003-3471-8400; Tiralongo, Joe/0000-0002-3529-6310	German Research Foundation (DFG) [MU1849/1, BA 1034/15-19]; DFG for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy)	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) Grant MU1849/1 (to A. K. M. K.) and BA 1034/15-19 (to M. B. and J.B.) and by funding from the DFG for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy).	Bentrop J, 2008, DEV DYNAM, V237, P808, DOI 10.1002/dvdy.21451; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chang LY, 2009, GLYCOCONJUGATE J, V26, P263, DOI 10.1007/s10719-008-9165-1; Chang LY, 2009, GLYCOCONJUGATE J, V26, P247, DOI 10.1007/s10719-008-9161-5; Christophe D, 2000, CELL SIGNAL, V12, P337, DOI 10.1016/S0898-6568(00)00077-2; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Guerardel Y, 2006, GLYCOBIOLOGY, V16, P244, DOI 10.1093/glycob/cwj062; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Heppell J, 1998, FISH SHELLFISH IMMUN, V8, P271, DOI 10.1006/fsim.1997.0133; Inoue S, 2006, GLYCOCONJUGATE J, V23, P277, DOI 10.1007/s10719-006-6484-y; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; KEAN E L, 1991, Glycobiology, V1, P441, DOI 10.1093/glycob/1.5.441; KEAN EL, 1969, EXP EYE RES, V8, P44, DOI 10.1016/S0014-4835(69)80079-5; Kean EL, 2004, BBA-GEN SUBJECTS, V1673, P56, DOI 10.1016/j.bbagen.2004.04.006; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krapp S, 2003, J MOL BIOL, V334, P625, DOI 10.1016/j.jmb.2003.09.080; Langhauser M, 2012, GLYCOBIOLOGY, V22, P196, DOI 10.1093/glycob/cwr129; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawrence SM, 2001, GLYCOCONJUGATE J, V18, P205, DOI 10.1023/A:1012452705349; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Marx M, 2001, DEVELOPMENT, V128, P4949; Marx M, 2007, DEV BIOL, V306, P560, DOI 10.1016/j.ydbio.2007.03.032; Mosimann SC, 2001, J BIOL CHEM, V276, P8190, DOI 10.1074/jbc.M007235200; Munster AK, 2002, J BIOL CHEM, V277, P19688, DOI 10.1074/jbc.M201093200; Munster AK, 1998, P NATL ACAD SCI USA, V95, P9140, DOI 10.1073/pnas.95.16.9140; Munster-Kuhnel AK, 2004, GLYCOBIOLOGY, V14, p43R, DOI 10.1093/glycob/cwh113; Nakata D, 2001, GLYCOBIOLOGY, V11, P685, DOI 10.1093/glycob/11.8.685; Oschlies M, 2009, J MOL BIOL, V393, P83, DOI 10.1016/j.jmb.2009.08.003; Potvin B, 1995, J BIOL CHEM, V270, P30415, DOI 10.1074/jbc.270.51.30415; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Sohn H, 2006, FASEB J, V20, P1248, DOI 10.1096/fj.05-4911fje; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Thisse B., 2001, ZFIN ON LINE PUBLICA; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tiralongo J, 2007, GLYCOBIOLOGY, V17, P945, DOI 10.1093/glycob/cwm064	42	14	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13239	13248		10.1074/jbc.M111.327544	http://dx.doi.org/10.1074/jbc.M111.327544			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351762	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000302903700061
J	Xiao, SH; Tang, YS; Khan, RA; Zhang, YH; Kusumanchi, P; Stabler, SP; Jayaram, HN; Antony, AC				Xiao, Suhong; Tang, Ying-Sheng; Khan, Rehana A.; Zhang, Yonghua; Kusumanchi, Praveen; Stabler, Sally P.; Jayaram, Hiremagalur N.; Antony, Asok C.			Influence of Physiologic Folate Deficiency on Human Papillomavirus Type 16 (HPV16)-harboring Human Keratinocytes in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMMON FRAGILE SITES; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS; MESSENGER-RNA; 3'-UNTRANSLATED REGION; CERVICAL DYSPLASIA; URACIL MISINCORPORATION; UNTRANSLATED REGION; NATURAL-HISTORY; DOMAIN PROTEINS; BINDING-PROTEIN	Although HPV16 transforms infected epithelial tissues to cancer in the presence of several co-factors, there is insufficient molecular evidence that poor nutrition has any such role. Because physiological folate deficiency led to the intracellular homocysteinylation of heterogeneous nuclear ribonucleoprotein E1 (hnRNP-E1) and activated a nutrition-sensitive (homocysteine-responsive) posttranscriptional RNA operon that included interaction with HPV16 L2 mRNA, we investigated the functional consequences of folate deficiency on HPV16 in immortalized HPV16-harboring human (BC-1-Ep/SL) keratinocytes and HPV16-organotypic rafts. Although homocysteinylated hnRNP-E1 interacted with HPV16 L2 mRNA cis-element, it also specifically bound another HPV16 57-nucleotide poly(U)-rich cis-element in the early polyadenylation element (upstream of L2 boolean AND L1 genes) with greater affinity. Together, these interactions led to a profound reduction of both L1 and L2 mRNA and proteins without effects on HPV16 E6 and E7 in vitro, and in cultured keratinocyte monolayers and HPV16-low folate-organotypic rafts developed in physiological low folate medium. In addition, HPV16-low folate-organotypic rafts contained fewer HPV16 viral particles, a similar HPV16 DNA viral load, and a much greater extent of integration of HPV16 DNA into genomic DNA when compared with HPV16-high folate-organotypic rafts. Subcutaneous implantation of 18-day old HPV16-low folate-organotypic rafts into folate-replete immunodeficient mice transformed this benign keratinocyte-derived raft tissue into an aggressive HPV16-induced cancer within 12 weeks. Collectively, these studies establish a likely molecular linkage between poor folate nutrition and HPV16 and predict that nutritional folate and/or vitamin-B12 deficiency, which are both common worldwide, will alter the natural history of HPV16 infections and also warrant serious consideration as reversible co-factors in oncogenic transformation of HPV16-infected tissues to cancer.	[Xiao, Suhong; Tang, Ying-Sheng; Khan, Rehana A.; Zhang, Yonghua; Kusumanchi, Praveen; Antony, Asok C.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Jayaram, Hiremagalur N.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Stabler, Sally P.] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Kusumanchi, Praveen; Jayaram, Hiremagalur N.; Antony, Asok C.] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Antony, AC (corresponding author), 980 W Walnut St,Walther Hall R3 C321B, Indianapolis, IN 46202 USA.	aantony@iupui.edu			National Institutes of Health [R01CA120843, R01HD39295, AG09834]; Veterans Affairs Merit Review Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039295] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA120843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA120843 and R01HD39295 (to A. C. A.) and AG09834 (to S. P. S.). This work was also supported by a Veterans Affairs Merit Review Award (to A. C. A. and H. N. J.). One of the authors (S. P. S.) and the University of Colorado hold patents on the use of assays for total homocysteine and other metabolites to diagnose vitamin-B<INF>12</INF> (cobalamin) and folate deficiencies, and a company has been formed at the University of Colorado to perform such assays.	Ames BN, 2002, NAT REV CANCER, V2, P694, DOI 10.1038/nrc886; Antony A. C., 2009, HEMATOLOGY BASIC PRI, P491; Antony AC, 2004, J CLIN INVEST, V113, P285, DOI 10.1172/JCI200411548; Antony AC, 2003, AM J CLIN NUTR, V78, P3, DOI 10.1093/ajcn/78.1.3; Antony AC, 2001, AM J CLIN NUTR, V74, P157; BARBI G, 1984, HUM GENET, V68, P290, DOI 10.1007/BF00292586; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Bonnez W, 2005, METH MOLEC MED, V119, P203; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; BRANDSMA JL, 1995, J VIROL, V69, P2716, DOI 10.1128/JVI.69.4.2716-2721.1995; Budy B, 2006, ARCH BIOCHEM BIOPHYS, V446, P119, DOI 10.1016/j.abb.2005.12.014; BUTTERWORTH CE, 1992, JAMA-J AM MED ASSOC, V267, P528, DOI 10.1001/jama.267.4.528; BUTTERWORTH CE, 1982, AM J CLIN NUTR, V35, P73, DOI 10.1093/ajcn/35.1.73; BUTTERWORTH CE, 1993, J AM COLL NUTR, V12, P438, DOI 10.1080/07315724.1993.10718334; Campos SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004463; Carcopino X, 2006, J MED VIROL, V78, P1131, DOI 10.1002/jmv.20673; Chakravarty I, 2002, NUTR REV, V60, pS53, DOI 10.1301/00296640260130740; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chitambar C. R., 2006, MODERN NUTR HLTH DIS, P1436; CHOI YD, 1986, SCIENCE, V231, P1534, DOI 10.1126/science.3952495; Ciappio E, 2010, FOLATE HLTH DIS, P235; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Czyzyk-Krzeska MF, 1999, BLOOD, V93, P2111, DOI 10.1182/blood.V93.6.2111.406k24_2111_2120; DAS KC, 1989, AM J HEMATOL, V31, P11, DOI 10.1002/ajh.2830310103; DIANOV GL, 1991, MOL GEN GENET, V225, P448, DOI 10.1007/BF00261686; Duthie SJ, 1998, FASEB J, V12, P1491, DOI 10.1096/fasebj.12.14.1491; Feldman JP, 2009, J APPL QUANT METHODS, V4, P455, DOI DOI 10.1111/J.2042-3306.2010.TB05629.X; Flores ER, 1999, VIROLOGY, V262, P344, DOI 10.1006/viro.1999.9868; Flores ER, 2000, J VIROL, V74, P6622, DOI 10.1128/JVI.74.14.6622-6631.2000; Gamarnik AV, 1997, RNA, V3, P882; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GOULIAN M, 1980, J BIOL CHEM, V255, P630; GOULIAN M, 1980, P NATL ACAD SCI-BIOL, V77, P1956, DOI 10.1073/pnas.77.4.1956; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Jiang Y, 2006, MOL CELL BIOL, V26, P2419, DOI 10.1128/MCB.26.6.2419-2429.2006; Johnston C, 2000, LANCET, V355, P2179, DOI 10.1016/S0140-6736(00)02395-3; Kalantari M, 1998, INT J GYNECOL PATHOL, V17, P146, DOI 10.1097/00004347-199804000-00009; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kim YI, 1997, AM J CLIN NUTR, V65, P46, DOI 10.1093/ajcn/65.1.46; Kwanbunjan K, 2005, NUTR RES, V25, P641, DOI 10.1016/j.nutres.2005.05.004; LAIMINS LA, 1993, INFECT AGENT DIS, V2, P74; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Mashiyama ST, 2004, ANAL BIOCHEM, V330, P58, DOI 10.1016/j.ab.2004.03.065; Motulsky H., 2004, FITTING MODELS BIOL, P296; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Paulding WR, 1999, J BIOL CHEM, V274, P2532, DOI 10.1074/jbc.274.4.2532; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Piyathilake CJ, 2010, INT J WOMENS HEALTH, V2, P7; Piyathilake CJ, 2004, CANCER RES, V64, P8788, DOI 10.1158/0008-5472.CAN-04-2402; REIDY JA, 1988, MUTAT RES, V200, P215, DOI 10.1016/0027-5107(88)90085-1; Savelyeva L, 2006, CANCER LETT, V232, P58, DOI 10.1016/j.canlet.2005.08.033; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; Schwartz S, 2000, UPSALA J MED SCI, V105, P171; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Stabler SP, 2004, ANNU REV NUTR, V24, P299, DOI 10.1146/annurev.nutr.24.012003.132440; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Sun XL, 1996, J BIOL CHEM, V271, P25539; SUTHERLAND GR, 1995, CURR OPIN GENET DEV, V5, P323, DOI 10.1016/0959-437X(95)80046-8; Tang YS, 2011, J BIOL CHEM, V286, P39100, DOI 10.1074/jbc.M111.230938; Thomson SW, 2000, NUTR CANCER, V37, P128, DOI 10.1207/S15327914NC372_2; Thorland EC, 2003, ONCOGENE, V22, P1225, DOI 10.1038/sj.onc.1206170; Thorland EC, 2000, CANCER RES, V60, P5916; Thyagarajan A, 2004, J BIOL CHEM, V279, P49680, DOI 10.1074/jbc.M408915200; WANG XM, 1995, MOL CELL BIOL, V15, P1769; Weinstein SJ, 2001, CANCER CAUSE CONTROL, V12, P317, DOI 10.1023/A:1011290103779; White WI, 1998, J VIROL, V72, P959, DOI 10.1128/JVI.72.2.959-964.1998; WICKRAMASINGHE SN, 1994, BLOOD, V83, P1656; Wilke CM, 1996, HUM MOL GENET, V5, P187, DOI 10.1093/hmg/5.2.187; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Woolaway K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-28; Xiao SH, 2005, BIRTH DEFECTS RES A, V73, P6, DOI 10.1002/bdra.20105; Xiao XL, 2001, J BIOL CHEM, V276, P41510, DOI 10.1074/jbc.M106824200; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zhao XM, 2005, J VIROL, V79, P4270, DOI 10.1128/JVI.79.7.4270-4288.2005	81	16	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12559	12577		10.1074/jbc.M111.317040	http://dx.doi.org/10.1074/jbc.M111.317040			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351779	hybrid, Green Published			2022-12-25	WOS:000302782200095
J	Blanco, M; Campos, F; Rodriguez-Yanez, M; Arias, S; Fernandez-Ferro, J; Gomez-Sanchez, JC; Castillo, J				Blanco, Miguel; Campos, Francisco; Rodriguez-Yanez, Manuel; Arias, Susana; Fernandez-Ferro, Jose; Carlos Gomez-Sanchez, Jose; Castillo, Jose			Neuroprotection or Increased Brain Damage Mediated by Temperature in Stroke Is Time Dependent	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; BODY-TEMPERATURE; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; COPENHAGEN STROKE; CARDIAC-ARREST; METAANALYSIS; FEASIBILITY; SEVERITY; THROMBOLYSIS	The control of temperature during the acute phase of stroke may be a new therapeutic target that can be applied in all stroke patients, however therapeutic window or timecourse of the temperature effect is not well established. Our aim is to study the association between changes in body temperature in the first 72 hours and outcome in patients with ischemic (IS) and hemorrhagic (ICH) stroke. We prospectively studied 2931 consecutive patients (2468 with IS and 463 with ICH). Temperature was obtained at admission, and at 24, 48 and 72 hours after admission. Temperature was categorized as low (<36 degrees C), normal (36-37 degrees C) and high (>37 degrees C). As the main variable, we studied functional outcome at 3 months determined by modified Rankin Scale. Temperature in stroke patients is higher than in controls, and increases gradually in the first 72 hours after stroke. A positive correlation between temperature and stroke severity determined by NIHSS was found at 24 and 48 hours, but not at admission or 72 hours. In a logistic regression model, high temperature was associated with poor outcome at 24 hours (OR 2.05, 95% CI 1.59-2.64, p<0.0001) and 48 hours (OR 1.93, 95% CI 1.08-2.34, p = 0.007), but not at admission or 72 hours. Temperature increases in patients with stroke in the first 72 hours, with the harmful effect of high temperature occurring in the first 48 hours. The neuroprotective effect of low temperature occurs within the first 24 hours from stroke onset.	[Blanco, Miguel; Campos, Francisco; Rodriguez-Yanez, Manuel; Arias, Susana; Fernandez-Ferro, Jose; Castillo, Jose] Univ Santiago de Compostela, Hosp Clin Univ, Clin Neurosci Res Lab, Dept Neurol, Santiago De Compostela, Spain; [Carlos Gomez-Sanchez, Jose] Hosp Clin Univ, Dept Neurol, Salamanca, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Blanco, M (corresponding author), Univ Santiago de Compostela, Hosp Clin Univ, Clin Neurosci Res Lab, Dept Neurol, Santiago De Compostela, Spain.	jose.castillo@usc.es	Rodríguez-Yáñez, Manuel/ABI-1283-2020; Ferro, Jose/ABH-1763-2021	Rodríguez-Yáñez, Manuel/0000-0002-5381-8557; Castillo, Jose/0000-0002-6685-3001; Fernandez-Ferro, Jose/0000-0003-1172-0153; Gomez-Sanchez, Jose Carlos/0000-0001-6096-7051	Spanish Ministry of Science and Innovation [SAF2011-30517]; Fondo de Investigaciones Sanitarias, Instituto Salud Carlos III [RETICS-RD06/0026]; Xunta de Galicia (Conselleria de Innovacion, Industria e Comercio) [09CSA057918PR]; Xunta de Galicia (Conselleria de Sanidade) [PS09/32]; Xunta de Galicia (Programa Angeles Alvarino); Fundacion Mutua Madrilena; Red de Investigacion Cooperativa Neurovascular	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias, Instituto Salud Carlos III(Instituto de Salud Carlos III); Xunta de Galicia (Conselleria de Innovacion, Industria e Comercio)(Xunta de Galicia); Xunta de Galicia (Conselleria de Sanidade)(Xunta de Galicia); Xunta de Galicia (Programa Angeles Alvarino)(Xunta de Galicia); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Red de Investigacion Cooperativa Neurovascular	This project has been partially supported by grants from the Spanish Ministry of Science and Innovation SAF2011-30517 and Fondo de Investigaciones Sanitarias, Instituto Salud Carlos III, RETICS-RD06/0026; Xunta de Galicia (Conselleria de Innovacion, Industria e Comercio: 09CSA057918PR; Conselleria de Sanidade: PS09/32 and Programa Angeles Alvarino); Fundacion Mutua Madrilena and by Red de Investigacion Cooperativa Neurovascular. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Boysen G, 2001, STROKE, V32, P413, DOI 10.1161/01.STR.32.2.413; Castellanos Mar, 2007, Cerebrovasc Dis, V24 Suppl 1, P7, DOI 10.1159/000107374; CASTILLO J, 1994, CEREBROVASC DIS, V4, P66, DOI 10.1159/000108454; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Clark DL, 2008, EXP NEUROL, V212, P386, DOI 10.1016/j.expneurol.2008.04.016; den Hertog HM, 2011, J NEUROL, V258, P302, DOI 10.1007/s00415-010-5756-4; den Hertog HM, 2009, LANCET NEUROL, V8, P434, DOI 10.1016/S1474-4422(09)70051-1; Ernon L, 2006, ACTA NEUROL SCAND, V114, P23, DOI 10.1111/j.1600-0404.2006.00596.x; Fingas M, 2009, EXP NEUROL, V219, P156, DOI 10.1016/j.expneurol.2009.05.007; Friedman LK, 2001, MOL BRAIN RES, V86, P34, DOI 10.1016/S0169-328X(00)00252-7; Georgiadis D, 2001, STROKE, V32, P2550, DOI 10.1161/hs1101.097382; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jaramillo A, 2008, J NEUROL SCI, V266, P1, DOI 10.1016/j.jns.2007.08.037; Kammersgaard LP, 2000, STROKE, V31, P2251, DOI 10.1161/01.STR.31.9.2251; Kammersgaard LP, 2002, STROKE, V33, P1759, DOI 10.1161/01.STR.0000019910.90280.F1; Karaszewski B, 2006, ANN NEUROL, V60, P438, DOI 10.1002/ana.20957; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kollmar R, 2009, STROKE, V40, P1907, DOI 10.1161/STROKEAHA.108.530410; Leira R, 2012, CLIN SCI, V122, P113, DOI 10.1042/CS20110143; Millan M, 2008, EUR J NEUROL, V15, P1384, DOI 10.1111/j.1468-1331.2008.02321.x; Naess H, 2010, ACTA NEUROL SCAND, V122, P414, DOI 10.1111/j.1600-0404.2010.01331.x; Olsen TS, 2003, LANCET NEUROL, V2, P410, DOI 10.1016/S1474-4422(03)00436-8; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Saini M, 2009, STROKE, V40, P3051, DOI 10.1161/STROKEAHA.109.556134; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Schwarzenberg H, 1998, CARDIOVASC INTER RAD, V21, P142, DOI 10.1007/s002709900231; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Steiner T, 2001, STROKE, V32, P2833, DOI 10.1161/hs1201.99511; Tang XN, 2009, J NEUROTRAUM, V26, P325, DOI 10.1089/neu.2008.0594; Tomsick TA, 2010, NEUROLOGY, V74, P1069, DOI 10.1212/WNL.0b013e3181d76b8f; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375	39	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30700	10.1371/journal.pone.0030700	http://dx.doi.org/10.1371/journal.pone.0030700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363473	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600057
J	Fu, Y; Kunz, R; Wu, JH; Dong, C				Fu, Yi; Kunz, Robert; Wu, Jianhua; Dong, Cheng			Study of Local Hydrodynamic Environment in Cell-Substrate Adhesion Using Side-View mu PIV Technology	PLOS ONE			English	Article							WALL-SHEAR-STRESS; LEUKOCYTE ROLLING ADHESION; MICRO-PIV; BLOOD-FLOW; ADHERENT LEUKOCYTES; MELANOMA ADHESION; SURFACE ADHESION; TUMOR-METASTASIS; CANCER; DEFORMATION	Tumor cell adhesion to the endothelium under shear flow conditions is a critical step that results in circulation-mediated tumor metastasis. This study presents experimental and computational techniques for studying the local hydrodynamic environment around adherent cells and how local shear conditions affect cell-cell interactions on the endothelium in tumor cell adhesion. To study the local hydrodynamic profile around heterotypic adherent cells, a side-view flow chamber assay coupled with micro particle imaging velocimetry (mPIV) technique was developed, where interactions between leukocytes and tumor cells in the near-endothelial wall region and the local shear flow environment were characterized. Computational fluid dynamics (CFD) simulations were also used to obtain quantitative flow properties around those adherent cells. Results showed that cell dimension and relative cell-cell positions had strong influence on local shear rates. The velocity profile above leukocytes and tumor cells displayed very different patterns. Larger cell deformations led to less disturbance to the flow. Local shear rates above smaller cells were observed to be more affected by relative positions between two cells.	[Fu, Yi; Wu, Jianhua] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Fu, Yi; Dong, Cheng] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA; [Kunz, Robert] Penn State Univ, Appl Res Lab, University Pk, PA 16802 USA	South China University of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Fu, Y (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	cxd23@psu.edu	Kunz, Robert/GOV-3020-2022		National Institute of Health [CA-125707]; National Science Foundation [CBET-0729091]; National Natural Science Foundation of China [31170887]; Chinese Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA125707] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000127] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work is supported by grants from National Institute of Health Grants (CA-125707, to C. D.), National Science Foundation Grant (CBET-0729091, to C. D.) National Natural Science Foundation of China (31170887, to J.W.), and the Fellowship from Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao J, 1997, ANN BIOMED ENG, V25, P573, DOI 10.1007/BF02684196; Cao J, 1998, MICROVASC RES, V55, P124, DOI 10.1006/mvre.1997.2064; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chambers AF, 1995, CANCER METAST REV, V14, P279, DOI 10.1007/BF00690599; Chapman GB, 1997, BIORHEOLOGY, V34, P37, DOI 10.1016/S0006-355X(97)00003-6; Chapman GB, 1998, BIOPHYS J, V74, P3292, DOI 10.1016/S0006-3495(98)78036-1; CHIEN S, 1987, ANNU REV PHYSIOL, V49, P177, DOI 10.1146/annurev.ph.49.030187.001141; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dong C, 2005, FRONT BIOSCI-LANDMRK, V10, P379, DOI 10.2741/1535; Dong C, 1999, ANN BIOMED ENG, V27, P298, DOI 10.1114/1.143; Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8; Dong Cheng, 2005, Molecular & Cellular Biomechanics, V2, P145; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; GASIC GJ, 1984, CANCER METAST REV, V3, P99, DOI 10.1007/BF00047657; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Gui L, 2002, P 11 INT S APPL LAS, V12, P4; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Hoskins M, 2008, THESIS PENNSYLVANIA; Hoskins MH, 2009, J FLUID STRUCT, V25, P936, DOI 10.1016/j.jfluidstructs.2009.02.002; Jadhav S, 2005, BIOPHYS J, V88, P96, DOI 10.1529/biophysj.104.051029; Jadhav S, 2007, J BIOMECH, V40, P2891, DOI 10.1016/j.jbiomech.2007.03.017; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kahler CJ, 2006, EXP FLUIDS, V41, P327, DOI 10.1007/s00348-006-0167-0; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Lee JY, 2007, PHYSIOL MEAS, V28, P1149, DOI 10.1088/0967-3334/28/10/002; LEE KH, 1992, J INVEST DERMATOL, V98, P79, DOI 10.1111/1523-1747.ep12495643; Lei X, 1999, J BIOMECH ENG-T ASME, V121, P636, DOI 10.1115/1.2800866; Leong C, 2007, B AM PHYS SOC, V52; Leyton-Mange J, 2006, J BIOMECH ENG-T ASME, V128, P271, DOI 10.1115/1.2165689; Liang S, 2005, EXP CELL RES, V310, P282, DOI 10.1016/j.yexcr.2005.07.028; Liang S, 2008, ANN BIOMED ENG, V36, P661, DOI 10.1007/s10439-008-9445-8; Lima R, 2007, J BIOMECH, V40, P2752, DOI 10.1016/j.jbiomech.2007.01.012; Lima R, 2006, MEAS SCI TECHNOL, V17, P797, DOI 10.1088/0957-0233/17/4/026; Lindken R, 2009, LAB CHIP, V9, P2551, DOI 10.1039/b906558j; Lyczkowski RW, 2009, ANN BIOMED ENG, V37, P1516, DOI 10.1007/s10439-009-9729-7; MCGOVERN VJ, 1982, J CUTAN PATHOL, V9, P61, DOI 10.1111/j.1600-0560.1982.tb01044.x; Meinhart CD, 1999, EXP FLUIDS, V27, P414, DOI 10.1007/s003480050366; Meinhart CD, 2000, J FLUID ENG-T ASME, V122, P285, DOI 10.1115/1.483256; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Munn LL, 2008, ANN BIOMED ENG, V36, P534, DOI 10.1007/s10439-007-9429-0; Nguyen C, 2008, 14 INT S APPL LAS TE, P7; Pappu V, 2008, COMPUT BIOL MED, V38, P738, DOI 10.1016/j.compbiomed.2008.04.002; Pawar P, 2008, AM J PHYSIOL-HEART C, V295, pH1439, DOI 10.1152/ajpheart.91536.2007; Pickard JE, 2009, BIOPHYS J, V96, P4249, DOI 10.1016/j.bpj.2009.01.060; Poelma C, 2008, EXP FLUIDS, V45, P703, DOI 10.1007/s00348-008-0476-6; Poelma C, 2010, J R SOC INTERFACE, V7, P91, DOI 10.1098/rsif.2009.0063; Pommer M, 2005, P 6 INT S PART IM VE, V5, P21; Rossi M, 2008, PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON NANOCHANNELS, MICROCHANNELS, AND MINICHANNELS, PTS A AND B, P1093; Santiago JG, 1998, EXP FLUIDS, V25, P316, DOI 10.1007/s003480050235; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Silva G, 2008, INT J HEAT FLUID FL, V29, P1211, DOI 10.1016/j.ijheatfluidflow.2008.03.013; Slattery MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC831, DOI 10.1152/ajpcell.00439.2004; Slattery MJ, 2003, INT J CANCER, V106, P713, DOI 10.1002/ijc.11297; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sugii Y, 2005, MEAS SCI TECHNOL, V16, P1126, DOI 10.1088/0957-0233/16/5/011; Tolouei E, IN VITRO MICROPIV ME; Voorhees A, 2007, P ROY SOC A-MATH PHY, V463, P1409, DOI 10.1098/rspa.2006.1805; Wereley ST, 2010, ANNU REV FLUID MECH, V42, P557, DOI 10.1146/annurev-fluid-121108-145427; Ying H, 1999, NAT MED, V5, P823, DOI 10.1038/10548; YOUNGREN GK, 1975, J FLUID MECH, V69, P377, DOI 10.1017/S0022112075001486; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219; Zhang P, 2011, J IMMUNOL, V186, P242, DOI 10.4049/jimmunol.1000494; Zhu C, 2008, ANN BIOMED ENG, V36, P604, DOI 10.1007/s10439-008-9464-5	67	6	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30721	10.1371/journal.pone.0030721	http://dx.doi.org/10.1371/journal.pone.0030721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363477	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600060
J	Gao, X; Zhu, YB; Li, G; Huang, HT; Zhang, GB; Wang, FM; Sun, J; Yang, QT; Zhang, XG; Lu, BF				Gao, Xin; Zhu, Yibei; Li, Gang; Huang, Haitao; Zhang, Guangbo; Wang, Fengming; Sun, Jing; Yang, Qianting; Zhang, Xueguang; Lu, Binfeng			TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression	PLOS ONE			English	Article							AUTOIMMUNE; INFLAMMATION; GENERATION; INDUCTION; RESPONSES; PROMOTES; TH17	Background: T cell immunoglobulin-3 (TIM-3) has been established as a negative regulatory molecule and plays a critical role in immune tolerance. TIM-3 is upregulated in exhausted CD8(+) T cells in both chronic infection and tumor. However, the nature of TIM-3(+)CD4(+) T cells in the tumor microenvironment is unclear. This study is to characterize TIM-3 expressing lymphocytes within human lung cancer tissues and establish clinical significance of TIM-3 expression in lung cancer progression. Methodology: A total of 51 human lung cancer tissue specimens were obtained from pathologically confirmed and newly diagnosed non-small cell lung cancer (NSCLC) patients. Leukocytes from tumor tissues, distal normal lung tissues, and peripheral blood mononuclear cells (PBMC) were analyzed for TIM-3 surface expression by flow cytometry. TIM-3 expression on tumor-infiltrating lymphocytes (TILs) was correlated with clinicopathological parameters. Conclusions: TIM-3 is highly upregulated on both CD4(+) and CD8(+) TILs from human lung cancer tissues but negligibly expressed on T cells from patients' peripheral blood. Frequencies of IFN-gamma(+) cells were reduced in TIM-3(+)CD8(+) TILs compared to TIM-3(-)CD8(+) TILs. However, the level of TIM-3 expression on CD8(+) TILs failed to associate with any clinical pathological parameter. Interestingly, we found that approximately 70% of TIM-3(+)CD4(+) TILs expressed FOXP3 and about 60% of FOXP3(+) TILs were TIM-3(+). Importantly, TIM-3 expression on CD4(+) T cells correlated with poor clinicopathological parameters of NSCLC such as nodal metastasis and advanced cancer stages. Our study reveals a new role of TIM-3 as an important immune regulator in the tumor microenvironment via its predominant expression in regulatory T cells.	[Gao, Xin; Zhu, Yibei; Li, Gang; Wang, Fengming; Sun, Jing; Zhang, Xueguang] Soochow Univ, Inst Med Biotechnol, Dept Immunol, Suzhou, Peoples R China; [Zhu, Yibei; Lu, Binfeng] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Lu, Binfeng] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Huang, Haitao; Zhang, Guangbo] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Clin Immunol, Suzhou, Peoples R China; [Zhang, Xueguang] Soochow Univ, Jiangsu Prov Key Lab Stem Cell Res, Suzhou, Peoples R China; [Yang, Qianting] Shenzhen Third Peoples Hosp, Shenzhen Clin Ctr Infect Dis, Shenzhen, Peoples R China	Soochow University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Soochow University - China; Soochow University - China	Gao, X (corresponding author), Soochow Univ, Inst Med Biotechnol, Dept Immunol, Suzhou, Peoples R China.	xueguangzh@yahoo.com.cn; binfeng@pitt.edu		Gao, Xin/0000-0001-8622-1522	NSFC (National Natural Science Foundation of China) [30528008]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0849]; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Cancer Research Institute; University of Pittsburgh; Eleven-Fifth Mega-Scientific Project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases" [2008ZX10003-012]; China Scholarship council; NSFC [31170866]; Jiangsu Natural Science Fund [BK2011289]; Suzhou Social Development Project [SYS201009]	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Cancer Research Institute; University of Pittsburgh(University of Pittsburgh); Eleven-Fifth Mega-Scientific Project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases"; China Scholarship council(China Scholarship Council); NSFC(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Fund; Suzhou Social Development Project	This work is partly supported by NSFC (National Natural Science Foundation of China) grants 30528008, Program for Changjiang Scholars and Innovative Research Team in University (IRT0849) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD) (to BL and XZ). BL was partly supported by the Young Investigator Award from Cancer Research Institute and University of Pittsburgh Startup fund. QY is supported by Eleven-Fifth Mega-Scientific Project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases" (2008ZX10003-012). GL and XG are supported by a scholarship from China Scholarship council. YZ is supported by NSFC grant 31170866, Jiangsu Natural Science Fund BK2011289 and Suzhou Social Development Project (SYS201009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Boenisch O, 2010, J IMMUNOL, V185, P5806, DOI 10.4049/jimmunol.0903435; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Lu BF, 2011, IMMUNOL RES, V50, P269, DOI 10.1007/s12026-011-8227-9; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sakuishi K, 2011, TRENDS IMMUNOL, V21, P21; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	21	249	280	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30676	10.1371/journal.pone.0030676	http://dx.doi.org/10.1371/journal.pone.0030676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363469	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000302853600053
J	Chand, AL; Wijayakumara, DD; Knower, KC; Herridge, KA; Howard, TL; Lazarus, KA; Clyne, CD				Chand, Ashwini L.; Wijayakumara, Dhilushi D.; Knower, Kevin C.; Herridge, Kerrie A.; Howard, Tamara L.; Lazarus, Kyren A.; Clyne, Colin D.			The Orphan Nuclear Receptor LRH-1 and ER alpha Activate GREB1 Expression to Induce Breast Cancer Cell Proliferation	PLOS ONE			English	Article							BILE-ACID SYNTHESIS; ESTROGEN-RECEPTOR; POSTMENOPAUSAL WOMEN; FEEDBACK-REGULATION; GENE-EXPRESSION; HOMOLOG-1 LRH-1; GRANULOSA-CELLS; AROMATASE; STEROIDOGENESIS; TRANSCRIPTION	Background: Liver Receptor Homolog 1 (LRH-1, NR5A2) is an orphan nuclear receptor that is over-expressed in cancers in tissues such as the breast, colon and pancreas. LRH-1 plays important roles in embryonic development, steroidogenesis and cholesterol homeostasis. In tumor cells, LRH-1 induces proliferation and cell cycle progression. High LRH-1 expression is demonstrated in breast cancers, positively correlating with ER alpha status and aromatase activity. LRH-1 dependent cellular mechanisms in breast cancer epithelial cells are poorly defined. Hence in the present study we investigated the actions of LRH-1 in estrogen receptor alpha (ER alpha) positive breast cancer cells. Results: The study aimed to investigate LRH-1 dependent mechanisms that promote breast cancer proliferation. We identified that LRH-1 regulated the expression of Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) in MCF-7 and MDA-MB-231 cells. Over-expression of LRH-1 increased GREB1 mRNA levels while knockdown of LRH-1 reduced its expression. GREB1 is a well characterised ER alpha target gene, with three estrogen response elements (ERE) located on its promoter. Chromatin immunoprecipitation studies provided evidence of the co-localisation of LRH-1 and ER alpha at all three EREs. With electrophoretic mobility shift assays, we demonstrated direct binding of LRH-1 to EREs located on GREB1 and Trefoil Factor 1 (TFF1, pS2) promoters. LRH-1 and ER alpha co-operatively activated transcription of ERE luciferase reporter constructs suggesting an overlap in regulation of target genes in breast cancer cells. Over-expression of LRH-1 resulted in an increase in cell proliferation. This effect was more pronounced with estradiol treatment. In the presence of ICI 182,780, an ER alpha antagonist, LRH-1 still induced proliferation. Conclusions: We conclude that in ER-positive breast cancer cells, LRH-1 promotes cell proliferation by enhancing ER alpha mediated transcription of target genes such as GREB-1. Collectively these findings indicate the importance of LRH-1 in the progression of hormone-dependent breast cancer and implicate LRH-1 as a potential avenue for drug development.	[Chand, Ashwini L.; Wijayakumara, Dhilushi D.; Knower, Kevin C.; Herridge, Kerrie A.; Howard, Tamara L.; Lazarus, Kyren A.; Clyne, Colin D.] Monash Med Ctr, Prince Henrys Inst, Clayton, Vic 3168, Australia	Monash University; Prince Henry's Institute of Medical Research	Chand, AL (corresponding author), Monash Med Ctr, Prince Henrys Inst, Clayton, Vic 3168, Australia.	colin.clyne@princehenrys.org	Chand, Ashwini L/D-1531-2017; Knower, Kevin/C-2869-2014	Chand, Ashwini L/0000-0002-1245-729X; 	Victorian Government through the Victorian Cancer Agency; United States Department of Defense; Victorian Government	Victorian Government through the Victorian Cancer Agency; United States Department of Defense(United States Department of Defense); Victorian Government	This research was supported by the Victorian Government, through the Victorian Cancer Agency's funding of the Victorian Breast Cancer Research Consortium and Early Career Seed Grant, Cancer Council Victoria (to CDC), the United States Department of Defense (to ALC and KCK), and by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annicotte JS, 2005, ONCOGENE, V24, P8167, DOI 10.1038/sj.onc.1208950; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chand AL, 2010, ENDOCR-RELAT CANCER, V17, P965, DOI 10.1677/ERC-10-0179; Chand AL, 2011, STEROIDS, V76, P741, DOI 10.1016/j.steroids.2011.02.024; Chu S, 2004, MOL ENDOCRINOL, V18, P1919, DOI 10.1210/me.2004-0021; Clyne CD, 2004, MOL CELL ENDOCRINOL, V215, P39, DOI 10.1016/j.mce.2003.11.001; Clyne CD, 2002, J BIOL CHEM, V277, P20591, DOI 10.1074/jbc.M201117200; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Dunbier AK, 2010, J CLIN ONCOL, V28, P1161, DOI 10.1200/JCO.2009.23.9616; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Ghosh MG, 2000, CANCER RES, V60, P6367; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hnatyszyn HJ, 2010, BREAST CANCER RES TR, V122, P371, DOI 10.1007/s10549-009-0584-x; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Kim JW, 2004, J CLIN ENDOCR METAB, V89, P3042, DOI 10.1210/jc.2003-031599; Labelle-Dumais C, 2006, DEV DYNAM, V235, P3359, DOI 10.1002/dvdy.20996; Lee YK, 2002, J BIOL CHEM, V277, P2463, DOI 10.1074/jbc.M105161200; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Luo Y, 2001, J BIOL CHEM, V276, P24767, DOI 10.1074/jbc.M100912200; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; Miki Y, 2006, CANCER LETT, V244, P24, DOI 10.1016/j.canlet.2005.11.038; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Pare JF, 2004, J BIOL CHEM, V279, P21206, DOI 10.1074/jbc.M401523200; Power KA, 2003, BREAST CANCER RES TR, V81, P209, DOI 10.1023/A:1026114501364; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Saxena D, 2007, ENDOCRINOLOGY, V148, P726, DOI 10.1210/en.2006-0108; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoonjans K, 2005, P NATL ACAD SCI USA, V102, P2058, DOI 10.1073/pnas.0409756102; Schoonjans K, 2002, EMBO REP, V3, P1181, DOI 10.1093/embo-reports/kvf238; Simpson ER, 2001, ANN NY ACAD SCI, V949, P58; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Thiruchelvam PTR, 2011, BREAST CANCER RES TR, V127, P385, DOI 10.1007/s10549-010-0994-9; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang SL, 2008, MOL CELL BIOCHEM, V308, P93, DOI 10.1007/s11010-007-9616-1; Zeleniuch-Jacquotte A, 2004, BRIT J CANCER, V90, P153, DOI 10.1038/sj.bjc.6601517; Zhou J, 2005, CANCER RES, V65, P657	41	43	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31593	10.1371/journal.pone.0031593	http://dx.doi.org/10.1371/journal.pone.0031593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359603	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200072
J	Singh, P; Mishra, SK; Noel, S; Sharma, S; Rath, SK				Singh, Prabhat; Mishra, Shrawan Kumar; Noel, Sanjeev; Sharma, Sharad; Rath, Srikanta Kumar			Acute Exposure of Apigenin Induces Hepatotoxicity in Swiss Mice	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN-70 HSP70; LIPID-PEROXIDATION; CELL-DEATH; FLAVONOIDS; DAMAGE; ASSAY; ACTIVATION; EXPRESSION; BIOMARKERS; APOPTOSIS	Apigenin, a dietary flavonoid, is reported to have several therapeutic effects in different diseases including cancer. Toxicity of Apigenin is however, least explored, and reports are scanty in literature. This warrants dose-specific evaluation of toxicity in vivo. In the present study, Apigenin was administered intraperitoneally to Swiss mice at doses of 25, 50, 100 and 200 mg/kg. Serum levels of alanine amino transferase (ALT), aspartate amino transferase (AST) and alkaline phosphatase (ALP) were measured along with the examination of liver histology, reactive oxygen species (ROS) in blood, lipid peroxidation (LPO), glutathione level, superoxide dismutase activity, catalase activity, glutathione S-transferase activity and gene expression in liver tissue. Increase in ALT, AST, ALP, ROS, ratio of oxidized to reduced glutathione (GSSG/GSH) and LPO, altered enzyme activities along with damaged histoarchitecture in the liver of 100 or 200 mg/kg Apigenin treated animals were found. Microarray analysis revealed the differential expression of genes that correspond to different biologically relevant pathways including oxidative stress and apoptosis. In conclusion, these results suggested the oxidative stress induced liver damage which may be due to the regulation of multiple genes by Apigenin at higher doses in Swiss mice.	[Singh, Prabhat; Mishra, Shrawan Kumar; Noel, Sanjeev; Sharma, Sharad; Rath, Srikanta Kumar] Cent Drug Res Inst CSIR, Div Toxicol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Singh, P (corresponding author), Cent Drug Res Inst CSIR, Div Toxicol, Lucknow, Uttar Pradesh, India.	skrath@cdri.res.in	Mishra, Shrawan K/J-7972-2013; Mishra, Shrawan/N-1592-2019	Mishra, Shrawan/0000-0001-5513-9876	Council of Scientific and Industrial Research (CSIR) Network [NWP0034]	Council of Scientific and Industrial Research (CSIR) Network(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research (CSIR) Network project NWP0034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ENZYMATIC BASIS DETO; Chuang CM, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-49; De Zwart LL, 1999, FREE RADICAL BIO MED, V26, P202, DOI 10.1016/S0891-5849(98)00196-8; Elble RC, 2001, J BIOL CHEM, V276, P40510, DOI 10.1074/jbc.M104821200; ELIA G, 1994, BIOCHEM J, V300, P201, DOI 10.1042/bj3000201; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014; Ghribi O, 2001, BRAIN RES, V903, P66, DOI 10.1016/S0006-8993(01)02406-4; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HOSOKAWA N, 1990, CELL STRUCT FUNCT, V15, P393, DOI 10.1247/csf.15.393; Kachadourian R, 2006, FREE RADICAL BIO MED, V41, P65, DOI 10.1016/j.freeradbiomed.2006.03.002; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kang HK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2682; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Miyoshi N, 2007, ARCH BIOCHEM BIOPHYS, V466, P274, DOI 10.1016/j.abb.2007.07.026; Morrissey C, 2005, PROSTATE, V63, P131, DOI 10.1002/pros.20167; Mullie P, 2007, PLANT FOOD HUM NUTR, V62, P93, DOI 10.1007/s11130-007-0047-7; Noel S, 2007, TOXICOLOGY, V239, P96, DOI 10.1016/j.tox.2007.06.098; Noel S, 2006, TOXICOL IN VITRO, V20, P1168, DOI 10.1016/j.tiv.2006.03.007; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Patel D, 2007, INT J ONCOL, V30, P233; Poli M, 2010, NEUROBIOL DIS, V39, P204, DOI 10.1016/j.nbd.2010.04.009; Sahu SC, 1997, FOOD CHEM TOXICOL, V35, P443, DOI 10.1016/S0278-6915(97)00011-2; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Stroheker T, 2004, FOOD CHEM TOXICOL, V42, P887, DOI 10.1016/j.fct.2004.01.012; Sugihara N, 1999, FREE RADICAL BIO MED, V27, P1313, DOI 10.1016/S0891-5849(99)00167-7; Tsuji PA, 2008, CHEM-BIOL INTERACT, V171, P37, DOI 10.1016/j.cbi.2007.08.007; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Vargo MA, 2006, BIOCHEM PHARMACOL, V72, P681, DOI 10.1016/j.bcp.2006.06.010; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Xu LT, 2008, IMMUNOL LETT, V121, P74, DOI 10.1016/j.imlet.2008.08.004; Zhang YH, 2000, GEN PHARMACOL-VASC S, V35, P341, DOI 10.1016/S0306-3623(02)00113-1	38	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31964	10.1371/journal.pone.0031964	http://dx.doi.org/10.1371/journal.pone.0031964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359648	gold, Green Submitted, Green Published			2022-12-25	WOS:000302796200117
J	Yang, JM; Ip, SP; Xian, YF; Zhao, M; Lin, ZX; Yeung, JHK; Chan, RCY; Lee, SS; Che, CT				Yang, Jia-Ming; Ip, Siu-Po; Xian, Yanfang; Zhao, Ming; Lin, Zhi-Xiu; Yeung, John Hok Keung; Chan, Raphael Chiu Yeung; Lee, Shui-Shan; Che, Chun-Tao			Impact of the Herbal Medicine Sophora flavescens on the Oral Pharmacokinetics of Indinavir in Rats: The Involvement of CYP3A and P-Glycoprotein	PLOS ONE			English	Article							HIV-PROTEASE INHIBITOR; IN-VITRO; LIQUID-CHROMATOGRAPHY; CYTOCHROME P450S; METABOLISM; INDUCTION; EXTRACT; DEXAMETHASONE; EXPRESSION; FLAVONOIDS	Sophora flavescens is a Chinese medicinal herb used for the treatment of gastrointestinal hemorrhage, skin diseases, pyretic stranguria and viral hepatitis. In this study the herb-drug interactions between S. flavescens and indinavir, a protease inhibitor for HIV treatment, were evaluated in rats. Concomitant oral administration of Sophora extract (0.158 g/kg or 0.63 g/kg, p.o.) and indinavir (40 mg/kg, p.o.) in rats twice a day for 7 days resulted in a dose-dependent decrease of plasma indinavir concentrations, with 55%-83% decrease in AUC(0-infinity) and 38%-78% reduction in C-max. The CL (Clearance)/F (fraction of dose available in the systemic circulation) increased up to 7.4-fold in Sophora-treated rats. Oxymatrine treatment (45 mg/kg, p.o.) also decreased indinavir concentrations, while the ethyl acetate fraction of Sophora extract had no effect. Urinary indinavir (24-h) was reduced, while the fraction of indinavir in faeces was increased after Sophora treatment. Compared to the controls, multiple dosing of Sophora extract elevated both mRNA and protein levels of P-gp in the small intestine and liver. In addition, Sophora treatment increased intestinal and hepatic mRNA expression of CYP3A1, but had less effect on CYP3A2 expression. Although protein levels of CYP3A1 and CYP3A2 were not altered by Sophora treatment, hepatic CYP3A activity increased in the Sophora-treated rats. All available data demonstrated that Sophora flavescens reduced plasma indinavir concentration after multiple concomitant doses, possibly through hepatic CYP3A activity and induction of intestinal and hepatic P-gp. The animal study would be useful for predicting potential interactions between natural products and oral pharmaceutics and understanding the mechanisms prior to human studies. Results in the current study suggest that patients using indinavir might be cautioned in the use of S. flavescens extract or Sophora-derived products.	[Yang, Jia-Ming; Ip, Siu-Po; Xian, Yanfang; Zhao, Ming; Lin, Zhi-Xiu; Che, Chun-Tao] Chinese Univ Hong Kong, Sch Chinese Med, Shatin, Hong Kong, Peoples R China; [Yeung, John Hok Keung] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Chan, Raphael Chiu Yeung; Lee, Shui-Shan] Chinese Univ Hong Kong, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Lee, Shui-Shan] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China; [Zhao, Ming; Che, Chun-Tao] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yang, JM (corresponding author), Chinese Univ Hong Kong, Sch Chinese Med, Shatin, Hong Kong, Peoples R China.	chect@uic.edu	Xian, Yan-Fang/AAA-6876-2020; Chan, Raphael Chiu Yeung/J-9649-2013; Lee, Shui Shan/B-9374-2008; Ip, Paul/M-8831-2014; Che, Chun-Tao/AAV-2795-2020; Lin, Zhi-Xiu/H-2807-2016	Lee, Shui Shan/0000-0003-1448-765X; Ip, Paul/0000-0001-8657-6585; 	Food and Health Bureau, Hong Kong Special Administrative Region Government [HHSRF-6902777]; Chinese University of Hong Kong	Food and Health Bureau, Hong Kong Special Administrative Region Government; Chinese University of Hong Kong(Chinese University of Hong Kong)	The research reported in this manuscript has been partially supported by the Health and Health Services Research Fund of the Food and Health Bureau, Hong Kong Special Administrative Region Government (HHSRF-6902777). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manscript. This study was also supported by internal university funds from the Chinese University of Hong Kong; no additional outside funding received for this study.	Agus HH, 2009, PHYTOTHER RES, V23, P1763, DOI 10.1002/ptr.2848; [Anonymous], CDER CBER GUID IND D; Azzam HS, 2007, LIVER INT, V27, P17, DOI 10.1111/j.1478-3231.2006.01408.x; Benet LZ, 2004, INT J PHARM, V277, P3, DOI 10.1016/j.ijpharm.2002.12.002; Burk O, 2005, MOL PHARMACOL, V67, P1954, DOI 10.1124/mol.104.009019; Chen X, 2004, J CHROMATOGR B, V812, P149, DOI 10.1016/j.jchromb.2004.08.032; Chiba M, 1996, DRUG METAB DISPOS, V24, P307; Chiba M, 1997, BIOCHEM PHARMACOL, V53, P1187, DOI 10.1016/S0006-2952(97)00100-7; Clevenbergh P, 1999, AIDS REV, V1, P156; DiCenzo R, 2003, PHARMACOTHERAPY, V23, P866, DOI 10.1592/phco.23.7.866.32723; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Goodwin B, 2002, ANNU REV PHARMACOL, V42, P1, DOI 10.1146/annurev.pharmtox.42.111901.111051; Gui FS, 2007, LINCHUANG HE SHIYAN, V6, P151; Hamidi M, 2006, LIFE SCI, V79, P991, DOI 10.1016/j.lfs.2006.05.010; He N, 2011, BIOSCI TRENDS, V5, P1, DOI 10.5582/bst.2011.v5.1.1; Ho YF, 2009, LIFE SCI, V85, P296, DOI 10.1016/j.lfs.2009.06.008; Hochman JH, 2000, J PHARMACOL EXP THER, V292, P310; Hong-Li S, 2008, PHYTOTHER RES, V22, P985, DOI 10.1002/ptr.2452; Huang LY, 2001, DRUG METAB DISPOS, V29, P754; Kennedy DA, 2010, EXPERT OPIN DRUG SAF, V9, P79, DOI 10.1517/14740330903405593; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; Kivisto KT, 2004, FUND CLIN PHARMACOL, V18, P621, DOI 10.1111/j.1472-8206.2004.00291.x; Li CQ, 2005, WORLD J GASTROENTERO, V11, P426; Lin JH, 1996, DRUG METAB DISPOS, V24, P1111; Lin JUN, 1999, DRUG METAB DISPOS, V27, P1187; Liu Y, 2009, BRAIN RES, V1268, P174, DOI 10.1016/j.brainres.2009.02.069; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Re V, 2007, JAIDS-J ACQ IMM DEF, V44, P315, DOI 10.1097/QAI.0b013e31802ea499; Mei Q, 2004, J PHARM SCI-US, V93, P2488, DOI 10.1002/jps.20102; National Committee of Chinese Pharmacopoeia, 2010, PHARM PEOPL REP CHIN, P61; Pal D, 2006, LIFE SCI, V78, P2131, DOI 10.1016/j.lfs.2005.12.010; Piscitelli SC, 2000, LANCET, V355, P547, DOI 10.1016/S0140-6736(99)05712-8; Rezk NL, 2006, THER DRUG MONIT, V28, P517, DOI 10.1097/00007691-200608000-00006; Sadler BM, 2001, ANTIMICROB AGENTS CH, V45, P30, DOI 10.1128/AAC.45.1.30-37.2001; Slain D, 2005, PHARMACOTHERAPY, V25, P165, DOI 10.1592/phco.25.2.165.56945; Solas C, 2002, J ACQ IMMUN DEF SYND, V29, P374, DOI 10.1097/00126334-200204010-00008; Sun MY, 2007, PHYTOTHER RES, V21, P269, DOI 10.1002/ptr.2066; Ueng YF, 2010, DRUG METAB PHARMACOK, V25, P560, DOI 10.2133/dmpk.DMPK-10-RG-055; Ueng YF, 2009, J ETHNOPHARMACOL, V126, P437, DOI 10.1016/j.jep.2009.09.018; Wang LY, 2010, DRUG METAB DISPOS, V38, P2226, DOI 10.1124/dmd.110.035253; Wu CY, 2005, PHARM RES-DORDR, V22, P11, DOI 10.1007/s11095-004-9004-4; Yuan F, 2010, BASIC CLIN PHARMACOL, V107, P906, DOI 10.1111/j.1742-7843.2010.00596.x; Yuan R, 2002, DRUG METAB DISPOS, V30, P1311, DOI 10.1124/dmd.30.12.1311; Zhang L, 2007, J PHARMACEUT BIOMED, V44, P1019, DOI 10.1016/j.jpba.2007.04.019	44	15	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31312	10.1371/journal.pone.0031312	http://dx.doi.org/10.1371/journal.pone.0031312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359586	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200055
J	Duprez, L; Bertrand, MJM; Vanden Berghe, T; Dondelinger, Y; Festjens, N; Vandenabeele, P				Duprez, Linde; Bertrand, Mathieu J. M.; Vanden Berghe, Tom; Dondelinger, Yves; Festjens, Nele; Vandenabeele, Peter			Intermediate Domain of Receptor-interacting Protein Kinase 1 (RIPK1) Determines Switch between Necroptosis and RIPK1 Kinase-dependent Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NONAPOPTOTIC CELL-DEATH; L929 CELLS; NECROSIS; ACTIVATION; COMPLEX; CIAP1; UBIQUITINATION; MECHANISMS; REQUIRES	Receptor-interacting protein kinase 1 (RIPK1) is an important component of the tumor necrosis factor receptor 1 (TNFR1) signaling pathway. Depending on the cell type and conditions, RIPK1 mediates MAPK and NF-kappa B activation as well as cell death. Using a mutant form of RIPK1 (RIPK1 Delta ID) lacking the intermediate domain (ID), we confirm the requirement of this domain for activation of these signaling events. Moreover, expression of RIPK1 Delta ID resulted in enhanced recruitment of caspase-8 to the TNFR1 complex II component Fas-associated death domain (FADD), which allowed a shift from TNF-induced necroptosis to apoptosis in L929 cells. Addition of the RIPK1 kinase inhibitor necrostatin-1 strongly reduced recruitment of RIPK1 and caspase-8 to FADD and subsequent apoptosis, indicating a role for RIPK1 kinase activity in apoptotic complex formation. Our study shows that RIPK1 has an anti-apoptotic function residing in its ID and demonstrates a cellular system as an elegant genetic model for RIPK1 kinase-dependent apoptosis that, in contrast to the Smac mimetic model, does not rely on depletion of cellular inhibitor of apoptosis protein 1 and 2 (cIAP1/2).	[Duprez, Linde; Bertrand, Mathieu J. M.; Vanden Berghe, Tom; Dondelinger, Yves; Festjens, Nele; Vandenabeele, Peter] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Duprez, Linde; Bertrand, Mathieu J. M.; Vanden Berghe, Tom; Dondelinger, Yves; Festjens, Nele; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Vandenabeele, P (corresponding author), Univ Ghent VIB, Dept Mol Biomed Res, Technol Pk 927, B-9052 Ghent, Belgium.	Peter.Vandenabeele@dmbr.vib-UGent.be	Festjens, Nele/C-2093-2009; Vandenabeele, Peter/C-8597-2009; Bertrand, Mathieu JM/AAD-2653-2019; Bertrand, Mathieu J/P-6465-2016; Berghe, Tom Vanden/N-2902-2019; Vandenabeele, Peter/AAD-5793-2022; Vanden Berghe, Tom/C-4916-2009	Festjens, Nele/0000-0002-3429-5463; Bertrand, Mathieu JM/0000-0001-9000-0626; Bertrand, Mathieu J/0000-0001-9000-0626; Berghe, Tom Vanden/0000-0002-1633-0974; Vandenabeele, Peter/0000-0002-6669-8822; Vanden Berghe, Tom/0000-0002-1633-0974; Dondelinger, Yves/0000-0002-5242-6834	European grants (FP6 ApopTrain) [MRTN-CT-035624]; European Commission for Research and Technological Development [FP7-200767]; Euregional PACT II; Belgian grants [IAP 6/18]; Flemish grants (Research Foundation Flanders) [FWO G.0875.11, FWO G.0973.11]; Ghent University (GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Agency for Innovation by Science and Technology; Flemish Government [BOF09/01M00709]	European grants (FP6 ApopTrain); European Commission for Research and Technological Development; Euregional PACT II; Belgian grants; Flemish grants (Research Foundation Flanders)(FWO); Ghent University (GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Agency for Innovation by Science and Technology; Flemish Government(European Commission)	This work was supported by European grants (FP6 ApopTrain, MRTN-CT-035624; FP7 European Commission for Research and Technological Development Integrated Project, Apo-Sys, FP7-200767; Euregional PACT II), Belgian grants (Interuniversity Attraction Poles, IAP 6/18), Flemish grants (Research Foundation Flanders, FWO G.0875.11 and FWO G.0973.11), Ghent University grants (Multidisciplinary Research Partnerships, GROUP-ID consortium), and grants from Flanders Institute for Biotechnology (VIB).; Recipient of a PhD grant from the Agency for Innovation by Science and Technology.; Recipient of Methusalem Grant BOF09/01M00709 from the Flemish Government.	Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Bertrand MJM, 2010, CELL DEATH DIFFER, V17, P379, DOI 10.1038/cdd.2009.213; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Grimm S, 1996, P NATL ACAD SCI USA, V93, P10923, DOI 10.1073/pnas.93.20.10923; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holcik M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-5; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Ikner A, 2011, J BIOL CHEM, V286, P21546, DOI 10.1074/jbc.M110.203745; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Knox PG, 2011, J CELL BIOL, V192, P391, DOI 10.1083/jcb.201003087; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Legarda-Addison D, 2009, CELL DEATH DIFFER, V16, P1279, DOI 10.1038/cdd.2009.41; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Lim SY, 2007, CARDIOVASC DRUG THER, V21, P467, DOI 10.1007/s10557-007-6067-6; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; O'Donnell MA, 2011, FEBS J, V278, P877, DOI 10.1111/j.1742-4658.2011.08016.x; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	56	32	38	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14863	14872		10.1074/jbc.M111.288670	http://dx.doi.org/10.1074/jbc.M111.288670			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22362767	hybrid, Green Published			2022-12-25	WOS:000304003200050
J	De Bock, M; Wang, N; Bol, M; Decrock, E; Ponsaerts, R; Bultynck, G; Dupont, G; Leybaert, L				De Bock, Marijke; Wang, Nan; Bol, Melissa; Decrock, Elke; Ponsaerts, Raf; Bultynck, Geert; Dupont, Genevieve; Leybaert, Luc			Connexin 43 Hemichannels Contribute to Cytoplasmic Ca2+ Oscillations by Providing a Bimodal Ca2+-dependent Ca2+ Entry Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CAPACITATIVE CALCIUM-ENTRY; ATP RELEASE; 2-AMINOETHOXYDIPHENYL BORATE; EXTRACELLULAR CALCIUM; CYTOSOLIC CALCIUM; TEMPORAL ASPECTS; CYTOCHROME-C; CELL-DEATH; BRADYKININ	Many cellular functions are driven by changes in the intracellular Ca2+ concentration ([Ca2+](i)) that are highly organized in time and space. Ca2+ oscillations are particularly important in this respect and are based on positive and negative [Ca2+](i) feedback on inositol 1,4,5-trisphosphate receptors (InsP(3)Rs). Connexin hemichannels are Ca2+-permeable plasma membrane channels that are also controlled by [Ca2+](i). We aimed to investigate how hemichannels may contribute to Ca2+ oscillations. Madin-Darby canine kidney cells expressing connexin-32 (Cx32) and Cx43 were exposed to bradykinin (BK) or ATP to induce Ca2+ oscillations. BK-induced oscillations were rapidly (minutes) and reversibly inhibited by the connexin-mimetic peptides (32)Gap27/(43)Gap26, whereas ATP-induced oscillations were unaffected. Furthermore, these peptides inhibited the BK-triggered release of calcein, a hemichannel-permeable dye. BK-induced oscillations, but not those induced by ATP, were dependent on extracellular Ca2+. Alleviating the negative feedback of [Ca2+](i) on InsP(3)Rs using cytochrome c inhibited BK- and ATP-induced oscillations. Cx32 and Cx43 hemichannels are activated by < 500 nM [Ca2+](i) but inhibited by higher concentrations and CT9 peptide (last 9 amino acids of the Cx43 C terminus) removes this high [Ca2+](i) inhibition. Unlike interfering with the bell-shaped dependence of InsP3Rs to [Ca2+](i), CT9 peptide prevented BK-induced oscillations but not those triggered by ATP. Collectively, these data indicate that connexin hemichannels contribute to BK-induced oscillations by allowing Ca2+ entry during the rising phase of the Ca2+ spikes and by providing an OFF mechanism during the falling phase of the spikes. Hemichannels were not sufficient to ignite oscillations by themselves; however, their contribution was crucial as hemichannel inhibition stopped the oscillations.	[Leybaert, Luc] Univ Ghent, Dept Basic Med Sci, Physiol Grp, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Ponsaerts, Raf; Bultynck, Geert] KULeuven, Dept Mol Cell Biol, Lab Mol & Cellular Signaling, B-3000 Louvain, Belgium; [Dupont, Genevieve] Univ Libre Bruxelles, Theoret Chronobiol Unit, B-1050 Brussels, Belgium	Ghent University; KU Leuven; Universite Libre de Bruxelles	Leybaert, L (corresponding author), Univ Ghent, Dept Basic Med Sci, Physiol Grp, Fac Med & Hlth Sci, De Pintelaan 185,Bldg B,Rm 310, B-9000 Ghent, Belgium.	Luc.Leybaert@UGent.be	Leybaert, Luc/F-4079-2015; De Bock, Marijke/J-3253-2016	Leybaert, Luc/0000-0001-6452-6982; Bultynck, Geert/0000-0002-5968-4828; De Bock, Marijke/0000-0001-8823-0000; De Bock, Marijke/0000-0002-5590-2760	Institute for the Promotion of Innovation of Science and Technology in Flanders (IWT Vlaanderen) [63352]; Fund for Scientific Research Flanders (FWO) [G.0140.08, 3G.0134.09, G.0298.11]; Interuniversity Attraction Poles Program (Belgian Science Policy) [P6/31, P6/28]	Institute for the Promotion of Innovation of Science and Technology in Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research Flanders (FWO)(FWO); Interuniversity Attraction Poles Program (Belgian Science Policy)(Belgian Federal Science Policy Office)	This work was supported by the Institute for the Promotion of Innovation of Science and Technology in Flanders (IWT Vlaanderen) Grant 63352 (to M. D. B.), the Fund for Scientific Research Flanders (FWO) grants G.0140.08 and 3G.0134.09 (to L. L.) and G.0298.11 (L. L. and G. B.), and the Interuniversity Attraction Poles Program (Belgian Science Policy) P6/31 (to L. L.) and P6/28 (to G. B.).	Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Bergner A, 2002, AM J PHYSIOL-LUNG C, V283, pL1271, DOI 10.1152/ajplung.00139.2002; BERRIDGE MJ, 1988, PHILOS T ROY SOC B, V320, P325, DOI 10.1098/rstb.1988.0080; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bindschadler M, 2001, CHAOS, V11, P237, DOI 10.1063/1.1342161; BIRD GSJ, 1993, J BIOL CHEM, V268, P8425; BOARDER MR, 1992, BRIT J PHARMACOL, V107, P1140, DOI 10.1111/j.1476-5381.1992.tb13420.x; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Boehning D, 2004, CELL CYCLE, V3, P252; Braet K, 2003, J CELL PHYSIOL, V197, P205, DOI 10.1002/jcp.10365; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; CARTER TD, 1991, BIOCHEM J, V278, P697, DOI 10.1042/bj2780697; Case RM, 2007, CELL CALCIUM, V42, P345, DOI 10.1016/j.ceca.2007.05.001; Clarke TC, 2009, EUR J PHARMACOL, V605, P9, DOI 10.1016/j.ejphar.2008.12.005; Colosetti P, 2003, J CELL SCI, V116, P2791, DOI 10.1242/jcs.00482; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Davis RJ, 1999, BIOCHEM J, V341, P813, DOI 10.1042/0264-6021:3410813; Dawson AP, 1997, CURR BIOL, V7, pR544, DOI 10.1016/S0960-9822(06)00277-6; De Blasio BF, 2004, EUR BIOPHYS J BIOPHY, V33, P657, DOI 10.1007/s00249-004-0409-0; De Blasio BF, 2004, ACTA PHYSIOL SCAND, V180, P335, DOI 10.1111/j.1365-201X.2004.01261.x; De Bock M, 2011, J CEREBR BLOOD F MET, V31, P1942, DOI 10.1038/jcbfm.2011.86; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; De Vuyst E, 2008, BIOPHYS J, V94, P469, DOI 10.1529/biophysj.107.109470; De Vuyst E, 2009, CELL CALCIUM, V46, P176, DOI 10.1016/j.ceca.2009.07.002; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; Dupont G, 2011, COLD SPRING HARB PER, V3; Dupont G, 2007, INT REV CYTOL, V261, P193, DOI 10.1016/S0074-7696(07)61005-5; Easton AS, 2002, BRAIN RES, V953, P157, DOI 10.1016/S0006-8993(02)03281-X; Estrada M, 2005, J ENDOCRINOL, V184, P371, DOI 10.1677/joe.1.05921; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Fioretti B, 2005, BIOPHYS CHEM, V113, P17, DOI 10.1016/j.bpc.2004.07.037; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; GOLDBETER A, 1990, P NATL ACAD SCI USA, V87, P1461, DOI 10.1073/pnas.87.4.1461; Gomez-Hernandez JM, 2003, P NATL ACAD SCI USA, V100, P16030, DOI 10.1073/pnas.2530348100; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Iyer S, 2007, COMPUT METH PROG BIO, V85, P203, DOI 10.1016/j.cmpb.2006.11.004; Jones BF, 2008, HEPATOLOGY, V48, P1273, DOI 10.1002/hep.22461; Kawano S, 2006, CELL CALCIUM, V39, P313, DOI 10.1016/j.ceca.2005.11.008; KEIZER J, 1992, BIOPHYS J, V61, P649, DOI 10.1016/S0006-3495(92)81870-2; Kennedy C, 1997, CAN J PHYSIOL PHARM, V75, P563, DOI 10.1139/cjpp-75-6-563; Koizumi S, 2010, FEBS J, V277, P286, DOI 10.1111/j.1742-4658.2009.07438.x; Leybaert L, 2003, CELL COMMUN ADHES, V10, P251, DOI 10.1080/15419060390262985; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; MARTIN SC, 1994, FEBS LETT, V352, P32, DOI 10.1016/0014-5793(94)00913-9; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; Monaco G, 2012, CELL DEATH DIFFER, V19, P295, DOI 10.1038/cdd.2011.97; Nash MS, 2002, J BIOL CHEM, V277, P35947, DOI 10.1074/jbc.M205622200; Nash MS, 2001, NATURE, V413, P381, DOI 10.1038/35096643; O'Quinn MP, 2011, CIRC RES, V108, P704, DOI 10.1161/CIRCRESAHA.110.235747; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; PARKER I, 1990, P NATL ACAD SCI USA, V87, P260, DOI 10.1073/pnas.87.1.260; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pizzo P, 2001, J NEUROCHEM, V79, P98, DOI 10.1046/j.1471-4159.2001.00539.x; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reetz G, 1996, CELL CALCIUM, V19, P143, DOI 10.1016/S0143-4160(96)90083-4; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Rottingen JA, 1997, CELL CALCIUM, V21, P195, DOI 10.1016/S0143-4160(97)90044-0; Sacks RS, 2008, AM J PHYSIOL-LUNG C, V295, pL1048, DOI 10.1152/ajplung.90259.2008; SAGE SO, 1989, J BIOL CHEM, V264, P6; Sanchez HA, 2009, AM J PHYSIOL-CELL PH, V297, pC665, DOI 10.1152/ajpcell.00200.2009; Schalper KA, 2010, AM J PHYSIOL-CELL PH, V299, pC1504, DOI 10.1152/ajpcell.00015.2010; Shintani-Ishida K, 2007, AM J PHYSIOL-HEART C, V293, pH1714, DOI 10.1152/ajpheart.00022.2007; Shuttleworth TJ, 2003, BIOCHEM SOC T, V31, P916; Shuttleworth TJ, 1999, CELL CALCIUM, V25, P237, DOI 10.1054/ceca.1999.0022; Shuttleworth TJ, 1996, BIOCHEM J, V313, P815, DOI 10.1042/bj3130815; Sneyd J, 2006, P NATL ACAD SCI USA, V103, P1675, DOI 10.1073/pnas.0506135103; SNEYD J, 1995, FASEB J, V9, P1463, DOI 10.1096/fasebj.9.14.7589988; Stridh MH, 2008, J BIOL CHEM, V283, P10347, DOI 10.1074/jbc.M704153200; Swann K, 2008, INT J DEV BIOL, V52, P585, DOI 10.1387/ijdb.072530ks; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tai CJ, 2001, J CLIN ENDOCR METAB, V86, P773, DOI 10.1210/jc.86.2.773; Tao L, 2007, MOL PHARMACOL, V71, P570, DOI 10.1124/mol.106.027508; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; Thore S, 2004, J BIOL CHEM, V279, P19396, DOI 10.1074/jbc.C400088200; Tu HP, 2005, BIOPHYS J, V88, P1056, DOI 10.1529/biophysj.104.049601; Uhlen P, 2010, BIOCHEM BIOPH RES CO, V396, P28, DOI 10.1016/j.bbrc.2010.02.117; Van Moorhem M, 2010, CELL CALCIUM, V47, P287, DOI 10.1016/j.ceca.2010.01.001; Verma V, 2009, EUR J CELL BIOL, V88, P79, DOI 10.1016/j.ejcb.2008.08.005; Vinken M, 2010, CELL MOL LIFE SCI, V67, P907, DOI 10.1007/s00018-009-0220-2; Willars GB, 1999, AM J PHYSIOL-CELL PH, V277, pC859, DOI 10.1152/ajpcell.1999.277.5.C859; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Young KW, 2003, J BIOL CHEM, V278, P20753, DOI 10.1074/jbc.M211555200; Zhang SW, 2007, TOXICOL IN VITRO, V21, P1476, DOI 10.1016/j.tiv.2007.06.013	97	87	87	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12250	12266		10.1074/jbc.M111.299610	http://dx.doi.org/10.1074/jbc.M111.299610			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351781	Green Published, hybrid			2022-12-25	WOS:000302782200066
J	Vetterkind, S; Saphirstein, RJ; Morgan, KG				Vetterkind, Susanne; Saphirstein, Robert J.; Morgan, Kathleen G.			Stimulus-Specific Activation and Actin Dependency of Distinct, Spatially Separated ERK1/2 Fractions in A7r5 Smooth Muscle Cells	PLOS ONE			English	Article							SIGNAL-REGULATED KINASES; RAT THORACIC AORTA; MAP-KINASE; PROTEIN-KINASES; PHENOTYPIC MODULATION; PROLIFERATION; PATHWAY; CAVEOLIN-1; CALPONIN; PHOSPHORYLATION	A proliferative response of smooth muscle cells to activation of extracellular signal regulated kinases 1 and 2 (ERK1/2) has been linked to cardiovascular disease. In fully differentiated smooth muscle, however, ERK1/2 activation can also regulate contraction. Here, we use A7r5 smooth muscle cells, stimulated with 12-deoxyphorbol 13-isobutylate 20-acetate (DPBA) to induce cytoskeletal remodeling or fetal calf serum (FCS) to induce proliferation, to identify factors that determine the outcomes of ERK1/2 activation in smooth muscle. Knock down experiments, immunoprecipitation and proximity ligation assays show that the ERK1/2 scaffold caveolin-1 mediates ERK1/2 activation in response to DPBA, but not FCS, and that ERK1/2 is released from caveolin-1 upon DPBA, but not FCS, stimulation. Conversely, ERK1/2 associated with the actin cytoskeleton is significantly reduced after FCS, but not DPBA stimulation, as determined by Triton X fractionation. Furthermore, cytochalasin treatment inhibits DPBA, but not FCS-induced ERK1/2 phosphorylation, indicating that the actin cytoskeleton is not only a target but also is required for ERK1/2 activation. Our results show that (1) at least two ERK1/2 fractions are regulated separately by specific stimuli, and that (2) the association of ERK1/2 with the actin cytoskeleton regulates the outcome of ERK1/2 signaling.	[Vetterkind, Susanne; Saphirstein, Robert J.; Morgan, Kathleen G.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA	Boston University	Vetterkind, S (corresponding author), Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA.	svetter@bu.edu		Morgan, Kathleen/0000-0003-3300-3630	National Institutes of Health [HL80003, HL86655]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655, R01HL080003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (www.nih.gov) grant numbers HL80003 and HL86655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Atten MJ, 1998, ANTICANCER RES, V18, P4377; BASHEY A, 1994, BLOOD, V83, P949, DOI 10.1182/blood.V83.4.949.bloodjournal834949; Bharadwaj S., 2008, J CANC MOL, V4, P139; Burgstaller G, 2005, AM J PHYSIOL-HEART C, V288, pH3001, DOI 10.1152/ajpheart.01002.2004; Campbell DH, 1999, CANCER RES, V59, P5376; Carrillo-Sepulveda MA, 2010, MOL CELL BIOCHEM, V341, P279, DOI 10.1007/s11010-010-0459-9; CHILDS TJ, 1992, J BIOL CHEM, V267, P22853; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Firulli AB, 1998, IN VITRO CELL DEV-AN, V34, P217; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Gimona M, 2003, MOL BIOL CELL, V14, P2482, DOI 10.1091/mbc.E02-11-0743; Gosens R, 2010, J CELL MOL MED; Gu ZZ, 2007, EXP CELL RES, V313, P849, DOI 10.1016/j.yexcr.2006.12.005; Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967; Hu YH, 2000, ARTERIOSCL THROM VAS, V20, P18, DOI 10.1161/01.ATV.20.1.18; Hunter I, 2011, CARDIOVASC RES, V90, P557, DOI 10.1093/cvr/cvr039; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Ishihata A, 2002, EUR J PHARMACOL, V445, P247, DOI 10.1016/S0014-2999(02)01790-9; Je HD, 2001, J PHYSIOL-LONDON, V537, P567, DOI 10.1111/j.1469-7793.2001.00567.x; Je HD, 2004, AM J PHYSIOL-HEART C, V286, pH91, DOI 10.1152/ajpheart.00472.2003; KHALIL RA, 1995, CIRC RES, V76, P1101, DOI 10.1161/01.RES.76.6.1101; Kim J, 2005, EUR J PHARMACOL, V514, P209, DOI 10.1016/j.ejphar.2005.03.030; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; Kusuhara M, 1997, ARTERIOSCL THROM VAS, V17, P141, DOI 10.1161/01.ATV.17.1.141; Leinweber BD, 1999, BIOCHEM J, V344, P117, DOI 10.1042/0264-6021:3440117; Liao DF, 1996, CIRC RES, V79, P1007, DOI 10.1161/01.RES.79.5.1007; Luo DX, 2010, BIOCHEM BIOPH RES CO, V391, P1693, DOI 10.1016/j.bbrc.2009.12.132; MARTE BM, 1995, ONCOGENE, V10, P167; McNicol A, 2001, THROMB RES, V103, P25, DOI 10.1016/S0049-3848(01)00271-7; Menice CB, 1997, J BIOL CHEM, V272, P25157, DOI 10.1074/jbc.272.40.25157; Peterson TE, 2003, ARTERIOSCL THROM VAS, V23, P1521, DOI 10.1161/01.ATV.0000081743.35125.05; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Roy J, 2001, DIFFERENTIATION, V67, P50, DOI 10.1046/j.1432-0436.2001.067001050.x; Sathish V, 2011, AM J PHYSIOL-LUNG C, V300, pL920, DOI 10.1152/ajplung.00322.2010; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; Sen A, 2010, J BIOL CHEM, V285, P28787, DOI 10.1074/jbc.M110.134064; Touyz RM, 1999, J HYPERTENS, V17, P907, DOI 10.1097/00004872-199917070-00006; Vetterkind S, 2005, EXP CELL RES, V305, P392, DOI 10.1016/j.yexcr.2005.01.012; Wang JB, 2009, J CELL SCI, V122, P2024, DOI 10.1242/jcs.044644; Xiao DL, 2002, AM J PHYSIOL-HEART C, V282, pH292, DOI 10.1152/ajpheart.2002.282.1.H292; Xu QB, 1996, J CLIN INVEST, V97, P508, DOI 10.1172/JCI118442; Zhang Y, 1997, ATHEROSCLEROSIS, V133, P37, DOI 10.1016/S0021-9150(97)00113-5	44	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30409	10.1371/journal.pone.0030409	http://dx.doi.org/10.1371/journal.pone.0030409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363435	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700007
J	Alinsug, MV; Chen, FF; Luo, M; Tai, R; Jiang, LW; Wu, KQ				Alinsug, Malona V.; Chen, Fang Fang; Luo, Ming; Tai, Ready; Jiang, Liwen; Wu, Keqiang			Subcellular Localization of Class II HDAs in Arabidopsis thaliana: Nucleocytoplasmic Shuttling of HDA15 Is Driven by Light	PLOS ONE			English	Article							REVERSIBLE HISTONE ACETYLATION; GENE-EXPRESSION; NUCLEAR EXPORT; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; DEACETYLASES HDA6; GENOME-WIDE; KINASE; PROTEINS; ABA	Class II histone deacetylases in humans and other model organisms undergo nucleocytoplasmic shuttling. This unique functional regulatory mechanism has been well elucidated in eukaryotic organisms except in plant systems. In this study, we have paved the baseline evidence for the cytoplasmic and nuclear localization of Class II HDAs as well as their mRNA expression patterns. RT-PCR analysis on the different vegetative parts and developmental stages reveal that Class II HDAs are ubiquitously expressed in all tissues with minimal developmental specificity. Moreover, stable and transient expression assays using HDA-YFP/GFP fusion constructs indicate cytoplasmic localization of HDA5, HDA8, and HDA14 further suggesting their potential for nuclear transport and deacetylating organellar and cytoplasmic proteins. Organelle markers and stains confirm HDA14 to abound in the mitochondria and chloroplasts while HDA5 localizes in the ER. HDA15, on the other hand, shuttles in and out of the nucleus upon light exposure. In the absence of light, it is exported out of the nucleus where further re-exposition to light treatments signals its nuclear import. Unlike HDA5 which binds with 14-3-3 proteins, HDA15 fails to interact with these chaperones. Instead, HDA15 relies on its own nuclear localization and export signals to navigate its subcellular compartmentalization classifying it as a Class IIb HDA. Our study indicates that nucleocytoplasmic shuttling is indeed a hallmark for all eukaryotic Class II histone deacetylases.	[Alinsug, Malona V.; Chen, Fang Fang; Luo, Ming; Tai, Ready; Wu, Keqiang] Natl Taiwan Univ, Inst Plant Biol, Coll Life Sci, Taipei 10764, Taiwan; [Luo, Ming] Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Jiang, Liwen] Chinese Univ Hong Kong, Sch Life Sci, Ctr Cell & Dev Biol, Hong Kong, Hong Kong, Peoples R China	National Taiwan University; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese University of Hong Kong	Alinsug, MV (corresponding author), Natl Taiwan Univ, Inst Plant Biol, Coll Life Sci, Taipei 10764, Taiwan.	kewu@ntu.edu.tw	Wu, Keqiang/C-9743-2013; JIANG, Liwen/S-6046-2018	Wu, Keqiang/0000-0002-5791-3594; JIANG, Liwen/0000-0002-7829-1472; Alinsug, Malona V/0000-0001-9279-0705	National Science Council of Taiwan [97-2311-B-002-004-MY3, 98-2628-B-002-016-MY3, 99-2321-B-002-027-MY3]; National Taiwan University [98R0066-36, 99R80840]; Democratic Pacific Union; NSC	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); Democratic Pacific Union; NSC(Ministry of Science and Technology, Taiwan)	This study was funded by grants from the National Science Council of Taiwan (97-2311-B-002-004-MY3, 98-2628-B-002-016-MY3 and 99-2321-B-002-027-MY3) and National Taiwan University (98R0066-36 and 99R80840). MVA is supported by a grant from the Democratic Pacific Union graduate studies program and research fellowship from NSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinsug MV, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-37; Aoyagi S, 2005, TRENDS CELL BIOL, V15, P565, DOI 10.1016/j.tcb.2005.09.003; Bakin RE, 2004, J BIOL CHEM, V279, P51218, DOI 10.1074/jbc.M409271200; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Benhamed M, 2006, PLANT CELL, V18, P2893, DOI 10.1105/tpc.106.043489; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bunney TD, 2002, PLANT MOL BIOL, V50, P1041, DOI 10.1023/A:1021231805697; Chang IF, 2009, PROTEOMICS, V9, P2967, DOI 10.1002/pmic.200800445; Chang SR, 2005, P NATL ACAD SCI USA, V102, P8120, DOI 10.1073/pnas.0503275102; Chen LT, 2010, PLANT SIGNAL BEHAV, V5, P1318, DOI 10.4161/psb.5.10.13168; Chen LT, 2010, J EXP BOT, V61, P3345, DOI 10.1093/jxb/erq154; Chen ZJ, 2007, BBA-GENE STRUCT EXPR, V1769, P295, DOI 10.1016/j.bbaexp.2007.04.007; Chua YL, 2003, PLANT CELL, V15, P1468, DOI 10.1105/tpc.011825; Chung PJ, 2009, FEBS LETT, V583, P2249, DOI 10.1016/j.febslet.2009.06.003; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Ferl RJ, 2004, PHYSIOL PLANTARUM, V120, P173, DOI 10.1111/j.0031-9317.2004.0239.x; Finkemeier I, 2011, PLANT PHYSIOL, V155, P1779, DOI 10.1104/pp.110.171595; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hollender C, 2008, J INTEGR PLANT BIOL, V50, P875, DOI 10.1111/j.1744-7909.2008.00704.x; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huber SC, 2002, PLANT MOL BIOL, V50, P1053, DOI 10.1023/A:1021284002779; Igarashi D, 2001, PLANT CELL, V13, P2483, DOI 10.1105/tpc.13.11.2483; Ishida S, 2004, PLANT CELL, V16, P2641, DOI 10.1105/tpc.104.024604; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kim KC, 2008, PLANT CELL, V20, P2357, DOI 10.1105/tpc.107.055566; Kim MA, 2007, EXP MOL MED, V39, P205, DOI 10.1038/emm.2007.23; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Oecking C, 2009, CURR OPIN PLANT BIOL, V12, P760, DOI 10.1016/j.pbi.2009.08.003; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Paul AL, 2009, J PROTEOME RES, V8, P1913, DOI 10.1021/pr8008644; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Ryu H, 2007, PLANT CELL, V19, P2749, DOI 10.1105/tpc.107.053728; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Sehnke PC, 2002, PLANT MOL BIOL, V50, P1011, DOI 10.1023/A:1021289127519; Sehnke PC, 2002, PLANT CELL, V14, pS339, DOI 10.1105/tpc.010430; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Sheldon CC, 2006, PLANT J, V45, P871, DOI 10.1111/j.1365-313X.2006.02652.x; Sohn EJ, 2003, PLANT CELL, V15, P1057, DOI 10.1105/tpc.009779; Tanaka M, 2008, PLANT PHYSIOL, V146, P149, DOI 10.1104/pp.107.111674; Tian L, 2005, GENETICS, V169, P337, DOI 10.1534/genetics.104.033142; Tian L, 2003, GENETICS, V165, P399; Tian L, 2001, P NATL ACAD SCI USA, V98, P200, DOI 10.1073/pnas.011347998; To TK, 2011, BIOCHEM BIOPH RES CO, V406, P414, DOI 10.1016/j.bbrc.2011.02.058; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wallace DC, 2010, GENE DEV, V24, P1571, DOI 10.1101/gad.1960210; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wu K, 2008, J EXP BOT, V59, P225, DOI 10.1093/jxb/erm300; Wu KQ, 2000, PLANT J, V22, P19, DOI 10.1046/j.1365-313x.2000.00711.x; Wu X, 2011, PLANT PHYSIOL, V155, P1769, DOI 10.1104/pp.110.165852; Xu CR, 2005, P NATL ACAD SCI USA, V102, P14469, DOI 10.1073/pnas.0503143102; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu CW, 2011, PLANT PHYSIOL, V156, P173, DOI 10.1104/pp.111.174417; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514	88	40	47	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30846	10.1371/journal.pone.0030846	http://dx.doi.org/10.1371/journal.pone.0030846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363501	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600077
J	Nicol, S; Chades, I				Nicol, Sam; Chades, Iadine			Which States Matter? An Application of an Intelligent Discretization Method to Solve a Continuous POMDP in Conservation Biology	PLOS ONE			English	Article							VALUE-ITERATION; SPACE	When managing populations of threatened species, conservation managers seek to make the best conservation decisions to avoid extinction. Making the best decision is difficult because the true population size and the effects of management are uncertain. Managers must allocate limited resources between actively protecting the species and monitoring. Resources spent on monitoring reduce expenditure on management that could be used to directly improve species persistence. However monitoring may prevent sub-optimal management actions being taken as a result of observation error. Partially observable Markov decision processes (POMDPs) can optimize management for populations with partial detectability, but the solution methods can only be applied when there are few discrete states. We use the Continuous U-Tree (CU-Tree) algorithm to discretely represent a continuous state space by using only the states that are necessary to maintain an optimal management policy. We exploit the compact discretization created by CU-Tree to solve a POMDP on the original continuous state space. We apply our method to a population of sea otters and explore the trade-off between allocating resources to management and monitoring. We show that accurately discovering the population size is less important than management for the long term survival of our otter population.	[Nicol, Sam] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Chades, Iadine] CSIRO, CSIRO Ecosyst Sci, Brisbane, Qld, Australia	University of Alaska System; University of Alaska Fairbanks; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Nicol, S (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA.	scnicol@alaska.edu	Nicol, Sam/I-1074-2012; Chades, iadine/A-4052-2011	Nicol, Sam/0000-0002-1160-7444; Chades, iadine/0000-0002-7442-2850	University of Queensland; applied environmental decision analysis research center; CSIRO ecosystem sciences	University of Queensland(University of Queensland); applied environmental decision analysis research center; CSIRO ecosystem sciences	The work was supported by a University of Queensland postgraduate research scholarship. The University of Queensland website is http://www.uq.edu.au/. An additional stipend scholarship was provided to SN by the applied environmental decision analysis research center (http://www.aeda.edu.au/). IC received salary from CSIRO ecosystem sciences while participating in the research (http://www.csiro.au/org/CSE.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellman R., 1957, DYNAMIC PROGRAMMING; Cassandra A., PARTIALLY OBSERVABLE; Chades I, 2008, P NATL ACAD SCI USA, V105, P13936, DOI 10.1073/pnas.0805265105; Chernova S, 2006, WS0613 AAAI; Erez T, 2010, P UAI 2010; Gerber LR, 2004, BIODIVERS CONSERV, V13, P2741, DOI 10.1007/s10531-004-2146-1; Gibbons J, 2003, NONPARAMETRIC STAT I, P239; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Laidre KL, 2002, WILDLIFE SOC B, V30, P1172; Lance M.M., 2004, WASHINGTON STATE REC; Lee ISK, 2004, ENG APPL ARTIF INTEL, V17, P577, DOI 10.1016/j.engappai.2004.08.005; Li L., 2006, ISAIM; Madani O, 2003, ARTIF INTELL, V147, P5, DOI 10.1016/S0004-3702(02)00378-8; McCallum A. K., 1995, THESIS U ROCHESTER R; McDonald-Madden E, 2011, ECOL APPL, V21, P844, DOI 10.1890/09-2075.1; Morris W. F., 2002, QUANTITATIVE CONSERV; PAPADIMITRIOU CH, 1987, MATH OPER RES, V12, P441, DOI 10.1287/moor.12.3.441; Porta JM, 2006, J MACH LEARN RES, V7, P2329; Puterman ML., 2014, MARKOV DECISION PROC; Tomberlin D, 2010, P 5 IEMSS C ENV MOD; Uther WTB, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P769; White B, 2005, ECOL MODEL, V189, P241, DOI 10.1016/j.ecolmodel.2005.03.010; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	24	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e28993	10.1371/journal.pone.0028993	http://dx.doi.org/10.1371/journal.pone.0028993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363398	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600003
J	Poncin, G; Beaulieu, A; Humblet, C; Thiry, A; Oda, K; Boniver, J; Defresne, MP				Poncin, Geraldine; Beaulieu, Aurore; Humblet, Chantal; Thiry, Albert; Oda, Kimimitsu; Boniver, Jacques; Defresne, Marie-Paule			Characterization of Spontaneous Bone Marrow Recovery after Sublethal Total Body Irradiation: Importance of the Osteoblastic/Adipocytic Balance	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HEMATOPOIETIC-STEM; STROMAL CELLS; INHIBIT DIFFERENTIATION; ALKALINE-PHOSPHATASE; IN-VITRO; NICHE; MAINTENANCE; OSTEOBLASTS; ADIPOCYTES	Many studies have already examined the hematopoietic recovery after irradiation but paid with very little attention to the bone marrow microenvironment. Nonetheless previous studies in a murine model of reversible radio-induced bone marrow aplasia have shown a significant increase in alkaline phosphatase activity (ALP) prior to hematopoietic regeneration. This increase in ALP activity was not due to cell proliferation but could be attributed to modifications of the properties of mesenchymal stem cells (MSC). We thus undertook a study to assess the kinetics of the evolution of MSC correlated to their hematopoietic supportive capacities in mice treated with sub lethal total body irradiation. In our study, colony-forming units - fibroblasts (CFU-Fs) assay showed a significant MSC rate increase in irradiated bone marrows. CFU-Fs colonies still possessed differentiation capacities of MSC but colonies from mice sacrificed 3 days after irradiation displayed high rates of ALP activity and a transient increase in osteoblastic markers expression while pparc and neuropilin-1 decreased. Hematopoietic supportive capacities of CFU-Fs were also modified: as compared to controls, irradiated CFU-Fs significantly increased the proliferation rate of hematopoietic precursors and accelerated the differentiation toward the granulocytic lineage. Our data provide the first evidence of the key role exerted by the balance between osteoblasts and adipocytes in spontaneous bone marrow regeneration. First, (pre) osteoblast differentiation from MSC stimulated hematopoietic precursor's proliferation and granulopoietic regeneration. Then, in a second time (pre) osteoblasts progressively disappeared in favour of adipocytic cells which down regulated the proliferation and granulocytic differentiation and then contributed to a return to pre-irradiation conditions.	[Poncin, Geraldine; Beaulieu, Aurore; Humblet, Chantal; Thiry, Albert; Boniver, Jacques; Defresne, Marie-Paule] Univ Liege, Dept Cytol & Histol & Pathol Anat Giga R, Liege, Belgium; [Oda, Kimimitsu] Niigata Univ, Dept Biochem, Grad Sch Med & Dent Sci, Niigata, Japan	University of Liege; Niigata University	Poncin, G (corresponding author), Univ Liege, Dept Cytol & Histol & Pathol Anat Giga R, CHU B23, Liege, Belgium.	G.poncin@ulg.ac.be			University of Liege; FRS-FNRS (Televie); Fond Leon Fredericq; Centre anti-cancereux; Grants-in-Aid for Scientific Research [21592355] Funding Source: KAKEN	University of Liege(University of Liege); FRS-FNRS (Televie)(Fonds de la Recherche Scientifique - FNRS); Fond Leon Fredericq; Centre anti-cancereux; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project is co-financed by the University of Liege, the FRS-FNRS (Televie), the Fond Leon Fredericq and the Centre anti-cancereux. Geraldine Poncin and Aurore Beaulieu are Televie (FRS-FNRS) fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almohamad K, 2003, INT J RADIAT BIOL, V79, P259, DOI 10.1080/0955300031000085740; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Belaid-Choucair Z, 2008, STEM CELLS, V26, P1556, DOI 10.1634/stemcells.2008-0068; BIANCO P, 1993, BONE, V14, P315, DOI 10.1016/8756-3282(93)90158-7; Bianco P, 2011, BEST PRACT RES CL HA, V24, P37, DOI 10.1016/j.beha.2011.01.005; Brusnahan SK, 2010, MECH AGEING DEV, V131, P718, DOI 10.1016/j.mad.2010.10.002; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; DEBRUYN PPH, 1981, SEMIN HEMATOL, V18, P179; Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205; DILLY SA, 1993, J CLIN PATHOL, V46, P611, DOI 10.1136/jcp.46.7.611; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Georgiou KR, 2010, CURR MOL MED, V10, P440, DOI 10.2174/156652410791608243; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Hubin F, 2005, STEM CELLS, V23, P1626, DOI 10.1634/stemcells.2005-0041; Hubin F, 2004, CELL TRANSPLANT, V13, P823, DOI 10.3727/000000004783983387; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jo DY, 2003, BRIT J HAEMATOL, V121, P649, DOI 10.1046/j.1365-2141.2003.04326.x; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kutznetsov S, 2004, J CELL BIOL, V167, P1113; Kuznetsov SA, 1997, BRIT J HAEMATOL, V97, P561, DOI 10.1046/j.1365-2141.1997.902904.x; Lataillade JJ, 2002, BLOOD, V99, P1117, DOI 10.1182/blood.V99.4.1117; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Lo Celso C, 2009, J BIOPHOTONICS, V2, P619, DOI 10.1002/jbio.200910072; Ma J, 2007, HAEMATOLOGICA, V92, P889, DOI 10.3324/haematol.11106; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakao N, 2010, AM J PATHOL, V177, P547, DOI 10.2353/ajpath.2010.091042; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Neiva K, 2005, BRAZ J MED BIOL RES, V38, P1449, DOI 10.1590/S0100-879X2005001000001; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Prince HM, 2004, BRIT J HAEMATOL, V126, P536, DOI 10.1111/j.1365-2141.2004.05081.x; Ren HY, 2006, BIOCHEM BIOPH RES CO, V347, P12, DOI 10.1016/j.bbrc.2006.05.169; Slayton WB, 2007, STEM CELLS, V25, P2945, DOI 10.1634/stemcells.2007-0158; SNYDER F, 1965, RADIAT RES, V25, P417, DOI 10.2307/3571982; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Van Overstraeten-Schloegel N, 2006, EUR J HAEMATOL, V76, P488, DOI 10.1111/j.1600-0609.2006.00633.x; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; WESTEN H, 1979, J EXP MED, V150, P919, DOI 10.1084/jem.150.4.919; WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; WILSON DA, 1972, INFECT IMMUN, V5, P461, DOI 10.1128/IAI.5.4.461-466.1972; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Wolf NS, 2003, EXP CELL RES, V290, P346, DOI 10.1016/S0014-4827(03)00321-5; Xie QP, 2009, DIFFERENTIATION, V77, P483, DOI 10.1016/j.diff.2009.01.001; Yang Y, 2010, BIOELECTROMAGNETICS, V31, P277, DOI 10.1002/bem.20560; Zhang C, 2010, MED HYPOTHESES, V76, P241	56	20	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30818	10.1371/journal.pone.0030818	http://dx.doi.org/10.1371/journal.pone.0030818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363493	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600070
J	Rellick, SL; O'Leary, H; Piktel, D; Walton, C; Fortney, JE; Akers, SM; Martin, KH; Denvir, J; Boskovic, G; Primerano, DA; Vos, J; Bailey, N; Gencheva, M; Gibson, LF				Rellick, Stephanie L.; O'Leary, Heather; Piktel, Debbie; Walton, Cheryl; Fortney, James E.; Akers, Stephen M.; Martin, Karen H.; Denvir, James; Boskovic, Goran; Primerano, Donald A.; Vos, Jeffrey; Bailey, Nathanael; Gencheva, Marieta; Gibson, Laura F.			Bone Marrow Osteoblast Damage by Chemotherapeutic Agents	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; HIGH-DOSE CHEMOTHERAPY; STROMAL CELLS; IN-VITRO; TRANSPLANT RECIPIENTS; SOLID TUMORS; GROWTH; NICHE; PROGENITORS; CHEMOTAXIS	Hematopoietic reconstitution, following bone marrow or stem cell transplantation, requires a microenvironment niche capable of supporting both immature progenitors and stem cells with the capacity to differentiate and expand. Osteoblasts comprise one important component of this niche. We determined that treatment of human primary osteoblasts (HOB) with melphalan or VP-16 resulted in increased phospho-Smad2, consistent with increased TGF-beta 1 activity. This increase was coincident with reduced HOB capacity to support immature B lineage cell chemotaxis and adherence. The supportive deficit was not limited to committed progenitor cells, as human embryonic stem cells (hESC) or human CD34+ bone marrow cells co-cultured with HOB pre-exposed to melphalan, VP-16 or rTGF-beta 1 had profiles distinct from the same populations co-cultured with untreated HOB. Functional support deficits were downstream of changes in HOB gene expression profiles following chemotherapy exposure. Melphalan and VP-16 induced damage of HOB suggests vulnerability of this critical niche to therapeutic agents frequently utilized in pre-transplant regimens and suggests that dose escalated chemotherapy may contribute to post-transplantation hematopoietic deficits by damaging structural components of this supportive niche.	[Rellick, Stephanie L.; O'Leary, Heather; Akers, Stephen M.; Gencheva, Marieta; Gibson, Laura F.] W Virginia Univ, Sch Med, Canc Cell Biol Program, Morgantown, WV 26506 USA; [Rellick, Stephanie L.; O'Leary, Heather; Piktel, Debbie; Fortney, James E.; Akers, Stephen M.; Gencheva, Marieta; Gibson, Laura F.] W Virginia Univ, Sch Med, Alexander B Osborn Hematopoiet Malignancy & Trans, Morgantown, WV 26506 USA; [Gibson, Laura F.] W Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; [Walton, Cheryl] W Virginia Univ, Sch Med, Dept Pediat, Morgantown, WV 26506 USA; [Martin, Karen H.] W Virginia Univ, Sch Med, Dept Neurobiol & Anat, Morgantown, WV 26506 USA; [Denvir, James] W Virginia Univ, Sch Med, Dept Stat, Morgantown, WV 26506 USA; [Boskovic, Goran; Primerano, Donald A.] Marshall Univ, Microarray Core Facil, Huntington, WV USA; [Vos, Jeffrey; Bailey, Nathanael] W Virginia Univ, Sch Med, Dept Pathol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University; West Virginia University; West Virginia University; Marshall University; West Virginia University	Rellick, SL (corresponding author), W Virginia Univ, Sch Med, Canc Cell Biol Program, Morgantown, WV 26506 USA.	lgibson@hsc.wvu.edu	Vos, Jeffrey/W-7374-2019	Vos, Jeffrey/0000-0002-6715-1415; Gibson, Laura/0000-0002-7291-9046; O'Leary, Heather/0000-0003-1321-1520; Bailey, Nathanael/0000-0002-6747-680X; Martin, Karen/0000-0001-8916-4092	National Institutes of Health (NIH) [R01 HL056888, P20 RR016440]; National Cancer Institute (NCI) [RO1 CA134573]; Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program; WV Research Trust; NATIONAL CANCER INSTITUTE [R01CA134573] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program; WV Research Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) R01 HL056888 (Dr. Gibson), NIH P20 RR016440 (Dr. Gibson), National Cancer Institute (NCI) RO1 CA134573 and the Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, the WV Research Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anscher MS, 2008, INT J RADIAT ONCOL, V71, P829, DOI 10.1016/j.ijrobp.2008.02.046; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Batard P, 2000, J CELL SCI, V113, P383; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cao J, 2008, CANCER LETT, V263, P197, DOI 10.1016/j.canlet.2008.01.011; Chabanon A, 2008, STEM CELLS, V26, P3150, DOI 10.1634/stemcells.2008-0219; Corazza F, 2004, PEDIATR RES, V55, P152, DOI 10.1203/01.PDR.0000099773.71438.91; Davies JH, 2002, CALCIFIED TISSUE INT, V70, P408, DOI 10.1007/s002230020039; Davies JH, 2002, BONE, V31, P319, DOI 10.1016/S8756-3282(02)00822-0; DEVRIES EGE, 1995, STEM CELLS, V13, P597, DOI 10.1002/stem.5530130604; DITTEL BN, 1995, BLOOD, V86, P2833; Dutt P, 1998, J IMMUNOL, V161, P3652; El-Badri NS, 1998, EXP HEMATOL, V26, P110; Fan C, 2011, CURR MOL MED, V11, P140, DOI 10.2174/156652411794859223; Galotto M, 1999, EXP HEMATOL, V27, P1460, DOI 10.1016/S0301-472X(99)00076-4; Gibson, 2003, ANAL PHARM, V4, P21; Gibson L F, 1997, Biol Blood Marrow Transplant, V3, P122; GIBSON LF, 1993, BLOOD, V82, P3005; Gillette Jennifer M, 2009, Commun Integr Biol, V2, P305; Guest I, 2000, IMMUNOPHARMACOLOGY, V46, P103, DOI 10.1016/S0162-3109(99)00168-X; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; Jabbour E, 2006, BLOOD, V108, P1421, DOI 10.1182/blood-2006-02-001933; Jo DY, 2000, J CLIN INVEST, V105, P101, DOI 10.1172/JCI7954; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; LAGNEAUX L, 1995, LEUKEMIA LYMPHOMA, V17, P127, DOI 10.3109/10428199509051712; Legras S, 1997, BLOOD, V89, P1905, DOI 10.1182/blood.V89.6.1905; Li J, 2004, BRIT J HAEMATOL, V127, P326, DOI 10.1111/j.1365-2141.2004.05200.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morris JC, 2008, J CLIN ONCOL S, V26, P2008; NEBEN S, 1993, EXP HEMATOL, V21, P156; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Nieboer P, 2004, EUR J CANCER, V40, P1199, DOI 10.1016/j.ejca.2004.01.029; Nieboer P, 2001, BONE MARROW TRANSPL, V27, P959, DOI 10.1038/sj.bmt.1703030; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; RYAN DH, 1991, J CLIN INVEST, V88, P995, DOI 10.1172/JCI115403; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Syed HA, 2006, BIOTECHNIQUES, V41, P685, DOI 10.2144/000112290; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Taichman RS, 1998, STEM CELLS, V16, P7, DOI 10.1002/stem.160007; Tauchmanova L, 2002, J CLIN ENDOCR METAB, V87, P5058, DOI 10.1210/jc.2002-020800; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang L, 2005, STEM CELLS, V23, P1122, DOI 10.1634/stemcells.2004-0354; Xian CJ, 2008, J CELL PHYSIOL, V214, P777, DOI 10.1002/jcp.21274; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	50	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30758	10.1371/journal.pone.0030758	http://dx.doi.org/10.1371/journal.pone.0030758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363485	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600066
J	Zhao, XR; Higashikawa, F; Noda, M; Kawamura, Y; Matoba, Y; Kumagai, T; Sugiyama, M				Zhao, Xingrong; Higashikawa, Fumiko; Noda, Masafumi; Kawamura, Yusuke; Matoba, Yasuyuki; Kumagai, Takanori; Sugiyama, Masanori			The Obesity and Fatty Liver Are Reduced by Plant-Derived Pediococcus pentosaceus LP28 in High Fat Diet-Induced Obese Mice	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; LACTIC-ACID BACTERIA; PPAR-GAMMA; CD36; DIFFERENTIATION; CONTRIBUTES; METABOLISM; EXPRESSION; PROBIOTICS; RECEPTOR	We evaluated the effect of an oral administration of a plant-derived lactic acid bacterium, Pediococcus pentosaceus LP28 (LP28), on metabolic syndrome by using high fat diet-induced obese mice. The obese mice were divided into 2 groups and fed either a high fat or regular diet for 8 weeks. Each group was further divided into 3 groups, which took LP28, another plant-derived Lactobacillus plantarum SN13T (SN13T) or no lactic acid bacteria (LAB). The lean control mice were fed a regular diet without inducing obesity prior to the experiment. LP28 reduced body weight gain and liver lipid contents (triglyceride and cholesterol), in mice fed a high fat diet for 8 weeks (40%, 54%, and 70% less than those of the control group without LAB, and P = 0.018, P<0.001, and P = 0.021, respectively), whereas SN13T and the heat treated LP28 at 121 degrees C for 15 min were ineffective. Abdominal visceral fat in the high fat diet mice fed with LP28 was also lower than that without LAB by 44%, although it was not significant but borderline (P = 0.076). The sizes of the adipocytes and the lipid droplets in the livers were obviously decreased. A real-time PCR analyses showed that lipid metabolism-related genes, such as CD36 (P = 0.013), SCD1 encoding stearoyl-CoA desaturase 1 (not significant but borderline, P = 0.066), and PPAR gamma encoding peroxisome proliferator-activated receptor gamma (P = 0.039), were down-regulated by taking LP28 continuously, when compared with those of the control group. In conclusion, LP28 may be a useful LAB strain for the prevention and reduction of the metabolic syndrome.	[Zhao, Xingrong; Higashikawa, Fumiko; Noda, Masafumi; Kawamura, Yusuke; Matoba, Yasuyuki; Kumagai, Takanori; Sugiyama, Masanori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Biotechnol, Hiroshima, Japan	Hiroshima University	Zhao, XR (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Biotechnol, Hiroshima, Japan.	sugi@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [22790068] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by City Area Program for Industry-Academia-Government joint research (Hiroshima area) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to MS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Adolfsson O, 2004, AM J CLIN NUTR, V80, P245, DOI 10.1093/ajcn/80.2.245; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; de LeBlanc AD, 2007, BRIT J NUTR, V98, pS105, DOI 10.1017/S0007114507839602; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Higashikawa F, 2010, NUTRITION, V26, P367, DOI 10.1016/j.nut.2009.05.008; HIRAISHI A, 1992, LETT APPL MICROBIOL, V15, P210, DOI 10.1111/j.1472-765X.1992.tb00765.x; Jin HK, 2010, BIOL PHARM BULL, V33, P289, DOI 10.1248/bpb.33.289; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lau DCW, 2007, CAN MED ASSOC J, V176, P1103, DOI 10.1503/cmaj.070306; Liong MT, 2006, J DAIRY SCI, V89, P1390, DOI 10.3168/jds.S0022-0302(06)72207-X; MacDonald MLE, 2008, J LIPID RES, V49, P217, DOI 10.1194/jlr.M700478-JLR200; Mathieu P, 2008, CAN J CARDIOL, V24, P521; Nguyen TDT, 2007, INT J FOOD MICROBIOL, V113, P358, DOI 10.1016/j.ijfoodmicro.2006.08.015; Nomura M, 2006, J APPL MICROBIOL, V101, P396, DOI 10.1111/j.1365-2672.2006.02949.x; Ntambi JM, 1999, J LIPID RES, V40, P1549; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rolfe RD, 2000, J NUTR, V130, p396S, DOI 10.1093/jn/130.2.396S; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Wada T, 2009, MICROBIOL-SGM, V155, P1726, DOI 10.1099/mic.0.022871-0; Wang YP, 2009, APPL MICROBIOL BIOT, V84, P341, DOI 10.1007/s00253-009-2012-x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; West NP, 2009, EXERC IMMUNOL REV, V15, P107; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; Zabala A, 2006, NUTRITION, V22, P528, DOI 10.1016/j.nut.2005.10.005; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	32	61	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30696	10.1371/journal.pone.0030696	http://dx.doi.org/10.1371/journal.pone.0030696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363472	Green Published, gold			2022-12-25	WOS:000302853600056
J	Chakraborty, S; Rao, BJ				Chakraborty, Sandeep; Rao, Basuthkar J.			A Measure of the Promiscuity of Proteins and Characteristics of Residues in the Vicinity of the Catalytic Site That Regulate Promiscuity	PLOS ONE			English	Article							LATENT EVOLUTIONARY POTENTIALS; COMPUTATIONAL ENZYME DESIGN; DIRECTED EVOLUTION; DIVERGENT EVOLUTION; ENOLASE SUPERFAMILY; ELECTROSTATICS; PREDICTION; BIOLOGY; SPECIFICITY; PERSPECTIVE	Promiscuity, the basis for the evolution of new functions through 'tinkering' of residues in the vicinity of the catalytic site, is yet to be quantitatively defined. We present a computational method Promiscuity Indices Estimator (PROMISE) - based on signatures derived from the spatial and electrostatic properties of the catalytic residues, to estimate the promiscuity (PromIndex) of proteins with known active site residues and 3D structure. PromIndex reflects the number of different active site signatures that have congruent matches in close proximity of its native catalytic site, the quality of the matches and difference in the enzymatic activity. Promiscuity in proteins is observed to follow a lognormal distribution (mu = 0.28, sigma = 1.1 reduced chi-square = 3.0E-5). The PROMISE predicted promiscuous functions in any protein can serve as the starting point for directed evolution experiments. PROMISE ranks carboxypeptidase A and ribonuclease A amongst the more promiscuous proteins. We have also investigated the properties of the residues in the vicinity of the catalytic site that regulates its promiscuity. Linear regression establishes a weak correlation (R-2 similar to 0.1) between certain properties of the residues (charge, polar, etc) in the neighborhood of the catalytic residues and PromIndex. A stronger relationship states that most proteins with high promiscuity have high percentages of charged and polar residues within a radius of 3 angstrom of the catalytic site, which is validated using one-tailed hypothesis tests (P-values similar to 0.05). Since it is known that these characteristics are key factors in catalysis, their relationship with the promiscuity index cross validates the methodology of PROMISE.	[Chakraborty, Sandeep; Rao, Basuthkar J.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Chakraborty, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	bjrao@tifr.res.in			Tata Institute of Fundamental Research (Department of Atomic Energy)	Tata Institute of Fundamental Research (Department of Atomic Energy)	This work was funded by the Tata Institute of Fundamental Research (Department of Atomic Energy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amitai G, 2007, HFSP J, V1, P67, DOI [10.2976/1.2739115/10.2976/1, 10.2976/1.2739115]; Babtie A, 2010, CURR OPIN CHEM BIOL, V14, P200, DOI 10.1016/j.cbpa.2009.11.028; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Basu MK, 2009, BRIEF BIOINFORM, V10, P205, DOI 10.1093/bib/bbn057; BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P1158, DOI 10.1021/bi00404a013; Bloom JD, 2005, CURR OPIN STRUC BIOL, V15, P447, DOI 10.1016/j.sbi.2005.06.004; Bloom JD, 2007, GENETICS, V175, P255, DOI 10.1534/genetics.106.061754; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; BONE R, 1989, NATURE, V339, P191, DOI 10.1038/339191a0; Bornscheuer UT, 2004, ANGEW CHEM INT EDIT, V43, P6032, DOI 10.1002/anie.200460416; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Chakraborty S, PLOS ONE IN PRESS; Cohen-Gihon I, 2011, MOL BIOSYST, V7, P784, DOI 10.1039/c0mb00182a; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Copley Shelley D, 2009, F1000 Biol Rep, V1, P91, DOI 10.3410/B1-91; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DePristo MA, 2007, HFSP J, V1, P94, DOI 10.2976/1.2754665; Di Nardo G, 2009, J BIOL INORG CHEM, V14, P497, DOI 10.1007/s00775-009-0465-0; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; Fernandez A, 2005, J BIOMOL STRUCT DYN, V22, P615, DOI 10.1080/07391102.2005.10531228; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Gronholm T, 2007, MATH BIOSCI, V210, P659, DOI 10.1016/j.mbs.2007.07.004; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hult K, 2007, TRENDS BIOTECHNOL, V25, P231, DOI 10.1016/j.tibtech.2007.03.002; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; KIMURA M, 1986, PHILOS T ROY SOC B, V312, P343, DOI 10.1098/rstb.1986.0012; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Kristensen DM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-17; Leitgeb S, 2010, CHEMBIOCHEM, V11, P502, DOI 10.1002/cbic.200900688; LEWIS EB, 1951, COLD SPRING HARB SYM, V16, P159, DOI 10.1101/SQB.1951.016.01.014; Lombard J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-232; Martin AC, 1998, STRUCTURE, V6, P875, DOI 10.1016/S0969-2126(98)00089-6; Nagatani RA, 2007, BIOCHEMISTRY-US, V46, P6688, DOI 10.1021/bi700507d; Nath A, 2008, BIOCHEMISTRY-US, V47, P157, DOI 10.1021/bi701448p; Nielsen JE, 1999, EUR J BIOCHEM, V264, P816, DOI 10.1046/j.1432-1327.1999.00664.x; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Park C, 2003, BIOCHEMISTRY-US, V42, P3509, DOI 10.1021/bi026076k; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Redfern OC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000485; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Russell RB, 1998, J MOL BIOL, V279, P1211, DOI 10.1006/jmbi.1998.1844; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Torrance JW, 2005, J MOL BIOL, V347, P565, DOI 10.1016/j.jmb.2005.01.044; van Loo B, 2010, P NATL ACAD SCI USA, V107, P2740, DOI 10.1073/pnas.0903951107; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Wroe R, 2007, HFSP J, V1, P79, DOI [10.2976/1.2739116, 10.2976/1.2739116/10.2976/1]; YAMAMURA K, 1976, J CHEM SOC CHEM COMM, P830, DOI 10.1039/c39760000830; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	69	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32011	10.1371/journal.pone.0032011	http://dx.doi.org/10.1371/journal.pone.0032011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359655	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200124
J	Haddaway, NR; Wilcox, RH; Heptonstall, REA; Griffiths, HM; Mortimer, RJG; Christmas, M; Dunn, AM				Haddaway, Neal R.; Wilcox, Ruth H.; Heptonstall, Rachael E. A.; Griffiths, Hannah M.; Mortimer, Robert J. G.; Christmas, Martin; Dunn, Alison M.			Predatory Functional Response and Prey Choice Identify Predation Differences between Native/Invasive and Parasitised/Unparasitised Crayfish	PLOS ONE			English	Article							PACIFASTACUS-LENIUSCULUS; IMPACT; PARASITES; GROWTH; STREAM; FISH; BIODIVERSITY; COMPETITION; INVASION; DISEASE	Background: Invasive predators may change the structure of invaded communities through predation and competition with native species. In Europe, the invasive signal crayfish Pacifastacus leniusculus is excluding the native white clawed crayfish Austropotamobius pallipes. Methodology and Principal Findings: This study compared the predatory functional responses and prey choice of native and invasive crayfish and measured impacts of parasitism on the predatory strength of the native species. Invasive crayfish showed a higher (>10%) prey (Gammarus pulex) intake rate than (size matched) natives, reflecting a shorter (16%) prey handling time. The native crayfish also showed greater selection for crustacean prey over molluscs and bloodworm, whereas the invasive species was a more generalist predator. A. pallipes parasitised by the microsporidian parasite Thelohania contejeani showed a 30% reduction in prey intake. We suggest that this results from parasite-induced muscle damage, and this is supported by a reduced (38%) attack rate and increased (30%) prey handling time. Conclusions and Significance: Our results indicate that the per capita (i.e., functional response) difference between the species may contribute to success of the invader and extinction of the native species, as well as decreased biodiversity and biomass in invaded rivers. In addition, the reduced predatory strength of parasitized natives may impair their competitive abilities, facilitating exclusion by the invader.	[Haddaway, Neal R.] Bangor Univ, Sch Environm Nat Resources & Geog, Coll Nat Sci, Bangor, Gwynedd, Wales; [Haddaway, Neal R.; Wilcox, Ruth H.; Heptonstall, Rachael E. A.; Griffiths, Hannah M.; Dunn, Alison M.] Univ Leeds, Inst Integrat & Comparat Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Mortimer, Robert J. G.] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Christmas, Martin] Environm Agcy, Leeds, W Yorkshire, England	Bangor University; University of Leeds; University of Leeds	Haddaway, NR (corresponding author), Bangor Univ, Sch Environm Nat Resources & Geog, Coll Nat Sci, Bangor, Gwynedd, Wales.	a.dunn@leeds.ac.uk		Mortimer, Robert/0000-0003-1292-8861; Haddaway, Neal R/0000-0003-3902-2234; Dunn, Alison/0000-0002-4855-1077	NERC CASE; British Environment Agency	NERC CASE(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Environment Agency	This work was funded by a NERC (www.nerc.ac.uk) CASE PhD studentship in partnership with the British Environment Agency (www.environment-agency.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Bates D., 2008, LME4 LINEAR MIXED EF; Bolker B., 2009, BBMLE TOOLS GEN MAXI; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolker BM, 2010, EMDBOOK ECOLOGICAL M; Bollache L, 2004, ARCH HYDROBIOL, V160, P57, DOI 10.1127/0003-9136/2004/0160-0057; Bollache L, 2008, BIOL LETTERS, V4, P166, DOI 10.1098/rsbl.2007.0554; Crawford L, 2006, AQUAT CONSERV, V16, P611, DOI 10.1002/aqc.761; Dick JTA, 2010, BIOL LETT; Dorn NJ, 1999, VIE MILIEU, V49, P229; Dunn AM, 2009, ADV PARASIT, V68, P161, DOI 10.1016/S0065-308X(08)00607-6; Dunn AM, 2011, INT J PARAS IN PRESS; Dunn JC, 2009, BIOL INVASIONS, V11, P315, DOI 10.1007/s10530-008-9249-7; EGGLESTON DB, 1990, J EXP MAR BIOL ECOL, V143, P73, DOI 10.1016/0022-0981(90)90112-P; Ellis BK, 2011, P NATL ACAD SCI USA, V108, P1070, DOI 10.1073/pnas.1013006108; Everard M., 2009, ENV LAW MANAGEMENT, V21, P250; Gherardi F., 1999, CRAYFISH EUROPE ALIE; Gherardi Francesca, 2007, BFPP Connaisance et Gestion Patrimoine Aquatique, V387, P7; Goddard J.S., 1988, P145; Guan Rui-Zhang, 1994, Freshwater Forum, V4, P155; Guan RZ, 1999, FISH RES, V42, P245, DOI 10.1016/S0165-7836(99)00044-2; Guan RZ, 1996, AQUAT LIVING RESOUR, V9, P265, DOI 10.1051/alr:1996030; HANSON JM, 1990, FRESHWATER BIOL, V24, P69, DOI 10.1111/j.1365-2427.1990.tb00308.x; Hassell MP., 1978, DYNAMICS ARTHROPOD P; Hatcher M. J., 2011, PARASITES ECOLOGICAL; Hatcher MJ, 2006, ECOL LETT, V9, P1253, DOI 10.1111/j.1461-0248.2006.00964.x; Holdich DM, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009025; Holdich DM, 1999, CRUSTACEAN ISS, V11, P281; Holling C. S., 1959, Canadian Entomologist, V91, P385; Holling C. S., 1965, Mem ent Soc Canada Ottawa, Vno. 45, P1; Hooff RC, 2004, MAR ECOL PROG SER, V277, P167, DOI 10.3354/meps277167; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; Imhoff Emily M., 2009, P49; IUCN, 2011, CONS DIV LIF; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; MacNeil C, 2003, FRESHWATER BIOL, V48, P2085, DOI 10.1046/j.1365-2427.2003.01145.x; MacNeil C, 2003, P ROY SOC B-BIOL SCI, V270, P1309, DOI 10.1098/rspb.2003.2358; Maitland Peter S., 2001, Glasgow Naturalist, V23, P26; McGeoch MA, 2010, DIVERS DISTRIB, V16, P95, DOI 10.1111/j.1472-4642.2009.00633.x; Morgan JF, 2007, EVID-BASED MENT HEAL, V10, P34, DOI 10.1136/ebmh.10.2.34; Mouritsen KN, 2005, OIKOS, V108, P344, DOI 10.1111/j.0030-1299.2005.13507.x; Nystrom P, 1996, FRESHWATER BIOL, V36, P631, DOI 10.1046/j.1365-2427.1996.d01-528.x; Oidtmann B., 1996, FRESHWATER CRAYFISH, V11, P465; Olden JD, 2009, AQUAT ECOL, V43, P1073, DOI 10.1007/s10452-009-9244-9; Peay S, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2010003; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pulliam H, 1989, PERSPECTIVES ECOLOGI, P23; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; R Development Core Team, 2005, R LANG ENV STAT COMP; Radford IJ, 2007, AUSTRAL ECOL, V32, P338, DOI 10.1111/j.1442-9993.2007.01700.x; Rehage JS, 2005, ECOL FRESHW FISH, V14, P352, DOI 10.1111/j.1600-0633.2005.00109.x; Renai B, 2004, BIOL INVASIONS, V6, P89, DOI 10.1023/B:BINV.0000010126.94675.50; Reynolds J., 2011, MANAGEMENT FRESHWATE; Reynolds JD, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011024; Ricciardi A, 1998, CAN J FISH AQUAT SCI, V55, P1759, DOI 10.1139/cjfas-55-7-1759; ROGERS D, 1972, J ANIM ECOL, V41, P369, DOI 10.2307/3474; Rogers D, 2003, CONSERVING NATURA 20, V8; Royama T., 1971, Researches Popul Ecol Kyoto Univ, V1, P1; Rushton SP, 2000, J APPL ECOL, V37, P997, DOI 10.1046/j.1365-2664.2000.00553.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; SETTLE WH, 1990, ECOLOGY, V71, P1461, DOI 10.2307/1938283; Snyder WE, 2006, ANNU REV ECOL EVOL S, V37, P95, DOI 10.1146/annurev.ecolsys.37.091305.110107; Stenroth P, 2003, FRESHWATER BIOL, V48, P466, DOI 10.1046/j.1365-2427.2003.01020.x; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; TRUDGILL N, 2000, N AM SIGNAL CRAYFISH; VINSON SB, 1970, J INSECT PHYSIOL, V16, P1329, DOI 10.1016/0022-1910(70)90132-0; Vogt G, 1999, CRUSTACEAN ISS, V11, P87; Wilmers CC, 2006, ECOL LETT, V9, P383, DOI 10.1111/j.1461-0248.2006.00890.x; ZARET TM, 1973, SCIENCE, V182, P449, DOI 10.1126/science.182.4111.449	69	81	82	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32229	10.1371/journal.pone.0032229	http://dx.doi.org/10.1371/journal.pone.0032229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359673	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000302796200142
J	Jindrichova, M; Lansdell, SJ; Millar, NS				Jindrichova, Marie; Lansdell, Stuart J.; Millar, Neil S.			Changes in Temperature Have Opposing Effects on Current Amplitude in alpha 7 and alpha 4 beta 2 Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							POSITIVE ALLOSTERIC MODULATORS; SENSITIVE EXPRESSION; DROSOPHILA; CHANNELS; AGONIST; BINDING; DESENSITIZATION; PHARMACOLOGY; ACTIVATION; TARGETS	We have examined the effect of temperature on the electrophysiological properties of three neuronal nicotinic acetylcholine receptor (nAChR) subtypes: the rapidly desensitizing homomeric alpha 7 nAChR, the more slowly desensitizing heteromeric alpha 4 beta 2 nAChR and on alpha 7 nAChRs containing a transmembrane mutation (L247T) that results in dramatically reduced desensitization. In all cases, the functional properties of receptors expressed in Xenopus oocytes at room temperature (RT; 21 degrees C) were compared to those recorded at either physiological temperature (37 degrees C) or at lower temperature (4 degrees C). Alterations in temperature had dramatically differing effects on the amplitude of whole-cell responses detected with these three nAChR subtypes. Compared to responses at RT, the amplitude of agonist-evoked responses with alpha 4 beta 2 nAChRs was increased at high temperature (125 +/- 9%, n=6, P<0.01) and reduced at low temperature (47 +/- 5%, n=6, P<0.01), whereas the amplitude of alpha 7 responses was reduced at high temperature (27 +/- 7%, n = 11, P<0.001) and increased at low temperatures (224 +/- 16%, n = 10, P<0.001). In contrast to the effects of temperature on alpha 4 beta 2 and wild type alpha 7 nAChRs, the amplitude of alpha 7 nAChRs containing the L247T mutation was unaffected by changes in temperature. In addition, changes in temperature had little or no effect on current amplitude when alpha 7 nAChRs were activated by the largely non-desensitizing allosteric agonist 4BP-TQS. Despite these differing effects of temperature on the amplitude of agonist-evoked responses in different nAChRs, changes in temperature had a consistent effect on the rate of receptor desensitization on all subtypes examined. In all cases, higher temperature resulted in increased rates of desensitization. Thus, it appears that the differing effects of temperature on the amplitudes of whole-cell responses cannot be explained by temperature-induced changes in receptor desensitization rates.	[Jindrichova, Marie; Lansdell, Stuart J.; Millar, Neil S.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Jindrichova, Marie] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic	University of London; University College London; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Jindrichova, M (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	n.millar@ucl.ac.uk	Jindrichova, Marie/H-4320-2014; Jindrichova, Marie/C-3401-2012		Federation of European Biochemical Societies (FEBS); Wellcome Trust [WT085141]	Federation of European Biochemical Societies (FEBS); Wellcome Trust(Wellcome TrustEuropean Commission)	MJ was supported by a Short Term Fellowship from Federation of European Biochemical Societies (FEBS). SJL was supported by a grant awarded to NSM from The Wellcome Trust (WT085141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CR, 1973, J PHYSIOL-LONDON, V235, P655, DOI 10.1113/jphysiol.1973.sp010410; Arneric SP, 2007, BIOCHEM PHARMACOL, V74, P1092, DOI 10.1016/j.bcp.2007.06.033; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; Bertrand S, 1997, NEUROREPORT, V8, P3591, DOI 10.1097/00001756-199711100-00034; BOYD ND, 1987, J PHYSIOL-LONDON, V389, P45, DOI 10.1113/jphysiol.1987.sp016646; BREGESTOVSKI PD, 1972, NATURE, V236, P453, DOI 10.1038/236453a0; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; Cooper ST, 1999, J BIOL CHEM, V274, P27145, DOI 10.1074/jbc.274.38.27145; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; D'hoedt D, 2009, EXPERT OPIN THER TAR, V13, P395, DOI [10.1517/14728220902841045 , 10.1517/14728220902841045]; DICKINSON R, 1995, BRIT J PHARMACOL, V116, P2949, DOI 10.1111/j.1476-5381.1995.tb15949.x; DILGER JP, 1991, BIOCHIM BIOPHYS ACTA, V1063, P253, DOI 10.1016/0005-2736(91)90379-M; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gupta S, 2011, BIOPHYS J, V100, P895, DOI 10.1016/j.bpj.2010.12.3727; Haydar SN, 2010, CURR TOP MED CHEM, V10, P144, DOI 10.2174/156802610790410983; HEAD SD, 1983, J PHYSIOL-LONDON, V334, P441, DOI 10.1113/jphysiol.1983.sp014505; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; Khmyz V, 2008, EUR J PHYSL, V456, P399; KORDAS M, 1972, J PHYSIOL-LONDON, V224, P333, DOI 10.1113/jphysiol.1972.sp009898; Korinek M, 2010, NEUROSCIENCE, V165, P736, DOI 10.1016/j.neuroscience.2009.10.058; Lansdell SJ, 2004, J NEUROCHEM, V90, P479, DOI 10.1111/j.1471-4159.2004.02499.x; Lansdell SJ, 1997, J NEUROCHEM, V68, P1812; Lansdell SJ, 2008, J NEUROCHEM, V105, P1573, DOI 10.1111/j.1471-4159.2008.05235.x; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P173, DOI 10.1113/jphysiol.1972.sp009840; Millar NS, 2009, BIOCHEM PHARMACOL, V78, P766, DOI 10.1016/j.bcp.2009.06.015; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Nelson ME, 2001, J GEN PHYSIOL, V118, P563, DOI 10.1085/jgp.118.5.563; PAULSON HL, 1990, J CELL BIOL, V110, P1705, DOI 10.1083/jcb.110.5.1705; QUARTARARO N, 1988, PFLUG ARCH EUR J PHY, V411, P101, DOI 10.1007/BF00581653; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Rollema H, 2007, TRENDS PHARMACOL SCI, V28, P316, DOI 10.1016/j.tips.2007.05.003; SINE SM, 1984, BIOPHYS J, V45, P175, DOI 10.1016/S0006-3495(84)84146-6; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sitzia F, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00081; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Young GT, 2007, MOL PHARMACOL, V71, P389, DOI 10.1124/ml.106.030809; Zanello LP, 1996, BIOPHYS J, V70, P2155, DOI 10.1016/S0006-3495(96)79781-3	42	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32073	10.1371/journal.pone.0032073	http://dx.doi.org/10.1371/journal.pone.0032073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359659	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200128
J	Lund, TC; Stadem, PS; Panoskaltsis-Mortari, A; Raymond, G; Miller, WP; Tolar, J; Orchard, PJ				Lund, Troy C.; Stadem, Paul S.; Panoskaltsis-Mortari, Angela; Raymond, Gerald; Miller, Weston P.; Tolar, Jakub; Orchard, Paul J.			Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI Severity	PLOS ONE			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; MULTIPLE-SCLEROSIS; CHEMOKINE RECEPTORS; DISEASE; CHITOTRIOSIDASE; TRANSPLANTATION; CXCR4/CXCL12; ACCUMULATION; INFLAMMATION; MECHANISMS	Background: X-linked adrenoleukodystrophy (ALD) is a metabolic, peroxisomal disease that results from a mutation in the ABCD1 gene. The most severe course of ALD progression is the cerebral inflammatory and demyelinating form of the disease, cALD. To date there is very little information on the cytokine mediators in the cerebral spinal fluid (CSF) of these boys. Methodology/Principal Findings: Measurement of 23 different cytokines was performed on CSF and serum of boys with cerebral ALD and patients without ALD. Significant elevations in CSF IL-8 (29.3 +/- 2.2 vs 12.8 +/- 1.1 pg/ml, p = 0.0001), IL-1ra (166 +/- 30 vs 8.6 +/- 6.5 pg/ml, p = 0.005), MCP-1 (610 +/- 47 vs 328 +/- 34 pg/ml, p = 0.002), and MIP-1b (14.2 +/- 1.3 vs 2.0 +/- 1.4 pg/ml, p<0.0001) were found in boys with cALD versus the control group. The only serum cytokine showing an elevation in the ALD group was SDF-1 (2124 +/- 155 vs 1175 +/- 125 pg/ml, p = 0.0001). The CSF cytokines of IL-8 and MCP-1b correlated with the Loes MRI severity score (p = 0.04 and p = 0.008 respectively), as well as the serum SDF-1 level (p = 0.002). Finally, CSF total protein was also significantly elevated in boys with cALD and correlated with both IL-8, MCP-1b (p = 0.0001 for both), as well as Loes MRI severity score (p = 0.0007). Conclusions/Significance: IL-8, IL-1ra, MCP-1, MIP-1b and CSF total protein were significantly elevated in patients with cALD; IL-8, MCP-1b, and CSF total protein levels correlated with disease severity determined by MRI. This is the largest report of CSF cytokine levels in cALD to date, and identification of these key cytokines will provide further insight into disease progression and perhaps lead to improved targeted therapies.	[Lund, Troy C.; Stadem, Paul S.; Panoskaltsis-Mortari, Angela; Miller, Weston P.; Tolar, Jakub; Orchard, Paul J.] Univ Minnesota, Div Pediat Blood & Marrow Transplant, Minneapolis, MN 55455 USA; [Raymond, Gerald] Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD USA	University of Minnesota System; University of Minnesota Twin Cities; Kennedy Krieger Institute	Lund, TC (corresponding author), Univ Minnesota, Div Pediat Blood & Marrow Transplant, Minneapolis, MN 55455 USA.	lundx072@umn.edu		Tolar, Jakub/0000-0002-0957-4380	Children's Cancer Research Fund	Children's Cancer Research Fund	This work was funded, in part, by the Children's Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Casal JA, 2003, CLIN BIOCHEM, V36, P553, DOI 10.1016/S0009-9120(03)00093-6; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Deon M, 2006, J NEUROL SCI, V247, P157, DOI 10.1016/j.jns.2006.04.004; Eichler FS, 2008, ANN NEUROL, V63, P729, DOI 10.1002/ana.21391; Ferrer I, 2010, BRAIN PATHOL, V20, P817, DOI 10.1111/j.1750-3639.2010.00390.x; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hallegua DS, 2002, ANN RHEUM DIS, V61, P960, DOI 10.1136/ard.61.11.960; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Hudspeth MP, 2007, J NEUROIMMUNOL, V182, P5, DOI 10.1016/j.jneuroim.2006.10.009; Koehne P, 2002, CHILD NERV SYST, V18, P137, DOI 10.1007/s00381-002-0567-2; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; LOES DJ, 1994, AM J NEURORADIOL, V15, P1761; McGuinness MC, 1997, J NEUROIMMUNOL, V75, P174, DOI 10.1016/S0165-5728(97)00020-9; MCGUINNESS MC, 1995, J NEUROIMMUNOL, V61, P161, DOI 10.1016/0165-5728(95)00084-F; Mennicken F, 1999, TRENDS PHARMACOL SCI, V20, P73, DOI 10.1016/S0165-6147(99)01308-5; Miller WP, 2011, BLOOD; Moll NM, 2009, ARCH NEUROL-CHICAGO, V66, P44, DOI 10.1001/archneurol.2008.512; Orchard PJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-144; Paintlia AS, 2003, NEUROBIOL DIS, V14, P425, DOI 10.1016/j.nbd.2003.08.013; Peters C, 2004, BLOOD, V104, P881, DOI 10.1182/blood-2003-10-3402; PHILLIPS JP, 1994, PEDIATR NEUROL, V10, P289, DOI 10.1016/0887-8994(94)90124-4; Polgreen LE, 2011, EUROPEAN J PEDIAT; POWERS JM, 1992, J NEUROPATH EXP NEUR, V51, P630, DOI 10.1097/00005072-199211000-00007; Shapiro E, 2000, LANCET, V356, P713, DOI 10.1016/S0140-6736(00)02629-5; Sotgiu S, 2006, MULT SCLER J, V12, P551, DOI 10.1177/1352458506070614; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Zajkowska J, 2011, ADV MED SCI, P1	29	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32218	10.1371/journal.pone.0032218	http://dx.doi.org/10.1371/journal.pone.0032218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359672	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200141
J	Medrano, LM; Garcia-Magarinos, M; Dema, B; Espino, L; Maluenda, C; Polanco, I; Figueredo, MA; Fernandez-Arquero, M; Nunez, C				Maria Medrano, Luz; Garcia-Magarinos, Manuel; Dema, Barbara; Espino, Laura; Maluenda, Carlos; Polanco, Isabel; Angeles Figueredo, M.; Fernandez-Arquero, Miguel; Nunez, Concepcion			Th17-Related Genes and Celiac Disease Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK VARIANTS; TH17 CELLS; IL23R; INTERLEUKIN-23; INFLAMMATION; EPISTASIS; PSORIASIS; COLITIS; GLIADIN	Th17 cells are known to be involved in several autoimmune or inflammatory diseases. In celiac disease (CD), recent studies suggest an implication of those cells in disease pathogenesis. We aimed at studying the role of genes relevant for the Th17 immune response in CD susceptibility. A total of 101 single nucleotide polymorphisms (SNPs), mainly selected to cover most of the variability present in 16 Th17-related genes (IL23R, RORC, IL6R, IL17A, IL17F, CCR6, IL6, JAK2, TNFSF15, IL23A, IL22, STAT3, TBX21, SOCS3, IL12RB1 and IL17RA), were genotyped in 735 CD patients and 549 ethnically matched healthy controls. Case-control comparisons for each SNP and for the haplotypes resulting from the SNPs studied in each gene were performed using chi-square tests. Gene-gene interactions were also evaluated following different methodological approaches. No significant results emerged after performing the appropriate statistical corrections. Our results seem to discard a relevant role of Th17 cells on CD risk.	[Maria Medrano, Luz; Dema, Barbara; Espino, Laura; Angeles Figueredo, M.; Fernandez-Arquero, Miguel; Nunez, Concepcion] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, UGC Inmunol, Hosp Clin San Carlos, Madrid, Spain; [Garcia-Magarinos, Manuel] Univ Santiago de Compostela, Fac Med, Inst Med Legal, Unidade Xenet, Santiago De Compostela, Spain; [Garcia-Magarinos, Manuel] Univ Santiago de Compostela, Fac Med, Dept Anat Patol & Ciencias Forenses, Santiago De Compostela, Spain; [Garcia-Magarinos, Manuel] Univ Publ Navarra, Dept Estadist & IO, Pamplona, Spain; [Maluenda, Carlos] Hosp Clin San Carlos, Serv Pediat, Madrid, Spain; [Polanco, Isabel] Hosp La Paz, Serv Gastroenterol Pediat, Madrid, Spain	Hospital Clinico San Carlos; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidad Publica de Navarra; Hospital Clinico San Carlos; Hospital Universitario La Paz	Medrano, LM (corresponding author), Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, UGC Inmunol, Hosp Clin San Carlos, Madrid, Spain.	conchita.npardo@gmail.com	Núñez, Concepción/H-8517-2017; de dios, luz maria medrano/K-1946-2016; Garcia-Magariños, Manuel/K-2252-2014; Dema, Barbara/AAM-2354-2020	de dios, luz maria medrano/0000-0003-3717-5384; Garcia-Magariños, Manuel/0000-0001-8257-8719; Nunez, Concepcion/0000-0002-9489-1603; Espino-Paisan, Laura/0000-0001-9136-4106	Fondo de Investigaciones Sanitarias [CP08/00213]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by a grant from "Fondo de Investigaciones Sanitarias" (CP08/00213). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush WS, 2011, GENES IMMUN, V12, P335, DOI 10.1038/gene.2011.3; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Castellanos-Rubio A, 2009, AUTOIMMUNITY, V42, P69, DOI 10.1080/08916930802350789; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dema B, 2009, HUM IMMUNOL, V70, P191, DOI 10.1016/j.humimm.2009.01.010; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Einarsdottir E, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-8; Fernandez S, 2011, AM J GASTROENTEROL, V106, P528, DOI 10.1038/ajg.2010.465; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Harris KM, 2008, J IMMUNOL, V181, P4457, DOI 10.4049/jimmunol.181.7.4457; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Lees CW, 2011, GUT; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P883, DOI 10.1002/ibd.20855; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nunez C, 2008, GENES IMMUN, V9, P289, DOI 10.1038/gene.2008.16; Oukka M, 2008, ANN RHEUM DIS, V67, P26, DOI 10.1136/ard.2008.098004; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Torok P, 2009, AM J GASTROENTEROL, V104, P1723, DOI 10.1038/ajg.2009.184; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	26	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31244	10.1371/journal.pone.0031244	http://dx.doi.org/10.1371/journal.pone.0031244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359581	Green Published, gold			2022-12-25	WOS:000302796200050
J	Oakley, S; Vedula, LS; Bu, WM; Meng, QC; Xi, J; Liu, RY; Eckenhoff, RG; Loll, PJ				Oakley, Simon; Vedula, L. Sangeetha; Bu, Weiming; Meng, Qing Cheng; Xi, Jin; Liu, Renyu; Eckenhoff, Roderic G.; Loll, Patrick J.			Recognition of Anesthetic Barbiturates by a Protein Binding Site: A High Resolution Structural Analysis	PLOS ONE			English	Article							GABA(A) RECEPTOR; ION-CHANNEL; IDENTIFICATION; PROPOFOL; SENSITIVITY; MODULATION; ETOMIDATE; QUALITY; BUNDLE; SET	Barbiturates potentiate GABA actions at the GABA(A) receptor and act as central nervous system depressants that can induce effects ranging from sedation to general anesthesia. No structural information has been available about how barbiturates are recognized by their protein targets. For this reason, we tested whether these drugs were able to bind specifically to horse spleen apoferritin, a model protein that has previously been shown to bind many anesthetic agents with affinities that are closely correlated with anesthetic potency. Thiopental, pentobarbital, and phenobarbital were all found to bind to apoferritin with affinities ranging from 10-500 mu M, approximately matching the concentrations required to produce anesthetic and GABAergic responses. X-ray crystal structures were determined for the complexes of apoferritin with thiopental and pentobarbital at resolutions of 1.9 and 2.0 angstrom, respectively. These structures reveal that the barbiturates bind to a cavity in the apoferritin shell that also binds haloalkanes, halogenated ethers, and propofol. Unlike these other general anesthetics, however, which rely entirely upon van der Waals interactions and the hydrophobic effect for recognition, the barbiturates are recognized in the apoferritin site using a mixture of both polar and nonpolar interactions. These results suggest that any protein binding site that is able to recognize and respond to the chemically and structurally diverse set of compounds used as general anesthetics is likely to include a versatile mixture of both polar and hydrophobic elements.	[Oakley, Simon; Vedula, L. Sangeetha; Bu, Weiming; Meng, Qing Cheng; Xi, Jin; Liu, Renyu; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Loll, Patrick J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Drexel University	Oakley, S (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	ploll@drexelmed.edu		Eckenhoff, Roderic/0000-0002-5581-746X	National Institutes of Health/National Institute of General Medical Sciences [P01 GM055876]; U.S. Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health/National Institute of General Medical Sciences [P01 GM055876]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; We thank the staff of beam line X6A of the National Synchrotron Light Source (NSLS), which is supported by the National Institute of General Medical Sciences, National Institutes of Health. The NSLS at Brookhaven National Laboratory is supported by the U.S. Department of Energy.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANDREWS PR, 1982, ANESTHESIOLOGY, V57, P314, DOI 10.1097/00000542-198210000-00014; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Bertaccini EJ, 2007, ANESTH ANALG, V104, P318, DOI 10.1213/01.ane.0000253029.67331.8d; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Butts CA, 2009, P NATL ACAD SCI USA, V106, P6501, DOI 10.1073/pnas.0810590106; Chang CSS, 2003, J BIOL CHEM, V278, P42821, DOI 10.1074/jbc.M306978200; Cheng TJ, 2007, J CHEM INF MODEL, V47, P2140, DOI 10.1021/ci700257y; DINGEMANSE J, 1990, J PHARM SCI, V79, P207, DOI 10.1002/jps.2600790305; Eckenhoff R G, 2001, Mol Interv, V1, P258; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falk MJ, 2006, CURR BIOL, V16, P1641, DOI 10.1016/j.cub.2006.06.072; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; Granier T, 1997, ACTA CRYSTALLOGR D, V53, P580, DOI 10.1107/S0907444997003314; Jenkins A, 2002, NEUROPHARMACOLOGY, V43, P669, DOI 10.1016/S0028-3908(02)00175-2; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Krasowski MD, 2002, J MED CHEM, V45, P3210, DOI 10.1021/jm010461a; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazarenko RM, 2010, J NEUROSCI, V30, P7691, DOI 10.1523/JNEUROSCI.1655-10.2010; Lee JK, 2010, CURR OPIN STRUC BIOL, V20, P464, DOI 10.1016/j.sbi.2010.05.004; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Liu RY, 2005, FASEB J, V19, P567, DOI 10.1096/fj.04-3171com; Lopez-Munoz Francisco, 2005, Neuropsychiatr Dis Treat, V1, P329; Ma DJ, 2008, BIOPHYS J, V94, P4454, DOI 10.1529/biophysj.107.117838; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mecozzi S, 1998, CHEM-EUR J, V4, P1016, DOI 10.1002/(SICI)1521-3765(19980615)4:6<1016::AID-CHEM1016>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Olsen RW, 2011, CAN J ANESTH, V58, P206, DOI 10.1007/s12630-010-9429-7; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Rho JM, 1996, J PHYSIOL-LONDON, V497, P509, DOI 10.1113/jphysiol.1996.sp021784; Sandorfy C, 2004, ANESTHESIOLOGY, V101, P1225, DOI 10.1097/00000542-200411000-00024; Schofield CM, 2005, BRAIN RES, V1032, P30, DOI 10.1016/j.brainres.2004.11.002; Tomlin SL, 1999, ANESTHESIOLOGY, V90, P1714, DOI 10.1097/00000542-199906000-00029; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vedula LS, 2009, J BIOL CHEM, V284, P24176, DOI 10.1074/jbc.M109.017814; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; YAKUSHIJI T, 1989, BRAIN RES, V488, P357, DOI 10.1016/0006-8993(89)90730-0	45	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32070	10.1371/journal.pone.0032070	http://dx.doi.org/10.1371/journal.pone.0032070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359658	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200127
J	Wang, CY; Tsai, AC; Peng, CY; Chang, YL; Lee, KH; Teng, CM; Pan, SL				Wang, Chih-Ya; Tsai, An-Chi; Peng, Chieh-Yu; Chang, Ya-Ling; Lee, Kuo-Hsiung; Teng, Che-Ming; Pan, Shiow-Lin			Dehydrocostuslactone Suppresses Angiogenesis In Vitro and In Vivo through Inhibition of Akt/GSK-3 beta and mTOR Signaling Pathways	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ENDOPLASMIC-RETICULUM STRESS; CYCLIN D1; CANCER CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; SAUSSUREA-LAPPA; TUMOR-GROWTH; AKT; LACTONE; EXPRESSION	The traditional Chinese medicine component dehydrocostuslactone (DHC) isolated from Saussurea costus (Falc.) Lipschitz, has been shown to have anti-cancer activity. Angiogenesis is an essential process in the growth and progression of cancer. In this study, we demonstrated, for the first time, the anti-angiogenic mechanism of action of DHC to be via the induction of cell cycle progression at the G0/G1 phase due to abrogation of the Akt/glycogen synthase kinase-3 beta (GSK-3 beta)/cyclin D1 and mTOR signaling pathway. First, we demonstrated that DHC has an anti-angiogenic effect in the matrigel-plug nude mice model and an inhibitory effect on human umbilical vein endothelial cell (HUVEC) proliferation and capillary-like tube formation in vitro. DHC caused G0/G1 cell cycle arrest, which was associated with the down-regulation of cyclin D1 expression, leading to the suppression of retinoblastoma protein phosphorylation and subsequent inhibition of cyclin A and cdk2 expression. With respect to the molecular mechanisms underlying the DHC-induced cyclin D1 down-regulation, this study demonstrated that DHC significantly inhibits Akt expression, resulting in the suppression of GSK-3b phosphorylation and mTOR expression. These effects are capable of regulating cyclin D1 degradation, but they were significantly reversed by constitutively active myristoylated (myr)-Akt. Furthermore, the abrogation of tube formation induced by DHC was also reversed by overexpression of Akt. And the co-treatment with LiCl and DHC significantly reversed the growth inhibition induced by DHC. Taken together, our study has identified Akt/GSK-3 beta and mTOR as important targets of DHC and has thus highlighted its potential application in angiogenesis-related diseases, such as cancer.	[Wang, Chih-Ya; Chang, Ya-Ling; Teng, Che-Ming] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan; [Tsai, An-Chi; Pan, Shiow-Lin] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan Town, Taiwan; [Peng, Chieh-Yu] China Med Univ Hosp, Nat Med Prod Res Ctr, Taichung, Taiwan; [Peng, Chieh-Yu] China Med Univ, Coll Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan; [Lee, Kuo-Hsiung] Univ N Carolina, Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC USA; [Lee, Kuo-Hsiung] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; University of North Carolina; University of North Carolina Chapel Hill; China Medical University Taiwan; China Medical University Hospital - Taiwan	Wang, CY (corresponding author), Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan.	cmteng@ntu.edu.tw; apan0826@nhri.org.tw	Pan, Shiow-Lin/C-1372-2010	TENG, CHE-MING/0000-0002-9719-7334	National Science Council of Taiwan [NSC 99-2320-B400-008-MY3, NSC 99-2628-B002-024-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Grants from the National Science Council of Taiwan (NSC 99-2320-B400-008-MY3) and (NSC 99-2628-B002-024-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CHEN HC, 1995, ANTIVIR RES, V27, P99, DOI 10.1016/0166-3542(94)00083-K; Choi EJ, 2009, INT J MOL MED, V23, P211, DOI 10.3892/ijmm_00000119; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; El Sayed KA, 2005, MINI-REV MED CHEM, V5, P971, DOI 10.2174/138955705774575291; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Hanai J, 2002, J BIOL CHEM, V277, P16464, DOI 10.1074/jbc.M112274200; Hsu YL, 2009, J PHARMACOL EXP THER, V329, P808, DOI 10.1124/jpet.108.148395; Hung JY, 2010, LUNG CANCER, V68, P355, DOI 10.1016/j.lungcan.2009.07.017; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Jiang BH, 2008, CURR CANCER DRUG TAR, V8, P19, DOI 10.2174/156800908783497122; Kanda S, 1997, J BIOL CHEM, V272, P23347, DOI 10.1074/jbc.272.37.23347; Kim HS, 2002, J BIOL CHEM, V277, P41888, DOI 10.1074/jbc.M206657200; Kuo PL, 2009, MOL CANCER THER, V8, P1328, DOI 10.1158/1535-7163.MCT-08-0914; Lee HJ, 1999, PLANTA MED, V65, P104, DOI 10.1055/s-1999-13968; Matsuda H, 2000, TETRAHEDRON, V56, P7763, DOI 10.1016/S0040-4020(00)00696-7; Nelsen CJ, 2003, J BIOL CHEM, V278, P3656, DOI 10.1074/jbc.M209374200; Oh GS, 2004, IMMUNOPHARM IMMUNOT, V26, P163, DOI 10.1081/IPH-120037712; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; ROSENWALD IB, 1995, J BIOL CHEM, V270, P21176, DOI 10.1074/jbc.270.36.21176; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schnell CR, 2008, CANCER RES, V68, P6598, DOI 10.1158/0008-5472.CAN-08-1044; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Skurk C, 2005, CIRC RES, V96, P308, DOI 10.1161/01.RES.0000156273.30274.f7; TANIGUCHI M, 1995, BIOSCI BIOTECH BIOCH, V59, P2064, DOI 10.1271/bbb.59.2064; Tsai AC, 2010, CANCER LETT, V292, P163, DOI 10.1016/j.canlet.2009.11.020; Yasui M, 2006, CLIN CANCER RES, V12, P4720, DOI 10.1158/1078-0432.CCR-05-1213; Yuan TL, 2008, P NATL ACAD SCI USA, V105, P9739, DOI 10.1073/pnas.0804123105; Yuuya S, 1999, J NAT PROD, V62, P22, DOI 10.1021/np980092u	44	39	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31195	10.1371/journal.pone.0031195	http://dx.doi.org/10.1371/journal.pone.0031195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359572	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200041
J	Wang, YZ; Wang, X; Ye, L; Li, JL; Song, L; Fulambarkar, N; Ho, WZ				Wang, Yizhong; Wang, Xu; Ye, Li; Li, Jieliang; Song, Li; Fulambarkar, Nilija; Ho, Wenzhe			Morphine Suppresses IFN Signaling Pathway and Enhances AIDS Virus Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C-VIRUS; INTERFERON REGULATORY FACTOR; GENE-EXPRESSION; INNATE IMMUNITY; ANTIVIRAL ACTIVITY; HIV-1 REPLICATION; TYPE-1 INFECTION; ALPHA EXPRESSION; HUMAN-MONOCYTES	Background: Opioids exert a profound influence on immunomodulation and enhance HIV infection and replication. However, the mechanism(s) of their action remains to be determined. We thus investigated the impact of morphine on the intracellular innate antiviral immunity. Methodology/Principal Findings: Seven-day-cultured macrophages were infected with equal amounts of cell-free HIV Bal or SIV Delta(B670) for 2 h at 37 degrees C after 24 h of treatment with or without morphine. Effect of morphine on HIV/SIV infection and replication was evaluated by HIV/SIV RT activity assay and indirect immunofluorescence for HIV p24 or SIV p28 antigen. The mRNA expression of cellular factors suppressed or induced by morphine treatment was analyzed by the real-time RTPCR. We demonstrated that morphine treatment of human blood monocyte-derived macrophages significantly inhibited the expression of interferons (IFN-alpha, IFN-beta and IFN-lambda) and IFN-inducible genes (APOBEC3C/3F/3G and 3H). The further experiments showed that morphine suppressed the expression of several key elements ( RIG-I and IRF-7) in IFN signaling pathway. In addition, morphine treatment induced the expression of suppressor of cytokine signaling protein-1, 2, 3 (SOCS- 2, 3) and protein inhibitors of activated STAT-1, 3, X, Y (PIAS-1, 3, X, Y), the key negative regulators of IFN signaling pathway. Conclusions: These findings indicate that morphine impairs intracellular innate antiviral mechanism(s) in macrophages, contributing to cell susceptibility to AIDS virus infection.	[Wang, Yizhong; Wang, Xu; Ye, Li; Li, Jieliang; Song, Li; Fulambarkar, Nilija; Ho, Wenzhe] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA; [Ye, Li; Ho, Wenzhe] Wuhan Univ, Ctr Anim Expt, ABSL Lab 3, Wuhan, Hubei, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Wuhan University	Wang, YZ (corresponding author), Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA.	wenzheho@temple.edu			National Institutes of Health [DA12815, DA22177, DA27550]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022177, R01DA012815, R01DA027550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health [grant numbers DA12815, DA22177, and DA27550]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCABES P, 1995, CLIN INFECT DIS, V20, P1467, DOI 10.1093/clinids/20.6.1467; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Ank N, 2006, J INTERF CYTOK RES, V26, P373, DOI 10.1089/jir.2006.26.373; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; BATTJES RJ, 1988, B NARCOTICS, V40, P21; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; CHUANG LF, 1993, BIOCHEM BIOPH RES CO, V195, P1165, DOI 10.1006/bbrc.1993.2167; Dang Y, 2008, J BIOL CHEM, V283, P11606, DOI 10.1074/jbc.M707586200; DONAHOE RM, 1993, ADV EXP MED BIOL, V335, P21; Donahoe RM, 1998, J NEUROIMMUNOL, V83, P77, DOI 10.1016/S0165-5728(97)00224-5; Donahoe RM, 2009, JAIDS-J ACQ IMM DEF, V50, P241, DOI 10.1097/QAI.0b013e3181967354; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Friedman H, 2003, CLIN MICROBIOL REV, V16, P209, DOI 10.1128/CMR.16.2.209-219.2003; Guo CJ, 2002, J INVEST MED, V50, P435, DOI 10.1136/jim-50-06-03; HASSAN NF, 1986, J IMMUNOL METHODS, V95, P273, DOI 10.1016/0022-1759(86)90415-1; HO WZ, 1992, J VIROL, V66, P573, DOI 10.1128/JVI.66.1.573-579.1992; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kumar R, 2004, J VIROL, V78, P11425, DOI 10.1128/JVI.78.20.11425-11428.2004; Li Y, 2003, AM J PATHOL, V163, P1167, DOI 10.1016/S0002-9440(10)63476-1; Li Y, 2003, PEDIATR RES, V54, P282, DOI 10.1203/01.PDR.0000074973.83826.4C; Li Y, 2007, J INFECT DIS, V196, P719, DOI 10.1086/520093; Mahajan SD, 2005, CURR HIV RES, V3, P277, DOI 10.2174/1570162054368048; Mahajan SD, 2002, J IMMUNOL, V169, P3589, DOI 10.4049/jimmunol.169.7.3589; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Mbisa JL, 2010, J VIROL, V84, P5250, DOI 10.1128/JVI.02358-09; McCarthy L, 2001, DRUG ALCOHOL DEPEN, V62, P111, DOI 10.1016/S0376-8716(00)00181-2; Miyagi T, 2000, J BIOL CHEM, V275, P31305, DOI 10.1074/jbc.M001269200; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nair MPN, 1997, CLIN DIAGN LAB IMMUN, V4, P127, DOI 10.1128/CDLI.4.2.127-132.1997; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Norkina O, 2008, ALCOHOL CLIN EXP RES, V32, P1565, DOI 10.1111/j.1530-0277.2008.00726.x; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; PETERSON PK, 1990, AIDS, V4, P869, DOI 10.1097/00002030-199009000-00006; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rakesh K, 2005, BIOCHEM PHARMACOL, V70, P649, DOI 10.1016/j.bcp.2005.04.042; Risdahl JM, 1998, J NEUROIMMUNOL, V83, P4, DOI 10.1016/S0165-5728(97)00216-6; RONALD PJM, 1994, AIDS, V8, P339, DOI 10.1097/00002030-199403000-00007; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Specter S, 1994, J Fla Med Assoc, V81, P485; Steele AD, 2003, VIROLOGY, V309, P99, DOI 10.1016/S0042-6822(03)00015-1; StollKeller F, 1997, INT J IMMUNOPHARMACO, V19, P95, DOI 10.1016/S0192-0561(97)00017-9; Suzuki S, 2002, J INFECT DIS, V185, P1826, DOI 10.1086/340816; Suzuki S, 2002, EXP CELL RES, V280, P192, DOI 10.1006/excr.2002.5638; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; Wang FX, 2008, J GEN VIROL, V89, P722, DOI 10.1099/vir.0.83530-0; Wang J, 2008, ARCH IMMUNOL THER EX, V56, P299, DOI 10.1007/s00005-008-0035-0; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; Ye L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009602; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang T, 2005, HEPATOLOGY, V42, P819, DOI 10.1002/hep.20854; Zhang T, 2006, REV MED VIROL, V16, P311, DOI 10.1002/rmv.508	69	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31167	10.1371/journal.pone.0031167	http://dx.doi.org/10.1371/journal.pone.0031167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359571	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200040
J	Carthey, AJR; Banks, PB				Carthey, Alexandra J. R.; Banks, Peter B.			When Does an Alien Become a Native Species? A Vulnerable Native Mammal Recognizes and Responds to Its Long-Term Alien Predator	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; PREY; INVADERS; MARSUPIALS; AUSTRALIA; PATTERNS; NAIVETE; DINGOES; ECOLOGY	The impact of alien predators on native prey populations is often attributed to prey naivete 'towards a novel threat. Yet evolutionary theory predicts that alien predators cannot remain eternally novel; prey species must either become extinct or learn and adapt to the new threat. As local enemies lose their naivete' and coexistence becomes possible, an introduced species must eventually become 'native'. But when exactly does an alien become a native species? The dingo (Canis lupus dingo) was introduced to Australia about 4000 years ago, yet its native status remains disputed. To determine whether a vulnerable native mammal (Perameles nasuta) recognizes the close relative of the dingo, the domestic dog (Canis lupus familiaris), we surveyed local residents to determine levels of bandicoot visitation to yards with and without resident dogs. Bandicoots in this area regularly emerge from bushland to forage in residential yards at night, leaving behind tell-tale deep, conical diggings in lawns and garden beds. These diggings were less likely to appear at all, and appeared less frequently and in smaller quantities in yards with dogs than in yards with either resident cats (Felis catus) or no pets. Most dogs were kept indoors at night, meaning that bandicoots were not simply chased out of the yards or killed before they could leave diggings, but rather they recognized the threat posed by dogs and avoided those yards. Native Australian mammals have had thousands of years experience with wild dingoes, which are very closely related to domestic dogs. Our study suggests that these bandicoots may no longer be naive towards dogs. We argue that the logical criterion for determining native status of a long-term alien species must be once its native enemies are no longer naive.	[Carthey, Alexandra J. R.; Banks, Peter B.] Univ New S Wales, Ecol & Evolut Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Carthey, AJR (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	alex.carthey@sydney.edu.au		Carthey, Alexandra Jane Repin/0000-0002-0472-2217; Banks, Peter/0000-0002-4340-6495	Royal Zoological Society of NSW; Hermon Slade Foundation [HSF 10/10]	Royal Zoological Society of NSW; Hermon Slade Foundation	This work was funded by an Ethel Mary Read Grant from the Royal Zoological Society of NSW (http://www.rzsnsw.org.au/), and by the Hermon Slade Foundation (Grant HSF 10/10 http://www.hermonslade.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1996, INTRO CATEGORICAL DA; AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Banks PB, 2007, TRENDS ECOL EVOL, V22, P229, DOI 10.1016/j.tree.2007.02.006; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Blumstein DT, 2005, P ROY SOC B-BIOL SCI, V272, P1663, DOI 10.1098/rspb.2005.3147; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Carlsson NOL, 2010, BIOL INVASIONS, V12, P633, DOI 10.1007/s10530-009-9470-z; Chew MK, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P35; Corbett L. K., 1995, DINGO AUSTR ASIA; Cox GW, 2004, ALIEN SPECIES EVOLUT; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Diamond J, 1986, COMMUNITY ECOLOGY, P65; Dickman C., 1996, OVERVIEW IMPACTS FER; Dickman C. R., 2008, MAMMALS AUSTR, P189; Elledge AE, 2006, MAMMAL REV, V36, P142, DOI 10.1111/j.1365-2907.2006.00086.x; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Johnson CN, 2009, AUSTRAL ECOL, V34, P35, DOI 10.1111/j.1442-9993.2008.01878.x; Jones Menna A., 2003, P422; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Mech LD, 2001, J WILDLIFE MANAGE, V65, P998, DOI 10.2307/3803048; NOLTE DL, 1994, J CHEM ECOL, V20, P1505, DOI 10.1007/BF02059876; Phillips BL, 2006, P ROY SOC B-BIOL SCI, V273, P1545, DOI 10.1098/rspb.2006.3479; Pollock MS, 2003, ENVIRON BIOL FISH, V66, P313, DOI 10.1023/A:1023905824660; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Ricciardi A, 2004, ECOL LETT, V7, P781, DOI 10.1111/j.1461-0248.2004.00642.x; Richardson DM, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P409; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Sand H, 2006, P R SOC B, V273, P1421, DOI 10.1098/rspb.2005.3447; Scott LK, 1999, WILDLIFE RES, V26, P805, DOI 10.1071/WR98074; Short J, 2002, BIOL CONSERV, V103, P283, DOI 10.1016/S0006-3207(01)00139-2; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Verhoeven KJF, 2009, ECOL LETT, V12, P107, DOI 10.1111/j.1461-0248.2008.01248.x; Vermeij GJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P315; Webb JK, 2008, AUSTRAL ECOL, V33, P821, DOI 10.1111/j.1442-9993.2008.01847.x	36	63	65	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31804	10.1371/journal.pone.0031804	http://dx.doi.org/10.1371/journal.pone.0031804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355396	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300096
J	Sakaguchi, H; Tsunoda, M; Wada, K; Ohta, H; Kawashima, M; Yoshino, Y; Aizawa, Y				Sakaguchi, Hiroko; Tsunoda, Masashi; Wada, Koji; Ohta, Hiroshi; Kawashima, Masatoshi; Yoshino, Yae; Aizawa, Yoshiharu			Assessment of Border Control Measures and Community Containment Measures Used in Japan during the Early Stages of Pandemic (H1N1) 2009	PLOS ONE			English	Article							INFLUENZA-A H1N1; INTERNATIONAL AIRPORT; VIRUS-INFECTION; FACE MASKS; TRANSMISSION; SPREAD; SARS; QUARANTINE; FEVER; CHINA	Background: In the early stages of Pandemic (H1N1) 2009, border control measures were taken by quarantine stations to block the entry of infected individuals into Japan and community containment measures were implemented to prevent the spreading. The objectives of this study were to describe these measures and the characteristics of infected individuals, and to assess the measures' effectiveness. Methodology/Principal Findings: Border control and community containment measures implemented from April to June (Period I: April 28-May 21, Period II: May 22-June 18) 2009 were described. Number of individuals identified and disease characteristics were analyzed. For entry screening, a health declaration form and an infrared thermoscanner were used to detect symptomatic passengers. Passengers indicated for the rapid influenza test underwent the test followed by RT-PCR. Patients positive for H1N1 were isolated, and close contacts were quarantined. Entry cards were handed out to all asymptomatic passengers informing them about how to contact a health center in case they developed symptoms. Nine individuals were identified by entry screening and 1 during quarantine to have Pandemic (H1N1) 2009. Health monitoring by health centers was performed in period I for passengers arriving from affected countries and in period II for those who had come into contact with the individuals identified by entry screening. Health monitoring identified 3 infected individuals among 129,546 in Period I and 5 among 746 in Period II. Enhanced surveillance, which included mandatory reporting of details of the infected individuals, identified 812 individuals, 141 (18%) of whom had a history of international travel. Twenty-four of these 141 passengers picked up by enhanced surveillance had been developing symptoms on entry and were missed at screening. Conclusion/Significance: Symptomatic passengers were detected by the various entry screening measures put in place. Enhanced surveillance provided data for the improvement of public health measures in future pandemics.	[Sakaguchi, Hiroko; Kawashima, Masatoshi; Yoshino, Yae] Kitasato Univ, Grad Sch Med Sci, Dept Occupat Hlth, Sagamihara, Kanagawa 228, Japan; [Tsunoda, Masashi; Aizawa, Yoshiharu] Kitasato Univ, Sch Med, Dept Prevent Med, Sagamihara, Kanagawa 228, Japan; [Wada, Koji; Ohta, Hiroshi] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 228, Japan	Kitasato University; Kitasato University; Kitasato University	Sakaguchi, H (corresponding author), Kitasato Univ, Grad Sch Med Sci, Dept Occupat Hlth, Sagamihara, Kanagawa 228, Japan.	mtsunoda@med.kitasato-u.ac.jp			Ministry of Health, Labour and Welfare [H23-Policy-033]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was funded by a research project for Emerging and Re-emerging Infectious Diseases of the Ministry of Health, Labour and Welfare (H23-Policy-033). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho M, 2010, EUROSURVEILLANCE, V15, P14; Arguin PM, 2009, EMERG INFECT DIS, V15, P1713, DOI 10.3201/eid1511.091426; Baker MG, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2424; Bradley Michael, 2008, REGIONAL ALASKA TRIB; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Caley P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000143; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Cowling BJ, 2010, EPIDEMIOL INFECT, V138, P449, DOI 10.1017/S0950268809991658; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Del Valle SY, 2010, AM J INFECT CONTROL, V38, P676, DOI 10.1016/j.ajic.2010.03.012; Department of Quarantine Narita Airport Quarantine Station, 2009, REP RESP PAND INFL N; European Centre for Disease Prevention and Control, 2009, ECDC RISK ASS PAND H; Foxwell AR, 2011, EMERG INFECT DIS, V17, P1188, DOI 10.3201/eid1707.101135; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Jordan H. T., 2009, Morbidity and Mortality Weekly Report, V58, P470; Kawaguchi R, 2009, EMERG INFECT DIS, V15, P1685, DOI 10.3201/eid1510.091029; Lance C, 2011, PLOS ONE, V6; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Malone JD, 2009, TRAVEL MED INFECT DI, V7, P181, DOI 10.1016/j.tmaid.2009.02.006; McBride WJH, 2010, AUST NZ J PUBL HEAL, V34, P5, DOI 10.1111/j.1753-6405.2010.00466.x; Ministry of Education Culture Sports Science and Technology, 2009, DAIL REP SCH CLOS AS; Miyamura T, 2011, PANDEMIC H1N1 2009 J; Mutsch M, 2005, CLIN INFECT DIS, V40, P1282, DOI 10.1086/429243; NEC Avio Infrared Technologies Co. Ltd, 2001, TVS 500EX; Ng EYK, 2005, MED PHYS, V32, P93, DOI 10.1118/1.1819532; Nishiura H, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-111; Ooi PL, 2005, AM J INFECT CONTROL, V33, P252, DOI 10.1016/j.ajic.2004.08.007; Pang XH, 2011, EMERG INFECT DIS, V17, P1824, DOI 10.3201/eid1710.101344; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Reynolds DL, 2008, EPIDEMIOL INFECT, V136, P997, DOI 10.1017/S0950268807009156; Shimada T, 2009, EUROSURVEILLANCE, V14; The Governmental Committee of Action Plans against Influenza Pandemic in Japan, 2009, GUID PREV CONTR PAND; Wada Koji, 2011, Nihon Koshu Eisei Zasshi, V58, P259; World Health Organization, 2010, WEEKLY EPIDEMIOLOGIC, V85, P185; World Health Organization, 2009, TECHN ADV CAS MAN IN; Yasuda H, 2009, EUROSURVEILLANCE, V14, P12	40	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31289	10.1371/journal.pone.0031289	http://dx.doi.org/10.1371/journal.pone.0031289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355354	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300054
J	Sharma, RI; Snedeker, JG				Sharma, Ram I.; Snedeker, Jess G.			Paracrine Interactions between Mesenchymal Stem Cells Affect Substrate Driven Differentiation toward Tendon and Bone Phenotypes	PLOS ONE			English	Article							MARROW STROMAL CELLS; ROTATOR CUFF; IN-VITRO; PROLIFERATION; MATRIX; REPAIR; EXPRESSION; OSTEOGENESIS; ANGIOGENESIS; TENOMODULIN	We investigated substrate dependent paracrine signaling between subpopulations of bone marrow stromal cells (BMSCs) that may affect the formation, or perhaps malformation, of the regenerating tendon to bone enthesis. Polyacrylamide substrates approximating the elastic modulus of tendon granulation tissue and the osteoid of healing bone (10-90 kPa) were functionalized with whole length fibronectin (Fn), type-I collagen (Col), or a mixed ligand solution (Fn/Col), and BMSCs were cultured in growth media alone or media supplemented with soluble Col or Fn. More rigid substrates with a narrow mechanical gradient (70-90 kPa) robustly induced osteogenic cell differentiation when functionalized with either Col or Fn. On broader mechanical gradient substrates (with a linear elastic modulus gradient from 10-90 kPa), cell differentiation was markedly osteogenic on subregions of Fn functionalized substrates above 20 kPa, but osteogenic activity was inhibited on all subregions of Col substrates. Osteogenic behavior was not observed when cells were cultured on Fn substrates if Col was present either in the media or on the substrate (Fn/Col). Tenogenic differentiation markers were observed only on Col substrates with moderate rigidity (similar to 30-50 kPa). Tenogenic differentiation was unaltered by soluble or substrate bound Fn. Co-culture of narrow gradient subsections revealed that any inclusion of tenogenic substrates (30-50 kPa, Col), caused otherwise osteogenic substrates to not develop markers of osteogenic differentiation, while increasing cell proliferation. These apparently paracrine effects could be mediated by bone morphogenetic protein-2 (BMP-2), as first confirmed by gene-level expression of BMP-2 and the transcription factor Smad8, and verified by BMP-2 media supplementation at levels similar to observed cell-secreted concentrations, which arrested osteogenic differentiation in 14 day cultures. Thus, cell instructive biomaterials with engineered mechanical and biochemical properties represent potentially powerful tools for directing BMSC differentiation to tendon and bone, however paracrine signals from tenogenic cells may delay osteogenesis at the healing enthesis.	[Sharma, Ram I.; Snedeker, Jess G.] Univ Zurich Balgrist, Dept Orthoped, Zurich, Switzerland; [Sharma, Ram I.; Snedeker, Jess G.] Swiss Fed Inst Technol EHT Zurich, Dept Mech Engn, Zurich, Switzerland	University of Zurich	Sharma, RI (corresponding author), Univ Zurich Balgrist, Dept Orthoped, Zurich, Switzerland.	snedeker@ethz.ch	Snedeker, Jess G./X-2098-2019; Snedeker, Jess/C-2105-2009	Snedeker, Jess G./0000-0002-8115-0275; Snedeker, Jess/0000-0002-8115-0275	Bonizzi Theler Foundation	Bonizzi Theler Foundation	This work was generously supported by the Bonizzi Theler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931; Bleuming SA, 2007, CANCER RES, V67, P8149, DOI 10.1158/0008-5472.CAN-06-4659; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Bullough R, 2008, DISABIL REHABIL, V30, P1746, DOI 10.1080/09638280701788258; Carter EM, 2009, CURR OPIN PEDIATR, V21, P46, DOI 10.1097/MOP.0b013e32832185c5; Chandler EM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015008; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chen X, 2009, STEM CELLS, V27, P1276, DOI 10.1002/stem.61; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Du J, 2011, P NATL ACAD SCI USA, V108, P9466, DOI 10.1073/pnas.1106467108; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Giuliani N, 2009, EXP HEMATOL, V37, P879, DOI 10.1016/j.exphem.2009.04.004; Hirschi KK, 2002, ANN NY ACAD SCI, V961, P223, DOI 10.1111/j.1749-6632.2002.tb03090.x; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Hoerstrup SP, 2002, CIRCULATION, V106, pI143, DOI 10.1161/01.cir.0000032872.55215.05; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; Huang Z, 2010, CYTOKINE, V51, P305, DOI 10.1016/j.cyto.2010.06.002; Javazon EH, 2007, WOUND REPAIR REGEN, V15, P350, DOI 10.1111/j.1524-475X.2007.00237.x; Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974; Kolacna L, 2007, PHYSIOL RES, V56, pS51, DOI 10.33549/physiolres.931302; Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110; Liu SB, 2009, CHINESE MED J-PEKING, V122, P839, DOI 10.3760/cma.j.issn.0366-6999.2009.07.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McFarlin K, 2006, WOUND REPAIR REGEN, V14, P471, DOI 10.1111/j.1743-6109.2006.00153.x; Miyamoto S, 1998, ANN NY ACAD SCI, V857, P119, DOI 10.1111/j.1749-6632.1998.tb10112.x; Moffat KL, 2008, P NATL ACAD SCI USA, V105, P7947, DOI 10.1073/pnas.0712150105; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Rak-Mardyla A, 2010, J PHYSIOL PHARMACOL, V61, P451; Rodeo SA, 2010, J BONE JOINT SURG AM, V92A, P2491, DOI 10.2106/JBJS.J.01174; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011; Shahab-Osterloh S, 2010, STEM CELLS, V28, P1590, DOI 10.1002/stem.487; Sharma RI, 2010, BIOMATERIALS, V31, P7695, DOI 10.1016/j.biomaterials.2010.06.046; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001; Southwood M, 2008, J PATHOL, V214, P85, DOI 10.1002/path.2261; Suzuki Y, 2008, J BIOCHEM, V143, P199, DOI 10.1093/jb/mvm215; Violini S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-29; Wopenka B, 2008, APPL SPECTROSC, V62, P1285, DOI 10.1366/000370208786822179; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Wulsten D, 2011, EUR CELLS MATER, V21, P177, DOI 10.22203/eCM.v021a14; Zumstein MA, 2008, J BONE JOINT SURG AM, V90A, P2423, DOI 10.2106/JBJS.G.00677	50	63	66	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31504	10.1371/journal.pone.0031504	http://dx.doi.org/10.1371/journal.pone.0031504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355373	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300073
J	Schafer, H; Struck, B; Feldmann, EM; Bergmann, F; Grage-Griebenow, E; Geismann, C; Ehlers, S; Altevogt, P; Sebens, S				Schaefer, H.; Struck, B.; Feldmann, E-M; Bergmann, F.; Grage-Griebenow, E.; Geismann, C.; Ehlers, S.; Altevogt, P.; Sebens, S.			TGF-beta 1-dependent L1CAM expression has an essential role in macrophage-induced apoptosis resistance and cell migration of human intestinal epithelial cells	ONCOGENE			English	Article						colon cancer; inflammatory bowel disease; CD171; cellular microenvironment	INFLAMMATORY-BOWEL-DISEASE; PANCREATIC DUCTAL ADENOCARCINOMA; OVARIAN-CARCINOMA CELLS; ULCERATIVE-COLITIS; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; COLONIC MACROPHAGES; PROTEASOME ACTIVITY; ADHESION MOLECULE; UP-REGULATION	Patients with chronic inflammatory bowel disease (IBD) have an increased risk to develop colorectal cancer (CRC) particularly after long duration of the disease. Chronic inflammation of the intestinal mucosa is characterized by a marked enrichment of immune cells such as macrophages as well as by high expression of cytokines and growth factors including transforming growth factor-beta 1 (TGF-beta 1). The adhesion molecule L1CAM mediates chemoresistance and migration of tumor cells and is elevated in CRC tissues being associated with metastatic spread and poor prognosis for the patients. In this study, we examine the role of TGF-beta 1-induced L1CAM expression and macrophages in malignant transformation of intestinal epithelial cells. We demonstrate that TGF-beta 1 stimulation leads to a Slug-dependent upregulation of L1CAM expression already in the colonic intestinal epithelial cell line NCM460 thereby enhancing cell motility and apoptosis resistance. Accordingly, NCM460 cells acquired a migratory and apoptosis-resistant phenotype if transfected with L1CAM. Immunohistochemistry of colonic biopsies revealed considerable L1CAM expression in intestinal epithelial cells in tissues from IBD patients but not in normal colonic tissues. Moreover, L1CAM expression increased with duration of disease being associated with the presence of CD33+ macrophages. Coculture with macrophages generated from monocyte colony-stimulating factor (MCSF)-treated monocytes led to the upregulation of Slug and L1CAM in NCM460 cells thereby elevating cell motility and apoptosis resistance. Pharmacological inhibition of TGF-beta 1 signalling abolished expression of Slug and L1CAM in cocultured NCM460 cells resulting in decreased cell migration and apoptosis resistance. In conclusion, these data provide new insights into the mechanisms by which IBD promotes malignant transformation of intestinal epithelial cells and underscore the role of L1CAM and macrophages in this scenario. Oncogene (2013) 32, 180-189; doi:10.1038/onc.2012.44; published online 20 February 2012	[Schaefer, H.; Struck, B.; Feldmann, E-M; Grage-Griebenow, E.; Geismann, C.] UKSH, Lab Mol Gastroenterol & Hepatol, Dept Internal Med 1, D-24105 Kiel, Germany; [Struck, B.; Feldmann, E-M; Grage-Griebenow, E.; Geismann, C.; Sebens, S.] UKSH, Inst Expt Med, Dept Internal Med 1, D-24105 Kiel, Germany; [Bergmann, F.] Heidelberg Univ, Dept Pathol, Heidelberg, Germany; [Ehlers, S.] Forschungszentrum, Dept Mol Infect Biol, Borstel, Germany; [Altevogt, P.] German Canc Res Ctr, Dept Translat Immunol D015, Heidelberg, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Sebens, S (corresponding author), UKSH, Inst Expt Med, Dept Internal Med 1, Campus Kiel,Arnold Heller Str 3,Haus 6, D-24105 Kiel, Germany.	mueerkoe@1med.uni-kiel.de	Schäfer, Heiner/C-1055-2011; Geismann, Claudia/AAX-8158-2021; Sebens, Susanne/C-1222-2010; Ehlers, Stefan/B-4075-2010	Geismann, Claudia/0000-0003-0640-9256; 	German Research Society DFG [Scha677/9-1, SE-1831/2-1]; German Cluster of Excellence 'Inflammation at Interfaces'	German Research Society DFG(German Research Foundation (DFG)); German Cluster of Excellence 'Inflammation at Interfaces'	Excellent technical assistance by Dagmar Leisner, Erika Kuhlenhauser, Christina Trabandt and Maike Witt-Ramdohr, statistical advice by Jurgen Hedderich and funding by the German Research Society DFG (Scha677/9-1 and SE-1831/2-1) as well as the German Cluster of Excellence 'Inflammation at Interfaces' are acknowledged.	Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Arlt MJE, 2006, CANCER RES, V66, P936, DOI 10.1158/0008-5472.CAN-05-1818; Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P975, DOI 10.1053/gast.1996.v110.pm8613031; Bergmann F, 2010, ONCOL REP, V24, P909, DOI 10.3892/or_00000936; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; BULL DM, 1977, J CLIN INVEST, V59, P966, DOI 10.1172/JCI108719; Clovel T, 2007, INFLAMM BOWEL DIS, V13, P1153, DOI 10.1002/ibd.20174; Ellenrieder V, 2002, J GASTROINTEST CANC, V31, P61, DOI 10.1385/IJGC:31:1-3:61; Ellenrieder V, 2001, CANCER RES, V61, P4222; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gavert N, 2007, CANCER RES, V67, P7703, DOI 10.1158/0008-5472.CAN-07-0991; Gavert N, 2011, MOL CANCER RES, V9, P14, DOI 10.1158/1541-7786.MCR-10-0406; Geismann C, 2011, INT J ONCOL, V38, P257, DOI 10.3892/ijo_00000846; Geismann C, 2009, CANCER RES, V69, P4517, DOI 10.1158/0008-5472.CAN-08-3493; GOLDER JP, 1983, GASTROENTEROLOGY, V84, P795; Grage-Griebenow E, 2001, EUR J IMMUNOL, V31, P48; Herszenyi L, 2007, DIGEST DIS, V25, P267, DOI 10.1159/000103898; Hosui A, 2009, J EXP MED, V206, P819, DOI 10.1084/jem.20080003; Huszar M, 2006, HUM PATHOL, V37, P1000, DOI 10.1016/j.humpath.2006.03.014; Huszar M, 2010, J PATHOL, V220, P551, DOI 10.1002/path.2673; Kaifi JT, 2007, MODERN PATHOL, V20, P1183, DOI 10.1038/modpathol.3800955; Kamada N, 2005, J IMMUNOL, V175, P6900, DOI 10.4049/jimmunol.175.10.6900; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lawrance IC, 2001, INFLAMM BOWEL DIS, V7, P16, DOI 10.1097/00054725-200102000-00003; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Min JK, 2010, CLIN CANCER RES, V16, P3571, DOI 10.1158/1078-0432.CCR-09-3075; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-1860; Rahimi R, 2002, MED SCI MONITOR, V13, pPI13; Rezaie A, 2006, ANN NY ACAD SCI, V1091, P110, DOI 10.1196/annals.1378.060; Roessner A, 2008, PATHOL RES PRACT, V204, P511, DOI 10.1016/j.prp.2008.04.011; Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205; Rogler G, 1997, EUR J GASTROEN HEPAT, V9, P893, DOI 10.1097/00042737-199709000-00013; Schiechl G, 2011, J CLIN INVEST, V121, P1692, DOI 10.1172/JCI42540; Schniewind B, 2007, ONCOGENE, V26, P4850, DOI 10.1038/sj.onc.1210272; Sebens S, 2011, J BIOL CHEM, V286, P40911, DOI 10.1074/jbc.M111.274902; Smith PD, 2001, J IMMUNOL, V167, P2651, DOI 10.4049/jimmunol.167.5.2651; Smith PD, 2005, IMMUNOL REV, V206, P149, DOI 10.1111/j.0105-2896.2005.00288.x; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Stadnicki A, 2009, INT IMMUNOPHARMACOL, V9, P761, DOI 10.1016/j.intimp.2009.02.014; Stoeck A, 2007, GYNECOL ONCOL, V104, P461, DOI 10.1016/j.ygyno.2006.08.038; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Wiercinska-Drapalo A, 2001, CYTOKINE, V14, P343, DOI 10.1006/cyto.2001.0901; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xie JL, 2008, WORLD J GASTROENTERO, V14, P378, DOI 10.3748/wjg.14.378; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	47	37	37	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2013	32	2					180	189		10.1038/onc.2012.44	http://dx.doi.org/10.1038/onc.2012.44			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	078CK	22349829				2022-12-25	WOS:000314075500006
J	Kwan, R; Hanada, S; Harada, M; Strnad, P; Li, DH; Omary, MB				Kwan, Raymond; Hanada, Shinichiro; Harada, Masaru; Strnad, Pavel; Li, Daniel H.; Omary, M. Bishr			Keratin 8 phosphorylation regulates its transamidation and hepatocyte Mallory-Denk body formation	FASEB JOURNAL			English	Article						intermediate filaments; steatohepatitis; transglutaminase 2	SIMPLE EPITHELIAL KERATINS; GRISEOFULVIN-FED MICE; TRANSGLUTAMINASE ACTIVITY; INFRARED-SPECTROSCOPY; ALCOHOLIC HEPATITIS; OXIDATIVE STRESS; MULTIPLE SITES; HUMAN-DISEASE; CROSS-LINKS; MOUSE-LIVER	Mallory-Denk bodies (MDBs) are hepatocyte inclusions that are associated with poor liver disease prognosis. The intermediate filament protein keratin 8 (K8) and its cross-linking by transglutaminase-2 (TG2) are essential for MDB formation. K8 hyperphosphorylation occurs in association with liver injury and MDB formation, but the link between keratin phosphorylation and MDB formation is unknown. We used a mutational approach to identify K8 Q70 as a residue that is important for K8 cross-linking to itself and other liver proteins. K8 cross-linking is markedly enhanced on treating cells with a phosphatase inhibitor and decreases dramatically on K8 S74A or Q70N mutation in the presence of phosphatase inhibition. K8 Q70 cross-linking, in the context of synthetic peptides or intact proteins transfected into cells, is promoted by phosphorylation at K8 S74 or by an S74D substitution and is inhibited by S74A mutation. Transgenic mice that express K8 S74A or a K8 G62C liver disease variant that inhibits K8 S74 phosphorylation have a markedly reduced ability to form MDBs. Our findings support a model in which the stress-triggered phosphorylation of K8 S74 induces K8 cross-linking by TG2, leading to MDB formation. These findings may extend to neuropathies and myopathies that are characterized by intermediate filament-containing inclusions.-Kwan, R., Hanada, S., Harada, M., Strnad, P., Li, D. H., Omary, M. B. Keratin 8 phosphorylation regulates its transamidation and hepatocyte Mallory-Denk body formation. FASEB J. 26, 2318-2326 (2012). www.fasebj.org	[Kwan, Raymond; Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Hanada, Shinichiro] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Kurume, Fukuoka 830, Japan; [Harada, Masaru] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 3, Kitakyushu, Fukuoka 807, Japan; [Strnad, Pavel] Univ Ulm, Dept Internal Med 1, Ulm, Germany; [Li, Daniel H.] AnaSpec, Fremont, CA USA	University of Michigan System; University of Michigan; Kurume University; University of Occupational & Environmental Health - Japan; Ulm University	Kwan, R (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, 7744 Med Sci Bldg 2,1301 E Catherine, Ann Arbor, MI 48109 USA.	raykwan@umich.edu		Omary, Bishr/0000-0002-8624-2347	U.S. National Institutes of Health (NIH) [R01 DK-52951]; U.S. Department of Veterans Affairs; NIH Michigan Gastrointestinal Peptide Research Center [P30 DK34933]; German Research Foundation [STR 1095/2-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052951, P30DK034933] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NIH Michigan Gastrointestinal Peptide Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by U.S. National Institutes of Health (NIH) grant R01 DK-52951, by the U.S. Department of Veterans Affairs (M. B. O.), and by NIH Michigan Gastrointestinal Peptide Research Center grant P30 DK34933. P. S. is supported by the Emmy Noether Program of the German Research Foundation (STR 1095/2-1). The authors are grateful to Dr. Chaitan Khosla (Stanford University, Stanford, CA, USA) for providing TG2 and thank Dr. Sujith Weerasinghe (University of Michigan) for performing mouse hepatocyte isolations.	Armstrong RA, 2006, EUR J NEUROL, V13, P528, DOI 10.1111/j.1468-1331.2006.01284.x; BONAR L, 1969, P SOC EXP BIOL MED, V131, P1373; CADRIN M, 1992, J HEPATOL, V14, P226, DOI 10.1016/0168-8278(92)90162-I; CADRIN M, 1991, EXP MOL PATHOL, V55, P170, DOI 10.1016/0014-4800(91)90050-8; Cortez-Pinto H, 2003, DIGEST DIS SCI, V48, P1909, DOI 10.1023/A:1026152415917; de Lima VM, 2008, J HEPATOL, V49, P1055, DOI 10.1016/j.jhep.2008.07.024; DENK H, 1975, LAB INVEST, V32, P773; DENK H, 1984, LIVER, V4, P208; GLENNER GG, 1974, J HISTOCHEM CYTOCHEM, V22, P1141, DOI 10.1177/22.12.1141; Goebel HH, 2003, MUSCLE NERVE, V27, P527, DOI 10.1002/mus.10322; Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055; Harada M, 2008, HEPATOLOGY, V47, P2026, DOI 10.1002/hep.22294; Harada M, 2007, HEPATOLOGY, V45, P88, DOI 10.1002/hep.21471; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; He T, 2002, J BIOL CHEM, V277, P10767, DOI 10.1074/jbc.M111436200; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Jeitner TM, 2001, J NEUROCHEM, V79, P1109, DOI 10.1046/j.1471-4159.2001.00673.x; KACHI K, 1993, EXP MOL PATHOL, V59, P197, DOI 10.1006/exmp.1993.1039; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Ku NO, 2002, J BIOL CHEM, V277, P10775, DOI 10.1074/jbc.M107623200; Lesort M, 2000, J NEUROCHEM, V75, P1951, DOI 10.1046/j.1471-4159.2000.0751951.x; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; Mahajan V, 2011, GASTROENTEROLOGY, V141, P1080, DOI 10.1053/j.gastro.2011.05.039; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Nakamichi I, 2005, J CELL BIOL, V171, P931, DOI 10.1083/jcb.200507093; Nemes Z, 2009, J BIOL CHEM, V284, P27252, DOI 10.1074/jbc.M109.033969; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Rakoski MO, 2011, CLIN GASTROENTEROL H, V9, P902, DOI 10.1016/j.cgh.2011.07.006; Riley NE, 2002, EXP MOL PATHOL, V72, P17, DOI 10.1006/exmp.2001.2413; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Schmid AW, 2009, J BIOL CHEM, V284, P13128, DOI 10.1074/jbc.M809067200; Shin DM, 2004, J BIOL CHEM, V279, P15032, DOI 10.1074/jbc.M308734200; Shin DM, 2008, FASEB J, V22, P2498, DOI 10.1096/fj.07-095455; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Snider NT, 2011, J BIOL CHEM, V286, P2273, DOI 10.1074/jbc.M110.171314; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Stmad P, 2008, HEPATOLOGY, V48, P931, DOI 10.1002/hep.22430; Strnad P, 2006, FEBS LETT, V580, P2351, DOI 10.1016/j.febslet.2006.03.051; Strnad P, 2007, GASTROENTEROLOGY, V132, P1515, DOI 10.1053/j.gastro.2007.02.020; Strnad R, 2008, BBA-MOL BASIS DIS, V1782, P764, DOI 10.1016/j.bbadis.2008.08.008; Stumptner C, 2000, AM J PATHOL, V156, P77, DOI 10.1016/S0002-9440(10)64708-6; Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Tao GZ, 2006, EXP CELL RES, V312, P411, DOI 10.1016/j.yexcr.2005.11.010; Tatsukawa H, 2009, GASTROENTEROLOGY, V136, P1783, DOI 10.1053/j.gastro.2009.01.007; TAZAWA J, 1983, HEPATOLOGY, V3, P989; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2002, MOL BIOL CELL, V13, P1857, DOI 10.1091/mbc.01-12-0591; YOKOO H, 1982, GASTROENTEROLOGY, V83, P109; Zainelli GM, 2003, J NEUROPATH EXP NEUR, V62, P14, DOI 10.1093/jnen/62.1.14; ZATLOUKAL K, 1992, LAB INVEST, V66, P774; ZATLOUKAL K, 1989, LAB INVEST, V61, P603; Zatloukal K, 2000, AM J PATHOL, V156, P1263, DOI 10.1016/S0002-9440(10)64997-8; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024	58	22	23	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2318	2326		10.1096/fj.11-198580	http://dx.doi.org/10.1096/fj.11-198580			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22362895	Green Submitted, Green Published			2022-12-25	WOS:000305017200010
J	Zhang, X; Zhang, Y; Tao, B; Teng, L; Li, YW; Cao, R; Gui, Q; Ye, MD; Mou, XZ; Cheng, HQ; Hu, H; Zhou, R; Wu, XM; Xie, QM; Ning, W; Lai, MD; Shen, HH; Feng, GS; Ke, YH				Zhang, Xue; Zhang, Yun; Tao, Bo; Teng, Li; Li, Yanwei; Cao, Rui; Gui, Qiu; Ye, Madong; Mou, Xiaozhou; Cheng, Hongqiang; Hu, Hu; Zhou, Ren; Wu, Ximei; Xie, Qiangmin; Ning, Wen; Lai, Maode; Shen, Huahao; Feng, Gen-Sheng; Ke, Yuehai			Loss of Shp2 in alveoli epithelia induces deregulated surfactant homeostasis, resulting in spontaneous pulmonary fibrosis	FASEB JOURNAL			English	Article						Abca3; TTF-1; FGFs; surfactant proteins; IPF	TYROSINE-PHOSPHATASE; GROWTH-FACTOR; PROTEIN-A; CELLS; APOPTOSIS; MICE; STEM; PATHOGENESIS; MUTATIONS; DELETION	Type II alveolar epithelial (AT-II) cells produce pulmonary surfactant proteins that are essential for alveolar function. AT-II is a major target in lung injury, and ineffective repair of damaged alveolar epithelia has been postulated to cause pulmonary fibrosis. Previous studies have shown that tyrosine phosphatase Shp2 is expressed highly in the embryonic lung epithelial buds, and Shp2 activity is required for FGF-induced lung branching morphogenesis. To investigate in vivo function of pulmonary Shp2, we generated alveoli epithelia-specific Shp2-knockout (Shp2(Delta/Delta)) mice. Shp2(Delta/Delta) mice exhibit marked reduction in surfactant proteins, disorganized lamellar bodies, increased alveolar epithelial apoptosis, and interstitial pulmonary fibrosis without preceding inflammation. Mechanistically, Shp2 acts to mediate expression of thyroid transcription factor 1 (TTF1) and ATP-binding cassette subfamily A member 3 (ABCA3). Shp2 also plays a central role in mediating FGF/GAB/ERK activity, required for epithelial repair program. Together, our results identify a novel role of tyrosine phosphatase Shp2 in surfactant homeostasis, and deregulation of Shp2 triggers spontaneous pulmonary fibrosis with minimal inflammation.-Zhang, X., Zhang, Y., Tao, B., Teng, L., Li, Y., Cao, R., Gui, Q., Ye, M., Mou, X., Cheng, H., Hu, H., Zhou, R., Wu, X., Xie, Q., Ning, W., Lai, M., Shen, H., Feng, G.-S., Ke, Y. Loss of Shp2 in alveoli epithelia induces deregulated surfactant homeostasis, resulting in spontaneous pulmonary fibrosis. FASEB J. 26, 2338-2350 (2012). www.fasebj.org	[Zhang, Xue; Zhang, Yun; Tao, Bo; Teng, Li; Li, Yanwei; Cao, Rui; Gui, Qiu; Ye, Madong; Mou, Xiaozhou; Cheng, Hongqiang; Hu, Hu; Zhou, Ren; Wu, Ximei; Lai, Maode; Ke, Yuehai] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Xue; Zhang, Yun; Tao, Bo; Teng, Li; Li, Yanwei; Cao, Rui; Gui, Qiu; Ye, Madong; Mou, Xiaozhou; Cheng, Hongqiang; Hu, Hu; Zhou, Ren; Wu, Ximei; Lai, Maode; Ke, Yuehai] Zhejiang Univ, Sch Med, Program Mol Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Xue; Zhang, Yun; Tao, Bo; Teng, Li; Li, Yanwei; Cao, Rui; Gui, Qiu; Ye, Madong; Mou, Xiaozhou; Cheng, Hongqiang; Hu, Hu; Zhou, Ren; Wu, Ximei; Xie, Qiangmin; Lai, Maode; Shen, Huahao; Ke, Yuehai] Zhejiang Univ, Sch Med, Inst Resp Dis, Hangzhou 310058, Zhejiang, Peoples R China; [Ning, Wen] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Feng, Gen-Sheng] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Zhejiang University; Zhejiang University; Zhejiang University; Nankai University; University of California System; University of California San Diego; University of California System; University of California San Diego	Ke, YH (corresponding author), Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, POB 59,866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	yke@zju.edu.cn	Xie, Qiang-min/AAV-7711-2021; li, yan/GTI-4638-2022	Wu, Ximei/0000-0002-3316-893X; Cheng, Hongqiang/0000-0001-9662-1570; Xie, qiang-min/0000-0002-7975-9962	National Basic Research Program of China (973 Program) [2009CB522103]; National Natural Science Foundation of China [30871291, 30971504, 30900849]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank L. Lu and D. Wang for critical review of the manuscript and for helpful comments; J. A. Whitsett (College of Medicine, University of Cincinnati, Cincinnati, OH, USA) for SP-C-rtTA<SUP>tg</SUP>/<SUP>-</SUP> and (tetO)<INF>7</INF>CMV-Cre<SUP>tg/-</SUP> transgenic mice; L. Wang for conducting electronic microscopy; A. Chen, Dr. X Qin, (Zhejiang University School of Medicine, Hangzhou, China) and M. Chen (Zhejiang University of Traditional Chinese Medicine, Hangzhou, China) for their technical assistance. This work was supported by National Basic Research Program of China (973 Program) grant 2009CB522103 to Y.K., and National Natural Science Foundation of China grants 30871291 and 30971504 to Y.K., and 30900849 to X.Z.	Allam JS, 2006, CURR OPIN PULM MED, V12, P312, DOI 10.1097/01.mcp.0000239546.24831.61; Aoki Y, 2000, FASEB J, V14, P1965, DOI 10.1096/fj.00-0105com; Atabai K, 2002, AM J PHYSIOL-LUNG C, V283, pL163, DOI 10.1152/ajplung.00396.2001; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Cai ZG, 2011, MOL CELL BIOL, V31, P2973, DOI 10.1128/MCB.05054-11; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chauhan D, 2000, J BIOL CHEM, V275, P27845; Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627; Deng YM, 2006, EUR J PHARMACOL, V547, P125, DOI 10.1016/j.ejphar.2006.07.002; Devendra G, 2002, RESPIR RES, V3, DOI 10.1186/rr168; du Bois RM, 2010, NAT REV DRUG DISCOV, V9, P129, DOI 10.1038/nrd2958; El Firar A, 2009, FASEB J, V23, P4069, DOI 10.1096/fj.09-131367; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Galambos C, 2010, AM J RESP CRIT CARE, V182, P549, DOI 10.1164/rccm.201002-0167CR; Gharaee-Kermani M, 2005, AM J PATHOL, V166, P1593, DOI 10.1016/S0002-9440(10)62470-4; Gupte VV, 2009, AM J RESP CRIT CARE, V180, P424, DOI 10.1164/rccm.200811-1794OC; Hamvas A, 2007, NEONATOLOGY, V91, P311, DOI 10.1159/000101347; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Hokuto I, 2004, J CLIN INVEST, V113, P28, DOI 10.1172/JCI200419491; Horowitz A, 2009, CIRC RES, V104, pE21, DOI 10.1161/CIRCRESAHA.108.191494; Johansson J, 1997, EUR J BIOCHEM, V244, P675, DOI 10.1111/j.1432-1033.1997.00675.x; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Ke YH, 2006, J BIOL CHEM, V281, P34374, DOI 10.1074/jbc.M607325200; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lawson WE, 2005, AM J PATHOL, V167, P1267, DOI 10.1016/S0002-9440(10)61214-X; Lee YH, 2010, J CELL SCI, V123, P1634, DOI 10.1242/jcs.063545; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Perl AK, 2009, AM J RESP CELL MOL, V40, P1, DOI 10.1165/rcmb.2008-0011ED; Perl AKT, 2011, AM J RESP CRIT CARE, V183, P511, DOI 10.1164/rccm.201005-0744OC; Qu CK, 1999, P NATL ACAD SCI USA, V96, P8528, DOI 10.1073/pnas.96.15.8528; Ramos C, 2010, AM J PHYSIOL-LUNG C, V299, pL222, DOI 10.1152/ajplung.00070.2010; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Saxton TM, 1999, P NATL ACAD SCI USA, V96, P3790, DOI 10.1073/pnas.96.7.3790; Selman M, 2003, HUM GENET, V113, P542, DOI 10.1007/s00439-003-1015-4; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Stahlman MT, 2000, LAB INVEST, V80, P395, DOI 10.1038/labinvest.3780044; Strieter RM, 2009, CHEST, V136, P1364, DOI 10.1378/chest.09-0510; Tefft D, 2005, DEV BIOL, V282, P422, DOI 10.1016/j.ydbio.2005.03.022; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; van Moorsel CHM, 2010, AM J RESP CRIT CARE, V182, P1419, DOI 10.1164/rccm.200906-0953OC; VERDER H, 1994, NEW ENGL J MED, V331, P1051, DOI 10.1056/NEJM199410203311603; Weichert N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-4; White MK, 2001, EXP CELL RES, V263, P183, DOI 10.1006/excr.2000.5120; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Zhu HH, 2011, BLOOD, V117, P5350, DOI 10.1182/blood-2011-01-333476; Zoz DF, 2011, AM J MED SCI, V341, P435, DOI 10.1097/MAJ.0b013e31821a9d8e	55	48	51	3	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2338	2350		10.1096/fj.11-200139	http://dx.doi.org/10.1096/fj.11-200139			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22362894				2022-12-25	WOS:000305017200012
J	Muer, A; Overkamp, T; Gillissen, B; Richter, A; Pretzsch, T; Milojkovic, A; Dorken, B; Daniel, PT; Hemmati, P				Mueer, Annika; Overkamp, Tim; Gillissen, Bernd; Richter, Antje; Pretzsch, Thomas; Milojkovic, Ana; Doerken, Bernd; Daniel, Peter T.; Hemmati, Philipp			p14(ARF)-induced Apoptosis in p53 Protein-deficient Cells Is Mediated by BH3-only Protein-independent Derepression of Bak Protein through Down-regulation of Mcl-1 and Bcl-x(L) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY; MITOCHONDRIAL APOPTOSIS; P53-INDEPENDENT APOPTOSIS; P53-DEPENDENT APOPTOSIS; CYCLE ARREST; ARF; DEATH; ACTIVATION; INDUCTION	The p14(ARF) tumor suppressor plays a central role in regulating cell cycle arrest and apoptosis. We reported previously that p14(ARF) is capable of triggering apoptosis in a p53-independent manner. However, the mechanism remained unclear. Here we demonstrate that the p53-independent activation of the mitochondrial apoptosis pathway by p14(ARF) is primarily mediated by the pro-apoptotic Bax-homolog Bak. Expression of p14(ARF) exclusively triggers a N-terminal conformational switch of Bak, but not Bax, which allows for mitochondrial permeability shift, release of cytochrome c, activation of caspases, and subsequent fragmentation of genomic DNA. Although forced expression of Bak markedly sensitizes toward p14(ARF)-induced apoptosis, re-expression of Bax has no effect. Vice versa, knockdown of Bak by RNA interference attenuates p14(ARF)-induced apoptosis, whereas down-regulation of Bax has no effect. Bak activation coincides with a prominent, caspase-independent deprivation of the endogenous Bak inhibitors Mcl-1 and Bcl-x(L). In turn, mitochondrial apoptosis is fully blocked by overexpression of either Mcl-1 or Bcl-x(L). Taken together, these data indicate that in the absence of functional p53 and Bax, p14(ARF) triggers mitochondrial apoptosis signaling by activating Bak, which is facilitated by down-regulating anti-apoptotic Mcl-1 and Bcl-x(L). Moreover, our data suggest that the simultaneous inhibition of two central endogenous Bak inhibitors, i.e. Mcl-1 and Bcl-x(L), may be sufficient to activate mitochondrial apoptosis in the absence of BH3-only protein regulation.	[Daniel, Peter T.] Charite, ECRC, Max Delbruck Ctr Mol Med Clin & Mol Oncol, D-13125 Berlin, Germany; [Mueer, Annika; Overkamp, Tim; Gillissen, Bernd; Richter, Antje; Milojkovic, Ana; Doerken, Bernd; Daniel, Peter T.; Hemmati, Philipp] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Pretzsch, Thomas; Doerken, Bernd; Daniel, Peter T.; Hemmati, Philipp] Charite, Dept Hematol Oncol & Tumor Immunol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Daniel, PT (corresponding author), Charite, ECRC, Max Delbruck Ctr Mol Med Clin & Mol Oncol, Campus Berlin Buch,Lindenberger Weg 80, D-13125 Berlin, Germany.	pdaniel@mdc-berlin.de		Milojkovic, Ana/0000-0001-7505-9996; Gillissen, Bernhard/0000-0002-1815-2091				Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bornkamm GW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni137; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cartron PF, 2003, MOL CELL BIOL, V23, P4701, DOI 10.1128/MCB.23.13.4701-4712.2003; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Czabotar PE, 2009, CELL DEATH DIFFER, V16, P1187, DOI 10.1038/cdd.2009.83; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; DURO D, 1995, ONCOGENE, V11, P21; Eymin B, 2001, ONCOGENE, V20, P1033, DOI 10.1038/sj.onc.1204220; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gelinas W, 2005, GENE DEV, V19, P1263, DOI 10.1101/gad.1326205; Giam M, 2008, ONCOGENE, V27, pS128, DOI 10.1038/onc.2009.50; Gillissen B, 2003, EMBO J, V22, P3580, DOI 10.1093/emboj/cdg343; Gillissen B, 2007, J CELL BIOL, V179, P701, DOI 10.1083/jcb.200703040; Gillissen B, 2010, J CELL BIOL, V188, P851, DOI 10.1083/jcb.200912070; Hasenjager A, 2004, ONCOGENE, V23, P4523, DOI 10.1038/sj.onc.1207594; Hemmati PG, 2006, ONCOGENE, V25, P6582, DOI 10.1038/sj.onc.1209668; Hemmati PG, 2005, ONCOGENE, V24, P4114, DOI 10.1038/sj.onc.1208579; Hemmati PG, 2002, ONCOGENE, V21, P3149, DOI 10.1038/sj.onc.1205458; Hemmati PG, 2010, J MOL MED, V88, P609, DOI 10.1007/s00109-010-0606-5; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Inoue R, 1999, ANTICANCER RES, V19, P2939; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lindenboim L, 2005, CELL DEATH DIFFER, V12, P713, DOI 10.1038/sj.cdd.4401638; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; MAO L, 1995, CANCER RES, V55, P2995; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Normand G, 2005, J BIOL CHEM, V280, P7118, DOI 10.1074/jbc.M412330200; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pardo J, 2006, J CELL BIOL, V174, P509, DOI 10.1083/jcb.200604044; Pimkina J, 2009, J BIOL CHEM, V284, P2803, DOI 10.1074/jbc.M804705200; QUELLE DE, 1995, CELL, V83, P993; Radfar A, 1998, P NATL ACAD SCI USA, V95, P13194, DOI 10.1073/pnas.95.22.13194; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; STONE S, 1995, CANCER RES, V55, P2988; Sturm I, 2006, CELL DEATH DIFFER, V13, P619, DOI 10.1038/sj.cdd.4401782; Suzuki H, 2003, BIOCHEM BIOPH RES CO, V312, P1273, DOI 10.1016/j.bbrc.2003.11.071; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Theodorakis P, 2002, CANCER RES, V62, P3373; Tsuji K, 2002, BIOCHEM BIOPH RES CO, V295, P621, DOI 10.1016/S0006-291X(02)00723-4; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; von Haefen C, 2004, ONCOGENE, V23, P8320, DOI 10.1038/sj.onc.1207971; Warr MR, 2008, CURR MOL MED, V8, P138; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wendt J, 2005, ONCOGENE, V24, P4052, DOI 10.1038/sj.onc.1208580; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	67	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17343	17352		10.1074/jbc.M111.314898	http://dx.doi.org/10.1074/jbc.M111.314898			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22354970	Green Published, hybrid			2022-12-25	WOS:000306373000034
J	Gonzalez-Salgado, A; Steinmann, ME; Greganova, E; Rauch, M; Maser, P; Sigel, E; Butikofer, P				Gonzalez-Salgado, Amaia; Steinmann, Michael E.; Greganova, Eva; Rauch, Monika; Maeser, Pascal; Sigel, Erwin; Buetikofer, Peter			myo-Inositol Uptake Is Essential for Bulk Inositol Phospholipid but Not Glycosylphosphatidylinositol Synthesis in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM-FORM; DEVELOPMENTAL VARIATION; FUNCTIONAL EXPRESSION; SUBSTRATE-SPECIFICITY; METABOLITE INOSITOL; TRANSPORT FUNCTION; CANDIDA-ALBICANS; MEMBRANE ANCHORS; LIPID-METABOLISM; POLAR LIPIDS	myo-Inositol is an essential precursor for the production of inositol phosphates and inositol phospholipids in all eukaryotes. Intracellular myo-inositol is generated by de novo synthesis from glucose 6-phosphate or is provided from the environment via myo-inositol symporters. We show that in Trypanosoma brucei, the causative pathogen of human African sleeping sickness and nagana in domestic animals, myo-inositol is taken up via a specific proton-coupled electrogenic symport and that this transport is essential for parasite survival in culture. Down-regulation of the myo-inositol transporter using RNA interference inhibited uptake of myo-inositol and blocked the synthesis of the myo-inositol-containing phospholipids, phosphatidylinositol and inositol phosphorylceramide; in contrast, it had no effect on glycosylphosphatidylinositol production. This together with the unexpected localization of the myo-inositol transporter in both the plasma membrane and the Golgi demonstrate that metabolism of endogenous and exogenous myo-inositol in T. brucei is strictly segregated.	[Gonzalez-Salgado, Amaia; Steinmann, Michael E.; Rauch, Monika; Sigel, Erwin; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Greganova, Eva; Maeser, Pascal] Swiss Trop & Publ Hlth Inst, CH-4051 Basel, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	peter.buetikofer@ibmm.unibe.ch	Sigel, Erwin/F-7736-2015	Maser, Pascal/0000-0003-3122-1941	Sinergia [CRSII3-127300]; Swiss National Science Foundation [31003A-130815]	Sinergia; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Sinergia Grant CRSII3-127300 and in part by Grant 31003A-130815 from the Swiss National Science Foundation.	Baur R, 2007, J NEUROCHEM, V103, P2556, DOI 10.1111/j.1471-4159.2007.04982.x; Berry GT, 2003, J BIOL CHEM, V278, P18297, DOI 10.1074/jbc.M213176200; Bersudsky Y, 2008, BIPOLAR DISORD, V10, P453, DOI 10.1111/j.1399-5618.2007.00546.x; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; BRUN R, 1979, ACTA TROP, V36, P289; Butikofer P, 1997, BIOCHEM J, V326, P415; BUTIKOFER P, 1989, BLOOD, V73, P1699; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Chau JFL, 2005, FASEB J, V19, P1887, DOI 10.1096/fj.05-4192fje; Chen YL, 2008, INFECT IMMUN, V76, P2793, DOI 10.1128/IAI.01514-07; Coady MJ, 2002, J BIOL CHEM, V277, P35219, DOI 10.1074/jbc.M204321200; Di Daniel E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-54; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DREW ME, 1995, MOL CELL BIOL, V15, P5508; Einicker-Lamas M, 2000, EUR J BIOCHEM, V267, P2533, DOI 10.1046/j.1432-1327.2000.01302.x; Einicker-Lamas M, 2007, EXP PARASITOL, V117, P171, DOI 10.1016/j.exppara.2007.04.011; FIELD MC, 1991, J BIOL CHEM, V266, P8392; FIELD MC, 1992, J BIOL CHEM, V267, P5324; FISCHL AS, 1986, J BIOL CHEM, V261, P3178; Gibellini F, 2009, MOL MICROBIOL, V73, P826, DOI 10.1111/j.1365-2958.2009.06764.x; Guan XL, 2008, FRONT BIOSCI-LANDMRK, V13, P3239; Guther MLS, 2006, MOL BIOL CELL, V17, P5265, DOI 10.1091/mbc.E06-08-0702; HAGER K, 1995, J MEMBRANE BIOL, V143, P103; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jin JHQ, 2003, MICROBIOL-SGM, V149, P3371, DOI 10.1099/mic.0.26644-0; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Koga Y, 2007, MICROBIOL MOL BIOL R, V71, P97, DOI 10.1128/MMBR.00033-06; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Loewus Frank A., 2006, V39, P21; Majumder AL, 2003, FEBS LETT, V553, P3, DOI 10.1016/S0014-5793(03)00974-8; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Martin KL, 2006, MOL MICROBIOL, V61, P89, DOI 10.1111/j.1365-2958.2006.05216.x; Martin KL, 2006, BIOCHEM J, V396, P287, DOI 10.1042/BJ20051825; Martin KL, 2005, BIOCHEM SOC T, V33, P983, DOI 10.1042/BST20050983; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Mongan TP, 2004, MOL BIOCHEM PARASIT, V135, P133, DOI 10.1016/j.molbiopara.2004.01.015; Morita YS, 2011, BBA-GEN SUBJECTS, V1810, P630, DOI 10.1016/j.bbagen.2011.03.017; Niederberger C, 1998, CURR GENET, V33, P255, DOI 10.1007/s002940050334; NIKAWA J, 1991, J BIOL CHEM, V266, P11184; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Reynolds TB, 2009, MICROBIOL-SGM, V155, P1386, DOI 10.1099/mic.0.025718-0; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Schneider S, 2008, PLANT CELL, V20, P1073, DOI 10.1105/tpc.107.055632; Schneider S, 2006, PLANT PHYSIOL, V141, P565, DOI 10.1104/pp.106.077123; Serricchio M, 2011, FEBS J, V278, P1035, DOI 10.1111/j.1742-4658.2011.08012.x; Sevova ES, 2010, J BIOL CHEM, V285, P20580, DOI 10.1074/jbc.M110.127662; Seyfang A, 2000, J BIOL CHEM, V275, P5687, DOI 10.1074/jbc.275.8.5687; Seyfang A, 1997, J BIOL CHEM, V272, P24210, DOI 10.1074/jbc.272.39.24210; Sigel E, 2005, MOL NUTR FOOD RES, V49, P228, DOI 10.1002/mnfr.200400104; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; Signorell A, 2008, J BIOL CHEM, V283, P23636, DOI 10.1074/jbc.M803600200; Signorell A, 2009, MOL MICROBIOL, V72, P1068, DOI 10.1111/j.1365-2958.2009.06713.x; Smith TK, 2010, MOL BIOCHEM PARASIT, V172, P66, DOI 10.1016/j.molbiopara.2010.04.001; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sutterwala SS, 2008, MOL MICROBIOL, V70, P281, DOI 10.1111/j.1365-2958.2008.06393.x; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730	65	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13313	13323		10.1074/jbc.M112.344812	http://dx.doi.org/10.1074/jbc.M112.344812			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351763	Green Published, hybrid			2022-12-25	WOS:000302903700067
J	Ohnishi, H; Oka, K; Mizuno, S; Nakamura, T				Ohnishi, Hiroyuki; Oka, Kiyomasa; Mizuno, Shinya; Nakamura, Toshikazu			Identification of Mannose Receptor as Receptor for Hepatocyte Growth Factor beta-Chain NOVEL LIGAND-RECEPTOR PATHWAY FOR ENHANCING MACROPHAGE PHAGOCYTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE BIOLOGICAL RESPONSES; C-MET PROTOONCOGENE; APOPTOTIC CELLS; NEUTROPHIL ELASTASE; LIVER-REGENERATION; ENDOTHELIAL-CELLS; SERINE-PROTEASE; INVASIVE GROWTH; SCATTER FACTOR; BINDING	Hepatocyte growth factor (HGF), a heterodimer composed of the alpha-chain and beta-chain, exerts multifunctional actions for tissue repair and homeostasis via its receptor, MET. HGF is cleaved by proteases secreted from inflammatory cells, and NK4 and beta-chain remnant (HGF-beta) are generated. Here, we provide evidence that HGF-beta binds to a new receptor other than MET for promoting a host cell clearance system. By an affinity cross-linking, radiolabeled HGF-beta was bound to liver non-parenchymal cells, particularly to Kupffer cells and sinusoidal endothelial cells, but not to parenchymal hepatocytes. The cross-linked complex was immunoprecipitated by anti-HGF antibody, but not anti-MET antibody, implying that HGF-beta binds to non-parenchymal cells at a site distinct from MET. Mass spectrometric detection of the ligand receptor complex revealed that the binding site of HGF-beta was the mannose receptor (MR). Actually, an ectopic expression of MR in COS-7 cells, which express no endogenous MR or MET, enabled HGF-beta to bind these cells at a K-D of 89 nM, demonstrating that MR is the new receptor for HGF-beta. Interaction of HGF-beta and MR was diminished by EGTA, and by an enzymatic digestion of HGF-beta sugar chains, suggesting that MR may recognize the glycosylation site(s) of HGF-beta in a Ca2+-dependent fashion. Notably, HGF-beta, but not other MR ligands, enhanced the ingestion of latex beads, or of apoptotic neutrophils, by Kupffer cells, possibly via an F-actin-dependent pathway. Thus, the HGF-beta center dot MRcomplex may provide a new pathway for the enhancement of cell clearance systems, which is associated with resolution of inflammation.	[Ohnishi, Hiroyuki; Oka, Kiyomasa; Nakamura, Toshikazu] Osaka Univ, Grad Sch Med, Kringle Pharma Joint Res Div Regenerat Drug Disco, Ctr Adv Sci & Innovat, Suita, Osaka 5650871, Japan; [Mizuno, Shinya] Osaka Univ, Grad Sch Med, Div Virol, Dept Microbiol & Immunol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Nakamura, T (corresponding author), Osaka Univ, Grad Sch Med, Kringle Pharma Joint Res Div Regenerat Drug Disco, Ctr Adv Sci & Innovat, Yamadaoka 2-1, Suita, Osaka 5650871, Japan.	nakamura@casi.osaka-u.ac.jp			Ministry of Education, Science, Technology, Sports and Culture of Japan [21390079, 23590458]; COE	Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by Ministry of Education, Science, Technology, Sports and Culture of Japan Grants 21390079 (to T. N.) and 23590458 (to S. M.) and the 21st Century global COE program (to T. N.).	Allavena P, 2004, CRIT REV IMMUNOL, V24, P179, DOI 10.1615/CritRevImmunol.v24.i3.20; Amanzada A, 2011, HISTOCHEM CELL BIOL, V135, P305, DOI 10.1007/s00418-011-0787-1; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Buchstein N, 2009, AM J PATHOL, V174, P2116, DOI 10.2353/ajpath.2009.080597; Campo GM, 2008, BRIT J PHARMACOL, V155, P945, DOI 10.1038/bjp.2008.338; Date K, 1997, FEBS LETT, V420, P1, DOI 10.1016/S0014-5793(97)01475-0; DeFife KM, 1999, FASEB J, V13, P823, DOI 10.1096/fasebj.13.8.823; DINI L, 1992, FEBS LETT, V296, P174, DOI 10.1016/0014-5793(92)80373-O; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Fukuta K, 2005, BIOCHEM J, V388, P555, DOI 10.1042/BJ20041698; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; HARA H, 1993, J BIOCHEM-TOKYO, V114, P76, DOI 10.1093/oxfordjournals.jbchem.a124143; Hart SP, 2008, METHODS, V44, P280, DOI 10.1016/j.ymeth.2007.11.009; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; HIGUCHI O, 1992, FEBS LETT, V301, P282, DOI 10.1016/0014-5793(92)80257-H; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Ichinose M, 1996, PEPTIDES, V17, P1405, DOI 10.1016/S0196-9781(96)00198-2; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Kawao N, 2011, THROMB HAEMOSTASIS, V105, P892, DOI 10.1160/TH10-08-0516; KINOSHITA T, 1989, BIOCHEM BIOPH RES CO, V165, P1229, DOI 10.1016/0006-291X(89)92733-2; Kirchhofer D, 2004, J BIOL CHEM, V279, P39915, DOI 10.1074/jbc.M404795200; Kosai K, 1998, BIOCHEM BIOPH RES CO, V244, P683, DOI 10.1006/bbrc.1998.8293; Kuba K, 2000, CANCER RES, V60, P6737; Kumar S, 2010, CYTOM PART A, V77A, P467, DOI 10.1002/cyto.a.20852; Kurtagic E, 2009, AM J PHYSIOL-LUNG C, V296, pL534, DOI 10.1152/ajplung.90505.2008; Kyo E, 2001, J NUTR, V131, p1075S, DOI 10.1093/jn/131.3.1075S; Leclerc L, 2010, INHAL TOXICOL, V22, P1091, DOI 10.3109/08958378.2010.522781; Linehan SA, 2001, EUR J IMMUNOL, V31, P1857, DOI 10.1002/1521-4141(200106)31:6<1857::AID-IMMU1857>3.0.CO;2-D; Lungarella G, 2008, INT J BIOCHEM CELL B, V40, P1287, DOI 10.1016/j.biocel.2007.12.008; Maderna P, 2003, BBA-MOL BASIS DIS, V1639, P141, DOI 10.1016/j.bbadis.2003.09.004; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; MIZUNO K, 1994, J BIOL CHEM, V269, P1131; MIZUNO K, 1992, BIOCHEM BIOPH RES CO, V189, P1631, DOI 10.1016/0006-291X(92)90264-L; Morimoto K, 2001, AM J RESP CELL MOL, V24, P608, DOI 10.1165/ajrcmb.24.5.4292; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nakamura T, 1997, CANCER RES, V57, P3305; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Nakamura T, 2010, ANTI-CANCER AGENT ME, V10, P36, DOI 10.2174/1871520611009010036; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Oka K, 2011, CURR SIGNAL TRANSD T, V6, P200, DOI 10.2174/157436211795659973; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; PANDIELLA A, 1991, P NATL ACAD SCI USA, V88, P1726, DOI 10.1073/pnas.88.5.1726; Raymond WW, 2006, J BIOL CHEM, V281, P1489, DOI 10.1074/jbc.M511154200; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Sakai K, 2009, J BIOL CHEM, V284, P22491, DOI 10.1074/jbc.M109.025148; SCHAFER S, 1987, HEPATOLOGY, V7, P680, DOI 10.1002/hep.1840070411; Sender V, 2011, J IMMUNOL, V186, P2397, DOI 10.4049/jimmunol.1002446; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Tokairin T, 2002, J HEPATOL, V36, P725, DOI 10.1016/S0168-8278(02)00048-X; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200	57	13	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13371	13381		10.1074/jbc.M111.318568	http://dx.doi.org/10.1074/jbc.M111.318568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22354962	Green Published, hybrid			2022-12-25	WOS:000302903700072
J	Wei, X; Roettger, Y; Tan, BL; He, YZ; Dodel, R; Hampel, H; Wei, G; Haney, J; Gu, HY; Johnstone, BH; Liu, JY; Farlow, MR; Du, YS				Wei, Xing; Roettger, Yvonne; Tan, Bailin; He, Yongzheng; Dodel, Richard; Hampel, Harald; Wei, Gang; Haney, Jillian; Gu, Huiying; Johnstone, Brian H.; Liu, Junyi; Farlow, Martin R.; Du, Yansheng			Human Anti-prion Antibodies Block Prion Peptide Fibril Formation and Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAUSSLER-SCHEINKER-DISEASE; CEREBELLAR GRANULE NEURONS; AMYLOID-BETA-PEPTIDE; PROTEIN-FRAGMENT; ALZHEIMERS-DISEASE; INTRAVENOUS IMMUNOGLOBULINS; MONOCLONAL-ANTIBODIES; CYSTEINE PROTEASE; CELLS; PRP	Prion diseases are a group of rare, fatal neurodegenerative disorders associated with a conformational transformation of the cellular prion protein (PrPC) into a self-replicating and proteinase K-resistant conformer, termed scrapie PrP (PrPSc). Aggregates of PrPSc deposited around neurons lead to neuropathological alterations. Currently, there is no effective treatment for these fatal illnesses; thus, the development of an effective therapy is a priority. PrP peptide-based ELISA assay methods were developed for detection and immunoaffinity chromatography capture was developed for purification of naturally occurring PrP peptide autoantibodies present in human CSF, individual donor serum, and commercial preparations of pooled intravenous immunoglobulin (IVIg). The ratio of anti-PrP autoantibodies (PrP-AA) to total IgG was similar to 1:1200. The binding epitope of purified PrP-AA was mapped to an N-terminal region comprising the PrP amino acid sequence KTNMK. Purified PrP-AA potently blocked fibril formation by a toxic 21-amino acid fragment of the PrP peptide containing the amino acid alanine to valine substitution corresponding to position 117 of the full-length peptide (A117V). Furthermore, PrP-AA attenuated the neurotoxicity of PrP(A117V) and wildtype peptides in rat cerebellar granule neuron (CGN) cultures. In contrast, IgG preparations depleted of PrP-AA had little effect on PrP fibril formation or PrP neurotoxicity. The specificity of PrP-AA was demonstrated by immunoprecipitating PrP protein in brain tissues of transgenic mice expressing the human PrP(A117V) epitope and Sc237 hamster. Based on these intriguing findings, it is suggested that human PrP-AA may be useful for interfering with the pathogenic effects of pathogenic prion proteins and, thereby has the potential to be an effective means for preventing or attenuating human prion disease progression.	[Wei, Xing; Tan, Bailin; He, Yongzheng; Wei, Gang; Haney, Jillian; Gu, Huiying; Farlow, Martin R.; Du, Yansheng] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Roettger, Yvonne; Dodel, Richard] Univ Marburg, Dept Neurol, D-35039 Marburg, Germany; [Hampel, Harald] Goethe Univ Frankfurt, Dept Psychiat, D-60528 Frankfurt, Germany; [Liu, Junyi] Peking Univ, Sch Pharmaceut Sci, Beijing 100083, Peoples R China; [Johnstone, Brian H.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Philipps University Marburg; Goethe University Frankfurt; Peking University; Indiana University System; Indiana University Bloomington	Du, YS (corresponding author), Indiana Univ, Dept Neurol, Sch Med, 975 W Walnut St,IB 457, Indianapolis, IN 46202 USA.	ydu@iupui.edu	Du, Yansheng/L-2244-2015	Hampel, Harald/0000-0003-0894-8982				Beekes M, 2007, FEBS J, V274, P575, DOI 10.1111/j.1742-4658.2006.05629.x; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Brown DR, 1996, GLIA, V18, P59, DOI 10.1002/(SICI)1098-1136(199609)18:1<59::AID-GLIA6>3.0.CO;2-Z; BROWN DR, 1994, NEUROREPORT, V5, P2057, DOI 10.1097/00001756-199410270-00017; Brown DR, 2000, BIOCHEM J, V346, P785, DOI 10.1042/0264-6021:3460785; Brown DR, 1998, J NEUROSCI RES, V54, P331; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Bugiani O, 2000, MICROSC RES TECHNIQ, V50, P10, DOI 10.1002/1097-0029(20000701)50:1<10::AID-JEMT3>3.3.CO;2-Y; Ciani E, 1995, J MOL NEUROSCI, V6, P131, DOI 10.1007/BF02736772; DEARMOND SJ, 1993, P NATL ACAD SCI USA, V90, P6449, DOI 10.1073/pnas.90.14.6449; Dodel R, 2002, ANN NEUROL, V52, P253, DOI 10.1002/ana.10253; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dodel R, 2010, DRUGS, V70, P513, DOI 10.2165/11533070-000000000-00000; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191; Du YS, 1998, J NEUROCHEM, V70, P1182; Du YS, 1997, J NEUROCHEM, V69, P1382; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Fioriti L, 2005, MOL CELL NEUROSCI, V28, P165, DOI 10.1016/j.mcn.2004.09.006; Flego M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-38; FORLONI G, 1994, EUR J NEUROSCI, V6, P1415, DOI 10.1111/j.1460-9568.1994.tb01003.x; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GHETTI B, 1989, NEUROLOGY, V39, P1453, DOI 10.1212/WNL.39.11.1453; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; GIACCONE G, 1992, P NATL ACAD SCI USA, V89, P9349, DOI 10.1073/pnas.89.19.9349; Hanan E, 2001, BIOCHEM BIOPH RES CO, V280, P115, DOI 10.1006/bbrc.2000.4097; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; HSIAO KK, 1991, NEUROLOGY, V41, P681, DOI 10.1212/WNL.41.5.681; KIEDROWSKI L, 1992, NEUROSCI LETT, V135, P59, DOI 10.1016/0304-3940(92)90135-T; KITAMOTO T, 1986, ANN NEUROL, V20, P204, DOI 10.1002/ana.410200205; MASTRIANNI JA, 1995, NEUROLOGY, V45, P2042, DOI 10.1212/WNL.45.11.2042; Molina F, 1996, PEPTIDE RES, V9, P151; Morel N, 2004, J BIOL CHEM, V279, P30143, DOI 10.1074/jbc.M403896200; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; RESINK A, 1994, BRAIN RES, V655, P222, DOI 10.1016/0006-8993(94)91617-9; Sigurdsson EM, 2002, AM J PATHOL, V161, P13, DOI 10.1016/S0002-9440(10)64151-X; Sparapani M, 1997, EXP NEUROL, V148, P157, DOI 10.1006/exnr.1997.6627; Tagliavini F, 2001, ADV PROTEIN CHEM, V57, P171; TATEISHI J, 1988, ANN NEUROL, V24, P35, DOI 10.1002/ana.410240108; Tateishi J, 1990, Tanpakushitsu Kakusan Koso, V35, P1327; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Weissmann C, 2001, PHILOS T R SOC B, V356, P177, DOI 10.1098/rstb.2000.0763; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Wisniewski T, 2007, FEBS J, V274, P3784, DOI 10.1111/j.1742-4658.2007.05919.x; Wisniewski T, 2001, J ALZHEIMERS DIS, V3, P7, DOI 10.3233/JAD-2001-3104; Yokoyama T, 2001, J BIOL CHEM, V276, P11265, DOI 10.1074/jbc.M008734200	51	20	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12858	12866		10.1074/jbc.M111.255836	http://dx.doi.org/10.1074/jbc.M111.255836			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362783	Green Published, hybrid			2022-12-25	WOS:000302903700025
J	Ahn, J; Hao, CL; Yan, JP; Delucia, M; Mehrens, J; Wang, CP; Gronenborn, AM; Skowronski, J				Ahn, Jinwoo; Hao, Caili; Yan, Junpeng; Delucia, Maria; Mehrens, Jennifer; Wang, Chuanping; Gronenborn, Angela M.; Skowronski, Jacek			HIV/Simian Immunodeficiency Virus (SIV) Accessory Virulence Factor Vpx Loads the Host Cell Restriction Factor SAMHD1 onto the E3 Ubiquitin Ligase Complex CRL4(DCAF1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELLS; WD40-REPEAT PROTEINS; BETA-TRCP; DEGRADATION; TRANSDUCTION; ARCHITECTURE; REPLICATION; ACTIVATION; INTERACTS; RECEPTOR	The sterile alpha motif and HD domain-containing protein-1 (SAMHD1) inhibits infection of myeloid cells by human and related primate immunodeficiency viruses (HIV and SIV). This potent inhibition is counteracted by the Vpx accessory virulence factor of HIV-2/SIVsm viruses, which targets SAMHD1 for proteasome-dependent degradation, by reprogramming cellular CRL4(DCAF1) E3 ubiquitin ligase. However, the precise mechanism of Vpx-dependent recruitment of human SAMHD1 onto the ligase, and the molecular interfaces on the respective molecules have not been defined. Here, we show that human SAMHD1 is recruited to the CRL4(DCAF1-Vpx) E3 ubiquitin ligase complex by interacting with the DCAF1 substrate receptor subunit in a Vpx-dependent manner. No stable association is detectable with DCAF1 alone. The SAMHD1 determinant for the interaction is a short peptide located distal to the SAMHD1 catalytic domain and requires the presence of Vpx for stable engagement. This peptide is sufficient to confer Vpx-dependent recruitment to CRL4(DCAF1) and ubiquitination when fused to heterologous proteins. The precise amino acid sequence of the peptide diverges among SAMHD1 proteins from different vertebrate species, explaining selective down-regulation of human SAMHD1 levels by Vpx. Critical amino acid residues of SAMHD1 and Vpx involved in the DCAF1-Vpx-SAMDH1 interaction were identified by mutagenesis. Our findings show that the N terminus of Vpx, bound to DCAF1, recruits SAMHD1 via its C terminus to CRL4, in a species-specific manner for proteasomal degradation.	[Hao, Caili; Yan, Junpeng; Wang, Chuanping; Skowronski, Jacek] Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Ahn, Jinwoo; Delucia, Maria; Mehrens, Jennifer; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Ahn, Jinwoo; Delucia, Maria; Mehrens, Jennifer; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA	Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Skowronski, J (corresponding author), Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	jacek.skowronski@case.edu		Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [P50GM082251, R01 AI077459]; Case CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P50GM082251 (to A. M. G.), R01 AI077459 (to J. S.), and Case CFAR funds (to J. S.).	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Barry Michele, 2006, Sci STKE, V2006, ppe21; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fletcher TM, 1996, EMBO J, V15, P6155, DOI 10.1002/j.1460-2075.1996.tb01003.x; Fujita M, 2008, J VIROL, V82, P7752, DOI 10.1128/JVI.01003-07; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P607, DOI 10.1089/aid.1994.10.607; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407, DOI 10.1002/jlb.37.4.407; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	44	138	145	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12550	12558		10.1074/jbc.M112.340711	http://dx.doi.org/10.1074/jbc.M112.340711			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22362772	Green Published, hybrid			2022-12-25	WOS:000302782200094
J	Oh, J; Riek, AE; Weng, SR; Petty, M; Kim, D; Colonna, M; Cella, M; Bernal-Mizrachi, C				Oh, Jisu; Riek, Amy E.; Weng, Sherry; Petty, Marvin; Kim, David; Colonna, Marco; Cella, Marina; Bernal-Mizrachi, Carlos			Endoplasmic Reticulum Stress Controls M2 Macrophage Differentiation and Foam Cell Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADVANCED ATHEROSCLEROTIC LESIONS; UNFOLDED PROTEIN RESPONSE; MONOCYTE-DERIVED CELLS; E-DEFICIENT MICE; GENE-EXPRESSION; ALTERNATIVE ACTIVATION; INSULIN-RESISTANCE; IN-VITRO; APOPTOSIS; GAMMA	Macrophages are essential in atherosclerosis progression, but regulation of the M1 versus M2 phenotype and their role in cholesterol deposition are unclear. We demonstrate that endoplasmic reticulum (ER) stress is a key regulator of macrophage differentiation and cholesterol deposition. Macrophages from diabetic patients were classically or alternatively stimulated and then exposed to oxidized LDL. Alternative stimulation into M2 macrophages lead to increased foam cell formation by inducing scavenger receptor CD36 and SR-A1 expression. ER stress induced by alternative stimulation was necessary to generate the M2 phenotype through JNK activation and increased PPAR gamma expression. The absence of CD36 or SR-A1 signaling independently of modified cholesterol uptake decreased ER stress and prevented the M2 differentiation typically induced by alternative stimulation. Moreover, suppression of ER stress shifted differentiated M2 macrophages toward an M1 phenotype and subsequently suppressed foam cell formation by increasing HDL- and apoA-1-induced cholesterol efflux indicating suppression of macrophage ER stress as a potential therapy for atherosclerosis.	[Bernal-Mizrachi, Carlos] Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Colonna, Marco; Cella, Marina] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Bernal-Mizrachi, Carlos] Washington Univ, Div Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bernal-Mizrachi, C (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Lipid Res, 660 S Euclid Ave,Campus Box 8127, St Louis, MO 63110 USA.	cbernal@dom.wustl.edu	Cella, Marina/ABA-8564-2020	Cella, Marina/0000-0003-1230-1313; Bernal-Mizrachi, Carlos/0000-0002-8991-7522; Colonna, Marco/0000-0001-5222-4987	National Institutes of Health [R01HL094818-0, P30 DK079333, P60 20579]; American Diabetes Association [7-08-CR-08]; Endocrine Society; Endocrine Fellows Foundation; National Institutes of Health National Center for Research Resources (a component of the National Institutes of Health) [UL1 RR024992, KL2 RR024994]; National Institutes of Health Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024994, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Endocrine Society; Endocrine Fellows Foundation; National Institutes of Health National Center for Research Resources (a component of the National Institutes of Health); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01HL094818-0, P30 DK079333, and P60 20579. This work was also supported by the American Diabetes Association (7-08-CR-08).; Supported by the Endocrine Society, the Endocrine Fellows Foundation and by Grant UL1 RR024992, Sub-award KL2 RR024994 from the National Institutes of Health National Center for Research Resources (a component of the National Institutes of Health), and the National Institutes of Health Roadmap for Medical Research.	BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Buono C, 2003, ARTERIOSCL THROM VAS, V23, P454, DOI 10.1161/01.ATV.0000059419.11002.6E; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Desvergne B, 2008, CELL METAB, V7, P467, DOI 10.1016/j.cmet.2008.05.002; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Dickhout JG, 2011, FASEB J, V25, P576, DOI 10.1096/fj.10-159319; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; King VL, 2007, AM J PATHOL, V171, P2040, DOI 10.2353/ajpath.2007.060857; King VL, 2002, ARTERIOSCL THROM VAS, V22, P456, DOI 10.1161/hq0302.104905; Kuda O, 2011, J BIOL CHEM, V286, P17785, DOI 10.1074/jbc.M111.232975; Launay S, 1999, BLOOD, V93, P4395, DOI 10.1182/blood.V93.12.4395.412k06_4395_4405; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oh J, 2009, CIRCULATION, V120, P687, DOI 10.1161/CIRCULATIONAHA.109.856070; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Rader DJ, 2005, CELL METAB, V1, P223, DOI 10.1016/j.cmet.2005.03.005; Satoh Noriko, 2010, Diabetes Care, V33, pe7, DOI 10.2337/dc09-1315; SCHAEFER A, 1994, J BIOL CHEM, V269, P8786; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Tabas I, 2010, CIRC RES, V106, P58, DOI 10.1161/CIRCRESAHA.109.208488; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Tsukano H, 2010, ARTERIOSCL THROM VAS, V30, P1925, DOI 10.1161/ATVBAHA.110.206094; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	51	209	229	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11629	11641		10.1074/jbc.M111.338673	http://dx.doi.org/10.1074/jbc.M111.338673			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22356914	Green Published, hybrid			2022-12-25	WOS:000302782200003
J	Wang, J; Wang, YM; Lu, L				Wang, Jie; Wang, Yumei; Lu, Luo			De-SUMOylation of CCCTC Binding Factor (CTCF) in Hypoxic Stress-induced Human Corneal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULATOR PROTEIN; C-MYC; INDUCED APOPTOSIS; GROWTH-FACTOR; SUMO PATHWAY; CHROMATIN; TRANSCRIPTION; COHESIN; GENOME; SITES	Epigenetic factor CCCTC binding factor (CTCF) plays important roles in the genetic control of cell fate. Previous studies found that CTCF is positively and negatively regulated at the transcriptional level by epidermal growth factor (EGF) and ultraviolet (UV) stimulation, respectively. However, it is unknown whether other stresses modify the CTCF protein. Here, we report that regulation of CTCF by de-SUMOylation is dependent upon hypoxic and oxidative stresses. We found that stimulation of human corneal epithelial cells with hypoxic stress suppressed a high molecular mass form of CTCF (150 kDa), but not a lower molecular weight form of CTCF (130 kDa). Further investigation revealed that the hypoxic stress-suppressed 150kDa CTCF was a small ubiquitin-related modifier (SUMO)ylated form of the protein. Hypoxic stress-induced de-SUMOylation of human CTCF was associated with lysine 74 and 689 residues, but not to the phosphorylation of CTCF. Overexpression of SENP1 induced de-SUMOylation of CTCF. However, knockdown of SENP1 could not rescue hypoxic stress-induced CTCF de-SUMOylation. Overexpression of SUMO1 and SUMO2 increased SUMOylation of CTCF and partially blocked hypoxic stress-induced CTCF de-SUMOylation, suggesting that free cellular SUMO proteins play roles in regulating hypoxia-induced CTCF de-SUMOylation. In addition, hypoxic stress significantly inhibited PAX6 mRNA and protein expressions by suppression of PAX6-P0 promoter activity. The result was further supported by data showing that knockdown of CTCF significantly enhanced expression of PAX6 and abolished hypoxia-induced suppression of PAX6. Thus, we conclude that hypoxic stress induces de-SUMOylation of CTCF to functionally regulate CTCF activity.	[Wang, Jie; Wang, Yumei; Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lu, L (corresponding author), 1124 W Carson St,H-H Bldg, Torrance, CA 90502 USA.	lluou@ucla.edu			National Institutes of Health [R01-EY015282]; NATIONAL EYE INSTITUTE [R01EY022364, R01EY015281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-EY015282 (to L. L.).	Agbor TA, 2008, BIOCHEM SOC T, V36, P445, DOI 10.1042/BST0360445; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Docquier F, 2009, CLIN CANCER RES, V15, P5762, DOI 10.1158/1078-0432.CCR-09-0329; El-Kady A, 2005, FEBS LETT, V579, P1424, DOI 10.1016/j.febslet.2005.01.044; Farrar D, 2010, MOL CELL BIOL, V30, P1199, DOI 10.1128/MCB.00827-09; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fink T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-98; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kimura K, 2010, EXP EYE RES, V90, P337, DOI 10.1016/j.exer.2009.11.012; Kitchen NS, 2010, J CELL BIOCHEM, V111, P665, DOI 10.1002/jcb.22751; Klenova EM, 2001, MOL CELL BIOL, V21, P2221, DOI 10.1128/MCB.21.6.2221-2234.2001; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li T, 2004, J BIOL CHEM, V279, P27575, DOI 10.1074/jbc.M313942200; Li T, 2007, EXP CELL RES, V313, P3057, DOI 10.1016/j.yexcr.2007.05.018; Li T, 2006, INVEST OPHTH VIS SCI, V47, P5218, DOI 10.1167/iovs.06-0254; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Lu L, 2010, J BIOL CHEM, V285, P9373, DOI 10.1074/jbc.M109.094425; MacPherson MJ, 2009, MOL CELL BIOL, V29, P714, DOI 10.1128/MCB.00825-08; Meinecke I, 2007, P NATL ACAD SCI USA, V104, P5073, DOI 10.1073/pnas.0608773104; Morris JR, 2010, BIOCHEM SOC T, V38, P92, DOI 10.1042/BST0380092; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Teranishi S, 2008, INVEST OPHTH VIS SCI, V49, P2432, DOI 10.1167/iovs.07-1464; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; Wang L, 2008, J BIOL CHEM, V283, P25928, DOI 10.1074/jbc.M801326200; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Wu D, 2006, INVEST OPHTH VIS SCI, V47, P2422, DOI 10.1167/iovs.05-0536; Yan S, 2010, EMBO J, V29, P3773, DOI 10.1038/emboj.2010.245; Yanai R, 2008, EXP EYE RES, V86, P412, DOI 10.1016/j.exer.2007.11.014; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Yun CW, 2008, J CELL BIOL, V183, P589, DOI 10.1083/jcb.200807185; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	48	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12469	12479		10.1074/jbc.M111.286641	http://dx.doi.org/10.1074/jbc.M111.286641			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354964	hybrid, Green Published			2022-12-25	WOS:000302782200086
J	Zhao, YJ; Wang, YS; Hu, J; Zhang, X; Zhang, YW				Zhao, Yingjun; Wang, Yunshu; Hu, Jin; Zhang, Xian; Zhang, Yun-wu			CutA Divalent Cation Tolerance Homolog (Escherichia coli) (CUTA) Regulates beta-Cleavage of beta-Amyloid Precursor Protein (APP) through Interacting with beta-Site APP Cleaving Protein 1 (BACE1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; SECRETASE ACTIVITY; MEMORY DEFICITS; CELL-SURFACE; HELA-CELLS; PHOSPHORYLATION; PRESENILIN-1; EXPRESSION; GENERATION	Background: The function of the CutA divalent cation tolerance homolog (Escherichia coli) (CUTA) is largely unknown. Results: CUTA has several isoforms, and the longest interacts with BACE1, regulates intracellular trafficking of BACE1, and affects A beta generation. Conclusion: CUTA is a novel BACE1-interacting protein and regulates the beta-cleavage of APP. Significance: CUTA may play a role in Alzheimer disease.	[Zhao, Yingjun; Wang, Yunshu; Hu, Jin; Zhang, Xian; Zhang, Yun-wu] Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361005, Fujian, Peoples R China	Xiamen University	Zhang, YW (corresponding author), Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361005, Fujian, Peoples R China.	yunzhang@xmu.edu.cn	Zhao, Yingjun/G-9173-2016; Zhang, Xian/AAV-7491-2021; Zhang, YW/G-3999-2010	Zhao, Yingjun/0000-0003-2832-6590; Zhang, Yun-wu/0000-0002-7152-7630	Alzheimer Association; National Natural Science Foundation of China [30973150, 81161120496]; 973 Prophase Project [2010CB535004]; Natural Science Foundation of Fujian Province of China [2009J06022, 2010J01235]; Program for New Century Excellent Talents in Universities; Fundamental Research Funds for the Central Universities; Fok Ying Tung Education Foundation; NATIONAL INSTITUTE ON AGING [R21AG038968] Funding Source: NIH RePORTER	Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Prophase Project(National Basic Research Program of China); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Alzheimer Association (to Y.- W. Z.), National Natural Science Foundation of China (Grants 30973150 and 81161120496), 973 Prophase Project (Grant 2010CB535004), and Natural Science Foundation of Fujian Province of China Grants 2009J06022 (to Y.- W. Z.) and 2010J01235 (to X. Z.).; Supported by the Program for New Century Excellent Talents in Universities, the Fundamental Research Funds for the Central Universities, and the Fok Ying Tung Education Foundation. To whom correspondence should be addressed. Tel.: 86-592-2188528; Fax: 86-592-2188528; E-mail: yunzhang@xmu.edu.cn.	Arnesano F, 2003, J BIOL CHEM, V278, P45999, DOI 10.1074/jbc.M304398200; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; FONG ST, 1995, MOL MICROBIOL, V15, P1127, DOI 10.1111/j.1365-2958.1995.tb02286.x; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Johnston JA, 2005, BIOCHEM SOC T, V33, P1096, DOI 10.1042/BST0331096; Kwak YD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-17; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Liang D, 2009, J BIOL CHEM, V284, P5195, DOI 10.1074/jbc.M806260200; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Murayama KS, 2006, EUR J NEUROSCI, V24, P1237, DOI 10.1111/j.1460-9568.2006.05005.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Okada H, 2010, FASEB J, V24, P2783, DOI 10.1096/fj.09-146357; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Savchenko A, 2004, PROTEINS, V54, P162, DOI 10.1002/prot.10585; Shi Q, 2009, J NEUROSCI, V29, P9163, DOI 10.1523/JNEUROSCI.5741-08.2009; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Tanaka Y, 2004, FEBS LETT, V556, P167, DOI 10.1016/S0014-5793(03)01402-9; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yang JC, 2008, ACTA BIOCHIM POL, V55, P411, DOI 10.18388/abp.2008_3089; Yang JC, 2009, MOL BIOL REP, V36, P63, DOI 10.1007/s11033-007-9152-9; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zhang YW, 2009, NEURON, V64, P328, DOI 10.1016/j.neuron.2009.08.036	40	18	20	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11141	11150		10.1074/jbc.M111.330209	http://dx.doi.org/10.1074/jbc.M111.330209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22351782	Green Published, hybrid			2022-12-25	WOS:000302780100042
J	Kassubek, J; Sperfeld, AD; Pinkhardt, EH; Unrath, A; Muller, HP; Scharffetter-Kochanek, K; Ludolph, AC; Berneburg, M				Kassubek, Jan; Sperfeld, Anne-Dorte; Pinkhardt, Elmar H.; Unrath, Alexander; Mueller, Hans-Peter; Scharffetter-Kochanek, Karin; Ludolph, Albert C.; Berneburg, Mark			The Cerebro-Morphological Fingerprint of a Progeroid Syndrome: White Matter Changes Correlate with Neurological Symptoms in Xeroderma Pigmentosum	PLOS ONE			English	Article							DNA-REPAIR; COCKAYNE-SYNDROME; FIBER TRACKING; DISORDERS; TRICHOTHIODYSTROPHY; NEURODEGENERATION; GENOTYPE; LESIONS	Background: Xeroderma pigmentosum (XP) is a rare autosomal recessive progeroid syndrome. It has recently been shown that the underlying DNA repair defect plays a central role in the aging process. In addition to skin symptoms, various premature neurological abnormalities have been reported. Methodology/Principal Findings: We present the clinical neurological phenotype in 14 XP patients (seven subtypes), in seven of these patients together with conventional and multiparametric advanced MRI data to assess the macrostructural and microstructural cerebral morphology in comparison to controls, including volumetric measurements, MR spectroscopy (H-1 MRS), and diffusion tensor imaging (DTI). Clinical hallmarks were spinocerebellar ataxia, pyramidal tract signs, and mild cognitive deficits. DTI demonstrated significantly reduced WM directionality in all regions investigated, i.e. the thalamus, the corticospinal tracts and the dorsal corpus callosum. Single patients showed a marked relative hippocampal volume reduction, but the patients were not different from controls in the volumetric measurements of hippocampal and whole brain volumes at group level. However, 1 H MRS demonstrated that the hippocampal formation was metabolically altered. Conclusions: The most prominent feature was the white matter affectation, as assessed by DTI, with volume and directionality reductions of the fiber projections involving both the craniocaudal fibers and the interhemispheric connections. These findings, although heterogeneous among the study sample, could be correlated with the clinico-neurological symptoms. The imaging findings support the position that myelin structures degrade prematurely in the brain of XP patients.	[Kassubek, Jan; Sperfeld, Anne-Dorte; Pinkhardt, Elmar H.; Unrath, Alexander; Mueller, Hans-Peter; Ludolph, Albert C.] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Scharffetter-Kochanek, Karin] Univ Ulm, Dept Dermatol, Ulm, Germany; [Berneburg, Mark] Univ Tubingen, Dept Dermatol, Tubingen, Germany	Ulm University; Ulm University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kassubek, J (corresponding author), Univ Ulm, Dept Neurol, D-7900 Ulm, Germany.	jan.kassubek@uni-ulm.de	Kassubek, Jan/GPX-0910-2022; Kassubek, Jan/O-1740-2019; Kassubek, Jan/F-2774-2015	Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Scharffetter-Kochanek, Karin/0000-0002-9655-685X	German Research Foundation (DFG) [KFO142]	German Research Foundation (DFG)(German Research Foundation (DFG))	A.C.L., K.S.K. and M.B. were supported by a grant of the German Research Foundation (DFG) to a Clinical Research Group (KFO142, Molecular and Cellular Aging). There was no external funding of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttinen A, 2008, BRAIN, V131, P1979, DOI 10.1093/brain/awn126; Berneburg M, 2001, ADV GENET, V43, P71, DOI 10.1016/S0065-2660(01)43004-5; Bootsma D, 2001, MUTAT RES-DNA REPAIR, V485, P37, DOI 10.1016/S0921-8777(00)00080-X; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Brooks PJ, 2007, NEUROSCIENCE, V145, P1407, DOI 10.1016/j.neuroscience.2006.10.025; Chio A, 2007, J NEUROL NEUROSUR PS, V78, P1349, DOI 10.1136/jnnp.2007.114868; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; de Sanctis C, 1932, RIV SPER FRENIATR ME, V56, P269; Emmert S, 2002, J INVEST DERMATOL, V118, P972, DOI 10.1046/j.1523-1747.2002.01782.x; Faghri S, 2008, J MED GENET, V45, P609, DOI 10.1136/jmg.2008.058743; Gaist D, 2001, EUR J CLIN PHARMACOL, V56, P931, DOI 10.1007/s002280000248; Giesel FL, 2008, EUR J RADIOL, V66, P268, DOI 10.1016/j.ejrad.2007.06.009; Grewal RP, 1999, J NEUROL SCI, V163, P183, DOI 10.1016/S0022-510X(99)00031-3; Hayashi M, 2004, J NEUROPATH EXP NEUR, V63, P1048, DOI 10.1093/jnen/63.10.1048; KANDA T, 1990, BRAIN, V113, P1025, DOI 10.1093/brain/113.4.1025; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kleijer WJ, 2008, DNA REPAIR, V7, P744, DOI 10.1016/j.dnarep.2008.01.014; Kobayashi T, 1997, HUM MUTAT, V9, P322, DOI 10.1002/(SICI)1098-1004(1997)9:4<322::AID-HUMU4>3.0.CO;2-7; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; Lindenbaum Y, 2001, Eur J Paediatr Neurol, V5, P225, DOI 10.1053/ejpn.2001.0523; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Ludolph AG, 2008, DEV MED CHILD NEUROL, V50, P524, DOI 10.1111/j.1469-8749.2008.03014.x; Muller HP, 2007, PHYS MED BIOL, V52, pN99, DOI 10.1088/0031-9155/52/6/N01; Muller HP, 2009, MAGN RESON IMAGING, V27, P324, DOI 10.1016/j.mri.2008.07.003; Mueller HP, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-42; Niedernhofer LJ, 2008, MECH AGEING DEV, V129, P408, DOI 10.1016/j.mad.2008.04.010; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Norman GR, 2007, BIOSTATISTICS BARE E; Oh KS, 2006, HUM MUTAT, V27, P1092, DOI 10.1002/humu.20392; Petit-Frere C, 2000, J INVEST DERMATOL, V115, P687, DOI 10.1046/j.1523-1747.2000.00093.x; Rao KS, 2007, NEUROSCIENCE, V145, P1330, DOI 10.1016/j.neuroscience.2006.09.032; Rapin I, 2000, NEUROLOGY, V55, P1442, DOI 10.1212/WNL.55.10.1442; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; ROBBINS JH, 1991, BRAIN, V114, P1335, DOI 10.1093/brain/114.3.1335; Shen YJ, 2004, MAGN RESON MED, V52, P1184, DOI 10.1002/mrm.20267; YAMAMURA K, 1989, BRIT J DERMATOL, V121, P471, DOI 10.1111/j.1365-2133.1989.tb15514.x	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30926	10.1371/journal.pone.0030926	http://dx.doi.org/10.1371/journal.pone.0030926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363517	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700014
J	Braun, RD; Bissig, D; North, R; Vistisen, KS; Berkowitz, BA				Braun, Rod D.; Bissig, David; North, Robert; Vistisen, Kerry S.; Berkowitz, Bruce A.			Human Tumor Cell Proliferation Evaluated Using Manganese-Enhanced MRI	PLOS ONE			English	Article							RESONANCE-IMAGING MEMRI; IN-VIVO; CALCIUM-CHANNELS; PROSTATE-CANCER; CA2+ ENTRY; UVEAL MELANOMA; RAT-BRAIN; MN; OVEREXPRESSION; PROGRESSION	Background: Tumor cell proliferation can depend on calcium entry across the cell membrane. As a first step toward the development of a non-invasive test of the extent of tumor cell proliferation in vivo, we tested the hypothesis that tumor cell uptake of a calcium surrogate, Mn2+ [measured with manganese-enhanced MRI (MEMRI)], is linked to proliferation rate in vitro. Methodology/Principal Findings: Proliferation rates were determined in vitro in three different human tumor cell lines: C918 and OCM-1 human uveal melanomas and PC-3 prostate carcinoma. Cells growing at different average proliferation rates were exposed to 1 mM MnCl2 for one hour and then thoroughly washed. MEMRI R-1 values (longitudinal relaxation rates), which have a positive linear relationship with Mn2+ concentration, were then determined from cell pellets. Cell cycle distributions were determined using propidium iodide staining and flow cytometry. All three lines showed Mn2+-induced increases in R-1 compared to cells not exposed to Mn2+. C918 and PC-3 cells each showed a significant, positive correlation between MEMRI R-1 values and proliferation rate (p <= 0.005), while OCM-1 cells showed no significant correlation. Preliminary, general modeling of these positive relationships suggested that pellet R-1 for the PC-3 cells, but not for the C918 cells, could be adequately described by simply accounting for changes in the distribution of the cell cycle-dependent subpopulations in the pellet. Conclusions/Significance: These data clearly demonstrate the tumor-cell dependent nature of the relationship between proliferation and calcium influx, and underscore the usefulness of MEMRI as a non-invasive method for investigating this link. MEMRI is applicable to study tumors in vivo, and the present results raise the possibility of evaluating proliferation parameters of some tumor types in vivo using MEMRI.	[Braun, Rod D.; Bissig, David; North, Robert; Vistisen, Kerry S.; Berkowitz, Bruce A.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Braun, Rod D.] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI USA; [Berkowitz, Bruce A.] Wayne State Univ, Kresge Eye Inst, Detroit, MI USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Braun, RD (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.	rbraun@med.wayne.edu		Bissig, David/0000-0001-9664-5433	Karmanos Cancer Institute; National Institutes of Health (NIH) [EY018109, AG034752]; NIH National Eye Institute [P30EY04068]; NIH Center [P30CA22453]; Juvenile Diabetes Research Foundation; Wayne State University School of Medicine; Research to Prevent Blindness (Kresge Eye Institute); NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY018109, P30EY004068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG034752] Funding Source: NIH RePORTER	Karmanos Cancer Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Wayne State University School of Medicine; Research to Prevent Blindness (Kresge Eye Institute)(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Pilot Project Grant from Karmanos Cancer Institute (RDB, BAB), National Institutes of Health (NIH) EY018109 (BAB), NIH National Eye Institute Departmental Core Grant (P30EY04068), NIH Center Grant to the Karmanos Cancer Institute (P30CA22453), Juvenile Diabetes Research Foundation (BAB), NIH AG034752 (DB), Wayne State University School of Medicine MD/PhD program (DB), and an unrestricted grant from Research to Prevent Blindness (Kresge Eye Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON M, 1983, J GEN PHYSIOL, V81, P805, DOI 10.1085/jgp.81.6.805; Bading JR, 2008, J NUCL MED, V49, p64S, DOI 10.2967/jnumed.107.046391; Banerjee D, 2007, NEUROIMAGE, V35, P1434, DOI 10.1016/j.neuroimage.2007.02.019; Berkowitz BA, 2006, INVEST OPHTH VIS SCI, V47, P2668, DOI 10.1167/iovs.05-1588; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P2351, DOI 10.1167/iovs.08-2918; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P1880, DOI 10.1167/iovs.08-2958; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bissig D, 2009, NEUROIMAGE, V44, P627, DOI 10.1016/j.neuroimage.2008.10.013; Braun RD, 2007, INVEST OPHTH VIS SCI, V48, P963, DOI 10.1167/iovs.06-1156; Buhmeida A, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-4; Cross DJ, 2007, AM J NEURORADIOL, V28, P1865, DOI 10.3174/ajnr.A0693; Daniels KJ, 1996, LAB INVEST, V75, P55; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; Erikson KM, 2007, PHARMACOL THERAPEUT, V113, P369, DOI 10.1016/j.pharmthera.2006.09.002; Fiske JL, 2006, CANCER METAST REV, V25, P493, DOI 10.1007/s10555-006-9017-z; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Hasegawa S, 2010, INT J CANC; KAIGHN ME, 1979, INVEST UROL, V17, P16; KANMITCHELL J, 1989, INVEST OPHTH VIS SCI, V30, P829; KJAER L, 1988, ACTA RADIOL, V29, P473; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001; Lopez S, 2004, INT J FOOD MICROBIOL, V96, P289, DOI 10.1016/j.ijfoodmicro.2004.03.026; Minner S, 2010, CLIN CANCER RES, V16, P1553, DOI 10.1158/1078-0432.CCR-09-2546; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Munaron L, 2004, J CELL MOL MED, V8, P161, DOI 10.1111/j.1582-4934.2004.tb00271.x; Munaron L, 2004, CURR MED CHEM, V11, P1533, DOI 10.2174/0929867043365008; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; Panner A, 2006, CELL CALCIUM, V40, P253, DOI 10.1016/j.ceca.2006.04.029; R Development Core Team, 2009, R FDN STAT COMP; Ritz C, 2011, ENVIRON ECOL STAT, V18, P349, DOI 10.1007/s10651-010-0136-x; Roth JA, 2006, BIOL RES, V39, P45, DOI 10.4067/S0716-97602006000100006; Schokker EP, 1997, J AGR FOOD CHEM, V45, P4740, DOI 10.1021/jf970429i; Seshadri M, 2010, MAGN RESON MED, V64, P902, DOI 10.1002/mrm.22452; SHIBUYA I, 1993, CELL CALCIUM, V14, P33, DOI 10.1016/0143-4160(93)90016-Y; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Tamano H, 2002, NUCL MED BIOL, V29, P505, DOI 10.1016/S0969-8051(02)00289-5; Taylor JT, 2008, WORLD J GASTROENTERO, V14, P4984, DOI 10.3748/wjg.14.4984; Thebault S, 2006, CANCER RES, V66, P2038, DOI 10.1158/0008-5472.CAN-05-0376; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Valera V, 2005, BRIT J SURG, V92, P1002, DOI 10.1002/bjs.4858; VALOIS AA, 1989, TOXICOLOGY, V57, P315, DOI 10.1016/0300-483X(89)90119-4; Wadghiri YZ, 2004, NMR BIOMED, V17, P613, DOI 10.1002/nbm.932; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477; Zeng X, 2009, PROSTATE CANC P D; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	49	13	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30572	10.1371/journal.pone.0030572	http://dx.doi.org/10.1371/journal.pone.0030572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363447	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600035
J	Cortes, R; Rivera, M; Rosello-Lleti, E; Martinez-Dolz, L; Almenar, L; Azorin, I; Lago, F; Gonzalez-Juanatey, JR; Portoles, M				Cortes, Raquel; Rivera, Miguel; Rosello-Lleti, Esther; Martinez-Dolz, Luis; Almenar, Luis; Azorin, Inmaculada; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Portoles, Manuel			Differences in MEF2 and NFAT Transcriptional Pathways According to Human Heart Failure Aetiology	PLOS ONE			English	Article							CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; CARDIAC-HYPERTROPHY; CARDIOMYOCYTE HYPERTROPHY; DILATED CARDIOMYOPATHY; IN-VIVO; CALCINEURIN; MYOCARDIUM; EXPRESSION; MYOCYTES; INSIGHTS	Background: Ca2+ handling machinery modulates the activation of cardiac transcription pathways involved in heart failure (HF). The present study investigated the effect of HF aetiology on Ca+2 handling proteins and NFAT1, MEF2C and GATA4 (transcription factors) in the same cardiac tissue. Methodology and Principal Findings: A total of 83 hearts from ischemic (ICM, n = 43) and dilated (DCM, n = 31) patients undergoing heart transplantation and controls (CNT, n = 9) were analyzed by western blotting. Subcellular distribution was analyzed by fluorescence and electron microscopy. When we compared Ca+2 handling proteins according to HF aetiology, ICM showed higher levels of calmodulin (24%, p<0.01), calcineurin (26%, p<0.01) and Ca2+/Calmodulin-dependent kinase II (CaMKII delta(b) nuclear isoform 62%, p<0.001) than the CNT group. However, these proteins in DCM did not significantly increase. Furthermore, ICM showed a significant elevation in MEF2C (33%, p<0.01), and GATA4 (49%, p<0.05); also NFAT1 (66%, p<0.001) was increased, producing the resultant translocation of this transcriptional factor into the nuclei. These results were supported by fluorescence and electron microscopy analysis. Whereas, DCM only had a significant increase in GATA4 (52%, p<0.05). Correlations between NFAT1 and MEF2C in both groups (ICM r = 0.38 and DCM r = 0.59, p<0.05 and p<0.01, respectively) were found; only ICM showed a correlation between GATA4 and NFAT1 (r = 0.37, p<0.05). Conclusions/Significance: This study shows an increase of Ca2+ handling machinery synthesis and their cardiac transcription pathways in HF, being more markedly increased in ICM. Furthermore, there is a significant association between MEF2, NFAT1 and GATA4. These proteins could be therapeutic targets to improve myocardial function.	[Cortes, Raquel; Rivera, Miguel; Rosello-Lleti, Esther] Hosp Univ La Fe, Cardiocirculatory Unit, Res Ctr, Valencia, Spain; [Martinez-Dolz, Luis; Almenar, Luis] Hosp Univ La Fe, Cardiol Unit, Valencia, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Hosp Clin Univ, Mol & Cellular Cardiol Unit, Inst Biomed Res, Santiago De Compostela, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Hosp Clin Univ, Dept Cardiol, Santiago De Compostela, Spain; [Portoles, Manuel] Hosp Univ La Fe, Res Ctr, Cell Biol & Pathol Unit, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitari i Politecnic La Fe	Cortes, R (corresponding author), Hosp Univ La Fe, Cardiocirculatory Unit, Res Ctr, Valencia, Spain.	portoles_man@gva.es	CORTES, RAQUEL/K-2777-2014; Cortes, Raquel/GQH-6347-2022; Dolz, Luis Martinez/X-4627-2018; PORTOLES, MANUEL/B-4789-2009; Roselló Lletí, Esther/ABG-8503-2020; Roselló-Lletí, Esther/B-2695-2017	CORTES, RAQUEL/0000-0001-9607-997X; Cortes, Raquel/0000-0001-9607-997X; Dolz, Luis Martinez/0000-0001-5145-8191; PORTOLES, MANUEL/0000-0002-4415-7160; Roselló Lletí, Esther/0000-0003-2627-6104; Roselló-Lletí, Esther/0000-0003-2627-6104; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	National Institute of Health "Fondo de Investigaciones Sanitarias of Instituto de Salud Carlos III" [REDINSCOR 06/0003/1001, PI07/0462]	National Institute of Health "Fondo de Investigaciones Sanitarias of Instituto de Salud Carlos III"	This work was supported by grants from the National Institute of Health "Fondo de Investigaciones Sanitarias of Instituto de Salud Carlos III", [REDINSCOR 06/0003/1001, Project PI07/0462]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Barry SP, 2010, INT REV CEL MOL BIO, V284, P113, DOI 10.1016/S1937-6448(10)84003-1; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; BOHM M, 1990, CIRCULATION, V82, P1249, DOI 10.1161/01.CIR.82.4.1249; Bueno OF, 2002, CARDIOVASC RES, V53, P806, DOI 10.1016/S0008-6363(01)00493-X; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Cortes R, 2010, CARDIOVASC RES, V85, P464, DOI 10.1093/cvr/cvp336; Frank KF, 2003, CARDIOVASC RES, V57, P20, DOI 10.1016/S0008-6363(02)00694-6; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hoch B, 1999, CIRC RES, V84, P713, DOI 10.1161/01.RES.84.6.713; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; KAPILOFF MS, 1991, P NATL ACAD SCI USA, V88, P3710, DOI 10.1073/pnas.88.9.3710; Khoo MSC, 2006, CIRCULATION, V114, P1352, DOI 10.1161/CIRCULATIONAHA.106.644583; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Lu YM, 2010, BBA-GENE REGUL MECH, V1799, P429, DOI 10.1016/j.bbagrm.2010.02.004; Lynch J, 2005, J CELL BIOL, V170, P37, DOI 10.1083/jcb.200412156; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; Mishra S, 2003, AM J PHYSIOL-HEART C, V284, pH876, DOI 10.1152/ajpheart.00266.2002; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Pauschinger M, 1998, CARDIOVASC RES, V37, P123, DOI 10.1016/S0008-6363(97)00217-4; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Putt ME, 2009, CIRC-CARDIOVASC GENE, V2, P212, DOI 10.1161/CIRCGENETICS.108.816686; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Sossalla S, 2010, CIRC RES, V107, P1150, DOI 10.1161/CIRCRESAHA.110.220418; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhu WD, 2000, J BIOL CHEM, V275, P15239, DOI 10.1074/jbc.275.20.15239	33	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30915	10.1371/journal.pone.0030915	http://dx.doi.org/10.1371/journal.pone.0030915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363514	Green Submitted, gold, Green Published			2022-12-25	WOS:000302853600087
J	Dayan, E; Inzelberg, R; Flash, T				Dayan, Eran; Inzelberg, Rivka; Flash, Tamar			Altered Perceptual Sensitivity to Kinematic Invariants in Parkinson's Disease	PLOS ONE			English	Article							BIOLOGICAL MOTION; POWER-LAW; VISUAL DYSFUNCTION; ACTION RECOGNITION; MOTOR DYSFUNCTION; ARM MOVEMENTS; EYE-MOVEMENTS; VELOCITY; IMPAIRMENT; CURVATURE	Ample evidence exists for coupling between action and perception in neurologically healthy individuals, yet the precise nature of the internal representations shared between these domains remains unclear. One experimentally derived view is that the invariant properties and constraints characterizing movement generation are also manifested during motion perception. One prominent motor invariant is the "two-third power law," describing the strong relation between the kinematics of motion and the geometrical features of the path followed by the hand during planar drawing movements. The two-thirds power law not only characterizes various movement generation tasks but also seems to constrain visual perception of motion. The present study aimed to assess whether motor invariants, such as the two thirds power law also constrain motion perception in patients with Parkinson's disease (PD). Patients with PD and age-matched controls were asked to observe the movement of a light spot rotating on an elliptical path and to modify its velocity until it appeared to move most uniformly. As in previous reports controls tended to choose those movements close to obeying the two-thirds power law as most uniform. Patients with PD displayed a more variable behavior, choosing on average, movements closer but not equal to a constant velocity. Our results thus demonstrate impairments in how the two-thirds power law constrains motion perception in patients with PD, where this relationship between velocity and curvature appears to be preserved but scaled down. Recent hypotheses on the role of the basal ganglia in motor timing may explain these irregularities. Alternatively, these impairments in perception of movement may reflect similar deficits in motor production.	[Dayan, Eran; Flash, Tamar] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Dayan, Eran] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Inzelberg, Rivka] Tel Hashomer & Tel Aviv Univ, Sheba Med Ctr, Sagol Neurosci Ctr, Dept Neurol, Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Chaim Sheba Medical Center	Dayan, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	dayan.eran@gmail.com	Inzelberg, Rivka/E-5861-2010; Dayan, Eran/C-3449-2009	Inzelberg, Rivka/0000-0002-0720-0502; Dayan, Eran/0000-0001-9710-9210	Human Frontier Science Program [RGP0054/2004-C]; European Commission [043403, 249858]; Tango	Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Tango	This work was supported in part by a Human Frontier Science Program Grant (RGP0054/2004-C) [http://www.hfsp.org/], by the European Commission-funded COBOL Contract (043403). [http://ec.europa.eu/index_en.htm] and by Tango. The project Tango acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Program for Research of the European Commission, under 14 FET-Open grant number: 249858. [http://cordis.europa.eu/ist/fet/home.html] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEND W, 1982, BRAIN, V105, P331, DOI 10.1093/brain/105.2.331; Alberts JL, 2000, EXP BRAIN RES, V134, P353, DOI 10.1007/s002210000468; Archibald NK, 2009, BRAIN, V132, P1128, DOI 10.1093/brain/awp068; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bennequin D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000426; Beudel M, 2008, NEUROREPORT, V19, P1055, DOI 10.1097/WNR.0b013e328303b7b9; Bidet-Ildei C, 2006, PERCEPTION, V35, P1137, DOI 10.1068/p5482; BODISWOLLNER I, 1987, BRAIN, V110, P1675, DOI 10.1093/brain/110.6.1675; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Casile A, 2010, CEREB CORTEX, V20, P1647, DOI 10.1093/cercor/bhp229; Castelo-Branco M, 2009, NEUROPSYCHOLOGIA, V47, P314, DOI 10.1016/j.neuropsychologia.2008.09.003; Castiello U, 2000, NEUROPSYCHOLOGIA, V38, P46, DOI 10.1016/S0028-3932(99)00049-4; Castiello U, 2009, NEUROPSYCHOLOGIA, V47, P835, DOI 10.1016/j.neuropsychologia.2008.12.016; Cooper CA, 2009, PARKINSONISM RELAT D, V15, P315, DOI 10.1016/j.parkreldis.2008.07.009; Dayan E, 2007, P NATL ACAD SCI USA, V104, P20582, DOI 10.1073/pnas.0710033104; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Desmurget M, 2004, BRAIN, V127, P1755, DOI 10.1093/brain/awh206; deSperati C, 1997, J NEUROSCI, V17, P3932; DESPERATI C, 1995, EXP BRAIN RES, V105, P254; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Flach R, 2004, VIS COGN, V11, P461, DOI 10.1080/13506280344000392; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FLASH T, 1992, EXP NEUROL, V118, P215, DOI 10.1016/0014-4886(92)90038-R; FLASH T, 1992, HUM MOVEMENT SCI, V11, P83, DOI 10.1016/0167-9457(92)90052-D; FLASH T, 1992, PARKINSONS DIS PROBL, P87; Flash T, 2007, BIOL CYBERN, V96, P577, DOI 10.1007/s00422-007-0145-5; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; HARNOIS C, 1990, INVEST OPHTH VIS SCI, V31, P2473; Harrington DL, 1999, REV NEUROSCIENCE, V10, P91, DOI 10.1515/REVNEURO.1999.10.2.91; Hicheur H, 2005, EXP BRAIN RES, V162, P145, DOI 10.1007/s00221-004-2122-8; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; HUFSCHMIDT A, 1995, MOVEMENT DISORD, V10, P267, DOI 10.1002/mds.870100306; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Inzelberg R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003663; Jin DZ, 2009, P NAT AC SCI; Johnson MTV, 1996, BRAIN, V119, P801, DOI 10.1093/brain/119.3.801; Kandel S, 2000, PERCEPT PSYCHOPHYS, V62, P706, DOI 10.3758/BF03206917; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Lekwuwa GU, 1999, J NEUROL NEUROSUR PS, V66, P746, DOI 10.1136/jnnp.66.6.746; Levit-Binnun N, 2006, EXP BRAIN RES, V172, P533, DOI 10.1007/s00221-006-0355-4; Maetzler W, 2009, LANCET NEUROL, V8, P1158, DOI 10.1016/S1474-4422(09)70291-1; Mahon BZ, 2008, CURR BIOL, V18, pR1068, DOI 10.1016/j.cub.2008.10.001; Mahon BZ, 2005, COGN NEUROPSYCHOL, V22, P480, DOI 10.1080/02643290442000446; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Mosimann UP, 2004, NEUROLOGY, V63, P2091, DOI 10.1212/01.WNL.0000145764.70698.4E; Muslimovic D, 2007, J INT NEUROPSYCH SOC, V13, P920, DOI 10.1017/S1355617707071160; Negri GAL, 2007, COGN NEUROPSYCHOL, V24, P795, DOI 10.1080/02643290701707412; Owen AM, 2004, NEUROSCIENTIST, V10, P525, DOI 10.1177/1073858404266776; Poliakoff E, 2007, NEUROREPORT, V18, P483, DOI 10.1097/WNR.0b013e32805867a1; Pollick FE, 1997, VISION RES, V37, P347, DOI 10.1016/S0042-6989(96)00116-2; Polyakov F, 2009, BIOL CYBERN, V100, P159, DOI 10.1007/s00422-008-0287-0; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; REED CL, 1995, J EXP PSYCHOL HUMAN, V21, P334, DOI 10.1037/0096-1523.21.2.334; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; STERN Y, 1983, J NEUROL NEUROSUR PS, V46, P145, DOI 10.1136/jnnp.46.2.145; Tasko SM, 2004, J PHONETICS, V32, P65, DOI 10.1016/S0095-4470(03)00006-8; Tremblay F, 2008, EXP BRAIN RES, V185, P249, DOI 10.1007/s00221-007-1150-6; TRICK GL, 1994, OPTOMETRY VISION SCI, V71, P242, DOI 10.1097/00006324-199404000-00002; Uc EY, 2005, NEUROLOGY, V65, P1907, DOI 10.1212/01.wnl.0000191565.11065.11; Van Gemmert AWA, 1999, NEUROPSYCHOLOGIA, V37, P685; Van Gemmert AWA, 2003, J NEUROL NEUROSUR PS, V74, P1502, DOI 10.1136/jnnp.74.11.1502; VIVIANI P, 1992, J EXP PSYCHOL HUMAN, V18, P603, DOI 10.1037/0096-1523.18.3.603; VIVIANI P, 1985, J EXP PSYCHOL HUMAN, V11, P828, DOI 10.1037/0096-1523.11.6.828; Viviani P, 2002, ATTENTION PERFORM, V19, P406; Viviani P, 2009, EXP BRAIN RES, V194, P259, DOI 10.1007/s00221-008-1695-z; WANN J, 1988, J EXP PSYCHOL HUMAN, V14, P622, DOI 10.1037/0096-1523.14.4.622; WHITE OB, 1983, BRAIN, V106, P571, DOI 10.1093/brain/106.3.571; Williams LN, 2007, MOVEMENT DISORD, V22, P141, DOI 10.1002/mds.21220	75	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30369	10.1371/journal.pone.0030369	http://dx.doi.org/10.1371/journal.pone.0030369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363430	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600024
J	Delgado, E; Carrera, C; Nebreda, P; Fernandez-Garcia, A; Pinilla, M; Garcia, V; Perez-Alvarez, L; Thomson, MM				Delgado, Elena; Carrera, Cristina; Nebreda, Paloma; Fernandez-Garcia, Aurora; Pinilla, Milagros; Garcia, Valentina; Perez-Alvarez, Lucia; Thomson, Michael M.			Identification of New Splice Sites Used for Generation of rev Transcripts in Human Immunodeficiency Virus Type 1 Subtype C Primary Isolates	PLOS ONE			English	Article							NF-KAPPA-B; LONG TERMINAL REPEAT; POLYPYRIMIDINE TRACT; FUNCTIONAL-ANALYSIS; CORECEPTOR USAGE; U2 SNRNP; HIV-1; RNA; TAT; ACTIVATION	The HIV-1 primary transcript undergoes a complex splicing process by which more than 40 different spliced RNAs are generated. One of the factors contributing to HIV-1 splicing complexity is the multiplicity of 39 splice sites (3'ss) used for generation of rev RNAs, with two 3'ss, A4a and A4b, being most commonly used, a third site, A4c, used less frequently, and two additional sites, A4d and A4e, reported in only two and one isolates, respectively. HIV-1 splicing has been analyzed mostly in subtype B isolates, and data on other group M clades are lacking. Here we examine splice site usage in three primary isolates of subtype C, the most prevalent clade in the HIV-1 pandemic, by using an in vitro infection assay of peripheral blood mononuclear cells. Viral spliced RNAs were identified by RT-PCR amplification using a fluorescently-labeled primer and software analyses and by cloning and sequencing the amplified products. The results revealed that splice site usage for generation of rev transcripts in subtype C differs from that reported for subtype B, with most rev RNAs using two previously unreported 3'ss, one located 7 nucleotides upstream of 3'ss A4a, designated A4f, preferentially used by two isolates, and another located 14 nucleotides upstream of 3'ss A4c, designated A4g, preferentially used by the third isolate. A new 59 splice site, designated D2a, was also identified in one virus. Usage of the newly identified splice sites is consistent with sequence features commonly found in subtype C viruses. These results show that splice site usage may differ between HIV-1 subtypes.	[Delgado, Elena; Carrera, Cristina; Nebreda, Paloma; Fernandez-Garcia, Aurora; Pinilla, Milagros; Garcia, Valentina; Perez-Alvarez, Lucia; Thomson, Michael M.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Delgado, E (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.	mthomson@isciii.es	CARRERA, CRISTINA/N-1887-2019; Thomson, Michael M/P-8949-2017; Delgado, Elena/E-2785-2019	CARRERA, CRISTINA/0000-0003-1608-8820; Thomson, Michael M/0000-0002-0622-7527; Delgado, Elena/0000-0002-0754-8533	Ministerio de Ciencia e Innovacion (Spain) [SAF2007-61688, SAF2010-20961]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by Ministerio de Ciencia e Innovacion (Spain), Plan Nacional I+D+I, through grants SAF2007-61688 and SAF2010-20961. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe A, 1999, AIDS, V13, P1305, DOI 10.1097/00002030-199907300-00006; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; BENKO DM, 1990, J VIROL, V64, P2505, DOI 10.1128/JVI.64.6.2505-2518.1990; Berkhout B, 1996, ARCH VIROL, V141, P839, DOI 10.1007/BF01718159; Bilodeau PS, 1999, J VIROL, V73, P9764, DOI 10.1128/JVI.73.12.9764-9772.1999; Bjorndal A, 1999, AIDS RES HUM RETROV, V15, P647, DOI 10.1089/088922299310944; Borensztajn K, 2006, PLOS GENET, V2, P1297, DOI 10.1371/journal.pgen.0020138; Buvoli M, 1997, EMBO J, V16, P7174, DOI 10.1093/emboj/16.23.7174; Caputi M, 2004, J VIROL, V78, P6517, DOI 10.1128/JVI.78.12.6517-6526.2004; Carrera C, 2010, AIDS RES HUM RETROV, V26, P815, DOI 10.1089/aid.2010.0011; Coolidge CJ, 1997, NUCLEIC ACIDS RES, V25, P888, DOI 10.1093/nar/25.4.888; Corvelo A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001016; Cuevas MT, 2010, AIDS RES HUM RETROV, V26, P1019, DOI 10.1089/aid.2010.0018; FURTADO MR, 1991, VIROLOGY, V185, P258, DOI 10.1016/0042-6822(91)90773-5; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; HIV Sequence Database, HIV SEQ DAT; Huang W, 2007, J VIROL, V81, P7885, DOI 10.1128/JVI.00218-07; Iordanskiy S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-85; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Kol G, 2005, HUM MOL GENET, V14, P1559, DOI 10.1093/hmg/ddi164; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; LEAR AL, 1990, J MOL BIOL, V211, P103, DOI 10.1016/0022-2836(90)90014-D; Lemieux AM, 2004, J BIOL CHEM, V279, P52949, DOI 10.1074/jbc.M409896200; Lutzelberger M, 2006, J BIOL CHEM, V281, P18644, DOI 10.1074/jbc.M513698200; Madsen JM, 2005, J VIROL, V79, P10478, DOI 10.1128/JVI.79.16.10478-10486.2005; Madsen JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-10; Montano MA, 1998, J VIROL, V72, P8446, DOI 10.1128/JVI.72.10.8446-8452.1998; Montano MA, 2000, J INFECT DIS, V181, P76, DOI 10.1086/315185; NELSON KK, 1989, GENE DEV, V3, P1562, DOI 10.1101/gad.3.10.1562; NORTON PA, 1994, NUCLEIC ACIDS RES, V22, P3854, DOI 10.1093/nar/22.19.3854; OREILLY MM, 1995, VIROLOGY, V213, P373, DOI 10.1006/viro.1995.0010; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Quivy V, 2002, J VIROL, V76, P11091, DOI 10.1128/JVI.76.21.11091-11103.2002; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Roca X, 2005, RNA, V11, P683, DOI 10.1261/rna.2040605; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; SALFELD J, 1990, EMBO J, V9, P965, DOI 10.1002/j.1460-2075.1990.tb08195.x; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; Si ZH, 1997, NUCLEIC ACIDS RES, V25, P861, DOI 10.1093/nar/25.4.861; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; SMITH J, 1992, J GEN VIROL, V73, P1825, DOI 10.1099/0022-1317-73-7-1825; STAFFA A, 1994, J VIROL, V68, P3071, DOI 10.1128/JVI.68.5.3071-3079.1994; Stoltzfus CM, 2009, ADV VIRUS RES, V74, P1, DOI 10.1016/S0065-3527(09)74001-1; Swanson AK, 1998, J BIOL CHEM, V273, P34551, DOI 10.1074/jbc.273.51.34551; Tscherning C, 1998, VIROLOGY, V241, P181, DOI 10.1006/viro.1997.8980; Verhoef K, 1996, VIROLOGY, V225, P316, DOI 10.1006/viro.1996.0606; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; ZHUANG Y, 1989, Proceedings of the National Academy of Sciences of the United States of America, V86, P2752, DOI 10.1073/pnas.86.8.2752	52	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30574	10.1371/journal.pone.0030574	http://dx.doi.org/10.1371/journal.pone.0030574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363449	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600037
J	Fethers, K; Twin, J; Fairley, CK; Fowkes, FJI; Garland, SM; Fehler, G; Morton, AM; Hocking, JS; Tabrizi, SN; Bradshaw, CS				Fethers, Katherine; Twin, Jimmy; Fairley, Christopher K.; Fowkes, Freya J. I.; Garland, Suzanne M.; Fehler, Glenda; Morton, Anna M.; Hocking, Jane S.; Tabrizi, Sepehr N.; Bradshaw, Catriona S.			Bacterial Vaginosis (BV) Candidate Bacteria: Associations with BV and Behavioural Practices in Sexually-Experienced and Inexperienced Women	PLOS ONE			English	Article							VAGINAL MICROBIAL COMMUNITIES; GARDNERELLA-VAGINALIS; METRONIDAZOLE THERAPY; ATOPOBIUM-VAGINAE; RISK-FACTORS; TRANSMITTED-DISEASES; PCR; PREVALENCE; LESBIANS; HEALTH	Background: In recent years several new fastidious bacteria have been identified that display a high specificity for BV; however no previous studies have comprehensively assessed the behavioural risk associations of these bacterial vaginosis-candidate organisms (BV-COs). Methods: We examined the associations between 8 key previously described BV-COs and BV status established by Nugent's score (NS). We also examined the sexual practices associated with each BV-CO. We incorporated 2 study populations: 193 from a sexually-inexperienced university population and 146 from a highly sexually-active clinic population. Detailed behavioural data was collected by questionnaire and vaginal smears were scored by the Nugent method. Stored samples were tested by quantitative PCR assays for the 8 BV-COs: Atopobium vaginae, Gardnerella vaginalis, Leptotrichia spp., Megasphaera type I, Sneathia spp., and the Clostridia-like bacteria BVAB1, BVAB2 and BVAB3. Associations between BV-COs and BV and behaviours were examined by univariate and multivariable analyses. Results: On univariate analysis, all BV-COs were more common in BV compared to normal flora. However, only Megasphaera type I, BVAB2, A. vaginae and G. vaginalis were significantly independently associated with BV by multivariable analysis. Six of the eight BV-COs (Megasphaera type I, BVAB2, BVAB3, Sneathia, Leptotrichia and G. vaginalis) were rare or absent in sexually-unexposed women, and demonstrated increasing odds of detection with increasing levels of sexual activity and/or numbers of lifetime sexual partners. Only G. vaginalis and A. vaginae were commonly detected in sexually-unexposed women. Megasphaera type I was independently associated with women-who-have-sex-with women (WSW) and lifetime sexual partner numbers, while unprotected penile-vaginal-sex was associated with BVAB2 detection by multivariate analysis. Conclusions: Four of eight key BV-COs were significantly associated with BV after adjusting for the presence of other BVCOs. The majority of BV-COs were absent or rare in sexually-unexposed women, and associated with increasing sexual exposure, suggesting potential sexual transmission of BV-COs.	[Fethers, Katherine; Fowkes, Freya J. I.; Hocking, Jane S.; Bradshaw, Catriona S.] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [Fethers, Katherine; Fairley, Christopher K.; Fehler, Glenda; Morton, Anna M.; Bradshaw, Catriona S.] Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Twin, Jimmy; Garland, Suzanne M.; Tabrizi, Sepehr N.] Royal Womens Hosp, Dept Mol Microbiol, Melbourne, Vic, Australia; [Twin, Jimmy; Garland, Suzanne M.; Tabrizi, Sepehr N.] Murdoch Childrens Res Inst, Dept Infect Dis & Microbiol, Melbourne, Vic, Australia; [Fowkes, Freya J. I.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Garland, Suzanne M.; Tabrizi, Sepehr N.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; Murdoch Children's Research Institute; Burnet Institute; University of Melbourne; Monash University	Fethers, K (corresponding author), Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia.	kfethers@mshc.org.au	Hocking, Jane/AAD-5203-2021	Hocking, Jane/0000-0001-9329-8501; Christopher, Fairley/0000-0001-9081-1664; Fowkes, Freya/0000-0001-5832-9464; bradshaw, catriona/0000-0002-6643-5678	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Dr. Fethers, Dr. Bradshaw, Dr. Fowkes, Dr. Garland and Dr. Hocking are currently or were supported by the Australian National Health and Medical Research Council Fellowship scheme for the period of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Berger BJ, 1995, CLIN INFECT DIS, V21, P1402, DOI 10.1093/clinids/21.6.1402; Bradshaw CS, 2006, J INFECT DIS, V194, P828, DOI 10.1086/506621; Bradshaw CS, 2005, OBSTET GYNECOL, V106, P105, DOI 10.1097/01.AOG.0000163247.78533.7b; Bukusi E, 2011, SEX TRANSM DIS, V38, P483, DOI 10.1097/OLQ.0b013e318214b82d; BUMP RC, 1988, AM J OBSTET GYNECOL, V158, P935, DOI 10.1016/0002-9378(88)90097-X; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; Ferris MJ, 2004, J CLIN MICROBIOL, V42, P5892, DOI [10.1128/JCM.42.12.5892-5894.2004, 10.1128/jcm.42.12.5892-5894.2004]; Fethers K, 2000, SEX TRANSM INFECT, V76, P345, DOI 10.1136/sti.76.5.345; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fethers KA, 2011, SEX TRANSM DIS, V38, P124, DOI 10.1097/OLQ.0b013e3181f0bc37; Fethers KA, 2009, J INFECT DIS, V200, P1662, DOI 10.1086/648092; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Goldenberg RL, 1997, CLIN PERINATOL, V24, P23, DOI 10.1016/S0095-5108(18)30182-9; GRAVETT MG, 1986, OBSTET GYNECOL, V67, P229, DOI 10.1097/00006250-198602000-00013; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Josey WE, 2008, INT J STD AIDS, V19, P152, DOI 10.1258/ijsa.2007.007260; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Lamont RF, 2000, INT J STD AIDS, V11, P495, DOI 10.1258/0956462001916371; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; Martin David H, 2008, Curr Infect Dis Rep, V10, P128, DOI 10.1007/s11908-008-0023-x; MEIS PJ, 1995, AM J OBSTET GYNECOL, V173, P1231, DOI 10.1016/0002-9378(95)91360-2; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; MENGEL MB, 1989, J FAM PRACTICE, V28, P163; Mitchell C, 2009, INFECT DIS OBSTET GY, V2009; Morris MC, 2001, SEX TRANSM INFECT, V77, P63, DOI 10.1136/sti.77.1.63; Nelson DB, 2003, J CLIN EPIDEMIOL, V56, P862, DOI 10.1016/S0895-4356(03)00073-8; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Papanikolaou EG, 2002, INFECTION, V30, P403, DOI 10.1007/s15010-002-2001-9; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schwebke JR, 1999, J INFECT DIS, V180, P1632, DOI 10.1086/315065; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; Skinner CJ, 1996, GENITOURIN MED, V72, P277; Smart S, 2004, SEX TRANSM INFECT, V80, P58, DOI 10.1136/sti.2003.004978; Srinivasan S., 2008, INTERDISCIP PERSPECT, V2008; Strauss Robert A, 2005, Infect Dis Obstet Gynecol, V13, P31; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; Tabrizi SN, 2004, SEX TRANSM INFECT, V80, P68, DOI 10.1136/sti.2003.006239; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; VEJTORP M, 1988, BRIT J OBSTET GYNAEC, V95, P920, DOI 10.1111/j.1471-0528.1988.tb06581.x; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; VUTYAVANICH T, 1993, OBSTET GYNECOL, V82, P550; Zariffard MR, 2002, FEMS IMMUNOL MED MIC, V34, P277, DOI 10.1111/j.1574-695X.2002.tb00634.x; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	53	54	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30633	10.1371/journal.pone.0030633	http://dx.doi.org/10.1371/journal.pone.0030633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363457	Green Published, gold			2022-12-25	WOS:000302853600044
J	Graewe, B; De Weerd, P; Farivar, R; Castelo-Branco, M				Graewe, Britta; De Weerd, Peter; Farivar, Reza; Castelo-Branco, Miguel			Stimulus Dependency of Object-Evoked Responses in Human Visual Cortex: An Inverse Problem for Category Specificity	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; FACE PERCEPTION; ELECTROMAGNETIC TOMOGRAPHY; UNFAMILIAR FACES; MOTION-ONSET; N170; RECOGNITION; BRAIN; ERPS; TEXTURE	Many studies have linked the processing of different object categories to specific event-related potentials (ERPs) such as the face-specific N170. Despite reports showing that object-related ERPs are influenced by visual stimulus features, there is consensus that these components primarily reflect categorical aspects of the stimuli. Here, we re-investigated this idea by systematically measuring the effects of visual feature manipulations on ERP responses elicited by both structure-from-motion (SFM)-defined and luminance-defined object stimuli. SFM objects elicited a novel component at 200-250 ms (N250) over parietal and posterior temporal sites. We found, however, that the N250 amplitude was unaffected by restructuring SFM stimuli into meaningless objects based on identical visual cues. This suggests that this N250 peak was not uniquely linked to categorical aspects of the objects, but is strongly determined by visual stimulus features. We provide strong support for this hypothesis by parametrically manipulating the depth range of both SFM- and luminance-defined object stimuli and showing that the N250 evoked by SFM stimuli as well as the well-known N170 to static faces were sensitive to this manipulation. Importantly, this effect could not be attributed to compromised object categorization in low depth stimuli, confirming a strong impact of visual stimulus features on object-related ERP signals. As ERP components linked with visual categorical object perception are likely determined by multiple stimulus features, this creates an interesting inverse problem when deriving specific perceptual processes from variations in ERP components.	[Graewe, Britta; De Weerd, Peter] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Graewe, Britta] Univ Coimbra, Inst Biomeed Res Light & Image, Visual Neurosci Lab, Coimbra, Portugal; [De Weerd, Peter] Radboud Univ Nijmegen, Donders Inst Brain Behav & Cognit, NL-6525 ED Nijmegen, Netherlands; [Farivar, Reza] Harvard Univ, Sch Med, Charlestown, MA USA; [Farivar, Reza] Massachusetts Gen Hosp, A Athinoula Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Castelo-Branco, Miguel] Univ Coimbra, IBILI, Visual Neurosci Lab, Coimbra, Portugal	Maastricht University; Universidade de Coimbra; Radboud University Nijmegen; Harvard University; Harvard University; Massachusetts General Hospital; Universidade de Coimbra	Graewe, B (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	britta.graewe@maastrichtuniversity.nl	Castelo-Branco, Miguel/F-3866-2019; Farivar, Reza/AAA-5762-2020; Castelo-Branco, Miguel/E-5689-2010	Castelo-Branco, Miguel/0000-0003-4364-6373; 	Foundation for Science and Technology Portugal [SFRH/BD/37385/2007, PTDC/SAU/NEU/68483/2006, PIC/IC/82986/2007]; Bial Foundation [94/06]; BIN (Brain Imaging Network of Portugal)	Foundation for Science and Technology Portugal(Portuguese Foundation for Science and Technology); Bial Foundation(Bial Foundation); BIN (Brain Imaging Network of Portugal)	This work was supported by a grant to BG, MC-B and PDW (SFRH/BD/37385/2007), Grants PTDC/SAU/NEU/68483/2006 and PIC/IC/82986/2007 from the Foundation for Science and Technology Portugal (http://www.fct.pt/) and the Bial Foundation 94/06 (http://www.bial.com/en/bial_foundation.11/grants.18/grants.a38.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support of the BIN (Brain Imaging Network of Portugal). We would like to thank Jose Rebola for his help with creating the luminance-defined stimuli and Valerie Goffaux for valuable comments during manuscript revision.	Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; BACH M, 1994, VISION RES, V34, P1541, DOI 10.1016/0042-6989(94)90111-2; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 2002, COGNITION, V86, pB1, DOI 10.1016/S0010-0277(02)00124-5; Caharel S, 2002, INT J NEUROSCI, V112, P1499, DOI 10.1080/00207450290158368; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 1999, NEUROREPORT, V10, P255, DOI 10.1097/00001756-199902050-00010; FARAH MJ, 1988, J EXP PSYCHOL GEN, V117, P248, DOI 10.1037/0096-3445.117.3.248; Farivar R, 2009, BRAIN RES REV, V61, P144, DOI 10.1016/j.brainresrev.2009.05.006; Farivar R, 2009, J NEUROSCI, V29, P5336, DOI 10.1523/JNEUROSCI.4978-08.2009; Fleuaris AV, 2008, BRAIN RES, V1194, P100, DOI 10.1016/j.brainres.2007.11.071; George N, 2005, COGNITIVE BRAIN RES, V24, P663, DOI 10.1016/j.cogbrainres.2005.03.017; Goffaux V, 2003, COGNITIVE BRAIN RES, V16, P416, DOI 10.1016/S0926-6410(03)00056-9; Haushofer J, 2008, J NEUROPHYSIOL, V100, P753, DOI 10.1152/jn.90310.2008; Herrmann MJ, 2005, J NEURAL TRANSM, V112, P1073, DOI 10.1007/s00702-004-0250-8; Hirai M, 2003, NEUROSCI LETT, V344, P41, DOI 10.1016/S0304-3940(03)00413-0; Hopf JM, 2002, J NEUROPHYSIOL, V88, P2088, DOI 10.1152/jn.2002.88.4.2088; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Itier RJ, 2004, NEUROREPORT, V15, P1261, DOI 10.1097/01.wnr.0000127827.73576.d8; Jacques C, 2007, NEUROIMAGE, V36, P863, DOI 10.1016/j.neuroimage.2007.04.016; Jeffreys DA, 1996, EXP BRAIN RES, V111, P100; Jemel B, 2003, COGNITIVE BRAIN RES, V17, P431, DOI 10.1016/S0926-6410(03)00145-9; Jiang Y, 2008, J COGNITIVE NEUROSCI, V20, P553, DOI 10.1162/jocn.2008.20050; Kayaert G, 2005, CEREB CORTEX, V15, P1308, DOI 10.1093/cercor/bhi014; Kriegeskorte N, 2003, J NEUROSCI, V23, P1451, DOI 10.1523/JNEUROSCI.23-04-01451.2003; KUBA M, 1992, DOC OPHTHALMOL, V80, P83, DOI 10.1007/BF00161234; Lamme VAF, 1999, CEREB CORTEX, V9, P406, DOI 10.1093/cercor/9.4.406; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Latinus M, 2006, BRAIN RES, V1123, P179, DOI 10.1016/j.brainres.2006.09.031; Liu CH, 2005, PERCEPT PSYCHOPHYS, V67, P158, DOI 10.3758/BF03195019; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Mueller Andreas, 2010, Nonlinear Biomed Phys, V4 Suppl 1, pS1, DOI 10.1186/1753-4631-4-S1-S1; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Paradis AL, 2000, CEREB CORTEX, V10, P772, DOI 10.1093/cercor/10.8.772; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pegna AJ, 2004, HUM BRAIN MAPP, V22, P300, DOI 10.1002/hbm.20039; Righart R, 2011, BRAIN TOPOGR, V24, P9, DOI 10.1007/s10548-010-0164-8; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B., 2011, OXFORD HDB ERP COMPO; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Rousselet GA, 2008, BMC NEUROSCI, V10, P114; Rousselet GA, 2008, J VISION, V8, DOI 10.1167/8.12.3; Schellart NAM, 2004, VISION RES, V44, P119, DOI 10.1016/j.visres.2003.09.016; Schlykowa SS, 1993, BRAIN RES COGN BRAIN, V1, P169; Schweinberger SR, 2004, NEUROREPORT, V15, P1501, DOI 10.1097/01.wnr.0000131675.00319.42; Sparacino G, 2002, COMPUT METH PROG BIO, V68, P233, DOI 10.1016/S0169-2607(01)00175-4; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Vizioli L, 2010, J VISION, V10, DOI 10.1167/10.1.15; Vlamings PH, 2009, J VIS, V14, P121; ZEKI S, 1991, J NEUROSCI, V11, P641; Zion-Golumbic E, 2007, CEREB CORTEX, V17, P1741, DOI 10.1093/cercor/bhl100	59	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30727	10.1371/journal.pone.0030727	http://dx.doi.org/10.1371/journal.pone.0030727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363479	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600062
J	Wang, QX; Liu, HT; Gao, AN; Yang, XM; Liu, WH; Li, XQ; Li, LH				Wang, Qiuxia; Liu, Huitao; Gao, Ainong; Yang, Xinming; Liu, Weihua; Li, Xiuquan; Li, Lihui			Intergenomic Rearrangements after Polyploidization of Kengyilia thoroldiana (Poaceae: Triticeae) Affected by Environmental Factors	PLOS ONE			English	Article							QINGHAI-XIZANG PLATEAU; MULTICOLOR GISH; THINOPYRUM-INTERMEDIUM; HYBRID SPECIATION; GENOME EVOLUTION; PLANT POLYPLOIDS; GENE-EXPRESSION; DNA-SEQUENCES; WHEAT; HYBRIDIZATION	Polyploidization is a major evolutionary process. Approximately 70-75% species of Triticeae (Poaceae) are polyploids, involving 23 genomes. To investigate intergenomic rearrangements after polyploidization of Triticeae species and to determine the effects of environmental factors on them, nine populations of a typical polyploid Triticeae species, Kengyilia thoroldiana (Keng) J.L. Yang et al. (2n = 6x = 42, StStPPYY), collected from different environments, were studied using genome in situ hybridization (GISH). We found that intergenomic rearrangements occurred between the relatively large P genome and the small genomes, St (8.15%) and Y (22.22%), in polyploid species via various types of translocations compared to their diploid progenitors. However, no translocation was found between the relatively small St and Y chromosomes. Environmental factors may affect rearrangements among the three genomes. Chromosome translocations were significantly more frequent in populations from cold alpine and grassland environments than in populations from valley and lake-basin habitats (P<0.05). The relationship between types of chromosome translocations and altitude was significant (r=0.809, P<0.01). Intergenomic rearrangements associated with environmental factors and genetic differentiation of a single basic genome should be considered as equally important genetic processes during species' ecotype evolution.	[Wang, Qiuxia; Gao, Ainong; Yang, Xinming; Liu, Weihua; Li, Xiuquan; Li, Lihui] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Liu, Huitao] Chinese Acad Agr Sci, Inst Special Wild Anim & Plant Sci, State Key Lab Special Econ Anim Mol Biol, Jilin, Jilin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Institute of Special Animal & Plant Sciences, CAAS	Wang, QX (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	gaoainong@caas.net.cn; lilihui@caas.net.cn			National Natural Science Foundation of China [30871520]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support provided by the National Natural Science Foundation of China (project numbers 30871520) is gratefully appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bento M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001402; Bing C.L., 2001, J SYST EVOL, V39, P248; Brysting AK, 2000, ANN BOT-LONDON, V85, P439, DOI 10.1006/anbo.1999.1088; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Chen ZJ, 2004, BIOL J LINN SOC, V82, P689, DOI 10.1111/j.1095-8312.2004.00351.x; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Crombach A, 2007, MOL BIOL EVOL, V24, P1130, DOI 10.1093/molbev/msm033; DEVOS KM, 1993, THEOR APPL GENET, V85, P784, DOI 10.1007/BF00225020; DEWEY D R, 1984, P209; Dong YS, 2001, THEOR APPL GENET, V103, P98, DOI 10.1007/s001220000522; DONG YS, 1998, CHIN CROPS, V1, P18; Ehrendorfer F, POLYPLOIDY DISTRIBUT, P45; Feldman M, 1997, GENETICS, V147, P1381; Feldman M., 2001, ORIGIN CULTIVATED WH, P1; Gaeta RT, 2010, NEW PHYTOL, V186, P18, DOI 10.1111/j.1469-8137.2009.03089.x; Gale MD, 1998, SCIENCE, V282, P656, DOI 10.1126/science.282.5389.656; GAO YX, 1981, B AM METEOROL SOC, V62, P31, DOI 10.1175/1520-0477(1981)062<0031:SAORRO>2.0.CO;2; Gill B, 1991, NUCL ORGANELLAR GENO, P48; Grant V, ORIGIN ADAPTATIONS; GRANT V, PLANT SPECIATION; GRUN P, 1952, AM J BOT, V39, P318, DOI 10.2307/2438260; Han FP, 2004, THEOR APPL GENET, V109, P1070, DOI 10.1007/s00122-004-1720-y; Han FP, 2003, GENOME, V46, P490, DOI [10.1139/g03-032, 10.1139/G03-032]; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Hegarty MJ, 2005, NEW PHYTOL, V165, P411, DOI 10.1111/j.1469-8137.2004.01253.x; JENSEN KB, 1994, J NEMATOL, V26, P635; Lagercrantz U, 1996, GENETICS, V144, P1903; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Leitch IJ, 1997, TRENDS PLANT SCI, V2, P470, DOI 10.1016/S1360-1385(97)01154-0; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Lu B, 1995, CHINESE BIODIVERSITY, V2, P63; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Mu J, 2000, CHINESE SCI BULL, V45, P293; Naranjo T, 2004, ENCY PLANT CROP SCI, V1, P270; NEDERLOF PM, 1990, CYTOMETRY, V11, P126, DOI 10.1002/cyto.990110115; Nevo E, 1998, GENET RESOUR CROP EV, V45, P151, DOI 10.1023/A:1008616923427; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Piao SL, 2006, CLIMATIC CHANGE, V74, P253, DOI 10.1007/s10584-005-6339-8; SANKOFF D, 1999, COMP MAPPING GENOME, P124; Sepsi A, 2008, THEOR APPL GENET, V116, P825, DOI 10.1007/s00122-008-0716-4; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; SOLTIS DE, 1993, CRIT REV PLANT SCI, V12, P243, DOI 10.1080/713608048; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; Stebbins G, VARIATION EVOLUTION; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Ungerer MC, 1998, P NATL ACAD SCI USA, V95, P11757, DOI 10.1073/pnas.95.20.11757; Wang QX, 2010, GENOME, V53, P241, DOI [10.1139/G09-098, 10.1139/g09-098]; WANG RRC, 1986, CROP SCI, V26, P723, DOI 10.2135/cropsci1986.0011183X002600040018x; Weidema IR, 2000, HEREDITY, V84, P311, DOI 10.1046/j.1365-2540.2000.00669.x; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Wu J, 2006, THEOR APPL GENET, V114, P13, DOI 10.1007/s00122-006-0405-0; Yen C, 2006, SYSTEMATICS TRITICEA, V3, P1	55	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31033	10.1371/journal.pone.0031033	http://dx.doi.org/10.1371/journal.pone.0031033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363542	gold, Green Submitted, Green Published			2022-12-25	WOS:000302853600102
J	Zhou, CC; Chang, J; Mi, TJ; Abbasi, S; Gu, DM; Huang, L; Zhang, WZ; Kellems, RE; Schwartz, RJ; Xia, Y				Zhou, Cissy Chenyi; Chang, Jiang; Mi, Tiejuan; Abbasi, Shahrzad; Gu, Dongmin; Huang, Le; Zhang, WenZheng; Kellems, Rodney E.; Schwartz, Robert J.; Xia, Yang			Targeted Expression of Cre Recombinase Provokes Placental-Specific DNA Recombination in Transgenic Mice	PLOS ONE			English	Article							ADENOSINE-DEAMINASE; HLA-G; REGULATORY REGION; MOUSE MUTANTS; GENE-TRANSFER; IN-VIVO; TRANSCRIPTION; PREECLAMPSIA; CELLS; STRATEGY	Background: Inadequate placental development is associated with a high incidence of early embryonic lethality and serious pregnancy disorders in both humans and mice. However, the lack of well-defined trophoblast-specific gene regulatory elements has hampered investigations regarding the role of specific genes in placental development and fetal growth. Principal Findings: By random assembly of placental enhancers from two previously characterized genes, trophoblast specific protein a (Tpbpa) and adenosine deaminase (Ada), we identified a chimeric Tpbpa/Ada enhancer that when combined with the basal Ada promoter provided the highest luciferase activity in cultured human trophoblast cells, in comparison with non-trophoblast cell lines. We used this chimeric enhancer arrangement to drive the expression of a Cre recombinase transgene in the placentas of transgenic mice. Cre transgene expression occurred throughout the placenta but not in maternal organs examined or in the fetus. Significance: In conclusion, we have provided both in vitro and in vivo evidence for a novel genetic system to achieve placental transgene expression by the use of a chimeric Tpbpa/Ada enhancer driven transgene. The availability of this expression vector provides transgenic opportunities to direct the production of desired proteins to the placenta.	[Zhou, Cissy Chenyi; Mi, Tiejuan; Abbasi, Shahrzad; Gu, Dongmin; Kellems, Rodney E.; Xia, Yang] Texas A&M Hlth Sci Ctr, Dept Biochem, Houston, TX USA; [Chang, Jiang; Schwartz, Robert J.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Huang, Le; Zhang, WenZheng] Univ Texas Houston, Sch Med, Dept Internal Med, Houston, TX USA; [Zhou, Cissy Chenyi; Mi, Tiejuan; Abbasi, Shahrzad; Gu, Dongmin; Kellems, Rodney E.; Xia, Yang] Texas A&M Hlth Sci Ctr, Dept Mol Biol, Houston, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Zhou, CC (corresponding author), Texas A&M Hlth Sci Ctr, Dept Biochem, Houston, TX USA.	yang.xia@uth.tmc.edu	Gu, Dongmin/C-9048-2013	Chang, Jiang/0000-0003-3707-7557	National Institute of Health [HL076558, HL102314, HL094844]; American Heart Association [3760081-AHA-GA, 0855030F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094844, K02HL098956, R01HL076558, R01HL102314] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health Grants HL076558 (Y.X.), HL102314 (J.C.) HL094844 (J.C.) and in part by American Heart Association Grant-in-Aid 3760081-AHA-GA (Y.X.) and 0855030F (J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; BLACKBURN MR, 1995, J BIOL CHEM, V270, P23891, DOI 10.1074/jbc.270.41.23891; Blackburn MR, 1998, J BIOL CHEM, V273, P5093, DOI 10.1074/jbc.273.9.5093; CALZONETTI T, 1995, DEV BIOL, V171, P615, DOI 10.1006/dbio.1995.1309; Cross JC, 2006, REPROD FERT DEVELOP, V18, P71, DOI 10.1071/RD05121; Deussing J, 2002, GENOMICS, V79, P225, DOI 10.1006/geno.2002.6696; Georgiades P, 2007, BIOTECHNIQUES, V42, P317, DOI 10.2144/000112341; HORUZSKO A, 1994, IMMUNOLOGY, V83, P324; INGOLIA DE, 1985, J BIOL CHEM, V260, P3261; Irani RA, 2009, J EXP MED, V206, P2809, DOI 10.1084/jem.20090872; Joshi MU, 2008, BIOTECHNIQUES, V45, P247, DOI 10.2144/000112913; KNUDSEN TB, 1991, BIOL REPROD, V44, P171, DOI 10.1095/biolreprod44.1.171; Krebs C, 1996, AM J OBSTET GYNECOL, V175, P1534, DOI 10.1016/S0002-9378(96)70103-5; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Rossant J, 1999, GENE DEV, V13, P142, DOI 10.1101/gad.13.2.142; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; SCHMIDT CM, 1993, J IMMUNOL, V151, P2633; SCHMIDT CM, 1995, IMMUNOL REV, V147, P53, DOI 10.1111/j.1600-065X.1995.tb00087.x; Senut MC, 1998, J CLIN INVEST, V101, P1565, DOI 10.1172/JCI1959; Shi DQ, 1997, J BIOL CHEM, V272, P2334, DOI 10.1074/jbc.272.4.2334; Thomson JG, 2003, GENESIS, V36, P162, DOI 10.1002/gene.10211; Xing AY, 2000, HUM GENE THER, V11, P167, DOI 10.1089/10430340050016247; YELAVARTHI KK, 1993, J IMMUNOL, V151, P3638; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856; Zhou CCY, 2008, HYPERTENSION, V51, P1010, DOI 10.1161/HYPERTENSIONAHA.107.097790; Zhou CC, 2007, CIRC RES, V100, P88, DOI 10.1161/01.RES.0000254703.11154.18; ZHOU Y, 1993, J CLIN INVEST, V91, P950, DOI 10.1172/JCI116316	28	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e29236	10.1371/journal.pone.0029236	http://dx.doi.org/10.1371/journal.pone.0029236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363401	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600005
J	Casadevall, A; Nakouzi, A; Crippa, PR; Eisner, M				Casadevall, Arturo; Nakouzi, Antonio; Crippa, Pier R.; Eisner, Melvin			Fungal Melanins Differ in Planar Stacking Distances	PLOS ONE			English	Article							X-RAY CHARACTERIZATION	Melanins are notoriously difficult to study because they are amorphous, insoluble and often associated with other biological materials. Consequently, there is a dearth of structural techniques to study this enigmatic pigment. Current models of melanin structure envision the stacking of planar structures. X ray diffraction has historically been used to deduce stacking parameters. In this study we used X ray diffraction to analyze melanins derived from Cryptococcus neoformans, Aspergillus niger, Wangiella dermatitides and Coprinus comatus. Analysis of melanin in melanized C. neoformans encapsulated cells was precluded by the fortuitous finding that the capsular polysaccharide had a diffraction spectrum that was similar to that of isolated melanin. The capsular polysaccharide spectrum was dominated by a broad non-Bragg feature consistent with origin from a repeating structural motif that may arise from inter-molecular interactions and/or possibly gel organization. Hence, we isolated melanin from each fungal species and compared diffraction parameters. The results show that the inferred stacking distances of fungal melanins differ from that reported for synthetic melanin and neuromelanin, occupying intermediate position between these other melanins. These results suggest that all melanins have a fundamental diffracting unit composed of planar graphitic assemblies that can differ in stacking distance. The stacking peak appears to be a distinguishing universal feature of melanins that may be of use in characterizing these enigmatic pigments.	[Casadevall, Arturo; Nakouzi, Antonio] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Casadevall, Arturo; Nakouzi, Antonio] Albert Einstein Coll Med, Div Infect Dis, Bronx, NY 10467 USA; [Crippa, Pier R.] Univ Parma, Dept Environm Sci, I-43100 Parma, Italy; [Eisner, Melvin] Univ Houston, Dept Phys, Houston, TX USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Parma; University of Houston System; University of Houston	Casadevall, A (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	arturo.casadevall@einstein.yu.edu			United States National Institutes of Health; PHS [AI052733, AI03314, HL059842, AI033774]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052733, R01AI033774] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was received from the United States National Institutes of Health. AC is supported by PHS grants numbers AI052733, AI03314, HL059842, AI033774. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; CHENG J, 1994, PIGM CELL RES, V7, P255, DOI 10.1111/j.1600-0749.1994.tb00060.x; CHENG J, 1994, PIGM CELL RES, V7, P263, DOI 10.1111/j.1600-0749.1994.tb00061.x; Dadachova E, 2008, PIGM CELL MELANOMA R, V21, P192, DOI 10.1111/j.1755-148X.2007.00430.x; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Frases S, 2008, EUKARYOT CELL, V7, P319, DOI 10.1128/EC.00378-07; Jacobson ES, 2000, CLIN MICROBIOL REV, V13, P708, DOI 10.1128/CMR.13.4.708-717.2000; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; McFadden DC, 2006, J BIOL CHEM, V281, P1868, DOI 10.1074/jbc.M509465200; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Tian SY, 2003, BIOCHEMISTRY-US, V42, P8105, DOI 10.1021/bi0341859; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; Wheeler M H, 1988, Curr Top Med Mycol, V2, P338; ZAJAC GW, 1994, BBA-GEN SUBJECTS, V1199, P271, DOI 10.1016/0304-4165(94)90006-X; Zecca L, 2008, P NATL ACAD SCI USA, V105, P17567, DOI 10.1073/pnas.0808768105; Zhong JY, 2008, BIOCHEMISTRY-US, V47, P4701, DOI 10.1021/bi702093r	17	19	21	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30299	10.1371/journal.pone.0030299	http://dx.doi.org/10.1371/journal.pone.0030299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359541	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200010
J	Dudkiewicz, M; Szczepinska, T; Grynberg, M; Pawlowski, K				Dudkiewicz, Malgorzata; Szczepinska, Teresa; Grynberg, Marcin; Pawlowski, Krzysztof			A Novel Protein Kinase-Like Domain in a Selenoprotein, Widespread in the Tree of Life	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; ABC-TRANSPORTER; SUBCELLULAR-LOCALIZATION; STRUCTURE CLASSIFICATION; COMPARATIVE GENOMICS; ASSEMBLY PROTEINS; CRYSTAL-STRUCTURE	Selenoproteins serve important functions in many organisms, usually providing essential oxidoreductase enzymatic activity, often for defense against toxic xenobiotic substances. Most eukaryotic genomes possess a small number of these proteins, usually not more than 20. Selenoproteins belong to various structural classes, often related to oxidoreductase function, yet a few of them are completely uncharacterised. Here, the structural and functional prediction for the uncharacterised selenoprotein O (SELO) is presented. Using bioinformatics tools, we predict that SELO protein adopts a three-dimensional fold similar to protein kinases. Furthermore, we argue that despite the lack of conservation of the "classic" catalytic aspartate residue of the archetypical His-Arg-Asp motif, SELO kinases might have retained catalytic phosphotransferase activity, albeit with an atypical active site. Lastly, the role of the selenocysteine residue is considered and the possibility of an oxidoreductase-regulated kinase function for SELO is discussed. The novel kinase prediction is discussed in the context of functional data on SELO orthologues in model organisms, FMP40 a.k.a.YPL222W (yeast), and ydiU (bacteria). Expression data from bacteria and yeast suggest a role in oxidative stress response. Analysis of genomic neighbourhoods of SELO homologues in the three domains of life points toward a role in regulation of ABC transport, in oxidative stress response, or in basic metabolism regulation. Among bacteria possessing SELO homologues, there is a significant over-representation of aquatic organisms, also of aerobic ones. The selenocysteine residue in SELO proteins occurs only in few members of this protein family, including proteins from Metazoa, and few small eukaryotes (Ostreococcus, stramenopiles). It is also demonstrated that enterobacterial mchC proteins involved in maturation of bactericidal antibiotics, microcins, form a distant subfamily of the SELO proteins. The new protein structural domain, with a putative kinase function assigned, expands the known kinome and deserves experimental determination of its biological role within the cell-signaling network.	[Szczepinska, Teresa; Pawlowski, Krzysztof] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland; [Grynberg, Marcin] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Dudkiewicz, Malgorzata; Pawlowski, Krzysztof] Warsaw Univ Life Sci, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Warsaw University of Life Sciences	Dudkiewicz, M (corresponding author), Warsaw Univ Life Sci, Warsaw, Poland.	k.pawlowski@nencki.gov.pl	Pawłowski, Krzysztof/C-2949-2013; Pawlowski, Krzysztof/E-3262-2012; Dudkiewicz, Małgorzata/AAG-4553-2020	Pawłowski, Krzysztof/0000-0002-5367-0935; Dudkiewicz, Malgorzata/0000-0003-4432-2530; Grynberg, Marcin/0000-0003-1887-7209	Polish Ministry of Science and Higher Education [N N301 3165 33]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	MD, KP, TS and MG were supported by the Polish Ministry of Science and Higher Education grant N N301 3165 33. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2011, INFECT IMMUN, V79, P1728, DOI 10.1128/IAI.01194-10; Andreeva A, 2010, ACTA CRYSTALLOGR F, V66, P1190, DOI 10.1107/S1744309110007177; Arciuch VGA, 2009, ADV DRUG DELIVER REV, V61, P1234, DOI 10.1016/j.addr.2009.04.025; Arenas FA, 2010, PLOS ONE, V6; Arenas FA, 2010, BIOCHEM BIOPH RES CO, V398, P690, DOI 10.1016/j.bbrc.2010.07.002; ARMSTRONG RN, 1979, BIOCHEMISTRY-US, V18, P1230, DOI 10.1021/bi00574a018; Arner ESJ, 2010, EXP CELL RES, V316, P1296, DOI 10.1016/j.yexcr.2010.02.032; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Azpiroz MF, 2009, MICROB PATHOGENESIS, V47, P274, DOI 10.1016/j.micpath.2009.09.003; Azpiroz MF, 2001, ANTIMICROB AGENTS CH, V45, P969, DOI 10.1128/AAC.45.3.969-972.2001; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; BENNER SA, 1991, ADV ENZYME REGUL, V31, P121, DOI 10.1016/0065-2571(91)90012-B; Bhattacharjee A, 2009, BIOCHEM BIOPH RES CO, V388, P612, DOI 10.1016/j.bbrc.2009.08.077; Bodenmiller B, 2010, METHOD ENZYMOL, V470, P317, DOI 10.1016/S0076-6879(10)70013-6; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; BOSSEMEYER D, 1993, NATURE, V363, P590, DOI 10.1038/363590a0; BRAMSON HN, 1984, CRC CR REV BIOCH MOL, V15, P93, DOI 10.3109/10409238409102298; Brooijmans N, 2010, PROTEIN SCI, V19, P763, DOI 10.1002/pro.355; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cheek S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-6; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Chen R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-548; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; COKER KJ, 1994, P NATL ACAD SCI USA, V91, P6967, DOI 10.1073/pnas.91.15.6967; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Costa SCP, 2010, MICROBES INFECT, V12, P182, DOI 10.1016/j.micinf.2009.12.003; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Ambrosio K, 2009, PROTEINS, V76, P995, DOI 10.1002/prot.22408; Neto JFD, 2009, NUCLEIC ACIDS RES, V37, P4812, DOI 10.1093/nar/gkp509; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; DeJongh M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-139; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DEVEAUX LC, 1986, J BACTERIOL, V167, P920, DOI 10.1128/jb.167.3.920-927.1986; Djordjevic S, 2002, TRENDS BIOCHEM SCI, V27, P426, DOI 10.1016/S0968-0004(02)02136-9; Du SQ, 2010, ARCH BIOCHEM BIOPHYS, V502, P137, DOI 10.1016/j.abb.2010.08.001; Du SQ, 2010, BBA-GEN SUBJECTS, V1800, P511, DOI 10.1016/j.bbagen.2010.01.005; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Eglen R, 2011, PHARM THER; Eglen RM, 2009, ASSAY DRUG DEV TECHN, V7, P22, DOI 10.1089/adt.2008.164; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Finn R. D., 2009, NUCL ACIDS RES; Fomenko DE, 2003, BIOCHEMISTRY-US, V42, P11214, DOI 10.1021/bi034459s; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Galperin MY, 2010, TRENDS BIOTECHNOL, V28, P398, DOI 10.1016/j.tibtech.2010.05.006; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gershburg E, 2008, BBA-PROTEINS PROTEOM, V1784, P203, DOI 10.1016/j.bbapap.2007.08.009; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Goonesekere NCW, 2010, COMPUT BIOL CHEM, V34, P210, DOI 10.1016/j.compbiolchem.2010.04.001; GRANOT J, 1979, FEBS LETT, V103, P265, DOI 10.1016/0014-5793(79)81342-3; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Ishii A, 2005, EXTREMOPHILES, V9, P65, DOI 10.1007/s00792-004-0414-3; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jaroszewski L, 2000, PROTEIN SCI, V9, P1487, DOI 10.1110/ps.9.8.1487; Jaroszewski L, 2009, METHODS MOL BIOL, V569, P129, DOI 10.1007/978-1-59745-524-4_7; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kannan N, 2008, CELL, V133, P204, DOI 10.1016/j.cell.2008.04.005; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929; Kim MJ, 2011, MOL MICROBIOL, V79, P1194, DOI 10.1111/j.1365-2958.2010.07500.x; Klemm P, 2007, INFECT IMMUN, V75, P3688, DOI 10.1128/IAI.01730-06; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kornev AP, 2009, STRUCTURE, V17, P5, DOI 10.1016/j.str.2008.12.005; Krupa A, 2002, PROTEIN SCI, V11, P1580, DOI 10.1110/ps.3560102; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee BC, 2009, BBA-GEN SUBJECTS, V1790, P1471, DOI 10.1016/j.bbagen.2009.04.014; Lee KC, 2008, J BACTERIOL, V190, P8244, DOI 10.1128/JB.01161-08; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li WZ, 2000, BIOINFORMATICS, V16, P1105, DOI 10.1093/bioinformatics/16.12.1105; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; LORD JM, 1972, BIOCHIM BIOPHYS ACTA, V267, P227, DOI 10.1016/0005-2728(72)90111-9; Luo CW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-552; Maddison D. R., 2007, TREE LIFE WEB PROJEC; Manning BD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263pe15; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Martin DMA, 2009, NUCLEIC ACIDS RES, V37, pD244, DOI 10.1093/nar/gkn834; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Nesbit AD, 2009, J MOL BIOL, V387, P28, DOI 10.1016/j.jmb.2009.01.055; Niedner RH, 2006, PROTEINS, V63, P78, DOI 10.1002/prot.20825; Nolan EM, 2008, BIOCHEMISTRY-US, V47, P9289, DOI 10.1021/bi800826j; Novoselov SV, 2007, J BIOL CHEM, V282, P11960, DOI 10.1074/jbc.M701605200; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Partridge JD, 2006, J BIOL CHEM, V281, P27806, DOI 10.1074/jbc.M603450200; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Pawlowski K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-590; Pawlowski Krzysztof, 2008, Briefings in Functional Genomics & Proteomics, V7, P283, DOI 10.1093/bfgp/eln033; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Pei J, 2007, BIOINFORMATICS; Persson OP, 2009, ENVIRON MICROBIOL, V11, P1348, DOI 10.1111/j.1462-2920.2008.01861.x; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Poey ME, 2006, ANTIMICROB AGENTS CH, V50, P1411, DOI 10.1128/AAC.50.4.1411-1418.2006; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Rock C, 2010, PROSTAG LEUKOTR ESS, V83, P203, DOI 10.1016/j.plefa.2010.08.006; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santiago APSA, 2008, BIOCHIMIE, V90, P1566, DOI 10.1016/j.biochi.2008.06.013; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Schmidl SR, 2010, MOL CELL PROTEOMICS, V9, P1228, DOI 10.1074/mcp.M900267-MCP200; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Singh J, 2005, APPL ENVIRON MICROB, V71, P8752, DOI 10.1128/AEM.71.12.8752-8763.2005; Smajs D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-288; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Steinbacher S, 1999, EMBO J, V18, P2923, DOI 10.1093/emboj/18.11.2923; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tai SL, 2005, J BIOL CHEM, V280, P437, DOI 10.1074/jbc.M410573200; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Trent MS, 1999, BIOCHEMISTRY-US, V38, P3433, DOI 10.1021/bi982491u; TROWER MK, 1990, NUCLEIC ACIDS RES, V18, P4615, DOI 10.1093/nar/18.15.4615; Vassiliadis G, 2010, ANTIMICROB AGENTS CH, V54, P288, DOI 10.1128/AAC.00744-09; Vejborg RM, 2010, MOL GENET GENOMICS, V283, P469, DOI 10.1007/s00438-010-0532-9; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vieira-Silva S, 2008, MOL BIOL EVOL, V25, P1931, DOI 10.1093/molbev/msn142; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Ward JJ, 2003, BIOINFORMATICS, V19, P1650, DOI 10.1093/bioinformatics/btg223; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; YOON MY, 1987, BIOCHEMISTRY-US, V26, P4118, DOI 10.1021/bi00387a056; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005	154	44	46	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32138	10.1371/journal.pone.0032138	http://dx.doi.org/10.1371/journal.pone.0032138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359664	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200133
J	Hothorn, T; Brandl, R; Muller, J				Hothorn, Torsten; Brandl, Roland; Mueller, Joerg			Large-Scale Model-Based Assessment of Deer-Vehicle Collision Risk	PLOS ONE			English	Article							ROE-DEER; CAPREOLUS-CAPREOLUS; POPULATION-DENSITY; BODY-MASS; FORESTS; REGENERATION; PENNSYLVANIA; HERBIVORES; REDUCTION; EUROPE	Ungulates, in particular the Central European roe deer Capreolus capreolus and the North American white-tailed deer Odocoileus virginianus, are economically and ecologically important. The two species are risk factors for deer-vehicle collisions and as browsers of palatable trees have implications for forest regeneration. However, no large-scale management systems for ungulates have been implemented, mainly because of the high efforts and costs associated with attempts to estimate population sizes of free-living ungulates living in a complex landscape. Attempts to directly estimate population sizes of deer are problematic owing to poor data quality and lack of spatial representation on larger scales. We used data on >74,000 deer-vehicle collisions observed in 2006 and 2009 in Bavaria, Germany, to model the local risk of deer-vehicle collisions and to investigate the relationship between deer-vehicle collisions and both environmental conditions and browsing intensities. An innovative modelling approach for the number of deer-vehicle collisions, which allows nonlinear environment-deer relationships and assessment of spatial heterogeneity, was the basis for estimating the local risk of collisions for specific road types on the scale of Bavarian municipalities. Based on this risk model, we propose a new "deer-vehicle collision index" for deer management. We show that the risk of deer-vehicle collisions is positively correlated to browsing intensity and to harvest numbers. Overall, our results demonstrate that the number of deer-vehicle collisions can be predicted with high precision on the scale of municipalities. In the densely populated and intensively used landscapes of Central Europe and North America, a model-based risk assessment for deer-vehicle collisions provides a cost-efficient instrument for deer management on the landscape scale. The measures derived from our model provide valuable information for planning road protection and defining hunting quota. Open-source software implementing the model can be used to transfer our modelling approach to wildlife-vehicle collisions elsewhere.	[Hothorn, Torsten] Univ Munich, Inst Stat, Munich, Germany; [Brandl, Roland] Univ Marburg, Fachbereich Biol, D-3550 Marburg, Germany; [Mueller, Joerg] Natl Pk Verwaltung Bayer Wald, Grafenau, Germany; [Mueller, Joerg] Tech Univ Munich, Lehrstuhl Terr Okol, Munich, Germany	University of Munich; Philipps University Marburg; Technical University of Munich	Hothorn, T (corresponding author), Univ Munich, Inst Stat, Munich, Germany.	Torsten.Hothorn@stat.uni-muenchen.de		Muller, Jorg/0000-0002-1409-1586				Baiser B, 2008, BIOL INVASIONS, V10, P785, DOI 10.1007/s10530-008-9247-9; BASHORE TL, 1985, J WILDLIFE MANAGE, V49, P769, DOI 10.2307/3801709; BELLIS ED, 1971, J WILDLIFE MANAGE, V35, P232, DOI 10.2307/3799596; Boulesteix AL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-78; Bruinderink GWTAG, 1996, CONSERV BIOL, V10, P1059, DOI 10.1046/j.1523-1739.1996.10041059.x; Buhlmann P, 2007, STAT SCI, V22, P477, DOI 10.1214/07-STS242; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Collier BA, 2007, J WILDLIFE MANAGE, V71, P277, DOI 10.2193/2005-728; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; *DTSCH JAGDSCH, 2010, DJV HDB JAGD; Ellenberg H, 1978, SPIXIANA S, V2, P5; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Farrell MC, 2007, J WILDLIFE MANAGE, V71, P2727, DOI 10.2193/2006-085; Forstliches Gutachten, 2009, FORSTL GUT SIT WALDV; Gill RMA, 2010, FORESTRY, V83, P53, DOI 10.1093/forestry/cpp031; GILL RMA, 1992, FORESTRY, V65, P145, DOI 10.1093/forestry/65.2.145; Gill RMA, 1997, J APPL ECOL, V34, P1273, DOI 10.2307/2405237; Gkritza K, 2010, ACCIDENT ANAL PREV, V42, P1916, DOI 10.1016/j.aap.2010.05.013; Hewison AJM, 2009, ECOGRAPHY, V32, P1062, DOI 10.1111/j.1600-0587.2009.05888.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hofner B, 2011, J COMPUT GRAPH STAT, V20, P956, DOI 10.1198/jcgs.2011.09220; Hofner B, 2011, ECOLOGY, V92, P1895, DOI 10.1890/10-2276.1; Hothorn T, 2011, ECOL MONOGR, V81, P329, DOI 10.1890/10-0602.1; Hothorn T, 2010, FOREST ECOL MANAG, V260, P1416, DOI 10.1016/j.foreco.2010.07.019; Hothorn T, 2010, J MACH LEARN RES, V11, P2109; Iverson AL, 1999, OHIO J SCI, V99, P84; JAHN LAURENCE R., 1959, JOUR WILDLIFE MANAGEMENT, V23, P187, DOI 10.2307/3797639; Jenkins KJ, 2008, J APPL ECOL, V45, P1339, DOI 10.1111/j.1365-2664.2008.01512.x; Joyce TL, 2001, WILDLIFE SOC B, V29, P281; KENNEL E, 1988, ALLGEMEINE FORSTZEIT, V43, P21; Kuiters AT, 2002, BIOL CONSERV, V105, P65, DOI 10.1016/S0006-3207(01)00204-X; Latham J, 1997, J ZOOL, V242, P681, DOI 10.1111/j.1469-7998.1997.tb05820.x; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; Millington JDA, 2010, FOREST ECOL MANAG, V259, P1102, DOI 10.1016/j.foreco.2009.12.020; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; Mysterud A, 2008, PHILOS T R SOC B, V363, P2359, DOI 10.1098/rstb.2007.2206; Pettorelli N, 2006, OIKOS, V112, P565, DOI 10.1111/j.0030-1299.2006.14447.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reimoser S, 2009, ECOL MODEL, V220, P2231, DOI 10.1016/j.ecolmodel.2009.05.022; Rooney TP, 2002, FOREST ECOL MANAG, V163, P119, DOI 10.1016/S0378-1127(01)00532-1; Russell FL, 2001, AM MIDL NAT, V146, P1, DOI 10.1674/0003-0031(2001)146[0001:EOWTDO]2.0.CO;2; Schwabe KA, 2002, J AGR RESOUR ECON, V27, P261; Seiler A, 2005, J APPL ECOL, V42, P371, DOI 10.1111/j.1365-2664.2005.01013.x; Seiler A, 2004, WILDLIFE BIOL, V10, P301, DOI 10.2981/wlb.2004.036; Senn J, 2003, FOREST ECOL MANAG, V181, P151, DOI 10.1016/S0378-1127(03)00129-4; Stewart AJA, 2001, FORESTRY, V74, P259, DOI 10.1093/forestry/74.3.259; Toigo C, 2006, ECOGRAPHY, V29, P301, DOI 10.1111/j.2006.0906-7590.04394.x; Tremblay JP, 2007, J APPL ECOL, V44, P552, DOI 10.1111/j.1365-2664.2007.01290.x	50	43	43	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e29510	10.1371/journal.pone.0029510	http://dx.doi.org/10.1371/journal.pone.0029510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359535	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200004
J	Kanehira, M; Kikuchi, T; Ohkouchi, S; Shibahara, T; Tode, N; Santoso, A; Daito, H; Ohta, H; Tamada, T; Nukiwa, T				Kanehira, Masahiko; Kikuchi, Toshiaki; Ohkouchi, Shinya; Shibahara, Taizou; Tode, Naoki; Santoso, Arif; Daito, Hisayoshi; Ohta, Hiromitsu; Tamada, Tsutomu; Nukiwa, Toshihiro			Targeting Lysophosphatidic Acid Signaling Retards Culture-Associated Senescence of Human Marrow Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-VITRO; STEM/PROGENITOR CELLS; SELF-RENEWAL; RECEPTORS; LPA; DIFFERENTIATION; TELOMERASE; MECHANISMS; THERAPIES	Marrow stromal cells (MSCs) isolated from mesenchymal tissues can propagate in vitro to some extent and differentiate into various tissue lineages to be used for cell-based therapies. Cellular senescence, which occurs readily in continual MSC culture, leads to loss of these characteristic properties, representing one of the major limitations to achieving the potential of MSCs. In this study, we investigated the effect of lysophosphatidic acid (LPA), a ubiquitous metabolite in membrane phospholipid synthesis, on the senescence program of human MSCs. We show that MSCs preferentially express the LPA receptor subtype 1, and an abrogation of the receptor engagement with the antagonistic compound Ki16425 attenuates senescence induction in continually propagated human MSCs. This anti-aging effect of Ki16425 results in extended rounds of cellular proliferation, increased clonogenic potential, and retained plasticity for osteogenic and adipogenic differentiation. Expressions of p16(Ink4a), Rb, p53, and p21(Cip1), which have been associated with cellular senescence, were all reduced in human MSCs by the pharmacological inhibition of LPA signaling. Disruption of this signaling pathway was accompanied by morphological changes such as cell thinning and elongation as well as actin filament deformation through decreased phosphorylation of focal adhesion kinase. Prevention of LPA receptor engagement also promoted ubiquitination-mediated c-Myc elimination in MSCs, and consequently the entry into a quiescent state, G(0) phase, of the cell cycle. Collectively, these results highlight the potential of pharmacological intervention against LPA signaling for blunting senescence-associated loss of function characteristic of human MSCs.	[Kanehira, Masahiko; Shibahara, Taizou; Tode, Naoki; Santoso, Arif; Daito, Hisayoshi; Nukiwa, Toshihiro] Tohoku Univ, Dept Resp Med, Grad Sch Med, Sendai, Miyagi 980, Japan; [Kikuchi, Toshiaki; Ohkouchi, Shinya; Ohta, Hiromitsu; Tamada, Tsutomu; Nukiwa, Toshihiro] Tohoku Univ Hosp, Dept Resp Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Kanehira, M (corresponding author), Tohoku Univ, Dept Resp Med, Grad Sch Med, Sendai, Miyagi 980, Japan.	kikuchi@rm.med.tohoku.ac.jp	Ohkouchi, Shinya/AEV-0334-2022	Ohkouchi, Shinya/0000-0002-4658-6487; Santoso, Arif/0000-0003-4125-005X	Ministry of Education, Culture, Sports, Science and Technology (Tokyo, Japan); Core Research for Evolutional Science and Technology Program; Japan Science and Technology Agency (Tokyo, Japan); Grants-in-Aid for Scientific Research [21590980] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology Program(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (Tokyo, Japan)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants-in-Aid for Scientific Research and Network Medicine Global-COE Program from the Ministry of Education, Culture, Sports, Science and Technology (Tokyo, Japan), the Core Research for Evolutional Science and Technology Program and the Adaptable and Seamless Technology Transfer Program of the Japan Science and Technology Agency (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Beausejour C., 2007, V180, P67; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen JH, 2008, STEM CELLS, V26, P135, DOI 10.1634/stemcells.2007-0098; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Fibbe WE, 2007, ANN NY ACAD SCI, V1106, P272, DOI 10.1196/annals.1392.025; Flores I, 2010, FEBS LETT, V584, P3826, DOI 10.1016/j.febslet.2010.07.042; Florian MC, 2010, STEM CELLS, V28, P1623, DOI 10.1002/stem.481; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Gendaszewska-Darmach E, 2008, ACTA BIOCHIM POL, V55, P227, DOI 10.18388/abp.2008_3070; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Katsube Y, 2008, BIOCHEM BIOPH RES CO, V368, P256, DOI 10.1016/j.bbrc.2008.01.051; Krtolica A, 2005, INT J BIOCHEM CELL B, V37, P935, DOI 10.1016/j.biocel.2004.10.007; Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643; Lee MJ, 2008, J CELL BIOCHEM, V104, P499, DOI 10.1002/jcb.21641; Li ZW, 2010, J CELL BIOCHEM, V111, P811, DOI 10.1002/jcb.22731; Liu XB, 2009, STEM CELLS DEV, V18, P947, DOI 10.1089/scd.2008.0352; Liu YB, 2010, J CELL BIOCHEM, V109, P794, DOI 10.1002/jcb.22471; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mansell JP, 2011, PROSTAG OTH LIPID M, V95, P45, DOI [10.1016/j.prostaglandins.2011.05.003, 10.1016/j.prostaglandins.2011.05.002]; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mishra PJ, 2009, CANCER RES, V69, P1255, DOI 10.1158/0008-5472.CAN-08-3562; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Pebay A, 2007, PROSTAG OTH LIPID M, V84, P83, DOI 10.1016/j.prostaglandins.2007.08.004; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Rayment EA, 2010, STEM CELLS, V28, P996, DOI 10.1002/stem.416; Rubin H, 2002, NAT BIOTECHNOL, V20, P675, DOI 10.1038/nbt0702-675; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Volarevic V, 2011, STEM CELLS, V29, P5, DOI 10.1002/stem.556; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	52	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32185	10.1371/journal.pone.0032185	http://dx.doi.org/10.1371/journal.pone.0032185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359668	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200137
J	Liu, JM; Zhu, CX; Shi, YJ; Li, H; Wang, LP; Qin, ST; Kang, SE; Huang, YP; Jin, YM; Lin, JJ				Liu, Jinming; Zhu, Chunxia; Shi, Yaojun; Li, Hao; Wang, Lanpin; Qin, Shangtian; Kang, Saie; Huang, Yanpin; Jin, Yamei; Lin, Jiaojiao			Surveillance of Schistosoma japonicum Infection in Domestic Ruminants in the Dongting Lake Region, Hunan Province, China	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; TRANSMISSION	Background: Schistosomiasis japonica is prevalent in Asian countries and it remains a major public health problem in China. The major endemic foci are the marsh and lake regions of southern China, particularly the Dongting Lake region bordering Hunan and Hubei provinces, and the Poyang Lake region in Jiangxi province. Domestic ruminants, especially bovines, have long been considered to play a major role in the transmission of Schistosoma japonicum to humans. Methods and Findings: A miracidial hatching technique was used to investigate the prevalence of S. japonicum infections in domestic ruminants and field feces collected from two towns located to the south and east of Dongting Lake, Hunan province, between 2005 and 2010. The overall prevalence of infection was not significantly reduced from 4.93% in 2005 to 3.64% in 2008, after which it was maintained at this level. Bovines comprised 23.5-58.2% of the total infected ruminants, while goats comprised 41.8-76.5%. Infection rates in cattle and goats were significantly higher than those found in buffalo in most study years. The prevalence in buffalo younger than three years was significantly higher than that in those aged over three years. All the positive field samples of feces were derived from bovines in Nandashan. In Matang Town, 61.22% of the positive field feces were from bovines, while the rest were from goats. The positive rates for field feces were approximately the same in April and November/October. Conclusions: The present study found that bovines and goats are major sources of S. japonicum infection in the Dongting lake region and there was age-related resistance in buffalo. Both bovines and goats should be treated equally when controlling S. japonicum infections in the Dongting lake region. It is essential to conduct an additional mass treatment in late March or early April, in addition to the original treatment scheme.	[Liu, Jinming; Shi, Yaojun; Li, Hao; Jin, Yamei; Lin, Jiaojiao] Chinese Acad Agr Sci, Natl Lab Anim Schistosomiasis Control, Key Lab Anim Parasitol, Minist Agr,Shanghai Vet Res Inst, Shanghai, Peoples R China; [Zhu, Chunxia; Wang, Lanpin; Qin, Shangtian] Hunan Anim Dis Control Ctr, Changsha, Hunan, Peoples R China; [Kang, Saie] Yueyang Cty Anim Husb Bur, Yueyang, Peoples R China; [Huang, Yanpin] Yuanjiang Municipal Anim Husb & Fishery Bur, Yuanjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Liu, JM (corresponding author), Chinese Acad Agr Sci, Natl Lab Anim Schistosomiasis Control, Key Lab Anim Parasitol, Minist Agr,Shanghai Vet Res Inst, Shanghai, Peoples R China.	jimyliu@shvri.ac.cn			Ministry of Agriculture of China [200903036]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (Project No. 200903036) from Ministry of Agriculture of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen MG, 1993, HUMAN SCHISTOSOMIASI, P241; Dai ZhuoJian, 2004, Southwest China Journal of Agricultural Sciences, V17, P393; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Gray DJ, 2007, AM J TROP MED HYG, V77, P866, DOI 10.4269/ajtmh.2007.77.866; Gray DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004058; Hao Yang, 2010, Chinese Journal of Schistosomiasis Control, V22, P521; Hao Yang, 2009, Chinese Journal of Schistosomiasis Control, V21, P451; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Morel CM, 2000, PARASITOL TODAY, V16, P522, DOI 10.1016/S0169-4758(00)01815-9; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Wang LD, 2009, TROP MED INT HEALTH, V14, P1475, DOI 10.1111/j.1365-3156.2009.02403.x; Wang TP, 2005, ACTA TROP, V96, P198, DOI 10.1016/j.actatropica.2005.07.017; WHO, 2002, WHO TECH REP SER; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423	16	30	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31876	10.1371/journal.pone.0031876	http://dx.doi.org/10.1371/journal.pone.0031876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359638	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200107
J	Lo, WC; Dai, T; Liu, YY; Wang, LF; Hwang, JK; Lyu, PC				Lo, Wei-Cheng; Dai, Tian; Liu, Yen-Yi; Wang, Li-Fen; Hwang, Jenn-Kang; Lyu, Ping-Chiang			Deciphering the Preference and Predicting the Viability of Circular Permutations in Proteins	PLOS ONE			English	Article							RELATIVE SOLVENT ACCESSIBILITY; STRUCTURAL SIMILARITY; MOLECULAR EVOLUTION; AMINO-ACIDS; STABILITY; LIGATION; DATABASE; DYNAMICS; PROGRAM; BINDING	Circular permutation (CP) refers to situations in which the termini of a protein are relocated to other positions in the structure. CP occurs naturally and has been artificially created to study protein function, stability and folding. Recently CP is increasingly applied to engineer enzyme structure and function, and to create bifunctional fusion proteins unachievable by tandem fusion. CP is a complicated and expensive technique. An intrinsic difficulty in its application lies in the fact that not every position in a protein is amenable for creating a viable permutant. To examine the preferences of CP and develop CP viability prediction methods, we carried out comprehensive analyses of the sequence, structural, and dynamical properties of known CP sites using a variety of statistics and simulation methods, such as the bootstrap aggregating, permutation test and molecular dynamics simulations. CP particularly favors Gly, Pro, Asp and Asn. Positions preferred by CP lie within coils, loops, turns, and at residues that are exposed to solvent, weakly hydrogen-bonded, environmentally unpacked, or flexible. Disfavored positions include Cys, bulky hydrophobic residues, and residues located within helices or near the protein's core. These results fostered the development of an effective viable CP site prediction system, which combined four machine learning methods, e. g., artificial neural networks, the support vector machine, a random forest, and a hierarchical feature integration procedure developed in this work. As assessed by using the hydrofolate reductase dataset as the independent evaluation dataset, this prediction system achieved an AUC of 0.9. Large-scale predictions have been performed for nine thousand representative protein structures; several new potential applications of CP were thus identified. Many unreported preferences of CP are revealed in this study. The developed system is the best CP viability prediction method currently available. This work will facilitate the application of CP in research and biotechnology.	[Lo, Wei-Cheng; Dai, Tian; Lyu, Ping-Chiang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Lo, Wei-Cheng; Liu, Yen-Yi; Wang, Li-Fen; Hwang, Jenn-Kang] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Dai, Tian] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Lyu, Ping-Chiang] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Tsing Hua University; National Yang Ming Chiao Tung University; Emory University; National Tsing Hua University	Lo, WC (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	jkhwang@cc.nctu.edu.tw; pclyu@life.nthu.edu.tw		Lo, Wei-Cheng/0000-0001-8865-5113; Liu, Yen-Yi/0000-0001-8386-4418	National Science Council, Taiwan; NSC [99-2745-B-009-001-ASP]; Ministry of Education, Taiwan; Development Plan for World Class University and Research Centers of Excellence (MOU ATU);  [99-2811-M-007-073];  [99-3112-B-007-003]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); Development Plan for World Class University and Research Centers of Excellence (MOU ATU); ; 	This work was funded by the National Science Council, Taiwan (http://www.nsc.gov.tw) with NSC grant number 99-2745-B-009-001-ASP (Academic Summit Program) to JH; 99-2811-M-007-073 and 99-3112-B-007-003 to PL. The Ministry of Education, Taiwan (http://english.moe.gov.tw/) also funded this study with the Development Plan for World Class University and Research Centers of Excellence (MOU ATU Plan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma S, 2005, J MOL BIOL, V353, P1161, DOI 10.1016/j.jmb.2005.08.070; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Anand B, 2006, NUCLEIC ACIDS RES, V34, P2196, DOI 10.1093/nar/gkl178; Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Aranko AS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005185; Arnold FH, 2006, NAT BIOTECHNOL, V24, P328, DOI 10.1038/nbt0306-328; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Bakan A, 2010, PYGNM 0 1 PYTHON PAC; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Bujnicki JM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-3; Bulaj G, 2004, PROTEIN SCI, V13, P1182, DOI 10.1110/ps.03563704; CARRINGTON DM, 1985, NATURE, V313, P64, DOI 10.1038/313064a0; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen J, 2004, PROTEINS, V57, P153, DOI 10.1002/prot.20175; Chen LN, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-18; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Crasto CJ, 2001, PROTEINS, V42, P399, DOI 10.1002/1097-0134(20010215)42:3<399::AID-PROT100>3.0.CO;2-E; CUNNINGHAM BA, 1979, P NATL ACAD SCI USA, V76, P3218, DOI 10.1073/pnas.76.7.3218; ELARABATY M, 1989, AIAA COMPUTERS IN AEROSPACE VII CONFERENCE, PTS 1 AND 2, P300; Garrett R, 2008, BIOCHEMISTRY-US, P134; Gebhard LG, 2006, J MOL BIOL, V358, P280, DOI 10.1016/j.jmb.2006.01.095; Guerler A, 2008, PROTEIN SCI, V17, P1374, DOI 10.1110/ps.035469.108; Guerler A, 2010, NUCLEIC ACIDS RES, V38, pW46, DOI 10.1093/nar/gkq314; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Halle B, 2002, P NATL ACAD SCI USA, V99, P1274, DOI 10.1073/pnas.032522499; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Hesterberg T, 2005, BOOTSTRAP METHODS PE, P1411; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; Hsu STD, 2009, CHEM SOC REV, V38, P2951, DOI 10.1039/b908170b; Hubbard S. J., 1993, NACCESS; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; Jeltsch A, 1999, J MOL EVOL, V49, P161, DOI 10.1007/PL00006529; JONES BE, 1995, PROTEIN SCI, V4, P167; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kojima M, 2005, J BIOSCI BIOENG, V100, P197, DOI 10.1263/jbb.100.197; Kundu S, 2002, BIOPHYS J, V83, P723, DOI 10.1016/S0006-3495(02)75203-X; Kuzmanic A, 2010, BIOPHYS J, V98, P861, DOI 10.1016/j.bpj.2009.11.011; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li L, 2001, J MOL BIOL, V306, P121, DOI 10.1006/jmbi.2000.4375; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang HK, 2005, PROTEINS, V59, P58, DOI 10.1002/prot.20386; Lin CP, 2008, PROTEINS, V72, P929, DOI 10.1002/prot.21983; Lindqvist Y, 1997, CURR OPIN STRUC BIOL, V7, P422, DOI 10.1016/S0959-440X(97)80061-9; Lo WC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r11; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pD328, DOI 10.1093/nar/gkn679; Lo WC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-307; Lu CH, 2008, PROTEINS, V72, P625, DOI 10.1002/prot.21954; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; Moreau RJ, 2009, J AM CHEM SOC, V131, P13107, DOI 10.1021/ja904271k; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Nakamura T, 1999, J BIOL CHEM, V274, P19041, DOI 10.1074/jbc.274.27.19041; Nelson DL, 2004, LEHNINGER PRINCIPLES, P75; Nguyen MN, 2005, PROTEINS, V59, P30, DOI 10.1002/prot.20404; NISHIKAWA K, 1986, J BIOCHEM-TOKYO, V100, P1043, DOI 10.1093/oxfordjournals.jbchem.a121783; Noguchi T, 2001, NUCLEIC ACIDS RES, V29, P219, DOI 10.1093/nar/29.1.219; Ostermeier M, 2005, PROTEIN ENG DES SEL, V18, P359, DOI 10.1093/protein/gzi048; Paluszewski M, 2008, LECT N BIOINFORMAT, V5251, P382, DOI 10.1007/978-3-540-87361-7_32; Panchenko AR, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-10; Paszkiewicz KH, 2006, BIOINFORMATICS, V22, P1353, DOI 10.1093/bioinformatics/btl095; Pearson W R, 2000, Methods Mol Biol, V132, P185; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peisajovich SG, 2006, NAT GENET, V38, P168, DOI 10.1038/ng1717; Pintar A, 2003, BIOPHYS J, V84, P2553, DOI 10.1016/S0006-3495(03)75060-7; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Pommie C, 2004, J MOL RECOGNIT, V17, P17, DOI 10.1002/jmr.647; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P179, DOI 10.1016/S0968-0004(00)89003-9; Qian Z, 2005, J AM CHEM SOC, V127, P13466, DOI 10.1021/ja053932h; Quinlan JR, 1996, PROCEEDINGS OF THE THIRTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE EIGHTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE, VOLS 1 AND 2, P725; Remy I, 2007, NAT PROTOC, V2, P2120, DOI 10.1038/nprot.2007.266; Ribeiro EA, 2005, BIOCHEMISTRY-US, V44, P4699, DOI 10.1021/bi047908c; Schwartz TU, 2004, PROTEIN SCI, V13, P2814, DOI 10.1110/ps.04917504; Shih CH, 2007, PROTEINS, V68, P34, DOI 10.1002/prot.21430; Shih ESC, 2010, SEQUENCE GENOME ANAL, P63; Todd AE, 2002, TRENDS BIOCHEM SCI, V27, P419, DOI 10.1016/S0968-0004(02)02158-8; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Tsai LC, 2003, J MOL BIOL, V330, P607, DOI 10.1016/S0022-2836(03)00630-2; Uliel S, 2001, PROTEIN ENG, V14, P533, DOI 10.1093/protein/14.8.533; Uliel S, 1999, BIOINFORMATICS, V15, P930, DOI 10.1093/bioinformatics/15.11.930; van Erkel AR, 1998, EUR J RADIOL, V27, P88, DOI 10.1016/S0720-048X(97)00157-5; VANDRUNEN R, 1995, ABSTR PAP AM CHEM S, V209, P49; Vogel C, 2006, BIOESSAYS, V28, P973, DOI 10.1002/bies.20474; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weiner J, 2005, BIOINFORMATICS, V21, P932, DOI 10.1093/bioinformatics/bti085; Werbos P. J., 1994, ROOTS BACKPROPAGATIO; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yang JM, 2006, NUCLEIC ACIDS RES, V34, P3646, DOI 10.1093/nar/gkl395; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004; Zavodszky M, 2001, PROTEIN SCI, V10, P149, DOI 10.1110/ps.26801; Zhang H, 2009, PROTEINS, V76, P617, DOI 10.1002/prot.22375; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zheng WJ, 2008, BIOPHYS J, V94, P3853, DOI 10.1529/biophysj.107.125831; Zhu JH, 2005, PROTEINS, V58, P618, DOI 10.1002/prot.20331	98	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31791	10.1371/journal.pone.0031791	http://dx.doi.org/10.1371/journal.pone.0031791			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359629	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200098
J	McMurdo, MET; Argo, I; Crombie, IK; Feng, ZQ; Sniehotta, FF; Vadiveloo, T; Witham, MD; Donnan, PT				McMurdo, Marion E. T.; Argo, Ishbel; Crombie, Iain K.; Feng, Zhiqiang; Sniehotta, Falko F.; Vadiveloo, Thenmalar; Witham, Miles D.; Donnan, Peter T.			Social, Environmental and Psychological Factors Associated with Objective Physical Activity Levels in the Over 65s	PLOS ONE			English	Article							ACCELEROMETER; VALIDITY; HEALTH; IMPACT; QUESTIONNAIRE; BEHAVIOR; PROGRAM; PEOPLE; WOMEN; SF-36	Objective: To assess physical activity levels objectively using accelerometers in community dwelling over 65 s and to examine associations with health, social, environmental and psychological factors. Design: Cross sectional survey. Setting: 17 general practices in Scotland, United Kingdom. Participants: Random sampling of over 65 s registered with the practices in four strata young-old (65-80 years), old-old (over 80 years), more affluent and less affluent groups. Main Outcome Measures: Accelerometry counts of activity per day. Associations between activity and Theory of Planned Behaviour variables, the physical environment, health, wellbeing and demographic variables were examined with multiple regression analysis and multilevel modelling. Results: 547 older people (mean (SD) age 79(8) years, 54% female) were analysed representing 94% of those surveyed. Accelerometry counts were highest in the affluent younger group, followed by the deprived younger group, with lowest levels in the deprived over 80 s group. Multiple regression analysis showed that lower age, higher perceived behavioural control, the physical function subscale of SF-36, and having someone nearby to turn to were all independently associated with higher physical activity levels (R-2 = 0.32). In addition, hours of sunshine were independently significantly associated with greater physical activity in a multilevel model. Conclusions: Other than age and hours of sunlight, the variables identified are modifiable, and provide a strong basis for the future development of novel multidimensional interventions aimed at increasing activity participation in later life.	[McMurdo, Marion E. T.; Crombie, Iain K.; Vadiveloo, Thenmalar; Donnan, Peter T.] Univ Dundee, Div Populat Hlth Sci, Dundee, Tayside, Scotland; [Feng, Zhiqiang] Univ St Andrews, Sch Geog & Geosci, St Andrews, Fife, Scotland; [Sniehotta, Falko F.] Newcastle Univ, Ctr Translat Res Publ Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Dundee; University of St Andrews; Newcastle University - UK	McMurdo, MET (corresponding author), Univ Dundee, Div Populat Hlth Sci, Dundee, Tayside, Scotland.	m.e.t.mcmurdo@dundee.ac.uk	Sniehotta, Falko/ABF-7131-2021; Sniehotta, Falko F/C-5481-2008	Sniehotta, Falko/0000-0003-1738-4269; Sniehotta, Falko F/0000-0003-1738-4269; Donnan, Peter/0000-0001-7828-0610; Witham, Miles/0000-0002-1967-0990; Vadiveloo, Thenmalar/0000-0001-5531-6289	Scottish Executive grant [CZH/4/518]; University of Dundee; ESRC [ES/G007470/1] Funding Source: UKRI; MRC [G0900686] Funding Source: UKRI; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish; Medical Research Council [G0900686] Funding Source: researchfish; Chief Scientist Office [CZG/2/569, CZH/4/518] Funding Source: researchfish	Scottish Executive grant; University of Dundee; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This study was funded by Scottish Executive grant CZH/4/518. The sponsor was the University of Dundee. Neither funder nor sponsor had a role in the design, conduct or interpretation of the study.	ABBASI AA, 1995, AM J MED SCI, V310, P229; Ashford S, 2010, BRIT J HEALTH PSYCH, V15, P265, DOI 10.1348/135910709X461752; Baert V, 2011, AGEING RES REV, V10, P464, DOI 10.1016/j.arr.2011.04.001; Baker PRA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008366.pub2; Butler L, 2004, HLTH PROMOT J AUSTR, V2004, P134, DOI DOI 10.1071/HE04134; Cattan M, 2011, HEALTH SOC CARE COMM, V19, P198, DOI 10.1111/j.1365-2524.2010.00967.x; Cunningham GO, 2004, AM J HEALTH PROMOT, V18, P435, DOI 10.4278/0890-1171-18.6.435; Davis MG, 2011, MED SCI SPORT EXER, V43, P647, DOI 10.1249/MSS.0b013e3181f36196; Department of Health, 2000, HLTH SURV ENGL; Environmental Systems Research Institute, ARCGIS 9 3; Fox KR, 2011, HEALTH PLACE, V17, P633, DOI 10.1016/j.healthplace.2011.01.002; Hagger MS, 2002, BRIT J HEALTH PSYCH, V7, P283, DOI 10.1348/135910702760213689; Hagger MS, 2002, J SPORT EXERCISE PSY, V24, P3, DOI 10.1123/jsep.24.1.3; Harper R, 2003, MEASURING SOCIAL CAP; Harris TJ, 2009, MED SCI SPORT EXER, V41, P1392, DOI 10.1249/MSS.0b013e31819b3533; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Kochersberger G, 1996, ARCH PHYS MED REHAB, V77, P793, DOI 10.1016/S0003-9993(96)90258-0; Litwin H, 2001, GERONTOLOGIST, V41, P516, DOI 10.1093/geront/41.4.516; LYONS RA, 1994, AGE AGEING, V23, P182, DOI 10.1093/ageing/23.3.182; Mazzeo RS, 1998, MED SCI SPORT EXER, V30, P992, DOI 10.1097/00005768-199806000-00033; McMurdo MET, 2010, J AM GERIATR SOC, V58, P2099, DOI 10.1111/j.1532-5415.2010.03127.x; MCMURDO MET, 1995, AGE AGEING, V24, P425, DOI 10.1093/ageing/24.5.425; Morie M, 2010, J AM GERIATR SOC, V58, P1727, DOI 10.1111/j.1532-5415.2010.03012.x; ONS, 2011, ONS POSTC DIR US GUI; Pollard B, 2001, SOC SCI MED, V52, P921, DOI 10.1016/S0277-9536(00)00194-5; Richardson EA, 2010, SOC SCI MED, V71, P568, DOI 10.1016/j.socscimed.2010.04.015; ROWLAND L, 1994, J EPIDEMIOL COMMUN H, V48, P123, DOI 10.1136/jech.48.2.123; Sumukadas D, 2009, J EPIDEMIOL COMMUN H, V63, P305, DOI 10.1136/jech.2008.080838; Sumukadas D, 2008, AGING CLIN EXP RES, V20, P15; Talbot LA, 2002, AM J CARDIOL, V89, P1187, DOI 10.1016/S0002-9149(02)02302-0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c; van Stralen MM, 2009, HEALTH PSYCHOL REV, V3, P147, DOI 10.1080/17437190903229462; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	37	37	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31878	10.1371/journal.pone.0031878	http://dx.doi.org/10.1371/journal.pone.0031878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925XS	22359640	Green Published, gold			2022-12-25	WOS:000302796200109
J	Permyakov, S; Suzina, N; Valiakhmetov, A				Permyakov, Sergey; Suzina, Nataliya; Valiakhmetov, Airat			Activation of H+-ATPase of the Plasma Membrane of Saccharomyces cerevisiae by Glucose: The Role of Sphingolipid and Lateral Enzyme Mobility	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; P-TYPE ATPASES; CELL-SURFACE; ELECTRON CRYOMICROSCOPY; RAFT ASSOCIATION; BASE SYNTHESIS; CLUSTER SIZES; YEAST; OLIGOMERIZATION; DELIVERY	Activation of the plasma membrane H+-ATPase of the yeast Saccharomyces cerevisiae by glucose is a complex process that has not yet been completely elucidated. This study aimed to shed light on the role of lipids and the lateral mobility of the enzyme complex during its activation by glucose. The significance of H+-ATPase oligomerization for the activation of H+-ATPase by glucose was shown using the strains lcb1-100 and erg6, with the disturbed synthesis of sphyngolipid and ergosterol, respectively. Experiments with GFP-fused H+-ATPase showed a decrease in fluorescence anisotropy during the course of glucose activation, suggesting structural reorganization of the molecular domains. An immunogold assay showed that the incubation with glucose results in the spatial redistribution of ATPase complexes in the plasma membrane. The data suggest that (1) to be activated by glucose, H+-ATPase is supposed to be in an oligomeric state, and (2) glucose activation is accompanied by the spatial movements of H+-ATPase clusters in the PM.	[Permyakov, Sergey] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia; [Suzina, Nataliya; Valiakhmetov, Airat] Russian Acad Sci, Skryabin Inst Biochem & Physiol Microorganisms, Pushchino 142292, Moscow Region, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences	Permyakov, S (corresponding author), Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia.	airatv@ibpm.pushchino.ru	Suzina, Nataliya E/G-7972-2014; Permyakov, Sergei/O-1386-2019; Valiakhmetov, Airat/AAN-1307-2020; Permyakov, Sergei E./B-8156-2011	Suzina, Nataliya E/0000-0002-4960-1910; Permyakov, Sergei/0000-0003-4086-3137; Valiakhmetov, Airat/0000-0002-4739-0806; Permyakov, Sergei E./0000-0003-4086-3137	Russian Foundation for Basic Research [10-04-01248]; Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences)	This work was funded by the Russian Foundation for Basic Research grant #10-04-01248; Program of the Russian Academy of Sciences "Molecular and Cell Biology." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Bader AN, 2007, OPT EXPRESS, V15, P6934, DOI 10.1364/OE.15.006934; Bader AN, 2011, CHEMPHYSCHEM, V12, P475, DOI 10.1002/cphc.201000801; Bader AN, 2009, BIOPHYS J, V97, P2613, DOI 10.1016/j.bpj.2009.07.059; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Brachmann CB, 1998, YEAST, V14, P115; Campetelli AN, 2005, FEBS J, V272, P5742, DOI 10.1111/j.1742-4658.2005.04959.x; CHADWICK CC, 1987, ARCH BIOCHEM BIOPHYS, V252, P348, DOI 10.1016/0003-9861(87)90041-5; CYRKLAFF M, 1995, EMBO J, V14, P1854, DOI 10.1002/j.1460-2075.1995.tb07177.x; ERASO P, 1994, J BIOL CHEM, V269, P10393; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Hink MA, 2000, J BIOL CHEM, V275, P17556, DOI 10.1074/jbc.M001348200; LACOWICZ JR, 2006, PRINCIPLES FLUORESCE; Lakowicz JR, 1999, ANAL BIOCHEM, V267, P397, DOI 10.1006/abio.1998.3029; Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; MONK BC, 1991, J BACTERIOL, V173, P6826, DOI 10.1128/jb.173.21.6826-6836.1991; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821; Permyakov EA, 1993, LUMINESCENT SPECTROS; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; RAO R, 1992, ANN NY ACAD SCI, V671, P195, DOI 10.1111/j.1749-6632.1992.tb43796.x; Rhee KH, 2002, EMBO J, V21, P3582, DOI 10.1093/emboj/cdf385; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Serrano R., 1991, MOL CELLULAR BIOL YE, P523; SETOYOUNG D, 1992, BIOCHIM BIOPHYS ACTA, V1102, P213, DOI 10.1016/0167-4838(92)90512-C; Souza MAA, 2001, MICROBIOL-SGM, V147, P2849, DOI 10.1099/00221287-147-10-2849; STEWART DJ, 1974, ANAL BIOCHEM, V62, P349, DOI 10.1016/0003-2697(74)90167-5; Toulmay A, 2007, BIOCHIMIE, V89, P249, DOI 10.1016/j.biochi.2006.07.020; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Volkmer A, 2000, BIOPHYS J, V78, P1589, DOI 10.1016/S0006-3495(00)76711-7; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Yeow EKL, 2007, BIOPHYS J, V92, P3098, DOI [10.1529/biophysj.106.099424, 10.1529/biophysj. 106.099424]; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824; [No title captured]	47	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30966	10.1371/journal.pone.0030966	http://dx.doi.org/10.1371/journal.pone.0030966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359558	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200027
J	Ueno, T; Masuda, N; Kume, S; Kume, K				Ueno, Taro; Masuda, Naoki; Kume, Shoen; Kume, Kazuhiko			Dopamine Modulates the Rest Period Length without Perturbation of Its Power Law Distribution in Drosophila melanogaster	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; FLIGHT SEARCH PATTERNS; LOCOMOTOR-ACTIVITY; ANIMAL BEHAVIOR; REMOTE-CONTROL; SLEEP; TEMPERATURE; AROUSAL; NEURONS; DYNAMICS	We analyzed the effects of dopamine signaling on the temporal organization of rest and activity in Drosophila melanogaster. Locomotor behaviors were recorded using a video-monitoring system, and the amounts of movements were quantified by using an image processing program. We, first, confirmed that rest bout durations followed long-tailed (i.e., power-law) distributions, whereas activity bout durations did not with a strict method described by Clauset et al. We also studied the effects of circadian rhythm and ambient temperature on rest bouts and activity bouts. The fraction of activity significantly increased during subjective day and at high temperature, but the power-law exponent of the rest bout distribution was not affected. The reduction in rest was realized by reduction in long rest bouts. The distribution of activity bouts did not change drastically under the above mentioned conditions. We then assessed the effects of dopamine. The distribution of rest bouts became less long-tailed and the time spent in activity significantly increased after the augmentation of dopamine signaling. Administration of a dopamine biosynthesis inhibitor yielded the opposite effects. However, the distribution of activity bouts did not contribute to the changes. These results suggest that the modulation of locomotor behavior by dopamine is predominantly controlled by changing the duration of rest bouts, rather than the duration of activity bouts.	[Ueno, Taro; Kume, Shoen; Kume, Kazuhiko] Kumamoto Univ, Dept Stem Cell Biol, Inst Embryol & Genet, Kumamoto, Japan; [Masuda, Naoki] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo, Japan; [Masuda, Naoki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Kume, Shoen] Kumamoto Univ, Global COE Program, Kumamoto, Japan	Kumamoto University; University of Tokyo; Japan Science & Technology Agency (JST); Kumamoto University	Ueno, T (corresponding author), Kumamoto Univ, Dept Stem Cell Biol, Inst Embryol & Genet, Kumamoto, Japan.	kkume@kumamoto-u.ac.jp	Ueno, Taro/AAN-7260-2021; Kume, Shoen/M-4356-2016	Ueno, Taro/0000-0003-3697-4301; Kume, Shoen/0000-0002-4292-205X; Kume, Kazuhiko/0000-0003-4232-1657; Masuda, Naoki/0000-0003-1567-801X	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [17024049, 20115009, 20760258]; Japanese Society for the Promotion of Science (JSPS) [17300105, 22300132]; 21st Century Center of Excellence (COE); MEXT; Grants-in-Aid for Scientific Research [20115009, 23681033] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 21st Century Center of Excellence (COE)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid (17024049) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and the Grants-in-Aid (17300105, 22300132) from the Japanese Society for the Promotion of Science (JSPS) to KK; a 21st Century Center of Excellence (COE) grant; and a Global COE grant from MEXT. NM acknowledges support through the Grants-in-Aid for Scientific Research on Innovative Areas "Systems Molecular Ethology"(20115009) and the Grant-in-Aid for Scientific Research (20760258) from MEXT, Japan. TU is a global COE junior research associate and JSPS fellow. SK is a member of the Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Belgacem YH, 2002, P NATL ACAD SCI USA, V99, P15154, DOI 10.1073/pnas.232244199; BRAND AH, 1993, DEVELOPMENT, V118, P401; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; COLE BJ, 1995, ANIM BEHAV, V50, P1317, DOI 10.1016/0003-3472(95)80047-6; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Efron B, 1993, INTRO BOOTSTRAP, P16; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gall AJ, 2009, SLEEP, V32, P920, DOI 10.1093/sleep/32.7.920; Gatti S, 2000, CURR BIOL, V10, P667, DOI 10.1016/S0960-9822(00)00517-0; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Koganezawa M, 2009, J THEOR BIOL, V260, P353, DOI 10.1016/j.jtbi.2009.06.018; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Lo CC, 2002, EUROPHYS LETT, V57, P625, DOI 10.1209/epl/i2002-00508-7; Loeb J, 1917, J BIOL CHEM, V32, P103; Makos MA, 2009, ANAL CHEM, V81, P1848, DOI 10.1021/ac802297b; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Martin JR, 2003, BEHAV PROCESS, V64, P145, DOI 10.1016/S0376-6357(03)00132-3; Martin JR, 2001, J NEUROGENET, V15, P205, DOI 10.3109/01677060109167377; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Nakamura T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138103; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; NEWBY LM, 1991, GENETICS, V128, P571; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; R Development Core Team, 2009, R FDN STAT COMP; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; SEWELL DF, 1979, ANIM BEHAV, V27, P312, DOI 10.1016/0003-3472(79)90155-6; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SHIMADA I, 1993, BIOL CYBERN, V68, P477, DOI 10.1007/BF00200806; Slawson Justin B, 2009, J Vis Exp, DOI 10.3791/1096; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Zimmerman JE, 2008, SLEEP, V31, P1587, DOI 10.1093/sleep/31.11.1587	52	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32007	10.1371/journal.pone.0032007	http://dx.doi.org/10.1371/journal.pone.0032007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359653	gold, Green Submitted, Green Published			2022-12-25	WOS:000302796200122
J	Hess, S; Sausen, N; Melkonian, M				Hess, Sebastian; Sausen, Nicole; Melkonian, Michael			Shedding Light on Vampires: The Phylogeny of Vampyrellid Amoebae Revisited	PLOS ONE			English	Article							REVISED CLASSIFICATION; SEQUENCE ALIGNMENT; FILOSE AMEBA; CERCOZOA; DNA; PERFORATION; SEAVIEW; REVEALS; CONIDIA; TREE	With the advent of molecular phylogenetic techniques the polyphyly of naked filose amoebae has been proven. They are interspersed in several supergroups of eukaryotes and most of them already found their place within the tree of life. Although the `vampire amoebae' have attracted interest since the middle of the 19th century, the phylogenetic position and even the monophyly of this traditional group are still uncertain. In this study clonal co-cultures of eight algivorous vampyrellid amoebae and the respective food algae were established. Culture material was characterized morphologically and a molecular phylogeny was inferred using SSU rDNA sequence comparisons. We found that the limnetic, algivorous vampyrellid amoebae investigated in this study belong to a major clade within the Endomyxa CAVALIER-SMITH, 2002 (Cercozoa), grouping together with a few soil-dwelling taxa. They split into two robust clades, one containing species of the genus Vampyrella CIENKOWSKI, 1865, the other containing the genus Leptophrys HERTWIG & LESSER, 1874, together with terrestrial members. Supported by morphological data these clades are designated as the two families Vampyrellidae ZOPF, 1885, and Leptophryidae fam. nov. Furthermore the order Vampyrellida WEST, 1901 was revised and now corresponds to the major vampyrellid clade within the Endomyxa, comprising the Vampyrellidae and Leptophryidae as well as several environmental sequences. In the light of the presented phylogenetic analyses morphological and ecological aspects, the feeding strategy and nutritional specialization within the vampyrellid amoebae are discussed.	[Hess, Sebastian; Sausen, Nicole; Melkonian, Michael] Univ Cologne, Inst Bot, Cologne Bioctr, Cologne, Germany	University of Cologne	Hess, S (corresponding author), Univ Cologne, Inst Bot, Cologne Bioctr, Gyrhofstr 15, Cologne, Germany.	shess@uni-bonn.de	Hess, Sebastian/AAT-8824-2021					Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; ANDERSON TR, 1980, SOIL BIOL BIOCHEM, V12, P159, DOI 10.1016/0038-0717(80)90053-X; Bass D, 2005, PROTIST, V156, P149, DOI 10.1016/j.protis.2005.03.001; Bass D, 2004, INT J SYST EVOL MICR, V54, P2393, DOI 10.1099/ijs.0.63229-0; Bass D, 2009, PROTIST, V160, P75, DOI 10.1016/j.protis.2008.07.002; CANN JP, 1979, ARCH PROTISTENKD, V122, P226, DOI 10.1016/S0003-9365(79)80034-2; CANTER HM, 1973, ZOOL J LINN SOC-LOND, V52, P63; Canter-Lund H, 1994, FRESHWATER ALGAE THE; Cash J., 1904, Journal of the Linnean Society, Vxxix, P218; Cash J, 1905, BRIT FRESHWATER RHIZ; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; Cienkowski L., 1881, TRAVEAUX SOC IMPERIA, V12, P130; Cienkowski L, 1865, ARCH MIKROSK ANAT, V5, P203, DOI DOI 10.1007/BF02961414; Cienkowski L, 1876, ARCH MIKROSK ANAT, V12, P15; de SAEDELEER HENRI, 1934, MEM MUS ROY HIST NAT BELGIQUE, V60, P1; Dobell Clifford, 1913, Archiv fuer Protistenkunde Jena, V31; DOFLEIN F, 1916, LEHRBUCH PROTOZOENKU; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gromov BV, 1976, MIKROORGANISMY PARAZ; Haeckel E, 1870, STUDIEN MONEREN ANDE; Hall R.P., 1953, PROTOZOOLOGY; Hertwig R, 1874, ARCH MIKROSK ANAT, V10, P61; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; HOMMA Y, 1984, Annals of the Phytopathological Society of Japan, V50, P229, DOI 10.3186/jjphytopath.50.229; HOMMA Y, 1979, PHYTOPATHOLOGY, V69, P1118, DOI 10.1094/Phyto-69-1118; HONIGBERG BM, 1964, J PROTOZOOL, V11, P7, DOI 10.1111/j.1550-7408.1964.tb01715.x; HOOGENRAAD H. R., 1927, BIOL ZENTRALBL, V47, P517; Howe AT, 2011, PROTIST, V162, P332, DOI 10.1016/j.protis.2010.10.002; HULSMANN N, 1993, J EUKARYOT MICROBIOL, V40, P141, DOI 10.1111/j.1550-7408.1993.tb04894.x; IVANI MOMILO, 1934, CELLULE, V43, P149; Kepner WA, 1906, AM NAT, V40, P335, DOI 10.1086/278621; Klein J, 1882, BOT ZBL, V11, P247; Klein J, 1882, BOT CENTRALBL, V11, P187; Kudo RR., 1946, PROTOZOOLOGY, P778; Leidy J, 1879, FRESH WATER RHIZOPOD; Lloyd FE, 1926, SCIENCE, V63, P364, DOI 10.1126/science.63.1631.364; LOEBLICH ALFRED R., 1965, PROC BIOL SOC WASH, V78, P115; Marin B, 2003, PROTIST, V154, P99, DOI 10.1078/143446103764928521; Marin B, 1998, PROTIST, V149, P265, DOI 10.1016/S1434-4610(98)70033-1; MCFADDEN GI, 1986, PHYCOLOGIA, V25, P551, DOI 10.2216/i0031-8884-25-4-551.1; OLD KM, 1977, T BRIT MYCOL SOC, V68, P277, DOI 10.1016/S0007-1536(77)80018-1; OLD KM, 1978, SOIL BIOL BIOCHEM, V10, P93, DOI 10.1016/0038-0717(78)90077-9; OLD KM, 1980, PROTISTOLOGICA, V16, P277; OLD KM, 1980, SOIL BIOL BIOCHEM, V12, P169, DOI 10.1016/0038-0717(80)90054-1; PAGE FC, 1987, ARCH PROTISTENKD, V133, P199, DOI 10.1016/S0003-9365(87)80053-2; Page FC, 1991, PROTOZOENFAUNA, V2, P297; Pakzad U, 2003, UNTERSUCHUNGEN MYKOP; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; PATTERSON DJ, 1983, J PROTOZOOL, V30, P301, DOI 10.1111/j.1550-7408.1983.tb02920.x; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; PATTERSON DJ, 1987, J PROTOZOOL, V34, P63, DOI 10.1111/j.1550-7408.1987.tb03133.x; Pawlowski Jan, 2008, Protistology, V5, P281; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; Penard E, 1904, HELIOZOAIRES EAU DOU; PERNIN P, 1976, PROTISTOLOGICA, V12, P555; Poche Franz, 1913, Archiv fuer Protistenkunde Jena, V30; Poisson B., 1933, Compte Rendu des Seances de la Societe de Biologie Paris, V113, P1149; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rolleston G, 1888, FORMS ANIMAL LIFE MA; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROPSTORF P, 1994, J EUKARYOT MICROBIOL, V41, P18, DOI 10.1111/j.1550-7408.1994.tb05930.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAYRE RM, 1973, J NEMATOL, V5, P258; Schepotieff A, 1912, ZOOL JB ABT F ANAT, V32, P367; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Smirnov AV, 2011, PROTIST, V162, P545, DOI 10.1016/j.protis.2011.04.004; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tregouboff G, 1866, TRAITE ZOOLOGIE PROT, P437; VALKANOV A., 1940, ARCH PROTISTENK, V93, P225; WEBER AP, 1952, NATURE, V169, P834, DOI 10.1038/169834b0; West G. S., 1901, Journal of the Linnean Society, Vxxviii, P308; WINSLOW R. D., 1957, TIJDSCHR PLANTENZIEKTEN, V63, P242, DOI 10.1007/BF01988794; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698; Zettler LAA, 2001, J EUKARYOT MICROBIOL, V48, P293, DOI 10.1111/j.1550-7408.2001.tb00317.x; Zopf, 1885, MORPHOLOGIE BIOL NIE, P45; Zopf W, 1885, HDB BOT, P1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; ZWILLENBERG L. O., 1953, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V19, P101, DOI 10.1007/BF02594837	84	60	61	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31165	10.1371/journal.pone.0031165	http://dx.doi.org/10.1371/journal.pone.0031165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355342	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300042
J	Huard, B; Tran, NL; Benkhoucha, M; Manzin-Lorenzi, C; Santiago-Raber, ML				Huard, Bertrand; Ngoc Lan Tran; Benkhoucha, Mahdia; Manzin-Lorenzi, Celine; Santiago-Raber, Marie-Laure			Selective APRIL Blockade Delays Systemic Lupus Erythematosus in Mouse	PLOS ONE			English	Article							DEFICIENT MICE; AUTOIMMUNE-DISEASE; MONOCYTE SUBSET; B-CELLS; BAFF; RECEPTOR; TACI; BCMA; PROLIFERATION; PROTEOGLYCANS	SLE pathogenesis is complex, but it is now widely accepted that autoantibodies play a key role in the process by forming excessive immune complexes; their deposits within tissues leading to inflammation and functional damages. A proliferation inducing ligand (APRIL) is a member of the tumor necrosis factor (TNF) superfamily mediating antibody-producing plasma cell (PC)-survival that may be involved in the duration of pathogenic autoantibodies in lupus. We found significant increases of APRIL at the mRNA and protein levels in bone marrow but not spleen cells from NZB/W lupus mice, as compared to control mice. Selective antibody-mediated APRIL blockade delays disease development in this model by preventing proteinuria, kidney lesions, and mortality. Notably, this was achieved by decreasing anti-DNA and anti-chromatin autoantibody levels, without any perturbation of B- and T- cell homeostasis. Thus, anti-APRIL treatment may constitute an alternative therapy in SLE highly specific to PCs compared to other B-cell targeting therapies tested in this disease, and likely to be associated with less adverse effects than any anti-inflammatory and immunosuppressant agents previously used.	[Huard, Bertrand; Ngoc Lan Tran; Benkhoucha, Mahdia; Manzin-Lorenzi, Celine; Santiago-Raber, Marie-Laure] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Huard, Bertrand] Univ Hosp Geneva, Div Hematol, Geneva, Switzerland	University of Geneva; University of Geneva	Huard, B (corresponding author), Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland.	marie.santiago@unige.ch	huard, bertrand/L-8011-2013	huard, bertrand/0000-0003-1358-6576; Tran, Ngoc Lan/0000-0003-4270-376X	Alliance for Lupus Research; Swiss National Science Foundation; Leenaards Foundation	Alliance for Lupus Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leenaards Foundation	This work was supported by grants from the Alliance for Lupus Research, Swiss National Science Foundation, and Leenaards Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2005, ARTHRITIS RHEUM-US, V52, P2790, DOI 10.1002/art.21365; Burjanadze M, 2009, HISTOL HISTOPATHOL, V24, P1061, DOI 10.14670/HH-24.1061; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; George-Chandy A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2484; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Haubitz M, 2010, BIOL-TARGETS THER, V4, P263, DOI 10.2147/BTT.S7581; Hegazy M, 2010, CLIN IMMUNOL, V135, P118, DOI 10.1016/j.clim.2009.12.012; Hendriks J, 2005, CELL DEATH DIFFER, V12, P637, DOI 10.1038/sj.cdd.4401647; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; IZUI S, 1988, EUR J IMMUNOL, V18, P911, DOI 10.1002/eji.1830180612; Kawasaki A, 2007, RHEUMATOLOGY, V46, P776, DOI 10.1093/rheumatology/kem019; Kikuchi S, 2006, J IMMUNOL, V176, P3240, DOI 10.4049/jimmunol.176.5.3240; Koyama T, 2005, ANN RHEUM DIS, V64, P1065, DOI 10.1136/ard.2004.022491; Levesque MC, 2009, CLIN EXP IMMUNOL, V157, P198, DOI 10.1111/j.1365-2249.2009.03979.x; Liu WM, 2004, ARTHRITIS RHEUM-US, V50, P1884, DOI 10.1002/art.20290; Matthes T, 2011, BLOOD IN PRESS; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Ramanujam M, 2004, J IMMUNOL, V173, P3524, DOI 10.4049/jimmunol.173.5.3524; Ramanujam M, 2010, ARTHRITIS RHEUM-US, V62, P1457, DOI 10.1002/art.27368; Santiago-Raber ML, 2009, ARTHRITIS RHEUM-US, V60, P2408, DOI 10.1002/art.24787; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schwaller J, 2007, BLOOD, V109, P331, DOI 10.1182/blood-2006-02-001800; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Tsantikos E, 2010, J IMMUNOL, V184, P1348, DOI 10.4049/jimmunol.0901878; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Varfolomeev E, 2004, MOL CELL BIOL, V24, P997, DOI 10.1128/MCB.24.3.997-1006.2004; Yang M, 2005, J IMMUNOL, V175, P2814, DOI 10.4049/jimmunol.175.5.2814; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	29	28	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31837	10.1371/journal.pone.0031837	http://dx.doi.org/10.1371/journal.pone.0031837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355399	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300099
J	Lehner, M; Gotz, G; Proff, J; Schaft, N; Dorrie, J; Full, F; Ensser, A; Muller, YA; Cerwenka, A; Abken, H; Parolini, O; Ambros, PF; Kovar, H; Holter, W				Lehner, Manfred; Goetz, Gabriel; Proff, Julia; Schaft, Niels; Doerrie, Jan; Full, Florian; Ensser, Armin; Muller, Yves A.; Cerwenka, Adelheid; Abken, Hinrich; Parolini, Ornella; Ambros, Peter F.; Kovar, Heinrich; Holter, Wolfgang			Redirecting T Cells to Ewing's Sarcoma Family of Tumors by a Chimeric NKG2D Receptor Expressed by Lentiviral Transduction or mRNA Transfection	PLOS ONE			English	Article							RECOMBINANT IMMUNORECEPTORS; ADOPTIVE IMMUNOTHERAPY; CD28 COSTIMULATION; PROGNOSTIC-FACTORS; LYMPHOCYTES; CYTOTOXICITY; ACTIVATION; DNAM-1; SECRETION; ASYMMETRY	We explored the possibility to target Ewing's sarcoma family of tumors (ESFT) by redirecting T cells. To this aim, we considered NKG2D-ligands (NKG2D-Ls) as possible target antigens. Detailed analysis of the expression of MICA, MICB, ULBP-1, -2, and -3 in fourteen ESFT cell lines revealed consistent expression of at least one NKG2D-L. Thus, for redirecting T cells, we fused a CD3 zeta/CD28-derived signaling domain to the ectodomain of NKG2D, however, opposite transmembrane orientation of this signaling domain and NKG2D required inverse orientation fusion of either of them. We hypothesized that the particularly located C-terminus of the NKG2D ectodomain should allow reengineering of the membrane anchoring from a native N-terminal to an artificial C-terminal linkage. Indeed, the resulting chimeric NKG2D receptor (chNKG2D) was functional and efficiently mediated ESFT cell death triggered by activated T cells. Notably, ESFT cells with even low NKG2D-L expression were killed by CD8(pos) and also CD4(pos) cells. Both, mRNA transfection and lentiviral transduction resulted in high level surface expression of chNKG2D. However, upon target-cell recognition receptor surface levels were maintained by tranfected RNA only during the first couple of hours after transfection. Later, target-cell contact resulted in strong and irreversible receptor down-modulation, whereas lentivirally mediated expression of chNKG2D remained constant under these conditions. Together, our study defines NKG2D-Ls as targets for a CAR-mediated T cell based immunotherapy of ESFT. A comparison of two different methods of gene transfer reveals strong differences in the susceptibility to ligand-induced receptor down-modulation with possible implications for the applicability of RNA transfection.	[Lehner, Manfred; Goetz, Gabriel; Proff, Julia; Holter, Wolfgang] Univ Erlangen Nurnberg, Lab Cellular Therapy, Childrens Univ Hosp, Univ Klinikum Erlangen, D-91054 Erlangen, Germany; [Schaft, Niels; Doerrie, Jan] Univ Erlangen Nurnberg, Dept Dermatol, Univ Klinikum Erlangen, Erlangen, Germany; [Full, Florian; Ensser, Armin] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Erlangen, Germany; [Muller, Yves A.] Univ Erlangen Nurnberg, Lehrstuhl Biotech, Dept Biol, Erlangen, Germany; [Cerwenka, Adelheid] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Abken, Hinrich] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Parolini, Ornella] Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy; [Ambros, Peter F.; Kovar, Heinrich] St Anna Hosp, CCRI, Vienna, Austria	University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Cologne; Saint Anna Children's Hospital	Lehner, M (corresponding author), Univ Erlangen Nurnberg, Lab Cellular Therapy, Childrens Univ Hosp, Univ Klinikum Erlangen, D-91054 Erlangen, Germany.	manfred.lehner@uk-erlangen.de	Ambros, Peter/AAA-1266-2021; Muller, Yves A/R-5397-2016; Schaft, Niels/H-3713-2011; Dörrie, Jan/H-3678-2011; PAROLINI, ORNELLA/C-7946-2013; PAROLINI, ORNELLA/ABI-7862-2020	Ambros, Peter/0000-0002-5507-7211; Muller, Yves A/0000-0003-0519-8928; Schaft, Niels/0000-0001-8236-9298; Dörrie, Jan/0000-0002-3478-0741; PAROLINI, ORNELLA/0000-0002-5211-6430; PAROLINI, ORNELLA/0000-0002-5211-6430; Cerwenka, Adelheid/0000-0001-6977-3536; Lehner, Manfred/0000-0002-5776-4218; Full, Florian/0000-0003-1900-5891; Kovar, Heinrich/0000-0001-6873-9109	Wilhelm Sander-Foundation [2002.034.1, 2009.002.1]; Staedtler-Foundation [24/09]; Interdisciplinary Center for Clinical Research (IZKF: Genesis, Diagnostics and Therapy of Inflammation Processes); German Research Foundation (DFG) [SCHA 1247/1-1, EN 423/2-1, SFB796]; Fondazione Berlucchi, Brescia, Italy	Wilhelm Sander-Foundation; Staedtler-Foundation; Interdisciplinary Center for Clinical Research (IZKF: Genesis, Diagnostics and Therapy of Inflammation Processes); German Research Foundation (DFG)(German Research Foundation (DFG)); Fondazione Berlucchi, Brescia, Italy	This work was financially supported by the Wilhelm Sander-Foundation (project Nr. 2002.034.1 and 2009.002.1), Staedtler-Foundation (project 24/09), the Interdisciplinary Center for Clinical Research (IZKF: Genesis, Diagnostics and Therapy of Inflammation Processes), the German Research Foundation (DFG: project SCHA 1247/1-1), EN 423/2-1, and SFB796) and a grant from the Fondazione Berlucchi, Brescia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber A, 2008, EXP HEMATOL, V36, P1318, DOI 10.1016/j.exphem.2008.04.010; Barber A, 2007, CANCER RES, V67, P5003, DOI 10.1158/0008-5472.CAN-06-4047; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Birkholz K, 2009, GENE THER, V16, P596, DOI 10.1038/gt.2008.189; Brinkrolf P, 2009, INT J CANCER, V125, P879, DOI 10.1002/ijc.24461; Cho D, 2010, CLIN CANCER RES, V16, P3901, DOI 10.1158/1078-0432.CCR-10-0735; Cooper LJN, 2000, J VIROL, V74, P8207, DOI 10.1128/JVI.74.17.8207-8212.2000; Eagle RA, 2009, EUR J IMMUNOL, V39, P3207, DOI 10.1002/eji.200939502; Full F, 2010, J VIROL, V84, P4083, DOI 10.1128/JVI.02117-09; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Hombach A, 2001, J IMMUNOL, V167, P6123, DOI 10.4049/jimmunol.167.11.6123; James SE, 2010, J IMMUNOL, V184, P4284, DOI 10.4049/jimmunol.0903701; James ST, 2008, J IMMUNOL, V180, P7028, DOI 10.4049/jimmunol.180.10.7028; Kloess S, 2010, EUR J IMMUNOL, V40, P3255, DOI 10.1002/eji.201040568; Kovar H, 1997, ONCOGENE, V15, P2225, DOI 10.1038/sj.onc.1201397; KOVAR H, 1993, ONCOGENE, V8, P2683; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Leavey PJ, 2008, PEDIATR BLOOD CANCER, V51, P334, DOI 10.1002/pbc.21618; Lehner M, 2007, J IMMUNOTHER, V30, P312, DOI 10.1097/01.cji.0000211345.11707.46; Loskog A, 2006, LEUKEMIA, V20, P1819, DOI 10.1038/sj.leu.2404366; McFarland BJ, 2003, STRUCTURE, V11, P411, DOI 10.1016/S0969-2126(03)00047-9; Meidenbauer N, 2003, J IMMUNOL, V170, P2161, DOI 10.4049/jimmunol.170.4.2161; Miser JS, 2007, PEDIATR BLOOD CANCER, V49, P894, DOI 10.1002/pbc.21233; Mitchell MS, 2002, J CLIN ONCOL, V20, P1075, DOI 10.1200/JCO.20.4.1075; Mitsiades N, 1998, AM J PATHOL, V153, P1947, DOI 10.1016/S0002-9440(10)65708-2; Molinero LL, 2002, J LEUKOCYTE BIOL, V71, P791; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Rodriguez-Galindo C, 2007, CANCER-AM CANCER SOC, V110, P375, DOI 10.1002/cncr.22821; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Rubnitz JE, 2010, J CLIN ONCOL, V28, P955, DOI 10.1200/JCO.2009.24.4590; de Hooge ASK, 2007, CLIN CANCER RES, V13, P206, DOI 10.1158/1078-0432.CCR-06-1457; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; Salih HR, 2006, HUM IMMUNOL, V67, P188, DOI 10.1016/j.humimm.2006.02.008; Salmon P, 2000, BLOOD, V96, P3392; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sun Q, 2002, BLOOD, V99, P3302, DOI 10.1182/blood.V99.9.3302; Textor S, 2008, INT J CANCER, V123, P2343, DOI 10.1002/ijc.23733; Thomas S, 2011, BLOOD, V118, P319, DOI 10.1182/blood-2010-12-326736; van Valen F, 1999, HUMAN CELL CULTURE, V1, P55; Van Valen F, 2000, INT J CANCER, V88, P252, DOI 10.1002/1097-0215(20001015)88:2<252::AID-IJC17>3.0.CO;2-U; Verhoeven DHJ, 2008, MOL IMMUNOL, V45, P3917, DOI 10.1016/j.molimm.2008.06.016; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Zhang T, 2005, BLOOD, V106, P1544, DOI 10.1182/blood-2004-11-4365; Zhang T, 2006, CANCER RES, V66, P5927, DOI 10.1158/0008-5472.CAN-06-0130; Zhao YB, 2010, CANCER RES, V70, P9053, DOI 10.1158/0008-5472.CAN-10-2880	51	85	98	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31210	10.1371/journal.pone.0031210	http://dx.doi.org/10.1371/journal.pone.0031210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355347	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300047
J	Li, P; Zhu, SY				Li, Ping; Zhu, Shunyi			Mutational Analysis of the Analgesic Peptide DrTx(1-42) Revealing a Functional Role of the Amino-Terminal Turn	PLOS ONE			English	Article							RESISTANT SODIUM-CHANNELS; ANTINOCICEPTIVE ACTIVITY; PAIN PATHWAYS; MICE; CONOTOXIN; DRUGS; DROSOTOXIN; DROSOMYCIN; ACID	Background: DrTx(1-42) (a carboxyl-terminally truncated version of drosotoxin) is a potent and selective blocker of tetrodotoxin-resistant (TTX-R) Na+ channels in rat dorsal root ganglion neurons with analgesic activity. This purpose is to identify key amino acids which are responsible for both blocking and analgesic effects of DrTx(1-42). Methods: On the basis of previous study, we designed five mutants of DrTx(1-42) (delN, D8A, D8K, G9A, and G9R) in the amino-terminal turn (N-turn) region, a proposed functional region located in the amino-terminus of the molecule. All these mutants were expressed in E. coli and purified by RP-HPLC. Electrophysiological properties of these analogues were examined by whole-cell patch-clamp recordings and their antinociceptive effects were investigated by the formalin test and acetic acid induced writhing test. Results: All the mutants except for G9A possess a similar secondary structure to that of DrTx(1-42), as identified by circular dichroism analysis. Three mutants (delN, D8A and G9A) were found almost inactive to TTX-R Na+ channels, whereas D8K retains similar activity and G9R showed decreased potency when compared with the wild-type molecule. Consistent with the electrophysiological observations, D8K and G9R exhibited antinociceptive effects in the second phase (inflammatory pain) of the formalin test and the acetic acid induced writhing test, while delN, D8A and G9A lack such effects. Conclusions: Our results show that the N-turn is closely related to function of DrTx(1-42). The mutant (D8A) as a control peptide further reveals that a charged residue at site 8 of the N-terminus is important for channel blockade and analgesic activity. This study indicates that blocking of voltage-gated TTX-R Na+ channel in DRG neurons contributes to analgesic effect in rat inflammatory pain. Structural and functional data described here offers support for the development of novel analgesic drugs through targeting TTX-R Na+ channels.	[Li, Ping; Zhu, Shunyi] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Li, P (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	Zhusy@ioz.ac.cn			National Natural Science Foundation of China [30730015, 30921006]; National Basic Research Program of China [2010CB945300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grants 30730015 and 30921006) and the National Basic Research Program of China (Grant 2010CB945300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Arihan O, 2009, J ETHNOPHARMACOL, V125, P274, DOI 10.1016/j.jep.2009.06.032; Billen B, 2008, CURR PHARM DESIGN, V14, P2492, DOI 10.2174/138161208785777423; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; DERAEDT R, 1980, EUR J PHARMACOL, V61, P17, DOI 10.1016/0014-2999(80)90377-5; Ekberg J, 2008, INT J BIOCHEM CELL B, V40, P2363, DOI 10.1016/j.biocel.2007.08.017; Ekberg J, 2006, P NATL ACAD SCI USA, V103, P17030, DOI 10.1073/pnas.0601819103; Ekberg J, 2006, INT J BIOCHEM CELL B, V38, P2005, DOI 10.1016/j.biocel.2006.06.008; Gao B, 2008, INSECT MOL BIOL, V17, P405, DOI 10.1111/j.1365-2583.2008.00810.x; Gomes NM, 2007, J ETHNOPHARMACOL, V109, P486, DOI 10.1016/j.jep.2006.08.018; Ikeda Y, 2001, LIFE SCI, V69, P2911, DOI 10.1016/S0024-3205(01)01374-1; Landon C, 2008, PROTEINS, V72, P229, DOI 10.1002/prot.21912; Martinez V, 1999, PAIN, V81, P179, DOI 10.1016/S0304-3959(99)00008-1; Romeo S, 2008, BBA-GEN SUBJECTS, V1780, P750, DOI 10.1016/j.bbagen.2008.01.012; Sakaue A, 2004, J PHARMACOL SCI, V95, P181, DOI 10.1254/jphs.FPJ03087X; Silos-Santiago I, 2008, CURR OPIN INVEST DR, V9, P83; Silver K, 2010, INT J BIOCHEM CELL B, V42, P2030, DOI 10.1016/j.biocel.2010.09.007; Wang CZ, 2006, TOXICON, V47, P122, DOI 10.1016/j.toxicon.2005.10.008; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Xiao YC, 2005, J BIOL CHEM, V280, P12069, DOI 10.1074/jbc.M411651200; Yu YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019865; Zhang ZT, 2010, DEV COMP IMMUNOL, V34, P953, DOI 10.1016/j.dci.2010.04.003; Zhu SY, 2008, MOL IMMUNOL, V45, P2531, DOI 10.1016/j.molimm.2008.01.007; Zhu SY, 2011, BIOCHEM PHARMACOL, V81, P425, DOI 10.1016/j.bcp.2010.10.015; Zhu SY, 2010, BIOCHEM PHARMACOL, V80, P1296, DOI 10.1016/j.bcp.2010.07.008	26	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31830	10.1371/journal.pone.0031830	http://dx.doi.org/10.1371/journal.pone.0031830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355398	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300098
J	Starkhammar, M; Georen, SK; Swedin, L; Dahlen, SE; Adner, M; Cardell, LO				Starkhammar, Magnus; Georen, Susanna Kumlien; Swedin, Linda; Dahlen, Sven-Erik; Adner, Mikael; Cardell, Lars Olaf			Intranasal Administration of poly(I:C) and LPS in BALB/c Mice Induces Airway Hyperresponsiveness and Inflammation via Different Pathways	PLOS ONE			English	Article							SMOOTH-MUSCLE; BRADYKININ; ASTHMA	Background: Bacterial and viral infections are known to promote airway hyperresponsiveness (AHR) in asthmatic patients. The mechanism behind this reaction is poorly understood, but pattern recognizing Toll-like receptors (TLRs) have recently been suggested to play a role. Materials and Methods: To explore the relation between infection-induced airway inflammation and the development of AHR, poly(I:C) activating TLR3 and LPS triggering TLR4, were chosen to represent viral and bacterial induced interactions, respectively. Female BALB/c or MyD88-deficient C57BL/6 mice were treated intranasally with either poly(I:C), LPS or PBS (vehicle for the control group), once a day, during 4 consecutive days. Results: When methacholine challenge was performed on day 5, BALB/c mice responded with an increase in airway resistance. The maximal resistance was higher in the poly(I:C) and LPS treated groups than among the controls, indicating development of AHR in response to repeated TLR activation. The proportion of lymphocytes in broncheoalveolar lavage fluid (BALF) increased after poly(I:C) treatment whereas LPS enhanced the amount of neutrophils. A similar cellular pattern was seen in lung tissue. Analysis of 21 inflammatory mediators in BALF revealed that the TLR response was receptor-specific. MyD88-deficient C57BL/6 mice responded to poly (I:C) with an influx of lymphocytes, whereas LPS caused no inflammation. Conclusion: In vivo activation of TLR3 and TLR4 in BALB/c mice both caused AHR in conjunction with a local inflammatory reaction. The AHR appeared to be identical regardless of which TLR that was activated, whereas the inflammation exhibited a receptor specific profile in terms of both recruited cells and inflammatory mediators. The inflammatory response caused by LPS appeared to be dependent on MyD88 pathway. Altogether the presented data indicate that the development of AHR and the induction of local inflammation might be the result of two parallel events, rather than one leading to another.	[Starkhammar, Magnus; Georen, Susanna Kumlien; Cardell, Lars Olaf] Karolinska Univ Hosp, Karolinska Inst, Div ENT Dis, CLINTEC, Stockholm, Sweden; [Starkhammar, Magnus; Georen, Susanna Kumlien; Swedin, Linda; Dahlen, Sven-Erik; Adner, Mikael] Karolinska Inst, Natl Inst Environm Med, Unit Expt Asthma & Allergy Res, Stockholm, Sweden; [Swedin, Linda; Dahlen, Sven-Erik; Adner, Mikael; Cardell, Lars Olaf] Karolinska Inst, Ctr Allergy Reseach, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Starkhammar, M (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Div ENT Dis, CLINTEC, Stockholm, Sweden.	lars-olaf.cardell@ki.se		Kumlien Georen, Susanna/0000-0001-7292-9255	Swedish Medical Research Council; The Swedish Heart Lung Foundation; Swedish Asthma and Allergy Foundation; The Stockholm County Council (ALF); Vinnova (CiDAT); Tore Nilsson's Foundation for Medical Research; Magnus Bergvalls Foundation; The Centre for Allergy Reseach, Karolinska Institutet	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); The Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Asthma and Allergy Foundation; The Stockholm County Council (ALF)(Stockholm County Council); Vinnova (CiDAT)(Vinnova); Tore Nilsson's Foundation for Medical Research; Magnus Bergvalls Foundation; The Centre for Allergy Reseach, Karolinska Institutet	This study was financially supported by the Swedish Medical Research Council, The Swedish Heart Lung Foundation, the Swedish Asthma and Allergy Foundation, The Stockholm County Council (ALF), Vinnova (CiDAT), Tore Nilsson's Foundation for Medical Research, Magnus Bergvalls Foundation and by The Centre for Allergy Reseach, Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adner M, 2002, BRIT J PHARMACOL, V137, P971, DOI 10.1038/sj.bjp.0704928; Bachar O, 2004, EUR J IMMUNOL, V34, P1196, DOI 10.1002/eji.200324569; Bachar O, 2006, AM J PHYSIOL-LUNG C, V291, pL322, DOI 10.1152/ajplung.00141.2006; Bozanicha EM, 2008, RESP PHYSIOL NEUROBI, V162, P190, DOI 10.1016/j.resp.2008.06.011; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Bryborn M, 2004, CLIN EXP ALLERGY, V34, P1291, DOI 10.1111/j.1365-2222.2004.02031.x; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Ekman AK, 2009, INT ARCH ALLERGY IMM, V149, P154, DOI 10.1159/000189199; Fransson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-100; Fransson M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-17; Huang TJ, 1999, AM J RESP CRIT CARE, V160, P1717, DOI 10.1164/ajrccm.160.5.9901029; Komlosi ZI, 2006, CLIN EXP ALLERGY, V36, P951, DOI 10.1111/j.1365-2222.2006.02514.x; Luo SF, 2000, BRIT J PHARMACOL, V130, P1799, DOI 10.1038/sj.bjp.0703489; Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36; Mansson A, 2006, IMMUNOLOGY, V118, P539, DOI 10.1111/j.1365-2567.2006.02392.x; Mansson A, 2009, J LEUKOCYTE BIOL, V85, P719, DOI 10.1189/jlb.0808494; Micillo E, 2000, ALLERGY, V55, P42; Newcomb Dawn C, 2009, Proc Am Thorac Soc, V6, P266, DOI 10.1513/pats.200806-056RM; Okuma T, 2004, J PATHOL, V204, P594, DOI 10.1002/path.1667; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Rodrigo GJ, 2004, CHEST, V125, P1081, DOI 10.1378/chest.125.3.1081; Safholm J, 2011, PULM PHARMACOL THER, V24, P361, DOI 10.1016/j.pupt.2011.01.001; Shan XY, 2006, AM J PHYSIOL-LUNG C, V291, pL324, DOI 10.1152/ajplung.00056.2006; Simpson JL, 2008, PAEDIATR RESPIR REV, V9, P263, DOI 10.1016/j.prrv.2008.05.007; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Swedin L, 2010, INT ARCH ALLERGY IMM, V153, P249, DOI 10.1159/000314365; Sykes A, 2008, J ALLERGY CLIN IMMUN, V122, P685, DOI 10.1016/j.jaci.2008.08.017; Tliba O, 2008, CURR ALLERGY ASTHM R, V8, P262, DOI 10.1007/s11882-008-0043-5; Togbe D, 2006, J LEUKOCYTE BIOL, V80, P451, DOI 10.1189/jlb.0206099	31	41	46	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32110	10.1371/journal.pone.0032110	http://dx.doi.org/10.1371/journal.pone.0032110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355412	Green Submitted, gold, Green Published			2022-12-25	WOS:000302741300112
J	Raza, S; Humayun, A; Abouna, S; Nattkemper, TW; Epstein, DBA; Khan, M; Rajpoot, NM				Raza, Shan-e-Ahmed; Humayun, Ahmad; Abouna, Sylvie; Nattkemper, Tim W.; Epstein, David B. A.; Khan, Michael; Rajpoot, Nasir M.			RAMTaB: Robust Alignment of Multi-Tag Bioimages	PLOS ONE			English	Article							IMAGE REGISTRATION METHODS; PROTEIN CLUSTERS; MICROSCOPY; INFORMATICS; ANNOTATION; SYSTEM	Background: In recent years, new microscopic imaging techniques have evolved to allow us to visualize several different proteins (or other biomolecules) in a visual field. Analysis of protein co-localization becomes viable because molecules can interact only when they are located close to each other. We present a novel approach to align images in a multi-tag fluorescence image stack. The proposed approach is applicable to multi-tag bioimaging systems which (a) acquire fluorescence images by sequential staining and (b) simultaneously capture a phase contrast image corresponding to each of the fluorescence images. To the best of our knowledge, there is no existing method in the literature, which addresses simultaneous registration of multi-tag bioimages and selection of the reference image in order to maximize the overall overlap between the images. Methodology/Principal Findings: We employ a block-based method for registration, which yields a confidence measure to indicate the accuracy of our registration results. We derive a shift metric in order to select the Reference Image with Maximal Overlap (RIMO), in turn minimizing the total amount of non-overlapping signal for a given number of tags. Experimental results show that the Robust Alignment of Multi-Tag Bioimages (RAMTaB) framework is robust to variations in contrast and illumination, yields sub-pixel accuracy, and successfully selects the reference image resulting in maximum overlap. The registration results are also shown to significantly improve any follow-up protein co-localization studies. Conclusions: For the discovery of protein complexes and of functional protein networks within a cell, alignment of the tag images in a multi-tag fluorescence image stack is a key pre-processing step. The proposed framework is shown to produce accurate alignment results on both real and synthetic data. Our future work will use the aligned multi-channel fluorescence image data for normal and diseased tissue specimens to analyze molecular co-expression patterns and functional protein networks.	[Raza, Shan-e-Ahmed; Rajpoot, Nasir M.] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Humayun, Ahmad] Georgia Inst Technol, Coll Comp, Atlanta, GA 30332 USA; [Abouna, Sylvie; Khan, Michael] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Nattkemper, Tim W.] Univ Bielefeld, Biodata Min Grp, D-33615 Bielefeld, Germany; [Epstein, David B. A.] Univ Warwick, Dept Math, Coventry CV4 7AL, W Midlands, England	University of Warwick; University System of Georgia; Georgia Institute of Technology; University of Warwick; University of Bielefeld; University of Warwick	Raza, S (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	nasir@dcs.warwick.ac.uk	Nattkemper, Tim W/F-3332-2017	Nattkemper, Tim W/0000-0002-7986-1158; Raza, Shan E Ahmed/0000-0002-1097-1738; Khan, Michael/0000-0002-8591-384X; Rajpoot, Nasir/0000-0002-4706-1308	Department of Computer Science at the University of Warwick; University of Warwick on the Institute of Advanced Study (IAS) [IAIC1003]	Department of Computer Science at the University of Warwick; University of Warwick on the Institute of Advanced Study (IAS)	SEAR is partially funded by the Department of Computer Science at the University of Warwick. Part of this work was completed when Dr. Humayun was employed by the University of Warwick on the Institute of Advanced Study (IAS) incubation award# IAIC1003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet C, 2003, SIAM J OPTIMIZ, V13, P889, DOI 10.1137/S1052623400378742; Barash E, 2010, IEEE T MED IMAGING, V29, P1457, DOI 10.1109/TMI.2010.2045005; Bhattacharya S, 2011, IDENTIFICATION COLON; Bhattacharya S, 2010, J PROTEOME RES, V9, P6112, DOI 10.1021/pr100157p; Bode M, 2007, NATURE METHODS APPL, V4, P1; Can A, 2008, I S BIOMED IMAGING, P288, DOI 10.1109/ISBI.2008.4540989; Chen HM, 2003, IEEE T MED IMAGING, V22, P1111, DOI 10.1109/TMI.2003.816949; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Friedenberger M, 2007, NAT PROTOC, V2, P2285, DOI 10.1038/nprot.2007.320; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Herold J, 2011, WIRES DATA MIN KNOWL, V1, P2, DOI 10.1002/widm.4; Herold J, 2010, COMPUT MED IMAG GRAP, V34, P446, DOI 10.1016/j.compmedimag.2009.10.004; KEYS RG, 1981, IEEE T ACOUST SPEECH, V29, P1153, DOI 10.1109/TASSP.1981.1163711; Kim I, 2007, I S BIOMED IMAGING, P1328, DOI 10.1109/ISBI.2007.357105; Kolda T.G., 2006, GENERATING SET DIREC; Langenkamper D., 2011, P WORKSH COMP SYST B; Li Y, 2011, IEEE T MED IMAGING, V30, P707, DOI 10.1109/TMI.2010.2093908; Likar B, 2001, IMAGE VISION COMPUT, V19, P33, DOI 10.1016/S0262-8856(00)00053-6; Lu XS, 2008, COMPUT MED IMAG GRAP, V32, P202, DOI 10.1016/j.compmedimag.2007.12.001; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Matula P, 2006, IEEE T IMAGE PROCESS, V15, P2388, DOI 10.1109/TIP.2006.875209; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Murphy RF, 2006, NAT BIOTECHNOL, V24, P1223, DOI 10.1038/nbt1006-1223; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Rieger B, 2004, MICROSC RES TECHNIQ, V64, P142, DOI 10.1002/jemt.20069; Rohde GK, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P712; Rohde GK, 2003, LECT NOTES COMPUT SC, V2717, P214; Salvi J, 2007, IMAGE VISION COMPUT, V25, P578, DOI 10.1016/j.imavis.2006.05.012; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Schubert W, 2009, J PROTEOME RES, V8, P2696, DOI 10.1021/pr800944f; Starkuviene V, 2007, BRIT J PHARMACOL, V152, P62, DOI 10.1038/sj.bjp.0707346; Swedlow JR, 2009, TRENDS CELL BIOL, V19, P656, DOI 10.1016/j.tcb.2009.08.007; Swedlow JR, 2009, ANNU REV BIOPHYS, V38, P327, DOI 10.1146/annurev.biophys.050708.133641; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; van Manen HJ, 2005, P NATL ACAD SCI USA, V102, P10159, DOI 10.1073/pnas.0502746102; Verveer PJ, 2008, HISTOCHEM CELL BIOL, V130, P833, DOI 10.1007/s00418-008-0517-5; Wang YP, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P57; Wells W M 3rd, 1996, Med Image Anal, V1, P35; Wilson CA, 2006, IEEE T IMAGE PROCESS, V15, P1939, DOI 10.1109/TIP.2006.873434; Yang SW, 2008, IEEE T IMAGE PROCESS, V17, P493, DOI 10.1109/TIP.2008.918017; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	43	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30894	10.1371/journal.pone.0030894	http://dx.doi.org/10.1371/journal.pone.0030894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22363510	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100030
J	Wang, HC; Kunz, S; Chen, G; Seebeck, T; Wan, YQ; Robinson, H; Martinelli, S; Ke, HM				Wang, Huanchen; Kunz, Stefan; Chen, Gong; Seebeck, Thomas; Wan, Yiqian; Robinson, Howard; Martinelli, Sibylla; Ke, Hengming			Biological and Structural Characterization of Trypanosoma cruzi Phosphodiesterase C and Implications for Design of Parasite Selective Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-SPECIFIC PHOSPHODIESTERASE; NUCLEOTIDE SPECIFIC PHOSPHODIESTERASES; SUBSTRATE-SPECIFICITY; DRUGS; OSMOREGULATION; LOCALIZATION; MECHANISMS; INSIGHT; ENZYMES; BINDING	Trypanosoma cruzi phosphodiesterase C (TcrPDEC) is a potential new drug target for the treatment of Chagas disease but has not been well studied. This study reports the enzymatic properties of various kinetoplastid PDECs and the crystal structures of the unliganded TcrPDEC1 catalytic domain and its complex with an inhibitor. Mutations of PDEC during the course of evolution led to inactivation of PDEC in Trypanosoma brucei/Trypanosoma evansi/Trypanosoma congolense, whereas the enzyme is active in all other kinetoplastids. The TcrPDEC1 catalytic domain hydrolyzes both cAMP and cGMP with a Km of 23.8 mu M and a k(cat) of 31 s(-1) for cAMP and a K-m of 99.1 mu M and a k(cat) of 17 s(-1) for cGMP, thus confirming its dual specificity. The crystal structures show that the N-terminal fragment wraps around the TcrPDEC catalytic domain and may thus regulate its enzymatic activity via direct interactions with the active site residues. A PDE5 selective inhibitor that has an IC50 of 230 nM for TcrPDEC1 binds to TcrPDEC1 in an orientation opposite to that of sildenafil. This observation, together with the screen of the inhibitory potency of human PDE inhibitors against TcrPDEC, implies that the scaffold of some human PDE inhibitors might be used as the starting model for design of parasite PDE inhibitors. The structural study also identified a unique parasite pocket that neighbors the active site and may thus be valuable for the design of parasite-specific inhibitors.	[Wang, Huanchen; Ke, Hengming] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Wang, Huanchen; Ke, Hengming] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kunz, Stefan; Seebeck, Thomas] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Chen, Gong; Wan, Yiqian] Sun Yat Sen Univ, Sch Chem & Chem Engn, Guangzhou 510275, Guangdong, Peoples R China; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Martinelli, Sibylla] Univ Bern, Dept Pathol, CH-3012 Bern, Switzerland	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Bern; Sun Yat Sen University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Bern	Ke, HM (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hke@meYnc.edu	, PEP-MX Core/AGV-4051-2022	Wang, Huanchen/0000-0003-2701-7155	National Institutes of Health [GM59791]; Swiss National Science Foundation [3100A-109245]; TI Pharma [T4-302]; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); TI Pharma; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM59791 (to H. K.). This work was also supported by Grant 3100A-109245 from the Swiss National Science Foundation and TI Pharma Project T4-302 (to T. S.), the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy, and the National Center for Research Resources of National Institutes of Health (to H. R.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alonso GD, 2006, MOL BIOCHEM PARASIT, V145, P40, DOI 10.1016/j.molbiopara.2005.09.005; Alonso GD, 2007, MOL BIOCHEM PARASIT, V152, P72, DOI 10.1016/j.molbiopara.2006.12.002; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Beavo J.A., 2006, CYCLIC NUCLEOTIDE PH; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buckner FS, 2010, CURR OPIN INFECT DIS, V23, P609, DOI 10.1097/QCO.0b013e3283402956; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; D'Angelo MA, 2004, BIOCHEM J, V378, P63, DOI 10.1042/BJ20031147; De Koning HP, 2012, J INFECT DI IN PRESS; Diaz-Benjumea R, 2006, BIOCHEM J, V399, P305, DOI 10.1042/BJ20060757; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Fersht A., 1999, STRUCTURE MECH PROTE, P103; Gould MK, 2011, FEMS MICROBIOL REV, V35, P515, DOI 10.1111/j.1574-6976.2010.00262.x; Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Johner A, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-25; Jones A, 2006, PROTEOMICS, V6, P259, DOI 10.1002/pmic.200500119; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; Ke HM, 2007, CURR TOP MED CHEM, V7, P391, DOI 10.2174/156802607779941242; King-Keller S, 2010, ANTIMICROB AGENTS CH, V54, P3738, DOI 10.1128/AAC.00313-10; Kunz S, 2006, MOL BIOCHEM PARASIT, V145, P133, DOI 10.1016/j.molbiopara.2005.09.018; Kunz S, 2005, FEBS J, V272, P6412, DOI 10.1111/j.1742-4658.2005.05039.x; Kunz S, 2004, EUR J BIOCHEM, V271, P637, DOI 10.1111/j.1432-1033.2003.03967.x; Laxman S, 2007, MOL INTERV, V7, P203, DOI 10.1124/mi.7.4.7; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lescure FX, 2010, LANCET INFECT DIS, V10, P556, DOI 10.1016/S1473-3099(10)70098-0; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Oberholzer M, 2007, FASEB J, V21, P720, DOI 10.1096/fj.06-6818com; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Pils B, 2004, MOL BIOL EVOL, V21, P625, DOI 10.1093/molbev/msh055; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Salas CO, 2011, CURR MED CHEM, V18, P144; Schoijet AC, 2011, MOL MICROBIOL, V79, P50, DOI 10.1111/j.1365-2958.2010.07429.x; Seebeck T, 2004, CURR MOL MED, V4, P585, DOI 10.2174/1566524043360113; Seebeck T, 2011, FUTURE MED CHEM, V3, P1289, DOI [10.4155/fmc.11.77, 10.4155/FMC.11.77]; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Stevens J, 2001, INFECT GENET EVOL, V1, P143, DOI 10.1016/S1567-1348(01)00018-1; Wang HC, 2005, J BIOL CHEM, V280, P30949, DOI 10.1074/jbc.M504398200; Wang H, 2008, MOL PHARMACOL, V73, P104, DOI 10.1124/mol.107.040212; Wang H, 2007, MOL MICROBIOL, V66, P1029, DOI 10.1111/j.1365-2958.2007.05976.x; Wang HC, 2007, P NATL ACAD SCI USA, V104, P5782, DOI 10.1073/pnas.0700279104; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Wang HC, 2008, BIOCHEMISTRY-US, V47, P12760, DOI 10.1021/bi801487x; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	53	23	23	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11788	11797		10.1074/jbc.M111.326777	http://dx.doi.org/10.1074/jbc.M111.326777			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22356915	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000302782200018
J	Geerts-Dimitriadou, C; Lu, YY; Geertsema, C; Goldbach, R; Kormelink, R				Geerts-Dimitriadou, Christina; Lu, Yun-Yueh; Geertsema, Corinne; Goldbach, Rob; Kormelink, Richard			Analysis of the Tomato spotted wilt virus Ambisense S RNA-Encoded Hairpin Structure in Translation	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN NSS; AFFECTING TRANSCRIPTION TERMINATION; TAIL-INDEPENDENT TRANSLATION; CAP-SNATCHING MECHANISM; ESCHERICHIA-COLI RNA; STEM-LOOP STRUCTURE; CDNA-BASED RESCUE; MESSENGER-RNA; INFLUENZA-VIRUS; INTERGENIC REGION	Background: The intergenic region (IR) of ambisense RNA segments from animal- and plant-infecting (-)RNA viruses functions as a bidirectional transcription terminator. The IR sequence of the Tomato spotted wilt virus (TSWV) ambisense S RNA contains stretches that are highly rich in A-residues and U-residues and is predicted to fold into a stable hairpin structure. The presence of this hairpin structure sequence in the 3' untranslated region (UTR) of TSWV mRNAs implies a possible role in translation. Methodology/Principal Findings: To analyse the role of the predicted hairpin structure in translation, various Renilla luciferase constructs containing modified 3' and/or 5' UTR sequences of the TSWV S RNA encoded nucleocapsid (N) gene were analyzed for expression. While good luciferase expression levels were obtained from constructs containing the 5' UTR and the 3' UTR, luciferase expression was lost when the hairpin structure sequence was removed from the 3' UTR. Constructs that only lacked the 5' UTR, still rendered good expression levels. When in addition the entire 3' UTR was exchanged for that of the S RNA encoded non-structural (NSs) gene transcript, containing the complementary hairpin folding sequence, the loss of luciferase expression could only be recovered by providing the 5' UTR sequence of the NSs transcript. Luciferase activity remained unaltered when the hairpin structure sequence was swapped for the analogous one from Tomato yellow ring virus, another distinct tospovirus. The addition of N and NSs proteins further increased luciferase expression levels from hairpin structure containing constructs. Conclusions/Significance: The results suggest a role for the predicted hairpin structure in translation in concert with the viral N and NSs proteins. The presence of stretches highly rich in A-residues does not rule out a concerted action with a poly(A)-tail-binding protein. A common transcription termination and translation strategy for plant- and animal-infecting ambisense RNA viruses is being discussed.	[Geerts-Dimitriadou, Christina; Lu, Yun-Yueh; Geertsema, Corinne; Goldbach, Rob; Kormelink, Richard] Wageningen Univ, Virol Lab, Wageningen, Netherlands	Wageningen University & Research	Geerts-Dimitriadou, C (corresponding author), Wageningen Univ, Virol Lab, Wageningen, Netherlands.	richard.kormelink@wur.nl	Kormelink, Richard/F-7437-2010	Kormelink, Richard/0000-0001-7360-1884	Netherlands Organization of Scientific Research, division of Chemical Sciences (NWO/CW)	Netherlands Organization of Scientific Research, division of Chemical Sciences (NWO/CW)(Netherlands Organization for Scientific Research (NWO)United States Department of Energy (DOE))	This work was financed by The Netherlands Organization of Scientific Research, division of Chemical Sciences (NWO/CW), www.nwo.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Bailey-Serres J, 1999, TRENDS PLANT SCI, V4, P142, DOI 10.1016/S1360-1385(99)01386-2; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Barr JN, 2003, VIROLOGY, V311, P326, DOI 10.1016/S0042-6822(03)00130-2; Blakqori G, 2005, J VIROL, V79, P10420, DOI 10.1128/JVI.79.16.10420-10428.2005; Blakqori G, 2009, J VIROL, V83, P3637, DOI 10.1128/JVI.02201-08; Borman AM, 2000, NUCLEIC ACIDS RES, V28, P4068, DOI 10.1093/nar/28.21.4068; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Bucher E, 2003, J VIROL, V77, P1329, DOI 10.1128/JVI.77.2.1329-1336.2003; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; DEAVILA AC, 1990, J GEN VIROL, V71, P2801, DOI 10.1099/0022-1317-71-12-2801; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; Di Bonito P, 1999, ARCH VIROL, V144, P1947, DOI 10.1007/s007050050717; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Duijsings D, 2001, EMBO J, V20, P2545, DOI 10.1093/emboj/20.10.2545; Duijsings D, 2001, THESIS WAGENINGEN U; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; EMERY VC, 1987, VIROLOGY, V156, P1, DOI 10.1016/0042-6822(87)90430-2; Fabian MR, 2006, RNA, V12, P1304, DOI 10.1261/rna.69506; Fabian MR, 2004, J BIOL CHEM, V279, P28862, DOI 10.1074/jbc.M401272200; Flick K, 2004, J VIROL, V78, P11726, DOI 10.1128/JVI.78.21.11726-11738.2004; GALLIE DR, 1994, GENE, V142, P159, DOI 10.1016/0378-1119(94)90256-9; Gallie DR, 2002, PLANT MOL BIOL, V50, P949, DOI 10.1023/A:1021220910664; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; Geerts-Dimitriadou C, 2011, VIROLOGY, V409, P17, DOI 10.1016/j.virol.2010.09.003; Geerts-Dimitriadou C, 2011, VIROLOGY, V409, P27, DOI 10.1016/j.virol.2010.09.006; GIORGI C, 1991, VIROLOGY, V180, P738, DOI 10.1016/0042-6822(91)90087-R; Habjan M, 2008, J GEN VIROL, V89, P2157, DOI 10.1099/vir.0.2008/002097-0; IAPALUCCI S, 1991, VIROLOGY, V182, P269, DOI 10.1016/0042-6822(91)90670-7; KORMELINK R, 1992, J GEN VIROL, V73, P2795, DOI 10.1099/0022-1317-73-11-2795; KORMELINK R, 1991, VIROLOGY, V181, P459, DOI 10.1016/0042-6822(91)90878-F; Kormelink R, 2011, BUNYAVIRIDAE: MOLECULAR AND CELLULAR BIOLOGY, P163; Leonard S, 2004, J GEN VIROL, V85, P1055, DOI 10.1099/vir.0.19706-0; Lopez N, 2001, J VIROL, V75, P12241, DOI 10.1128/JVI.75.24.12241-12251.2001; Lopez N, 2007, VIRUS RES, V124, P237, DOI 10.1016/j.virusres.2006.10.007; Marion RM, 1997, NUCLEIC ACIDS RES, V25, P4271, DOI 10.1093/nar/25.21.4271; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Meulewaeter F, 2004, NUCLEIC ACIDS RES, V32, P1721, DOI 10.1093/nar/gkh338; MEYER BJ, 1993, J VIROL, V67, P2621, DOI 10.1128/JVI.67.5.2621-2627.1993; Mir MA, 2008, P NATL ACAD SCI USA, V105, P19294, DOI 10.1073/pnas.0807211105; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; Mumford RA, 1996, ANN APPL BIOL, V128, P159, DOI 10.1111/j.1744-7348.1996.tb07097.x; Neeleman L, 2001, P NATL ACAD SCI USA, V98, P14286, DOI 10.1073/pnas.251542798; Nguyen M, 2003, VIRUS RES, V93, P141, DOI 10.1016/S0168-1702(03)00094-7; Pinschewer DD, 2005, J VIROL, V79, P4519, DOI 10.1128/JVI.79.7.4519-4526.2005; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; QIU Y, 1994, J VIROL, V68, P2425, DOI 10.1128/JVI.68.4.2425-2432.1994; Rao P, 2003, EMBO J, V22, P1188, DOI 10.1093/emboj/cdg109; REYNOLDS R, 1992, J MOL BIOL, V224, P53, DOI 10.1016/0022-2836(92)90575-5; REYNOLDS R, 1992, J MOL BIOL, V224, P31, DOI 10.1016/0022-2836(92)90574-4; Salvatore M, 2002, J VIROL, V76, P1206, DOI 10.1128/JVI.76.3.1206-1212.2002; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; SIDHU MS, 1995, VIROLOGY, V208, P800, DOI 10.1006/viro.1995.1215; SIMONS JF, 1991, J VIROL, V65, P4741, DOI 10.1128/JVI.65.9.4741-4748.1991; SIMONS JF, 1992, J VIROL, V66, P4233, DOI 10.1128/JVI.66.7.4233-4241.1992; SUTTER G, 1995, FEBS LETT, V371, P9, DOI 10.1016/0014-5793(95)00843-X; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Tortorici MA, 2001, VIRUS RES, V73, P41, DOI 10.1016/S0168-1702(00)00222-7; van Knippenberg I, 2005, VIRUS RES, V110, P125, DOI 10.1016/j.virusres.2005.01.012; van Knippenberg I, 2005, VIROLOGY, V335, P122, DOI 10.1016/j.virol.2005.01.041; van Knippenberg I, 2002, VIROLOGY, V303, P278, DOI 10.1006/viro.2002.1632; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; Yanguez E, 2011, VIRUS RES, V156, P1, DOI 10.1016/j.virusres.2010.12.016; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	68	29	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31013	10.1371/journal.pone.0031013	http://dx.doi.org/10.1371/journal.pone.0031013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363535	Green Submitted, gold, Green Published			2022-12-25	WOS:000302873700022
J	Abdullahi, O; Karani, A; Tigoi, CC; Mugo, D; Kungu, S; Wanjiru, E; Jomo, J; Musyimi, R; Lipsitch, M; Scott, JAG				Abdullahi, Osman; Karani, Angela; Tigoi, Caroline C.; Mugo, Daisy; Kungu, Stella; Wanjiru, Eva; Jomo, Jane; Musyimi, Robert; Lipsitch, Marc; Scott, J. Anthony G.			The Prevalence and Risk Factors for Pneumococcal Colonization of the Nasopharynx among Children in Kilifi District, Kenya	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; HAEMOPHILUS-INFLUENZAE; ANTIBIOTIC-RESISTANCE; SEROTYPE DISTRIBUTION; UNITED-STATES; RURAL AREA; CARRIAGE; DISEASE; ANTIBODY	Background: Pneumococcal conjugate vaccines (PCV) reduce nasopharyngeal carriage of vaccine-serotype pneumococci but increase in the carriage of non-vaccine serotypes. We studied the epidemiology of carriage among children 3-59 months old before vaccine introduction in Kilifi, Kenya. Methods: In a rolling cross-sectional study from October 2006 to December 2008 we approached 3570 healthy children selected at random from the population register of the Kilifi Health and Demographic Surveillance System and 134 HIV-infected children registered at a specialist clinic. A single nasopharyngeal swab was transported in STGG and cultured on gentamicin blood agar. A single colony of pneumococcus was serotyped by Quellung reaction. Results: Families of 2840 children in the population-based sample and 99 in the HIV-infected sample consented to participate; carriage prevalence was 65.8% (95% CI, 64.0-67.5%) and 76% (95% CI, 66-84%) in the two samples, respectively. Carriage prevalence declined progressively with age from 79% at 6-11 months to 51% at 54-59 months (p < 0.0005). Carriage was positively associated with coryza (Odds ratio 2.63, 95% CI 2.12-3.25) and cough (1.55, 95% CI 1.26-1.91) and negatively associated with recent antibiotic use (0.53 95% CI 0.34-0.81). 53 different serotypes were identified and 42% of isolates were of serotypes contained in the 10-valent PCV. Common serotypes declined in prevalence with age while less common serotypes did not. Conclusion: Carriage prevalence in children was high, serotypes were diverse, and the majority of strains were of serotypes not represented in the 10-valent PCV. Vaccine introduction in Kenya will provide a natural test of virulence for the many circulating non-vaccine serotypes.	[Abdullahi, Osman; Karani, Angela; Tigoi, Caroline C.; Mugo, Daisy; Kungu, Stella; Wanjiru, Eva; Jomo, Jane; Musyimi, Robert; Scott, J. Anthony G.] Ctr Geog Med Res Coast, Kenya Med Res Inst, Wellcome Trust Res Program, Kilifi, Kenya; [Abdullahi, Osman; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Scott, J. Anthony G.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	Kenya Medical Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford	Abdullahi, O (corresponding author), Ctr Geog Med Res Coast, Kenya Med Res Inst, Wellcome Trust Res Program, Kilifi, Kenya.	oabdulla@hsph.harvard.edu		Lipsitch, Marc/0000-0003-1504-9213	Wellcome Trust [081835, 092654/Z/10/A]	Wellcome Trust(Wellcome TrustEuropean Commission)	Professor Scott is funded by a research fellowship from the Wellcome Trust (grant 081835). The KEMRI-Wellcome Trust Research Programme is supported by core funding from the Wellcome Trust (#092654/Z/10/A). This paper is published with the permission of the Director of the Kenya Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2011, CLIN INFECT DI UNPUB; Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Abdullahi O, 2007, J CLIN MICROBIOL, V45, P3408, DOI 10.1128/JCM.01393-07; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P434; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Campbell JD, 2004, PEDIATR INFECT DIS J, V23, P642, DOI 10.1097/01.inf.0000130951.85974.79; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Feikin DR, 2003, PEDIATR INFECT DIS J, V22, P564, DOI 10.1097/00006454-200306000-00016; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Gonzalez BE, 2006, PEDIATR INFECT DIS J, V25, P301, DOI 10.1097/01.inf.0000207484.52850.38; HENDLEY JO, 1975, J INFECT DIS, V132, P55, DOI 10.1093/infdis/132.1.55; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Joloba ML, 2001, INT J ANTIMICROB AG, V17, P395, DOI 10.1016/S0924-8579(00)00345-9; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lipsitch M, 2011, EPIDEMIOLOGY UNPUB, DOI 10.1097/EDE.0b013e31824f2f32; LloydEvans N, 1996, PEDIATR INFECT DIS J, V15, P866, DOI 10.1097/00006454-199610000-00007; MASTRO TD, 1993, PEDIATR INFECT DIS J, V12, P824, DOI 10.1097/00006454-199310000-00006; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; McCool TL, 2004, INFECT IMMUN, V72, P5807, DOI 10.1128/IAI.72.10.5807-5813.2004; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Nicoletti C, 2007, DIAGN MICR INFEC DIS, V57, P259, DOI 10.1016/j.diagmicrobio.2006.08.021; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; ODempsey TJD, 1996, PEDIATR INFECT DIS J, V15, P431, DOI 10.1097/00006454-199605000-00010; Paul J, 1997, T ROY SOC TROP MED H, V91, P632, DOI 10.1016/S0035-9203(97)90500-9; Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P144; Rusen ID, 1997, PEDIATR INFECT DIS J, V16, P656, DOI 10.1097/00006454-199707000-00007; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Scott JAG, 2011, CLIN INFECT DIS, V53, P663, DOI 10.1093/cid/cir444; Scott JA, 2011, INT J EPIDEMIO UNPUB; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Smillie WG, 1929, J EXP MED, V50, P233, DOI 10.1084/jem.50.2.233; Steenhoff AP, 2006, CLIN INFECT DIS, V42, P907, DOI 10.1086/500941; Straker E, STUDY NASOPHARYNGEAL; Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; Yomo A, 1997, ANN TROP PAEDIATR, V17, P239, DOI 10.1080/02724936.1997.11747894	44	74	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30787	10.1371/journal.pone.0030787	http://dx.doi.org/10.1371/journal.pone.0030787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363489	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000302871500017
J	de Sampaio, PC; Auslaender, D; Krubasik, D; Failla, AV; Skepper, JN; Murphy, G; English, WR				de Sampaio, Pedro Correa; Auslaender, David; Krubasik, Davia; Failla, Antonio Virgilio; Skepper, Jeremy N.; Murphy, Gillian; English, William R.			A Heterogeneous In Vitro Three Dimensional Model of Tumour-Stroma Interactions Regulating Sprouting Angiogenesis	PLOS ONE			English	Article							SPHEROIDAL COCULTURE MODEL; ENDOTHELIAL GROWTH-FACTOR; MATRIX METALLOPROTEINASES; MULTICELLULAR SPHEROIDS; TYROSINE KINASE; BREAST-CANCER; SOLID TUMORS; MURAL CELLS; FIBRIN GELS; TIP CELLS	Angiogenesis, the formation of new blood vessels, is an essential process for tumour progression and is an area of significant therapeutic interest. Different in vitro systems and more complex in vivo systems have been described for the study of tumour angiogenesis. However, there are few human 3D in vitro systems described to date which mimic the cellular heterogeneity and complexity of angiogenesis within the tumour microenvironment. In this study we describe the Minitumour model - a 3 dimensional human spheroid-based system consisting of endothelial cells and fibroblasts in coculture with the breast cancer cell line MDA-MB-231, for the study of tumour angiogenesis in vitro. After implantation in collagen-I gels, Minitumour spheroids form quantifiable endothelial capillary-like structures. The endothelial cell precapillary sprouts are supported by the fibroblasts, which act as mural cells, and their growth is increased by the presence of cancer cells. Characterisation of the Minitumour model using small molecule inhibitors and inhibitory antibodies show that endothelial sprout formation is dependent on growth factors and cytokines known to be important for tumour angiogenesis. The model also shows a response to anti-angiogenic agents similar to previously described in vivo data. We demonstrate that independent manipulation of the different cell types is possible, using common molecular techniques, before incorporation into the model. This aspect of Minitumour spheroid analysis makes this model ideal for high content studies of gene function in individual cell types, allowing for the dissection of their roles in cell-cell interactions. Finally, using this technique, we were able to show the requirement of the metalloproteinase MT1-MMP in endothelial cells and fibroblasts, but not cancer cells, for sprouting angiogenesis.	[de Sampaio, Pedro Correa; Auslaender, David; Krubasik, Davia; Murphy, Gillian; English, William R.] Univ Cambridge, Dept Oncol, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England; [Failla, Antonio Virgilio] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Microscopy Unit, Cambridge, England; [Skepper, Jeremy N.] Univ Cambridge, Dept Physiol Dev & Neurosci, Multiimaging Ctr, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	de Sampaio, PC (corresponding author), Univ Cambridge, Dept Oncol, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England.	w.english@sheffield.ac.uk		Correa de Sampaio, Pedro/0000-0001-5597-2825; English, William/0000-0003-3024-2441	Cancer Research UK and Hutchinson Whampoa Limited; Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e Tecnologia) [SFRH/BD/35884/2007]; DAAD (Deutscher Akademischer Austausch Dienst); Trinity College Cambridge; British Heart Foundation [FS/03/055/15910]	Cancer Research UK and Hutchinson Whampoa Limited; Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); DAAD (Deutscher Akademischer Austausch Dienst)(Deutscher Akademischer Austausch Dienst (DAAD)); Trinity College Cambridge; British Heart Foundation(British Heart Foundation)	This work was supported by Cancer Research UK and Hutchinson Whampoa Limited. PCdS was funded by the Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e Tecnologia, grant number SFRH/BD/35884/2007). DK was supported by the DAAD (Deutscher Akademischer Austausch Dienst) and Trinity College Cambridge. A British Heart Foundation Intermediate Research Fellowship (grant number FS/03/055/15910) supported WRE during initiation of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; CHIQUETEHRISMANN R, 1986, CELL, V47, P131, DOI 10.1016/0092-8674(86)90374-0; Clamp AR, 2005, BRIT J CANCER, V93, P967, DOI 10.1038/sj.bjc.6602820; Cooley LS, 2010, J CELL SCI, V123, P3808, DOI 10.1242/jcs.064279; d'Ortho MP, 1998, FEBS LETT, V421, P159, DOI 10.1016/S0014-5793(97)01555-X; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Deryugina EI, 2002, CANCER RES, V62, P580; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Freund A, 2003, ONCOGENE, V22, P256, DOI 10.1038/sj.onc.1206113; GALARDY RE, 1994, CANCER RES, V54, P4715; Galvez BG, 2001, J BIOL CHEM, V276, P37491, DOI 10.1074/jbc.M104094200; Genis L, 2006, CANCER METAST REV, V25, P77, DOI 10.1007/s10555-006-7891-z; Ghosh S, 2007, FEBS LETT, V581, P4523, DOI 10.1016/j.febslet.2007.08.038; GORCZYCA W, 1993, ANTICANCER RES, V13, P851; Guttery DS, 2010, CANCER METAST REV, V29, P595, DOI 10.1007/s10555-010-9249-9; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; Jubb AM, 2006, NAT REV CANCER, V6, P626, DOI 10.1038/nrc1946; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; KAWAKATSU H, 1992, JPN J CANCER RES, V83, P1073, DOI 10.1111/j.1349-7006.1992.tb02724.x; Kebers F, 1998, EXP CELL RES, V240, P197, DOI 10.1006/excr.1998.3935; Kendall RL, 1999, J BIOL CHEM, V274, P6453, DOI 10.1074/jbc.274.10.6453; Kim JB, 2004, BREAST CANCER RES TR, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b; Knobloch J, 2008, CELL CYCLE, V7, P1121, DOI 10.4161/cc.7.9.5793; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; KOVALENKO M, 1994, CANCER RES, V54, P6106; Krubasik D, 2008, INT J CANCER, V122, P1261, DOI 10.1002/ijc.23234; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Kunz-Schughart LA, 1999, CELL BIOL INT, V23, P157, DOI 10.1006/cbir.1999.0384; Kunz-Schughart LA, 1998, INT J EXP PATHOL, V79, P1, DOI 10.1046/j.1365-2613.1998.00051.x; Kunz-Schughart LA, 2006, AM J PHYSIOL-CELL PH, V290, pC1385, DOI 10.1152/ajpcell.00248.2005; Lafleur MA, 2002, J CELL SCI, V115, P3427; LAWLEY TJ, 1989, J INVEST DERMATOL, V93, pS59, DOI 10.1111/1523-1747.ep12581070; Lee CC, 2010, INFLAMMATION; Liu H, 2008, ANGIOGENESIS, V11, P223, DOI 10.1007/s10456-008-9102-8; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Menu E, 2006, BLOOD, V107, P655, DOI 10.1182/blood-2005-01-0293; MONTESANO R, 1993, J CELL SCI, V105, P1013; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Noel A, 2008, SEMIN CELL DEV BIOL, V19, P52, DOI 10.1016/j.semcdb.2007.05.011; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; OFFNER FA, 1992, AM J PATHOL, V141, P601; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Reinmuth N, 2002, CLIN CANCER RES, V8, P3259; Salter JT, 2007, CANCER INVEST, V25, P518, DOI 10.1080/07357900701648516; Sleijfer S, 2004, EUR J CANCER, V40, P2377, DOI 10.1016/j.ejca.2004.07.023; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Walter-Yohrling J, 2003, CANCER CHEMOTH PHARM, V52, P263, DOI 10.1007/s00280-003-0664-2; Wenger A, 2005, CELLS TISSUES ORGANS, V181, P80, DOI 10.1159/000091097; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679	65	102	102	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30753	10.1371/journal.pone.0030753	http://dx.doi.org/10.1371/journal.pone.0030753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363483	gold, Green Published, Green Accepted			2022-12-25	WOS:000302871500016
J	Maeda, K; Kurata, H				Maeda, Kazuhiro; Kurata, Hiroyuki			A Symmetric Dual Feedback System Provides a Robust and Entrainable Oscillator	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; LIGHT-DARK CYCLES; PER-TIM COMPLEX; MULTIPARAMETER SENSITIVITY; DROSOPHILA-MELANOGASTER; BIOCHEMICAL NETWORKS; GENETIC REDUNDANCY; HEAT-SHOCK; MODEL; RHYTHMS	Many organisms have evolved molecular clocks to anticipate daily changes in their environment. The molecular mechanisms by which the circadian clock network produces sustained cycles have extensively been studied and transcriptional-translational feedback loops are common structures to many organisms. Although a simple or single feedback loop is sufficient for sustained oscillations, circadian clocks implement multiple, complicated feedback loops. In general, different types of feedback loops are suggested to affect the robustness and entrainment of circadian rhythms. To reveal the mechanism by which such a complex feedback system evolves, we quantify the robustness and light entrainment of four competing models: the single, semi-dual, dual, and redundant feedback models. To extract the global properties of those models, all plausible kinetic parameter sets that generate circadian oscillations are searched to characterize their oscillatory features. To efficiently perform such analyses, we used the two-phase search (TPS) method as a fast and non-biased search method and quasi-multiparameter sensitivity (QMPS) as a fast and exact measure of robustness to uncertainty of all kinetic parameters. So far the redundant feedback model has been regarded as the most robust oscillator, but our extensive analysis corrects or overcomes this hypothesis. The dual feedback model, which is employed in biology, provides the most robust oscillator to multiple parameter perturbations within a cell and most readily entrains to a wide range of light-dark cycles. The kinetic symmetry between the dual loops and their coupling via a protein complex are found critically responsible for robust and entrainable oscillations. We first demonstrate how the dual feedback architecture with kinetic symmetry evolves out of many competing feedback systems.	[Maeda, Kazuhiro; Kurata, Hiroyuki] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan	Kyushu Institute of Technology	Maeda, K (corresponding author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan.	kurata@bio.kyutech.ac.jp	Maeda, Kazuhiro/Y-3151-2019	Maeda, Kazuhiro/0000-0002-6038-1322	Ministry of Education, Culture, Sports, Science and Technology of Japan [22300101]; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) on Scientific Research (B) (22300101) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. KM was supported by Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Alves R, 2000, BIOINFORMATICS, V16, P534, DOI 10.1093/bioinformatics/16.6.534; Alves R, 2000, BIOINFORMATICS, V16, P786, DOI 10.1093/bioinformatics/16.9.786; Bae K, 2000, J NEUROSCI, V20, P1746; Bagheri N, 2008, J BIOL RHYTHM, V23, P525, DOI 10.1177/0748730408325041; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Cooke J, 1997, TRENDS GENET, V13, P360, DOI 10.1016/S0168-9525(97)01233-X; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; El-Samad H, 2005, P NATL ACAD SCI USA, V102, P2736, DOI 10.1073/pnas.0403510102; GOLDBETER A, 1995, P ROY SOC B-BIOL SCI, V261, P319, DOI 10.1098/rspb.1995.0153; Gonze D, 2000, J STAT PHYS, V101, P649, DOI 10.1023/A:1026410121183; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Kurata H, 2005, GENOME RES, V15, P590, DOI 10.1101/gr.3463705; Kurata H, 2003, NUCLEIC ACIDS RES, V31, P4071, DOI 10.1093/nar/gkg461; Kurata H, 2006, PLOS COMPUT BIOL, V2, P663, DOI 10.1371/journal.pcbi.0020059; Kurata H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001103; Kurata H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm769; Kurosawa G, 2002, J THEOR BIOL, V216, P193, DOI 10.1006/jtbi.2002.2546; Kurosawa G, 2006, J THEOR BIOL, V242, P478, DOI 10.1016/j.jtbi.2006.03.016; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Leloup JC, 1998, J BIOL RHYTHM, V13, P70, DOI 10.1177/074873098128999934; Maeda K., 2009, IPSJ T BIOINFO, V2, P2; Maeda K, 2011, J THEOR BIOL, V272, P174, DOI 10.1016/j.jtbi.2010.12.012; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; ROSENBLUM AL, 1971, IEEE T CIRCUITS SYST, VCT18, P592, DOI 10.1109/TCT.1971.1083355; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; SAVAGEAU MA, 1971, NATURE, V229, P542, DOI 10.1038/229542a0; SCHOEFFLER J, 1964, IEEE T CIRCUITS SYST, VCT11, P271, DOI 10.1109/TCT.1964.1082278; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Smolen P, 2004, BIOPHYS J, V86, P2786, DOI 10.1016/S0006-3495(04)74332-5; Smolen P, 2001, J NEUROSCI, V21, P6644, DOI 10.1523/JNEUROSCI.21-17-06644.2001; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; THOMAS JH, 1993, TRENDS GENET, V9, P395, DOI 10.1016/0168-9525(93)90140-D; Ueda HR, 2001, J THEOR BIOL, V210, P401, DOI 10.1006/jtbi.2000.2226; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Wilkins AS, 1997, BIOESSAYS, V19, P257, DOI 10.1002/bies.950190312; Xie Z, 2007, J THEOR BIOL, V245, P290, DOI 10.1016/j.jtbi.2006.10.028; Xie Z, 2010, BIOTECHNOL BIOENG, V105, P250, DOI 10.1002/bit.22540; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30489	10.1371/journal.pone.0030489	http://dx.doi.org/10.1371/journal.pone.0030489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363442	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500009
J	Han, J; Kim, HJ; Lee, SC; Hong, SP; Park, KW; Jeon, YH; Kim, DS; Cheong, HK; Kim, HS				Han, Jieun; Kim, Hyun Jung; Lee, Sang-Chul; Hong, Seungpyo; Park, Keunwan; Jeon, Young Ho; Kim, Dongsup; Cheong, Hae-Kap; Kim, Hak-Sung			Structure-Based Rational Design of a Toll-like Receptor 4 (TLR4) Decoy Receptor with High Binding Affinity for a Target Protein	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; CRYSTAL-STRUCTURE; MOLECULAR RECOGNITION; TLR4-MD-2 COMPLEX; FORCE-FIELD; SCAFFOLDS	Repeat proteins are increasingly attracting much attention as alternative scaffolds to immunoglobulin antibodies due to their unique structural features. Nonetheless, engineering interaction interface and understanding molecular basis for affinity maturation of repeat proteins still remain a challenge. Here, we present a structure-based rational design of a repeat protein with high binding affinity for a target protein. As a model repeat protein, a Toll-like receptor4 (TLR4) decoy receptor composed of leucine-rich repeat (LRR) modules was used, and its interaction interface was rationally engineered to increase the binding affinity for myeloid differentiation protein 2 (MD2). Based on the complex crystal structure of the decoy receptor with MD2, we first designed single amino acid substitutions in the decoy receptor, and obtained three variants showing a binding affinity (KD) one-order of magnitude higher than the wild-type decoy receptor. The interacting modes and contributions of individual residues were elucidated by analyzing the crystal structures of the single variants. To further increase the binding affinity, single positive mutations were combined, and two double mutants were shown to have about 3000- and 565-fold higher binding affinities than the wild-type decoy receptor. Molecular dynamics simulations and energetic analysis indicate that an additive effect by two mutations occurring at nearby modules was the major contributor to the remarkable increase in the binding affinities.	[Han, Jieun; Lee, Sang-Chul; Kim, Hak-Sung] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Hyun Jung; Jeon, Young Ho; Cheong, Hae-Kap] Korea Basic Sci Inst, Div Magnet Resonance Res, Cheongwon, Chungbuk, South Korea; [Kim, Hyun Jung] Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea; [Hong, Seungpyo; Park, Keunwan; Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Hak-Sung] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Basic Science Institute (KBSI); Chungbuk National University; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Han, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	haekap@kbsi.re.kr; skim76@kaist.ac.kr	Hong, Seungpyo/ABA-4461-2021; Kim, Hak-Sung/C-1929-2011; Kim, Dongsup/C-1612-2011	Hong, Seungpyo/0000-0003-1273-0740; LEE, Sangchul/0000-0002-7002-1179	Pioneer Research Program for Converging Technology [20110001745]; WCU [R31-2009-000-10071-0]; Brain Korea 21; Advanced Biomass RD Center [ABC-2010-0029800]; MEST	Pioneer Research Program for Converging Technology; WCU; Brain Korea 21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Advanced Biomass RD Center; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Pioneer Research Program for Converging Technology (20110001745), WCU program (R31-2009-000-10071-0), Brain Korea 21, and Advanced Biomass R&D Center (Grant ABC-2010-0029800) of Global Frontier Project funded by MEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Bublitz M, 2008, J MOL BIOL, V378, P87, DOI 10.1016/j.jmb.2008.01.100; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; Cho SW, 2005, STRUCTURE, V13, P1775, DOI 10.1016/j.str.2005.08.015; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jianmin M, 2011, J IMMUNOL, V187, P3683; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jung K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007403; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Ko J, 2007, J NEUROSCI RES, V85, P2824, DOI 10.1002/jnr.21306; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Liping L, 2011, CHEM BIO CHEM, V12, P1827; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nuttall SD, 2008, CURR OPIN PHARMACOL, V8, P609, DOI 10.1016/j.coph.2008.06.007; Papageorgiou AC, 1997, EMBO J, V16, P5162, DOI 10.1093/emboj/16.17.5162; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Tasumi S, 2009, P NATL ACAD SCI USA, V106, P12891, DOI 10.1073/pnas.0904443106; Velikovsky CA, 2009, NAT STRUCT MOL BIOL, V16, P725, DOI 10.1038/nsmb.1619; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028	35	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30929	10.1371/journal.pone.0030929	http://dx.doi.org/10.1371/journal.pone.0030929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363519	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600091
J	Jager, HC; McKinley, TJ; Wood, JLN; Pearce, GP; Williamson, S; Strugnell, B; Done, S; Habernoll, H; Palzer, A; Tucker, AW				Jaeger, Henrike C.; McKinley, Trevelyan J.; Wood, James L. N.; Pearce, Gareth P.; Williamson, Susanna; Strugnell, Benjamin; Done, Stanley; Habernoll, Henrike; Palzer, Andreas; Tucker, Alexander W.			Factors Associated with Pleurisy in Pigs: A Case-Control Analysis of Slaughter Pig Data for England and Wales	PLOS ONE			English	Article							EXPERIMENTAL HEMOPHILUS INFECTION; HAEMOPHILUS-PARASUIS; RISK-FACTORS; SPF-PIGLETS; LESIONS; HERDS; PREVALENCE; SEROVARS; SWINE	A case-control investigation was undertaken to determine management and health related factors associated with pleurisy in slaughter pigs in England and Wales. Methods: The British Pig Executive Pig Health Scheme database of abattoir pathology was used to identify 121 case (. 10% prevalence of pleurisy on 3 or more assessment dates in the preceding 24 months) and 121 control units (<= 5% prevalence of pleurisy on 3 or more assessment dates in the preceding 24 months). Farm data were collected by postal questionnaire. Data from respondents (70 cases and 51 controls) were analysed using simple logistic regression models with Bonferroni corrections. Limited multivariate analyses were also performed to check the robustness of the overall conclusions. Results and Conclusions: Management factors associated with increased odds of pleurisy included no all-in all-out pig flow (OR 9.3, 95% confidence interval [CI]: 3.3-29), rearing of pigs with an age difference of >1 month in the same airspace (OR 6.5 [2.8-17]) and repeated mixing (OR 2.2 [1.4-3.8]) or moving (OR 2.2 [1.5-3.4]) of pigs during the rearing phase. Those associated with decreased odds of pleurisy included filling wean-to-finish or grower-to-finish systems with piglets from <= 3 sources (OR 0.18 [0.07-0.41]) compared to farrow-to-finish systems, cleaning and disinfecting of grower (ORs 0.28 [0.13-0.61] and 0.29 [0.13-0.61]) and finisher (ORs 0.24 [0.11-0.51] and 0.2 [0.09-0.44]) accommodation between groups, and extended down time of grower and finisher accommodation (OR 0.84 [0.75-0.93] and 0.86 [0.77-0.94] respectively for each additional day of downtime). This study demonstrated the value of national-level abattoir pathology data collection systems for case control analyses and generated guidance for on-farm interventions to help reduce the prevalence of pleurisy in slaughter pigs.	[Jaeger, Henrike C.; McKinley, Trevelyan J.; Wood, James L. N.; Pearce, Gareth P.; Tucker, Alexander W.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Williamson, Susanna] Vet Labs Agcy AHVLA, Bury St Edmunds, Suffolk, England; [Strugnell, Benjamin; Done, Stanley] Vet Labs Agcy AHVLA, Thirsk, N Yorkshire, England; [Habernoll, Henrike] BQP Ltd, Stradbroke Business Ctr, Stradbroke, Suffolk, England; [Palzer, Andreas] Univ Munich, Clin Swine, Oberschleissheim, Germany	University of Cambridge; University of Munich	Jager, HC (corresponding author), Garth Partnership, Straight Lane, Beeford, East Yorkshire, England.	awt1000@cam.ac.uk	Wood, James/A-1626-2008; Pearce, Gareth P/D-1044-2013	Wood, James/0000-0002-0258-3188; Pearce, Gareth/0000-0002-0656-6553; Tucker, Alexander William/0000-0003-0062-0843	British Pig Executive (BPEX - a part of the UK's Agricultural and Horticultural Development Board); BBSRC [BB/G019274/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G019274/1] Funding Source: researchfish	British Pig Executive (BPEX - a part of the UK's Agricultural and Horticultural Development Board); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the British Pig Executive (BPEX - a part of the UK's Agricultural and Horticultural Development Board) for funding this project and providing the BPHS data base. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, BRIT PIG HLTH SCHEME; Augustijn M, 2008, P 20 C INT PIG VET S; Christensen G., 1999, Dansk Veterinartidsskrift, V82, P1006; Cleveland-Nielsen A, 2002, PREV VET MED, V55, P121, DOI 10.1016/S0167-5877(02)00089-2; ELBERS ARW, 1992, PREV VET MED, V14, P217, DOI 10.1016/0167-5877(92)90018-B; Enoe C, 2002, PREV VET MED, V54, P337, DOI 10.1016/S0167-5877(02)00029-6; FALK K, 1991, ACTA VET SCAND, V32, P67; Fraile L, 2010, VET J, V184, P326, DOI 10.1016/j.tvjl.2009.03.029; Gottschalk M, 2006, DIS SWINE, P563; Harrell FE, DESIGN PACKAGE R PAC; Hosmer D. W., APPL LOGISTIC REGRES; Hosmer DW, 1997, STAT MED, V16, P965; JANETSCHKE P, 1977, ARCH EXP VET MED, V31, P129; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; LECESSIE S, 1991, BIOMETRICS, V47, P1267, DOI 10.2307/2532385; Maes DG, 2001, VET REC, V148, P41, DOI 10.1136/vr.148.2.41; Martin J, 1977, Arch Exp Veterinarmed, V31, P347; Meyns T, 2011, VET J, V187, P388, DOI 10.1016/j.tvjl.2009.12.027; MOUSING J, 1990, PREV VET MED, V9, P107, DOI 10.1016/0167-5877(90)90029-H; Program N-RA, 2010, PROGRAM N RA VERIFIC; Rubies X, 1999, VET MICROBIOL, V66, P245, DOI 10.1016/S0378-1135(99)00007-3; Salak-Johnson JL, 2007, J ANIM SCI, V85, pE81, DOI 10.2527/jas.2006-538; Sanchez-Vazquez MJ, 2011, VET REC, V169, P413, DOI 10.1136/vr.d4814; SCHIMMEL D, 1985, ARCH EXP VET MED, V39, P944; Sorensen V, 2006, DIS SWINE, V9th, P149; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wiegand M, 1997, TIERARZTL PRAX, V25, P226; Zimmerman J., 2006, DIS SWINE, P387	28	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e29655	10.1371/journal.pone.0029655	http://dx.doi.org/10.1371/journal.pone.0029655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363407	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600008
J	Volpicelli, F; De Gregorio, R; Pulcrano, S; Perrone-Capano, C; di Porzio, U; Bellenchi, GC				Volpicelli, Floriana; De Gregorio, Roberto; Pulcrano, Salvatore; Perrone-Capano, Carla; di Porzio, Umberto; Bellenchi, Gian Carlo			Direct Regulation of Pitx3 Expression by Nurr1 in Culture and in Developing Mouse Midbrain	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; DOPAMINERGIC-NEURONS; DOWNSTREAM TARGET; SUBSTANTIA-NIGRA; BRAIN; CELLS; GENE; TRANSCRIPTION; SURVIVAL; STEM	Due to their correlation with major human neurological diseases, dopaminergic neurons are some of the most studied neuronal subtypes. Mesencephalic dopaminergic (mDA) differentiation requires the activation of a cascade of transcription factors, among which play a crucial role the nuclear receptor Nurr1 and the paired-like homeodomain 3, Pitx3. During development the expression of Nurr1 precedes that of Pitx3 and those of typical dopaminergic markers such as tyrosine hydroxylase (TH) and dopamine Transporter (DAT) that are directly regulated by Nurr1. Interestingly we have previously demonstrated that Nurr1 RNA silencing reduced Pitx3 transcripts, leading to the hypothesis that Nurr1 may control Pitx3 expression. Here we show that Nurr1 overexpression up-regulates that of Pitx3 in a dose-dependent manner by binding to a non-canonical NBRE consensus sequence, located at the 5' site of the gene. Interestingly, this sequence shows the same effect as the canonical one in promoting gene translation, and its deletion abolishes the ability of Nurr1 to sustain reporter gene expression. Moreover, we show that there is a direct interaction between Nurr1 and the Pitx3 gene promoter in dopaminergic cell cultures and midbrain embryonic tissue. Altogether, our results suggest that the regulation of Pitx3 by Nurr1 may be an essential event controlling the development and function of mDA neurons.	[Volpicelli, Floriana; De Gregorio, Roberto; Pulcrano, Salvatore; Perrone-Capano, Carla; di Porzio, Umberto; Bellenchi, Gian Carlo] Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy; [Perrone-Capano, Carla] Univ Naples Federico 2, Dept Biol Sci, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Naples Federico II	Volpicelli, F (corresponding author), Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy.	giancarlo.bellenchi@igb.cnr.it	Perrone-Capano, Carla/O-7708-2015; Perrone-Capano, Carla/AAX-3217-2020	Perrone-Capano, Carla/0000-0002-6327-9753; Perrone-Capano, Carla/0000-0002-6327-9753; di Porzio, Umberto/0000-0002-2139-8754; Pulcrano, Salvatore/0000-0002-5324-8689; BELLENCHI, GIANCARLO/0000-0002-9302-0021; Volpicelli, Floriana/0000-0003-0618-5504; De Gregorio, Roberto/0000-0001-6024-5913	Fondo per gli Investimenti di Ricerca di Base [FIRB-RBIN062YH4]; MEdical Research ITaly [MERIT-RBNE08LN4P]; Prrogetti di Ricerca di Interesse NAzionale [PRIN-2009TBCZJB_003]; Ministero della Salute [40]	Fondo per gli Investimenti di Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); MEdical Research ITaly; Prrogetti di Ricerca di Interesse NAzionale; Ministero della Salute(Ministry of Health, Italy)	This work was supported by "Fondo per gli Investimenti di Ricerca di Base" FIRB-RBIN062YH4, "MEdical Research ITaly" MERIT-RBNE08LN4P, "Prrogetti di Ricerca di Interesse NAzionale" PRIN-2009TBCZJB_003, and Ministero della Salute, Under-40 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; BRUNDIN P, 1985, BRAIN RES, V331, P251, DOI 10.1016/0006-8993(85)91550-1; CHOI HK, 1992, P NATL ACAD SCI USA, V89, P8943, DOI 10.1073/pnas.89.19.8943; Colon-Cesario WI, 2006, LEARN MEMORY, V13, P734, DOI 10.1101/lm.407706; Hermanson E, 2003, EXP CELL RES, V288, P324, DOI 10.1016/S0014-4827(03)00216-7; Hermanson E, 2006, J NEUROCHEM, V97, P1403, DOI 10.1111/j.1471-4159.2006.03829.x; Hwang DY, 2009, J NEUROCHEM, V111, P1202, DOI 10.1111/j.1471-4159.2009.06404.x; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Sacchetti P, 2001, J NEUROCHEM, V76, P1565, DOI 10.1046/j.1471-4159.2001.00181.x; Sacchetti P, 2002, J BIOL CHEM, V277, P35088, DOI 10.1074/jbc.M205816200; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simeone A, 2005, TRENDS NEUROSCI, V28, P62, DOI 10.1016/j.tins.2004.11.007; Sirin O, 2010, NAT CELL BIOL, V12, P1213, DOI 10.1038/ncb2125; Smidt MP, 2004, CELL TISSUE RES, V318, P35, DOI 10.1007/s00441-004-0943-1; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Smits SM, 2003, EUR J NEUROSCI, V18, P1731, DOI 10.1046/j.1460-9568.2003.02885.x; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Volpicelli F, 2007, J NEUROCHEM, V102, P441, DOI 10.1111/j.1471-4159.2007.04494.x; Xiao Q, 1996, NEUROSCIENCE, V75, P221, DOI 10.1016/0306-4522(96)00159-5; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	26	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30661	10.1371/journal.pone.0030661	http://dx.doi.org/10.1371/journal.pone.0030661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363463	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600049
J	Martinerie, L; Pussard, E; Meduri, G; Delezoide, AL; Boileau, P; Lombes, M				Martinerie, Laetitia; Pussard, Eric; Meduri, Geri; Delezoide, Anne-Lise; Boileau, Pascal; Lombes, Marc			Lack of Renal 11 Beta-Hydroxysteroid Dehydrogenase Type 2 at Birth, a Targeted Temporal Window for Neonatal Glucocorticoid Action in Human and Mice	PLOS ONE			English	Article							APPARENT MINERALOCORTICOID EXCESS; PARTIAL ALDOSTERONE RESISTANCE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; GENE-EXPRESSION; IN-UTERO; PRENATAL DEXAMETHASONE; RECEPTOR EXPRESSION; FETAL MEMBRANES; BLOOD-PRESSURE; HUMAN PLACENTA	Background: Glucocorticoid hormones play a major role in fetal organ maturation. Yet, excessive glucocorticoid exposure in utero can result in a variety of detrimental effects, such as growth retardation and increased susceptibility to the development of hypertension. To protect the fetus, maternal glucocorticoids are metabolized into inactive compounds by placental 11beta-hydroxysteroid dehydrogenase type2 (11 beta HSD2). This enzyme is also expressed in the kidney, where it prevents illicit occupation of the mineralocorticoid receptor by glucocorticoids. We investigated the role of renal 11 beta HSD2 in the control of neonatal glucocorticoid metabolism in the human and mouse. Methods: Cortisol (F) and cortisone (E) concentrations were measured in maternal plasma, umbilical cord blood and human newborn urine using HPLC. 11 beta HSD2 activity was indirectly assessed by comparing the F/E ratio between maternal and neonatal plasma (placental activity) and between plasma and urine in newborns (renal activity). Direct measurement of renal 11 beta HSD2 activity was subsequently evaluated in mice at various developmental stages. Renal 11 beta HSD2 mRNA and protein expression were analyzed by quantitative RT-PCR and immunohistochemistry during the perinatal period in both species. Results: We demonstrate that, at variance with placental 11 beta HSD2 activity, renal 11 beta HSD2 activity is weak in newborn human and mouse and correlates with low renal mRNA levels and absence of detectable 11 beta HSD2 protein. Conclusions: We provide evidence for a weak or absent expression of neonatal renal 11 beta HSD2 that is conserved among species. This temporal and tissue-specific 11 beta HSD2 expression could represent a physiological window for glucocorticoid action yet may constitute an important predictive factor for adverse outcomes of glucocorticoid excess through fetal programming.	[Martinerie, Laetitia; Pussard, Eric; Meduri, Geri; Lombes, Marc] INSERM, U693, F-94275 Le Kremlin Bicetre, France; [Martinerie, Laetitia; Pussard, Eric; Lombes, Marc] Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France; [Martinerie, Laetitia; Lombes, Marc] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Pussard, Eric; Meduri, Geri] Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Delezoide, Anne-Lise] Univ Paris Diderot, Serv Biol Dev, Hop Robert Debre, AP HP, Paris, France; [Delezoide, Anne-Lise; Boileau, Pascal; Lombes, Marc] PremUp Fdn, Paris, France; [Boileau, Pascal] Univ Paris 11, Serv Pediat & Reanimat Neonatale, Hop Antoine Beclere, AP HP, Clamart, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay	Martinerie, L (corresponding author), INSERM, U693, F-94275 Le Kremlin Bicetre, France.	marc.lombes@u-psud.fr	Boileau, Pascal/AAG-9683-2021; Boileau, Pascal/H-7508-2015; PUSSARD, Eric/S-6059-2018; Lombes, Marc/L-5933-2018; pussard, eric/J-9916-2013; Martinerie, Laetitia/S-7493-2018	Boileau, Pascal/0000-0001-9755-6467; Boileau, Pascal/0000-0001-9755-6467; Lombes, Marc/0000-0003-3189-023X; 	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Sud 11, France	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris-Sud 11, France	This work was supported by fundings from Institut National de la Sante et de la Recherche Medicale (Inserm) and Universite Paris-Sud 11, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaidy N, 2003, J CLIN ENDOCR METAB, V88, P5033, DOI 10.1210/jc.2002-021915; Atanasov AG, 2007, J AM SOC NEPHROL, V18, P1262, DOI 10.1681/ASN.2006111235; Aucott SW, 2008, PEDIATRICS, V122, P775, DOI 10.1542/peds.2007-2252; Baum M, 2010, AM J PHYSIOL-RENAL, V298, pF235, DOI 10.1152/ajprenal.00288.2009; BENEDIKTSSON R, 1993, LANCET, V341, P339, DOI 10.1016/0140-6736(93)90138-7; Bertram CE, 2002, REPRODUCTION, V124, P459, DOI 10.1530/rep.0.1240459; BROWN RW, 1993, ENDOCRINOLOGY, V132, P2614, DOI 10.1210/en.132.6.2614; Brown RW, 1996, ENDOCRINOLOGY, V137, P794, DOI 10.1210/en.137.2.794; Condon J, 1998, J CLIN ENDOCR METAB, V83, P4490, DOI 10.1210/jc.83.12.4490; Condon J, 1997, MOL CELL ENDOCRINOL, V127, P121, DOI 10.1016/S0303-7207(97)04000-8; Diaz R, 1998, J NEUROSCI, V18, P2570; Diederich S, 2002, J CLIN ENDOCR METAB, V87, P5695, DOI 10.1210/jc.2002-020970; Dodic M, 1999, TRENDS ENDOCRIN MET, V10, P86, DOI 10.1016/S1043-2760(98)00125-8; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; Farman N, 2000, KIDNEY INT, V57, P1364, DOI 10.1046/j.1523-1755.2000.00976.x; Gwathmey TM, 2011, HYPERTENSION, V57, P620, DOI 10.1161/HYPERTENSIONAHA.110.164970; Hirasawa G, 1999, J CLIN ENDOCR METAB, V84, P1453, DOI 10.1210/jc.84.4.1453; Holmes MC, 2006, NEUROSCIENCE, V137, P865, DOI 10.1016/j.neuroscience.2005.09.037; Huh SY, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-25; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Hundertmark S, 2001, HORM METAB RES, V33, P78, DOI 10.1055/s-2001-12429; Itani OA, 2002, AM J PHYSIOL-LUNG C, V282, pL631, DOI 10.1152/ajplung.00085.2001; Kajantie E, 2003, J CLIN ENDOCR METAB, V88, P493, DOI 10.1210/jc.2002-021378; Lin CL, 1997, J CLIN ENDOCR METAB, V82, P151, DOI 10.1210/jc.82.1.151; Martinerie L, 2009, PEDIATR RES, V66, P323, DOI 10.1203/PDR.0b013e3181b1bbec; Martinerie L, 2009, ENDOCRINOLOGY, V150, P4414, DOI 10.1210/en.2008-1498; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Moritz KM, 2011, AM J PHYSIOL-REG I, V301, pR500, DOI 10.1152/ajpregu.00818.2010; Mune T, 1996, HYPERTENSION, V27, P1193, DOI 10.1161/01.HYP.27.6.1193; MURPHY BEP, 1973, J CLIN ENDOCR METAB, V36, P1037, DOI 10.1210/jcem-36-5-1037; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Ortiz LA, 2001, KIDNEY INT, V59, P1663, DOI 10.1046/j.1523-1755.2001.0590051663.x; Pasqualini JR, 2005, J STEROID BIOCHEM, V97, P401, DOI 10.1016/j.jsbmb.2005.08.004; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Schoof E, 2001, J CLIN ENDOCR METAB, V86, P1313, DOI 10.1210/jc.86.3.1313; Shams M, 1998, HUM REPROD, V13, P799, DOI 10.1093/humrep/13.4.799; Sloboda DM, 2000, J ENDOCRINOL, V165, P79, DOI 10.1677/joe.0.1650079; Speirs HJL, 2004, J ENDOCRINOL, V181, P105, DOI 10.1677/joe.0.1810105; STEWART PM, 1988, J CLIN INVEST, V82, P340, DOI 10.1172/JCI113592; STEWART PM, 1995, J CLIN ENDOCR METAB, V80, P885, DOI 10.1210/jc.80.3.885; Thompson A, 2004, J STEROID BIOCHEM, V88, P367, DOI 10.1016/j.jsbmb.2003.12.014; THONY HC, 1995, EUR J PEDIATR, V154, pS65, DOI 10.1007/BF02191509; ULICK S, 1979, J CLIN ENDOCR METAB, V49, P757, DOI 10.1210/jcem-49-5-757; van Beek JP, 2004, J CLIN ENDOCR METAB, V89, P5614, DOI 10.1210/jc.2004-0113; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Welberg LAM, 2001, NEUROSCIENCE, V104, P71, DOI 10.1016/S0306-4522(01)00065-3; Wyrwoll CS, 2007, HYPERTENSION, V50, P579, DOI 10.1161/HYPERTENSIONAHA.107.091603; Wyrwoll CS, 2009, ENDOCRINOLOGY, V150, P1287, DOI 10.1210/en.2008-1100	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31949	10.1371/journal.pone.0031949	http://dx.doi.org/10.1371/journal.pone.0031949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359645	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200114
J	Zhang, LL; Hong, Z; Lin, WY; Shao, RX; Goto, K; Hsu, VW; Chung, RT				Zhang, Leiliang; Hong, Zhi; Lin, Wenyu; Shao, Run-Xuan; Goto, Kaku; Hsu, Victor W.; Chung, Raymond T.			ARF1 and GBF1 Generate a PI4P-Enriched Environment Supportive of Hepatitis C Virus Replication	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; 4-KINASE III ALPHA; TELAPREVIR; PEGINTERFERON; REGULATORS; RIBAVIRIN; LIPIDS; TRAFFICKING; RECRUITMENT; PHOSPHATASE	Cellular levels of phosphatidylinositol 4-phosphate (PI4P) have been shown to be upregulated during RNA replication of several viruses, including the HCV replicon model. However, whether PI4P is required in an infectious HCV model remains unknown. Moreover, it is not established whether the host transport machinery is sequestered by the generation of PI4P during HCV infection. Here we found that PI4P was enriched in HCV replication complexes when Huh7.5.1 cells were infected with JFH1. HCV replication was inhibited upon overexpression of the PI4P phosphatase Sac1. The PI4P kinase PI4KIII beta was also found to be required for HCV replication. Moreover, the vesicular transport proteins ARF1 and GBF1 colocalized with PI4KIII beta and were both required for HCV replication. During authentic HCV infection, PI4P plays an integral role in virus replication.	[Zhang, Leiliang; Hong, Zhi] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Zhang, Leiliang; Hong, Zhi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Leiliang; Lin, Wenyu; Shao, Run-Xuan; Goto, Kaku; Chung, Raymond T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA USA; [Hsu, Victor W.] Harvard Univ, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Sch Med, Boston, MA 02115 USA; [Hsu, Victor W.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Zhang, LL (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China.	rtchung@partners.org			National Institutes of Health (NIH) [AI069939, AI082630, DK078772]; Institute of Pathogen Biology, Chinese Academy of Medical Sciences [2011IPB108]; NIH-MGH Center for Human Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082630, R01AI069939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098079, K24DK078772] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Pathogen Biology, Chinese Academy of Medical Sciences; NIH-MGH Center for Human Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants AI069939, AI082630 and DK078772 (to RTC) from the National Institutes of Health (NIH), 2011IPB108 from Intramural Research Program of the Institute of Pathogen Biology, Chinese Academy of Medical Sciences (to LZ), and NIH-MGH Center for Human Immunology Pilot/Feasibility Study Grant (to WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Amako Y, 2011, J BIOL CHEM, V286, P11265, DOI 10.1074/jbc.M110.182097; Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; Antaki N, 2010, LIVER INT, V30, P342, DOI 10.1111/j.1478-3231.2009.02188.x; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Belov GA, 2005, J VIROL, V79, P7207, DOI 10.1128/JVI.79.11.7207-7216.2005; Belov GA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000216; Berger KL, 2011, J VIROL, V85, P8870, DOI 10.1128/JVI.00059-11; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; Bostan N, 2010, CRIT REV MICROBIOL, V36, P91, DOI 10.3109/10408410903357455; Einav S, 2008, NAT BIOTECHNOL, V26, P1019, DOI 10.1038/nbt.1490; Faure J, 2004, CURR BIOL, V14, P1056, DOI 10.1016/j.cub.2004.06.021; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jang Jae Young, 2010, Korean J Hepatol, V16, P263, DOI 10.3350/kjhep.2010.16.3.263; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Krauss M, 2007, FEBS LETT, V581, P2105, DOI 10.1016/j.febslet.2007.01.089; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Lim YS, 2011, J BIOL CHEM, V286, P11290, DOI 10.1074/jbc.M110.194472; Liu Y, 2009, ADV ENZYME REGUL, V49, P75, DOI 10.1016/j.advenzreg.2009.01.006; Matto M, 2011, J VIROL, V85, P946, DOI 10.1128/JVI.00753-10; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Santiago-Tirado FH, 2011, TRENDS CELL BIOL, V21, P515, DOI 10.1016/j.tcb.2011.05.005; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Tahirovic S, 2005, TRAFFIC, V6, P116, DOI 10.1111/j.1600-0854.2004.00255.x; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhang LL, 2009, P NATL ACAD SCI USA, V106, P163, DOI 10.1073/pnas.0811631106	46	47	47	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32135	10.1371/journal.pone.0032135	http://dx.doi.org/10.1371/journal.pone.0032135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359663	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200132
J	Delorme, A; Palmer, J; Onton, J; Oostenveld, R; Makeig, S				Delorme, Arnaud; Palmer, Jason; Onton, Julie; Oostenveld, Robert; Makeig, Scott			Independent EEG Sources Are Dipolar	PLOS ONE			English	Article							BLIND SOURCE SEPARATION; EVENT-RELATED POTENTIALS; COMPONENT ANALYSIS; VISUAL-CORTEX; ELECTROENCEPHALOGRAPHIC DATA; NEURONAL AVALANCHES; WORKING-MEMORY; BRAIN SOURCES; RESPONSES; DYNAMICS	Independent component analysis (ICA) and blind source separation (BSS) methods are increasingly used to separate individual brain and non-brain source signals mixed by volume conduction in electroencephalographic (EEG) and other electrophysiological recordings. We compared results of decomposing thirteen 71-channel human scalp EEG datasets by 22 ICA and BSS algorithms, assessing the pairwise mutual information (PMI) in scalp channel pairs, the remaining PMI in component pairs, the overall mutual information reduction (MIR) effected by each decomposition, and decomposition 'dipolarity' defined as the number of component scalp maps matching the projection of a single equivalent dipole with less than a given residual variance. The least well-performing algorithm was principal component analysis (PCA); best performing were AMICA and other likelihood/mutual information based ICA methods. Though these and other commonly-used decomposition methods returned many similar components, across 18 ICA/BSS algorithms mean dipolarity varied linearly with both MIR and with PMI remaining between the resulting component time courses, a result compatible with an interpretation of many maximally independent EEG components as being volume-conducted projections of partially-synchronous local cortical field activity within single compact cortical domains. To encourage further method comparisons, the data and software used to prepare the results have been made available (http://sccn.ucsd.edu/wiki/BSSComparison).	[Delorme, Arnaud; Palmer, Jason; Onton, Julie; Makeig, Scott] Univ Calif San Diego, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA; [Delorme, Arnaud] Univ Toulouse 3, Ctr Rech Cerveau & Cognit, F-31062 Toulouse, France; [Oostenveld, Robert] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Delorme, Arnaud] CNRS, CERCO, Toulouse, France; [Onton, Julie] Naval Hlth Res Ctr, San Diego, CA USA	University of California System; University of California San Diego; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC)	Delorme, A (corresponding author), Univ Calif San Diego, Swartz Ctr Computat Neurosci, La Jolla, CA 92093 USA.	arno@ucsd.edu	Delorme, Arnaud/F-8917-2011; Oostenveld, Robert/D-3259-2009	Oostenveld, Robert/0000-0002-1974-1293; Delorme, Arnaud/0000-0002-0799-3557	Swartz Foundation (Old Field NY); National Institute of Mental Health USA [RO1-NS047293-01A1]; National Science Foundation USA [NSF IIS-0613595]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047293] Funding Source: NIH RePORTER	Swartz Foundation (Old Field NY); National Institute of Mental Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation USA(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a gift from the Swartz Foundation (Old Field NY) and by grants from the National Institute of Mental Health USA (RO1-NS047293-01A1) and the National Science Foundation USA (NSF IIS-0613595). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin Acar Z, 2009, PATACH BASIS ELECTRO; Akalin Acar Z, 2011, J NEUROSCIE IN PRESS; Akalin Acar Z, 2011, ADAPTIVE MIXTURE IND; Amari S, 1999, NEURAL COMPUT, V11, P1875, DOI 10.1162/089976699300015990; Anemuller J, 2003, NEURAL NETWORKS, V16, P1311, DOI 10.1016/j.neunet.2003.08.003; Beggs JM, 2003, J NEUROSCI, V23, P11167; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Belouchrani A, 2000, ELECTRON LETT, V36, P2050, DOI 10.1049/el:20001436; Benayoun M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000846; Cardoso JF, 1999, NEURAL COMPUT, V11, P157, DOI 10.1162/089976699300016863; Chen Y, 2008, IEEE ENG MED BIO, P1879, DOI 10.1109/IEMBS.2008.4649552; Cichocki A., 2012, ADAPTIVE BLIND SIGNA, DOI DOI 10.1002/0470845899; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Crespo-Garcia M, 2008, ANN BIOMED ENG, V36, P467, DOI 10.1007/s10439-008-9442-y; Cruces S, 2002, NEUROCOMPUTING, V49, P87, DOI 10.1016/S0925-2312(02)00525-8; Dehghani N, 2010, J NEUROPHYSIOL, V104, P179, DOI 10.1152/jn.00198.2010; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, J NEUROSCI, V27, P11949, DOI 10.1523/JNEUROSCI.3477-07.2007; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Dien J, 2006, HUM BRAIN MAPP; Dyrholm M, 2007, NEURAL COMPUT, V19, P934, DOI 10.1162/neco.2007.19.4.934; Freeman WJ, 2000, J NEUROPHYSIOL, V84, P1266, DOI 10.1152/jn.2000.84.3.1266; Freeman WJ, 1975, MASS ACTION NERVOUS; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Gomez-Herrero G, 2008, NEUROIMAGE, V43, P497, DOI 10.1016/j.neuroimage.2008.07.032; Grau C, 2007, NEUROIMAGE, V36, P522, DOI 10.1016/j.neuroimage.2007.03.027; Hoffmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003004; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kang K, 2010, J COMPUT NEUROSCI, V29, P495, DOI 10.1007/s10827-009-0190-2; Karvanen J, 2002, SIGNAL PROCESS, V82, P663, DOI 10.1016/S0165-1684(01)00213-4; Kerkhof GA, 2010, PROG BRAIN RES, V185, P1, DOI 10.1016/B978-0-444-53702-7.00001-4; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Lee TW, 2000, COMPUT MATH APPL, V39, P1, DOI 10.1016/S0898-1221(00)00101-2; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Makeig S, 1996, ADV NEUR IN, V8, P145; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; MOCKS J, 1986, ELECTROEN CLIN NEURO, V65, P393, DOI 10.1016/0168-5597(86)90018-3; MODDEMEIJER R, 1989, SIGNAL PROCESS, V16, P233, DOI 10.1016/0165-1684(89)90132-1; Mullen T, 2011, MODELING CORTICAL SO; NUNEZ P L, 1974, Mathematical Biosciences, V21, P279, DOI 10.1016/0025-5564(74)90020-0; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Onton J, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.061.2009; Palmer JA, 2008, INT CONF ACOUST SPEE, P1805, DOI 10.1109/ICASSP.2008.4517982; Palmer JA, 2007, LECT NOTES COMPUTER; Pham DT, 1997, IEEE T SIGNAL PROCES, V45, P1712, DOI 10.1109/78.599941; Robinson PA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041904; Sarnthein J, 2005, INT J PSYCHOPHYSIOL, V57, P87, DOI 10.1016/j.ijpsycho.2005.03.015; SCHERG M, 1991, Brain Topography, V4, P143, DOI 10.1007/BF01132771; Stepanyants A, 2009, P NATL ACAD SCI USA, V106, P3555, DOI 10.1073/pnas.0810390106; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550	56	503	512	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30135	10.1371/journal.pone.0030135	http://dx.doi.org/10.1371/journal.pone.0030135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355308	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300008
J	Rosenthal, LA; Szakaly, RJ; Amineva, SP; Xing, YN; Hill, MR; Palmenberg, AC; Gern, JE; Sorkness, RL				Rosenthal, Louis A.; Szakaly, Renee J.; Amineva, Svetlana P.; Xing, Yina; Hill, Marchel R.; Palmenberg, Ann C.; Gern, James E.; Sorkness, Ronald L.			Lower Respiratory Tract Infection Induced by a Genetically Modified Picornavirus in Its Natural Murine Host	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; EXPERIMENTAL RHINOVIRUS INFECTION; LOWER AIRWAY RESPONSES; VIRUS-INDUCED ASTHMA; NF-KAPPA-B; POLY(C) TRACT; IN-VITRO; VIRAL-INFECTIONS; MONOCYTIC CELLS; INFLAMMATION	Infections with the picornavirus, human rhinovirus (HRV), are a major cause of wheezing illnesses and asthma exacerbations. In developing a murine model of picornaviral airway infection, we noted the absence of murine rhinoviruses and that mice are not natural hosts for HRV. The picornavirus, mengovirus, induces lethal systemic infections in its natural murine hosts, but small genetic differences can profoundly affect picornaviral tropism and virulence. We demonstrate that inhalation of a genetically attenuated mengovirus, vMC(0), induces lower respiratory tract infections in mice. After intranasal vMC(0) inoculation, lung viral titers increased, peaking at 24 h postinoculation with viral shedding persisting for 5 days, whereas HRV-A01a lung viral titers decreased and were undetectable 24 h after intranasal inoculation. Inhalation of vMC(0), but not vehicle or UV-inactivated vMC(0), induced an acute respiratory illness, with body weight loss and lower airway inflammation, characterized by increased numbers of airway neutrophils and lymphocytes and elevated pulmonary expression of neutrophil chemoattractant CXCR2 ligands (CXCL1, CXCL2, CXCL5) and interleukin-17A. Mice inoculated with vMC(0), compared with those inoculated with vehicle or UV-inactivated vMC(0), exhibited increased pulmonary expression of interferon (IFN-alpha, IFN-beta, IFN-lambda), viral RNA sensors [toll-like receptor (TLR) 3, TLR7, nucleotide-binding oligomerization domain containing 2 (NOD2)], and chemokines associated with HRV infection in humans (CXCL10, CCL2). Inhalation of vMC(0), but not vehicle or UV-inactivated vMC(0), was accompanied by increased airway fluid myeloperoxidase levels, an indicator of neutrophil activation, increased MUC5B gene expression, and lung edema, a sign of infection-related lung injury. Consistent with experimental HRV inoculations of nonallergic, nonasthmatic human subjects, there were no effects on airway hyperresponsiveness after inhalation of vMC(0) by healthy mice. This novel murine model of picornaviral airway infection and inflammation should be useful for defining mechanisms of HRV pathogenesis in humans.	[Rosenthal, Louis A.; Szakaly, Renee J.; Xing, Yina; Sorkness, Ronald L.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Amineva, Svetlana P.; Gern, James E.; Sorkness, Ronald L.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Hill, Marchel R.; Palmenberg, Ann C.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Sorkness, Ronald L.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rosenthal, LA (corresponding author), Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA.	lar@medicine.wisc.edu			National Institutes of Health [U19 AI070503]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health (http://www.nih.gov/) grant U19 AI070503 to LAR, ACP, and JEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini B, 1997, J ALLERGY CLIN IMMUN, V99, P618, DOI 10.1016/S0091-6749(97)70022-8; Avila PC, 2000, J ALLERGY CLIN IMMUN, V105, P923, DOI 10.1067/mai.2000.106214; Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Cakebread JA, 2011, J ALLERGY CLIN IMMUN, V127, P1148, DOI 10.1016/j.jaci.2011.01.023; Contoli M, 2005, CLIN EXP ALLERGY, V35, P137, DOI 10.1111/j.1365-2222.2005.02163.x; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; de Gouw HWFM, 1998, EUR RESPIR J, V11, P126, DOI 10.1183/09031936.98.11010126; DeMore JP, 2009, J ALLERGY CLIN IMMUN, V124, P245, DOI 10.1016/j.jaci.2009.05.030; Denlinger LC, 2009, AM J RESP CRIT CARE, V179, P265, DOI 10.1164/rccm.200802-293OC; Donninger H, 2003, J INFECT DIS, V187, P1809, DOI 10.1086/375246; DUKE GM, 1990, NATURE, V343, P474, DOI 10.1038/343474a0; FAHY JV, 1995, J ALLERGY CLIN IMMUN, V95, P843, DOI 10.1016/S0091-6749(95)70128-1; Fleming HE, 1999, AM J RESP CRIT CARE, V160, P100, DOI 10.1164/ajrccm.160.1.9808074; Fuji N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027247; Gern JE, 2002, PEDIAT ALLERG IMM-UK, V13, P386, DOI 10.1034/j.1399-3038.2002.01093.x; Gern JE, 1997, AM J RESP CRIT CARE, V155, P1872, DOI 10.1164/ajrccm.155.6.9196088; Gern JE, 1997, AM J RESP CRIT CARE, V155, P1159, DOI 10.1164/ajrccm.155.3.9117003; Gern JE, 1996, J IMMUNOL, V156, P621; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Grunberg K, 1997, CLIN EXP ALLERGY, V27, P36, DOI 10.1111/j.1365-2222.1997.tb00670.x; Grunberg K, 2002, EUR RESPIR J, V20, P274; Hall DJ, 2005, J IMMUNOL, V174, P8056, DOI 10.4049/jimmunol.174.12.8056; Hewson CA, 2010, EUR RESPIR J, V36, P1425, DOI 10.1183/09031936.00026910; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jarjour NN, 2000, J ALLERGY CLIN IMMUN, V105, P1169, DOI 10.1067/mai.2000.106376; Jartti T, 2008, EUR RESPIR J, V32, P314, DOI 10.1183/09031936.00161907; Kelly JT, 2008, J ALLERGY CLIN IMMUN, V122, P671, DOI 10.1016/j.jaci.2008.08.013; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Korpi-Steiner NL, 2006, J LEUKOCYTE BIOL, V80, P1364, DOI 10.1189/jlb.0606412; Kuo C, 2011, AM J PHYSIOL-LUNG C, V300, pL951, DOI 10.1152/ajplung.00411.2010; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; LEMANSKE RF, 1989, J CLIN INVEST, V83, P1, DOI 10.1172/JCI113843; Malmstrom K, 2006, J ALLERGY CLIN IMMUN, V118, P591, DOI 10.1016/j.jaci.2006.04.032; Martin LR, 2000, J VIROL, V74, P3074, DOI 10.1128/JVI.74.7.3074-3081.2000; Martin LR, 1996, J VIROL, V70, P2027, DOI 10.1128/JVI.70.3.2027-2031.1996; Maus UA, 2003, J IMMUNOL, V170, P3273, DOI 10.4049/jimmunol.170.6.3273; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Mosser AG, 2005, AM J RESP CRIT CARE, V171, P645, DOI 10.1164/rccm.200407-970OC; Mosser AG, 2002, J INFECT DIS, V185, P734, DOI 10.1086/339339; Nagarkar DR, 2010, J IMMUNOL, V185, P2525, DOI 10.4049/jimmunol.1000286; Nagarkar DR, 2009, J IMMUNOL, V183, P6698, DOI 10.4049/jimmunol.0900298; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; Olenec JP, 2010, J ALLERGY CLIN IMMUN, V125, P1001, DOI 10.1016/j.jaci.2010.01.059; Osorio JE, 1996, VIROLOGY, V223, P344, DOI 10.1006/viro.1996.0485; Osorio JE, 2000, VIRAL IMMUNOL, V13, P27, DOI 10.1089/vim.2000.13.27; PALMENBERG AC, 1994, ARCH VIROL, P67; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Rosenthal LA, 2010, IMMUNOL ALLERGY CLIN, V30, P497, DOI 10.1016/j.iac.2010.08.005; Rosenthal LA, 2010, J ALLERGY CLIN IMMUN, V125, P1212, DOI 10.1016/j.jaci.2010.04.002; Rosenthal LA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-122; Rueckert R R, 1981, Methods Enzymol, V78, P315; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Sajjan U, 2009, AM J PHYSIOL-LUNG C, V297, pL931, DOI 10.1152/ajplung.00150.2009; Schroth MK, 1999, AM J RESP CELL MOL, V20, P1220, DOI 10.1165/ajrcmb.20.6.3261; Singh AM, 2007, AM J RESP CRIT CARE, V175, P108, DOI 10.1164/rccm.200603-435PP; Skoner DP, 1996, EUR RESPIR J, V9, P1402, DOI 10.1183/09031936.96.09071402; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Sorkness RL, 1999, AM J RESP CRIT CARE, V160, P705, DOI 10.1164/ajrccm.160.2.9810002; Sorkness RL, 2007, AM J PHYSIOL-LUNG C, V292, pL85, DOI 10.1152/ajplung.00234.2006; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Tate MD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-57; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2002, EUR RESPIR J, V19, P68, DOI 10.1183/09031936.02.00226302; Wiehler S, 2007, AM J PHYSIOL-LUNG C, V293, pL505, DOI 10.1152/ajplung.00066.2007; Wos M, 2008, AM J RESP CRIT CARE, V177, P1082, DOI 10.1164/rccm.200607-973OC; Xatzipsaiti M, 2005, AM J RESP CRIT CARE, V172, P1037, DOI 10.1164/rccm.200502-315OC; Yuta A, 1998, AM J PHYSIOL-LUNG C, V274, pL1017, DOI 10.1152/ajplung.1998.274.6.L1017; Zambrano JC, 2003, J ALLERGY CLIN IMMUN, V111, P1008, DOI 10.1067/mai.2003.1396; Zhu Z, 1997, AM J PHYSIOL-LUNG C, V273, pL814, DOI 10.1152/ajplung.1997.273.4.L814	76	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32061	10.1371/journal.pone.0032061	http://dx.doi.org/10.1371/journal.pone.0032061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355409	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300109
J	Schomacker, H; Hebner, RM; Boonyaratanakornkit, J; Surman, S; Amaro-Carambot, E; Collins, PL; Schmidt, AC				Schomacker, Henrick; Hebner, Rebecca M.; Boonyaratanakornkit, Jim; Surman, Sonja; Amaro-Carambot, Emerito; Collins, Peter L.; Schmidt, Alexander C.			The C Proteins of Human Parainfluenza Virus Type 1 Block IFN Signaling by Binding and Retaining Stat1 in Perinuclear Aggregates at the Late Endosome	PLOS ONE			English	Article							SENDAI-VIRUS; V-PROTEIN; VACCINE CANDIDATES; ALPHA-INTERFERON; RNA-SYNTHESIS; NUCLEAR ACCUMULATION; MANNOSE 6-PHOSPHATE; NONHUMAN-PRIMATES; GAMMA-INTERFERON; PREVENTING STAT1	Interferons (IFNs) play a crucial role in the antiviral immune response. Whereas the C proteins of wild-type human parainfluenza virus type 1 (WT HPIV1) inhibit both IFN-beta induction and signaling, a HPIV1 mutant encoding a single amino acid substitution (F170S) in the C proteins is unable to block either host response. Here, signaling downstream of the type 1 IFN receptor was examined in Vero cells to define at what stage WT HPIV1 can block, and F170S HPIV1 fails to block, IFN signaling. WT HPIV1 inhibited phosphorylation of both Stat1 and Stat2, and this inhibition was only slightly reduced for F170S HPIV1. Degradation of Stat1 or Stat2 was not observed. The HPIV1 C proteins were found to accumulate in the perinuclear space, often forming large granules, and co-localized with Stat1 and the cation-independent mannose 6-phosphate receptor (M6PR) that is a marker for late endosomes. Upon stimulation with IFN-beta, both the WT and F170S C proteins remained in the perinuclear space, but only the WT C proteins prevented Stat1 translocation to the nucleus. In addition, WT HPIV1 C proteins, but not F170S C proteins, co-immunoprecipitated both phosphorylated and unphosphorylated Stat1. Our findings suggest that the WT HPIV1 C proteins form a stable complex with Stat1 in perinuclear granules that co-localize with M6PR, and that this direct interaction between the WT HPIV1 C proteins and Stat1 is the basis for the ability of HPIV1 to inhibit IFN signaling. The F170S mutation in HPIV1 C did not prevent perinuclear co-localization with Stat1, but apparently weakened this interaction such that, upon IFN stimulation, Stat1 was translocated to the nucleus to induce an antiviral response.	[Schomacker, Henrick; Hebner, Rebecca M.; Boonyaratanakornkit, Jim; Surman, Sonja; Amaro-Carambot, Emerito; Collins, Peter L.; Schmidt, Alexander C.] NIAID, RNA Viruses Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schomacker, H (corresponding author), NIAID, RNA Viruses Sect, Infect Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	schmidta@niaid.nih.gov		Tripp, Ralph/0000-0002-2924-9956	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NIH; MedImmune, LLC	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MedImmune, LLC(AstraZenecaMedimmune)	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. This research was also supported in part by a cooperative research and development agreement (CRADA) between NIH and MedImmune, LLC, for the development of HPIV, RSV and HPMV vaccines. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Andrejeva J, 2002, J VIROL, V76, P2159, DOI 10.1128/JVI.76.5.2159-2167.2002; Bartlett EJ, 2005, VACCINE, V23, P4631, DOI 10.1016/j.vaccine.2005.04.035; Bartlett EJ, 2008, J VIROL, V82, P8965, DOI 10.1128/JVI.00853-08; Bartlett EJ, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-67; Boonyaratanakornkit J, 2010, J VIROL; Boonyaratanakornkit JB, 2009, J VIROL, V83, P1892, DOI 10.1128/JVI.01373-08; Bousse T, 2006, VIRUS RES, V121, P23, DOI 10.1016/j.virusres.2006.03.012; Chambers R, 2009, J GEN VIROL, V90, P1906, DOI 10.1099/vir.0.011700-0; Counihan ME, 2001, PEDIATR INFECT DIS J, V20, P646, DOI 10.1097/00006454-200107000-00003; CURRAN J, 1992, VIROLOGY, V189, P647, DOI 10.1016/0042-6822(92)90588-G; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Durbin AP, 1999, VIROLOGY, V261, P319, DOI 10.1006/viro.1999.9878; GALINSKI MS, 1992, VIROLOGY, V186, P543, DOI 10.1016/0042-6822(92)90020-P; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Garcin D, 2000, J VIROL, V74, P8823, DOI 10.1128/JVI.74.19.8823-8830.2000; Garcin D, 2004, J VIROL, V78, P8799, DOI 10.1128/JVI.78.16.8799-8811.2004; Garcin D, 2003, J VIROL, V77, P2321, DOI 10.1128/JVI.77.4.2321-2329.2003; Garcin D, 2002, VIROLOGY, V295, P256, DOI 10.1006/viro.2001.1342; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Garcin D, 1997, VIROLOGY, V238, P424, DOI 10.1006/viro.1997.8836; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Gosselin-Grenet AS, 2007, VIROLOGY, V365, P101, DOI 10.1016/j.virol.2007.03.039; Gotoh B, 2003, J VIROL, V77, P3360, DOI 10.1128/JVI.77.6.3360-3370.2003; Hasan MK, 2000, J VIROL, V74, P5619, DOI 10.1128/JVI.74.12.5619-5628.2000; Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; Irie T, 2008, VIROLOGY, V374, P495, DOI 10.1016/j.virol.2008.01.004; Irie T, 2008, VIROLOGY, V371, P108, DOI 10.1016/j.virol.2007.09.020; Itoh M, 1992, Uirusu, V42, P111; Itoh M, 1997, J GEN VIROL, V78, P3207, DOI 10.1099/0022-1317-78-12-3207; Itoh M, 1998, J VIROL, V72, P2927, DOI 10.1128/JVI.72.4.2927-2934.1998; Kato A, 2004, J VIROL, V78, P7443, DOI 10.1128/JVI.78.14.7443-7454.2004; Kato A, 2002, J VIROL, V76, P7114, DOI 10.1128/JVI.76.14.7114-7124.2002; KIYOTANI K, 1990, VIROLOGY, V177, P65, DOI 10.1016/0042-6822(90)90460-9; Kiyotani K, 2007, VIROLOGY, V359, P82, DOI 10.1016/j.virol.2006.08.053; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; KOMADA H, 1992, J GEN VIROL, V73, P875, DOI 10.1099/0022-1317-73-4-875; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Komatsu T, 2002, FEBS LETT, V511, P139, DOI 10.1016/S0014-5793(01)03301-4; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Kurotani A, 1998, GENES CELLS, V3, P111, DOI 10.1046/j.1365-2443.1998.00170.x; LODISH H, 2000, MOL CELL BIOL, P712; Marq JB, 2007, J VIROL, V81, P3187, DOI 10.1128/JVI.02465-06; Marx A, 1997, J INFECT DIS, V176, P1423, DOI 10.1086/514137; Nishio M, 1997, J GEN VIROL, V78, P1303, DOI 10.1099/0022-1317-78-6-1303; Nishio M, 2002, VIROLOGY, V300, P92, DOI 10.1006/viro.2002.1509; Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003; Parisien JP, 2001, VIROLOGY, V283, P230, DOI 10.1006/viro.2001.0856; Reed G, 1997, J INFECT DIS, V175, P807, DOI 10.1086/513975; REICHELDERFER TE, 1958, SCIENCE, V128, P779, DOI 10.1126/science.128.3327.779; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; Saito S, 2002, VIROLOGY, V293, P205, DOI 10.1006/viro.2001.1250; Sakaguchi T, 2005, J VIROL, V79, P8933, DOI 10.1128/JVI.79.14.8933-8941.2005; Schaap-Nutt A, 2010, VIROLOGY, V406, P65, DOI 10.1016/j.virol.2010.07.011; Slobod KS, 2004, VACCINE, V22, P3182, DOI 10.1016/j.vaccine.2004.01.053; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Takeuchi K, 2003, FEBS LETT, V545, P177, DOI 10.1016/S0014-5793(03)00528-3; Takeuchi K, 2001, GENES CELLS, V6, P545, DOI 10.1046/j.1365-2443.2001.00442.x; Van Cleve W, 2006, VIROLOGY, V352, P61, DOI 10.1016/j.virol.2006.04.011; Weinberg GA, 2009, J PEDIATR-US, V154, P694, DOI 10.1016/j.jpeds.2008.11.034; Wood RJ, 2008, J BIOL CHEM, V283, P4165, DOI 10.1074/jbc.M708723200; Young DF, 2000, VIROLOGY, V269, P383, DOI 10.1006/viro.2000.0240; Zuniga EI, 2007, CURR TOP MICROBIOL, V316, P337	66	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e28382	10.1371/journal.pone.0028382	http://dx.doi.org/10.1371/journal.pone.0028382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355301	gold, Green Published, Green Submitted			2022-12-25	WOS:000302741300001
J	Senderovich, Y; Ken-Dror, S; Vainblat, I; Blau, D; Izhaki, I; Halpern, M				Senderovich, Yigal; Ken-Dror, Shifra; Vainblat, Irina; Blau, Dvora; Izhaki, Ido; Halpern, Malka			A Molecular Study on the Prevalence and Virulence Potential of Aeromonas spp. Recovered from Patients Suffering from Diarrhea in Israel	PLOS ONE			English	Article							CHIRONOMID EGG MASSES; III SECRETION SYSTEM; VIBRIO-CHOLERAE; GENUS AEROMONAS; GENES; IDENTIFICATION; INFECTIONS; HYDROPHILA; CHILDREN; BACTERIA	Background: Species of the genus Aeromonas are native inhabitants of aquatic environments and have recently been considered emerging human pathogens. Although the gastrointestinal tract is by far the most common anatomic site from which aeromonads are recovered, their role as etiologic agents of bacterial diarrhea is still disputed. Aeromonas-associated diarrhea is a phenomenon occurring worldwide; however, the exact prevalence of Aeromonas infections on a global scale is unknown. Methodology/Principal Findings: The prevalence and virulence potential of Aeromonas in patients suffering from diarrhea in Israel was studied using molecular methods. 1,033 diarrheal stools were sampled between April and September 2010 and Aeromonas species were identified in 17 (similar to 2%) patients by sequencing the rpoD gene. Aeromonas species identity and abundance was: A. caviae (65%), A. veronii (29%) and Aeromonas taiwanensis (6%). This is the first clinical record of A. taiwanensis as a diarrheal causative since its recent discovery from a wound infection in a patient in Taiwan. Most of the patients (77%) from which Aeromonas species were isolated were negative for any other pathogens. The patients ranged from 1 to 92 years in age. Aeromonas isolates were found to possess different virulence-associated genes: ahpB (88%), pla/lip/lipH3/apl-1 (71%), act/hlyA/aerA (35%), alt (18%), ast (6%), fla (65%), lafA (41%), TTSS ascV (12%), TTSS ascF-ascG (12%), TTSS-dependent ADP-ribosylating toxins aexU (41%) and aexT (6%) in various combinations. Most of the identified strains were resistant to beta-lactam antibiotics but susceptible to third-generation cephalosporin antibiotics. Conclusions: Aeromonas may be a causative agent of diarrhea in patients in Israel and therefore should be included in routine bacteriological screenings.	[Senderovich, Yigal; Izhaki, Ido; Halpern, Malka] Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Ken-Dror, Shifra; Vainblat, Irina; Blau, Dvora] Clalit Hlth Serv Haifa, Microbiol Lab, Haifa, Israel; [Halpern, Malka] Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Oranim, Tivon, Israel	University of Haifa; Clalit Health Services; University of Haifa	Senderovich, Y (corresponding author), Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	mhalpern@research.haifa.ac.il	Halpern, Malka/AAH-1498-2019; Izhaki, Ido/I-9712-2019; Izhaki, Ido/D-5586-2011	Halpern, Malka/0000-0002-3407-2198; Izhaki, Ido/0000-0002-4525-4683; Izhaki, Ido/0000-0002-4525-4683	Research Authority, University of Haifa, Israel	Research Authority, University of Haifa, Israel	This study was supported by the Research Authority, University of Haifa, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R. K., 1998, Journal of Communicable Diseases, V30, P71; Aguilera-Arreola MG, 2005, FEMS MICROBIOL LETT, V242, P231, DOI 10.1016/j.femsle.2004.11.011; Albert MJ, 2000, J CLIN MICROBIOL, V38, P3785, DOI 10.1128/JCM.38.10.3785-3790.2000; Alperi A, 2010, INT J SYST EVOL MICR, V60, P2048, DOI 10.1099/ijs.0.014621-0; Anaissie EJ, 2002, ARCH INTERN MED, V162, P1483, DOI 10.1001/archinte.162.13.1483; Bin Kingombe CI, 1999, APPL ENVIRON MICROB, V65, P5293; Borchardt MA, 2003, EMERG INFECT DIS, V9, P224; Broza M, 2005, ENVIRON MICROBIOL, V7, P576, DOI 10.1111/j.1462-2920.2005.00745.x; Broza M, 2001, NATURE, V412, P40, DOI 10.1038/35083691; BURKE V, 1983, J INFECT DIS, V148, P68, DOI 10.1093/infdis/148.1.68; Chacon MR, 2004, J CLIN MICROBIOL, V42, P1285, DOI 10.1128/JCM.42.3.1285-1287.2004; ECHEVERRIA P, 1981, J INFECT DIS, V143, P767, DOI 10.1093/infdis/143.6.767; Essers B, 2000, CLIN INFECT DIS, V31, P192, DOI 10.1086/313901; Figueras MI, 2007, J MED MICROBIOL, V56, P996, DOI 10.1099/jmm.0.47062-0; Figueras MJ, 2005, REV MED MICROBIOL, V16, P145; Garcia LS, 2010, CLIN MICROBIOLOGY PR; GOLIK A, 1990, J CLIN GASTROENTEROL, V12, P148, DOI 10.1097/00004836-199004000-00007; Halpern M, 2002, HYDROBIOLOGIA, V470, P49, DOI 10.1023/A:1015665027535; Heuzenroeder MW, 1999, FEMS MICROBIOL LETT, V174, P131, DOI 10.1016/S0378-1097(99)00130-5; Janda JM, 2006, REV MED MICROBIOL, V17, P27; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; JONES BL, 1995, J ANTIMICROB CHEMOTH, V35, P453, DOI 10.1093/jac/35.4.453; Jorgensen JH, 2010, M45A2 CLSINCCLS; Figueras MJ, 2011, ENV MICROBIOL REP, V3, P239, DOI 10.1111/j.1758-2229.2010.00216.x; Kong RYC, 1999, MAR POLLUT BULL, V38, P802, DOI 10.1016/S0025-326X(99)00044-2; Miller RA, 2003, J CLIN MICROBIOL, V41, P4318, DOI 10.1128/JCM.41.9.4318-4323.2003; MORGAN DR, 1985, INFECT IMMUN, V50, P62, DOI 10.1128/IAI.50.1.62-65.1985; MOYER NP, 1987, J CLIN MICROBIOL, V25, P2044, DOI 10.1128/JCM.25.11.2044-2048.1987; Murray PR, 2003, MANUAL CLIN MICROBIO, p[654, 902]; OGUNSANYA TI, 1994, J MED MICROBIOL, V40, P10, DOI 10.1099/00222615-40-1-10; Ormen O, 2003, MICROB PATHOGENESIS, V35, P189, DOI 10.1016/S0882-4010(03)00124-4; Pablos M, 2010, EUR J CLIN MICROBIOL, V29, P1163, DOI 10.1007/s10096-010-0982-3; Sen K, 2004, J APPL MICROBIOL, V97, P1077, DOI 10.1111/j.1365-2672.2004.02398.x; Senderovich Y, 2008, ISME J, V2, P276, DOI 10.1038/ismej.2007.114; Silver AC, 2009, DNA CELL BIOL, V28, P383, DOI 10.1089/dna.2009.0867; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; Sun XB, 2007, J HAZARD MATER, V142, P348, DOI 10.1016/j.jhazmat.2006.08.030; Yu HB, 2004, INFECT IMMUN, V72, P1248, DOI 10.1128/IAI.72.3.1248-1256.2004	39	51	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30070	10.1371/journal.pone.0030070	http://dx.doi.org/10.1371/journal.pone.0030070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355306	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300006
J	Buxbaum, JN; Tagoe, C; Gallo, G; Walker, JR; Kurian, S; Salomon, DR				Buxbaum, Joel N.; Tagoe, Clement; Gallo, Gloria; Walker, John R.; Kurian, Sunil; Salomon, Daniel R.			Why are some amyloidoses systemic? Does hepatic "chaperoning at a distance" prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis?	FASEB JOURNAL			English	Article						protein misfolding diseases; microarrays	ENDOPLASMIC-RETICULUM STRESS; RESPONSE ACTIVATOR PXBP1(S); HEAT-SHOCK RESPONSE; POLYNEUROPATHY; GENE; TRB3; TRANSMISSION; PROTEOSTASIS; REGULATOR; DISEASES	In the human systemic amyloidoses caused by mutant or wild-type transthyretin (TTR), deposition occurs at a distance from the site of synthesis. The TTR synthesized and secreted by the hepatocyte circulates in plasma, then deposits in target tissues far from the producing cell, a pattern reproduced in mice transgenic for multiple copies of the human wild-type TTR gene. By 2 yr of age, half of the transgenic males show cardiac deposition resembling human senile systemic amyloidosis. However, as early as 3 mo of age, when there are no deposits, cardiac gene transcription differs from that of nontransgenic littermates, primarily in the expression of a large number of genes associated with inflammation and the immune response. At 24 mo, the hearts with histologically proven TTR deposits show expression of stress response genes, exuberant mitochondrial gene transcription, and increased expression of genes associated with apoptosis, relative to the hearts without TTR deposition. These 24-mo-old hearts with TTR deposits also show a decrease in transcription of inflammatory genes relative to that in the younger transgenic mice. After 2 yr of expressing large amounts of human TTR, the livers of the transgenic mice without cardiac deposition display chaperone gene expression and evidence of an activated unfolded protein response, while the livers of animals with cardiac TTR deposition display neither, showing increased transcription of interferon-responsive inflammatory genes and those encoding an antioxidant response. With time, in animals with cardiac deposition, it appears that hepatic proteostatic capacity is diminished, exposing the heart to a greater load of misfolded TTR with subsequent extracellular deposition. Hence systemic (cardiac) TTR deposition may be the direct result of the diminution in the distant chaperoning capacity of the liver related to age or long-standing exposure to misfolded TTR, or both.-Buxbaum, J. N., Tagoe, C., Gallo, G., Walker, J. R., Kurian, S., Salomon, D. R. Why are some amyloidoses systemic? Does hepatic "chaperoning at a distance" prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis? FASEB J. 26, 2283-2293 (2012). www.fasebj.org	[Buxbaum, Joel N.; Kurian, Sunil; Salomon, Daniel R.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Tagoe, Clement] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Gallo, Gloria] NYU, Sch Med, Dept Pathol, New York, NY USA; [Walker, John R.] Novartis Fdn, Funct Genom Inst, La Jolla, CA USA	Scripps Research Institute; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; New York University; Novartis	Buxbaum, JN (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd,Mail Code MEM-230, La Jolla, CA 92037 USA.	jbux@scripps.edu	Salomon, Daniel/E-9380-2012; Kurian, Sunil/C-4493-2008	Kurian, Sunil/0000-0002-7782-7263	U.S. National Institutes of Health [R01 AG30027]; NATIONAL INSTITUTE ON AGING [R01AG030027] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by U.S. National Institutes of Health grant R01 AG30027 (J.N.B.).	Araki S, 2000, NEUROPATHOLOGY, V20, pS47; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buxbaum JN, 2007, PROTEIN MISFOLDING A, P259; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; HOFER PA, 1975, ACTA PATH MICRO IM A, VA 83, P309; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Llado L, 2010, LIVER TRANSPLANT, V16, P1386, DOI 10.1002/lt.22174; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Reixach N, 2008, J BIOL CHEM, V283, P2098, DOI 10.1074/jbc.M708028200; Santos SD, 2008, J NEUROPATH EXP NEUR, V67, P449, DOI 10.1097/NEN.0b013e31816fd648; Santos SD, 2010, NEUROBIOL AGING, V31, P280, DOI 10.1016/j.neurobiolaging.2008.04.001; Sato T, 2007, EMBO J, V26, P2501, DOI 10.1038/sj.emboj.7601685; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Shoag J, 2010, ARTERIOSCL THROM VAS, V30, P662, DOI 10.1161/ATVBAHA.108.181636; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Sousa MM, 2004, FASEB J, V18, P124, DOI 10.1096/fj.04-2022fje; Stangou AJ, 2005, NEW ENGL J MED, V352, P2356, DOI 10.1056/NEJM200506023522219; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takei Y, 2007, LIVER TRANSPLANT, V13, P215, DOI 10.1002/lt.20954; Teixeira PF, 2006, J BIOL CHEM, V281, P21998, DOI 10.1074/jbc.M602302200; Teng MH, 2001, LAB INVEST, V81, P385, DOI 10.1038/labinvest.3780246; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P269, DOI 10.1080/10409230500315352; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Yamamoto S, 2007, TRANSPL INT, V20, P926, DOI 10.1111/j.1432-2277.2007.00516.x; YI S, 1991, AM J PATHOL, V138, P403; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yoshida H, 2009, CELL STRUCT FUNCT, V34, P1, DOI 10.1247/csf.06028; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang K, 2006, HANDB EXP PHARM, V172, P69	37	41	41	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2283	2293		10.1096/fj.11-189571	http://dx.doi.org/10.1096/fj.11-189571			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22362898	Green Published			2022-12-25	WOS:000305017200007
J	Svensson, G; Awad, W; Hakansson, M; Mani, K; Logan, DT				Svensson, Gabriel; Awad, Wael; Hakansson, Maria; Mani, Katrin; Logan, Derek T.			Crystal Structure of N-Glycosylated Human Glypican-1 Core Protein STRUCTURE OF TWO LOOPS EVOLUTIONARILY CONSERVED IN VERTEBRATE GLYPICAN-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; DALLY-LIKE; HEPATOCELLULAR-CARCINOMA; CHAIN INITIATION; LINKAGE REGION; LINKED GLYCANS; KEY ENZYME; GENE; SEQUENCE; GROWTH	Glypicans are a family of cell-surface proteoglycans that regulate Wnt, hedgehog, bone morphogenetic protein, and fibroblast growth factor signaling. Loss-of-function mutations in glypican core proteins and in glycosaminoglycan-synthesizing enzymes have revealed that glypican core proteins and their glycosaminoglycan chains are important in shaping animal development. Glypican core proteins consist of a stable alpha-helical domain containing 14 conserved Cys residues followed by a glycosaminoglycan attachment domain that becomes exclusively substituted with heparan sulfate (HS) and presumably adopts a random coil conformation. Removal of the alpha-helical domain results in almost exclusive addition of the glycosaminoglycan chondroitin sulfate, suggesting that factors in the alpha-helical domain promote assembly of HS. Glypican-1 is involved in brain development and is one of six members of the vertebrate family of glypicans. We expressed and crystallized N-glycosylated human glypican-1 lacking HS and N-glycosylated glypican-1 lacking the HS attachment domain. The crystal structure of glypican-1 was solved using crystals of selenomethionine-labeled glypican-1 core protein lacking the HS domain. No additional electron density was observed for crystals of glypican-1 containing the HS attachment domain, and CD spectra of the two protein species were highly similar. The crystal structure of N-glycosylated human glypican-1 core protein at 2.5 angstrom, the first crystal structure of a vertebrate glypican, reveals the complete disulfide bond arrangement of the conserved Cys residues, and it also extends the structural knowledge of glypicans for one alpha-helix and two long loops. Importantly, the loops are evolutionarily conserved in vertebrate glypican-1, and one of them is involved in glycosaminoglycan class determination.	[Awad, Wael; Logan, Derek T.] Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden; [Svensson, Gabriel; Mani, Katrin] Lund Univ, Biomed Ctr A13, Glycobiol Grp, Dept Expt Med Sci,Div Neurosci, SE-22184 Lund, Sweden; [Awad, Wael] Cairo Univ, Fac Sci, Dept Biophys, Giza 12613, Egypt; [Hakansson, Maria] SARom Biostruct AB, Medicon Village, SE-22381 Lund, Sweden	Lund University; Lund University; Egyptian Knowledge Bank (EKB); Cairo University	Logan, DT (corresponding author), Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Box 124, SE-22100 Lund, Sweden.	derek.logan@biochemistry.lu.se	awad, Wael/B-8353-2013; Logan, Derek T/A-1114-2011; Logan, Derek/O-2497-2019	Logan, Derek T/0000-0002-0098-8560; Logan, Derek/0000-0002-0098-8560; Mani, Katrin/0000-0002-1821-0634; Awad, Wael/0000-0002-7597-2133	Swedish Research Council [2006-4387, 2005-6749, 2010-3914]; Swedish Cancer Foundation; Medical Faculty of Lund University; Royal Physiographic Society in Lund; Crafoord, Wiberg, Jeanson, Segerfalk, and Kock Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Medical Faculty of Lund University; Royal Physiographic Society in Lund; Crafoord, Wiberg, Jeanson, Segerfalk, and Kock Foundations	This work was supported by Swedish Research Council Grants 2006-4387 (to D. L.) and 2005-6749 and 2010-3914 (to K. M.), the Swedish Cancer Foundation, the Medical Faculty of Lund University, the Royal Physiographic Society in Lund, and the Crafoord, Wiberg, Jeanson, Segerfalk, and Kock Foundations.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Campos-Xavier AB, 2009, AM J HUM GENET, V84, P760, DOI 10.1016/j.ajhg.2009.05.002; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Capurro MI, 2005, J BIOL CHEM, V280, P41201, DOI 10.1074/jbc.M507004200; Chen RL, 2001, J BIOL CHEM, V276, P7507, DOI 10.1074/jbc.M008283200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng W, 2008, CARCINOGENESIS, V29, P1319, DOI 10.1093/carcin/bgn091; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; De Cat B, 2003, J CELL BIOL, V163, P625, DOI 10.1083/jcb.200302152; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HOWELL PL, 1992, J APPL CRYSTALLOGR, V25, P81, DOI 10.1107/S0021889891010385; Jen YHLD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-33; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Khan S, 2011, J BIOL CHEM, V286, P24842, DOI 10.1074/jbc.M111.226027; Kim MS, 2011, P NATL ACAD SCI USA, V108, P13112, DOI 10.1073/pnas.1109877108; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Matsumoto Y, 2007, J NEUROSCI, V27, P4342, DOI 10.1523/JNEUROSCI.0700-07.2007; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohkawara B, 2003, DEVELOPMENT, V130, P2129, DOI 10.1242/dev.00435; Okamoto K, 2011, NAT GENET, V43, P459, DOI 10.1038/ng.792; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; READ RJ, 1988, J APPL CRYSTALLOGR, V21, P490, DOI 10.1107/S002188988800562X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Svensson G, 2011, BIOCHEMISTRY-US, V50, P9377, DOI 10.1021/bi200218s; Svensson G, 2009, BIOCHEMISTRY-US, V48, P9994, DOI 10.1021/bi901402x; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Veugelers M, 2000, HUM MOL GENET, V9, P1321, DOI 10.1093/hmg/9.9.1321; Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200; Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yan D, 2010, DEVELOPMENT, V137, P2033, DOI 10.1242/dev.045740; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295; ZHANG LJ, 1995, J BIOL CHEM, V270, P27127, DOI 10.1074/jbc.270.45.27127	55	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14040	14051		10.1074/jbc.M111.322487	http://dx.doi.org/10.1074/jbc.M111.322487			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22351761	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000303996300058
J	Mazina, OM; Rossi, MJ; Deakyne, JS; Huang, F; Mazin, AV				Mazina, Olga M.; Rossi, Matthew J.; Deakyne, Julianna S.; Huang, Fei; Mazin, Alexander V.			Polarity and Bypass of DNA Heterology during Branch Migration of Holliday Junctions by Human RAD54, BLM, and RECQ1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOMS-SYNDROME HELICASE; MODEL REPLICATION FORK; SYNDROME GENE-PRODUCT; STRAND BREAK REPAIR; D-LOOPS; RECOMBINATION PROTEINS; UNWINDING ACTIVITY; ESCHERICHIA-COLI; REGRESSION; PROMOTES	Several proteins have been shown to catalyze branch migration (BM) of the Holliday junction, a key intermediate in DNA repair and recombination. Here, using joint molecules made by human RAD51 or Escherichia coli RecA, we find that the polarity of the displaced ssDNA strand of the joint molecules defines the polarity of BM of RAD54, BLM, RECQ1, and RuvAB. Our results demonstrate that RAD54, BLM, and RECQ1 promote BMpreferentially in the 3' -> 5' direction, whereas RuvAB drives it in the 5' -> 3' direction relative to the displaced ssDNA strand. Our data indicate that the helicase activity of BM proteins does not play a role in the heterology bypass. Thus, RAD54 that lacks helicase activity is more efficient in DNA heterology bypass than BLM or REQ1 helicases. Furthermore, we demonstrate that the BLM helicase and BM activities require different protein stoichiometries, indicating that different complexes, monomers and multimers, respectively, are responsible for these two activities. These results define BM as a mechanistically distinct activity of DNA translocating proteins, which may serve an important function in DNA repair and recombination.	[Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, NCB, Philadelphia, PA 19102 USA; [Mazin, Alexander V.] Inst Cytol & Genet, Novosibirsk 630090, Russia	Drexel University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Mazin, AV (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, NCB, 245 N 15th St,Rm 10103, Philadelphia, PA 19102 USA.	amazin@drexelmed.edu		Rossi, Matthew/0000-0002-7796-919X	National Institutes of Health [CA100839, F31 AG033484]; Leukemia and Lymphoma Society [1054-09]; NATIONAL CANCER INSTITUTE [R56CA100839, R01CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG033484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100839 (to A. V. M.) and F31 AG033484 (to M. J. R.) This work was also supported by Leukemia and Lymphoma Society Scholar Award 1054-09 (to A. V. M.).	Adams DE, 1996, J MOL BIOL, V263, P582, DOI 10.1006/jmbi.1996.0600; Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Biswas I, 1998, J MOL BIOL, V279, P795, DOI 10.1006/jmbi.1998.1769; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Bugreev DV, 2008, J BIOL CHEM, V283, P20231, DOI 10.1074/jbc.M801582200; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; Bugreev DV, 2011, NUCLEIC ACIDS RES, V39, P2153, DOI 10.1093/nar/gkq1139; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Dennis C, 2004, EMBO J, V23, P2413, DOI 10.1038/sj.emboj.7600249; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Kowalczykowski SC, 2008, NATURE, V453, P463, DOI 10.1038/453463a; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Liu YL, 2004, NAT REV MOL CELL BIO, V5, P937, DOI 10.1038/nrm1502; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Machwe A, 2011, BIOCHEMISTRY-US, V50, P6774, DOI 10.1021/bi2001054; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Mazina OM, 2007, J BIOL CHEM, V282, P21068, DOI 10.1074/jbc.M701992200; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Murayama Y, 2008, NATURE, V451, P1018, DOI 10.1038/nature06609; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Orren DK, 2002, BIOCHEMISTRY-US, V41, P13483, DOI 10.1021/bi0266986; PANYUTIN IG, 1993, J MOL BIOL, V230, P413, DOI 10.1006/jmbi.1993.1159; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Rossi MJ, 2008, J BIOL CHEM, V283, P24698, DOI 10.1074/jbc.M800839200; Rossi MJ, 2011, P NATL ACAD SCI USA, V108, P6432, DOI 10.1073/pnas.1016072108; Rossi MJ, 2010, METHODS, V51, P336, DOI 10.1016/j.ymeth.2010.02.010; Rudolph CJ, 2010, DNA REPAIR, V9, P210, DOI 10.1016/j.dnarep.2009.12.014; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; UMEZU K, 1993, J MOL BIOL, V230, P1145, DOI 10.1006/jmbi.1993.1231; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451	51	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11820	11832		10.1074/jbc.M112.341347	http://dx.doi.org/10.1074/jbc.M112.341347			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22356911	hybrid, Green Published			2022-12-25	WOS:000302782200021
J	Mediouni, S; Watkins, JD; Pierres, M; Bole, A; Loret, EP; Baillat, G				Mediouni, Sonia; Watkins, Jennifer D.; Pierres, Michel; Bole, Angelique; Loret, Erwann P.; Baillat, Gilbert			A Monoclonal Antibody Directed against a Conformational Epitope of the HIV-1 Trans-activator (Tat) Protein Neutralizes Cross-clade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; APOPTOSIS; GLYCOPROTEIN; COMBINATION; PERSISTENCE; INFECTION; DEFINES; ESCAPE; BLOOD; 2G12	The identification of a neutralizing mAb against extracellular HIV-1 transactivator of transcription (Tat) is important for the development of an efficient HIV-1 treatment. Tat plays an essential role in HIV-1 pathogenesis, not only for HIV-1 replication but also as an extracellular toxin able to disrupt the immune system. We showed previously that immunization of rabbits with Tat Oyi, a variant cloned from an African woman who did not develop AIDS following HIV-1 infection, raised antibodies able to recognize different Tat variants. We carried out mice immunization with Tat Oyi and selected a mAb named 7G12, which had the capacity to cross-recognize heterologous Tat variants by a common three-dimensional epitope. These results highlighted that Tat variants were able to acquire a structure, in contrast to a number of studies showing Tat as an unfolded protein. mAb 7G12 also had the capacity to neutralize the biological activities of these Tat variants by blocking the cellular uptake of extracellular Tat. This is the first study using Tat Oyi to produce a mAb able to neutralize effectively activities of extracellular Tats from different HIV-1 subtypes. This mAb has an important potential in therapeutic passive immunization and could help HIV-1 infected patients to restore their immunity.	[Mediouni, Sonia; Loret, Erwann P.; Baillat, Gilbert] Univ Mediterranee, Fac Pharm, Equipe Rech Technol 2011, F-13385 Marseille 5, France; [Watkins, Jennifer D.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Boston, MA 02215 USA; [Pierres, Michel; Bole, Angelique] Univ Mediterranee UNIVMED UM631, Ctr Immunol Marseille Luminy, INSERM, CNRS,UMR S613,UMR 6102, F-13288 Marseille 9, France	UDICE-French Research Universities; Aix-Marseille Universite; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Loret, EP (corresponding author), Univ Mediterranee, Fac Pharm, Equipe Rech Technol 2011, 27 BD Jean Moulin, F-13385 Marseille 5, France.	erwann.loret@univmed.fr; gilbert.baillat@univmed.fr						Campbell GR, 2005, J BIOL CHEM, V280, P38376, DOI 10.1074/jbc.M506630200; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Chen WZ, 2012, AIDS RES HUM RETROV, V28, P425, DOI [10.1089/aid.2011.0226, 10.1089/AID.2011.0226]; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; CULLEN BR, 1990, CELL, V63, P655, DOI 10.1016/0092-8674(90)90129-3; de Mareuil J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-5; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Fuller S. A., 1991, CURRENT PROTOCOLS MO, P1101; FURLINI MCRG, 1995, J ACQ IMMUN DEF SYND, V10, P408, DOI 10.1097/00042560-199512000-00003; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Harakeh S, 2006, LEUKEMIA RES, V30, P869, DOI 10.1016/j.leukres.2005.11.027; Hardy F, 1997, J IMMUNOL METHODS, V200, P155, DOI 10.1016/S0022-1759(96)00201-3; Huang L, 1998, J VIROL, V72, P8952, DOI 10.1128/JVI.72.11.8952-8960.1998; HUET T, 1989, AIDS, V3, P707, DOI 10.1097/00002030-198911000-00004; Kitabwalla M, 2003, AIDS RES HUM RETROV, V19, P125, DOI 10.1089/088922203762688630; Kramer VG, 2007, CURR HIV RES, V5, P642, DOI 10.2174/157016207782418506; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Ma MH, 1997, J VIROL, V71, P2495, DOI 10.1128/JVI.71.3.2495-2499.1997; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Manrique A, 2007, J VIROL, V81, P8793, DOI 10.1128/JVI.00598-07; Mediouni Sonia, 2011, Infectious Disorders - Drug Targets, V11, P57; Moreau E, 2004, J VIROL, V78, P3792, DOI 10.1128/JVI.78.7.3792-3796.2004; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; Opi S, 2002, J BIOL CHEM, V277, P35915, DOI 10.1074/jbc.M204393200; Peloponese JM, 1999, J BIOL CHEM, V274, P11473, DOI 10.1074/jbc.274.17.11473; Rodman TC, 2001, EXP HEMATOL, V29, P1004, DOI 10.1016/S0301-472X(01)00678-6; Saitoh A, 2002, J INFECT DIS, V185, P1409, DOI 10.1086/340614; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; Siddappa NB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-53; STEINAA L, 1994, ARCH VIROL, V139, P263, DOI 10.1007/BF01310790; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Tudor D, 2011, AIDS, V25, P751, DOI 10.1097/QAD.0b013e32834507bd; Valvatne H, 1996, AIDS RES HUM RETROV, V12, P611, DOI 10.1089/aid.1996.12.611; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Watkins JD, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-8; Watkins JD, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-83; WONGSTAAL F, 1985, NATURE, V317, P395, DOI 10.1038/317395a0; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; Zhang MY, 2003, J IMMUNOL METHODS, V283, P17, DOI 10.1016/j.jim.2003.07.003; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	47	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11942	11950		10.1074/jbc.M111.319863	http://dx.doi.org/10.1074/jbc.M111.319863			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22362765	Green Published, hybrid			2022-12-25	WOS:000302782200033
J	Murase, S; McKay, RD				Murase, Sachiko; McKay, Ronald D.			Matrix Metalloproteinase-9 Regulates Survival of Neurons in Newborn Hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OCCURRING CELL-DEATH; MATRIX METALLOPROTEINASE-3; ALZHEIMERS-DISEASE; MOUSE HIPPOCAMPUS; LAMININ; EXPRESSION; RAT; SPECIFICITY; ACTIVATION; INTEGRINS	The number of neurons in the adult rodent brain is strongly influenced by events in early postnatal life that eliminate approximately half of the neurons. Recently, we reported that neurotrophins induced survival of neonatal rat hippocampal neurons by promoting neural activity and activation of the Ser/Thr kinase, Akt. The survival of neurons also depended on integrin signaling, but a role for the extracellular matrix (ECM) in this mechanism was yet to be explored. Here, we show that levels of the matrix metalloproteinase-9 (MMP9) decrease, and the level of the ECM protein laminin increases in rat hippocampus during the period of neuronal death. Hippocampi from MMP9 null mice showed higher levels of laminin expression than wild type at P1 and no further increase at P10. In vitro, the matrix metalloproteinase inhibitor FN-439 promoted survival of neurons in a laminin-integrin beta 1-dependent manner. Blocking laminin signaling attenuated activation of Akt by depolarization. In vivo, injecting FN-439 into the neonatal hippocampus increased the level of laminin and promoted neuronal survival through an integrin-dependent mechanism. These results show signals from the ECM are not simply permissive but rather actively regulated, and they interact with neuronal activity to control the number of hippocampal neurons. This work is the first to report a role for MMP9 in regulating neuronal survival through the developmental process that establishes the functional brain.	[Murase, Sachiko; McKay, Ronald D.] NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [McKay, Ronald D.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Murase, S (corresponding author), NINDS, Mol Biol Lab, NIH, 35 Lincoln Dr, Bethesda, MD 20892 USA.	sachikom@ninds.nih.gov	Murase, Sachiko/AAC-5496-2022	Murase, Sachiko/0000-0002-9078-0471	National Institutes of Health from NINDS	National Institutes of Health from NINDS	This work was supported by a National Institutes of Health grant from the Intramural Research Program, NINDS.	BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Choi DH, 2008, J NEUROCHEM, V106, P405, DOI 10.1111/j.1471-4159.2008.05399.x; CUNNINGHAM MG, 1993, J NEUROSCI METH, V47, P105, DOI 10.1016/0165-0270(93)90026-N; FERRER I, 1994, NEUROSCI LETT, V182, P77, DOI 10.1016/0304-3940(94)90210-0; GOULD E, 1991, J COMP NEUROL, V304, P408, DOI 10.1002/cne.903040306; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hewitt JE, 2009, BBA-MOL BASIS DIS, V1792, P853, DOI 10.1016/j.bbadis.2009.06.003; Horstmann S, 2010, INT PSYCHOGERIATR, V22, P966, DOI 10.1017/S1041610210000827; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Indyk JA, 2003, NEUROSCIENCE, V116, P359, DOI 10.1016/S0306-4522(02)00704-2; IZANT JG, 1980, P NATL ACAD SCI-BIOL, V77, P4741, DOI 10.1073/pnas.77.8.4741; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kikkawa Y, 2000, J CELL SCI, V113, P869; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; MENDRICK DL, 1993, LAB INVEST, V69, P690; MORITA A, 1985, BIOCHEM J, V229, P259, DOI 10.1042/bj2290259; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Murase S, 2006, J NEUROSCI, V26, P9750, DOI 10.1523/JNEUROSCI.2745-06.2006; Murase S, 2011, EUR J NEUROSCI, V34, P374, DOI 10.1111/j.1460-9568.2011.07758.x; Murase S, 2011, J NEUROSCI, V31, P7791, DOI 10.1523/JNEUROSCI.0202-11.2011; Oh LYS, 1999, J NEUROSCI, V19, P8464; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Plateroti M, 1997, J CELL SCI, V110, P1227; Sharif KA, 2004, NEUROSCIENCE, V126, P967, DOI 10.1016/j.neuroscience.2004.03.064; Shibata N, 2005, NEUROBIOL AGING, V26, P1011, DOI 10.1016/j.neurobiolaging.2004.09.004; Staniszewska I, 2008, J CELL SCI, V121, P504, DOI 10.1242/jcs.000232; Staun-Ram E, 2009, PLACENTA, V30, P1029, DOI 10.1016/j.placenta.2009.09.010; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Yoshiyama Y, 2000, ACTA NEUROPATHOL, V99, P91, DOI 10.1007/PL00007428	39	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12184	12194		10.1074/jbc.M111.297671	http://dx.doi.org/10.1074/jbc.M111.297671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351756	Green Published, hybrid			2022-12-25	WOS:000302782200060
J	Wright, WR; Parzych, K; Crawford, D; Mein, C; Mitchell, JA; Paul-Clark, MJ				Wright, William R.; Parzych, Katarzyna; Crawford, Damian; Mein, Charles; Mitchell, Jane A.; Paul-Clark, Mark J.			Inflammatory Transcriptome Profiling of Human Monocytes Exposed Acutely to Cigarette Smoke	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; AIRWAY EPITHELIAL-CELLS; HEME OXYGENASE-1 GENE; TOBACCO-SMOKE; OXIDATIVE STRESS; MATRIX METALLOPROTEINASES; NORMALIZATION METHODS; ALVEOLAR MACROPHAGES; AQUEOUS EXTRACTS; SMOOTH-MUSCLE	Background: Cigarette smoking is responsible for 5 million deaths worldwide each year, and is a major risk factor for cardiovascular and lung diseases. Cigarette smoke contains a complex mixture of over 4000 chemicals containing 10(15) free radicals. Studies show smoke is perceived by cells as an inflammatory and xenobiotic stimulus, which activates an immune response. The specific cellular mechanisms driving cigarette smoke-induced inflammation and disease are not fully understood, although the innate immune system is involved in the pathology of smoking related diseases. Methodology/Principle findings: To address the impact of smoke as an inflammagen on the innate immune system, THP-1 cells and Human PBMCs were stimulated with 3 and 10% (v/v) cigarette smoke extract (CSE) for 8 and 24 hours. Total RNA was extracted and the transcriptome analysed using Illumina BeadChip arrays. In THP-1 cells, 10% CSE resulted in 80 genes being upregulated and 37 downregulated by >= 1.5 fold after 8 hours. In PBMCs stimulated with 10% CSE for 8 hours, 199 genes were upregulated and 206 genes downregulated by >= 1.5 fold. After 24 hours, the number of genes activated and repressed by >= 1.5 fold had risen to 311 and 306 respectively. The major pathways that were altered are associated with cell survival, such as inducible antioxidants, protein chaperone and folding proteins, and the ubiquitin/proteosome pathway. Conclusions: Our results suggest that cigarette smoke causes inflammation and has detrimental effects on the metabolism and function of innate immune cells. In addition, THP-1 cells provide a genetically stable alternative to primary cells for the study of the effects of cigarette smoke on human monocytes.	[Wright, William R.; Parzych, Katarzyna; Crawford, Damian; Mitchell, Jane A.; Paul-Clark, Mark J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Cardiothorac Pharmacol Pharmacol & Toxicol, London, England; [Mein, Charles] Barts & London Queen Marys Sch Med & Dent, Genome Ctr, London, England	Imperial College London; University of London; Queen Mary University London	Wright, WR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Cardiothorac Pharmacol Pharmacol & Toxicol, London, England.	m.paul-clark@imperial.ac.uk		Mein, Charles/0000-0003-0811-9658	Wellcome Trust [4627]	Wellcome Trust(Wellcome TrustEuropean Commission)	This manuscript was supported by Wellcome Trust, eGrants Ref: 4627, http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; Blake DJ, 2010, AM J RESP CELL MOL, V42, P524, DOI 10.1165/rcmb.2009-0054OC; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bosio A, 2002, CARCINOGENESIS, V23, P741, DOI 10.1093/carcin/23.5.741; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; Churg A, 2002, AM J RESP CRIT CARE, V166, P849, DOI 10.1164/rccm.200202-097OC; Comandini A, 2010, PULM PHARM THER; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Demedts IK, 2005, CURR OPIN PHARMACOL, V5, P257, DOI 10.1016/j.coph.2004.12.005; Demirjian L, 2006, BBA-MOL BASIS DIS, V1762, P592, DOI 10.1016/j.bbadis.2006.04.004; Doyle I, 2010, MOL IMMUNOL, V47, P1058, DOI 10.1016/j.molimm.2009.11.008; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Favatier F, 2001, BIOCHEM J, V353, P475, DOI 10.1042/0264-6021:3530475; Fukano Yasuo, 2006, Journal of Toxicological Sciences, V31, P99, DOI 10.2131/jts.31.99; Gebel S, 2004, CARCINOGENESIS, V25, P169, DOI 10.1093/carcin/bgg193; Gebel S, 2006, TOXICOL SCI, V93, P422, DOI 10.1093/toxsci/kfl071; Gelbman BD, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-10; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Gumus ZH, 2008, CANCER PREV RES, V1, P100, DOI 10.1158/1940-6207.CAPR-08-0007; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Halappanavar S, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-56; Han GC, 2006, J PHARMACOL EXP THER, V316, P1025, DOI 10.1124/jpet.105.093542; Hansel TT, 2009, LANCET, V374, P744, DOI 10.1016/S0140-6736(09)61342-8; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Kent L, 2008, CYTOKINE, V42, P205, DOI 10.1016/j.cyto.2008.02.001; Knorr-Wittmann C, 2005, FREE RADICAL BIO MED, V39, P1438, DOI 10.1016/j.freeradbiomed.2005.07.003; Kuschner WG, 1996, EUR RESPIR J, V9, P1989, DOI 10.1183/09031936.96.09101989; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lou XY, 2007, HUM MOL GENET, V16, P142, DOI 10.1093/hmg/ddl450; Maunders H, 2007, AM J PHYSIOL-LUNG C, V292, pL1248, DOI 10.1152/ajplung.00290.2006; McMaster SK, 2008, BRIT J PHARMACOL, V153, P536, DOI 10.1038/sj.bjp.0707595; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Oltmanns U, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-74; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; Ouyang Y, 2000, J ALLERGY CLIN IMMUN, V106, P280, DOI 10.1067/mai.2000.107751; Paul-Clark MJ, 2009, AM J RESP CRIT CARE, V179, P299, DOI 10.1164/rccm.200707-1019OC; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Perretti M, 1999, J LEUKOCYTE BIOL, V65, P583, DOI 10.1002/jlb.65.5.583; Pickett G, 2010, TOXICOL SCI, V114, P79, DOI 10.1093/toxsci/kfp298; Pierrou S, 2007, AM J RESP CRIT CARE, V175, P577, DOI 10.1164/rccm.200607-931OC; Port JL, 2004, CARCINOGENESIS, V25, P2275, DOI 10.1093/carcin/bgh243; Rahman I, 1998, AM J PHYSIOL-LUNG C, V275, pL80, DOI 10.1152/ajplung.1998.275.1.L80; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; Schmid R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-349; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Stevenson CS, 2007, AM J PHYSIOL-LUNG C, V293, pL1183, DOI 10.1152/ajplung.00105.2007; Sunaga N, 2002, CANCER EPIDEM BIOMAR, V11, P730; Takaku M, 2009, J BIOL CHEM, V284, P14326, DOI 10.1074/jbc.M807715200; Tomita K, 2002, AM J RESP CRIT CARE, V166, P724, DOI 10.1164/rccm.2104010; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; van Leeuwen DM, 2007, CARCINOGENESIS, V28, P691, DOI 10.1093/carcin/bgl199; van Leeuwen DM, 2005, TOXICOL SCI, V86, P200, DOI 10.1093/toxsci/kfi168; Vihinen P, 2002, INT J CANCER, V99, P157, DOI 10.1002/ijc.10329; Walters MJ, 2005, MOL PHARMACOL, V68, P1343, DOI 10.1124/mol.105.012591; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008	66	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30120	10.1371/journal.pone.0030120	http://dx.doi.org/10.1371/journal.pone.0030120			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363418	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600013
J	Botero, CA; Rubenstein, DR				Botero, Carlos A.; Rubenstein, Dustin R.			Fluctuating Environments, Sexual Selection and the Evolution of Flexible Mate Choice in Birds	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; FEMALE CHOICE; BRAIN SIZE; TEMPORAL DYNAMICS; GOOD GENES; DIVORCE; VARIABILITY; PATTERNS; ECOLOGY; TIT	Environmentally-induced fluctuation in the form and strength of natural selection can drive the evolution of morphology, physiology, and behavior. Here we test the idea that fluctuating climatic conditions may also influence the process of sexual selection by inducing unexpected reversals in the relative quality or sexual attractiveness of potential breeding partners. Although this phenomenon, known as 'ecological cross-over', has been documented in a variety of species, it remains unclear the extent to which it has driven the evolution of major interspecific differences in reproductive behavior. We show that after controlling for potentially influential life history and demographic variables, there are significant positive associations between the variability and predictability of annual climatic cycles and the prevalence of infidelity and divorce within populations of a taxonomically diverse array of socially monogamous birds. Our results are consistent with the hypothesis that environmental factors have shaped the evolution of reproductive flexibility and suggest that in the absence of severe time constraints, secondary mate choice behaviors can help prevent, correct, or minimize the negative consequences of ecological cross-overs. Our findings also illustrate how a basic evolutionary process like sexual selection is susceptible to the increasing variability and unpredictability of climatic conditions that is resulting from climate change.	[Botero, Carlos A.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Rubenstein, Dustin R.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA	The National Evolutionary Synthesis Center; Columbia University	Botero, CA (corresponding author), N Carolina State Univ, Initiat Biocomplex, Raleigh, NC 27695 USA.	cabotero@ncsu.edu	Rubenstein, Dustin R./N-9302-2019; Rubenstein, Dustin R/A-3451-2015	Rubenstein, Dustin R./0000-0002-4999-3723; Rubenstein, Dustin R/0000-0002-4999-3723; Botero, Carlos A./0000-0003-0955-2795	National Evolutionary Synthesis Center (NESCent), NSF [EF-0905606]; Columbia University	National Evolutionary Synthesis Center (NESCent), NSF(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Columbia University	The authors acknowledge the National Evolutionary Synthesis Center (NESCent), NSF #EF-0905606, for fostering this collaboration, as well as for funding C.A.B. D.R.R was funded by Columbia University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; [Anonymous], 1985, THEORY PRACTICE ECON; BENNETT PM, 1985, J ZOOL, V207, P151; Birkhead T.R., 1996, Oxford Ornithology Series, V6, P323; Botero CA, 2009, CURR BIOL, V19, P1151, DOI 10.1016/j.cub.2009.04.061; Candolin U, 2007, J EVOLUTION BIOL, V20, P233, DOI 10.1111/j.1420-9101.2006.01207.x; CEZILLY F, 1995, P ROY SOC B-BIOL SCI, V262, P7, DOI 10.1098/rspb.1995.0169; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Charmantier A, 2004, J AVIAN BIOL, V35, P524, DOI 10.1111/j.0908-8857.2004.03296.x; CHOUDHURY S, 1995, ANIM BEHAV, V50, P413, DOI 10.1006/anbe.1995.0256; Cockburn A, 2008, P R SOC B, V275, P605, DOI 10.1098/rspb.2007.0916; COLWELL RK, 1974, ECOLOGY, V55, P1148, DOI 10.2307/1940366; Cornwallis CK, 2010, TRENDS ECOL EVOL, V25, P145, DOI 10.1016/j.tree.2009.09.008; Deaner RO, 1999, P ROY SOC B-BIOL SCI, V266, P687, DOI 10.1098/rspb.1999.0690; DHONDT AA, 1994, J ANIM ECOL, V63, P979, DOI 10.2307/5274; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; ENS BJ, 1993, ANIM BEHAV, V45, P1199, DOI 10.1006/anbe.1993.1142; Ens Bruno J., 1996, Oxford Ornithology Series, V6, P344; FELSENSTEIN J, 1976, ANNU REV GENET, V10, P253, DOI 10.1146/annurev.ge.10.120176.001345; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Forstmeier W, 2011, P NATL ACAD SCI USA, V108, P10608, DOI 10.1073/pnas.1103195108; Gerlach NM, 2012, P ROY SOC B-BIOL SCI, V279, P860, DOI 10.1098/rspb.2011.1547; GIBBS HL, 1987, NATURE, V327, P511, DOI 10.1038/327511a0; GILBURN AS, 1994, P ROY SOC B-BIOL SCI, V255, P159, DOI 10.1098/rspb.1994.0023; GILLESPIE JH, 1989, GENETICS, V121, P129; Gosden TP, 2008, EVOLUTION, V62, P845, DOI 10.1111/j.1558-5646.2008.00323.x; Greenfield MD, 2004, ANIM BEHAV, V68, P1461, DOI 10.1016/j.anbehav.2004.01.014; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Houerou H. N. le, 1989, The grazing land ecosystems of the African Sahel.; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jeschke JM, 2008, BEHAV ECOL SOCIOBIOL, V63, P1, DOI 10.1007/s00265-008-0646-9; Jetz W, 2011, CURR BIOL, V21, P72, DOI 10.1016/j.cub.2010.11.075; Johnsen A, 2000, NATURE, V406, P296, DOI 10.1038/35018556; KARL TR, 1995, NATURE, V377, P217, DOI 10.1038/377217a0; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; Kraaijeveld K, 2003, P ROY SOC B-BIOL SCI, V270, P1785, DOI 10.1098/rspb.2003.2450; Kutner M., 2005, APPL LINEAR STAT MOD; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Le Hou?rou H.N., 2009, BIOCLIMATOLOGY BIOGE; Lesna I, 1999, NATURE, V401, P581, DOI 10.1038/44125; Li WH, 2011, J CLIMATE, V24, P1499, DOI 10.1175/2010JCLI3829.1; Mauck RA, 1999, AM NAT, V154, P99, DOI 10.1086/303216; MOLLER AP, 1993, AM NAT, V142, P118, DOI 10.1086/285531; Morrissey MB, 2011, EVOLUTION IN PRESS; Nettle D, 1998, J ANTHROPOL ARCHAEOL, V17, P354, DOI 10.1006/jaar.1998.0328; ORELL M, 1994, ANIM BEHAV, V48, P1143, DOI 10.1006/anbe.1994.1347; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pall P, 2011, NATURE, V470, P382, DOI 10.1038/nature09762; Petrie M, 1998, P NATL ACAD SCI USA, V95, P9390, DOI 10.1073/pnas.95.16.9390; POULIN B, 1992, ECOLOGY, V73, P2295, DOI 10.2307/1941476; Robinson MR, 2008, CURR BIOL, V18, P751, DOI 10.1016/j.cub.2008.04.059; Rubenstein DR, 2007, CURR BIOL, V17, P1414, DOI 10.1016/j.cub.2007.07.032; Rubenstein DR, 2011, P NATL ACAD SCI USA, V108, P10816, DOI 10.1073/pnas.1100303108; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schuck-Paim C, 2008, BRAIN BEHAV EVOLUT, V71, P200, DOI 10.1159/000119710; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Sol D, 2006, J ORNITHOL, V147, P34; Sol D, 2005, P ROY SOC B-BIOL SCI, V272, P1433, DOI 10.1098/rspb.2005.3099; Sol Daniel, 2009, P111; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Welch AM, 2003, EVOLUTION, V57, P883; Westneat D.F., 1990, Current Ornithology, V7, P331; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Wikelski Martin, 2001, Trends in Ecology and Evolution, V16, P479, DOI 10.1016/S0169-5347(01)02279-0; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	73	73	73	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32311	10.1371/journal.pone.0032311	http://dx.doi.org/10.1371/journal.pone.0032311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359681	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200150
J	McIntyre, JB; Bose, P; Klimowicz, AC; Brockton, NT; Petrillo, S; Matthews, W; Easaw, J; Magliocco, A; Dort, JC				McIntyre, John B.; Bose, Pinaki; Klimowicz, Alexander C.; Brockton, Nigel T.; Petrillo, Stephanie; Matthews, Wayne; Easaw, Jay; Magliocco, Anthony; Dort, Joseph C.			Specific and Sensitive Hydrolysis Probe-Based Real-Time PCR Detection of Epidermal Growth Factor Receptor Variant III in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							LUNG-CANCER; NECK-CANCER; KINASE INHIBITORS; EGF RECEPTOR; COPY NUMBER; PHASE-II; EXPRESSION; HEAD; EGFRVIII; GENE	Background: The tumor-specific EGFR deletion mutant, EGFRvIII, is characterised by ligand-independent constitutive signalling. Tumors expressing EGFRvIII are resistant to current EGFR-targeted therapy. The frequency of EGFRvIII in head and neck squamous cell carcinoma (HNSCC) is disputed and may vary by specific sub-site. The purpose of this study was to measure the occurrence of EGFRvIII mutations in a specific HNSCC subsite, oral squamous cell carcinoma (OSCC), using a novel real-time PCR assay. Methodology: Pre-treatment Formalin Fixed Paraffin Embedded (FFPE) cancer specimens from 50 OSCC patients were evaluated for the presence of EGFRvIII using a novel hydrolysis probe-based real-time PCR assay. EGFR protein expression in tumor samples was quantified using fluorescent immunohistochemistry (IHC) and AQUA (R) technology. Principal findings: We detected EGFRvIII in a single OSCC patient in our cohort (2%). We confirmed the validity of our detection technique in an independent cohort of glioblastoma patients. We also compared the sensitivity and specificity of our novel real-time EGFRvIII detection assay to conventional RT-PCR and direct sequencing. Our assay can specifically detect EGFRvIII and can discriminate against wild-type EGFR in FFPE tumor samples. AQUAnalysis (R) revealed that the presence of EGFRvIII transcript is associated with very high EGFR protein expression (98th percentile). Contrary to previous reports, only 44% of OSCC over-expressed EGFR in our study. Conclusion and Significance: Our results suggest that the EGFRvIII mutation is rare in OSCC and corroborate previous reports of EGFRvIII expression only in tumors with extreme over-expression of EGFR. We conclude that EGFRvIII-specific therapies may not be ideally suited as first-line treatment in OSCC. Furthermore, highly specific and sensitive methods, such as the real-time RT-PCR assay and AQUAnalysis (R) described here, will provide accurate assessment of EGFR mutation frequency and EGFR expression, and will facilitate the selection of optimal tailored therapies for OSCC patients.	[McIntyre, John B.] Univ Calgary, Dept Pathol & Lab Med, Tom Baker Canc Ctr, Calgary, AB, Canada; [Bose, Pinaki; Klimowicz, Alexander C.; Petrillo, Stephanie; Magliocco, Anthony] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Brockton, Nigel T.] Alberta Hlth Serv Canc Care, Dept Populat Hlth Res, Calgary, AB, Canada; [Matthews, Wayne; Dort, Joseph C.] Univ Calgary, Dept Surg, Div Otolaryngol Head & Neck Surg, Calgary, AB, Canada; [Easaw, Jay] Univ Calgary, Div Neurosurg, Dept Clin Neurosci, Calgary, AB, Canada	Tom Baker Cancer Clinic; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary	McIntyre, JB (corresponding author), Univ Calgary, Dept Pathol & Lab Med, Tom Baker Canc Ctr, Calgary, AB, Canada.	jdort@ucalgary.ca	Brockton, Nigel/AAE-6893-2020; Brockton, Nigel/AAV-2010-2021; McIntyre, JB/ABE-9340-2021	Brockton, Nigel/0000-0002-5434-2490; 	Ohlson Research Initiative within the University of Calgary - Faculty of Medicine; Southern Alberta Cancer Research Institute (SACRI)	Ohlson Research Initiative within the University of Calgary - Faculty of Medicine; Southern Alberta Cancer Research Institute (SACRI)	Yes, we have the following competing interest. This study was funded by the Ohlson Research Initiative, which functions within the University of Calgary - Faculty of Medicine as well as the Southern Alberta Cancer Research Institute (SACRI). The corresponding author (JCD) is the Director of the Ohlson Research Initiative. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	BATRA SK, 1995, CELL GROWTH DIFFER, V6, P1251; Bernier J, 2009, NAT REV CLIN ONCOL, V6, P266, DOI 10.1038/nrclinonc.2009.40; Biernat W, 2004, BRAIN PATHOL, V14, P131, DOI 10.1111/j.1750-3639.2004.tb00045.x; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chau NG, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-11; DEPALAZZO IEG, 1993, CANCER RES, V53, P3217; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Farah CS, 2008, AUST DENT J, V53, P2, DOI 10.1111/j.1834-7819.2007.00002.x; Frederick L, 2000, NEURO-ONCOLOGY, V2, P159, DOI 10.1093/neuonc/2.3.159; GRANDIS JR, 1993, J CELL BIOCHEM, P188; Hama T, 2009, ONCOLOGIST, V14, P900, DOI 10.1634/theoncologist.2009-0058; Harris TJR, 2010, NAT REV CLIN ONCOL, V7, P251, DOI 10.1038/nrclinonc.2010.41; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Ji HB, 2006, P NATL ACAD SCI USA, V103, P7817, DOI 10.1073/pnas.0510284103; Lai SY, 2010, DRUG RESIST UPDATE, V13, P67, DOI 10.1016/j.drup.2010.04.001; Lammering G, 2004, CLIN CANCER RES, V10, P6732, DOI 10.1158/1078-0432.CCR-04-0393; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Monteiro LS, 2010, J ORAL PATHOL MED, V39, P571, DOI 10.1111/j.1600-0714.2009.00876.x; Montgomery RB, 2000, J BIOL CHEM, V275, P17358, DOI 10.1074/jbc.M000966200; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Olapade-Olaopa EO, 2000, BRIT J CANCER, V82, P186; OZANNE B, 1986, J PATHOL, V149, P9, DOI 10.1002/path.1711490104; Pao W, 2009, CLIN CANCER RES, V15, P5317, DOI 10.1158/1078-0432.CCR-09-0913; Sasaki H, 2007, ONCOL REP, V17, P319; Siu LL, 2007, J CLIN ONCOL, V25, P2178, DOI 10.1200/JCO.2006.07.6547; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; Stewart JSW, 2009, J CLIN ONCOL, V27, P1864, DOI 10.1200/JCO.2008.17.0530; Takes RP, 1998, ANTICANCER RES, V18, P4793; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; Wikstrand CJ, 1997, CANCER RES, V57, P4130; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; YAMAZAKI H, 1990, JPN J CANCER RES, V81, P773, DOI 10.1111/j.1349-7006.1990.tb02644.x; Yang BB, 2009, AURIS NASUS LARYNX, V36, P682, DOI 10.1016/j.anl.2009.03.002; Yoshimoto K, 2008, CLIN CANCER RES, V14, P488, DOI 10.1158/1078-0432.CCR-07-1966; Zhang ZF, 2010, ONCOTARGET, V1, P497	39	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31723	10.1371/journal.pone.0031723	http://dx.doi.org/10.1371/journal.pone.0031723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359620	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200089
J	Menkhorst, EM; Lane, N; Winship, AL; Li, P; Yap, J; Meehan, K; Rainczuk, A; Stephens, A; Dimitriadis, E				Menkhorst, Ellen Melaleuca; Lane, Natalie; Winship, Amy Louise; Li, Priscilla; Yap, Joanne; Meehan, Katie; Rainczuk, Adam; Stephens, Andrew; Dimitriadis, Evdokia			Decidual-Secreted Factors Alter Invasive Trophoblast Membrane and Secreted Proteins Implying a Role for Decidual Cell Regulation of Placentation	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-I; ENDOMETRIAL STROMAL CELLS; NATURAL-KILLER-CELLS; BREAST-CANCER CELLS; PROTEOMIC ANALYSIS; GROWTH-FACTOR; PROLACTIN PRODUCTION; CONDITIONED MEDIUM; SERINE PROTEASES; CATHEPSIN-C	Inadequate or inappropriate implantation and placentation during the establishment of human pregnancy is thought to lead to first trimester miscarriage, placental insufficiency and other obstetric complications. To create the placental blood supply, specialized cells, the 'extravillous trophoblast' (EVT) invade through the differentiated uterine endometrium (the decidua) to engraft and remodel uterine spiral arteries. We hypothesized that decidual factors would regulate EVT function by altering the production of EVT membrane and secreted factors. We used a proteomics approach to identify EVT membrane and secreted proteins regulated by decidual cell factors. Human endometrial stromal cells were decidualized in vitro by treatment with estradiol (10(-8) M), medroxyprogesterone acetate (10(-7) M) and cAMP (0.5 mM) for 14 days. Conditioned media (CM) was collected on day 2 (non-decidualized CM) and 14 (decidualized CM) of treatment. Isolated primary EVT cultured on Matrigel (TM) were treated with media control, non-decidualized or decidualized CM for 16 h. EVT CM was fractionated for proteins <30 kDa using size-exclusion affinity nanoparticles (SEAN) before trypsin digestion and HPLC-MS/MS. 43 proteins produced by EVT were identified; 14 not previously known to be expressed in the placenta and 12 which had previously been associated with diseases of pregnancy including preeclampsia. Profilin 1, lysosome associated membrane glycoprotein 1 (LAMP1), dipeptidyl peptidase 1 (DPP1/cathepsin C) and annexin A2 expression by interstitial EVT in vivo was validated by immunhistochemistry. Decidual CM regulation in vitro was validated by western blotting: decidualized CM upregulated profilin 1 in EVT CM and non-decidualized CM upregulated annexin A2 in EVT CM and pro-DPP1 in EVT cell lysate. Here, non-decidualized factors induced protease expression by EVT suggesting that non-decidualized factors may induce a pro-inflammatory cascade. Preeclampsia is a pro-inflammatory condition. Overall, we have demonstrated the potential of a proteomics approach to identify novel proteins expressed by EVT and to uncover the mechanisms leading to disease states.	[Menkhorst, Ellen Melaleuca; Lane, Natalie; Winship, Amy Louise; Li, Priscilla; Yap, Joanne; Meehan, Katie; Rainczuk, Adam; Stephens, Andrew; Dimitriadis, Evdokia] Prince Henrys Inst, Clayton, Vic, Australia	Prince Henry's Institute of Medical Research	Menkhorst, EM (corresponding author), Prince Henrys Inst, Clayton, Vic, Australia.	evdokia.dimitriadis@princehenrys.org	Menkhorst, Ellen/P-5759-2014; Menkhorst, Ellen/AAU-4329-2021; Meehan, Katie/H-5431-2014; dimitriadis, e/AAD-7601-2021; Stephens, Andrew/G-5161-2013	Menkhorst, Ellen/0000-0003-2440-6665; Meehan, Katie/0000-0002-9179-4592; dimitriadis, eva/0000-0003-1425-950X; Winship, Amy/0000-0001-7848-1447; Dimitriadis, Eva/0000-0001-8698-1927	National Health and Medical Research Council (NHMRC) (Australia) [GNT0388901, 611827, 550905]; Victorian Government	National Health and Medical Research Council (NHMRC) (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	The work was supported by National Health and Medical Research Council (NHMRC) (Australia) Project Grant (GNT0388901) to ED, and by the Victorian Government's Operational Infrastructure Support Program. EMM was supported by a NHMRC (Australia) Postdoctoral Training Fellowship (#611827). ED was supported by a NHMRC (Australia) Career Development Fellowship (#550905). EMM received travel support from The CASS Foundation. PHI Data Audit 11-23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Agudo M, 2009, INVEST OPHTH VIS SCI, V50, P424, DOI 10.1167/iovs.08-2404; Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Aplin JD, 2010, INT J DEV BIOL, V54, P323, DOI 10.1387/ijdb.082759ja; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Benson GV, 1996, DEVELOPMENT, V122, P2687; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Cartwright JE, 2002, PLACENTA, V23, P232, DOI 10.1053/plac.2001.0760; Carty DM, 2011, HYPERTENSION, V57, P561, DOI 10.1161/HYPERTENSIONAHA.110.164285; Centlow M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/458748; Dimitriadis E, 2005, J CLIN ENDOCR METAB, V90, P3458, DOI 10.1210/jc.2004-1014; Dimitriadis E, 2002, MOL HUM REPROD, V8, P636, DOI 10.1093/molehr/8.7.636; Dimitriadis E, 2010, PLACENTA, V31, pS99, DOI 10.1016/j.placenta.2009.12.027; Dimitriadis E, 2006, ENDOCRINOLOGY, V147, P3809, DOI 10.1210/en.2006-0264; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; Dowling P, 2011, PROTEOMICS, V11, P794, DOI 10.1002/pmic.201000530; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; GENBACEV O, 1992, PLACENTA, V13, P439, DOI 10.1016/0143-4004(92)90051-T; GILABERT J, 1990, THROMB HAEMOSTASIS, V63, P361; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Godbole G, 2011, FERTIL STERIL, V95, P1278, DOI 10.1016/j.fertnstert.2010.09.045; Gonzalez M, 2011, MOL HUM REPROD, V17, P421, DOI 10.1093/molehr/gar015; GRAHAM CH, 1991, J CELL PHYSIOL, V148, P228, DOI 10.1002/jcp.1041480207; Grobman WA, 2001, OBSTET GYNECOL, V97, P521, DOI 10.1016/S0029-7844(00)01193-5; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Hoang VM, 2001, BIOCHEMISTRY-US, V40, P4077, DOI 10.1021/bi0023910; Hu R, 2007, PLACENTA, V28, P399, DOI 10.1016/j.placenta.2006.07.005; Hu Y, 2010, PLACENTA, V31, P213, DOI 10.1016/j.placenta.2009.12.011; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Jarvenpaa J, 2007, GYNECOL ENDOCRINOL, V23, P351, DOI 10.1080/09513590701350291; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; KaczanBourgois D, 1996, PLACENTA, V17, P669, DOI 10.1016/S0143-4004(96)80017-8; Khong TY, 2008, J CLIN PATHOL, V61, P1243, DOI 10.1136/jcp.2008.055202; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Lash GE, 2011, HUM REPROD, V26, P2289, DOI 10.1093/humrep/der198; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Laverriere A, 2009, MOL HUM REPROD, V15, P569, DOI 10.1093/molehr/gap037; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; Li ZY, 2008, INT J CANCER, V123, P2377, DOI 10.1002/ijc.23808; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Lunghi L, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-6; MASLAR IA, 1979, AM J OBSTET GYNECOL, V135, P751, DOI 10.1016/0002-9378(79)90386-7; MCGUIRE MJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P280, DOI 10.1016/0003-9861(92)90519-3; Meade JL, 2009, J IMMUNOL, V183, P803, DOI 10.4049/jimmunol.0713829; Mellembakken JR, 2002, HYPERTENSION, V39, P155, DOI 10.1161/hy0102.100778; Methot N, 2008, MOL PHARMACOL, V73, P1857, DOI 10.1124/mol.108.045682; Methot N, 2007, J BIOL CHEM, V282, P20836, DOI 10.1074/jbc.M702615200; MUNO D, 1993, ARCH BIOCHEM BIOPHYS, V306, P103, DOI 10.1006/abbi.1993.1486; Naruse K, 2009, PLACENTA, V30, P398, DOI 10.1016/j.placenta.2009.02.002; NG LC, 1994, PLACENTA, V15, P201, DOI 10.1016/S0143-4004(05)80456-4; Nilsson U, 2010, REPROD FERT DEVELOP, V22, P71; Paradela A, 2005, J PROTEOME RES, V4, P2435, DOI 10.1021/pr050308v; Paule S, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-50; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Podack ER, 1999, P NATL ACAD SCI USA, V96, P8312, DOI 10.1073/pnas.96.15.8312; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Rainczuk A, 2010, PROTEOMICS, V10, P332, DOI 10.1002/pmic.200900187; Rao NV, 1997, J BIOL CHEM, V272, P10260; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Roy P, 2004, CELL MOTIL CYTOSKEL, V57, P84, DOI 10.1002/cm.10160; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Sharma M, 2010, EXP MOL PATHOL, V88, P278, DOI 10.1016/j.yexmp.2010.01.001; Shibata E, 2001, PLACENTA, V22, P566, DOI 10.1053/plac.2001.0693; Sifakis S, 2010, THROMB RES, V125, P326, DOI 10.1016/j.thromres.2009.11.033; Sun LZ, 2007, GYNECOL OBSTET INVES, V64, P17, DOI 10.1159/000098399; Swisher JFA, 2010, BLOOD, V115, P549, DOI 10.1182/blood-2009-06-226944; Tjoa ML, 2004, HYPERTENS PREGNANCY, V23, P171, DOI 10.1081/PRG-120028292; Tranquilli AL, 2007, CYTOKINE, V40, P82, DOI 10.1016/j.cyto.2007.08.010; Tsai CY, 2008, J BIOL CHEM, V283, P26302, DOI 10.1074/jbc.C800117200; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; Yan GR, 2011, OMICS, V15, P83, DOI 10.1089/omi.2010.0056; Yap J, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-73; Yarmola EG, 2009, BIOESSAYS, V31, P1150, DOI 10.1002/bies.200900049; Yun SP, 2011, J CELL PHYSIOL, V226, P559, DOI 10.1002/jcp.22366; Zeldovich VB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002005; Zhang Y, 2008, PROTEOMICS, V8, P4344, DOI 10.1002/pmic.200800294; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019390; Zhu XM, 2009, PLACENTA, V30, P74, DOI 10.1016/j.placenta.2008.09.013; Zou L, 2010, J CELL PHYSIOL, V223, P623, DOI 10.1002/jcp.22058	81	36	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31418	10.1371/journal.pone.0031418	http://dx.doi.org/10.1371/journal.pone.0031418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359590	gold, Green Published			2022-12-25	WOS:000302796200059
J	Wulfmeyer, T; Polzer, C; Hiepler, G; Hamacher, K; Shoeman, R; Dunigan, DD; Van Etten, JL; Lolicato, M; Moroni, A; Thiel, G; Meckel, T				Wulfmeyer, Timo; Polzer, Christian; Hiepler, Gregor; Hamacher, Kay; Shoeman, Robert; Dunigan, David D.; Van Etten, James L.; Lolicato, Marco; Moroni, Anna; Thiel, Gerhard; Meckel, Tobias			Structural Organization of DNA in Chlorella Viruses	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BINDING PROTEINS; GRANULOSIS-VIRUS; BASIC-PROTEIN; HOST-CELLS; BACTERIOPHAGE; INFECTION; PBCV-1; ORIGIN; DEPOLARIZATION	Chlorella viruses have icosahedral capsids with an internal membrane enclosing their large dsDNA genomes and associated proteins. Their genomes are packaged in the particles with a predicted DNA density of ca. 0.2 bp nm(-3). Occasionally infection of an algal cell by an individual particle fails and the viral DNA is dynamically ejected from the capsid. This shows that the release of the DNA generates a force, which can aid in the transfer of the genome into the host in a successful infection. Imaging of ejected viral DNA indicates that it is intimately associated with proteins in a periodic fashion. The bulk of the protein particles detected by atomic force microscopy have a size of similar to 60 kDa and two proteins (A278L and A282L) of about this size are among 6 basic putative DNA binding proteins found in a proteomic analysis of DNA binding proteins packaged in the virion. A combination of fluorescence images of ejected DNA and a bioinformatics analysis of the DNA reveal periodic patterns in the viral DNA. The periodic distribution of GC rich regions in the genome provides potential binding sites for basic proteins. This DNA/protein aggregation could be responsible for the periodic concentration of fluorescently labeled DNA observed in ejected viral DNA. Collectively the data indicate that the large chlorella viruses have a DNA packaging strategy that differs from bacteriophages; it involves proteins and share similarities to that of chromatin structure in eukaryotes.	[Wulfmeyer, Timo; Hamacher, Kay] Tech Univ Darmstadt, Computat Biol Grp, Darmstadt, Germany; [Shoeman, Robert] Max Planck Inst Med Res, Dept Biomol Mech, Heidelberg, Germany; [Dunigan, David D.; Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Dunigan, David D.; Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Lolicato, Marco; Moroni, Anna] Univ Milan, Dept Biol, Milan, Italy; [Lolicato, Marco; Moroni, Anna] Univ Milan, CNR IBF Mi, Milan, Italy	Technical University of Darmstadt; Max Planck Society; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan	Wulfmeyer, T (corresponding author), Tech Univ Darmstadt, Computat Biol Grp, Darmstadt, Germany.	thiel@bio.tu-darmstadt.de	Lolicato, Marco/ABC-6878-2020; Meckel, Tobias/F-4372-2010; Dunigan, David/AAF-1386-2019; moroni, anna/H-2097-2014; Lolicato, Marco/AAL-3614-2020	Lolicato, Marco/0000-0002-2022-7961; Meckel, Tobias/0000-0003-0759-2072; moroni, anna/0000-0002-1860-406X; Lolicato, Marco/0000-0002-2022-7961; Hamacher, Kay/0000-0002-6921-8345; Thiel, Gerhard/0000-0002-2335-1351; Dunigan, David D/0000-0001-9496-5396	Deutsche Forschungsgemeinschaft [DFG-TH558/16]; National Science Foundation [NSF-EPSCoR EPS-1004094]; Department of Energy (DOE) [DE-FG36-08GO88055, DOE-DE-EE0003142]; National Institutes of Health/National Center for Research Resources (NIH/NCRR) [P20RR15635]; Fonds der Chemischen Industrie; Vigoni program; Center of Smart Interfaces at TU-Darmstadt; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Department of Energy (DOE)(United States Department of Energy (DOE)); National Institutes of Health/National Center for Research Resources (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Vigoni program; Center of Smart Interfaces at TU-Darmstadt; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by: 1) Deutsche Forschungsgemeinschaft (DFG-TH558/16), 2) Vigoni program, 3) National Science Foundation Experimental Program to Stimulate Competitive Research (NSF-EPSCoR EPS-1004094), 4) Department of Energy (DOE DE-FG36-08GO88055; DOE-DE-EE0003142), 5) National Institutes of Health/National Center for Research Resources (NIH/NCRR P20RR15635), and 6) Fonds der Chemischen Industrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Center of Smart Interfaces at TU-Darmstadt for providing measuring time and support for the AFM. We acknowledge the assistance of the Ron Cerny and the Nebraska Center for Mass Spectrometry for PBCV-1 proteomic analyses.	Agarkova I, 2008, J VIROL, V82, P12181, DOI 10.1128/JVI.01687-08; AMES BN, 1960, J BIOL CHEM, V235, P769; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Bremm S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-330; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Cavalcanti MCO, 2009, ANIM REPROD SCI, V111, P220, DOI 10.1016/j.anireprosci.2008.03.018; Cherrier MV, 2009, P NATL ACAD SCI USA, V106, P11085, DOI 10.1073/pnas.0904716106; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cordova A, 2003, BIOPHYS J, V85, P70, DOI 10.1016/S0006-3495(03)74455-5; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; Frohns F, 2006, J VIROL, V80, P2437, DOI 10.1128/JVI.80.5.2437-2444.2006; FUNK CJ, 1993, VIROLOGY, V193, P396, DOI 10.1006/viro.1993.1136; Grayson P, 2007, CURR OPIN MICROBIOL, V10, P401, DOI 10.1016/j.mib.2007.04.004; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; Greiner T, 2009, J GEN VIROL, V90, P2033, DOI 10.1099/vir.0.010629-0; HAAS R, 1982, J MOL BIOL, V159, P71, DOI 10.1016/0022-2836(82)90032-8; Hamacher K, 2008, GENE, V422, P30, DOI 10.1016/j.gene.2008.06.007; Hoshina R, 2010, PHYCOL RES, V58, P188, DOI 10.1111/j.1440-1835.2010.00579.x; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Kindt J, 2001, P NATL ACAD SCI USA, V98, P13671, DOI 10.1073/pnas.241486298; Koonin EV, 2010, INTERVIROLOGY, V53, P284, DOI 10.1159/000312913; Kumetsov Y, 2008, J VIROL, V82, P7551, DOI 10.1128/JVI.00016-08; Kuznetsov YG, 2005, J STRUCT BIOL, V149, P256, DOI 10.1016/j.jsb.2004.10.007; Kuznetsov YG, 2010, VIROLOGY, V404, P127, DOI 10.1016/j.virol.2010.05.007; Li ZD, 2008, BIOPHYS J, V94, P737, DOI 10.1529/biophysj.107.112508; Mangenot S, 2005, CURR BIOL, V15, P430, DOI 10.1016/j.cub.2004.12.080; MEINTS RH, 1988, VIROLOGY, V164, P15, DOI 10.1016/0042-6822(88)90614-9; MEINTS RH, 1984, VIROLOGY, V138, P341, DOI 10.1016/0042-6822(84)90358-1; Neupartl M, 2008, VIROLOGY, V372, P340, DOI 10.1016/j.virol.2007.10.024; ORE A, 1956, SCIENCE, V124, P430, DOI 10.1126/science.124.3219.430; PFISTER H, 1978, MED MICROBIOL IMMUN, V166, P13, DOI 10.1007/BF02121129; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; SERWER P, 1986, J MOL BIOL, V190, P509, DOI 10.1016/0022-2836(86)90019-7; TAN KB, 1977, P NATL ACAD SCI USA, V74, P2805, DOI 10.1073/pnas.74.7.2805; Thiel G, 2010, PROG BOT, V71, P169, DOI 10.1007/978-3-642-02167-1_7; TWEETEN KA, 1980, J VIROL, V33, P866, DOI 10.1128/JVI.33.2.866-876.1980; VANETTEN JL, 1983, SCIENCE, V219, P994, DOI 10.1126/science.219.4587.994; Villarreal LP, 2000, J VIROL, V74, P7079, DOI 10.1128/JVI.74.15.7079-7084.2000; Wang ML, 2010, J VIROL, V84, P8821, DOI 10.1128/JVI.00072-10; Yamada T, 1996, VIROLOGY, V219, P395, DOI 10.1006/viro.1996.0265; Yan XD, 2000, NAT STRUCT BIOL, V7, P101, DOI 10.1038/72360; Zhang XZ, 2011, P NATL ACAD SCI USA, V108, P14837, DOI 10.1073/pnas.1107847108	45	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30133	10.1371/journal.pone.0030133	http://dx.doi.org/10.1371/journal.pone.0030133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359540	gold, Green Published			2022-12-25	WOS:000302796200009
J	Xia, JY; Wan, SQ				Xia, Jianyang; Wan, Shiqiang			The Effects of Warming-Shifted Plant Phenology on Ecosystem Carbon Exchange Are Regulated by Precipitation in a Semi-Arid Grassland	PLOS ONE			English	Article							CLIMATE-CHANGE; REPRODUCTIVE PHENOLOGY; FLOWERING PHENOLOGY; SOIL RESPIRATION; TEMPERATURE; RESPONSES; GROWTH; COMMUNITY; DIOXIDE; INCREASES	Background: The longer growing season under climate warming has served as a crucial mechanism for the enhancement of terrestrial carbon (C) sink over the past decades. A better understanding of this mechanism is critical for projection of changes in C cycling of terrestrial ecosystems. Methodology/Principal Findings: A 4-year field experiment with day and night warming was conducted to examine the responses of plant phenology and their influences on plant coverage and ecosystem C cycling in a temperate steppe in northern China. Greater phenological responses were observed under night than day warming. Both day and night warming prolonged the growing season by advancing phenology of early-blooming species but without changing that of late-blooming species. However, no warming response of vegetation coverage was found for any of the eight species. The variances in species-level coverage and ecosystem C fluxes under different treatments were positively dependent upon the accumulated precipitation within phenological duration but not the length of phenological duration. Conclusions/Significance: These plants' phenology is more sensitive to night than day warming, and the warming effects on ecosystem C exchange via shifting plant phenology could be mediated by precipitation patterns in semi-arid grasslands.	[Xia, Jianyang; Wan, Shiqiang] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Wan, Shiqiang] Henan Univ, Key Lab Plant Stress Biol, Coll Life Sci, Kaifeng, Henan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Henan University	Xia, JY (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	swan@ibcas.ac.cn	Wan, Shiqiang/B-5799-2009; Xia, Jianyang/S-9499-2019; Wan, Shiqiang/L-9166-2019; Xia, Jianyang/A-7886-2008	Wan, Shiqiang/0000-0003-0631-1232; Wan, Shiqiang/0000-0003-0631-1232; 	National Natural Science Foundation of China [30925009, 90511006]; Ministry of Science and Technology [2007CB106803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was financially supported by the National Natural Science Foundation of China (30925009, 90511006) and the Ministry of Science and Technology (2007CB106803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahas R, 2000, INT J BIOMETEOROL, V44, P159, DOI 10.1007/s004840000069; Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; Angert A, 2005, P NATL ACAD SCI USA, V102, P10823, DOI 10.1073/pnas.0501647102; Baptist F, 2010, PLANT BIOLOGY, V12, P755, DOI 10.1111/j.1438-8677.2009.00286.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Dhakhwa GB, 1998, CLIMATIC CHANGE, V40, P647, DOI 10.1023/A:1005339800665; [董文军 Dong Wenjun], 2011, [生态学报, Acta Ecologica Sinica], V31, P2169; Dunne JA, 2003, ECOL MONOGR, V73, P69, DOI 10.1890/0012-9615(2003)073[0069:SMFPRT]2.0.CO;2; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Forrest J, 2010, ECOLOGY, V91, P431, DOI 10.1890/09-0099.1; Gimenez-Benavides L, 2007, NEW PHYTOL, V173, P367, DOI 10.1111/j.1469-8137.2006.01932.x; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Gu Shiliang, 1998, 生物数学学报, V13, P426; HARTE J, 1995, SCIENCE, V267, P876, DOI 10.1126/science.267.5199.876; Hooper DU, 1998, ECOLOGY, V79, P704, DOI 10.1890/0012-9658(1998)079[0704:TROCAC]2.0.CO;2; Hu J, 2010, GLOBAL CHANGE BIOL, V16, P771, DOI 10.1111/j.1365-2486.2009.01967.x; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; LECHOWICZ MJ, 1984, AM NAT, V124, P821, DOI 10.1086/284319; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2003, CLIMATIC CHANGE, V57, P243, DOI 10.1023/A:1022880418362; Menzel A, 2000, INT J BIOMETEOROL, V44, P76, DOI 10.1007/s004840000054; Menzel A, PHENOLOGY INTEGRATIV, P319; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Niemand C, 2005, METEOROL Z, V14, P197, DOI 10.1127/0941-2948/2005/0022; Norby RJ, 2003, GLOBAL CHANGE BIOL, V9, P1792, DOI 10.1111/j.1365-2486.2003.00714.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Price MV, 1998, ECOLOGY, V79, P1261, DOI 10.1890/0012-9658(1998)079[1261:EOEWOP]2.0.CO;2; Prieto P, 2008, ANN BOT-LONDON, V102, P275, DOI 10.1093/aob/mcn090; Prieto P, 2009, GLOBAL ECOL BIOGEOGR, V18, P473, DOI 10.1111/j.1466-8238.2009.00460.x; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 1996, AGR FOREST METEOROL, V80, P215, DOI 10.1016/0168-1923(95)02299-6; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Slaney M, 2007, TREE PHYSIOL, V27, P301, DOI 10.1093/treephys/27.2.301; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; White MA, 1999, INT J BIOMETEOROL, V42, P139, DOI 10.1007/s004840050097; Xia J, 2009, BIOGEOSCIENCES, V6, P1361, DOI 10.5194/bg-6-1361-2009; Xia JY, 2010, SCI TOTAL ENVIRON, V408, P2807, DOI 10.1016/j.scitotenv.2010.03.016; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; Ziska LH, 1996, AUST J PLANT PHYSIOL, V23, P791, DOI 10.1071/PP9960791	56	40	46	10	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32088	10.1371/journal.pone.0032088	http://dx.doi.org/10.1371/journal.pone.0032088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359660	gold, Green Published			2022-12-25	WOS:000302796200129
J	Bachmaier, K; Guzman, E; Kawamura, T; Gao, XP; Malik, AB				Bachmaier, Kurt; Guzman, Edgar; Kawamura, Takeshi; Gao, Xiaopei; Malik, Asrar B.			Sphingosine Kinase 1 Mediation of Expression of the Anaphylatoxin Receptor C5L2 Dampens the Inflammatory Response to Endotoxin	PLOS ONE			English	Article							LYMPHOCYTE EGRESS; HUMAN NEUTROPHILS; KEY ROLE; C5A; 1-PHOSPHATE; COMPLEMENT; SPHINGOSINE-1-PHOSPHATE; S1P; PROTEIN; PERMEABILITY	The complement anaphylatoxin C5a has a pathogenetic role in endotoxin-induced lung inflammatory injury by regulating phagocytic cell migration and activation. Endotoxin and C5a activate the enzyme sphingosine kinase (Sphk) 1 to generate the signaling lipid sphingosine-1-phosphate (S1P), a critical regulator of phagocyte function. We assessed the function of Sphk1 and S1P in experimental lung inflammatory injury and determined their roles in anaphylatoxin receptor signaling and on the expression of the two C5a receptors, C5aR (CD88) and C5L2, on phagocytes. We report that Sphk1 gene deficient (Sphk1(-/-)) mice had augmented lung inflammatory response to endotoxin compared to wild type mice. Sphk1 was required for C5a-mediated reduction in cytokine and chemokine production by macrophages. Moreover, neutrophils from Sphk1(-/-) mice failed to upregulate the anaphylatoxin receptor C5L2 in response to LPS. Exogenous S1P restored C5L2 cell surface expression of Sphk1(-/-) mouse neutrophils to wild type levels but had no effect on cell surface expression of the other anaphylatoxin receptor, CD88. These results provide the first genetic evidence of the crucial role of Sphk1 in regulating the balance between expression of CD88 and C5L2 in phagocytes. S1P-mediated up-regulation of C5L2 is a novel therapeutic target for mitigating endotoxin-induced lung inflammatory injury.	[Bachmaier, Kurt; Guzman, Edgar; Kawamura, Takeshi; Gao, Xiaopei; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, Ctr Lung & Vasc Biol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bachmaier, K (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Ctr Lung & Vasc Biol, Chicago, IL 60607 USA.	kbachmai@uic.edu	Bachmaier, Kurt/AHC-5491-2022; Bachmaier, Kurt/B-6331-2014	Bachmaier, Kurt/0000-0002-0299-2707; Bachmaier, Kurt/0000-0002-0299-2707; Malik, Asrar/0000-0002-8205-7128	United States National Institutes of Health [HL060678, HL077806, HL45638]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678, R01HL045638, P01HL077806] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by United States National Institutes of Health grants HL060678, HL077806, and HL45638. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Bachmaier K, 2007, NAT MED, V13, P920, DOI 10.1038/nm1607; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Camerer E, 2006, BLOOD, V107, P3912, DOI 10.1182/blood-2005-08-3130; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Di AK, 2010, J BIOL CHEM, V285, P15848, DOI 10.1074/jbc.M109.075549; Dorsam G, 2003, J IMMUNOL, V171, P3500, DOI 10.4049/jimmunol.171.7.3500; Flierl MA, 2008, FASEB J, V22, P3483, DOI 10.1096/fj.08-110595; Gavrilyuk V, 2005, J NEUROCHEM, V92, P1140, DOI 10.1111/j.1471-4159.2004.02942.x; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Hopken UE, 1997, J EXP MED, V186, P749, DOI 10.1084/jem.186.5.749; Huber-Lang M, 2005, J IMMUNOL, V174, P1104, DOI 10.4049/jimmunol.174.2.1104; Ibrahim FBM, 2004, J BIOL CHEM, V279, P44802, DOI 10.1074/jbc.M403977200; Jacobson JR, 2007, CURR DRUG TARGETS, V8, P509, DOI 10.2174/138945007780362719; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liu HB, 2008, PANCREAS, V36, pE10, DOI 10.1097/MPA.0b013e31815f3905; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Oskouian B, 2007, CELL CYCLE, V6, P522, DOI 10.4161/cc.6.5.3903; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Perianayagam MC, 2002, KIDNEY INT, V61, P456, DOI 10.1046/j.1523-1755.2002.00139.x; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; Pushparaj PN, 2008, INT J BIOCHEM CELL B, V40, P1817, DOI 10.1016/j.biocel.2008.01.015; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Wang LY, 2010, CLIN IMMUNOL, V137, P157, DOI 10.1016/j.clim.2010.05.012; Ward PA, 2004, MOL IMMUNOL, V41, P323; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	47	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30742	10.1371/journal.pone.0030742	http://dx.doi.org/10.1371/journal.pone.0030742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355325	Green Published, gold			2022-12-25	WOS:000302741300025
J	Eerland, A; Guadalupe, TM; Franken, IHA; Zwaan, RA				Eerland, Anita; Guadalupe, Tulio M.; Franken, Ingmar H. A.; Zwaan, Rolf A.			Posture as Index for Approach-Avoidance Behavior	PLOS ONE			English	Article							AUTOMATIC EVALUATION; MOTIVATION	Approach and avoidance are two behavioral responses that make people tend to approach positive and avoid negative situations. This study examines whether postural behavior is influenced by the affective state of pictures. While standing on the Wii (TM) Balance Board, participants viewed pleasant, neutral, and unpleasant pictures (passively viewing phase). Then they had to move their body to the left or the right (lateral movement phase) to make the next picture appear. We recorded movements in the anterior-posterior direction to examine approach and avoidant behavior. During passively viewing, people approached pleasant pictures. They avoided unpleasant ones while they made a lateral movement. These findings provide support for the idea that we tend to approach positive and avoid negative situations.	[Eerland, Anita; Franken, Ingmar H. A.; Zwaan, Rolf A.] Erasmus Univ, Dept Psychol, Rotterdam, Netherlands; [Guadalupe, Tulio M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Erasmus University Rotterdam; Max Planck Society	Eerland, A (corresponding author), Erasmus Univ, Dept Psychol, Rotterdam, Netherlands.	eerland@fsw.eur.nl	Franken, Ingmar/AAB-7562-2019; Franken, Ingmar/C-2382-2008	Franken, Ingmar/0000-0002-7853-2694; Franken, Ingmar/0000-0002-7853-2694; Zwaan, Rolf/0000-0001-9967-7879				Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bargh JA, 1996, J EXP SOC PSYCHOL, V32, P104, DOI 10.1006/jesp.1996.0005; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Elliot AJ, 2001, EDUC PSYCHOL REV, V13, P73, DOI 10.1023/A:1009009018235; Frijda N.H.., 1986, REV PHILOS LOUVAIN; Hillman CH, 2004, BIOL PSYCHOL, V66, P51, DOI 10.1016/j.biopsycho.2003.07.005; Lang P.J., 2008, A8 U FLOR; Roelofs K, 2010, PSYCHOL SCI, V21, P1575, DOI 10.1177/0956797610384746; Rutherford HJV, 2011, EMOT REV, V3, P333, DOI 10.1177/1754073911402392; SOLARZ AK, 1960, J EXP PSYCHOL, V59, P239, DOI 10.1037/h0047274; Stins JF, 2011, EXP BRAIN RES, V212, P603, DOI 10.1007/s00221-011-2767-z; van Dantzig S, 2008, Q J EXP PSYCHOL, V61, P1298, DOI 10.1080/17470210802027987	13	37	37	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31291	10.1371/journal.pone.0031291	http://dx.doi.org/10.1371/journal.pone.0031291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355355	Green Published, gold			2022-12-25	WOS:000302741300055
J	Ho, KM; Litton, E; Geelhoed, E; Gope, M; Burrell, M; Coribel, J; McDowall, A; Rao, S				Ho, Kwok M.; Litton, Edward; Geelhoed, Elizabeth; Gope, Monica; Burrell, Maxine; Coribel, Jacqueline; McDowall, Angela; Rao, Sudhakar			Effect of an Injury Awareness Education Program on Risk-Taking Behaviors and Injuries in Juvenile Justice Offenders: A Retrospective Cohort Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ALCOHOL; TRAUMA; STATES	Background: Risk-taking behavior is a leading cause of injury and death amongst young people. Methodology and Principal Findings: This was a retrospective cohort study on the effectiveness of a 1-day youth injury awareness education program (Prevent Alcohol and Risk-related Trauma in Youth, P.A.R.T.Y.) program in reducing risk taking behaviors and injuries of juvenille justice offenders in Western Australia. Of the 3659 juvenile justice offenders convicted by the court magistrates between 2006 and 2010, 225 were referred to the P.A.R.T.Y. education program. In a before and after survey of these 225 participants, a significant proportion of them stated that they were more receptive to modifying their risk-taking behavior (21% before vs. 57% after). Using data from the Western Australia Police and Department of Health, the incidence of subsequent offences and injuries of all juvenile justice offenders was assessed. The incidence of subsequent traffic or violence-related offences was significantly lower for those who had attended the program compared to those who did not (3.6% vs. 26.8%; absolute risk reduction [ARR] = 23.2%, 95% confidence interval [CI] 19.9%-25.8%; number needed to benefit = 4.3, 95% CI 3.9-5.1; p = 0.001), as were injuries leading to hospitalization (0% vs. 1.6% including 0.2% fatality; ARR = 1.6%, 95% CI 1.2%-2.1%) and alcohol or drug-related offences (0% vs. 2.4%; ARR 2.4%, 95% CI 1.9%-2.9%). In the multivariate analysis, only P.A.R.T.Y. education program attendance (odds ratio [OR] 0.10, 95% CI 0.05-0.21) and a higher socioeconomic background (OR 0.97 per decile increment in Index of Relative Socioeconomic Advantage and Disadvantage, 95% CI 0.93-0.99) were associated with a lower risk of subsequent traffic or violence-related offences. Significance: Participation in an injury education program involving real-life trauma scenarios was associated with a reduced subsequent risk of committing violence-or traffic-related offences, injuries, and death for juvenille justice offenders.	[Ho, Kwok M.; Litton, Edward; Coribel, Jacqueline] Royal Perth Hosp, Dept Intens Care, Perth, WA, Australia; [Ho, Kwok M.; Geelhoed, Elizabeth] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Litton, Edward] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Gope, Monica; Burrell, Maxine] Royal Perth Hosp, Dept Emergency Med, Perth, WA, Australia; [McDowall, Angela; Rao, Sudhakar] Royal Perth Hosp, State Trauma Unit, Perth, WA, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital	Ho, KM (corresponding author), Royal Perth Hosp, Dept Intens Care, Perth, WA, Australia.	kwok.ho@health.wa.gov.au	Ho, Kwok M./E-3546-2010; litton, edward/C-5384-2017	Ho, Kwok M./0000-0002-6705-6004; litton, edward/0000-0002-5125-6829; Geelhoed, Elizabeth/0000-0001-6718-9264	State Health Research Advisory Council (SHRAC) of Western Australia [11698]	State Health Research Advisory Council (SHRAC) of Western Australia	We would like to thank the State Health Research Advisory Council (SHRAC) of Western Australia for funding this study (grant number 11698) and Western Australia Police in providing the data for this study. No funding was received from NIH, Wellcome Trust or NHMRC for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 20390 AUSTR BUR STAT; [Anonymous], 2004, 3311 5 55 001 DEMOGR; [Anonymous], MORT SURV SER; Banfield J, OUTCOMES INJURY AWAR; Banfield JM, 2011, J TRAUMA, V70, P732, DOI 10.1097/TA.0b013e31820783a3; Ch'ng CW, 2007, EMERG MED AUSTRALAS, V19, P359, DOI 10.1111/j.1742-6723.2007.00958.x; Chapman A, MEASURING ROAD CRASH; Connelly LB, 2006, ACCIDENT ANAL PREV, V38, P1087, DOI 10.1016/j.aap.2006.04.015; Eldridge D, 2008, AIHW B; Ho KM, 2011, BRIT J ANAESTH, V106, P528, DOI 10.1093/bja/aeq417; Ho KM, 2008, MED J AUSTRALIA, V189, P26, DOI 10.5694/j.1326-5377.2008.tb01890.x; Ho KM, 2011, CHEST, V140, P1436, DOI 10.1378/chest.11-1444; Ho KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003226; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Howat Peter, 2004, Traffic Inj Prev, V5, P208; Petrie DJ, 2010, ADDICT BEHAV, V35, P359, DOI 10.1016/j.addbeh.2009.10.022; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39	18	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31776	10.1371/journal.pone.0031776	http://dx.doi.org/10.1371/journal.pone.0031776			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355394	gold, Green Published, Green Submitted			2022-12-25	WOS:000302741300094
J	Smith, BJ; Cote, PD				Smith, Benjamin J.; Cote, Patrice D.			Reduced Retinal Function in the Absence of Na(v)1.6	PLOS ONE			English	Article							CONE BIPOLAR CELLS; SODIUM-CHANNELS; A-WAVE; MAMMALIAN RETINA; ELECTRORETINOGRAM; PHOTORECEPTORS; RESPONSES; NEURONS; MACAQUE; MOUSE	Background: Mice with a function-blocking mutation in the Scn8a gene that encodes Na(v)1.6, a voltage-gated sodium channel (VGSC) isoform normally found in several types of retinal neurons, have previously been found to display a profoundly abnormal dark adapted flash electroretinogram. However the retinal function of these mice in light adapted conditions has not been studied. Methodology/Principal Findings: In the present report we reveal that during light adaptation these animals are shown to have electroretinograms with significant decreases in the amplitude of the a-and b-waves. The percent decrease in the a-and b-waves substantially exceeds the acute effect of VGSC block by tetrodotoxin in control littermates. Intravitreal injection of CoCl2 or CNQX to isolate the a-wave contributions of the photoreceptors in littermates revealed that at high background luminance the cone-isolated component of the a-wave is of the same amplitude as the a-wave of mutants. Conclusions/Significance: Our results indicate that Scn8a mutant mice have reduced function in both rod and the cone retinal pathways. The extent of the reduction in the cone pathway, as quantified using the ERG b-wave, exceeds the reduction seen in control littermates after application of TTX, suggesting that a defect in cone photoreceptors contributes to the reduction. Unless the postreceptoral component of the a-wave is increased in Scn8a mutant mice, the reduction in the b-wave is larger than can be accounted for by reduced photoreceptor function alone. Our data suggests that the reduction in the light adapted ERG of Scn8a mutant mice is caused by a combination of reduced cone photoreceptor function and reduced depolarization of cone ON bipolar cells. This raises the possibility that Na(v)1.6 augments signaling in cone bipolar cells.	[Smith, Benjamin J.; Cote, Patrice D.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Cote, Patrice D.] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Smith, BJ (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	patrice@dal.ca		Cote, Patrice/0000-0002-4189-7526	Natural Sciences and Engineering Research Council of Canada [326943-06]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (grant number, 326943-06; www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; BUSH RA, 1994, INVEST OPHTH VIS SCI, V35, P635; Chen Y, 2008, MOL CELL NEUROSCI, V38, P607, DOI 10.1016/j.mcn.2008.05.009; Cote PD, 2005, J NEUROSCI, V25, P5046, DOI 10.1523/JNEUROSCI.4692-04.2005; Cui JJ, 2008, VISUAL NEUROSCI, V25, P635, DOI 10.1017/S0952523808080851; Dang TM, 2011, DOC OPHTHALMOL, V122, P149, DOI 10.1007/s10633-011-9269-y; De Repentigny Y, 2001, HUM MOL GENET, V10, P1819, DOI 10.1093/hmg/10.17.1819; Holzhausen LC, 2009, J COMP NEUROL, V517, P633, DOI 10.1002/cne.22176; Ichinose T, 2005, J NEUROSCI, V25, P1856, DOI 10.1523/jneurosci.5208-04.2005; Ichinose T, 2007, J NEUROSCI, V27, P4756, DOI 10.1523/JNEUROSCI.0183-07.2007; Kurimoto Y, 2009, EXP EYE RES, V88, P92, DOI 10.1016/j.exer.2008.10.012; Miura G, 2009, EXP EYE RES, V89, P49, DOI 10.1016/j.exer.2009.02.009; Mojumder DK, 2007, MOL VIS, V13, P2163; Mojumder DK, 2008, J PHYSIOL-LONDON, V586, P2551, DOI 10.1113/jphysiol.2008.150755; Ohkuma M, 2007, PHOTOCHEM PHOTOBIOL, V83, P317, DOI 10.1562/2006-06-15-RA-923; Pan ZH, 2000, J NEUROPHYSIOL, V84, P2564, DOI 10.1152/jn.2000.84.5.2564; Popova E, 2010, VISION RES, V50, P88, DOI 10.1016/j.visres.2009.10.015; Robson JG, 2003, J PHYSIOL-LONDON, V547, P509, DOI 10.1113/jphysiol.2002.030304; Sharma S, 2005, VISUAL NEUROSCI, V22, P631, DOI 10.1017/S0952523805225129; Shirato S, 2008, EXP EYE RES, V86, P914, DOI 10.1016/j.exer.2008.03.008; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Zenisek D, 2001, J NEUROSCI, V21, P4543, DOI 10.1523/JNEUROSCI.21-13-04543.2001	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31476	10.1371/journal.pone.0031476	http://dx.doi.org/10.1371/journal.pone.0031476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355369	Green Published, gold			2022-12-25	WOS:000302741300069
J	Soares, SC; Abreu, VAC; Ramos, RTJ; Cerdeira, L; Silva, A; Baumbach, J; Trost, E; Tauch, A; Hirata, R; Mattos-Guaraldi, AL; Miyoshi, A; Azevedo, V				Soares, Siomar C.; Abreu, Vinicius A. C.; Ramos, Rommel T. J.; Cerdeira, Louise; Silva, Artur; Baumbach, Jan; Trost, Eva; Tauch, Andreas; Hirata, Raphael, Jr.; Mattos-Guaraldi, Ana L.; Miyoshi, Anderson; Azevedo, Vasco			PIPS: Pathogenicity Island Prediction Software	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; COMPLETE GENOME SEQUENCE; PROKARYOTIC GENOMES; CORYNEBACTERIUM-GLUTAMICUM; IDENTIFICATION; DNA; VIRULENCE; DATABASE; GENES; TOOL	The adaptability of pathogenic bacteria to hosts is influenced by the genomic plasticity of the bacteria, which can be increased by such mechanisms as horizontal gene transfer. Pathogenicity islands play a major role in this type of gene transfer because they are large, horizontally acquired regions that harbor clusters of virulence genes that mediate the adhesion, colonization, invasion, immune system evasion, and toxigenic properties of the acceptor organism. Currently, pathogenicity islands are mainly identified in silico based on various characteristic features: (1) deviations in codon usage, G+C content or dinucleotide frequency and (2) insertion sequences and/or tRNA genetic flanking regions together with transposase coding genes. Several computational techniques for identifying pathogenicity islands exist. However, most of these techniques are only directed at the detection of horizontally transferred genes and/or the absence of certain genomic regions of the pathogenic bacterium in closely related non-pathogenic species. Here, we present a novel software suite designed for the prediction of pathogenicity islands (pathogenicity island prediction software, or PIPS). In contrast to other existing tools, our approach is capable of utilizing multiple features for pathogenicity island detection in an integrative manner. We show that PIPS provides better accuracy than other available software packages. As an example, we used PIPS to study the veterinary pathogen Corynebacterium pseudotuberculosis, in which we identified seven putative pathogenicity islands.	[Soares, Siomar C.; Miyoshi, Anderson; Azevedo, Vasco] Univ Fed Minas Gerais, Dept Gen Biol, Belo Horizonte, MG, Brazil; [Abreu, Vinicius A. C.; Azevedo, Vasco] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Ramos, Rommel T. J.; Cerdeira, Louise; Silva, Artur] Fed Univ Para, Dept Genet, BR-66059 Belem, Para, Brazil; [Baumbach, Jan] Max Planck Inst Informat, Dept Comp Sci, Saarbrucken, Saarland, Germany; [Trost, Eva; Tauch, Andreas] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Nordrhein Westf, Germany; [Hirata, Raphael, Jr.; Mattos-Guaraldi, Ana L.] Univ Estado Rio De Janeiro, Fac Med Sci, Microbiol & Immunol Discipline, Rio De Janeiro, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal do Para; Max Planck Society; University of Bielefeld; Universidade do Estado do Rio de Janeiro	Soares, SC (corresponding author), Univ Fed Minas Gerais, Dept Gen Biol, Belo Horizonte, MG, Brazil.	vasco@icb.ufmg.br	Luiz Silva, Artur da Costa da/AAI-3516-2021; Azevedo, Vasco A.C/F-4315-2011; Abreu, Vinicius AC/G-3694-2014; Ramos, Rommel Thiago Juca/L-9329-2013; Silva, Artur/E-1474-2014; Cerdeira, Louise/C-3749-2013; de Castro Soares, Siomar/I-2705-2012; Hirata, Raphael Jr./F-9256-2012; de Mattos Guaraldi, Ana Luíza/AAL-5335-2021; Azevedo, Vasco/B-1556-2019; Cerdeira, Louise Teixeira/AAR-4668-2020; Hirata Junior, Raphael/O-9845-2015	Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Azevedo, Vasco A.C/0000-0002-4775-2280; Ramos, Rommel Thiago Juca/0000-0002-8032-1474; Silva, Artur/0000-0002-4082-1132; Cerdeira, Louise/0000-0002-4495-2615; de Castro Soares, Siomar/0000-0001-7299-3724; de Mattos Guaraldi, Ana Luíza/0000-0003-2522-0416; Azevedo, Vasco/0000-0002-4775-2280; Trost, Eva/0000-0002-1924-1416; Hirata Junior, Raphael/0000-0003-3091-6020; Baumbach, Jan/0000-0002-0282-0462	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/MAPA) [578219/2008-5]; Fundacao de Apoio a Pesquisa de Minas Gerais (FAPEMIG) [APQ-01004-08]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/MAPA)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by grants from the Brazilian Funding Agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant CNPq/MAPA; http://cnpq.br/) [grant number 578219/2008-5] and Fundacao de Apoio a Pesquisa de Minas Gerais (FAPEMIG; http://www.fapemig.br/) [grant number APQ-01004-08]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLUM G, 1994, INFECT IMMUN, V62, P606, DOI 10.1128/IAI.62.2.606-614.1994; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Dobrindt U, 2001, CURR OPIN MICROBIOL, V4, P550, DOI 10.1016/S1369-5274(00)00250-2; Dorella FA, 2006, VET RES, V37, P201, DOI 10.1051/vetres:2005056; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gao JX, 2010, RES MICROBIOL, V161, P1, DOI 10.1016/j.resmic.2009.10.007; HACKER J, 1990, MICROB PATHOGENESIS, V8, P213, DOI 10.1016/0882-4010(90)90048-U; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hadfield TL, 2000, J INFECT DIS, V181, pS116, DOI 10.1086/315551; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Hochhut Bianca, 2005, V12, P234, DOI 10.1159/000081698; Hou YM, 1999, TRENDS BIOCHEM SCI, V24, P295, DOI 10.1016/S0968-0004(99)01428-0; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Jain R, 2008, ICIT 2008: PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY, P131, DOI 10.1109/ICIT.2008.42; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lio P, 2000, BIOINFORMATICS, V16, P932, DOI 10.1093/bioinformatics/16.10.932; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Mantri Y, 2004, NUCLEIC ACIDS RES, V32, pD55, DOI 10.1093/nar/gkh059; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; Merkl R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-22; Oren A, 2004, PHILOS T R SOC B, V359, P623, DOI 10.1098/rstb.2003.1458; Ou HY, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj005; Pundhir Sachin, 2008, In Silico Biology, V8, P223; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Schumann W, 2007, J BIOSCIENCES, V32, P549, DOI 10.1007/s12038-007-0054-8; Tsai NP, 2006, BIOCHEM J, V393, P591, DOI 10.1042/BJ20051201; Tu Q, 2003, FEMS MICROBIOL LETT, V221, P269, DOI 10.1016/S0378-1097(03)00204-0; van Passel MWJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh115; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Zhang CT, 2004, NAT BIOTECHNOL, V22, P1078, DOI 10.1038/nbt0904-1078b; Zhang CT, 2001, J BIOMOL STRUCT DYN, V19, P333, DOI 10.1080/07391102.2001.10506743; Zhang R, 2004, BIOINFORMATICS, V20, P612, DOI 10.1093/bioinformatics/btg453; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791; ZWEIG MH, 1993, CLIN CHEM, V39, P561	50	50	51	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30848	10.1371/journal.pone.0030848	http://dx.doi.org/10.1371/journal.pone.0030848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355329	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300029
J	Zito, CR; Jilaveanu, LB; Anagnostou, V; Rimm, D; Bepler, G; Maira, SM; Hackl, W; Camp, R; Kluger, HM; Chao, HH				Zito, Christopher R.; Jilaveanu, Lucia B.; Anagnostou, Valsamo; Rimm, David; Bepler, Gerold; Maira, Sauveur-Michel; Hackl, Wolfgang; Camp, Robert; Kluger, Harriet M.; Chao, Herta H.			Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; DUAL PI3K/MTOR INHIBITOR; P85 REGULATORY SUBUNIT; GROWTH-FACTOR RECEPTOR; AKT/PROTEIN-KINASE-B; ONCOGENIC K-RAS; PHOSPHOINOSITIDE 3-KINASE; MAMMALIAN TARGET; NEGATIVE REGULATION; APOPTOSIS	Introduction: We assessed expression of p85 and p110 alpha PI3K subunits in non-small cell lung cancer (NSCLC) specimens and the association with mTOR expression, and studied effects of targeting the PI3K/AKT/mTOR pathway in NSCLC cell lines. Methods: Using Automated Quantitative Analysis we quantified expression of PI3K subunits in two cohorts of 190 and 168 NSCLC specimens and correlated it with mTOR expression. We studied effects of two PI3K inhibitors, LY294002 and NVP-BKM120, alone and in combination with rapamycin in 6 NSCLC cell lines. We assessed activity of a dual PI3K/mTOR inhibitor, NVP-BEZ235 alone and with an EGFR inhibitor. Results: p85 and p110 alpha tend to be co-expressed (p<0.001); p85 expression was higher in adenocarcinomas than squamous cell carcinomas. High p85 expression was associated with advanced stage and poor survival. p110 alpha expression correlated with mTOR (rho = 0.276). In six NSCLC cell lines, addition of rapamycin to LY294002 or NVP-BKM120 was synergistic. Even very low rapamycin concentrations (1 nM) resulted in sensitization to PI3K inhibitors. NVP-BEZ235 was highly active in NSCLC cell lines with IC(50)s in the nanomolar range and resultant down-regulation of pAKT and pP70S6K. Adding Erlotinib to NVP-BEZ235 resulted in synergistic growth inhibition. Conclusions: The association between PI3K expression, advanced stage and survival in NSCLC suggests that it might be a valuable drug target. Concurrent inhibition of PI3K and mTOR is synergistic in vitro, and a dual PI3K/mTOR inhibitor was highly active. Adding EGFR inhibition resulted in further growth inhibition. Targeting the PI3K/AKT/mTOR pathway at multiple levels should be tested in clinical trials for NSCLC.	[Zito, Christopher R.; Jilaveanu, Lucia B.; Anagnostou, Valsamo; Rimm, David; Camp, Robert; Kluger, Harriet M.; Chao, Herta H.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Chao, Herta H.] VA Connecticut Healthcare Syst, Med Serv, West Haven, CT USA; [Bepler, Gerold] Karmanos Canc Inst, Detroit, MI USA; [Maira, Sauveur-Michel; Hackl, Wolfgang] Novartis Inst Biomed Res, Cambridge, MA USA; [Zito, Christopher R.; Jilaveanu, Lucia B.; Anagnostou, Valsamo; Rimm, David; Camp, Robert; Kluger, Harriet M.; Chao, Herta H.] Yale Comprehens Canc, New Haven, CT USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Barbara Ann Karmanos Cancer Institute; Novartis	Zito, CR (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	herta.chao@yale.edu		Rimm, David/0000-0001-5820-4397	American Association for Cancer Research; Yale SPORE in Skin Cancer [1 P50 CA121974]; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER	American Association for Cancer Research; Yale SPORE in Skin Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Career Development Award of the American Association for Cancer Research to Dr. Chao. Dr. Kluger is supported by the Yale SPORE in Skin Cancer, 1 P50 CA121974 (to R. Halaban). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2010, AM CANC SOC CANC FAC; Anagnostou VK, 2009, CLIN CANCER RES, V15, P4157, DOI 10.1158/1078-0432.CCR-09-0099; Anagnostou VK, 2009, J CLIN ONCOL, V27, P271, DOI 10.1200/JCO.2008.17.0043; Aziz SA, 2010, CLIN CANCER RES, V16, P6029, DOI 10.1158/1078-0432.CCR-10-1490; Bendell JC, 2011, J CLIN ONCOL    1227; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Brognard J, 2001, CANCER RES, V61, P3986; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; BURRIS H, 2010, J CLIN ONCOL S, V28, pS15; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chun KH, 2003, JNCI-J NATL CANCER I, V95, P291, DOI 10.1093/jnci/95.4.291; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dolled-Filhart M, 2006, CANCER RES, V66, P5487, DOI 10.1158/0008-5472.CAN-06-0100; Edling CE, 2010, CLIN CANCER RES, V16, P4928, DOI 10.1158/1078-0432.CCR-10-1210; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Herrera VA, 2011, ANTICANCER RES, V31, P849; Hidalgo M, 2001, J CLIN ONCOL, V19, P3267, DOI 10.1200/JCO.2001.19.13.3267; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Lee HY, 2004, BIOCHEM PHARMACOL, V68, P1119, DOI 10.1016/j.bcp.2004.05.033; Lee HY, 2004, JNCI-J NATL CANCER I, V96, P1536, DOI 10.1093/jnci/djh286; Lee HY, 2003, J BIOL CHEM, V278, P23630, DOI 10.1074/jbc.M300997200; Lin XB, 2001, LANGENBECK ARCH SURG, V386, P293, DOI 10.1007/s004230100203; Luo J, 2005, J CELL BIOL, V170, P455, DOI 10.1083/jcb.200503088; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Massion PP, 2004, AM J RESP CRIT CARE, V170, P1088, DOI 10.1164/rccm.200404-487OC; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Roche S, 1998, MOL CELL BIOL, V18, P7119, DOI 10.1128/MCB.18.12.7119; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Tsao MS, 1996, EXP CELL RES, V223, P268, DOI 10.1006/excr.1996.0081; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420; Xu CX, 2011, CANCER BIOL THER, V12, P549, DOI 10.4161/cbt.12.6.16397; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020899; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002220; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	55	52	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31331	10.1371/journal.pone.0031331	http://dx.doi.org/10.1371/journal.pone.0031331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355357	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300057
J	Abu-Elheiga, L; Wu, HM; Gu, ZW; Bressler, R; Wakil, SJ				Abu-Elheiga, Lutfi; Wu, Hongmei; Gu, Ziwei; Bressler, Rubin; Wakil, Salih J.			Acetyl-CoA Carboxylase 2(-/-) Mutant Mice are Protected against Fatty Liver under High-fat, High-carbohydrate Dietary and de Novo Lipogenic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; PEROXISOME PROLIFERATOR; GENE-TRANSCRIPTION; ENERGY-EXPENDITURE; ACID OXIDATION; KNOCKOUT MICE; GLUCOSE; BETA; EXPRESSION; STEATOSIS	Hepatic fat accumulation resulting from increased de novo fatty acid synthesis leads to hepatic steatosis and hepatic insulin resistance. We have shown previously that acetyl-CoA carboxylase 2 (Acc2(-/-)) mutant mice, when fed a high-fat (HF) or high-fat, high-carbohydrate (HFHC) diet, are protected against diet-induced obesity and maintained whole body and hepatic insulin sensitivity. To determine the effect of an ACC2 deletion on hepatic fat metabolism, we studied the regulation of the enzymes involved in the lipogenic pathway under Western HFHC dietary and de novo lipogenic conditions. After completing the HFHC regimen, Acc2(-/-) mutant mice were found to have lower body weight, smaller epididymal fat pads, lower blood levels of nonesterified fatty acids and triglycerides, and higher hepatic cholesterol than wild-type mice. Significant up-regulation of lipogenic enzymes and an elevation in hepatic peroxisome proliferator-activated receptor-gamma (PPAR-gamma) protein were found in Acc2(-/-) mutant mice under de novo lipogenic conditions. The increase in lipogenic enzyme levels was accompanied by up-regulation of the transcription factors, sterol regulatory element-binding proteins 1 and 2, and carbohydrate response element-binding protein. In contrast, hepatic levels of the PPAR-gamma and PPAR-gamma proteins were significantly lower in the Acc2(-/-) mutant mice fed an HFHC diet. When compared with wild-type mice fed the same diet, Acc2(-/-) mutant mice exhibited a similar level of AKT but with a significant increase in pAKT. Hence, deleting ACC2 ameliorates the metabolic syndrome and protects against fatty liver despite increased de novo lipogenesis and dietary conditions known to induce obesity and diabetes.	[Bressler, Rubin] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85724 USA; [Abu-Elheiga, Lutfi; Wu, Hongmei; Gu, Ziwei; Wakil, Salih J.] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Arizona; Baylor College of Medicine	Abu-Elheiga, L (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	lutfia@bcm.edu; swakil@bcm.edu		Abu-Elheiga, Lutfi/0000-0002-7366-3556	National Institutes of Health [GM-63115]; Hefni Technical Training Foundation; Medallion Foundation; McLean Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hefni Technical Training Foundation; Medallion Foundation; McLean Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-63115, the Hefni Technical Training Foundation, the Medallion Foundation (to S. J. W.), and the McLean Foundation Pilot Project (to L. A.).	Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; AbuElheiga L, 1997, J BIOL CHEM, V272, P10669; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Delzenne NM, 1997, J HEPATOL, V26, P880, DOI 10.1016/S0168-8278(97)80256-5; Essop MF, 2008, AM J PHYSIOL-HEART C, V295, pH256, DOI 10.1152/ajpheart.91489.2007; Gu YG, 2006, J MED CHEM, V49, P3770, DOI 10.1021/jm060484v; Ha J, 1996, P NATL ACAD SCI USA, V93, P11466, DOI 10.1073/pnas.93.21.11466; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; Kim H, 2004, DIABETES, V53, pS60, DOI 10.2337/diabetes.53.2007.S60; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; NIH, 2010, GUIDE CARE USE LAB A, V8th, DOI [10.1163/1573-3912_islam_DUM_3825, DOI 10.1163/1573-3912_ISLAM_DUM_3825]; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Olson DP, 2010, P NATL ACAD SCI USA, V107, P7598, DOI 10.1073/pnas.0913492107; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Sul HS, 1998, ANNU REV NUTR, V18, P331, DOI 10.1146/annurev.nutr.18.1.331; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; WIGGINS D, 1992, BIOCHEM J, V284, P457, DOI 10.1042/bj2840457; WINDER WW, 1995, J APPL PHYSIOL, V78, P578, DOI 10.1152/jappl.1995.78.2.578	32	63	65	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12578	12588		10.1074/jbc.M111.309559	http://dx.doi.org/10.1074/jbc.M111.309559			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22362781	Green Published, hybrid			2022-12-25	WOS:000302782200096
J	Haag, AF; Kerscher, B; Dall'Angelo, S; Sani, M; Longhi, R; Baloban, M; Wilson, HM; Mergaert, P; Zanda, M; Ferguson, GP				Haag, Andreas F.; Kerscher, Bernhard; Dall'Angelo, Sergio; Sani, Monica; Longhi, Renato; Baloban, Mikhail; Wilson, Heather M.; Mergaert, Peter; Zanda, Matteo; Ferguson, Gail P.			Role of Cysteine Residues and Disulfide Bonds in the Activity of a Legume Root Nodule-specific, Cysteine-rich Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; PROTEIN; GENES; DIFFERENTIATION; SYMBIOSIS; GENOME	The root nodules of certain legumes including Medicago truncatula produce >300 different nodule-specific cysteine-rich (NCR) peptides. Medicago NCR antimicrobial peptides (AMPs) mediate the differentiation of the bacterium, Sinorhizobium meliloti into a nitrogen-fixing bacteroid within the legume root nodules. In vitro, NCRAMPs such as NCR247 induced bacteroid features and exhibited antimicrobial activity against S. meliloti. The bacterial BacA protein is critical to prevent S. meliloti from being hypersensitive toward NCR AMPs. NCR AMPs are cationic and have conserved cysteine residues, which form disulfide (S-S) bridges. However, the natural configuration of NCRAMP S-S bridges and the role of these in the activity of the peptide are unknown. In this study, we found that either cysteine replacements or S-S bond modifications influenced the activity of NCR247 against S. meliloti. Specifically, either substitution of cysteines for serines, changing the S-S bridges from cysteines 1-2, 3-4 to 1-3, 2-4 or oxidation of NCR247 lowered its activity against S. meliloti. We also determined that BacA specifically protected S. meliloti against oxidized NCR247. Due to the large number of different NCRs synthesized by legume root nodules and the importance of bacterial BacA proteins for prolonged hostinfections, these findings have important implications for analyzing the function of these novel peptides and the protective role of BacA in the bacterial response toward these peptides.	[Haag, Andreas F.; Kerscher, Bernhard; Wilson, Heather M.; Ferguson, Gail P.] Univ Aberdeen, Inst Med Sci, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland; [Dall'Angelo, Sergio; Zanda, Matteo] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; [Sani, Monica; Longhi, Renato; Zanda, Matteo] CNR, Inst Chim Riconoscimento Mol, I-20131 Milan, Italy; [Sani, Monica] KemoTech Soc Responsabilita Limitata, I-09010 Cagliari, Italy; [Baloban, Mikhail; Mergaert, Peter] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France	University of Aberdeen; University of Aberdeen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Haag, AF (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland.	a.haag@live.co.uk; bernhard.kerscher@abdn.ac.uk	Dall'Angelo, Sergio/J-5333-2014; Mergaert, Peter/M-1265-2019; Zanda, Matteo/AAC-2391-2022; Kerscher, Bernhard G R/B-1907-2015; Haag, Andreas F/R-8775-2019	Dall'Angelo, Sergio/0000-0001-9377-0474; Mergaert, Peter/0000-0002-5919-7317; Kerscher, Bernhard G R/0000-0001-9300-7401; Haag, Andreas F/0000-0002-6783-0231; Wilson, Heather M/0000-0002-1407-7274; Baloban, Mikhail/0000-0003-3919-1222	Medical Research Council [G0501107]; Agence Nationale de la Recherche [ANR-09-BLAN-0396-01]; MRC [G0501107] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Agence Nationale de la Recherche(French National Research Agency (ANR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council New Investigator Grant G0501107 (to G. P. F.).; Supported by the Agence Nationale de la Recherche Grant ANR-09-BLAN-0396-01.	Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; Alkhalfioui F, 2008, PLANT PHYSIOL, V148, P424, DOI 10.1104/pp.108.123778; Alunni B, 2007, MOL PLANT MICROBE IN, V20, P1138, DOI 10.1094/MPMI-20-9-1138; Barker D. G., 1990, Plant Molecular Biology Reporter, V8, P40, DOI 10.1007/BF02668879; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Domenech P, 2009, J BACTERIOL, V191, P477, DOI 10.1128/JB.01132-08; Ferguson GP, 2002, J BACTERIOL, V184, P5625, DOI 10.1128/JB.184.20.5625-5632.2002; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Graham MA, 2004, PLANT PHYSIOL, V135, P1179, DOI 10.1104/pp.104.037531; Haag AF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001169; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; LeVier K, 2000, SCIENCE, V287, P2492, DOI 10.1126/science.287.5462.2492; Marlow VL, 2009, J BACTERIOL, V191, P1519, DOI 10.1128/JB.01661-08; Maroti G, 2011, RES MICROBIOL, V162, P363, DOI 10.1016/j.resmic.2011.02.005; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Missiakas D, 1997, J BACTERIOL, V179, P2465, DOI 10.1128/jb.179.8.2465-2471.1997; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Saeki K, 2011, CELL MOL LIFE SCI, V68, P1327, DOI 10.1007/s00018-011-0650-5; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Wang D, 2010, SCIENCE, V327, P1126, DOI 10.1126/science.1184096; Wehmeier S, 2010, MICROBIOL-SGM, V156, P2702, DOI 10.1099/mic.0.039909-0; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	29	59	60	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10791	10798		10.1074/jbc.M111.311316	http://dx.doi.org/10.1074/jbc.M111.311316			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22351783	Green Published, hybrid			2022-12-25	WOS:000302780100008
J	Spindler, SR; Li, R; Dhahbi, JM; Yamakawa, A; Sauer, F				Spindler, Stephen R.; Li, Rui; Dhahbi, Joseph M.; Yamakawa, Amy; Sauer, Frank			Novel Protein Kinase Signaling Systems Regulating Lifespan Identified by Small Molecule Library Screening Using Drosophila	PLOS ONE			English	Article							DIETARY RESTRICTION; GROWTH; INHIBITORS; PATHWAY; ASSAY	Protein kinase signaling cascades control most aspects of cellular function. The ATP binding domains of signaling protein kinases are the targets of most available inhibitors. These domains are highly conserved from mammals to flies. Herein we describe screening of a library of small molecule inhibitors of protein kinases for their ability to increase Drosophila lifespan. We developed an assay system which allowed screening using the small amounts of materials normally present in commercial chemical libraries. The studies identified 17 inhibitors, the majority of which targeted tyrosine kinases associated with the epidermal growth factor receptor (EGFR), platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) receptors, G-protein coupled receptor (GPCR), Janus kinase (JAK)/signal transducer and activator of transcription (STAT), the insulin and insulin-like growth factor (IGFI) receptors. Comparison of the protein kinase signaling effects of the inhibitors in vitro defined a consensus intracellular signaling profile which included decreased signaling by p38MAPK (p38), c-Jun N-terminal kinase (JNK) and protein kinase C (PKC). If confirmed, many of these kinases will be novel additions to the signaling cascades known to regulate metazoan longevity.	[Spindler, Stephen R.; Li, Rui; Dhahbi, Joseph M.; Yamakawa, Amy; Sauer, Frank] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Spindler, SR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	spindler@ucr.edu			Alva LLC	Alva LLC	The research was supported by Alva LLC, a private, basic research foundation. Alva has no web site. To the best of the authors' knowledge, Alva is not associated with any commercial entity. The one agreement the author was asked to (and did) make with Alva regarding their funding is that the author make the results freely available and report them in peer reviewed publications. Alva's funder, a high net worth individual, prefers to remain anonymous. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Aritakula A, 2008, J BIOSCIENCES, V33, P731, DOI 10.1007/s12038-008-0093-9; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Baldal EA, 2005, MECH AGEING DEV, V126, P407, DOI 10.1016/j.mad.2004.09.035; Biteau B, 2011, EXP GERONTOL, V46, P349, DOI 10.1016/j.exger.2010.11.003; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Clancy David J., 2001, Drosophila Information Service, V84, P168; DRIVER CJI, 1986, EXP GERONTOL, V21, P497, DOI 10.1016/0531-5565(86)90002-1; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Goto M, 2008, BIOSCI TRENDS, V2, P218; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Johnson EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012799; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Karpac J, 2009, TRENDS ENDOCRIN MET, V20, P100, DOI 10.1016/j.tem.2008.11.004; LAMB MJ, 1968, NATURE, V220, P808, DOI 10.1038/220808a0; Li R, 2011, PLOS ONE IN PRESS; Libert S, 2008, MOL IMMUNOL, V45, P810, DOI 10.1016/j.molimm.2007.06.353; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; MILLER RS, 1958, ECOLOGY, V39, P118, DOI 10.2307/1929973; Min KJ, 2006, MECH AGEING DEV, V127, P93, DOI 10.1016/j.mad.2005.09.004; Min KJ, 2007, EXP GERONTOL, V42, P247, DOI 10.1016/j.exger.2006.10.009; Oliva JL, 2005, GROWTH FACTORS, V23, P245, DOI 10.1080/08977190500366043; Spindler SR, 2010, FUTURE OF AGING: PATHWAYS TO HUMAN LIFE EXTENSION, P367, DOI 10.1007/978-90-481-3999-6_12; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X	28	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e29782	10.1371/journal.pone.0029782	http://dx.doi.org/10.1371/journal.pone.0029782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363408	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500002
J	Hardoim, PR; Hardoim, CCP; van Overbeek, LS; van Elsas, JD				Hardoim, Pablo R.; Hardoim, Cristiane C. P.; van Overbeek, Leonard S.; van Elsas, Jan Dirk			Dynamics of Seed-Borne Rice Endophytes on Early Plant Growth Stages	PLOS ONE			English	Article							SP-NOV.; BACTERIAL ENDOPHYTES; PROMOTING RHIZOBACTERIA; ENTEROBACTER-CLOACAE; BIOLOGICAL-CONTROL; ROOT COLONIZATION; GEN. NOV.; DIVERSITY; SOIL; COMMUNITIES	Bacterial endophytes are ubiquitous to virtually all terrestrial plants. With the increasing appreciation of studies that unravel the mutualistic interactions between plant and microbes, we increasingly value the beneficial functions of endophytes that improve plant growth and development. However, still little is known on the source of established endophytes as well as on how plants select specific microbial communities to establish associations. Here, we used cultivation-dependent and independent approaches to assess the endophytic bacterrial community of surface-sterilized rice seeds, encompassing two consecutive rice generations. We isolated members of nine bacterial genera. In particular, organisms affiliated with Stenotrophomonas maltophilia and Ochrobactrum spp. were isolated from both seed generations. PCR-based denaturing gradient gel electrophoresis (PCR-DGGE) of seed-extracted DNA revealed that approximately 45% of the bacterial community from the first seed generation was found in the second generation as well. In addition, we set up a greenhouse experiment to investigate abiotic and biotic factors influencing the endophytic bacterial community structure. PCR-DGGE profiles performed with DNA extracted from different plant parts showed that soil type is a major effector of the bacterial endophytes. Rice plants cultivated in neutral-pH soil favoured the growth of seed-borne Pseudomonas oryzihabitans and Rhizobium radiobacter, whereas Enterobacter-like and Dyella ginsengisoli were dominant in plants cultivated in low-pH soil. The seed-borne Stenotrophomonas maltophilia was the only conspicuous bacterial endophyte found in plants cultivated in both soils. Several members of the endophytic community originating from seeds were observed in the rhizosphere and surrounding soils. Their impact on the soil community is further discussed.	[Hardoim, Pablo R.; Hardoim, Cristiane C. P.; van Elsas, Jan Dirk] Univ Groningen, Ctr Ecol & Evolutionary Studies, Dept Microbial Ecol, Groningen, Netherlands; [Hardoim, Pablo R.; van Overbeek, Leonard S.] Plant Res Int, Wageningen, Netherlands	University of Groningen	Hardoim, PR (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Dept Microbial Ecol, Groningen, Netherlands.	phardoim@gmail.com	Hardoim, Cristiane C.P./D-4544-2015; Hardoim, Pablo Rodrigo/M-7048-2013	Hardoim, Cristiane C.P./0000-0003-4650-0177; Hardoim, Pablo Rodrigo/0000-0002-5079-4959	University of Groningen; Plant Research International	University of Groningen; Plant Research International(Plant Research International)	This study was supported by a collaborative agreement between the University of Groningen and Plant Research International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandham R, 2008, J BASIC MICROB, V48, P439, DOI 10.1002/jobm.200700380; Andreote FD, 2009, APPL ENVIRON MICROB, V75, P3396, DOI 10.1128/AEM.00491-09; BAKER KF, 1966, ANNU REV PHYTOPATHOL, V14, P311; Behrendt U, 2002, INT J SYST EVOL MICR, V52, P1441, DOI 10.1099/00207713-52-5-1441; Belimov AA, 2001, CAN J MICROBIOL, V47, P642, DOI 10.1139/cjm-47-7-642; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Collavino MM, 2010, BIOL FERT SOILS, V46, P727, DOI 10.1007/s00374-010-0480-x; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Cottyn B, 2009, J APPL MICROBIOL, V107, P885, DOI 10.1111/j.1365-2672.2009.04268.x; DECLEENE M, 1985, PHYTOPATHOL Z, V113, P81; deFreitas JR, 1997, BIOL FERT SOILS, V24, P358, DOI 10.1007/s003740050258; Dias ACF, 2009, WORLD J MICROB BIOT, V25, P189, DOI 10.1007/s11274-008-9878-0; Puente ME, 2009, ENVIRON EXP BOT, V66, P402, DOI 10.1016/j.envexpbot.2009.04.007; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; GLICK BR, 1994, CAN J MICROBIOL, V40, P911, DOI 10.1139/m94-146; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hallmann J, 2006, MICROBIAL ROOT ENDOP, V9, P15, DOI DOI 10.1007/3-540-33526-9_2; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hardoim PR, 2011, FEMS MICROBIOL ECOL, V77, P154, DOI 10.1111/j.1574-6941.2011.01092.x; Hardoim PR, 2011, BACTERIAL ENDOPHYTES, P77; Hashidoko Y, 2006, TROPICS, V15, P391, DOI 10.3759/tropics.15.391; Hayward AC, 2010, J APPL MICROBIOL, V108, P756, DOI 10.1111/j.1365-2672.2009.04471.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Holland MA, 1997, PLANT PHYSIOL, V115, P865, DOI 10.1104/pp.115.3.865; HUREK T, 1994, J BACTERIOL, V176, P1913, DOI 10.1128/jb.176.7.1913-1923.1994; Idris A, 2009, J AGR SCI-CAMBRIDGE, V147, P17, DOI 10.1017/S0021859608008174; Johnston-Monje D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020396; Jung HM, 2009, INT J SYST EVOL MICR, V59, P460, DOI 10.1099/ijs.0.64514-0; Kaga H, 2009, MICROBES ENVIRON, V24, P154, DOI 10.1264/jsme2.ME09113; Kageyama K, 2003, APPL ENVIRON MICROB, V69, P1114, DOI 10.1128/AEM.69.2.1114-1120.2003; Kampfer P, 2000, INT J SYST EVOL MICR, V50, P355, DOI 10.1099/00207713-50-1-355; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Lai WA, 2006, INT J SYST EVOL MICR, V56, P787, DOI 10.1099/ijs.0.64007-0; Lebuhn M, 2000, INT J SYST EVOL MICR, V50, P2207, DOI 10.1099/00207713-50-6-2207; Loaces I, 2011, MICROB ECOL, V61, P606, DOI 10.1007/s00248-010-9780-9; Lucero M, 2008, PLANT SCI, V174, P570, DOI 10.1016/j.plantsci.2008.02.012; Lucero ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017693; Mano H., 2006, Microbes and Environments, V21, P86, DOI 10.1264/jsme2.21.86; Mano H, 2008, MICROBES ENVIRON, V23, P109, DOI 10.1264/jsme2.23.109; Mano H, 2007, MICROBES ENVIRON, V22, P175, DOI 10.1264/jsme2.22.175; Mastretta C, 2009, INT J PHYTOREMEDIAT, V11, P251, DOI 10.1080/15226510802432678; Mehnaz S, 2010, SOIL BIOL BIOCHEM, V42, P1848, DOI 10.1016/j.soilbio.2010.07.003; Miche L, 2001, APPL ENVIRON MICROB, V67, P3046, DOI 10.1128/AEM.67.7.3046-3052.2001; MUNDT JO, 1976, APPL ENVIRON MICROB, V32, P694, DOI 10.1128/AEM.32.5.694-698.1976; Cuong ND, 2011, MICROB ECOL, V62, P425, DOI 10.1007/s00248-011-9823-x; Oehrle NW, 2000, CAN J MICROBIOL, V46, P600, DOI 10.1139/cjm-46-7-600; Okunishi S., 2005, MICROBES ENVIRON, V20, P168, DOI [10.1264/jsme2.20.168, DOI 10.1264/JSME2.20.168]; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ramette A, 2011, SYST APPL MICROBIOL, V34, P180, DOI 10.1016/j.syapm.2010.10.005; Reiter B, 2002, APPL ENVIRON MICROB, V68, P2261, DOI 10.1128/AEM.68.5.2261-2268.2002; Roberts DP, 2007, SOIL BIOL BIOCHEM, V39, P2150, DOI 10.1016/j.soilbio.2007.03.027; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Sessitsch A, 2005, INT J SYST EVOL MICR, V55, P1187, DOI 10.1099/ijs.0.63149-0; Shrestha PM, 2007, ENVIRON MICROBIOL, V9, P2464, DOI 10.1111/j.1462-2920.2007.01364.x; Steindler L, 2008, FEMS MICROBIOL LETT, V288, P102, DOI 10.1111/j.1574-6968.2008.01344.x; Stevens P, 2010, ANTON LEEUW INT J G, V97, P171, DOI 10.1007/s10482-009-9400-1; Sturz AV, 2001, CAN J MICROBIOL, V47, P1013, DOI 10.1139/cjm-47-11-1013; Sun L, 2008, MICROB ECOL, V55, P415, DOI 10.1007/s00248-007-9287-1; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; van der Lelie D, 2009, CRIT REV PLANT SCI, V28, P346, DOI 10.1080/07352680903241204; Venema JH, 2008, ENVIRON EXP BOT, V63, P359, DOI 10.1016/j.envexpbot.2007.12.015; Weyens N, 2009, TRENDS BIOTECHNOL, V27, P591, DOI 10.1016/j.tibtech.2009.07.006	65	245	278	8	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30438	10.1371/journal.pone.0030438	http://dx.doi.org/10.1371/journal.pone.0030438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363438	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600031
J	Lei, D; Ma, J; Shen, XM; Du, XX; Shen, GH; Liu, W; Yan, X; Li, GY				Lei, Du; Ma, Jun; Shen, Xiaoming; Du, Xiaoxia; Shen, Guohua; Liu, Wei; Yan, Xu; Li, Gengying			Changes in the Brain Microstructure of Children with Primary Monosymptomatic Nocturnal Enuresis: A Diffusion Tensor Imaging Study	PLOS ONE			English	Article							BLADDER CONTROL; MICTURITION; THALAMUS; SLEEP; ELECTROENCEPHALOGRAPHY; INCONTINENCE; POTENTIALS; MATURATION; DISORDERS; CHILDHOOD	Background: Primary monosymptomatic nocturnal enuresis (PMNE) is a common disorder in school-aged children. Previous studies have suggested that a developmental delay might play a role in the pathology of children with PMNE. However, microstructural abnormalities in the brains of these children have not been thoroughly investigated. Methodology/Principal Findings: In this work, we evaluated structural changes in the brains of children with PMNE using diffusion tensor imaging (DTI). Two groups consisting of 26 children with PMNE and 26 healthy controls were scanned using magnetic resonance DTI. The diffusion parameters of fractional anisotropy (FA) and mean diffusivity (MD) were subjected to whole-brain, voxel-wise group comparisons using statistical parametric mapping (SPM). When compared to healthy subjects, children with PMNE showed both a decrease in FA and an increase in MD in the thalamus. MD also increased in the frontal lobe, the anterior cingulate cortex and the insula; these areas are all involved in controlling micturition. The significant changes seen in the thalamus could affect both urine storage and arousal from sleep. Conclusions/Significance: The microstructure abnormalities were observed in the thalamus, the medial frontal gyrus, the anterior cingulate cortex and the insula, which are involved in micturition control network. This indicates developmental delay in these areas may be the cause of PMNE.	[Lei, Du; Du, Xiaoxia; Shen, Guohua; Liu, Wei; Yan, Xu; Li, Gengying] E China Normal Univ, Dept Phys, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Ma, Jun; Shen, Xiaoming] Shanghai Jiao Tong Univ, Sch Med,Shanghai Childrens Med Ctr, XinHua Hosp Affiliated,Dept Dev & Behav Pediat, Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China	East China Normal University; Shanghai Jiao Tong University	Lei, D (corresponding author), E China Normal Univ, Dept Phys, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China.	merryxiaoxia@163.com; gyli@phy.ecnu.edu.cn	Ma, Jun/R-8732-2019	Du, Xiaoxia/0000-0001-8470-7852	Science and Technology Commission of Shanghai [08DZ1900702]; Shanghai Children's Medical Center; Shanghai Key Laboratory of Children's Environmental Health [10DZ2272200, 09DZ2200900]; Development of Science and Technology Fund of Pudong New Area, Shanghai [PKJ2009-Y03]	Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Children's Medical Center; Shanghai Key Laboratory of Children's Environmental Health; Development of Science and Technology Fund of Pudong New Area, Shanghai	This research was funded by the Science and Technology Commission of Shanghai (08DZ1900702), the Shanghai Children's Medical Center Fund, the Shanghai Key Laboratory of Children's Environmental Health (10DZ2272200, 09DZ2200900), and the Development of Science and Technology Fund of Pudong New Area, Shanghai (PKJ2009-Y03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkonyi B, 2011, AM J NEURORADIOL, V32, P962, DOI 10.3174/ajnr.A2417; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Beckel Jonathan M, 2011, Handb Exp Pharmacol, P149, DOI 10.1007/978-3-642-16499-6_8; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Blok BFM, 1997, BRAIN, V120, P111, DOI 10.1093/brain/120.1.111; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cheon KA, 2011, BRAIN RES, V1417, P77, DOI 10.1016/j.brainres.2011.08.020; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Eckert U, 2011, HUM BRAIN MAPP; Ferraz-Filho JR, 2011, PEDIAT RADIOL; Fowler CJ, 2010, NEUROUROL URODYNAM, V29, P49, DOI 10.1002/nau.20740; Freitag CM, 2006, DEV MED CHILD NEUROL, V48, P278, DOI 10.1017/S0012162206000600; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Griffiths D, 2005, J UROLOGY, V174, P1862, DOI 10.1097/01.ju.0000177450.34451.97; Griffiths D, 2008, NEUROUROL URODYNAM, V27, P466, DOI 10.1002/nau.20549; Griffiths D, 2007, NEUROIMAGE, V37, P1, DOI 10.1016/j.neuroimage.2007.04.061; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hallioglu O, 2001, J CHILD NEUROL, V16, P714, DOI 10.1177/088307380101601002; Jan JE, 2009, J PINEAL RES, V46, P1, DOI 10.1111/j.1600-079X.2008.00628.x; Karlidag R, 2004, NEUROUROL URODYNAM, V23, P237, DOI 10.1002/nau.20031; Kawauchi A, 1998, BRIT J UROL, V81, P72, DOI 10.1046/j.1464-410x.1998.00012.x; Kuchel GA, 2009, J GERONTOL A-BIOL, V64, P902, DOI 10.1093/gerona/glp037; Lei D, 2011, HUM BRAIN MAPP, DOI [10.1002/hbm.21411, DOI 10.1002/HBM.21411.]; Lei D, 2012, NEUROUROL URODYNAM, V31, P99, DOI 10.1002/nau.21205; Matsuura S, 2002, J UROLOGY, V168, P2035, DOI 10.1016/S0022-5347(05)64290-5; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Namatame S, 2010, NEUROL SCI, V31, P205, DOI 10.1007/s10072-009-0189-5; Neveus T, 2003, ACTA PAEDIATR, V92, P1118, DOI 10.1080/08035250310005837; Neveus T, 2006, J UROLOGY, V176, P314, DOI 10.1016/S0022-5347(06)00305-3; Neveus T, 2009, CURR OPIN PEDIATR, V21, P199, DOI 10.1097/MOP.0b013e3283229b12; Nour S, 2000, BRAIN, V123, P781, DOI 10.1093/brain/123.4.781; Riccabona M, 2010, UROLOGE, V49, P861, DOI 10.1007/s00120-010-2328-2; Sherman SM, 2007, CURR OPIN NEUROBIOL, V17, P417, DOI 10.1016/j.conb.2007.07.003; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Tai CF, 2009, J NEUROPHYSIOL, V102, P2719, DOI 10.1152/jn.00700.2009; Theunis M, 2002, EUR UROL, V41, P660, DOI 10.1016/S0302-2838(02)00127-6; Verhoeven JS, 2010, HUM BRAIN MAPP, V31, P470, DOI 10.1002/hbm.20880; Wilke M, 2001, NEUROIMAGE, V13, P814, DOI 10.1006/nimg.2001.0751; Yu B, 2011, J PAEDIAT CHILD HLTH	44	34	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31023	10.1371/journal.pone.0031023	http://dx.doi.org/10.1371/journal.pone.0031023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363538	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600099
J	Osorio-Paz, I; Sanchez-Chavez, G; Salceda, R				Osorio-Paz, Ixchel; Sanchez-Chavez, Gustavo; Salceda, Rocio			Control of Glycogen Content in Retina: Allosteric Regulation of Glycogen Synthase	PLOS ONE			English	Article							RABBIT SKELETAL-MUSCLE; RICH PRIMARY CULTURES; GLUCOSE-TRANSPORTER; INSULIN-RECEPTORS; OUTER SEGMENTS; RAT RETINA; HUMAN EYE; METABOLISM; HYPOGLYCEMIA; BRAIN	Retinal tissue is exceptional because it shows a high level of energy metabolism. Glycogen content represents the only energy reserve in retina, but its levels are limited. Therefore, elucidation of the mechanisms controlling glycogen content in retina will allow us to understand retina response under local energy demands that can occur under normal and pathological conditions. Thus, we studied retina glycogen levels under different experimental conditions and correlated them with glucose-6-phosphate (G-6-P) content and glycogen synthase (GS) activity. Glycogen and G-6-P content were studied in ex vivo retinas from normal, fasted, streptozotocin-treated, and insulin-induced hypoglycemic rats. Expression levels of GS and its phosphorylated form were also analyzed. Ex vivo retina from normal rats showed low G-6-P (14+/-2 pmol/mg protein) and glycogen levels (43+/-3 nmol glycosyl residues/mg protein), which were increased 6 and 3 times, respectively, in streptozotocin diabetic rats. While no changes in phosphorylated GS levels were observed in any condition tested, a positive correlation was found between G-6-P levels with GS activity and glycogen content. The results indicated that in vivo, retina glycogen may act as an immediately accessible energy reserve and that its content was controlled primarily by G-6-P allosteric activation of GS. Therefore, under hypoglycemic situations retina energy supply is strongly compromised and could lead to the alterations observed in type 1 diabetes.	[Osorio-Paz, Ixchel; Sanchez-Chavez, Gustavo; Salceda, Rocio] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Osorio-Paz, I (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Mexico City 04510, DF, Mexico.	rsalceda@ifc.unam.mx		Sanchez-Chavez, Gustavo/0000-0002-1331-9358; Osorio-Paz, Ixchel/0000-0002-3754-7304	Direccion General de Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica UNAM/DGAPA/PAPIIT [IN207810-3]	Direccion General de Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica UNAM/DGAPA/PAPIIT	This work was supported by a grant from the Direccion General de Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica UNAM/DGAPA/PAPIIT (IN207810-3) (http://dgapa.unam.mx/investigacion/papiit/conv_papiit_2010.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouskila M, 2010, CELL METAB, V12, P456, DOI 10.1016/j.cmet.2010.10.006; Brown AM, 2003, J PHYSIOL-LONDON, V549, P501, DOI 10.1113/jphysiol.2003.042416; Coffe V, 2004, J NEUROCHEM, V88, P885, DOI 10.1046/j.1471-4159.2003.02207.x; Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9; Cryer PE, 2004, NEW ENGL J MED, V350, P2272, DOI 10.1056/NEJMra031354; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; DAS A, 1984, CURR EYE RES, V3, P1397, DOI 10.3109/02713688409000835; DRINGEN R, 1993, GLIA, V8, P143, DOI 10.1002/glia.440080302; DRINGEN R, 1992, J NEUROCHEM, V58, P511, DOI 10.1111/j.1471-4159.1992.tb09750.x; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Emery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021586; FERNANDEZNOVELL JM, 1994, EUR J BIOCHEM, V226, P665, DOI 10.1111/j.1432-1033.1994.tb20094.x; Graymore C. N., 1970, BIOCH EYE, P645; HSU SC, 1991, J BIOL CHEM, V266, P21745; Khan MI, 2011, VISION RES, V51, P1623, DOI 10.1016/j.visres.2011.05.003; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; MAGISTRETTI PJ, 1988, DIABETES METAB, V14, P237; MANTYCH GJ, 1993, ENDOCRINOLOGY, V133, P600, DOI 10.1210/en.133.2.600; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Michal G, 1984, METHOD ENZYMAT AN, P191; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; Pfeiffer-Guglielmi B, 2005, GLIA, V49, P84, DOI 10.1002/glia.20102; ROSENZWEIG SA, 1990, J BIOL CHEM, V265, P18030; Salceda R, 1998, NEUROCHEM RES, V23, P893, DOI 10.1023/A:1022467230259; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Sanchez-Chavez G, 2008, NEUROCHEM RES, V33, P1301, DOI 10.1007/s11064-007-9583-7; Siegelaar SE, 2010, ENDOCR REV, V31, P171, DOI 10.1210/er.2009-0021; SWANSON RA, 1992, CAN J PHYSIOL PHARM, V70, pS138, DOI 10.1139/y92-255; Takata K, 1997, INT REV CYTOL, V172, P1, DOI 10.1016/S0074-7696(08)62357-8; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; WALDBILLIG RJ, 1987, EXP EYE RES, V45, P837, DOI 10.1016/S0014-4835(87)80100-8; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667	33	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30822	10.1371/journal.pone.0030822	http://dx.doi.org/10.1371/journal.pone.0030822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363495	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600072
J	Scrima, M; De Marco, C; Fabiani, F; Franco, R; Pirozzi, G; Rocco, G; Ravo, M; Weisz, A; Zoppoli, P; Ceccarelli, M; Botti, G; Malanga, D; Viglietto, G				Scrima, Marianna; De Marco, Carmela; Fabiani, Fernanda; Franco, Renato; Pirozzi, Giuseppe; Rocco, Gaetano; Ravo, Maria; Weisz, Alessandro; Zoppoli, Pietro; Ceccarelli, Michele; Botti, Gerardo; Malanga, Donatella; Viglietto, Giuseppe			Signaling Networks Associated with AKT Activation in Non-Small Cell Lung Cancer (NSCLC): New Insights on the Role of Phosphatydil-Inositol-3 kinase	PLOS ONE			English	Article							PIK3CA GENE; PHOSPHORYLATED AKT; THERAPEUTIC TARGET; COLORECTAL-CANCER; PTEN EXPRESSION; KRAS MUTATIONS; THYROID-TUMORS; HIGH-FREQUENCY; PATHWAY; CARCINOMA	Aberrant activation of PI3K/AKT signalling represents one of the most common molecular alterations in lung cancer, though the relative contribution of the single components of the cascade to the NSCLC development is still poorly defined. In this manuscript we have investigated the relationship between expression and genetic alterations of the components of the PI3K/AKT pathway [KRAS, the catalytic subunit of PI3K (p110 alpha), PTEN, AKT1 and AKT2] and the activation of AKT in 107 surgically resected NSCLCs and have analyzed the existing relationships with clinico-pathologic features. Expression analysis was performed by immunohistochemistry on Tissue Micro Arrays (TMA); mutation analysis was performed by DNA sequencing; copy number variation was determined by FISH. We report that activation of PI3K/AKT pathway in Italian NSCLC patients is associated with high grade (G3-G4 compared with G1-G2; n = 83; p < 0.05) and more advanced disease (TNM stage III vs. stages I and II; n = 26; p, 0.05). In addition, we found that PTEN loss (41/104, 39%) and the overexpression of p110 alpha (27/92, 29%) represent the most frequent aberration observed in NSCLCs. Less frequent molecular lesions comprised the overexpression of AKT2 (18/83, 22%) or AKT1 (17/96, 18%), and KRAS mutation (7/63, 11%). Our results indicate that, among all genes, only p110 alpha overexpression was significantly associated to AKT activation in NSCLCs (p = 0.02). Manipulation of p110 alpha expression in lung cancer cells carrying an active PI3K allele (NCI-H460) efficiently reduced proliferation of NSCLC cells in vitro and tumour growth in vivo. Finally, RNA profiling of lung epithelial cells (BEAS-2B) expressing a mutant allele of PIK3 (E545K) identified a network of transcription factors such as MYC, FOS and HMGA1, not previously recognised to be associated with aberrant PI3K signalling in lung cancer.	[Scrima, Marianna; De Marco, Carmela; Zoppoli, Pietro; Ceccarelli, Michele; Malanga, Donatella; Viglietto, Giuseppe] Inst Genet Res Gaetano Salvatore, Avellino, Italy; [De Marco, Carmela; Fabiani, Fernanda; Malanga, Donatella; Viglietto, Giuseppe] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Franco, Renato; Pirozzi, Giuseppe; Rocco, Gaetano; Botti, Gerardo] Natl Canc Inst, Fdn G Pascale, Naples, Italy; [Ravo, Maria; Weisz, Alessandro] Univ Salerno, Mol Med Lab, Fac Med & Surg, I-84081 Baronissi, Italy; [Ceccarelli, Michele] Univ Sannio, Dept Biol & Environm Studies, Benevento, Italy	Magna Graecia University of Catanzaro; IRCCS Fondazione Pascale; University of Salerno; University of Sannio	Scrima, M (corresponding author), Inst Genet Res Gaetano Salvatore, Avellino, Italy.	viglietto@unicz.it	De Marco, Carmela/J-6797-2015; Viglietto, Giuseppe/AAC-2852-2019; Zoppoli, Pietro/J-9954-2018; Weisz, Alessandro/A-1317-2014; scrima, marianna/J-7431-2016; scrima, marianna/ABE-3003-2021; Malanga, Donatella/J-4877-2018; Rocco, Gaetano/K-4801-2016; Scrima, Marianna/S-3320-2017; Ceccarelli, Michele/AGP-1739-2022	De Marco, Carmela/0000-0002-4893-4246; Viglietto, Giuseppe/0000-0003-2327-7515; Zoppoli, Pietro/0000-0002-7860-9655; Weisz, Alessandro/0000-0003-0455-2083; scrima, marianna/0000-0003-4636-7695; scrima, marianna/0000-0003-4636-7695; Malanga, Donatella/0000-0002-0491-7698; Rocco, Gaetano/0000-0003-4150-8604; Scrima, Marianna/0000-0003-4636-7695; Ravo, Maria/0000-0003-1003-2922; Ceccarelli, Michele/0000-0002-4702-6617; Franco, Renato/0000-0002-8340-3184; Botti, Gerardo/0000-0002-6287-733X	Associazione Italiana Ricerca sul Cancro (AIRC); European Union (I.P: CRESCENDO) [LSHM-CT-2005-018652]; Ministero dell'Universita e della Ricerca [2008CJ4SYW_004]	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Union (I.P: CRESCENDO); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (AIRC) to GV and AW and by European Union (I.P: CRESCENDO, contract n.er LSHM-CT-2005-018652), Ministero dell'Universita e della Ricerca (PRIN, Grant n.er 2008CJ4SYW_004) to A. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-51; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Amodio N, 2010, AM J PATHOL, V177, P2622, DOI 10.2353/ajpath.2010.091075; Aziz SA, 2009, CLIN CANCER RES, V15, P3029, DOI 10.1158/1078-0432.CCR-08-2768; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Brognard J, 2001, CANCER RES, V61, P3986; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Carvalho S, 2010, VIRCHOWS ARCH, V456, P235, DOI 10.1007/s00428-010-0881-0; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Endoh H, 2006, J THORAC ONCOL, V1, P629; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hirsh FR, 2004, WHO CLASSIFICATION T, P16; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kawano O, 2007, LUNG CANCER, V58, P159, DOI 10.1016/j.lungcan.2007.06.020; Kirkegaard T, 2010, HISTOPATHOLOGY, V56, P203, DOI 10.1111/j.1365-2559.2009.03467.x; Kurie JM, 2004, CHEST, V125, p141S, DOI 10.1378/chest.125.5_suppl.141S-a; Lee SH, 2002, APMIS, V110, P587, DOI 10.1034/j.1600-0463.2002.11007811.x; Lim WT, 2007, ONCOL REP, V17, P853; Lin Y, 2009, ENDOCR-RELAT CANCER, V16, P301, DOI 10.1677/ERC-08-0167; Liu JF, 2010, WORLD J GASTROENTERO, V16, P4986, DOI 10.3748/wjg.v16.i39.4986; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Malanga D, 2008, CELL CYCLE, V7, P665, DOI 10.4161/cc.7.5.5485; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Massion PP, 2002, CANCER RES, V62, P3636; Memmott RM, 2010, CLIN CANCER RES, V16, P4, DOI 10.1158/1078-0432.CCR-09-0234; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Mountain CF, 2000, SEMIN SURG ONCOL, V18, P106, DOI 10.1002/(SICI)1098-2388(200003)18:2<106::AID-SSU4>3.0.CO;2-P; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/0008-5472.CAN-05-2620; REDDEL RR, 1988, CANCER RES, V48, P1904; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Rimm DL, 2001, CANCER J, V7, P24; RODENHUIS S, 1988, CANCER RES, V48, P5738; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; SAMBROOK J, 1992, MOL CLONING LAB MANU; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang GX, 2010, CLIN NEUROL NEUROSUR, V112, P324, DOI 10.1016/j.clineuro.2010.01.003; Wang YG, 2007, J CLIN ENDOCR METAB, V92, P2387, DOI 10.1210/jc.2006-2019; Wu GJ, 2005, J CLIN ENDOCR METAB, V90, P4688, DOI 10.1210/jc.2004-2281; Xu Cheng-Xiong, 2010, Front Biosci (Elite Ed), V2, P1472; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	57	92	98	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30427	10.1371/journal.pone.0030427	http://dx.doi.org/10.1371/journal.pone.0030427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363436	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600029
J	Wang, YH; Ledgerwood, C; Grills, C; Fitzgerald, DC; Hamilton, PW				Wang, Yinhai; Ledgerwood, Craig; Grills, Claire; Fitzgerald, Denise C.; Hamilton, Peter W.			A Robust Co-Localisation Measurement Utilising Z-Stack Image Intensity Similarities for Biological Studies	PLOS ONE			English	Article							CROSS-CORRELATION SPECTROSCOPY; CONFOCAL MICROSCOPY; COMPLEX; CELLS	Background: Co-localisation is a widely used measurement in immunohistochemical analysis to determine if fluorescently labelled biological entities, such as cells, proteins or molecules share a same location. However the measurement of co-localisation is challenging due to the complex nature of such fluorescent images, especially when multiple focal planes are captured. The current state-of-art co-localisation measurements of 3-dimensional (3D) image stacks are biased by noise and cross-overs from non-consecutive planes. Method: In this study, we have developed Co-localisation Intensity Coefficients (CICs) and Co-localisation Binary Coefficients (CBCs), which uses rich z-stack data from neighbouring focal planes to identify similarities between image intensities of two and potentially more fluorescently-labelled biological entities. This was developed using z-stack images from murine organotypic slice cultures from central nervous system tissue, and two sets of pseudo-data. A large amount of non-specific cross-over situations are excluded using this method. This proposed method is also proven to be robust in recognising co-localisations even when images are polluted with a range of noises. Results: The proposed CBCs and CICs produce robust co-localisation measurements which are easy to interpret, resilient to noise and capable of removing a large amount of false positivity, such as non-specific cross-overs. Performance of this method of measurement is significantly more accurate than existing measurements, as determined statistically using pseudo datasets of known values. This method provides an important and reliable tool for fluorescent 3D neurobiological studies, and will benefit other biological studies which measure fluorescence co-localisation in 3D.	[Wang, Yinhai; Grills, Claire; Hamilton, Peter W.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Ledgerwood, Craig; Fitzgerald, Denise C.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Wang, YH (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	y.wang@qub.ac.uk; d.fitzgerald@qub.ac.uk		, denise/0000-0002-8608-430X	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative; Biotechnology and Biological Sciences Research Council [BB/J01026X/1] Funding Source: researchfish; BBSRC [BB/J01026X/1] Funding Source: UKRI	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS JH, 1974, COMPUTING, V12, P223, DOI 10.1007/BF02293108; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Botti M, 2005, ANATOMIA HISTOLOGIA, V34, P6; Comeau JWD, 2008, MOL BIOSYST, V4, P672, DOI 10.1039/b719826d; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Fletcher PA, 2010, BIOPHYS J, V99, P1996, DOI 10.1016/j.bpj.2010.07.006; Forutanpour B, 2010, H04N5232 WIPO DIAZ H; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Villalta JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019031; Lachmanovich E, 2003, J MICROSC-OXFORD, V212, P122, DOI 10.1046/j.1365-2818.2003.01239.x; Landmann L, 2004, MICROSC RES TECHNIQ, V64, P103, DOI 10.1002/jemt.20066; Landmann L, 2002, J MICROSC-OXFORD, V208, P134, DOI 10.1046/j.1365-2818.2002.01068.x; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lian J, 2010, SIGNAL PROCESS, V90, P684, DOI 10.1016/j.sigpro.2009.07.010; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Riner K, 2005, ANATOMIA HISTOLOGIA, V34, P43; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Steensel Bv, 1996, J CELL SCI, V109, P782; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tong H, 2004, BLUR DETECTION DIGIT; Wiseman PW, 2000, J MICROSC-OXFORD, V200, P14, DOI 10.1046/j.1365-2818.2000.00736.x; Wu Y, 2010, BIOPHYS J, V98, P493, DOI 10.1016/j.bpj.2009.10.037; Zhang H, 2011, EXPT NEUROL IN PRESS; Zhou Wang, 1999, CIRCUITS SYSTEMS 2 A, V46, P78	29	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30632	10.1371/journal.pone.0030632	http://dx.doi.org/10.1371/journal.pone.0030632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363456	gold, Green Submitted, Green Published			2022-12-25	WOS:000302853600043
J	Casolari, JM; Thompson, MA; Salzman, J; Champion, LM; Moerner, WE; Brown, PO				Casolari, Jason M.; Thompson, Michael A.; Salzman, Julia; Champion, Lowry M.; Moerner, W. E.; Brown, Patrick O.			Widespread mRNA Association with Cytoskeletal Motor Proteins and Identification and Dynamics of Myosin-Associated mRNAs in S. cerevisiae	PLOS ONE			English	Article							POINT-SPREAD FUNCTION; CLASS-V MYOSIN; GENOMIC INTEGRATION METHOD; SINGLE-PARTICLE TRACKING; ACTIN-PATCH MOVEMENT; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; BINDING PROTEIN; GENE-EXPRESSION; XENOPUS-OOCYTES	Programmed mRNA localization to specific subcellular compartments for localized translation is a fundamental mechanism of post-transcriptional regulation that affects many, and possibly all, mRNAs in eukaryotes. We describe her e a systematic approach to identify the RNA cargoes associated with the cytoskeletal motor proteins of Saccharomyces cerevisiae in combination with live-cell 3D super-localization microscopy of endogenously tagged mRNAs. Our analysis identified widespread association of mRNAs with cytoskeletal motor proteins, including association of Myo3 with mRNAs encoding key regulators of actin branching and endocytosis such as WASP and WIP. Using conventional fluorescence microscopy and expression of MS2-tagged mRNAs from endogenous loci, we observed a strong bias for actin patch nucleator mRNAs to localize to the cell cortex and the actin patch in a Myo3- and F-actin dependent manner. Use of a double-helix point spread function (DH-PSF) microscope allowed super-localization measurements of single mRNPs at a spatial precision of 25 nm in x and y and 50 nm in z in live cells with 50 ms exposure times, allowing quantitative profiling of mRNP dynamics. The actin patch mRNA exhibited distinct and characteristic diffusion coefficients when compared to a control mRNA. In addition, disruption of F-actin significantly expanded the 3D confinement radius of an actin patch nucleator mRNA, providing a quantitative assessment of the contribution of the actin cytoskeleton to mRNP dynamic localization. Our results provide evidence for specific association of mRNAs with cytoskeletal motor proteins in yeast, suggest that different mRNPs have distinct and characteristic dynamics, and lend insight into the mechanism of actin patch nucleator mRNA localization to actin patches.	[Casolari, Jason M.; Salzman, Julia; Champion, Lowry M.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Casolari, Jason M.; Salzman, Julia; Champion, Lowry M.; Brown, Patrick O.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Thompson, Michael A.; Moerner, W. E.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Salzman, Julia] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Casolari, JM (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	pbrown@stanford.edu	Moerner, William E/C-3260-2008	Moerner, William E/0000-0002-2830-209X	National Institutes of Health [R01CA77097, R01CA111487]; National Institute of General Medical Sciences [R01GM085437]; Jane Coffin Childs Memorial Research Fund; National Science Foundation; Bert and DeeDee McMurtry Stanford Graduate Fellowship; NATIONAL CANCER INSTITUTE [R01CA077097, R01CA111487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Jane Coffin Childs Memorial Research Fund; National Science Foundation(National Science Foundation (NSF)); Bert and DeeDee McMurtry Stanford Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (R01CA77097 and R01CA111487) to POB and a grant from the National Institute of General Medical Sciences (R01GM085437) to WEM. JMC acknowledges the Jane Coffin Childs Memorial Research Fund for a postdoctoral fellowship and MAT acknowledges support from a National Science Foundation Graduate Research Fellowship and a Bert and DeeDee McMurtry Stanford Graduate Fellowship. POB is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Akhtar N, 2000, FEBS LETT, V483, P87, DOI 10.1016/S0014-5793(00)02087-1; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06; Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Betley JN, 2004, CURR BIOL, V14, P219, DOI 10.1016/j.cub.2004.01.028; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; Bohl F, 2000, EMBO J, V19, P5514, DOI 10.1093/emboj/19.20.5514; Boldogh IR, 2004, MOL BIOL CELL, V15, P3994, DOI 10.1091/mbc.E04-01-0053; BONVEN B, 1979, MOL GEN GENET, V170, P225, DOI 10.1007/BF00337800; Bouzigues C, 2007, BIOPHYS J, V92, P654, DOI 10.1529/biophysj.106.094524; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Brunstein M, 2009, BIOPHYS J, V97, P1548, DOI 10.1016/j.bpj.2009.06.048; Carlsson AE, 2002, BIOPHYS J, V82, P2333, DOI 10.1016/S0006-3495(02)75579-3; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Catlett NL, 1998, P NATL ACAD SCI USA, V95, P14799, DOI 10.1073/pnas.95.25.14799; Chang W, 2008, RNA, V14, P491, DOI 10.1261/rna.665008; Chung SL, 2010, J CELL BIOL, V189, P755, DOI 10.1083/jcb.200912011; Condeelis J, 2005, BIOL CELL, V97, P97; CRABEEL M, 1981, P NATL ACAD SCI-BIOL, V78, P5026, DOI 10.1073/pnas.78.8.5026; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Deng YF, 2008, GENE DEV, V22, P1037, DOI 10.1101/gad.1611308; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; Duncan MC, 2001, NAT CELL BIOL, V3, P687, DOI 10.1038/35083087; Dunn BD, 2007, J CELL BIOL, V178, P1193, DOI 10.1083/jcb.200707080; Epp JA, 1997, CURR BIOL, V7, P921, DOI 10.1016/S0960-9822(06)00411-8; Fagarasanu A, 2006, DEV CELL, V10, P587, DOI 10.1016/j.devcel.2006.04.012; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Goodson HV, 1996, J CELL BIOL, V133, P1277, DOI 10.1083/jcb.133.6.1277; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Zimmermann M, 1987, Schmerz, V1, P1, DOI 10.1016/S0890-4065(87)80018-X; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Haim L, 2007, NAT METHODS, V4, P409, DOI 10.1038/NMETH1040; Haim-Vilmovsky L, 2009, NAT PROTOC, V4, P1274, DOI 10.1038/nprot.2009.115; Hallett MA, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-16; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Irie K, 2002, EMBO J, V21, P1158, DOI 10.1093/emboj/21.5.1158; Ishikawa K, 2003, J CELL BIOL, V160, P887, DOI 10.1083/jcb.200210139; Itoh T, 2004, EMBO J, V23, P2520, DOI 10.1038/sj.emboj.7600271; Itoh T, 2002, MOL CELL BIOL, V22, P7744, DOI 10.1128/MCB.22.22.7744-7757.2002; Iwase M, 2001, GENES GENET SYST, V76, P335, DOI 10.1266/ggs.76.335; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; JAUNIAUX JC, 1978, J BACTERIOL, V133, P1096, DOI 10.1128/JB.133.3.1096-1107.1978; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; Jonsdottir GA, 2004, CURR BIOL, V14, P1604, DOI 10.1016/j.cub.2004.08.055; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Karpova TS, 1998, J CELL BIOL, V142, P1501, DOI 10.1083/jcb.142.6.1501; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Laakso JM, 2010, P NATL ACAD SCI USA, V107, P698, DOI 10.1073/pnas.0911426107; LATHAM VM, 1994, J CELL BIOL, V126, P1211, DOI 10.1083/jcb.126.5.1211; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Li Y, 2000, J BACTERIOL, V182, P2886, DOI 10.1128/JB.182.10.2886-2892.2000; LIM F, 1994, NUCLEIC ACIDS RES, V22, P3748, DOI 10.1093/nar/22.18.3748; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Long RM, 2000, EMBO J, V19, P6592, DOI 10.1093/emboj/19.23.6592; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; LOWARY PT, 1987, NUCLEIC ACIDS RES, V15, P10483, DOI 10.1093/nar/15.24.10483; MacDougall N, 2003, DEV CELL, V4, P307, DOI 10.1016/S1534-5807(03)00058-3; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; MARTON MJ, 1993, MOL CELL BIOL, V13, P3541, DOI 10.1128/MCB.13.6.3541; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; MELTON DA, 1987, NATURE, V328, P80, DOI 10.1038/328080a0; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Messitt TJ, 2008, DEV CELL, V15, P426, DOI 10.1016/j.devcel.2008.06.014; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Mochida J, 2002, GENETICS, V160, P923; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Muller M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000611; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Niessing D, 2004, CELL, V119, P491, DOI 10.1016/j.cell.2004.10.018; NOVICK P, 1985, CELL, V40, P405, DOI 10.1016/0092-8674(85)90154-0; Paquin N, 2007, MOL CELL, V26, P795, DOI 10.1016/j.molcel.2007.05.016; Pavani SRP, 2008, OPT EXPRESS, V16, P3484, DOI 10.1364/OE.16.003484; Pavani SRP, 2008, OPT EXPRESS, V16, P22048, DOI 10.1364/OE.16.022048; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Pereira AJ, 1997, J CELL BIOL, V136, P1081, DOI 10.1083/jcb.136.5.1081; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413; SAXTON MJ, 1993, BIOPHYS J, V64, P1766, DOI 10.1016/S0006-3495(93)81548-0; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Shen ZF, 2010, GENE DEV, V24, P1914, DOI 10.1101/gad.1937510; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Sun YD, 2006, DEV CELL, V11, P33, DOI 10.1016/j.devcel.2006.05.008; Takizawa PA, 2000, P NATL ACAD SCI USA, V97, P5273, DOI 10.1073/pnas.080585897; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Tang FS, 2003, NATURE, V422, P87, DOI 10.1038/nature01453; Tang HY, 2000, MOL CELL BIOL, V20, P12, DOI 10.1128/MCB.20.1.12-25.2000; Thompson MA, 2010, P NATL ACAD SCI USA, V107, P17864, DOI 10.1073/pnas.1012868107; Thompson MA, 2010, NANO LETT, V10, P211, DOI 10.1021/nl903295p; Tolliday N, 2003, MOL BIOL CELL, V14, P798, DOI 10.1091/mbc.E02-09-0558; Toret CP, 2006, J CELL SCI, V119, P4585, DOI 10.1242/jcs.03251; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Vrljic Marija, 2007, V398, P193, DOI 10.1007/978-1-59745-513-8_14; Waddle JA, 1996, J CELL BIOL, V132, P861, DOI 10.1083/jcb.132.5.861; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WITHERELL GW, 1991, PROG NUCLEIC ACID RE, V40, P185; Yoon YJ, 2004, DEVELOPMENT, V131, P3035, DOI 10.1242/dev.01170; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	136	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31912	10.1371/journal.pone.0031912	http://dx.doi.org/10.1371/journal.pone.0031912			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359641	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200110
J	Tsuda, K; Yamanaka, K; Kitagawa, H; Akeda, T; Naka, M; Niwa, K; Nakanishi, T; Kakeda, M; Gabazza, EC; Mizutani, H				Tsuda, Kenshiro; Yamanaka, Keiichi; Kitagawa, Hiroshi; Akeda, Tomoko; Naka, Masanao; Niwa, Kaori; Nakanishi, Takehisa; Kakeda, Masato; Gabazza, Esteban C.; Mizutani, Hitoshi			Calcineurin Inhibitors Suppress Cytokine Production from Memory T Cells and Differentiation of Naive T Cells into Cytokine-Producing Mature T Cells	PLOS ONE			English	Article							INTERLEUKIN-17 FAMILY; INTERFERON-GAMMA; PSORIASIS; CYCLOSPORINE; INFLAMMATION; TACROLIMUS; ALPHA; IL-4	T cells have been classified as belonging to the Th1 or Th2 subsets according to the production of defining cytokines such as IFN-gamma and IL-4. The discovery of the Th17 lineage and regulatory T cells shifted the simple concept of the Th1/Th2 balance into a 4-way mechanistic pathway of local and systemic immunological activity. Clinically, the blockage of cytokine signals or non-specific suppression of cytokine predominance by immunosuppressants is the first-line treatment for inflammatory T cell-mediated disorders. Cyclosporine A (CsA) and Tacrolimus (Tac) are commonly used immunosuppressants for the treatment of autoimmune disease, psoriasis, and atopic disorders. Many studies have shown that these compounds suppress the activation of the calcium-dependent phosphatase calcineurin, thereby inhibiting T-cell activation. Although CsA and Tac are frequently utilized, their pharmacological mechanisms have not yet been fully elucidated. In the present study, we focused on the effects of CsA and Tac on cytokine secretion from purified human memory CD4(+)T cells and the differentiation of naive T cells into cytokine-producing memory T cells. CsA or Tac significantly inhibited IFN-gamma, IL-4, and IL-17 production from memory T cells. These compounds also inhibited T cell differentiation into the Th1, Th2, and Th17 subsets, even when used at a low concentration. This study provided critical information regarding the clinical efficacies of CsA and Tac as immunosuppressants.	[Tsuda, Kenshiro; Yamanaka, Keiichi; Kitagawa, Hiroshi; Akeda, Tomoko; Naka, Masanao; Niwa, Kaori; Nakanishi, Takehisa; Kakeda, Masato; Mizutani, Hitoshi] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan; [Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan	Mie University; Mie University	Tsuda, K (corresponding author), Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan.	yamake@clin.medic.mie-u.ac.jp		Gabazza, Esteban/0000-0001-5748-1499; Nakanishi, Takehisa/0000-0002-4035-1695; Kakeda, Masato/0000-0001-9011-3655	Ministry of Education, Culture, Sports, Science and Technology, Japan [23591643, 21591461]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	KY (23591643) and HM (21591461) received grants for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Other authors do not receive any financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brune A, 2007, PEDIATR DERMATOL, V24, P76, DOI 10.1111/j.1525-1470.2007.00341.x; DELPRETE G, 1992, ALLERGY, V47, P450; Grinyo JM, 2004, TRANSPLANTATION, V78, P1400, DOI 10.1097/01.TP.0000141227.63639.63; Ioannou Y, 2000, ARTHRITIS RHEUM-US, V43, P1431, DOI 10.1002/1529-0131(200007)43:7<1431::AID-ANR3>3.0.CO;2-E; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kobayashi T, 2007, J VET MED SCI, V69, P887, DOI 10.1292/jvms.69.887; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Nakanishi Kenji, 2010, Allergology International, V59, P137, DOI 10.2332/allergolint.10-RAI-0208; Schulze-Koops H, 2001, BEST PRACT RES CL RH, V15, P677, DOI 10.1053/berh.2001.0187; SEDER RA, 1994, J EXP MED, V179, P299, DOI 10.1084/jem.179.1.299; Yamamoto T, 2006, J EUR ACAD DERMATOL, V20, P1137, DOI 10.1111/j.1468-3083.2006.01630.x; Yamanaka K, 2011, CURR PROBL DERMATOL, V41, P80, DOI 10.1159/000323299	15	77	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31465	10.1371/journal.pone.0031465	http://dx.doi.org/10.1371/journal.pone.0031465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359594	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200063
J	Krill, AL; Platek, SM				Krill, Austen L.; Platek, Steven M.			Working Together May Be Better: Activation of Reward Centers during a Cooperative Maze Task	PLOS ONE			English	Article							EVENT-RELATED FMRI; ORBITOFRONTAL CORTEX; SOCIAL COGNITION; BASAL GANGLIA; SELF; MIND; HYPOTHESIS; MECHANISMS; EVOLUTION	Humans use theory of mind when predicting the thoughts and feelings and actions of others. There is accumulating evidence that cooperation with a computerized game correlates with a unique pattern of brain activation. To investigate the neural correlates of cooperation in real-time we conducted an fMRI hyperscanning study. We hypothesized that real-time cooperation to complete a maze task, using a blind-driving paradigm, would activate substrates implicated in theory of mind. We also hypothesized that cooperation would activate neural reward centers more than when participants completed the maze themselves. Of interest and in support of our hypothesis we found left caudate and putamen activation when participants worked together to complete the maze. This suggests that cooperation during task completion is inherently rewarding. This finding represents one of the first discoveries of a proximate neural mechanism for group based interactions in real-time, which indirectly supports the social brain hypothesis.	[Krill, Austen L.; Platek, Steven M.] Georgia Gwinnett Coll, Sch Liberal Arts, Lawrenceville, GA USA; [Krill, Austen L.; Platek, Steven M.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Platek, Steven M.] Univ Liverpool, Magnet Resonance & Image Anal Res Ctr, Liverpool L69 3BX, Merseyside, England	University System of Georgia; Georgia Gwinnett College; University of Liverpool; University of Liverpool	Krill, AL (corresponding author), Georgia Gwinnett Coll, Sch Liberal Arts, Lawrenceville, GA USA.	akrill@ggc.edu			Pioneer Fund	Pioneer Fund	This work was partially funded by a grant from the Pioneer Fund (a private organization) to SMP. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bechara A, 1998, PHARMACOL BIOCHEM BE, V59, P1, DOI 10.1016/S0091-3057(97)00047-6; Brune M, 2006, NEUROSCI BIOBEHAV R, V30, P437, DOI 10.1016/j.neubiorev.2005.08.001; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A. R., 1999, FEELING WHAT HAPPENS; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Frank R. H., 1988, PASSIONS REASON; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; GALLUP GG, 1982, AM J PRIMATOL, V2, P237, DOI 10.1002/ajp.1350020302; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P1; Gusnard D., 2006, SOCIAL NEUROSCIENCE; Hamilton D, 1964, J THEO BIO, V7, P1; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Lissek S, 2008, PUBLIC LIB SCI, V3; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Platek SM, 2006, HUM BRAIN MAPP, V27, P91, DOI 10.1002/hbm.20168; Platek SM, 2004, COGNITIVE BRAIN RES, V19, P114, DOI 10.1016/j.cogbrainres.2003.11.014; Platek SM, 2005, NEUROIMAGE, V25, P1336, DOI 10.1016/j.neuroimage.2004.12.037; Premack D., 1978, BEHAVIORAL BRAIN SCI, V4, P515, DOI [10.1017/S0140525X00076512, DOI 10.1017/S0140525X00076512]; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Trivers RL, 1971, Q REV BIOL, P4635; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789	37	29	30	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30613	10.1371/journal.pone.0030613	http://dx.doi.org/10.1371/journal.pone.0030613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355319	gold, Green Published, Green Submitted			2022-12-25	WOS:000302741300019
J	Torner, N; Broner, S; Martinez, A; Tortajada, C; de Olalla, PG; Barrabeig, I; Sala, M; Camps, N; Minguell, S; Alvarez, J; Ferrus, G; Torra, R; Godoy, P; Dominguez, A				Torner, Nuria; Broner, Sonia; Martinez, Ana; Tortajada, Cecilia; Garcia de Olalla, Patricia; Barrabeig, Irene; Sala, MariaRosa; Camps, Neus; Minguell, Sofia; Alvarez, Josep; Ferrus, Gloria; Torra, Roser; Godoy, Pere; Dominguez, Angela		Hepatitis A Surveillance Grp	Factors Associated to Duration of Hepatitis A Outbreaks: Implications for Control	PLOS ONE			English	Article							DAY-CARE; VACCINE; IMMUNIZATION; EPIDEMIOLOGY; INFECTION; DISEASE	Even though hepatitis A mass vaccination effectiveness is high, outbreaks continue to occur. The aim of this study was to investigate the association between duration and characteristics of hepatitis A outbreaks. Hepatitis A (HA) outbreaks reported between 1991 and 2007 were studied. An outbreak was defined as >= 2 epidemiologically-linked cases with >= 1 case laboratory-confirmed by detection of HA immunoglobulin M (IgM) antibodies. Relationships between explanatory variables and outbreak duration were assessed by logistic regression. During the study period, 268 outbreaks (rate 2.45 per million persons-year) and 1396 cases (rate 1.28 per 10(5) persons-year) were reported. Factors associated with shorter duration were time to intervention (OR = 0.96; 95% CI: 0.94-0.98) and school setting (OR = 0.39; 95% CI: 0.16-0.92). In person-to-person transmission outbreaks only time to intervention was associated with shorter outbreak duration (OR = 0.96; 95% CI: 0.95-0.98). The only variables associated with shorter outbreak duration were early administration of IG or vaccine and a school setting. Timely reporting HA outbreaks was associated with outbreak duration. Making confirmed HA infections statutory reportable for clinical laboratories could diminish outbreak duration.	[Torner, Nuria; Martinez, Ana; Barrabeig, Irene; Sala, MariaRosa; Camps, Neus; Minguell, Sofia; Alvarez, Josep; Ferrus, Gloria; Torra, Roser; Godoy, Pere] Generalitat Catalonia, Dept Hlth, Barcelona, Spain; [Torner, Nuria; Broner, Sonia; Garcia de Olalla, Patricia; Godoy, Pere; Dominguez, Angela] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Torner, Nuria; Dominguez, Angela] Univ Barcelona, Dept Publ Hlth, Barcelona, Spain; [Tortajada, Cecilia; Garcia de Olalla, Patricia] Publ Hlth Agcy Barcelona, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Public Health Agency of Barcelona	Torner, N (corresponding author), Generalitat Catalonia, Dept Hlth, Barcelona, Spain.	nuria.torner@gencat.cat	Sala, Maria/H-2562-2013; , Nuria/AAG-8951-2019; Godoy, Pere/A-7662-2010	Sala, Maria/0000-0002-9955-8746; , Nuria/0000-0003-0143-5295; Godoy, Pere/0000-0002-2896-7286; Barrabeig, Irene/0000-0003-4789-7620; Tortajada, Cecilia/0000-0001-7320-3632	CIBER Epidemiologia y Salud Publica (CIBERESP), Spain; Centros de Investigacion Biomedica en Red; AGAUR [2009/SGR 42]	CIBER Epidemiologia y Salud Publica (CIBERESP), Spain; Centros de Investigacion Biomedica en Red; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was partially funded by CIBER Epidemiologia y Salud Publica (CIBERESP), Spain, [Centros de Investigacion Biomedica en Red) and by AGAUR (expedient number 2009/SGR 42). [Agencia de Gestio d'Ajuts Universitaris i de Recerca] www10.gencat.net/agaur_web/AppJava/castellano/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adamson R, 2010, AM J PUBLIC HEALTH, V100, P1249, DOI 10.2105/AJPH.2009.178335; Belmaker I, 2007, PEDIATR INFECT DIS J, V26, P36, DOI 10.1097/01.inf.0000247105.45185.13; Comm Infect Dis, 2007, PEDIATRICS, V120, P189, DOI 10.1542/peds.2007-1088; Craig AS, 2007, AM J MED SCI, V334, P180, DOI 10.1097/MAJ.0b013e3181425411; Craig AS, 1998, CLIN INFECT DIS, V27, P531, DOI 10.1086/514700; Diel R, 2001, EUR J EPIDEMIOL, V17, P175, DOI 10.1023/A:1017972820699; Dominguez A, 2008, VACCINE, V26, P1737, DOI 10.1016/j.vaccine.2008.01.048; Hauri AM, 2006, VACCINE, V24, P5684, DOI 10.1016/j.vaccine.2006.04.053; Hershey JH, 2005, AM J MED, V118, P100, DOI 10.1016/j.amjmed.2005.07.028; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Llach-Berne M, 2006, ENFERM INFEC MICR CL, V24, P431, DOI 10.1157/13091780; Lopalco PL, 2005, J VIRAL HEPATITIS, V12, P315, DOI 10.1111/j.1365-2893.2005.00593.x; Luyten J, 2009, PHARMACOECONOMICS, V27, P379, DOI 10.2165/00019053-200927050-00003; Novak R., 2007, Morbidity and Mortality Weekly Report, V56, P1080; Oviedo M, 2006, ANN EPIDEMIOL, V16, P812, DOI 10.1016/j.annepidem.2006.02.005; Shen YG, 2008, WORLD J GASTROENTERO, V14, P2771, DOI 10.3748/wjg.14.2771; Steffen R, 2005, AM J MED, V118, P46, DOI 10.1016/j.amjmed.2005.07.016; Taylor-Robinson D C, 2007, Euro Surveill, V12, pE5; Torner N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015699; Victor JC, 2007, NEW ENGL J MED, V357, P1685, DOI 10.1056/NEJMoa070546	20	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31339	10.1371/journal.pone.0031339	http://dx.doi.org/10.1371/journal.pone.0031339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355358	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300058
J	Wang, H; Yin, YG; Li, W; Zhao, XH; Yu, Y; Zhu, JK; Qin, ZX; Wang, Q; Wang, K; Lu, W; Liu, J; Huang, L				Wang, Hang; Yin, Yangguang; Li, Wei; Zhao, Xiaohui; Yu, Yang; Zhu, Jinkun; Qin, Zhexue; Wang, Qiang; Wang, Kui; Lu, Wei; Liu, Jie; Huang, Lan			Over-Expression of PDGFR-beta Promotes PDGF-Induced Proliferation, Migration, and Angiogenesis of EPCs through PI3K/Akt Signaling Pathway	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; SMOOTH-MUSCLE-CELLS; FACTOR RECEPTOR-BETA; FACTOR-B-CHAIN; GROWTH-FACTOR; BONE-MARROW; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; MESSENGER-RNA; GENE-TRANSFER	The proliferation, migration, and angiogenesis of endothelial progenitor cells (EPCs) play critical roles in postnatal neovascularization and re-endothelialization following vascular injury. Here we evaluated whether the over-expression of platelet-derived growth factor receptor-beta (PDGFR-beta) can enhance the PDGF-BB-stimulated biological functions of EPCs through the PDGFR-beta/phosphoinositide 3-kinase (PI3K)/Akt signaling pathway. We first confirmed the expression of endogenous PDGFR-beta and its plasma membrane localization in spleen-derived EPCs. We then demonstrated that the PDGFR-beta over-expression in EPCs enhanced the PDGF-BB-induced proliferation, migration, and angiogenesis of EPCs. Using AG1295 (a PDGFR kinase inhibitor), LY294002 (a PI3K inhibitor), and sc-221226 (an Akt inhibitor), we further showed that the PI3K/Akt signaling pathway participates in the PDGF-BB-induced proliferation, migration, and angiogenesis of EPCs. In addition, the PI3K/Akt signaling pathway is required for PDGFR-beta over-expression to enhance these PDGF-BB-induced phenotypes.	[Wang, Hang; Li, Wei; Zhao, Xiaohui; Yu, Yang; Zhu, Jinkun; Qin, Zhexue; Wang, Qiang; Wang, Kui; Lu, Wei; Liu, Jie; Huang, Lan] Third Mil Med Univ, Inst Cardiovasc Sci, Xinqiao Hosp, Chongqing, Peoples R China; [Yin, Yangguang] Third Mil Med Univ, Emergency Dept, Xinqiao Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University	Wang, H (corresponding author), Third Mil Med Univ, Inst Cardiovasc Sci, Xinqiao Hosp, Chongqing, Peoples R China.	huanglan260@126.com			National Natural Science Foundation of China [30900620, 81000070]; Science Foundation of the Third Military Medical University [2009XQN33]; Natural Foundation of Chongqing [CSTC,2009BB5020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of the Third Military Medical University; Natural Foundation of Chongqing	This work was supported by grants from the National Natural Science Foundation of China (No. 30900620) and the Science Foundation of the Third Military Medical University (No. 2009XQN33). This study was also supported in part by grants from the National Natural Science Foundation of China (NO. 81000070) and the Natural Foundation of Chongqing (No. CSTC,2009BB5020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bao HF, 1999, BLOOD, V93, P3757, DOI 10.1182/blood.V93.11.3757.411a34_3757_3773; Behrendt D, 2002, AM J CARDIOL, V90, p40L, DOI 10.1016/S0002-9149(02)02963-6; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Choi KH, 2010, CARDIOVASC RES, V85, P836, DOI 10.1093/cvr/cvp359; Ciarrocchi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001338; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Deguchi J, 1999, GENE THER, V6, P956, DOI 10.1038/sj.gt.3300918; DeMali KA, 1997, J BIOL CHEM, V272, P9011; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; George J, 2003, ARTERIOSCL THROM VAS, V23, pE57, DOI 10.1161/01.ATV.0000107029.65274.db; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Guo SF, 2011, CELL BIOL INT, V35, P545, DOI 10.1042/CBI20100401; He TR, 2004, STROKE, V35, P2378, DOI 10.1161/01.STR.0000141893.33677.5d; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; HERMANSON M, 1992, CANCER RES, V52, P3213; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; HOLMGREN L, 1991, DEVELOPMENT, V113, P749; Huang PH, 2010, ARTERIOSCL THROM VAS, V30, P869, DOI 10.1161/ATVBAHA.109.200618; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; Levitzki A, 2005, CARDIOVASC RES, V65, P581, DOI 10.1016/j.cardiores.2004.08.008; LINDNER V, 1995, CIRC RES, V76, P951, DOI 10.1161/01.RES.76.6.951; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Majumdar K, 2009, SURG NEUROL, V72, P54, DOI 10.1016/j.surneu.2008.10.001; Mills NL, 2009, HEART, V95, P2003, DOI 10.1136/hrt.2008.163162; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; PLATE KH, 1992, LAB INVEST, V67, P529; Raica M, 2010, PHARMACEUTICALS, V3, P572, DOI 10.3390/ph3030572; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Siow RCM, 2007, CARDIOVASC RES, V75, P659, DOI 10.1016/j.cardiores.2007.06.007; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; Urbich C, 2005, KIDNEY INT, V67, P1672, DOI 10.1111/j.1523-1755.2005.00261.x; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; von Ballmoos MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014107; Vrekoussis T, 2007, ONCOL REP, V17, P1115; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yin YG, 2007, J CARDIOVASC PHARM, V50, P61, DOI 10.1097/FJC.0b013e3180587e4d; Zhao XH, 2008, MICROVASC RES, V75, P45, DOI 10.1016/j.mvr.2007.02.009; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006922	48	69	84	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30503	10.1371/journal.pone.0030503	http://dx.doi.org/10.1371/journal.pone.0030503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355314	gold, Green Published, Green Submitted			2022-12-25	WOS:000302741300014
J	Yeh, PC; Yeh, CC; Chen, YC; Juang, YL				Yeh, Pei-Chi; Yeh, Chang-Ching; Chen, Yi-Cheng; Juang, Yue-Li			RED, a Spindle Pole-associated Protein, Is Required for Kinetochore Localization of MAD1, Mitotic Progression, and Activation of the Spindle Assembly Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME SEGREGATION; CELLS; P31(COMET); COMPLEXES; ANAPHASE; BINDING; ZW10; SPLICEOSOME; STABILITY; DYNAMICS	The spindle assembly checkpoint (SAC) is essential for ensuring the proper attachment of kinetochores to the spindle and, thus, the precise separation of paired sister chromatids during mitosis. The SAC proteins are recruited to the unattached kinetochores for activation of the SAC in prometaphase. However, it has been less studied whether activation of the SAC also requires the proteins that do not localize to the kinetochores. Here, we show that the nuclear protein RED, also called IK, a down-regulator of human leukocyte antigen (HLA) II, interacts with the human SAC protein MAD1. Two RED-interacting regions identified in MAD1 are from amino acid residues 301-340 and 439-480, designated as MAD1(301-340) and MAD1(439-480), respectively. Our observations reveal that RED is a spindle pole-associated protein that colocalizes with MAD1 at the spindle poles in metaphase and anaphase. Depletion of RED can cause a shorter mitotic timing, a failure in the kinetochore localization of MAD1 in prometaphase, and a defect in the SAC. Furthermore, the RED-interacting peptides MAD1(301-340) and MAD1(439-480), fused to enhanced green fluorescence protein, can colocalize with RED at the spindle poles in prometaphase, and their expression can abrogate the SAC. Taken together, we conclude that RED is required for kinetochore localization of MAD1, mitotic progression, and activation of the SAC.	[Juang, Yue-Li] Tzu Chi Univ, Inst Microbiol Immunol & Biochem, Hualien 97004, Taiwan; [Yeh, Pei-Chi; Juang, Yue-Li] Tzu Chi Univ, Inst Med Sci, Hualien 97004, Taiwan; [Yeh, Chang-Ching] Tzu Chi Univ, Inst Mol Biol & Human Genet, Hualien 97004, Taiwan; [Chen, Yi-Cheng] Mackay Med Coll, Dept Med, New Taipei City 25245, Taiwan	Tzu Chi University; Tzu Chi University; Tzu Chi University; Mackay Medical College	Juang, YL (corresponding author), Tzu Chi Univ, Inst Microbiol Immunol & Biochem, 701,Chung Yang Rd,Sec 3, Hualien 97004, Taiwan.	yljylk@mail.tcu.edu.tw			National Health Research Institute, Taiwan [NHRI-EX95-9101BC]; Tzu-Chi Foundation	National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); Tzu-Chi Foundation	This work was supported by grants from the National Health Research Institute, Taiwan (NHRI-EX95-9101BC) and the Tzu-Chi Foundation (to Y. L. J.).	Assier E, 1999, GENE, V230, P145, DOI 10.1016/S0378-1119(99)00066-9; Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Campbell MS, 2001, J CELL SCI, V114, P953; Chan GKT, 2000, NAT CELL BIOL, V2, P944, DOI 10.1038/35046598; Chen TC, 2009, PROTEOMICS, V9, P4048, DOI 10.1002/pmic.200900231; Chung EN, 2002, MOL BIOL CELL, V13, P1501, DOI 10.1091/mbc.02-01-0003; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Iwanaga Y, 2002, J BIOL CHEM, V277, P31005, DOI 10.1074/jbc.M110666200; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; KRIEF P, 1994, ONCOGENE, V9, P3449; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Lin YT, 2006, ONCOGENE, V25, P6901, DOI 10.1038/sj.onc.1209687; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Montembault E, 2007, J CELL BIOL, V179, P601, DOI 10.1083/jcb.200703133; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Osmundson EC, 2008, J CELL BIOL, V183, P267, DOI 10.1083/jcb.200801049; Rahmani Z, 2009, J CELL BIOL, V187, P597, DOI 10.1083/jcb.200905026; Rees S, 1996, BIOTECHNIQUES, V20, P102; Rogers L., 1998, CELLS LAB MANUAL, P1611; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Trachana V, 2007, P NATL ACAD SCI USA, V104, P2691, DOI 10.1073/pnas.0611132104; Wang XS, 2001, J BIOL CHEM, V276, P26559, DOI 10.1074/jbc.M101083200; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	49	13	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11704	11716		10.1074/jbc.M111.299131	http://dx.doi.org/10.1074/jbc.M111.299131			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351768	Green Published, hybrid			2022-12-25	WOS:000302782200010
J	Bhoo-Pathy, N; Hartman, M; Yip, CH; Saxena, N; Taib, NA; Lim, SE; Iau, P; Adami, HO; Bulgiba, AM; Lee, SC; Verkooijen, HM				Bhoo-Pathy, Nirmala; Hartman, Mikael; Yip, Cheng-Har; Saxena, Nakul; Taib, Nur Aishah; Lim, Siew-Eng; Iau, Philip; Adami, Hans-Olov; Bulgiba, Awang M.; Lee, Soo-Chin; Verkooijen, Helena M.			Ethnic Differences in Survival after Breast Cancer in South East Asia	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; AFRICAN-AMERICAN; STAGE; WOMEN; OBESITY; RACE; DIAGNOSIS; MALAYSIA	Background: The burden of breast cancer in Asia is escalating. We evaluated the impact of ethnicity on survival after breast cancer in the multi-ethnic region of South East Asia. Methodology/Principal Findings: Using the Singapore-Malaysia hospital-based breast cancer registry, we analyzed the association between ethnicity and mortality following breast cancer in 5,264 patients diagnosed between 1990 and 2007 (Chinese: 71.6%, Malay: 18.4%, Indian: 10.0%). We compared survival rates between ethnic groups and calculated adjusted hazard ratios (HR) to estimate the independent effect of ethnicity on survival. Malays (n = 968) presented at a significantly younger age, with larger tumors, and at later stages than the Chinese and Indians. Malays were also more likely to have axillary lymph node metastasis at similar tumor sizes and to have hormone receptor negative and poorly differentiated tumors. Five year overall survival was highest in the Chinese women (75.8%; 95%CI: 74.4%-77.3%) followed by Indians (68.0%; 95%CI: 63.8%-72.2%), and Malays (58.5%; 95%CI: 55.2%-61.7%). Compared to the Chinese, Malay ethnicity was associated with significantly higher risk of all-cause mortality (HR: 1.34; 95%CI: 1.19-1.51), independent of age, stage, tumor characteristics and treatment. Indian ethnicity was not significantly associated with risk of mortality after breast cancer compared to the Chinese (HR: 1.14; 95%CI: 0.98-1.34). Conclusion: In South East Asia, Malay ethnicity is independently associated with poorer survival after breast cancer. Research into underlying reasons, potentially including variations in tumor biology, psychosocial factors, treatment responsiveness and lifestyle after diagnosis, is warranted.	[Bhoo-Pathy, Nirmala] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bhoo-Pathy, Nirmala] Kuala Lumpur Hosp, Natl Clin Res Ctr, Kuala Lumpur, Malaysia; [Hartman, Mikael; Saxena, Nakul; Verkooijen, Helena M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Hartman, Mikael; Iau, Philip] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Yip, Cheng-Har; Taib, Nur Aishah] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Lim, Siew-Eng; Lee, Soo-Chin] Natl Univ Hlth Syst, Natl Univ Canc Inst, Dept Hematol Oncol, Singapore, Singapore; [Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Bulgiba, Awang M.] Univ Malaya, Julius Ctr Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Verkooijen, Helena M.] Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; National University of Singapore; National University of Singapore; Universiti Malaya; National University of Singapore; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Universiti Malaya; Utrecht University; Utrecht University Medical Center	Bhoo-Pathy, N (corresponding author), Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	h.m.verkooijen@umcutrecht.nl	Yip, Cheng-Har/B-1909-2010; Lee, Soo Chin/S-9111-2016; LIM, SIEW ENG/AGO-6654-2022; Pathy, Nirmala Bhoo/C-1228-2010; Bulgiba, Awang/B-8271-2010; Taib, Nur Aishah Mohd/B-2370-2010; Iau, Philip/B-4641-2011; Hartman, Mikael/B-4324-2011	Lee, Soo Chin/0000-0002-5835-6419; Pathy, Nirmala Bhoo/0000-0003-0568-8863; Bulgiba, Awang/0000-0002-5313-0445; Taib, Nur Aishah Mohd/0000-0001-8419-0478; Hartman, Mikael/0000-0001-5726-9965	European Union [MY/AsiaLink/044 (128-713)]; Singapore National Medical Research Council [NMRC/1180/2008]; Ministry of Higher Education, Malaysia [UM.C/HIR/MOHE/06]	European Union(European Commission); Singapore National Medical Research Council(National Medical Research Council, Singapore); Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	Dr. Bhoo-Pathy was financially supported by the European Union, AsiaLink program MY/AsiaLink/044 (128-713). Dr. Verkooijen and Dr. Hartman were supported by the Singapore National Medical Research Council ( grant no. NMRC/1180/2008). The Malaysian data was supported by a High Impact Research Grant (UM.C/HIR/MOHE/06) from the Ministry of Higher Education, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuin J, 2011, LANCET, V377, P534, DOI 10.1016/S0140-6736(10)61426-2; Amend K, 2006, CANCER RES, V66, P8327, DOI 10.1158/0008-5472.CAN-06-1927; Amin S., 2004, J SOCIO-ECON, V33, P291, DOI [https://doi.org/10.1016/j.socec.2003.12.023, DOI 10.1016/J.SOCEC.2003.12.023]; Bradley CJ, 2002, J NATL CANCER I, V94, P490; Brawley OW, 2002, JNCI-J NATL CANCER I, V94, P471; Chlebowski RT, 2005, J CLIN ONCOL, V23, P1345, DOI 10.1200/JCO.2005.10.949; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Deglise C, 2010, BREAST CANCER RES TR, V120, P185, DOI 10.1007/s10549-009-0459-1; Deurenberg-Yap M, 2001, INT J OBESITY, V25, P1554, DOI 10.1038/sj.ijo.0801739; Deurenberg-Yap M, 2001, ASIA PAC J CLIN NUTR, V10, P39, DOI 10.1046/j.1440-6047.2001.00202.x; Fan L, 2008, PHARMACOGENET GENOM, V18, P621, DOI 10.1097/FPC.0b013e328301a869; Hershman D, 2005, J CLIN ONCOL, V23, P6639, DOI 10.1200/JCO.2005.12.633; Ismail M N, 2002, Obes Rev, V3, P203, DOI 10.1046/j.1467-789X.2002.00074.x; Lal S, 2007, PHARMACOGENOMICS, V8, P567, DOI 10.2217/14622416.8.6.567; Lannin DR, 1998, JAMA-J AM MED ASSOC, V279, P1801, DOI 10.1001/jama.279.22.1801; Lim GCC, 2004, 2 NAT CANC REG; Ma BBY, 2010, LANCET ONCOL, V11, P75, DOI 10.1016/S1470-2045(09)70160-3; Mak KH, 2003, EUR HEART J, V24, P151, DOI 10.1016/S0195-668X(02)00423-2; McKenzie F, 2009, EPIDEMIOL REV, V31, P52, DOI 10.1093/epirev/mxp007; Newman LA, 2006, J CLIN ONCOL, V24, P1342, DOI 10.1200/JCO.2005.03.3472; Pathy NB, 2011, BREAST, V20, pS75, DOI 10.1016/j.breast.2011.01.015; Pisani P, 2006, INT J CANCER, V118, P149, DOI 10.1002/ijc.21343; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; RICHARDSON JL, 1992, BRIT J CANCER, V65, P922, DOI 10.1038/bjc.1992.193; Saw SH, 2007, POPULATION SINGAPORE; Saw Swee-Hock, 2007, POPULATION MALAYSIA; Seow A, 2003, TRENDS CANC INCIDENC; Shu XO, 2009, JAMA-J AM MED ASSOC, V302, P2437, DOI 10.1001/jama.2009.1783; Taib NA, 2007, ASIAN PAC J CANCER P, V8, P141; Taib NABM, 2008, ASIAN PAC J CANCER P, V9, P197; Telli ML, 2011, BREAST CANCER RES TR, V127, P471, DOI 10.1007/s10549-010-1173-8; Wang PP, 1996, BREAST CANCER RES TR, V37, P197, DOI 10.1007/BF01806501	32	54	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30995	10.1371/journal.pone.0030995	http://dx.doi.org/10.1371/journal.pone.0030995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363531	Green Published, gold			2022-12-25	WOS:000302873700020
J	Rankin, J; Walker, JJ; Windle, R; Lightman, SL; Terry, JR				Rankin, James; Walker, Jamie J.; Windle, Richard; Lightman, Stafford L.; Terry, John R.			Characterizing Dynamic Interactions between Ultradian Glucocorticoid Rhythmicity and Acute Stress Using the Phase Response Curve	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ACTH-SECRETION; RECEPTOR; BRAIN; FEEDBACK; RATS; HYPOTHALAMUS; ADAPTATION	The hypothalamic-pituitary-adrenal (HPA) axis is a dynamic oscillatory hormone signalling system that regulates the pulsatile secretion of glucocorticoids from the adrenal glands. In addition to regulation of basal levels of glucocorticoids, the HPA axis provides a rapid hormonal response to stress that is vitally important for homeostasis. Recently it has become clear that glucocorticoid pulses encode an important biological signal that regulates receptor signalling both in the central nervous system and in peripheral tissues. It is therefore important to understand how stressful stimuli disrupt the pulsatile dynamics of this system. Using a computational model that incorporates the crucial feed-forward and feedback components of the axis, we provide novel insight into experimental observations that the size of the stress-induced hormonal response is critically dependent on the timing of the stress. Further, we employ the theory of Phase Response Curves to show that an acute stressor acts as a phase-resetting mechanism for the ultradian rhythm of glucocorticoid secretion. Using our model, we demonstrate that the magnitude of an acute stress is a critical factor in determining whether the system resets via a Type 1 or Type 0 mechanism. By fitting our model to our in vivo stress-response data, we show that the glucocorticoid response to an acute noise stress in rats is governed by a Type 0 phase-resetting curve. Our results provide additional evidence for the concept of a deterministic sub-hypothalamic oscillator regulating the ultradian glucocorticoid rhythm, which constitutes a highly responsive peripheral hormone system that interacts dynamically with hypothalamic inputs to regulate the overall hormonal response to stress.	[Rankin, James; Walker, Jamie J.] Univ Bristol, Bristol Ctr Appl Nonlinear Math, Bristol, Avon, England; [Rankin, James] INRIA Sophia Antipolis, Sophia Antipolis, France; [Walker, Jamie J.; Lightman, Stafford L.; Terry, John R.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England; [Windle, Richard] Univ Nottingham, Sch Nursing Midwifery & Physiotherapy, Nottingham NG7 2RD, England; [Terry, John R.] Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield, S Yorkshire, England; [Terry, John R.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England	University of Bristol; University of Bristol; University of Nottingham; University of Sheffield; University of Sheffield	Rankin, J (corresponding author), Univ Bristol, Bristol Ctr Appl Nonlinear Math, Bristol, Avon, England.	J.Terry@exeter.ac.uk	Terry, John/ABA-2609-2020; Terry, John/P-6585-2014; Terry, John/F-5734-2010; Rankin, James/AAN-9648-2021	Terry, John/0000-0002-6829-5736; Rankin, James/0000-0002-8850-6027; Lightman, Stafford/0000-0002-8546-9646	Engineering and Physical Sciences Research Council (EPSRC) [EP/E032249/1]; Wellcome Trust [074112/Z/04/Z]; MRC [MR/J008893/1] Funding Source: UKRI; Medical Research Council [MR/J008893/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC) grant EP/E032249/1 and The Wellcome Trust grant 074112/Z/04/Z. The original biological data was generated from a Wellcome Trust grant to Stafford Lightman and Colin Ingram. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson HC, 2008, AM J PHYSIOL-ENDOC M, V294, pE1011, DOI 10.1152/ajpendo.00721.2007; Brown E, 2004, NEURAL COMPUT, V16, P673, DOI 10.1162/089976604322860668; Conway-Campbell BL, 2010, J NEUROENDOCRINOL, V22, P1093, DOI 10.1111/j.1365-2826.2010.02051.x; Dallman MF, 2005, FRONT NEUROENDOCRIN, V26, P103, DOI 10.1016/j.yfrne.2005.08.001; DALLMAN MF, 1987, RECENT PROG HORM RES, V43, P113; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Gupta S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-8; Hinz B, 2000, PHARMACEUT RES, V17, P1273, DOI 10.1023/A:1026499604848; IXART G, 1991, EXP BRAIN RES, V87, P153; JONES MT, 1977, J ENDOCRINOL, V73, P405, DOI 10.1677/joe.0.0730405; Lightman SL, 2010, NAT REV NEUROSCI, V11, P710, DOI 10.1038/nrn2914; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; MERSHON JL, 1992, ENDOCRINOLOGY, V130, P2991, DOI 10.1210/en.130.5.2991; Russell GM, 2010, J NEUROSCI, V30, P6106, DOI 10.1523/JNEUROSCI.5332-09.2010; Spiga F, 2009, J ENDOCRINOL, V200, P273, DOI 10.1677/JOE-08-0421; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Walker JJ, 2010, J NEUROENDOCRINOL, V22, P1226, DOI 10.1111/j.1365-2826.2010.02087.x; Walker JJ, 2010, P ROY SOC B-BIOL SCI, V277, P1627, DOI 10.1098/rspb.2009.2148; Windle RJ, 1998, ENDOCRINOLOGY, V139, P443, DOI 10.1210/en.139.2.443; Windle RJ, 1998, ENDOCRINOLOGY, V139, P4044, DOI 10.1210/en.139.10.4044; Windle RJ, 2001, J NEUROENDOCRINOL, V13, P905, DOI 10.1046/j.1365-2826.2001.00715.x; Winfree AT., 1980, GEOMETRY BIOL TIME	24	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30978	10.1371/journal.pone.0030978	http://dx.doi.org/10.1371/journal.pone.0030978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363526	Green Submitted, gold, Green Published			2022-12-25	WOS:000302873700017
J	Seidel, C; Zekert, N; Fischer, R				Seidel, Constanze; Zekert, Nadine; Fischer, Reinhard			The Aspergillus nidulans Kinesin-3 Tail Is Necessary and Sufficient to Recognize Modified Microtubules	PLOS ONE			English	Article							MOTOR PROTEINS; ALPHA-TUBULIN; FHA DOMAIN; IDENTIFICATION; TRANSPORT; DYNACTIN; NCKIN3; DYNEIN; KIF1A; GENE	Posttranslational microtubule modifications (PTMs) are numerous; however, the biochemical and cell biological roles of those modifications remain mostly an enigma. The Aspergillus nidulans kinesin-3 UncA uses preferably modified microtubules (MTs) as tracks for vesicle transportation. Here, we show that a positively charged region in the tail of UncA (amino acids 1316 to 1402) is necessary for the recognition of modified MTs. Chimeric proteins composed of the kinesin-1 motor domain and the UncA tail displayed the same specificity as UncA, suggesting that the UncA tail is sufficient to establish specificity. Interaction between the UncA tail and alpha-tubulin was shown using a yeast two-hybrid assay and in A. nidulans by bimolecular fluorescence complementation. This is the first demonstration of how a kinesin-3 motor protein distinguishes among different MT populations in fungal cells, and how specificity determination depends on the tail rather than the motor domain, as has been demonstrated for kinesin 1 in neuronal cells.	[Seidel, Constanze; Zekert, Nadine; Fischer, Reinhard] Karlsruhe Inst Technol, Dept Microbiol, Inst Appl Biosci, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Seidel, C (corresponding author), Karlsruhe Inst Technol, Dept Microbiol, Inst Appl Biosci, Karlsruhe, Germany.	reinhard.fischer@bio.uka.de	Fischer, Reinhard/I-1220-2016	Fischer, Reinhard/0000-0002-6704-2569	German Science Foundation [FOR1334]; Deutsche Forschungsgemeinschaft; Karlsruhe Institute of Technology	German Science Foundation(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	The study was funded by the German Science Foundation FOR1334. We thank Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology for support. CS is a fellow of the Landesgraduiertenforderung of the state Baden Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Adio S, 2009, FEBS J, V276, P3641, DOI 10.1111/j.1742-4658.2009.07083.x; Penalva MA, 2010, CURR OPIN MICROBIOL, V13, P684, DOI 10.1016/j.mib.2010.09.005; ARCE CA, 1975, EUR J BIOCHEM, V59, P145, DOI 10.1111/j.1432-1033.1975.tb02435.x; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Fuchs F, 2005, MOL BIOL CELL, V16, P153, DOI 10.1091/mbc.E04-05-0413; Hill TW., 2001, FUNGAL GENET NEWSL, V48, P20, DOI [DOI 10.4148/1941-4765.1173, 10.4148/1941-4765.1173]; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P877, DOI 10.1038/nrm2807; Huckaba TM, 2011, J BIOL CHEM, V286, P7457, DOI 10.1074/jbc.M110.167023; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Lee JR, 2004, EMBO J, V23, P1506, DOI 10.1038/sj.emboj.7600164; Lehmler C, 1997, EMBO J, V16, P3464, DOI 10.1093/emboj/16.12.3464; Marx A, 2009, CELL MOTIL CYTOSKEL, V66, P958, DOI 10.1002/cm.20392; Mialhe A, 2001, CANCER RES, V61, P5024; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; MORRIS NR, 1979, CELL, V16, P437; Nitta R, 2008, NAT STRUCT MOL BIOL, V15, P1067, DOI 10.1038/nsmb.1487; Oakley BR, 2004, FUNGAL GENET BIOL, V41, P420, DOI 10.1016/j.fgb.2003.11.013; Quinones GB, 2011, MOL BIOL CELL, V22, P1045, DOI 10.1091/mbc.E10-06-0519; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Requena N, 2001, MOL MICROBIOL, V42, P121, DOI 10.1046/j.1365-2958.2001.02609.x; Sambrook J., 1999, MOL CLONING LAB MANU; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; SHEIRNEISS G, 1978, CELL, V15, P639, DOI 10.1016/0092-8674(78)90032-6; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Westerholm-Parvinen A, 2000, FEBS LETT, V486, P285, DOI 10.1016/S0014-5793(00)02310-3; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470; Zekert N, 2009, MOL BIOL CELL, V20, P673, DOI 10.1091/mbc.E08-07-0685; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516; Zhang J, 2011, J CELL BIOL, V193, P1245, DOI 10.1083/jcb.201011022	34	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30976	10.1371/journal.pone.0030976	http://dx.doi.org/10.1371/journal.pone.0030976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363525	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500022
J	Kinnamon, DD; Hershberger, RE; Martin, ER				Kinnamon, Daniel D.; Hershberger, Ray E.; Martin, Eden R.			Reconsidering Association Testing Methods Using Single-Variant Test Statistics as Alternatives to Pooling Tests for Sequence Data with Rare Variants	PLOS ONE			English	Article							SAMPLE-SIZE; LINKAGE DISEQUILIBRIUM; COMMON DISEASES; GENETIC-MARKERS; ALLELE MODEL; SUSCEPTIBILITY; POWER; SNPS	Association tests that pool minor alleles into a measure of burden at a locus have been proposed for case-control studies using sequence data containing rare variants. However, such pooling tests are not robust to the inclusion of neutral and protective variants, which can mask the association signal from risk variants. Early studies proposing pooling tests dismissed methods for locus-wide inference using nonnegative single-variant test statistics based on unrealistic comparisons. However, such methods are robust to the inclusion of neutral and protective variants and therefore may be more useful than previously appreciated. In fact, some recently proposed methods derived within different frameworks are equivalent to performing inference on weighted sums of squared single-variant score statistics. In this study, we compared two existing methods for locus-wide inference using nonnegative single-variant test statistics to two widely cited pooling tests under more realistic conditions. We established analytic results for a simple model with one rare risk and one rare neutral variant, which demonstrated that pooling tests were less powerful than even Bonferroni-corrected single-variant tests in most realistic situations. We also performed simulations using variants with realistic minor allele frequency and linkage disequilibrium spectra, disease models with multiple rare risk variants and extensive neutral variation, and varying rates of missing genotypes. In all scenarios considered, existing methods using nonnegative single-variant test statistics had power comparable to or greater than two widely cited pooling tests. Moreover, in disease models with only rare risk variants, an existing method based on the maximum single-variant Cochran-Armitage trend chi-square statistic in the locus had power comparable to or greater than another existing method closely related to some recently proposed methods. We conclude that efficient locus-wide inference using single-variant test statistics should be reconsidered as a useful framework for devising powerful association tests in sequence data with rare variants.	[Kinnamon, Daniel D.; Martin, Eden R.] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL 33136 USA; [Hershberger, Ray E.] Univ Miami, Miller Sch Med, Cardiovasc Div, Miami, FL 33136 USA	University of Miami; University of Miami	Kinnamon, DD (corresponding author), Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL 33136 USA.	emartin1@med.miami.edu	Kinnamon, Daniel D./J-4207-2013	Kinnamon, Daniel D./0000-0002-0867-5227; Hershberger, Ray/0000-0001-5683-6526	National Institutes of Health [RC2HG005605, HL58626]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058626] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by National Institutes of Health grants RC2HG005605 (ERM, DDK) and HL58626 (REH). No additional external funding was received for this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonarakis SE, 2010, VOGEL AND MOTULSKY'S HUMAN GENETICS, FOURTH EDITION, P31, DOI 10.1007/978-3-540-37654-5_2; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Casella G., 2002, STAT INFERENCE, V2nd; Chapman J, 2008, GENET EPIDEMIOL, V32, P560, DOI 10.1002/gepi.20330; Davison AC, 1997, BOOTSTRAP METHODS TH; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; GOODNIGHT JH, 1979, AM STAT, V33, P149, DOI 10.2307/2683825; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; HUDSON RR, 1985, GENETICS, V109, P611; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Leemis LM, 1996, AM STAT, V50, P63, DOI 10.2307/2685046; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Little R.J.A., 2002, STAT ANAL MISSING DA; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McIntyre LM, 2000, GENET EPIDEMIOL, V19, P18, DOI 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Nachman MW, 2000, GENETICS, V156, P297; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Rampersaud E, 2010, ANN HUM GENET, V74, P110, DOI 10.1111/j.1469-1809.2010.00566.x; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Slager SL, 2001, HUM HERED, V52, P149, DOI 10.1159/000053370; Sul JH, 2011, GENETICS, V188, P181, DOI 10.1534/genetics.110.125070; Thomas DC, 2004, STAT METHODS GENETIC; Timm NH, 2002, APPL MULTIVARIATE AN, DOI 10.1007/b98963; WEIR BS, 1979, HEREDITY, V42, P105, DOI 10.1038/hdy.1979.10; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	39	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30238	10.1371/journal.pone.0030238	http://dx.doi.org/10.1371/journal.pone.0030238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363423	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600017
J	Preuss, SB; Meister, R; Xu, QZ; Urwin, CP; Tripodi, FA; Screen, SE; Anil, VS; Zhu, SQ; Morrell, JA; Liu, G; Ratcliffe, OJ; Reuber, TL; Khanna, R; Goldman, BS; Bell, E; Ziegler, TE; McClerren, AL; Ruff, TG; Petracek, ME				Preuss, Sasha B.; Meister, Robert; Xu, Qingzhang; Urwin, Carl P.; Tripodi, Federico A.; Screen, Steven E.; Anil, Veena S.; Zhu, Shuquan; Morrell, James A.; Liu, Grace; Ratcliffe, Oliver J.; Reuber, T. Lynne; Khanna, Rajnish; Goldman, Barry S.; Bell, Erin; Ziegler, Todd E.; McClerren, Amanda L.; Ruff, Thomas G.; Petracek, Marie E.			Expression of the Arabidopsis thaliana BBX32 Gene in Soybean Increases Grain Yield	PLOS ONE			English	Article							CIRCADIAN CLOCK; FLOWERING TIME; KEY PATHWAYS; ARABIDOPSIS; COMPONENTS; CONSTANS; CCA1; FOOD; LHY; PRODUCTIVITY	Crop yield is a highly complex quantitative trait. Historically, successful breeding for improved grain yield has led to crop plants with improved source capacity, altered plant architecture, and increased resistance to abiotic and biotic stresses. To date, transgenic approaches towards improving crop grain yield have primarily focused on protecting plants from herbicide, insects, or disease. In contrast, we have focused on identifying genes that, when expressed in soybean, improve the intrinsic ability of the plant to yield more. Through the large scale screening of candidate genes in transgenic soybean, we identified an Arabidopsis thaliana B-box domain gene (AtBBX32) that significantly increases soybean grain yield year after year in multiple transgenic events in multi-location field trials. In order to understand the underlying physiological changes that are associated with increased yield in transgenic soybean, we examined phenotypic differences in two AtBBX32-expressing lines and found increases in plant height and node, flower, pod, and seed number. We propose that these phenotypic changes are likely the result of changes in the timing of reproductive development in transgenic soybean that lead to the increased duration of the pod and seed development period. Consistent with the role of BBX32 in A. thaliana in regulating light signaling, we show that the constitutive expression of AtBBX32 in soybean alters the abundance of a subset of gene transcripts in the early morning hours. In particular, AtBBX32 alters transcript levels of the soybean clock genes GmTOC1 and LHY-CCA1-like2 (GmLCL2). We propose that through the expression of AtBBX32 and modulation of the abundance of circadian clock genes during the transition from dark to light, the timing of critical phases of reproductive development are altered. These findings demonstrate a specific role for AtBBX32 in modulating soybean development, and demonstrate the validity of expressing single genes in crops to deliver increased agricultural productivity.	[Preuss, Sasha B.; Meister, Robert; Xu, Qingzhang; Urwin, Carl P.; Tripodi, Federico A.; Screen, Steven E.; Zhu, Shuquan; Morrell, James A.; Liu, Grace; Goldman, Barry S.; Bell, Erin; Ziegler, Todd E.; McClerren, Amanda L.; Ruff, Thomas G.; Petracek, Marie E.] Monsanto Co, St Louis, MO 63167 USA; [Anil, Veena S.] Monsanto Co, Monsanto Res Ctr, Bangalore, Karnataka, India; [Ratcliffe, Oliver J.; Reuber, T. Lynne; Khanna, Rajnish] Mendel Biotechnol Inc, Hayward, CA USA	Monsanto; Monsanto	Preuss, SB (corresponding author), Monsanto Co, St Louis, MO 63167 USA.	sasha.preuss@monsanto.com	Anil, Veena/ABI-3683-2020	Ziegler, Todd/0000-0001-8947-5763; Anil, Veena/0000-0002-7404-7683; Reuber, Lynne/0000-0001-7806-2437	Monsanto Company; Mendel Biotechnology	Monsanto Company; Mendel Biotechnology	This work was supported by the Monsanto Company and conducted in collaboration with Mendel Biotechnology. Since all authors are or were employed by Monsanto (SBP, RM, QX, CPU, FAT, SES, VSA, SZ, JAM, GL, BSG, EB, TEZ, ALM, TGR, MEP) or Mendel Biotechnology (OJR, TLR, RK) the funders played a role in the design, data analysis and the decision to publish.; All authors are or were affiliated with the Monsanto Company or Mendel Biotechnology, who were also funders of this study. In the United States, the authors have one issued patent: US 7,692,067 ("Yield and Stress Tolerance in Transgenic Plants"). This does not alter the authors' attempt to adhere to all the PLoS ONE policies on sharing data and materials.	Alston JM, 2009, SCIENCE, V325, P1209, DOI 10.1126/science.1170451; BOARD JE, 1995, CROP SCI, V35, P846, DOI 10.2135/cropsci1995.0011183X003500030035x; Burney JA, 2010, P NATL ACAD SCI US; Carpenter AC, 1997, CROP SCI, V37, P1520, DOI 10.2135/cropsci1997.0011183X003700050018x; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edgerton MD, 2009, PLANT PHYSIOL, V149, P7, DOI 10.1104/pp.108.130195; Egli DB, 2004, ADV AGRON, V83, P243, DOI 10.1016/S0065-2113(04)83005-0; EGLI DB, 1993, FIELD CROP RES, V32, P147, DOI 10.1016/0378-4290(93)90027-K; Endo-Higashi N, 2011, PLANT CELL PHYSIOL, V52, P1083, DOI 10.1093/pcp/pcr059; ETHREDGE WJ, 1989, AGRON J, V81, P947, DOI 10.2134/agronj1989.00021962008100060020x; FAO H, 2009, INT TREAT PLANT GEN; Fehr W. R., 1971, STAGE DEV DESCRIPTIO; Fujiwara S, 2008, PLANT CELL, V20, P2960, DOI 10.1105/tpc.108.061531; GOLI A, 1986, CROP SCI, V26, P156, DOI 10.2135/cropsci1986.0011183X002600010036x; Green RE, 2005, SCIENCE, V308, P1257; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Heatherly L.G., 2004, SOYBEANS, V16, P451, DOI [10.2134/agronmonogr16.3ed.c10, DOI 10.2134/AGRONMONOGR16.3ED.C10]; Holtan HE, 2011, PLANT PHYSIOL, V156, P2109, DOI 10.1104/pp.111.177139; JIANG HF, 1993, AGRON J, V85, P221, DOI 10.2134/agronj1993.00021962008500020011x; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Liu H, 2009, J PLANT PHYSIOL, V166, P278, DOI 10.1016/j.jplph.2008.06.003; Liu LJ, 2008, PLANT CELL, V20, P292, DOI 10.1105/tpc.107.057281; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Mockler T, 2003, P NATL ACAD SCI USA, V100, P2140, DOI 10.1073/pnas.0437826100; Niwa Y, 2007, PLANT CELL PHYSIOL, V48, P925, DOI 10.1093/pcp/pcm067; Pruneda-Paz JL, 2010, TRENDS PLANT SCI, V15, P259, DOI 10.1016/j.tplants.2010.03.003; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; SCHWEITZER LE, 1985, CROP SCI, V25, P995, DOI 10.2135/cropsci1985.0011183X002500060023x; Specht JE, 1999, CROP SCI, V39, P1560, DOI 10.2135/cropsci1999.3961560x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014	38	67	70	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30717	10.1371/journal.pone.0030717	http://dx.doi.org/10.1371/journal.pone.0030717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363475	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600059
J	Saba, R; Gushue, S; Huzarewich, RLCH; Manguiat, K; Medina, S; Robertson, C; Booth, SA				Saba, Reuben; Gushue, Shantel; Huzarewich, Rhiannon L. C. H.; Manguiat, Kathy; Medina, Sarah; Robertson, Catherine; Booth, Stephanie A.			MicroRNA 146a (miR-146a) Is Over-Expressed during Prion Disease and Modulates the Innate Immune Response and the Microglial Activation State	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-COUPLED RECEPTOR; TOLL-LIKE RECEPTORS; HUMAN BRAIN-CELLS; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; MOUSE MODEL; MICE; INFLAMMATION; TOLL-LIKE-RECEPTOR-2	Increasing evidence supports the involvement of microRNAs ( miRNAs) in inflammatory and immune processes in prion neuropathogenesis. MiRNAs are small, non-coding RNA molecules which are emerging as key regulators of numerous cellular processes. We established miR-146a over-expression in prion-infected mouse brain tissues concurrent with the onset of prion deposition and appearance of activated microglia. Expression profiling of a variety of central nervous system derived cell-lines revealed that miR-146a is preferentially expressed in cells of microglial lineage. Prominent up-regulation of miR-146a was evident in the microglial cell lines BV-2 following TLR2 or TLR4 activation and also EOC 13.31 via TLR2 that reached a maximum 24-48 hours post-stimulation, concomitant with the return to basal levels of transcription of induced cytokines. Gain-and loss-of-function studies with miR-146a revealed a substantial deregulation of inflammatory response pathways in response to TLR2 stimulation. Significant transcriptional alterations in response to miR-146a perturbation included downstream mediators of the pro-inflammatory transcription factor, nuclear factor-kappa B (NF-kappa B) and the JAK-STAT signaling pathway. Microarray analysis also predicts a role for miR-146a regulation of morphological changes in microglial activation states as well as phagocytic mediators of the oxidative burst such as CYBA and NOS3. Based on our results, we propose a role for miR-146a as a potent modulator of microglial function by regulating the activation state during prion induced neurodegeneration.	[Saba, Reuben; Gushue, Shantel; Huzarewich, Rhiannon L. C. H.; Manguiat, Kathy; Medina, Sarah; Robertson, Catherine; Booth, Stephanie A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Mol PathoBiol, Winnipeg, MB, Canada; [Saba, Reuben; Gushue, Shantel; Booth, Stephanie A.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba	Saba, R (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Mol PathoBiol, Winnipeg, MB, Canada.	Stephanie.Booth@phac-aspc.gc.ca	Booth, Stephanie/AAX-6671-2020	Booth, Stephanie/0000-0001-8108-5955	PrioNet Canada; Public Health Agency of Canada; Genomics Initiative for Government Laboratories	PrioNet Canada; Public Health Agency of Canada; Genomics Initiative for Government Laboratories	This study was supported by the PrioNet Canada, the Public Health Agency of Canada and the Canadian Biotechnology Strategy Fund: Genomics Initiative for Government Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen KQ, 2006, J BIOL CHEM, V281, P3651, DOI 10.1074/jbc.M508125200; COUTINHO A, 1978, IMMUNOGENETICS, V7, P17, DOI 10.1007/BF01843983; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Giese A, 1998, BRAIN PATHOL, V8, P449; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Hill JM, 2009, NEUROREPORT, V20, P1500, DOI 10.1097/WNR.0b013e3283329c05; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Hu GK, 2010, AM J PHYSIOL-GASTR L, V298, pG542, DOI 10.1152/ajpgi.00490.2009; Hughes MM, 2010, GLIA, V58, P2017, DOI 10.1002/glia.21070; Iribarren P, 2005, FASEB J, V19, P2032, DOI 10.1096/fj.05-4578fje; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landreth GE, 2009, CURR TOP MICROBIOL, V336, P137, DOI 10.1007/978-3-642-00549-7_8; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; Letiembre M, 2009, NEUROBIOL AGING, V30, P759, DOI 10.1016/j.neurobiolaging.2007.08.018; Li YY, 2011, NEUROSCI LETT, V487, P94, DOI 10.1016/j.neulet.2010.09.079; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Michaud JP, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-5; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; Pogue AI, 2009, J INORG BIOCHEM, V103, P1591, DOI 10.1016/j.jinorgbio.2009.05.012; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prinz M, 2003, EMBO REP, V4, P195, DOI 10.1038/sj.embor.embor731; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin HW, 2005, BLOOD, V106, P3114, DOI 10.1182/blood-2005-02-0759; Richard KL, 2008, J NEUROSCI, V28, P5784, DOI 10.1523/JNEUROSCI.1146-08.2008; Saba Reuben, 2006, BMC Biotechnol, V6, P47, DOI 10.1186/1472-6750-6-47; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sethi S, 2002, LANCET, V360, P229, DOI 10.1016/S0140-6736(02)09513-2; Shepard LW, 2001, J BIOL CHEM, V276, P45979, DOI 10.1074/jbc.M104783200; Spinner DS, 2008, J VIROL, V82, P10701, DOI 10.1128/JVI.00522-08; Spinner DS, 2007, J LEUKOCYTE BIOL, V81, P1374, DOI 10.1189/jlb.1106665; Stoeck K, 2006, J NEUROIMMUNOL, V172, P175, DOI 10.1016/j.jneuroim.2005.10.008; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Walker WS, 1995, J NEUROIMMUNOL, V63, P163, DOI 10.1016/0165-5728(95)00146-8; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	55	121	127	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30832	10.1371/journal.pone.0030832	http://dx.doi.org/10.1371/journal.pone.0030832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363497	Green Submitted, gold, Green Published			2022-12-25	WOS:000302853600074
J	Sriram, KB; Larsen, JE; Francis, SMS; Wright, CM; Clarke, BE; Duhig, EE; Brown, KM; Hayward, NK; Yang, IA; Bowman, RV; Fong, KM				Sriram, Krishna B.; Larsen, Jill E.; Francis, Santiyagu M. Savarimuthu; Wright, Casey M.; Clarke, Belinda E.; Duhig, Edwina E.; Brown, Kevin M.; Hayward, Nicholas K.; Yang, Ian A.; Bowman, Rayleen V.; Fong, Kwun M.			Array-Comparative Genomic Hybridization Reveals Loss of SOCS6 Is Associated with Poor Prognosis in Primary Lung Squamous Cell Carcinoma	PLOS ONE			English	Article							COPY NUMBER VARIATION; GENE-EXPRESSION; BREAST-CANCER; DNA; MICROARRAY; MARKER; STAGE; ADENOCARCINOMA; AMPLIFICATION; PROGRESSION	Background: Primary tumor recurrence commonly occurs after surgical resection of lung squamous cell carcinoma (SCC). Little is known about the genes driving SCC recurrence. Methods: We used array comparative genomic hybridization (aCGH) to identify genes affected by copy number alterations that may be involved in SCC recurrence. Training and test sets of resected primary lung SCC were assembled. aCGH was used to determine genomic copy number in a training set of 62 primary lung SCCs (28 with recurrence and 34 with no evidence of recurrence) and the altered copy number of candidate genes was confirmed by quantitative PCR (qPCR). An independent test set of 72 primary lung SCCs (20 with recurrence and 52 with no evidence of recurrence) was used for biological validation. mRNA expression of candidate genes was studied using qRT-PCR. Candidate gene promoter methylation was evaluated using methylation microarrays and Sequenom EpiTYPER analysis. Results: 18q22.3 loss was identified by aCGH as being significantly associated with recurrence (p = 0.038). Seven genes within 18q22.3 had aCGH copy number loss associated with recurrence but only SOCS6 copy number was both technically replicated by qPCR and biologically validated in the test set. SOCS6 copy number loss correlated with reduced mRNA expression in the study samples and in the samples with copy number loss, there was a trend for increased methylation, albeit non-significant. Overall survival was significantly poorer in patients with SOCS6 loss compared to patients without SOCS6 loss in both the training (30 vs. 43 months, p = 0.023) and test set (27 vs. 43 months, p = 0.010). Conclusion: Reduced copy number and mRNA expression of SOCS6 are associated with disease recurrence in primary lung SCC and may be useful prognostic biomarkers.	[Sriram, Krishna B.; Larsen, Jill E.; Francis, Santiyagu M. Savarimuthu; Wright, Casey M.; Yang, Ian A.; Bowman, Rayleen V.; Fong, Kwun M.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Sriram, Krishna B.; Francis, Santiyagu M. Savarimuthu; Yang, Ian A.; Bowman, Rayleen V.; Fong, Kwun M.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia; [Larsen, Jill E.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Clarke, Belinda E.; Duhig, Edwina E.] Prince Charles Hosp, Dept Anat Pathol, Brisbane, Qld 4032, Australia; [Brown, Kevin M.] Translat Genom Res Inst TGen, Integrat Canc Genom Div, Phoenix, AZ USA; [Hayward, Nicholas K.] Queensland Inst Med Res, Oncogen Lab, Brisbane, Qld 4006, Australia	University of Queensland; Prince Charles Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Prince Charles Hospital; Translational Genomics Research Institute; QIMR Berghofer Medical Research Institute	Sriram, KB (corresponding author), Univ Queensland, Sch Med, Brisbane, Qld, Australia.	bajee.sriram@uqconnect.edu.au	Wright, Casey M/J-9693-2014; Bowman, Rayleen V/G-4144-2013; Fong, Kwun M/G-6369-2010; Wright, Casey/G-1078-2011; hayward, nick/AAV-8802-2020; Yang, Ian A/B-9609-2008; Dodds, Casey/HGC-6866-2022; Larsen, Jill E/G-3787-2010; hayward, nicholas k/C-1367-2015; Sriram, Krishna Bajee/J-9316-2014	Wright, Casey M/0000-0001-9214-5749; Yang, Ian A/0000-0001-8338-1993; Larsen, Jill E/0000-0001-7806-3931; hayward, nicholas k/0000-0003-4760-1033; Fong, Kwun/0000-0002-6507-1403; Sriram, Krishna Bajee/0000-0002-1865-2133	NHMRC; Queensland Smart State project; UQ; Cancer Council Queensland; Queensland Clinical Research Fellowship; Prince Charles Hospital Foundation; NATIONAL CANCER INSTITUTE [ZIACP010201] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Queensland Smart State project; UQ; Cancer Council Queensland(Cancer Council Queensland); Queensland Clinical Research Fellowship; Prince Charles Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NH&MRC and Queensland Smart State project grants; UQ Postgraduate Medical Scholarship and NH&MRC Postgraduate Medical Scholarship (to KBS), NH&MRC Practitioner Fellowship (KMF), NH&MRC Career Development Award (IAY), NH&MRC Biomedical Scholarship (SMS, CMW), Cancer Council Queensland Senior Research Fellowship (KMF), Queensland Clinical Research Fellowship (KMF, IAY) and The Prince Charles Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2007, ONCOL REP, V17, P1005; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bayle J, 2004, J BIOL CHEM, V279, P12249, DOI 10.1074/jbc.M313381200; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Boelens MC, 2009, LUNG CANCER, V66, P372, DOI 10.1016/j.lungcan.2009.02.017; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Boyd D Barry, 2003, Integr Cancer Ther, V2, P315, DOI 10.1177/1534735403259152; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Charchar FJ, 2010, HYPERTENSION, V55, P1231, DOI 10.1161/HYPERTENSIONAHA.109.141663; Choi YW, 2007, LUNG CANCER, V55, P43, DOI 10.1016/j.lungcan.2006.09.018; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrich M, 2006, CANCER RES, V66, P10911, DOI 10.1158/0008-5472.CAN-06-0400; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Hassan HT, 2009, LEUKEMIA RES, V33, P5, DOI 10.1016/j.leukres.2008.06.011; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Iwakawa R, 2011, CLIN CANCER RES, V17, P1481, DOI 10.1158/1078-0432.CCR-10-2484; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Kang JU, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-237; Kondo Y, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001559; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Kristensen LS, 2009, CLIN CHEM, V55, P1471, DOI 10.1373/clinchem.2008.121962; Lai RH, 2010, CANCER LETT, V288, P75, DOI 10.1016/j.canlet.2009.06.025; Lai RH, 2009, GENE, V448, P64, DOI 10.1016/j.gene.2009.07.022; Larsen JE, 2007, CARCINOGENESIS, V28, P760, DOI 10.1093/carcin/bgl207; Larsen L, 2002, APMIS, V110, P833, DOI 10.1034/j.1600-0463.2002.1101201.x; Luk C, 2001, CANCER GENET CYTOGEN, V125, P87, DOI 10.1016/S0165-4608(00)00363-0; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Newnham GM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-93; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Petersen S, 2000, BRIT J CANCER, V82, P65; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Przybytkowski E, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-16; Scott WJ, 2007, CHEST, V132, p234S, DOI 10.1378/chest.07-1378; Spiro SG, 2005, AM J RESP CRIT CARE, V172, P523, DOI 10.1164/rccm.200504-531OE; Sung JS, 2010, CANCER GENET CYTOGEN, V198, P27, DOI 10.1016/j.cancergencyto.2009.12.001; Sy SMH, 2004, EUR J CANCER, V40, P1082, DOI 10.1016/j.ejca.2004.01.012; Takebayashi S, 2004, GENE CHROMOSOME CANC, V41, P145, DOI 10.1002/gcc.20066; Tan DSP, 2007, LAB INVEST, V87, P737, DOI 10.1038/labinvest.3700593; Tanaka T, 2009, DIAGN MOL PATHOL, V18, P219, DOI 10.1097/PDM.0b013e3181910f17; Tommasi S, 2010, ANAL CELL PATHOL, V33, P113, DOI [10.1155/2010/468280, 10.3233/ACP-CLO-2010-0544]; Ueno T, 2002, CLIN CANCER RES, V8, P526; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Yan WS, 2005, TUMOR BIOL, V26, P158, DOI 10.1159/000086488	54	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30398	10.1371/journal.pone.0030398	http://dx.doi.org/10.1371/journal.pone.0030398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363434	Green Published, gold			2022-12-25	WOS:000302853600028
J	Zallocchi, M; Meehan, DT; Delimont, D; Rutledge, J; Gratton, MA; Flannery, J; Cosgrove, D				Zallocchi, Marisa; Meehan, Daniel T.; Delimont, Duane; Rutledge, Joseph; Gratton, Michael Anne; Flannery, John; Cosgrove, Dominic			Role for a Novel Usher Protein Complex in Hair Cell Synaptic Maturation	PLOS ONE			English	Article							ALTERNATIVE SPLICE FORMS; CA(V)1.3 CA2+ CHANNELS; ANKLE-LINK COMPLEX; RIBBON SYNAPSES; MUTANT ALLELES; MYOSIN-VIIA; TIP-LINK; GENOMIC STRUCTURE; COUPLED RECEPTOR; PLASMA-MEMBRANE	The molecular mechanisms underlying hair cell synaptic maturation are not well understood. Cadherin-23 (CDH23), protocadherin-15 (PCDH15) and the very large G-protein coupled receptor 1 (VLGR1) have been implicated in the development of cochlear hair cell stereocilia, while clarin-1 has been suggested to also play a role in synaptogenesis. Mutations in CDH23, PCDH15, VLGR1 and clarin-1 cause Usher syndrome, characterized by congenital deafness, vestibular dysfunction and retinitis pigmentosa. Here we show developmental expression of these Usher proteins in afferent spiral ganglion neurons and hair cell synapses. We identify a novel synaptic Usher complex comprised of clarin-1 and specific isoforms of CDH23, PCDH15 and VLGR1. To establish the in vivo relevance of this complex, we performed morphological and quantitative analysis of the neuronal fibers and their synapses in the Clrn1-/- mouse, which was generated by incomplete deletion of the gene. These mice showed a delay in neuronal/synaptic maturation by both immunostaining and electron microscopy. Analysis of the ribbon synapses in Ames waltzer(av3J) mice also suggests a delay in hair cell synaptogenesis. Collectively, these results show that, in addition to the well documented role for Usher proteins in stereocilia development, Usher protein complexes comprised of specific protein isoforms likely function in synaptic maturation as well.	[Zallocchi, Marisa; Meehan, Daniel T.; Delimont, Duane; Cosgrove, Dominic] Boys Town Natl Res Hosp, Omaha, NE 68131 USA; [Rutledge, Joseph; Gratton, Michael Anne] St Louis Univ, St Louis, MO 63103 USA; [Flannery, John] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Cosgrove, Dominic] Univ Nebraska Med Ctr, Omaha, NE USA	Boys Town National Research Hospital; Saint Louis University; University of California System; University of California Berkeley; University of Nebraska System; University of Nebraska Medical Center	Zallocchi, M (corresponding author), Boys Town Natl Res Hosp, Omaha, NE 68131 USA.	dominic.cosgrove@boystown.org	Zallocchi, Marisa/HHS-7445-2022	Flannery, John/0000-0002-0720-8897	IBIF, Creighton University, Omaha, NE [RR17417-01]; NIH [R01 DC004844, DC006442]; Foundation Fighting Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006442, R01DC004844] Funding Source: NIH RePORTER	IBIF, Creighton University, Omaha, NE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Confocal microscopy was conducted at the IBIF, Creighton University, Omaha, NE (C06 Grant RR17417-01, NCRR, NIH). Electron microscopy was conducted at the RCAVS at Washington University (P300DC046651). This work was supported by NIH grants R01 DC004844 to DC, DC006442 to MAG, and a grant from The Foundation Fighting Blindness to JF. The IBIF (Integrated Biomedical Imaging Facility) and RCAVS (Research Center for Auditory and Vestibular Studies) are CORE services provided by University facilities funded by the NIH. The support does indeed represent a source of funding. As users the authors are requested to acknowledge the support in any publications resulting from data acquired through use of the facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 2002, EUR J HUM GENET, V10, P339, DOI 10.1038/sj.ejhg.5200831; Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Ahmed ZM, 2008, HUM GENET, V124, P215, DOI 10.1007/s00439-008-0543-3; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Ahmed ZM, 2008, MOL VIS, V14, P2227; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Alagramam KN, 2007, GENOMICS, V90, P482, DOI 10.1016/j.ygeno.2007.06.007; Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; Barclay M, 2010, NEUROSCI LETT, V478, P51, DOI 10.1016/j.neulet.2010.01.063; Beurg M, 2010, J NEUROSCI, V30, P13281, DOI 10.1523/JNEUROSCI.2528-10.2010; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Boyer S, 2004, BRAIN RES PROTOC, V13, P91, DOI 10.1016/j.brainresprot.2004.02.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cosgrove D, 2010, HEARING RES, V259, P117, DOI 10.1016/j.heares.2009.09.006; DANNHOF BJ, 1993, HEARING RES, V66, P8, DOI 10.1016/0378-5955(93)90255-Y; Di Palma F, 2001, GENE, V281, P31, DOI 10.1016/S0378-1119(01)00761-2; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; Geller SF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000607; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; GILLOYZAGA P, 1990, EUR ARCH OTO-RHINO-L, V248, P40, DOI 10.1007/BF00634780; Grati M, 2006, J NEUROSCI, V26, P6386, DOI 10.1523/JNEUROSCI.1215-06.2006; Gregory FD, 2011, NAT NEUROSCI, V14, P1109, DOI 10.1038/nn.2895; Hallgren B, 1959, ACTA PSYCHIAT SCAND, V138, P100; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Haywood-Watson RJL, 2006, INVEST OPHTH VIS SCI, V47, P3074, DOI 10.1167/iovs.06-0108; Heidrych P, 2008, HUM MOL GENET, V17, P3814, DOI 10.1093/hmg/ddn279; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Huang LC, 2007, DEVELOPMENT, V134, P2925, DOI 10.1242/dev.001925; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Lagziel A, 2009, MOL VIS, V15, P1843; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Legendre K, 2008, J CELL SCI, V121, P3347, DOI 10.1242/jcs.028134; Lillo C, 2006, ADV EXP MED BIOL, V572, P341; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; McMillan DR, 2004, MOL CELL NEUROSCI, V26, P322, DOI 10.1016/j.mcn.2004.02.005; McMillan DR, 2002, J BIOL CHEM, V277, P785, DOI 10.1074/jbc.M108929200; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Moser T, 2006, J PHYSIOL-LONDON, V576, P55, DOI 10.1113/jphysiol.2006.114835; Nemzou RM, 2006, NEUROSCIENCE, V141, P1849, DOI 10.1016/j.neuroscience.2006.05.057; Nikkila H, 2000, MOL ENDOCRINOL, V14, P1351, DOI 10.1210/me.14.9.1351; Petit C, 2001, ANNU REV GENOM HUM G, V2, P271, DOI 10.1146/annurev.genom.2.1.271; PUJOL R, 1985, ACTA OTO-LARYNGOL, P5; Raphael Y, 2003, BRAIN RES BULL, V60, P397, DOI 10.1016/S0361-9230(03)00047-9; Reiners J, 2005, MOL VIS, V11, P347; Reiners J, 2003, INVEST OPHTH VIS SCI, V44, P5006, DOI 10.1167/iovs.03-0483; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Rivolta MN, 2002, GENOME RES, V12, P1091, DOI 10.1101/gr.225602; Rivolta MN, 1998, P ROY SOC B-BIOL SCI, V265, P1595, DOI 10.1098/rspb.1998.0477; Roux I, 2009, HUM MOL GENET, V18, P4615, DOI 10.1093/hmg/ddp429; Ruel J, 2007, HEARING RES, V227, P19, DOI 10.1016/j.heares.2006.08.017; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Scheel H, 2002, HUM MOL GENET, V11, P1757, DOI 10.1093/hmg/11.15.1757; Sendin G, 2007, J NEUROSCI, V27, P3163, DOI 10.1523/JNEUROSCI.3974-06.2007; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; SIMMONS DD, 1994, NEUROREPORT, V5, P1309, DOI 10.1097/00001756-199406270-00003; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; SOBKOWICZ HM, 1982, J NEUROSCI, V2, P942; SOBKOWICZ HM, 1986, J NEUROCYTOL, V15, P693, DOI 10.1007/BF01625188; Soni LE, 2005, CELL MOTIL CYTOSKEL, V62, P13, DOI 10.1002/cm.20080; Staub E, 2002, TRENDS BIOCHEM SCI, V27, P441, DOI 10.1016/S0968-0004(02)02163-1; Tomita S, 2007, P NATL ACAD SCI USA, V104, P18784, DOI 10.1073/pnas.0708970104; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Webb SW, 2011, DEVELOPMENT, V138, P1607, DOI 10.1242/dev.060061; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Yagi H, 2005, J NEUROCHEM, V92, P191, DOI 10.1111/j.1471-4159.2004.02875.x; Yagi H, 2007, GENES CELLS, V12, P235, DOI 10.1111/j.1365-2443.2007.01046.x; Zallocchi M, 2010, BIOCHEMISTRY-US, V49, P1236, DOI 10.1021/bi9020617; Zallocchi M, 2009, HEARING RES, V255, P109, DOI 10.1016/j.heares.2009.06.006	82	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30573	10.1371/journal.pone.0030573	http://dx.doi.org/10.1371/journal.pone.0030573			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363448	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600036
J	Aranday-Cortes, E; Hogarth, PJ; Kaveh, DA; Whelan, AO; Villarreal-Ramos, B; Lalvani, A; Vordermeier, HM				Aranday-Cortes, Elihu; Hogarth, Philip J.; Kaveh, Daryan A.; Whelan, Adam O.; Villarreal-Ramos, Bernardo; Lalvani, Ajit; Vordermeier, H. Martin			Transcriptional Profiling of Disease-Induced Host Responses in Bovine Tuberculosis and the Identification of Potential Diagnostic Biomarkers	PLOS ONE			English	Article							DELTA-T-CELLS; GAMMA-INTERFERON PRODUCTION; MYCOBACTERIUM-BOVIS; BCG VACCINATION; TH17 CELLS; INFECTION; CD4(+); CATTLE; IL-22; IP-10	Bovine tuberculosis (bTb) remains a major and economically important disease of livestock. Improved ante-mortem diagnostic tools would help to underpin novel control strategies. The definition of biomarkers correlating with disease progression could have impact on the rational design of novel diagnostic approaches for bTb. We have used a murine bTb model to identify promising candidates in the host transcriptome post-infection. RNA from in vitro-stimulated splenocytes and lung cells from BALB/c mice infected aerogenically with Mycobacterium bovis were probed with high-density microarrays to identify possible biomarkers of disease. In antigen-stimulated splenocytes we found statistically significant differential regulation of 1109 genes early (3 days) after infection and 1134 at a later time-point post-infection (14 days). 618 of these genes were modulated at both time points. In lung cells, 282 genes were significantly modulated post-infection. Amongst the most strongly up-regulated genes were: granzyme A, granzyme B, cxcl9, interleukin-22, and ccr6. The expression of 14 out of the most up-regulated genes identified in the murine studies was evaluated using in vitro with antigen-stimulated PBMC from uninfected and naturally infected cattle. We show that the expression of cxcl9, cxcl10, granzyme A and interleukin-22 was significantly increased in PBMC from infected cattle compared to naive animals following PPD stimulation in vitro. Thus, murine transcriptome analysis can be used to predict immunological responses in cattle allowing the prioritisation of CXCLl9, CXCL10, Granzyme A and IL-22 as potential additional readout systems for the ante-mortem diagnosis of bovine tuberculosis.	[Aranday-Cortes, Elihu; Hogarth, Philip J.; Kaveh, Daryan A.; Whelan, Adam O.; Villarreal-Ramos, Bernardo; Vordermeier, H. Martin] Anim Hlth & Vet Labs Agcy Weybridge, TB Res Grp, Addlestone, Surrey, England; [Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, TB Immunol Grp, London, England	Veterinary Laboratories Agency; Imperial College London	Aranday-Cortes, E (corresponding author), Anim Hlth & Vet Labs Agcy Weybridge, TB Res Grp, Addlestone, Surrey, England.	martin.vordermeier@ahvla.gsi.gov.uk	Vordermeier, H Martin/C-6936-2011; Whelan, Adam O/C-9497-2011; Hogarth, Philip/C-6085-2011; Aranday-Cortes, Elihu/G-3706-2012	Hogarth, Philip/0000-0002-6343-7846; Lalvani, Ajit/0000-0002-2396-246X; Kaveh, Daryan/0000-0002-1451-0082; Aranday-Cortes, Elihu/0000-0003-2637-2307	Department for Environment, Food and Rural Affairs, United Kingdom	Department for Environment, Food and Rural Affairs, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food and Rural Affairs, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony DA, 2010, IMMUNOL REV, V235, P73, DOI 10.1111/j.0105-2896.2010.00907.x; Canaday DH, 2001, J IMMUNOL, V167, P2734, DOI 10.4049/jimmunol.167.5.2734; Blanco FC, 2011, TUBERCULOSIS, V91, P57, DOI 10.1016/j.tube.2010.11.007; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Clark S, 2011, J ALLERGY CLIN IMMUN, V128, P838, DOI 10.1016/j.jaci.2011.05.025; Cortes EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011319; Dhiman R, 2009, J IMMUNOL, V183, P6639, DOI 10.4049/jimmunol.0902587; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gallegos AM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002052; Gormley E, 2006, VET MICROBIOL, V112, P171, DOI 10.1016/j.vetmic.2005.11.029; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hogarth PJ, 2005, VACCINE, V23, P2557, DOI 10.1016/j.vaccine.2004.11.030; Jones GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1946, DOI 10.1128/CVI.00377-10; Kasprowicz VO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020606; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lalvani A, 2008, J INFECT DIS, V197, P941, DOI 10.1086/529049; Lieberman J, 2010, IMMUNOL REV, V235, P93, DOI 10.1111/j.0105-2896.2010.00902.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Logan KE, 2008, TUBERCULOSIS, V88, P437, DOI 10.1016/j.tube.2008.05.005; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; Peng MY, 2008, CELL MOL IMMUNOL, V5, P203, DOI 10.1038/cmi.2008.25; Qiu LY, 2008, J INFECT DIS, V198, P1514, DOI 10.1086/592448; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Ruhwald M, 2011, TUBERCULOSIS, V91, P260, DOI 10.1016/j.tube.2011.01.001; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Sallusto F, 2009, MICROBES INFECT, V11, P620, DOI 10.1016/j.micinf.2009.04.004; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; Vesosky B, 2010, J LEUKOCYTE BIOL, V87, P1153, DOI 10.1189/jlb.1109742; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier HM, 1999, CLIN DIAGN LAB IMMUN, V6, P675, DOI 10.1128/CDLI.6.5.675-682.1999; Vordermeier M, 2011, TROP ANIM HLTH PROD; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Waters W Ray, 2011, Clin Dev Immunol, V2011, P768542, DOI 10.1155/2011/768542; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wood PR, 2001, TUBERCULOSIS, V81, P147, DOI 10.1054/tube.2000.0272; Wozniak TM, 2010, INFECT IMMUN, V78, P4187, DOI 10.1128/IAI.01392-09; Yao SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000789; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zarate-Blades CR, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/192630; Zeng GC, 2011, J IMMUNOL, V187, P190, DOI 10.4049/jimmunol.1004129	52	46	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30626	10.1371/journal.pone.0030626	http://dx.doi.org/10.1371/journal.pone.0030626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359547	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000302796200016
J	Spencer, JD; Hains, DS; Porter, E; Bevins, CL; DiRosario, J; Becknell, B; Wang, HY; Schwaderer, AL				Spencer, John David; Hains, David S.; Porter, Edith; Bevins, Charles L.; DiRosario, Julianne; Becknell, Brian; Wang, Huanyu; Schwaderer, Andrew L.			Human Alpha Defensin 5 Expression in the Human Kidney and Urinary Tract	PLOS ONE			English	Article							HUMAN BETA-DEFENSIN-1; ANTIMICROBIAL PEPTIDES; MECHANISM; INFECTION; INNATE; MOLECULES; BINDING	Background: The mechanisms that maintain sterility in the urinary tract are incompletely understood. Recent studies have implicated the importance of antimicrobial peptides (AMP) in protecting the urinary tract from infection. Here, we characterize the expression and relevance of the AMP human alpha-defensin 5 (HD5) in the human kidney and urinary tract in normal and infected subjects. Methodology/Principal Findings: Using RNA isolated from human kidney, ureter, and bladder tissue, we performed quantitative real-time PCR to show that DEFA5, the gene encoding HD5, is constitutively expressed throughout the urinary tract. With pyelonephritis, DEFA5 expression significantly increased in the kidney. Using immunoblot analysis, HD5 production also increased with pyelonephritis. Immunostaining localized HD5 to the urothelium of the bladder and ureter. In the kidney, HD5 was primarily produced in the distal nephron and collecting tubules. Using immunoblot and ELISA assays, HD5 was not routinely detected in non-infected human urine samples while mean urinary HD5 production increased with E. coli urinary tract infection. Conclusions/Significance: DEFA5 is expressed throughout the urinary tract in non-infected subjects. Specifically, HD5 is expressed throughout the urothelium of the lower urinary tract and in the collecting tubules of the kidney. With infection, HD5 expression increases in the kidney and levels become detectable in the urine. To our knowledge, our findings represent the first to quantitate HD5 expression and production in the human kidney. Moreover, this is the first report to detect the presence of HD5 in infected urine samples. Our results suggest that HD5 may have an important role in maintaining urinary tract sterility.	[Spencer, John David; Becknell, Brian] Nationwide Childrens Hosp, Pediat Nephrol Fellowship Program, Columbus, OH USA; [Spencer, John David; Hains, David S.; Becknell, Brian; Schwaderer, Andrew L.] Nationwide Childrens Hosp, Div Nephrol, Dept Pediat, Columbus, OH USA; [Hains, David S.; DiRosario, Julianne; Wang, Huanyu; Schwaderer, Andrew L.] Nationwide Childrens Hosp, Ctr Clin & Translat Res, Res Inst, Columbus, OH USA; [Porter, Edith] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA; [Bevins, Charles L.] Univ Calif Davis, Dept Microbiol & Immunol, Sch Med, Davis, CA 95616 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; California State University System; California State University Los Angeles; University of California System; University of California Davis	Spencer, JD (corresponding author), Nationwide Childrens Hosp, Pediat Nephrol Fellowship Program, Columbus, OH USA.	andrew.schwaderer@nationwidechildrens.org	Bevins, Charles L/P-4438-2015; Hains, David/E-3186-2011; Hains, David/AAR-1112-2020; Becknell, Michael/E-6995-2014; Schwaderer, Andrew/E-4049-2011; Wang, Huanyu/W-3145-2019	Bevins, Charles L/0000-0003-2725-2622; Wang, Huanyu/0000-0002-5982-6371; Hains, David/0000-0001-6511-9561	Research Institute at Nationwide Children's Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738] Funding Source: NIH RePORTER	Research Institute at Nationwide Children's Hospital(Ohio State University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JDS received intramural support from The Research Institute at Nationwide Children's Hospital. No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Bevins CL, 2006, BIOCHEM SOC T, V34, P263, DOI 10.1042/BST0340263; CARONE FA, 1982, J LAB CLIN MED, V100, P1; Chon CH, 2001, PEDIATR CLIN N AM, V48, P1441, DOI 10.1016/S0031-3955(05)70385-0; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Com E, 2003, BIOL REPROD, V68, P95, DOI 10.1095/biolreprod.102.005389; Cunliffe RN, 2003, MOL IMMUNOL, V40, P463, DOI 10.1016/S0161-5890(03)00157-3; Dugan AS, 2008, J BIOL CHEM, V283, P31125, DOI 10.1074/jbc.M805902200; Ganz T, 2001, Semin Respir Infect, V16, P4; Ganz T, 2001, J INFECT DIS, V183, pS41, DOI 10.1086/318838; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Gropp R, 1999, HUM GENE THER, V10, P957, DOI 10.1089/10430349950018355; Hiratsuka T, 2000, NEPHRON, V85, P34, DOI 10.1159/000045627; Lehmann J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-20; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Liu LD, 1997, GENOMICS, V43, P316, DOI 10.1006/geno.1997.4801; LIVOLSI VA, 1993, CANCER, V71, P1391, DOI 10.1002/1097-0142(19930215)71:4<1391::AID-CNCR2820710434>3.0.CO;2-X; Malagolini N, 1997, KIDNEY INT, V52, P1340, DOI 10.1038/ki.1997.459; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Nitschke M, 2002, EXP NEPHROL, V10, P332, DOI 10.1159/000065296; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Porter EM, 1998, FEBS LETT, V434, P272, DOI 10.1016/S0014-5793(98)00994-6; Quayle AJ, 2002, J REPROD IMMUNOL, V57, P61, DOI 10.1016/S0165-0378(02)00019-0; Quayle AJ, 1998, AM J PATHOL, V152, P1247; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shen B, 2005, J CLIN PATHOL, V58, P687, DOI 10.1136/jcp.2004.022426; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Spencer JD, 2011, KIDNEY INT; Tikhonov I, 1997, NEPHROL DIAL TRANSPL, V12, P2557, DOI 10.1093/ndt/12.12.2557; Townes CL, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.08.019; VALORE EV, 1992, BLOOD, V79, P1538; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Wang AP, 2010, AFR J MICROBIOL RES, V4, P626; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2006, FEBS LETT, V580, P5344, DOI 10.1016/j.febslet.2006.08.083; Weichhart T, 2008, EUR J CLIN INVEST, V38, P29, DOI 10.1111/j.1365-2362.2008.02006.x; Zasloff M, 2007, J AM SOC NEPHROL, V18, P2810, DOI 10.1681/ASN.2007050611; Zhang Dai, 2009, Zhonghua Fu Chan Ke Za Zhi, V44, P13	41	54	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31712	10.1371/journal.pone.0031712	http://dx.doi.org/10.1371/journal.pone.0031712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359618	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200087
J	Xie, L; Luo, CL; Zhang, CG; Zhang, R; Tang, J; Nie, QH; Ma, L; Hu, XX; Li, N; Da, Y; Zhang, XQ				Xie, Liang; Luo, Chenglong; Zhang, Chengguang; Zhang, Rong; Tang, Jun; Nie, Qinghua; Ma, Li; Hu, Xiaoxiang; Li, Ning; Da, Yang; Zhang, Xiquan			Genome-Wide Association Study Identified a Narrow Chromosome 1 Region Associated with Chicken Growth Traits	PLOS ONE			English	Article							ABDOMINAL FAT WEIGHT; BODY-WEIGHT; QUANTITATIVE TRAITS; F-2 INTERCROSS; LOCI; EXPRESSION; GENES; FOXO1; QTL; PREDICTION	Chicken growth traits are important economic traits in broilers. A large number of studies are available on finding genetic factors affecting chicken growth. However, most of these studies identified chromosome regions containing putative quantitative trait loci and finding causal mutations is still a challenge. In this genome-wide association study (GWAS), we identified a narrow 1.5 Mb region (173.5-175 Mb) of chicken (Gallus gallus) chromosome (GGA) 1 to be strongly associated with chicken growth using 47,678 SNPs and 489 F2 chickens. The growth traits included aggregate body weight (BW) at 0-90 d of age measured weekly, biweekly average daily gains (ADG) derived from weekly body weight, and breast muscle weight (BMW), leg muscle weight (LMW) and wing weight (WW) at 90 d of age. Five SNPs in the 1.5 Mb KPNA3-FOXO1A region at GGA1 had the highest significant effects for all growth traits in this study, including a SNP at 8.9 Kb upstream of FOXO1A for BW at 22-48 d and 70 d, a SNP at 1.9 Kb downstream of FOXO1A for WW, a SNP at 20.9 Kb downstream of ENSGALG00000022732 for ADG at 29-42 d, a SNP in INTS6 for BW at 90 d, and a SNP in KPNA3 for BMW and LMW. The 1.5 Mb KPNA3-FOXO1A region contained two microRNA genes that could bind to messenger ribonucleic acid (mRNA) of IGF1, FOXO1A and KPNA3. It was further indicated that the 1.5 Mb GGA1 region had the strongest effects on chicken growth during 22-42 d.	[Xie, Liang; Luo, Chenglong; Zhang, Chengguang; Zhang, Rong; Tang, Jun; Nie, Qinghua; Zhang, Xiquan] Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China; [Ma, Li; Da, Yang] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA; [Luo, Chenglong] State Key Lab Livestock & Poultry Breeding, Guangzhou, Guangdong, Peoples R China; [Xie, Liang] Hainan Acad Agr Sci, Inst Anim Sci & Vet, Haikou, Hainan, Peoples R China; [Hu, Xiaoxiang; Li, Ning] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; China Agricultural University	Xie, L (corresponding author), Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China.	yda@umn.edu; xqzhang@scau.edu.cn	ma, li/C-1585-2014; Ma, Li/B-1844-2010		National High Technology Research and Development Program of China (863 Program) [2006AA10A120, 2010AA10A102];  [CARS-42-G05]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); 	This research was supported by funding for China Agriculture Research System (CARS-42-G05) and by the National High Technology Research and Development Program of China (863 Program), projects 2006AA10A120 and 2010AA10A102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambo M, 2009, ANIM GENET, V40, P200, DOI 10.1111/j.1365-2052.2008.01824.x; Ankra-Badu GA, 2010, ANIM GENET, V41, P400, DOI 10.1111/j.1365-2052.2009.02017.x; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Atzmon G, 2006, ANIM GENET, V37, P352, DOI 10.1111/j.1365-2052.2006.01487.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Besnier F, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-3; Carlborg O, 2003, GENOME RES, V13, P413, DOI 10.1101/gr.528003; Cho JE, 2010, J APPL PHYSIOL, V108, P137, DOI 10.1152/japplphysiol.00704.2009; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Ensembl Genome Browser, 2011, ENSEMBL RELEASE 63; Gao Y, 2006, ANIM GENET, V37, P276, DOI 10.1111/j.1365-2052.2006.01428.x; Gao Y, 2009, ANIM GENET, V40, P952, DOI 10.1111/j.1365-2052.2009.01911.x; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Groenen M, 2009, PLANT AN GEN 17 C TO; Gu XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021872; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hu ZL, 2010, 9 WORLD C GEN APPL L; IBM Research, 2001, RNA22 MICRORNA TARG; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lagarrigue S, 2006, GENET SEL EVOL, V38, P85, DOI 10.1051/gse:2005028; Le Rouzic A, 2008, GENETICS, V179, P1591, DOI 10.1534/genetics.108.089300; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Lei MM, 2005, POULTRY SCI, V84, P1191, DOI 10.1093/ps/84.8.1191; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu X, 2008, POULTRY SCI, V87, P1314, DOI 10.3382/ps.2007-00512; Liu X, 2007, POULTRY SCI, V86, P1084, DOI 10.1093/ps/86.6.1084; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Mao YC, 2006, PHYSIOL GENOMICS, V28, P46, DOI 10.1152/physiolgenomics.00096.2006; Marklund S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-665; Minitab Inc, 2011, MIN 16; National Center for Biotechnology Information, 2011, ENTR GEN; Rao Y, 2007, GENET SEL EVOL, V39, P569, DOI 10.1051/gse:2007022; Sewalem A, 2002, POULTRY SCI, V81, P1775, DOI 10.1093/ps/81.12.1775; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Southgate RJ, 2007, J BIOL CHEM, V282, P21176, DOI 10.1074/jbc.M702039200; Uemoto Y, 2009, POULTRY SCI, V88, P477, DOI 10.3382/ps.2008-00296; Wahlberg P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-248; WANG S, 2011, SNPEVG GRAPHICAL TOO; Whitehead Institute for Biomedical Research, 2011, TARGETSCAN REL 5 2; Yuan YA, 2011, MOL CELL BIOCHEM, V348, P77, DOI 10.1007/s11010-010-0640-1; Zavadil J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012362; Zhou H, 2007, POULTRY SCI, V86, P255, DOI 10.3382/ps.2007-00267	49	86	100	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30910	10.1371/journal.pone.0030910	http://dx.doi.org/10.1371/journal.pone.0030910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359555	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200024
J	Bourlier, V; Sengenes, C; Zakaroff-Girard, A; Decaunes, P; Wdziekonski, B; Galitzky, J; Villageois, P; Esteve, D; Chiotasso, P; Dani, C; Bouloumie, A				Bourlier, Virginie; Sengenes, Coralie; Zakaroff-Girard, Alexia; Decaunes, Pauline; Wdziekonski, Brigitte; Galitzky, Jean; Villageois, Phi; Esteve, David; Chiotasso, Patrick; Dani, Christian; Bouloumie, Anne			TGFbeta Family Members Are Key Mediators in the Induction of Myofibroblast Phenotype of Human Adipose Tissue Progenitor Cells by Macrophages	PLOS ONE			English	Article							INSULIN-RESISTANCE; HUMAN OBESITY; CHRONIC INFLAMMATION; GENE-EXPRESSION; TGF-BETA; FIBROSIS; INFILTRATION; ACTIVATION; MECHANISMS; MATRIX	Objective: The present study was undertaken to characterize the remodeling phenotype of human adipose tissue (AT) macrophages (ATM) and to analyze their paracrine effects on AT progenitor cells. Research Design and Methods: The phenotype of ATM, immunoselected from subcutaneous (Sc) AT originating from subjects with wide range of body mass index and from paired biopsies of Sc and omental (Om) AT from obese subjects, was studied by gene expression analysis in the native and activated states. The paracrine effects of ScATM on the phenotype of human ScAT progenitor cells (CD34(+)CD31(-)) were investigated. Results: Two main ATM phenotypes were distinguished based on gene expression profiles. For ScAT-derived ATM, obesity and adipocyte-derived factors favored a pro-fibrotic/remodeling phenotype whereas the OmAT location and hypoxic culture conditions favored a pro-angiogenic phenotype. Treatment of native human ScAT progenitor cells with ScATM-conditioned media induced the appearance of myofibroblast-like cells as shown by expression of both alpha-SMA and the transcription factor SNAIL, an effect mimicked by TGF beta 1 and activinA. Immunohistochemical analyses showed the presence of double positive alpha-SMA and CD34 cells in the stroma of human ScAT. Moreover, the mRNA levels of SNAIL and SLUG in ScAT progenitor cells were higher in obese compared with lean subjects. Conclusions: Human ATM exhibit distinct pro-angiogenic and matrix remodeling/fibrotic phenotypes according to the adiposity and the location of AT, that may be related to AT microenvironment including hypoxia and adipokines. Moreover, human ScAT progenitor cells have been identified as target cells for ScATM-derived TGF beta and as a potential source of fibrosis through their induction of myofibroblast-like cells.	[Bourlier, Virginie; Sengenes, Coralie; Zakaroff-Girard, Alexia; Decaunes, Pauline; Galitzky, Jean; Esteve, David; Bouloumie, Anne] Univ Toulouse 3, UMR1048, INSERM, Inst Malad Metabol & Cardiovasc I2MC, F-31062 Toulouse, France; [Wdziekonski, Brigitte; Villageois, Phi; Dani, Christian] Univ Nice Sophia Antipolis, Fac Med, CNRS, UMR6543, Nice, France; [Chiotasso, Patrick] Hop Purpan, Serv Chirurg Digest, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CHU de Toulouse	Bourlier, V (corresponding author), Univ Toulouse 3, UMR1048, INSERM, Inst Malad Metabol & Cardiovasc I2MC, F-31062 Toulouse, France.	virginie.bourlier@inserm.fr	Galitzky, Jean/R-6599-2017; DANI, Christian/G-3639-2014; Bouloumie-Diehl, Anne/M-4446-2017; Sengenes, Coralie/GSN-0709-2022	DANI, Christian/0000-0003-3228-0230; Bouloumie-Diehl, Anne/0000-0001-5496-8891; Sengenes, Coralie/0000-0002-4820-6660; BOURLIER, Virginie/0000-0003-2407-6408	INSERM; ALFEDIAM/Roche Diagnostic; European Union Commission [HEALTH-F2-2008-2011 00]; Clarins SA	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ALFEDIAM/Roche Diagnostic; European Union Commission(European Commission); Clarins SA	This work was supported by INSERM, a grant from ALFEDIAM/Roche Diagnostic, the European Union Commission (Collaborative Project ADAPT (www.adapt-eu.net), Contract No. HEALTH-F2-2008-2011 00) and Clarins SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Duffaut C, 2009, ARTERIOSCL THROM VAS, V29, P1608, DOI 10.1161/ATVBAHA.109.192583; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Sivakumar P, 2008, INFLAMM RES, V57, P410, DOI 10.1007/s00011-008-7166-y; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Villaret A, 2010, DIABETES, V59, P2755, DOI 10.2337/db10-0398; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	38	56	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31274	10.1371/journal.pone.0031274	http://dx.doi.org/10.1371/journal.pone.0031274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355352	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300052
J	Mei, H; Chen, W; Jiang, F; He, J; Srinivasan, S; Smith, EN; Schork, N; Murray, S; Berenson, GS				Mei, Hao; Chen, Wei; Jiang, Fan; He, Jiang; Srinivasan, Sathanur; Smith, Erin N.; Schork, Nicholas; Murray, Sarah; Berenson, Gerald S.			Longitudinal Replication Studies of GWAS Risk SNPs Influencing Body Mass Index over the Course of Childhood and Adulthood	PLOS ONE			English	Article							OBESITY; VARIANTS; LOCI; DISEASES; BOGALUSA; WEIGHT; BIRTH; GENE; FTO	Genome-wide association studies (GWAS) have identified multiple common variants associated with body mass index (BMI). In this study, we tested 23 genotyped GWAS-significant SNPs (p-value<5*10-8) for longitudinal associations with BMI during childhood (3-17 years) and adulthood (18-45 years) for 658 subjects. We also proposed a heuristic forward search for the best joint effect model to explain the longitudinal BMI variation. After using false discovery rate (FDR) to adjust for multiple tests, childhood and adulthood BMI were found to be significantly associated with six SNPs each (q-value<0.05), with one SNP associated with both BMI measurements: KCTD15 rs29941 (q-value<7.6*10-4). These 12 SNPs are located at or near genes either expressed in the brain (BDNF, KCTD15, TMEM18, MTCH2, and FTO) or implicated in cell apoptosis and proliferation (FAIM2, MAP2K5, and TFAP2B). The longitudinal effects of FAIM2 rs7138803 on childhood BMI and MAP2K5 rs2241423 on adulthood BMI decreased as age increased (q-value<0.05). The FTO candidate SNPs, rs6499640 at the 5'-end and rs1121980 and rs8050136 downstream, were associated with childhood and adulthood BMI, respectively, and the risk effects of rs6499640 and rs1121980 increased as birth weight decreased. The best joint effect model for childhood and adulthood BMI contained 14 and 15 SNPs each, with 11 in common, and the percentage of explained variance increased from 0.17% and 9.0*10(-6)% to 2.22% and 2.71%, respectively. In summary, this study evidenced the presence of long-term major effects of genes on obesity development, implicated in pathways related to neural development and cell metabolism, and different sets of genes associated with childhood and adulthood BMI, respectively. The gene effects can vary with age and be modified by prenatal development. The best joint effect model indicated that multiple variants with effects that are weak or absent alone can nevertheless jointly exert a large longitudinal effect on BMI.	[Mei, Hao; He, Jiang] Tulane Univ, Dept Epidemiol, New Orleans, LA 70118 USA; [Chen, Wei; Srinivasan, Sathanur; Berenson, Gerald S.] Tulane Univ, Tulane Ctr Cardiovasc Hlth, New Orleans, LA 70118 USA; [Jiang, Fan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China; [Smith, Erin N.] Univ Calif San Diego, Sch Med, Dept Pediat & Radys, La Jolla, CA 92093 USA; [Schork, Nicholas; Murray, Sarah] Scripps Genom Med & Scripps Translat Sci Inst, La Jolla, CA USA	Tulane University; Tulane University; Shanghai Jiao Tong University; University of California System; University of California San Diego	Mei, H (corresponding author), Tulane Univ, Dept Epidemiol, New Orleans, LA 70118 USA.	berenson@tulane.edu	He, Jiang/AAF-5303-2020; Jiang, Fan/AGX-9052-2022; Jiang, Fan/AHA-6297-2022; Smith, Erin/E-5933-2011	He, Jiang/0000-0002-8286-9652; Jiang, Fan/0000-0003-0634-101X; Schork, Nicholas/0000-0003-0920-5013	National Institute of Child Health and Human Development [HD-061437, HD-062783]; National Institute on Aging [AG-16592]; National Institutes of Health/National Center for Research Resources [UL1 RR025774]; NHLBI [U01HL072507, R01HL087263, R01HL090682]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD061437, R03HD062783] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087263, U01HL072507, R01HL090682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants HD-061437 and HD-062783 from the National Institute of Child Health and Human Development, AG-16592 from the National Institute on Aging and in part by National Institutes of Health/National Center for Research Resources Grant UL1 RR025774 and NHLBI research grants (U01HL072507, R01HL087263, and R01HL090682). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berenson GS, 1995, AM J MED SCI, V310, pS133, DOI 10.1097/00000441-199512000-00024; Berenson GS., 1980, CARDIOVASCULAR RISK; Broyles S, 2010, PEDIATRICS, V125, P900, DOI 10.1542/peds.2009-2748; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; FABSITZ RR, 1992, INT J OBESITY, V16, P657; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gauderman W, QUANTO 1 1 COMPUTER; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hindorff LA, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; Jurvansuu J, 2008, CANCER RES, V68, P4614, DOI 10.1158/0008-5472.CAN-07-5291; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Mei H, 2010, HUM GENET, V128, P589, DOI 10.1007/s00439-010-0883-7; Parsons TJ, 2001, BRIT MED J, V323, P1331, DOI 10.1136/bmj.323.7325.1331; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Webber LS, 1995, AM J MED SCI, V310, pS53, DOI 10.1097/00000441-199512000-00010; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Williamson JA, 1996, GENOMICS, V35, P262, DOI 10.1006/geno.1996.0351; Yerushalmi GM, 2002, NEOPLASIA, V4, P510, DOI 10.1038/sj.neo.7900272; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	36	45	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31470	10.1371/journal.pone.0031470	http://dx.doi.org/10.1371/journal.pone.0031470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355368	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300068
J	Shome, S; Dasgupta, PS; Basu, S				Shome, Saurav; Dasgupta, Partha Sarathi; Basu, Sujit			Dopamine Regulates Mobilization of Mesenchymal Stem Cells during Wound Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MARROW STROMAL CELLS; BONE-MARROW; PROGENITOR CELLS; VASCULAR-PERMEABILITY; ADIPOSE-TISSUE; IN-VIVO; DIABETIC MICE; TUMOR-GROWTH; MIGRATION	Angiogenesis is an important step in the complex biological and molecular events leading to successful healing of dermal wounds. Among the different cellular effectors of wound angiogenesis, the role of mesenchymal stem cells (MSCs) is of current interest due to their transdifferentiation and proangiogenic potentials. Skin is richly innervated by sympathetic nerves which secrete dopamine (DA) and we have recently shown that concentration of DA present in synaptic cleft can significantly inhibit wound tissue neovascularization. As recent reports indicate that MSCs by mobilizing into wound bed play an important role in promoting wound angiogenesis, we therefore investigated the effect of DA on the migration of MSCs in wound tissues. DA acted through its D-2 receptors present in the MSCs to inhibit their mobilization to the wound beds by suppressing Akt phosphorylation and actin polymerization. In contrast, this inhibitory effect of DA was reversed after treatment with specific DA D-2 receptor antagonist. Increased mobilization of MSCs was demonstrated in the wound site following blockade of DA D-2 receptor mediated actions, and this in turn was associated with significantly more angiogenesis in wound tissues. This study is of translational value and indicates use of DA D-2 receptor antagonists to stimulate mobilization of these stem cells for faster regeneration of damaged tissues.	[Shome, Saurav; Dasgupta, Partha Sarathi] Chittaranjan Natl Canc Inst, Dept Signal Transduct & Biogen Amines, Kolkata, W Bengal, India; [Basu, Sujit] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Basu, Sujit] Ohio State Univ, Dorthy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Basu, Sujit] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Shome, S (corresponding author), Chittaranjan Natl Canc Inst, Dept Signal Transduct & Biogen Amines, Kolkata, W Bengal, India.	partha42002@yahoo.com; sujit.basu@osumc.edu			DRDO (Defence Research and Development Organisation, Government of India) [DLS/81/48222/LSRB-117/ID/2006]; National Institutes of Health, USA [R01-CA124763]; CSIR (Council of Scientific and Industrial Research, Government of India) [9/30(54)/2009-EMR-1]; NATIONAL CANCER INSTITUTE [R01CA124763] Funding Source: NIH RePORTER	DRDO (Defence Research and Development Organisation, Government of India)(Defence Research & Development Organisation (DRDO)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSIR (Council of Scientific and Industrial Research, Government of India)(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by DRDO (Defence Research and Development Organisation, Government of India) Grants DLS/81/48222/LSRB-117/ID/2006 to Dr. Dasgupta and National Institutes of Health, USA R01-CA124763 to Dr. Basu; CSIR (Council of Scientific and Industrial Research, Government of India) Pre-doctoral Fellowship 9/30(54)/2009-EMR-1 (Dr. Shome). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bartunek J, 2007, AM J PHYSIOL-HEART C, V292, pH1095, DOI 10.1152/ajpheart.01009.2005; Basu S, 2004, CANCER RES, V64, P5551, DOI 10.1158/0008-5472.CAN-04-1600; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Berthoud HR, 2006, AM J PHYSIOL-REG I, V291, pR1240, DOI 10.1152/ajpregu.00428.2006; Busletta C, 2011, STEM CELLS, V29, P952, DOI 10.1002/stem.642; Chakroborty D, 2008, J CLIN INVEST, V118, P1380, DOI 10.1172/JCI33125; Chiou WF, 2007, LIFE SCI, V81, P109, DOI 10.1016/j.lfs.2007.04.028; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Edelberg JM, 2002, CIRC RES, V90, pE89, DOI 10.1161/01.RES.0000020861.20064.7E; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; EWING AG, 1983, SCIENCE, V221, P169, DOI 10.1126/science.6857277; Ferrari A, 2001, J BIOMED MATER RES, V56, P361, DOI 10.1002/1097-4636(20010905)56:3<361::AID-JBM1104>3.0.CO;2-4; Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Ganguly S, 2010, AM J PATHOL, V177, P2701, DOI 10.2353/ajpath.2010.100617; Gruber R, 2005, TISSUE ENG, V11, P896, DOI 10.1089/ten.2005.11.896; He QL, 2007, STEM CELLS, V25, P69, DOI 10.1634/stemcells.2006-0335; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Javazon EH, 2007, WOUND REPAIR REGEN, V15, P350, DOI 10.1111/j.1524-475X.2007.00237.x; Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432; Lau K, 2009, EXP DERMATOL, V18, P921, DOI 10.1111/j.1600-0625.2009.00942.x; Lee SH, 2010, AM J PHYSIOL-CELL PH, V298, pC847, DOI 10.1152/ajpcell.00418.2009; Li LR, 2011, CELL BIOL INT, V35, P961, DOI 10.1042/CBI20100544; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Liu LZ, 2011, STEM CELLS DEV, V20, P1961, DOI 10.1089/scd.2010.0453; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Ma J, 2007, HAEMATOLOGICA, V92, P889, DOI 10.3324/haematol.11106; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Nissen NN, 1998, AM J PATHOL, V152, P1445; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ritter E, 2008, ANN SURG, V247, P310, DOI 10.1097/SLA.0b013e31816401d5; Romijn JA, 2005, CURR OPIN CLIN NUTR, V8, P440, DOI 10.1097/01.mco.0000172586.09762.55; Rubi B, 2010, ENDOCRINOLOGY, V151, P5570, DOI 10.1210/en.2010-0745; Rustad KC, 2012, BIOMATERIALS, V33, P80, DOI 10.1016/j.biomaterials.2011.09.041; Ryu CH, 2010, BIOCHEM BIOPH RES CO, V398, P105, DOI 10.1016/j.bbrc.2010.06.043; Sarkar C, 2004, AM J PHYSIOL-HEART C, V287, pH1554, DOI 10.1152/ajpheart.00272.2004; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191; Seiffert K, 2008, NEUROIMMUNOLOGY SKIN, P65; Shi EY, 2007, ANN THORAC SURG, V83, P1484, DOI 10.1016/j.athoracsur.2006.11.048; Shiota M, 2007, EXP CELL RES, V313, P1008, DOI 10.1016/j.yexcr.2006.12.017; Shome S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025215; Sorrell JM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt30; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Vargovic P, 2011, FEBS LETT, V585, P2279, DOI 10.1016/j.febslet.2011.06.001; Wang CH, 2008, ARTERIOSCL THROM VAS, V28, P54, DOI 10.1161/ATVBAHA.107.147256; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420	60	28	32	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31682	10.1371/journal.pone.0031682	http://dx.doi.org/10.1371/journal.pone.0031682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355389	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300089
J	Yeh, CB; Hsieh, MJ; Hsieh, YH; Chien, MH; Chiou, HL; Yang, SF				Yeh, Chao-Bin; Hsieh, Ming-Ju; Hsieh, Yi-Hsien; Chien, Ming-Hsien; Chiou, Hui-Ling; Yang, Shun-Fa			Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity	PLOS ONE			English	Article							LUNG-CANCER CELLS; TERMINALIA-CATAPPA L.; HUMAN HEPATOMA-CELLS; SIGNALING PATHWAYS; DOWN-REGULATION; ORAL-CANCER; KAPPA-B; ANTICANCER ACTIVITY; IN-VITRO; INVASION	Background: The rate of morbidity and mortality of hepatocellular carcinoma (HCC) in Taiwan has not lessened because of difficulty in treating tumor metastasis. Norcantharidin (NCTD) is currently used as an anticancer drug for hepatoma, breast cancer, and colorectal adenocarcinoma. NCTD possesses various biological anticancer activities, including apoptosis. However, detailed effects and molecular mechanisms of NCTD on metastasis are unclear. Thus, HCC cells were subjected to treatment with NCTD and then analyzed to determine the effects of NCTD on cell metastasis. Methodology/Principal Findings: Modified Boyden chamber assays revealed that NCTD treatment inhibited cell migration and invasion capacities of HCC cells substantially. Results of zymography and western blotting showed that activities and protein levels of matrix metalloproteinase-9 (MMP-9) and urokinase plasminogen activator (u-PA) were inhibited by NCTD. Western blot analysis showed that NCTD inhibits phosphorylation of ERK1/2. Testing of mRNA level, quantitative real-time PCR, and promoter assays evaluated the inhibitory effects of NCTD on MMP-9 and u-PA expression in HCC cells. The chromatin immunoprecipitation (ChIP) assay for analyzing the genomic DNA sequences bound to these proteins was reactive to the transcription protein nuclear factor (NF)-kappaB, which was inhibited by NCTD. The expression of NF-kappa B was measured by western blot analysis, which revealed decreased nuclear-factor DNA-binding activity after NCTD treatment. Conclusions: NCTD inhibited MMP-9 and u-PA expression through the phosphorylation of ERK1/2 and NF-kappaB signaling pathway which serves as a powerful chemopreventive agent in HCC cell metastasis.	[Yeh, Chao-Bin] Chung Shan Med Univ, Sch Med, Dept Emergency Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Hsieh, Ming-Ju; Chiou, Hui-Ling] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Yeh, CB (corresponding author), Chung Shan Med Univ, Sch Med, Dept Emergency Med, Taichung, Taiwan.	hlchiou@csmu.edu.tw; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234; Yeh, Chao-Bin/0000-0002-3978-5576	Chung Shan Medical University Hospital, Taiwan [CSH-2011-C-001]	Chung Shan Medical University Hospital, Taiwan	This study was supported by a research grant from Chung Shan Medical University Hospital, Taiwan (CSH-2011-C-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; An W, 2004, J KOREAN MED SCI, V19, P560, DOI 10.3346/jkms.2004.19.4.560; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang C, 2011, MOL BIOL REP, V38, P163, DOI 10.1007/s11033-010-0090-6; Chang C, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-145; Chen PN, 2005, CHEM-BIOL INTERACT, V156, P141, DOI 10.1016/j.cbi.2005.08.005; Chen YJ, 2005, ANTI-CANCER DRUG, V16, P293, DOI 10.1097/00001813-200503000-00008; Chen YN, 2002, INT J CANCER, V100, P158, DOI 10.1002/ijc.10479; Chen YN, 2003, BRIT J PHARMACOL, V140, P461, DOI 10.1038/sj.bjp.0705461; Chen YJ, 2008, ANTI-CANCER DRUG, V19, P55, DOI 10.1097/CAD.0b013e3282f18826; Chen YJ, 2009, CHEM-BIOL INTERACT, V181, P440, DOI 10.1016/j.cbi.2009.07.004; Chu SC, 2004, MOL CARCINOGEN, V40, P143, DOI 10.1002/mc.20018; Chu SC, 2007, FOOD CHEM TOXICOL, V45, P1194, DOI 10.1016/j.fct.2006.12.028; Cimmino F, 2011, J NEUROONCOL    0707; Fan YZ, 2007, HEPATOB PANCREAT DIS, V6, P72; Fang Y., 1993, Yaoxue Xuebao, V28, P931; Ghiso JAA, 1999, EUR J BIOCHEM, V263, P295, DOI 10.1046/j.1432-1327.1999.00507.x; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Hill TA, 2008, CHEMMEDCHEM, V3, P1878, DOI 10.1002/cmdc.200800192; Hsiao YC, 2007, CHEM-BIOL INTERACT, V167, P193, DOI 10.1016/j.cbi.2007.02.012; Huang Y, 2009, CYTOTECHNOLOGY, V59, P201, DOI [10.1007/s10616-009-9210-3, 10.1007/s10616-009-9221-0]; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Liao HF, 2011, TOXICOL IN VITRO, V25, P206, DOI 10.1016/j.tiv.2010.11.001; Luan JL, 2010, CYTOTECHNOLOGY, V62, P349, DOI 10.1007/s10616-009-9250-8; Ma Y, 2011, CANCER LETT, V301, P75, DOI 10.1016/j.canlet.2010.10.022; McCluskey A, 2001, ANTI-CANCER DRUG DES, V16, P291; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagendraprabhu P, 2011, INVEST NEW DRUG, V29, P207, DOI 10.1007/s10637-009-9342-5; Peng F, 2002, J CANCER RES CLIN, V128, P223, DOI 10.1007/S00432-002-0326-5; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Sliva D, 2004, CURR CANCER DRUG TAR, V4, P327, DOI 10.2174/1568009043332961; Takada Y, 2004, J BIOL CHEM, V279, P15096, DOI 10.1074/jbc.M311192200; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Wang ZD, 2010, ONCOL REP, V23, P413, DOI 10.3892/or_00000650; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Weng CJ, 2009, J AGR FOOD CHEM, V57, P5049, DOI 10.1021/jf900828k; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Yang HY, 2007, ANTI-CANCER DRUG, V18, P1133, DOI 10.1097/CAD.0b013e3282eeb1c5; Yang PY, 2011, TOXICOL IN VITRO, V25, P699, DOI 10.1016/j.tiv.2011.01.011; Yang PY, 2010, TOXICOL IN VITRO, V24, P766, DOI 10.1016/j.tiv.2009.12.025; Yang SF, 2008, J DENT RES, V87, P401, DOI 10.1177/154405910808700413; Yang SF, 2007, J ETHNOPHARMACOL, V110, P483, DOI 10.1016/j.jep.2006.10.010; Yang SF, 2008, ARCH ORAL BIOL, V53, P287, DOI 10.1016/j.archoralbio.2007.09.001; Yang SF, 2010, J BIOL CHEM, V285, P29808, DOI 10.1074/jbc.M110.108183; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yeh CB, 2010, EUR J MED CHEM, V45, P3981, DOI 10.1016/j.ejmech.2010.05.053	47	97	105	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31055	10.1371/journal.pone.0031055	http://dx.doi.org/10.1371/journal.pone.0031055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22363545	Green Published, gold, Green Submitted			2022-12-25	WOS:000302180600026
J	Geczy, T; Peach, ML; El Kazzouli, S; Sigano, DM; Kang, JH; Valle, CJ; Selezneva, J; Woo, W; Kedei, N; Lewin, NE; Garfield, SH; Lim, L; Mannan, P; Marquez, VE; Blumberg, PM				Geczy, Tamas; Peach, Megan L.; El Kazzouli, Said; Sigano, Dina M.; Kang, Ji-Hye; Valle, Christopher J.; Selezneva, Julia; Woo, Wonhee; Kedei, Noemi; Lewin, Nancy E.; Garfield, Susan H.; Lim, Langston; Mannan, Poonam; Marquez, Victor E.; Blumberg, Peter M.			Molecular Basis for Failure of "Atypical" C1 Domain of Vav1 to Bind Diacylglycerol/Phorbol Ester	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CONFORMATIONALLY CONSTRAINED ANALOGS; DROSOPHILA-MELANOGASTER HOMOLOG; SIGNAL TRANSDUCER PROTEIN; SITE-DIRECTED MUTAGENESIS; CYSTEINE-RICH DOMAINS; PHORBOL ESTER; BIOLOGICAL-ACTIVITIES; HUMAN MALIGNANCIES; CRYSTAL-STRUCTURE	C1 domains, the recognition motif of the second messenger diacylglycerol and of the phorbol esters, are classified as typical (ligand-responsive) or atypical (not ligand-responsive). The C1 domain of Vav1, a guanine nucleotide exchange factor, plays a critical role in regulation of Vav activity through stabilization of the Dbl homology domain, which is responsible for exchange activity of Vav. Although the C1 domain of Vav1 is classified as atypical, it retains a binding pocket geometry homologous to that of the typical C1 domains of PKCs. This study clarifies the basis for its failure to bind ligands. Substituting Vav1-specific residues into the C1b domain of PKC delta, we identified five crucial residues (Glu(9), Glu(10), Thr(11), Thr(24), and Tyr(26)) along the rim of the binding cleft that weaken binding potency in a cumulative fashion. Reciprocally, replacing these incompatible residues in the Vav1 C1 domain with the corresponding residues from PKC delta C1b (delta C1b) conferred high potency for phorbol ester binding. Computer modeling predicts that these unique residues in Vav1 increase the hydrophilicity of the rim of the binding pocket, impairing membrane association and thereby preventing formation of the ternary C1-ligand-membrane binding complex. The initial design of diacylglycerol-lactones to exploit these Vav1 unique residues showed enhanced selectivity for C1 domains incorporating these residues, suggesting a strategy for the development of ligands targeting Vav1.	[Geczy, Tamas; Valle, Christopher J.; Selezneva, Julia; Woo, Wonhee; Kedei, Noemi; Lewin, Nancy E.; Blumberg, Peter M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Garfield, Susan H.; Lim, Langston; Mannan, Poonam] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [El Kazzouli, Said; Sigano, Dina M.; Kang, Ji-Hye; Marquez, Victor E.] NCI, Biol Chem Lab, Mol Discovery Program, Ctr Canc Res,NIH, Ft Detrick, MD 21702 USA; [Peach, Megan L.] NCI, Basic Res Program, SAIC Frederick, NIH, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Blumberg, PM (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bldg 37,Rm 4048,37 Convent Dr,MSC 4255, Bethesda, MD 20892 USA.	blumberp@dc37a.nci.nih.gov	Sigano, Dina/M-6144-2014; Marquez, Victor/AAP-3549-2021	Sigano, Dina/0000-0001-7489-9555; Geczy, Tamas/0000-0002-8199-8831; Peach, Megan/0000-0002-4290-5268	National Institutes of Health from NCI [Z1A BC 005270]; NATIONAL CANCER INSTITUTE [ZICBC010858, ZICBC010639, ZIABC005270] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Project Z1A BC 005270 from the Intramural Research Program, NCI.	AHMED S, 1991, BIOCHEM J, V280, P233, DOI 10.1042/bj2800233; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Booden MA, 2002, MOL CELL BIOL, V22, P2487, DOI 10.1128/MCB.22.8.2487-2497.2002; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chen J, 2008, BIOCHEM J, V411, P333, DOI 10.1042/BJ20071334; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Chrencik JE, 2008, J MOL BIOL, V380, P828, DOI 10.1016/j.jmb.2008.05.024; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Dekel I, 2000, FEBS LETT, V472, P99, DOI 10.1016/S0014-5793(00)01413-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Duan D, 2008, J MED CHEM, V51, P5198, DOI 10.1021/jm8001907; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; El Kazzouli S, 2008, J MED CHEM, V51, P5371, DOI 10.1021/jm800380b; Farah CA, 2008, MOL CELL BIOL, V28, P4719, DOI 10.1128/MCB.00178-08; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; FURET P, 1988, J MOL GRAPHICS, V6, P182, DOI 10.1016/S0263-7855(98)80001-5; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; GULBINS E, 1994, MOL CELL BIOL, V14, P4749, DOI 10.1128/MCB.14.7.4749; HEIDEN W, 1993, J COMPUT AID MOL DES, V7, P503, DOI 10.1007/BF00124359; HENSKE EP, 1995, ANN HUM GENET, V59, P25, DOI 10.1111/j.1469-1809.1995.tb01603.x; Heo J, 2005, BIOCHEMISTRY-US, V44, P6573, DOI 10.1021/bi047443q; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Hornstein I, 2003, ONCOGENE, V22, P6774, DOI 10.1038/sj.onc.1207027; Hurley JH, 1997, PROTEIN SCI, V6, P477; Irie K, 2005, CHEM REC, V5, P185, DOI 10.1002/tcr.20044; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Katzav S, 2007, CANCER LETT, V255, P241, DOI 10.1016/j.canlet.2007.04.015; Katzav S, 2009, INT J BIOCHEM CELL B, V41, P1245, DOI 10.1016/j.biocel.2008.11.006; KAZANIETZ MG, 1994, J BIOL CHEM, V269, P11590; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lewin Nancy E, 2003, Methods Mol Biol, V233, P129; Marquez VE, 2003, ACCOUNTS CHEM RES, V36, P434, DOI 10.1021/ar020124b; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; Miller JM, 2010, MOL PHARMACEUT, V7, P1223, DOI 10.1021/mp100050d; Movilla N, 2001, ONCOGENE, V20, P8057, DOI 10.1038/sj.onc.1205000; Movilla N, 1999, MOL CELL BIOL, V19, P7870; NEUBERT R, 1989, PHARMACEUT RES, V6, P743, DOI 10.1023/A:1015963128124; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Norman KR, 2005, CELL, V123, P119, DOI 10.1016/j.cell.2005.08.001; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Pak Y, 2001, J MED CHEM, V44, P1690, DOI 10.1021/jm000488e; Pellecchia M, 2004, CURR PHARM DESIGN, V10, P1371, DOI 10.2174/1381612043384907; Prieto-Sanchez RM, 2006, BRIT J HAEMATOL, V133, P642, DOI 10.1111/j.1365-2141.2006.06094.x; Pu YM, 2005, J BIOL CHEM, V280, P27329, DOI 10.1074/jbc.M414132200; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Raifman O, 2010, CHEMBIOCHEM, V11, P2003, DOI 10.1002/cbic.201000343; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schrodinger LLC, 2010, MACROMODEL VERS 9 8; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Steinkellner G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-32; Stewart MD, 2011, J MOL BIOL, V408, P949, DOI 10.1016/j.jmb.2011.03.020; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Wang QMJ, 2001, J BIOL CHEM, V276, P19580, DOI 10.1074/jbc.M010089200; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	69	14	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13137	13158		10.1074/jbc.M111.320010	http://dx.doi.org/10.1074/jbc.M111.320010			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351766	Green Published, hybrid			2022-12-25	WOS:000302903700053
J	Peters-Klimm, F; Laux, G; Campbell, S; Muller-Tasch, T; Lossnitzer, N; Schultz, JH; Remppis, A; Junger, J; Nikendei, C				Peters-Klimm, Frank; Laux, Gunter; Campbell, Stephen; Mueller-Tasch, Thomas; Lossnitzer, Nicole; Schultz, Jobst-Hendrik; Remppis, Andrew; Juenger, Jana; Nikendei, Christoph			Physician and Patient Predictors of Evidence-Based Prescribing in Heart Failure: A Multilevel Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CLINICAL-PRACTICE; PRIMARY-CARE; GENERAL-PRACTICE; EDUCATIONAL INTERVENTION; EFFECTIVE MANAGEMENT; SELF-ASSESSMENT; BEHAVIOR-CHANGE; EUROPEAN SURVEY; GUIDELINES	Background: The management of patients with heart failure (HF) needs to account for changeable and complex individual clinical characteristics. The use of renin angiotensin system inhibitors (RAAS-I) to target doses is recommended by guidelines. But physicians seemingly do not sufficiently follow this recommendation, while little is known about the physician and patient predictors of adherence. Methods: To examine the coherence of primary care (PC) physicians' knowledge and self-perceived competencies regarding RAAS-I with their respective prescribing behavior being related to patient-associated barriers. Cross-sectional follow-up study after a randomized medical educational intervention trial with a seven month observation period. PC physicians (n = 37) and patients with systolic HF (n = 168) from practices in Baden-Wuerttemberg. Measurements were knowledge (blueprint-based multiple choice test), self-perceived competencies (questionnaire on global confidence in the therapy and on frequency of use of RAAS-I), and patient variables (age, gender, NYHA functional status, blood pressure, potassium level, renal function). Prescribing was collected from the trials' documentation. The target variable consisted of >= 50% of recommended RAAS-I dosage being investigated by two-level logistic regression models. Results: Patients (69% male, mean age 68.8 years) showed symptomatic and objectified left ventricular (NYHA II vs. III/IV: 51% vs. 49% and mean LVEF 33.3%) and renal (GFR < 50%: 22%) impairment. Mean percentage of RAAS-I target dose was 47%, 59% of patients receiving >= 50%. Determinants of improved prescribing of RAAS-I were patient age (OR 0.95, CI 0.92-0.99, p = 0.01), physician's global self-confidence at follow-up (OR 1.09, CI 1.02-1.05, p = 0.01) and NYHA class (II vs. III/IV) (OR 0.63, CI 0.38-1.05, p = 0.08). Conclusions: A change in physician's confidence as a predictor of RAAS-I dose increase is a new finding that might reflect an intervention effect of improved physicians' intention and that might foster novel strategies to improve safe evidence-based prescribing. These should include targeting knowledge, attitudes and skills.	[Peters-Klimm, Frank; Laux, Gunter; Campbell, Stephen] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Baden Wurttemberg, Germany; [Mueller-Tasch, Thomas; Lossnitzer, Nicole; Schultz, Jobst-Hendrik; Juenger, Jana; Nikendei, Christoph] Univ Heidelberg Hosp, Dept Psychosomat & Gen Internal Med, Baden Wurttemberg, Germany; [Remppis, Andrew] Univ Heidelberg Hosp, Dept Cardiol & Pneumol, Baden Wurttemberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Peters-Klimm, F (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Baden Wurttemberg, Germany.	frank.peters-klimm@med.uni-heidelberg.de	Laux, Gunter/AAL-9020-2021	Campbell, Stephen/0000-0002-2328-4136; Schultz, Jobst-Hendrik/0000-0001-9433-3970	German Ministry of Education and Research (BMBF) [01GI0205]; Competence Network of Heart Failure	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Competence Network of Heart Failure	No current external funding sources for this study. The corresponding parental trial was funded by the German Ministry of Education and Research (BMBF), grant no. 01GI0205 (http://www.gesundheitsforschung-bmbf.de/de/350.php) and by the Competence Network of Heart Failure (www.knhi.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Abraham C, 2009, PSYCHOL HEALTH MED, V14, P1, DOI 10.1080/13548500802537903; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cleland JGF, 2002, LANCET, V360, P1631, DOI 10.1016/S0140-6736(02)11601-1; Cleland JGF, 2002, HEART, V88, P5; Cochrane LJ, 2007, J CONTIN EDUC HEALTH, V27, P94, DOI 10.1002/chp.106; de Groote P, 2007, EUR J HEART FAIL, V9, P1205, DOI 10.1016/j.ejheart.2007.09.008; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Eva KW, 2005, ACAD MED, V80, pS46, DOI 10.1097/00001888-200510001-00015; Fuat A, 2003, BRIT MED J, V326, P196, DOI 10.1136/bmj.326.7382.196; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Hickling JA, 2001, BRIT J GEN PRACT, V51, P615; Hoppe UC, 2005, Z KARDIOL, V94, P488, DOI 10.1007/s00392-005-0268-4; Hoppe UC, 2001, Z KARDIOL, V90, P218, DOI 10.1007/s003920170187; Hudon C, 2005, J CLIN EPIDEMIOL, V58, P603, DOI 10.1016/j.jclinepi.2004.10.017; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kasje Willeke N, 2005, BMC Fam Pract, V6, P19, DOI 10.1186/1471-2296-6-19; Kasje WN, 2005, EUR J CLIN PHARMACOL, V61, P145, DOI 10.1007/s00228-005-0897-6; Kern D, 1998, CURRICULUM DEV MED E; Khunti K, 2002, EUR J HEART FAIL, V4, P771, DOI 10.1016/S1388-9842(02)00119-8; Komajda M, 2005, EUR HEART J, V26, P1653, DOI 10.1093/eurheartj/ehi251; Komajda M, 2003, EUR HEART J, V24, P464, DOI 10.1016/S0195-668X(02)00700-5; Koschack J, 2009, INT J CLIN PRACT, V63, P226, DOI 10.1111/j.1742-1241.2008.01937.x; Lenzen MJ, 2005, EUR HEART J, V26, P2706, DOI 10.1093/eurheartj/ehi499; Leopold SS, 2005, J BONE JOINT SURG AM, V87A, P1031, DOI 10.2106/JBJS.D.02434; LUKE DR, 1990, CLIN PHARMACOL THER, V48, P503, DOI 10.1038/clpt.1990.186; McCoubrie P, 2004, MED TEACH, V26, P709, DOI 10.1080/01421590400013495; McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Moret L, 2004, AM J INFECT CONTROL, V32, P384, DOI 10.1016/j.ajic.2004.02.004; Muth C, 2006, HEART FAILURE CLIN P; Peters-Klimm F, 2008, CLIN RES CARDIOL, V97, P244, DOI 10.1007/s00392-007-0617-6; Peters-Klimm F, 2008, J EVAL CLIN PRACT, V14, P823, DOI 10.1111/j.1365-2753.2008.01060.x; Peters-Klimm F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-68; Phillips SM, 2004, MED J AUSTRALIA, V181, P78, DOI 10.5694/j.1326-5377.2004.tb06178.x; Robertson N, 1996, QUAL HEALTH CARE, V5, P51, DOI 10.1136/qshc.5.1.51; Rutten FH, 2003, EUR J HEART FAIL, V5, P337, DOI 10.1016/S1388-9842(03)00050-3; Shaw B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470; Sinha S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008522; Skinner EA, 1996, J PERS SOC PSYCHOL, V71, P549, DOI 10.1037/0022-3514.71.3.549; Sturm HB, 2007, PHARMACOEPIDEM DR S, V16, P96, DOI 10.1002/pds.1216; Sturm HB, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-57; Sturm HB, 2006, EUR J HEART FAIL, V8, P31, DOI 10.1016/j.ejheart.2005.03.010; Swedberg K, 2005, EUR HEART J SUPPL, V7, pJ21, DOI 10.1093/eurheartj/sui059; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; van Weel C, 2006, LANCET, V367, P550, DOI 10.1016/S0140-6736(06)68198-1; VANLEEUWEN YD, 1995, FAM PRACT, V12, P313, DOI 10.1093/fampra/12.3.313; Walker AE, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-22	50	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31082	10.1371/journal.pone.0031082	http://dx.doi.org/10.1371/journal.pone.0031082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363553	Green Submitted, gold, Green Published			2022-12-25	WOS:000302873700024
J	Kearney, MF; Spindler, J; Wiegand, A; Shao, W; Anderson, EM; Maldarelli, F; Ruscetti, FW; Mellors, JW; Hughes, SH; Le Grice, SFJ; Coffin, JM				Kearney, Mary F.; Spindler, Jonathan; Wiegand, Ann; Shao, Wei; Anderson, Elizabeth M.; Maldarelli, Frank; Ruscetti, Francis W.; Mellors, John W.; Hughes, Steve H.; Le Grice, Stuart F. J.; Coffin, John M.			Multiple Sources of Contamination in Samples from Patients Reported to Have XMRV Infection	PLOS ONE			English	Article							VIRUS-RELATED VIRUS; CHRONIC-FATIGUE-SYNDROME; RETROVIRUS XMRV; BLOOD-CELLS; MOUSE DNA; LEUKEMIA	Xenotropic murine leukemia virus (MLV)-related retrovirus (XMRV) was reported to be associated with prostate cancer by Urisman, et al. in 2006 and chronic fatigue syndrome (CFS) by Lombardi, et al. in 2009. To investigate this association, we independently evaluated plasma samples from 4 patients with CFS reported by Lombardi, et al. to have XMRV infection and from 5 healthy controls reported to be XMRV uninfected. We also analyzed viral sequences obtained from supernatants of cell cultures found to contain XMRV after coculture with 9 clinical samples from 8 patients. A qPCR assay capable of distinguishing XMRV from endogenous MLVs showed that the viral sequences detected in the CFS patient plasma behaved like endogenous MLVs and not XMRV. Single-genome sequences (N = 89) from CFS patient plasma were indistinguishable from endogenous MLVs found in the mouse genome that are distinct from XMRV. By contrast, XMRV sequences were detected by qPCR in 2 of the 5 plasma samples from healthy controls (sequencing of the qPCR product confirmed XMRV not MLV). Single-genome sequences (N = 234) from the 9 culture supernatants reportedly positive for XMRV were indistinguishable from XMRV sequences obtained from 22Rv1 and XMRV-contaminated 293T cell-lines. These results indicate that MLV DNA detected in the plasma samples from CFS patients evaluated in this study was from contaminating mouse genomic DNA and that XMRV detected in plasma samples from healthy controls and in cultures of patient samples was due to cross-contamination with XMRV (virus or nucleic acid).	[Kearney, Mary F.; Spindler, Jonathan; Wiegand, Ann; Anderson, Elizabeth M.; Maldarelli, Frank; Hughes, Steve H.; Le Grice, Stuart F. J.] NCI, HIV Drug Resistance Program, Frederick, MD 21701 USA; [Shao, Wei] SAIC, Adv Biomed Comp Ctr, Frederick, MD USA; [Ruscetti, Francis W.] NCI, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21701 USA; [Mellors, John W.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Coffin, John M.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tufts University	Kearney, MF (corresponding author), NCI, HIV Drug Resistance Program, Frederick, MD 21701 USA.	kearneym@mail.nih.gov	Maldarelli, Frank/O-2428-2016; Kearney, Mary/AAU-8132-2020	Kearney, Mary/0000-0003-3839-6576	FM Kirby Foundation; National Cancer Institute; National Cancer Institute (SAIC) [25XS119]; NATIONAL CANCER INSTITUTE [ZIABC010494, ZIABC010252] Funding Source: NIH RePORTER	FM Kirby Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute (SAIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Coffin was a Research Professor of the American Cancer Society, with support from the FM Kirby Foundation. Funding for this research was provided by the Intramural Research Program of the National Cancer Institute. Dr. Mellors was supported by a contract from the National Cancer Institute (SAIC contract 25XS119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cornelissen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012040; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017592; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; FRANKEL WN, 1990, GENETICS, V124, P221; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; Gray ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018096; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hohn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015632; Huber BT, 2010, RETROVIROLOGY, V7; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Kearney MF, 2011, ADV VIROL, V2011, DOI 10.1155/2011/272193; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Knox K, 2011, SCIENCE; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Mikovits JA, 2010, VIRULENCE, V1, P386, DOI 10.4161/viru.1.5.12486; Mikovits JA, 2010, AIDS REV, V12, P149; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Paprotka T, 2011, SCIENCE; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Sfanos KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020874; Shin CH, 2011, J VIROLOGY; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Stang A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-86; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Zhang YA, 2011, CANC BIOL THERAPY, V12	33	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30889	10.1371/journal.pone.0030889	http://dx.doi.org/10.1371/journal.pone.0030889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363509	Green Accepted, Green Published, gold			2022-12-25	WOS:000302871500020
J	Higgins, MF; Russell, NE; Crossey, PA; Nyhan, KC; Brazil, DP; McAuliffe, FM				Higgins, Mary F.; Russell, Noirin E.; Crossey, Paul A.; Nyhan, Kristine C.; Brazil, Derek P.; McAuliffe, Fionnuala M.			Maternal and Fetal Placental Growth Hormone and IGF Axis in Type 1 Diabetic Pregnancy	PLOS ONE			English	Article							FACTOR-I; INSULIN REQUIREMENTS; BINDING-PROTEIN; VARIANT GENE; WOMEN; EXPRESSION; SERUM; HYPOGLYCEMIA; MACROSOMIA; MELLITUS	Aim: Placental growth hormone (PGH) is a major growth hormone in pregnancy and acts with Insulin Like Growth Factor I (IGF-I) and Insulin Like Growth Hormone Binding Protein 3 (IGFBP3). The aim of this study was to investigate PGH, IGF-I and IGFBP3 in non-diabetic (ND) compared to Type 1 Diabetic (T1DM) pregnancies. Methods: This is a prospective study. Maternal samples were obtained from 25 ND and 25 T1DM mothers at 36 weeks gestation. Cord blood was obtained after delivery. PGH, IGF-I and IGFBP3 were measured using ELISA. Results: There was no difference in delivery type, gender of infants or birth weight between groups. In T1DM, maternal PGH significantly correlated with ultrasound estimated fetal weight (r = 0.4, p = 0.02), birth weight (r = 0.51, p<0.05) and birth weight centile (r = 0.41, p = 0.03) PGH did not correlate with HbA1c. Maternal IGF-I was lower in T1DM (p = 0.03). Maternal and fetal serum IGFBP3 was higher in T1DM. Maternal third trimester T1DM serum had a significant band at 16 kD on western blot, which was not present in ND. Conclusion: Maternal T1DM PGH correlated with both antenatal fetal weight and birth weight, suggesting a significant role for PGH in growth in diabetic pregnancy. IGFBP3 is significantly increased in maternal and fetal serum in T1DM pregnancies compared to ND controls, which was explained by increased proteolysis in maternal but not fetal serum. These results suggest that the normal PGH-IGF-I-IGFBP3 axis in pregnancy is abnormal in T1DM pregnancies, which are at higher risk of macrosomia.	[Higgins, Mary F.; Russell, Noirin E.; McAuliffe, Fionnuala M.] Univ Coll Dublin, Natl Matern Hosp, Sch Med & Med Sci, UCD Obstet & Gynaecol, Dublin 2, Ireland; [Higgins, Mary F.; Crossey, Paul A.; Nyhan, Kristine C.; McAuliffe, Fionnuala M.] Univ Coll Dublin, Inst Biomol & Biomed Res, UCD Conway, Dublin 2, Ireland; [Brazil, Derek P.] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland	National Maternity Hospital, Dublin; University College Dublin; University College Dublin; Queens University Belfast	Higgins, MF (corresponding author), Univ Coll Dublin, Natl Matern Hosp, Sch Med & Med Sci, UCD Obstet & Gynaecol, Dublin 2, Ireland.	Fionnuala.mcauliffe@ucd.ie		Higgins, Mary/0000-0002-6469-5169; Russell, Noirin/0000-0002-2759-3294; Brazil, Derek/0000-0003-1375-1076	Health Research Board Ireland	Health Research Board Ireland	This study was funded by Health Research Board Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsat E, 1998, MOL CELL ENDOCRINOL, V140, P121, DOI 10.1016/S0303-7207(98)00040-9; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Barbour LA, 2004, ENDOCRINOLOGY, V145, P1144, DOI 10.1210/en.2003-1297; BERK MA, 1989, PEDIATRICS, V83, P1029; Bjorklund AO, 1998, BRIT J OBSTET GYNAEC, V105, P649, DOI 10.1111/j.1471-0528.1998.tb10180.x; Confidential Enquiry into Maternal and Child Health, 2005, PREGN WOM TYP 1 TYP; COOKE NE, 1988, J CLIN INVEST, V82, P270, DOI 10.1172/JCI113582; Corrigan N, 2009, BIRTH DEFECTS RES A, V85, P523, DOI 10.1002/bdra.20567; Diabet Control Complications Trial Res Grp, 1996, AM J OBSTET GYNECOL, V174, P1343; DiPiro J, 1989, GYNAECOLOGIC DISORDE; ERIKSSON T, 1989, J PSYCHIAT RES, V23, P241, DOI 10.1016/0022-3956(89)90029-0; FRANKENNE F, 1988, J CLIN ENDOCR METAB, V66, P1171, DOI 10.1210/jcem-66-6-1171; Fuglsang J, 2008, HORM METAB RES, V40, P189, DOI 10.1055/s-2007-1004575; Fuglsang J, 2005, GROWTH HORM IGF RES, V15, P223, DOI 10.1016/j.ghir.2005.03.004; Fuglsang J, 2003, J CLIN ENDOCR METAB, V88, P4355, DOI 10.1210/jc.2003-030726; GULER HP, 1989, ACTA ENDOCRINOL-COP, V121, P753, DOI 10.1530/acta.0.1210753; Higgins M, 2010, CURR DIABETES REV, V6, P116, DOI 10.2174/157339910790909431; Higgins MF, 2008, EUR J OBSTET GYN R B, V140, P43, DOI 10.1016/j.ejogrb.2008.02.021; Holmes RP, 1999, HUM REPROD, V14, P1879, DOI 10.1093/humrep/14.7.1879; Hu LM, 1999, MOL CELL ENDOCRINOL, V157, P131, DOI 10.1016/S0303-7207(99)00152-5; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Langer O, 2000, CLIN OBSTET GYNECOL, V43, P283, DOI 10.1097/00003081-200006000-00006; Liu YJ, 1996, ENDOCR J, V43, P221, DOI 10.1507/endocrj.43.221; McIntyre HD, 2000, J CLIN ENDOCR METAB, V85, P1143, DOI 10.1210/jc.85.3.1143; McIntyre HD, 2002, HORM METAB RES, V34, P250; MIRLESSE V, 1993, PEDIATR RES, V34, P439, DOI 10.1203/00006450-199310000-00011; Mittal P, 2007, J MATERN-FETAL NEO M, V20, P651, DOI 10.1080/14767050701463571; Nielsen LR, 2008, DIABETIC MED, V25, P826, DOI 10.1111/j.1464-5491.2008.02495.x; Russell NE, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.016; SARA VR, 1990, PHYSIOL REV, V70, P591, DOI 10.1152/physrev.1990.70.3.591; SELDEN RF, 1988, P NATL ACAD SCI USA, V85, P8241, DOI 10.1073/pnas.85.21.8241; TAN K, 1986, J CLIN ENDOCR METAB, V63, P651, DOI 10.1210/jcem-63-3-651; WHITTAKER PG, 1990, OBSTET GYNECOL, V76, P223; Yamashita H, 2000, CLIN OBSTET GYNECOL, V43, P87, DOI 10.1097/00003081-200003000-00009	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e29164	10.1371/journal.pone.0029164	http://dx.doi.org/10.1371/journal.pone.0029164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363400	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600004
J	Niechwiej-Szwedo, E; Goltz, HC; Chandrakumar, M; Wong, AMF				Niechwiej-Szwedo, Ewa; Goltz, Herbert C.; Chandrakumar, Manokaraananthan; Wong, Agnes M. F.			The Effect of Sensory Uncertainty Due to Amblyopia (Lazy Eye) on the Planning and Execution of Visually-Guided 3D Reaching Movements	PLOS ONE			English	Article							BINOCULAR VISION; ONLINE CONTROL; MOTOR CONTROL; SPATIAL LOCALIZATION; MACAQUE MONKEYS; DEFICITS; HUMANS; HAND; CUES; INFORMATION	Background: Impairment of spatiotemporal visual processing in amblyopia has been studied extensively, but its effects on visuomotor tasks have rarely been examined. Here, we investigate how visual deficits in amblyopia affect motor planning and online control of visually-guided, unconstrained reaching movements. Methods: Thirteen patients with mild amblyopia, 13 with severe amblyopia and 13 visually-normal participants were recruited. Participants reached and touched a visual target during binocular and monocular viewing. Motor planning was assessed by examining spatial variability of the trajectory at 50-100 ms after movement onset. Online control was assessed by examining the endpoint variability and by calculating the coefficient of determination (R-2) which correlates the spatial position of the limb during the movement to endpoint position. Results: Patients with amblyopia had reduced precision of the motor plan in all viewing conditions as evidenced by increased variability of the reach early in the trajectory. Endpoint precision was comparable between patients with mild amblyopia and control participants. Patients with severe amblyopia had reduced endpoint precision along azimuth and elevation during amblyopic eye viewing only, and along the depth axis in all viewing conditions. In addition, they had significantly higher R-2 values at 70% of movement time along the elevation and depth axes during amblyopic eye viewing. Conclusion: Sensory uncertainty due to amblyopia leads to reduced precision of the motor plan. The ability to implement online corrections depends on the severity of the visual deficit, viewing condition, and the axis of the reaching movement. Patients with mild amblyopia used online control effectively to compensate for the reduced precision of the motor plan. In contrast, patients with severe amblyopia were not able to use online control as effectively to amend the limb trajectory especially along the depth axis, which could be due to their abnormal stereopsis.	[Niechwiej-Szwedo, Ewa; Goltz, Herbert C.; Chandrakumar, Manokaraananthan; Wong, Agnes M. F.] Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON M5G 1X8, Canada; [Goltz, Herbert C.; Wong, Agnes M. F.] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Niechwiej-Szwedo, E (corresponding author), Hosp Sick Children, Dept Ophthalmol & Vis Sci, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	agnes.wong@sickkids.ca	Chandrakumar, Manokaraananthan/AHD-0133-2022	Goltz, Herbert/0000-0002-6496-754X	Canadian Institutes of Health Research (CIHR) [MOP 106663]; Canadian Foundation for Innovation (CFI); Department of Ophthalmology and Vision Sciences and Research Training Centre at The Hospital for Sick Children	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Department of Ophthalmology and Vision Sciences and Research Training Centre at The Hospital for Sick Children	Supported by grant MOP 106663 from the Canadian Institutes of Health Research (CIHR), Leaders Opportunity Fund from the Canadian Foundation for Innovation (CFI), and the Department of Ophthalmology and Vision Sciences and Research Training Centre at The Hospital for Sick Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apker GA, 2010, J NEUROPHYSIOL, V104, P2654, DOI 10.1152/jn.00590.2010; Barnes GR, 2001, J PHYSIOL-LONDON, V533, P281, DOI 10.1111/j.1469-7793.2001.0281b.x; Barrett BT, 2003, INVEST OPHTH VIS SCI, V44, P1555, DOI 10.1167/iovs.02-0515; Battaglia PW, 2007, J NEUROSCI, V27, P6984, DOI 10.1523/JNEUROSCI.1309-07.2007; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; BEDELL HE, 1985, INVEST OPHTH VIS SCI, V26, P909; BEDELL HE, 1983, AM J OPTOM PHYS OPT, V60, P426; Bernstein N.A., 1967, COORDINATION REGULAT; Bonneh YS, 2007, VISION RES, V47, P1950, DOI 10.1016/j.visres.2007.02.015; Bradshaw MF, 2004, SPATIAL VISION, V17, P95, DOI 10.1163/156856804322778288; Bradshaw MF, 2003, SPATIAL VISION, V16, P295, DOI 10.1163/156856803322467545; Brenner E, 2006, EXP BRAIN RES, V170, P302, DOI 10.1007/s00221-005-0213-9; Brenner E, 2000, VISION RES, V40, P1649, DOI 10.1016/S0042-6989(00)00062-6; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; CONTI P, 1980, PERCEPT MOTOR SKILL, V50, P239, DOI 10.2466/pms.1980.50.1.239; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; Danckert J, 2001, EXP BRAIN RES, V137, P303; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Desmurget M, 1998, NEUROSCI BIOBEHAV R, V22, P761, DOI 10.1016/S0149-7634(98)00004-9; DESMURGET M, 1995, CAN J PHYSIOL PHARM, V73, P262, DOI 10.1139/y95-037; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; El-Shamayleh Y, 2010, J NEUROSCI, V30, P12198, DOI 10.1523/JNEUROSCI.3055-10.2010; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; FRISEN L, 1975, INVEST OPHTH VISUAL, V14, P528; FRONIUS M, 1994, VISION RES, V34, P689, DOI 10.1016/0042-6989(94)90022-1; FRONIUS M, 1989, INVEST OPHTH VIS SCI, V30, P2034; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GORDON J, 1987, EXP BRAIN RES, V67, P253, DOI 10.1007/BF00248547; Grant S, 2007, INVEST OPHTH VIS SCI, V48, P1139, DOI 10.1167/iovs.06-0976; Grant S, 2011, STRABISMUS, V19, P119, DOI 10.3109/09273972.2011.600423; Greenwald HS, 2009, VISUAL NEUROSCI, V26, P63, DOI 10.1017/S0952523808080668; Greenwald HS, 2005, VISION RES, V45, P1975, DOI 10.1016/j.visres.2005.01.025; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Heath M, 2005, MOTOR CONTROL, V9, P281, DOI 10.1123/mcj.9.3.281; Heath M, 2008, MOTOR CONTROL, V12, P252, DOI 10.1123/mcj.12.3.252; Hess RF, 1999, VISION RES, V39, P901, DOI 10.1016/S0042-6989(98)00157-6; HESS RF, 1992, VISION RES, V32, P1319, DOI 10.1016/0042-6989(92)90225-8; HESS RF, 1985, VISION RES, V25, P1577, DOI 10.1016/0042-6989(85)90128-2; Hess RF, 2010, OPTOMETRY VISION SCI, V87, P697, DOI 10.1097/OPX.0b013e3181ea18e9; Hess RF, 2009, EUR J NEUROSCI, V29, P1064, DOI 10.1111/j.1460-9568.2009.06650.x; Hillis JM, 2004, J VISION, V4, P967, DOI 10.1167/4.12.1; Ho CS, 2005, VISION RES, V45, P1615, DOI 10.1016/j.visres.2004.12.009; Hrisos S, 2006, BRIT J OPHTHALMOL, V90, P836, DOI 10.1136/bjo.2006.090910; Hu B, 2011, J VISION, V11, DOI 10.1167/11.7.23; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Khan MA, 2005, EXP BRAIN RES, V164, P395, DOI 10.1007/s00221-005-2325-7; Khan MA, 2006, NEUROSCI BIOBEHAV R, V30, P1106, DOI 10.1016/j.neubiorev.2006.05.002; Kiorpes L, 1998, J NEUROSCI, V18, P6411; Kiorpes L, 2006, STRABISMUS, V14, P3, DOI 10.1080/09273970500536193; Knill DC, 2011, J NEUROSCI, V31, P1219, DOI 10.1523/JNEUROSCI.3522-09.2011; Knill DC, 2005, J VISION, V5, P103, DOI 10.1167/5.2.2; Knill DC, 2004, J NEUROPHYSIOL, V91, P1350, DOI 10.1152/jn.00184.2003; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Krigolson A, 2006, EXP BRAIN RES, V170, P127, DOI 10.1007/s00221-006-0386-x; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Levi DM, 2006, STRABISMUS, V14, P11, DOI 10.1080/09273970500536243; LEVI DM, 1994, VISION RES, V34, P3293, DOI 10.1016/0042-6989(94)90066-3; LEVI DM, 1983, VISION RES, V23, P1005, DOI 10.1016/0042-6989(83)90011-1; Loftus A, 2004, EXP BRAIN RES, V158, P317, DOI 10.1007/s00221-004-1905-2; Mansouri B, 2009, INVEST OPHTH VIS SCI, V50, P3218, DOI 10.1167/iovs.08-2914; McIntyre J, 1998, J NEUROSCI, V18, P8423, DOI 10.1523/JNEUROSCI.18-20-08423.1998; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Melmoth DR, 2006, EXP BRAIN RES, V171, P371, DOI 10.1007/s00221-005-0273-x; Melmoth DR, 2009, INVEST OPHTH VIS SCI, V50, P3711, DOI 10.1167/iovs.08-3229; MERIGAN WH, 1990, VISION RES, V30, P985, DOI 10.1016/0042-6989(90)90107-V; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; Mirabella G, 2011, ARCH OPHTHALMOL-CHIC, V129, P176, DOI 10.1001/archophthalmol.2010.354; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; MOVSHON JA, 1987, J NEUROSCI, V7, P1340; Neely KA, 2008, EXP BRAIN RES, V186, P375, DOI 10.1007/s00221-007-1238-z; Niechwiej-Szwedo E, 2011, INVEST OPHTH VIS SCI, V52, P795, DOI 10.1167/iovs.10-6092; O'Connor AR, 2010, OPTOMETRY VISION SCI, V87, P942, DOI 10.1097/OPX.0b013e3181fd132e; O'Connor AR, 2009, INVEST OPHTH VIS SCI, V51, P2019; Popple AV, 2008, J VISION, V8, DOI 10.1167/8.13.12; Redon C, 2005, NEUROREPORT, V16, P2065, DOI 10.1097/00001756-200512190-00020; ROSSETTI Y, 1994, EXP BRAIN RES, V101, P323, DOI 10.1007/BF00228753; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; SERVOS P, 1994, EXP BRAIN RES, V98, P119; Servos P, 1998, EXP BRAIN RES, V119, P92, DOI 10.1007/s002210050323; Sharma V, 2000, NAT NEUROSCI, V3, P496, DOI 10.1038/74872; Simmers AJ, 2006, VISION RES, V46, P2571, DOI 10.1016/j.visres.2006.01.009; Simmers AJ, 2003, VISION RES, V43, P729, DOI 10.1016/S0042-6989(02)00684-3; Sireteanu R, 2007, STRABISMUS, V15, P45, DOI 10.1080/09273970601180263; Snyder LH, 2000, CURR OPIN NEUROBIOL, V10, P747, DOI 10.1016/S0959-4388(00)00152-5; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Suttle CM, 2011, INVEST OPHTH VIS SCI, V52, P1851, DOI 10.1167/iovs.10-6341; Thiel A, 2009, VISION RES, V49, P287, DOI 10.1016/j.visres.2008.08.005; Trommershauser J, 2005, J NEUROSCI, V25, P7169, DOI 10.1523/JNEUROSCI.1906-05.2005; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302; Webber AL, 2008, INVEST OPHTH VIS SCI, V49, P594, DOI 10.1167/iovs.07-0869; Webber AL, 2009, OPTOMETRY VISION SCI, V86, P760, DOI 10.1097/OPX.0b013e3181a523b7; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wolpert DM, 2007, HUM MOVEMENT SCI, V26, P511, DOI 10.1016/j.humov.2007.05.005; Woo GC, 1991, CLIN EXP OPTOM, V74, P1	99	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31075	10.1371/journal.pone.0031075	http://dx.doi.org/10.1371/journal.pone.0031075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363549	Green Published, gold			2022-12-25	WOS:000302853600106
J	Wang, Q; Bolhuis, J; Rothkopf, CA; Kolling, T; Knopf, M; Triesch, J				Wang, Quan; Bolhuis, Jantina; Rothkopf, Constantin A.; Kolling, Thorsten; Knopf, Monika; Triesch, Jochen			Infants in Control: Rapid Anticipation of Action Outcomes in a Gaze-Contingent Paradigm	PLOS ONE			English	Article							PERCEPTION; CATEGORIES; ATTENTION	Infants' poor motor abilities limit their interaction with their environment and render studying infant cognition notoriously difficult. Exceptions are eye movements, which reach high accuracy early, but generally do not allow manipulation of the physical environment. In this study, real-time eye tracking is used to put 6- and 8-month-old infants in direct control of their visual surroundings to study the fundamental problem of discovery of agency, i.e. the ability to infer that certain sensory events are caused by one's own actions. We demonstrate that infants quickly learn to perform eye movements to trigger the appearance of new stimuli and that they anticipate the consequences of their actions in as few as 3 trials. Our findings show that infants can rapidly discover new ways of controlling their environment. We suggest that gaze-contingent paradigms offer effective new ways for studying many aspects of infant learning and cognition in an interactive fashion and provide new opportunities for behavioral training and treatment in infants.	[Wang, Quan; Rothkopf, Constantin A.; Triesch, Jochen] Frankfurt Inst Adv Studies, Frankfurt, Germany; [Bolhuis, Jantina; Kolling, Thorsten; Knopf, Monika] Goethe Univ Frankfurt, Dept Psychol, Frankfurt, Germany	Goethe University Frankfurt	Wang, Q (corresponding author), Frankfurt Inst Adv Studies, Frankfurt, Germany.	triesch@fias.uni-frankfurt.de	Kolling, Thorsten/AAN-9694-2020	Wang, Quan/0000-0003-4826-2408; Rothkopf, Constantin/0000-0002-5636-0801	Bundesministerium fur Bildung und Forschung [FKZ 01GQ0840]; European Union [IM-CLeVeR, FP7-ICT-IP-231722]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by the Bundesministerium fur Bildung und Forschung (http://www.bmbf.de/) project "Bernstein Focus: Neurotechnology Frankfurt, FKZ 01GQ0840" and by the European Union (http://ec.europa.eu/research/fp7/) under grant IM-CLeVeR, FP7-ICT-IP-231722. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APGAR V, 1953, Curr Res Anesth Analg, V32, P260; BRONSON GW, 1990, J EXP CHILD PSYCHOL, V49, P101, DOI 10.1016/0022-0965(90)90051-9; COHEN LB, 1972, CHILD DEV, V43, P869, DOI 10.2307/1127638; Csibra G, 1999, COGNITION, V72, P237, DOI 10.1016/S0010-0277(99)00039-6; Deligianni F, 2011, DEV PSYCHOL, V47, P1499, DOI 10.1037/a0025659; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; HAITH MM, 1988, CHILD DEV, V59, P467, DOI 10.2307/1130325; HOROWITZ FD, 1972, DEV PSYCHOL, V7, P90, DOI 10.1037/h0032855; JOHNSON MH, 1991, J COGNITIVE NEUROSCI, V3, P335, DOI 10.1162/jocn.1991.3.4.335; Johnson SP, 2003, P NATL ACAD SCI USA, V100, P10568, DOI 10.1073/pnas.1630655100; Johnson S, 1998, DEVELOPMENTAL SCI, V1, P233, DOI 10.1111/1467-7687.00036; KALNINS IV, 1973, PERCEPTION, V2, P307, DOI 10.1068/p020307; Kenward B, 2010, INFANCY, V15, P337, DOI 10.1111/j.1532-7078.2009.00018.x; McMurray B, 2004, INFANCY, V6, P203, DOI 10.1207/s15327078in0602_4; QUINN PC, 1993, PERCEPTION, V22, P463, DOI 10.1068/p220463; Reader SM, 1973, BEHAV RES METH INSTR, V5, P218; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; ROVEECOLLIER CK, 1980, SCIENCE, V208, P1159, DOI 10.1126/science.7375924; Smith WC, 2003, COGNITIVE PSYCHOL, V46, P31, DOI 10.1016/S0010-0285(02)00501-7; Wass S, 2011, CURR BIOL, V21, P1543, DOI 10.1016/j.cub.2011.08.004	21	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30884	10.1371/journal.pone.0030884	http://dx.doi.org/10.1371/journal.pone.0030884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363507	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600082
J	Ng, CA; Perry, MD; Tan, PS; Hill, AP; Kuchel, PW; Vandenberg, JI				Chai Ann Ng; Perry, Matthew D.; Tan, Peter S.; Hill, Adam P.; Kuchel, Philip W.; Vandenberg, Jamie I.			The S4-S5 Linker Acts as a Signal Integrator for hERG K+ Channel Activation and Deactivation Gating	PLOS ONE			English	Article							AMINO-TERMINAL DOMAIN; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; XENOPUS OOCYTES; VOLTAGE SENSOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MOLECULAR-BASIS; N-TERMINUS; INACTIVATION	Human ether-a-go-go-related gene (hERG) K+ channels have unusual gating kinetics. Characterised by slow activation/deactivation but rapid inactivation/recovery from inactivation, the unique gating kinetics underlie the central role hERG channels play in cardiac repolarisation. The slow activation and deactivation kinetics are regulated in part by the S4-S5 linker, which couples movement of the voltage sensor domain to opening of the activation gate at the distal end of the inner helix of the pore domain. It has also been suggested that cytosolic domains may interact with the S4-S5 linker to regulate activation and deactivation kinetics. Here, we show that the solution structure of a peptide corresponding to the S4-S5 linker of hERG contains an amphipathic helix. The effects of mutations at the majority of residues in the S4-S5 linker of hERG were consistent with the previously identified role in coupling voltage sensor movement to the activation gate. However, mutations to Ser543, Tyr545, Gly546 and Ala548 had more complex phenotypes indicating that these residues are involved in additional interactions. We propose a model in which the S4-S5 linker, in addition to coupling VSD movement to the activation gate, also contributes to interactions that stabilise the closed state and a separate set of interactions that stabilise the open state. The S4-S5 linker therefore acts as a signal integrator and plays a crucial role in the slow deactivation kinetics of the channel.	[Chai Ann Ng; Perry, Matthew D.; Tan, Peter S.; Hill, Adam P.; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia; [Chai Ann Ng; Kuchel, Philip W.; Vandenberg, Jamie I.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Kuchel, Philip W.] Agcy Sci Technol & Res, Mech Syst Biol NMR Grp, Singapore Bioimaging Consortium, Singapore, Singapore; [Chai Ann Ng; Hill, Adam P.; Vandenberg, Jamie I.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia	Victor Chang Cardiac Research Institute; University of Sydney; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); University of New South Wales Sydney	Ng, CA (corresponding author), Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia.	j.vandenberg@victorchang.edu.au	Vandenberg, Jamie I/B-6608-2013	Vandenberg, Jamie I/0000-0002-3859-3716; Ng, Chai Ann/0000-0002-3120-5450; Kuchel, Philip/0000-0003-4100-7332	Australian Research Council [DP0986316]; National Health & Medical Research Council [459401, 1010029]; National Heart Foundation of Australia [G09S-]	Australian Research Council(Australian Research Council); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was funded by grants from the Australian Research Council (DP0986316; http://www.arc.gov.au/), the National Health & Medical Research Council (459401 and 1010029; http://www.nhmrc.gov.au/), National Heart Foundation of Australia (G09S-(50www.heartfoundation.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; Alonso-Ron C, 2008, BIOPHYS J, V94, P3893, DOI 10.1529/biophysj.107.116731; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bax A, 1985, MLEV 17 BASED 2 DIME, P355; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Case D.A., 2022, AMBER 2020; Clarke CE, 2006, J PHYSIOL-LONDON, V573, P291, DOI 10.1113/jphysiol.2006.108332; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Gayen S, 2011, J PEPT SCI; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Kumar A, 1980, BIOCH BIOPHYS RES CO, V95; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Perry M, 2007, P NATL ACAD SCI USA, V104, P13827, DOI 10.1073/pnas.0703934104; Piper DR, 2005, J BIOL CHEM, V280, P7206, DOI 10.1074/jbc.M411042200; Piper DR, 2003, P NATL ACAD SCI USA, V100, P10534, DOI 10.1073/pnas.1832721100; Saenen JB, 2006, BIOPHYS J, V91, P4381, DOI 10.1529/biophysj.106.087247; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Schonherr R, 1996, J PHYSL LOND; Shaka AJ, 1988, J MAGN RESON, P96; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Subbiah RN, 2004, J PHYSIOL-LONDON, V558, P417, DOI 10.1113/jphysiol.2004.062588; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Van Slyke AC, 2010, BIOPHYS J, V99, P2841, DOI 10.1016/j.bpj.2010.08.030; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Wang SM, 1997, J PHYSIOL-LONDON, V502, P45, DOI 10.1111/j.1469-7793.1997.045bl.x; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117; Wynia-Smith SL, 2008, J GEN PHYSIOL, V132, P507, DOI 10.1085/jgp.200810083; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119; Zou AR, 1997, AM J PHYSIOL-HEART C, V272, pH1309, DOI 10.1152/ajpheart.1997.272.3.H1309	50	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31640	10.1371/journal.pone.0031640	http://dx.doi.org/10.1371/journal.pone.0031640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359612	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200081
J	Kennedy, A; Gruen, ML; Gutierrez, DA; Surmi, BK; Orr, JS; Webb, CD; Hasty, AH				Kennedy, Arion; Gruen, Marnie L.; Gutierrez, Dario A.; Surmi, Bonnie K.; Orr, Jeb S.; Webb, Corey D.; Hasty, Alyssa H.			Impact of Macrophage Inflammatory Protein-1 alpha Deficiency on Atherosclerotic Lesion Formation, Hepatic Steatosis, and Adipose Tissue Expansion	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; REDUCES ATHEROSCLEROSIS; KNOCKOUT MICE; FATTY LIVER; ACCUMULATION; CHEMOKINES; HYPERLIPIDEMIA; ABSENCE	Macrophage inflammatory protein-1 alpha (CCL3) plays a well-known role in infectious and viral diseases; however, its contribution to atherosclerotic lesion formation and lipid metabolism has not been determined. Low density lipoprotein receptor deficient (LDLR-/-) mice were transplanted with bone marrow from CCL3(-/-) or C57BL/6 wild type donors. After 6 and 12 weeks on western diet (WD), recipients of CCL3(-/-) marrow demonstrated lower plasma cholesterol and triglyceride concentrations compared to recipients of C57BL/6 marrow. Atherosclerotic lesion area was significantly lower in female CCL3(-/-) recipients after 6 weeks and in male CCL3(-/-) recipients after 12 weeks of WD feeding (P<0.05). Surprisingly, male CCL3(-/-) recipients had a 50% decrease in adipose tissue mass after WD-feeding, and plasma insulin, and leptin levels were also significantly lower. These results were specific to CCL3, as LDLR-/- recipients of monocyte chemoattractant protein(-/-) (CCL2) marrow were not protected from the metabolic consequences of high fat feeding. Despite these improvements in LDLR-/- recipients of CCL3(-/-) marrow in the bone marrow transplantation (BMT) model, double knockout mice, globally deficient in both proteins, did not have decreased body weight, plasma lipids, or atherosclerosis compared with LDLR-/- controls. Finally, there were no differences in myeloid progenitors or leukocyte populations, indicating that changes in body weight and plasma lipids in CCL3(-/-) recipients was not due to differences in hematopoiesis. Taken together, these data implicate a role for CCL3 in lipid metabolism in hyperlipidemic mice following hematopoietic reconstitution.	[Kennedy, Arion; Gruen, Marnie L.; Gutierrez, Dario A.; Surmi, Bonnie K.; Orr, Jeb S.; Webb, Corey D.; Hasty, Alyssa H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Kennedy, A (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.	alyssa.hasty@vanderbilt.edu	Hasty, Alyssa/AAA-2757-2020	Hasty, Alyssa/0000-0001-7302-8045; Kennedy, Arion/0000-0002-8443-3131	American Diabetes Association (ADA) [1-07-CD-10, 7-10-MI-05]; Molecular Endocrinology Training Grant [DK07563]; NIH NRSA [DK091128, DK091040]; NIH [CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; Vanderbilt Digestive Disease Research Center [DK058404]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, F31DK091128, U24DK059637, F32DK091040, P60DK020593, P30DK020593] Funding Source: NIH RePORTER	American Diabetes Association (ADA)(American Diabetes Association); Molecular Endocrinology Training Grant; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Disease Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Career Development Award from the American Diabetes Association (ADA) to AH Hasty (1-07-CD-10). Both A. Kennedy and D. Gutierrez were supported by the Molecular Endocrinology Training Grant (DK07563) during their first year of training. A. Kennedy is currently supported by a Postdoctoral Fellowship from the ADA (7-10-MI-05), D. Gutierrez is supported by an NIH NRSA (DK091128), and J. Orr is supported by an NIH NRSA (DK091040). Insulin and leptin assays were performed in the Analytical Services Core of the Diabetes Research and Training Center (DK20593)/MMPC (DK59637). Fluorescence imaging of CD4 positive cells in lesions were performed in part through the use of the VUMC Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126) with the expert assistance of Carol Ann Bonner. Liver TG fatty acid analyses were performed in the Lipid Core of the MMPC. Flow Cytometry experiments were performed in the VMC Flow Cytometry Shared Resource supported by the Vanderbilt Digestive Disease Research Center (DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; BROXMEYER HE, 1990, BLOOD, V76, P1110; Coenen KR, 2007, AM J PHYSIOL-ENDOC M, V293, pE492, DOI 10.1152/ajpendo.00171.2007; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; Dahlman I, 2005, J CLIN ENDOCR METAB, V90, P5834, DOI 10.1210/jc.2005-0369; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; Dol F, 2001, J CARDIOVASC PHARM, V38, P395, DOI 10.1097/00005344-200109000-00008; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Gerhardt CC, 2001, MOL CELL ENDOCRINOL, V175, P81, DOI 10.1016/S0303-7207(01)00394-X; Gruen ML, 2006, ATHEROSCLEROSIS, V186, P54, DOI 10.1016/j.atherosclerosis.2005.07.007; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Gutierrez DA, 2011, DIABETES, V60, P2820, DOI 10.2337/db11-0314; Holven KB, 2003, EUR HEART J, V24, P1756, DOI 10.1016/S0195-668X(03)00467-6; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kirk EA, 2008, DIABETES, V57, P1254, DOI 10.2337/db07-1061; Kuziel WA, 2003, ATHEROSCLEROSIS, V167, P25, DOI 10.1016/S0021-9150(02)00382-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; MAZE R, 1992, J IMMUNOL, V149, P1004; Moos MPW, 2005, ARTERIOSCL THROM VAS, V25, P2386, DOI 10.1161/01.ATV.0000187470.31662.fe; Namiki M, 2002, ARTERIOSCL THROM VAS, V22, P115, DOI 10.1161/hq0102.102278; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Parissis JT, 2000, AM J CARDIOL, V85, P777, DOI 10.1016/S0002-9149(99)00862-0; Potteaux S, 2005, MOL MED, V11, P16, DOI [10.2119/2005-00028.Poffeaux, 10.2119/2005-00028.Potteaux]; Potteaux S, 2006, ARTERIOSCL THROM VAS, V26, P1858, DOI 10.1161/01.ATV.0000231527.22762.71; Quinones Marlon P, 2007, Atherosclerosis, V195, pe92, DOI 10.1016/j.atherosclerosis.2007.03.026; Rezaie-Majd A, 2002, ARTERIOSCL THROM VAS, V22, P1194, DOI 10.1161/01.ATV.0000022694.16328.CC; Saraswathi V, 2006, J LIPID RES, V47, P1406, DOI 10.1194/jlr.M600159-JLR200; Soehnlein O, 2009, J CELL MOL MED, V13, P4293, DOI 10.1111/j.1582-4934.2009.00965.x; Surmi BK, 2010, AM J PHYSIOL-ENDOC M, V299, pE437, DOI 10.1152/ajpendo.00050.2010; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Waehre T, 2003, J AM COLL CARDIOL, V41, P1460, DOI 10.1016/S0735-1097(03)00263-8; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Wilcox J N, 1994, J Atheroscler Thromb, V1 Suppl 1, pS10; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zernecke A, 2006, BLOOD, V107, P4240, DOI 10.1182/blood-2005-09-3922; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	43	25	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31508	10.1371/journal.pone.0031508	http://dx.doi.org/10.1371/journal.pone.0031508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359597	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200066
J	Lu, YH; Pang, YP; Park, Y; Gao, XW; Yao, JX; Zhang, X; Zhu, KY				Lu, Yanhui; Pang, Yuan-Ping; Park, Yoonseong; Gao, Xiwu; Yao, Jianxiu; Zhang, Xin; Zhu, Kun Yan			Genome Organization, Phylogenies, Expression Patterns, and Three-Dimensional Protein Models of Two Acetylcholinesterase Genes from the Red Flour Beetle	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER ACETYLCHOLINESTERASE; CDNA-ENCODING ACETYLCHOLINESTERASE; AMINO-ACID SUBSTITUTION; ACTIVE-SITE GORGE; MOLECULAR-DYNAMICS; X-RAY; INSECTICIDE-INSENSITIVITY; IRREVERSIBLE INHIBITORS; CRYSTAL-STRUCTURE; POINT MUTATION	Since the report of a paralogous acetylcholinesterase (AChE, EC3.1.1.7) gene in the greenbug (Schizaphis graminum) in 2002, two different AChE genes (Ace1 and Ace2) have been identified in each of at least 27 insect species. However, the gene models of Ace1 and Ace2, and their molecular properties have not yet been comprehensively analyzed in any insect species. In this study, we sequenced the full-length cDNAs, computationally predicted the corresponding three-dimensional protein models, and profiled developmental stage and tissue-specific expression patterns of two Ace genes from the red flour beetle (Tribolium castaneum; TcAce1 and TcAce2), a globally distributed major pest of stored grain products and an emerging model organism. TcAce1 and TcAce2 encode 648 and 604 amino acid residues, respectively, and have conserved motifs including a choline-binding site, a catalytic triad, and an acyl pocket. Phylogenetic analysis show that both TcAce genes are grouped into two insect Ace clusters and TcAce1 is completely diverged from TcAce2, suggesting that these two genes evolve from their corresponding Ace gene lineages in insect species. In addition, TcAce1 is located on chromosome 5, whereas TcAce2 is located on chromosome 2. Reverse transcription polymerase chain reaction (PCR) and quantitative real-time PCR analyses indicate that both genes are virtually transcribed in all the developmental stages and predominately expressed in the insect brain. Our computational analyses suggest that the TcAce1 protein is a robust acetylcholine (ACh) hydrolase and has susceptibility to sulfhydryl agents whereas the TcAce2 protein is not a catalytically efficient ACh hydrolase.	[Lu, Yanhui; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Pang, Yuan-Ping] Mayo Clin, Comp Aided Mol Design Lab, Rochester, MN USA; [Lu, Yanhui; Park, Yoonseong; Yao, Jianxiu; Zhang, Xin; Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	China Agricultural University; Mayo Clinic; Kansas State University	Lu, YH (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	pang@mayo.edu; kzhu@ksu.edu	Lu, gls19581211!/L-6918-2019; Park, Yoonseong/J-5861-2013	Zhu, Kun Yan/0000-0001-9372-8030; Pang, Yuan-Ping/0000-0003-0838-2560; Park, Yoonseong/0000-0003-1191-7335	Kansas Agricultural Experiment Station; Arthropod Genomics Center; Kansas State University; China Scholarship Council; U.S. Department of Agriculture [USDA/NIFA 2009-05236]; University of Minnesota Supercomputing Institute	Kansas Agricultural Experiment Station; Arthropod Genomics Center; Kansas State University; China Scholarship Council(China Scholarship Council); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); University of Minnesota Supercomputing Institute	This study was supported by the Kansas Agricultural Experiment Station and the Arthropod Genomics Center funded by K-State Targeted Excellence program at Kansas State University to KYZ, China Scholarship Council to YL, and the U.S. Department of Agriculture (USDA/NIFA 2009-05236) to YPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Ming-Shun Chen for his helpful comments on an earlier draft of this manuscript. The computational studies were supported in part by the University of Minnesota Supercomputing Institute. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by Kansas State University or the Mayo Clinic. This paper is contribution No. 11-210-J from the Kansas Agricultural Experiment Station. The T. castaneum voucher specimens (voucher No. 159) are located in the Kansas State University Museum of Entomological and Prairie Arthropod Research, Manhattan, Kansas, United States of America.	Alon M, 2008, INSECT BIOCHEM MOLEC, V38, P940, DOI 10.1016/j.ibmb.2008.07.007; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Baek JH, 2005, PESTIC BIOCHEM PHYS, V81, P164, DOI 10.1016/j.pestbp.2004.12.003; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; Bourne Y, 1999, J BIOL CHEM, V274, P30370, DOI 10.1074/jbc.274.43.30370; Bourne Y, 1999, J BIOL CHEM, V274, P2963, DOI 10.1074/jbc.274.5.2963; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cassanelli S, 2006, INSECT BIOCHEM MOLEC, V36, P642, DOI 10.1016/j.ibmb.2006.05.007; Chen HJ, 2009, INSECT SCI, V16, P297, DOI 10.1111/j.1744-7917.2009.01259.x; Chen MH, 2006, GENOME, V49, P239, DOI 10.1139/G05-104; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Felder CE, 2007, NUCLEIC ACIDS RES, V35, pW512, DOI 10.1093/nar/gkm307; FOURNIER D, 1994, COMP BIOCHEM PHYS C, V108, P19, DOI 10.1016/1367-8280(94)90084-1; Gao JR, 2002, INSECT BIOCHEM MOLEC, V32, P765, DOI 10.1016/S0965-1748(01)00159-X; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; GNAGEY AL, 1987, J BIOL CHEM, V262, P13290; Guedes RNC, 1997, PESTIC BIOCHEM PHYS, V58, P55, DOI 10.1006/pest.1997.2285; HAAS R, 1988, BIOCHEMISTRY-US, V27, P6453, DOI 10.1021/bi00417a038; HALISCAK JP, 1983, J ECON ENTOMOL, V76, P717, DOI 10.1093/jee/76.4.717; HALL LMC, 1986, EMBO J, V5, P2949, DOI 10.1002/j.1460-2075.1986.tb04591.x; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huchard E, 2006, P R SOC B, V273, P2595, DOI 10.1098/rspb.2006.3621; Jiang XJ, 2009, BIOCHEM BIOPH RES CO, V378, P269, DOI 10.1016/j.bbrc.2008.11.046; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim JI, 2006, INSECT MOL BIOL, V15, P513, DOI 10.1111/j.1365-2583.2006.00666.x; Kono Y, 2006, PESTIC BIOCHEM PHYS, V85, P123, DOI 10.1016/j.pestbp.2005.12.002; Kozaki T, 2008, ARCH INSECT BIOCHEM, V67, P130, DOI 10.1002/arch.20229; Lang GJ, 2010, PESTIC BIOCHEM PHYS, V98, P175, DOI 10.1016/j.pestbp.2010.06.003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DW, 2007, BIOCHEM BIOPH RES CO, V353, P591, DOI 10.1016/j.bbrc.2006.12.088; Lee DW, 2006, BBA-GEN SUBJECTS, V1760, P125, DOI 10.1016/j.bbagen.2005.10.009; Lee SW, 2007, J MED ENTOMOL, V44, P72, DOI 10.1603/0022-2585(2007)44[72:MCOTAC]2.0.CO;2; Li F, 2002, GENOME, V45, P1134, DOI 10.1139/G02-085; Li HR, 2005, INSECT BIOCHEM MOLEC, V35, P847, DOI 10.1016/j.ibmb.2005.03.004; MACPHEEQUIGLEY K, 1986, J BIOL CHEM, V261, P3565; Mori A, 2001, INSECT MOL BIOL, V10, P197, DOI 10.1046/j.1365-2583.2001.00255.x; Mori A, 2007, INSECT BIOCHEM MOLEC, V37, P667, DOI 10.1016/j.ibmb.2007.03.014; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nabeshima T, 2004, BIOCHEM BIOPH RES CO, V313, P794, DOI 10.1016/j.bbrc.2003.11.141; Nabeshima T, 2003, BIOCHEM BIOPH RES CO, V307, P15, DOI 10.1016/S0006-291X(03)01101-X; Nachon F, 2008, FEBS J, V275, P2659, DOI 10.1111/j.1742-4658.2008.06413.x; Nardi F, 2009, INSECT MOL BIOL, V18, P45, DOI 10.1111/j.1365-2583.2008.00848.x; Ni XY, 2003, APPL ENTOMOL ZOOL, V38, P49, DOI 10.1303/aez.2003.49; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; Page R.D.M., 1998, MOL EVOLUTION PHYLOG; Pang Y-P, 2011, CURR DRUG T IN PRESS; Pang YP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000058; Pang YP, 2007, BIOORG MED CHEM LETT, V17, P197, DOI 10.1016/j.bmcl.2006.09.073; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006851; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004349; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Raves ML, 1997, NAT STRUCT BIOL, V4, P57, DOI 10.1038/nsb0197-57; Sanson B, 2011, PROTEIN SCI, V20, P1114, DOI 10.1002/pro.661; Sanson B, 2009, J MED CHEM, V52, P7593, DOI 10.1021/jm900433t; SCHRAG JD, 1993, J MOL BIOL, V230, P575, DOI 10.1006/jmbi.1993.1171; Seino A, 2007, PESTIC BIOCHEM PHYS, V88, P92, DOI 10.1016/j.pestbp.2006.09.005; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Soderlund D. M., 1990, PESTICIDE RESISTANCE, P58; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Togawa T, 2008, INSECT BIOCHEM MOLEC, V38, P508, DOI 10.1016/j.ibmb.2007.12.008; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Xu YC, 2008, BIOPHYS J, V95, P2500, DOI 10.1529/biophysj.108.129601; Zhu KY, 1996, PESTIC BIOCHEM PHYS, V55, P100, DOI 10.1006/pest.1996.0039; ZHU KY, 1992, INSECT BIOCHEM MOLEC, V22, P245, DOI 10.1016/0965-1748(92)90061-I; Zhu KY, 1995, INSECT BIOCHEM MOLEC, V25, P1129, DOI 10.1016/0965-1748(95)00055-0; [No title captured]	71	33	33	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32288	10.1371/journal.pone.0032288	http://dx.doi.org/10.1371/journal.pone.0032288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359679	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200148
J	Machado, MV; Ferreira, DMS; Castro, RE; Silvestre, AR; Evangelista, T; Coutinho, J; Carepa, F; Costa, A; Rodrigues, CMP; Cortez-Pinto, H				Machado, Mariana Verdelho; Ferreira, Duarte M. S.; Castro, Rui E.; Silvestre, Ana Rita; Evangelista, Teresinha; Coutinho, Joao; Carepa, Fatima; Costa, Adilia; Rodrigues, Cecilia M. P.; Cortez-Pinto, Helena			Liver and Muscle in Morbid Obesity: The Interplay of Fatty Liver and Insulin Resistance	PLOS ONE			English	Article							SKELETAL-MUSCLE; OXIDATIVE CAPACITY; LIPID-METABOLISM; ADIPOSE-TISSUE; FOLLOW-UP; SENSITIVITY; ADIPONECTIN; STEATOHEPATITIS; HOMEOSTASIS; EXPRESSION	Introduction: Nonalcoholic fatty liver disease (NAFLD) can be seen as a manifestation of overnutrition. The muscle is a central player in the adaptation to energy overload, and there is an association between fatty-muscle and -liver. We aimed to correlate muscle morphology, mitochondrial function and insulin signaling with NAFLD severity in morbid obese patients. Methods: Liver and deltoid muscle biopsies were collected during bariatric surgery in NAFLD patients. NAFLD Activity Score and Younossi's classification for nonalcoholic steatohepatitis (NASH) were applied to liver histology. Muscle evaluation included morphology studies, respiratory chain complex I to IV enzyme assays, and analysis of the insulin signaling cascade. A healthy lean control group was included for muscle morphology and mitochondrial function analyses. Results: Fifty one NAFLD patients were included of whom 43% had NASH. Intramyocellular lipids (IMCL) were associated with the presence of NASH (OR 12.5, p<0.001), progressive hepatic inflammation (p = 0.029) and fibrosis severity (p = 0.010). There was a trend to an association between IMCL and decreased Akt phosphorylation (p = 0.059), despite no association with insulin resistance. In turn, hepatic steatosis (p = 0.015) and inflammation (p = 0.013) were associated with decreased Akt phosphoryation. Citrate synthase activity was lower in obese patients (p = 0.047) whereas complex I (p = 0.040) and III (p = 0.036) activities were higher, compared with controls. Finally, in obese patients, complex I activity increased with progressive steatosis (p = 0.049) and with a trend with fibrosis severity (p = 0.056). Conclusions: In morbid obese patients, presence of IMCL associates with NASH and advanced fibrosis. Muscle mitochondrial dysfunction does not appear to be a major driving force contributing to muscle fat accumulation, insulin resistance or liver disease. Importantly, insulin resistance in muscle might occur at a late point in the insulin signaling cascade and be associated with IMCL and NAFLD severity.	[Machado, Mariana Verdelho; Cortez-Pinto, Helena] Hosp Santa Maria, Dept Gastroenterol, Unidade Nutr & Metab, Fac Med Lisboa,IMM, Lisbon, Portugal; [Ferreira, Duarte M. S.; Castro, Rui E.; Rodrigues, Cecilia M. P.] Univ Lisbon, Res Inst Med & Pharmaceut Sci iMed UL, Fac Pharm, P-1699 Lisbon, Portugal; [Silvestre, Ana Rita; Evangelista, Teresinha] Hosp Santa Maria, Dept Neuropatol, Lisbon, Portugal; [Coutinho, Joao; Carepa, Fatima] Hosp Santa Maria, Dept Cirurgia, Lisbon, Portugal; [Costa, Adilia] Hosp Santa Maria, Dept Anat Patol, Lisbon, Portugal	Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa; Hospital Santa Maria	Machado, MV (corresponding author), Hosp Santa Maria, Dept Gastroenterol, Unidade Nutr & Metab, Fac Med Lisboa,IMM, Lisbon, Portugal.	hlcortezpinto@netcabo.pt	Castro, Rui E/I-2975-2013; Rodrigues, Cecilia MP/M-3572-2013; Evangelista, Teresinha/AAF-3216-2020; Cortez-Pinto, Helena/AAN-2712-2020; iMed.ULisboa, CellFun/A-4244-2014; Cortez-Pinto, Helena/A-3586-2012; de Carvalho, Mamede/I-6295-2019; Ferreira, Duarte M Sacramento/E-4270-2012; Castro, Rui E/AAG-4179-2021	Castro, Rui E/0000-0002-7417-0091; Rodrigues, Cecilia MP/0000-0002-4829-754X; Evangelista, Teresinha/0000-0002-1329-9131; Cortez-Pinto, Helena/0000-0002-8537-8744; de Carvalho, Mamede/0000-0001-7556-0158; Ferreira, Duarte M Sacramento/0000-0001-5940-7102; Castro, Rui E/0000-0002-7417-0091	FCT, Portugal [PTDC/SAU-OSM/100878/2008]	FCT, Portugal(Portuguese Foundation for Science and Technology)	This study was supported by a grant: PTDC/SAU-OSM/100878/2008, from FCT, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Alves RMP, 2010, J GERONTOL A-BIOL, V65, P832, DOI 10.1093/gerona/glq081; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Bachmann OP, 2001, DIABETES, V50, P2579, DOI 10.2337/diabetes.50.11.2579; Benton CR, 2008, APPL PHYSIOL NUTR ME, V33, P843, DOI 10.1139/H08-074; Bugianesi E, 2005, J CLIN ENDOCR METAB, V90, P3498, DOI 10.1210/jc.2004-2240; Chanseaume E, 2007, OBESITY, V15, P50, DOI 10.1038/oby.2007.511; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Dengel DR, 1996, J APPL PHYSIOL, V81, P318, DOI 10.1152/jappl.1996.81.1.318; Dube JJ, 2011, DIABETOLOGIA, V54, P1147, DOI 10.1007/s00125-011-2065-0; Eckardt K, 2011, REV ENDOCR METAB DIS, V12, P163, DOI 10.1007/s11154-011-9168-2; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Ellis BA, 2000, AM J PHYSIOL-ENDOC M, V279, pE554, DOI 10.1152/ajpendo.2000.279.3.E554; Ferreira DMS, 2011, DIABETOLOGIA, V54, P1788, DOI 10.1007/s00125-011-2130-8; Fiorentino L, 2010, HEPATOLOGY, V51, P103, DOI 10.1002/hep.23250; Genuth S, 2003, DIABETES CARE, V26, P3160; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; Group NHBPEPW, 1993, ARCH INTERN MED, V153, P325; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Hawley JA, 2007, DIABETOLOGIA, V50, P699, DOI 10.1007/s00125-007-0595-2; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Holloway GP, 2009, AM J CLIN NUTR, V89, p455S, DOI 10.3945/ajcn.2008.26717B; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kitajima Y, 2010, J GASTROENTEROL, V45, P218, DOI 10.1007/s00535-009-0147-2; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kraegen EW, 2008, P NATL ACAD SCI USA, V105, P7627, DOI 10.1073/pnas.0803901105; Kuhlmann J, 2003, DIABETES, V52, P138, DOI 10.2337/diabetes.52.1.138; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Monroy A, 2009, DIABETOLOGIA, V52, P2169, DOI 10.1007/s00125-009-1451-3; National Institutes of Health (USA), 1992, American Journal of Clinical Nutrition, V55, p615S; Perseghin G, 2002, AM J PHYSIOL-ENDOC M, V283, pE556, DOI 10.1152/ajpendo.00127.2002; Polyzos SA, 2011, METABOLISM, V60, P313, DOI 10.1016/j.metabol.2010.09.003; Polyzos SA, 2010, DIABETES OBES METAB, V12, P365, DOI 10.1111/j.1463-1326.2009.01176.x; Ramalho RM, 2006, EUR J GASTROEN HEPAT, V18, P21, DOI 10.1097/00042737-200601000-00005; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Rimbert V, 2004, FASEB J, V18, P737, DOI 10.1096/fj.03-1104fje; Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; Thamer C, 2003, J CLIN ENDOCR METAB, V88, P1785, DOI 10.1210/jc.2002-021674; Thrush AB, 2009, J CLIN ENDOCR METAB, V94, P5053, DOI 10.1210/jc.2008-2565; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	55	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31738	10.1371/journal.pone.0031738	http://dx.doi.org/10.1371/journal.pone.0031738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359625	gold, Green Submitted, Green Published			2022-12-25	WOS:000302796200094
J	Mehes, E; Mones, E; Nemeth, V; Vicsek, T				Mehes, Elod; Mones, Enys; Nemeth, Valeria; Vicsek, Tamas			Collective Motion of Cells Mediates Segregation and Pattern Formation in Co-Cultures	PLOS ONE			English	Article							DIFFERENTIAL ADHESION; BROWNIAN-MOTION; RAC; RECONSTRUCTION; MORPHOGENESIS; SIMULATION; MIGRATION; TISSUES	Pattern formation by segregation of cell types is an important process during embryonic development. We show that an experimentally yet unexplored mechanism based on collective motility of segregating cells enhances the effects of known pattern formation mechanisms such as differential adhesion, mechanochemical interactions or cell migration directed by morphogens. To study in vitro cell segregation we use time-lapse videomicroscopy and quantitative analysis of the main features of the motion of individual cells or groups. Our observations have been extensive, typically involving the investigation of the development of patterns containing up to 200,000 cells. By either comparing keratocyte types with different collective motility characteristics or increasing cells' directional persistence by the inhibition of Rac1 GTP-ase we demonstrate that enhanced collective cell motility results in faster cell segregation leading to the formation of more extensive patterns. The growth of the characteristic scale of patterns generally follows an algebraic scaling law with exponent values up to 0.74 in the presence of collective motion, compared to significantly smaller exponents in case of diffusive motion.	[Mehes, Elod; Mones, Enys; Nemeth, Valeria; Vicsek, Tamas] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Vicsek, Tamas] Hungarian Acad Sci, Stat & Biol Phys Res Grp, Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences	Mehes, E (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary.	emehes@angel.elte.hu	Mehes, Elod/AAD-8229-2019	Mones, Enys/0000-0001-7724-0094	European Union ERC COLLMOT	European Union ERC COLLMOT	European Union ERC COLLMOT Project, http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmonte JM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.248702; Beysens DA, 2000, P NATL ACAD SCI USA, V97, P9467, DOI 10.1073/pnas.97.17.9467; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; DUNN GA, 1987, J CELL SCI, P81; Foty RA, 1996, DEVELOPMENT, V122, P1611; Furth R, 1920, Z PHYS, V2, P244, DOI 10.1007/BF01328731; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Henkes S, 2011, ARXIV11074072V1; Kabla AJ, 2011, ARXIV11084286V1QBIOC; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Maheshwari G, 1998, MICROSC RES TECHNIQ, V43, P358, DOI 10.1002/(SICI)1097-0029(19981201)43:5<358::AID-JEMT2>3.0.CO;2-D; Maree AFM, 2001, P NATL ACAD SCI USA, V98, P3879, DOI 10.1073/pnas.061535198; McCandlish SR, 2011, ARXIV11102479V2; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Murray JD, 2003, CR BIOL, V326, P239, DOI 10.1016/S1631-0691(03)00065-9; Nakajima A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/033035; Ornstein LS, 1919, P K AKAD WET-AMSTERD, V21, P96; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Savill NJ, 1997, J THEOR BIOL, V184, P229, DOI 10.1006/jtbi.1996.0237; Schotz EM, 2008, HFSP J, V2, P42, DOI 10.2976/1.2834817; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Szabo A, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046007; Szabo B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061908; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012	28	39	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31711	10.1371/journal.pone.0031711	http://dx.doi.org/10.1371/journal.pone.0031711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359617	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200086
J	Perrault, JR; Miller, DL; Eads, E; Johnson, C; Merrill, A; Thompson, LJ; Wyneken, J				Perrault, Justin R.; Miller, Debra L.; Eads, Erica; Johnson, Chris; Merrill, Anita; Thompson, Larry J.; Wyneken, Jeanette			Maternal Health Status Correlates with Nest Success of Leatherback Sea Turtles (Dermochelys coriacea) from Florida	PLOS ONE			English	Article							CHELONIA-MYDAS; CARETTA-CARETTA; GREEN TURTLES; HEMATOLOGICAL PARAMETERS; REPRODUCTIVE-CYCLE; BREEDING SUCCESS; TRACE-ELEMENTS; NORTH-CAROLINA; BLOOD VALUES; ENERGY	Of the seven sea turtle species, the critically endangered leatherback sea turtle (Dermochelys coriacea) exhibits the lowest and most variable nest success (i.e., hatching success and emergence success) for reasons that remain largely unknown. In an attempt to identify or rule out causes of low reproductive success in this species, we established the largest sample size (n = 60-70 for most values) of baseline blood parameters (protein electrophoresis, hematology, plasma biochemistry) for this species to date. Hematologic, protein electrophoretic and biochemical values are important tools that can provide information regarding the physiological condition of an individual and population health as a whole. It has been proposed that the health of nesting individuals affects their reproductive output. In order to establish correlations with low reproductive success in leatherback sea turtles from Florida, we compared maternal health indices to hatching success and emergence success of their nests. As expected, hatching success (median = 57.4%) and emergence success (median = 49.1%) in Floridian leatherbacks were low during the study period (2007-2008 nesting seasons), a trend common in most nesting leatherback populations (average global hatching success = similar to 50%). One protein electrophoretic value (gamma globulin protein) and one hematologic value (red blood cell count) significantly correlated with hatching success and emergence success. Several maternal biochemical parameters correlated with hatching success and/or emergence success including alkaline phosphatase activity, blood urea nitrogen, calcium, calcium: phosphorus ratio, carbon dioxide, cholesterol, creatinine, and phosphorus. Our results suggest that in leatherbacks, physiological parameters correlate with hatching success and emergence success of their nests. We conclude that long-term and comparative studies are needed to determine if certain individuals produce nests with lower hatching success and emergence success than others, and if those individuals with evidence of chronic suboptimal health have lower reproductive success.	[Perrault, Justin R.; Wyneken, Jeanette] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA; [Miller, Debra L.; Merrill, Anita] Univ Georgia, Coll Vet Med, Vet Diagnost & Invest Lab, Tifton, GA USA; [Eads, Erica] Univ Tennessee, Coll Vet Med, Knoxville, TN USA; [Johnson, Chris] Loggerhead Marinelife Ctr, Juno Beach, FL USA; [Thompson, Larry J.] Nestle Purina PetCare, St Louis, MO USA	State University System of Florida; Florida Atlantic University; University System of Georgia; University of Georgia; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Nestle SA	Perrault, JR (corresponding author), Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA.	jperrau2@fau.edu		Miller, Debra/0000-0002-8544-174X; Perrault, Justin/0000-0002-5046-6701	Florida Sea Turtle License Plate grant [07-004R]; Nelligan Sea Turtle Research Fund	Florida Sea Turtle License Plate grant; Nelligan Sea Turtle Research Fund	Our study was supported in part by a Florida Sea Turtle License Plate grant (grant #07-004R) to Debra L. Miller (URL: http://www.helpingseaturtles.org/grants.php). The University of Georgia Veterinary Diagnostic and Investigational Laboratory provided equipment and personnel for sample analyses (URL: http://www.vet.uga.edu/dlab/index.php). Partial funding for travel was provided by the Nelligan Sea Turtle Research Fund (URL: https://fauf.fau.edu/NetCommunity/SSLPage.aspx?pid = 1766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AA, 2000, COMP HAEMATOL INT, V10, P132, DOI 10.1007/s005800070004; Alkindi AYA, 2001, PAKISTAN J BIOL SCI, V4, P608; Apanius V., 2008, ORNITHOL MONOGR, V65, P1, DOI [10.1525/om.2008.65.1.1, DOI 10.1525/OM.2008.65.1.1]; Bell BA, 2004, BIOL CONSERV, V115, P131, DOI 10.1016/S0006-3207(03)00102-2; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Bjorndal Karen A., 1997, P199; BOLTEN AB, 1992, J WILDLIFE DIS, V28, P407, DOI 10.7589/0090-3558-28.3.407; BUSTARD HR, 1968, ECOLOGY, V49, P269, DOI 10.2307/1934455; C?lix M., 2018, EUROPEAN RED LIST SA; Campbell T., 2006, REPTILE MED SURG, P453, DOI 10.1016/B0-72-169327-X/50032-8; Campbell Terry W., 1996, P248; Carminati CE., 1994, P 14 ANN S SEA TURTL, P203; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; Casey J, 2010, J EXP BIOL, V213, P3961, DOI 10.1242/jeb.048611; Chaffin K, 2008, J WILDLIFE DIS, V44, P670, DOI 10.7589/0090-3558-44.3.670; Cheeks R, 1997, THESIS FLORIDA ATLAN; Chesley LC, 1934, BIOL BULL-US, V66, P133, DOI 10.2307/1537327; COTTRAL GE, 1952, ANN NY ACAD SCI, V55, P221, DOI 10.1111/j.1749-6632.1952.tb26538.x; Cray C, 1998, J AVIAN MED SURG, V12, P4; CUTTING JA, 1973, BIOCHIM BIOPHYS ACTA, V298, P951, DOI 10.1016/0005-2736(73)90398-2; Deem SL, 2006, J ZOO WILDLIFE MED, V37, P464, DOI 10.1638/05-102.1; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; Dessaner H. C., 1970, P1; Doyle TK, 2007, J EXP MAR BIOL ECOL, V343, P239, DOI 10.1016/j.jembe.2006.12.010; Dufva R, 1996, J AVIAN BIOL, V27, P83, DOI 10.2307/3676964; DUGUY R., 1970, BIOL REPTILIA, P93; Dunbar MR, 2005, J ZOO WILDLIFE MED, V36, P422, DOI 10.1638/04-065.1; Dutton P.H., 1996, P INT S SEA TURTL CO, V396, P17, DOI [10.1051/parasite/2014024, DOI 10.1051/PARASITE/2014024]; Dutton Peter, 1994, Marine Turtle Newsletter, V67, P13; DUTTON PH, 1995, THESIS TEXAS A M U C; Eales J.G., 1979, P341; Eckert SA, 2006, CHELONIAN CONSERV BI, V5, P239, DOI 10.2744/1071-8443(2006)5[239:IAPMAF]2.0.CO;2; Evans EW, 2003, DUNCAN PRASSES VET L, P162; Field CL, 2001, THROMB RES, V101, P267, DOI 10.1016/S0049-3848(00)00392-3; Fukushi K, 2005, BUNSEKI KAGAKU, V54, P175, DOI 10.2116/bunsekikagaku.54.175; George RH, 1996, BIOL SEA TURTLES, P363; Gicking John C., 2004, Journal of Herpetological Medicine and Surgery, V14, P13; Graveland J, 1997, J ANIM ECOL, V66, P279, DOI 10.2307/6028; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Hamann M, 2002, J COMP PHYSIOL B, V172, P485, DOI [10.1002/s00360-002-0271-2, 10.1007/s00360-002-0271-2]; Hamann M, 2003, CRC MAR BIOL SER, P135; Hamann Mark, 2006, Endangered Species Research, V2, P81, DOI 10.3354/esr002081; Harms CA, 2007, VET REC, V161, P15, DOI 10.1136/vr.161.1.15; Harr KE, 2002, VET CLIN PATH, V31, P140, DOI 10.1111/j.1939-165X.2002.tb00295.x; Harris HS, 2011, J WILDLIFE DIS, V47, P321, DOI 10.7589/0090-3558-47.2.321; Hasbun CR, 1998, COMP HAEMATOL INT, V8, P174, DOI 10.1007/BF02642510; Hatch MI, 2010, J ORNITHOL, V151, P545, DOI 10.1007/s10336-009-0487-y; Hernandez R, 2007, CHELONIAN CONSERV BI, V6, P79, DOI 10.2744/1071-8443(2007)6[79:NDAHSO]2.0.CO;2; Honarvar S, 2011, HERPETOLOGICA, V67, P222, DOI 10.1655/HERPETOLOGICA-D-10-00061.1; Hsieh YHP, 2001, HYDROBIOLOGIA, V451, P11, DOI 10.1023/A:1011875720415; HUNT JR, 1970, BRIT POULTRY SCI, V11, P259, DOI 10.1080/00071667008415813; Innis C, 2010, CHELONIAN CONSERV BI, V9, P205, DOI 10.2744/CCB-0838.1; JACOBSON E, 2008, ESTABLISHING PLASMA; Keller JM, 2004, ENVIRON HEALTH PERSP, V112, P1074, DOI 10.1289/ehp.6923; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; LANCE V, 1983, CAN J ZOOL, V61, P1744, DOI 10.1139/z83-225; LOEKEN MR, 1983, IMMUNOLOGY, V49, P21; LUTCAVAGE M, 1986, COPEIA, P796, DOI 10.2307/1444962; LUTCAVAGE ME, 1990, PHYSIOL ZOOL, V63, P1012, DOI 10.1086/physzool.63.5.30152626; Lutcavage Molly E., 1997, P277; MASAT RJ, 1968, COMP BIOCHEM PHYSIOL, V25, P119, DOI 10.1016/0010-406X(68)90918-3; Masello JF, 2004, J AVIAN BIOL, V35, P445, DOI 10.1111/j.0908-8857.2004.03278.x; MCKNIGHT GS, 1980, J BIOL CHEM, V255, P144; Miller J.D., 1999, IUCN SSC MARINE TURT, V4; Miller Jeffrey D., 1997, P51; MORTIMER JA, 1990, COPEIA, P802, DOI 10.2307/1446446; MUSQUERA S, 1976, COMP BIOCHEM PHYS A, V55, P225, DOI 10.1016/0300-9629(76)90136-5; NATT MP, 1952, POULTRY SCI, V31, P735, DOI 10.3382/ps.0310735; Perrault J, 2011, MAR POLLUT BULL, V62, P1671, DOI 10.1016/j.marpolbul.2011.06.009; Rafferty AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021038; RAMSAY WNM, 1954, BIOCHEM J, V58, P313, DOI 10.1042/bj0580313; Rostal David C., 1996, Chelonian Conservation and Biology, V2, P230; Rostal DC, 1998, GEN COMP ENDOCR, V109, P232, DOI 10.1006/gcen.1997.7026; Rostal DC, 2001, GEN COMP ENDOCR, V122, P139, DOI 10.1006/gcen.2001.7615; SAKAI H, 1995, MAR POLLUT BULL, V30, P347, DOI 10.1016/0025-326X(94)00185-C; Sokal R. R., 2012, BIOMETRY; Soslau G, 2005, COMP BIOCHEM PHYS B, V142, P353, DOI 10.1016/j.cbpb.2005.08.006; Soslau G, 2004, COMP BIOCHEM PHYS B, V138, P399, DOI 10.1016/j.cbpc.2004.05.004; Stamper MA, 2005, J ZOO WILDLIFE MED, V36, P635, DOI 10.1638/04-074.1; Stay NI, 2011, CLIN LAB MED, V31, P87, DOI 10.1016/j.cll.2010.10.006; Stein Geoff, 1996, P473; STEWART K, 2007, THESIS DUKE U DURHAM; Stewart Kelly, 2006, Chelonian Research Monographs, V3, P144; STONEBURNER DL, 1980, J HERPETOL, V14, P171, DOI 10.2307/1563850; Storelli MM, 2005, ENVIRON POLLUT, V135, P163, DOI 10.1016/j.envpol.2004.09.005; Swimmer JY, 2000, J WILDLIFE DIS, V36, P102, DOI 10.7589/0090-3558-36.1.102; Sypek J., 1988, P211; Thompson MB, 2002, COMP BIOCHEM PHYS A, V133, P529, DOI 10.1016/S1095-6433(02)00188-5; Wallace BP, 2006, MAR ECOL PROG SER, V318, P263, DOI 10.3354/meps318263; WOOD FE, 1984, HERPETOLOGICA, V40, P331; Wyneken J, 2001, NMFSSEFSC470 NOAA, DOI DOI 10.1007/SPRINGERREFERENCE_; Zaias Julia, 2002, Journal of Herpetological Medicine and Surgery, V12, P30	93	43	43	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31841	10.1371/journal.pone.0031841	http://dx.doi.org/10.1371/journal.pone.0031841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359635	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200104
J	Yang, CY; Wang, LL; Siva, VS; Shi, XW; Jiang, QF; Wang, JJ; Zhang, H; Song, LS				Yang, Chuanyan; Wang, Lingling; Siva, Vinu S.; Shi, Xiaowei; Jiang, Qiufen; Wang, Jingjing; Zhang, Huan; Song, Linsheng			A Novel Cold-Regulated Cold Shock Domain Containing Protein from Scallop Chlamys farreri with Nucleic Acid-Binding Activity	PLOS ONE			English	Article							Y-BOX PROTEIN; MESSENGER-RNA; ESCHERICHIA-COLI; CSPA-FAMILY; FUNCTIONAL-PROPERTIES; FREEZING-TOLERANCE; GENE; TRANSCRIPTION; TRANSLATION; IDENTIFICATION	Background: The cold shock domain (CSD) containing proteins (CSDPs) are one group of the evolutionarily conserved nucleic acid-binding proteins widely distributed in bacteria, plants, animals, and involved in various cellular processes, including adaptation to low temperature, cellular growth, nutrient stress and stationary phase. Methodology: The cDNA of a novel CSDP was cloned from Zhikong scallop Chlamys farreri (designated as CfCSP) by expressed sequence tag (EST) analysis and rapid amplification of cDNA ends (RACE) approach. The full length cDNA of CfCSP was of 1735 bp containing a 927 bp open reading frame which encoded an N-terminal CSD with conserved nucleic acids binding motif and a C-terminal domain with four Arg-Gly-Gly (RGG) repeats. The CSD of CfCSP shared high homology with the CSDs from other CSDPs in vertebrate, invertebrate and bacteria. The mRNA transcripts of CfCSP were mainly detected in the tissue of adductor and also marginally detectable in gill, hepatopancreas, hemocytes, kidney, mantle and gonad of healthy scallop. The relative expression level of CfCSP was up-regulated significantly in adductor and hemocytes at 1 h and 24 h respectively after low temperature treatment (P < 0.05). The recombinant CfCSP protein (rCfCSP) could bind ssDNA and in vitro transcribed mRNA, but it could not bind dsDNA. BX04, a cold sensitive Escherichia coli CSP quadruple-deletion mutant, was used to examine the cold adaptation ability of CfCSP. After incubation at 17 degrees C for 120 h, the strain of BX04 containing the vector pINIII showed growth defect and failed to form colonies, while strain containing pINIII-CSPA or pINIII-CfCSP grew vigorously, indicating that CfCSP shared a similar function with E. coli CSPs for the cold adaptation. Conclusions: These results suggest that CfCSP is a novel eukaryotic cold-regulated nucleic acid-binding protein and may function as an RNA chaperone in vivo during the cold adaptation process.	[Yang, Chuanyan; Wang, Lingling; Siva, Vinu S.; Shi, Xiaowei; Jiang, Qiufen; Wang, Jingjing; Zhang, Huan; Song, Linsheng] Chinese 7 Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China; [Yang, Chuanyan; Siva, Vinu S.; Shi, Xiaowei; Jiang, Qiufen; Wang, Jingjing] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, CY (corresponding author), Chinese 7 Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn	zhi, zhouzhi/J-8063-2013		National Basic Research Program of China (973 program) [2010CB126404]; National Science Foundation of China [30925028]; Shandong Provincial Natural Science Foundation, China [JQ201110]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This research was supported by National Basic Research Program of China (973 program, no. 2010CB126404), and grants from the National Science Foundation of China (no. 30925028 to LS) and Shandong Provincial Natural Science Foundation, China (no. JQ201110 to LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; BOUVET P, 1994, CELL, V77, P931, DOI 10.1016/0092-8674(94)90141-4; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; Fusaro AF, 2007, PLANTA, V225, P1339, DOI 10.1007/s00425-006-0444-4; Franco GR, 1997, GENE, V198, P5, DOI 10.1016/S0378-1119(97)00261-8; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; GOLDSTEIN J, 1990, P NATL ACAD SCI USA, V87, P283, DOI 10.1073/pnas.87.1.283; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Gu W, 1998, BIOL REPROD, V59, P1266, DOI 10.1095/biolreprod59.5.1266; Gupta-Malhotra M, 2003, CARDIOLOGY, V99, P121, DOI 10.1159/000070668; Hayman ML, 1999, J BIOL CHEM, V274, P12067, DOI 10.1074/jbc.274.17.12067; HOUDE M, 1995, PLANT J, V8, P583, DOI 10.1046/j.1365-313X.1995.8040583.x; Karlson D, 2003, PLANT PHYSIOL, V131, P12, DOI 10.1104/pp.014472; Karlson D, 2002, J BIOL CHEM, V277, P35248, DOI 10.1074/jbc.M205774200; Keresztessy Z, 1998, PLANT J, V14, P523, DOI 10.1046/j.1365-313X.1998.00149.x; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Kim MH, 2009, J BIOL CHEM, V284, P23454, DOI 10.1074/jbc.M109.025791; Kloks CPAM, 2002, J MOL BIOL, V316, P317, DOI 10.1006/jmbi.2001.5334; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kwak KJ, 2005, J EXP BOT, V56, P3007, DOI 10.1093/jxb/eri298; Li FM, 2010, FISH SHELLFISH IMMUN, V29, P521, DOI 10.1016/j.fsi.2010.05.015; Matsumoto K, 1998, TRENDS CELL BIOL, V8, P318, DOI 10.1016/S0962-8924(98)01300-2; Matsumoto K, 2003, BIOCHEM BIOPH RES CO, V306, P53, DOI 10.1016/S0006-291X(03)00909-4; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P11, DOI 10.1073/pnas.89.1.11; Nakaminami K, 2005, FEBS LETT, V579, P4887, DOI 10.1016/j.febslet.2005.07.074; Nakaminami K, 2006, P NATL ACAD SCI USA, V103, P10122, DOI 10.1073/pnas.0603168103; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Pelletier M, 2000, NUCLEIC ACIDS RES, V28, P1266, DOI 10.1093/nar/28.5.1266; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Phadtare S, 2002, J BIOL CHEM, V277, P46706, DOI 10.1074/jbc.M208118200; Pisarev AV, 2002, J BIOL CHEM, V277, P15445, DOI 10.1074/jbc.M111954200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; RANJAN M, 1993, GENE DEV, V7, P1725, DOI 10.1101/gad.7.9.1725; Salvetti A, 1998, DEV BIOL, V201, P217, DOI 10.1006/dbio.1998.8996; Sasaki K, 2007, BIOCHEM BIOPH RES CO, V364, P633, DOI 10.1016/j.bbrc.2007.10.059; SKEHEL PA, 1994, GENE, V145, P231, DOI 10.1016/0378-1119(94)90011-6; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sommerville J, 1999, BIOESSAYS, V21, P319, DOI 10.1002/(SICI)1521-1878(199904)21:4<319::AID-BIES8>3.3.CO;2-V; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; Thieringer HA, 1998, BIOESSAYS, V20, P49; Thieringer HA, 1997, NUCLEIC ACIDS RES, V25, P4764, DOI 10.1093/nar/25.23.4764; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang LL, 2009, FISH SHELLFISH IMMUN, V26, P744, DOI 10.1016/j.fsi.2009.03.002; Wang N, 2000, MOL MICROBIOL, V38, P526, DOI 10.1046/j.1365-2958.2000.02146.x; Weber MHW, 2002, NUCLEIC ACIDS RES, V30, P375, DOI 10.1093/nar/30.1.375; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Yang CY, 2012, PLOS ONE IN PRESS; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang Y, 2010, DEV COMP IMMUNOL, V34, P418, DOI 10.1016/j.dci.2009.11.012	54	18	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32012	10.1371/journal.pone.0032012	http://dx.doi.org/10.1371/journal.pone.0032012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359656	Green Submitted, gold, Green Published			2022-12-25	WOS:000302796200125
J	Zhou, MY; Xu, AM; Tam, PKH; Lam, KSL; Huang, BS; Liang, Y; Lee, IK; Wu, DH; Wang, Y				Zhou, Mingyan; Xu, Aimin; Tam, Paul K. H.; Lam, Karen S. L.; Huang, Bosheng; Liang, Yan; Lee, In-Kyu; Wu, Donghai; Wang, Yu			Upregulation of UCP2 by Adiponectin: The Involvement of Mitochondrial Superoxide and hnRNP K	PLOS ONE			English	Article							FATTY LIVER-DISEASES; UNCOUPLING PROTEIN-2; NONALCOHOLIC STEATOHEPATITIS; TNF-ALPHA; INSULIN-RESISTANCE; HYDROGEN-PEROXIDE; MICE; OBESITY; GENE; ACTIVATION	Background: The adipocyte-derived hormone adiponectin elicits protective functions against fatty liver diseases and hepatic injuries at least in part by stimulating the expression of a mitochondrial inner membrane transporter, uncoupling protein 2 (UCP2). The present study was designed to investigate the cellular and molecular mechanisms underlying adiponectin-induced UCP2 expression. Methodology/Principal Findnigs: Mice were treated with adiponectin and/or different drug inhibitors. Parenchymal (PCs) and nonparenchymal (NPCs) cells were fractionated from the liver tissues for mitochondria isolation, Western blotting and quantitative PCR analysis. Mitochondrial superoxide production was monitored by MitoSOX staining and flow cytometry analysis. Compared to control mice, the expression of UCP2 was significantly lower in NPCs, but not PCs of adiponectin knockout mice (AKO). Both chronic and acute treatment with adiponectin selectively increased the mRNA and protein abundance of UCP2 in NPCs, especially in the enriched endothelial cell fractions. The transcription inhibitor actinomycin D could not block adiponectin-induced UCP2 expression, whereas the protein synthesis inhibitor cycloheximide inhibited the elevation of UCP2 protein but not its mRNA levels. Mitochondrial content of heterogeneous nuclear ribonucleoprotein K (hnRNP K), a nucleic acid binding protein involved in regulating mRNA transportation and stabilization, was significantly enhanced by adiponectin, which also evoked a transient elevation of mitochondrial superoxide. Rotenone, an inhibitor of mitochondrial respiratory complex I, abolished adiponectin-induced superoxide production, hnRNP K recruitment and UCP2 expression. Conclusions/Significance: Mitochondrial superoxide production stimulated by adiponectin serves as a trigger to initiate the translocation of hnRNP K, which in turn promotes UCP2 expressions in liver.	[Zhou, Mingyan; Xu, Aimin; Huang, Bosheng; Liang, Yan; Wang, Yu] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin; Lam, Karen S. L.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Tam, Paul K. H.] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Taegu, South Korea; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Kyungpook National University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Zhou, MY (corresponding author), Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.	yuwanghk@hku.hk	Xu, Aimin/D-3291-2013; Lee, In-Kyu/AAR-6374-2021; /C-4405-2009	Xu, Aimin/0000-0002-0668-033X; /0000-0001-6231-3035; wang, yu/0000-0001-8697-2940	Research Grants Council of Hong Kong [HKU777908M]; National Basic Research Program of China [2010CB945500]; US National Institutes of Health [HL-51586]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Basic Research Program of China(National Basic Research Program of China); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by Research Grants Council of Hong Kong (Project no. HKU777908M), the National Basic Research Program of China (2010CB945500). Adiponectin knockout mice were kindly provided by Dr. Lawrence Chan at Baylor College of Medicine, who generated these mice with the support of the US National Institutes of Health grant HL-51586. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Aygun C, 2006, EUR J GASTROEN HEPAT, V18, P175, DOI 10.1097/00042737-200602000-00010; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Baffy G, 2005, FRONT BIOSCI-LANDMRK, V10, P2082, DOI 10.2741/1683; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Bajaj M, 2004, J CLIN ENDOCR METAB, V89, P200, DOI 10.1210/jc.2003-031315; Balmer Maria Luisa, 2011, Ther Umsch, V68, P183, DOI 10.1024/0040-5930/a000148; Baranova A, 2006, OBES SURG, V16, P1118, DOI 10.1381/096089206778392149; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Ding XK, 2005, AM J PATHOL, V166, P1655, DOI 10.1016/S0002-9440(10)62476-5; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P2098, DOI 10.1016/j.biocel.2008.02.007; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Fulop P, 2006, HEPATOLOGY, V44, P592, DOI 10.1002/hep.21310; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Horimoto M, 2004, HEPATOLOGY, V39, P386, DOI 10.1002/hep.20047; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Kadowaki T, 2008, FEBS LETT, V582, P74, DOI 10.1016/j.febslet.2007.11.070; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Kamada Y, 2007, J HEPATOL, V47, P556, DOI 10.1016/j.jhep.2007.03.020; Klimek-Tomczak K, 2006, ACTA BIOCHIM POL, V53, P169; Krawczyk M, 2010, BEST PRACT RES CL GA, V24, P695, DOI 10.1016/j.bpg.2010.08.005; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Machado M, 2006, CURR OPIN CLIN NUTR, V9, P637, DOI 10.1097/01.mco.0000241677.40170.17; Mangge H, 2010, CURR MED CHEM, V17, P4511, DOI 10.2174/092986710794183006; Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939; Masaki T, 2004, HEPATOLOGY, V40, P177, DOI 10.1002/hep.20282; Matsumoto H, 2006, WORLD J GASTROENTERO, V12, P3352, DOI 10.3748/wjg.v12.i21.3352; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; Musso G, 2008, HEPATOLOGY, V47, P1167, DOI 10.1002/hep.22142; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Ostrowski J, 2004, J BIOL CHEM, V279, P54599, DOI 10.1074/jbc.M406753200; Ostrowski J, 2002, J BIOL CHEM, V277, P6303, DOI 10.1074/jbc.M110267200; Polyzos SA, 2010, DIABETES OBES METAB, V12, P365, DOI 10.1111/j.1463-1326.2009.01176.x; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Schullery DS, 1999, J BIOL CHEM, V274, P15101, DOI 10.1074/jbc.274.21.15101; Sennello JA, 2005, ENDOCRINOLOGY, V146, P2157, DOI 10.1210/en.2004-1572; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Vuppalanchi R, 2005, J CLIN GASTROENTEROL, V39, P237, DOI 10.1097/01.mcg.0000152747.79773.2f; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2009, ARQ BRAS ENDOCRINOL, V53, P201, DOI 10.1590/S0004-27302009000200012; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wree A, 2011, DIGESTION, V83, P124, DOI 10.1159/000318741; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yoneda M, 2007, ALCOHOL CLIN EXP RES, V31, p15S, DOI 10.1111/j.1530-0277.2006.00281.x; Zhou MY, 2008, HEPATOLOGY, V48, P1087, DOI 10.1002/hep.22444; Zhou MY, 2010, J HEPATOL, V53, P1108, DOI 10.1016/j.jhep.2010.05.034; Zhu WD, 2008, CLIN SCI, V114, P361, DOI 10.1042/CS20070347	59	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32349	10.1371/journal.pone.0032349	http://dx.doi.org/10.1371/journal.pone.0032349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359684	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200153
J	Chuang, SF; Su, LH; Cho, CC; Pan, YJ; Sun, CH				Chuang, Shen-Fung; Su, Li-Hsin; Cho, Chao-Cheng; Pan, Yu-Jiao; Sun, Chin-Hung			Functional Redundancy of Two Pax-Like Proteins in Transcriptional Activation of Cyst Wall Protein Genes in Giardia lamblia	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; DOMAIN-DNA COMPLEX; PAIRED DOMAIN; PRIMITIVE EUKARYOTE; CELL-DIFFERENTIATION; CRYSTAL-STRUCTURE; BINDING-SITES; ENCYSTATION; EXPRESSION; IDENTIFICATION	The protozoan Giardia lamblia differentiates from a pathogenic trophozoite into an infectious cyst to survive outside of the host. During encystation, genes encoding cyst wall proteins (CWPs) are coordinately induced. Pax family transcription factors are involved in a variety of developmental processes in animals. Nine Pax proteins have been found to play an important role in tissue and organ development in humans. To understand the progression from primitive to more complex eukaryotic cells, we tried to identify putative pax genes in the G. lamblia genome and found two genes, pax1 and pax2, with limited similarity. We found that Pax1 may transactivate the encystation-induced cwp genes and interact with AT-rich initiatior elements that are essential for promoter activity and transcription start site selection. In this study, we further characterized Pax2 and found that, like Pax1, Pax2 was present in Giardia nuclei and it may specifically bind to the AT-rich initiator elements of the encystation-induced cwp1-3 and myb2 genes. Interestingly, overexpression of Pax2 increased the cwp1-3 and myb2 gene expression and cyst formation. Deletion of the C-terminal paired domain or mutation of the basic amino acids of the paired domain resulted in a decrease of nuclear localization, DNA-binding activity, and transactivation activity of Pax2. These results are similar to those found in the previous Pax1 study. In addition, the profiles of gene expression in the Pax2 and Pax1 overexpressing cells significantly overlap in the same direction and ERK1 associated complexes may phosphorylate Pax2 and Pax1, suggesting that Pax2 and Pax1 may be downstream components of a MAPK/ERK1 signaling pathway. Our results reveal functional redundancy between Pax2 and Pax1 in up-regulation of the key encystation-induced genes. These results illustrate functional redundancy of a gene family can occur in order to increase maintenance of important gene function in the protozoan organism G. lamblia.	[Chuang, Shen-Fung; Su, Li-Hsin; Cho, Chao-Cheng; Pan, Yu-Jiao; Sun, Chin-Hung] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 10764, Taiwan	National Taiwan University	Chuang, SF (corresponding author), Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 10764, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021	SUN, CHIN-HUNG/0000-0002-8604-8085	National Science Council [NSC 98-2320-B-002-018-MY2, NSC 99-2320-B-002-017-MY3, NSC 100-2325-B-002 - 039]; National Health Research Institutes in Taiwan [NHRI-EX98-9510NC, NHRI-EX99-9510NC]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the National Science Council grants NSC 98-2320-B-002-018-MY2, NSC 99-2320-B-002-017-MY3, and NSC 100-2325-B-002 - 039, and the National Health Research Institutes grants NHRI-EX98-9510NC and NHRI-EX99-9510NC in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amin NM, 2009, DEV BIOL, V331, P350, DOI 10.1016/j.ydbio.2009.05.538; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Araki S, 2004, J BIOL CHEM, V279, P32979, DOI 10.1074/jbc.M403171200; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; CAI JX, 1994, MECH DEVELOP, V47, P139, DOI 10.1016/0925-4773(94)90086-8; Carranza PG, 2010, MICROBES INFECT, V12, P71, DOI 10.1016/j.micinf.2009.09.008; CARRIERE C, 1995, CELL GROWTH DIFFER, V6, P1531; Celiksoz A, 2005, PEDIATR INT, V47, P567, DOI 10.1111/j.1442-200x.2005.02110.x; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Chiu PW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000677; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Davids BJ, 2011, MOL BIOCHEM PARASIT, V175, P169, DOI 10.1016/j.molbiopara.2010.11.008; Davis-Hayman SR, 2003, INT J PARASITOL, V33, P1005, DOI 10.1016/S0020-7519(03)00177-2; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dorfler P, 1996, EMBO J, V15, P1971, DOI 10.1002/j.1460-2075.1996.tb00548.x; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Ellis JG, 2003, J BIOL CHEM, V278, P1936, DOI 10.1074/jbc.M209274200; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Emrick MA, 2006, P NATL ACAD SCI USA, V103, P18101, DOI 10.1073/pnas.0608849103; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Frost V, 2008, CRIT REV BIOCHEM MOL, V43, P371, DOI [10.1080/10409230802486208, 10.1080/10409230802486208 ]; Gillin FD, 1996, ANNU REV MICROBIOL, V50, P679, DOI 10.1146/annurev.micro.50.1.679; Gosmain Y, 2007, J BIOL CHEM, V282, P35024, DOI 10.1074/jbc.M702795200; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; HAGMAN J, 1994, CURR OPIN IMMUNOL, V6, P222, DOI 10.1016/0952-7915(94)90095-7; Hanevik K, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-27; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; Huang YC, 2008, J BIOL CHEM, V283, P31021, DOI 10.1074/jbc.M805023200; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; Lalle M, 2010, INT J PARASITOL, V40, P201, DOI 10.1016/j.ijpara.2009.07.010; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Lauwaet T, 2011, INT J PARASITOL, V41, P1079, DOI 10.1016/j.ijpara.2011.06.001; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; Morken MH, 2009, SCAND J GASTROENTERO, V44, P308, DOI 10.1080/00365520802588091; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Nornes S, 1996, J BIOL CHEM, V271, P26914, DOI 10.1074/jbc.271.43.26914; Pan YJ, 2009, J BIOL CHEM, V284, P17975, DOI 10.1074/jbc.M109.012047; Pellizzari L, 1999, BIOCHEM J, V337, P253, DOI 10.1042/0264-6021:3370253; Phelps DE, 1996, J BIOL CHEM, V271, P7978, DOI 10.1074/jbc.271.14.7978; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Robertson LJ, 2010, TRENDS PARASITOL, V26, P75, DOI 10.1016/j.pt.2009.11.010; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Seshadri V, 2003, J BIOL CHEM, V278, P27804, DOI 10.1074/jbc.M303316200; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; Stark D, 2007, INT J PARASITOL, V37, P11, DOI 10.1016/j.ijpara.2006.09.009; Stuart ET, 1996, CELL GROWTH DIFFER, V7, P405; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Su LH, 2011, J BIOL CHEM, V286, P34101, DOI 10.1074/jbc.M111.280206; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Sun CH, 1998, MOL BIOCHEM PARASIT, V92, P123, DOI 10.1016/S0166-6851(97)00239-9; Van Keulen H, 1998, J EUKARYOT MICROBIOL, V45, P637, DOI 10.1111/j.1550-7408.1998.tb04560.x; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; Wang YT, 2010, J BIOL CHEM, V285, P32213, DOI 10.1074/jbc.M110.156620; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432	80	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30614	10.1371/journal.pone.0030614	http://dx.doi.org/10.1371/journal.pone.0030614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355320	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300020
J	Herweg, J; Schwarz, G				Herweg, Jens; Schwarz, Guenter			Splice-specific Glycine Receptor Binding, Folding, and Phosphorylation of the Scaffolding Protein Gephyrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM COFACTOR BIOSYNTHESIS; INHIBITORY SYNAPSES; CRYSTAL-STRUCTURE; ALPHA-1 SUBUNIT; MOLECULAR-BASIS; CYTOSKELETON; VARIANTS; DOMAINS; SITES; GENE	The multimeric scaffolding protein gephyrin forms post-synaptic clusters at inhibitory sites, thereby anchoring inhibitory glycine (GlyR) and subsets of gamma-aminobutyric acid type A (GABAA) receptors. Gephyrin is composed of three domains, the conserved N-terminal G- and C-terminal E-domain, connected by the central (C-) domain. In this study we investigated the oligomerization, folding and stability, GlyR beta-loop binding, and phosphorylation of three gephyrin splice variants (Geph, Geph-C3, Geph-C4) after expression and purification from insect cells (Sf9). In contrast to Escherichia coli-derived trimeric gephyrin, we found that Sf9 gephyrins form hexamers as basic oligomeric form. In the case of Geph and Geph-C4, also high-oligomeric forms (similar to 900 kDa) were isolated. Partial proteolysis revealed a compact folding of the Gephyrin G and C domain in one complex, whereas a much lower stability for the E domain was found. After GlyR beta-loop binding, the stability of the E domain increased in Geph and Geph-C4 significantly. In contrast, the E domain in Geph-C3 is less stable and binds the GlyR beta-loop with one order of magnitude lower affinity. Finally, we identified 18 novel phosphorylation sites in gephyrin, of which all except one are located within the C domain. We propose two models for the domain arrangement in hexameric gephyrin based on the oligomerization of either the E or C domains, with the latter being crucial for the regulation of gephyrin clustering.	Univ Cologne, Inst Biochem, Dept Chem, D-50674 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50674 Cologne, Germany	University of Cologne; University of Cologne	Schwarz, G (corresponding author), Zuelpicher Str 47, D-50674 Cologne, Germany.	gschwarz@uni-koeln.de	Schwarz, Guenter/ABE-9643-2021; Schwarz, Guenter/F-2217-2013	Schwarz, Guenter/0000-0002-2118-9338; 	German Science Foundation (DFG) [Schw 759/6-1, DFG-SFB635 TP-A11]; Fonds der Chemischen Industrie	German Science Foundation (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the German Science Foundation (DFG Schw 759/6-1, DFG-SFB635 TP-A11 (to G. S.) and Fonds der Chemischen Industrie (to G. S.).	Bausen M, 2010, MOL CELL NEUROSCI, V44, P201, DOI 10.1016/j.mcn.2010.02.007; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cascio M, 2001, J BIOL CHEM, V276, P20981, DOI 10.1074/jbc.M010968200; Charrier C, 2010, NAT NEUROSCI, V13, P1388, DOI 10.1038/nn.2645; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Dumoulin A, 2010, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.028.2009; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Giesemann T, 2003, J NEUROSCI, V23, P8330; Han GH, 2010, ELECTROPHORESIS, V31, P1080, DOI 10.1002/elps.200900493; Jockusch BM, 2004, NEUROREPORT, V15, P1535, DOI 10.1097/01.wnr.0000131673.92694.58; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kneussel M, 1999, J NEUROCHEM, V72, P1323, DOI 10.1046/j.1471-4159.1999.0721323.x; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; LANGOSCH D, 1992, FEBS LETT, V298, P113, DOI 10.1016/0014-5793(92)80034-E; Lardi-Studler B, 2007, J CELL SCI, V120, P1371, DOI 10.1242/jcs.003905; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Meier J, 2000, MOL CELL NEUROSCI, V16, P566, DOI 10.1006/mcne.2000.0899; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Nawrotzki R, 2012, HISTOCHEM CELL BIOL, V137, P471, DOI 10.1007/s00418-012-0914-7; Paarmann I, 2006, J BIOL CHEM, V281, P34918, DOI 10.1074/jbc.M607764200; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Ramming M, 1997, FEBS LETT, V405, P137, DOI 10.1016/S0014-5793(97)00164-6; Ramming M, 2000, P NATL ACAD SCI USA, V97, P10266, DOI 10.1073/pnas.97.18.10266; Rees MI, 2003, J BIOL CHEM, V278, P24688, DOI 10.1074/jbc.M301070200; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; Schrader N, 2004, J BIOL CHEM, V279, P18733, DOI 10.1074/jbc.M311245200; Schwarz G, 2001, J MOL BIOL, V312, P405, DOI 10.1006/jmbi.2001.4952; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Smolinsky B, 2008, J BIOL CHEM, V283, P17370, DOI 10.1074/jbc.M800985200; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Sola M, 2001, J BIOL CHEM, V276, P25294, DOI 10.1074/jbc.M101923200; Specht CG, 2011, EMBO J, V30, P3842, DOI 10.1038/emboj.2011.276; Srinivasan S, 1999, J BIOL CHEM, V274, P26633, DOI 10.1074/jbc.274.38.26633; Stallmeyer B, 1999, P NATL ACAD SCI USA, V96, P1333, DOI 10.1073/pnas.96.4.1333; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tretter V, 2011, J BIOL CHEM, V286, P37702, DOI 10.1074/jbc.M111.291336; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Xia QW, 2008, J PROTEOME RES, V7, P2845, DOI 10.1021/pr8000496; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	49	53	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12645	12656		10.1074/jbc.M112.341826	http://dx.doi.org/10.1074/jbc.M112.341826			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351777	Green Published, hybrid			2022-12-25	WOS:000302903700005
J	Foster, AW; Patterson, CJ; Pernil, R; Hess, CR; Robinson, NJ				Foster, Andrew W.; Patterson, Carl J.; Pernil, Rafael; Hess, Corinna R.; Robinson, Nigel J.			Cytosolic Ni(II) Sensor in Cyanobacterium NICKEL DETECTION FOLLOWS NICKEL AFFINITY ACROSS FOUR FAMILIES OF METAL SENSORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-ION SELECTIVITY; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; REPRESSOR CSOR; COPPER EFFLUX; PROTEIN; NICKEL; BINDING; EXPRESSION; HYDROGEN	Efflux of surplus Ni(II) across the outer and inner membranes of Synechocystis PCC 6803 is mediated by the Nrs system under the control of a sensor of periplasmic Ni(II), NrsS. Here, we show that the product of ORF sll0176, which encodes a CsoR/RcnR-like protein now designated InrS (for internal nickel-responsive sensor), represses nrsD (NrsD is deduced to efflux Ni(II) across the inner membrane) from a cryptic promoter between the final two ORFs in the nrs operon. Transcripts initiated from the newly identified nrsD promoter accumulate in response to nickel or cobalt but not copper, and recombinant InrS forms specific, Ni(II)-inhibited complexes with the nrsD promoter region. Metal-dependent difference spectra of Ni(II)- and Cu(I)InrS are similar to Cu(I)-sensing CsoR and dissimilar to Ni(II)/Co(II)-sensing RcnR, consistent with factors beyond the primary coordination sphere switching metal selectivity. Competition with chelators mag-fura-2, nitrilotriacetic acid, EDTA, and EGTA estimate K-D Ni(II) for the tightest site of InrS as 2.05 (+/-1.5) x 10(-14) M, and weaker K-D Ni(II) for the cells' metal sensors of other types: Zn(II) co-repressor Zur, Co(II) activator CoaR, and Zn(II) derepressor ZiaR. Ni(II) transfer to InrS occurs upon addition to Ni(II) forms of each other sensor. InrS binds Ni(II) sufficiently tightly to derepress Ni(II) export at concentrations below K-D Ni(II) of the other sensors.	[Foster, Andrew W.; Patterson, Carl J.; Pernil, Rafael; Hess, Corinna R.; Robinson, Nigel J.] Univ Durham, Dept Chem, Sch Biol & Biomed Sci, Biophys Sci Inst, Durham DH1 3LE, England; [Foster, Andrew W.] Newcastle Univ, Sch Med, Inst Cell & Mol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Durham University; Newcastle University - UK	Robinson, NJ (corresponding author), Univ Durham, Dept Chem, Sch Biol & Biomed Sci, Biophys Sci Inst, South Rd, Durham DH1 3LE, England.	nigel.robinson@durham.ac.uk	Robinson, Nigel J/J-6363-2012; Hess, Corinna/J-1504-2012	Robinson, Nigel J/0000-0001-5586-1092; Hess, Corinna/0000-0002-9607-9184	Biotechnology and Biological Research Council [BB/H006052/2, BB/E001688/1]; Biotechnology and Biological Sciences Research Council [BB/E001688/1, BB/H006052/2, BB/H006052/1] Funding Source: researchfish; BBSRC [BB/H006052/2, BB/H006052/1, BB/E001688/1] Funding Source: UKRI	Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Research Council Grants BB/H006052/2 and BB/E001688/1.	Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Axelsson R, 2002, APPL ENVIRON MICROB, V68, P444, DOI 10.1128/AEM.68.1.444-447.2002; Baker J, 2011, ENVIRON MICROBIOL, V13, P2495, DOI 10.1111/j.1462-2920.2011.02522.x; BULLERJAHN GS, 1986, J BACTERIOL, V167, P396, DOI 10.1128/jb.167.1.396-399.1986; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Cobine PA, 2002, BIOCHEMISTRY-US, V41, P5822, DOI 10.1021/bi025515c; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; DADAY A, 1985, J GEN MICROBIOL, V131, P231; Dainty SJ, 2010, J BIOL INORG CHEM, V15, P77, DOI 10.1007/s00775-009-0555-z; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FERRIS NS, 1979, BIOCHEM BIOPH RES CO, V88, P288, DOI 10.1016/0006-291X(79)91728-5; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Garcia-Dominguez M, 2000, J BACTERIOL, V182, P1507, DOI 10.1128/JB.182.6.1507-1514.2000; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Grossoehme N, 2011, J BIOL CHEM, V286, P13522, DOI 10.1074/jbc.M111.220012; Guedon E, 2003, MOL MICROBIOL, V48, P495, DOI 10.1046/j.1365-2958.2003.03445.x; HUCKLE JW, 1993, MOL MICROBIOL, V7, P177, DOI 10.1111/j.1365-2958.1993.tb01109.x; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; Iwig JS, 2009, J MOL BIOL, V393, P514, DOI 10.1016/j.jmb.2009.08.038; Jenkins RM, 2009, INORG CHEM, V48, P7280, DOI 10.1021/ic900778k; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; Kumar S., 1991, P IND NATL SCI ACAD, V1357, P281; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Lopez-Maury L, 2002, MOL MICROBIOL, V43, P247, DOI 10.1046/j.1365-2958.2002.02741.x; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; MERCHANT S, 1991, EMBO J, V10, P1383, DOI 10.1002/j.1460-2075.1991.tb07658.x; ODERMATT A, 1995, J BIOL CHEM, V270, P4349, DOI 10.1074/jbc.270.9.4349; Olson JW, 1997, MOL MICROBIOL, V24, P119, DOI 10.1046/j.1365-2958.1997.3251690.x; OXELFELT F, 1995, PLANT PHYSIOL BIOCH, V33, P617; Pakrasi H. B., 2004, TRANSPORT METALS KEY, P253; Quinn JM, 2002, PLANT PHYSIOL, V128, P463, DOI 10.1104/pp.010694; Rakhimberdieva MG, 2004, FEBS LETT, V574, P85, DOI 10.1016/j.febslet.2004.07.087; Reyes-Caballero H, 2011, BIOCHEMISTRY-US, V50, P7941, DOI 10.1021/bi200737a; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Rutherford JC, 1999, J BIOL CHEM, V274, P25827, DOI 10.1074/jbc.274.36.25827; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Sambrook J, 2001, MOL CLONING LAB MANU; Savage N, 2011, NATURE, V474, pS15, DOI 10.1038/474S015a; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; So AKC, 1998, PLANT MOL BIOL, V37, P205, DOI 10.1023/A:1005959200390; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; Tottey Stephen, 2007, V6, P3, DOI 10.1007/7171_2006_072; Tottey S, 2012, P NATL ACAD SCI USA, V109, P95, DOI 10.1073/pnas.1117515109; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; VASAK M, 1981, BIOCHEMISTRY-US, V20, P6659, DOI 10.1021/bi00526a021; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010432; Wang SC, 2004, BIOCHEMISTRY-US, V43, P10018, DOI 10.1021/bi049405c; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x; XIANKONG Z, 1984, Journal of General Microbiology, V130, P1815; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Zhu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017367	60	41	41	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12142	12151		10.1074/jbc.M111.338301	http://dx.doi.org/10.1074/jbc.M111.338301			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22356910	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000302782200050
J	Kim, SI; Na, HJ; Ding, Y; Wang, ZB; Lee, SJ; Choi, ME				Kim, Sung Il; Na, Hee-Jun; Ding, Yan; Wang, Zhibo; Lee, Seon Jin; Choi, Mary E.			Autophagy Promotes Intracellular Degradation of Type I Collagen Induced by Transforming Growth Factor (TGF)-beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM; MATRIX METALLOPROTEINASES; CARBON-MONOXIDE; FACTOR-BETA; TGF-BETA; ACTIVATES AUTOPHAGY; MESANGIAL CELLS; TUBULAR CELLS; BECLIN-1	Autophagy is a highly conserved cellular process regulating turnover of cytoplasmic proteins via a lysosome-dependent pathway. Here we show that kidneys from mice deficient in autophagic protein Beclin 1 exhibited profibrotic phenotype, with increased collagen deposition. Reduced Beclin 1 expression, through genetic disruption of beclin 1 or knockdown by specific siRNA in primary mouse mesangial cells (MMC), resulted in increased protein levels of type I collagen (Col-I). Inhibition of autolysosomal protein degradation by bafilomycin A(1) also increased Col-I protein levels and colocalization of Col-I with LC3, an autophagy marker, or LAMP-1, a lysosome marker, whereas treatment with TFP, an inducer of autophagy, resulted in decreased Col-I protein levels induced by TGF-beta 1, without alterations in Col-I alpha 1 mRNA. Heterozygous deletion of beclin 1 increased accumulation of aggregated Col-I under nonstimulated conditions, and stimulation with TGF-beta 1 further increased aggregated Col-I. These data indicate that Col-I and aggregated, insoluble procollagen I undergo intracellular degradation via autophagy. A cytoprotective role of autophagy is implicated in kidney injury, and we demonstrate that low-dose carbon monoxide, shown to exert cytoprotection against renal fibrosis, induces autophagy to suppress accumulation of Col-I induced by TGF-beta 1. We also show that TGF-beta 1 induces autophagy in MMC via TAK1-MKK3-p38 signaling pathway. The dual functions of TGF-beta 1, as both an inducer of Col-I synthesis and an inducer of autophagy and Col-I degradation, underscore the multifunctional nature of TGF-beta 1. Our findings suggest a novel role of autophagy as a cytoprotective mechanism to negatively regulate and prevent excess collagen accumulation in the kidney.	[Kim, Sung Il; Na, Hee-Jun; Ding, Yan; Wang, Zhibo; Choi, Mary E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Renal Div, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Choi, ME (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Renal Div, 4 Blackfan Circle,HIM 5, Boston, MA 02115 USA.	mchoi@rics.bwh.harvard.edu	Lee, Seon-Jin/AAJ-8258-2020; Wang, Zhibo/GSD-3371-2022	Lee, Seon-Jin/0000-0001-7214-7536	National Institutes of Health from the NIDDK [R01 DK57661]; American Society of Nephrology (ASN); American Heart Association (AHA) [0665379U]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057661] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; American Society of Nephrology (ASN); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK57661 from the NIDDK and the M. James Scherbenske Grant from the American Society of Nephrology (to M. E. C.); Carl W. Gottschalk Research Scholar Grant from the American Society of Nephrology (ASN) and Beginning Grant-in-Aid 0665379U from the American Heart Association (AHA) (to S. I. K.).	Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; Arsov I, 2008, CELL DEATH DIFFER, V15, P1385, DOI 10.1038/cdd.2008.59; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Burman C, 2010, SEMIN IMMUNOPATHOL, V32, P397, DOI 10.1007/s00281-010-0222-z; Calvaruso G, 2006, MOL CELL BIOCHEM, V287, P13, DOI 10.1007/s11010-005-9016-3; Chin BY, 2001, AM J PHYSIOL-RENAL, V280, pF495, DOI 10.1152/ajprenal.2001.280.3.F495; Ding Y, 2010, J BIOL CHEM, V285, P37909, DOI 10.1074/jbc.M109.093724; Dolcet X, 2006, J BIOL CHEM, V281, P22118, DOI 10.1074/jbc.M601350200; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Ecker N, 2010, AUTOPHAGY, V6, P879, DOI 10.4161/auto.6.7.12753; Fineschi S, 2006, FASEB J, V20, P562, DOI 10.1096/fj.05-4870fje; Forloni G, 2002, NEUROBIOL AGING, V23, P957, DOI 10.1016/S0197-4580(02)00076-3; Gajewska M, 2005, J Physiol Pharmacol, V56 Suppl 3, P143; Gewin L, 2010, J AM SOC NEPHROL, V21, P1334, DOI 10.1681/ASN.2010020147; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Kim S. I., 2007, AM J PHYSIOL-RENAL, V292, pF1471, DOI DOI 10.1152/AJPRENAL.00485.2006; Kim SI, 2008, J BIOL CHEM, V283, P10753, DOI 10.1074/jbc.M801263200; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Lee SJ, 2011, AM J RESP CELL MOL, V45, P867, DOI 10.1165/rcmb.2010-0352OC; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li CY, 2010, J BIOL CHEM, V285, P16096, DOI 10.1074/jbc.M109.072694; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Meijer AJ, 2011, CURR BIOL, V21, pR227, DOI 10.1016/j.cub.2011.02.007; Meiners S, 2004, HYPERTENSION, V44, P471, DOI 10.1161/01.HYP.0000142772.71367.65; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Motterlini R, 2005, EXPERT OPIN INV DRUG, V14, P1305, DOI 10.1517/13543784.14.11.1305; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakamura N, 1997, J BIOCHEM, V121, P338; Nijholt DAT, 2011, CELL DEATH DIFFER, V18, P1071, DOI 10.1038/cdd.2010.176; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang L, 2002, J BIOL CHEM, V277, P47257, DOI 10.1074/jbc.M208573200; Wang L, 2008, AM J PHYSIOL-RENAL, V294, pF508, DOI 10.1152/ajprenal.00306.2007; Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YOSHIOKA K, 1990, J PATHOL, V162, P141, DOI 10.1002/path.1711620207; Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	68	165	188	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11677	11688		10.1074/jbc.M111.308460	http://dx.doi.org/10.1074/jbc.M111.308460			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351764	Green Published, hybrid			2022-12-25	WOS:000302782200008
J	Egger, J; Kapur, T; Dukatz, T; Kolodziej, M; Zukic, D; Freisleben, B; Nimsky, C				Egger, Jan; Kapur, Tina; Dukatz, Thomas; Kolodziej, Malgorzata; Zukic, Dzenan; Freisleben, Bernd; Nimsky, Christopher			Square-Cut: A Segmentation Algorithm on the Basis of a Rectangle Shape	PLOS ONE			English	Article							IMAGES	We present a rectangle-based segmentation algorithm that sets up a graph and performs a graph cut to separate an object from the background. However, graph-based algorithms distribute the graph's nodes uniformly and equidistantly on the image. Then, a smoothness term is added to force the cut to prefer a particular shape. This strategy does not allow the cut to prefer a certain structure, especially when areas of the object are indistinguishable from the background. We solve this problem by referring to a rectangle shape of the object when sampling the graph nodes, i.e., the nodes are distributed non-uniformly and non-equidistantly on the image. This strategy can be useful, when areas of the object are indistinguishable from the background. For evaluation, we focus on vertebrae images from Magnetic Resonance Imaging (MRI) datasets to support the time consuming manual slice-by-slice segmentation performed by physicians. The ground truth of the vertebrae boundaries were manually extracted by two clinical experts (neurological surgeons) with several years of experience in spine surgery and afterwards compared with the automatic segmentation results of the proposed scheme yielding an average Dice Similarity Coefficient (DSC) of 90.97 +/- 2.2%.	[Egger, Jan; Kapur, Tina] Harvard Univ, Brigham & Womens Hosp, Sch Med, Surg Planning Lab,Dept Radiol, Boston, MA 02115 USA; [Egger, Jan; Dukatz, Thomas; Kolodziej, Malgorzata; Nimsky, Christopher] Univ Marburg, Dept Neurosurg, Marburg, Germany; [Egger, Jan; Freisleben, Bernd] Univ Marburg, Dept Math & Comp Sci, Marburg, Germany; [Zukic, Dzenan] Univ Siegen, Comp Graph Grp, Siegen, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Philipps University Marburg; Philipps University Marburg; Universitat Siegen	Egger, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Surg Planning Lab,Dept Radiol, Boston, MA 02115 USA.	egger@bwh.harvard.edu	Nimsky, Christopher/E-3702-2014	Nimsky, Christopher/0000-0002-8216-9410; Zukic, Dzenan/0000-0002-9546-9703; Freisleben, Bernd/0000-0002-7205-8389	NIH [P41RR19703, R03EB013792]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR019703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149, R03EB013792] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by NIH P41RR19703 and R03EB013792. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DSLICER FREE OP SOUR; Bauer MHA, 2010, 20 INT C PATT REC IC; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Carballido-Gamio J, 2004, IEEE T MED IMAGING, V23, P36, DOI 10.1109/TMI.2003.819929; DSlicer Wiki, 36 DSLICER WIK; Egger J., 2008, 4th European Conference of the International Federation for Medical and Biological Engineering - ECIFMBE 2008, P584; Egger J, 2012, P BILDV MED IN PRESS; Egger J, 2011, 4 NCIGT NIH IM GUID; Egger J., 2010, P 6 RUSS BAV C BIOM; Egger J, 2011, J MED SYSTEMS JOMS; Egger J., 2010, LNCS, V6376, P383; Egger J., 2009, 12 INT C MED IM COMP; Egger J, 2010, BIOS PROC C DGBMT; Ghebreab S, 2004, IEEE T BIO-MED ENG, V51, P1821, DOI 10.1109/TBME.2004.831540; Grady L, 2006, IEEE T PATTERN ANAL, V28, P469, DOI 10.1109/TPAMI.2006.57; Hicks GE, 2009, SPINE, V34, P1301, DOI 10.1097/BRS.0b013e3181a18263; Hoad CL, 2002, PHYS MED BIOL, V47, P3503, DOI 10.1088/0031-9155/47/19/305; Huang SH, 2009, IEEE T MED IMAGING, V28, P1595, DOI 10.1109/TMI.2009.2023362; Ishikawa H, 1998, PROC CVPR IEEE, P125, DOI 10.1109/CVPR.1998.698598; JACKSON RP, 1989, SPINE, V14, P1362, DOI 10.1097/00007632-198912000-00013; Jeanneret B, 1997, Acta Chir Orthop Traumatol Cech, V64, P133; Joaquim AF, 2009, ARQ NEURO-PSIQUIAT, V67, P553, DOI 10.1590/S0004-282X2009000300039; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Klinder T, 2008, LECT NOTES COMPUT SC, V5241, P227, DOI 10.1007/978-3-540-85988-8_28; Li K, 2006, IEEE T PATTERN ANAL, V28, P119, DOI 10.1109/TPAMI.2006.19; McInerney T, 1996, Med Image Anal, V1, P91, DOI 10.1016/S1361-8415(96)80007-7; Michopoulou SK, 2009, IEEE T BIO-MED ENG, V56, P2225, DOI 10.1109/TBME.2009.2019765; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Peng ZG, 2005, P ANN INT IEEE EMBS, P2527; Richards PJ, 2010, SPINE, V35, P430, DOI 10.1097/BRS.0b013e3181cdde47; Sampat M. P., 2006, IEEE INT C IM PROC; Seifert S, 2009, SPIE MED IMAGING C; Shi RQ, 2007, 2007 IEEE/ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, VOLS 1-4, P713, DOI 10.1109/ICCME.2007.4381830; Stern D, 2011, P SPIE MED IMAGING, V7963; Veksler O, 2008, LECT NOTES COMPUT SC, V5304, P454, DOI 10.1007/978-3-540-88690-7_34; Vezhnevets V., 2005, P GRAPH, V1, P150, DOI DOI 10.1016/J.AJ0D0.2004.07.036; Weber MA, 2007, RADIOLOGE, V47, P492, DOI 10.1007/s00117-007-1495-7; Weese J., 2001, Information Processing in Medical Imaging. 17th International Conference, IPMI 2001. Proceedings (Lecture Notes in Computer Science Vol.2082), P380; Yao JH, 2006, I S BIOMED IMAGING, P390; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	41	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31064	10.1371/journal.pone.0031064	http://dx.doi.org/10.1371/journal.pone.0031064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363547	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700023
J	Chang, J; Dinney, CP; Huang, MS; Wu, XF; Gu, J				Chang, Joshua; Dinney, Colin P.; Huang, Maosheng; Wu, Xifeng; Gu, Jian			Genetic Variants in Telomere-Maintenance Genes and Bladder Cancer Risk	PLOS ONE			English	Article							LENGTH; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION; SHELTERIN	Telomeres are critical in maintaining genomic stability. Genetic variants in telomere pathway genes may affect telomere and telomerase function, and subsequently cancer risk. We evaluated 126 SNPs from 10 genes related to telomere regulation in relation to bladder cancer risk. Five SNPs, 4 from TEP1 gene and 1 from PINX1 gene, were found to be highly significant (P<0.01). Out of these, the most significant association was found in rs2228041 of TEP1 (OR 1.66, 95% CI 1.19-2.31) while rs1469557 of PINX1 had a protective effect (OR 0.75, 95% CI 0.61-0.93). Haplotype analysis showed that a TEP1 haplotype consisting of the variant alleles of 7 SNPs exhibited a 2.28 fold increased risk (95% CI 1.13-4.60). We then performed cumulative analysis of multiple risk variants, as well as Classification and Regression Tree (CART) to look for gene-gene interactions. In cumulative effect analysis, the group with 4-5 risk variants had an OR of 2.57 (95% CI = 1.62-4.09) versus the reference group with 0 risk variants. The CART analysis categorized individuals into five subgroups with different bladder cancer risk profiles based on their distinct genotype background. To our knowledge, this is one of the largest, most comprehensive studies on bladder cancer risk concerning telomere-regulating pathway gene SNPs and our results support that genetic variations of telomere maintenance modulate bladder cancer risk individually and jointly.	[Chang, Joshua; Wu, Xifeng; Gu, Jian] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Dinney, Colin P.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chang, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	jiangu@mdanderson.org	Gu, Jian/Q-4780-2018	Gu, Jian/0000-0003-3499-0973; Dinney, Colin/0000-0002-8969-711X	National Institutes of Health [CA131335, CA74880, CA91846, CA127615]; NATIONAL CANCER INSTITUTE [R01CA131335, R01CA074880, U01CA127615, P50CA091846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grants CA131335, CA74880, CA91846, and CA127615. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AS, 2009, HUM GENET, V125, P527, DOI 10.1007/s00439-009-0645-6; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Baird DM, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000147X; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; Carreon T, 2006, FRONT BIOSCI-LANDMRK, V11, P2889, DOI 10.2741/2017; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1995, TELOMERES, P265; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Greider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90; Hiyama E, 2003, CANCER LETT, V194, P221, DOI 10.1016/S0304-3835(02)00709-7; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Klapper W, 2001, MECH AGEING DEV, V122, P695, DOI 10.1016/S0047-6374(01)00223-8; Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045; Mavrommatis J, 2005, ANTICANCER RES, V25, P3109; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mirabello L, 2010, CANCER CAUSE CONTROL, V21, P77, DOI 10.1007/s10552-009-9436-6; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Risques RA, 2007, CANCER EPIDEM BIOMAR, V16, P2649, DOI 10.1158/1055-9965.EPI-07-0624; Shao L, 2007, J UROLOGY, V178, P1492, DOI 10.1016/j.juro.2007.05.112; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489; Terry PD, 2006, INT J CANCER, V118, P3170, DOI 10.1002/ijc.21768; Verfaillie Catherine M, 2002, Hematology Am Soc Hematol Educ Program, P369; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Wu XF, 2007, FRONT BIOSCI-LANDMRK, V12, P192, DOI 10.2741/2058; Zheng YL, 2011, HUM MOL GENET, V20, P378, DOI 10.1093/hmg/ddq461; Zhou XZ, 2011, J CLIN INVEST, V121, P1266, DOI 10.1172/JCI43452; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	33	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30665	10.1371/journal.pone.0030665	http://dx.doi.org/10.1371/journal.pone.0030665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363464	Green Published, gold			2022-12-25	WOS:000302853600050
J	de la Concha, EG; Cavanillas, ML; Cenit, MC; Urcelay, E; Arroyo, R; Fernandez, O; Alvarez-Cermeno, JC; Leyva, L; Villar, LM; Nunez, C				de la Concha, Emilio G.; Cavanillas, Maria L.; Cenit, M. Carmen; Urcelay, Elena; Arroyo, Rafael; Fernandez, Oscar; Alvarez-Cermeno, Jose C.; Leyva, Laura; Villar, Luisa M.; Nunez, Concepcion			DRB1*03:01 Haplotypes: Differential Contribution to Multiple Sclerosis Risk and Specific Association with the Presence of Intrathecal IgM Bands	PLOS ONE			English	Article							OLIGOCLONAL IGM; DISEASE COURSE; SUSCEPTIBILITY; ALLELES; POLYMORPHISM; POPULATION; RESISTANCE; SARDINIA; HLA-DRB1; PREDICTS	Background: Multiple sclerosis (MS) is a multifactorial disease with a genetic basis. The strongest associations with the disease lie in the Human Leukocyte Antigen (HLA) region. However, except for the DRB1*15:01 allele, the main risk factor associated to MS so far, no consistent effect has been described for any other variant. One example is HLA-DRB1*03:01, with a heterogeneous effect across populations and studies. We postulate that those discrepancies could be due to differences in the diverse haplotypes bearing that allele. Thus, we aimed at studying the association of DRB1*03:01 with MS susceptibility considering this allele globally and stratified by haplotypes. We also evaluated the association with the presence of oligoclonal IgM bands against myelin lipids (OCMB) in cerebrospinal fluid. Methods: Genotyping of HLA-B, -DRB1 and -DQA1 was performed in 1068 MS patients and 624 ethnically matched healthy controls. One hundred and thirty-nine MS patients were classified according to the presence (M+, 58 patients)/absence (M-, 81 patients) of OCMB. Comparisons between groups (MS patients vs. controls and M+ vs. M-) were performed with the chisquare test or the Fisher exact test. Results: Association of DRB1*03: 01 with MS susceptibility was observed but with different haplotypic contribution, being the ancestral haplotype (AH) 18.2 the one causing the highest risk. Comparisons between M+, M- and controls showed that the AH 18.2 was affecting only M+ individuals, conferring a risk similar to that caused by DRB1*15:01. Conclusions: The diverse DRB1*03:01-containing haplotypes contribute with different risk to MS susceptibility. The AH 18.2 causes the highest risk and affects only to individuals showing OCMB.	[de la Concha, Emilio G.; Cavanillas, Maria L.; Cenit, M. Carmen; Urcelay, Elena; Nunez, Concepcion] Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Dept Clin Immunol, Madrid, Spain; [Arroyo, Rafael] Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Dept Neurol, Madrid, Spain; [Fernandez, Oscar] Hosp Reg Univ Carlos Haya, Clin Neurosci Inst, Dept Neurol, Malaga, Spain; [Alvarez-Cermeno, Jose C.] Hosp Ramon & Cajal, Dept Neurol, E-28034 Madrid, Spain; [Leyva, Laura] Hosp Reg Univ Carlos Haya & Fdn IMABIS, Clin Neurosci Inst, Res Lab, Malaga, Spain; [Villar, Luisa M.] Hosp Ramon & Cajal, Dept Immunol, E-28034 Madrid, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Carlos Haya; Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal	de la Concha, EG (corresponding author), Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Dept Clin Immunol, Madrid, Spain.	conchita.npardo@gmail.com	Cenit, Maria Carmen MC/E-9538-2017; Leyva, Laura/B-5574-2019; Leyva, Laura/R-2187-2019	Cenit, Maria Carmen MC/0000-0001-8667-5313; Leyva, Laura/0000-0003-0620-9625; Leyva, Laura/0000-0003-0620-9625; Urcelay, Elena/0000-0001-8470-8396; Villar, Luisa M/0000-0002-9067-3668	Fondo de Investigaciones Sanitarias [PI10/1985]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by project PI10/1985 from "Fondo de Investigaciones Sanitarias". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Baschal EE, 2009, CLIN IMMUNOL, V132, P203, DOI 10.1016/j.clim.2009.03.530; Benedek G, 2010, GENES IMMUN, V11, P423, DOI 10.1038/gene.2010.20; Bosca I, 2010, MULT SCLER J, V16, P810, DOI 10.1177/1352458510371961; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Fernandez-Arquero M, 1999, NEUROLOGY, V53, P1361, DOI 10.1212/WNL.53.6.1361; Garcia-Barragan N, 2009, EUR J NEUROL, V16, P380, DOI 10.1111/j.1468-1331.2008.02504.x; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; Marrosu MG, 1997, AM J HUM GENET, V61, P454; Martinez A, 2004, NEUROLOGY, V62, P809, DOI 10.1212/01.WNL.0000113722.93895.8B; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; NEDOSPASOV SA, 1991, J IMMUNOL, V147, P1053; Perini P, 2006, J NEUROL NEUROSUR PS, V77, P953, DOI 10.1136/jnnp.2005.086116; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Ramagopalan SV, 2007, PLOS GENET, V3, P1607, DOI 10.1371/journal.pgen.0030150; Thangarajh M, 2008, MULT SCLER J, V14, P1208, DOI 10.1177/1352458508095729; Villar LM, 2005, J CLIN INVEST, V115, P187, DOI 10.1172/JCI200522833; Villar LM, 2010, CLIN IMMUNOL, V137, P51, DOI 10.1016/j.clim.2010.06.007	20	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31018	10.1371/journal.pone.0031018	http://dx.doi.org/10.1371/journal.pone.0031018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363536	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600097
J	Deco, G; Hugues, E				Deco, Gustavo; Hugues, Etienne			Balanced Input Allows Optimal Encoding in a Stochastic Binary Neural Network Model: An Analytical Study	PLOS ONE			English	Article							AREA V4; ATTENTION; INHIBITION; MECHANISMS; CORTEX	Recent neurophysiological experiments have demonstrated a remarkable effect of attention on the underlying neural activity that suggests for the first time that information encoding is indeed actively influenced by attention. Single cell recordings show that attention reduces both the neural variability and correlations in the attended condition with respect to the non-attended one. This reduction of variability and redundancy enhances the information associated with the detection and further processing of the attended stimulus. Beyond the attentional paradigm, the local activity in a neural circuit can be modulated in a number of ways, leading to the general question of understanding how the activity of such circuits is sensitive to these relatively small modulations. Here, using an analytically tractable neural network model, we demonstrate how this enhancement of information emerges when excitatory and inhibitory synaptic currents are balanced. In particular, we show that the network encoding sensitivity - as measured by the Fisher information-is maximized at the exact balance. Furthermore, we find a similar result for a more realistic spiking neural network model. As the regime of balanced inputs has been experimentally observed, these results suggest that this regime is functionally important from an information encoding standpoint.	[Deco, Gustavo; Hugues, Etienne] Univ Pompeu Fabra, Ctr Brain & Cognit, Barcelona, Spain; [Deco, Gustavo] Univ Pompeu Fabra, ICREA, Barcelona, Spain	Pompeu Fabra University; University of Barcelona; ICREA; Pompeu Fabra University	Deco, G (corresponding author), Univ Pompeu Fabra, Ctr Brain & Cognit, Barcelona, Spain.	gustavo.deco@upf.edu	2010, BRAINGLOT Consolider Ingenio/D-1235-2009; DECO, GUSTAVO/A-6341-2008; Hugues, Etienne/D-7988-2014	DECO, GUSTAVO/0000-0002-8995-7583; Hugues, Etienne/0000-0002-6008-2381	European Union [269921, 269459]; Spanish Research Project [SAF2010-16085]; CONSOLIDER-INGENIO Programme [CSD2007-00012]; ICREA Funding Source: Custom	European Union(European Commission); Spanish Research Project(Spanish Government); CONSOLIDER-INGENIO Programme(Spanish Government); ICREA(ICREA)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreements no. 269921(BrainScaleS) and no. 269459 (Coronet), from the Spanish Research Project SAF2010-16085 and from the CONSOLIDER-INGENIO 2010 Programme CSD2007-00012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Buice MA, 2009, PROG BIOPHYS MOL BIO, V99, P53, DOI 10.1016/j.pbiomolbio.2009.07.003; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Deco G, 2005, J NEUROPHYSIOL, V94, P295, DOI 10.1152/jn.01095.2004; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; GLAUBER RJ, 1963, J MATH PHYS, V4, P294, DOI 10.1063/1.1703954; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hertz J., 1990, INTRO THEORY NEURAL; Hugues E, 2010, J PHYSIOL-PARIS, V104, P84, DOI 10.1016/j.jphysparis.2009.11.006; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Rolls E. T., 2010, NOISY BRAIN; Rolls ET, 2002, COMPUTATIONAL NEUROS; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724	21	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30723	10.1371/journal.pone.0030723	http://dx.doi.org/10.1371/journal.pone.0030723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359550	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200019
J	Liu, CY; Li, JJ; Gao, JH; Shen, ZC; Lu, BR; Lin, CY				Liu, Chengyi; Li, Jingjing; Gao, Jianhua; Shen, Zhicheng; Lu, Bao-Rong; Lin, Chaoyang			A Built-In Mechanism to Mitigate the Spread of Insect-Resistance and Herbicide-Tolerance Transgenes into Weedy Rice Populations	PLOS ONE			English	Article							ORYZA-SATIVA L.; GENE FLOW; BACILLUS-THURINGIENSIS; CULTIVATED RICE; CRY1AB GENE; DIFFERENTIATION; BEHAVIOR	Background: The major challenge of cultivating genetically modified (GM) rice (Oryza sativa) at the commercial scale is to prevent the spread of transgenes from GM cultivated rice to its coexisting weedy rice (O. sativa f. spontanea). The strategic development of GM rice with a built-in control mechanism can mitigate transgene spread in weedy rice populations. Methodology/Principal Findings: An RNAi cassette suppressing the expression of the bentazon detoxifying enzyme CYP81A6 was constructed into the T-DNA which contained two tightly linked transgenes expressing the Bt insecticidal protein Cry1Ab and the glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), respectively. GM rice plants developed from this T-DNA were resistant to lepidopteran pests and tolerant to glyphosate, but sensitive to bentazon. The application of bentazon of 2000 mg/L at the rate of 40 mL/m(2), which is approximately the recommended dose for the field application to control common rice weeds, killed all F-2 plants containing the transgenes generated from the Crop-weed hybrids between a GM rice line (CGH-13) and two weedy rice strains (PI-63 and PI-1401). Conclusions/Significance: Weedy rice plants containing transgenes from GM rice through gene flow can be selectively killed by the spray of bentazon when a non-GM rice variety is cultivated alternately in a few-year interval. The built-in control mechanism in combination of cropping management is likely to mitigate the spread of transgenes into weedy rice populations.	[Liu, Chengyi; Li, Jingjing; Gao, Jianhua; Shen, Zhicheng; Lin, Chaoyang] Zhejiang Univ, State Key Lab Rice Biol, Inst Insect Sci, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Bao-Rong] Fudan Univ, Minist Educ, Key Lab Biodivers & Ecol Engn, Inst Biodivers Sci, Shanghai 200433, Peoples R China	Zhejiang University; Fudan University	Liu, CY (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Inst Insect Sci, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	chylin@zju.edu.cn	Lu, Bao-Rong/C-3130-2009	Lu, Bao-Rong/0000-0002-0214-2390	National Natural Science Foundation of China [31021003, 30900950]; Department of Agriculture of China [2011ZX08011-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Agriculture of China	This work was suppored by the National Natural Science Foundation of China (31021003 and 30900950) and Grants from the Department of Agriculture of China (2011ZX08011-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj S, 2005, PLANT BIOTECHNOL J, V3, P275, DOI 10.1111/j.1467-7652.2005.00130.x; Burgos NR., 2007, WEEDY RICE ORIGIN BI; Cao QJ, 2007, WEED BIOL MANAG, V7, P97, DOI 10.1111/j.1445-6664.2007.00241.x; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Ferrero A, 1999, CROP PROT, V18, P245, DOI 10.1016/S0261-2194(99)00022-8; HUBER R, 1994, REV ENVIRON CONTAM T, V137, P111; Jiang H., 1985, CROP GENET RES, V2, P4; Lin CY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001818; Lu BR, 2009, BIOTECHNOL ADV, V27, P1083, DOI 10.1016/j.biotechadv.2009.05.018; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; Lu BR, 2003, PROG NAT SCI-MATER, V13, P17; Madsen KH, 2002, WEED TECHNOL, V16, P215, DOI 10.1614/0890-037X(2002)016[0215:RAOHRC]2.0.CO;2; Messeguer J, 2004, MOL BREEDING, V13, P103, DOI 10.1023/B:MOLB.0000012285.39859.9d; Olofsdotter M, 2000, ANN APPL BIOL, V137, P279, DOI 10.1111/j.1744-7348.2000.tb00069.x; Pan G, 2006, PLANT MOL BIOL, V61, P933, DOI 10.1007/s11103-006-0058-z; Qaim M, 2009, ANNU REV RESOUR ECON, V1, P665, DOI 10.1146/annurev.resource.050708.144203; Shu QY, 2000, MOL BREEDING, V6, P433, DOI 10.1023/A:1009658024114; Song ZP, 2006, EVOL ECOL, V20, P501, DOI 10.1007/s10682-006-9113-0; Sun J.D., 2005, WEED SCI CHINA, V2, P21; [王黎明 Wang Liming], 2009, [植物保护, Plant Protection], V35, P14; Wang W.X., 2005, WEED SCI CHINA, V2, P1; Xia HB, 2011, NEW PHYTOL, V191, P1119, DOI 10.1111/j.1469-8137.2011.03766.x; Xia HB, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016189, 10.1371/journal.pone.0028553]; Ye GY, 2003, CROP PROT, V22, P171, DOI 10.1016/S0261-2194(02)00142-4; Yu GQ, 2005, BIOCHEM GENET, V43, P261, DOI 10.1007/s10528-005-5218-3; Zhang CX, 2000, WILD WEEDY RICE RICE	27	12	15	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31625	10.1371/journal.pone.0031625	http://dx.doi.org/10.1371/journal.pone.0031625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359609	gold, Green Submitted, Green Published			2022-12-25	WOS:000302796200078
J	Taheri-Talesh, N; Xiong, Y; Oakley, BR				Taheri-Talesh, Naimeh; Xiong, Yi; Oakley, Berl R.			The Functions of Myosin II and Myosin V Homologs in Tip Growth and Septation in Aspergillus nidulans	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; MOTOR-LIKE DOMAIN; FUNGUS USTILAGO-MAYDIS; SPINDLE POLE BODY; ACTIN CYTOSKELETON; HYPHAL GROWTH; GAMMA-TUBULIN; FILAMENTOUS FUNGUS; POLARIZED GROWTH; CHITIN SYNTHASES	Because of the industrial and medical importance of members of the fungal genus Aspergillus, there is considerable interest in the functions of cytoskeletal components in growth and secretion in these organisms. We have analyzed the genome of Aspergillus nidulans and found that there are two previously unstudied myosin genes, a myosin II homolog, myoB (product = MyoB) and a myosin V homolog, myoE (product = MyoE). Deletions of either cause significant growth defects. MyoB localizes in strings that coalesce into contractile rings at forming septa. It is critical for septation and normal deposition of chitin but not for hyphal extension. MyoE localizes to the Spitzenkorper and to moving puncta in the cytoplasm. Time-lapse imaging of SynA, a v-SNARE, reveals that in myoE deletion strains vesicles no longer localize to the Spitzenkorper. Tip morphology is slightly abnormal and branching occurs more frequently than in controls. Tip extension is slower than in controls, but because hyphal diameter is greater, growth (increase in volume/time) is only slightly reduced. Concentration of vesicles into the Spitzenkorper before incorporation into the plasma membrane is, thus, not required for hyphal growth but facilitates faster tip extension and a more normal hyphal shape.	[Taheri-Talesh, Naimeh; Oakley, Berl R.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Xiong, Yi; Oakley, Berl R.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University of Kansas; University System of Ohio; Ohio State University	Taheri-Talesh, N (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	boakley@ku.edu	Xiong, Yi/E-3083-2010	Oakley, Berl/0000-0002-3046-8240	National Institute of General Medical Sciences; University of Kansas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031837] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Kansas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences, http://www.nigms.nih.gov/, and the University of Kansas Endowment Fund, http://www.kuendowment.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; Bartnicki-Garcia S, 2000, BIOPHYS J, V79, P2382, DOI 10.1016/S0006-3495(00)76483-6; Bartnicki-Garcia S., 1990, TIP GROWTH PLANT FUN, P211; BARTNICKIGARCIA S, 1995, EXP MYCOL, V19, P153, DOI 10.1006/emyc.1995.1017; BARTNICKIGARCIA S, 1989, PROTOPLASMA, V153, P46, DOI 10.1007/BF01322464; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Canovas D, 2011, EUKARYOT CELL, V10, P302, DOI 10.1128/EC.00201-10; CLUTTERBUCK AJ, 1970, J GEN MICROBIOL, V60, P133, DOI 10.1099/00221287-60-1-133; Fernandez-Abalos JM, 1998, MOL MICROBIOL, V27, P121, DOI 10.1046/j.1365-2958.1998.00664.x; FIDDY C, 1976, J GEN MICROBIOL, V97, P169, DOI 10.1099/00221287-97-2-169; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Gierz G, 2001, J THEOR BIOL, V208, P151, DOI 10.1006/jtbi.2000.2209; GROVE SN, 1970, J BACTERIOL, V104, P989, DOI 10.1128/JB.104.2.989-1009.1970; HARRIS SD, 1994, GENETICS, V136, P517; Harris SD, 2001, CURR OPIN MICROBIOL, V4, P736, DOI 10.1016/S1369-5274(01)00276-4; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Heath I. Brent, 1996, Mycoscience, V37, P71; HEATH IB, 2000, ACTIN DYNAMIC FRAMEW, P275; Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798; Jung MK, 2001, MOL BIOL CELL, V12, P2119, DOI 10.1091/mbc.12.7.2119; Kim JM, 2009, MOL BIOL CELL, V20, P2874, DOI 10.1091/mbc.E08-12-1177; Laporte D, 2010, SEMIN CELL DEV BIOL, V21, P892, DOI 10.1016/j.semcdb.2010.08.004; Lee SB, 1990, PCR PROTOCOLS GUIDE, P282, DOI DOI 10.1016/B978-0-12-372180-8.50038-X; Martin MA, 1997, J CELL SCI, V110, P623; MCGOLDRICK CA, 1995, J CELL BIOL, V128, P577, DOI 10.1083/jcb.128.4.577; Mishra M, 2008, CURR BIOL, V18, pR247, DOI 10.1016/j.cub.2008.01.029; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; OAKLEY CE, 1987, GENE, V53, P293, DOI 10.1016/0378-1119(87)90019-9; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Osmani AH, 2006, NAT PROTOC, V1, P2517, DOI 10.1038/nprot.2006.406; OSMANI SA, 1988, CELL, V52, P241, DOI 10.1016/0092-8674(88)90513-2; Pearson CL, 2004, MOL BIOL CELL, V15, P3658, DOI 10.1091/mbc.E03-11-0803; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Riquelme M, 2007, EUKARYOT CELL, V6, P1853, DOI 10.1128/EC.00088-07; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Schuchardt I, 2005, MOL BIOL CELL, V16, P5191, DOI 10.1091/mbc.E05-04-0272; Schuster M, 2011, EMBO J; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Steinberg G, 2007, NAT REV MICROBIOL, V5, P309, DOI 10.1038/nrmicro1618; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Szewczyk E, 2011, FUNGAL GENET BIOL, V48, P998, DOI 10.1016/j.fgb.2011.07.003; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Takeshita N, 2006, MOL MICROBIOL, V59, P1380, DOI 10.1111/j.1365-2958.2006.05030.x; Takeshita N, 2005, MOL BIOL CELL, V16, P1961, DOI 10.1091/mbc.E04-09-0761; Torralba S, 1998, MICROBIOL-SGM, V144, P45, DOI 10.1099/00221287-144-1-45; Tsuizaki M, 2009, BIOSCI BIOTECH BIOCH, V73, P1163, DOI 10.1271/bbb.90074; Virag A, 2006, MYCOL RES, V110, P4, DOI 10.1016/j.mycres.2005.09.005; VISHNIAC W, 1957, BACTERIOL REV, V21, P195, DOI 10.1128/MMBR.21.3.195-213.1957; Weber I, 2003, PLANT CELL, V15, P2826, DOI 10.1105/tpc.016246; Wedlich-Soldner R, 2000, EMBO J, V19, P1974, DOI 10.1093/emboj/19.9.1974; Weidner G, 1998, CURR GENET, V33, P378, DOI 10.1007/s002940050350; Wolkow TD, 1996, J CELL SCI, V109, P2179; Woo M, 2003, FEMS MICROBIOL LETT, V218, P195, DOI 10.1111/j.1574-6968.2003.tb11518.x; Xiang X, 2003, CURR OPIN MICROBIOL, V6, P628, DOI 10.1016/j.mib.2003.10.009; Yamashita RA, 1998, J BIOL CHEM, V273, P14644, DOI 10.1074/jbc.273.23.14644; Yamashita RA, 2000, CELL MOTIL CYTOSKEL, V45, P163, DOI 10.1002/(SICI)1097-0169(200002)45:2<163::AID-CM7>3.0.CO;2-D; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004	61	66	70	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31218	10.1371/journal.pone.0031218	http://dx.doi.org/10.1371/journal.pone.0031218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359575	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200044
J	Virgilio, M; Jordaens, K; Breman, FC; Backeljau, T; De Meyer, M				Virgilio, Massimiliano; Jordaens, Kurt; Breman, Floris C.; Backeljau, Thierry; De Meyer, Marc			Identifying Insects with Incomplete DNA Barcode Libraries, African Fruit Flies (Diptera: Tephritidae) as a Test Case	PLOS ONE			English	Article							IDENTIFICATION; TAXONOMY; RATES; FULL	We propose a general working strategy to deal with incomplete reference libraries in the DNA barcoding identification of species. Considering that (1) queries with a large genetic distance with their best DNA barcode match are more likely to be misidentified and (2) imposing a distance threshold profitably reduces identification errors, we modelled relationships between identification performances and distance thresholds in four DNA barcode libraries of Diptera (n = 4270), Lepidoptera (n = 7577), Hymenoptera (n = 2067) and Tephritidae (n = 602 DNA barcodes). In all cases, more restrictive distance thresholds produced a gradual increase in the proportion of true negatives, a gradual decrease of false positives and more abrupt variations in the proportions of true positives and false negatives. More restrictive distance thresholds improved precision, yet negatively affected accuracy due to the higher proportions of queries discarded (viz. having a distance query-best match above the threshold). Using a simple linear regression we calculated an ad hoc distance threshold for the tephritid library producing an estimated relative identification error <0.05. According to the expectations, when we used this threshold for the identification of 188 independently collected tephritids, less than 5% of queries with a distance query-best match below the threshold were misidentified. Ad hoc thresholds can be calculated for each particular reference library of DNA barcodes and should be used as cut-off mark defining whether we can proceed identifying the query with a known estimated error probability (e.g. 5%) or whether we should discard the query and consider alternative/complementary identification methods.	[Virgilio, Massimiliano; Jordaens, Kurt; Breman, Floris C.; De Meyer, Marc] Royal Museum Cent Africa, Tervuren, Belgium; [Virgilio, Massimiliano; Backeljau, Thierry] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Jordaens, Kurt; Breman, Floris C.] Joint Expt Mol Unit, Tervuren, Belgium; [Backeljau, Thierry] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium	Royal Museum for Central Africa; Royal Belgian Institute of Natural Sciences; University of Antwerp	Virgilio, M (corresponding author), Royal Museum Cent Africa, Tervuren, Belgium.	massimilano.virgilio@africamuseum.be		Virgilio, Massimiliano/0000-0002-1323-6886	Belgian Science Policy (BELSPO) [MO/37/029]	Belgian Science Policy (BELSPO)(Belgian Federal Science Policy Office)	Massimiliano Virgilio was funded by the Belgian Science Policy (BELSPO) Action 1 project MO/37/029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Barr NB, 2012, ANN ENTOMOL SOC AM, V105, P339, DOI 10.1603/AN11100; De Meyer M, 2005, INSECT SYST EVOL, V36, P459, DOI 10.1163/187631205794761012; Ekesi S, 2007, FIELD GUIDE MANAGEME; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, INSECT BIODIVERSITY; Hebert Paul D. N., 2004, PLoS Biology, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Van Houdt JKJ, 2010, MOL ECOL RESOUR, V10, P459, DOI 10.1111/j.1755-0998.2009.02800.x; Virgilio M, 2009, MOL PHYLOGENET EVOL, V51, P531, DOI 10.1016/j.ympev.2009.01.003; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; White I, 1994, FRUIT FLIES EC SIGNI, V82, P433, DOI 10.1017/S0007485300041237; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Yoo HS, 2006, MOL CELLS, V22, P323	28	65	67	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31581	10.1371/journal.pone.0031581	http://dx.doi.org/10.1371/journal.pone.0031581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359600	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200069
J	Wang, JH; Shih, KS; Liou, JP; Wu, YW; Chang, ASY; Wang, KL; Tsai, CL; Yang, CR				Wang, Jyh-Horng; Shih, Kao-Shang; Liou, Jing-Ping; Wu, Yi-Wen; Chang, Anita Shin-Yuan; Wang, Kang-Li; Tsai, Ching-Lin; Yang, Chia-Ron			Anti-Arthritic Effects of Magnolol in Human Interleukin 1 beta-Stimulated Fibroblast-Like Synoviocytes and in a Rat Arthritis Model	PLOS ONE			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; IN-VITRO; EXPRESSION; OSTEOARTHRITIS; HONOKIOL; CELLS; OFFICINALIS; INHIBITION; CYTOKINES	Fibroblast-like synoviocytes (FLS) play an important role in the pathologic processes of destructive arthritis by producing a number of catabolic cytokines and metalloproteinases (MMPs). The expression of these mediators is controlled at the transcriptional level. The purposes of this study were to evaluate the anti-arthritic effects of magnolol (5,5'-Diallyl-biphenyl2,2'-diol), the major bioactive component of the bark of Magnolia officinalis, by examining its inhibitory effects on inflammatory mediator secretion and the NF-kappa B and AP-1 activation pathways and to investigate its therapeutic effects on the development of arthritis in a rat model. The in vitro anti-arthritic activity of magnolol was tested on interleukin (IL)-1 beta-stimulated FLS by measuring levels of IL-6, cyclooxygenase-2, prostaglandin E-2, and matrix metalloproteinases (MMPs) by ELISA and RT-PCR. Further studies on how magnolol inhibits IL-1 beta-stimulated cytokine expression were performed using Western blots, reporter gene assay, electrophoretic mobility shift assay, and confocal microscope analysis. The in vivo antiarthritic effects of magnolol were evaluated in a Mycobacterium butyricum-induced arthritis model in rats. Magnolol markedly inhibited IL-1 beta (10 ng/mL)-induced cytokine expression in a concentration-dependent manner (2.5-25 mu g/mL). In clarifying the mechanisms involved, magnolol was found to inhibit the IL-1 beta-induced activation of the IKK/I kappa B/NF-kappa B and MAPKs pathways by suppressing the nuclear translocation and DNA binding activity of both transcription factors. In the animal model, magnolol (100 mg/kg) significantly inhibited paw swelling and reduced serum cytokine levels. Our results demonstrate that magnolol inhibits the development of arthritis, suggesting that it might provide a new therapeutic approach to inflammatory arthritis diseases.	[Wang, Jyh-Horng; Wu, Yi-Wen; Tsai, Ching-Lin] Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan; [Shih, Kao-Shang] Shin Kong Wu Ho Su Mem Hosp, Dept Orthoped, Taipei, Taiwan; [Liou, Jing-Ping] Taipei Med Univ, Sch Pharm, Taipei, Taiwan; [Chang, Anita Shin-Yuan; Wang, Kang-Li; Yang, Chia-Ron] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; National Taiwan University	Wang, JH (corresponding author), Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan.	cryang@ntu.edu.tw		YANG, CHIA-RON/0000-0001-5990-1346; Wang, Jyh- Horng/0000-0002-1531-5297	National Science Council of Taiwan [NSC100-2320-B-002-004-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work received grant support from National Science Council of Taiwan (NSC100-2320-B-002-004-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2008, NAT BIOTECHNOL, V26, P817, DOI 10.1038/nbt1412; [Anonymous], 2011, WHO FOOD ADDITIVES S, P64; Aya K, 2005, J CLIN INVEST, V115, P1848, DOI 10.1172/JCI23763; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Barsante MM, 2005, EUR J PHARMACOL, V516, P282, DOI 10.1016/j.ejphar.2005.05.005; Belcaro G, 2010, ALTERN MED REV, V15, P337; Boileau C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2649; Chen LC, 2009, J AGR FOOD CHEM, V57, P7331, DOI 10.1021/jf901477g; Chen PH, 2008, J IMMUNOL, V181, P8441, DOI 10.4049/jimmunol.181.12.8441; Chen YH, 2002, BRIT J PHARMACOL, V135, P37, DOI 10.1038/sj.bjp.0704458; Cooles FAH, 2011, CURR OPIN RHEUMATOL, V23, P233, DOI 10.1097/BOR.0b013e32834518a3; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; Dayer JM, 2003, RHEUMATOLOGY, V42, P3, DOI 10.1093/rheumatology/keg326; Feldmann M, 2002, ANN RHEUM DIS, V61, P13; Gaby A R, 1999, Altern Med Rev, V4, P392; HOLOSHITZ J, 1983, SCIENCE, V219, P56, DOI 10.1126/science.6336851; Hwang ES, 2010, BIOSCI BIOTECH BIOCH, V74, P961, DOI 10.1271/bbb.90785; Jacobs JWG, 2001, CLIN RHEUMATOL, V20, P192, DOI 10.1007/PL00011199; Jawan B, 2003, J SURG RES, V110, P378, DOI 10.1016/S0022-4804(03)00034-9; Kao YH, 2010, PHYTOMEDICINE, V17, P469, DOI 10.1016/j.phymed.2009.07.012; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kim HM, 2007, INT IMMUNOPHARMACOL, V7, P1083, DOI 10.1016/j.intimp.2007.04.004; Kim KR, 2010, J PHARMACOL SCI, V114, P69, DOI 10.1254/jphs.10070FP; Lee YJ, 2011, PHARMACOL THERAPEUT, V130, P157, DOI 10.1016/j.pharmthera.2011.01.010; Lin YR, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-94; Matsuda H, 2001, CHEM PHARM BULL, V49, P716, DOI 10.1248/cpb.49.716; Park J, 2004, EUR J PHARMACOL, V496, P189, DOI 10.1016/j.ejphar.2004.05.047; Schuehly W., 2009, Inflammopharmacology, V17, P106, DOI 10.1007/s10787-009-7013-y; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shen YC, 1998, EUR J PHARMACOL, V343, P79, DOI 10.1016/S0014-2999(97)01519-7; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; Suleyman H, 2010, INFLAMMATION, V33, P224, DOI 10.1007/s10753-009-9176-5; TENG CM, 1991, J PHARM PHARMACOL, V43, P667, DOI 10.1111/j.2042-7158.1991.tb03561.x; TENG CM, 1990, LIFE SCI, V47, P1153, DOI 10.1016/0024-3205(90)90176-R; Tsai YC, 2010, EUR J PHARMACOL, V641, P67, DOI 10.1016/j.ejphar.2010.05.011; Tse AKW, 2007, MOL IMMUNOL, V44, P2647, DOI 10.1016/j.molimm.2006.12.004; WANG JP, 1995, J PHARM PHARMACOL, V47, P857, DOI 10.1111/j.2042-7158.1995.tb05754.x; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106	38	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31368	10.1371/journal.pone.0031368	http://dx.doi.org/10.1371/journal.pone.0031368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359588	gold, Green Submitted, Green Published			2022-12-25	WOS:000302796200057
J	Khurana, S; Chakraborty, S; Lam, M; Liu, Y; Su, YT; Zhao, X; Saleem, MA; Mathieson, PW; Bruggeman, LA; Kao, HY				Khurana, Simran; Chakraborty, Sharmistha; Lam, Minh; Liu, Yu; Su, Yu-Ting; Zhao, Xuan; Saleem, Moin A.; Mathieson, Peter W.; Bruggeman, Leslie A.; Kao, Hung-Ying			Familial Focal Segmental Glomerulosclerosis (FSGS)-linked alpha-Actinin 4 (ACTN4) Protein Mutants Lose Ability to Activate Transcription by Nuclear Hormone Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEPHRIN GENE-EXPRESSION; PODOCYTE INJURY; SLIT DIAPHRAGM; GAMMA AGONIST; ACID RECEPTOR; ALPHA-ACTININ-4; MECHANISM; MOTIF; DIFFERENTIATION; GLUCOCORTICOIDS	Mutations in alpha-actinin 4 (ACTN4) are linked to familial forms of focal segmental glomerulosclerosis (FSGS), a kidney disease characterized by proteinuria due to podocyte injury. The mechanisms underlying ACTN4 mutant-associated FSGS are not completely understood. Although alpha-actinins are better known to cross-link actin filaments and modulate cytoskeletal organization, we have previously shown that ACTN4 interacts with transcription factors including estrogen receptor and MEF2s and potentiates their transcriptional activity. Nuclear receptors including retinoic acid receptor (RAR) have been proposed to play a protective role in podocytes. We show here that ACTN4 interacts with and enhances transcriptional activation by RAR alpha. In addition, FSGS-linked ACTN4 mutants not only mislocalized to the cytoplasm, but also lost their ability to associate with nuclear receptors. Consequently, FSGS-linked ACTN4 mutants failed to potentiate transcriptional activation by nuclear hormone receptors in podocytes. In addition, overexpression of these mutants suppressed the transcriptional activity mediated by endogenous wild-type ACTN4 possibly by a cytoplasmic sequestration mechanism. Our data provide the first link between FSGS-linked ACTN4 mutants and transcriptional activation by nuclear receptor such as RAR alpha and peroxisome proliferator-activated receptor gamma.	[Khurana, Simran; Chakraborty, Sharmistha; Liu, Yu; Su, Yu-Ting; Zhao, Xuan; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Khurana, Simran; Chakraborty, Sharmistha; Liu, Yu; Su, Yu-Ting; Zhao, Xuan; Kao, Hung-Ying] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Khurana, Simran; Chakraborty, Sharmistha; Liu, Yu; Su, Yu-Ting; Zhao, Xuan; Kao, Hung-Ying] Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA; [Lam, Minh] Univ Hosp, Case Med Ctr, Dept Dermatol, Cleveland, OH 44106 USA; [Bruggeman, Leslie A.] Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Educ & Res, Cleveland, OH 44106 USA; [Bruggeman, Leslie A.] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Dept Med, Cleveland, OH 44106 USA; [Saleem, Moin A.; Mathieson, Peter W.] Univ Bristol, Southmead Hosp, Childrens Renal Unit, Bristol BS10 5NB, Avon, England; [Saleem, Moin A.; Mathieson, Peter W.] Univ Bristol, Southmead Hosp, Acad Renal Unit, Bristol BS10 5NB, Avon, England	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System; Southmead Hospital; University of Bristol; Southmead Hospital; University of Bristol	Kao, HY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	hxk43@cwru.edu		Saleem, Moin/0000-0002-9808-4518	National Institutes of Health [R01 DK078965, HL093269]; Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (National Institutes of Health) [P30 CA43703-12]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER; Medical Research Council [G0800200] Funding Source: researchfish; MRC [G0800200] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078965 and HL093269 (to H.-Y.K.). This work was also supported by the Confocal Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (National Institutes of Health Grant P30 CA43703-12).	Amann PM, 2011, CURR MED CHEM, V18, P1405; Benigni A, 2006, J AM SOC NEPHROL, V17, P1624, DOI 10.1681/ASN.2005090983; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Cheng HF, 2010, INT J BIOCHEM CELL B, V42, P1380, DOI 10.1016/j.biocel.2010.05.014; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Fujii Y, 2006, KIDNEY INT, V69, P1350, DOI 10.1038/sj.ki.5000317; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Guess A, 2010, AM J PHYSIOL-RENAL, V299, pF845, DOI 10.1152/ajprenal.00161.2010; He JCJ, 2007, J AM SOC NEPHROL, V18, P93, DOI 10.1681/ASN.2006070727; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kumeta M, 2010, J CELL SCI, V123, P1020, DOI 10.1242/jcs.059568; Langham RG, 2002, DIABETOLOGIA, V45, P1572, DOI 10.1007/s00125-002-0946-y; Liu H, 2004, J BIOL CHEM, V279, P45208, DOI 10.1074/jbc.M408033200; Lowik MM, 2009, EUR J PEDIATR, V168, P1291, DOI 10.1007/s00431-009-1017-x; Mahajan MA, 2005, ENDOCR REV, V26, P583, DOI 10.1210/er.2004-0012; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Michaud JLR, 2006, KIDNEY INT, V70, P1054, DOI 10.1038/sj.ki.5001665; Michaud JLR, 2007, CLIN SCI, V112, P325, DOI 10.1042/CS20060143; Miglio G, 2011, BRIT J PHARMACOL, V162, P111, DOI 10.1111/j.1476-5381.2010.01032.x; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Okamura M, 2009, NEPHROL DIAL TRANSPL, V24, P3006, DOI 10.1093/ndt/gfp243; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Patrakka J, 2010, BIOCHEM BIOPH RES CO, V396, P164, DOI 10.1016/j.bbrc.2010.04.069; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; RANA B, 1994, MOL CELL BIOL, V14, P5858, DOI 10.1128/MCB.14.9.5858; Ransom RF, 2005, KIDNEY INT, V68, P2473, DOI 10.1111/j.1523-1755.2005.00723.x; Ratnam KK, 2011, KIDNEY INT, V79, P624, DOI 10.1038/ki.2010.470; Ren SY, 2005, BIOCHEM BIOPH RES CO, V338, P1818, DOI 10.1016/j.bbrc.2005.10.158; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; SCHLONDORFF D, 1990, METHOD ENZYMOL, V191, P130; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Suzuki A, 2003, J AM SOC NEPHROL, V14, P981, DOI 10.1097/01.ASN.0000057857.66268.8F; Takano Y, 2007, AM J PHYSIOL-RENAL, V292, pF1573, DOI 10.1152/ajprenal.00423.2006; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Weins A, 2005, J AM SOC NEPHROL, V16, P3694, DOI 10.1681/ASN.2005070706; Xing CY, 2006, KIDNEY INT, V70, P1038, DOI 10.1038/sj.ki.5001655; Yamauchi K, 2006, KIDNEY INT, V70, P892, DOI 10.1038/sj.ki.5001625; Yang HC, 2006, KIDNEY INT, V69, P1756, DOI 10.1038/sj.ki.5000336; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167	53	29	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12027	12035		10.1074/jbc.M112.345421	http://dx.doi.org/10.1074/jbc.M112.345421			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351778	Green Published, hybrid			2022-12-25	WOS:000302782200040
J	Zhang, SZ; He, H; Day, AJ; Tseng, SCG				Zhang, Suzhen; He, Hua; Day, Anthony J.; Tseng, Scheffer C. G.			Constitutive Expression of Inter-alpha-inhibitor (I alpha I) Family Proteins and Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) by Human Amniotic Membrane Epithelial and Stromal Cells Supporting Formation of the Heavy Chain-Hyaluronan (HC-HA) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URINARY TRYPSIN-INHIBITOR; HUMAN ARTICULAR CHONDROCYTES; BINDING-PROTEIN; HUMAN-PLASMA; RHEUMATOID-ARTHRITIS; EXTRACELLULAR-MATRIX; COVALENT TRANSFER; BIKUNIN PROTEINS; HUMAN-SERUM; ACID	Recently, we reported HC-HA, a covalent complex formed between heavy chains (HCs) of inter-alpha -inhibitor (I alpha I) and hyaluronan (HA) by the catalytic action of tumor necrosis factor (TNF)-stimulated gene-6 (TSG-6), is responsible for human amniotic membrane (AM) anti-inflammatory, anti-scarring, and anti-angiogenic actions. At the present time, the only well characterized source of I alpha I is serum being produced by the liver. This study showed that AM epithelial and stromal cells and stromal matrix all stained positively for HA, HC 1, 2, and 3, bikunin, and TSG-6. TSG-6 mRNA and protein were constitutively expressed by cultured AM epithelial and stromal cells without being up-regulated by TNF. In serum-free conditions, these cells expressed I alpha I, leading to the formation of HC-HA complex that contained both HC1 and HC2. In contrast, only HC1 was found in the HC-HA complex purified from AM. Local production of I alpha I, the HC-TSG-6 intermediate complex, and HC-HA were abolished when cells were treated with siRNA to HC1, HC2, bikunin (all of which impair the biosynthesis of I alpha I), or TSG-6 but not to HC3. Collectively, these results indicate that AM is another tissue in addition to the liver to constitutively produce I alpha I and that the HC-HA complex made by this tissue is different from that found at inflammatory sites (e. g. in asthma and arthritis) and in the matrix of the cumulus oocyte complex.	[Tseng, Scheffer C. G.] Ocular Surface Ctr, Miami, FL 33173 USA; [He, Hua; Tseng, Scheffer C. G.] TissueTech Inc, Miami, FL 33173 USA; [Zhang, Suzhen; Tseng, Scheffer C. G.] Ocular Surface Res & Educ Fdn, Miami, FL 33173 USA; [Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Tseng, SCG (corresponding author), Ocular Surface Ctr, 7000 SW,97 Ave,Suite 213, Miami, FL 33173 USA.	stseng@ocularsurface.com	Zhang, Suzhen/J-8011-2013; Day, Anthony/O-1658-2015	Day, Anthony/0000-0002-1415-3134	National Institutes of Health through the NEI [R44 EY017497, R43 EY021045]; TissueTech, Inc.; Ocular Surface Research and Education Foundation, Miami, FL; Arthritis Research United Kingdom [18472, 19489]; Versus Arthritis [19489, 18472] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R43EY021045, R44EY017497, R01EY006819] Funding Source: NIH RePORTER	National Institutes of Health through the NEI; TissueTech, Inc.; Ocular Surface Research and Education Foundation, Miami, FL; Arthritis Research United Kingdom(Versus Arthritis); Versus Arthritis(Versus Arthritis); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R44 EY017497 and R43 EY021045 through the NEI (to S. C. G. T.). This work was also supported by a research grant from TissueTech, Inc., and an unrestricted grant from Ocular Surface Research and Education Foundation, Miami, FL.; Supported by Arthritis Research United Kingdom Grants 18472 and 19489.	Blom AM, 1999, J BIOL CHEM, V274, P298, DOI 10.1074/jbc.274.1.298; BOST F, 1993, EUR J BIOCHEM, V218, P283, DOI 10.1111/j.1432-1033.1993.tb18376.x; Bouchard Charles S, 2004, Ocul Surf, V2, P201; Bourguignon J, 1999, J HISTOCHEM CYTOCHEM, V47, P1625, DOI 10.1177/002215549904701214; CAMAIONI A, 1993, J BIOL CHEM, V268, P20473; CHEN L, 1994, J BIOL CHEM, V269, P28282; Chen L, 1996, J BIOL CHEM, V271, P19409, DOI 10.1074/jbc.271.32.19409; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.TEC.2010.0609, 10.1089/ten.tec.2010.0609]; Chen YT, 2007, STEM CELLS, V25, P1995, DOI 10.1634/stemcells.2006-0677; DAVEAU M, 1993, BIOCHEM J, V292, P485, DOI 10.1042/bj2920485; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Diarra-Mehrpour M, 1998, J BIOL CHEM, V273, P26809, DOI 10.1074/jbc.273.41.26809; Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Flahaut C, 1998, BIOCHEM J, V333, P749, DOI 10.1042/bj3330749; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fujimoto T, 2002, AM J PATHOL, V160, P1495, DOI 10.1016/S0002-9440(10)62575-8; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Hamm A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-25; He H, 2008, INVEST OPHTH VIS SCI, V49, P4468, DOI 10.1167/iovs.08-1781; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; HERON A, 1994, BIOCHEM J, V302, P573, DOI 10.1042/bj3020573; Higa K, 2005, CORNEA, V24, P206, DOI 10.1097/01.ico.0000133999.45262.83; Himmelfarb M, 2004, CANCER LETT, V204, P69, DOI 10.1016/j.canlet.2003.09.011; Janssen U, 2001, KIDNEY INT, V60, P126, DOI 10.1046/j.1523-1755.2001.00779.x; JESSEN TE, 1994, BIOL CHEM H-S, V375, P521, DOI 10.1515/bchm3.1994.375.8.521; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; JESSEN TE, 1988, FEBS LETT, V230, P195, DOI 10.1016/0014-5793(88)80670-7; Kehlen A, 2003, ARTHRITIS RES THER, V5, pR186, DOI 10.1186/ar762; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LEE TH, 1993, J BIOL CHEM, V268, P6154; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Li W, 2008, J CELL PHYSIOL, V215, P657, DOI 10.1002/jcp.21345; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Maier R, 1996, ARTHRITIS RHEUM, V39, P552, DOI 10.1002/art.1780390403; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; Margerie D, 1997, OSTEOARTHR CARTILAGE, V5, P129, DOI 10.1016/S1063-4584(97)80006-4; Martin-Vandelet N, 1999, EUR J BIOCHEM, V259, P476, DOI 10.1046/j.1432-1327.1999.00067.x; Meinert M, 2001, AM J OBSTET GYNECOL, V184, P679, DOI 10.1067/mob.2001.110294; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mizon C, 1996, J IMMUNOL METHODS, V190, P61, DOI 10.1016/0022-1759(95)00257-X; Mizushima S, 1998, BIOL PHARM BULL, V21, P167; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; MURAMATU M, 1980, J BIOCHEM-TOKYO, V88, P1317, DOI 10.1093/oxfordjournals.jbchem.a133100; Nagyova E, 2004, BIOL REPROD, V71, P1838, DOI 10.1095/biolreprod.104.029595; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; ODUM L, 1990, BIOL CHEM H-S, V371, P1153, DOI 10.1515/bchm3.1990.371.2.1153; Pineiro M, 1999, BIOCHEM BIOPH RES CO, V263, P224, DOI 10.1006/bbrc.1999.1349; PU XP, 1994, BBA-PROTEIN STRUCT M, V1208, P338, DOI 10.1016/0167-4838(94)90122-8; Roberts S, 2005, EUR SPINE J, V14, P36, DOI 10.1007/s00586-004-0798-x; ROUET P, 1992, BIOL CHEM H-S, V373, P1019, DOI 10.1515/bchm3.1992.373.2.1019; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; SALIER JP, 1983, BIOCHIM BIOPHYS ACTA, V742, P206; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Shay E, 2011, INVEST OPHTH VIS SCI, V52, P2669, DOI 10.1167/iovs.10-5888; SJOBERG EM, 1992, ARCH BIOCHEM BIOPHYS, V295, P217, DOI 10.1016/0003-9861(92)90509-U; Tan KT, 2011, J EUR ACAD DERMATOL, V25, P317, DOI 10.1111/j.1468-3083.2010.03792.x; Tan KT, 2011, AESTHET SURG J, V31, P47, DOI 10.1177/1090820X10391778; THOGERSEN IB, 1995, J BIOL CHEM, V270, P18700; Thuveson M, 1999, J BIOL CHEM, V274, P6741, DOI 10.1074/jbc.274.10.6741; Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CR0070034; Tseng SCG, 2001, BIOSCIENCE REP, V21, P481, DOI 10.1023/A:1017995810755; Tseng Scheffer C G, 2004, Ocul Surf, V2, P177; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; YONEDA M, 1990, J BIOL CHEM, V265, P5247; Yoshihara Y, 2008, OSTEOARTHR CARTILAGE, V16, P1343, DOI 10.1016/j.joca.2008.04.004; Yu SJ, 2009, CELL TRANSPLANT, V18, P111, DOI 10.3727/096368909788341243; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhu L, 2008, CONNECT TISSUE RES, V49, P48, DOI 10.1080/03008200701820955; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	79	50	55	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12433	12444		10.1074/jbc.M112.342873	http://dx.doi.org/10.1074/jbc.M112.342873			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351758	Green Published, hybrid			2022-12-25	WOS:000302782200083
J	D'Agata, EMC; Horn, MA; Ruan, SG; Webb, GF; Wares, JR				D'Agata, Erika M. C.; Horn, Mary Ann; Ruan, Shigui; Webb, Glenn F.; Wares, Joanna R.			Efficacy of Infection Control Interventions in Reducing the Spread of Multidrug-Resistant Organisms in the Hospital Setting	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; INTENSIVE-CARE UNITS; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL RESISTANCE; ENTEROCOCCI; COLONIZATION; TRANSMISSION; IMPACT; SURVEILLANCE; PATHOGENS	Multidrug-resistant organisms (MDRO) continue to spread in hospitals globally, but the population-level impact of recommended preventive strategies and the relative benefit of individual strategies targeting all MDRO in the hospital setting are unclear. To explore the dynamics of MDRO transmission in the hospital, we develop a model extending data from clinical individual-level studies to quantify the impact of hand hygiene, contact precautions, reducing antimicrobial exposure and screening surveillance cultures in decreasing the prevalence of MDRO colonization and infection. The effect of an ongoing increase in the influx of patients colonized with MDRO into the hospital setting is also quantified. We find that most recommended strategies have substantial effect in decreasing the prevalence of MDRO over time. However, screening for asymptomatic MDRO colonization among patients who are not receiving antimicrobials is of minimal value in reducing the spread of MDRO.	[D'Agata, Erika M. C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Infect Dis, Boston, MA 02215 USA; [Horn, Mary Ann; Webb, Glenn F.] Vanderbilt Univ, Dept Math, Nashville, TN USA; [Horn, Mary Ann] Natl Sci Fdn, Div Math Sci, Arlington, VA 22230 USA; [Ruan, Shigui] Univ Miami, Dept Math, Coral Gables, FL 33124 USA; [Wares, Joanna R.] Univ Richmond, Dept Math & Comp Sci, Richmond, VA 23173 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Vanderbilt University; National Science Foundation (NSF); NSF - Directorate for Mathematical & Physical Sciences (MPS); NSF - Division of Mathematical Sciences (DMS); University of Miami; University of Richmond	D'Agata, EMC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Infect Dis, Boston, MA 02215 USA.	edagata@bidmc.harvard.edu	Ruan, Shigui/AAF-9165-2020; Webb, Glenn/AAW-7228-2021	Ruan, Shigui/0000-0002-6348-8205; 	joint Division of Mathematical Sciences/National Institute of General Medical Sciences (DMS/NIGMS) Initiative through National Institutes of Health (NIH) [R01GM083607]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083607] Funding Source: NIH RePORTER	joint Division of Mathematical Sciences/National Institute of General Medical Sciences (DMS/NIGMS) Initiative through National Institutes of Health (NIH); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the joint Division of Mathematical Sciences/National Institute of General Medical Sciences (DMS/NIGMS) Initiative through National Institutes of Health (NIH) Grant R01GM083607 (EMCD, GFW, SR). This work was also partially supported by the National Science Foundation (MAH, SR). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Baker SE, 2010, INFECT CONT HOSP EP, V31, P42, DOI 10.1086/649222; Bedimo R, 2001, CLIN INFECT DIS, V33, P1706, DOI 10.1086/338215; Ben-Ami R, 2006, CLIN INFECT DIS, V42, P925, DOI 10.1086/500936; Bonten MJM, 2001, CLIN INFECT DIS, V33, P1739, DOI 10.1086/323761; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; Calderwood MS, 2008, INFECT CONT HOSP EP, V29, P1019, DOI 10.1086/591454; Cooper B, 2004, BIOSTATISTICS, V5, P223, DOI 10.1093/biostatistics/5.2.223; D'Agata EMC, 2002, CLIN INFECT DIS, V34, P167, DOI 10.1086/338234; D'Agata EMC, 2007, J THEOR BIOL, V249, P487, DOI 10.1016/j.jtbi.2007.08.011; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Donskey CJ, 2006, CLIN INFECT DIS, V43, pS62, DOI 10.1086/504481; Friedmann R, 2009, INFECT CONT HOSP EP, V30, P534, DOI 10.1086/597505; Gbaguidi-Haore H, 2008, INFECT CONT HOSP EP, V29, P1118, DOI 10.1086/592697; Huang SS, 2007, J INFECT DIS, V195, P330, DOI 10.1086/510622; Huang SS, 2007, J INFECT DIS, V195, P339, DOI 10.1086/510624; Koopman J, 2004, ANNU REV PUBL HEALTH, V25, P303, DOI 10.1146/annurev.publhealth.25.102802.124353; Lautenbach E, 2008, ANN INTERN MED, V148, P474, DOI 10.7326/0003-4819-148-6-200803180-00009; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Montecalvo MA, 1995, INFECT CONT HOSP EP, V16, P680; O'Fallon E, 2009, CLIN INFECT DIS, V48, P1375, DOI 10.1086/598194; Olivier CN, 2008, INFECT CONT HOSP EP, V29, P404, DOI 10.1086/587647; Ostrowsky BE, 1999, ARCH INTERN MED, V159, P1467, DOI 10.1001/archinte.159.13.1467; Raboud J, 2005, INFECT CONT HOSP EP, V26, P607, DOI 10.1086/502589; Schwaber MJ, 2006, ANTIMICROB AGENTS CH, V50, P1257, DOI 10.1128/AAC.50.4.1257-1262.2006; Sebille V, 1997, INFECT CONT HOSP EP, V18, P84; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Temime L, 2009, P NATL ACAD SCI USA, V106, P18420, DOI 10.1073/pnas.0900974106; Trick WE, 2007, INFECT CONT HOSP EP, V28, P42, DOI 10.1086/510809; Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS3, DOI 10.1086/591063; Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS12, DOI 10.1086/591060	32	43	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30170	10.1371/journal.pone.0030170	http://dx.doi.org/10.1371/journal.pone.0030170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363420	Green Submitted, gold, Green Published			2022-12-25	WOS:000302871500007
J	Salvado, B; Vilaprinyo, E; Karathia, H; Sorribas, A; Alves, R				Salvado, Baldiri; Vilaprinyo, Ester; Karathia, Hiren; Sorribas, Albert; Alves, Rui			Two Component Systems: Physiological Effect of a Third Component	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SIGNAL-TRANSDUCTION; REGULATORY SYSTEMS; RESPONSE REGULATOR; NITROGEN ASSIMILATION; BACTERIA; RESISTANCE; PATHWAY; KINASE; SENSOR	Signal transduction systems mediate the response and adaptation of organisms to environmental changes. In prokaryotes, this signal transduction is often done through Two Component Systems (TCS). These TCS are phosphotransfer protein cascades, and in their prototypical form they are composed by a kinase that senses the environmental signals (SK) and by a response regulator (RR) that regulates the cellular response. This basic motif can be modified by the addition of a third protein that interacts either with the SK or the RR in a way that could change the dynamic response of the TCS module. In this work we aim at understanding the effect of such an additional protein (which we call "third component'') on the functional properties of a prototypical TCS. To do so we build mathematical models of TCS with alternative designs for their interaction with that third component. These mathematical models are analyzed in order to identify the differences in dynamic behavior inherent to each design, with respect to functionally relevant properties such as sensitivity to changes in either the parameter values or the molecular concentrations, temporal responsiveness, possibility of multiple steady states, or stochastic fluctuations in the system. The differences are then correlated to the physiological requirements that impinge on the functioning of the TCS. This analysis sheds light on both, the dynamic behavior of synthetically designed TCS, and the conditions under which natural selection might favor each of the designs. We find that a third component that modulates SK activity increases the parameter space where a bistable response of the TCS module to signals is possible, if SK is monofunctional, but decreases it when the SK is bifunctional. The presence of a third component that modulates RR activity decreases the parameter space where a bistable response of the TCS module to signals is possible.	[Salvado, Baldiri; Karathia, Hiren; Sorribas, Albert; Alves, Rui] Univ Lleida, Dept Ciencies Med Basiques, Lleida, Spain; [Salvado, Baldiri; Karathia, Hiren; Sorribas, Albert; Alves, Rui] IRBLleida, Lleida, Spain; [Vilaprinyo, Ester] Parc de Salut Mar, Evaluat & Clin Epidemiol Dept, Barcelona, Spain; [Vilaprinyo, Ester] CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain	Universitat de Lleida; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Salvado, B (corresponding author), Univ Lleida, Dept Ciencies Med Basiques, Lleida, Spain.	ralves@cmb.udl.es	Vilaprinyo, Ester/A-6702-2010; Alves, Rui/C-5920-2009; Sorribas, Albert/A-2181-2009; Karathia, Hiren/AAD-2361-2021	Vilaprinyo, Ester/0000-0002-5787-5890; Alves, Rui/0000-0002-8112-5184; Sorribas, Albert/0000-0002-7407-4075; Karathia, Hiren/0000-0003-3607-6552	MICINN (Ministerio de Ciencia e Innovacion, Spain) [BFU2008-0196, BFU2010-17704]; AGAUR (Agencia de Gestio d'Ajuts Universitaris i de Recerca, Catalunya)	MICINN (Ministerio de Ciencia e Innovacion, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AGAUR (Agencia de Gestio d'Ajuts Universitaris i de Recerca, Catalunya)	This work was partially supported by grants BFU2008-0196 to AS and BFU2010-17704 to RA, both from MICINN (Ministerio de Ciencia e Innovacion, Spain). HK is funded by a Ph. D. fellowship and EV is funded by a Beatriu de Pinos Post-doctoral fellowship, both from AGAUR (Agencia de Gestio d'Ajuts Universitaris i de Recerca, Catalunya). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodor S, 2009, INFECT IMMUN, V77, P374, DOI 10.1128/IAI.01081-08; Alves R, 2003, MOL MICROBIOL, V48, P25, DOI 10.1046/j.1365-2958.2003.03344.x; Alves R, 2000, BIOINFORMATICS, V16, P786, DOI 10.1093/bioinformatics/16.9.786; Alves R, 2008, BIOTECHNOL GENET ENG, V25, P1; Atkinson MR, 1998, MOL MICROBIOL, V29, P431, DOI 10.1046/j.1365-2958.1998.00932.x; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Bhattacharya M, 2010, BIOCHIMIE, V92, P263, DOI 10.1016/j.biochi.2009.11.009; Boots M, 2004, SCIENCE, V303, P842, DOI 10.1126/science.1088542; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Chen HD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002184; Cheng HY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-60; Eguchi Y, 2005, TRENDS BIOCHEM SCI, V30, P70, DOI 10.1016/j.tibs.2004.12.003; Fange D, 2009, P NATL ACAD SCI USA, V106, P8215, DOI 10.1073/pnas.0811514106; Vescovi EG, 2010, CURR OPIN MICROBIOL, V13, P210, DOI 10.1016/j.mib.2009.12.012; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Hazelbauer GL, 2010, CURR OPIN MICROBIOL, V13, P124, DOI 10.1016/j.mib.2009.12.014; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Igoshin OA, 2008, MOL MICROBIOL, V68, P1196, DOI 10.1111/j.1365-2958.2008.06221.x; Igoshin OA, 2006, MOL MICROBIOL, V61, P165, DOI 10.1111/j.1365-2958.2006.05212.x; KAMBEROV ES, 1994, CELL MOL BIOL RES, V40, P175; Kato A, 2004, GENE DEV, V18, P2302, DOI 10.1101/gad.1230804; Kato A, 2007, P NATL ACAD SCI USA, V104, P12063, DOI 10.1073/pnas.0704462104; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Mattison K, 2002, J BIOL CHEM, V277, P11143, DOI 10.1074/jbc.M111128200; McPhee JB, 2006, J BACTERIOL, V188, P3995, DOI 10.1128/JB.00053-06; Minoia M, 2008, P NATL ACAD SCI USA, V105, P20792, DOI 10.1073/pnas.0806164106; Mitrophanov AY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000233; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Nalca Y, 2006, ANTIMICROB AGENTS CH, V50, P1680, DOI 10.1128/AAC.50.5.1680-1688.2006; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Perez JC, 2009, CELL, V138, P233, DOI 10.1016/j.cell.2009.07.002; Raghavan V, 2010, CURR OPIN MICROBIOL, V13, P226, DOI 10.1016/j.mib.2009.12.010; Salvado B, 2011, MATH BIOSCI, V231, P3, DOI 10.1016/j.mbs.2011.02.005; Silversmith RE, 2010, CURR OPIN MICROBIOL, V13, P177, DOI 10.1016/j.mib.2010.01.004; Stewart RC, 2004, J MOL BIOL, V336, P287, DOI 10.1016/j.jmb.2003.11.059; Tiwari A, 2011, MATH BIOSCI, V231, P76, DOI 10.1016/j.mbs.2011.03.004; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; WOLFE AJ, 1987, J BACTERIOL, V169, P1878, DOI 10.1128/jb.169.5.1878-1885.1987; Wolfram Research I, 2010, MATH; Workentine ML, 2009, FEMS MICROBIOL LETT, V292, P50, DOI 10.1111/j.1574-6968.2008.01445.x; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; Yan Q, 2009, MICROBIOL RES, V164, P18, DOI 10.1016/j.micres.2008.02.001; Yoshida T, 2002, MOL MICROBIOL, V46, P1283, DOI 10.1046/j.1365-2958.2002.03240.x	48	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31095	10.1371/journal.pone.0031095	http://dx.doi.org/10.1371/journal.pone.0031095			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363555	Green Published, gold			2022-12-25	WOS:000302853600110
J	Chiang, CH; Huang, PH; Chung, FP; Chen, ZY; Leu, HB; Huang, CC; Wu, TC; Chen, JW; Lin, SJ				Chiang, Chia-Hung; Huang, Po-Hsun; Chung, Fa-Po; Chen, Zu-Yin; Leu, Hsin-Bang; Huang, Chin-Chou; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong			Decreased Circulating Endothelial Progenitor Cell Levels and Function in Patients with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; INCREASED CARDIOVASCULAR RISK; METABOLIC SYNDROME; GENERAL-POPULATION; INSULIN-RESISTANCE; PERIPHERAL-BLOOD; DYSFUNCTION; ATHEROSCLEROSIS; PREVALENCE	Objectives: Nonalcoholic fatty liver disease (NAFLD) is associated with advanced atherosclerosis and a higher risk of cardiovascular disease. Increasing evidence suggests that injured endothelial monolayer is regenerated by circulating bone marrow derived-endothelial progenitor cells (EPCs), and levels of circulating EPCs reflect vascular repair capacity. However, the relation between NAFLD and EPC remains unclear. Here, we tested the hypothesis that patients with nonalcoholic fatty liver disease (NAFLD) might have decreased endothelial progenitor cell (EPC) levels and attenuated EPC function. Methods and Results: A total of 312 consecutive patients undergoing elective coronary angiography because of suspected coronary artery disease were screened and received examinations of abdominal ultrasonography between July 2009 and November 2010. Finally, 34 patients with an ultrasonographic diagnosis of NAFLD, and 68 age-and sex-matched controls without NAFLD were enrolled. Flow cytometry with quantification of EPC markers (defined as CD34(+), CD34(+)KDR(+), and CD34(+)KDR(+)CD133(+))in peripheral blood samples was used to assess circulating EPC numbers. The adhesive function, and migration, and tube formation capacities of EPCs were also determined in NAFLD patients and controls. Patients with NAFLD had a significantly higher incidence of metabolic syndrome, previous myocardial infarction, hyperuricemia, and higher waist circumference, body mass index, fasting glucose and triglyceride levels. In addition, patients with NAFLD had significantly decreased circulating EPC levels (all P<0.05), attenuated EPC functions, and enhanced systemic inflammation compared to controls. Multivariate logistic regression analysis showed that circulating EPC level (CD34(+)KDR(+) [cells/10(5) events]) was an independent reverse predictor of NAFLD (Odds ratio: 0.78; 95% confidence interval: 0.69-0.89, P<0.001). Conclusions: NAFLD patients have decreased circulating EPC numbers and functions than those without NAFLD, which may be one of the mechanisms to explain atherosclerotic disease progression and enhanced cardiovascular risk in patients with NAFLD.	[Chiang, Chia-Hung; Huang, Po-Hsun; Chung, Fa-Po; Chen, Zu-Yin; Leu, Hsin-Bang; Huang, Chin-Chou; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Huang, Po-Hsun; Leu, Hsin-Bang; Wu, Tao-Cheng; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chiang, Chia-Hung; Huang, Po-Hsun; Chung, Fa-Po; Chen, Zu-Yin; Leu, Hsin-Bang; Huang, Chin-Chou; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst & Dept Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chiang, CH (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan.	huangbs@vghtpe.gov.tw			UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council [NSC-99-2911-I-009-101]; Taipei Veterans General Hospital [VGH-V98B1-003, VGH-V100E2-002]; Ministry of Education;  [NSC 97-2314-B-075-039];  [NSC 98-2314-B-075-035]	UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education; ; 	This study was supported in part by research grants from the NSC 97-2314-B-075-039, NSC 98-2314-B-075-035, and UST-UCSD International Center of Excellence in Advanced Bio-engineering NSC-99-2911-I-009-101 from the National Science Council; VGH-V98B1-003 and VGH-V100E2-002 from Taipei Veterans General Hospital, and also a grant from the Ministry of Education "Aim for the Top University" Plan. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, DIABETIC MED, V22, P1129, DOI 10.1111/j.1464-5491.2005.01748.x; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Brea A, 2005, ARTERIOSCL THROM VAS, V25, P1045, DOI 10.1161/01.ATV.0000160613.57985.18; Chen JZ, 2004, CLIN SCI, V107, P273, DOI 10.1042/CS20030389; Chiang CH, 2010, CLIN BIOCHEM, V43, P1399, DOI 10.1016/j.clinbiochem.2010.09.003; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Drexler H, 1999, J MOL CELL CARDIOL, V31, P51, DOI 10.1006/jmcc.1998.0843; ELHASSAN AY, 1992, BRIT J RADIOL, V65, P774, DOI 10.1259/0007-1285-65-777-774; Fadini GP, 2008, ATHEROSCLEROSIS, V197, P496, DOI 10.1016/j.atherosclerosis.2007.12.039; Fadini GP, 2006, STROKE, V37, P2277, DOI 10.1161/01.STR.0000236064.19293.79; Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042; Feldstein AE, 2010, SEMIN LIVER DIS, V30, P391, DOI 10.1055/s-0030-1267539; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Galli A, 2005, HEPATOLOGY, V41, P1074, DOI 10.1002/hep.20683; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Huang PH, 2008, CORONARY ARTERY DIS, V19, P187, DOI 10.1097/MCA.0b013e3282f399e2; Huang PH, 2007, HEART, V93, P1064, DOI 10.1136/hrt.2006.107763; Huang PH, 2010, J HYPERTENS, V28, P1655, DOI 10.1097/HJH.0b013e32833a4d0a; Huang PH, 2010, ARTERIOSCL THROM VAS, V30, P869, DOI 10.1161/ATVBAHA.109.200618; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Jepsen P, 2003, HEPATO-GASTROENTEROL, V50, P2101; Jialal I, 2010, ATHEROSCLEROSIS, V211, P297, DOI 10.1016/j.atherosclerosis.2010.01.036; Koh JH, 2009, DIABETES CARE, V32, P147, DOI 10.2337/dc08-1379; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Lin YC, 2005, WORLD J GASTROENTERO, V11, P4838, DOI 10.3748/wjg.v11.i31.4838; Lonardo A, 1997, ITAL J GASTROENTEROL, V29, P351; Miller-Kasprzak E, 2011, OBESITY, V19, P736, DOI 10.1038/oby.2010.169; Mirbagheri SA, 2007, LIVER INT, V27, P891, DOI 10.1111/j.1478-3231.2007.01531.x; Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Senturk O, 2008, INTERN MED J, V38, P183, DOI 10.1111/j.1445-5994.2007.01481.x; Sung KC, 2009, ATHEROSCLEROSIS, V203, P581, DOI 10.1016/j.atherosclerosis.2008.07.024; Tarantino G, 2007, J GASTROEN HEPATOL, V22, P293, DOI 10.1111/j.1440-1746.2007.04824.x; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Verhaar MC, 1998, CARDIOVASC DRUG THER, V12, P125, DOI 10.1023/A:1007737412395; Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24; Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781; Vlachopoulos C, 2010, AM J HYPERTENS, V23, P1183, DOI 10.1038/ajh.2010.144; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8	43	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31799	10.1371/journal.pone.0031799	http://dx.doi.org/10.1371/journal.pone.0031799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359630	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200099
J	Cournil, A; Eymard-Duvernay, S; Diouf, A; Moquet, C; Coutherut, J; Gueye, NFN; Cames, C; Taverne, B; Bork, K; Sow, PS; Delaporte, E				Cournil, Amandine; Eymard-Duvernay, Sabrina; Diouf, Assane; Moquet, Claire; Coutherut, Julie; Gueye, Ndeye Fatou Ngom; Cames, Cecile; Taverne, Bernard; Bork, Kirsten; Sow, Papa Salif; Delaporte, Eric		ANRS 1215 Study Grp	Reduced Quantitative Ultrasound Bone Mineral Density in HIV-Infected Patients on Antiretroviral Therapy in Senegal	PLOS ONE			English	Article							ABACAVIR-LAMIVUDINE; FRACTURE RISK; TENOFOVIR DF; OSTEOPOROSIS; PREVALENCE; EFAVIRENZ; WOMEN; MEN; EMTRICITABINE; COMBINATION	Background: Bone status in HIV-infected patients on antiretroviral treatment (ART) is poorly documented in resource-limited settings. We compared bone mineral density between HIV-infected patients and control subjects from Dakar, Senegal. Methods: A total of 207 (134 women and 73 men) HIV-infected patients from an observational cohort in Dakar (ANRS 1215) and 207 age-and sex-matched controls from the general population were enrolled. Bone mineral density was assessed by quantitative ultrasound (QUS) at the calcaneus, an alternative to the reference method (i.e. dual X-absorptiometry), often not available in resource-limited countries. Results: Mean age was 47.0 (+/- 8.5) years. Patients had received ART for a median duration of 8.8 years; 45% received a protease inhibitor and 27% tenofovir; 84% had undetectable viral load. Patients had lower body mass index (BMI) than controls (23 versus 26 kg/m(2), P<0.001). In unadjusted analysis, QUS bone mineral density was lower in HIV-infected patients than in controls (difference: -0.36 standard deviation, 95% confidence interval (CI): -0.59;-0.12, P = 0.003). Adjusting for BMI, physical activity, smoking and calcium intake attenuated the difference (-0.27, CI: -0.53; -0.002, P = 0.05). Differences in BMI between patients and controls explained a third of the difference in QUS bone mineral density. Among patients, BMI was independently associated with QUS bone mineral density (P<0.001). An association between undetectable viral load and QUS bone density was also suggested (beta = 0.48, CI: 0.02; 0.93; P = 0.04). No association between protease inhibitor or tenofovir use and QUS bone mineral density was found. Conclusion: Senegalese HIV-infected patients had reduced QUS bone mineral density in comparison with control subjects, in part related to their lower BMI. Further investigation is needed to clarify the clinical significance of these observations.	[Cournil, Amandine; Eymard-Duvernay, Sabrina; Moquet, Claire; Cames, Cecile; Bork, Kirsten; Delaporte, Eric] Univ Montpellier I, Inst Rech Dev, UMI 233, Montpellier, France; [Diouf, Assane; Sow, Papa Salif] Fann Univ, Reg Res & Training Ctr HIV AIDS, Teaching Hosp, Dakar, Senegal; [Coutherut, Julie; Taverne, Bernard] Univ Montpellier I, Inst Rech Dev, UMI 233, Dakar, Senegal; [Gueye, Ndeye Fatou Ngom] Fann Univ, Ambulatory Care Unit, Teaching Hosp, Dakar, Senegal; [Sow, Papa Salif] Fann Univ, Dept Infect Dis, Teaching Hosp, Dakar, Senegal	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD)	Cournil, A (corresponding author), Univ Montpellier I, Inst Rech Dev, UMI 233, Montpellier, France.	amandine.cournil@ird.fr	Delaporte, Eric/J-5397-2018; Desclaux, Alice/D-9566-2017	Delaporte, Eric/0000-0002-1822-9853; Cames, Cecile/0000-0001-8374-7107; Laurent, Christian/0000-0003-2658-7113; Bork, Kirsten/0000-0002-5909-7332; Desclaux, Alice/0000-0002-4268-2818	French National Agency for Research on AIDS and Viral Hepatitis (ANRS) [1215, 1290]; Institut de Recherche pour le Developpement (IRD)	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); Institut de Recherche pour le Developpement (IRD)	The study was funded by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS, Projects 1215 and 1290) and the Institut de Recherche pour le Developpement (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel C, 2004, J BONE MINER RES, V19, P402, DOI 10.1359/JBMR.0301246; Arnsten JH, 2006, CLIN INFECT DIS, V42, P1014, DOI 10.1086/501015; Arnsten JH, 2007, AIDS, V21, P617, DOI 10.1097/QAD.0b013e3280148c05; Aspray TJ, 1996, J BONE MINER RES, V11, P1019; Bolland MJ, 2007, J CLIN ENDOCR METAB, V92, P4522, DOI 10.1210/jc.2007-1660; Bolland MJ, 2011, J CLIN ENDOCR METAB, V96, P2721, DOI 10.1210/jc.2011-0591; Briot K, 2011, BONE, V48, P1133, DOI 10.1016/j.bone.2011.01.015; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Brown TT, 2010, ANTIVIR THER, V15, P425, DOI [10.3851/IMP1502, 10.3851/IMP15021]; Brown TT, 2009, JAIDS-J ACQ IMM DEF, V51, P554, DOI 10.1097/QAI.0b013e3181adce44; Bruera D, 2003, AIDS, V17, P1917, DOI 10.1097/00002030-200309050-00010; Calmy A, 2009, J INFECT DIS, V200, P1746, DOI 10.1086/644785; Cassetti I, 2007, HIV CLIN TRIALS, V8, P164, DOI 10.1310/hct0803-164; Cazanave C, 2008, AIDS, V22, P395, DOI 10.1097/QAD.0b013e3282f423dd; Constant Deborah, 2009, Arch Osteoporos, V4, P55; Desclaux A, 2003, AIDS, V17, pS95, DOI 10.1097/00002030-200317003-00013; Dolan SE, 2006, J CLIN ENDOCR METAB, V91, P2938, DOI 10.1210/jc.2006-0127; Dop M-C, 2003, OUTILS ENQUETE ALIME; Duvivier C, 2009, AIDS, V23, P817, DOI 10.1097/QAD.0b013e328328f789; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fausto A, 2006, BONE, V38, P893, DOI 10.1016/j.bone.2005.11.001; Fernandez-Rivera J, 2003, HIV CLIN TRIALS, V4, P337, DOI 10.1310/4X0H-UVMJ-BHYW-CPFB; Fessel WJ, 2003, AIDS, V17, P255, DOI 10.1097/00002030-200301240-00016; Finkelstein JS, 2008, J CLIN ENDOCR METAB, V93, P861, DOI 10.1210/jc.2007-1876; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Guglielmi G, 2010, RADIOL CLIN N AM, V48, P577, DOI 10.1016/j.rcl.2010.02.013; Hans D, 1996, LANCET, V348, P511, DOI 10.1016/S0140-6736(95)11456-4; Hans D, 2008, J BONE MINER RES, V23, P1045, DOI 10.1359/JBMR.080229; Khaw KT, 2004, LANCET, V363, P197, DOI 10.1016/S0140-6736(03)15325-1; Krieg MA, 2008, J CLIN DENSITOM, V11, P163, DOI 10.1016/j.jocd.2007.12.011; Landman Roland, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P379, DOI 10.1177/1545109709344352; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412; Melton LJ, 2002, OSTEOPOROSIS INT, V13, P551, DOI 10.1007/s001980200072; Moayyeri A, 2009, J BONE MINER RES, V24, P1319, DOI [10.1359/jbmr.090212, 10.1359/JBMR.090212]; Nam HS, 2010, OSTEOPOROSIS INT, V21, P2115, DOI 10.1007/s00198-010-1188-3; Ndiaye S, 2005, SENEGAL DEMOGRAPHIC; Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; VanderJagt DJ, 2001, CALCIFIED TISSUE INT, V68, P277, DOI 10.1007/BF02390834; Womack JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017217; Yin M, 2005, OSTEOPOROSIS INT, V16, P1345, DOI 10.1007/s00198-005-1845-0; Zebaze RMD, 2003, OSTEOPOROSIS INT, V14, P301, DOI 10.1007/s00198-002-1356-1	46	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31726	10.1371/journal.pone.0031726	http://dx.doi.org/10.1371/journal.pone.0031726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359621	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200090
J	Dong, SZ; Zeng, QW; Mitchell, ES; Xiu, J; Duan, Y; Li, CX; Tiwari, JK; Hu, YH; Cao, XH; Zhao, Z				Dong, Suzhen; Zeng, Qingwen; Mitchell, E. Siobhan; Xiu, Jin; Duan, Yale; Li, Chunxia; Tiwari, Jyoti K.; Hu, Yinghe; Cao, Xiaohua; Zhao, Zheng			Curcumin Enhances Neurogenesis and Cognition in Aged Rats: Implications for Transcriptional Interactions Related to Growth and Synaptic Plasticity	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; ALZHEIMERS-DISEASE; NEUROTROPHIC FACTOR; ADENYLYL-CYCLASE; OXIDATIVE STRESS; SPATIAL MEMORY; MESSENGER-RNA; EXPRESSION; NEURONS; IMPAIRMENT	Background: Curcumin has been demonstrated to have many neuroprotective properties, including improvement of cognition in humans and neurogenesis in animals, yet the mechanism of such effects remains unclear. Methodology: We assessed behavioural performance and hippocampal cell proliferation in aged rats after 6- and 12-week curcumin-fortified diets. Curcumin enhanced non-spatial and spatial memory, as well as dentate gyrate cell proliferation as compared to control diet rats. We also investigated underlying mechanistic pathways that might link curcumin treatment to increased cognition and neurogenesis via exon array analysis of cortical and hippocampal mRNA transcription. The results revealed a transcriptional network interaction of genes involved in neurotransmission, neuronal development, signal transduction, and metabolism in response to the curcumin treatment. Conclusions: The results suggest a neurogenesis- and cognition-enhancing potential of prolonged curcumin treatment in aged rats, which may be due to its diverse effects on genes related to growth and plasticity.	[Dong, Suzhen; Zeng, Qingwen; Duan, Yale; Li, Chunxia; Hu, Yinghe; Cao, Xiaohua; Zhao, Zheng] E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China; [Dong, Suzhen; Hu, Yinghe] E China Normal Univ, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China; [Mitchell, E. Siobhan] Unilever R&D, Vlaardingen, Netherlands; [Xiu, Jin] Unilever R&D, Shanghai, Peoples R China; [Tiwari, Jyoti K.] Unilever R&D, Bangalore, Karnataka, India	East China Normal University; East China Normal University; Unilever; Unilever; Unilever	Dong, SZ (corresponding author), E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China.	xhcao@brain.ecnu.edu.cn; zzhao@brain.ecnu.edu.cn		tiwari, jyoti kumar/0000-0002-6154-6512; Mitchell, Ellen/0000-0001-7851-6283; Duan, Yale/0000-0001-5166-4091				Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Alvania RS, 2006, NEURON, V50, P813, DOI 10.1016/j.neuron.2006.06.001; Baum L, 2008, J CLIN PSYCHOPHARM, V28, P110, DOI 10.1097/jcp.0b013e318160862c; Baxter KK, 2009, ASN NEURO, V1, DOI 10.1042/AN20090036; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Berberoglu MA, 2009, GENE EXPR PATTERNS, V9, P411, DOI 10.1016/j.gep.2009.06.002; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Calabrese V, 2008, NEUROCHEM RES, V33, P2444, DOI 10.1007/s11064-008-9775-9; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Conboy L, 2009, BIOCHEM PHARMACOL, V77, P1254, DOI 10.1016/j.bcp.2008.12.011; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Ferguson GD, 2004, HIPPOCAMPUS, V14, P964, DOI 10.1002/hipo.20013; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Gaudreault SB, 2004, NEUROBIOL AGING, V25, P753, DOI 10.1016/j.neurobiolaging.2003.07.004; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Ishrat T, 2009, EUR NEUROPSYCHOPHARM, V19, P636, DOI 10.1016/j.euroneuro.2009.02.002; Jiang J, 2007, EUR J PHARMACOL, V561, P54, DOI 10.1016/j.ejphar.2006.12.028; Kang SK, 2006, STEM CELLS DEV, V15, P165, DOI 10.1089/scd.2006.15.165; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Kuhad A, 2007, EUR J PHARMACOL, V576, P34, DOI 10.1016/j.ejphar.2007.08.001; Kumar A, 2007, J MED FOOD, V10, P486, DOI 10.1089/jmf.2006.076; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Leuner B, 2006, J NEUROSCI, V26, P13437, DOI 10.1523/JNEUROSCI.2781-06.2006; Leuner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011597; Liu YF, 2009, J PHYSIOL-LONDON, V587, P3221, DOI 10.1113/jphysiol.2009.173088; Madsen TM, 2003, BIOL PSYCHIAT, V54, P1006, DOI 10.1016/S0006-3223(03)00700-5; Matsuda S, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-41; McKinney BC, 2006, LEARN MEMORY, V13, P584, DOI 10.1101/lm.279006; Meneses A, 2007, BEHAV BRAIN RES, V184, P81, DOI 10.1016/j.bbr.2007.06.026; Mons N, 2004, NEUROBIOL AGING, V25, P1095, DOI 10.1016/j.neurobiolaging.2003.10.014; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Ng TP, 2006, AM J EPIDEMIOL, V164, P898, DOI 10.1093/aje/kwj267; Ono K, 2006, CURR PHARM DESIGN, V12, P4357, DOI 10.2174/138161206778793010; Pei JJ, 2002, ACTA NEUROPATHOL, V104, P369, DOI 10.1007/s00401-002-0565-1; Reeta KH, 2009, BRAIN RES, V1301, P52, DOI 10.1016/j.brainres.2009.09.027; Rouaux C, 2010, NAT NEUROSCI, V13, P1345, DOI 10.1038/nn.2658; Sasaki N, 2010, MOL CELL NEUROSCI, V45, P335, DOI 10.1016/j.mcn.2010.07.006; Shan Q, 2008, J NEUROSCI, V28, P12864, DOI 10.1523/JNEUROSCI.2413-08.2008; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; SQUIRE LR, 1993, TRENDS NEUROSCI, V16, P56, DOI 10.1016/0166-2236(93)90016-F; Tang T, 2007, BRAIN RES, V1175, P134, DOI 10.1016/j.brainres.2007.08.028; Uittenbogaard M, 2010, J NEUROSCI RES, V88, P33, DOI 10.1002/jnr.22182; Veng LM, 2003, MOL BRAIN RES, V110, P193, DOI 10.1016/S0169-328X(02)00643-5; Wang Q, 2005, J NEUROSCI RES, V82, P138, DOI 10.1002/jnr.20610; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Xu Y, 2007, BRAIN RES, V1162, P9, DOI 10.1016/j.brainres.2007.05.071; Xu Y, 2009, NEUROPHARMACOLOGY, V57, P463, DOI 10.1016/j.neuropharm.2009.06.010; Xue MS, 2008, P NATL ACAD SCI USA, V105, P7875, DOI 10.1073/pnas.0803012105; Zhang L, 2006, J ALZHEIMERS DIS, V10, P1; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao J, 2010, NEUROCHEM RES, V35, P374, DOI 10.1007/s11064-009-0065-y	59	116	125	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31211	10.1371/journal.pone.0031211	http://dx.doi.org/10.1371/journal.pone.0031211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359574	gold, Green Submitted, Green Published			2022-12-25	WOS:000302796200043
J	Dubrovska, A; Elliott, J; Salamone, RJ; Telegeev, GD; Stakhovsky, AE; Schepotin, IB; Yan, F; Wang, Y; Bouchez, LC; Kularatne, SA; Watson, J; Trussell, C; Reddy, VA; Cho, CY; Schultz, PG				Dubrovska, Anna; Elliott, Jimmy; Salamone, Richard J.; Telegeev, Gennady D.; Stakhovsky, Alexander E.; Schepotin, Ihor B.; Yan, Feng; Wang, Yan; Bouchez, Laure C.; Kularatne, Sumith A.; Watson, James; Trussell, Christopher; Reddy, Venkateshwar A.; Cho, Charles Y.; Schultz, Peter G.			CXCR4 Expression in Prostate Cancer Progenitor Cells	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; STEM-CELLS; STEM/PROGENITOR CELLS; TUMOR-GROWTH; IDENTIFICATION; MIGRATION; ADHESION; ALPHA(V)BETA(3); PROLIFERATION; MAINTENANCE	Tumor progenitor cells represent a population of drug-resistant cells that can survive conventional chemotherapy and lead to tumor relapse. However, little is known of the role of tumor progenitors in prostate cancer metastasis. The studies reported herein show that the CXCR4/CXCL12 axis, a key regulator of tumor dissemination, plays a role in the maintenance of prostate cancer stem-like cells. The CXCL4/CXCR12 pathway is activated in the CD44(+)/CD133(+) prostate progenitor population and affects differentiation potential, cell adhesion, clonal growth and tumorigenicity. Furthermore, prostate tumor xenograft studies in mice showed that a combination of the CXCR4 receptor antagonist AMD3100, which targets prostate cancer stem-like cells, and the conventional chemotherapeutic drug Taxotere, which targets the bulk tumor, is significantly more effective in eradicating tumors as compared to monotherapy.	[Dubrovska, Anna; Bouchez, Laure C.; Kularatne, Sumith A.; Reddy, Venkateshwar A.; Schultz, Peter G.] Scripps Res Inst, La Jolla, CA 92037 USA; [Elliott, Jimmy; Salamone, Richard J.; Yan, Feng; Wang, Yan; Watson, James; Trussell, Christopher; Reddy, Venkateshwar A.; Cho, Charles Y.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Stakhovsky, Alexander E.; Schepotin, Ihor B.] Natl Canc Inst, Kiev, Ukraine; [Telegeev, Gennady D.] Inst Mol Biol & Genet NAS Ukraine, Kiev, Ukraine	Scripps Research Institute; Novartis; Ministry of Health of Ukraine; National Cancer Institute; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	Dubrovska, A (corresponding author), Tech Univ Dresden, Med Fac Dresden Carl Gustav Carus, D-01062 Dresden, Germany.	anna.dubrovska@oncoray.de; schultz@scripps.edu	Dubrovska, Anna/AAE-8514-2019	Dubrovska, Anna/0000-0002-3375-1500; bouchez, laure/0000-0003-4583-6760	Susan G. Komen for the Cure [PDF0707903]; Novartis Research Foundation; Skaggs Institute for Chemical Biology	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Novartis Research Foundation; Skaggs Institute for Chemical Biology	This study was supported by Susan G. Komen for the Cure Grant PDF0707903 (to A.D). This work was supported by the Novartis Research Foundation and The Skaggs Institute for Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JT, 2002, ENDOCR-RELAT CANCER, V9, P61, DOI 10.1677/erc.0.0090061; Barretina J, 2003, ANN HEMATOL, V82, P500, DOI 10.1007/s00277-003-0679-0; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; Caruz A, 1998, FEBS LETT, V426, P271, DOI 10.1016/S0014-5793(98)00359-7; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Dubrovska A, 2010, CLIN CANCER RES, V16, P5692, DOI 10.1158/1078-0432.CCR-10-1601; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Ehtesham M, 2009, CANCER LETT, V274, P305, DOI 10.1016/j.canlet.2008.09.034; Engl T, 2006, NEOPLASIA, V8, P290, DOI 10.1593/neo.05694; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Goel HL, 2008, ENDOCR-RELAT CANCER, V15, P657, DOI 10.1677/ERC-08-0019; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Huang Haojie, 2006, Future Oncol, V2, P83, DOI 10.2217/14796694.2.1.83; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; NEAL DE, 2005, J CELL SCI, V117, P3539; Pan JD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-56; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Porvasnik S, 2009, PROSTATE, V69, P1460, DOI 10.1002/pros.21008; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Struckhoff AP, 2010, J CELL SCI, V123, P401, DOI 10.1242/jcs.052167; Sun YX, 2007, PROSTATE, V67, P61, DOI 10.1002/pros.20500; Taichman RS, 2002, CANCER RES, V62, P1832; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; VANDERCAPPELLEN J, 2008, CANC LETT, V28, P226, DOI DOI 10.1007/S00277-003-0679-0; Vishnu P, 2010, ONCOTARGETS THER, V3, P39; Wu YM, 2009, J NEUROCHEM, V109, P1157, DOI 10.1111/j.1471-4159.2009.06043.x; Zeng Z, 2006, MOL CANCER THER, V5, P3113, DOI 10.1158/1535-7163.MCT-06-0228; Zheng DQ, 1999, CANCER RES, V59, P1655; Zhu SK, 2008, CIRCULATION, V118, P2156, DOI 10.1161/CIRCULATIONAHA.108.787200; Zlotnik A, 2008, J PATHOL, V215, P211, DOI 10.1002/path.2350	44	95	99	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31226	10.1371/journal.pone.0031226	http://dx.doi.org/10.1371/journal.pone.0031226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359577	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200046
J	Gao, DY; Chen, JF; Chen, MS; Meyers, BC; Jackson, S				Gao, Dongying; Chen, Jinfeng; Chen, Mingsheng; Meyers, Blake C.; Jackson, Scott			A Highly Conserved, Small LTR Retrotransposon that Preferentially Targets Genes in Grass Genomes	PLOS ONE			English	Article							PLANT TRANSPOSABLE ELEMENTS; RICE ORYZA-SATIVA; EVOLUTIONARY DYNAMICS; DNA METHYLATION; REPEAT; FAMILY; RECOMBINATION; GENETICS; REGIONS; BARLEY	LTR retrotransposons are often the most abundant components of plant genomes and can impact gene and genome evolution. Most reported LTR retrotransposons are large elements (>4 kb) and are most often found in heterochromatic (gene poor) regions. We report the smallest LTR retrotransposon found to date, only 292 bp. The element is found in rice, maize, sorghum and other grass genomes, which indicates that it was present in the ancestor of grass species, at least 50-80 MYA. Estimated insertion times, comparisons between sequenced rice lines, and mRNA data indicate that this element may still be active in some genomes. Unlike other LTR retrotransposons, the small LTR retrotransposons (SMARTs) are distributed throughout the genomes and are often located within or near genes with insertion patterns similar to MITEs (miniature inverted repeat transposable elements). Our data suggests that insertions of SMARTs into or near genes can, in a few instances, alter both gene structures and gene expression. Further evidence for a role in regulating gene expression, SMART-specific small RNAs (sRNAs) were identified that may be involved in gene regulation. Thus, SMARTs may have played an important role in genome evolution and genic innovation and may provide a valuable tool for gene tagging systems in grass.	[Gao, Dongying; Jackson, Scott] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Gao, Dongying; Jackson, Scott] Univ Georgia, Inst Plant Breeding Genet & Genom, Athens, GA 30602 USA; [Chen, Jinfeng; Chen, Mingsheng] Chinese Acad Sci, State Key Lab Plant Genom, Inst Genet & Dev Biol, Beijing, Peoples R China; [Meyers, Blake C.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [Meyers, Blake C.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of Delaware; University of Delaware	Gao, DY (corresponding author), Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA.	sjackson@uga.edu	Meyers, Blake/B-6535-2012; Chen, Jinfeng/K-4024-2015; Chen, Jinfeng/ABE-4816-2020	Meyers, Blake/0000-0003-3436-6097; Chen, Jinfeng/0000-0002-5628-6322; jackson, scott/0000-0002-3172-1607	National Science Foundation DBI [0603927, 0424833, 30770143, 2010B0527]	National Science Foundation DBI(National Science Foundation (NSF))	This study was supported by grants from The National Science Foundation DBI 0603927 and 0424833 to SAJ and grants #30770143 and #2010B0527 to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammiraju JSS, 2007, PLANT J, V52, P342, DOI 10.1111/j.1365-313X.2007.03242.x; Bai L, 2011, GENETICS, V187, P749, DOI 10.1534/genetics.110.124149; Bedell JA, 2005, PLOS BIOL, V3, P103, DOI 10.1371/journal.pbio.0030013; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; BUREAU TE, 1994, PLANT CELL, V6, P907, DOI 10.1105/tpc.6.6.907; Charles M, 2009, MOL BIOL EVOL, V26, P1651, DOI 10.1093/molbev/msp076; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Diao XM, 2006, PLOS BIOL, V4, P119, DOI 10.1371/journal.pbio.0040005; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Ehrlich S. D., 1989, MOBILE DNA-UK, P799; Fernandes J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r82; Feschotte C, 2002, P NATL ACAD SCI USA, V99, P280, DOI 10.1073/pnas.022626699; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Gao DY, 2009, PLANT J, V60, P820, DOI 10.1111/j.1365-313X.2009.04005.x; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Jiang N, 2002, GENETICS, V161, P1293; Kalendar R, 2004, GENETICS, V166, P1437, DOI 10.1534/genetics.166.3.1437; Kalendar R, 2008, P NATL ACAD SCI USA, V105, P5833, DOI 10.1073/pnas.0709698105; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Malik HS, 2001, GENOME RES, V11, P1187, DOI 10.1101/gr.185101; Marin I, 2000, MOL BIOL EVOL, V17, P1040, DOI 10.1093/oxfordjournals.molbev.a026385; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Maxwell PH, 2006, NUCLEIC ACIDS RES, V34, P5498, DOI 10.1093/nar/gkl709; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Neumann P, 2003, PLANT MOL BIOL, V53, P399, DOI 10.1023/B:PLAN.0000006945.77043.ce; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pelissier T, 1996, GENETICA, V97, P141, DOI 10.1007/BF00054621; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; Roulin A, 2008, PLANT J, V53, P950, DOI 10.1111/j.1365-313X.2007.03388.x; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shirasu K, 2000, GENOME RES, V10, P908, DOI 10.1101/gr.10.7.908; Soleimani VD, 2006, GENOME, V49, P389, DOI 10.1139/G05-119; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Vitte C, 2003, MOL BIOL EVOL, V20, P528, DOI 10.1093/molbev/msg055; Vitte C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-218; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wendel JF, 2000, P NATL ACAD SCI USA, V97, P6250, DOI 10.1073/pnas.97.12.6250; Wessler SR, 2001, PLANT PHYSIOL, V125, P149, DOI 10.1104/pp.125.1.149; Wessler SR, 2006, P NATL ACAD SCI USA, V103, P17600, DOI 10.1073/pnas.0607612103; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Witte CP, 2001, P NATL ACAD SCI USA, V98, P13778, DOI 10.1073/pnas.241341898; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yan HH, 2010, PLANT J, V63, P353, DOI 10.1111/j.1365-313X.2010.04246.x; Yang G, 2001, MOL GENET GENOMICS, V266, P417, DOI 10.1007/s004380100530; Ying SY, 2010, METHODS MOL BIOL, V629, P203, DOI 10.1007/978-1-60761-657-3_14; Zhang CH, 2008, PLANT CELL, V20, P995, DOI 10.1105/tpc.107.055350	71	40	43	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32010	10.1371/journal.pone.0032010	http://dx.doi.org/10.1371/journal.pone.0032010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359654	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200123
J	Hu, XH; Kuhn, JR				Hu, Xiaohua; Kuhn, Jeffrey R.			Actin Filament Attachments for Sustained Motility In Vitro Are Maintained by Filament Bundling	PLOS ONE			English	Article							GROWTH-FACTOR INCREASES; ARP2/3 COMPLEX; F-ACTIN; CAPPING PROTEIN; N-WASP; INTRACELLULAR MAGNESIUM; DENDRITIC ORGANIZATION; NETWORK FORMATION; FORCE GENERATION; BINDING-SITES	We reconstructed cellular motility in vitro from individual proteins to investigate how actin filaments are organized at the leading edge. Using total internal reflection fluorescence microscopy of actin filaments, we tested how profilin, Arp2/3, and capping protein (CP) function together to propel thin glass nanofibers or beads coated with N-WASP WCA domains. Thin nanofibers produced wide comet tails that showed more structural variation in actin filament organization than did bead substrates. During sustained motility, physiological concentrations of Mg2+ generated actin filament bundles that processively attached to the nanofiber. Reduction of total Mg2+ abolished particle motility and actin attachment to the particle surface without affecting actin polymerization, Arp2/3 nucleation, or filament capping. Analysis of similar motility of microspheres showed that loss of filament bundling did not affect actin shell formation or symmetry breaking but eliminated sustained attachments between the comet tail and the particle surface. Addition of Mg2+, Lys-Lys(2+), or fascin restored both comet tail attachment and sustained particle motility in low Mg2+ buffers. TIRF microscopic analysis of filaments captured by WCA-coated beads in the absence of Arp2/3, profilin, and CP showed that filament bundling by polycation or fascin addition increased barbed end capture by WCA domains. We propose a model in which CP directs barbed ends toward the leading edge and polycation-induced filament bundling sustains processive barbed end attachment to the leading edge.	[Hu, Xiaohua; Kuhn, Jeffrey R.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Hu, XH (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	jrkuhn@vt.edu			Burroughs Wellcome Fund [1003964]; Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust [J-991]	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust	This work was supported by an Interfaces in Science Career Award from the Burroughs Wellcome Fund (Award 1003964) and a Research Grant (Award J-991) from the Thomas F. Jeffress and Kate Miller Jeffress Memorial Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard V, 2010, CURR BIOL, V20, P423, DOI 10.1016/j.cub.2009.12.056; Adams JC, 2000, J CELL BIOL, V150, P807, DOI 10.1083/jcb.150.4.807; Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Alberts JB, 2004, PLOS BIOL, V2, P2054, DOI 10.1371/journal.pbio.0020412; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Bernardini D, 2005, FRONT BIOSCI-LANDMRK, V10, P1177, DOI 10.2741/1610; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; BONDER EM, 1983, CELL, V34, P491, DOI 10.1016/0092-8674(83)90382-3; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; DABIRI GA, 1990, P NATL ACAD SCI USA, V87, P6068, DOI 10.1073/pnas.87.16.6068; Dayel MJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000201; DELATOUR V, 2008, BIOPHYS J; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Dickinson RB, 2002, BIOPHYS J, V82, P605, DOI 10.1016/S0006-3495(02)75425-8; Dickinson RB, 2008, CELL MOL BIOENG, V1, P110, DOI 10.1007/s12195-008-0027-5; DOMANN E, 1992, EMBO J, V11, P1981, DOI 10.1002/j.1460-2075.1992.tb05252.x; Dominguez R, 2007, ANN NY ACAD SCI, V1112, P86, DOI 10.1196/annals.1415.011; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Footer MJ, 2008, J BIOL CHEM, V283, P23852, DOI 10.1074/jbc.M803448200; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Giardini PA, 2003, P NATL ACAD SCI USA, V100, P6493, DOI 10.1073/pnas.1031670100; Giganti A, 2005, J CELL SCI, V118, P1255, DOI 10.1242/jcs.01698; GOLDBERG MB, 1995, P NATL ACAD SCI USA, V92, P6572, DOI 10.1073/pnas.92.14.6572; GRZESIAK JJ, 1995, J CLIN INVEST, V95, P227, DOI 10.1172/JCI117644; Gunther T, 2006, MAGNESIUM RES, V19, P225; Haviv L, 2006, P NATL ACAD SCI USA, V103, P4906, DOI 10.1073/pnas.0508269103; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Higley S, 1997, CURR OPIN CELL BIOL, V9, P62, DOI 10.1016/S0955-0674(97)80153-6; Hong BZ, 2006, BIOCHEM BIOPH RES CO, V347, P496, DOI 10.1016/j.bbrc.2006.06.125; Hong BZ, 2009, MOL CELLS, V28, P13, DOI 10.1007/s10059-009-0103-2; Hosek M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051907; Ideses Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003297; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; Kohler S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002736; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuhn JR, 2007, J BIOL CHEM, V282, P28014, DOI 10.1074/jbc.M705287200; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; Lapidos Karen A., 2001, Angiogenesis, V4, P21, DOI 10.1023/A:1016619414817; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; MATSUNO K, 1993, THROMB RES, V69, P131, DOI 10.1016/0049-3848(93)90010-L; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Misra A, 2007, BIOCHEM BIOPH RES CO, V364, P908, DOI 10.1016/j.bbrc.2007.10.086; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mullins RD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003392; Nuccitelli R, 1994, PRACTICAL GUIDE STUD; Onley DJ, 2000, J BIOL CHEM, V275, P24560, DOI 10.1074/jbc.M004111200; Ono S, 1997, J BIOL CHEM, V272, P2527; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Paluch E, 2006, BIOPHYS J, V91, P3113, DOI 10.1529/biophysj.106.088054; Pasic L, 2008, J BIOL CHEM, V283, P9814, DOI 10.1074/jbc.M710475200; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Popp D, 2007, J MOL BIOL, V368, P365, DOI 10.1016/j.jmb.2007.01.087; Popp D, 2006, BIOCHEM BIOPH RES CO, V351, P348, DOI 10.1016/j.bbrc.2006.10.041; Rebowski G, 2010, J MOL BIOL, V403, P11, DOI 10.1016/j.jmb.2010.08.040; Reymann AC, 2010, NAT MATER, V9, P827, DOI 10.1038/nmat2855; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rubin H, 2007, ARCH BIOCHEM BIOPHYS, V458, P16, DOI 10.1016/j.abb.2006.03.026; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Schwartz IM, 2004, CURR BIOL, V14, P1094, DOI 10.1016/j.cub.2004.06.023; Sengupta K, 2006, BIOPHYS J, V91, P4638, DOI [10.1529/biophysj.105.080382, 10.1529/biophysj.106.080382]; Soo FS, 2005, P NATL ACAD SCI USA, V102, P16233, DOI 10.1073/pnas.0507022102; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suzuki A, 1996, BIOCHEMISTRY-US, V35, P5238, DOI 10.1021/bi952693f; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Takaya J, 1998, EXP MOL PATHOL, V65, P104, DOI 10.1006/exmp.1998.2232; TAKEICHI M, 1972, EXP CELL RES, V74, P51, DOI 10.1016/0014-4827(72)90480-6; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Tang JX, 1997, BIOCHEMISTRY-US, V36, P12600, DOI 10.1021/bi9711386; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; THERIOT JA, 1994, CELL, V76, P505, DOI 10.1016/0092-8674(94)90114-7; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Upadhyaya A, 2003, P NATL ACAD SCI USA, V100, P4521, DOI 10.1073/pnas.0837027100; van der Gucht J, 2005, P NATL ACAD SCI USA, V102, P7847, DOI 10.1073/pnas.0502121102; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148	103	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31385	10.1371/journal.pone.0031385	http://dx.doi.org/10.1371/journal.pone.0031385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359589	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200058
J	Parczewski, M; Leszczyszyn-Pynka, M; Bander, D; Urbanska, A; Boron-Kaczmarska, A				Parczewski, Milosz; Leszczyszyn-Pynka, Magdalena; Bander, Dorota; Urbanska, Anna; Boron-Kaczmarska, Anna			HIV-1 Subtype D Infections among Caucasians from Northwestern Poland-Phylogenetic and Clinical Analysis	PLOS ONE			English	Article							TRANSMITTED DRUG-RESISTANCE; DISEASE PROGRESSION; RECOMBINANT STRAINS; HIGH PREVALENCE; VIRAL SUBTYPE; TYPE-1; TRANSMISSION; EPIDEMIC; MUTATIONS; INDIVIDUALS	Background: HIV-1 subtype D infections, which are associated with a faster rate of progression and lymphocyte CD4 decline, cognitive deficit and higher mortality, have rarely been found in native Europeans. In Northwestern Poland, however, infections with this subtype had been identified. This study aimed to analyze the sequence and clinical data for patients with subtype D using molecular phylogeography and identify transmission clusters and ancestry, as well as drug resistance, baseline HIV tropism and antiretroviral treatment efficacy. Methods: Phylogenetic analyses of local HIV-1 subtype D sequences were performed, with time to the most recent common ancestor inferred using Bayesian modeling. Sequence and drug resistance data were linked with the clinical and epidemiological information. Results: Subtype D was found in 24 non-immigrant Caucasian, heterosexually infected patients (75% of females, median age at diagnosis of 49.5 years; IQR: 29-56 years). Partial pol sequences clustered monophyletically with the clades of Ugandan origin and no evidence of transmission from other European countries was found. Time to the most common recent ancestor was 1989.24 (95% HPD: 1968.83-1994.46). Baseline drug resistance to nucleoside reverse transcriptase inhibitors was observed in 54.5% of cases (mutations: M41L, K103N, T215S/D) with evidence of clustering, no baseline integrase or protease resistance and infrequent non-R5 tropism (13.6%). Virologic failure was observed in 60% of cases and was associated with poor adherence (p<0.001) and subsequent development of drug resistance (p = 0.008, OR: 20 (95%CI: 1.7-290). Conclusions: Local subtype D represented an independently transmitted network with probably single index case, high frequency of primary drug resistance and evidence of transmission clusters.	[Parczewski, Milosz; Leszczyszyn-Pynka, Magdalena; Bander, Dorota; Urbanska, Anna; Boron-Kaczmarska, Anna] Pomeranian Med Univ, Dept Infect Dis & Hepatol, Szczecin, Poland	Pomeranian Medical University	Parczewski, M (corresponding author), Pomeranian Med Univ, Dept Infect Dis & Hepatol, Szczecin, Poland.	mparczewski@yahoo.co.uk	Parczewski, Milosz/I-1869-2014; Parczewski, Milosz/AAV-4280-2021	Parczewski, Milosz/0000-0003-1869-1084; Parczewski, Milosz/0000-0003-1869-1084; Bander, Dorota/0000-0002-1717-6198	Polish Ministry of Science IUVENTUS PLUS [IP2010 030570]	Polish Ministry of Science IUVENTUS PLUS	The study was supported by the project of the Polish Ministry of Science IUVENTUS PLUS IP2010 030570. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audelin AM, 2011, AIDS RES HUM RETROV, V27, P1284, DOI 10.1089/aid.2010.0368; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Bander Dorota, 2009, Przegl Epidemiol, V63, P61; Barlow KL, 2001, AIDS RES HUM RETROV, V17, P467, DOI 10.1089/088922201750102607; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bousheri S, 2009, JAIDS-J ACQ IMM DEF, V52, P548, DOI 10.1097/QAI.0b013e3181c1d456; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Buonaguro Luigi, 2008, Infect Agent Cancer, V3, P13, DOI 10.1186/1750-9378-3-13; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; de Felipe B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-416; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Esteves A, 2003, AIDS RES HUM RETROV, V19, P511, DOI 10.1089/088922203766774568; Frange P, 2010, J CLIN MICROBIOL, V48, P3487, DOI 10.1128/JCM.00704-10; Garcia F, 2011, ANTIVIR RES, V91, P150, DOI 10.1016/j.antiviral.2011.05.010; Geretti AM, 2006, CURR OPIN INFECT DIS, V19, P1, DOI 10.1097/01.qco.0000200293.45532.68; Geretti AM, 2009, CLIN INFECT DIS, V48, P1296, DOI 10.1086/598502; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harrigan PR DW, 2002, 14 INT AIDS C SPAIN; Holguin A, 2002, AIDS RES HUM RETROV, V18, P523, DOI 10.1089/088922202317406682; Holguin A, 2002, AIDS, V16, P1163, DOI 10.1097/00002030-200205240-00010; Huang W, 2007, J VIROL, V81, P7885, DOI 10.1128/JVI.00218-07; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2009, J VIROL, V83, P2645, DOI 10.1128/JVI.01556-08; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Kaye M, 2008, JAIDS-J ACQ IMM DEF, V49, P9, DOI 10.1097/QAI.0b013e318180c8af; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Lai A, 2012, AIDS RES HUM RETROV, V28, P857, DOI [10.1089/aid.2011.0245, 10.1089/AID.2011.0245]; Lamers SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016659; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Liitsola K, 1998, AIDS, V12, P1907, DOI 10.1097/00002030-199814000-00023; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lutalo T, 2007, AIDS, V21, pS15, DOI 10.1097/01.aids.0000299406.44775.de; Mehta SR, 2011, INFECT GENET EVOL, V11, P975, DOI 10.1016/j.meegid.2011.03.009; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Parczewski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022215; Parczewski M, 2010, J MED VIROL, V82, P1306, DOI 10.1002/jmv.21797; PATRASCU IV, 1993, AIDS RES HUM RETROV, V9, P99, DOI 10.1089/aid.1993.9.99; Raymond S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-56; Reekie J, 2010, HIV MED, V11, P469, DOI 10.1111/j.1468-1293.2009.00816.x; Sacktor N, 2009, CLIN INFECT DIS, V49, P780, DOI 10.1086/605284; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Skoura L, 2011, J ANTIMICROB CHEMOTH, V66, P2831, DOI 10.1093/jac/dkr386; Stanczak GP, 2010, J MED VIROL, V82, P1291, DOI 10.1002/jmv.21782; Stanczak Grzegorz Piotr, 2007, Przegl Epidemiol, V61, P29; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Cuevas MT, 2009, JAIDS-J ACQ IMM DEF, V51, P99, DOI 10.1097/QAI.0b013e318199063e; Thomson MM, 2001, CLIN INFECT DIS, V32, P1732, DOI 10.1086/320764; Vachot L, 2004, AIDS RES HUM RETROV, V20, P687, DOI 10.1089/0889222041524607; Van Laethem K, 2008, J VIROL METHODS, V153, P176, DOI 10.1016/j.jviromet.2008.07.008; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Vergne L, 2000, J CLIN MICROBIOL, V38, P3919, DOI 10.1128/JCM.38.11.3919-3925.2000; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Werbinska-Sienkiewicz Beata, 2011, Przegl Epidemiol, V65, P289; Xiridou M, 2004, AIDS, V18, P1311, DOI 10.1097/00002030-200406180-00010; Zetterberg V, 2004, AIDS RES HUM RETROV, V20, P1148, DOI 10.1089/aid.2004.20.1148	64	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31674	10.1371/journal.pone.0031674	http://dx.doi.org/10.1371/journal.pone.0031674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359615	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200084
J	Quinzii, CM; Tadesse, S; Naini, A; Hirano, M				Quinzii, Catarina M.; Tadesse, Saba; Naini, Ali; Hirano, Michio			Effects of Inhibiting CoQ(10) Biosynthesis with 4-nitrobenzoate in Human Fibroblasts	PLOS ONE			English	Article							COENZYME-Q BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; GENE ENCODES; DEFICIENCY; UBIQUINONE; Q(10); MUTANT; NEPHROPATHY; RESPIRATION	Coenzyme Q(10) (CoQ(10)) is a potent lipophilic antioxidant in cell membranes and a carrier of electrons in the mitochondrial respiratory chain. We previously characterized the effects of varying severities of CoQ(10) deficiency on ROS production and mitochondrial bioenergetics in cells harboring genetic defects of CoQ(10) biosynthesis. We observed a unimodal distribution of ROS production with CoQ(10) deficiency: cells with <20% of CoQ(10) and 50-70% of CoQ(10) did not generate excess ROS while cells with 30-45% of CoQ(10) showed increased ROS production and lipid peroxidation. Because our previous studies were limited to a small number of mutant cell lines with heterogeneous molecular defects, here, we treated 5 control and 2 mildly CoQ(10) deficient fibroblasts with varying doses of 4-nitrobenzoate (4-NB), an analog of 4-hydroxybenzoate (4-HB) and inhibitor of 4-para-hydroxybenzoate: polyprenyl transferase (COQ2) to induce a range of CoQ(10) deficiencies. Our results support the concept that the degree of CoQ(10) deficiency in cells dictates the extent of ATP synthesis defects and ROS production and that 40-50% residual CoQ(10) produces maximal oxidative stress and cell death.	[Quinzii, Catarina M.; Tadesse, Saba; Naini, Ali; Hirano, Michio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA; [Naini, Ali] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; Columbia University	Quinzii, CM (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA.	mh29@columbia.edu			Eunice Kennedy Shriver National Institute of Child Health & Human Development [K23 HD065871, 1R01 HD057543]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057543, K23HD065871] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project was supported by K23 HD065871 (CMQ) and 1R01 HD057543 (MH) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2010, BRAIN, V133, P797, DOI 10.1093/brain/awq015; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Busso C, 2010, FEBS LETT, V584, P1609, DOI 10.1016/j.febslet.2010.03.024; Cotan D, 2011, FASEB J IN PRESS; Davidson JF, 2001, MOL CELL BIOL, V21, P8483, DOI 10.1128/MCB.21.24.8483-8489.2001; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Earls LR, 2010, P NATL ACAD SCI USA, V107, P14460, DOI 10.1073/pnas.0910630107; Emmanuele V, 2011, CLIN GENETIC H UNPUB; Falk MJ, 2011, EMBO MOL MED, V3, P410, DOI 10.1002/emmm.201100149; Forsman U, 2010, NAT CHEM BIOL, V6, P515, DOI [10.1038/NCHEMBIO.372, 10.1038/nchembio.372]; Geromel V, 2001, FREE RADICAL RES, V35, P11, DOI 10.1080/10715760100300551; Gin P, 2003, J BIOL CHEM, V278, P25308, DOI 10.1074/jbc.M303234200; Gonzalez-Aragon D, 2005, BIOFACTORS, V25, P31, DOI 10.1002/biof.5520250105; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Kawamukai M, 2009, BIOTECHNOL APPL BIOC, V53, P217, DOI 10.1042/BA20090035; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Lopez LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011897; Lopez LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200; Miki R, 2008, FEBS J, V275, P5309, DOI 10.1111/j.1742-4658.2008.06661.x; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; Nakai D, 2004, AGING CELL, V3, P273, DOI 10.1111/j.1474-9728.2004.00116.x; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; Peng M, 2004, KIDNEY INT, V66, P20, DOI 10.1111/j.1523-1755.2004.00702.x; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Quinzii CM, 2008, FASEB J, V22, P1874, DOI 10.1096/fj.07-100149; Quinzii CM, 2010, FASEB J, V24, P3733, DOI 10.1096/fj.09-152728; Quinzii CM, 2010, DEV DISABIL RES REV, V16, P183, DOI 10.1002/ddrr.108; Rahman S, 2011, NEUROMUSCUL IN PRESS; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Rodriguez-Aguilera JC, 2005, AGEING RES REV, V4, P41, DOI 10.1016/j.arr.2004.09.001; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Saiki R, 2005, FEBS J, V272, P5606, DOI 10.1111/j.1742-4658.2005.04956.x; Saiki R, 2008, AM J PHYSIOL-RENAL, V295, pF1535, DOI 10.1152/ajprenal.90445.2008; Tauche A, 2008, FEMS YEAST RES, V8, P1263, DOI 10.1111/j.1567-1364.2008.00436.x; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Uchida N, 2000, J BACTERIOL, V182, P6933, DOI 10.1128/JB.182.24.6933-6939.2000; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009	43	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30606	10.1371/journal.pone.0030606	http://dx.doi.org/10.1371/journal.pone.0030606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359546	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200015
J	Sajic, M; Hunt, DPJ; Lee, W; Compston, DAS; Schweimer, JV; Gregson, NA; Chandran, S; Smith, KJ				Sajic, Marija; Hunt, David P. J.; Lee, Woojin; Compston, D. Alastair S.; Schweimer, Judith V.; Gregson, Norman A.; Chandran, Siddharthan; Smith, Kenneth J.			Mesenchymal Stem Cells Lack Efficacy in the Treatment of Experimental Autoimmune Neuritis despite In Vitro Inhibition of T-Cell Proliferation	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; STROMAL CELLS; BONE-MARROW; ENCEPHALOMYELITIS; TRANSPLANTATION; DISEASES	Mesenchymal stem cells have been demonstrated to ameliorate experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis, prompting clinical trials in multiple sclerosis which are currently ongoing. An important question is whether this therapeutic effect generalises to other autoimmune neurological diseases. We performed two trials of efficacy of MSCs in experimental autoimmune neuritis (EAN) in Lewis (LEW/Han (M)Hsd) rats, a model of human autoimmune inflammatory neuropathies. No differences between the groups were found in clinical, histological or electrophysiological outcome measures. This was despite the ability of mesenchymal stem cells to inhibit proliferation of CD4+ T-cells in vitro. Therefore the efficacy of MSCs observed in autoimmune CNS demyelination models do not necessarily generalise to the treatment of other forms of neurological autoimmunity.	[Sajic, Marija; Hunt, David P. J.; Lee, Woojin; Gregson, Norman A.; Smith, Kenneth J.] UCL, Inst Neurol, Dept Neuroinflammat, London, England; [Hunt, David P. J.; Compston, D. Alastair S.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Schweimer, Judith V.] Kings Coll London, Dept Neuroimmunol, London WC2R 2LS, England; [Hunt, David P. J.; Chandran, Siddharthan] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland	University of London; University College London; University of Cambridge; University of London; King's College London; University of Edinburgh	Sajic, M (corresponding author), UCL, Inst Neurol, Dept Neuroinflammat, London, England.	david.hunt@hgu.mrc.ac.uk	Schweimer, Judith/AAP-9802-2020; Schweimer, Judith/GWZ-7711-2022; Smith, Kenneth/I-9197-2014; Sajic, Marija/G-4035-2012	Schweimer, Judith/0000-0002-5968-3534; Smith, Kenneth/0000-0003-4408-7809; Sajic, Marija/0000-0002-4050-7477	Brain entrance scholarship; Wellcome Trust; Medical Research Council, United Kingdom; Multiple Sclerosis Society of Great Britian & Northern Ireland; European Union; Brain Research Trust; National Institute for Health Research Biomedical Research; MRC [G0800954] Funding Source: UKRI; Medical Research Council [G0800954] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10335] Funding Source: researchfish	Brain entrance scholarship; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Multiple Sclerosis Society of Great Britian & Northern Ireland; European Union(European Commission); Brain Research Trust; National Institute for Health Research Biomedical Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	DH is funded by a Brain entrance scholarship (Guarantors of Brain) and by the Wellcome Trust. KJS is funded by the Medical Research Council, United Kingdom, the Multiple Sclerosis Society of Great Britian & Northern Ireland, the European Union (FP6 NeuroproMiSe) and the Brain Research Trust. SC is supported by the National Institute for Health Research Biomedical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechtold DA, 2005, BRAIN, V128, P18, DOI 10.1093/brain/awh328; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Freedman MS, 2010, MULT SCLER J, V16, P503, DOI 10.1177/1352458509359727; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Hadden RDM, 2002, NEUROPATH APPL NEURO, V28, P489, DOI 10.1046/j.1365-2990.2002.00421.x; Hughes RAC, 2006, J PERIPHER NERV SYST, V11, P30, DOI 10.1111/j.1085-9489.2006.00061.x; Hunt DPJ, 2008, CELL TRANSPLANT, V17, P865, DOI 10.3727/096368908786516738; Hunt DP, 2010, STEM CELLS DEV, V19, P1055, DOI 10.1089/scd.2009.0371; Jones JL, 2009, J CLIN INVEST, V119, P2052, DOI 10.1172/JCI37878; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Martino G, 2010, NAT REV NEUROL, V6, P247, DOI 10.1038/nrneurol.2010.35; Maurer M, 2002, NEUROMUSCULAR DISORD, V12, P405, DOI 10.1016/S0960-8966(01)00302-9; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Sajic M, 2011, MULT SCLER      0930; Tyndall A, 2009, BONE MARROW TRANSPL, V43, P821, DOI 10.1038/bmt.2009.63; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uccelli A, 2008, AUTOIMMUNITY, V41, P592, DOI 10.1080/08916930802200166; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	21	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30708	10.1371/journal.pone.0030708	http://dx.doi.org/10.1371/journal.pone.0030708			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359549	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200018
J	Schnell, R; Oehlmann, W; Sandalova, T; Braun, Y; Huck, C; Maringer, M; Singh, M; Schneider, G				Schnell, Robert; Oehlmann, Wulf; Sandalova, Tatyana; Braun, Yvonne; Huck, Carmen; Maringer, Marko; Singh, Mahavir; Schneider, Gunter			Tetrahydrodipicolinate N-Succinyltransferase and Dihydrodipicolinate Synthase from Pseudomonas aeruginosa: Structure Analysis and Gene Deletion	PLOS ONE			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ACTIVE-SITE; MYCOBACTERIUM-TUBERCULOSIS; 3-DIMENSIONAL STRUCTURE; LYSINE BIOSYNTHESIS; RESOLUTION; CRYSTALLOGRAPHY; REPLACEMENT; SPECIFICITY	The diaminopimelic acid pathway of lysine biosynthesis has been suggested to provide attractive targets for the development of novel antibacterial drugs. Here we report the characterization of two enzymes from this pathway in the human pathogen Pseudomonas aeruginosa, utilizing structural biology, biochemistry and genetics. We show that tetrahydrodipicolinate N-succinyltransferase (DapD) from P. aeruginosa is specific for the L-stereoisomer of the amino substrate L-2-aminopimelate, and its D-enantiomer acts as a weak inhibitor. The crystal structures of this enzyme with L-2-aminopimelate and D-2-aminopimelate, respectively, reveal that both compounds bind at the same site of the enzyme. Comparison of the binding interactions of these ligands in the enzyme active site suggests misalignment of the amino group of D-2-aminopimelate for nucleophilic attack on the succinate moiety of the co-substrate succinyl-CoA as the structural basis of specificity and inhibition. P. aeruginosa mutants where the dapA gene had been deleted were viable and able to grow in a mouse lung infection model, suggesting that DapA is not an optimal target for drug development against this organism. Structure-based sequence alignments, based on the DapA crystal structure determined to 1.6 angstrom resolution revealed the presence of two homologues, PA0223 and PA4188, in P. aeruginosa that could substitute for DapA in the P. aeruginosa PAO1 Delta dapA mutant. In vitro experiments using recombinant PA0223 protein could however not detect any DapA activity.	[Schnell, Robert; Sandalova, Tatyana; Schneider, Gunter] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Oehlmann, Wulf; Braun, Yvonne; Singh, Mahavir] LIONEX Diagnost & Therapeut, Braunschweig, Germany; [Huck, Carmen; Maringer, Marko] Mfd Diagnost GmbH, Wendelsheim, Germany	Karolinska Institutet; Lionex Diagnostics & Therapeutics GmbH	Schnell, R (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	info@lionex.de; gunter.schneider@ki.se		Schneider, Gunter/0000-0003-0622-5713; Sandalova, Tatyana/0000-0002-7694-6420; SCHNELL, ROBERT/0000-0001-7530-3629	European Commission [223461]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the Seventh Framework Program of the European Commission (FP7/2007-2013) under grant agreement no 223461. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaman TW, 1997, BIOCHEMISTRY-US, V36, P489, DOI 10.1021/bi962522q; Beaman TW, 2002, PROTEIN SCI, V11, P974, DOI 10.1110/ps.4310102; Beaman TW, 1998, BIOCHEMISTRY-US, V37, P10363, DOI 10.1021/bi980759b; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; BERGES DA, 1986, J BIOL CHEM, V261, P6160; BHAT TN, 1988, J APPL CRYSTALLOGR, V21, P279, DOI 10.1107/S0021889887012755; Blagova E, 2006, PROTEINS, V62, P297, DOI 10.1002/prot.20684; Blickling S, 1997, BIOCHEMISTRY-US, V36, P24, DOI 10.1021/bi962272d; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; da Costa TPS, 2010, BIOCHIMIE, V92, P837, DOI 10.1016/j.biochi.2010.03.004; Devenish SRA, 2009, BBA-PROTEINS PROTEOM, V1794, P1168, DOI 10.1016/j.bbapap.2009.02.003; Dobson RCJ, 2005, BIOCHEMISTRY-US, V44, P13007, DOI 10.1021/bi051281w; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; Dobson RCJ, 2009, BIOCHIMIE, V91, P1036, DOI 10.1016/j.biochi.2009.05.013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel C, 1996, CURR OPIN STRUC BIOL, V6, P790, DOI 10.1016/S0959-440X(96)80009-1; Evans G, 2011, ARCH BIOCHEM BIOPHYS, V512, P154, DOI 10.1016/j.abb.2011.05.014; Girish TS, 2008, FEBS LETT, V582, P2923, DOI 10.1016/j.febslet.2008.07.035; Griffin MDW, 2008, J MOL BIOL, V380, P691, DOI 10.1016/j.jmb.2008.05.038; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Kaur N, 2011, INT J BIOL MACROMOL, V48, P779, DOI 10.1016/j.ijbiomac.2011.03.002; Kefala G, 2008, BIOCHEM J, V411, P351, DOI 10.1042/BJ20071360; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; MIRWALDT C, 1995, J MOL BIOL, V246, P227, DOI 10.1006/jmbi.1994.0078; Mooij WTM, 2009, STRUCTURE, V17, P183, DOI 10.1016/j.str.2008.12.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen L, 2008, FEBS LETT, V582, P623, DOI 10.1016/j.febslet.2008.01.032; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Pearce FG, 2006, BIOCHEM J, V400, P359, DOI 10.1042/BJ20060771; Rice EA, 2008, ARCH BIOCHEM BIOPHYS, V480, P111, DOI 10.1016/j.abb.2008.09.018; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Scapin G, 1998, ADV ENZYMOL RAMB, V72, P279; Schuldt L, 2009, J MOL BIOL, V389, P863, DOI 10.1016/j.jmb.2009.04.046; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; STARKE JR, 1987, PEDIATR RES, V22, P698, DOI 10.1203/00006450-198712000-00017; Thoma S, 2009, FEMS MICROBIOL LETT, V294, P127, DOI 10.1111/j.1574-6968.2009.01556.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Voss JE, 2010, J BIOL CHEM, V285, P5188, DOI 10.1074/jbc.M109.038166; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zavascki AP, 2010, EXPERT REV ANTI-INFE, V8, P71, DOI 10.1586/ERI.09.108	44	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31133	10.1371/journal.pone.0031133	http://dx.doi.org/10.1371/journal.pone.0031133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359568	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200037
J	Andersson, GKS; Rundlof, M; Smith, HG				Andersson, Georg K. S.; Rundlof, Maj; Smith, Henrik G.			Organic Farming Improves Pollination Success in Strawberries	PLOS ONE			English	Article							PORTUGAL SELECTION; FLORAL VISITORS; DIVERSITY; BIODIVERSITY; INCREASES; ABUNDANCE; BEES; LANDSCAPES; BENEFITS; RIBATEJO	Pollination of insect pollinated crops has been found to be correlated to pollinator abundance and diversity. Since organic farming has the potential to mitigate negative effects of agricultural intensification on biodiversity, it may also benefit crop pollination, but direct evidence of this is scant. We evaluated the effect of organic farming on pollination of strawberry plants focusing on (1) if pollination success was higher on organic farms compared to conventional farms, and (2) if there was a time lag from conversion to organic farming until an effect was manifested. We found that pollination success and the proportion of fully pollinated berries were higher on organic compared to conventional farms and this difference was already evident 2-4 years after conversion to organic farming. Our results suggest that conversion to organic farming may rapidly increase pollination success and hence benefit the ecosystem service of crop pollination regarding both yield quantity and quality.	[Andersson, Georg K. S.; Smith, Henrik G.] Lund Univ, Ctr Environm & Climate Res, Lund, Sweden; [Andersson, Georg K. S.; Rundlof, Maj; Smith, Henrik G.] Lund Univ, Dept Biol, Lund, Sweden; [Rundlof, Maj] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Lund University; Lund University; Swedish University of Agricultural Sciences	Andersson, GKS (corresponding author), Lund Univ, Ctr Environm & Climate Res, Lund, Sweden.	georg.andersson@biol.lu.se	Andersson, Georg/AAD-5985-2021; Rundlöf, Maj/AAB-7401-2022	Andersson, Georg/0000-0002-9669-6895; Rundlöf, Maj/0000-0003-3014-1544	Swedish Reseasrch Council FORMAS [1680]	Swedish Reseasrch Council FORMAS	This work was supported by The Swedish Reseasrch Council FORMAS: http://www.formas.se/default_529.aspx; Grant number in 2009: 1680. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano S., 2009, Advances in Horticultural Science, V23, P246; Albano S., 2009, Advances in Horticultural Science, V23, P238; Andersson G. K. S., 2010, Aspects of Applied Biology, P381; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Bissonette J. A., 2007, TEMPORAL DIMENSIONS; Brittain C, 2010, BIOL CONSERV, V143, P1860, DOI 10.1016/j.biocon.2010.04.029; CHAGNON M, 1993, J ECON ENTOMOL, V86, P416, DOI 10.1093/jee/86.2.416; Diekotter T, 2010, AGR ECOSYST ENVIRON, V137, P108, DOI 10.1016/j.agee.2010.01.008; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Ekroos J, 2010, AGR ECOSYST ENVIRON, V135, P288, DOI 10.1016/j.agee.2009.10.007; European Commission (EC), OFFICIAL J EUROPEAN; FAO, 2011, CROP PROD DAT 2008; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Fuller RJ, 2005, BIOL LETTERS, V1, P431, DOI 10.1098/rsbl.2005.0357; Gabriel D, 2007, AGR ECOSYST ENVIRON, V118, P43, DOI 10.1016/j.agee.2006.04.005; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Ghazoul J, 2010, FRONT ECOL ENVIRON, V8, P9, DOI 10.1890/10.WB.001; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Holzschuh A, 2008, OIKOS, V117, P354, DOI 10.1111/j.2007.0030-1299.16303.x; Jonason D, 2011, J APPL ECOL, V48, P543, DOI 10.1111/j.1365-2664.2011.01989.x; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2009, FOREST ECOL MANAG, V258, P1838, DOI 10.1016/j.foreco.2009.05.005; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Lopez-Medina J, 2006, ACTA HORTIC, P77, DOI 10.17660/ActaHortic.2006.708.8; Morandin LA, 2005, ECOL APPL, V15, P871, DOI 10.1890/03-5271; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Power EF, 2011, J APPL ECOL, V48, P561, DOI 10.1111/j.1365-2664.2010.01949.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roschewitz I, 2005, J APPL ECOL, V42, P873, DOI 10.1111/j.1365-2664.2005.01072.x; Rundlof M, 2008, BIOL CONSERV, V141, P417, DOI 10.1016/j.biocon.2007.10.011; Rundlof M, 2006, J APPL ECOL, V43, P1121, DOI 10.1111/j.1365-2664.2006.01233.x; Rundlof M, 2010, ECOGRAPHY, V33, P514, DOI 10.1111/j.1600-0587.2009.05938.x; Smith HG, 2010, OECOLOGIA, V162, P1071, DOI 10.1007/s00442-010-1588-2; Stockdale EA, 2001, ADV AGRON, V70, P261, DOI 10.1016/S0065-2113(01)70007-7; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Vergara CH, 2009, AGR ECOSYST ENVIRON, V129, P117, DOI 10.1016/j.agee.2008.08.001; With K.A., 2007, TEMPORAL DIMENSIONS, P43	43	52	54	2	158	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31599	10.1371/journal.pone.0031599	http://dx.doi.org/10.1371/journal.pone.0031599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355380	Green Published, gold			2022-12-25	WOS:000302741300080
J	Prince, LR; Graham, KJ; Connolly, J; Anwar, S; Ridley, R; Sabroe, I; Foster, SJ; Whyte, MKB				Prince, Lynne R.; Graham, Kirstie J.; Connolly, John; Anwar, Sadia; Ridley, Robert; Sabroe, Ian; Foster, Simon J.; Whyte, Moira K. B.			Staphylococcus aureus Induces Eosinophil Cell Death Mediated by alpha-hemolysin	PLOS ONE			English	Article							ATOPIC-DERMATITIS; CATIONIC PROTEIN; BETA-BARREL; TOXIN; APOPTOSIS; VIRULENCE; SKIN; INFECTION; DISEASE; NECROSIS	Staphylococcus aureus, a major human pathogen, exacerbates allergic disorders, including atopic dermatitis, nasal polyps and asthma, which are characterized by tissue eosinophilia. Eosinophils, via their destructive granule contents, can cause significant tissue damage, resulting in inflammation and further recruitment of inflammatory cells. We hypothesised that the relationship between S. aureus and eosinophils may contribute to disease pathology. We found that supernatants from S. aureus (SH1000 strain) cultures cause rapid and profound eosinophil necrosis, resulting in dramatic cell loss within 2 hours. This is in marked contrast to neutrophil granulocytes where no significant cell death was observed (at equivalent dilutions). Supernatants prepared from a strain deficient in the accessory gene regulator (agr) that produces reduced levels of many important virulence factors, including the abundantly produced alpha-hemolysin (Hla), failed to induce eosinophil death. The role of Hla in mediating eosinophil death was investigated using both an Hla deficient SH1000-modified strain, which did not induce eosinophil death, and purified Hla, which induced concentration-dependent eosinophil death via both apoptosis and necrosis. We conclude that S. aureus Hla induces aberrant eosinophil cell death in vitro and that this may increase tissue injury in allergic disease.	[Prince, Lynne R.; Graham, Kirstie J.; Anwar, Sadia; Ridley, Robert; Sabroe, Ian; Whyte, Moira K. B.] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Connolly, John; Foster, Simon J.] Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Prince, LR (corresponding author), Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England.	l.r.prince@sheffield.ac.uk	Sabroe, Ian/I-5981-2013; Sabroe, Ian/AAE-5858-2019	Sabroe, Ian/0000-0001-9750-8975; Prince, Lynne/0000-0001-6133-9372; Connolly, John/0000-0002-9232-7929	University of Sheffield; MRC [R/111251, G116/170]; Sheffield Cardiovascular Biomedical Research Unit; Medical Research Council [G116/170, G0501658] Funding Source: researchfish; MRC [G116/170, G0501658] Funding Source: UKRI	University of Sheffield; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sheffield Cardiovascular Biomedical Research Unit; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Russell Fellowship of University of Sheffield to LP, an MRC Clinical Fellowship to SA (Ref R/111251) and an MRC Senior Clinical Fellowship to IS (G116/170). www.mrc.ac.uk.IS is also supported by the Sheffield Cardiovascular Biomedical Research Unit. (http://www.shef.ac.uk/medicine/nihrbrus/cardiovascular-bru.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBUTHNOTT J P, 1970, P189; Bachert C, 2007, Chem Immunol Allergy, V93, P214, DOI 10.1159/000100897; Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; BRAMLEY AJ, 1989, INFECT IMMUN, V57, P2489, DOI 10.1128/IAI.57.8.2489-2494.1989; Breuer K, 2005, CLIN EXP ALLERGY, V35, P1088, DOI 10.1111/j.1365-2222.2005.02295.x; Cooper EL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-266; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; CZECH W, 1992, BRIT J DERMATOL, V126, P351, DOI 10.1111/j.1365-2133.1992.tb00677.x; da Silva MCA, 2004, AM J PHYSIOL-LUNG C, V287, pL543, DOI 10.1152/ajplung.00256.2003; De Benedetto A, 2009, J INVEST DERMATOL, V129, P14, DOI 10.1038/jid.2008.259; Dockrell DH, 2006, J LEUKOCYTE BIOL, V79, P904, DOI 10.1189/jlb.1005555; Driss V, 2009, BLOOD, V113, P3235, DOI 10.1182/blood-2008-07-166595; Essmann F, 2003, CELL DEATH DIFFER, V10, P1260, DOI 10.1038/sj.cdd.4401301; FADOK VA, 1992, J IMMUNOL, V148, P2207; FLAVAHAN NA, 1988, AM REV RESPIR DIS, V138, P685, DOI 10.1164/ajrccm/138.3.685; Gibson PG, 2003, THORAX, V58, P116, DOI 10.1136/thorax.58.2.116; Guzik TJ, 2005, CLIN EXP ALLERGY, V35, P448, DOI 10.1111/j.1365-2222.2005.02210.x; HASLETT C, 1985, AM J PATHOL, V119, P101; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; HENDERSON WR, 1980, J EXP MED, V152, P265, DOI 10.1084/jem.152.2.265; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Huvenne W, 2010, CLIN EXP ALLERGY; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; KAGI MK, 1992, DERMATOLOGY, V185, P88, DOI 10.1159/000247419; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kielian T, 2001, INFECT IMMUN, V69, P6902, DOI 10.1128/IAI.69.11.6902-6911.2001; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; LEUNG DYM, 1993, J CLIN INVEST, V92, P1374, DOI 10.1172/JCI116711; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Lim KG, 1996, J IMMUNOL, V156, P2566; McElroy MC, 1999, INFECT IMMUN, V67, P5541, DOI 10.1128/IAI.67.10.5541-5544.1999; Menestrina G, 2001, TOXICON, V39, P1661, DOI 10.1016/S0041-0101(01)00153-2; Menzies BE, 2000, FEMS IMMUNOL MED MIC, V29, P39, DOI 10.1016/S0928-8244(00)00185-1; Min DY, 2004, INT ARCH ALLERGY IMM, V133, P357, DOI 10.1159/000077355; Niimi A, 1998, CLIN EXP ALLERGY, V28, P233; NILSSON EJ, 1992, J AM ACAD DERMATOL, V27, P29, DOI 10.1016/0190-9622(92)70151-5; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; OREILLY M, 1986, MICROB PATHOGENESIS, V1, P125, DOI 10.1016/0882-4010(86)90015-X; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; RING J, 1992, ALLERGY, V47, P265, DOI 10.1111/j.1398-9995.1992.tb02051.x; Sabroe I, 1999, J IMMUNOL, V162, P2946; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Serradell MC, 2007, VET IMMUNOL IMMUNOP, V117, P197, DOI 10.1016/j.vetimm.2007.03.007; Shin Myeong-Heon, 2000, Korean Journal of Parasitology, V38, P17, DOI 10.3347/kjp.2000.38.1.17; STERN M, 1992, J IMMUNOL, V148, P3543; Torrent M, 2009, BIOCH J; Usher LR, 2002, J IMMUNOL, V168, P1861, DOI 10.4049/jimmunol.168.4.1861; Valeva A, 1997, P NATL ACAD SCI USA, V94, P11607, DOI 10.1073/pnas.94.21.11607; Walsh GM, 1998, J IMMUNOL METHODS, V217, P153, DOI 10.1016/S0022-1759(98)00103-3; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wichmann K, 2009, BRIT J DERMATOL, V161, P300, DOI 10.1111/j.1365-2133.2009.09229.x; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Zhang N, 2005, RHINOLOGY, V43, P162	59	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31506	10.1371/journal.pone.0031506	http://dx.doi.org/10.1371/journal.pone.0031506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355374	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300074
J	Trerotola, M; Cantanelli, P; Guerra, E; Tripaldi, R; Aloisi, AL; Bonasera, V; Lattanzio, R; de Lange, R; Weidle, UH; Piantelli, M; Alberti, S				Trerotola, M.; Cantanelli, P.; Guerra, E.; Tripaldi, R.; Aloisi, A. L.; Bonasera, V.; Lattanzio, R.; de Lange, R.; Weidle, U. H.; Piantelli, M.; Alberti, S.			Upregulation of Trop-2 quantitatively stimulates human cancer growth	ONCOGENE			English	Article						Trop-2; human tumours; cell growth; signalling; oncogene	CELL-SURFACE GLYCOPROTEIN; DNA METHYLATION PREVENTS; GENE-EXPRESSION; MAMMALIAN-CELLS; MONOCLONAL-ANTIBODIES; COLORECTAL-CANCER; HUMAN CARCINOMAS; TRANSGENIC MICE; FLOW-CYTOMETRY; BREAST-CANCER	Trop-2 is a calcium signal transducer that is associated with transformed cell growth in experimental systems. However, its role in human cancer remains essentially unknown. In this study, we profiled Trop-2 expression in normal human tissues at the mRNA and protein levels. We then systematically compared Trop-2 mRNA and protein levels in tumours with their tissues of origin. We find that Trop-2 expression is invariably upregulated in tumours, regardless of baseline expression in normal tissues, which suggests a corresponding selective advantage. Thus, we investigated the outcome of Trop-2 upregulation on tumour growth. Overexpression of wild-type Trop-2 was shown to be necessary and sufficient to drive cancer growth in a widely invariant manner across cell type and species. Upregulation of Trop-2 was shown to quantitatively stimulate tumour growth, as proportional to expression levels in vivo, and tumour cell growth was abrogated by somatic knockdown of Trop-2 expression. On the other hand, we found no evidence of tumour-associated TROP2 mutations, nor of TROP2 induction of oncogenic transformation per se. Our data support a model where above-baseline expression of wild-type Trop-2 is a key driver of human cancer growth. Oncogene (2013) 32, 222-233; doi:10.1038/onc.2012.36; published online 20 February 2012	[Trerotola, M.; Cantanelli, P.; Guerra, E.; Tripaldi, R.; Aloisi, A. L.; Bonasera, V.; Lattanzio, R.; Piantelli, M.; Alberti, S.] Fdn Univ G dAnnunzio, CeSI, Dept Oncol & Expt Med, Unit Canc Pathol, I-66100 Chieti, Italy; [de Lange, R.; Weidle, U. H.] Roche Diagnost GmbH, Pharma Res, Penzberg, Germany; [Alberti, S.] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; Roche Holding; G d'Annunzio University of Chieti-Pescara	Alberti, S (corresponding author), Fdn Univ G dAnnunzio, CeSI, Dept Oncol & Expt Med, Unit Canc Pathol, Via Colle dell Ara, I-66100 Chieti, Italy.	s.alberti@unich.it	Lattanzio, Rossano/K-1927-2018; Alberti, Saverio/M-4511-2014; Trerotola, Marco/J-9015-2016	Lattanzio, Rossano/0000-0001-9803-4476; Alberti, Saverio/0000-0002-4647-6042; Trerotola, Marco/0000-0003-1855-7002; Guerra, Emanuela/0000-0002-7091-8621; Piantelli, Mauro/0000-0003-0154-482X	Fondazione of the Cassa di Risparmio della Provincia di Chieti; ABO Foundation [CH01D0081]; Fondazione compagnia di San Paolo; Italian Ministry of Health [RicOncol RF-EMR-2006-361866]; Italian Foundation for Cancer Research (FIRC, Italy); Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Fondazione of the Cassa di Risparmio della Provincia di Chieti; ABO Foundation; Fondazione compagnia di San Paolo(Compagnia di San Paolo); Italian Ministry of Health(Ministry of Health, Italy); Italian Foundation for Cancer Research (FIRC, Italy)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We are grateful to Professor B Ponder and Dr S Martin for the generous supply of the genomic DNA of MEN-2A, pheochromocytoma and medullary thyroid carcinomas. We thank Dr A Mironov and GV Beznoussenko for help during the course of this work. This research was supported by the Fondazione of the Cassa di Risparmio della Provincia di Chieti, ABO Foundation (CH01D0081), Fondazione compagnia di San Paolo and Italian Ministry of Health (RicOncol RF-EMR-2006-361866). MT was a recipient of a scholarship from the Italian Foundation for Cancer Research (FIRC, Italy).	ALBERTI S, 1994, P NATL ACAD SCI USA, V91, P5833, DOI 10.1073/pnas.91.13.5833; ALBERTI S, 1988, P NATL ACAD SCI USA, V85, P8391, DOI 10.1073/pnas.85.22.8391; ALBERTI S, 1990, NUCLEIC ACIDS RES, V18, P351, DOI 10.1093/nar/18.2.351; ALBERTI S, 1987, CYTOMETRY, V8, P114, DOI 10.1002/cyto.990080203; ALBERTI S, 1991, J HISTOCHEM CYTOCHEM, V39, P701, DOI 10.1177/39.5.1901878; ALBERTI S, 1992, HYBRIDOMA, V11, P539, DOI 10.1089/hyb.1992.11.539; BASU A, 1995, INT J CANCER, V62, P472, DOI 10.1002/ijc.2910620419; Bignotti E, 2010, EUR J CANCER, V46, P944, DOI 10.1016/j.ejca.2009.12.019; Bonasera V, 2007, BIOTECHNIQUES, V43, P173, DOI 10.2144/000112500; BROWN WJ, 1989, METHOD CELL BIOL, V31, P553; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carletti E, 2006, TRENDS BIOTECHNOL, V24, P443, DOI 10.1016/j.tibtech.2006.07.006; Chalk AM, 2004, BIOCHEM BIOPH RES CO, V319, P264, DOI 10.1016/j.bbrc.2004.04.181; CORDONCARDO C, 1984, J HISTOCHEM CYTOCHEM, V32, P1035, DOI 10.1177/32.10.6384360; Cubas R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-253; Cubas R, 2009, BBA-REV CANCER, V1796, P309, DOI 10.1016/j.bbcan.2009.08.001; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; El Sewedy T, 1998, INT J CANCER, V75, P324, DOI 10.1002/(SICI)1097-0215(19980119)75:2<324::AID-IJC24>3.3.CO;2-5; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ERBA E, 1989, BRIT J CANCER, V60, P45, DOI 10.1038/bjc.1989.217; Fang YJ, 2009, INT J COLORECTAL DIS, V24, P875, DOI 10.1007/s00384-009-0725-z; Fong D, 2008, BRIT J CANCER, V99, P1290, DOI 10.1038/sj.bjc.6604677; Fong D, 2008, MODERN PATHOL, V21, P186, DOI 10.1038/modpathol.3801001; FORNARO M, 1995, INT J CANCER, V62, P610, DOI 10.1002/ijc.2910620520; FRADET Y, 1984, P NATL ACAD SCI-BIOL, V81, P224, DOI 10.1073/pnas.81.1.224; Goldstein AS, 2010, MOL ONCOL, V4, P385, DOI 10.1016/j.molonc.2010.06.009; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Guerra E, 2008, CANCER RES, V68, P8113, DOI 10.1158/0008-5472.CAN-07-6135; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; KLEIN CE, 1990, J INVEST DERMATOL, V95, P74, DOI 10.1111/1523-1747.ep12873988; KLEIN CE, 1987, J INVEST DERMATOL, V89, P500, DOI 10.1111/1523-1747.ep12460996; Lal A, 1999, CANCER RES, V59, P5403; LIPINSKI M, 1981, P NATL ACAD SCI-BIOL, V78, P5147, DOI 10.1073/pnas.78.8.5147; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Muhlmann G, 2009, J CLIN PATHOL, V62, P152, DOI 10.1136/jcp.2008.060590; Nakashima K, 2004, INT J CANCER, V112, P1029, DOI 10.1002/ijc.20517; NAQUET P, 1989, THYMUS, V13, P217; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Ohmachi T, 2006, CLIN CANCER RES, V12, P3057, DOI 10.1158/1078-0432.CCR-05-1961; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Querzoli P, 2006, CLIN CANCER RES, V12, P6696, DOI 10.1158/1078-0432.CCR-06-0569; Ripani E, 1998, INT J CANCER, V76, P671; Rossi C, 2008, EUR J CANCER, V44, P2696, DOI 10.1016/j.ejca.2008.08.021; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Sukhthankar M, 2010, ANTICANCER RES, V30, P2497; THORGEIRSSON UP, 1985, MOL CELL BIOL, V5, P259, DOI 10.1128/MCB.5.1.259; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Trerotola M, 2010, AM J TRANSL RES, V2, P135; Trerotola M, 2010, BBA-REV CANCER, V1805, P119, DOI 10.1016/j.bbcan.2009.12.002; Varughese J, 2011, CANCER-AM CANCER SOC, V117, P3163, DOI 10.1002/cncr.25891; Wang JB, 2008, MOL CANCER THER, V7, P280, DOI 10.1158/1535-7163.MCT-07-2003; Wang JB, 2011, MOL CANCER RES, V9, P1686, DOI 10.1158/1541-7786.MCR-11-0241; Wolter S, 2002, J BIOL CHEM, V277, P3576, DOI 10.1074/jbc.M105800200; Zanna P, 2007, CANCER-AM CANCER SOC, V110, P452, DOI 10.1002/cncr.22785; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	59	144	158	3	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2013	32	2					222	233		10.1038/onc.2012.36	http://dx.doi.org/10.1038/onc.2012.36			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	078CK	22349828				2022-12-25	WOS:000314075500010
J	Figuera-Losada, M; LoGrasso, PV				Figuera-Losada, Mariana; LoGrasso, Philip V.			Enzyme Kinetics and Interaction Studies for Human JNK1 beta 1 and Substrates Activating Transcription Factor 2 (ATF2) and c-Jun N-terminal kinase (c-Jun)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; SIGNAL-TRANSDUCTION; INSULIN-RESISTANCE; PEPTIDE INHIBITOR; JNK ACTIVITY; APOPTOSIS; MECHANISM; BIOSENSOR; ISOFORMS; NEURONS	c-Jun N-terminal kinase (JNK) is a stress signal transducer linked to cell death, and survival. JNK1 has been implicated in obesity, glucose intolerance, and insulin resistance. In this study we report the kinetic mechanism for JNK1 beta 1 with transcription factors ATF2 and c-Jun along with interaction kinetics for these substrates. JNK1 beta 1 followed a random sequential mechanism forming a ternary complex between JNK-substrate-ATP. K-m for ATF2 and c-Jun was 1.1 and 2.8 mu M, respectively. Inhibition studies using adenosine 5'-(beta,gamma-methylenetriphosphate) and a peptide derived from JNK interacting protein 1 (JIP1) supported the proposed kinetic mechanism. Biolayer interferometry studies showed that unphosphorylated JNK1 beta 1 bound to ATF2 with similar affinity as it did to c-Jun (K-D = 2.60 +/- 0.34 versus 1.00 +/- 0.35 mu M, respectively). The presence of ATP increased the affinity of unphosphorylated JNK1 beta 1 for ATF2 and c-Jun, to 0.80 +/- 0.04 versus 0.65 +/- 0.07 mu M, respectively. Phosphorylation of JNK1 beta 1 decreased the affinity of the kinase for ATF2 to 11.0 +/- 1.1 mu M and for c-Jun to 17.0 +/- 7.5 mu M in the absence of ATP. The presence of ATP caused a shift in the KD of the active kinase for ATF2 to 1.70 +/- 0.25 mu M and for c-Jun of 3.50 +/- 0.95 mu M. These results are the first kinetic and biochemical characterization of JNK1 beta 1 and uncover some of the differences in the enzymatic activity of JNK1 beta 1 compared with other variants and suggest that ATP binding or JNK phosphorylation could induce changes in the interactions with substrates, activators, and regulatory proteins.	Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	LoGrasso, PV (corresponding author), 130 Scripps Way, Jupiter, FL 33458 USA.	lograsso@scripps.edu			National Institutes of Health [NS057153]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS057153 (to P. L.).	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Arthur PG, 2007, J NEUROCHEM, V102, P65, DOI 10.1111/j.1471-4159.2007.04618.x; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Bayer E A, 1980, Methods Biochem Anal, V26, P1; Bender K, 1997, J PHOTOCH PHOTOBIO B, V37, P1, DOI 10.1016/S1011-1344(96)07459-3; Bowers S, 2011, BIOORG MED CHEM LETT, V21, P1838, DOI 10.1016/j.bmcl.2011.01.046; Bruckner SR, 2001, J NEUROCHEM, V78, P298, DOI 10.1046/j.1471-4159.2001.00400.x; Burkhard KA, 2011, J BIOL CHEM, V286, P2477, DOI 10.1074/jbc.M110.177899; Chamberlain SD, 2009, BIOORG MED CHEM LETT, V19, P360, DOI 10.1016/j.bmcl.2008.11.077; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dreskin SC, 2001, J IMMUNOL, V166, P5646, DOI 10.4049/jimmunol.166.9.5646; EDWARDS PR, 1995, ANAL BIOCHEM, V231, P210, DOI 10.1006/abio.1995.1522; Ember B, 2008, ARCH BIOCHEM BIOPHYS, V477, P324, DOI 10.1016/j.abb.2008.06.001; Ember B, 2008, BIOCHEMISTRY-US, V47, P3076, DOI 10.1021/bi701852z; Gilbert H. F., 2000, BASIC CONCEPTS BIOCH; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hara T, 1998, BIOCHEM BIOPH RES CO, V244, P41, DOI 10.1006/bbrc.1998.8210; Hayashi T, 2000, NEUROSCI LETT, V284, P195, DOI 10.1016/S0304-3940(00)01024-7; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hom RK, 2010, BIOORG MED CHEM LETT, V20, P7303, DOI 10.1016/j.bmcl.2010.10.066; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kamenecka T, 2010, J MED CHEM, V53, P419, DOI 10.1021/jm901351f; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Klintworth H, 2007, TOXICOL SCI, V97, P149, DOI 10.1093/toxsci/kfm029; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Leatherbarrow R.J., 2001, GRAFIT; Lisnock J, 2000, BIOCHEMISTRY-US, V39, P3141, DOI 10.1021/bi992410+; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; MOHIT AA, 1995, NEURON, V14, P67, DOI 10.1016/0896-6273(95)90241-4; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Ngoei KRW, 2011, BIOCHEM J, V434, P399, DOI 10.1042/BJ20101244; Niu LH, 2007, BIOCHEMISTRY-US, V46, P4775, DOI 10.1021/bi602423e; OShannessy DJ, 1996, ANAL BIOCHEM, V236, P275, DOI 10.1006/abio.1996.0167; Probst GD, 2011, BIOORG MED CHEM LETT, V21, P315, DOI 10.1016/j.bmcl.2010.11.010; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Scapin G, 2003, CHEM BIOL, V10, P705, DOI 10.1016/S1074-5521(03)00159-5; Segel I.H., 1975, ENZYME KINETICS; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; Stebbins JL, 2008, P NATL ACAD SCI USA, V105, P16809, DOI 10.1073/pnas.0805677105; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Waeber G, 2000, NAT GENET, V24, P291, DOI 10.1038/73523; WESTWICK JK, 1994, J BIOL CHEM, V269, P26396; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yang JY, 2007, CELL SIGNAL, V19, P2201, DOI 10.1016/j.cellsig.2007.07.001	51	18	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13291	13302		10.1074/jbc.M111.323766	http://dx.doi.org/10.1074/jbc.M111.323766			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351776	Green Published, hybrid			2022-12-25	WOS:000302903700065
J	Li, ZQ; Wang, YQ; Zhang, M; Xu, PF; Huang, HZ; Wu, D; Meng, AM				Li, Zhiqiang; Wang, Yeqi; Zhang, Min; Xu, Pengfei; Huang, Huizhe; Wu, Di; Meng, Anming			The Amotl2 Gene Inhibits Wnt/beta-Catenin Signaling and Regulates Embryonic Development in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL MIGRATION; BETA-CATENIN; MESODERM INDUCTION; COILED-COIL; ANGIOMOTIN; PROTEIN; PATHWAY; COMPLEX; BINDING; ANGIOGENESIS	The Motin family proteins can regulate cell polarity, cell mobility, and proliferation during embryonic development by controlling distinct signaling pathways. In this study, we demonstrate that amotl2 knockdown in zebrafish wild-type embryos results in embryonic dorsalization, and this effect can be antagonized by co-knockdown of the dorsal inducer beta-catenin2. Overexpression of amotl2 in masterblind (mbl) homozygous embryos, in which canonical Wnt signaling is up-regulated due to an axin1 mutation, transforms eyeless phenotype into smaller eyes, whereas co-knockdown of amot, amotl1, and amotl2 leads to development of smaller eyes in mbl heterozygotes. In cultured mammalian cells, Motin family members all possess the ability to attenuate Wnt/beta-catenin signaling. Focusing on Amotl2, we show that Amotl2 can associate with and trap beta-catenin in the Rab11-positive recycling endosomes, and as a result, the amount of beta-catenin in the cytosol and nucleus is reduced. Thus, our findings provide novel insights into functions of Motin family members and regulation of Wnt/beta-catenin signaling.	[Li, Zhiqiang; Wang, Yeqi; Zhang, Min; Xu, Pengfei; Huang, Huizhe; Wu, Di; Meng, Anming] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Engn, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Meng, Anming] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Zoology, CAS	Meng, AM (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Engn, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Meng, Anming/A-4785-2012; Wang, Yeqi/V-8445-2019	Wang, Yeqi/0000-0003-2881-4607; Li, Zhiqiang/0000-0002-2768-5332	Major Science Programs of China [2011CB943800]; National Natural Science Foundation of China [30921004/C061003]	Major Science Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Major Science Programs of China (2011CB943800) and from National Natural Science Foundation of China (30921004/C061003).	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Gagne V, 2009, CELL MOTIL CYTOSKEL, V66, P754, DOI 10.1002/cm.20405; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Heller B, 2010, J BIOL CHEM, V285, P12308, DOI 10.1074/jbc.M109.096230; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Leung TC, 2003, DEV DYNAM, V228, P424, DOI 10.1002/dvdy.10408; Levchenko T, 2003, J CELL SCI, V116, P3803, DOI 10.1242/jcs.00694; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Pellon-Cardenas O, 2011, CURR DRUG TARGETS, V12, P1216, DOI 10.2174/138945011795906552; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Ranahan WP, 2011, CANCER RES, V71, P2203, DOI 10.1158/0008-5472.CAN-10-1995; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Roudier E, 2009, J PHYSIOL-LONDON, V587, P4105, DOI 10.1113/jphysiol.2009.175554; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Stern CD, 2006, INT J DEV BIOL, V50, P3, DOI 10.1387/ijdb.052095cs; Su Y, 2007, FASEB J, V21, P682, DOI 10.1096/fj.06-6246com; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wang YQ, 2011, J BIOL CHEM, V286, P41095, DOI 10.1074/jbc.M111.296806; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569; Zhang Y, 2009, J CELL SCI, V122, P2197, DOI 10.1242/jcs.040659; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156	49	31	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13005	13015		10.1074/jbc.M112.347419	http://dx.doi.org/10.1074/jbc.M112.347419			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362771	Green Published, hybrid			2022-12-25	WOS:000302903700039
J	Maurer, LM; Ma, WJ; Eickstaedt, NL; Johnson, IA; Tomasini-Johansson, BR; Annis, DS; Mosher, DF				Maurer, Lisa M.; Ma, Wenjiang; Eickstaedt, Nathan L.; Johnson, Ian A.; Tomasini-Johansson, Bianca R.; Annis, Douglas S.; Mosher, Deane F.			Ligation of the Fibrin-binding Domain by beta-Strand Addition Is Sufficient for Expansion of Soluble Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL UPSTREAM DOMAIN; STREPTOCOCCUS-PYOGENES; COLLAGEN-BINDING; STAPHYLOCOCCUS-AUREUS; EXTRACELLULAR-MATRIX; TERMINAL MODULES; PROTEIN F1; SITES; CONFORMATION; FIBROBLASTS	How fibronectin (FN) converts from a compact plasma protein to a fibrillar component of extracellular matrix is not understood. "Functional upstream domain" (FUD), a polypeptide based on F1 adhesin of Streptococcus pyogenes, binds by anti-parallel beta-strand addition to discontinuous sets of N-terminal FN type I modules, 2-5FNI of the fibrin-binding domain and 8-9FNI of the gelatin-binding domain. Such binding blocks assembly of FN. To learn whether ligation of 2-5FNI, 8-9FNI, or the two sets in combination is important for inhibition, we tested "high affinity downstream domain" (HADD), which binds by beta-strand addition to the continuous set of FNI modules, 1-5FNI, comprising the fibrin-binding domain. HADD and FUD were similarly active in blocking fibronectin assembly. Binding of HADD or FUD to soluble plasma FN exposed the epitope to monoclonal antibody mAbIII-10 in the tenth FN type III module ((FNIII)-F-10) and caused expansion of FN as assessed by dynamic light scattering. Soluble N-terminal constructs truncated after (FNI)-F-9 or (FNIII)-F-3 competed better than soluble FN for binding of FUD or HADD to adsorbed FN, indicating that interactions involving type III modules more C-terminal than (FNIII)-F-3 limit beta-strand addition to 1-5FNI within intact soluble FN. Preincubation of FN with mAbIII-10 or heparin modestly increased binding to HADD or FUD. Thus, ligation of FNIII modules involved in binding of integrins and glycosaminoglycans, (FNIII)-F-10 and 12-14FNIII, increases accessibility of 1-5FNI. Allosteric loss of constraining interactions among 1-5FNI, (FNIII)-F-10, and 12-14FNIII likely enables assembly of FN into extracellular fibrils.	[Maurer, Lisa M.; Ma, Wenjiang; Eickstaedt, Nathan L.; Johnson, Ian A.; Tomasini-Johansson, Bianca R.; Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem & Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Biomol Chem & Med, 1300 Univ Ave,Rm 4285, Madison, WI 53706 USA.	dfmosher@wisc.edu		Maurer, Lisa/0000-0003-0492-9805	National Institutes of Health [R01 HL021644, T32 AG000213, T32GM008692, R21 NS07647]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL021644 (to D. F. M.), Grants T32 AG000213 and T32GM008692 (predoctoral support to L. M. M.), and Grant R21 NS07647 (to B. T. J.).	Abe Y, 2005, BIOCHEM BIOPH RES CO, V338, P1640, DOI 10.1016/j.bbrc.2005.10.134; Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; BALBONA K, 1992, J BIOL CHEM, V267, P20120; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Bultmann H, 1998, J BIOL CHEM, V273, P2601, DOI 10.1074/jbc.273.5.2601; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; HOMANDBERG GA, 1986, BIOCHEMISTRY-US, V25, P6917, DOI 10.1021/bi00370a027; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Lower SK, 2011, P NATL ACAD SCI USA, V108, P18372, DOI 10.1073/pnas.1109071108; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; Maurer LM, 2010, THROMB RES, V125, P287, DOI 10.1016/j.thromres.2009.12.017; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Norris NC, 2011, J BIOL CHEM, V286, P38311, DOI 10.1074/jbc.M111.276592; Odermatt E., 1989, FIBRONECTIN, P29; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PEARLSTEIN E, 1978, INT J CANCER, V22, P32, DOI 10.1002/ijc.2910220108; QUADE BJ, 1988, J BIOL CHEM, V263, P19602; ROCCO M, 1987, EMBO J, V6, P2343, DOI 10.1002/j.1460-2075.1987.tb02510.x; Sachchidanand, 2002, J BIOL CHEM, V277, P50629, DOI 10.1074/jbc.M208956200; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Tucker RP, 2009, INT J BIOCHEM CELL B, V41, P424, DOI 10.1016/j.biocel.2008.08.003; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; WILLIAMS EC, 1982, J BIOL CHEM, V257, P4973; Xu JL, 2010, J BIOL CHEM, V285, P8563, DOI 10.1074/jbc.M109.062646; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113	43	19	19	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13303	13312		10.1074/jbc.M111.294041	http://dx.doi.org/10.1074/jbc.M111.294041			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351755	hybrid, Green Published			2022-12-25	WOS:000302903700066
J	Osei-Owusu, P; Sabharwal, R; Kaltenbronn, KM; Rhee, MH; Chapleau, MW; Dietrich, HH; Blumer, KJ				Osei-Owusu, Patrick; Sabharwal, Rasna; Kaltenbronn, Kevin M.; Rhee, Man-Hee; Chapleau, Mark W.; Dietrich, Hans H.; Blumer, Kendall J.			Regulator of G Protein Signaling 2 Deficiency Causes Endothelial Dysfunction and Impaired Endothelium-derived Hyperpolarizing Factor-mediated Relaxation by Dysregulating G(i/o) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE CORONARY-ARTERIES; BLOOD-PRESSURE REGULATION; EDHF-TYPE RELAXATION; SENSITIVE G-PROTEIN; DEPENDENT RELAXATIONS; MESENTERIC-ARTERIES; GENETIC-VARIATIONS; RGS PROTEINS; HYPERTENSION; CALCIUM	Regulator of G protein signaling 2 (RGS2) is a GTPase-activating protein for G(q/11)alpha and G(i/o)alpha subunits. RGS2 deficiency is linked to hypertension in mice and humans, although causative mechanisms are not understood. Because endothelial dysfunction and increased peripheral resistance are hallmarks of hypertension, determining whether RGS2 regulates microvascular reactivity may reveal mechanisms relevant to cardiovascular disease. Here we have determined the effects of systemic versus endothelium-or vascular smooth muscle-specific deletion of RGS2 on microvascular contraction and relaxation. Contraction and relaxation of mesenteric resistance arteries were analyzed in response to phenylephrine, sodium nitroprusside, or acetylcholine with or without inhibitors of nitric oxide (NO) synthase or K+ channels that mediate endothelium-derived hyperpolarizing factor (EDHF)-dependent relaxation. The results showed that deleting RGS2 in vascular smooth muscle had minor effects. Systemic or endothelium-specific deletion of RGS2 strikingly inhibited acetylcholine-evoked relaxation. Endothelium-specific deletion of RGS2 had little effect on NO-dependent relaxation but markedly impaired EDHF-dependent relaxation. Acute, inducible deletion of RGS2 in endothelium did not affect blood pressure significantly. Impaired EDHF-mediated vasodilatation was rescued by blocking G(i/o)alpha activation with pertussis toxin. These findings indicated that systemic or endothelium-specific RGS2 deficiency causes endothelial dysfunction resulting in impaired EDHF-dependent vasodilatation. RGS2 deficiency enables endothelial G(i/o) activity to inhibit EDHF-dependent relaxation, whereas RGS2 sufficiency facilitates EDHF-evoked relaxation by squelching endothelial G(i/o) activity. Mutation or down-regulation of RGS2 in hypertension patients therefore may contribute to endothelial dysfunction and defective EDHF-dependent relaxation. Blunting G(i/o) signaling might improve endothelial function in such patients.	[Osei-Owusu, Patrick; Kaltenbronn, Kevin M.; Rhee, Man-Hee; Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Dietrich, Hans H.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA; [Sabharwal, Rasna; Chapleau, Mark W.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Chapleau, Mark W.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Chapleau, Mark W.] Vet Affairs Med Ctr, Iowa City, IA 52246 USA	Washington University (WUSTL); Washington University (WUSTL); University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Blumer, KJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave,Box 8228, St Louis, MO 63110 USA.	kblumer@wustl.edu	Osei-Owusu, Patrick/L-9104-2018; Blumer, Kendall J/C-5268-2012; Rhee, Man Hee/O-5705-2016; Osei-Owusu, Patrick/AAH-9063-2019	Rhee, Man Hee/0000-0002-3088-1318; Sabharwal, Rasna/0000-0001-7256-5359; Chapleau, Mark/0000-0001-6961-931X	National Institutes of Health [HL075632, GM44592, NS30555, HL041250, NS32636, HL14388]; American Heart Association [09POST2260099]; Blumer lab; Dietrich lab; Chapleau lab; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121, R01HL041250, P01HL014388, R01HL075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030555, P01NS032636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Blumer lab; Dietrich lab; Chapleau lab; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL075632 and GM44592 (to K. J. B.); NS30555, HL041250, and NS32636 (to H. H. D.); and HL14388 (to M. W. C.). This work was also supported by American Heart Association Postdoctoral Fellowship 09POST2260099 (to P. O.-O.).; We thank members of the Blumer, Dietrich, and Chapleau labs for providing advice and support.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; ADEAGBO ASO, 1990, BRIT J PHARMACOL, V100, P427, DOI 10.1111/j.1476-5381.1990.tb15823.x; Baloglu E, 2007, EUR J PHARMACOL, V564, P167, DOI 10.1016/j.ejphar.2007.02.054; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Boulanger CM, 1997, J VASC RES, V34, P175, DOI 10.1159/000159221; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Bryan RM, 1996, ANESTHESIOLOGY, V85, P82, DOI 10.1097/00000542-199607000-00012; BURFORD NT, 1995, EUR J PHARM-MOLEC PH, V289, P343, DOI 10.1016/0922-4106(95)90112-4; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Ceroni L, 2007, EUR J PHARMACOL, V560, P193, DOI 10.1016/j.ejphar.2007.01.018; Christopoulos A., 1999, Life Sciences, V64, P1; Dietrich HH, 2010, AM J PHYSIOL-HEART C, V298, pH2208, DOI 10.1152/ajpheart.00839.2009; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; FLAVAHAN NA, 1989, J PHYSIOL-LONDON, V408, P549, DOI 10.1113/jphysiol.1989.sp017475; FLAVAHAN NA, 1991, J PHARMACOL EXP THER, V256, P50; Forde A, 2002, GENESIS, V33, P191, DOI 10.1002/gene.10117; Goncalves ACD, 2008, J AM SOC HYPERTENS, V2, P403, DOI 10.1016/j.jash.2008.05.006; Griffith TM, 2002, P NATL ACAD SCI USA, V99, P6392, DOI 10.1073/pnas.092089799; Gross V, 2005, AM J PHYSIOL-REG I, V288, pR1134, DOI 10.1152/ajpregu.00246.2004; Gu S, 2008, MOL PHARMACOL, V73, P1037, DOI 10.1124/mol.107.044214; Gu S, 2009, CLIN SCI, V116, P391, DOI 10.1042/CS20080272; Gurley SB, 2010, J AM SOC NEPHROL, V21, P1847, DOI 10.1681/ASN.2009121306; Hercule HC, 2007, EXP PHYSIOL, V92, P1014, DOI 10.1113/expphysiol.2007.038240; Heximer Scott P, 2007, Sci STKE, V2007, ppe2, DOI 10.1126/stke.3702007pe2; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; HIMMEL HM, 1993, HYPERTENSION, V21, P112, DOI 10.1161/01.HYP.21.1.112; HOHLFELD J, 1990, J PHARMACOL EXP THER, V252, P260; Horiuchi T, 2003, STROKE, V34, P1473, DOI 10.1161/01.STR.0000071527.10129.65; Ingi T, 1998, J NEUROSCI, V18, P7178; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Lembo G, 1997, HYPERTENSION, V30, P1128, DOI 10.1161/01.HYP.30.5.1128; Li NF, 2010, CLIN EXP HYPERTENS, V32, P256, DOI 10.3109/10641960903265253; Matsumoto T, 2003, AM J PHYSIOL-HEART C, V285, pH283, DOI 10.1152/ajpheart.00954.2002; Matsumoto T, 2006, EUR J PHARMACOL, V538, P132, DOI 10.1016/j.ejphar.2006.04.006; Michel FS, 2008, BRIT J PHARMACOL, V155, P217, DOI 10.1038/bjp.2008.256; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; MILLER VM, 1991, J PHARMACOL EXP THER, V257, P290; Nakaike R, 1996, AM J PHYSIOL-HEART C, V271, pH296, DOI 10.1152/ajpheart.1996.271.1.H296; Neitzel KL, 2006, SEMIN CELL DEV BIOL, V17, P383, DOI 10.1016/j.semcdb.2006.03.002; Ng KFJ, 2008, ACTA PHARMACOL SIN, V29, P1419, DOI 10.1111/j.1745-7254.2008.00905.x; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Riddle EL, 2006, HYPERTENSION, V47, P415, DOI 10.1161/01.HYP.0000200714.81990.61; Sabharwal R, 2010, HYPERTENSION, V55, P627, DOI 10.1161/HYPERTENSIONAHA.109.148171; Semplicini A, 2010, J HYPERTENS, V28, P1104, DOI 10.1097/HJH.0b013e328339930f; SHIMOKAWA H, 1989, CIRC RES, V65, P740, DOI 10.1161/01.RES.65.3.740; SHIMOKAWA H, 1987, CIRC RES, V61, P256, DOI 10.1161/01.RES.61.2.256; SHIMOKAWA H, 1991, CIRCULATION, V83, P652, DOI 10.1161/01.CIR.83.2.652; Sugimoto K, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/196307; Sun XG, 2005, MOL PHARMACOL, V67, P631, DOI 10.1124/mol.104.007724; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tank J, 2007, AUTON NEUROSCI-BASIC, V136, P52, DOI 10.1016/j.autneu.2007.04.001; Watanabe Y, 2010, HYPERTENS RES, V33, P129, DOI 10.1038/hr.2009.193; White R, 1997, BRIT J PHARMACOL, V122, P1573, DOI 10.1038/sj.bjp.0701546; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wong WSF, 1996, CAN J PHYSIOL PHARM, V74, P559, DOI 10.1139/cjpp-74-5-559; Xie GX, 2007, J MOL BIOL, V366, P349, DOI 10.1016/j.jmb.2006.11.045; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae	61	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12541	12549		10.1074/jbc.M111.332130	http://dx.doi.org/10.1074/jbc.M111.332130			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354966	hybrid, Green Published			2022-12-25	WOS:000302782200093
J	Cockburn, N; Steven, D; Lecuona, K; Joubert, F; Rogers, G; Cook, C; Polack, S				Cockburn, Nicky; Steven, David; Lecuona, Karin; Joubert, Francois; Rogers, Graeme; Cook, Colin; Polack, Sarah			Prevalence, Causes and Socio-Economic Determinants of Vision Loss in Cape Town, South Africa	PLOS ONE			English	Article							VISUAL IMPAIRMENT; HEALTH-CARE; AVOIDABLE BLINDNESS; RAPID ASSESSMENT; WEST PROVINCE; DISTRICT; ACCESS; POPULATION; GLAUCOMA; CAMEROON	To estimate the prevalence and causes of blindness and visual impairment in Cape Town, South Africa and to explore socio-economic and demographic predictors of vision loss in this setting. Methods: A cross sectional population-based survey was conducted in Cape Town. Eighty-two clusters were selected using probability proportionate to size sampling. Within each cluster 35 or 40 people aged 50 years and above were selected using compact segment sampling. Visual acuity of participants was assessed and eyes with a visual acuity less than 6/18 were examined by an ophthalmologist to determine the cause of vision loss. Demographic data (age, gender and education) were collected and a socio-economic status (SES) index was created using principal components analysis. Results: Out of 3100 eligible people, 2750 (89%) were examined. The sample prevalence of bilateral blindness (presenting visual acuity < 3/60) was 1.4% (95% CI 0.9-1.8). Posterior segment diseases accounted for 65% of blindness and cataract was responsible for 27%. The prevalence of vision loss was highest among people over 80 years (odds ratio (OR) 6.9 95% CI 4.6-10.6), those in the poorest SES group (OR 3.9 95% CI 2.2-6.7) and people with no formal education (OR 5.4 95% CI 1.7-16.6). Cataract surgical coverage was 68% in the poorest SES tertile (68%) compared to 93% in the medium and 100% in the highest tertile. Conclusions: The prevalence of blindness among people >= 50 years in Cape Town was lower than expected and the contribution of posterior segment diseases higher than previously reported in South Africa and Sub Saharan Africa. There were clear socio-economic disparities in prevalence of vision loss and cataract surgical coverage in this setting which need to be addressed in blindness prevention programs.	[Cockburn, Nicky; Lecuona, Karin; Joubert, Francois; Rogers, Graeme; Cook, Colin] Groote Schuur Hosp, Dept Ophthalmol, ZA-7925 Cape Town, South Africa; [Steven, David] Eerste River Hosp, Cape Town, South Africa; [Polack, Sarah] London Sch Hyg & Trop Med, London WC1, England	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Cockburn, N (corresponding author), Groote Schuur Hosp, Dept Ophthalmol, ZA-7925 Cape Town, South Africa.	nicole.cockburn@uct.ac.za			Lions District 401a Sight Foundation	Lions District 401a Sight Foundation	This study received funds from the Lions District 401a Sight Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other external funding was received.	Abou-Gareeb I, 2001, Ophthalmic Epidemiol, V8, P39, DOI 10.1076/opep.8.1.39.1540; Braithwaite J., 2008, DISABILITY POVERTY S; BUCHER PJM, 1988, BRIT J OPHTHALMOL, V72, P721, DOI 10.1136/bjo.72.10.721; COOK CD, 1993, S AFR MED J, V83, P590; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Dandona R, 2001, BRIT J OPHTHALMOL, V85, P1484, DOI 10.1136/bjo.85.12.1484; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Gilbert CE, 2008, BMJ-BRIT MED J, V336, P29, DOI 10.1136/bmj.39395.500046.AE; Groenewald P, 2010, B WORLD HEALTH ORGAN, V88, P444, DOI 10.2471/BLT.09.069435; Habiyakire C, 2010, OPHTHAL EPIDEMIOL, V17, P90, DOI 10.3109/09286580903453514; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Harris B, 2011, J PUBLIC HEALTH POL, V32, pS102, DOI 10.1057/jphp.2011.35; Joubert J, 2006, CHRONIC DIS LIFESTYL; Kalua K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019226; Kon ZR, 2008, AM J PUBLIC HEALTH, V98, P2272, DOI 10.2105/AJPH.2007.127829; KUPER H, 2005, CURR MED LIT OPHTHAL, V15, P81; Kuper Hannah, 2006, Community Eye Health, V19, P68; Kuper H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015431; Lalloo R, 2004, SAMJ S AFR MED J, V94, P639; Lam D, 2008, CAPE AREA PANEL STUD; Lecuona K, 2011, SAMJ S AFR MED J, V101, P510; LEVITT NS, 1993, DIABETES CARE, V16, P601, DOI 10.2337/diacare.16.4.601; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Mathenge W, 2007, OPHTHALMOLOGY, V114, P599, DOI 10.1016/j.ophtha.2006.06.057; Myburgh NG, 2005, INT J QUAL HEALTH C, V17, P473, DOI 10.1093/intqhc/mzi062; Nkonki LL, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-13; Oye JE, 2006, BRIT J OPHTHALMOL, V90, P538, DOI 10.1136/bjo.2005.082271; Oye JE, 2007, BRIT J OPHTHALMOL, V91, P1435, DOI 10.1136/bjo.2007.115840; Polack S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010913; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Rotchford AP, 2002, ARCH OPHTHALMOL-CHIC, V120, P471, DOI 10.1001/archopht.120.4.471; SALMON JF, 1993, ARCH OPHTHALMOL-CHIC, V111, P1263, DOI 10.1001/archopht.1993.01090090115029; Small K, 2010, SMALL K 2010 POP EST; Statistics South Africa, 2011, GEN HOUS SURV 2010, P28; TIELSCH JM, 1990, ARCH OPHTHALMOL-CHIC, V108, P286, DOI 10.1001/archopht.1990.01070040138048; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; *WHO, 1988, PROGR PREV BLINDN DE, P1	39	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30718	10.1371/journal.pone.0030718	http://dx.doi.org/10.1371/journal.pone.0030718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926YY	22363476	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000302871500014
J	Madison, JL; Wegrzynowicz, M; Aschner, M; Bowman, AB				Madison, Jennifer L.; Wegrzynowicz, Michal; Aschner, Michael; Bowman, Aaron B.			Disease-Toxicant Interactions in Manganese Exposed Huntington Disease Mice: Early Changes in Striatal Neuron Morphology and Dopamine Metabolism	PLOS ONE			English	Article							YAC128 MOUSE MODEL; TRANSGENIC MICE; DENDRITIC SPINE; BASAL GANGLIA; RAT-BRAIN; QUANTITATIVE-ANALYSIS; ENVIRONMENTAL-FACTORS; TRINUCLEOTIDE REPEAT; DEGENERATIVE CHANGES; INDUCED PARKINSONISM	YAC128 Huntington's disease (HD) transgenic mice accumulate less manganese (Mn) in the striatum relative to wild-type (WT) littermates. We hypothesized that Mn and mutant Huntingtin (HTT) would exhibit gene-environment interactions at the level of neurochemistry and neuronal morphology. Twelve-week-old WT and YAC128 mice were exposed to MnCl2-4H(2)O (50 mg/kg) on days 0, 3 and 6. Striatal medium spiny neuron (MSN) morphology, as well as levels of dopamine (DA) and its metabolites (which are known to be sensitive to Mn-exposure), were analyzed at 13 weeks (7 days from initial exposure) and 16 weeks (28 days from initial exposure). No genotype-dependent differences in MSN morphology were apparent at 13 weeks. But at 16 weeks, a genotype effect was observed in YAC128 mice, manifested by an absence of the wild-type age-dependent increase in dendritic length and branching complexity. In addition, genotype-exposure interaction effects were observed for dendritic complexity measures as a function of distance from the soma, where only YAC128 mice were sensitive to Mn exposure. Furthermore, striatal DA levels were unaltered at 13 weeks by genotype or Mn exposure, but at 16 weeks, both Mn exposure and the HD genotype were associated with quantitatively similar reductions in DA and its metabolites. Interestingly, Mn exposure of YAC128 mice did not further decrease DA or its metabolites versus YAC128 vehicle exposed or Mn exposed WT mice. Taken together, these results demonstrate Mn-HD disease-toxicant interactions at the onset of striatal dendritic neuropathology in YAC128 mice. Our results identify the earliest pathological change in striatum of YAC128 mice as being between 13 to 16 weeks. Finally, we show that mutant HTT suppresses some Mn-dependent changes, such as decreased DA levels, while it exacerbates others, such as dendritic pathology.	[Madison, Jennifer L.; Aschner, Michael] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Madison, Jennifer L.; Wegrzynowicz, Michal; Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA; [Aschner, Michael; Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Aschner, Michael; Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Vanderbilt Univ Kennedy Ctr Res Human Dev, Nashville, TN USA; [Aschner, Michael; Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Nashville, TN USA; [Aschner, Michael; Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Ctr Mol Toxicol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Madison, JL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.	aaron.bowman@vanderbilt.edu	Wegrzynowicz, Michal/M-3277-2019	Bowman, Aaron/0000-0001-8728-3346; Wegrzynowicz, Michal/0000-0002-5082-9576	National Institute of Environmental Health Sciences (NIEHS) [RO1 ES10563, RO1 ES016931]; National Institute of Child Health and Human Development [P30HD15052]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016931, R01ES010563] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Environmental Health Sciences (NIEHS) RO1 ES10563 to MA and RO1 ES016931 to ABB; and by National Institute of Child Health and Human Development P30HD15052 to Vanderbilt University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIEHS or National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anca MH, 2004, AM J MED GENET A, V124A, P89, DOI 10.1002/ajmg.a.20328; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Aschner M, 2005, CRIT REV TOXICOL, V35, P1, DOI 10.1080/10408440590905920; Aschner M, 2000, ENVIRON HEALTH PERSP, V108, P429, DOI 10.2307/3454532; AUTISSIER N, 1982, TOXICOLOGY, V24, P175, DOI 10.1016/0300-483X(82)90055-5; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Bloss EB, 2010, J NEUROSCI, V30, P6726, DOI 10.1523/JNEUROSCI.0759-10.2010; Bowman AB, 2011, J TRACE ELEM MED BIO; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Burton NC, 2009, TOXICOL SCI, V111, P131, DOI 10.1093/toxsci/kfp124; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; Carroll JB, 2011, NEUROBIOL DIS, V43, P257, DOI 10.1016/j.nbd.2011.03.018; Carter AG, 2007, J NEUROSCI, V27, P8967, DOI 10.1523/JNEUROSCI.2798-07.2007; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; Dodd CA, 2005, INT J TOXICOL, V24, P389, DOI 10.1080/10915810500366500; Duan HL, 2003, CEREB CORTEX, V13, P950, DOI 10.1093/cercor/13.9.950; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Dydak U, 2011, ENVIRON HEALTH PERSP, V119, P219, DOI 10.1289/ehp.1002192; Erikson KM, 2005, ENVIRON TOXICOL PHAR, V20, P390, DOI 10.1016/j.etap.2005.03.009; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Gaeta A, 2005, BRIT J PHARMACOL, V146, P1041, DOI 10.1038/sj.bjp.0706416; Garcia BG, 2010, CEREB CORTEX, V20, P2423, DOI 10.1093/cercor/bhp317; Georgiou N, 1999, MOVEMENT DISORD, V14, P320, DOI 10.1002/1531-8257(199903)14:2<320::AID-MDS1018>3.0.CO;2-Z; GIANUTSOS G, 1982, NEUROTOXICOLOGY, V3, P75; Golub MS, 2005, NEUROTOXICOL TERATOL, V27, P615, DOI 10.1016/j.ntt.2005.04.003; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Grill JD, 2002, BRAIN RES, V937, P8, DOI 10.1016/S0006-8993(02)02457-5; Guidetti P, 2001, EXP NEUROL, V169, P340, DOI 10.1006/exnr.2000.7626; Guilarte TR, 2006, EXP NEUROL, V202, P381, DOI 10.1016/j.expneurol.2006.06.015; Guilarte TR, 2008, J NEUROCHEM, V107, P1236, DOI 10.1111/j.1471-4159.2008.05695.x; Gwiazda RH, 2002, NEUROTOXICOLOGY, V23, P69, DOI 10.1016/S0161-813X(02)00002-5; Hannan AJ, 2004, ACTA BIOCHIM POL, V51, P415; Harmon KM, 2003, BRAIN RES, V992, P60, DOI 10.1016/j.brainres.2003.08.029; JASLOVE SW, 1992, NEUROSCIENCE, V47, P495, DOI 10.1016/0306-4522(92)90161-T; Johnson MA, 2006, J NEUROCHEM, V97, P737, DOI 10.1111/j.1471-4159.2006.03762.x; KAWAGUCHI S, 1995, MECH AGEING DEV, V83, P11, DOI 10.1016/0047-6374(95)01607-2; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; KONTUR PJ, 1988, NEUROTOXICOL TERATOL, V10, P295, DOI 10.1016/0892-0362(88)90031-1; Kusnoor SV, 2010, J COMP NEUROL, V518, P2525, DOI 10.1002/cne.22350; Kwakye GE, 2011, NEUROTOXICOLOGY; Lipe GW, 1999, J ENVIRON SCI HEAL B, V34, P119, DOI 10.1080/03601239909373187; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Markham JA, 2002, NEUROBIOL AGING, V23, P579, DOI 10.1016/S0197-4580(02)00004-0; MCNEILL TH, 1990, NEUROBIOL AGING, V11, P537, DOI 10.1016/0197-4580(90)90115-G; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Nithianantharajah J, 2009, AM J GERIAT PSYCHIAT, V17, P196, DOI 10.1097/JGP.0b013e318196a632; Olanow CW, 1996, NEUROLOGY, V46, P492, DOI 10.1212/WNL.46.2.492; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Ortiz AN, 2011, NEUROSCI LETT, V492, P11, DOI 10.1016/j.neulet.2011.01.036; Ortiz AN, 2010, J NEUROCHEM, V112, P755, DOI 10.1111/j.1471-4159.2009.06501.x; Pal PK, 1999, NEUROTOXICOLOGY, V20, P227; Qin M, 2011, NEUROSCIENCE, V194, P282, DOI 10.1016/j.neuroscience.2011.06.047; Reaney SH, 2006, TOXICOL SCI, V93, P114, DOI 10.1093/toxsci/kfl028; Roth JA, 2003, BIOCHEM PHARMACOL, V66, P1, DOI 10.1016/S0006-2952(03)00145-X; Schmidt-Hieber C, 2007, J NEUROSCI, V27, P8430, DOI 10.1523/JNEUROSCI.1787-07.2007; SHOLL DA, 1953, J ANAT, V87, P387; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Spires TL, 2004, EUR J NEUROSCI, V19, P2799, DOI 10.1111/j.0953-816X.2004.03374.x; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Struve MF, 2007, AM J IND MED, V50, P772, DOI 10.1002/ajim.20489; Takeda A, 2003, BRAIN RES, V965, P279, DOI 10.1016/S0006-8993(02)04157-4; Takeda A, 2002, NEUROSCIENCE, V114, P669, DOI 10.1016/S0306-4522(02)00353-6; Tang TS, 2007, J NEUROSCI, V27, P7899, DOI 10.1523/JNEUROSCI.1396-07.2007; Tsay D, 2004, TRENDS NEUROSCI, V27, P77, DOI 10.1016/j.tins.2003.11.008; van Dellen A, 2004, NEUROGENETICS, V5, P9, DOI 10.1007/s10048-003-0169-5; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Vezer T, 2005, ENVIRON TOXICOL PHAR, V19, P797, DOI 10.1016/j.etap.2004.12.046; Vidal L, 2005, NEUROCHEM RES, V30, P1147, DOI 10.1007/s11064-005-7775-6; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Williams BB, 2010, TOXICOL SCI, V117, P169, DOI 10.1093/toxsci/kfq174; Williams BB, 2010, J NEUROCHEM, V112, P227, DOI 10.1111/j.1471-4159.2009.06445.x; Woolley CS, 1997, J NEUROSCI, V17, P1848; Yokel RA, 2006, J ALZHEIMERS DIS, V10, P223	83	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31024	10.1371/journal.pone.0031024	http://dx.doi.org/10.1371/journal.pone.0031024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363539	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600100
J	Maherally, Z; Smith, JR; An, Q; Pilkington, GJ				Maherally, Zaynah; Smith, James R.; An, Qian; Pilkington, Geoffrey J.			Receptors for Hyaluronic Acid and Poliovirus: A Combinatorial Role in Glioma Invasion?	PLOS ONE			English	Article							CD44 ADHESION MOLECULE; EXTRACELLULAR-MATRIX; CELL-MIGRATION; RHO FAMILY; EXPRESSION; CLEAVAGE; BINDING; CYTOSKELETON; ASSOCIATION; DISPERSAL	Background: CD44 has long been associated with glioma invasion while, more recently, CD155 has been implicated in playing a similar role. Notably, these two receptors have been shown closely positioned on monocytes. Methods and Findings: In this study, an up-regulation of CD44 and CD155 was demonstrated in established and early-passage cultures of glioblastoma. Total internal reflected fluorescence (TIRF) microscopy revealed close proximity of CD44 and CD155. CD44 antibody blocking and gene silencing (via siRNA) resulted in greater inhibition of invasion than that for CD155. Combined interference resulted in 86% inhibition of invasion, although in these investigations no obvious evidence of synergy between CD44 and CD155 in curbing invasion was shown. Both siRNA-CD44 and siRNA-CD155 treated cells lacked processes and were rounder, while live cell imaging showed reduced motility rate compared to wild type cells. Adhesion assay demonstrated that wild type cells adhered most efficiently to laminin, whereas siRNA-treated cells (p<0.0001 for both CD44 and CD155 expression) showed decreased adhesion on several ECMs investigated. BrdU assay showed a higher proliferation of siRNA-CD44 and siRNA-CD155 cells, inversely correlated with reduced invasion. Confocal microscopy revealed overlapping of CD155 and integrins (beta(1), alpha(v)beta(1) and alpha(v)beta(3)) on glioblastoma cell processes whereas siRNA-transfected cells showed consequent reduction in integrin expression with no specific staining patterns. Reduced expression of Rho GTPases, Cdc42, Rac1/2/3, RhoA and RhoB, was seen in siRNA-CD44 and siRNA-CD155 cells. In contrast to CD44-knockdown and 'double'-knockdown cells, no obvious decrease in RhoC expression was observed in CD155-knockdown cells. Conclusions: This investigation has enhanced our understanding of cell invasion and confirmed CD44 to play a more significant role in this biological process than CD155. Joint CD44/CD155 approaches may, however, merit further study in therapeutic targeting of infiltrating glioma cells.	[Maherally, Zaynah; Smith, James R.; An, Qian; Pilkington, Geoffrey J.] Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biomed & Biomol Sci, Cellular & Mol Neurooncol Res Grp, Portsmouth, Hants, England	University of Portsmouth	Maherally, Z (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biomed & Biomol Sci, Cellular & Mol Neurooncol Res Grp, Portsmouth, Hants, England.	Geoff.pilkington@port.ac.uk	Smith, James R/D-2350-2011; Smith, James R/F-1108-2014	Smith, James R/0000-0001-8805-3788; Smith, James R/0000-0001-8805-3788	Brain Tumour UK; Brain Tumour Research; Brainstrust; Isle of Man Anticancer Association	Brain Tumour UK; Brain Tumour Research; Brainstrust; Isle of Man Anticancer Association	This work was funded by grants to GJP from Brain Tumour UK (http://www.braintumouruk.org.uk), Brain Tumour Research (http://www.braintumourresearch.org), Brainstrust (http://www.brainstrust.org.uk/index.php), and the Isle of Man Anticancer Association. These are UK-based brain tumour charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2001, J NEURO-ONCOL, V53, P115, DOI 10.1023/A:1012297132047; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338; BERNHARDT G, 1994, VIROLOGY, V199, P105, DOI 10.1006/viro.1994.1102; Birks SM, 2011, NEURO-ONCOLOGY, V13, P950, DOI 10.1093/neuonc/nor108; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Bolteus A J, 2001, Curr Neurol Neurosci Rep, V1, P225, DOI 10.1007/s11910-001-0022-x; CHIQUETEHRISMANN R, 1995, BIOESSAYS, V17, P873, DOI 10.1002/bies.950171009; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Enloe BM, 2011, J NEURO-ONCOL, V102, P225, DOI 10.1007/s11060-010-0323-5; Frank S, 1996, BIOCHEM BIOPH RES CO, V222, P794, DOI 10.1006/bbrc.1996.0823; Freistadt MS, 1997, MOL IMMUNOL, V34, P1247, DOI 10.1016/S0161-5890(98)00003-0; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; GIESE A, 1995, NEUROSURGERY, V37, P294, DOI 10.1227/00006123-199508000-00015; GLADSON CL, 1995, J CELL SCI, V108, P947; Goetz C, 2011, FUTURE VIROL, V6, P1045, DOI 10.2217/FVL.11.76; Goldbrunner RH, 1999, ACTA NEUROCHIR, V141, P295, DOI 10.1007/s007010050301; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; KNUDSON W, 1989, CIBA F SYMP, V143, P150; Lange R, 2001, VIROLOGY, V285, P218, DOI 10.1006/viro.2001.0943; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Maidment SL, 1997, ANTICANCER RES, V17, P4145; Merzak A, 1997, CANCER METAST REV, V16, P155, DOI 10.1023/A:1005760726850; MERZAK A, 1994, CANCER RES, V54, P3988; Murai T, 2004, J BIOL CHEM, V279, P4541, DOI 10.1074/jbc.M307356200; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Okada H, 1996, INT J CANCER, V66, P255, DOI 10.1002/(SICI)1097-0215(19960410)66:2<255::AID-IJC20>3.0.CO;2-A; Okamoto I, 1999, J BIOL CHEM, V274, P25525, DOI 10.1074/jbc.274.36.25525; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; PILKINGTON GJ, 1993, NEUROREPORT, V4, P259, DOI 10.1097/00001756-199303000-00008; Pilkington GJ, 1996, BRAZ J MED BIOL RES, V29, P1159; Pilkington GJ, 2005, CELL PROLIFERAT, V38, P423, DOI 10.1111/j.1365-2184.2005.00358.x; PILKINGTON GJ, 1994, BRAIN PATHOL, V4, P157, DOI 10.1111/j.1750-3639.1994.tb00826.x; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SHEPLEY MP, 1994, J VIROL, V68, P1301, DOI 10.1128/JVI.68.3.1301-1308.1994; Siegelman MH, 2000, J CLIN INVEST, V105, P683, DOI 10.1172/JCI8692; Sloan KE, 2005, CANCER RES, V65, P10930, DOI 10.1158/0008-5472.CAN-05-1890; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Sneath RJS, 1998, J CLIN PATHOL-MOL PA, V51, P191, DOI 10.1136/mp.51.4.191; Stern R, 2001, EXP CELL RES, V266, P167, DOI 10.1006/excr.2001.5206; Szeto MD, 2009, CANCER RES, V69, P4502, DOI 10.1158/0008-5472.CAN-08-3884; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Wiranowska M, 2006, BRAIN CELL BIOL, V35, P159, DOI 10.1007/s11068-007-9009-0; Wiranowska M, 2010, INT J CANCER, V127, P532, DOI 10.1002/ijc.25085	52	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30691	10.1371/journal.pone.0030691	http://dx.doi.org/10.1371/journal.pone.0030691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363471	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600055
J	Saifur, RGM; Dieng, H; Abu Hassan, A; Salmah, MRC; Satho, T; Miake, F; Hamdan, A				Saifur, Rahman G. M.; Dieng, Hamady; Abu Hassan, Ahmad; Salmah, Md Rawi Che; Satho, Tomomitsu; Miake, Fumio; Hamdan, Ahmad			Changing Domesticity of Aedes aegypti in Northern Peninsular Malaysia: Reproductive Consequences and Potential Epidemiological Implications	PLOS ONE			English	Article							MARK-RELEASE-RECAPTURE; BLOOD MEAL SIZE; HOST-SEEKING; BODY-SIZE; INTRASPECIFIC COMPETITION; DEPENDENT DEVELOPMENT; PUERTO-RICO; L DIPTERA; CULICIDAE; DENGUE	Background: The domestic dengue vector Aedes aegypti mosquitoes breed in indoor containers. However, in northern peninsular Malaysia, they show equal preference for breeding in both indoor and outdoor habitats. To evaluate the epidemiological implications of this peridomestic adaptation, we examined whether Ae. aegypti exhibits decreased survival, gonotrophic activity, and fecundity due to lack of host availability and the changing breeding behavior. Methodology/Principal Findings: This yearlong field surveillance identified Ae. aegypti breeding in outdoor containers on an enormous scale. Through a sequence of experiments incorporating outdoors and indoors adapting as well as adapted populations, we observed that indoors provided better environment for the survival of Ae. aegypti and the observed death patterns could be explained on the basis of a difference in body size. The duration of gonotrophic period was much shorter in large-bodied females. Fecundity tended to be greater in indoor acclimated females. We also found increased tendency to multiple feeding in outdoors adapted females, which were smaller in size compared to their outdoors breeding counterparts. Conclusion/Significance: The data presented here suggest that acclimatization of Ae. aegypti to the outdoor environment may not decrease its lifespan or gonotrophic activity but rather increase breeding opportunities (increased number of discarded containers outdoors), the rate of larval development, but small body sizes at emergence. Size is likely to be correlated with disease transmission. In general, small size in Aedes females will favor increased blood-feeding frequency resulting in higher population sizes and disease occurrence.	[Saifur, Rahman G. M.; Dieng, Hamady; Abu Hassan, Ahmad; Salmah, Md Rawi Che; Hamdan, Ahmad] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Satho, Tomomitsu; Miake, Fumio] Fukuoka Univ, Fac Pharmaceut Sci, Fukuoka 81401, Japan	Universiti Sains Malaysia; Fukuoka University	Saifur, RGM (corresponding author), Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia.	gmsaifur20@yahoo.com	ahmad, hamdan/E-3635-2012; ahmad, abuhassan/E-5918-2013		Uniiversiti Sains Malaysia (USM); Research University (RU) [1001/PBIOLOGI/842004]	Uniiversiti Sains Malaysia (USM); Research University (RU)	This work was supported by the Uniiversiti Sains Malaysia (USM) Fellowship grant and by the Research University (RU) research grant # 1001/PBIOLOGI/842004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F., 2006, American Journal of Environmental Sciences, V2, P121, DOI 10.3844/ajessp.2006.121.128; Aida H. Nur, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P472, DOI 10.1016/S2221-1691(11)60103-2; Bedhomme S, 2005, ECOL ENTOMOL, V30, P1, DOI 10.1111/j.0307-6946.2005.00665.x; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; Briegel H, 2001, J VECTOR ECOL, V26, P21; Carrieri M, 2003, ENVIRON ENTOMOL, V32, P1313, DOI 10.1603/0046-225X-32.6.1313; Casanova C, 2009, J MED ENTOMOL, V46, P42, DOI 10.1603/033.046.0106; Pamplona LDC, 2009, TROP MED INT HEALTH, V14, P1347, DOI 10.1111/j.1365-3156.2009.02377.x; CHADEE DD, 1991, ANN TROP MED PARASIT, V85, P461, DOI 10.1080/00034983.1991.11812593; Chadee DD, 2000, J VECTOR ECOL, V25, P158; CHAN K. L., 1971, Sterility principle for insect control or eradication. Proceedings of a symposium on the sterility principle for insect control or eradication jointly organized by the IAEA and FAO and held in Athens, 14-18 September 1970. Vienna, Austria, International Atomic Energy Agency., P131; Cheong WH, 1986, I MED RES B, V23, P155; Cruz EI, 2008, DENGUE B, V32, P171; De Benedictis J, 2003, AM J TROP MED HYG, V68, P437, DOI 10.4269/ajtmh.2003.68.437; Dieng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011790; DYE C, 1982, ECOL ENTOMOL, V7, P39, DOI 10.1111/j.1365-2311.1982.tb00642.x; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Galliard H., 1957, Annales de Parasitologie Humaine et Comparee, V32, P563; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; GILLETT JD, 1961, ANN TROP MED PARASIT, V55, P427, DOI 10.1080/00034983.1961.11686070; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; HADDOW A J, 1957, Ann Trop Med Parasitol, V51, P159; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; IJUMBA JN, 1990, MED VET ENTOMOL, V4, P425, DOI 10.1111/j.1365-2915.1990.tb00461.x; Ishak Hasanuddin, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P844; Kawada H, 2005, J MED ENTOMOL, V42, P312, DOI 10.1603/0022-2585(2005)042[0312:CSONBO]2.0.CO;2; Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x; KLOWDEN MJ, 1979, J INSECT PHYSIOL, V25, P231, DOI 10.1016/0022-1910(79)90048-9; KLOWDEN MJ, 1978, AM J TROP MED HYG, V27, P827, DOI 10.4269/ajtmh.1978.27.827; Lee DJ, 1989, CULICIDAE AUSTRALASI, V7th; Lee H.L., 1990, Tropical Biomedicine, V7, P185; Li C F, 1985, Southeast Asian J Trop Med Public Health, V16, P560; Machado-Allison C. E., 1972, Annals of the Entomological Society of America, V65, P543, DOI 10.1093/aesa/65.3.542; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MCCLELLAND GA, 1974, T ROY ENT SOC LONDON, V126, P239, DOI 10.1111/j.1365-2311.1974.tb00853.x; MILLER BR, 1989, TROP MED PARASITOL, V40, P396; Monath TP, 1988, ARBOVIRUSES EPIDEMIO, P139; Naksathit AT, 1998, J AM MOSQUITO CONTR, V14, P148; NASCI RS, 1990, J MED ENTOMOL, V27, P716, DOI 10.1093/jmedent/27.4.716; NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61; Norhaslina H, 2003, P INT PLANN C CAIR E, V39, P1; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Ong WS, GEOLOGY ENG GEOLOGY; PANT CP, 1973, J MED ENTOMOL, V10, P219, DOI 10.1093/jmedent/10.2.219; PETERSEN JJ, 1977, J NEMATOL, V9, P343; Phillips ML, 2008, ENVIRON HEALTH PERSP, V116, pA382, DOI 10.1289/ehp.116-a382; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2; Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395; ROITBERG BD, 1993, NATURE, V364, P108, DOI 10.1038/364108a0; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x; Schneider JR, 2004, J MED ENTOMOL, V41, P634, DOI 10.1603/0022-2585-41.4.634; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94; SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922; SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042; Shriram AN, 2009, NATL MED J INDIA, V22, P116; SUCHARIT S, 1978, Southeast Asian Journal of Tropical Medicine and Public Health, V9, P93; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; TRPIS M, 1975, B ENTOMOL RES, V65, P199, DOI 10.1017/S0007485300005903; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; Tsuzuki A, 2009, AM J TROP MED HYG, V80, P752, DOI 10.4269/ajtmh.2009.80.752; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; Udaka M., 1959, Kontyu Tokyo, V27, P202; Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201; Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5; Wai N.M., 2005, TEKNOLOGI, V42, P1; Watts DM, 1997, AM J TROP MED HYG, V56, P148, DOI 10.4269/ajtmh.1997.56.148; WHO, 2009, DENG DENG HAEM FEV; Winarno F. G., 1991, Food, Nutrition and Agriculture, V1, P11; Wongkoon S., 2007, Dengue Bulletin, V31, P141; XUE RD, 1995, J MED ENTOMOL, V32, P471, DOI 10.1093/jmedent/32.4.471	75	28	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30919	10.1371/journal.pone.0030919	http://dx.doi.org/10.1371/journal.pone.0030919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363516	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600090
J	Thanasopoulou, A; Stravopodis, DJ; Dimas, KS; Schwaller, J; Anastasiadou, E				Thanasopoulou, Angeliki; Stravopodis, Dimitrios J.; Dimas, Konstantinos S.; Schwaller, Juerg; Anastasiadou, Ema			Loss of CCDC6 Affects Cell Cycle through Impaired Intra-S-Phase Checkpoint Control	PLOS ONE			English	Article							FACTOR RECEPTOR-BETA; DNA-DAMAGE; GENOMIC INSTABILITY; RET/PTC REARRANGEMENTS; CDC25 PHOSPHATASES; TOPOISOMERASE-II; CANCER-CELLS; H4 D10S170; IN-VIVO; GENE	In most cancers harboring Ccdc6 gene rearrangements, like papillary thyroid tumors or myeloproliferative disorders, the product of the normal allele is supposed to be functionally impaired or absent. To address the consequence of the loss of CCDC6 expression, we applied lentiviral shRNA in several cell lines. Loss of CCDC6 resulted in increased cell death with clear shortening of the S phase transition of the cell cycle. Upon exposure to etoposide, the cells lacking CCDC6 did not achieve S-phase accumulation. In the absence of CCDC6 and in the presence of genotoxic stress, like etoposide treatment or UV irradiation, increased accumulation of DNA damage was observed, as indicated by a significant increase of pH2Ax Ser139. 14-3-3 sigma, a major cell cycle regulator, was down-regulated in CCDC6 lacking cells, regardless of genotoxic stress. Interestingly, in the absence of CCDC6, the well-known genotoxic stress-induced cytoplasmic sequestration of the S-phase checkpoint CDC25C phosphatase did not occur. These observations suggest that CCDC6 plays a key role in cell cycle control, maintenance of genomic stability and cell survival and provide a rational of how disruption of CCDC6 normal function contributes to malignancy.	[Thanasopoulou, Angeliki; Anastasiadou, Ema] Biomed Res Fdn Acad Athens, Dept Genet & Gene Therapy, Athens, Greece; [Stravopodis, Dimitrios J.] Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens, Greece; [Dimas, Konstantinos S.] Univ Thessaly, Fac Med, Pharmacol Lab, Larisa, Greece; [Schwaller, Juerg] Univ Basel, Sch Med, Dept Biomed, Basel, Switzerland	Academy of Athens; National & Kapodistrian University of Athens; University of Thessaly; University of Basel	Thanasopoulou, A (corresponding author), Biomed Res Fdn Acad Athens, Dept Genet & Gene Therapy, Athens, Greece.	anastasiadou@bioacademy.gr	Dimas, Konstantinos/AAU-5461-2020; Schwaller, Juerg/A-3044-2016	Schwaller, Juerg/0000-0001-8616-0096; Stravopodis, Dimitrios/0000-0002-9535-2134	Swiss Government; Gertrude Von Meissner Foundation (Basel, Switzerland)	Swiss Government; Gertrude Von Meissner Foundation (Basel, Switzerland)	This work was partially funded by the Swiss Government Scholarships ESKAS. The work of JS is supported by the Gertrude Von Meissner Foundation (Basel, Switzerland). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Celetti A, 2004, ONCOGENE, V23, P109, DOI 10.1038/sj.onc.1206981; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Dierov J, 2004, CANCER CELL, V5, P275, DOI 10.1016/S1535-6108(04)00056-X; Dierov J, 2009, LEUKEMIA, V23, P279, DOI 10.1038/leu.2008.308; Drechsler M, 2007, ANN HEMATOL, V86, P353, DOI 10.1007/s00277-006-0247-5; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Elisei R, 2001, J CLIN ENDOCR METAB, V86, P3211, DOI 10.1210/jc.86.7.3211; Gandhi M, 2010, ONCOGENE, V29, P2272, DOI 10.1038/onc.2009.502; GRIECO M, 1994, ONCOGENE, V9, P2531; Guerra A, 2011, ENDOCR J, V58, P31, DOI 10.1507/endocrj.K10E-260; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Kaufmann WK, 1998, P SOC EXP BIOL MED, V217, P327; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kulkarni S, 2000, CANCER RES, V60, P3592; Lau E, 2006, CELL CYCLE, V5, P1602, DOI 10.4161/cc.5.15.3124; Leone V, 2010, ONCOGENE, V29, P4341, DOI 10.1038/onc.2010.179; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Merolla F, 2007, ONCOGENE, V26, P6167, DOI 10.1038/sj.onc.1210446; Mizuno T, 2000, ONCOGENE, V19, P438, DOI 10.1038/sj.onc.1203343; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Nikiforov YE, 2002, ENDOCR PATHOL, V13, P3, DOI 10.1385/EP:13:1:03; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Penserga ETP, 2007, ONCOGENE, V26, P11, DOI 10.1038/sj.onc.1209756; Puxeddu E, 2005, MUTAT RES-FUND MOL M, V570, P17, DOI 10.1016/j.mrfmmm.2004.09.010; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Salvatore D, 2000, J CLIN ENDOCR METAB, V85, P3898, DOI 10.1210/jc.85.10.3898; Santoro M, 1996, ONCOGENE, V12, P1821; Savage JRK, 2000, SCIENCE, V290, P62, DOI 10.1126/science.290.5489.62; Schwaller J, 2001, BLOOD, V97, P3910, DOI 10.1182/blood.V97.12.3910; Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a; Sheils OM, 2000, J PATHOL, V192, P32; Shen ZY, 2011, J MOL CELL BIOL, V3, P1, DOI 10.1093/jmcb/mjq057; Shimada M, 2006, J MOL HISTOL, V37, P253, DOI 10.1007/s10735-006-9039-4; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; TONG Q, 1995, ONCOGENE, V10, P1781; VIGLIETTO G, 1995, ONCOGENE, V11, P1207	43	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31007	10.1371/journal.pone.0031007	http://dx.doi.org/10.1371/journal.pone.0031007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363533	gold, Green Submitted, Green Published			2022-12-25	WOS:000302853600096
J	Yao, L; Li, ZR; Su, WR; Li, YP; Lin, ML; Zhang, WX; Liu, Y; Wan, Q; Liang, D				Yao, Lin; Li, Zhan-rong; Su, Wen-ru; Li, Yong-ping; Lin, Miao-li; Zhang, Wen-xin; Liu, Yi; Wan, Qian; Liang, Dan			Role of Mesenchymal Stem Cells on Cornea Wound Healing Induced by Acute Alkali Burn	PLOS ONE			English	Article							SEVERE OCULAR BURNS; STROMAL CELLS; CHEMICAL INJURY; T-CELLS; TRANSPLANTATION; MODEL; RECONSTRUCTION; MACROPHAGES; MANAGEMENT; EPITHELIUM	The aim of this study was to investigate the effects of subconjunctivally administered mesenchymal stem cells (MSCs) on corneal wound healing in the acute stage of an alkali burn. A corneal alkali burn model was generated by placing a piece of 3-mm diameter filter paper soaked in NaOH on the right eye of 48 Sprague-Dawley female rats. 24 rats were administered a subconjunctival injection of a suspension of 2610 6 MSCs in 0.1 ml phosphate-buffered saline (PBS) on day 0 and day 3 after the corneal alkali burn. The other 24 rats were administered a subconjunctival injection of an equal amount of PBS as a control. Deficiencies of the corneal epithelium and the area of corneal neovascularization (CNV) were evaluated on days 3 and 7 after the corneal alkali burn. Infiltrated CD68(+) cells were detected by immunofluorescence staining. The mRNA expression levels of macrophage inflammatory protein-1 alpha (MIP-1 alpha), tumor necrosis factor-alpha (TNF-alpha), monocyte chemotactic protein-1 (MCP-1) and vascular endothelial growth factor (VEGF) were analyzed using real-time polymerase chain reaction (real-time PCR). In addition, VEGF protein levels were analyzed using an enzyme-linked immunosorbent assay (ELISA). MSCs significantly enhanced the recovery of the corneal epithelium and decreased the CNV area compared with the control group. On day 7, the quantity of infiltrated CD68(+) cells was significantly lower in the MSC group and the mRNA levels of MIP-1 alpha, TNF-alpha, and VEGF and the protein levels of VEGF were also down-regulated. However, the expression of MCP-1 was not different between the two groups. Our results suggest that subconjunctival injection of MSCs significantly accelerates corneal wound healing, attenuates inflammation and reduces CNV in alkaline-burned corneas; these effects were found to be related to a reduction of infiltrated CD68(+) cells and the down-regulation of MIP-1 alpha, TNF-alpha and VEGF.	[Yao, Lin; Li, Zhan-rong; Su, Wen-ru; Li, Yong-ping; Lin, Miao-li; Zhang, Wen-xin; Liu, Yi; Wan, Qian; Liang, Dan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Yao, L (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	liangd2@mail.sysu.edu.cn		Su, Wenru/0000-0002-0506-6362	Doctoral Program Foundation of Institutions of Higher Education of China [20090171110084]	Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was funded by the Doctoral Program Foundation of Institutions of Higher Education of China (20090171110084; http://www.cutech.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis A P, 1999, Angiogenesis, V3, P9, DOI 10.1023/A:1009071601454; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Borderie V, 2003, J FR OPHTALMOL, V26, P710; Brodovsky SC, 2000, OPHTHALMOLOGY, V107, P1829, DOI 10.1016/S0161-6420(00)00289-X; Choi JA, 2011, MOL VIS, V17, P404; DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020; Fish R, 2010, CURR OPIN OPHTHALMOL, V21, P317, DOI 10.1097/ICU.0b013e32833a8da2; Fogla R, 2005, CORNEA, V24, P421, DOI 10.1097/01.ico.0000151550.51556.2d; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; He JC, 2006, ARCH OPHTHALMOL-CHIC, V124, P70, DOI 10.1001/archopht.124.1.70; Hoogduijn MJ, 2007, STEM CELLS DEV, V16, P597, DOI 10.1089/scd.2006.0110; Jiang TS, 2010, MOL VIS, V16, P1304; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kuckelkorn R, 2002, ACTA OPHTHALMOL SCAN, V80, P4, DOI 10.1034/j.1600-0420.2002.800102.x; Kuo Irene C, 2004, Curr Opin Ophthalmol, V15, P311, DOI 10.1097/00055735-200408000-00006; Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643; Ma YL, 2006, STEM CELLS, V24, P315, DOI 10.1634/stemcells.2005-0046; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Oh W, 2008, CELL IMMUNOL, V251, P116, DOI 10.1016/j.cellimm.2008.04.003; Popp FC, 2007, STEM CELLS, V25, P639, DOI 10.1634/stemcells.2006-0515; Shi WY, 2009, GRAEF ARCH CLIN EXP, V247, P101, DOI 10.1007/s00417-008-0934-0; Su WR, 2011, STEM CELLS, V29, P1849, DOI 10.1002/stem.738; Su WR, 2011, GRAEF ARCH CLIN EXP, V249, P421, DOI 10.1007/s00417-010-1539-y; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Ye J, 2006, EYE, V20, P482, DOI 10.1038/sj.eye.6701913; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503; Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345	33	117	123	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30842	10.1371/journal.pone.0030842	http://dx.doi.org/10.1371/journal.pone.0030842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363499	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600075
J	Dziewit, L; Baj, J; Szuplewska, M; Maj, A; Tabin, M; Czyzkowska, A; Skrzypczyk, G; Adamczuk, M; Sitarek, T; Stawinski, P; Tudek, A; Wanasz, K; Wardal, E; Piechucka, E; Bartosik, D				Dziewit, Lukasz; Baj, Jadwiga; Szuplewska, Magdalena; Maj, Anna; Tabin, Mateusz; Czyzkowska, Anna; Skrzypczyk, Grazyna; Adamczuk, Marcin; Sitarek, Tomasz; Stawinski, Piotr; Tudek, Agnieszka; Wanasz, Katarzyna; Wardal, Ewa; Piechucka, Ewa; Bartosik, Dariusz			Insights into the Transposable Mobilome of Paracoccus spp. (Alphaproteobacteria)	PLOS ONE			English	Article							FACULTATIVELY METHYLOTROPHIC BACTERIUM; GRAM-NEGATIVE BACTERIA; SP-NOV.; INSERTION-SEQUENCE; GENUS PARACOCCUS; PANTOTROPHUS DSM-11072; EMENDED DESCRIPTION; SP. NOV.; ELEMENTS; PLASMID	Several trap plasmids (enabling positive selection of transposition events) were used to identify a pool of functional transposable elements (TEs) residing in bacteria of the genus Paracoccus (Alphaproteobacteria). Complex analysis of 25 strains representing 20 species of this genus led to the capture and characterization of (i) 37 insertion sequences (ISs) representing 9 IS families (IS3, IS5, IS6, IS21, IS66, IS256, IS1182, IS1380 and IS1634), (ii) a composite transposon Tn6097 generated by two copies of the ISPfe2 (IS1634 family) containing two predicted genetic modules, involved in the arginine deiminase pathway and daunorubicin/doxorubicin resistance, (iii) 3 non-composite transposons of the Tn3 family, including Tn5393 carrying streptomycin resistance and (iv) a transposable genomic island TnPpa1 (45 kb). Some of the elements (e. g. Tn5393, Tn6097 and ISs of the IS903 group of the IS5 family) were shown to contain strong promoters able to drive transcription of genes placed downstream of the target site of transposition. Through the application of trap plasmid pCM132TC, containing a promoterless tetracycline resistance reporter gene, we identified five ways in which transposition can supply promoters to transcriptionally silent genes. Besides highlighting the diversity and specific features of several TEs, the analyses performed in this study have provided novel and interesting information on (i) the dynamics of the process of transposition (e. g. the unusually high frequency of transposition of TnPpa1) and (ii) structural changes in DNA mediated by transposition (e. g. the generation of large deletions in the recipient molecule upon transposition of ISPve1 of the IS21 family). We also demonstrated the great potential of TEs and transposition in the generation of diverse phenotypes as well as in the natural amplification and dissemination of genetic information (of adaptative value) by horizontal gene transfer, which is considered the driving force of bacterial evolution.	[Dziewit, Lukasz; Baj, Jadwiga; Szuplewska, Magdalena; Maj, Anna; Tabin, Mateusz; Czyzkowska, Anna; Skrzypczyk, Grazyna; Adamczuk, Marcin; Sitarek, Tomasz; Stawinski, Piotr; Tudek, Agnieszka; Wanasz, Katarzyna; Wardal, Ewa; Piechucka, Ewa; Bartosik, Dariusz] Univ Warsaw, Dept Bacterial Genet, Fac Biol, Inst Microbiol, Warsaw, Poland	University of Warsaw	Dziewit, L (corresponding author), Univ Warsaw, Dept Bacterial Genet, Fac Biol, Inst Microbiol, Warsaw, Poland.	bartosik@biol.uw.edu.pl	Tudek, Agnieszka/ABE-7845-2020; Wardal, Ewa/AAQ-9417-2021; Dziewit, Lukasz/L-1131-2016	Tudek, Agnieszka/0000-0002-6085-1072; Wardal, Ewa/0000-0003-3500-2199; Dziewit, Lukasz/0000-0002-5057-2811; Szuplewska, Magdalena/0000-0003-1900-4995; Bartosik, Dariusz/0000-0002-3589-8864	Ministry of Science and Higher Education, Poland [PBZ-MNiSW-04/I/2007]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the Ministry of Science and Higher Education, Poland (grant PBZ-MNiSW-04/I/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartosik D, 2003, APPL ENVIRON MICROB, V69, P7002, DOI 10.1128/AEM.69.12.7002-7008.2003; Bartosik D, 2002, MICROBIOL-SGM, V148, P2847, DOI 10.1099/00221287-148-9-2847; Bartosik D, 2001, J BACTERIOL, V183, P6234, DOI 10.1128/JB.183.21.6234-6243.2001; Bartosik D, 2008, J BACTERIOL, V190, P3306, DOI 10.1128/JB.01878-07; Berry A, 2003, INT J SYST EVOL MICR, V53, P231, DOI 10.1099/ijs.0.02368-0; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bortosik D, 2003, J BACTERIOL, V185, P3753, DOI 10.1128/JB.185.13.3753-3763.2003; CAMPBELL A, 1979, PLASMID, V2, P466, DOI 10.1016/0147-619X(79)90030-1; Chalmers R, 1998, CELL, V93, P897, DOI 10.1016/S0092-8674(00)81449-X; Chandler M, 2002, MOBILE DNA, V2, P305; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Daneshvar MI, 2003, J CLIN MICROBIOL, V41, P1289, DOI 10.1128/JCM.41.3.1289-1294.2003; De Palmenaer D, 2004, MOL MICROBIOL, V53, P457, DOI 10.1111/j.1365-2958.2004.04146.x; De Palmenaer D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-18; Doronina NV, 2000, MICROBIOLOGY+, V69, P593, DOI 10.1007/BF02756814; Doronina NV, 1998, SYST APPL MICROBIOL, V21, P230, DOI 10.1016/S0723-2020(98)80027-1; Drewniak L, 2008, ENVIRON POLLUT, V156, P1069, DOI 10.1016/j.envpol.2008.04.019; Dziewit L, 2011, J MICROBIOL METH, V86, P166, DOI 10.1016/j.mimet.2011.04.016; Dziewit L, 2010, APPL ENVIRON MICROB, V76, P1861, DOI 10.1128/AEM.01926-09; FRIEDMAN DI, 1988, CELL, V55, P545, DOI 10.1016/0092-8674(88)90213-9; GAMPER M, 1991, J BACTERIOL, V173, P4742, DOI 10.1128/jb.173.15.4742-4750.1991; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; GERSTENBERG C, 1982, ARCH MICROBIOL, V133, P90, DOI 10.1007/BF00413517; Ghosh W, 2006, SYST APPL MICROBIOL, V29, P396, DOI 10.1016/j.syapm.2005.10.004; Grindley NDF, 2002, MOBILE DNA, P272; GUMPERT J, 1982, Z ALLG MIKROBIOL, V22, P687, DOI 10.1002/jobm.3630221002; Harker M, 1998, INT J SYST BACTERIOL, V48, P543, DOI 10.1099/00207713-48-2-543; Hubner A, 1997, J BACTERIOL, V179, P2717; Jordan SL, 1997, ARCH MICROBIOL, V168, P225, DOI 10.1007/s002030050492; KATAYAMA Y, 1995, MICROBIOL-UK, V141, P1469, DOI 10.1099/13500872-141-6-1469; Kelly DP, 2006, INT J SYST EVOL MICR, V56, P2495, DOI 10.1099/ijs.0.64401-0; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kim BY, 2006, INT J SYST EVOL MICR, V56, P2387, DOI 10.1099/ijs.0.64275-0; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Kumaraswamy R, 2006, SYST APPL MICROBIOL, V29, P276, DOI 10.1016/j.syapm.2005.08.001; Kushner SR, 1978, GENET ENG N Y, P17; Kusumoto M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1152; Kwiatkowski AV, 1997, J BACTERIOL, V179, P5618, DOI 10.1128/jb.179.17.5618-5620.1997; L'abee-Lund TM, 2000, APPL ENVIRON MICROB, V66, P5533, DOI 10.1128/AEM.66.12.5533-5535.2000; La HJ, 2005, INT J SYST EVOL MICR, V55, P1657, DOI 10.1099/ijs.0.63494-0; Lee JH, 2004, INT J SYST EVOL MICR, V54, P1699, DOI 10.1099/ijs.0.63146-0; Li K, 2011, J BACTERIOL, V193, P1786, DOI 10.1128/JB.00014-11; Lipski A, 1998, INT J SYST BACTERIOL, V48, P529, DOI 10.1099/00207713-48-2-529; Liu XY, 2006, INT J SYST EVOL MICR, V56, P2693, DOI 10.1099/ijs.0.64548-0; Liu ZP, 2008, INT J SYST EVOL MICR, V58, P257, DOI 10.1099/ijs.0.65237-0; Maghnouj A, 1998, J BACTERIOL, V180, P6468, DOI 10.1128/JB.180.24.6468-6475.1998; Mahillon J, 1998, APMIS, V106, P29; Malta S, 2010, MICROBIOL RES, V165, P427, DOI 10.1016/j.micres.2009.11.006; Mikosa M, 2006, MICROBIOL-SGM, V152, P1063, DOI 10.1099/mic.0.28603-0; NAKATSU C, 1991, P NATL ACAD SCI USA, V88, P8312, DOI 10.1073/pnas.88.19.8312; Ogwang S, 2011, J BIOL CHEM, V286, P15377, DOI 10.1074/jbc.M111.231076; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; Peters JE, 2001, NAT REV MOL CELL BIO, V2, P806, DOI 10.1038/35099006; Pukall R, 2003, INT J SYST EVOL MICR, V53, P443, DOI 10.1099/ijs.0.02352-0; Rainey FA, 1999, INT J SYST BACTERIOL, V49, P645, DOI 10.1099/00207713-49-2-645; ROGERS MB, 1994, J BACTERIOL, V176, P4376, DOI 10.1128/jb.176.14.4376-4384.1994; Roh SW, 2009, INT J SYST EVOL MICR, V59, P790, DOI 10.1099/ijs.0.65759-0; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J, 2001, MOL CLONING LAB MANU; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schneider D, 2000, PLASMID, V44, P201, DOI 10.1006/plas.2000.1483; SEKINE Y, 1989, P NATL ACAD SCI USA, V86, P4609, DOI 10.1073/pnas.86.12.4609; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Siguier P, 2009, RES MICROBIOL, V160, P232, DOI 10.1016/j.resmic.2009.02.003; Siller H, 1996, INT J SYST BACTERIOL, V46, P1125, DOI 10.1099/00207713-46-4-1125; Smorawinska M, 2012, FEMS MICROBIOL LETT, V326, P76, DOI 10.1111/j.1574-6968.2011.02432.x; Solyga Aleksandra, 2004, Polish Journal of Microbiology, V53, P139; SUNDIN GW, 1995, APPL ENVIRON MICROB, V61, P2891, DOI 10.1128/AEM.61.8.2891-2897.1995; Szuplewska M, 2009, FEMS MICROBIOL LETT, V292, P216, DOI 10.1111/j.1574-6968.2009.01495.x; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; URAKAMI T, 1989, INT J SYST BACTERIOL, V39, P116, DOI 10.1099/00207713-39-2-116; URAKAMI T, 1990, INT J SYST BACTERIOL, V40, P287, DOI 10.1099/00207713-40-3-287; VANDERPLOEG J, 1995, J BACTERIOL, V177, P1348, DOI 10.1128/jb.177.5.1348-1356.1995; VANSPANNING RJM, 1995, J BACTERIOL, V177, P4772, DOI 10.1128/jb.177.16.4772-4778.1995; Winterstein C, 1998, ARCH MICROBIOL, V169, P275, DOI 10.1007/s002030050572; Wood NJ, 2001, J BACTERIOL, V183, P3606, DOI 10.1128/JB.183.12.3606-3613.2001; Wyndham R. Campbell, 1994, Biodegradation, V5, P323, DOI 10.1007/BF00696468; ZHENG JH, 1995, MOL MICROBIOL, V16, P669, DOI 10.1111/j.1365-2958.1995.tb02429.x; Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x; Zuniga M, 2002, MOL PHYLOGENET EVOL, V25, P429, DOI 10.1016/S1055-7903(02)00277-4	83	25	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32277	10.1371/journal.pone.0032277	http://dx.doi.org/10.1371/journal.pone.0032277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359677	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200146
J	He, DG; Li, H; Yusuf, N; Elmets, CA; Athar, M; Katiyar, SK; Xu, H				He, Donggou; Li, Hui; Yusuf, Nabiha; Elmets, Craig A.; Athar, Mohammad; Katiyar, Santosh K.; Xu, Hui			IL-17 Mediated Inflammation Promotes Tumor Growth and Progression in the Skin	PLOS ONE			English	Article							CD8(+) T-CELLS; INTERLEUKIN-17 FAMILY-MEMBERS; MYELOID SUPPRESSOR-CELLS; CHEMICAL CARCINOGENESIS; IMMUNE SUPPRESSION; MOUSE SKIN; CANCER; METASTASIS; MICROENVIRONMENT; TUMORIGENESIS	The mechanism for inflammation associated tumor development is a central issue for tumor biology and immunology and remains to be fully elucidated. Although IL-17 is implicated in association with inflammation mediated carcinogenesis, mechanisms are largely elusive. In the current studies, we showed that IL-17 receptor-A gene deficient (IL-17R-/-) mice were resistant to chemical carcinogen-induced cutaneous carcinogenesis, a well-established inflammation associated tumor model in the skin. The deficiency in IL-17R increased the infiltration of CD8+ T cells whereas it inhibited the infiltration of CD11b+ myeloid cells and development of myeloid derived suppressor cells. Inflammation induced skin hyperplasia and production of pro-tumor inflammatory molecules were inhibited in IL-17R-/- mice. We found that pre-existing inflammation in the skin increased the susceptibility to tumor growth, which was associated with increased development of tumor specific IL-17 producing T cells. This inflammation induced susceptibility to tumor growth was abrogated in IL-17R-/- mice. Finally, neutralizing IL-17 in mice that had already developed chemical carcinogen induced skin tumors could inhibit inflammation mediated tumor progression at late stages. These results demonstrate that IL-17 mediated inflammation is an important mechanism for inflammation mediated promotion of tumor development. The study has major implications for targeting IL-17 in prevention and treatment of tumors.	[He, Donggou; Li, Hui; Yusuf, Nabiha; Elmets, Craig A.; Athar, Mohammad; Katiyar, Santosh K.; Xu, Hui] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Yusuf, Nabiha; Elmets, Craig A.; Athar, Mohammad; Katiyar, Santosh K.; Xu, Hui] Univ Alabama Birmingham, Skin Dis Res Ctr, Birmingham, AL USA; [Yusuf, Nabiha; Elmets, Craig A.; Katiyar, Santosh K.; Xu, Hui] Birmingham VA Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	He, DG (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	xuhui@uab.edu			United States National Institutes of Health [ES017494, CA138998, AI071041, AR46256]; NATIONAL CANCER INSTITUTE [R01CA138998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046256, P30AR048311, P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017494] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This publication was made possible by grants (AI071041 and AR46256 [HX] and ES017494 and CA138998 [MA]) from the United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backlund MG, 2005, ONCOLOGY-BASEL, V69, P28, DOI 10.1159/000086629; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Carlos TM, 2001, J LEUKOCYTE BIOL, V70, P171; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; DiGiovanni J, 1992, PHARMACOL THERAPEUT, V54, P63; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hanson EM, 2009, J IMMUNOL, V183, P937, DOI 10.4049/jimmunol.0804253; He DG, 2006, J IMMUNOL, V177, P6852, DOI 10.4049/jimmunol.177.10.6852; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kim HK, 2008, NEOPLASIA, V10, P1411, DOI 10.1593/neo.08804; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Maniati E, 2010, ONCOGENE, V29, P5653, DOI 10.1038/onc.2010.367; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Owens DM, 1999, CARCINOGENESIS, V20, P1837, DOI 10.1093/carcin/20.9.1837; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tiano HF, 2002, CANCER RES, V62, P3395; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Whiteside TL, 2006, CANC TREAT, V130, P103; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yusuf N, 2008, CANCER RES, V68, P3924, DOI 10.1158/0008-5472.CAN-07-3059; Yusuf N, 2008, CANCER RES, V68, P615, DOI 10.1158/0008-5472.CAN-07-5219; Yusuf N, 2007, TOXICOL APPL PHARM, V224, P308, DOI 10.1016/j.taap.2006.12.009; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	63	56	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32126	10.1371/journal.pone.0032126	http://dx.doi.org/10.1371/journal.pone.0032126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359662	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200131
J	van Putten, M; Hulsker, M; Nadarajah, VD; van Heiningen, SH; van Huizen, E; van Iterson, M; Admiraal, P; Messemaker, T; den Dunnen, JT; 't Hoen, PAC; Aartsma-Rus, A				van Putten, Maaike; Hulsker, Margriet; Nadarajah, Vishna Devi; van Heiningen, Sandra H.; van Huizen, Ella; van Iterson, Maarten; Admiraal, Peter; Messemaker, Tobias; den Dunnen, Johan T.; 't Hoen, Peter A. C.; Aartsma-Rus, Annemieke			The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; TRANSGENIC MDX MICE; GENE-EXPRESSION; X-CHROMOSOME; CARRIER MICE; FULL-LENGTH; RESTORATION; DMD; CARDIOMYOPATHY; INACTIVATION	Duchenne muscular dystrophy (DMD) is a severe progressive muscular disorder caused by reading frame disrupting mutations in the DMD gene, preventing the synthesis of functional dystrophin. As dystrophin provides muscle fiber stability during contractions, dystrophin negative fibers are prone to exercise-induced damage. Upon exhaustion of the regenerative capacity, fibers will be replaced by fibrotic and fat tissue resulting in a progressive loss of function eventually leading to death in the early thirties. With several promising approaches for the treatment of DMD aiming at dystrophin restoration in clinical trials, there is an increasing need to determine more precisely which dystrophin levels are sufficient to restore muscle fiber integrity, protect against muscle damage and improve muscle function. To address this we generated a new mouse model (mdx-Xist(Delta hs)) with varying, low dystrophin levels (3-47%, mean 22.7%, stdev 12.1, n = 24) due to skewed X-inactivation. Longitudinal sections revealed that within individual fibers, some nuclei did and some did not express dystrophin, resulting in a random, mosaic pattern of dystrophin expression within fibers. Mdx-Xist(Delta hs), mdx and wild type females underwent a 12 week functional test regime consisting of different tests to assess muscle function at base line, or after chronic treadmill running exercise. Overall, mdx-Xist(Delta hs) mice with 3-14% dystrophin outperformed mdx mice in the functional tests. Improved histopathology was observed in mice with 15-29% dystrophin and these levels also resulted in normalized expression of pro-inflammatory biomarker genes, while for other parameters >30% of dystrophin was needed. Chronic exercise clearly worsened pathology, which needed dystrophin levels >20% for protection. Based on these findings, we conclude that while even dystrophin levels below 15% can improve pathology and performance, levels of >20% are needed to fully protect muscle fibers from exercise-induced damage.	[van Putten, Maaike; Hulsker, Margriet; Nadarajah, Vishna Devi; van Heiningen, Sandra H.; van Huizen, Ella; van Iterson, Maarten; Admiraal, Peter; Messemaker, Tobias; den Dunnen, Johan T.; 't Hoen, Peter A. C.; Aartsma-Rus, Annemieke] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Putten, M (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands.	a.m.rus@lumc.nl	Hoen, Peter A 't/D-3950-2018; dunnen, johan den/ABH-4228-2020	Hoen, Peter A 't/0000-0003-4450-3112; dunnen, johan den/0000-0002-6304-1710; V Nadarajah, Vishna Devi/0000-0002-7126-7189; van Putten, Maaike/0000-0002-0683-8897	FP6 [LSHM-CT-2006-036825]; FP7 BIO-NMD [FP7-HEALTH-241665]; Dutch organization for scientific research (NWO/ZonMW) [95100102]; Dutch Duchenne Parent Project	FP6(European Commission); FP7 BIO-NMD; Dutch organization for scientific research (NWO/ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Dutch Duchenne Parent Project	This work was supported by the FP6 funded TREAT-NMD network of excellence (LSHM-CT-2006-036825), the FP7 BIO-NMD project (FP7-HEALTH-241665), the Dutch organization for scientific research (NWO/ZonMW, 95100102), and the Dutch Duchenne Parent Project (www.duchenne.nl) and utilizes the infrastructure of the Center for Biomedical Genetics (the Netherlands) and the Center for Medical Systems Biology (the Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Aartsma-Rus A, 2010, ANN NY ACAD SCI, V1214, P199, DOI 10.1111/j.1749-6632.2010.05836.x; AZOFEIFA J, 1995, HUM GENET, V96, P167, DOI 10.1007/BF00207374; Bostick B, 2008, CIRC RES, V102, P121, DOI 10.1161/CIRCRESAHA.107.162982; BOYD Y, 1986, J MED GENET, V23, P484, DOI 10.1136/jmg.23.6.484; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Dunant P, 2003, MOL THER, V8, P80, DOI 10.1016/S1525-0016(03)00129-1; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; Hirawat S, 2007, J CLIN PHARMACOL, V47, P430, DOI 10.1177/0091270006297140; HOFFMAN EP, 1989, NEUROLOGY, V39, P1011, DOI 10.1212/WNL.39.8.1011; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Li DJ, 2008, AM J PATHOL, V172, P1332, DOI 10.2353/ajpath.2008.071042; LUPSKI JR, 1991, AM J MED GENET, V40, P354, DOI 10.1002/ajmg.1320400323; Malik Vinod, 2010, Ther Adv Neurol Disord, V3, P379, DOI 10.1177/1756285610388693; Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Nadarajah VD, 2011, NEUROMUSCULAR DISORD, V21, P569, DOI 10.1016/j.nmd.2011.05.011; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; Newall AET, 2001, HUM MOL GENET, V10, P581, DOI 10.1093/hmg/10.6.581; NICHOLSON LVB, 1993, ARCH DIS CHILD, V68, P632, DOI 10.1136/adc.68.5.632; Ogata H, 2000, INTERNAL MED, V39, P34, DOI 10.2169/internalmedicine.39.34; PEGORARO E, 1995, NEUROLOGY, V45, P677, DOI 10.1212/WNL.45.4.677; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; RAFAEL JA, 1994, HUM MOL GENET, V3, P1725, DOI 10.1093/hmg/3.10.1725; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; SCHMIDTACHERT M, 1993, CLIN INVESTIGATOR, V71, P247; Senner CE, 2009, CURR OPIN GENET DEV, V19, P122, DOI 10.1016/j.gde.2009.03.003; Sharp PS, 2011, MOL THER, V19, P165, DOI 10.1038/mt.2010.213; Soltanzadeh P, 2010, NEUROMUSCULAR DISORD, V20, P499, DOI 10.1016/j.nmd.2010.05.010; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Stillwell E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004759; TANAKA H, 1990, HISTOCHEMISTRY, V93, P447, DOI 10.1007/BF00266399; Turk R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-98; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Van Erp C, 2010, MUSCLE NERVE, V42, P504, DOI 10.1002/mus.21716; van Putten M, 2012, NEUROMUSCUL IN PRESS; van Putten M, 2010, NEUROMUSCULAR DISORD, V20, P273, DOI 10.1016/j.nmd.2010.02.004	42	69	80	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31937	10.1371/journal.pone.0031937	http://dx.doi.org/10.1371/journal.pone.0031937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359642	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200111
J	Prondvai, E; Stein, K; Osi, A; Sander, MP				Prondvai, Edina; Stein, Koen; Osi, Attila; Sander, Martin P.			Life History of Rhamphorhynchus Inferred from Bone Histology and the Diversity of Pterosaurian Growth Strategies	PLOS ONE			English	Article							DEVELOPMENTAL PLASTICITY; TRADE-OFFS; PATTERNS; BIRDS; EVOLUTION; PALEOHISTOLOGY; PHYSIOLOGY; ONTOGENY; ANATOMY	Background: Rhamphorhynchus from the Solnhofen Limestones is the most prevalent long tailed pterosaur with a debated life history. Whereas morphological studies suggested a slow crocodile-like growth strategy and superprecocial volant hatchlings, the only histological study hitherto conducted on Rhamphorhynchus concluded a relatively high growth rate for the genus. These controversial conclusions can be tested by a bone histological survey of an ontogenetic series of Rhamphorhynchus. Methodology/Principal Findings: Our results suggest that Bennett's second size category does not reflect real ontogenetic stage. Significant body size differences of histologically as well as morphologically adult specimens suggest developmental plasticity. Contrasting the 'superprecocial hatchling' hypothesis, the dominance of fibrolamellar bone in early juveniles implies that hatchlings sustained high growth rate, however only up to the attainment of 30-50% and 7-20% of adult wingspan and body mass, respectively. The early fast growth phase was followed by a prolonged, slow-growth phase indicated by parallel-fibred bone deposition and lines of arrested growth in the cortex, a transition which has also been observed in Pterodaustro. An external fundamental system is absent in all investigated specimens, but due to the restricted sample size, neither determinate nor indeterminate growth could be confirmed in Rhamphorhynchus. Conclusions/Significance: The initial rapid growth phase early in Rhamphorhynchus ontogeny supports the non-volant nature of its hatchlings, and refutes the widely accepted 'superprecocial hatchling' hypothesis. We suggest the onset of powered flight, and not of reproduction as the cause of the transition from the fast growth phase to a prolonged slower growth phase. Rapidly growing early juveniles may have been attended by their parents, or could have been independent precocial, but non-volant arboreal creatures until attaining a certain somatic maturity to get airborne. This study adds to the understanding on the diversity of pterosaurian growth strategies.	[Prondvai, Edina; Osi, Attila] Eotvos Lorand Univ, Hungarian Acad Sci, Lendulet Dinosaur Res Grp, Budapest, Hungary; [Stein, Koen; Sander, Martin P.] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany	Eotvos Lorand University; Hungarian Academy of Sciences; University of Bonn	Prondvai, E (corresponding author), Eotvos Lorand Univ, Hungarian Acad Sci, Lendulet Dinosaur Res Grp, Budapest, Hungary.	edina.prondvai@gmail.com	Ősi, Attila/K-2414-2018; Prondvai, Edina/I-3178-2019; Stein, Koen HW/G-5731-2015	Ősi, Attila/0000-0003-2967-997X; Prondvai, Edina/0000-0002-1284-8311; Stein, Koen/0000-0003-4246-3225	ELTE-MTA (Eotvos Lorand University - Hungarian Academy of Sciences, Dinosaur Research Group); OTKA (Orszagos Tudomanyos Kutatasi Alap) [NF 84193]; Hantken Foundation; Eotvos Lorand University, Department of Paleontology; Hungarian Natural History Museum; Hungarian Academy of Sciences	ELTE-MTA (Eotvos Lorand University - Hungarian Academy of Sciences, Dinosaur Research Group); OTKA (Orszagos Tudomanyos Kutatasi Alap)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hantken Foundation; Eotvos Lorand University, Department of Paleontology; Hungarian Natural History Museum; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This study was funded by an ELTE-MTA "Lendulet" grant (Eotvos Lorand University - Hungarian Academy of Sciences, Dinosaur Research Group), and an OTKA (Orszagos Tudomanyos Kutatasi Alap, Hungarian Scientific Research Fund) grant NF 84193. Further financial support was provided by Hantken Foundation (http://www.friweb.hu/hantken/), Eotvos Lorand University, Department of Paleontology (http://paleo.elte.hu), Hungarian Natural History Museum (http://www.nhmus.hu), and Hungarian Academy of Sciences (http://mta.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Andrews R.M., 1982, Biology of Reptilia, V13, P273; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; BENNETT SC, 1995, J PALEONTOL, V69, P569, DOI 10.1017/S0022336000034946; Cambra-Moo O, 2006, CR PALEVOL, V5, P685, DOI 10.1016/j.crpv.2005.12.018; CAMPOS DD, 1985, AN ACAD BRAS CIENC, V57, P141; CARRIER D, 1990, J ZOOL, V222, P375, DOI 10.1111/j.1469-7998.1990.tb04039.x; Castanet J., 1993, BONE, P245; Chinsamy A, 2008, BIOL LETTERS, V4, P282, DOI 10.1098/rsbl.2008.0004; Chinsamy A, 2001, NATURE, V412, P402, DOI 10.1038/35086650; Chinsamy A., 2005, MICROSTRUCTURE DINOS; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Dalla Vecchia F., 1993, B SOC PALEONTOLOGICA, V32, P401; Dalla Vecchia FM, 2009, RIV ITAL PALEONTOL S, V115, P159, DOI 10.13130/2039-4942/6377; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; de Ricqles A, 2006, TRENDS ECOL EVOL, V21, P596, DOI 10.1016/j.tree.2006.08.005; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 1999, NATURE, V398, P205, DOI 10.1038/18343; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Francillon-Vieillot H., 1990, P471; GROSS WALTER, 1934, ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V103, P731, DOI 10.1007/BF02118752; HOUCK MA, 1990, SCIENCE, V247, P195, DOI 10.1126/science.247.4939.195; Hutchison J.H., 1984, Journal of Vertebrate Paleontology, V3, P148; JACOBSEN T, 1989, J ZOOL, V219, P309, DOI 10.1111/j.1469-7998.1989.tb02583.x; Jenkins Farish A. Jr., 2001, Bulletin of the Museum of Comparative Zoology, V156, P151; Kozlowski J, 1996, P ROY SOC B-BIOL SCI, V263, P559, DOI 10.1098/rspb.1996.0084; Lincoln LJ, 1982, DICT ECOLOGY EVOLUTI; Lu JC, 2011, SCIENCE, V331, P321, DOI 10.1126/science.1197323; Mangel M, 2001, EVOL ECOL RES, V3, P583; Osi A, 2010, ANAT REC, V293, P243, DOI 10.1002/ar.21053; Osi A, 2009, NEUES JAHRB GEOL P-A, V252, P167, DOI 10.1127/0077-7749/2009/0252-0167; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; PADIAN K, 1993, AM J SCI, V293A, P91, DOI 10.2475/ajs.293.A.91; Padian K, 2004, DINOSAURIA, 2ND EDITION, P660; Palmer C, 2011, P ROY SOC B-BIOL SCI, V278, P1881, DOI 10.1098/rspb.2010.2179; Ponton F, 2004, ACTA ORNITHOL, V39, P137, DOI 10.3161/068.039.0210; Prondvai E, 2008, HIST BIOL, V20, P237, DOI 10.1080/08912960902859334; Reid R.E.H., 1996, Brigham Young University Geology Studies, V41, P25; RICKLEFS RE, 1980, AUK, V97, P768; RICKLEFS RE, 1979, BIOL REV, V54, P269, DOI 10.1111/j.1469-185X.1979.tb01013.x; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; Rodrigues Taissa, 2008, Zitteliana Reihe B, V28, P219; Sander PM, 2005, SCIENCE, V310, P1800, DOI 10.1126/science.1120125; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Sayao Juliana M., 2003, Geological Society Special Publication, V217, P335, DOI 10.1144/GSL.SP.2003.217.01.21; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Seitz ALL, 1907, NOVA ACTA ABHANDLUNG, V87, P230; SHINE R, 1992, AM NAT, V139, P1257, DOI 10.1086/285385; Starck J. Matthias, 1998, Oxford Ornithology Series, V8, P381; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Steel Lorna, 2008, Zitteliana Reihe B, V28, P109; Stein K., 2009, METHODS FOSSIL PREPA, P69; Tumarkin-Deratzian AR, 2007, J HERPETOL, V41, P341, DOI 10.1670/0022-1511(2007)41[341:FBIWAA]2.0.CO;2; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Unwin D, 2005, PTEROSAURS DEEP TIME, P140; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; VLECK D, 1984, PHYSIOL ZOOL, V57, P444, DOI 10.1086/physzool.57.4.30163346; WELLNHOFER P, 1985, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V187, P105; Wellnhofer P., 1975, PALAEONTOGRAPHICA A, V148, P132; WELLNHOFER P, 1978, HDB PALAOHERPETOL 19; Wellnhofer Peter, 1993, Archaeopteryx, V11, P1; Wells N.A., 1989, Paleontological Society Special Publication, P120; Witton Mark P., 2008, Zitteliana Reihe B, V28, P143; Wong S, 1999, THESIS GRIFFITH U QU, P64; Young B, 2006, WHEATERS FUNCTIONAL; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	70	45	45	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31392	10.1371/journal.pone.0031392	http://dx.doi.org/10.1371/journal.pone.0031392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355361	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000302741300061
J	Quicke, DLJ				Quicke, Donald L. J.			We Know Too Little about Parasitoid Wasp Distributions to Draw Any Conclusions about Latitudinal Trends in Species Richness, Body Size and Biology	PLOS ONE			English	Article							BRACONIDAE HYMENOPTERA ICHNEUMONOIDEA; ANOMALOUS DIVERSITY; COSTA-RICA; GRADIENTS; BUTTERFLIES; HYPOTHESIS; MORPHOLOGY; PATTERNS; HISTORY; FORESTS	Much has been written about latitudinal trends in parasitoid diversity and biology, though it is widely recognised that they are a comparatively poorly known group. Here I show that for both braconid and ichneumonid wasps there are highly significant relationships between body size and the mean recorded latitude of species. Numbers of species per genus (surrogates of clades) peaks in the temperate zone for both families contrasting with data from the virtually complete inventories for mammals, birds and monocot plants, suggesting massive under-description of tropical parasitoid faunas. If the ichneumonoids may be expected to show similar trends to mammals, birds and other groups, the implication is that taxonomic work both in terms of active generic revisions, but also likely, the collecting and processing of museum specimens, and selection of taxa for revision, is woefully inadequate to allow latitudinal patterns in biology to be analysed.	[Quicke, Donald L. J.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England; [Quicke, Donald L. J.] Nat Hist Museum, Dept Entomol, London SW7 5BD, England	Imperial College London; Natural History Museum London	Quicke, DLJ (corresponding author), Imperial Coll London, Dept Life Sci, Ascot, Berks, England.	d.quicke@imperial.ac.uk	Quicke, Donald LJ/I-5948-2012	Quicke, Donald/0000-0003-4471-6775				Belshaw R, 2002, SYST BIOL, V51, P450, DOI 10.1080/10635150290069896; BLACKBURN TM, 1994, P ROY SOC B-BIOL SCI, V257, P293, DOI 10.1098/rspb.1994.0128; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A., 2005, ENCY STAT SCI, V12, P7907, DOI DOI 10.1890/13-0133.1; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; Dolphin K, 2001, BIOL J LINN SOC, V73, P279, DOI [10.1111/j.1095-8312.2001.tb01363.x, 10.1006/bijl.2001.0537]; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; GASTON KJ, 1993, J TROP ECOL, V9, P491, DOI 10.1017/S0266467400007550; GASTON KJ, 1995, BIODIVERS CONSERV, V4, P119, DOI 10.1007/BF00137780; Gauld Ian D., 1994, P279; GAULD ID, 1992, OIKOS, V65, P353, DOI 10.2307/3545032; Giam XL, 2012, P ROY SOC B-BIOL SCI, V279, P67, DOI 10.1098/rspb.2011.0433; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; HAWKINS BA, 1995, ECOL ENTOMOL, V20, P195, DOI 10.1111/j.1365-2311.1995.tb00446.x; HAWKINS BA, 1995, OECOLOGIA, V102, P31, DOI 10.1007/BF00333307; Hawkins BA, 1994, PATTERN PROCESS HOST; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Horstmann Klaus, 1999, Ecotropica, V5, P1; JANZEN DH, 1981, ECOLOGY, V62, P532, DOI 10.2307/1937717; JANZEN DH, 1975, T ROY ENT SOC LONDON, V127, P33; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jones OR, 2009, INSECT CONSERV DIVER, V2, P204, DOI 10.1111/j.1752-4598.2009.00057.x; Kindlmann Pavel, 2007, P246; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; OWEN DF, 1974, NATURE, V249, P583, DOI 10.1038/249583a0; Quicke D. L. J., 1997, PARASITIC WASPS; Quicke DLJ, 2009, J NAT HIST, V43, P1305, DOI 10.1080/00222930902807783; R Development Core Team, 2009, R FDN STAT COMP; RATHCKE BJ, 1976, AM NAT, V110, P889; Saaksjarvi IE, 2004, ECOL ENTOMOL, V29, P735, DOI 10.1111/j.0307-6946.2004.00656.x; Santos AMC, 2011, ENTOMOL SCI, V14, P371, DOI 10.1111/j.1479-8298.2011.00481.x; Sharanowski BJ, 2011, SYST ENTOMOL, V36, P549, DOI 10.1111/j.1365-3113.2011.00580.x; Sime KR, 1998, J ANIM ECOL, V67, P387, DOI 10.1046/j.1365-2656.1998.00198.x; Skillen EL, 2000, ENVIRON ENTOMOL, V29, P460, DOI 10.1603/0046-225X-29.3.460; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Veijalainen A, 2012, INSECT CONS IN PRESS; Veijalainen A, 2011, ZOOKEYS, P59, DOI 10.3897/zookeys.124.1780; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Yu D.S.K., 2016, TAXAPAD 2016 ICHNEUM	39	65	70	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32101	10.1371/journal.pone.0032101	http://dx.doi.org/10.1371/journal.pone.0032101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355411	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300111
J	Kubota, T; Hamazoe, Y; Hashiguchi, S; Ishibashi, D; Akasaka, K; Nishida, N; Katamine, S; Sakaguchi, S; Kuroki, R; Nakashima, T; Sugimura, K				Kubota, Toshiya; Hamazoe, Yuta; Hashiguchi, Shuhei; Ishibashi, Daisuke; Akasaka, Kazuyuki; Nishida, Noriyuki; Katamine, Shigeru; Sakaguchi, Suehiro; Kuroki, Ryota; Nakashima, Toshihiro; Sugimura, Kazuhisa			Direct Evidence of Generation and Accumulation of beta-Sheet-rich Prion Protein in Scrapie-infected Neuroblastoma Cells with Human IgG1 Antibody Specific for beta-Form Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; CONFORMATIONAL TRANSITION; CYCLIC AMPLIFICATION; CULTURED-CELLS; IN-VITRO; CONVERSION; PRPSC; DISEASE; PHAGE; REPLICATION	We prepared beta-sheet-rich recombinant full-length prion protein (beta-form PrP) (Jackson, G. S., Hosszu, L. L., Power, A., Hill, A. F., Kenney, J., Saibil, H., Craven, C. J., Waltho, J. P., Clarke, A. R., and Collinge, J. (1999) Science 283, 1935-1937). Using this beta-form PrP and a human single chain Fv-displaying phage library, we have established a human IgG1 antibody specific to beta-form but not alpha-form PrP, PRB7 IgG. When prion-infected ScN2a cells were cultured with PRB7 IgG, they generated and accumulated PRB7-binding granules in the cytoplasm with time, consequently becoming apoptotic cells bearing very large PRB7-bound aggregates. The SAF32 antibody recognizing the N-terminal octarepeat region of full-length PrP stained distinct granules in these cells as determined by confocal laser microscopy observation. When the accumulation of proteinase K-resistant PrP was examined in prion-infected ScN2a cells cultured in the presence of PRB7 IgG or SAF32, it was strongly inhibited by SAF32 but not at all by PRB7 IgG. Thus, we demonstrated direct evidence of the generation and accumulation of beta-sheet-rich PrP in ScN2a cells de novo. These results suggest first that PRB7-bound PrP is not responsible for the accumulation of beta-form PrP aggregates, which are rather an end product resulting in the triggering of apoptotic cell death, and second that SAF32-bound PrP lacking the PRB7-recognizing beta-form may represent so-called PrPSc with prion propagation activity. PRB7 is the first human antibody specific to beta-form PrP and has become a powerful tool for the characterization of the biochemical nature of prion and its pathology.	[Kubota, Toshiya; Hamazoe, Yuta; Hashiguchi, Shuhei; Sugimura, Kazuhisa] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, Kagoshima 8900065, Japan; [Akasaka, Kazuyuki] Kinki Univ, Sch Biol Oriented Sci & Technol, Dept Biotechnol Sci, Kinokawa, Wakayama 6496493, Japan; [Ishibashi, Daisuke; Nishida, Noriyuki; Katamine, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 8528523, Japan; [Sakaguchi, Suehiro] Univ Tokushima, Inst Enzyme Res, Div Mol Neurobiol, Tokushima 7708503, Japan; [Kuroki, Ryota] Japan Atom Energy Res Inst, Neutron Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Nakashima, Toshihiro] Chemoserotherapeut Res Inst, Kumamoto 8691298, Japan	Kagoshima University; Kindai University (Kinki University); Nagasaki University; Tokushima University; Japan Atomic Energy Agency	Sugimura, K (corresponding author), Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, Kagoshima 1-21-40 Korimoto, Kagoshima 8900065, Japan.	kazu@be.kagoshima-u.ac.jp		Waltho, Jonathan/0000-0002-7402-5492	Ministry of Education, Culture, Sports, Science and Technology of Japan [16613008, 22790435]; Health and Labour Sciences Research Grants on Food Safety [Shokuhin-016]; Psychiatric and Neurological Diseases and Mental Health from the Ministry of Health, Labour and Welfare; Ministry of Agriculture, Forestry and Fisheries of Japan; Super Special Consortia; Grants-in-Aid for Scientific Research [24570180] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Sciences Research Grants on Food Safety; Psychiatric and Neurological Diseases and Mental Health from the Ministry of Health, Labour and Welfare; Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Super Special Consortia; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research C 16613008 and for Young Scientists B 22790435 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. H.), Health and Labour Sciences Research Grants on Food Safety (Shokuhin-016) ( to S. H.) and Psychiatric and Neurological Diseases and Mental Health from the Ministry of Health, Labour and Welfare (to S. H. and K. S.), a grant-in-aid from the Bovine Spongiform Encephalopathy Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan (to K. S.), and Super Special Consortia for supporting the development of cutting-edge medical care from 2008 to 2012 (to K. S.).	Anaya ZEA, 2011, J BIOL CHEM, V286, P8141, DOI 10.1074/jbc.M110.165233; Atarashi R, 2006, J VIROL, V80, P7854, DOI 10.1128/JVI.00424-06; Beringue V, 2004, J BIOL CHEM, V279, P39671, DOI 10.1074/jbc.M402270200; Biasini E, 2008, J NEUROCHEM, V105, P2190, DOI 10.1111/j.1471-4159.2008.05306.x; Biasini E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007816; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Boel E, 2000, J IMMUNOL METHODS, V239, P153, DOI 10.1016/S0022-1759(00)00170-8; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Hamasaki T, 2005, J BIOCHEM, V138, P433, DOI 10.1093/jb/mvi148; Hashiguchi S, 2003, J BIOCHEM, V133, P43, DOI 10.1093/jb/mvg001; Hnasko R, 2010, PRION, V4, P94, DOI 10.4161/pri.4.2.12622; Horiuchi M, 2009, VIROLOGY, V394, P200, DOI 10.1016/j.virol.2009.08.025; Ishibashi D, 2007, VACCINE, V25, P985, DOI 10.1016/j.vaccine.2006.09.078; Ishikawa K, 2004, J GEN VIROL, V85, P1785, DOI 10.1099/vir.0.19754-0; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Khalill-Shirazi A, 2007, BBA-PROTEINS PROTEOM, V1774, P1438, DOI 10.1016/j.bbapap.2007.08.028; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kosmac M, 2011, MOL IMMUNOL, V48, P746, DOI 10.1016/j.molimm.2010.11.012; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Liu CT, 2008, MOL BIOTECHNOL, V39, P141, DOI 10.1007/s12033-008-9051-x; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Petsch B, 2011, J VIROL, V85, P4538, DOI 10.1128/JVI.02467-10; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Sasaki K, 2008, PRION, V2, P118, DOI 10.4161/pri.2.3.7148; Sasamori E, 2010, ARCH BIOCHEM BIOPHYS, V501, P232, DOI 10.1016/j.abb.2010.06.025; Skrlj N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015783; Stanker LH, 2010, J IMMUNOL, V185, P729, DOI 10.4049/jimmunol.0902930; Tanaka K, 2011, J NEUROIMMUNOL, V236, P27, DOI 10.1016/j.jneuroim.2011.04.010; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Uryu M, 2007, MICROBIOL IMMUNOL, V51, P661, DOI 10.1111/j.1348-0421.2007.tb03954.x; Ushiki-Kaku Y, 2010, J BIOL CHEM, V285, P11931, DOI 10.1074/jbc.M109.058859; Veith NM, 2009, EUR J CELL BIOL, V88, P45, DOI 10.1016/j.ejcb.2008.08.001; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Williamson RA, 1996, P NATL ACAD SCI USA, V93, P7279, DOI 10.1073/pnas.93.14.7279; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Yoshihara T, 2008, J BIOCHEM, V143, P475, DOI 10.1093/jb/mvm239; Yoshinaga K, 2008, J BIOCHEM, V143, P593, DOI 10.1093/jb/mvn009; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	50	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14023	14039		10.1074/jbc.M111.318352	http://dx.doi.org/10.1074/jbc.M111.318352			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22356913	Green Published, hybrid			2022-12-25	WOS:000303996300057
J	Tosha, T; Behera, RK; Ng, HL; Bhattasali, O; Alber, T; Theil, EC				Tosha, Takehiko; Behera, Rabindra K.; Ng, Ho-Leung; Bhattasali, Onita; Alber, Tom; Theil, Elizabeth C.			Ferritin Protein Nanocage Ion Channels GATING BY N-TERMINAL EXTENSIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; IRON RELEASE; H-FERRITIN; MECHANISM; RESIDUES; PORES; MINERALIZATION; REVEALS; DEPENDS; BINDING	Ferritin protein nanocages, self-assembled from four-alpha-helix bundle subunits, use Fe2+ and oxygen to synthesize encapsulated, ferric oxide minerals. Ferritin minerals are iron concentrates stored for cell growth. Ferritins are also antioxidants, scavenging Fenton chemistry reactants. Channels for iron entry and exit consist of helical hairpin segments surrounding the 3-fold symmetry axes of the ferritin nanocages. We now report structural differences caused by amino acid substitutions in the Fe2+ ion entry and exit channels and at the cytoplasmic pores, from high resolution (1.3-1.8 angstrom) protein crystal structures of the eukaryotic model ferritin, frog M. Mutations that eliminate conserved ionic or hydrophobic interactions between Arg-72 and Asp-122 and between Leu-110 and Leu-134 increase flexibility in the ion channels, cytoplasmic pores, and/or the N-terminal extensions of the helix bundles. Decreased ion binding in the channels and changes in ordered water are also observed. Protein structural changes coincide with increased Fe2+ exit from dissolved, ferric minerals inside ferritin protein cages; Fe2+ exit from ferritin cages depends on a complex, surface-limited process to reduce and dissolve the ferric mineral. High concentrations of bovine serum albumin or lysozyme (protein crowders) to mimic the cytoplasm restored Fe2+ exit in the variants to wild type. The data suggest that fluctuations in pore structure control gating. The newly identified role of the ferritin subunit N-terminal extensions in gating Fe2+ exit from the cytoplasmic pores strengthens the structural and functional analogies between ferritin ion channels in the water-soluble protein assembly and membrane protein ion channels gated by cytoplasmic N-terminal peptides.	[Ng, Ho-Leung; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Theil, Elizabeth C.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Tosha, Takehiko; Behera, Rabindra K.; Bhattasali, Onita] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Alber, T (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 374B Stanley Hall 3220, Berkeley, CA 94720 USA.	tom@ucxray.berkeley.edu; etheil@chori.org	Ng, Ho Leung/B-5650-2016; Tosha, Takehiko/AAR-2404-2020; Ng, Ho Leung/E-3419-2010; Ng, Ho Leung/Q-7167-2019	Ng, Ho Leung/0000-0002-6415-1938; Tosha, Takehiko/0000-0002-8971-0759; Ng, Ho Leung/0000-0002-6415-1938; Behera, Rabindra/0000-0003-2849-3292	National Institutes of Health [DK20251, GM48958, GM70962]; Children's Hospital Oakland Research Institute Foundation; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020251, R37DK020251, R56DK020251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070962, R01GM048958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital Oakland Research Institute Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK20251 (to E. C. T., R. K. B., B. O., and T. T.), GM48958, and GM70962 (to H.-L. N. and T. A.). This work was also supported by the Children's Hospital Oakland Research Institute Foundation (to E. C. T.) and a Japan Society for the Promotion of Science postdoctoral fellowship for research abroad (to T. T.).	BANYARD SH, 1978, NATURE, V271, P282, DOI 10.1038/271282a0; BAUMINGER ER, 1993, BIOCHEM J, V296, P709, DOI 10.1042/bj2960709; BAYNES RD, 1990, ANNU REV NUTR, V10, P133, DOI [10.1146/annurev.nutr.10.1.133, 10.1146/annurev.nu.10.070190.001025]; Briat JF, 2010, ANN BOT-LONDON, V105, P811, DOI 10.1093/aob/mcp128; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Duong-Ly KC, 2005, PROTEIN SCI, V14, P856, DOI 10.1110/ps.041185805; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Goss DJ, 2011, ACCOUNTS CHEM RES, V44, P1320, DOI 10.1021/ar2001149; Ha Y, 1997, ACTA CRYSTALLOGR D, V53, P513, DOI 10.1107/S0907444997003983; Ha Y, 1999, J BIOL INORG CHEM, V4, P243, DOI 10.1007/s007750050310; Hailemariam K, 2010, J CELL SCI, V123, P3863, DOI 10.1242/jcs.073627; Haldar S, 2011, J BIOL CHEM, V286, P25620, DOI 10.1074/jbc.M110.205278; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Inanobe A, 2011, BIOCHEM BIOPH RES CO, V407, P366, DOI 10.1016/j.bbrc.2011.03.025; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; Li CG, 2009, J AM CHEM SOC, V131, P1368, DOI 10.1021/ja808428d; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Liu XS, 2007, J BIOL CHEM, V282, P31821, DOI 10.1074/jbc.C700153200; Lundmark R, 2010, SEMIN CELL DEV BIOL, V21, P363, DOI 10.1016/j.semcdb.2009.11.014; Makowski L, 2008, J MOL BIOL, V375, P529, DOI 10.1016/j.jmb.2007.07.075; Masuda T, 2010, J BIOL CHEM, V285, P4049, DOI 10.1074/jbc.M109.059790; Milman N, 2012, ANN HEMATOL, V91, P143, DOI 10.1007/s00277-011-1381-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oz S, 2011, J BIOL CHEM, V286, P13945, DOI 10.1074/jbc.M110.198424; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Rosenhouse-Dantsker A, 2011, BIOPHYS J, V100, P381, DOI 10.1016/j.bpj.2010.11.086; Soveral G, 2011, BIOL CELL, V103, P35, DOI 10.1042/BC20100102; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; Theil EC, 2011, CURR OPIN CHEM BIOL, V15, P304, DOI 10.1016/j.cbpa.2011.01.004; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Tosha T, 2010, J AM CHEM SOC, V132, P14562, DOI 10.1021/ja105583d; Tosha T, 2008, P NATL ACAD SCI USA, V105, P18182, DOI 10.1073/pnas.0805083105; Turano P, 2010, P NATL ACAD SCI USA, V107, P545, DOI 10.1073/pnas.0908082106; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Valiyaveetil FI, 2006, SCIENCE, V314, P1004, DOI 10.1126/science.1133415; WALDO GS, 1993, BIOCHEMISTRY-US, V32, P13262, DOI 10.1021/bi00211a039; Yuan Z, 2003, PROTEIN ENG, V16, P109, DOI 10.1093/proeng/gzg014	53	56	58	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13016	13025		10.1074/jbc.M111.332734	http://dx.doi.org/10.1074/jbc.M111.332734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362775	Green Published, hybrid			2022-12-25	WOS:000302903700040
J	Zuris, JA; Ali, SS; Yeh, H; Nguyen, TA; Nechushtai, R; Paddock, ML; Jennings, PA				Zuris, John A.; Ali, Syed S.; Yeh, Howard; Nguyen, Tung A.; Nechushtai, Rachel; Paddock, Mark L.; Jennings, Patricia A.			NADPH Inhibits [2Fe-2S] Cluster Protein Transfer from Diabetes Drug Target MitoNEET to an Apo-acceptor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEINS; MITOCHONDRIAL DYSFUNCTION; INSULIN SENSITIZERS; OXIDATIVE STRESS; HUMAN-DISEASE; BIOGENESIS; MELLITUS; NUCLEOTIDES; METABOLISM; MUTATION	MitoNEET (mNT) is the founding member of the recently discovered CDGSH family of [2Fe-2S] proteins capable of [2Fe-2S] cluster transfer to apo-acceptor proteins. It is a target of the thiazolidinedione (TZD) class of anti-diabetes drugs whose binding modulate both electron transfer and cluster transfer properties. The [2Fe-2S] cluster in mNT is destabilized upon binding of NADPH, which leads to loss of the [2Fe-2S] cluster to the solution environment. Because mNT is capable of transferring [2Fe-2S] clusters to apo-acceptor proteins, we sought to determine whether NADPH binding also affects cluster transfer. We show that NADPH inhibits transfer of the [2Fe-2S] cluster to an apo-acceptor protein with an inhibition constant (K-i) of 200 mu M, which reflects that of NADPH concentrations expected under physiological conditions. In addition, we determined that the strictly conserved cluster interacting residue Asp-84 in the CDGSH domain is necessary for the NADPH-dependent inhibition of [2Fe-2S] cluster transfer. The most critical cellular function of NADPH is in the maintenance of a pool of reducing equivalents, which is essential to counteract oxidative damage. Taken together, our findings suggest that NADPH can regulate both mNT [2Fe-2S] cluster levels in the cell as well as the ability of the protein to transfer [2Fe-2S] clusters to cytosolic or mitochondrial acceptors.	[Zuris, John A.; Ali, Syed S.; Yeh, Howard; Nguyen, Tung A.; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Paddock, Mark L.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Nechushtai, Rachel] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Dept Plant & Environm Sci, IL-91904 Givat Ram, Israel	University of California System; University of California San Diego; University of California System; University of California San Diego; Hebrew University of Jerusalem	Jennings, PA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pajennings@ucsd.edu			National Institutes of Health [GM41637, GM54038, DK54441]; Heme and Blood Proteins Training Grant [5T32DK007233-34]; Israel Science Foundation [863/09]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233, P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041637, R01GM054038, R01GM101467, R29GM054038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heme and Blood Proteins Training Grant; Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM41637 (to M. L. P.), GM54038 (to P. A. J.), and DK54441 (to P. A. J.). This work was also supported by Heme and Blood Proteins Training Grant 5T32DK007233-34 (to J. A. Z.) and Israel Science Foundation Grant 863/09 (to R. N.).	Abdul-Ghani MA, 2008, CURR DIABETES REP, V8, P173, DOI 10.1007/s11892-008-0030-1; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; ANDERSEN KB, 1977, J BIOL CHEM, V252, P4151; Bak DW, 2009, BIOCHEMISTRY-US, V48, P10193, DOI 10.1021/bi9016445; Baxter EL, 2011, P NATL ACAD SCI USA, V108, P5266, DOI 10.1073/pnas.1017604108; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Chen YF, 2010, ANN NY ACAD SCI, V1201, P58, DOI 10.1111/j.1749-6632.2010.05619.x; Colca JR, 2006, EXPERT OPIN INV DRUG, V15, P205, DOI 10.1517/13543784.15.3.205; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Conlan AR, 2011, ACTA CRYSTALLOGR D, V67, P516, DOI 10.1107/S0907444911011577; Cusimano EM, 2009, ADV EMERG NURS J, V31, P54, DOI 10.1097/TME.0b013e3181956200; Dicus MM, 2010, J AM CHEM SOC, V132, P2037, DOI 10.1021/ja909359g; Dutton P L, 1978, Methods Enzymol, V54, P411; HANSEN TM, 2003, SCI STKE, pPE31; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hernandez C, 2000, MED CLIN-BARCELONA, V115, P21, DOI 10.1016/S0025-7753(00)71450-3; HOFMANN CA, 1992, DIABETES CARE, V15, P1075, DOI 10.2337/diacare.15.8.1075; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Martinovich GG, 2005, EUR BIOPHYS J BIOPHY, V34, P937, DOI 10.1007/s00249-005-0470-3; Napier I, 2005, BLOOD, V105, P1867, DOI 10.1182/blood-2004-10-3856; Opara EC, 2004, J INVEST MED, V52, P19, DOI 10.1136/jim-52-01-22; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Sohn YS, 2008, BLOOD, V111, P1690, DOI 10.1182/blood-2007-07-102335; Tirrell TF, 2009, BIOCHEMISTRY-US, V48, P4747, DOI 10.1021/bi900028r; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; WOLFF SP, 1993, BRIT MED BULL, V49, P642, DOI 10.1093/oxfordjournals.bmb.a072637; Wu SP, 2003, BIOCHEMISTRY-US, V42, P5784, DOI 10.1021/bi026939+; Zhou T, 2010, BIOCHEMISTRY-US, V49, P9604, DOI 10.1021/bi101168c; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108; Zuris JA, 2010, J AM CHEM SOC, V132, P13120, DOI 10.1021/ja103920k	44	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11649	11655		10.1074/jbc.M111.319731	http://dx.doi.org/10.1074/jbc.M111.319731			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351774	Green Published, hybrid			2022-12-25	WOS:000302782200005
J	Liu, T; Lipnicki, DM; Zhu, WL; Tao, DC; Zhang, CQ; Cui, Y; Jin, JS; Sachdev, PS; Wen, W				Liu, Tao; Lipnicki, Darren M.; Zhu, Wanlin; Tao, Dacheng; Zhang, Chengqi; Cui, Yue; Jin, Jesse S.; Sachdev, Perminder S.; Wen, Wei			Cortical Gyrification and Sulcal Spans in Early Stage Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; HUMAN CEREBRAL-CORTEX; GRAY-MATTER LOSS; FOLDING PATTERNS; BRAIN ATROPHY; AD DEMENTIA; MRI; MORPHOLOGY; VOLUME	Alzheimer's disease (AD) is characterized by an insidious onset of progressive cerebral atrophy and cognitive decline. Previous research suggests that cortical folding and sulcal width are associated with cognitive function in elderly individuals, and the aim of the present study was to investigate these morphological measures in patients with AD. The sample contained 161 participants, comprising 80 normal controls, 57 patients with very mild AD, and 24 patients with mild AD. From 3D T1-weighted brain scans, automated methods were used to calculate an index of global cortex gyrification and the width of five individual sulci: superior frontal, intra-parietal, superior temporal, central, and Sylvian fissure. We found that global cortex gyrification decreased with increasing severity of AD, and that the width of all individual sulci investigated other than the intra-parietal sulcus was greater in patients with mild AD than in controls. We also found that cognitive functioning, as assessed by Mini-Mental State Examination (MMSE) scores, decreased as global cortex gyrification decreased. MMSE scores also decreased in association with a widening of all individual sulci investigated other than the intra-parietal sulcus. The results suggest that abnormalities of global cortex gyrification and regional sulcal span are characteristic of patients with even very mild AD, and could thus facilitate the early diagnosis of this condition.	[Liu, Tao; Tao, Dacheng; Zhang, Chengqi; Jin, Jesse S.] Univ Technol Sydney, Fac Engn & Informat Technol, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia; [Liu, Tao; Lipnicki, Darren M.; Zhu, Wanlin; Sachdev, Perminder S.; Wen, Wei] Univ New S Wales, Sch Psychiat, Brain & Ageing Res Program, Sydney, NSW, Australia; [Liu, Tao; Lipnicki, Darren M.; Zhu, Wanlin; Sachdev, Perminder S.; Wen, Wei] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia; [Cui, Yue; Jin, Jesse S.] Univ Newcastle, Sch Design Commun & IT, Callaghan, NSW 2308, Australia	University of Technology Sydney; University of New South Wales Sydney; University of Newcastle	Liu, T (corresponding author), Univ Technol Sydney, Fac Engn & Informat Technol, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia.	jesse.jin@newcastle.edu.au; W.Wen@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020; Tao, Dacheng/A-5449-2012; zhang, chi/GRX-3610-2022	Sachdev, Perminder/0000-0002-9595-3220; Liu, Tao/0000-0002-7783-3073; Wen, Wei/0000-0003-2753-3870; Zhang, Chengqi/0000-0001-5715-7154	National Health and Medical Research Council (NHMRC) [ID 510175]; Australian Research Council (ARC) [DP-0774213, DP-120103730]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	This research was supported by a National Health and Medical Research Council (NHMRC http://www.nhmrc.gov.au/) Project Grant (ID 510175), and Australian Research Council (ARC http://www.arc.gov.au/) Discovery Grants (ARC DP-0774213 and ARC DP-120103730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bakkour A, 2009, NEUROLOGY, V72, P1048, DOI 10.1212/01.wnl.0000340981.97664.2f; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Cachia A, 2008, NEUROIMAGE, V39, P927, DOI 10.1016/j.neuroimage.2007.08.049; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Hamalainen A, 2007, NEUROIMAGE, V37, P1122, DOI 10.1016/j.neuroimage.2007.06.016; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Holsinger T, 2007, JAMA-J AM MED ASSOC, V297, P2391, DOI 10.1001/jama.297.21.2391; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Im K, 2008, NEUROSCI LETT, V436, P227, DOI 10.1016/j.neulet.2008.03.032; Jacobs HIL, 2012, NEUROSCI BIOBEHAV R, V36, P297, DOI 10.1016/j.neubiorev.2011.06.009; Jouvent E, 2011, NEUROLOGY, V76, P1472, DOI 10.1212/WNL.0b013e31821810a4; Jouvent E, 2008, BRAIN, V131, P2201, DOI 10.1093/brain/awn129; Karas GB, 2003, NEUROIMAGE, V18, P895, DOI 10.1016/S1053-8119(03)00041-7; King RD, 2010, NEUROIMAGE, V53, P471, DOI 10.1016/j.neuroimage.2010.06.050; Kochunov P, 2005, HUM BRAIN MAPP, V26, P210, DOI 10.1002/hbm.20198; Kochunov P, 2008, HUM BRAIN MAPP, V29, P36, DOI 10.1002/hbm.20369; Kochunov P, 2012, NEUROINFORMATICS, V10, P81, DOI 10.1007/s12021-011-9127-9; Li S, 2008, ACTA RADIOL, V49, P84, DOI 10.1080/02841850701627181; Li SY, 2011, NEUROIMAGE, V58, P381, DOI 10.1016/j.neuroimage.2011.06.041; Li SY, 2010, CEREB CORTEX, V20, P25, DOI 10.1093/cercor/bhp074; Liu T, 2011, NEUROIMAGE, V56, P865, DOI 10.1016/j.neuroimage.2011.03.015; Liu T, 2010, NEUROIMAGE, V51, P19, DOI 10.1016/j.neuroimage.2010.02.016; Mangin JF, 2010, CURR OPIN NEUROL, V23, P359, DOI 10.1097/WCO.0b013e32833a0afc; MANGIN JF, 1995, COMP IMAG VIS, V3, P153; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morrison JH, 2002, PROG BRAIN RES, V136, P467; Penttilae J, 2009, J PSYCHIATR NEUROSCI, V34, P127; Riviere D, 2002, MED IMAGE ANAL, V6, P77, DOI 10.1016/S1361-8415(02)00052-X; Rogan Shannon, 2002, Am J Alzheimers Dis Other Demen, V17, P11, DOI 10.1177/153331750201700106; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Shi F, 2009, HIPPOCAMPUS, V19, P1055, DOI 10.1002/hipo.20573; Sluimer JD, 2008, RADIOLOGY, V248, P590, DOI 10.1148/radiol.2482070938; Thompson PM, 2003, J NEUROSCI, V23, P994; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Welker W., 1988, CEREB CORTEX, V8, P132; Wen W, 2006, NEUROIMAGE, V29, P1031, DOI 10.1016/j.neuroimage.2005.08.057; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112	49	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31083	10.1371/journal.pone.0031083	http://dx.doi.org/10.1371/journal.pone.0031083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363554	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700025
J	Gallardo-Cruz, JA; Meave, JA; Gonzalez, EJ; Lebrija-Trejos, EE; Romero-Romero, MA; Perez-Garcia, EA; Gallardo-Cruz, R; Hernandez-Stefanoni, JL; Martorell, C				Alberto Gallardo-Cruz, J.; Meave, Jorge A.; Gonzalez, Edgar J.; Lebrija-Trejos, Edwin E.; Romero-Romero, Marco A.; Perez-Garcia, Eduardo A.; Gallardo-Cruz, Rodrigo; Luis Hernandez-Stefanoni, Jose; Martorell, Carlos			Predicting Tropical Dry Forest Successional Attributes from Space: Is the Key Hidden in Image Texture?	PLOS ONE			English	Article							SECONDARY FOREST; THEMATIC MAPPER; RAIN-FOREST; LAND-COVER; COUNTRYSIDE BIOGEOGRAPHY; ABOVEGROUND BIOMASS; CROSS-VALIDATION; CARBON STOCKS; VEGETATION; BIODIVERSITY	Biodiversity conservation and ecosystem-service provision will increasingly depend on the existence of secondary vegetation. Our success in achieving these goals will be determined by our ability to accurately estimate the structure and diversity of such communities at broad geographic scales. We examined whether the texture (the spatial variation of the image elements) of very high-resolution satellite imagery can be used for this purpose. In 14 fallows of different ages and one mature forest stand in a seasonally dry tropical forest landscape, we estimated basal area, canopy cover, stem density, species richness, Shannon index, Simpson index, and canopy height. The first six attributes were also estimated for a subset comprising the tallest plants. We calculated 40 texture variables based on the red and the near infrared bands, and EVI and NDVI, and selected the best-fit linear models describing each vegetation attribute based on them. Basal area (R-2 = 0.93), vegetation height and cover (0.89), species richness (0.87), and stand age (0.85) were the best-described attributes by two-variable models. Cross validation showed that these models had a high predictive power, and most estimated vegetation attributes were highly accurate. The success of this simple method (a single image was used and the models were linear and included very few variables) rests on the principle that image texture reflects the internal heterogeneity of successional vegetation at the proper scale. The vegetation attributes best predicted by texture are relevant in the face of two of the gravest threats to biosphere integrity: climate change and biodiversity loss. By providing reliable basal area and fallow-age estimates, image-texture analysis allows for the assessment of carbon sequestration and diversity loss rates. New and exciting research avenues open by simplifying the analysis of the extent and complexity of successional vegetation through the spatial variation of its spectral information.	[Alberto Gallardo-Cruz, J.; Meave, Jorge A.; Gonzalez, Edgar J.; Romero-Romero, Marco A.; Perez-Garcia, Eduardo A.; Gallardo-Cruz, Rodrigo; Martorell, Carlos] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico; [Lebrija-Trejos, Edwin E.] Univ Wageningen & Res Ctr, Forest Ecol & Management Grp, Wageningen, Netherlands; [Luis Hernandez-Stefanoni, Jose] Ctr Invest Cient Yucatan AC, Merida, Yucatan, Mexico; [Lebrija-Trejos, Edwin E.] Tel Aviv Univ, Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel	Universidad Nacional Autonoma de Mexico; Wageningen University & Research; Centro de Investigacion Cientifica de Yucatan; Tel Aviv University	Gallardo-Cruz, JA (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico.	jagc@ciencias.unam.mx	González, Edgar J./AAH-7144-2019; Martorell, Carlos/A-2265-2008; Gallardo-Cruz, José Alberto/AAG-1579-2020; Meave, Jorge/B-3673-2008; Pérez-García, Eduardo/A-6517-2008	González, Edgar J./0000-0001-9113-1070; Martorell, Carlos/0000-0002-0758-3953; Gallardo-Cruz, José Alberto/0000-0002-0509-7003; Meave, Jorge/0000-0002-6241-8803; Hernandez-Stefanoni, Jose Luis/0000-0002-9559-7131; Romero Romero, Marco Antonio/0000-0003-1091-6584; Perez-Garcia, Eduardo A./0000-0002-4136-4500; Lebrija-Trejos, Edwin/0000-0003-1511-1718	CONACyT [CB-2009-01-128136]; PAPIIT [IN221503, IN220027]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This work received funding from CONACyT (www.conacyt.mx; project number: CB-2009-01-128136) and PAPIIT (http://dgapa.unam.mx; projects IN221503 and IN220027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide TM, 2000, RESTOR ECOL, V8, P328, DOI 10.1046/j.1526-100x.2000.80048.x; Gallardo-Cruz J, 2009, LANDSCAPE ECOL, V24, P473, DOI 10.1007/s10980-009-9332-1; [Anonymous], 2010, R LANG ENV STAT COMP; Arroyo-Mora JP, 2005, BIOTROPICA, V37, P497, DOI 10.1111/j.1744-7429.2005.00068.x; Barbier N, 2011, REMOTE SENS ENVIRON, V115, P167, DOI 10.1016/j.rse.2010.08.015; Barbier N, 2010, GLOBAL ECOL BIOGEOGR, V19, P72, DOI 10.1111/j.1466-8238.2009.00493.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Baumann K, 2003, TRAC-TREND ANAL CHEM, V22, P395, DOI 10.1016/S0165-9936(03)00607-1; Belisle M, 2001, ECOLOGY, V82, P1893, DOI 10.1890/0012-9658(2001)082[1893:IOFCOT]2.0.CO;2; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Boyd DS, 2005, PROG PHYS GEOG, V29, P1, DOI 10.1191/0309133305pp432ra; Boyd DS, 1996, INT J REMOTE SENS, V17, P249, DOI 10.1080/01431169608949003; BRANDT J, 1988, J BIOGEOGR, V15, P41, DOI 10.2307/2845044; Brearley FQ, 2004, FOREST ECOL MANAG, V195, P385, DOI 10.1016/j.foreco.2004.02.048; Brienen RJW, 2009, BIOTROPICA, V41, P186, DOI 10.1111/j.1744-7429.2008.00462.x; Brodie J, 2010, NATURE, V468, P634, DOI 10.1038/468634c; Brondizio E, 1996, PHOTOGRAMM ENG REM S, V62, P921; Brown S, 1997, ESTIMATING BIOMASS B; Browne MW, 2000, J MATH PSYCHOL, V44, P108, DOI 10.1006/jmps.1999.1279; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Canadell JG, 2007, TERRESTRIAL ECOSYSTE, P59, DOI [10.1007/978-3-540-32730-1_6, DOI 10.1007/978-3-540-32730-1]; Carreiras JMB, 2006, REMOTE SENS ENVIRON, V101, P283, DOI 10.1016/j.rse.2005.12.017; Castro KL, 2003, INT J REMOTE SENS, V24, P1853, DOI 10.1080/01431160210154056; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Chinea JD, 2003, FOREST ECOL MANAG, V180, P227, DOI 10.1016/S0378-1127(02)00565-0; Couteron P, 2005, J APPL ECOL, V42, P1121, DOI 10.1111/j.1365-2664.2005.01097.x; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Ewel J. J., 1977, Geo-Eco-Trop, V1, P103; Fearnside PM, 2004, ECOL APPL, V14, P982, DOI 10.1890/03-5225; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2007, P NATL ACAD SCI USA, V104, P12585, DOI 10.1073/pnas.0705190104; Foody GM, 2006, ECOL MODEL, V195, P37, DOI 10.1016/j.ecolmodel.2005.11.007; Foody GM, 2001, GLOBAL ECOL BIOGEOGR, V10, P379, DOI 10.1046/j.1466-822X.2001.00248.x; Frazer GW, 2005, FOREST ECOL MANAG, V214, P65, DOI 10.1016/j.foreco.2005.03.056; Fuchs H, 2009, REMOTE SENS ENVIRON, V113, P518, DOI 10.1016/j.rse.2008.07.017; Gao X, 2000, REMOTE SENS ENVIRON, V74, P609, DOI 10.1016/S0034-4257(00)00150-4; Garcia Sevilla P., 2006, IMAGE PROCESSING DEA; Gillespie TW, 2006, GLOBAL ECOL BIOGEOGR, V15, P225, DOI [10.1111/j.1466-8238.2005.00203.x, 10.1111/j.1466-822X.2005.00203.x]; Gould W, 2000, ECOL APPL, V10, P1861, DOI 10.1890/1051-0761(2000)010[1861:RSOVPS]2.0.CO;2; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; Harvey CA, 2006, ECOL APPL, V16, P1986, DOI 10.1890/1051-0761(2006)016[1986:POADID]2.0.CO;2; Hay GJ, 1996, REMOTE SENS ENVIRON, V55, P108, DOI 10.1016/0034-4257(95)00189-1; Helmer EH, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000568; Helmer EH, 2000, INT J REMOTE SENS, V21, P2163, DOI 10.1080/01431160050029495; Helmer EH, 2002, CARIBB J SCI, V38, P165; Helmer EH, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3082116; Hernandez-Stefanoni JL, 2011, ECOL INDIC, DOI [10.1016/j.ecolind.2010.1011.1003, DOI 10.1016/J.ECOLIND.2010.1011.1003]; ITT, 2008, ENVI 4 5 IDL VERS 7; Janzen D, 1998, SCIENCE, V279, P1312, DOI 10.1126/science.279.5355.1312; Jepsen MR, 2006, FOREST ECOL MANAG, V225, P287, DOI 10.1016/j.foreco.2006.01.005; Kalacska M, 2007, REMOTE SENS ENVIRON, V108, P82, DOI 10.1016/j.rse.2006.11.007; Kalacska M, 2004, FOREST ECOL MANAG, V200, P227, DOI 10.1016/j.foreco.2004.07.001; Kenzo T, 2010, FOREST ECOL MANAG, V260, P875, DOI 10.1016/j.foreco.2010.06.006; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kimes DS, 1999, INT J REMOTE SENS, V20, P3625, DOI 10.1080/014311699211246; Krause K., 2005, RADIOMETRIC USE QUIC; Kuplich TM, 2005, INT J REMOTE SENS, V26, P4829, DOI 10.1080/01431160500239107; Laliberte AS, 2004, REMOTE SENS ENVIRON, V93, P198, DOI 10.1016/j.rse.2004.07.011; Lebrija-Trejos E, 2008, BIOTROPICA, V40, P422, DOI 10.1111/j.1744-7429.2008.00398.x; Lebrija-Trejos E, 2011, J TROP ECOL, V27, P477, DOI 10.1017/S0266467411000253; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Lepers E, 2005, BIOSCIENCE, V55, P115, DOI 10.1641/0006-3568(2005)055[0115:ASOIOR]2.0.CO;2; Levin N, 2007, DIVERS DISTRIB, V13, P692, DOI 10.1111/j.1472-4642.2007.00372.x; Liu W, 2008, INT J REMOTE SENS, V29, P3855, DOI 10.1080/01431160701840166; Lu D, 2005, INT J REMOTE SENS, V26, P2509, DOI 10.1080/01431160500142145; Lu DS, 2006, INT J REMOTE SENS, V27, P1297, DOI 10.1080/01431160500486732; LUCAS RM, 1993, INT J REMOTE SENS, V14, P3061, DOI 10.1080/01431169308904419; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Malhi Y, 2008, REMOTE SENS ENVIRON, V112, P2074, DOI 10.1016/j.rse.2008.01.009; Marques MJ, 2007, SCI TOTAL ENVIRON, V378, P161, DOI 10.1016/j.scitotenv.2007.01.043; Marquez J, 2008, TEXTURE CHARACTERIZA; Mausel P., 1993, GEOCARTO INT, V8, P61, DOI [10.1080/10106049309354430., DOI 10.1080/10106049309354430]; Mayfield MM, 2005, ECOL APPL, V15, P423, DOI 10.1890/03-5369; Murray H, 2010, INT J APPL EARTH OBS, V12, P138, DOI 10.1016/j.jag.2010.01.006; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Nelson GC., 2005, ECOSYSTEMS HUMAN WEL, P73; Nelson RF, 2000, BIOSCIENCE, V50, P419, DOI 10.1641/0006-3568(2000)050[0419:SFAATF]2.0.CO;2; Palmer MW, 2002, ENVIRONMETRICS, V13, P121, DOI 10.1002/env.516; Perez-Garcia EA, 2010, FOLIA GEOBOT, V45, P143, DOI 10.1007/s12224-010-9064-7; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Proisy C, 2007, REMOTE SENS ENVIRON, V109, P379, DOI 10.1016/j.rse.2007.01.009; Putz FE, 2001, CONSERV BIOL, V15, P7, DOI 10.1046/j.1523-1739.2001.00018.x; Rhoades CC, 2000, ECOL APPL, V10, P497, DOI 10.1890/1051-0761(2000)010[0497:SCDAFA]2.0.CO;2; Rignot E, 1997, REMOTE SENS ENVIRON, V59, P167, DOI 10.1016/S0034-4257(96)00150-2; Rocchini D, 2004, ACTA OECOL, V26, P117, DOI 10.1016/j.actao.2004.03.008; Rocchini D, 2010, ECOL INFORM, V5, P318, DOI 10.1016/j.ecoinf.2010.06.001; Rocchini D, 2010, INT J REMOTE SENS, V31, P2745, DOI 10.1080/01431160903085651; SADER SA, 1989, REMOTE SENS ENVIRON, V28, P143, DOI 10.1016/0034-4257(89)90112-0; Safriel U., 2005, ECOSYSTEMS HUMAN WEL, P623; Sanchez-Azofeifa GA, 2009, ECOL APPL, V19, P480, DOI 10.1890/08-1149.1; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sarker LR, 2011, REMOTE SENS ENVIRON, V115, P968, DOI 10.1016/j.rse.2010.11.010; Satterthwaite D, 2008, ENVIRON URBAN, V20, P539, DOI 10.1177/0956247808096127; Schowengerdt R. A., 2007, REMOTE SENSING MODEL; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Shevliakova E, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2007GB003176; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; Sohn YS, 1999, PHOTOGRAMM ENG REM S, V65, P947; Song C, 2007, REMOTE SENS ENVIRON, V106, P228, DOI 10.1016/j.rse.2006.08.008; Steininger MK, 2000, INT J REMOTE SENS, V21, P1139, DOI 10.1080/014311600210119; Steininger MK, 1996, INT J REMOTE SENS, V17, P9, DOI 10.1080/01431169608948984; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomson AM, 2010, P NATL ACAD SCI USA, V107, P19633, DOI 10.1073/pnas.0910467107; Tottrup C, 2007, INT J REMOTE SENS, V28, P1263, DOI 10.1080/01431160600928575; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; van Dijk AIJM, 2002, J HYDROL, V261, P1, DOI 10.1016/S0022-1694(02)00020-3; Vieira ICG, 2003, REMOTE SENS ENVIRON, V87, P470, DOI 10.1016/j.rse.2002.09.002; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wijaya A, 2010, FOREST ECOL MANAG, V259, P2315, DOI 10.1016/j.foreco.2010.03.004; Wunderle AL, 2007, INT J REMOTE SENS, V28, P4351, DOI 10.1080/01431160701244849; Yang X, 2010, BIOGEOSCIENCES, V7, P3041, DOI 10.5194/bg-7-3041-2010	117	60	62	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30506	10.1371/journal.pone.0030506	http://dx.doi.org/10.1371/journal.pone.0030506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363443	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500010
J	Fadista, J; Bendixen, C				Fadista, Joao; Bendixen, Christian			Genomic Position Mapping Discrepancies of Commercial SNP Chips	PLOS ONE			English	Article							HIV-1 CONTROL; DETERMINANTS; SEQUENCE	The field of genetics has come to rely heavily on commercial genotyping arrays and accompanying annotations for insights into genotype-phenotype associations. However, in order to avoid errors and false leads, it is imperative that the annotation of SNP chromosomal positions is accurate and unambiguous. We report on genomic positional discrepancies of various SNP chips for human, cattle and mouse species, and discuss their causes and consequences.	[Fadista, Joao] Lund Univ, CRC, Dept Clin Sci Malmo, Malmo, Sweden; [Bendixen, Christian] Aarhus Univ, Fac Sci & Technol, Dept Mol Biol & Genet, Tjele, Denmark	Lund University; Aarhus University	Fadista, J (corresponding author), Lund Univ, CRC, Dept Clin Sci Malmo, Malmo, Sweden.	christian.bendixen@agrsci.dk	Fadista, Joao/AAM-4870-2020	Fadista, Joao/0000-0003-2539-634X; fadista, joao/0000-0001-7558-7043	European Commission [KBBE-2A-222664]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This research paper has been financed by the European Commission, within the 7th Framework Programme, Grant Agreement KBBE-2A-222664 ("Quantomics''). The text represents the authors' views and does not necessarily represent a position of the Commission who will not be liable for the use made of such information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson CA, 2008, AM J HUM GENET, V83, P112, DOI 10.1016/j.ajhg.2008.06.008; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ho MR, 2011, NUCLEIC ACIDS RES, V39, pD920, DOI 10.1093/nar/gkq1197; Luethy Roland, 2004, Biosilico, V2, P12; Macgregor S, 2010, HUM MOL GENET, V19, P2716, DOI 10.1093/hmg/ddq144; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Schmitt AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-80; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	13	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31025	10.1371/journal.pone.0031025	http://dx.doi.org/10.1371/journal.pone.0031025			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363540	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600101
J	Piras, D; Doro, MG; Casu, G; Melis, PM; Vaccargiu, S; Piras, I; Parracciani, D; Stradoni, R; Frongia, B; Lai, G; Sale, S; Cattari, W; Piras, R; Querci, O; Demuro, P; Cui, S; Atzori, F; Mancosu, M; Marchiori, F; Cammelli, R; Spiga, A; Loddo, PP; Pili, G; Boi, R; Argiolas, G; Mereu, P; Leoni, GG; Naitana, S; Pirastu, M; Novelletto, A				Piras, Daniela; Doro, Maria Grazia; Casu, Giuseppina; Melis, Paola Maria; Vaccargiu, Simona; Piras, Ignazio; Parracciani, Debora; Stradoni, Roberta; Frongia, Bruno; Lai, Graziano; Sale, Salvatore; Cattari, Walter; Piras, Roberto; Querci, Ombretta; Demuro, Piergiorgio; Cui, Sandro; Atzori, Franco; Mancosu, Marco; Marchiori, Francesca; Cammelli, Rossana; Spiga, Alessandra; Loddo, Pier Paolo; Pili, Gianfranco; Boi, Roberto; Argiolas, Giuseppe; Mereu, Paolo; Leoni, Giovanni Giuseppe; Naitana, Salvatore; Pirastu, Mario; Novelletto, Andrea			Haplotype Affinities Resolve a Major Component of Goat (Capra hircus) MtDNA D-Loop Diversity and Reveal Specific Features of the Sardinian Stock	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATION-GENETICS; BREEDS; DNA; EVOLUTION; LINEAGES; SOFTWARE; MUTATION; ANIMALS; ORIGIN	Goat mtDNA haplogroup A is a poorly resolved lineage absorbing most of the overall diversity and is found in locations as distant as Eastern Asia and Southern Africa. Its phylogenetic dissection would cast light on an important portion of the spread of goat breeding. The aims of this work were 1) to provide an operational definition of meaningful mtDNA units within haplogroup A, 2) to investigate the mechanisms underlying the maintenance of diversity by considering the modes of selection operated by breeders and 3) to identify the peculiarities of Sardinian mtDNA types. We sequenced the mtDNA D-loop in a large sample of animals (1,591) which represents a non-trivial quota of the entire goat population of Sardinia. We found that Sardinia mirrors a large quota of mtDNA diversity of Western Eurasia in the number of variable sites, their mutational pattern and allele frequency. By using Bayesian analysis, a distance-based tree and a network analysis, we recognized demographically coherent groups of sequences identified by particular subsets of the variable positions. The results showed that this assignment system could be reproduced in other studies, capturing the greatest part of haplotype diversity. We identified haplotype groups overrepresented in Sardinian goats as a result of founder effects. We found that breeders maintain diversity of matrilines most likely through equalization of the reproductive potential. Moreover, the relevant amount of inter-farm mtDNA diversity found does not increase proportionally with distance. Our results illustrate the effects of breeding practices on the composition of maternal gene pool and identify mtDNA types that may be considered in projects aimed at retrieving the maternal component of the oldest breeds of Sardinia.	[Piras, Daniela; Doro, Maria Grazia; Casu, Giuseppina; Melis, Paola Maria; Vaccargiu, Simona; Pirastu, Mario] CNR, Inst Populat Genet, Sassari, Italy; [Piras, Ignazio] Shardna Life Sci, Cagliari, Italy; [Parracciani, Debora; Stradoni, Roberta; Frongia, Bruno; Lai, Graziano; Pirastu, Mario] Genet Pk Ogliastra, Perdasdefogu, Italy; [Sale, Salvatore; Cattari, Walter; Piras, Roberto; Querci, Ombretta; Demuro, Piergiorgio; Cui, Sandro; Atzori, Franco; Mancosu, Marco; Marchiori, Francesca; Cammelli, Rossana; Spiga, Alessandra; Loddo, Pier Paolo; Pili, Gianfranco; Boi, Roberto; Argiolas, Giuseppe] Reg Assoc Sardinian Farmers, ARAS, Cagliari, Italy; [Mereu, Paolo] Univ Sassari, Dept Physiol Biochem & Cell Sci, I-07100 Sassari, Italy; [Leoni, Giovanni Giuseppe; Naitana, Salvatore] Univ Sassari, Fac Vet Sci, I-07100 Sassari, Italy; [Novelletto, Andrea] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Sassari; University of Sassari; University of Rome Tor Vergata	Piras, D (corresponding author), CNR, Inst Populat Genet, Sassari, Italy.	novelletto@bio.uniroma2.it	doro, maria grazia/AAX-8971-2020; Mereu, Paolo/AAE-7100-2019	Mereu, Paolo/0000-0001-6615-4828; Novelletto, Andrea/0000-0002-1146-7680; Piras, Ignazio/0000-0003-4024-3368	Sardinia Region (P.O.R. Sardegna); MIUR	Sardinia Region (P.O.R. Sardegna); MIUR(Ministry of Education, Universities and Research (MIUR))	Work supported by Sardinia Region (P.O.R. Sardegna 2000/2006, Asse 3 - Risorse Umane "Progetti di ricerca e innovazione al di sotto della soglia DE MINIMIS") http://www.regione.sardegna.it/regione/programmazione_europea/2000-2006/por/ and PRIN-MIUR 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti F, 1980, RIV SCI PREISTORICHE, V35, P75; Ajmone-Marsan P, 2002, ANIM GENET, V33, P280, DOI 10.1046/j.1365-2052.2002.00865.x; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berthouly C, 2009, MOL ECOL, V18, P3980, DOI 10.1111/j.1365-294X.2009.04342.x; Brandano P, 1978, ANN FAC AGR SASSARI, V26, P232; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Carenti G, 2006, INT J ARCHAEOLOGY, V4, P17; Cetti F, 1774, 1 QUADRUPEDI SARDEGN; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Dubeuf JP, 2009, LIVEST SCI, V120, P225, DOI 10.1016/j.livsci.2008.07.005; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez H, 2006, P NATL ACAD SCI USA, V103, P15375, DOI 10.1073/pnas.0602753103; Forster P, 1996, AM J HUM GENET, V59, P935; Frankham R., 2002, INTRO CONSERVATION G; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hassanin A, 2010, MITOCHONDR DNA, V21, P68, DOI 10.3109/19401736.2010.490583; Hedrick P, 2001, EUR J HUM GENET, V9, P969, DOI 10.1038/sj.ejhg.5200735; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iamartino D, 2005, SMALL RUMINANT RES, V57, P249, DOI 10.1016/j.smallrumres.2004.08.003; ISTAT, 2000, PLAN 5 AGR CENS IT; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Levine M., 1983, GROTTA FILIESTRU BON; Liu Ruo-Yu, 2006, Acta Genetica Sinica, V33, P420, DOI 10.1016/S0379-4172(06)60069-3; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Malone C, 2003, J WORLD PREHIST, V17, P235, DOI 10.1023/B:JOWO.0000012729.36053.42; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Mirkena T, 2010, LIVEST SCI, V132, P1, DOI 10.1016/j.livsci.2010.05.003; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Noe L., 2005, RAZZE CAPRINE ITALIA, P381; Ollivier L, 2002, 53 ANN M EUR ASS AN; Pariset Lorraine, 2009, BMC Ecology, V9, P20, DOI 10.1186/1472-6785-9-20; Pereira F, 2005, MOL ECOL, V14, P2313, DOI 10.1111/j.1365-294X.2005.02594.x; Pereira F, 2009, MOL BIOL EVOL, V26, P2765, DOI 10.1093/molbev/msp200; Rischkowsky B, 2007, STAT WORLDS AN GEN R; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowley-Conwy P, 2011, CURR ANTHROPOL S, VS4, pS000; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sechi T, 2007, ANIM GENET, V38, P614, DOI 10.1111/j.1365-2052.2007.01655.x; Sechi T, 2005, ITAL J ANIM SCI, V4, P58; Simianer H, 2005, ECOL ECON, V53, P559, DOI 10.1016/j.ecolecon.2004.11.016; Vacca GM, 2010, J ANIM BREED GENET, V127, P352, DOI 10.1111/j.1439-0388.2010.00863.x; Wang J, 2008, SMALL RUMINANT RES, V74, P231, DOI 10.1016/j.smallrumres.2007.03.007; Wilkens B, 2003, INT J ARCHEOLOGY I 2, V1, P181; Wu YP, 2009, ANIM SCI J, V80, P372, DOI 10.1111/j.1740-0929.2009.00659.x; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0	53	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30785	10.1371/journal.pone.0030785	http://dx.doi.org/10.1371/journal.pone.0030785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363488	gold, Green Submitted, Green Published			2022-12-25	WOS:000302853600068
J	Czech, C; Berndt, P; Busch, K; Schmitz, O; Wiemer, J; Most, V; Hampel, H; Kastler, J; Senn, H				Czech, Christian; Berndt, Peter; Busch, Kristina; Schmitz, Oliver; Wiemer, Jan; Most, Veronique; Hampel, Harald; Kastler, Juergen; Senn, Hans			Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid	PLOS ONE			English	Article							SENILE DEMENTIA; CSF; CORTISOL; NOREPINEPHRINE; HOMOCYSTEINE; DIAGNOSTICS; DYSFUNCTION; BIOMARKERS; DISCOVERY; MARKERS	Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive loss of cognitive functions. Today the diagnosis of AD relies on clinical evaluations and is only late in the disease. Biomarkers for early detection of the underlying neuropathological changes are still lacking and the biochemical pathways leading to the disease are still not completely understood. The aim of this study was to identify the metabolic changes resulting from the disease phenotype by a thorough and systematic metabolite profiling approach. For this purpose CSF samples from 79 AD patients and 51 healthy controls were analyzed by gas and liquid chromatography-tandem mass spectrometry (GC-MS and LC-MS/MS) in conjunction with univariate and multivariate statistical analyses. In total 343 different analytes have been identified. Significant changes in the metabolite profile of AD patients compared to healthy controls have been identified. Increased cortisol levels seemed to be related to the progression of AD and have been detected in more severe forms of AD. Increased cysteine associated with decreased uridine was the best paired combination to identify light AD (MMSE>22) with specificity and sensitivity above 75%. In this group of patients, sensitivity and specificity above 80% were obtained for several combinations of three to five metabolites, including cortisol and various amino acids, in addition to cysteine and uridine.	[Czech, Christian; Berndt, Peter; Senn, Hans] F Hoffmann La Roche, Div Pharmaceut, Basel, Switzerland; [Busch, Kristina] Badisch Anylene & Soda Fabriques BASF SE, Limburgerhof, Germany; [Schmitz, Oliver; Wiemer, Jan; Kastler, Juergen] Metanomics, Berlin, Germany; [Hampel, Harald] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Most, Veronique] Forenap Pharma, Rouffach, France	Roche Holding; BASF; Goethe University Frankfurt	Czech, C (corresponding author), F Hoffmann La Roche, Div Pharmaceut, Basel, Switzerland.	christian.czech@roche.com		Hampel, Harald/0000-0003-0894-8982; Czech, Christian/0000-0001-7746-0134	F. Hoffman-La Roche	F. Hoffman-La Roche	This study was supported by F. Hoffman-La Roche. CC, HS, and PB are employees of F. Hoffmann-La Roche. KB, OS, JW and JK were employed by metanomics during the time of the study, all these authors contributed to all aspects of the study. The funders had no role in data collection. The funders of the study had a role in study design, data analysis, decision to publish, and preparation of the manuscript.	BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BEAL MF, 1986, PROG NEURO-PSYCHOPH, V10, P259, DOI 10.1016/0278-5846(86)90006-0; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; BONDAREFF W, 1982, NEUROLOGY, V32, P164, DOI 10.1212/WNL.32.2.164; Choi YS, 2010, EXPERT REV PROTEOMIC, V7, P919, DOI 10.1586/EPR.10.75; Cummings JL, 2002, JAMA-J AM MED ASSOC, V287, P2335, DOI 10.1001/jama.287.18.2335; Czech Christian, 2004, Current Neuropharmacology, V2, P295, DOI 10.2174/1570159043359666; DAVIS KL, 1986, AM J PSYCHIAT, V143, P300; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Elrod R, 1997, AM J PSYCHIAT, V154, P25; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Laske C, 2009, EUR ARCH PSY CLIN N, V259, P80, DOI 10.1007/s00406-008-0838-3; Lerner Alan J., 2000, Journal of Alzheimer's Disease, V2, P193; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McCaddon A, 2003, BIOL PSYCHIAT, V53, P254, DOI 10.1016/S0006-3223(02)01451-8; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Murray IVJ, 2011, EXP BIOL MED, V236, P772, DOI 10.1258/ebm.2011.010355; Otto M, 2008, METHODS, V44, P289, DOI 10.1016/j.ymeth.2007.06.012; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Popp J, 2009, J ALZHEIMERS DIS, V18, P819, DOI 10.3233/JAD-2009-1187; Popp J, 2009, NEUROBIOL AGING, V30, P498, DOI 10.1016/j.neurobiolaging.2007.07.007; R Core Team, 2022, R LANG ENV STAT COMP; REINIKAINEN KJ, 1990, J NEUROSCI RES, V27, P576, DOI 10.1002/jnr.490270419; REINIKAINEN KJ, 1988, NEUROBIOL AGING, V9, P245, DOI 10.1016/S0197-4580(88)80061-7; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2; Schlotterbeck G, 2006, PHARMACOGENOMICS, V7, P1055, DOI 10.2217/14622416.7.7.1055; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; SWEATMAN BC, 1993, J PHARMACEUT BIOMED, V11, P651, DOI 10.1016/0731-7085(93)80171-V; TOHGI H, 1992, J NEURAL TRANSM-PARK, V4, P69, DOI 10.1007/BF02257623; TOHGI H, 1994, NEUROSCI LETT, V177, P139, DOI 10.1016/0304-3940(94)90064-7; van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021; Vogel T, 2009, INT J CLIN PRACT, V63, P1061, DOI 10.1111/j.1742-1241.2009.02026.x; Watson GS, 2006, NEUROBIOL AGING, V27, P38, DOI 10.1016/j.neurobiolaging.2004.11.011; Wurtman RJ, 2010, NUTR REV, V68, pS88, DOI 10.1111/j.1753-4887.2010.00344.x; Yamada H, 2002, J ANAL TOXICOL, V26, P17, DOI 10.1093/jat/26.1.17; ZWEIG MH, 1993, CLIN CHEM, V39, P561	37	126	128	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31501	10.1371/journal.pone.0031501	http://dx.doi.org/10.1371/journal.pone.0031501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359596	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200065
J	Linnertz, C; Saunders, AM; Lutz, MW; Crenshaw, DM; Grossman, I; Burns, DK; Whitfield, KE; Hauser, MA; McCarthy, JJ; Ulmer, M; Allingham, R; Welsh-Bohmer, KA; Roses, AD; Chiba-Falek, O				Linnertz, Colton; Saunders, Ann M.; Lutz, Michael W.; Crenshaw, Donna M.; Grossman, Iris; Burns, Daniel K.; Whitfield, Keith E.; Hauser, Michael A.; McCarthy, Jeanette J.; Ulmer, Megan; Allingham, Rand; Welsh-Bohmer, Kathleen A.; Roses, Allen D.; Chiba-Falek, Ornit			Characterization of the Poly-T Variant in the TOMM40 Gene in Diverse Populations	PLOS ONE			English	Article							LENGTH; ONSET; AGE	We previously discovered that a polymorphic, deoxythymidine-homopolymer (poly-T, rs10524523) in intron 6 of the TOMM40 gene is associated with age-of-onset of Alzheimer's disease and with cognitive performance in elderly. Three allele groups were defined for rs10524523, hereafter '523', based on the number of 'T'-residues: 'Short' (S, T <= 19), 'Long' (L, 20 <= T <= 29) and 'Very Long' (VL, T >= 30). Homopolymers, particularly long homopolymers like '523', are difficult to genotype because 'slippage' occurs during PCR-amplification. We initially genotyped this locus by PCR-amplification followed by Sanger-sequencing. However, we recognized the need to develop a higher-throughput genotyping method that is also accurate and reliable. Here we describe a new '523' genotyping assay that is simple and inexpensive to perform in a standard molecular genetics laboratory. The assay is based on the detection of differences in PCR-fragment length using capillary electrophoresis. We discuss technical problems, solutions, and the steps taken for validation. We employed the novel assay to investigate the '523' allele frequencies in different ethnicities. Whites and Hispanics have similar frequencies of S/L/VL alleles (0.45/0.11/0.44 and 0.43/0.09/0.48, respectively). In African-Americans, the frequency of the L-allele (0.10) is similar to Whites and Hispanics; however, the S-allele is more prevalent (0.65) and the VL-allele is concomitantly less frequent (0.25). The allele frequencies determined using the new methodology are compared to previous reports for Ghanaian, Japanese, Korean and Han Chinese cohorts. Finally, we studied the linkage pattern between TOMM40-'523' and APOE alleles. In Whites and Hispanics, consistent with previous reports, the L is primarily linked to epsilon 4, while the majority of the VL and S are linked to epsilon 3. Interestingly, in African-Americans, Ghanaians and Japanese, there is an increased frequency of the '523'S-APOE epsilon 4 haplotype. These data may be used as references for '523' allele and '523'-APOE haplotype frequencies in diverse populations for the design of research studies and clinical trials.	[Linnertz, Colton; McCarthy, Jeanette J.; Roses, Allen D.; Chiba-Falek, Ornit] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27706 USA; [Saunders, Ann M.; Lutz, Michael W.; Crenshaw, Donna M.; Roses, Allen D.] Duke Univ, Med Ctr, Deane Drug Discovery Inst, Durham, NC USA; [Saunders, Ann M.; Roses, Allen D.; Chiba-Falek, Ornit] Duke Univ, Med Ctr, Dept Med, Div Neurol, Durham, NC 27710 USA; [Grossman, Iris; Burns, Daniel K.] Cabernet Pharmaceut, Chapel Hill, NC USA; [Whitfield, Keith E.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Hauser, Michael A.; Ulmer, Megan] Duke Univ, Ctr Human Genet, Med Ctr, Durham, NC USA; [Allingham, Rand] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Welsh-Bohmer, Kathleen A.; Roses, Allen D.; Chiba-Falek, Ornit] Duke Univ, Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC USA; [Welsh-Bohmer, Kathleen A.] Duke Univ, Dept Psychiat & Behav Sci, Med Ctr, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Linnertz, C (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27706 USA.	o.chibafalek@duke.edu	Welsh-Bohmer, Kathleen/AAA-3178-2020	Carnes, Megan/0000-0002-7270-132X; Lutz, Michael/0000-0001-8809-5574	Ellison Medical Foundation [AG-NS-0441-08]; National Institute on Aging [1RC1AG035635-01]; NATIONAL INSTITUTE ON AGING [RC1AG035635] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by the Ellison Medical Foundation New Scholar award AG-NS-0441-08 (to OC-F). ADR and MWL are supported in part by National Institute on Aging Research Challenge Grant 1RC1AG035635-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caselli RJ, 2010, ALZHEIMERS DEMENT, V6, pS202; Chu SH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.016; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155; Grossman I, 2010, EPMA J, V1, P293, DOI 10.1007/s13167-010-0024-3; Johnson SC, 2011, ALZHEIMERS DEMENT, V7, P456, DOI 10.1016/j.jalz.2010.11.012; Koch W, 2002, CLIN CHEM LAB MED, V40, P1123, DOI 10.1515/CCLM.2002.197; Lutz MW, 2010, ALZHEIMERS DEMENT, V6, P125, DOI 10.1016/j.jalz.2010.01.011; Lutz MW, 2010, ANN M AM SOC HUM GEN; Maruszak A, 2011, J ALZHEIMERS DIS; Nelson Tamara, 2007, Metabolic Syndrome and Related Disorders, V5, P262, DOI 10.1089/met.2006.0035; Roses A, 2011, COMMENT ASS EXPRESSI; Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69	12	41	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30994	10.1371/journal.pone.0030994	http://dx.doi.org/10.1371/journal.pone.0030994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359560	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200029
J	Tian, LL; Karimi, M; Loftin, SK; Brown, CA; Xia, HC; Xu, JB; Mach, RH; Perlmutter, JS				Tian, LinLin; Karimi, Morvarid; Loftin, Susan K.; Brown, Chris A.; Xia, HuChuan; Xu, JinBin; Mach, Robert H.; Perlmutter, Joel S.			No Differential Regulation of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter 2 (VMAT2) Binding in a Primate Model of Parkinson Disease	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MONKEY BRAIN; PATHOLOGICAL RESEARCH; STRIATAL DOPAMINE; NONHUMAN-PRIMATES; NERVE-TERMINALS; H-3 CFT; MPTP; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; MARKERS	Radioligands for DAT and VMAT2 are widely used presynaptic markers for assessing dopamine (DA) nerve terminals in Parkinson disease (PD). Previous in vivo imaging and postmortem studies suggest that these transporter sites may be regulated as the numbers of nigrostriatal neurons change in pathologic conditions. To investigate this issue, we used in vitro quantitative autoradioradiography to measure striatal DAT and VMAT2 specific binding in postmortem brain from 14 monkeys after unilateral internal carotid artery infusion of 1-Methyl-4-Phenyl-1,2,3,6-tetrahydropyridine (MPTP) with doses varying from 0 to 0.31 mg/kg. Quantitative estimates of the number of tyrosine hydroxylase (TH)-immunoreactive (ir) neurons in substantia nigra (SN) were determined with unbiased stereology, and quantitative autoradiography was used to measure DAT and VMAT2 striatal specific binding. Striatal VMAT2 and DAT binding correlated with striatal DA (r(s) = 0.83, r(s) = 0.80, respectively, both with n = 14, p < 0.001) but only with nigra TH-ir cells when nigral cell loss was 50% or less (r = 0.93, n = 8, p = 0.001 and r = 0.91, n = 8, p = 0.002 respectively). Reduction of VMAT2 and DAT striatal specific binding sites strongly correlated with each other (r = 0.93, n = 14, p < 0.0005). These similar changes in DAT and VMAT2 binding sites in the striatal terminal fields of the surviving nigrostriatal neurons demonstrate that there is no differential regulation of these two sites at 2 months after MPTP infusion.	[Tian, LinLin; Karimi, Morvarid; Loftin, Susan K.; Brown, Chris A.; Xia, HuChuan; Perlmutter, Joel S.] Washington Univ, Dept Neurol, St Louis, MO 63130 USA; [Xu, JinBin; Mach, Robert H.; Perlmutter, Joel S.] Washington Univ, Dept Radiol, St Louis, MO USA; [Perlmutter, Joel S.] Washington Univ, Dept Neurobiol, St Louis, MO USA; [Perlmutter, Joel S.] Washington Univ, Dept Occupat Therapy, St Louis, MO USA; [Perlmutter, Joel S.] Washington Univ, Dept Phys Therapy, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Tian, LL (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63130 USA.	joel@npg.wustl.edu	Xu, Jinbin/ABG-1280-2020; Brown, Christopher/AAZ-6852-2021; Tian, LinLin/A-5861-2012	Xu, Jinbin/0000-0002-2120-8287; Brown, Christopher/0000-0003-2057-3976; Tian, LinLin/0000-0001-9504-1718; Mach, Robert/0000-0002-7645-2869	National Institutes of Health [NS050425, NS058714, NS41509, NS075321]; Michael J. Fox Foundation; American Parkinson Disease Association (APDA) Center for Advanced PD Research at Washington University; Greater St. Louis Chapter of the APDA; McDonnell Center for Higher Brain Function; Howard Hughes Medical Institute; Barnes-Jewish Hospital Foundation; Murphy Fund; Hartke Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075321, R03NS090214, R01NS058714, R01NS050425, R01NS041509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; American Parkinson Disease Association (APDA) Center for Advanced PD Research at Washington University; Greater St. Louis Chapter of the APDA; McDonnell Center for Higher Brain Function; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Barnes-Jewish Hospital Foundation; Murphy Fund; Hartke Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institutes of Health (NS050425, NS058714, NS41509, and NS075321) (http://www.nih.gov/); the Michael J. Fox Foundation (http://www.michaeljfox.org/); the American Parkinson Disease Association (APDA) Center for Advanced PD Research at Washington University (http://stlapda.org/); the Greater St. Louis Chapter of the APDA (http://stlapda.org/); the McDonnell Center for Higher Brain Function (http://centerserv.wustl.edu/funding/); the Howard Hughes Medical Institute (http://www.hhmi.org/); the Barnes-Jewish Hospital Foundation Elliot H. Stein Family Fund and PD Research Fund (http://www.barnesjewish.org/giving/about-us); the Murphy Fund; the Hartke Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdipranoto A, 2008, CNS NEUROL DISORD-DR, V7, P187, DOI 10.2174/187152708784083858; ALBANESE A, 1993, NEUROSCIENCE, V55, P823, DOI 10.1016/0306-4522(93)90444-K; BANKIEWICZ KS, 1986, LIFE SCI, V39, P7, DOI 10.1016/0024-3205(86)90431-5; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Bezard E, 1999, EXP NEUROL, V155, P268, DOI 10.1006/exnr.1998.6995; Bezard E, 2006, NEUROBIOL DIS, V23, P77, DOI 10.1016/j.nbd.2006.02.003; Bohnen NI, 2006, J CEREBR BLOOD F MET, V26, P1198, DOI 10.1038/sj.jcbfm.9600276; Buchert R, 2003, J CEREBR BLOOD F MET, V23, P612, DOI 10.1097/01.WCB.0000060565.21994.07; Burke RE, 2008, J NEUROCHEM, V104, P875, DOI 10.1111/j.1471-4159.2007.05106.x; CANFIELD DR, 1990, SYNAPSE, V6, P189, DOI 10.1002/syn.890060211; CARLSSON A, 1976, J NEURAL TRANSM, V38, P271, DOI 10.1007/BF01249444; Chen MK, 2008, J NEUROCHEM, V105, P78, DOI 10.1111/j.1471-4159.2007.05108.x; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de la Fuente-Fernandez R, 2011, ANN NEUROL, V69, P803, DOI 10.1002/ana.22284; De La Garza R, 1999, SYNAPSE, V34, P20, DOI 10.1002/(SICI)1098-2396(199910)34:1<20::AID-SYN3>3.3.CO;2-W; Doudet DJ, 2006, NEUROIMAGE, V30, P26, DOI 10.1016/j.neuroimage.2005.09.044; Frey K, 1997, EUR J PHARMACOL, V334, P273, DOI 10.1016/S0014-2999(97)01152-7; Gerlach M, 1996, J NEURAL TRANSM, V103, P987, DOI 10.1007/BF01291788; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; HERKENHAM M, 1991, NEUROSCIENCE, V40, P133, DOI 10.1016/0306-4522(91)90180-V; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Ichise M, 2002, J CEREBR BLOOD F MET, V22, P1271, DOI 10.1097/01.WCB.0000038000.34930.4E; Jakowec MW, 2004, COMPARATIVE MED, V54, P497; Jourdain S, 2005, J NEUROENDOCRINOL, V17, P509, DOI 10.1111/j.1365-2826.2005.01337.x; Karimi M, 2006, J CHROMATOGR B, V836, P120, DOI 10.1016/j.jchromb.2006.03.027; KAUFMAN MJ, 1991, SYNAPSE, V9, P177, DOI 10.1002/syn.890090304; KILBOURN M, 1995, EUR J PHARMACOL, V278, P249, DOI 10.1016/0014-2999(95)00162-E; Kilbourn MR, 2000, SYNAPSE, V35, P250, DOI 10.1002/(SICI)1098-2396(20000315)35:4<250::AID-SYN2>3.0.CO;2-S; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Kumar N, 2009, ANAT REC, V292, P976, DOI 10.1002/ar.20891; Lee CS, 2000, ANN NEUROL, V47, P493, DOI 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4; Nelson RJ, 2005, ILAR J, V46, P171, DOI 10.1093/ilar.46.2.171; Perlmutter JS, 1997, NEUROLOGY, V49, P1432, DOI 10.1212/WNL.49.5.1432; Przedborski S, 2000, RESTOR NEUROL NEUROS, V16, P135; Ribeiro MJ, 2002, ARCH NEUROL-CHICAGO, V59, P580, DOI 10.1001/archneur.59.4.580; SCHERMAN D, 1988, J NEUROCHEM, V50, P1131, DOI 10.1111/j.1471-4159.1988.tb10583.x; SHAPIRO SS, 1968, J AM STAT ASSOC, V63, P1343, DOI 10.2307/2285889; Slifstein M, 2000, J NUCL MED, V41, P2083; SLOVITER RS, 1977, J NEUROCHEM, V28, P1129, DOI 10.1111/j.1471-4159.1977.tb10678.x; Soucy JP, 1997, SYNAPSE, V25, P163, DOI 10.1002/(SICI)1098-2396(199702)25:2<163::AID-SYN7>3.0.CO;2-A; Stephenson DT, 2007, CELL TRANSPLANT, V16, P229, DOI 10.3727/000000007783464704; Tabbal SD, 2006, NEUROSCIENCE, V141, P1281, DOI 10.1016/j.neuroscience.2006.04.072; Tedroff J, 1999, ANN NEUROL, V46, P359; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; Wilson JM, 1996, NEUROLOGY, V47, P718, DOI 10.1212/WNL.47.3.718; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Xu JB, 2010, SYNAPSE, V64, P449, DOI 10.1002/syn.20748; Yee RE, 2001, MOVEMENT DISORD, V16, P838, DOI 10.1002/mds.1168	50	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31439	10.1371/journal.pone.0031439	http://dx.doi.org/10.1371/journal.pone.0031439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359591	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200060
J	Zhou, HW; DeLoid, G; Browning, E; Gregory, DJ; Tan, FX; Bedugnis, AS; Imrich, A; Koziel, H; Kramnik, I; Lu, Q; Kobzik, L				Zhou, Hongwei; DeLoid, Glen; Browning, Erica; Gregory, David J.; Tan, Fengxiao; Bedugnis, Alice S.; Imrich, Amy; Koziel, Henry; Kramnik, Igor; Lu, Quan; Kobzik, Lester			Genome-Wide RNAi Screen in IFN-gamma-Treated Human Macrophages Identifies Genes Mediating Resistance to the Intracellular Pathogen Francisella tularensis	PLOS ONE			English	Article							CD137 INDUCES PROLIFERATION; INNATE IMMUNE RECOGNITION; LIVE VACCINE STRAIN; REACTIVE NITROGEN; TULAREMIA VACCINE; GROWTH; ACTIVATION; INFECTION; SURVIVAL; CELLS	Interferon-gamma (IFN-gamma) inhibits intracellular replication of Francisella tularensis in human monocyte-derived macrophages (HMDM) and in mice, but the mechanisms of this protective effect are poorly characterized. We used genome-wide RNA interference (RNAi) screening in the human macrophage cell line THP-1 to identify genes that mediate the beneficial effects of IFN-gamma on F. tularensis infection. A primary screen identified similar to 200 replicated candidate genes. These were prioritized according to mRNA expression in IFN-gamma-primed and F. tularensis-challenged macrophages. A panel of 20 top hits was further assessed by re-testing using individual shRNAs or siRNAs in THP-1 cells, HMDMs and primary human lung macrophages. Six of eight validated genes tested were also found to confer resistance to Listeria monocytogenes infection, suggesting a broadly shared host gene program for intracellular pathogens. The F. tularensis-validated hits included 'druggable' targets such as TNFRSF9, which encodes CD137. Treating HMDM with a blocking antibody to CD137 confirmed a beneficial role of CD137 in macrophage clearance of F. tularensis. These studies reveal a number of important mediators of IFN-gamma activated host defense against intracellular pathogens, and implicate CD137 as a potential therapeutic target and regulator of macrophage interactions with Francisella tularensis.	[Zhou, Hongwei; DeLoid, Glen; Browning, Erica; Gregory, David J.; Tan, Fengxiao; Bedugnis, Alice S.; Imrich, Amy; Lu, Quan; Kobzik, Lester] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Koziel, Henry] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02115 USA; [Kramnik, Igor] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Kobzik, Lester] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zhou, HW (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	lkobzik@hsph.harvard.edu	Gregory, David/P-2582-2015	Gregory, David/0000-0001-6534-7150; Kramnik, Igor/0000-0001-6511-9246	Defense Threat Reduction Agency [HDTRA-1-06-C-0036]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by Defense Threat Reduction Agency HDTRA-1-06-C-0036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY LSD, 1992, J IMMUNOL, V148, P1829; ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Ascierto PA, 2010, SEMIN ONCOL, V37, P508, DOI 10.1053/j.seminoncol.2010.09.008; Balagopal A, 2006, INFECT IMMUN, V74, P5114, DOI 10.1128/IAI.00795-06; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Chiu HC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-110; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Conlan JW, 2002, MICROB PATHOGENESIS, V32, P127, DOI 10.1006/mpat.2001.0489; Coyne CB, 2011, CELL HOST MICROBE, V9, P70, DOI 10.1016/j.chom.2011.01.001; Cremer TJ, 2009, AUTOPHAGY, V5, P125, DOI 10.4161/auto.5.1.7305; DeLoid GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006209; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DiSepio D, 1998, P NATL ACAD SCI USA, V95, P14811, DOI 10.1073/pnas.95.25.14811; Edwards JA, 2010, MICROBIOL-SGM, V156, P327, DOI 10.1099/mic.0.031716-0; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Ghigo E, 2002, J IMMUNOL, V169, P4488, DOI 10.4049/jimmunol.169.8.4488; Jiang DS, 2008, J IMMUNOL, V181, P3923, DOI 10.4049/jimmunol.181.6.3923; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Jones JW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00016; Langstein J, 1999, BLOOD, V94, P3161, DOI 10.1182/blood.V94.9.3161.421k31_3161_3168; Langstein J, 1999, J LEUKOCYTE BIOL, V65, P829, DOI 10.1002/jlb.65.6.829; Langstein J, 1998, J IMMUNOL, V160, P2488; Lindgren H, 2005, MICROBES INFECT, V7, P467, DOI 10.1016/j.micinf.2004.11.020; Lindgren H, 2004, INFECT IMMUN, V72, P7172, DOI 10.1128/IAI.72.12.7172-7182.2004; Lindsay MA, 2003, NAT REV DRUG DISCOV, V2, P831, DOI 10.1038/nrd1202; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; NUTTER JE, 1966, J BACTERIOL, V92, P645, DOI 10.1128/JB.92.3.645-651.1966; Ouadrhiri Y, 1999, ANTIMICROB AGENTS CH, V43, P1242, DOI 10.1128/AAC.43.5.1242; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; POLSINELLI T, 1994, J IMMUNOL, V153, P1238; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Santic M, 2005, TRENDS MICROBIOL; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; Schwarz H, 2005, J LEUKOCYTE BIOL, V77, P281, DOI 10.1189/jlb.0904558; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Sulahian TH, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-59; Theus SA, 2004, INFECT IMMUN, V72, P1169, DOI 10.1128/IAI.72.2.1169-1173.2004; Titball RW, 2003, TRENDS MICROBIOL, V11, P118, DOI 10.1016/S0966-842X(03)00020-9; Verkman AS, 2006, CURR PHARM DESIGN, V12, P2235, DOI 10.2174/138161206777585148; Yang IV, 2011, MOL IMMUNOL	41	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31752	10.1371/journal.pone.0031752	http://dx.doi.org/10.1371/journal.pone.0031752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359626	Green Published, gold			2022-12-25	WOS:000302796200095
J	Mistlberger, RE; Kent, BA; Chan, S; Patton, DF; Weinberg, A; Parfyonov, M				Mistlberger, Ralph E.; Kent, Brianne A.; Chan, Sofina; Patton, Danica F.; Weinberg, Alexander; Parfyonov, Maksim			Circadian Clocks for All Meal-Times: Anticipation of 2 Daily Meals in Rats	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEI; GARDEN WARBLERS; FOOD ACCESS; OSCILLATORS; RHYTHMS; DISSOCIATION; ENTRAINMENT; EXPRESSION; PACEMAKER; INTACT	Anticipation of a daily meal in rats has been conceptualized as a rest-activity rhythm driven by a food-entrained circadian oscillator separate from the pacemaker generating light-dark (LD) entrained rhythms. Rats can also anticipate two daily mealtimes, but whether this involves independently entrained oscillators, one 'continuously consulted' clock, cue-dependent non-circadian interval timing or a combination of processes, is unclear. Rats received two daily meals, beginning 3-h (meal 1) and 13-h (meal 2) after lights-on (LD 14: 10). Anticipatory wheel running began 68 +/- 8 min prior to meal 1 and 101 +/- 9 min prior to meal 2 but neither the duration nor the variability of anticipation bout lengths exhibited the scalar property, a hallmark of interval timing. Meal omission tests in LD and constant dark (DD) did not alter the timing of either bout of anticipation, and anticipation of meal 2 was not altered by a 3-h advance of meal 1. Food anticipatory running in this 2-meal protocol thus does not exhibit properties of interval timing despite the availability of external time cues in LD. Across all days, the two bouts of anticipation were uncorrelated, a result more consistent with two independently entrained oscillators than a single consulted clock. Similar results were obtained for meals scheduled 3-h and 10-h after lights-on, and for a food-bin measure of anticipation. Most rats that showed weak or no anticipation to one or both meals exhibited elevated activity at mealtime during 1 or 2 day food deprivation tests in DD, suggesting covert operation of circadian timing in the absence of anticipatory behavior. A control experiment confirmed that daytime feeding did not shift LD-entrained rhythms, ruling out displaced nocturnal activity as an explanation for daytime activity. The results favor a multiple oscillator basis for 2-meal anticipatory rhythms and provide no evidence for involvement of cue-dependent interval timing.	[Mistlberger, Ralph E.; Kent, Brianne A.; Chan, Sofina; Patton, Danica F.; Weinberg, Alexander; Parfyonov, Maksim] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Mistlberger, RE (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	mistlber@sfu.ca	Parfyonov, Maksim/AAP-7478-2020	Parfyonov, Maksim/0000-0003-0582-0852; Kent, Brianne/0000-0003-0074-028X	Natural Sciences and Engineering Research Council of Canada [RGPIN155172, RGPAS380285]; Canadian Institutes of Health Research [MOP77579]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by Operating and Equipment grants from the Natural Sciences and Engineering Research Council of Canada (grants RGPIN155172, RGPAS380285; http://www.nserc-crsng.gc.ca) and by the Canadian Institutes of Health Research (grant MOP77579; http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Angeles-Castellanos M, 2010, NEUROSCIENCE, V165, P1115, DOI 10.1016/j.neuroscience.2009.11.061; Aragona BJ, 2002, J BIOL RHYTHM, V17, P330, DOI 10.1177/074873002129002636; ASCHOFF J, 1986, MONIT ZOOL ITAL, V20, P195; Balsam P, 2009, EUR J NEUROSCI, V30, P1749, DOI 10.1111/j.1460-9568.2009.06967.x; BIEBACH H, 1989, ANIM BEHAV, V37, P353, DOI 10.1016/0003-3472(89)90083-3; BIEBACH H, 1991, J BIOL RHYTHM, V6, P353, DOI 10.1177/074873049100600406; BOLLES RC, 1973, J COMP PHYSIOL PSYCH, V83, P510, DOI 10.1037/h0034666; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; BOULOS Z, 1990, PHYSIOL BEHAV, V48, P523, DOI 10.1016/0031-9384(90)90294-E; Challet E, 2009, EUR J NEUROSCI, V30, P1676, DOI 10.1111/j.1460-9568.2009.06962.x; CHURCH RM, 1994, J EXP PSYCHOL ANIM B, V20, P135, DOI 10.1037/0097-7403.20.2.135; Crystal JD, 2001, J EXP PSYCHOL ANIM B, V27, P68, DOI 10.1037/0097-7403.27.1.68; Crystal JD, 2009, EUR J NEUROSCI, V30, P1756, DOI 10.1111/j.1460-9568.2009.06968.x; Daan S, 1984, ADAPTIVE STRATEGIES, P275; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2003, GENES BRAIN BEHAV, V2, P32, DOI 10.1034/j.1601-183X.2003.00005.x; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; de Groot MHM, 2004, PHYSIOL BEHAV, V83, P447, DOI 10.1016/j.physbeh.2004.08.037; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; Gibbon J., 1997, TIME BEHAV PSYCHOL N, P329, DOI DOI 10.1016/S0166-4115(97)80060-X; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943; Lamont EW, 2007, NEUROSCIENCE, V144, P402, DOI 10.1016/j.neuroscience.2006.09.027; Mendoza J, 2005, J NEUROSCI, V25, P1514, DOI 10.1523/JNEUROSCI.4397-04.2005; Mistlberger R.E., 2009, J CIRC RHYTHMS, V7, P1; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 1996, BRAIN RES, V739, P12, DOI 10.1016/S0006-8993(96)00466-0; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Papachristos EB, 2011, J BIOL RHYTHM, V26, P305, DOI 10.1177/0748730411410026; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; PERSONS JE, 1993, PHYSIOL BEHAV, V54, P55, DOI 10.1016/0031-9384(93)90043-F; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Pitts SN, 2003, AM J PHYSIOL-REG I, V285, pR57, DOI 10.1152/ajpregu.00023.2003; Ribeiro AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023364; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; STEPHAN FK, 1989, J BIOL RHYTHM, V4, P467, DOI 10.1177/074873048900400406; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; STEPHAN FK, 1989, PHYSIOL BEHAV, V46, P489, DOI 10.1016/0031-9384(89)90026-7; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; TERMAN M, 1984, ANN NY ACAD SCI, V423, P470, DOI 10.1111/j.1749-6632.1984.tb23454.x; Van der Zee EA, 2008, CURR BIOL, V18, P844, DOI 10.1016/j.cub.2008.04.077; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; WHITE W, 1994, PHYSIOL BEHAV, V56, P17, DOI 10.1016/0031-9384(94)90256-9	49	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31772	10.1371/journal.pone.0031772	http://dx.doi.org/10.1371/journal.pone.0031772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355393	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300093
J	Strande, N; Roberts, SA; Oh, S; Hendrickson, EA; Ramsden, DA				Strande, Natasha; Roberts, Steven A.; Oh, Sehyun; Hendrickson, Eric A.; Ramsden, Dale A.			Specificity of the dRP/AP Lyase of Ku Promotes Nonhomologous End Joining (NHEJ) Fidelity at Damaged Ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-BETA; DOUBLE-STRAND BREAKS; URACIL EXCISION; OXIDIZED BASES; NUCLEIC-ACIDS; REPAIR; COMPLEX; LESIONS; GLYCOSYLASE; MECHANISM	Nonhomologous end joining (NHEJ) is essential for efficient repair of chromosome breaks. However, the NHEJ ligation step is often obstructed by break-associated nucleotide damage, including base loss (abasic site or 5'-dRP/AP sites). Ku, a 5'-dRP/AP lyase, can excise such damage at ends in preparation for the ligation step. We show here that this activity is greatest if the abasic site is within a short 5' overhang, when this activity is necessary and sufficient to prepare such termini for ligation. In contrast, Ku is less active near 3' strand termini, where excision would leave a ligation-blocking alpha,beta-unsaturated aldehyde. The Ku AP lyase activity is also strongly suppressed by as little as two paired bases 5' of the abasic site. Importantly, in vitro end joining experiments show that abasic sites significantly embedded in double-stranded DNA do not block the NHEJ ligation step. Suppression of the excision activity of Ku in this context therefore is not essential for ligation and further helps NHEJ retain terminal sequence in junctions. We show that the DNA between the 5' terminus and the abasic site can also be retained in junctions formed by cellular NHEJ, indicating that these sites are at least partly resistant to other abasic site-cleaving activities as well. High levels of the 5'-dRP/AP lyase activity of Ku are thus restricted to substrates where excision of an abasic site is required for ligation, a degree of specificity that promotes more accurate joining.	[Strande, Natasha; Roberts, Steven A.; Ramsden, Dale A.] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Strande, Natasha; Roberts, Steven A.; Ramsden, Dale A.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Oh, Sehyun; Hendrickson, Eric A.] Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities	Ramsden, DA (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	dale_ramsden@med.unc.edu	Strande, Natasha T./H-9894-2019	Strande, Natasha T./0000-0001-5148-9772; Ramsden, Dale/0000-0003-1575-4748; Oh, Sehyun/0000-0002-9490-3061	National Institutes of Health [R01 CA 84442, RO1 GM088351, RO1 CA154461]; NATIONAL CANCER INSTITUTE [R01CA154461, R01CA084442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA 84442 (to D. A. R.) and RO1 GM088351 and RO1 CA154461 (to E. A. H.).	Allinson SL, 2001, EMBO J, V20, P6919, DOI 10.1093/emboj/20.23.6919; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Chen S, 2001, J BIOL CHEM, V276, P24323, DOI 10.1074/jbc.M010544200; Datta K, 2011, RADIAT RES, V175, P97, DOI 10.1667/RR2332.1; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; Dobbs TA, 2008, DNA REPAIR, V7, P1372, DOI 10.1016/j.dnarep.2008.05.001; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Hashimoto M, 2001, J BIOL CHEM, V276, P12827, DOI 10.1074/jbc.M010906200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Ilina ES, 2008, BBA-PROTEINS PROTEOM, V1784, P1777, DOI 10.1016/j.bbapap.2008.08.001; JEGGO PA, 1990, MUTAT RES, V239, P1, DOI 10.1016/0165-1110(90)90028-A; Ma WJ, 2008, NUCLEIC ACIDS RES, V36, P1836, DOI 10.1093/nar/gkm1148; Malyarchuk S, 2008, NUCLEIC ACIDS RES, V36, P4872, DOI 10.1093/nar/gkn450; Malyarchuk S, 2009, DNA REPAIR, V8, P1343, DOI 10.1016/j.dnarep.2009.08.008; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Piersen CE, 2000, MUTAT RES-DNA REPAIR, V459, P43, DOI 10.1016/S0921-8777(99)00054-3; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Sekiguchi JM, 1999, COLD SPRING HARB SYM, V64, P169, DOI 10.1101/sqb.1999.64.169; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; Yang N, 2004, DNA REPAIR, V3, P1323, DOI 10.1016/j.dnarep.2004.04.014; Yoo S, 1999, J BIOL CHEM, V274, P20034, DOI 10.1074/jbc.274.28.20034	32	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13686	13693		10.1074/jbc.M111.329730	http://dx.doi.org/10.1074/jbc.M111.329730			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22362780	Green Published, hybrid			2022-12-25	WOS:000303996300024
J	Wang, PS; Wang, J; Zheng, Y; Pallen, CJ				Wang, Pei-Shan; Wang, Jing; Zheng, Yi; Pallen, Catherine J.			Loss of Protein-tyrosine Phosphatase alpha (PTP alpha) Increases Proliferation and Delays Maturation of Oligodendrocyte Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; GROWTH ARREST; RPTP-ALPHA; POSTTRANSCRIPTIONAL REGULATION; MORPHOLOGICAL-DIFFERENTIATION; INHIBITOR P27(KIP1); SIGNALING PATHWAYS; RAS ACTIVATION; MESSENGER-RNA; FYN	Tightly controlled termination of proliferation determines when oligodendrocyte progenitor cells (OPCs) can initiate differentiation and mature into myelin- forming cells. Protein- tyrosine phosphatase alpha (PTP alpha) promotes OPC differentiation, but its role in proliferation is unknown. Here we report that loss of PTP alpha enhanced in vitro proliferation and survival and decreased cell cycle exit and growth factor dependence of OPCs but not neural stem/progenitor cells. PTP alpha(-/-) mice have more oligodendrocyte lineage cells in embryonic forebrain and delayed OPC maturation. On the molecular level, PTP alpha-deficient mouse OPCs and rat CG4 cells have decreased Fyn and increased Ras, Cdc42, Rac1, and Rho activities, and reduced expression of the Cdk inhibitor p27Kip1. Moreover, Fyn was required to suppress Ras and Rho and for p27Kip1 accumulation, and Rho inhibition in PTP alpha-deficient cells restored expression of p27Kip1. We propose that PTP alpha-Fyn signaling negatively regulates OPC proliferation by down-regulating Ras and Rho, leading to p27Kip1 accumulation and cell cycle exit. Thus, PTP alpha acts in OPCs to limit self-renewal and facilitate differentiation.	[Wang, Pei-Shan; Wang, Jing; Pallen, Catherine J.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Wang, Pei-Shan; Pallen, Catherine J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Wang, Jing; Pallen, Catherine J.] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 4H4, Canada; [Zheng, Yi] Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	Child & Family Research Institute; University of British Columbia; University of British Columbia; University of British Columbia; Cincinnati Children's Hospital Medical Center	Pallen, CJ (corresponding author), Univ British Columbia, Child & Family Res Inst, 3102-950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	cpallen@mail.ubc.ca	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; Pallen, Catherine/0000-0002-3576-5295	Canadian Institutes of Health Research [MOP-62759]; Multiple Sclerosis Society of Canada; Child and Family Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Child and Family Research Institute	This work was supported by Grant MOP-62759 from the Canadian Institutes of Health Research (to C. J. P.). P.-S. Wang was supported by a studentship from the Multiple Sclerosis Society of Canada. C. J. Pallen is the recipient of an investigator award from the Child and Family Research Institute.	Ardini E, 2000, ONCOGENE, V19, P4979, DOI 10.1038/sj.onc.1203869; Attali B, 1997, J NEUROSCI, V17, P8234; Bansal R, 2005, J NEUROSCI RES, V80, P360, DOI 10.1002/jnr.20454; BANSAL R, 1994, DEV BIOL, V162, P511, DOI 10.1006/dbio.1994.1105; BARNETT SC, 1995, CELL GROWTH DIFFER, V6, P69; Barnett SC, 1998, CARCINOGENESIS, V19, P1529, DOI 10.1093/carcin/19.9.1529; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Bennett MR, 2003, J NEUROSCI, V23, P7207, DOI 10.1523/JNEUROSCI.23-18-07207.2003; Berwanger B, 2002, CANCER CELL, V2, P377, DOI 10.1016/S1535-6108(02)00179-4; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; Cabodi S, 2000, MOL CELL, V6, P1121, DOI 10.1016/S1097-2765(00)00110-6; Casaccia-Bonnefil P, 1999, DEVELOPMENT, V126, P4027; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Chew LJ, 2010, J NEUROSCI, V30, P11011, DOI 10.1523/JNEUROSCI.2546-10.2010; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Durand B, 1998, CURR BIOL, V8, P431, DOI 10.1016/S0960-9822(98)70177-0; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Friessen AJ, 1997, J NEUROSCI RES, V50, P373; HART IK, 1989, DEVELOPMENT, V105, P595; Hecker TP, 2004, ONCOGENE, V23, P3962, DOI 10.1038/sj.onc.1207541; Hu WM, 1999, J BIOL CHEM, V274, P3396, DOI 10.1074/jbc.274.6.3396; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Lee JS, 2010, HUM MOL GENET, V19, P4643, DOI 10.1093/hmg/ddq395; Li XK, 2009, J NEUROSCI, V29, P2902, DOI 10.1523/JNEUROSCI.4051-08.2009; Lu ZF, 2005, J BIOL CHEM, V280, P389, DOI 10.1074/jbc.M405973200; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Moeller SJ, 2003, MOL CELL BIOL, V23, P3735, DOI 10.1128/MCB.23.11.3735-3752.2003; Moon SY, 2003, J BIOL CHEM, V278, P4151, DOI 10.1074/jbc.M207789200; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Paez PM, 2006, NEUROCHEM INT, V49, P359, DOI 10.1016/j.neuint.2006.02.009; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Perez MJ, 2009, J NEUROSCI RES, V87, P3378, DOI 10.1002/jnr.21962; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Sa G, 2004, EXP CELL RES, V300, P427, DOI 10.1016/j.yexcr.2004.07.032; Samayawardhena LA, 2008, J BIOL CHEM, V283, P29175, DOI 10.1074/jbc.M804077200; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Smida M, 2007, BLOOD, V110, P596, DOI 10.1182/blood-2006-07-038752; Soliven B, 2003, AM J PHYSIOL-CELL PH, V284, pC85, DOI 10.1152/ajpcell.00145.2002; Sperber BR, 2001, J NEUROSCI RES, V63, P303, DOI 10.1002/1097-4547(20010215)63:4<303::AID-JNR1024>3.0.CO;2-A; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Tang XM, 2000, J CELL BIOCHEM, V76, P270, DOI 10.1002/(SICI)1097-4644(20000201)76:2<270::AID-JCB10>3.0.CO;2-6; Taniguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P151, DOI 10.1016/S0006-291X(03)00923-9; Thurnherr T, 2006, J NEUROSCI, V26, P10110, DOI 10.1523/JNEUROSCI.2158-06.2006; Tikoo R, 1998, J NEUROBIOL, V36, P431, DOI 10.1002/(SICI)1097-4695(19980905)36:3<431::AID-NEU10>3.3.CO;2-N; Tokumoto YM, 2002, DEV BIOL, V245, P224, DOI 10.1006/dbio.2002.0626; Vacaresse N, 2008, J BIOL CHEM, V283, P35815, DOI 10.1074/jbc.M807964200; Vidal A, 2002, J BIOL CHEM, V277, P16433, DOI 10.1074/jbc.M112090200; Wang PS, 2009, J BIOL CHEM, V284, P33692, DOI 10.1074/jbc.M109.061770; Wolf RM, 2003, GENE DEV, V17, P476, DOI 10.1101/gad.1040003; YASUDA T, 1995, J NEUROSCI RES, V40, P306, DOI 10.1002/jnr.490400304; Ye H, 2008, EMBO J, V27, P188, DOI 10.1038/sj.emboj.7601939; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; Zezula J, 2001, EMBO REP, V2, P27, DOI 10.1093/embo-reports/kve008; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866	65	9	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12529	12540		10.1074/jbc.M111.312769	http://dx.doi.org/10.1074/jbc.M111.312769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354965	hybrid, Green Published			2022-12-25	WOS:000302782200092
J	Atallah, M; Krispin, A; Trahtemberg, U; Ben-Hamron, S; Grau, A; Verbovetski, I; Mevorach, D				Atallah, Mizhir; Krispin, Alon; Trahtemberg, Uriel; Ben-Hamron, Sandrine; Grau, Amir; Verbovetski, Inna; Mevorach, Dror			Constitutive Neutrophil Apoptosis: Regulation by Cell Concentration via S100 A8/9 and the MEK - ERK Pathway	PLOS ONE			English	Article							BONE-MARROW; FAS LIGAND; PHOSPHATIDYLINOSITOL 3-KINASE; DIFFERENTIAL EXPRESSION; RHEUMATOID-ARTHRITIS; GM-CSF; DEATH; SURVIVAL; CYTOKINES; INFLAMMATION	Programmed cell death (PCD) is a fundamental mechanism in tissue and cell homeostasis. It was long suggested that apoptosis regulates the cell number in diverse cell populations; however no clear mechanism was shown. Neutrophils are the short-lived, first-line defense of innate immunity, with an estimated t = 1/2 of 8 hours and a high turnover rate. Here we first show that spontaneous neutrophil constitutive PCD is regulated by cell concentrations. Using a proteomic approach, we identified the S100 A8/9 complex, which constitutes roughly 40% of cytosolic protein in neutrophils, as mediating this effect. We further demonstrate that it regulates cell survival via a signaling mechanism involving MEK-ERK via TLR4 and CD11B/CD18. This mechanism is suggested to have a fine-tuning role in regulating the neutrophil number in bone marrow, peripheral blood, and inflammatory sites.	[Atallah, Mizhir; Krispin, Alon; Trahtemberg, Uriel; Ben-Hamron, Sandrine; Grau, Amir; Verbovetski, Inna; Mevorach, Dror] Hadassah Hebrew Univ, Med Ctr Jerusalem, Rheumatol Res Ctr, Lab Cellular & Mol Immunol,Dept Med, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Atallah, M (corresponding author), Hadassah Hebrew Univ, Med Ctr Jerusalem, Rheumatol Res Ctr, Lab Cellular & Mol Immunol,Dept Med, Jerusalem, Israel.	mevorachd@hadassah.org.il	Trahtemberg, Uriel/B-3127-2008	Trahtemberg, Uriel/0000-0001-9103-2494	Hadassah-Hebrew University Medical Center	Hadassah-Hebrew University Medical Center	This research was partially supported by a grant from the Hadassah-Hebrew University Medical Center. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altznauer F, 2004, J EXP MED, V199, P1343, DOI 10.1084/jem.20032033; BEGLEY CG, 1986, BLOOD, V68, P162; Brown SB, 1999, J IMMUNOL, V162, P480; Chuang PI, 1998, BIOCHEM BIOPH RES CO, V249, P361, DOI 10.1006/bbrc.1998.9155; COLOTTA F, 1992, BLOOD, V80, P2012; COX G, 1992, AM J RESP CELL MOL, V7, P507, DOI 10.1165/ajrcmb/7.5.507; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; DRANSFIELD I, 1994, J IMMUNOL, V153, P1254; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Fecho K, 1998, J LEUKOCYTE BIOL, V64, P373, DOI 10.1002/jlb.64.3.373; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; IWAI K, 1994, BLOOD, V84, P1201; JOYCE RA, 1976, J LAB CLIN MED, V88, P614; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kerkhoff C, 2001, BIOCHEMISTRY-US, V40, P241, DOI 10.1021/bi001791k; Kobayashi SD, 2003, MICROBES INFECT, V5, P1337, DOI 10.1016/j.micinf.2003.09.013; Kotone-Miyahara Y, 2004, J LEUKOCYTE BIOL, V76, P1047, DOI 10.1189/jlb.0104048; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Krispin A, 2006, BLOOD, V108, P3580, DOI 10.1182/blood-2006-03-013334; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Liles WC, 1996, J EXP MED, V184, P429, DOI 10.1084/jem.184.2.429; LOPEZ AF, 1986, J CLIN INVEST, V78, P1220, DOI 10.1172/JCI112705; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Moulding DA, 2001, J LEUKOCYTE BIOL, V70, P783; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Newton RA, 1998, J IMMUNOL, V160, P1427; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Passey RJ, 1999, J IMMUNOL, V163, P2209; Petrin D, 2006, CELL SIGNAL, V18, P479, DOI 10.1016/j.cellsig.2005.05.021; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryckman C, 2004, J LEUKOCYTE BIOL, V76, P433, DOI 10.1189/jlb.0603294; Santos-Beneit AM, 2000, J LEUKOCYTE BIOL, V67, P712, DOI 10.1002/jlb.67.5.712; SASAKI K, 1995, ACTA ANAT, V153, P111; Shi JL, 2001, BLOOD, V98, P1226, DOI 10.1182/blood.V98.4.1226; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Trahtemberg U, 2007, APOPTOSIS, V12, P1769, DOI 10.1007/s10495-007-0097-1; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Watson RWG, 1997, J IMMUNOL, V158, P945; Weinmann P, 1999, BLOOD, V93, P3106; Weinmann P, 2003, BLOOD, V101, P739, DOI 10.1182/blood-2002-01-0239	50	30	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e29333	10.1371/journal.pone.0029333	http://dx.doi.org/10.1371/journal.pone.0029333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363402	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600006
J	Malek, AA; Wargo, MJ; Hogan, DA				Malek, Adel A.; Wargo, Matthew J.; Hogan, Deborah A.			Absence of Membrane Phosphatidylcholine Does Not Affect Virulence and Stress Tolerance Phenotypes in the Opportunistic Pathogen Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS; PHOSPHOLIPASE-C; SYNTHESIZES PHOSPHATIDYLCHOLINE; SIGNAL-TRANSDUCTION; BIOFILM DEVELOPMENT; BRUCELLA-ABORTUS; BIOSYNTHESIS; BACTERIA; HOST; RESISTANCE	During growth in presence of choline, both laboratory and clinical Pseudomonas aeruginosa strains synthesize phosphatidylcholine (PC), and PC makes up similar to 4% of the total membrane phospholipid content. In all the strains tested, PC synthesis occurred only when choline is provided exogenously. Mutants defective in synthesis of PC were generated in the strain backgrounds PAO1 and PA14. Minimum inhibitory concentration studies testing sensitivity of PC-deficient strains towards various antibiotics and cationic antimicrobial peptides revealed no differences as compared to wild-type strains. Mutants incapable of synthesizing PC were also found to be unaffected in motility and biofilm formation on abiotic surfaces, colonization of biotic surfaces and virulence in a mouse infection model. A global phenotypic microarray was further used to identify conditions wherein membrane PC may play a role of in P. aeruginosa. No culture conditions were identified wherein wild-type and PC-deficient mutants showed phenotypic differences. Membrane PC may serve a highly specific role during P. aeruginosa interactions with its eukaryotic hosts based on all the clinical strains tested retaining the ability to synthesize it during availability of choline.	[Malek, Adel A.; Hogan, Deborah A.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03756 USA; [Wargo, Matthew J.] Univ Vermont, Coll Med, Dept Microbiol & Mol Genet, Burlington, VT USA	Dartmouth College; University of Vermont	Malek, AA (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03756 USA.	dhogan@dartmouth.edu	Malek, Adel/ABF-9944-2021	Hogan, Deborah A./0000-0002-6366-2971; Wargo, Matthew/0000-0001-5659-749X	National Institutes of Health from the National Center for Research Resources [P20-RR018787]; National Institutes of Health [RO1-AI091702]; NCRR [P20-RR021905]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018787, P20RR021905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants P20-RR018787 from the IDeA Program of the National Center for Research Resources (to D. A. H.), RO1-AI091702 (to D. A. H.) and NCRR P20-RR021905 (to M.J.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas M, 2010, EUR J CELL BIOL, V89, P888, DOI 10.1016/j.ejcb.2010.06.013; Anderson GG, 2008, INFECT IMMUN, V76, P1423, DOI 10.1128/IAI.01373-07; Baysse C, 2005, MICROBIOL-SGM, V151, P2529, DOI 10.1099/mic.0.28185-0; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bogdanov Mikhail, 2008, V49, P197, DOI 10.1007/978-1-4020-8831-5_8; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Comerci DJ, 2006, J BACTERIOL, V188, P1929, DOI 10.1128/JB.188.5.1929-1934.2006; Conde-Alvarez R, 2006, CELL MICROBIOL, V8, P1322, DOI 10.1111/j.1462-5822.2006.00712.x; Conover GM, 2008, CELL MICROBIOL, V10, P514, DOI 10.1111/j.1462-5822.2007.01066.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; de Rudder KEE, 1999, J BIOL CHEM, V274, P20011, DOI 10.1074/jbc.274.28.20011; de Rudder KEE, 2000, MOL MICROBIOL, V37, P763, DOI 10.1046/j.1365-2958.2000.02032.x; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Hamilton A, 2006, INFECT IMMUN, V74, P6179, DOI 10.1128/IAI.00895-06; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; HOLLSING AE, 1987, J CLIN MICROBIOL, V25, P1868, DOI 10.1128/JCM.25.10.1868-1874.1987; Jain M, 2004, J CLIN MICROBIOL, V42, P5229, DOI 10.1128/JCM.42.11.5229-5237.2004; Kang PJ, 1997, MOL MICROBIOL, V24, P1249; Kida Y, 2011, INFECT IMMUN, V79, P211, DOI 10.1128/IAI.01053-10; Klein S, 2009, MOL MICROBIOL, V71, P551, DOI 10.1111/j.1365-2958.2008.06562.x; Klusener S, 2009, J BACTERIOL, V191, P365, DOI 10.1128/JB.01183-08; KURIOKA S, 1976, ANAL BIOCHEM, V75, P281, DOI 10.1016/0003-2697(76)90078-6; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Lysenko ES, 2000, INFECT IMMUN, V68, P1664, DOI 10.1128/IAI.68.3.1664-1671.2000; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Martinez-Morales F, 2003, MICROBIOL-SGM, V149, P3461, DOI 10.1099/mic.0.26522-0; Minder AC, 2001, MOL MICROBIOL, V39, P1186, DOI 10.1111/j.1365-2958.2001.02325.x; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Moreau-Marquis S., 2010, J VIS EXP; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; SCHWEIZER HP, 1991, GENE, V97, P109, DOI 10.1016/0378-1119(91)90016-5; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; SHORTRIDGE VD, 1992, MOL MICROBIOL, V6, P863, DOI 10.1111/j.1365-2958.1992.tb01537.x; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; Wargo MJ, 2011, AM J RESP CRIT CARE, V184, P345, DOI 10.1164/rccm.201103-0374OC; Wargo MJ, 2009, INFECT IMMUN, V77, P1103, DOI 10.1128/IAI.01008-08; Wessel M, 2006, MOL MICROBIOL, V62, P906, DOI 10.1111/j.1365-2958.2006.05425.x; Wilderman PJ, 2002, J BACTERIOL, V184, P4792, DOI 10.1128/JB.184.17.4792-4799.2002; Willumeit R, 2005, BBA-BIOMEMBRANES, V1669, P125, DOI 10.1016/j.bbamem.2005.01.011; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200	56	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30829	10.1371/journal.pone.0030829	http://dx.doi.org/10.1371/journal.pone.0030829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363496	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600073
J	Yamaura, Y; Nakajima, M; Takagi, S; Fukami, T; Tsuneyama, K; Yokoi, T				Yamaura, Yu; Nakajima, Miki; Takagi, Shingo; Fukami, Tatsuki; Tsuneyama, Koichi; Yokoi, Tsuyoshi			Plasma MicroRNA Profiles in Rat Models of Hepatocellular Injury, Cholestasis, and Steatosis	PLOS ONE			English	Article							INDUCED LIVER-INJURY; CIRCULATING MICRORNAS; NONALCOHOLIC STEATOHEPATITIS; CANCER-DETECTION; BIOMARKERS; EXPRESSION; DISEASE; SERUM; MECHANISM; ZONATION	MicroRNAs (miRNAs) are small RNA molecules that function to modulate the expression of target genes, playing important roles in a wide range of physiological and pathological processes. The miRNAs in body fluids have received considerable attention as potential biomarkers of various diseases. In this study, we compared the changes of the plasma miRNA expressions by acute liver injury (hepatocellular injury or cholestasis) and chronic liver injury (steatosis, steatohepatitis and fibrosis) using rat models made by the administration of chemicals or special diets. Using miRNA array analysis, we found that the levels of a large number of miRNAs (121-317 miRNAs) were increased over 2-fold and the levels of a small number of miRNAs (6-35 miRNAs) were decreased below 0.5-fold in all models except in a model of cholestasis caused by bile duct ligation. Interestingly, the expression profiles were different between the models, and the hierarchical clustering analysis discriminated between the acute and chronic liver injuries. In addition, miRNAs whose expressions were typically changed in each type of liver injury could be specified. It is notable that, in acute liver injury models, the plasma level of miR-122, the most abundant miRNA in the liver, was more quickly and dramatically increased than the plasma aminotransferase level, reflecting the extent of hepatocellular injury. This study demonstrated that the plasma miRNA profiles could reflect the types of liver injury (e.g. acute/chronic liver injury or hepatocellular injury/cholestasis/steatosis/steatohepatitis/fibrosis) and identified the miRNAs that could be specific and sensitive biomarkers of liver injury.	[Yamaura, Yu; Nakajima, Miki; Takagi, Shingo; Fukami, Tatsuki; Yokoi, Tsuyoshi] Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa, Japan; [Tsuneyama, Koichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama, Japan	Kanazawa University; University of Toyama	Yamaura, Y (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, Kakuma Machi, Kanazawa, Ishikawa, Japan.	tyokoi@kenroku.kanazawa-u.ac.jp	yokoi, tsuyoshi/I-7115-2014; Nakajima, Miki/C-3990-2015; Fukami, Tatsuki/C-8907-2015	Tsuneyama, Koichi/0000-0002-0670-9868; Yokoi, Tsuyoshi/0000-0002-3239-2817; Fukami, Tatsuki/0000-0003-2416-5988	Japan Society for the Promotion of Science [21390174]; Ministry of Health, Labor and Welfare of Japan [H20-BIO-G001]; Grants-in-Aid for Scientific Research [21390174] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (21390174) and in part by a Health and Labor Science Research Grant from the Ministry of Health, Labor and Welfare of Japan (H20-BIO-G001). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine DJ, 2009, XENOBIOTICA, V39, P565, DOI 10.1080/00498250903046993; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENICHOU C, 1990, J HEPATOL, V11, P272; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; DESMET VJ, 1968, AM J PATHOL, V52, P401; Dillhoff M, 2009, J SURG RES, V154, P349, DOI 10.1016/j.jss.2008.02.046; Dolganiuc A, 2009, ALCOHOL CLIN EXP RES, V33, P1704, DOI 10.1111/j.1530-0277.2009.01007.x; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Jin X, 2009, DIGEST LIVER DIS, V41, P289, DOI 10.1016/j.dld.2008.08.008; JUNGERMANN K, 1995, HISTOCHEM CELL BIOL, V103, P81, DOI 10.1007/BF01454004; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Li WQ, FEBS J IN PRESS; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Nathwani RA, 2005, HEPATOLOGY, V41, P380, DOI 10.1002/hep.20548; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; Reid G., 2010, CRIT REV ON IN PRESS; Shi Q, 2010, EXPERT REV GASTROENT, V4, P225, DOI [10.1586/egh.10.8, 10.1586/EGH.10.8]; Shigehara K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023584; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	32	71	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30250	10.1371/journal.pone.0030250	http://dx.doi.org/10.1371/journal.pone.0030250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363424	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600018
J	Bergwitz, C; Rasmussen, MD; DeRobertis, C; Wee, MJ; Sinha, S; Chen, HH; Huang, J; Perrimon, N				Bergwitz, Clemens; Rasmussen, Matthew D.; DeRobertis, Charles; Wee, Mark J.; Sinha, Sumi; Chen, Hway H.; Huang, Joanne; Perrimon, Norbert			Roles of Major Facilitator Superfamily Transporters in Phosphate Response in Drosophila	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INORGANIC-PHOSPHATE; SACCHAROMYCES-CEREVISIAE; VASCULAR CALCIFICATION; KINASE; CELLS; MELANOGASTER; CALCIUM; DIETARY; FAMILY	The major facilitator superfamily (MFS) transporter Pho84 and the type III transporter Pho89 are responsible for metabolic effects of inorganic phosphate in yeast. While the Pho89 ortholog Pit1 was also shown to be involved in phosphate-activated MAPK in mammalian cells, it is currently unknown, whether orthologs of Pho84 have a role in phosphate-sensing in metazoan species. We show here that the activation of MAPK by phosphate observed in mammals is conserved in Drosophila cells, and used this assay to characterize the roles of putative phosphate transporters. Surprisingly, while we found that RNAi-mediated knockdown of the fly Pho89 ortholog dPit had little effect on the activation of MAPK in Drosophila S2R+ cells by phosphate, two Pho84/SLC17A1-9 MFS orthologs (MFS10 and MFS13) specifically inhibited this response. Further, using a Xenopus oocyte assay, we show that MSF13 mediates uptake of [P-33]-orthophosphate in a sodium-dependent fashion. Consistent with a role in phosphate physiology, MSF13 is expressed highest in the Drosophila crop, midgut, Malpighian tubule, and hindgut. Altogether, our findings provide the first evidence that Pho84 orthologs mediate cellular effects of phosphate in metazoan cells. Finally, while phosphate is essential for Drosophila larval development, loss of MFS13 activity is compatible with viability indicating redundancy at the levels of the transporters.	[Bergwitz, Clemens; DeRobertis, Charles; Wee, Mark J.; Sinha, Sumi; Chen, Hway H.; Huang, Joanne] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; [Rasmussen, Matthew D.] MIT, Comp Sci & Artificial Intelligence Lab, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bergwitz, C (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.	cbergwitz@partners.org		Perrimon, Norbert/0000-0001-7542-472X	Harvard Catalyst; National institutes of Health, NIDDK [5K08DK078361]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK078361] Funding Source: NIH RePORTER	Harvard Catalyst; National institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by Harvard Catalyst, http://catalyst.harvard.edu/ and http://www.google.com/url?sa=t&rct=j&rct=j&q=&q=&esrc=s&esrc=s&source=web&source=web&cd=3&cd=3&ved=0CC0QFjAC&url=http%3A%2F%2Fcatalyst.harvard.edu%2Fservices%2Fpilotfunding%2Fdoc%2FHarvardCatalystyr2pilotawardees.pdf&ei=Q7LoTsvbA4Hs0gGX_bX-CQ&usg=AFQjCNH5urQAzoFgECvnBx7291P3xQFYyQ&sig2=2txR0jw1srrB3xu-3HwW4A, and the National institutes of Health, NIDDK 5K08DK078361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009148; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Bergwitz C, 2011, ADV CHRONIC KIDNEY D, V18, P132, DOI 10.1053/j.ackd.2011.01.004; Bergwitz C, 2009, ENDOCR DEV, V16, P133, DOI 10.1159/000223693; Bevington A, 1992, CLIN CHEM ENZYMOL CO, V4, P235; Bringhurst FR, 2006, ENDOCRINOLOGY, V5, P805; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chang SH, 2006, AM J RESP CELL MOL, V35, P528, DOI 10.1165/rcmb.2005-0477OC; Chertow GM, 1999, CLIN NEPHROL, V51, P18; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Collins JF, 2004, PFLUG ARCH EUR J PHY, V447, P647, DOI 10.1007/s00424-003-1088-x; Festing MH, 2009, GENESIS, V47, P858, DOI 10.1002/dvg.20577; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jaureguiberry G, 2008, AM J PHYSIOL-RENAL, V295, pF371, DOI 10.1152/ajprenal.00090.2008; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; Julien M, 2009, J BONE MINER RES, V24, P1856, DOI [10.1359/JBMR.090508, 10.1359/jbmr.090508]; Khoshniat S, 2011, CELL MOL LIFE SCI, V68, P205, DOI 10.1007/s00018-010-0527-z; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Mouillon JM, 2006, FEMS YEAST RES, V6, P171, DOI 10.1111/j.1567-1364.2006.00036.x; Mozar A, 2008, J CELL PHYSIOL, V215, P47, DOI 10.1002/jcp.21283; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Nair D, 1997, J BIOL CHEM, V272, P18920, DOI 10.1074/jbc.272.30.18920; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Razzaque MS, 2009, NEPHROL DIAL TRANSPL, V24, P4, DOI 10.1093/ndt/gfn620; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Segal D, 1996, SOMAT CELL MOLEC GEN, V22, P159, DOI 10.1007/BF02369906; Sims D, 2006, NUCLEIC ACIDS RES, V34, pD479, DOI 10.1093/nar/gkj038; Sprecher E, 2010, J INVEST DERMATOL, V130, P652, DOI 10.1038/jid.2009.337; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; Suzuki A, 2010, J BONE MINER METAB, V28, P139, DOI 10.1007/s00774-009-0121-3; TENENHOUSE HS, 1989, BIOCHIM BIOPHYS ACTA, V984, P207, DOI 10.1016/0005-2736(89)90218-6; TOHE A, 1988, MOL GEN GENET, V214, P162, DOI 10.1007/BF00340196; Werner A, 2001, AM J PHYSIOL-REG I, V280, pR301, DOI 10.1152/ajpregu.2001.280.2.R301; Wittrant Y, 2009, BIOCHEM BIOPH RES CO, V381, P259, DOI 10.1016/j.bbrc.2009.02.034; Yamazaki M, 2010, J CELL BIOCH; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07	51	18	19	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31730	10.1371/journal.pone.0031730	http://dx.doi.org/10.1371/journal.pone.0031730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359624	Green Submitted, gold, Green Published			2022-12-25	WOS:000302796200093
J	Wu, KY; Koo, J; Jiang, XJ; Chen, R; Cohen, SN; Nathan, C				Wu, Kangyun; Koo, Jovanka; Jiang, Xiuju; Chen, Ran; Cohen, Stanley N.; Nathan, Carl			Improved Control of Tuberculosis and Activation of Macrophages in Mice Lacking Protein Kinase R	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; IFN-GAMMA; INTERFERON-GAMMA; MYCOBACTERIUM-TUBERCULOSIS; OXIDATIVE-METABOLISM; IL-10 PRODUCTION; INNATE IMMUNITY; PKR; INTERLEUKIN-10; IDENTIFICATION	Host factors that microbial pathogens exploit for their propagation are potential targets for therapeuic countermeasures. No host enzyme has been identified whose genetic absence benefits the intact mammalian host in vivo during infection with Mycobacterium tuberculosis (Mtb), the leading cause of death from bacterial infection. Here, we report that the dsRNA-dependent protein kinase (PKR) is such an enzyme. PKR-deficient mice contained fewer viable Mtb and showed less pulmonary pathology than wild type mice. We identified two potential mechanisms for the protective effect of PKR deficiency: increased apoptosis of macrophages in response to Mtb and enhanced activation of macrophages in response to IFN-gamma. The restraining effect of PKR on macrophage activation was explained by its mediation of a previously unrecognized ability of IFN-gamma to induce low levels of the macrophage deactivating factor interleukin 10 (IL10). These observations suggest that PKR inhibitors may prove useful as an adjunctive treatment for tuberculosis.	[Wu, Kangyun; Koo, Jovanka; Jiang, Xiuju; Nathan, Carl] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Chen, Ran; Cohen, Stanley N.] Stanford Univ, Sch Med, Dept Genet, Palo Alto, CA 94304 USA	Cornell University; Stanford University	Wu, KY (corresponding author), Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO 63130 USA.	cnathan@med.cornell.edu		Wu, Kangyun/0000-0002-8093-094X	Department of Defense through Defense Threat Reduction Agency (DTRA) [HDTRA 01-06-C-0039]; William Randolph Hearst Foundation	Department of Defense through Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); William Randolph Hearst Foundation	This work was supported by the Transformational Medical Technologies program contract HDTRA 01-06-C-0039 to SNC and CN from the Department of Defense Chemical and Biological Defense program through the Defense Threat Reduction Agency (DTRA). The Department of Microbiology and Immunology is supported by the William Randolph Hearst Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E, 2008, BIOCHEMISTRY-US, V47, P4887, DOI 10.1021/bi702211j; Bando Y, 2005, NEUROCHEM INT, V46, P11, DOI 10.1016/j.neuint.2004.07.005; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bryk R, 2011, BIOORG MED CHEM LETT, V21, P4108, DOI 10.1016/j.bmcl.2011.04.149; Chakrabarti A, 2008, J BIOL CHEM, V283, P25132, DOI 10.1074/jbc.M804770200; Chang ACY, 2006, J VIROL, V80, P8705, DOI 10.1128/JVI.00475-06; Chang RCC, 2002, J NEUROCHEM, V83, P1215, DOI 10.1046/j.1471-4159.2002.01237.x; CHOMARAT P, 1993, J EXP MED, V177, P523, DOI 10.1084/jem.177.2.523; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Davies Julian, 2009, P158; Deb A, 2001, J IMMUNOL, V166, P6170, DOI 10.4049/jimmunol.166.10.6170; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Goodman AG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000438; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Hu JH, 2003, J NEUROCHEM, V85, P432, DOI 10.1046/j.1471-4159.2003.01670.x; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jayaswal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000839; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kockx MM, 1998, ARTERIOSCL THROM VAS, V18, P1519, DOI 10.1161/01.ATV.18.10.1519; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Lu Q, 2004, P NATL ACAD SCI USA, V101, P17246, DOI 10.1073/pnas.0407794101; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; McKenna SA, 2007, J BIOL CHEM, V282, P11474, DOI 10.1074/jbc.M700301200; Mhyre TR, 2008, NEUROBIOL AGING, V29, P1631, DOI 10.1016/j.neurobiolaging.2007.04.004; Morel M, 2009, J CELL MOL MED, V13, P1476, DOI 10.1111/j.1582-4934.2009.00849.x; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nathan C, 2009, CELL HOST MICROBE, V5, P220, DOI 10.1016/j.chom.2009.02.004; NATHAN CF, 1986, NEW ENGL J MED, V315, P6, DOI 10.1056/NEJM198607033150102; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Schwegmann A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.129re8; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Sharma B, 2011, J BIOL CHEM, V286, P27506, DOI 10.1074/jbc.M111.238501; SZUROSUDOL A, 1982, J EXP MED, V156, P945, DOI 10.1084/jem.156.4.945; Torrado E, 2011, TRENDS IMMUNOL, V32, P66, DOI 10.1016/j.it.2010.12.001; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Uetani K, 2000, J IMMUNOL, V165, P988, DOI 10.4049/jimmunol.165.2.988; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Vogt G, 2011, J CLIN INVE IN PRESS; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x	58	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30512	10.1371/journal.pone.0030512	http://dx.doi.org/10.1371/journal.pone.0030512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359543	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200012
J	Finlay, EK; Berry, DP; Wickham, B; Gormley, EP; Bradley, DG				Finlay, Emma K.; Berry, Donagh P.; Wickham, Brian; Gormley, Eamonn P.; Bradley, Daniel G.			A Genome Wide Association Scan of Bovine Tuberculosis Susceptibility in Holstein-Friesian Dairy Cattle	PLOS ONE			English	Article							RAW 264.7 CELLS; TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-BOVIS; GENETIC SUSCEPTIBILITY; NITRIC-OXIDE; TAURINE; CHLORAMINE; INFECTION; EXPRESSION; DISEASE	Background: Bovine tuberculosis is a significant veterinary and financial problem in many parts of the world. Although many factors influence infection and progression of the disease, there is a host genetic component and dissection of this may enlighten on the wider biology of host response to tuberculosis. However, a binary phenotype of presence/absence of infection presents a noisy signal for genomewide association study. Methodology/Principal Findings: We calculated a composite phenotype of genetic merit for TB susceptibility based on disease incidence in daughters of elite sires used for artificial insemination in the Irish dairy herd. This robust measure was compared with 44,426 SNP genotypes in the most informative 307 subjects in a genome wide association analysis. Three SNPs in a 65 kb genomic region on BTA 22 were associated (i.e. p<10(-5), peaking at position 59588069, p = 4.02 x 10(-6)) with tuberculosis susceptibility. Conclusions/Significance: A genomic region on BTA 22 was suggestively associated with tuberculosis susceptibility; it contains the taurine transporter gene SLC6A6, or TauT, which is known to function in the immune system but has not previously been investigated for its role in tuberculosis infection.	[Finlay, Emma K.; Bradley, Daniel G.] Trinity Coll Dublin, Dept Genet, Smurfit Inst, Dublin, Ireland; [Berry, Donagh P.] TEAGASC, Anim & Grassland Res & Innovat Ctr, Fermoy, Cork, Ireland; [Wickham, Brian] Irish Cattle Breeding Federat, Bandon, Cork, Ireland; [Gormley, Eamonn P.] Univ Coll Dublin, Vet Sci Ctr, Sch Agr Food Sci & Vet Med, Dublin 2, Ireland	Trinity College Dublin; Teagasc; University College Dublin	Finlay, EK (corresponding author), Trinity Coll Dublin, Dept Genet, Smurfit Inst, Dublin, Ireland.	dbradley@tcd.ie	Berry, Donagh/J-7616-2012; Gormley, Eamonn/AAU-6678-2020	Berry, Donagh/0000-0003-4349-1447; Gormley, Eamonn/0000-0003-3900-0393; Finlay, Emma/0000-0003-0621-2744; Bradley, Daniel G/0000-0001-7335-7092	Irish Department of Agriculture, Fisheries and Food [06409]; Science Foundation Ireland PI [09/IN.1/B2642]; European Union [KBBE-211602-MACROSYS]	Irish Department of Agriculture, Fisheries and Food; Science Foundation Ireland PI(Science Foundation Ireland); European Union(European Commission)	The work was funded by the Irish Department of Agriculture, Fisheries and Food's Research Stimulus Fund, grant number 06409. DGB is a Science Foundation Ireland PI, grant number 09/IN.1/B2642. We also acknowledge support from European Union Framework 7 Project Grant (No: KBBE-211602-MACROSYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Bellamy R, 2005, CLIN CHEST MED, V26, P233, DOI 10.1016/j.ccm.2005.02.006; Bellamy R, 2006, MICROBES INFECT, V8, P1119, DOI 10.1016/j.micinf.2005.10.025; Bermingham ML, 2010, J DAIRY SCI, V93, P5413, DOI 10.3168/jds.2009-2925; Bermingham ML, 2009, J DAIRY SCI, V92, P3447, DOI 10.3168/jds.2008-1848; Bishop SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008940; Brotherstone S, 2010, J DAIRY SCI, V93, P1234, DOI 10.3168/jds.2009-2609; Carmichael J., 1941, VET JOUR, V97, P329; Chandra N, 2011, TUBERCULOSIS EDINB; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Delic D, 2010, INFECT IMMUN, V78, P1642, DOI 10.1128/IAI.01159-09; Driscoll EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018806; Falconer D. S, 1996, INTRO QUANTITATIVE G; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gilmour AR, 2009, ASREML USER GUIDE RE; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hewinson RG, 2006, VET MICROBIOL, V112, P127, DOI 10.1016/j.vetmic.2005.11.050; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Li C, 2004, J ANIM SCI, V82, P967; Mackintosh CG, 2000, INFECT IMMUN, V68, P1620, DOI 10.1128/IAI.68.3.1620-1625.2000; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meade KG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-400; Mochizuki T, 2002, FEBS LETT, V517, P92, DOI 10.1016/S0014-5793(02)02584-X; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; Neill SD, 2001, TUBERCULOSIS, V81, P79, DOI 10.1054/tube.2000.0279; Park E, 1997, J LEUKOCYTE BIOL, V61, P161, DOI 10.1002/jlb.61.2.161; PARK E, 1993, J LEUKOCYTE BIOL, V54, P119, DOI 10.1002/jlb.54.2.119; Park E, 2002, CLIN IMMUNOL, V102, P179, DOI 10.1006/clim.2001.5160; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Perry B. D, 2002, INVESTING ANIMAL HLT; Phillips Clive J. C., 2002, Animal Health Research Reviews, V3, P3, DOI 10.1079/AHRR200236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quinn MR, 1996, IMMUNOL LETT, V50, P185, DOI 10.1016/0165-2478(96)02542-4; Raman K, 2010, MOL BIOSYST, V6, P516, DOI 10.1039/b912129c; Redmond HP, 1998, NUTRITION, V14, P599, DOI 10.1016/S0899-9007(98)00097-5; Redmond HP, 1995, SURG FORUM, V45, P573; RITACCO V, 1991, RES VET SCI, V50, P365, DOI 10.1016/0034-5288(91)90143-C; Rockel N, 2007, J IMMUNOL, V179, P3604, DOI 10.4049/jimmunol.179.6.3604; Sahana G, 2010, ANIM GENET, V41, P579, DOI 10.1111/j.1365-2052.2010.02064.x; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Sheridan M, 2011, VET MICROBIOL, V151, P160, DOI 10.1016/j.vetmic.2011.02.040; Smith NH, 2011, INFECT GENET EVOL; Stapleton PP, 1997, J LEUKOCYTE BIOL, V61, P231, DOI 10.1002/jlb.61.2.231; Warskulat U, 2007, METHOD ENZYMOL, V428, P439, DOI 10.1016/S0076-6879(07)28025-5; Waters WR, 2011, CLIN DEV IMMUNOLOGY; Yim JJ, 2010, RESPIROLOGY, V15, P241, DOI 10.1111/j.1440-1843.2009.01690.x	50	61	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30545	10.1371/journal.pone.0030545	http://dx.doi.org/10.1371/journal.pone.0030545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355315	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300015
J	Richer, MJ; Lavallee, DJ; Shanina, I; Horwitz, MS				Richer, Martin J.; Lavallee, Danielle J.; Shanina, Iryna; Horwitz, Marc S.			Immunomodulation of Antigen Presenting Cells Promotes Natural Regulatory T Cells That Prevent Autoimmune Diabetes in NOD Mice	PLOS ONE			English	Article							TGF-BETA; CUTTING EDGE; COXSACKIEVIRUS INFECTION; VIRAL-INFECTIONS; INDUCTION; HOMEOSTASIS; VIRUS; FOXP3; COSTIMULATION; ACCELERATION	Progression towards type 1 diabetes (T1D) in susceptible patients is linked to a progressive decline in the capacity of regulatory T cells (Treg) to maintain tolerance. As such, therapies aimed at redressing the failing Treg compartment have been the subject of intense investigation. Treg dysfunction in T1D has recently been linked to a reduced capacity of antigen presenting cells (APCs) to maintain Treg function rather than Treg intrinsic defects. This suggests that therapies aimed simply at addressing the failing Treg compartment are unlikely to provide long-term protection. Here, we demonstrate that modulation of the inflammatory status of CD11b+CD11c- APCs favors the upregulation of protective Tregs in a mouse model of T1D. We further demonstrate that reduced expression of the costimulatory molecule CD40 plays a role in this increased immunoregulatory capacity. Strikingly, Treg upregulation resulted exclusively from an increase in natural Tregs rather than the peripheral conversion of conventional T cells. This suggests that modulation of CD11b+CD11c- APCs inflammatory properties favors the establishment of natural Treg responses that, unlike adaptive Treg responses, are likely to maintain tolerance to a broad range of antigens. As such, modulation of this APC subset represents a potential therapeutic avenue to reestablish peripheral tolerance and protect from autoimmune diseases such as T1D.	[Richer, Martin J.; Lavallee, Danielle J.; Shanina, Iryna; Horwitz, Marc S.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Richer, MJ (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	mhorwitz@mail.ubc.ca			Canadian Institutes of Health Research; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported by grants from the Canadian Institutes of Health Research and the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alard P, 2006, DIABETES, V55, P2098, DOI 10.2337/db05-0810; Anderson AC, 2008, J IMMUNOL, V181, P7449, DOI 10.4049/jimmunol.181.11.7449; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Bradshaw EM, 2009, J IMMUNOL, V183, P4432, DOI 10.4049/jimmunol.0900576; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Cui GL, 2009, CELL RES, V19, P574, DOI 10.1038/cr.2009.12; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Fairweather D, 2009, J AUTOIMMUN, V33, P222, DOI 10.1016/j.jaut.2009.09.012; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Filippi CM, 2009, J CLIN INVEST, V119, P1515, DOI 10.1172/JCI38503; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Ford ML, 2009, IMMUNOL REV, V229, P294, DOI 10.1111/j.1600-065X.2009.00776.x; Gaddy DF, 2010, DIABETES, V59, P3108, DOI 10.2337/db09-1886; Gregg RK, 2004, J IMMUNOL, V173, P7308, DOI 10.4049/jimmunol.173.12.7308; Gregori S, 2003, J IMMUNOL, V171, P4040, DOI 10.4049/jimmunol.171.8.4040; Guiducci C, 2005, EUR J IMMUNOL, V35, P557, DOI 10.1002/eji.200425810; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Horwitz MS, 2006, VIRAL IMMUNOL, V19, P722, DOI 10.1089/vim.2006.19.722; Horwitz MS, 2004, CLIN IMMUNOL, V110, P134, DOI 10.1016/j.clim.2003.09.014; Horwitz MS, 2002, J CLIN INVEST, V109, P79, DOI 10.1172/JCI11198; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; Jahromi MM, 2006, ANN NY ACAD SCI, V1079, P289, DOI 10.1196/annals.1375.044; Jin Y, 2009, CLIN IMMUNOL, V130, P272, DOI 10.1016/j.clim.2008.10.005; Jun HS, 2003, DIABETES-METAB RES, V19, P8, DOI 10.1002/dmrr.337; King C, 1998, IMMUNITY, V8, P601, DOI 10.1016/S1074-7613(00)80565-8; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kumanogoh A, 2001, J IMMUNOL, V166, P353, DOI 10.4049/jimmunol.166.1.353; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Manirarora JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003739; OLDSTONE MBA, 1988, SCIENCE, V239, P500, DOI 10.1126/science.3277269; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Richer MJ, 2008, DIABETES, V57, P1302, DOI 10.2337/db07-1460; Richer MJ, 2006, CLIN IMMUNOL, V121, P339, DOI 10.1016/j.clim.2006.07.009; Richer MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004127; Richer MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P4241, DOI 10.2741/3002; Riedel MJ, 2010, GENE THER, V17, P171, DOI 10.1038/gt.2009.143; Salama AD, 2003, J EXP MED, V198, P71, DOI 10.1084/jem.20022119; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Serreze DV, 2005, J VIROL, V79, P1045, DOI 10.1128/JVI.79.2.1045-1052.2005; Serreze DV, 2000, DIABETES, V49, P708, DOI 10.2337/diabetes.49.5.708; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Walker LSK, 2008, EXPERT OPIN BIOL TH, V8, P1691, DOI 10.1517/14712598.8.11.1691 ; WEBB SR, 1976, J EXP MED, V143, P1239, DOI 10.1084/jem.143.5.1239; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; Zhang XM, 2001, J IMMUNOL, V167, P4245, DOI 10.4049/jimmunol.167.8.4245; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	53	10	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31153	10.1371/journal.pone.0031153	http://dx.doi.org/10.1371/journal.pone.0031153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355341	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300041
J	Lee, SH; Che, X; Jeong, JH; Choi, JY; Lee, YJ; Lee, YH; Bae, SC; Lee, YM				Lee, Sun-Hee; Che, Xiangguo; Jeong, Jae-Hwan; Choi, Je-Yong; Lee, Young-Joo; Lee, Yong-Hee; Bae, Suk-Chul; Lee, You-Mie			Runx2 Protein Stabilizes Hypoxia-inducible Factor-1 alpha through Competition with von Hippel-Lindau Protein (pVHL) and Stimulates Angiogenesis in Growth Plate Hypertrophic Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCHONDRAL BONE-FORMATION; TRANSCRIPTION FACTOR; INDIAN-HEDGEHOG; VASCULAR CONTRIBUTION; GENE-EXPRESSION; CARTILAGE; DIFFERENTIATION; HIF-1-ALPHA; OSSIFICATION; CANCER	The regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) during endochondral bone formation is not fully understood. Here, we investigated the cross-talk between HIF-1 alpha and Runt-related transcription factor 2 (Runx2) in the growth plate. Runx2 caused the accumulation of HIF-1 alpha protein in ATDC5 chondrocytes and HEK293 cells under normoxic conditions. Runx2 also increased the nuclear translocation of HIF-1 alpha when coexpressed in HEK293 cells and interacted with HIF-1 alpha at the oxygen-dependent degradation domain (ODDD). In addition, Runx2 competed with von Hippel-Lindau tumor suppressor protein by directly binding to ODDD-HIF-1 alpha and significantly inhibited the ubiquitination of HIF-1 alpha, even though Runx2 did not change the hydroxylation status of HIF-1 alpha. Furthermore, overexpression of Runx2 resulted in the significant enhancement of vascular endothelial growth factor (VEGF) promoter reporter activity and protein secretion. Runx2 significantly increased angiogenic activity in human umbilical vein endothelial cells in vitro. In wild-type mice, HIF-1 alpha and Runx2 were colocalized in hypertrophic chondrocytes in which the cluster of differentiation 31 (CD31) protein was expressed at embryonic day 15.5 (E15.5). In contrast, the expression of HIF-1 alpha was markedly reduced in areas of CD31 expression in Runx2(-/-) mice. These results suggest that Runx2 stabilizes HIF-1 alpha by binding to ODDD to block the interaction between von Hippel-Lindau protein and HIF-1 alpha. In conclusion, Runx2, HIF-1 alpha, and VEGF may regulate vascular angiogenesis spatially and temporally in the hypertrophic zone of the growth plate during endochondral bone formation.	[Lee, You-Mie] Kyungpook Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Taegu 702701, South Korea; [Lee, Sun-Hee; Lee, You-Mie] Coll Nat Sci, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Che, Xiangguo; Jeong, Jae-Hwan; Choi, Je-Yong] Kyungpook Natl Univ, Sch Med, Taegu 700842, South Korea; [Lee, Young-Joo] Sejong Univ, Dept Biosci & Biotechnol, Seoul 142747, South Korea; [Lee, Yong-Hee; Bae, Suk-Chul] Chungbuk Natl Univ, Sch Med, Cheongju 361764, South Korea	Kyungpook National University; Kyungpook National University; Sejong University; Chungbuk National University	Lee, YM (corresponding author), Kyungpook Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, 80 Daehak Ro, Taegu 702701, South Korea.	lym@knu.ac.kr	Choi, Je-Yong/AAR-7334-2021	Choi, Je-Yong/0000-0002-5057-8842	Korea Science and Engineering Foundation [R01-2006-000-11046-0]; Korean Government Ministry of Science and Technology; National Research Foundation of Korea [2010-0026741, 2009-0084887]; Ministry of Education, Science and Technology	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean Government Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation Grant R01-2006-000-11046-0 funded by the Korean Government Ministry of Science and Technology and by the Mid-career Researcher Program through the National Research Foundation of Korea Grants 2010-0026741 and 2009-0084887 funded by the Ministry of Education, Science and Technology.	Anglin Ian, 2004, Cancer Treat Res, V119, P189; Brahimi-Horn C, 2001, TRENDS CELL BIOL, V11, pS32, DOI 10.1016/S0962-8924(01)02126-2; CANCEDDA FD, 1995, EUR J CELL BIOL, V66, P60; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; IYAMA K, 1991, ANAT RECORD, V229, P462, DOI 10.1002/ar.1092290405; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jang GH, 2010, FEBS LETT, V584, P141, DOI 10.1016/j.febslet.2009.11.031; Jeong JH, 2008, J CELL PHYSIOL, V217, P511, DOI 10.1002/jcp.21524; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jung MH, 2009, CARCINOGENESIS, V30, P655, DOI 10.1093/carcin/bgp039; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Khan WS, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2211; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; KUETTNER KE, 1983, CIBA F SYMP, V100, P163; Kwon TG, 2011, J CELL BIOCHEM, V112, P3582, DOI 10.1002/jcb.23289; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lin L, 2011, MOL THER, V19, P1426, DOI 10.1038/mt.2011.101; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; NINOMIYA Y, 1986, J BIOL CHEM, V261, P5041; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Peng ZG, 2008, ONCOGENE, V27, P839, DOI 10.1038/sj.onc.1210676; Peng ZH, 2006, CLIN CANCER RES, V12, P6386, DOI 10.1158/1078-0432.CCR-05-2359; Provot S, 2007, ANN NY ACAD SCI, V1117, P26, DOI 10.1196/annals.1402.076; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Riddle RC, 2009, J MOL MED, V87, P583, DOI 10.1007/s00109-009-0477-9; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schipani E, 2005, SEMIN CELL DEV BIOL, V16, P539, DOI 10.1016/j.semcdb.2005.03.003; Schipani E, 2001, GENE DEV, V15, P2865; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; TRUETA J, 1963, J BONE JOINT SURG BR, V45, P572, DOI 10.1302/0301-620X.45B3.572; TRUETA J, 1960, J BONE JOINT SURG BR, V42, P571, DOI 10.1302/0301-620X.42B3.571; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053	42	74	76	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14760	14771		10.1074/jbc.M112.340232	http://dx.doi.org/10.1074/jbc.M112.340232			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22351759	Green Published, hybrid			2022-12-25	WOS:000304003200041
J	Young, MM; Takahashi, Y; Khan, O; Park, S; Hori, T; Yun, J; Sharma, AK; Amin, S; Hu, CD; Zhang, JK; Kester, M; Wang, HG				Young, Megan M.; Takahashi, Yoshinori; Khan, Osman; Park, Sungman; Hori, Tsukasa; Yun, Jong; Sharma, Arun K.; Amin, Shantu; Hu, Chang-Deng; Zhang, Jianke; Kester, Mark; Wang, Hong-Gang			Autophagosomal Membrane Serves as Platform for Intracellular Death-inducing Signaling Complex (iDISC)-mediated Caspase-8 Activation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; SPHINGOSINE KINASE; MEDIATED CLEAVAGE; DEGRADATION; INHIBITION; CHLOROQUINE; BECLIN-1; BIF-1; MACROAUTOPHAGY; MITOCHONDRIA	Autophagy and apoptosis are two evolutionarily conserved processes that regulate cell fate in response to cytotoxic stress. However, the functional relationship between these two processes remains far from clear. Here, we demonstrate an autophagy-dependent mechanism of caspase-8 activation and initiation of the apoptotic cascade in response to SKI-I, a pan-sphingosine kinase inhibitor, and bortezomib, a proteasome inhibitor. Autophagy is induced concomitantly with caspase-8 activation, which is responsible for initiation of the caspase cascade and the mitochondrial amplification loop that is required for full execution of apoptosis. Inhibition of autophagosome formation by depletion of Atg5 or Atg3 results in a marked suppression of caspase-8 activation and apoptosis. Although caspase-8 self-association depends on p62/SQSTM1, its self-processing requires the autophagosomal membrane. Caspase-8 forms a complex with Atg5 and colocalizes with LC3 and p62. Moreover, FADD, an adaptor protein for caspase-8 activation, associates with Atg5 on Atg16L- and LC3-positive autophagosomal membranes and loss of FADD suppresses cell death. Taken together, these results indicate that the autophagosomal membrane serves as a platform for an intracellular death-inducing signaling complex (iDISC) that recruits self-associated caspase-8 to initiate the caspase-8/-3 cascade.	[Young, Megan M.; Takahashi, Yoshinori; Khan, Osman; Park, Sungman; Hori, Tsukasa; Yun, Jong; Sharma, Arun K.; Amin, Shantu; Kester, Mark; Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Young, Megan M.; Takahashi, Yoshinori; Khan, Osman; Park, Sungman; Hori, Tsukasa; Yun, Jong; Sharma, Arun K.; Amin, Shantu; Kester, Mark; Wang, Hong-Gang] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA 17033 USA; [Hu, Chang-Deng] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Zhang, Jianke] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Jefferson University	Wang, HG (corresponding author), 500 Univ Dr, Hershey, PA 17033 USA.	huw11@psu.edu	Wang, Hong-Gang/A-3018-2015; Kester, Mark/ABG-4615-2020	Wang, Hong-Gang/0000-0003-0551-0571; Young, Megan/0000-0003-1751-9979; Zhang, Jianke/0000-0002-5822-2226; Sharma, Arun/0000-0002-7679-7779; Yun, Jong/0000-0001-9476-7795; Takahashi, Yoshinori/0000-0002-8004-4817	National Institutes of Health [CA82197, CA129682]; NATIONAL CANCER INSTITUTE [R01CA082197, R01CA129682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA82197 and CA129682.	Beljanski V, 2010, J PHARMACOL EXP THER, V333, P454, DOI 10.1124/jpet.109.163337; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bonhoure E, 2006, LEUKEMIA, V20, P95, DOI 10.1038/sj.leu.2404023; Briceno Eduardo, 2003, Neurosurg Focus, V14, pe3; Cho DH, 2009, CANCER LETT, V274, P95, DOI 10.1016/j.canlet.2008.09.004; Coroneos E, 1996, BIOCHEM J, V316, P13, DOI 10.1042/bj3160013; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Edsall LC, 2001, J NEUROCHEM, V76, P1573, DOI 10.1046/j.1471-4159.2001.00164.x; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2003, CANCER RES, V63, P5962; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Giansanti V, 2011, APOPTOSIS, V16, P321, DOI 10.1007/s10495-011-0589-x; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hengst JA, 2010, BIOORG MED CHEM LETT, V20, P7498, DOI 10.1016/j.bmcl.2010.10.005; Hu C, 2008, BIOORGAN MED CHEM, V16, P7888, DOI 10.1016/j.bmc.2008.07.076; Jiang H, 2011, J VIROL, V85, P4720, DOI 10.1128/JVI.02032-10; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Laussmann MA, 2011, CELL DEATH DIFFER, V18, P1584, DOI 10.1038/cdd.2011.27; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Limaye V, 2005, BLOOD, V105, P3169, DOI 10.1182/blood-2004-02-0452; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Mullen T. D., 2011, ANTICANCER AGENTS ME; Myeku N, 2011, J BIOL CHEM, V286, P22426, DOI 10.1074/jbc.M110.149252; Nelson DA, 2004, GENE DEV, V18, P1223, DOI 10.1101/gad.1212404; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Qin ZH, 2001, J BIOL CHEM, V276, P8079, DOI 10.1074/jbc.M007028200; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Sharma AK, 2010, EUR J MED CHEM, V45, P4149, DOI 10.1016/j.ejmech.2010.06.005; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Yamaguchi H, 2008, J BIOL CHEM, V283, P19112, DOI 10.1074/jbc.M709882200; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhao H, 2005, RADIAT RES, V164, P250, DOI 10.1667/RR3436.1	60	260	270	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12455	12468		10.1074/jbc.M111.309104	http://dx.doi.org/10.1074/jbc.M111.309104			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22362782	hybrid, Green Published			2022-12-25	WOS:000302782200085
J	Jonas, RA; Yuan, TF; Liang, YX; Jonas, JB; Tay, DKC; Ellis-Behnke, RG				Jonas, Rahul A.; Yuan, Ti-Fei; Liang, Yu-Xiang; Jonas, Jost B.; Tay, David K. C.; Ellis-Behnke, Rutledge G.			The Spider Effect: Morphological and Orienting Classification of Microglia in Response to Stimuli in Vivo	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN; CELLS; MACROPHAGES; INFLAMMATION; MIGRATION; ACTIVATION; DISEASE; LESIONS; INJURY	The different morphological stages of microglial activation have not yet been described in detail. We transected the olfactory bulb of rats and examined the activation of the microglial system histologically. Six stages of bidirectional microglial activation (A) and deactivation (R) were observed: from stage 1A to 6A, the cell body size increased, the cell process number decreased, and the cell processes retracted and thickened, orienting toward the direction of the injury site; until stage 6A, when all processes disappeared. In contrast, in deactivation stages 6R to 1R, the microglia returned to the original site exhibiting a stepwise retransformation to the original morphology. Thin highly branched processes re-formed in stage 1R, similar to those in stage 1A. This reverse transformation mirrored the forward transformation except in stages 6R to 1R: cells showed multiple nuclei which were slowly absorbed. Our findings support a morphologically defined stepwise activation and deactivation of microglia cells.	[Jonas, Rahul A.; Jonas, Jost B.; Ellis-Behnke, Rutledge G.] Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, D-6800 Mannheim, Germany; [Yuan, Ti-Fei; Liang, Yu-Xiang; Tay, David K. C.; Ellis-Behnke, Rutledge G.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Liang, Yu-Xiang; Ellis-Behnke, Rutledge G.] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Ellis-Behnke, Rutledge G.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Ruprecht Karls University Heidelberg; University of Hong Kong; University of Hong Kong; Massachusetts Institute of Technology (MIT)	Jonas, RA (corresponding author), Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, D-6800 Mannheim, Germany.	rutledge@medma.uni-heidelberg.de	Jonas, Rahul A/N-9304-2017	Jonas, Rahul/0000-0002-5389-3047				ALROY J, 1987, HISTOCHEMISTRY, V86, P603, DOI 10.1007/BF00489554; Carbonell WS, 2005, J NEUROSCI, V25, P7040, DOI 10.1523/JNEUROSCI.5171-04.2005; Chew LJ, 2006, MENT RETARD DEV D R, V12, P105, DOI 10.1002/mrdd.20102; COLTON CA, 2009, CNS NEUROL DISORD DR; Dissing-Olesen L, 2007, NEUROSCIENCE, V149, P112, DOI 10.1016/j.neuroscience.2007.06.037; Duan YL, 2003, J NEUROBIOL, V57, P183, DOI 10.1002/neu.10262; Fischer HG, 2001, J IMMUNOL, V166, P2717, DOI 10.4049/jimmunol.166.4.2717; FORD AL, 1995, J IMMUNOL, V154, P4309; GEHRMANN J, 1993, GLIA, V7, P50, DOI 10.1002/glia.440070110; Gehrmann J, 1996, RES VIROLOGY, V147, P79, DOI 10.1016/0923-2516(96)80220-2; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Imai F, 1997, NEUROSCI LETT, V237, P49, DOI 10.1016/S0304-3940(97)00808-2; Kettenmann H, 1999, Adv Neurol, V79, P565; Lam D, 2009, MOL VIS, V15, P2217; Magnus T, 2002, J NEUROPATH EXP NEUR, V61, P760, DOI 10.1093/jnen/61.9.760; MCGLADEMCCULLOH E, 1989, P NATL ACAD SCI USA, V86, P1093, DOI 10.1073/pnas.86.3.1093; Ohsawa K, 2010, GLIA, V58, P790, DOI 10.1002/glia.20963; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Soulet D, 2008, CURR BIOL, V18, pR506, DOI 10.1016/j.cub.2008.04.047; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Streit WJ, 2005, BRAIN RES REV, V48, P234, DOI 10.1016/j.brainresrev.2004.12.013; WILLIAMS K, 1994, ADV NEUROIMMUNOL, V4, P273, DOI 10.1016/S0960-5428(06)80267-6; Wohl SG, 2010, INVEST OPHTH VIS SCI, V51, P2686, DOI 10.1167/iovs.09-4537	25	86	86	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30763	10.1371/journal.pone.0030763	http://dx.doi.org/10.1371/journal.pone.0030763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363486	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700011
J	Van Gameren-Oosterom, HBM; Van Dommelen, P; Oudesluys-Murphy, AM; Buitendijk, SE; Van Buuren, S; Van Wouwe, JP				Van Gameren-Oosterom, Helma B. M.; Van Dommelen, Paula; Oudesluys-Murphy, Anne Marie; Buitendijk, Simone E.; Van Buuren, Stef; Van Wouwe, Jacobus P.			Healthy Growth in Children with Down Syndrome	PLOS ONE			English	Article							BODY-MASS INDEX; HEAD CIRCUMFERENCE; DUTCH CHILDREN; HEIGHT; WEIGHT; CURVES; CHARTS; BIRTH; REFERENCES; CARE	Objective: To provide cross-sectional height and head circumference (HC) references for healthy Dutch children with Down syndrome (DS), while considering the influence of concomitant disorders on their growth, and to compare growth between children with DS and children from the general population. Study design: Longitudinal growth and medical data were retrospectively collected from medical records in 25 of the 30 regional hospital-based outpatient clinics for children with DS in the Netherlands. Children with Trisomy 21 karyotype of Dutch descent born after 1982 were included. The LMS method was applied to fit growth references. Results: We enrolled 1,596 children, and collected 10,558 measurements for height and 1,778 for HC. Children with DS without concomitant disorders (otherwise healthy children) and those suffering only from mild congenital heart defects showed similar growth patterns. The established growth charts, based on all measurements of these two groups, demonstrate the three age periods when height differences between children with and without DS increase: during pregnancy, during the first three years of life, and during puberty. This growth pattern results in a mean final height of 163.4 cm in boys and 151.8 cm in girls (-2.9 standard deviation (SD) and -3.0 SD on general Dutch charts, respectively). Mean HC (0 to 15 months) was 2 SD less than in the general Dutch population. The charts are available at www.tno.nl/growth. Conclusions: Height and HC references showed that growth retardation in otherwise healthy children with DS meanly occurs in three critical periods of growth, resulting in shorter final stature and smaller HC than the general Dutch population shows. With these references, health care professionals can optimize their preventive care: monitoring growth of individual children with DS optimal, so that growth retarding comorbidities can be identified early, and focusing on the critical age periods to establish ways to optimize growth.	[Van Gameren-Oosterom, Helma B. M.; Van Wouwe, Jacobus P.] Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands; [Van Gameren-Oosterom, Helma B. M.; Van Dommelen, Paula; Van Buuren, Stef] Netherlands Org Appl Sci Res TNO, Dept Life Style, Leiden, Netherlands; [Oudesluys-Murphy, Anne Marie] Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands; [Van Buuren, Stef] Univ Utrecht, Dept Methodol & Stat, FSS, Utrecht, Netherlands	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University	Van Gameren-Oosterom, HBM (corresponding author), Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands.	helma.vangameren@tno.nl	Van Wouwe, Jacobus P/D-5549-2018	Van Wouwe, Jacobus P/0000-0001-9273-6258; Oudesluys-Murphy, Anne Marie/0000-0003-2282-0571; van Buuren, Stef/0000-0003-1098-2119	Netherlands Organization for Health Research and Development (ZonMw) [150020031]; Tamarinde foundation (Stichting Tamarinde); Netherlands Organisation for Scientific Research (NWO)	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Tamarinde foundation (Stichting Tamarinde); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The study is financially supported by grant 150020031 from the Netherlands Organization for Health Research and Development (ZonMw) and by the Tamarinde foundation (Stichting Tamarinde). An additional funding is received for open access publication from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the maunscript.	Al Husain M, 2003, INT J CLIN PRACT, V57, P170; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Cole TJ, 1999, ANN HUM BIOL, V26, P303, DOI 10.1080/030144699282633; Cremers MJG, 1996, J INTELL DISABIL RES, V40, P412; CRONK C, 1988, PEDIATRICS, V81, P102; CRONK CE, 1978, PEDIATRICS, V61, P564; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Fredriks AM, 2004, ACTA PAEDIATR, V93, P817, DOI 10.1111/j.1651-2227.2004.tb03024.x; Fredriks AM, 2002, GROWTH CHARTS MANUAL; Grote FK, 2008, ARCH DIS CHILD, V93, P212, DOI 10.1136/adc.2007.120188; Hermanussen M, 2003, HORM RES, V59, P180, DOI 10.1159/000069321; Kamphuis Mascha, 2010, Ned Tijdschr Geneeskd, V154, pA2366; KARLBERG J, 1987, STAT MED, V6, P185, DOI 10.1002/sim.4780060210; Kimura J, 2003, ACTA PAEDIATR, V92, P1039, DOI 10.1080/08035250310004306; LYON AJ, 1985, ARCH DIS CHILD, V60, P932, DOI 10.1136/adc.60.10.932; Meguid N A, 2004, East Mediterr Health J, V10, P106; Myrelid A, 2002, ARCH DIS CHILD, V87, P97, DOI 10.1136/adc.87.2.97; PALMER CGS, 1992, AM J MED GENET, V42, P61, DOI 10.1002/ajmg.1320420114; PIRO E, 1990, AM J MED GENET, P66; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Styles ME, 2002, ARCH DIS CHILD, V87, P104, DOI 10.1136/adc.87.2.104; Talma H, 2010, GROWTH CHARTS 2010 M; Toledo C, 1999, ANN GENET-PARIS, V42, P81; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; van Buuren S, 2008, ARCH DIS CHILD, V93, P549, DOI 10.1136/adc.2007.136010; van Dommelen P, 2012, ARCH DIS CHILD, V97, DOI 10.1136/archdischild-2011-301095; Van Wouwe JP, 2001, NED TIJDSCHR GENEES, V145, P1617; Weijerman ME, 2010, EUR J PEDIATR, V169, P1195, DOI 10.1007/s00431-010-1200-0	30	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31079	10.1371/journal.pone.0031079	http://dx.doi.org/10.1371/journal.pone.0031079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363551	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600108
J	Green, J; Wang, D; Lilley, CJ; Urwin, PE; Atkinson, HJ				Green, Jayne; Wang, Dong; Lilley, Catherine J.; Urwin, Peter E.; Atkinson, Howard J.			Transgenic Potatoes for Potato Cyst Nematode Control Can Replace Pesticide Use without Impact on Soil Quality	PLOS ONE			English	Article							CONFERS RESISTANCE; GLOBODERA-PALLIDA; PLANT CYSTATIN; CELL-DEATH; EXPRESSION; DIVERSITY; FRAMEWORK; DISRUPTS	Current and future global crop yields depend upon soil quality to which soil organisms make an important contribution. The European Union seeks to protect European soils and their biodiversity for instance by amending its Directive on pesticide usage. This poses a challenge for control of Globodera pallida (a potato cyst nematode) for which both natural resistance and rotational control are inadequate. One approach of high potential is transgenically based resistance. This work demonstrates the potential in the field of a new transgenic trait for control of G. pallida that suppresses root invasion. It also investigates its impact and that of a second transgenic trait on the non-target soil nematode community. We establish that a peptide that disrupts chemoreception of nematodes without a lethal effect provides resistance to G. pallida in both a containment and a field trial when precisely targeted under control of a root tip-specific promoter. In addition we combine DNA barcoding and quantitative PCR to recognise nematode genera from soil samples without microscope-based observation and use the method for nematode faunal analysis. This approach establishes that the peptide and a cysteine proteinase inhibitor that offer distinct bases for transgenic plant resistance to G. pallida do so without impact on the nontarget nematode soil community.	[Green, Jayne; Wang, Dong; Lilley, Catherine J.; Urwin, Peter E.; Atkinson, Howard J.] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England	University of Leeds	Green, J (corresponding author), Adv Technol Cambridge Ltd, Cambridge, England.	p.e.urwin@leeds.ac.uk		Urwin, Peter Edward/0000-0003-0398-2372	Biotechnology and Biological Sciences Research Council, United Kingdom [BB/D001749/1]; Natural Environment Research Council, United Kingdom; BBSRC [BB/D001749/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D001749/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council, United Kingdom(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by research grant number BB/D001749/1 from the Biotechnology and Biological Sciences Research Council, United Kingdom. (http://www.bbsrc.ac.uk). DW was funded by a Dorothy Hodgkin post-graduate award from the Natural Environment Research Council, United Kingdom. (http://www.nerc.ac.uk) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, LAB METHODS WORK PLA; Atkinson HJ, 2004, DETERMINING RISKS SO; Baulcombe D., 2009, REAPING BENEFITS SCI, P72; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blum ES, 2008, CELL DEATH DIFFER, V15, P1124, DOI 10.1038/cdd.2008.56; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Canadian Food Inspection Agency Science Branch, 2008, OFF BIOT CONF RES FI; Celis C, 2004, NATURE, V432, P222, DOI 10.1038/nature03048; Clayton R, 2008, IMPACT REDUCED PESTI; Cowgill SE, 2004, MOL ECOL, V13, P639, DOI 10.1046/j.1365-294X.2004.02078.x; Cowgill SE, 2003, TRANSGENIC RES, V12, P439, DOI 10.1023/A:1024215922148; Cowgill SE, 2002, J APPL ECOL, V39, P915, DOI 10.1046/j.1365-2664.2002.00774.x; Dietze J., 1995, P24; Doran JW, 2000, APPL SOIL ECOL, V15, P3, DOI 10.1016/S0929-1393(00)00067-6; EC Regulation, 2009, OFFICIAL J EUROPEAN, V52, P1; European Commission Joint Research Institute of Health and Consumer Protection, 2010, DEL REL ENV GMOS AN; European Community Commission, 2010, SOIL BIOD FUNCT THRE, DOI [10.2779/14571, DOI 10.2779/14571]; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; Flemming AJ, 2000, P NATL ACAD SCI USA, V97, P5285, DOI 10.1073/pnas.97.10.5285; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Golden TR, 2007, AGING CELL, V6, P179, DOI 10.1111/j.1474-9726.2007.00273.x; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Ingham ER, 2000, SOIL BIOL PRIMER IOW; JEFFERIES RA, 1991, ANN APPL BIOL, V119, P387, DOI 10.1111/j.1744-7348.1991.tb04879.x; Leroy BLM, 2009, NEMATOLOGY, V11, P23, DOI 10.1163/156854108X398381; Lilley CJ, 2011, PLANT BIOTECHNOL J, V9, P151, DOI 10.1111/j.1467-7652.2010.00542.x; Lilley CJ, 2004, PLANT BIOTECHNOL J, V2, P3, DOI 10.1046/j.1467-7652.2003.00037.x; Liu B, 2005, PLANT BIOTECHNOL J, V3, P487, DOI 10.1111/j.1467-7652.2005.00139.x; Qian H, 2008, FASEB J, V22, P3247, DOI 10.1096/fj.08-110502; Sanchez-Moreno S, 2008, BIOL FERT SOILS, V44, P727, DOI 10.1007/s00374-007-0256-0; Sanchez-Moreno S, 2006, NEMATOLOGY, V8, P703, DOI 10.1163/156854106778877857; Trudgill David L., 1998, P117; Trudgill DL, 2003, ANN APPL BIOL, V143, P73, DOI 10.1111/j.1744-7348.2003.tb00271.x; Twining S, 2009, 20092 POT COUNC LTD; Urwin PE, 2003, MOL BREEDING, V12, P263, DOI 10.1023/A:1026352620308; URWIN PE, 1995, PLANT J, V8, P121, DOI 10.1046/j.1365-313X.1995.08010121.x; Urwin PE, 2001, MOL BREEDING, V8, P95, DOI 10.1023/A:1011942003994; Wang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017475; Winter MD, 2002, PARASITOLOGY, V125, P561, DOI 10.1017/S0031182002002482	39	21	22	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30973	10.1371/journal.pone.0030973	http://dx.doi.org/10.1371/journal.pone.0030973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359559	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200028
J	Hotte, M; Dauphin, F; Freret, T; Boulouard, M; Levallet, G				Hotte, Maite; Dauphin, Francois; Freret, Thomas; Boulouard, Michel; Levallet, Guenaelle			A Biphasic and Brain-Region Selective Down-Regulation of Cyclic Adenosine Monophosphate Concentrations Supports Object Recognition in the Rat	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; LONG-TERM-MEMORY; MEDIAL PREFRONTAL CORTEX; 5-HT4 RECEPTOR AGONISTS; KINASE-A; PHOSPHODIESTERASE ISOZYMES; CARDIAC MYOCYTES; MESSENGER-RNA; IN-VITRO; PARTICULATE PHOSPHODIESTERASE-4	Background: We aimed to further understand the relationship between cAMP concentration and mnesic performance. Methods and Findings: Rats were injected with milrinone (PDE3 inhibitor, 0.3 mg/kg, i.p.), rolipram (PDE4 inhibitor, 0.3 mg/kg, i.p.) and/or the selective 5-HT4R agonist RS 67333 (1 mg/kg, i.p.) before testing in the object recognition paradigm. Cyclic AMP concentrations were measured in brain structures linked to episodic-like memory (i.e. hippocampus, prefrontal and perirhinal cortices) before or after either the sample or the testing phase. Except in the hippocampus of rolipram treated-rats, all treatment increased cAMP levels in each brain sub-region studied before the sample phase. After the sample phase, cAMP levels were significantly increased in hippocampus (1.8 fold), prefrontal (1.3 fold) and perirhinal (1.3 fold) cortices from controls rat while decreased in prefrontal cortex (similar to 0.83 to 0.62 fold) from drug-treated rats (except for milrinone+RS 67333 treatment). After the testing phase, cAMP concentrations were still increased in both the hippocampus (2.76 fold) and the perirhinal cortex (2.1 fold) from controls animals. Minor increase were reported in hippocampus and perirhinal cortex from both rolipram (respectively, 1.44 fold and 1.70 fold) and milrinone (respectively 1.46 fold and 1.56 fold)-treated rat. Following the paradigm, cAMP levels were significantly lower in the hippocampus, prefrontal and perirhinal cortices from drug-treated rat when compared to controls animals, however, only drug-treated rats spent longer time exploring the novel object during the testing phase (inter-phase interval of 4 h). Conclusions: Our results strongly suggest that a "pre-sample" early increase in cAMP levels followed by a specific lowering of cAMP concentrations in each brain sub-region linked to the object recognition paradigm support learning efficacy after a middle-term delay.	[Hotte, Maite; Dauphin, Francois; Freret, Thomas; Boulouard, Michel; Levallet, Guenaelle] Univ Caen Basse Normandie, GMPc, EA4259, IFR 146, Caen, France; [Hotte, Maite] Univ Rouen, NeoVasc, EA 4309, IHURBM,IFRMP23, Rouen, France; [Levallet, Guenaelle] CHU Caen, Serv Anat Pathol, F-14000 Caen, France	Universite de Caen Normandie; Universite de Rouen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Hotte, M (corresponding author), Univ Caen Basse Normandie, GMPc, EA4259, IFR 146, Caen, France.	levallet-g@chu-caen.fr	Dauphin, Francois/B-1642-2012; freret, thomas/AAA-2491-2019; Levallet, Guenaelle GBL/L-1637-2015; freret, thomas/B-2068-2012; Michel, Boulouard/N-9028-2015	freret, thomas/0000-0002-4446-4451; freret, thomas/0000-0002-4446-4451; Michel, Boulouard/0000-0003-3825-8659				Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Aujla H, 2001, BEHAV NEUROSCI, V115, P1204, DOI 10.1037//0735-7044.115.6.1204; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Bernabeu R, 1996, NEUROREPORT, V7, P585, DOI 10.1097/00001756-199601310-00050; Bernabeu R, 1997, BRAZ J MED BIOL RES, V30, P961, DOI 10.1590/S0100-879X1997000800008; Besheer J, 1999, BEHAV BRAIN RES, V103, P35, DOI 10.1016/S0166-4328(99)00021-2; Bonaventure P, 2000, SYNAPSE, V36, P35, DOI 10.1002/(SICI)1098-2396(200004)36:1<35::AID-SYN4>3.0.CO;2-Y; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Bussey TJ, 2000, BEHAV BRAIN RES, V111, P187, DOI 10.1016/S0166-4328(00)00155-8; Chini CCS, 1997, J BIOL CHEM, V272, P9854; Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; Connolly DA, 1996, MEMORY, V4, P243, DOI 10.1080/096582196388942; DESJARDINS S, 1995, DRUG CHEM TOXICOL, V18, P43, DOI 10.3109/01480549509017857; Dodge-Kafka KL, 2010, J BIOL CHEM, V285, P11078, DOI 10.1074/jbc.M109.034868; Dousa Thomas P., 1998, Cell Biochemistry and Biophysics, V29, P19, DOI 10.1007/BF02737826; Dousa TP, 1999, KIDNEY INT, V55, P29, DOI 10.1046/j.1523-1755.1999.00233.x; EDELSON J, 1986, CIRCULATION, V73, P145; Egawa T, 1997, JPN J PHARMACOL, V75, P275, DOI 10.1254/jjp.75.275; EGLEN RM, 1995, BRIT J PHARMACOL, V115, P1387, DOI 10.1111/j.1476-5381.1995.tb16628.x; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Feschenko MS, 2002, J PHARMACOL EXP THER, V302, P111, DOI 10.1124/jpet.302.1.111; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Fontana DJ, 1997, NEUROPHARMACOLOGY, V36, P689, DOI 10.1016/S0028-3908(97)00055-5; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Galeotti N, 1998, J PHARMACOL EXP THER, V286, P1115; Giorgi M, 2004, BEHAV BRAIN RES, V154, P99, DOI 10.1016/j.bbr.2004.01.024; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; GRIEBEL G, 1991, PHARMACOL BIOCHEM BE, V39, P321, DOI 10.1016/0091-3057(91)90186-6; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Hotte M, 2006, BEHAV BRAIN RES, V171, P127, DOI 10.1016/j.bbr.2006.03.026; Houslay MD, 2001, PROG NUCLEIC ACID RE, V69, P249, DOI 10.1016/S0079-6603(01)69049-4; Houslay MD, 2003, BIOCHEM SOC T, V31, P1186; Hoyer D, 2004, P ANN INT IEEE EMBS, V26, P628; Huang Z, 2001, CURR OPIN CHEM BIOL, V5, P432, DOI 10.1016/S1367-5931(00)00224-6; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kelly MP, 2008, LEARN MEMORY, V15, P75, DOI 10.1101/lm.723708; King MV, 2008, TRENDS PHARMACOL SCI, V29, P482, DOI 10.1016/j.tips.2008.07.001; KRAUSE W, 1988, XENOBIOTICA, V18, P561, DOI 10.3109/00498258809041693; Lamirault L, 2003, PROG NEURO-PSYCHOPH, V27, P185, DOI 10.1016/S0278-5846(02)00351-2; Lamirault L, 2001, NEUROPHARMACOLOGY, V41, P844, DOI 10.1016/S0028-3908(01)00123-X; Lelong V, 2001, NEUROPHARMACOLOGY, V41, P517, DOI 10.1016/S0028-3908(01)00085-5; Letty S, 1997, NEUROPHARMACOLOGY, V36, P681, DOI 10.1016/S0028-3908(96)00169-4; Levallet G, 2008, J ENDOCRINOL, V197, P45, DOI 10.1677/JOE-07-0497; Levallet G, 2009, PSYCHOPHARMACOLOGY, V202, P125, DOI 10.1007/s00213-008-1283-8; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Lindsay CA, 1998, J PEDIATR-US, V132, P329, DOI 10.1016/S0022-3476(98)70454-8; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Marchetti E, 2008, NEUROBIOL LEARN MEM, V90, P185, DOI 10.1016/j.nlm.2008.03.010; Marchetti E, 2000, NEUROPHARMACOLOGY, V39, P2017, DOI 10.1016/S0028-3908(00)00038-1; MATOUSOVIC K, 1995, J CLIN INVEST, V96, P401, DOI 10.1172/JCI118049; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Meneses A, 2007, BEHAV BRAIN RES, V184, P81, DOI 10.1016/j.bbr.2007.06.026; Monti B, 2006, NEUROPSYCHOPHARMACOL, V31, P278, DOI 10.1038/sj.npp.1300813; Moon EY, 2003, BLOOD, V101, P4122, DOI 10.1182/blood-2002-10-3208; Moser PC, 2002, J PHARMACOL EXP THER, V302, P731, DOI 10.1124/jpet.102.034249; O'Donnell JM, 1999, PHARMACOL BIOCHEM BE, V63, P185, DOI 10.1016/S0091-3057(98)00267-6; Oliver C.J., 1998, FRONT BIOSCI, V3, P961; Orsetti M, 2003, LEARN MEMORY, V10, P420, DOI 10.1101/lm.67303; Parker A, 1998, EUR J NEUROSCI, V10, P3044, DOI 10.1046/j.1460-9568.1998.00306.x; Perez-Garcia G, 2008, BEHAV BRAIN RES, V195, P139, DOI 10.1016/j.bbr.2008.07.033; Pineda VV, 2004, NEURON, V41, P153, DOI 10.1016/S0896-6273(03)00813-4; Prickaerts J, 2002, EUR J PHARMACOL, V436, P83, DOI 10.1016/S0014-2999(01)01614-4; Pullar CE, 2006, FASEB J, V20, P76, DOI 10.1096/fj.05-4188com; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; RANDT CT, 1982, PHARMACOL BIOCHEM BE, V17, P677, DOI 10.1016/0091-3057(82)90344-6; Resjo S, 1999, BIOCHEM J, V341, P839, DOI 10.1042/0264-6021:3410839; Restivo L, 2008, NEUROPSYCHOPHARMACOL, V33, P2427, DOI 10.1038/sj.npp.1301644; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Rodriguez R, 2004, J APPL PHYSIOL, V97, P439, DOI 10.1152/japplphysiol.01115.2003; Rutten K, 2008, PSYCHOPHARMACOLOGY, V196, P643, DOI 10.1007/s00213-007-0999-1; Rutten K, 2006, NEUROBIOL LEARN MEM, V85, P132, DOI 10.1016/j.nlm.2005.09.002; Rutten K, 2007, EUR J PHARMACOL, V558, P107, DOI 10.1016/j.ejphar.2006.11.041; Rutten K, 2011, NEUROPHARMACOLOGY, V61, P138, DOI 10.1016/j.neuropharm.2011.03.020; Rutten K, 2009, NEUROPSYCHOPHARMACOL, V34, P1914, DOI 10.1038/npp.2009.24; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Silvestre JS, 1999, J PSYCHOPHARMACOL, V13, P274, DOI 10.1177/026988119901300309; Sim ATR, 2006, PHARMACOL THERAPEUT, V112, P425, DOI 10.1016/j.pharmthera.2006.04.011; Taylor JR, 1999, J NEUROSCI, V19; Terry AV, 1998, PSYCHOPHARMACOLOGY, V135, P407, DOI 10.1007/s002130050529; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; van Donkelaar EL, 2008, EUR J PHARMACOL, V600, P98, DOI 10.1016/j.ejphar.2008.10.027; Vilaro MT, 1996, MOL BRAIN RES, V43, P356, DOI 10.1016/S0169-328X(96)00248-3; Warburton EC, 2010, NEUROPSYCHOLOGIA, V48, P2262, DOI 10.1016/j.neuropsychologia.2009.12.022; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200; Zhang HT, 2009, CURR PHARM DESIGN, V15, P1688, DOI 10.2174/138161209788168092; Zhang HT, 2000, PSYCHOPHARMACOLOGY, V150, P311, DOI 10.1007/s002130000414; Zhang HT, 2004, NEUROPSYCHOPHARMACOL, V29, P1432, DOI 10.1038/sj.npp.1300440; Zhang HT, 2000, NEUROPSYCHOPHARMACOL, V23, P198, DOI 10.1016/S0893-133X(00)00108-1; Zhao J, 2010, NEUROPHARMACOLOGY, V58, P774, DOI 10.1016/j.neuropharm.2009.12.008	99	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32244	10.1371/journal.pone.0032244	http://dx.doi.org/10.1371/journal.pone.0032244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359674	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200143
J	Lacar, B; Herman, P; Hartman, NW; Hyder, F; Bordey, A				Lacar, Benjamin; Herman, Peter; Hartman, Nathaniel W.; Hyder, Fahmeed; Bordey, Angelique			S Phase Entry of Neural Progenitor Cells Correlates with Increased Blood Flow in the Young Subventricular Zone	PLOS ONE			English	Article							STEM-CELLS; IN-VIVO; OLFACTORY-BULB; VASCULAR NICHE; DENTATE GYRUS; GROWTH-FACTOR; CYCLE LENGTH; ADULT-RAT; BRAIN; PROLIFERATION	The postnatal subventricular zone (SVZ) contains proliferating neural progenitor cells in close proximity to blood vessels. Insults and drug treatments acutely stimulate cell proliferation in the SVZ, which was assessed by labeling cells entering S phase. Although G1-to-S progression is metabolically demanding on a minute-to-hour time scale, it remains unknown whether increased SVZ cell proliferation is accompanied by a local hemodynamic response. This neurovascular coupling provides energy substrates to active neuronal assemblies. Transcardial dye perfusion revealed the presence of capillaries throughout the SVZ that constrict upon applications of the thromboxane A(2) receptor agonist U-46119 in acute brain slice preparations. We then monitored in vivo blood flow using laser Doppler flowmetry via a microprobe located either in the SVZ or a mature network. U-46119 injections into the lateral ventricle decreased blood flow in the SVZ and the striatum, which are near the ventricle. A 1-hour ventricular injection of epidermal and basic fibroblast growth factor (EGF and bFGF) significantly increased the percentage of Sox2 transcription factor-positive cells in S phase 1.5 hours post-injection. This increase was accompanied by a sustained rise in blood flow in the SVZ but not in the striatum. Direct growth factor injections into the cortex did not alter local blood flow, ruling out direct effects on capillaries. These findings suggest that an acute increase in the number of G1-to-S cycling SVZ cells is accompanied by neurometabolic-vascular coupling, which may provide energy and nutrient for cell cycle progression.	[Lacar, Benjamin; Hartman, Nathaniel W.; Bordey, Angelique] Yale Univ, Sch Med, Dept Neurosurg & Cellular & Mol Physiol, New Haven, CT 06520 USA; [Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Hyder, Fahmeed] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Magnet Resonance Res Ctr, New Haven, CT USA; [Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Core Ctr Quantitat Neurosci Magnet Resonance, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University	Lacar, B (corresponding author), Yale Univ, Sch Med, Dept Neurosurg & Cellular & Mol Physiol, New Haven, CT 06520 USA.	angelique.bordey@yale.edu	Hyder, Fahmeed/A-2644-2015; Herman, Peter/E-7028-2010; Hartman, Nathaniel/P-7654-2014	Hyder, Fahmeed/0000-0001-7822-4002; Herman, Peter/0000-0003-2218-9652; Hartman, Nathaniel/0000-0003-4976-5525	National Institutes of Health (NIH) [R01 DC007681, P30 NS-052519]; Pardee foundation; National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS052519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007681] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) grant R01 DC007681 and the Pardee foundation (AB), by NIH grant P30 NS-052519 (FH), and by a National Science Foundation Graduate Research Fellowship (BL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Bordey A, 2006, CELL CYCLE, V5, P722, DOI 10.4161/cc.5.7.2614; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Craig CG, 1996, J NEUROSCI, V16, P2649; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fabricius M, 1996, J CEREBR BLOOD F MET, V16, P156, DOI 10.1097/00004647-199601000-00018; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kawamura H, 2003, J PHYSIOL-LONDON, V551, P787, DOI 10.1113/jphsiol.2003.047977; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Komitova M, 2009, J COMP NEUROL, V512, P702, DOI 10.1002/cne.21917; Lacar B, 2011, EUR J NEUROSCI, V34, P1895, DOI 10.1111/j.1460-9568.2011.07901.x; Lacza Z, 2001, STROKE, V32, P2609, DOI 10.1161/hs1101.098526; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Montcouquiol M, 2001, J NEUROSCI, V21, P974, DOI 10.1523/JNEUROSCI.21-03-00974.2001; Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; Radley JJ, 2003, BRAIN RES, V966, P1, DOI 10.1016/S0006-8993(02)03989-6; Roy C S, 1890, J Physiol, V11, P85; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sanganahalli BG, 2009, J NEUROSCI, V29, P1707, DOI 10.1523/JNEUROSCI.5549-08.2009; Sato A, 2010, NEUROSCI LETT, V470, P115, DOI 10.1016/j.neulet.2009.12.067; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; SHIPLEY GD, 1983, EXP CELL RES, V146, P261, DOI 10.1016/0014-4827(83)90128-3; Singleton MR, 2003, EMBO J, V22, P4579, DOI 10.1093/emboj/cdg441; Smith CM, 1998, DEV DYNAM, V213, P220, DOI 10.1002/(SICI)1097-0177(199810)213:2<220::AID-AJA7>3.0.CO;2-I; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; YEN A, 1978, EXP CELL RES, V114, P389, DOI 10.1016/0014-4827(78)90497-4; Young SZ, 2011, EUR J NEUROSCI, V33, P1123, DOI 10.1111/j.1460-9568.2011.07611.x; Zhang RL, 2006, J CEREBR BLOOD F MET, V26, P857, DOI 10.1038/sj.jcbfm.9600237	42	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31960	10.1371/journal.pone.0031960	http://dx.doi.org/10.1371/journal.pone.0031960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359646	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200115
J	Magnoni, LJ; Vraskou, Y; Palstra, AP; Planas, JV				Magnoni, Leonardo J.; Vraskou, Yoryia; Palstra, Arjan P.; Planas, Josep V.			AMP-Activated Protein Kinase Plays an Important Evolutionary Conserved Role in the Regulation of Glucose Metabolism in Fish Skeletal Muscle Cells	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; GLUT4 TRANSLOCATION; INSULIN SENSITIVITY; SIGNALING PATHWAYS; INTRACELLULAR POOL; GLYCOGEN-SYNTHASE; METFORMIN ACTION; GENE-EXPRESSION; AICAR TREATMENT; RAT MUSCLES	AMPK, a master metabolic switch, mediates the observed increase of glucose uptake in locomotory muscle of mammals during exercise. AMPK is activated by changes in the intracellular AMP:ATP ratio when ATP consumption is stimulated by contractile activity but also by AICAR and metformin, compounds that increase glucose transport in mammalian muscle cells. However, the possible role of AMPK in the regulation of glucose metabolism in skeletal muscle has not been investigated in other vertebrates, including fish. In this study, we investigated the effects of AMPK activators on glucose uptake, AMPK activity, cell surface levels of trout GLUT4 and expression of GLUT1 and GLUT4 as well as the expression of enzymes regulating glucose disposal and PGC1 alpha in trout myotubes derived from a primary muscle cell culture. We show that AICAR and metformin significantly stimulated glucose uptake (1.6 and 1.3 fold, respectively) and that Compound C completely abrogated the stimulatory effects of the AMPK activators on glucose uptake. The combination of insulin and AMPK activators did not result in additive nor synergistic effects on glucose uptake. Moreover, exposure of trout myotubes to AICAR and metformin resulted in an increase in AMPK activity (3.8 and 3 fold, respectively). We also provide evidence suggesting that stimulation of glucose uptake by AMPK activators in trout myotubes may take place, at least in part, by increasing the cell surface and mRNA levels of trout GLUT4. Finally, AICAR increased the mRNA levels of genes involved in glucose disposal (hexokinase, 6-phosphofructokinase, pyruvate kinase and citrate synthase) and mitochondrial biogenesis (PGC-1 alpha) and did not affect glycogen content or glycogen synthase mRNA levels in trout myotubes. Therefore, we provide evidence, for the first time in non-mammalian vertebrates, suggesting a potentially important role of AMPK in stimulating glucose uptake and utilization in the skeletal muscle of fish.	[Magnoni, Leonardo J.] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain; IBUB, Barcelona, Spain	University of Barcelona; University of Barcelona	Magnoni, LJ (corresponding author), Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain.	jplanas@ub.edu	Magnoni, Leonardo Julián/A-6275-2011; Palstra, Arjan/B-4122-2013	Magnoni, Leonardo Julián/0000-0001-8449-6071; Planas, Josep/0000-0002-6525-9617	Ministerio de Ciencia e Innovacion, Spain [CSD2007-0002, AGL2009-07006]; European Commission [235581]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the Ministerio de Ciencia e Innovacion, Spain (CSD2007-0002 and AGL2009-07006) to JVP. LJM was supported by a FP7-PIIF-2009 fellowship (Marie Curie Action) from the European Commission (GLUCOSE USE IN FISH) with grant agreement number 235581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2005, DIABETOLOGIA, V48, P1173, DOI 10.1007/s00125-005-1741-3; Aschenbach WG, 2002, DIABETES, V51, P567, DOI 10.2337/diabetes.51.3.567; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Bonen A, 2009, APPL PHYSIOL NUTR ME, V34, P307, DOI 10.1139/H09-008; BONTEMPS F, 1986, J CLIN INVEST, V77, P824, DOI 10.1172/JCI112379; Capilla E, 2002, AM J PHYSIOL-ENDOC M, V283, pE44, DOI 10.1152/ajpendo.00065.2002; Castillo J, 2006, AM J PHYSIOL-REG I, V290, pR1683, DOI 10.1152/ajpregu.00294.2005; CODERRE L, 1995, J BIOL CHEM, V270, P27584, DOI 10.1074/jbc.270.46.27584; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; Diaz M, 2007, ENDOCRINOLOGY, V148, P5248, DOI 10.1210/en.2007-0265; Diaz M, 2007, J EXP BIOL, V210, P2346, DOI 10.1242/jeb.002857; Diaz M, 2009, AM J PHYSIOL-REG I, V296, pR794, DOI 10.1152/ajpregu.90673.2008; DOBSON GP, 1987, J EXP BIOL, V129, P125; Dohm GL, 2002, J APPL PHYSIOL, V93, P782, DOI 10.1152/japplphysiol.01266.2001; Fauconneau F, 2000, CELL TISSUE RES, V301, P459, DOI 10.1007/s004419900168; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Halse R, 2003, DIABETES, V52, P9, DOI 10.2337/diabetes.52.1.9; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; HERTZ Y, 1989, AQUACULTURE, V80, P175, DOI 10.1016/0044-8486(89)90283-4; HOCHACHKA PW, 1992, J APPL PHYSIOL, V73, P1697, DOI 10.1152/jappl.1992.73.5.1697; Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005; Holloszy JO, 1996, REV PHYSIOL BIOCH P, V128, P99; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jessen N, 2005, J APPL PHYSIOL, V99, P330, DOI 10.1152/japplphysiol.00175.2005; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; Jibb LA, 2008, J EXP BIOL, V211, P3111, DOI 10.1242/jeb.019117; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Keppler D., 1974, METHOD ENZYMAT AN, V3, P1127, DOI DOI 10.1242/JEB.037275; Klip A, 1996, SEMIN CELL DEV BIOL, V7, P229, DOI 10.1006/scdb.1996.0031; KUBO K, 1986, AM J PHYSIOL, V250, pE100, DOI 10.1152/ajpendo.1986.250.1.E100; Kudo N, 1996, BBA-LIPID LIPID MET, V1301, P67, DOI 10.1016/0005-2760(96)00013-6; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lau G, 2011, J COMP PHYSIOL B, P1; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Leick L, 2010, AM J PHYSIOL-ENDOC M, V299, pE456, DOI 10.1152/ajpendo.00648.2009; LeMoine CMR, 2010, J COMP PHYSIOL B, V180, P151, DOI 10.1007/s00360-009-0398-5; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lira VA, 2010, J PHYSIOL-LONDON, V588, P3551, DOI 10.1113/jphysiol.2010.194035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLean PS, 2002, BIOCHEM BIOPH RES CO, V292, P409, DOI 10.1006/bbrc.2002.6654; McGee SL, 2006, CLIN EXP PHARMACOL P, V33, P395, DOI 10.1111/j.1440-1681.2006.04362.x; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Miyamoto L, 2007, J APPL PHYSIOL, V102, P1007, DOI 10.1152/japplphysiol.01034.2006; Moon TW, 2001, COMP BIOCHEM PHYS B, V129, P243, DOI 10.1016/S1096-4959(01)00316-5; Murgia M, 2009, J PHYSIOL-LONDON, V587, P4319, DOI 10.1113/jphysiol.2009.174888; Musi N, 2003, ACTA PHYSIOL SCAND, V178, P337, DOI 10.1046/j.1365-201X.2003.01168.x; NEUFER PD, 1993, AM J PHYSIOL, V265, pC1597; Niu WY, 2010, AM J PHYSIOL-ENDOC M, V298, pE1058, DOI 10.1152/ajpendo.00773.2009; Ojuka EO, 2000, J APPL PHYSIOL, V88, P1072, DOI 10.1152/jappl.2000.88.3.1072; Panserat S, 2009, AM J PHYSIOL-REG I, V297, pR707, DOI 10.1152/ajpregu.00120.2009; Planas JV, 2000, FEBS LETT, V481, P266, DOI 10.1016/S0014-5793(00)02020-2; Polakof S, 2011, AM J PHYSIOL-REG I, V300, pR166, DOI 10.1152/ajpregu.00619.2010; Polakof S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020228; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; REN JM, 1994, J BIOL CHEM, V269, P14396; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; Roy D, 1996, BIOCHEM BIOPH RES CO, V223, P147, DOI 10.1006/bbrc.1996.0860; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Sajan MP, 2010, AM J PHYSIOL-ENDOC M, V298, pE179, DOI 10.1152/ajpendo.00392.2009; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Stenslokken KO, 2008, AM J PHYSIOL-REG I, V295, pR1803, DOI 10.1152/ajpregu.90590.2008; Suwa M, 2003, J APPL PHYSIOL, V95, P960, DOI 10.1152/japplphysiol.00349.2003; Suwa M, 2006, J APPL PHYSIOL, V101, P1685, DOI 10.1152/japplphysiol.00255.2006; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Vraskou Y, 2011, AM J PHYSIOL-REG I, V300, pR716, DOI 10.1152/ajpregu.00514.2010; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Winder WW, 2001, J APPL PHYSIOL, V91, P1017, DOI 10.1152/jappl.2001.91.3.1017; Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284; Yang J, 2006, ENDOCRINOLOGY, V147, P2728, DOI 10.1210/en.2005-1433; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zierath JR, 2002, J APPL PHYSIOL, V93, P773, DOI 10.1152/japplphysiol.00126.2002	82	70	74	7	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31219	10.1371/journal.pone.0031219	http://dx.doi.org/10.1371/journal.pone.0031219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359576	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200045
J	Potter, CMF; Schobesberger, S; Lundberg, MH; Weinberg, PD; Mitchell, JA; Gorelik, J				Potter, Claire M. F.; Schobesberger, Sophie; Lundberg, Martina H.; Weinberg, Peter D.; Mitchell, Jane A.; Gorelik, Julia			Shape and Compliance of Endothelial Cells after Shear Stress In Vitro or from Different Aortic Regions: Scanning Ion Conductance Microscopy Study	PLOS ONE			English	Article							LOCAL MECHANICAL-PROPERTIES; NITRIC-OXIDE RELEASE; LIVING CELLS; ATHEROGENESIS	Objective: To measure the elongation and compliance of endothelial cells subjected to different patterns of shear stress in vitro, and to compare these parameters with the elongation and compliance of endothelial cells from different regions of the intact aorta. Materials and Methods: Porcine aortic endothelial cells were cultured for 6 days under static conditions or on an orbital shaker. The shaker generated a wave of medium, inducing pulsatile shear stress with a preferred orientation at the edge of the well or steadier shear stress with changing orientation at its centre. The topography and compliance of these cells and cells from the inner and outer curvature of ex vivo porcine aortic arches were measured by scanning ion conductance microscopy (SICM). Results: Cells cultured under oriented shear stress were more elongated and less compliant than cells grown under static conditions or under shear stress with no preferred orientation. Cells from the outer curvature of the aorta were more elongated and less compliant than cells from the inner curvature. Conclusion: The elongation and compliance of cultured endothelial cells vary according to the pattern of applied shear stress, and are inversely correlated. A similar inverse correlation occurs in the aortic arch, with variation between regions thought to experience different haemodynamic stresses.	[Potter, Claire M. F.; Schobesberger, Sophie; Lundberg, Martina H.; Mitchell, Jane A.; Gorelik, Julia] Natl Heart & Lung Inst, London, England; [Potter, Claire M. F.; Schobesberger, Sophie; Weinberg, Peter D.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	Imperial College London; Imperial College London	Potter, CMF (corresponding author), Natl Heart & Lung Inst, London, England.	j.a.mitchell@ic.ac.uk; j.gorelik@ic.ac.uk	; Slingsby, Martina H/B-1476-2015	Gorelik, Julia/0000-0003-1148-9158; Slingsby, Martina H/0000-0002-2620-7582; Lundberg, Martina H/0000-0001-6369-3041	British Heart Foundation Centre of Research Excellence at Imperial College London BHF [RE/08/02]; BBSRC [BB/D522711/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D522711/1] Funding Source: researchfish; British Heart Foundation [NH/10/3/28574] Funding Source: researchfish	British Heart Foundation Centre of Research Excellence at Imperial College London BHF; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	British Heart Foundation Centre of Research Excellence at Imperial College London BHF RE/08/02 (http://www.bhf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogle RG, 1996, J PHYSIOL-LONDON, V490, P229, DOI 10.1113/jphysiol.1996.sp021138; Bond AR, 2011, ARTERIOSCL THROM VAS, V31, P543, DOI 10.1161/ATVBAHA.110.219683; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; ESKIN SG, 1984, MICROVASC RES, V28, P87, DOI 10.1016/0026-2862(84)90031-1; Feneberg W, 2004, BIOPHYS J, V87, P1338, DOI 10.1529/biophysj.103.037044; FLAHERTY JT, 1972, CIRC RES, V30, P23, DOI 10.1161/01.RES.30.1.23; GOODE TB, 1977, ATHEROSCLEROSIS, V27, P235, DOI 10.1016/0021-9150(77)90061-2; Gorelik J, 2002, BIOPHYS J, V83, P3296, DOI 10.1016/S0006-3495(02)75330-7; HANSMA PK, 1989, SCIENCE, V243, P641, DOI 10.1126/science.2464851; Helmke BP, 2002, ANN BIOMED ENG, V30, P284, DOI 10.1114/1.1467926; Helmlinger GG, 1991, J BIOMECHANICAL ENG, P123; Kadir SHSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009689; Korchev YE, 1997, J MICROSC-OXFORD, V188, P17, DOI 10.1046/j.1365-2818.1997.2430801.x; LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567; Malek AM, 1996, J CELL SCI, V109, P713; Miragoli M, 2011, J R SOC INTERFACE, V8, P913, DOI 10.1098/rsif.2010.0597; Mott RE, 2007, AM J PHYSIOL-CELL PH, V293, pC1616, DOI 10.1152/ajpcell.00457.2006; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Novak P, 2009, NAT METHODS, V6, P279, DOI [10.1038/NMETH.1306, 10.1038/nmeth.1306]; Oberleithner H, 2009, P NATL ACAD SCI USA, V106, P2829, DOI 10.1073/pnas.0813069106; Potter CMF, 2011, ARTERIOSCL THROM VAS, V31, P384, DOI 10.1161/ATVBAHA.110.214031; REIDY MA, 1977, ATHEROSCLEROSIS, V28, P463, DOI 10.1016/0021-9150(77)90073-9; Sanchez D, 2008, BIOPHYS J, V95, P3017, DOI 10.1529/biophysj.108.129551; SATO M, 1987, ARTERIOSCLEROSIS, V7, P276, DOI 10.1161/01.ATV.7.3.276; Sato M, 2000, J BIOMECH, V33, P127, DOI 10.1016/S0021-9290(99)00178-5; Shevchuk AI, 2006, ANGEW CHEM INT EDIT, V45, P2212, DOI 10.1002/anie.200503915; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46	28	24	28	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31228	10.1371/journal.pone.0031228	http://dx.doi.org/10.1371/journal.pone.0031228			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359578	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200047
J	Pottiez, G; Jagadish, T; Yu, F; Letendre, S; Ellis, R; Duarte, NA; Grant, I; Gendelman, HE; Fox, HS; Ciborowski, P				Pottiez, Gwenael; Jagadish, Teena; Yu, Fang; Letendre, Scott; Ellis, Ronald; Duarte, Nichole A.; Grant, Igor; Gendelman, Howard E.; Fox, Howard S.; Ciborowski, Pawel			Plasma Proteomic Profiling in HIV-1 Infected Methamphetamine Abusers	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CLINICAL PROTEOMICS; YOUNG-ADULTS; HIV; BIOMARKERS; DISORDERS; SEX; MEN; RELIABILITY; COMPLEMENT	We wanted to determine whether methamphetamine use affects a subset of plasma proteins in HIV-infected persons. Plasma samples from two visits were identified for subjects from four groups: HIV+, ongoing, persistent METH use; HIV+, short-term METH abstinent; HIV+, long term METH abstinence; HIV negative, no history of METH use. Among 390 proteins identified, 28 showed significant changes in expression in the HIV+/persistent METH+ group over the two visits, which were not attributable to HIV itself. These proteins were involved in complement, coagulation pathways and oxidative stress. Continuous METH use is an unstable condition, altering levels of a number of plasma proteins.	[Pottiez, Gwenael; Jagadish, Teena; Gendelman, Howard E.; Fox, Howard S.; Ciborowski, Pawel] Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Yu, Fang] Univ Nebraska, Med Ctr, Omaha, NE USA; [Letendre, Scott; Ellis, Ronald; Duarte, Nichole A.; Grant, Igor] Univ Calif San Diego, San Diego, CA 92103 USA	University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California San Diego	Pottiez, G (corresponding author), Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	pciborowski@unmc.edu	Letendre, Scott L./GLU-6874-2022; Ellis, Ronald/K-3543-2015; Yu, Fang/B-9874-2013; Gendelman, Howard E/G-8242-2012	Ellis, Ronald/0000-0003-4931-752X; Fox, Howard/0000-0003-2032-374X	National Institutes of Health [P01DA026146, P30MH062261, P01NS043985, P50 DA26306]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS043985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA026306, P01DA026146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants P01DA026146, P30MH062261, P01NS043985, and P50 DA26306. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadet JL, 2007, NEUROTOX RES, V12, P181, DOI 10.1007/BF03033915; Cadet JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015643; Chana G, 2006, NEUROLOGY, V67, P1486, DOI 10.1212/01.wnl.0000240066.02404.e6; Ciborowski P, 2009, BIOMARK MED, V3, P771, DOI [10.2217/bmm.09.63, 10.2217/BMM.09.63]; Clark T, 2010, AIDS BEHAV; Degenhardt L, 2010, INT J DRUG POLICY, V21, P347, DOI 10.1016/j.drugpo.2009.11.007; Dowling P, 2011, PROTEOMICS, V11, P794, DOI 10.1002/pmic.201000530; Dunn BK, 2011, RECENT RESULTS CANC, V188, P21, DOI 10.1007/978-3-642-10858-7_3; Fournier PE, 2011, ANN REV MICROBIOL; Haverland N, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-137; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Imai K, 2011, BIOMED CHROMATOGR, V25, P59, DOI 10.1002/bmc.1541; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kiyatkin EA, 2009, INT REV NEUROBIOL, V88, P65, DOI 10.1016/S0074-7742(09)88004-5; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Letendre S, 2007, J INFECT DIS, V196, P361, DOI 10.1086/519285; Mahajan SD, 2008, BRAIN RES, V1203, P133, DOI 10.1016/j.brainres.2008.01.093; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Marshall BDL, 2010, ADDICTION, V105, P991, DOI 10.1111/j.1360-0443.2010.02932.x; Mertens I, 2004, PHARMACOGENOMICS, V5, P657, DOI 10.1517/14622416.5.6.657; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; Newsome SD, 2011, NEUROLOGY, V76, P787, DOI 10.1212/WNL.0b013e31820e7b4e; Peck JA, 2005, J ADDICT DIS, V24, P115, DOI 10.1300/J069v24n03_10; Pendyala G, 2010, J PROTEOME RES, V9, P352, DOI 10.1021/pr900685u; PERRICONE R, 1987, CLIN EXP IMMUNOL, V70, P500; Potula R, 2010, J IMMUNOL, V185, P2867, DOI 10.4049/jimmunol.0903691; Raimondo F, 2011, PROTEOMICS, V11, P709, DOI 10.1002/pmic.201000422; Rippeth JD, 2004, J INT NEUROPSYCH SOC, V10, P1, DOI 10.1017/S1355617704101021; Robins L.N., 1991, PSYCHIAT DISORDERS A; Rozek W, 2008, PROTEOM CLIN APPL, V2, P1498, DOI 10.1002/prca.200780114; Rozek W, 2007, J PROTEOME RES, V6, P4189, DOI 10.1021/pr070220c; Saito M, 2008, EXP ANIM TOKYO, V57, P35, DOI 10.1538/expanim.57.35; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Semple SJ, 2006, ARCH SEX BEHAV, V35, P461, DOI 10.1007/s10508-006-9045-3; Semple SJ, 2003, AIDS EDUC PREV, V15, P133, DOI 10.1521/aeap.15.3.133.23835; Silberring J, 2010, TRAC-TREND ANAL CHEM, V29, P128, DOI 10.1016/j.trac.2009.11.007; Stoiber H, 2001, IMMUNOL REV, V180, P168, DOI 10.1034/j.1600-065X.2001.1800115.x; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Thomas DM, 2010, J NEUROCHEM; Westover AN, 2008, DRUG ALCOHOL DEPEN, V96, P49, DOI 10.1016/j.drugalcdep.2008.01.027; Westover AN, 2007, ARCH GEN PSYCHIAT, V64, P495, DOI 10.1001/archpsyc.64.4.495; White SR, 2002, SEMIN RESP CRIT CARE, V23, P27, DOI 10.1055/s-2002-20586; Wiederin J, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-8; Wiederin JL, 2010, J PROTEOME RES, V9, P4721, DOI 10.1021/pr1004345; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Zetterberg H, 2008, ACTA NEUROL SCAND, V118, P1, DOI 10.1111/j.1600-0404.2007.00985.x	47	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31031	10.1371/journal.pone.0031031	http://dx.doi.org/10.1371/journal.pone.0031031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359561	gold, Green Submitted, Green Published			2022-12-25	WOS:000302796200030
J	Di Franco, A; Gillanders, BM; De Benedetto, G; Pennetta, A; De Leo, GA; Guidetti, P				Di Franco, Antonio; Gillanders, Bronwyn M.; De Benedetto, Giuseppe; Pennetta, Antonio; De Leo, Giulio A.; Guidetti, Paolo			Dispersal Patterns of Coastal Fish: Implications for Designing Networks of Marine Protected Areas	PLOS ONE			English	Article							REEF FISH; LARVAL DISPERSAL; OTOLITH CHEMISTRY; TRACE-ELEMENTS; SPATIAL SCALE; HABITAT USE; SEA BREAM; JUVENILE; POPULATIONS; CONNECTIVITY	Information about dispersal scales of fish at various life history stages is critical for successful design of networks of marine protected areas, but is lacking for most species and regions. Otolith chemistry provides an opportunity to investigate dispersal patterns at a number of life history stages. Our aim was to assess patterns of larval and post-settlement (i.e. between settlement and recruitment) dispersal at two different spatial scales in a Mediterranean coastal fish (i.e. white sea bream, Diplodus sargus sargus) using otolith chemistry. At a large spatial scale (similar to 200 km) we investigated natal origin of fish and at a smaller scale (similar to 30 km) we assessed "site fidelity" (i.e. post-settlement dispersal until recruitment). Larvae dispersed from three spawning areas, and a single spawning area supplied post-settlers (proxy of larval supply) to sites spread from 100 to 200 km of coastline. Post-settlement dispersal occurred within the scale examined of similar to 30 km, although about a third of post-settlers were recruits in the same sites where they settled. Connectivity was recorded both from a MPA to unprotected areas and vice versa. The approach adopted in the present study provides some of the first quantitative evidence of dispersal at both larval and post-settlement stages of a key species in Mediterranean rocky reefs. Similar data taken from a number of species are needed to effectively design both single marine protected areas and networks of marine protected areas.	[Di Franco, Antonio; Guidetti, Paolo] Univ Salento, Lab Conservat & Management Marine & Coastal Resou, Dipartimento Sci Etecnol Biol & Ambientali DiSTeB, Lecce, Italy; [Gillanders, Bronwyn M.] Univ Adelaide, So Seas Ecol Labs, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [De Benedetto, Giuseppe; Pennetta, Antonio] Univ Salento, Lab Anal Chim Ambiente & Beni Culturali, Dipartimento Beni Arti & Storia, Lecce, Italy; [De Leo, Giulio A.] Univ Parma, Dept Environm Sci, I-43100 Parma, Italy	University of Salento; University of Adelaide; University of Salento; University of Parma	Di Franco, A (corresponding author), Univ Salento, Lab Conservat & Management Marine & Coastal Resou, Dipartimento Sci Etecnol Biol & Ambientali DiSTeB, Lecce, Italy.	difry@libero.it	De Leo, Giulio/AAC-5098-2019; De Benedetto, Giuseppe Egidio/G-9470-2012; Gillanders, Bronwyn/B-4218-2013; Di Franco, Antonio/A-8796-2010	De Leo, Giulio/0000-0002-4186-3369; De Benedetto, Giuseppe Egidio/0000-0002-0832-5470; Pennetta, Antonio/0000-0002-6760-9393; Gillanders, Bronwyn/0000-0002-7680-2240; Di Franco, Antonio/0000-0003-3411-7015; Guidetti, Paolo/0000-0002-7983-8775	Total Foundation; Italian Ministero Istruzione Universita (MIUR) [2008E7KBAE]	Total Foundation(Total SA); Italian Ministero Istruzione Universita (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research was funded by Total Foundation (http://foundation.total.com/foundation/total-foundation-200090.html) and the Italian Ministero Istruzione Universita (MIUR) (PRIN Project: protocol no. 2008E7KBAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla A., 2008, STATUS MARINE PROTEC; Abecasis D, 2009, ESTUAR COAST SHELF S, V85, P525, DOI 10.1016/j.ecss.2009.09.001; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1515, DOI 10.1175/1520-0485(1997)027<1515:TASGCP>2.0.CO;2; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Berumen ML, 2010, CORAL REEFS, V29, P883, DOI 10.1007/s00338-010-0652-z; Bishop MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014267; Botsford LW, 2001, ECOL LETT, V4, P144; Brophy D, 2004, MAR BIOL, V144, P779, DOI 10.1007/s00227-003-1240-3; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Costello C, 2010, P NATL ACAD SCI USA, V107, P18294, DOI 10.1073/pnas.0908057107; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; D'Anna G, 2011, ITAL J ZOOL, V78, P255, DOI 10.1080/11250000903464059; Di Franco A, 2011, ITAL J ZOOL, V78, P182, DOI 10.1080/11250003.2011.566227; Di Franco A, 2011, BIOL LETTERS, V7, P454, DOI 10.1098/rsbl.2010.1149; Di Franco A, 2009, MAR ECOL PROG SER, V387, P275, DOI 10.3354/meps08051; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Elsdon TS, 2003, MAR ECOL PROG SER, V260, P263, DOI 10.3354/meps260263; Fontes J, 2009, MAR ECOL PROG SER, V387, P51, DOI 10.3354/meps08116; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; Frederick JL, 1997, MAR ECOL PROG SER, V150, P65, DOI 10.3354/meps150065; Gaines SD, 2007, OCEANOGRAPHY, V20, P90, DOI 10.5670/oceanog.2007.32; GARCIARUBIES A, 1995, MAR BIOL, V124, P35, DOI 10.1007/BF00349144; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gillanders BM, 1996, MAR ECOL PROG SER, V141, P13, DOI 10.3354/meps141013; Gillanders BM, 2005, ESTUAR COAST SHELF S, V64, P47, DOI 10.1016/j.ecss.2005.02.005; Gillanders BM, 2002, MAR ECOL PROG SER, V240, P215, DOI 10.3354/meps240215; Gillanders BM, 2003, MAR ECOL PROG SER, V247, P281, DOI 10.3354/meps247281; Gillanders BM, 2001, J FISH BIOL, V59, P350, DOI 10.1006/jfbi.2001.1643; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Hamilton SL, 2008, P NATL ACAD SCI USA, V105, P1561, DOI 10.1073/pnas.0707676105; HARMELINVIVIEN ML, 1995, HYDROBIOLOGIA, V300, P309, DOI 10.1007/BF00024471; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Lloret J, 2008, FISH RES, V91, P252, DOI 10.1016/j.fishres.2007.12.002; Lockwood DR, 2002, THEOR POPUL BIOL, V61, P297, DOI 10.1006/tpbi.2002.1572; MacPherson E, 1998, J EXP MAR BIOL ECOL, V220, P127, DOI 10.1016/S0022-0981(97)00086-5; Miller JA, 2004, CAN J FISH AQUAT SCI, V61, P1723, DOI 10.1139/F04-111; Miller MJ, 2002, J EXP MAR BIOL ECOL, V267, P15, DOI 10.1016/S0022-0981(01)00348-3; Mora C, 2002, TRENDS ECOL EVOL, V17, P422, DOI 10.1016/S0169-5347(02)02584-3; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Pinsky ML, 2010, EVOLUTION, V64, P2688, DOI 10.1111/j.1558-5646.2010.01003.x; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Ross SW, 2002, ENVIRON BIOL FISH, V63, P161, DOI 10.1023/A:1014287917297; Ruttenberg BI, 2008, CAN J FISH AQUAT SCI, V65, P1181, DOI 10.1139/F08-052; Ruttenberg BI, 2005, MAR ECOL PROG SER, V297, P273, DOI 10.3354/meps297273; Saenz-Agudelo P, 2009, MOL ECOL, V18, P1765, DOI 10.1111/j.1365-294X.2009.04109.x; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sanchez-Lamadrid A, 2001, FISHERIES MANAG ECOL, V8, P271, DOI 10.1046/j.1365-2400.2001.00249.x; Sandin SA, 2005, MAR FRESHWATER RES, V56, P725, DOI 10.1071/MF04144; Shanks AL, 2003, ECOL APPL, V13, pS159; Shima JS, 2010, J ANIM ECOL, V79, P1308, DOI 10.1111/j.1365-2656.2010.01733.x; Smith KM, 2005, T AM FISH SOC, V134, P1159, DOI 10.1577/T04-149.1; Standish JD, 2008, MAR ECOL PROG SER, V356, P259, DOI 10.3354/meps07244; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; TSUKAMOTO K, 1989, J FISH BIOL, V35, P59; Ungfors A, 2007, FISH RES, V84, P345, DOI 10.1016/j.fishres.2006.11.031; Vasconcelos RP, 2008, ESTUAR COAST SHELF S, V79, P317, DOI 10.1016/j.ecss.2008.04.006; Vigliola L, 2000, CAN J FISH AQUAT SCI, V57, P1291, DOI 10.1139/cjfas-57-6-1291; Walther BD, 2006, MAR ECOL PROG SER, V311, P125, DOI 10.3354/meps311125; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	68	65	65	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31681	10.1371/journal.pone.0031681	http://dx.doi.org/10.1371/journal.pone.0031681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355388	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300088
J	Kawashima, S; Ueki, Y; Kato, T; Matsukawa, N; Mima, T; Hallett, M; Ito, K; Ojika, K				Kawashima, Shoji; Ueki, Yoshino; Kato, Takashi; Matsukawa, Noriyuki; Mima, Tatsuya; Hallett, Mark; Ito, Kengo; Ojika, Kosei			Changes in Striatal Dopamine Release Associated with Human Motor-Skill Acquisition	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; LONG-TERM POTENTIATION; BASAL GANGLIA; SYNAPTIC PLASTICITY; PARKINSONS-DISEASE; PREFRONTAL CORTEX; HAND MOVEMENT; HUMAN-BRAIN; MEMORY; CONSOLIDATION	The acquisition of new motor skills is essential throughout daily life and involves the processes of learning new motor sequence and encoding elementary aspects of new movement. Although previous animal studies have suggested a functional importance for striatal dopamine release in the learning of new motor sequence, its role in encoding elementary aspects of new movement has not yet been investigated. To elucidate this, we investigated changes in striatal dopamine levels during initial skill-training (Day 1) compared with acquired conditions (Day 2) using C-11-raclopride positron-emission tomography. Ten volunteers learned to perform brisk contractions using their non-dominant left thumbs with the aid of visual feedback. On Day 1, the mean acceleration of each session was improved through repeated training sessions until performance neared asymptotic levels, while improved motor performance was retained from the beginning on Day 2. The C-11-raclopride binding potential (BP) in the right putamen was reduced during initial skill-training compared with under acquired conditions. Moreover, voxel-wise analysis revealed that C-11-raclopride BP was particularly reduced in the right antero-dorsal to the lateral part of the putamen. Based on findings from previous fMRI studies that show a gradual shift of activation within the striatum during the initial processing of motor learning, striatal dopamine may play a role in the dynamic cortico-striatal activation during encoding of new motor memory in skill acquisition.	[Kawashima, Shoji; Ueki, Yoshino; Matsukawa, Noriyuki; Ojika, Kosei] Nagoya City Univ, Dept Neurol & Neurosci, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi, Japan; [Kato, Takashi; Ito, Kengo] Natl Ctr Geriatr & Gerontol, Dept Brain Sci & Mol Imaging, Res Inst, Obu, Aichi, Japan; [Mima, Tatsuya] Kyoto Univ, Human Brain Res Ctr, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Hallett, Mark] NIH, Human Motor Control Sect, Bethesda, MD 20892 USA	Nagoya City University; National Center for Geriatrics & Gerontology; Kyoto University; National Institutes of Health (NIH) - USA	Kawashima, S (corresponding author), Nagoya City Univ, Dept Neurol & Neurosci, Grad Sch Med Sci, Mizuho Ku, Nagoya, Aichi, Japan.	yueki@med.nagoya-cu.ac.jp		Mima, Tatsuya/0000-0001-7787-4855	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002669, ZIANS003031] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ashe J, 1997, BEHAV BRAIN RES, V87, P255; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Breslin NP, 2000, GUT, V46, P93, DOI 10.1136/gut.46.1.93; Brooks DJ, 2001, J NEURAL TRANSM, V108, P1283, DOI 10.1007/s007020100005; Carson RE, 2000, NUCL MED BIOL, V27, P657, DOI 10.1016/S0969-8051(00)00138-4; Centonze D, 2003, J NEUROSCI, V23, P8506, DOI 10.1523/jneurosci.23-24-08506.2003; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Donoghue JP, ACQUISITION MOTOR BE, P363; Doyon J, 1996, EUR J NEUROSCI, V8, P637, DOI 10.1111/j.1460-9568.1996.tb01249.x; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Duff E, 2007, NEUROIMAGE, V34, P156, DOI 10.1016/j.neuroimage.2006.09.006; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; FARDE L, 1988, PSYCHOPHARMACOLOGY, V94, P471, DOI 10.1007/BF00212840; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Floel A, 2005, ANN NEUROL, V58, P121, DOI 10.1002/ana.20536; FRISTON KJ, 1995, P ROY SOC B-BIOL SCI, V261, P401, DOI 10.1098/rspb.1995.0166; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GEORGOPOULOS AP, 1991, ANNU REV NEUROSCI, V14, P361, DOI 10.1146/annurev.ne.14.030191.002045; Goerendt IK, 2003, BRAIN, V126, P312, DOI 10.1093/brain/awg035; Gupta P, 2002, PSYCHOL REV, V109, P401, DOI 10.1037//0033-295X.109.2.401; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hallett M., 2005, MOTOR LEARNING HIGHE, P123; HIKOSAKA O, 1995, J NEUROPHYSIOL, V74, P1652, DOI 10.1152/jn.1995.74.4.1652; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Hund-Georgiadis M, 1999, EXP BRAIN RES, V125, P417, DOI 10.1007/s002210050698; Ito H, 1999, NEUROIMAGE, V9, P235, DOI 10.1006/nimg.1998.0401; Jankowski J, 2009, NEUROIMAGE, V44, P1369, DOI 10.1016/j.neuroimage.2008.10.059; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Lappin JM, 2009, J CEREBR BLOOD F MET, V29, P554, DOI 10.1038/jcbfm.2008.146; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Levesque M, 2007, EXP BRAIN RES, V182, P499, DOI 10.1007/s00221-007-1010-4; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Luft AR, 2009, INT J DEV NEUROSCI, V27, P415, DOI 10.1016/j.ijdevneu.2009.05.004; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Muellbacher W, 2001, EXP BRAIN RES, V136, P431, DOI 10.1007/s002210000614; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Picconi B, 2004, J NEUROSCI, V24, P5283, DOI 10.1523/JNEUROSCI.1224-04.2004; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Reis J, 2008, BRAIN STIMUL, V1, P363, DOI 10.1016/j.brs.2008.08.001; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Sawamoto N, 2008, BRAIN, V131, P1294, DOI 10.1093/brain/awn054; Ueki Y, 2006, ANN NEUROL, V59, P60, DOI 10.1002/ana.20692; Whishaw IQ, 2007, NEUROSCIENCE, V146, P86, DOI 10.1016/j.neuroscience.2007.01.034; WICKENS JR, 1995, SYNAPSE, V20, P281, DOI 10.1002/syn.890200402; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Willuhn I, 2008, NEUROSCIENCE, V153, P249, DOI 10.1016/j.neuroscience.2008.01.041; Willuhn I, 2009, BEHAV BRAIN RES, V199, P103, DOI 10.1016/j.bbr.2008.07.010; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004	67	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31728	10.1371/journal.pone.0031728	http://dx.doi.org/10.1371/journal.pone.0031728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355391	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300091
J	Ren, LP; Chan, SMH; Zeng, XY; Laybutt, DR; Iseli, TJ; Sun, RQ; Kraegen, EW; Cooney, GJ; Turner, N; Ye, JM				Ren, Lu-Ping; Chan, Stanley M. H.; Zeng, Xiao-Yi; Laybutt, D. Ross; Iseli, Tristan J.; Sun, Ruo-Qiong; Kraegen, Edward W.; Cooney, Gregory J.; Turner, Nigel; Ye, Ji-Ming			Differing Endoplasmic Reticulum Stress Response to Excess Lipogenesis versus Lipid Oversupply in Relation to Hepatic Steatosis and Insulin Resistance	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ELEMENT-BINDING PROTEIN; OXIDATIVE STRESS; RAT-LIVER; IN-VIVO; NONALCOHOLIC STEATOHEPATITIS; CARDIOVASCULAR COMPLICATIONS; MITOCHONDRIAL-FUNCTION; INDUCED OBESITY; CELL BIOLOGY	Mitochondrial dysfunction and endoplasmic reticulum (ER) stress have been implicated in hepatic steatosis and insulin resistance. The present study investigated their roles in the development of hepatic steatosis and insulin resistance during de novo lipogenesis (DNL) compared to extrahepatic lipid oversupply. Male C57BL/6J mice were fed either a high fructose (HFru) or high fat (HFat) diet to induce DNL or lipid oversupply in/to the liver. Both HFru and HFat feeding increased hepatic triglyceride within 3 days (by 3.5 and 2.4 fold) and the steatosis remained persistent from 1 week onwards (p<0.01 vs Con). Glucose intolerance (iAUC increased by similar to 60%) and blunted insulin-stimulated hepatic Akt and GSK3 beta phosphorylation (similar to 40-60%) were found in both feeding conditions (p<0.01 vs Con, assessed after 1 week). No impairment of mitochondrial function was found (oxidation capacity, expression of PGC1 alpha, CPT1, respiratory complexes, enzymatic activity of citrate synthase & beta-HAD). As expected, DNL was increased (similar to 60%) in HFru-fed mice and decreased (32%) in HFat-fed mice (all p<0.05). Interestingly, associated with the upregulated lipogenic enzymes (ACC, FAS and SCD1), two (PERK/eIF2 alpha and IRE1/XBP1) of three ER stress pathways were significantly activated in HFru-fed mice. However, no significant ER stress was observed in HFat-fed mice during the development of hepatic steatosis. Our findings indicate that HFru and HFat diets can result in hepatic steatosis and insulin resistance without obvious mitochondrial defects via different lipid metabolic pathways. The fact that ER stress is apparent only with HFru feeding suggests that ER stress is involved in DNL per se rather than resulting from hepatic steatosis or insulin resistance.	[Ren, Lu-Ping; Chan, Stanley M. H.; Zeng, Xiao-Yi; Sun, Ruo-Qiong; Ye, Ji-Ming] RMIT Univ, Mol Pharmacol Diabet Grp, Hlth Innovat Res Inst, Melbourne, Vic, Australia; [Ren, Lu-Ping; Chan, Stanley M. H.; Zeng, Xiao-Yi; Sun, Ruo-Qiong; Ye, Ji-Ming] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia; [Ren, Lu-Ping; Zeng, Xiao-Yi; Laybutt, D. Ross; Iseli, Tristan J.; Kraegen, Edward W.; Cooney, Gregory J.; Turner, Nigel; Ye, Ji-Ming] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW, Australia; [Kraegen, Edward W.; Cooney, Gregory J.; Turner, Nigel] Univ New S Wales, Fac Med, Sydney, NSW, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Garvan Institute of Medical Research; University of New South Wales Sydney	Ren, LP (corresponding author), RMIT Univ, Mol Pharmacol Diabet Grp, Hlth Innovat Res Inst, Melbourne, Vic, Australia.	jiming.ye@rmit.edu.au	Iseli, Tristan/A-9537-2012; Turner, Nigel/H-7176-2013	Turner, Nigel/0000-0002-0119-9328; Chan, Stanley/0000-0002-4103-9441; Zeng, Xiaoyi/0000-0002-0102-0367	National Health and Medical Research Council of Australia (NHMRC) [535921, 535930]; National Natural Science Grant of China [30971391]; NHMRC [535921]; Career Development Award	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Natural Science Grant of China(National Natural Science Foundation of China (NSFC)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Career Development Award	This work was supported by funding from a Program Grant (535921 allocation to JMY) and a Project Grant (535930 to JMY) of the National Health and Medical Research Council of Australia (NHMRC). LPR was a visiting fellow from the General Hospital of Hebei supported by National Natural Science Grant of China (30971391) and NHMRC Program Grant (535921 allocation to JMY). NT is supported by a Career Development Award, and EWK and GJC by Research Fellowships from the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FK, 2005, CURR DRUG TARGETS, V6, P487, DOI 10.2174/1389450054021990; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Collison KS, 2009, OBESITY, V17, P2003, DOI 10.1038/oby.2009.58; Cortez-Pinto H, 2006, J HEPATOL, V44, P197, DOI 10.1016/j.jhep.2005.09.002; Denechaud PD, 2008, FEBS LETT, V582, P68, DOI 10.1016/j.febslet.2007.07.084; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; DIETSCHY JM, 1984, J LIPID RES, V25, P1469; Djouadi F, 1997, BIOCHEM J, V324, P289, DOI 10.1042/bj3240289; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Garcia-Ruiz C, 2006, J GASTROEN HEPATOL, V21, pS3, DOI 10.1111/j.1440-1746.2006.04570.x; Gawrieh S, 2004, J INVEST MED, V52, P506, DOI 10.1136/jim-52-08-22; Gorden DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022775; Hegarty BD, 2003, ACTA PHYSIOL SCAND, V178, P373, DOI 10.1046/j.1365-201X.2003.01162.x; Hiller S, 2009, CURR OPIN STRUC BIOL, V19, P396, DOI 10.1016/j.sbi.2009.07.013; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001; Idris I, 2001, DIABETOLOGIA, V44, P659, DOI 10.1007/s001250051675; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Koo HY, 2008, BBA-MOL BASIS DIS, V1782, P341, DOI 10.1016/j.bbadis.2008.02.007; Koo HY, 2009, BIOCHEM BIOPH RES CO, V390, P285, DOI 10.1016/j.bbrc.2009.09.109; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee AH, 2009, CELL MOL LIFE SCI, V66, P2835, DOI 10.1007/s00018-009-0049-8; Lim JS, 2010, NAT REV GASTROENTERO; Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868; Molero JC, 2006, DIABETES, V55, P708, DOI 10.2337/diabetes.55.03.06.db05-0312; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Perlemuter G, 2005, LIVER INT, V25, P946, DOI 10.1111/j.1478-3231.2005.01126.x; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; Rodriguez-Calvo R, 2009, HEPATOLOGY, V49, P106, DOI 10.1002/hep.22570; Ryu D, 2011, DIABETES, V60, P1072, DOI 10.2337/db10-1046; Sastre J, 2007, FRONT BIOSCI, V12, P1200, DOI 10.2741/2138; Satapati S, 2008, DIABETES, V57, P2012, DOI 10.2337/db08-0226; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Selva DM, 2007, J CLIN INVEST, V117, P3979, DOI 10.1172/JCI32249; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Spolarics Z, 2000, BBA-MOL CELL BIOL L, V1487, P190, DOI 10.1016/S1388-1981(00)00093-7; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Tan MJ, 2008, CHEM BIOL, V15, P263, DOI 10.1016/j.chembiol.2008.01.013; THORBURN AW, 1989, AM J CLIN NUTR, V49, P1155, DOI 10.1093/ajcn/49.6.1155; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Turner N, 2009, DIABETES, V58, P2547, DOI 10.2337/db09-0784; Verna EC, 2008, SEMIN LIVER DIS, V28, P407, DOI 10.1055/s-0028-1091985; Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285; Vila L, 2008, HEPATOLOGY, V48, P1506, DOI 10.1002/hep.22523; Wierzbicki M, 2009, ADV MED SCI-POLAND, V54, P59, DOI 10.2478/v10039-009-0010-y; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Woodman OL, 2009, LIFE SCI, V85, P54, DOI 10.1016/j.lfs.2009.04.012; Ye JM, 2003, AM J PHYSIOL-ENDOC M, V284, pE531, DOI 10.1152/ajpendo.00299.2002	61	87	95	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30816	10.1371/journal.pone.0030816	http://dx.doi.org/10.1371/journal.pone.0030816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355328	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300028
J	Sun, SS; Wang, QZ; Zhao, F; Chen, WT; Li, Z				Sun, Shisheng; Wang, Qinzhe; Zhao, Fei; Chen, Wentian; Li, Zheng			Prediction of Biological Functions on Glycosylation Site Migrations in Human Influenza H1N1 Viruses	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; N-LINKED GLYCOSYLATION; A VIRUS; HEMAGGLUTININ GLYCOSYLATION; STALK-LENGTH; NEURAMINIDASE; VIRULENCE; CLEAVAGE; PATHOGENICITY; GLYCOPROTEINS	Protein glycosylation alteration is typically employed by various viruses for escaping immune pressures from their hosts. Our previous work had shown that not only the increase of glycosylation sites (glycosites) numbers, but also glycosite migration might be involved in the evolution of human seasonal influenza H1N1 viruses. More importantly, glycosite migration was likely a more effectively alteration way for the host adaption of human influenza H1N1 viruses. In this study, we provided more bioinformatics and statistic evidences for further predicting the significant biological functions of glycosite migration in the host adaptation of human influenza H1N1 viruses, by employing homology modeling and in silico protein glycosylation of representative HA and NA proteins as well as amino acid variability analysis at antigenic sites of HA and NA. The results showed that glycosite migrations in human influenza viruses have at least five possible functions: to more effectively mask the antigenic sites, to more effectively protect the enzymatic cleavage sites of neuraminidase (NA), to stabilize the polymeric structures, to regulate the receptor binding and catalytic activities and to balance the binding activity of hemagglutinin (HA) with the release activity of NA. The information here can provide some constructive suggestions for the function research related to protein glycosylation of influenza viruses, although these predictions still need to be supported by experimental data.	[Sun, Shisheng; Wang, Qinzhe; Zhao, Fei; Chen, Wentian; Li, Zheng] Northwest Univ, Coll Life Sci, Lab Funct Glyc, Xian, Peoples R China	Northwest University Xi'an	Sun, SS (corresponding author), Northwest Univ, Coll Life Sci, Lab Funct Glyc, Xian, Peoples R China.	zhengli@nwu.edu.cn	Wang, Qinzhe/AAA-2964-2020; Sun, Shisheng/P-5027-2019	Sun, Shisheng/0000-0002-7242-7164	International S&T Cooperation Program [2009DFA32730]; Shaanxi Province of China [2010K12-02(5)]	International S&T Cooperation Program; Shaanxi Province of China	This work was supported by the International S&T Cooperation Program (2009DFA32730) and the Key Science and Technology Program (2010K12-02(5)) of the Shaanxi Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; BOSCH FX, 1981, VIROLOGY, V113, P725, DOI 10.1016/0042-6822(81)90201-4; Chang SH, 2007, NUCLEIC ACIDS RES, V35, pD376, DOI 10.1093/nar/gkl779; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; DeLano W.L., 2002, PYMOL OPEN SOURCE MO; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Gambaryan AS, 1998, VIROLOGY, V247, P170, DOI 10.1006/viro.1998.9224; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027; Mishin VP, 2005, J VIROL, V79, P12416, DOI 10.1128/JVI.79.19.12416-12424.2005; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; MUNK K, 1992, GLYCOBIOLOGY, V2, P233, DOI 10.1093/glycob/2.3.233; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; OHUCHI M, 1989, VIROLOGY, V168, P274, DOI 10.1016/0042-6822(89)90267-5; Ohuchi M, 1997, J VIROL, V71, P8377, DOI 10.1128/JVI.71.11.8377-8384.1997; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Schulze Irene T., 1997, Journal of Infectious Diseases, V176, pS24, DOI 10.1086/514170; Shi WF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014454; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844; Varghese JN, 1983, NATURE, P303; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wagner R, 2000, J VIROL, V74, P6316, DOI 10.1128/JVI.74.14.6316-6323.2000; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Wu ZLL, 2009, BIOCHEM BIOPH RES CO, V379, P749, DOI 10.1016/j.bbrc.2008.12.139; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhang YH, 2009, BIOCHEM BIOPH RES CO, V387, P405, DOI 10.1016/j.bbrc.2009.07.040	40	30	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32119	10.1371/journal.pone.0032119	http://dx.doi.org/10.1371/journal.pone.0032119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355413	Green Submitted, gold, Green Published			2022-12-25	WOS:000302741300113
J	Bu, WM; Liu, RY; Cheung-Lau, JC; Dmochowski, IJ; Loll, PJ; Eckenhoff, RG				Bu, Weiming; Liu, Renyu; Cheung-Lau, Jasmina C.; Dmochowski, Ivan J.; Loll, Patrick J.; Eckenhoff, Roderic G.			Ferritin couples iron and fatty acid metabolism	FASEB JOURNAL			English	Article						arachidonic acid; X-ray crystallography; calorimetry; ferrihydrite	SERUM FERRITIN; FERROXIDASE KINETICS; ANESTHETIC BINDING; OXIDATIVE STRESS; HUMAN H; SITE; EXPRESSION; PROTEINS; DISEASE; MEN	A physiological relationship between iron, oxidative injury, and fatty acid metabolism exists, but transduction mechanisms are unclear. We propose that the iron storage protein ferritin contains fatty acid binding sites whose occupancy modulates iron uptake and release. Using isothermal microcalorimetry, we found that arachidonic acid binds ferritin specifically and with 60 mu M affinity. Arachidonate binding by ferritin enhanced iron mineralization, decreased iron release, and protected the fatty acid from oxidation. Cocrystals of arachidonic acid and horse spleen apoferritin diffracted to 2.18 angstrom and revealed specific binding to the 2-fold intersubunit pocket. This pocket shields most of the fatty acid and its double bonds from solvent but allows the arachidonate tail to project well into the ferrihydrite mineralization site on the ferritin L-subunit, a structural feature that we implicate in the effects on mineralization by demonstrating that the much shorter saturated fatty acid, caprylate, has no significant effects on mineralization. These combined effects of arachidonate binding by ferritin are expected to lower both intracellular free iron and free arachidonate, thereby providing a previously unrecognized mechanism for limiting lipid peroxidation, free radical damage, and proinflammatory cascades during times of cellular stress.-Bu, W., Liu, R., Cheung-Lau, J. C., Dmochowski, I. J., Loll, P. J., Eckenhoff, R. G. Ferritin couples iron and fatty acid metabolism. FASEB J. 26, 2394-2400 (2012). www.fasebj.org	[Bu, Weiming; Liu, Renyu; Eckenhoff, Roderic G.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Cheung-Lau, Jasmina C.; Dmochowski, Ivan J.] Univ Penn, Sch Arts & Sci, Dept Chem, Philadelphia, PA 19104 USA; [Loll, Patrick J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Drexel University	Eckenhoff, RG (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,305 John Morgan, Philadelphia, PA 19104 USA.	roderic.eckenhoff@uphs.upenn.edu		Eckenhoff, Roderic/0000-0002-5581-746X	U.S. National Institutes of Health National Institute of General Medical Sciences [P0155876]; Austin Lamont Endowment; National Science Foundation [CHE 0548188]	U.S. National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austin Lamont Endowment; National Science Foundation(National Science Foundation (NSF))	This work was supported by U.S. National Institutes of Health National Institute of General Medical Sciences grant P0155876, the Austin Lamont Endowment (R. G. E.), and National Science Foundation CAREER Award CHE 0548188 (I.J.D.). The authors appreciate the technical support of David Liang. The authors declare no conflicts of interest.	ARAUJO FB, 1995, ATHEROSCLEROSIS, V117, P61, DOI 10.1016/0021-9150(94)05558-Z; Baldi A, 2005, CLIN CANCER RES, V11, P3175, DOI 10.1158/1078-0432.CCR-04-0631; Bar-Or D, 2001, BIOCHEM BIOPH RES CO, V284, P856, DOI 10.1006/bbrc.2001.5042; Bou-Abdallah F, 2004, BIOCHEMISTRY-US, V43, P4332, DOI 10.1021/bi0498813; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Crichton RR, 2010, BBA-GEN SUBJECTS, V1800, P706, DOI 10.1016/j.bbagen.2010.03.019; Curry S, 2009, DRUG METAB PHARMACOK, V24, P342, DOI 10.2133/dmpk.24.342; Elia G, 1999, EUR J BIOCHEM, V264, P736, DOI 10.1046/j.1432-1327.1999.00610.x; Festa M, 2000, J BIOL CHEM, V275, P36708, DOI 10.1074/jbc.M004988200; Gillum RF, 2001, INT J OBESITY, V25, P639, DOI 10.1038/sj.ijo.0801561; Giordani A, 2000, J PHOTOCH PHOTOBIO B, V54, P43, DOI 10.1016/S1011-1344(99)00154-2; Haldar S, 2011, J BIOL CHEM, V286, P25620, DOI 10.1074/jbc.M110.205278; HEMPSTEAD PD, 1994, FEBS LETT, V350, P258, DOI 10.1016/0014-5793(94)00781-0; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Hermans MP, 2010, DIABETIC MED, V27, P417, DOI 10.1111/j.1464-5491.2010.02979.x; Iwasaki T, 2005, DIABETES CARE, V28, P2486, DOI 10.2337/diacare.28.10.2486; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Knuiman MW, 2003, AM J EPIDEMIOL, V158, P144, DOI 10.1093/aje/kwg121; LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3; Liu RY, 2005, FASEB J, V19, P567, DOI 10.1096/fj.04-3171com; Mackenzie EL, 2008, BIOCHEM J, V411, P107, DOI 10.1042/BJ20071544; Ortiz E, 2004, J NEUROSCI RES, V77, P681, DOI 10.1002/jnr.20207; PRECIGOUX G, 1994, ACTA CRYSTALLOGR D, V50, P739, DOI 10.1107/S0907444994003227; SUN S, 1992, J BIOL CHEM, V267, P25160; SUN SJ, 1993, BIOCHEMISTRY-US, V32, P9362, DOI 10.1021/bi00087a015; TRIKHA J, 1995, J MOL BIOL, V248, P949, DOI 10.1006/jmbi.1995.0274; Tsuji Y, 2005, ONCOGENE, V24, P7567, DOI 10.1038/sj.onc.1208901; Vedula LS, 2009, J BIOL CHEM, V284, P24176, DOI 10.1074/jbc.M109.017814; Wang ZM, 2006, ACTA CRYSTALLOGR D, V62, P800, DOI 10.1107/S0907444906018294; Zacharski LR, 2007, JAMA-J AM MED ASSOC, V297, P603, DOI 10.1001/jama.297.6.603; ZANOTTI G, 1992, J BIOL CHEM, V267, P18541; Zimmerman AW, 2001, INT J BIOCHEM CELL B, V33, P865, DOI 10.1016/S1357-2725(01)00070-X	34	26	26	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2394	2400		10.1096/fj.11-198853	http://dx.doi.org/10.1096/fj.11-198853			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22362897	Green Published			2022-12-25	WOS:000305017200017
J	Teng, YW; Ellis, JM; Coleman, RA; Zeisel, SH				Teng, Ya-Wen; Ellis, Jessica M.; Coleman, Rosalind A.; Zeisel, Steven H.			Mouse Betaine-Homocysteine S-Methyltransferase Deficiency Reduces Body Fat via Increasing Energy Expenditure and Impairing Lipid Synthesis and Enhancing Glucose Oxidation in White Adipose Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR 21; HORMONE RECEPTOR-BETA; THYROID-HORMONE; SUBCUTANEOUS FAT; GENE-EXPRESSION; PPAR-GAMMA; BILE-ACIDS; MICE; LIVER; DIET	Betaine-homocysteine S-methyltransferase (BHMT) catalyzes the synthesis of methionine from homocysteine. In our initial report, we observed a reduced body weight in Bhmt(-/-) mice. We initiated this study to investigate the potential role of BHMT in energy metabolism. Compared with the controls (Bhmt(+/+)), Bhmt(-/-) mice had less fat mass, smaller adipocytes, and better glucose and insulin sensitivities. Compared with the controls, Bhmt(-/-) mice had increased energy expenditure, with no changes in food intake, fat uptake or absorption, or in locomotor activity. The reduced adiposity in Bhmt(-/-) mice was not due to hyperthermogenesis. Bhmt(-/-) mice failed to maintain a normal body temperature upon cold exposure because of limited fuel supplies. In vivo and ex vivo tests showed that Bhmt(-/-) mice had normal lipolytic function. The rate of C-14-labeled fatty acid incorporated into [C-14]triacylglycerol was the same in Bhmt(+/+) and Bhmt(-/-) gonadal fat depots (GWAT), but it was 62% lower in Bhmt(-/-) inguinal fat depots (IWAT) compared with that of Bhmt(+/+) mice. The rate of C-14-labeled fatty acid oxidation was the same in both GWAT and IWAT from Bhmt(+/+) and Bhmt(-/-) mice. At basal level, Bhmt(-/-) GWAT had the same [C-14] glucose oxidation as did the controls. When stimulated with insulin, Bhmt(-/-) GWAT oxidized 2.4-fold more glucose than did the controls. Compared with the controls, the rate of [C-14] glucose oxidation was 2.4- and 1.8-fold higher, respectively, in Bhmt(-/-) IWAT without or with insulin stimulus. Our results show for the first time a role for BHMT in energy homeostasis.	[Teng, Ya-Wen; Ellis, Jessica M.; Coleman, Rosalind A.; Zeisel, Steven H.] Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [Ellis, Jessica M.] Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21205 USA; [Zeisel, Steven H.] Univ N Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Zeisel, SH (corresponding author), 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu			National Institutes of Health [DK55865, DK56350, DK59935, DK56598, T32-HL069768]; University of North Carolina at Chapel Hill; American Heart Association Mid-Atlantic Division; McNeil Nutritionals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK055865, R01DK059935, R01DK056598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill; American Heart Association Mid-Atlantic Division(American Heart Association); McNeil Nutritionals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK55865 and DK56350 (to S. H. Z.), DK59935 and DK56598 (to R. A. C.), and Predoctoral Training Grant T32-HL069768 (to J. M. E.). This work was also supported by a McNeil Nutritionals predoctoral fellowship (to Y.-W. T.), a dissertation completion fellowship from the University of North Carolina at Chapel Hill (to Y.-W. T.), and a predoctoral fellowship from the American Heart Association Mid-Atlantic Division (to J. M. E.).	Adams AC, 2010, J BIOL CHEM, V285, P14078, DOI 10.1074/jbc.C110.107375; Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; Barrett T., 2008, U.S. Patent, Patent No. [7,433,787, 7433787]; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dasarathy S, 2011, EUR J GASTROEN HEPAT, V23, P382, DOI 10.1097/MEG.0b013e328345c8c7; Delgado-Reyes CV, 2001, ARCH BIOCHEM BIOPHYS, V393, P184, DOI 10.1006/abbi.2001.2474; Eklund M, 2005, NUTR RES REV, V18, P31, DOI 10.1079/NRR200493; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Flachs P, 2002, BIOCHEM J, V364, P369, DOI 10.1042/BJ20011438; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gullberg H, 2000, MOL ENDOCRINOL, V14, P1739, DOI 10.1210/me.14.11.1739; Gullberg H, 2002, MOL ENDOCRINOL, V16, P1767, DOI 10.1210/me.2002-0009; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Ji C, 2008, ALCOHOL CLIN EXP RES, V32, P1049, DOI 10.1111/j.1530-0277.2008.00666.x; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Li K, 2012, MOL CELL ENDOCRINOL, V348, P21, DOI 10.1016/j.mce.2011.07.026; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Lillie RD, 1965, HISTOPATHOLOGIC TECH, P1; LONCAR D, 1991, CELL TISSUE RES, V266, P149, DOI 10.1007/BF00678721; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Naggert J., 2012, DIET EFFECTS BONE DE; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Oishi K, 2011, BIOL PHARM BULL, V34, P1120, DOI 10.1248/bpb.34.1120; Ortega FJ, 2009, OBESITY, V17, P2134, DOI 10.1038/oby.2009.110; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Rajala MW, 2004, DIABETES, V53, P1671, DOI 10.2337/diabetes.53.7.1671; Raubenheimer PJ, 2006, DIABETES, V55, P2015, DOI 10.2337/db06-0097; Reaven P, 1997, ARTERIOSCL THROM VAS, V17, P2250, DOI 10.1161/01.ATV.17.10.2250; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Rossmeisl M, 2002, EUR J BIOCHEM, V269, P19, DOI 10.1046/j.0014-2956.2002.02627.x; Sanchez J, 2009, ENDOCRINOLOGY, V150, P5341, DOI 10.1210/en.2009-0466; Sewter CP, 2002, DIABETES, V51, P718, DOI 10.2337/diabetes.51.3.718; Shin DJ, 2006, NUCLEIC ACIDS RES, V34, P3853, DOI 10.1093/nar/gkl506; Szegedi SS, 2008, J BIOL CHEM, V283, P8939, DOI 10.1074/jbc.M710449200; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Viswanadha S, 2006, J LIPID RES, V47, P1859, DOI 10.1194/jlr.D600005-JLR200; Wang YiZhen, 1999, Journal of Zhejiang Agricultural University, V25, P281; Wang YiZhen, 2000, Chinese Journal of Veterinary Science, V20, P409; Wang ZG, 2010, AM J PHYSIOL-GASTR L, V298, pG634, DOI 10.1152/ajpgi.00249.2009; Warne JP, 2006, AM J PHYSIOL-ENDOC M, V291, pE1264, DOI 10.1152/ajpendo.00655.2005; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu ZiRong, 1998, Acta Veterinaria et Zootechnica Sinica, V29, P212; Xu ZiRong, 1999, Chinese Journal of Veterinary Science, V19, P399; Yu DongYou, 2001, Chinese Journal of Veterinary Science, V21, P200; Yu DongYou, 2000, Chinese Journal of Animal Science, V36, P8; Zou X. T., 2002, SCI CHINA, V1, P1043; Zou XiaoTing, 2001, Chinese Journal of Veterinary Science, V21, P300; Zou XiaoTing, 1998, Acta Agriculturae Zhejiangensis, V10, P144	61	30	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16187	16198		10.1074/jbc.M111.303255	http://dx.doi.org/10.1074/jbc.M111.303255			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22362777	Green Published, hybrid			2022-12-25	WOS:000304030900011
J	Chang, MY; Chan, CK; Braun, KR; Green, PS; O'Brien, KD; Chait, A; Day, AJ; Wight, TN				Chang, Mary Y.; Chan, Christina K.; Braun, Kathleen R.; Green, Pattie S.; O'Brien, Kevin D.; Chait, Alan; Day, Anthony J.; Wight, Thomas N.			Monocyte-to-Macrophage Differentiation SYNTHESIS AND SECRETION OF A COMPLEX EXTRACELLULAR MATRIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; SMOOTH-MUSCLE-CELLS; CHONDROITIN SULFATE PROTEOGLYCANS; ANTIINFLAMMATORY PROTEIN TSG-6; HUMAN-PLATELET PROTEOGLYCAN; AMYLOID PRECURSOR PROTEIN; TANDEM MASS-SPECTROMETRY; LOW-DENSITY LIPOPROTEINS; BLOOD MONONUCLEAR-CELLS; SHAP-HYALURONAN COMPLEX	Although monocyte- and macrophage-derived molecules are known to promote extracellular matrix (ECM) disruption and destabilization, it is less appreciated that they also synthesize molecules contributing to ECM formation, stabilization, and function. We have identified and characterized the synthesis of proteoglycans and related proteins, some not previously known to be associated with macrophages. Proteoglycan extracts of [S-35] sulfate- and S-35-trans amino acid-radiolabeled culture media from THP-1 monocytes induced to differentiate by treatment with phorbol myristate acetate revealed three major proteins of similar to 25, 90, and 100 kDa following chondroitin ABC lyase digestion. The 25-kDa protein was predominant for monocytes, whereas the 90- and 100-kDa proteins were predominant for macrophages. Tandem mass spectrometry identified (i) the 25-kDa core protein as serglycin, (ii) the 90-kDa core protein as inter-alpha-inhibitor heavy chain 2 (I alpha IHC2), and (iii) the 100-kDa core as amyloid precursor-like protein 2 (APLP2). Differentiation was also associated with(i) a > 500-fold increase in mRNA for TNF stimulated gene-6, an essential cofactor for heavy chain-mediated matrix stabilization; (ii) a > 800-fold increase in mRNA for HAS2, which is responsible for hyaluronan synthesis; and (iii) a 3-fold increase in mRNA for versican, which interacts with hyaluronan. Biochemical evidence is also presented for an I alpha IHC2-APLP2 complex, and immunohistochemical staining of human atherosclerotic lesions demonstrates similar staining patterns for APLP2 and I alpha IHC2 with macrophages, whereas serglycin localizes to the underlying glycosaminoglycan-rich region. These findings indicate that macrophages synthesize many of the molecules participating in ECM formation and function, suggesting a novel role for these molecules in the differentiation of macrophages in the development of atherosclerosis.	[Chan, Christina K.; Braun, Kathleen R.; Wight, Thomas N.] Benaroya Res Inst, Hope Heart Matrix Biol Program, Seattle, WA 98101 USA; [Chang, Mary Y.; Chait, Alan] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Green, Pattie S.; O'Brien, Kevin D.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	Benaroya Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Manchester	Wight, TN (corresponding author), Benaroya Res Inst, Hope Heart Matrix Biol Program, Seattle, WA 98101 USA.	twight@benaroyaresearch.org	Day, Anthony/O-1658-2015; O'Brien, Kevin/CAH-4638-2022; O'Brien, Kevin Douglas/HDO-1461-2022	Day, Anthony/0000-0002-1415-3134; O'Brien, Kevin/0000-0002-2293-9196; O'Brien, Kevin Douglas/0000-0002-2293-9196	National Institutes of Health [HL018645, HL098067, HL092969]; Arthritis Research UK [18472, 19489]; Versus Arthritis [18472, 19489] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL092969, P01HL098067, P01HL018645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL018645 and HL098067 (to T. N. W.) and HL092969 (to A. C. and T. N. W.). This work was also supported by Arthritis Research UK Grants 18472 and 19489 (to A. J. D.).	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; ALLIEL PM, 1988, FEBS LETT, V236, P123, DOI 10.1016/0014-5793(88)80298-9; Asplund A, 2011, ATHEROSCLEROSIS, V215, P77, DOI 10.1016/j.atherosclerosis.2010.12.017; Asplund A, 2010, GLYCOBIOLOGY, V20, P33, DOI 10.1093/glycob/cwp139; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; AUWERX JH, 1988, BIOCHEMISTRY-US, V27, P2651, DOI 10.1021/bi00408a003; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; Chang MY, 2000, J BIOL CHEM, V275, P4766, DOI 10.1074/jbc.275.7.4766; Chang MY, 2006, ARTERIOSCL THROM VAS, V26, P494, DOI 10.1161/01.ATV.0000200135.61362.27; Chang MY, 1998, J BIOL CHEM, V273, P15985, DOI 10.1074/jbc.273.26.15985; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Coulson EJ, 2000, NEUROCHEM INT, V36, P175, DOI 10.1016/S0197-0186(99)00125-4; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; EDELSON PJ, 1976, IN VITRO METHODS CEL, P333; ELLIOTT JF, 1993, MOL IMMUNOL, V30, P749, DOI 10.1016/0161-5890(93)90146-3; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; Eriksen GV, 1999, BIOCHEM J, V340, P613, DOI 10.1042/0264-6021:3400613; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; GOWN AM, 1986, AM J PATHOL, V125, P191; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Heng BC, 2008, J BIOL CHEM, V283, P32294, DOI 10.1074/jbc.M804155200; Kaczmarczyk A, 2002, J BIOL CHEM, V277, P13578, DOI 10.1074/jbc.M200288200; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; Kolset SO, 2008, GLYCOCONJUGATE J, V25, P305, DOI 10.1007/s10719-007-9073-9; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lebaron RG, 1996, PERSPECT DEV NEUROBI, V3, P261; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lemire JM, 2007, J CELL BIOCHEM, V101, P753, DOI 10.1002/jcb.21235; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Li QX, 1999, J LEUKOCYTE BIOL, V66, P567, DOI 10.1002/jlb.66.4.567; Libby P, 1996, CURR OPIN LIPIDOL, V7, P330, DOI 10.1097/00041433-199610000-00012; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Makatsori E, 2003, ANTICANCER RES, V23, P3303; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; McDonald TO, 2007, J HISTOCHEM CYTOCHEM, V55, P1149, DOI 10.1369/jhc.7A7221.2007; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Niemann CU, 2004, J LEUKOCYTE BIOL, V76, P406, DOI 10.1189/jlb.1003502; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Olsen NJ, 2004, ARTHRITIS RES THER, V6, P120, DOI 10.1186/ar1190; PANGALOS MN, 1995, J NEUROCHEM, V65, P762; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; PERIN JP, 1988, BIOCHEM J, V255, P1007, DOI 10.1042/bj2551007; Resing KA, 2005, FEBS LETT, V579, P885, DOI 10.1016/j.febslet.2004.12.001; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Russell DL, 2006, SEMIN REPROD MED, V24, P217, DOI 10.1055/s-2006-948551; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Schonherr E, 1997, ARCH BIOCHEM BIOPHYS, V339, P353, DOI 10.1006/abbi.1996.9854; Shibata N, 2009, J LIPID RES, V50, pS277, DOI 10.1194/jlr.R800063-JLR200; Shou JY, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1883; Stewart CR, 2007, J LIPID RES, V48, P2162, DOI 10.1194/jlr.M700098-JLR200; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Tan KT, 2011, J EUR ACAD DERMATOL, V25, P317, DOI 10.1111/j.1468-3083.2010.03792.x; TANTRAVAHI RV, 1986, P NATL ACAD SCI USA, V83, P9207, DOI 10.1073/pnas.83.23.9207; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; Toeda K, 2005, MOL CELL BIOCHEM, V280, P47, DOI 10.1007/s11010-005-8051-4; UHLINHANSEN L, 1989, J BIOL CHEM, V264, P14916; UHLINHANSEN L, 1993, BLOOD, V82, P2880; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vehmas A, 2004, J NEUROIMMUNOL, V157, P99, DOI 10.1016/j.jneuroim.2004.08.035; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang AM, 2009, AUTOPHAGY, V5, P864, DOI 10.4161/auto.9041; WASTESON A, 1971, J CHROMATOGR, V59, P87, DOI 10.1016/S0021-9673(01)80009-1; WASTESON A, 1973, BIOCHEM J, V136, P1069, DOI 10.1042/bj1361069; WIGHT TN, 2005, ATHEROTHROMBOSIS COR, P421; Willeaume V, 1996, J INFLAMM, V46, P1; Winberg JO, 2003, EUR J BIOCHEM, V270, P3996, DOI 10.1046/j.1432-1033.2003.03788.x; Winberg JO, 2000, J MOL BIOL, V304, P669, DOI 10.1006/jmbi.2000.4235; Wingrove JA, 2008, CIRC-CARDIOVASC GENE, V1, P31, DOI 10.1161/CIRCGENETICS.108.782730; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703; Yan W, 2004, MOL CELL PROTEOMICS, V3, P1039, DOI 10.1074/mcp.D400001-MCP200; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Yoshida M, 2004, ARTHRITIS RES THER, V6, pR514, DOI 10.1186/ar1223; Yoshihara Y, 2008, OSTEOARTHR CARTILAGE, V16, P1343, DOI 10.1016/j.joca.2008.04.004; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	101	72	74	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14122	14135		10.1074/jbc.M111.324988	http://dx.doi.org/10.1074/jbc.M111.324988			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22351750	Green Published, hybrid			2022-12-25	WOS:000303996300065
J	Chen, ZY; Hu, YT; Yang, WS; He, YW; Feng, J; Wang, B; Zhao, RM; Ding, JP; Cao, ZJ; Li, WX; Wu, YL				Chen, Zong-Yun; Hu, You-Tian; Yang, Wei-Shan; He, Ya-Wen; Feng, Jing; Wang, Bin; Zhao, Rui-Ming; Ding, Jiu-Ping; Cao, Zhi-Jian; Li, Wen-Xin; Wu, Ying-Liang			Hg1, Novel Peptide Inhibitor Specific for Kv1.3 Channels from First Scorpion Kunitz-type Potassium Channel Toxin Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMORY T-CELLS; THERAPEUTIC TARGET; PROTEASE INHIBITOR; DELTA-DENDROTOXIN; STRUCTURAL BASIS; FUNCTIONAL DYAD; HIGH-AFFINITY; K+ CHANNELS; NEUROTOXIN; CONKUNITZIN-S1	The potassium channel Kv1.3 is an attractive pharmacological target for autoimmune diseases. Specific peptide inhibitors are key prospects for diagnosing and treating these diseases. Here, we identified the first scorpion Kunitz-type potassium channel toxin family with three groups and seven members. In addition to their function as trypsin inhibitors with dissociation constants of 140 nM for recombinant LmKTT-1a, 160 nM for LmKTT-1b, 124 nM for LmKTT-1c, 136 nM for BmKTT-1, 420 nM for BmKTT-2, 760 nM for BmKTT-3, and 107 nM for Hg1, all seven recombinant scorpion Kunitz-type toxins could block the Kv1.3 channel. Electrophysiological experiments showed that six of seven scorpion toxins inhibited similar to 50-80% of Kv1.3 channel currents at a concentration of 1 mu M. The exception was rBm-KTT-3, which had weak activity. The IC50 values of rBmKTT-1, rBmKTT-2, and rHg1 for Kv1.3 channels were similar to 129.7, 371.3, and 6.2 nM, respectively. Further pharmacological experiments indicated that rHg1 was a highly selective Kv1.3 channel inhibitor with weak affinity for other potassium channels. Different from classical Kunitz-type potassium channel toxins with N-terminal regions as the channel-interacting interfaces, the channel-interacting interface of Hg1 was in the C-terminal region. In conclusion, these findings describe the first scorpion Kunitz-type potassium channel toxin family, of which a novel inhibitor, Hg1, is specific for Kv1.3 channels. Their structural and functional diversity strongly suggest that Kunitz-type toxins are a new source to screen and design potential peptides for diagnosing and treating Kv1.3-mediated autoimmune diseases.	[Chen, Zong-Yun; Hu, You-Tian; Yang, Wei-Shan; He, Ya-Wen; Feng, Jing; Wang, Bin; Zhao, Rui-Ming; Cao, Zhi-Jian; Li, Wen-Xin; Wu, Ying-Liang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Ding, Jiu-Ping] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Li, WX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	liwxlab@whu.edu.cn; ylwu@whu.edu.cn	Zhao, Ruiming/C-1817-2017; Feng, Jing/C-1729-2018; Hu, Youtian/G-5408-2014	Feng, Jing/0000-0001-6726-7912; 	National Basic Research Program of China [2010CB529800]; National Natural Sciences Foundation of China [30530140, 31071942, 30973636]; Hubei Province Natural Sciences Foundation of China [2009CDA076]	National Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province Natural Sciences Foundation of China	This work was supported by grants from the National Basic Research Program of China (2010CB529800), the National Natural Sciences Foundation of China (30530140, 31071942, and 30973636), and the Hubei Province Natural Sciences Foundation of China (2009CDA076).	Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; Dy CY, 2006, ACTA CRYSTALLOGR D, V62, P980, DOI [10.1107/S0907444906021123, 10.1107/S0907444906021122]; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gan GL, 2008, J BIOL CHEM, V283, P24177, DOI 10.1074/jbc.M800179200; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Han S, 2010, J PROTEOME RES, V9, P3118, DOI 10.1021/pr100027k; Harvey AL, 1997, GEN PHARMACOL-VASC S, V28, P7, DOI 10.1016/S0306-3623(96)00173-5; Imredy JP, 2000, J MOL BIOL, V296, P1283, DOI 10.1006/jmbi.2000.3522; Jin L, 2011, J MOL RECOGNIT, V24, P101, DOI 10.1002/jmr.1031; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; LANCELIN JM, 1994, NAT STRUCT BIOL, V1, P246, DOI 10.1038/nsb0494-246; Lanigan MD, 2001, BIOPOLYMERS, V58, P422, DOI 10.1002/1097-0282(20010405)58:4<422::AID-BIP1018>3.0.CO;2-T; Lebrun B, 1997, BIOCHEM J, V328, P321, DOI 10.1042/bj3280321; Lu J, 2008, PEPTIDES, V29, P369, DOI 10.1016/j.peptides.2007.11.013; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Mouhat S, 2006, MOL PHARMACOL, V69, P354, DOI 10.1124/mol.105.017210; Mouhat S, 2005, J PEPT SCI, V11, P65, DOI 10.1002/psc.630; Mouhat S, 2004, BIOCHEM J, V377, P25, DOI 10.1042/BJ20030115; Peigneur S, 2011, BIOCHEM PHARMACOL, V82, P81, DOI 10.1016/j.bcp.2011.03.023; de la Vega RCR, 2010, TOXICON, V56, P1155, DOI 10.1016/j.toxicon.2009.11.010; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; SCHWEITZ H, 1995, J BIOL CHEM, V270, P25121, DOI 10.1074/jbc.270.42.25121; SMITH LA, 1993, BIOCHEMISTRY-US, V32, P5692, DOI 10.1021/bi00072a026; Takacs Z, 2009, P NATL ACAD SCI USA, V106, P22211, DOI 10.1073/pnas.0910123106; Toldi G, 2010, IMMUNOL LETT, V133, P35, DOI 10.1016/j.imlet.2010.06.009; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Yi H, 2007, J PROTEOME RES, V6, P611, DOI 10.1021/pr060368g; You DW, 2009, J BIOL CHEM, V284, P22079, DOI 10.1074/jbc.M109.013276; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Zhao RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027548; Zhu SY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002832	41	100	109	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13813	13821		10.1074/jbc.M112.343996	http://dx.doi.org/10.1074/jbc.M112.343996			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22354971	Green Published, hybrid			2022-12-25	WOS:000303996300036
J	Katschke, KJ; Wu, P; Ganesan, R; Kelley, RF; Mathieu, MA; Hass, PE; Murray, J; Kirchhofer, D; Wiesmann, C; Campagne, MV				Katschke, Kenneth J., Jr.; Wu, Ping; Ganesan, Rajkumar; Kelley, Robert F.; Mathieu, Mary A.; Hass, Philip E.; Murray, Jeremy; Kirchhofer, Daniel; Wiesmann, Christian; Campagne, Menno van Lookeren			Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D Exosite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D MONOCLONAL-ANTIBODY; MACULAR DEGENERATION; CARDIOPULMONARY BYPASS; PROTEIN FAMILY; INSIGHT; MECHANISM; SYSTEM; C3B; REFINEMENT; COMPSTATIN	By virtue of its amplifying property, the alternative complement pathway has been implicated in a number of inflammatory diseases and constitutes an attractive therapeutic target. An anti-factor D Fab fragment (AFD) was generated to inhibit the alternative complement pathway in advanced dry age-related macular degeneration. AFD potently prevented factor D (FD)-mediated proteolytic activation of its macromolecular substrate C3bB, but not proteolysis of a small synthetic substrate, indicating that AFD did not block access of the substrate to the catalytic site. The crystal structures of AFD in complex with human and cynomolgus FD (at 2.4 and 2.3 angstrom, respectively) revealed the molecular details of the inhibitory mechanism. The structures show that the AFD-binding site includes surface loops of FD that form part of the FD exosite. Thus, AFD inhibits FD proteolytic function by interfering with macromolecular substrate access rather than by inhibiting FD catalysis, providing the molecular basis of AFD-mediated inhibition of a rate-limiting step in the alternative complement pathway.	[Katschke, Kenneth J., Jr.; Campagne, Menno van Lookeren] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Ganesan, Rajkumar; Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Kelley, Robert F.; Mathieu, Mary A.] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Hass, Philip E.] Genentech Inc, Dept Biol Chem, San Francisco, CA 94080 USA; [Wu, Ping; Murray, Jeremy; Wiesmann, Christian] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Campagne, MV (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	menno@gene.com	Ganesan, Rajkumar/B-1093-2008	Ganesan, Rajkumar/0000-0002-3431-9664; Wiesmann, Christian/0000-0002-4092-9880				BARNUM SR, 1984, J IMMUNOL METHODS, V67, P303, DOI 10.1016/0022-1759(84)90470-8; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Cole LB, 1997, ACTA CRYSTALLOGR D, V53, P143, DOI 10.1107/S0907444996012991; Cole LB, 1998, ACTA CRYSTALLOGR D, V54, P711, DOI 10.1107/S0907444997010457; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Farady CJ, 2007, J MOL BIOL, V369, P1041, DOI 10.1016/j.jmb.2007.03.078; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625; Fung M, 2001, J THORAC CARDIOV SUR, V122, P113, DOI 10.1067/mtc.2001.114777; Ganesan R, 2011, MOL CANCER RES, V9, P1175, DOI 10.1158/1541-7786.MCR-11-0004; Ganesan R, 2010, BIOCHEM J, V430, P179, DOI 10.1042/BJ20100634; Garcia BL, 2012, J BIOL CHEM, V287, P628, DOI 10.1074/jbc.M111.298984; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200; Jing H, 1998, J MOL BIOL, V282, P1061, DOI 10.1006/jmbi.1998.2089; Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200; KIM SH, 1995, J IMMUNOL, V154, P6073; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LESAVRE PH, 1978, J EXP MED, V148, P1498, DOI 10.1084/jem.148.6.1498; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NARAYANA SVL, 1994, J MOL BIOL, V235, P695, DOI 10.1006/jmbi.1994.1021; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Ricklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Roversi P, 2007, J MOL BIOL, V369, P784, DOI 10.1016/j.jmb.2007.03.064; SANDERS PW, 1986, J CLIN INVEST, V77, P1299, DOI 10.1172/JCI112434; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Stanton CM, 2011, INVEST OPHTH VIS SCI, V52, P8828, DOI 10.1167/iovs.11-7933; Tanhehco EJ, 1999, TRANSPLANT P, V31, P2168, DOI 10.1016/S0041-1345(99)00297-3; Undar A, 2002, ANN THORAC SURG, V74, P355, DOI 10.1016/S0003-4975(02)03656-1; Undar A, 2002, EUR J CARDIO-THORAC, V22, P330, DOI 10.1016/S1010-7940(02)00298-1; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104	39	61	73	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12886	12892		10.1074/jbc.M112.345082	http://dx.doi.org/10.1074/jbc.M112.345082			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362762	Green Published, hybrid			2022-12-25	WOS:000302903700028
J	Fujita, M; Ieguchi, K; Davari, P; Yamaji, S; Taniguchi, Y; Sekiguchi, K; Takada, YK; Takada, Y				Fujita, Masaaki; Ieguchi, Katsuaki; Davari, Parastoo; Yamaji, Satoshi; Taniguchi, Yukimasa; Sekiguchi, Kiyotoshi; Takada, Yoko K.; Takada, Yoshikazu			Cross-talk between Integrin alpha 6 beta 4 and Insulin-like Growth Factor-1 Receptor (IGF1R) through Direct alpha 6 beta 4 Binding to IGF1 and Subsequent alpha 6 beta 4-IGF1-IGF1R Ternary Complex Formation in Anchorage-independent Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; MONOCLONAL-ANTIBODIES; CELLS; CARCINOMA; ALPHA-V-BETA-3; SUBUNIT; INVASION; ADHESION; DOMAIN; SPECIFICITIES	Integrin alpha v beta 3 plays a role in insulin-like growth factor-1 (IGF1) signaling (integrin-IGF1 receptor (IGF1R) cross-talk). The specifics of the cross-talk are, however, unclear. In a current model, "ligand occupancy" of alpha v beta 3 (i.e. the binding of extracellular matrix proteins) enhances signaling induced by IGF1 binding to IGF1R. We recently reported that IGF1 directly binds to alpha v beta 3 and induces alpha v beta 3-IGF1-IGF1R ternary complex formation. Consistently, the integrin binding-defective IGF1 mutant (R36E/R37E) is defective in inducing ternary complex formation and IGF signaling, but it still binds to IGF1R. Like alpha v beta 3, integrin alpha 6 beta 4 is overexpressed in many cancers and is implicated in cancer progression. Here, we discovered that alpha 6 beta 4 directly bound to IGF1, but not to R36E/R37E. Grafting the beta 4 sequence WPNSDP (residues 167-172), which corresponds to the specificity loop of beta 3, to integrin beta 1 markedly enhanced IGF1 binding to beta 1, suggesting that the WPNSDP sequence is involved in IGF1 recognition. WT IGF1 induced alpha 6 beta 4-IGF1-IGF1R ternary complex formation, whereas R36E/R37E did not. When cells were attached to matrix, exogenous IGF1 or alpha 6 beta 4 expression had little or no effect on intracellular signaling. When cell-matrix adhesion was reduced (in poly(2-hydroxyethyl methacrylate-coated plates), IGF1 induced intracellular signaling and enhanced cell survival in an alpha 6 beta 4-dependent manner. Also IGF1 enhanced colony formation in soft agar in an alpha 6 beta 4-dependent manner. These results suggest that IGF binding to alpha 6 beta 4 plays a major role in IGF signaling in anchorage-independent conditions, which mimic the in vivo environment, and is a novel therapeutic target.	[Fujita, Masaaki; Ieguchi, Katsuaki; Davari, Parastoo; Yamaji, Satoshi; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Fujita, Masaaki; Ieguchi, Katsuaki; Davari, Parastoo; Yamaji, Satoshi; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Taniguchi, Yukimasa; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan	University of California System; University of California Davis; University of California System; University of California Davis; Osaka University	Takada, Y (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Res 3,Suite 3300,4645 2nd Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu		takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [CA13015]; Department of Defense [W81XWH-10-1-0312]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20370046]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA13015 and Department of Defense Grant W81XWH-10-1-0312 (to Y. T.). This work was also supported by Grant-in-aid for Scientific Research 20370046 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. S.).	Abdel-Ghany M, 2003, J BIOL CHEM, V278, P49406, DOI 10.1074/jbc.M309086200; Bon G, 2006, CLIN CANCER RES, V12, P3280, DOI 10.1158/1078-0432.CCR-05-2223; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; BROWN PJ, 1988, EXP CELL RES, V177, P303, DOI 10.1016/0014-4827(88)90464-8; BROWN PJ, 1985, SCIENCE, V228, P1448, DOI 10.1126/science.4012302; Chung J, 2004, J BIOL CHEM, V279, P32287, DOI 10.1074/jbc.M403809200; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Doerr ME, 1996, J BIOL CHEM, V271, P2443, DOI 10.1074/jbc.271.5.2443; FALCIONI R, 1986, CANCER RES, V46, P5772; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; FUKAZAWA H, 1995, ANAL BIOCHEM, V228, P83, DOI 10.1006/abio.1995.1318; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Jones JL, 1997, EXP CELL RES, V235, P325, DOI 10.1006/excr.1997.3662; Jones John I., 1995, Progress in Growth Factor Research, V6, P319, DOI 10.1016/0955-2235(95)00015-1; Kamata T, 2002, J IMMUNOL, V168, P2296, DOI 10.4049/jimmunol.168.5.2296; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Lipscomb EA, 2003, CLIN EXP METASTAS, V20, P569, DOI 10.1023/A:1025819521707; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; Murgia C, 1998, EMBO J, V17, P3940, DOI 10.1093/emboj/17.14.3940; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; STEPHENSON JR, 1971, P NATL ACAD SCI USA, V68, P1542, DOI 10.1073/pnas.68.7.1542; TAKADA Y, 1993, J BIOL CHEM, V268, P17597; Takagi J, 1997, J BIOCHEM, V121, P914; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zheng B, 1998, P NATL ACAD SCI USA, V95, P11217, DOI 10.1073/pnas.95.19.11217	35	32	36	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12491	12500		10.1074/jbc.M111.304170	http://dx.doi.org/10.1074/jbc.M111.304170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351760	Green Published, hybrid			2022-12-25	WOS:000302782200088
J	Failes, TW; Mitic, G; Abdel-Halim, H; Po'uha, ST; Liu, M; Hibbs, DE; Kavallaris, M				Failes, Timothy W.; Mitic, Gorjana; Abdel-Halim, Heba; Po'uha, Sela T.; Liu, Marjorie; Hibbs, David E.; Kavallaris, Maria			Evolution of Resistance to Aurora Kinase B Inhibitors in Leukaemia Cells	PLOS ONE			English	Article							III BETA-TUBULIN; GROWTH ARREST; LUNG-CANCER; DRUG-TARGET; IN-VIVO; OVEREXPRESSION; AMPLIFICATION; SENSITIVITY; ACTIVATION; APOPTOSIS	Aurora kinase inhibitors are new mitosis-targeting drugs currently in clinical trials for the treatment of haematological and solid malignancies. However, knowledge of the molecular factors that influence sensitivity and resistance remains limited. Herein, we developed and characterised an in vitro leukaemia model of resistance to the Aurora B inhibitor ZM447439. Human T-cell acute lymphoblastic leukaemia cells, CCRF-CEM, were selected for resistance in 4 mu M ZM447439. CEM/AKB4 cells showed no cross-resistance to tubulin-targeted and DNA-damaging agents, but were hypersensitive to an Aurora kinase A inhibitor. Sequencing revealed a mutation in the Aurora B kinase domain corresponding to a G160E amino acid substitution. Molecular modelling of drug binding in Aurora B containing this mutation suggested that resistance is mediated by the glutamate substitution preventing formation of an active drug-binding motif. Progression of resistance in the more highly selected CEM/AKB8 and CEM/AKB16 cells, derived sequentially from CEM/AKB4 in 8 and 16 mu M ZM447439 respectively, was mediated by additional defects. These defects were independent of Aurora B and multi-drug resistance pathways and are associated with reduced apoptosis mostly likely due to reduced inhibition of the catalytic activity of aurora kinase B in the presence of drug. Our findings are important in the context of the use of these new targeted agents in treatment regimes against leukaemia and suggest resistance to therapy may arise through multiple independent mechanisms.	[Failes, Timothy W.; Mitic, Gorjana; Po'uha, Sela T.; Liu, Marjorie; Kavallaris, Maria] Univ New S Wales, Childrens Canc Inst Australia, Randwick, NSW, Australia; [Abdel-Halim, Heba; Hibbs, David E.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Kavallaris, Maria] Univ New S Wales, Australian Ctr Nanomed, Sydney, NSW, Australia	Children's Cancer Institute; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney	Failes, TW (corresponding author), Univ New S Wales, Childrens Canc Inst Australia, Randwick, NSW, Australia.	m.kavallaris@ccia.unsw.edu.au	Kavallaris, Maria/J-5240-2014		Children's Cancer Institute Australia for Medical Research; Cancer Institute New South Wales [06-589]; Cancer Council New South Wales; University of New South Wales; Oncology Children's Foundation; National Health and Medical Research Council [568611]	Children's Cancer Institute Australia for Medical Research; Cancer Institute New South Wales; Cancer Council New South Wales(Cancer Council New South Wales); University of New South Wales; Oncology Children's Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Children's Cancer Institute Australia for Medical Research, which is affiliated with the University of New South Wales and Sydney Children's Hospital, and by grants from the Cancer Institute New South Wales (Dr. Failes and Dr. Kavallaris; #06-589), Cancer Council New South Wales (Dr. Kavallaris), University of New South Wales Early Career Researcher Grant (Dr. Failes) and Oncology Children's Foundation (Dr. Kavallaris and Dr. Po'uha). Dr. Failes was supported by a Vice Chancellors Postdoctoral Fellowship, University of New South Wales, and Dr. Kavallaris is supported by a National Health and Medical Research Council Senior Research Fellowship (#568611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AST, 1994, NUCLEIC ACIDS RES, V22, P5769; Andersen CB, 2008, ACS CHEM BIOL, V3, P180, DOI 10.1021/cb700200w; Andrews PD, 2005, ONCOGENE, V24, P5005, DOI 10.1038/sj.onc.1208752; [Anonymous], 2008, MACROMODEL V 9 6; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bolanos-Garcia VM, 2005, INT J BIOCHEM CELL B, V37, P1572, DOI 10.1016/j.biocel.2005.02.021; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Don S, 2004, MOL CANCER THER, V3, P1137; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Gan PP, 2007, CANCER RES, V67, P9356, DOI 10.1158/0008-5472.CAN-07-0509; Gifford AJ, 1998, INT J CANCER, V78, P176, DOI 10.1002/(SICI)1097-0215(19981005)78:2<176::AID-IJC10>3.3.CO;2-F; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Ikezoe T, 2007, MOL CANCER THER, V6, P1851, DOI 10.1158/1535-7163.MCT-07-0067; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Li DH, 2003, CLIN CANCER RES, V9, P991; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Pihan GA, 2001, CANCER RES, V61, P2212; Po'uha ST, 2010, ONCOGENE, V29, P597, DOI 10.1038/onc.2009.367; *SCHROD LLC, 2008, MAESTR V 8 5; *SCHROD LLC, 2008, GLID V 5 0; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Sharma SV, CELL, V141, P69; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Verrills NM, 2003, CHEM BIOL, V10, P597, DOI 10.1016/S1074-5521(03)00141-8; Walsby E, 2008, HAEMATOLOGICA, V93, P662, DOI 10.3324/haematol.12148; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Yang J, 2007, BLOOD, V110, P2034, DOI 10.1182/blood-2007-02-073700	37	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30734	10.1371/journal.pone.0030734	http://dx.doi.org/10.1371/journal.pone.0030734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359551	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200020
J	Luchetti, A; Filareto, A; Sanchez, M; Ferraguti, G; Lucarelli, M; Novelli, G; Sangiuolo, F; Malgieri, A				Luchetti, Andrea; Filareto, Antonio; Sanchez, Massimo; Ferraguti, Giampiero; Lucarelli, Marco; Novelli, Giuseppe; Sangiuolo, Federica; Malgieri, Arianna			Small Fragment Homologous Replacement: Evaluation of Factors Influencing Modification Efficiency in an Eukaryotic Assay System	PLOS ONE			English	Article							TARGETED GENE REPAIR; CELL-CYCLE; S-PHASE; DNA; RECOMBINATION; ATM; IDENTIFICATION; REPLICATION; INHIBITION; THERAPY	Homologous Replacement is used to modify specific gene sequences of chromosomal DNA in a process referred to as "Small Fragment Homologous Replacement", where DNA fragments replace genomic target resulting in specific sequence changes. To optimize the efficiency of this process, we developed a reporter based assay system where the replacement frequency is quantified by cytofluorimetric analysis following restoration of a stably integrated mutated eGFP gene in the genome of SV-40 immortalized mouse embryonic fibroblasts (MEF-SV-40). To obtain the highest correction frequency with this system, several parameters were considered: fragment synthesis and concentration, cell cycle phase and methylation status of both fragment and recipient genome. In addition, different drugs were employed to test their ability to improve technique efficiency. SFHR-mediated genomic modification resulted to be stably transmitted for several cell generations and confirmed at transcript and genomic levels. Modification efficiency was estimated in a range of 0.01-0.5%, further increasing when PARP-1 repair pathway was inhibited. In this study, for the first time SFHR efficiency issue was systematically approached and in part addressed, therefore opening new potential therapeutic ex-vivo applications.	[Luchetti, Andrea; Filareto, Antonio; Sangiuolo, Federica; Malgieri, Arianna] Univ Roma Tor Vergata, Sch Med, Dept Biopathol & Diagnost Imaging, Med Genet Sect, Rome, Italy; [Sanchez, Massimo] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Ferraguti, Giampiero; Lucarelli, Marco] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy; [Novelli, Giuseppe] Natl Agcy Evaluat Univ & Res ANVUR, Rome, Italy; [Novelli, Giuseppe] Osped San Pietro Fatebenefratelli, Rome, Italy	University of Rome Tor Vergata; Istituto Superiore di Sanita (ISS); Sapienza University Rome	Luchetti, A (corresponding author), Univ Roma Tor Vergata, Sch Med, Dept Biopathol & Diagnost Imaging, Med Genet Sect, Rome, Italy.	sangiuolo@med.uniroma2.it	sangiuolo, federica/I-4392-2019; Lucarelli, Marco/AAC-1667-2019; Novelli, Giuseppe/GQB-3329-2022; Novelli, Giuseppe/T-8822-2019; Sanchez, Massimo/AAD-1746-2021; Novelli, Giuseppe/A-5195-2013	sangiuolo, federica/0000-0002-6227-4248; Novelli, Giuseppe/0000-0002-7781-602X; Sanchez, Massimo/0000-0003-3696-7582; Novelli, Giuseppe/0000-0002-7781-602X; Lucarelli, Marco/0000-0002-5538-2494; FERRAGUTI, Giampiero/0000-0001-6129-4071	Fondazione Cenci Bolognetti; Fondazione Roma	Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Fondazione Roma(Fondazione RomaEuropean Commission)	This work was supported by Fondazione Cenci Bolognetti and by Fondazione Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Adams DJ, 2008, PHYSIOL GENOMICS, V34, P225, DOI 10.1152/physiolgenomics.90242.2008; Aguilar-Quesada R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-29; Althaus FR, 2005, ONCOGENE, V24, P11, DOI 10.1038/sj.onc.1208382; Bedayat B, 2010, OLIGONUCLEOTIDES, V20, P7, DOI 10.1089/oli.2009.0205; Brachman EE, 2005, DNA REPAIR, V4, P445, DOI 10.1016/j.dnarep.2004.11.007; Bryant HE, 2006, NUCLEIC ACIDS RES, V34, P1685, DOI 10.1093/nar/gkl108; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Calabrese G, 1996, HUM GENET, V97, P414; CAPECCHI MR, 1994, SCI AM, V270, P52, DOI 10.1038/scientificamerican0394-52; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Colosimo A, 2001, MOL THER, V3, P178, DOI 10.1006/mthe.2000.0242; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI [10.1002/0471142727.mb2303s51, 10.1002/0471142727.mb2302s51]; Cuozzo C, 2007, PLOS GENET, V3, P1144, DOI 10.1371/journal.pgen.0030110; de Semir D, 2006, CURR GENE THER, V6, P481, DOI 10.2174/156652306777934847; Engstrom JU, 2008, CELL CYCLE, V7, P1402, DOI 10.4161/cc.7.10.5826; Fischer A, 2008, LANCET, V371, P2044, DOI 10.1016/S0140-6736(08)60874-0; Goncz KK, 2006, OLIGONUCLEOTIDES, V16, P213, DOI 10.1089/oli.2006.16.213; Goncz KK, 2002, GENE THER, V9, P691, DOI 10.1038/sj.gt.3301743; Gruenert DC, 2003, J CLIN INVEST, V112, P637, DOI 10.1172/JCI200319773; Gruenert DC, 1999, GENE THER, V6, P1347, DOI 10.1038/sj.gt.3301011; Gruenert DC, 1998, CURR RES MOL THER, V1, P607; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hu YL, 2005, MOL BIOTECHNOL, V29, P197, DOI 10.1385/MB:29:3:197; Joshi MU, 2008, BIOTECHNIQUES, V45, P247, DOI 10.2144/000112913; Kapsa R, 2001, HUM GENE THER, V12, P629, DOI 10.1089/104303401300057324; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kunzelmann K, 1996, GENE THER, V3, P859; Leclerc X, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-35; Maurisse R, 2006, ANN NY ACAD SCI, V1082, P120, DOI 10.1196/annals.1348.063; Noel G, 2006, MOL CANCER THER, V5, P564, DOI 10.1158/1535-7163.MCT-05-0418; Rotman G, 1998, HUM MOL GENET, V7, P1555, DOI 10.1093/hmg/7.10.1555; Sangiuolo F, 2005, HUM GENE THER, V16, P869, DOI 10.1089/hum.2005.16.869; Sangiuolo F, 2008, FRONT BIOSCI-LANDMRK, V13, P2989, DOI 10.2741/2904; Sangiuolo Federica, 2002, BMC Med Genet, V3, P8, DOI 10.1186/1471-2350-3-8; Sargent RG, 2011, OLIGONUCLEOTIDES, V21, P55, DOI 10.1089/oli.2010.0273; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Semionov A, 2003, BIOCHEM CELL BIOL, V81, P17, DOI 10.1139/O02-172; Semionov A, 1999, NUCLEIC ACIDS RES, V27, P4526, DOI 10.1093/nar/27.22.4526; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sorrell DA, 2005, BIOTECHNOL ADV, V23, P431, DOI 10.1016/j.biotechadv.2005.03.003; Spitalieri P, 2009, CLONING STEM CELLS, V11, P535, DOI 10.1089/clo.2009.0046; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tenzen T, 2010, J CELL PHYSIOL, V222, P278, DOI 10.1002/jcp.21948; Todaro M, 2007, HUM MUTAT, V28, P816, DOI 10.1002/humu.20494; Tsai TF, 2003, GENESIS, V37, P151, DOI 10.1002/gene.10237; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Zayed H, 2006, HUM GENE THER, V17, P158, DOI 10.1089/hum.2006.17.158	48	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30851	10.1371/journal.pone.0030851	http://dx.doi.org/10.1371/journal.pone.0030851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359552	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200021
J	Suli, A; Watson, GM; Rubel, EW; Raible, DW				Suli, Arminda; Watson, Glen M.; Rubel, Edwin W.; Raible, David W.			Rheotaxis in Larval Zebrafish Is Mediated by Lateral Line Mechanosensory Hair Cells	PLOS ONE			English	Article							DANIO-RERIO; CIRCADIAN RHYTHMICITY; CHICK COCHLEA; SENSORY BASIS; CAVE FISH; REGENERATION; SYSTEM; FM1-43; RHEOTROPISM; NEUROMASTS	The lateral line sensory system, found in fish and amphibians, is used in prey detection, predator avoidance and schooling behavior. This system includes cell clusters, called superficial neuromasts, located on the surface of head and trunk of developing larvae. Mechanosensory hair cells in the center of each neuromast respond to disturbances in the water and convey information to the brain via the lateral line ganglia. The convenient location of mechanosensory hair cells on the body surface has made the lateral line a valuable system in which to study hair cell damage and regeneration. One way to measure hair cell survival and recovery is to assay behaviors that depend on their function. We built a system in which orientation against constant water flow, positive rheotaxis, can be quantitatively assessed. We found that zebrafish larvae perform positive rheotaxis and that, similar to adult fish, larvae use both visual and lateral line input to perform this behavior. Disruption or damage of hair cells in the absence of vision leads to a marked decrease in rheotaxis that recovers upon hair cell repair or regeneration.	[Suli, Arminda; Raible, David W.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Watson, Glen M.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Rubel, Edwin W.; Raible, David W.] Univ Washington, VM Bloedel Hearing Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Louisiana Lafayette; University of Washington; University of Washington Seattle	Suli, A (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	draible@u.washington.edu		Suli, Arminda/0000-0003-2690-8407; Raible, David/0000-0002-5342-5841	National Institute on Deafness and Other Communication Disorders (NIDCD) [R01DC005987]; Hearing Health Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005987] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Hearing Health Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by R01DC005987 to DWR from the National Institute on Deafness and Other Communication Disorders (NIDCD) (www.nidcd.nih.gov), and a research grant from the Hearing Health Foundation (www.drf.org) to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; Bagatto B, 2001, J EXP BIOL, V204, P4335; Baker CF, 1999, J COMP PHYSIOL A, V184, P519, DOI 10.1007/s003590050351; BALAK KJ, 1990, J NEUROSCI, V10, P2502; Behra M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000455; Berg A, 2002, HEARING RES, V174, P296, DOI 10.1016/S0378-5955(02)00705-0; Blaxter J. H. S., 1989, MECHANOSENSORY LATER, P482; Brignull HR, 2009, BRAIN RES, V1277, P12, DOI 10.1016/j.brainres.2009.02.028; Cahill GM, 1998, NEUROREPORT, V9, P3445, DOI 10.1097/00001756-199810260-00020; Clark DT, 1981, VISUAL RESPONSES DEV; Coffin AB, 2010, ZEBRAFISH, V7, P3, DOI 10.1089/zeb.2009.0639; COTANCHE DA, 1987, HEARING RES, V30, P181, DOI 10.1016/0378-5955(87)90135-3; CRUZ RM, 1987, ARCH OTOLARYNGOL, V113, P1058; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Faucherre A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004477; Feitl KE, 2010, J EXP BIOL, V213, P3131, DOI 10.1242/jeb.045518; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Hernandez PP, 2006, HEARING RES, V213, P1, DOI 10.1016/j.heares.2005.10.015; HOEKSTRA D, 1985, ENVIRON BIOL FISH, V12, P111, DOI 10.1007/BF00002763; Hurd MW, 2002, J BIOL RHYTHM, V17, P307, DOI 10.1177/074873002129002618; JONES JE, 1993, J NEUROSCI, V13, P1022; Lopez-Schier H, 2006, P NATL ACAD SCI USA, V103, P18615, DOI 10.1073/pnas.0608536103; Lyon EP, 1904, AM J PHYSIOL, V12, P149, DOI 10.1152/ajplegacy.1904.12.2.149; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; McHenry MJ, 2009, BIOL LETTERS, V5, P477, DOI 10.1098/rsbl.2009.0048; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Meyers JR, 2003, J NEUROSCI, V23, P4054; Montgomery JC, 1997, MAR FRESHW BEHAV PHY, V30, P209, DOI 10.1080/10236249709379026; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; Nagiel A, 2008, J NEUROSCI, V28, P8442, DOI 10.1523/JNEUROSCI.2425-08.2008; Neuhauss SCF, 2003, J NEUROBIOL, V54, P148, DOI 10.1002/neu.10165; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; Nishikawa S, 1996, J HISTOCHEM CYTOCHEM, V44, P733, DOI 10.1177/44.7.8675994; Owens KN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000020; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; Sheets L, 2011, DEVELOPMENT, V138, P1309, DOI 10.1242/dev.059451; Ton C, 2005, HEARING RES, V208, P79, DOI 10.1016/j.heares.2005.05.005; Westerfield M, 2007, ZEBRAFISH BOOK; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3	44	106	106	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e29727	10.1371/journal.pone.0029727	http://dx.doi.org/10.1371/journal.pone.0029727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359538	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200007
J	Weiss, VL; Lee, TH; Song, H; Kouo, TS; Black, CM; Sgouros, G; Jaffee, EM; Armstrong, TD				Weiss, Vivian L.; Lee, Timothy H.; Song, Hong; Kouo, Theodore S.; Black, Chelsea M.; Sgouros, George; Jaffee, Elizabeth M.; Armstrong, Todd D.			Trafficking of High Avidity HER-2/neu-Specific T Cells into HER-2/neu-Expressing Tumors after Depletion of Effector/Memory-Like Regulatory T Cells	PLOS ONE			English	Article							DENDRITIC CELLS; MAMMARY-TUMORS; EXPRESSION; MEMORY; IMMUNITY; CANCER; ANTIGEN; CYCLOPHOSPHAMIDE; MECHANISMS; RECEPTOR	Background: Cancer vaccines are designed to activate and enhance cancer-antigen-targeted T cells that are suppressed through multiple mechanisms of immune tolerance in cancer-bearing hosts. T regulatory cell (Treg) suppression of tumor-specific T cells is one barrier to effective immunization. A second mechanism is the deletion of high avidity tumor-specific T cells, which leaves a less effective low avidity tumor specific T cell repertoire available for activation by vaccines. Treg depleting agents including low dose cyclophosphamide (Cy) and antibodies that deplete CD25-expressing Tregs have been used with limited success to enhance the potency of tumor-specific vaccines. In addition, few studies have evaluated mechanisms that activate low avidity cancer antigen-specific T cells. Therefore, we developed high and low avidity HER-2/neu-specific TCR transgenic mouse colonies specific for the same HER-2/neu epitope to define the tolerance mechanisms that specifically affect high versus low avidity tumor-specific T cells. Methodology/Principal Findings: High and low avidity CD8(+) T cell receptor (TCR) transgenic mice specific for the breast cancer antigen HER-2/neu (neu) were developed to provide a purified source of naive, tumor-specific T cells that can be used to study tolerance mechanisms. Adoptive transfer studies into tolerant FVB/N-derived HER-2/neu transgenic (neu-N) mice demonstrated that high avidity, but not low avidity, neu-specific T cells are inhibited by Tregs as the dominant tolerizing mechanism. High avidity T cells persisted, produced IFN gamma, trafficked into tumors, and lysed tumors after adoptive transfer into mice treated with a neu-specific vaccine and low dose Cy to deplete Tregs. Analysis of Treg subsets revealed a Cy-sensitive CD4(+)Foxp3(+)CD25(low) tumor-seeking migratory phenotype, characteristic of effector/memory Tregs, and capable of high avidity T cell suppression. Conclusion/Significance: Depletion of CD25(low) Tregs allows activation of tumor-clearing high avidity T cells. Thus, the development of agents that specifically deplete Treg subsets should translate into more effective immunotherapies while avoiding autoimmunity.	[Weiss, Vivian L.; Lee, Timothy H.; Song, Hong; Kouo, Theodore S.; Black, Chelsea M.; Sgouros, George; Jaffee, Elizabeth M.; Armstrong, Todd D.] Johns Hopkins Univ, Sidney Kimmel Canc Ctr Johns Hopkins, Sch Med, Baltimore, MD 21218 USA; [Weiss, Vivian L.; Lee, Timothy H.; Song, Hong; Kouo, Theodore S.; Black, Chelsea M.; Sgouros, George; Jaffee, Elizabeth M.; Armstrong, Todd D.] Johns Hopkins Univ, Dept Oncol, Sch Med, Baltimore, MD USA; [Weiss, Vivian L.; Kouo, Theodore S.; Jaffee, Elizabeth M.] Johns Hopkins Univ, Grad Program Immunol, Sch Med, Baltimore, MD USA; [Song, Hong; Sgouros, George] Johns Hopkins Univ, Dept Radiol & Nucl Med, Sch Med, Baltimore, MD USA; [Black, Chelsea M.; Jaffee, Elizabeth M.] Johns Hopkins Univ, Grad Program Cellular & Mol Med, Sch Med, Baltimore, MD USA; [Jaffee, Elizabeth M.] Johns Hopkins Univ, Grad Program Pharmacol, Sch Med, Baltimore, MD USA; [Jaffee, Elizabeth M.] Skip Viragh Pancreat Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Weiss, VL (corresponding author), Johns Hopkins Univ, Sidney Kimmel Canc Ctr Johns Hopkins, Sch Med, Baltimore, MD 21218 USA.	tarmstro@jhmi.edu		Song, Hong/0000-0003-3997-6468; Jaffee, Elizabeth/0000-0003-3841-6549	National Institutes of Health [R01CA122081]; National Cancer Institute SPORE [P50CA088843]; American Association for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA122081, P50CA088843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health R01CA122081, and National Cancer Institute SPORE grant in breast cancer P50CA088843. This work was also supported by the American Association for Cancer Research (www.AACR.org) Centennial Pre-doctoral Research Fellowship awarded to VLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaoui-Jamali MA, 1997, BIOCHEM CELL BIOL, V75, P315, DOI 10.1139/bcb-75-4-315; Andersson A, 2009, J IMMUNOL, V182, P6951, DOI 10.4049/jimmunol.0803340; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Baldridge MT, 2011, TRENDS IMMUNOL, V32, P57, DOI 10.1016/j.it.2010.12.003; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; BRECHBIEL MW, 1991, J CHEM SOC CHEM COMM, P1169, DOI 10.1039/c39910001169; Butler NS, 2011, CELL MICROBIOL, V13, P925, DOI 10.1111/j.1462-5822.2011.01594.x; Chen DS, 2005, PLOS MED, V2, P1018, DOI 10.1371/journal.pmed.0020265; Colantonio L, 1999, BLOOD, V94, P2981, DOI 10.1182/blood.V94.9.2981.421k27_2981_2989; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; den Boer AT, 2004, J IMMUNOL, V172, P6074, DOI 10.4049/jimmunol.172.10.6074; Disis ML, 1997, ADV CANCER RES, V71, P343, DOI 10.1016/S0065-230X(08)60103-7; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Dutoit V, 2001, CANCER RES, V61, P5850; Emens LA, 2009, J CLIN ONCOL, V27, P5911, DOI 10.1200/JCO.2009.23.3494; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Ercolini AM, 2003, J IMMUNOL, V170, P4273, DOI 10.4049/jimmunol.170.8.4273; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gilboa E, 2004, NAT REV CANCER, V4, P401, DOI 10.1038/nrc1359; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Haworth O, 2008, RHEUMATOLOGY, V47, P1329, DOI 10.1093/rheumatology/ken263; Hege KM, 2006, INT REV IMMUNOL, V25, P321, DOI 10.1080/08830180600992498; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Janicki CN, 2008, CANCER RES, V68, P2993, DOI 10.1158/0008-5472.CAN-07-5008; June CH, 2007, J CLIN INVEST, V117, P1204, DOI 10.1172/JCI31446; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim PS, 2008, J CLIN INVEST, V118, P1700, DOI 10.1172/JCI34333; Kimpfler S, 2009, J IMMUNOL, V183, P6330, DOI 10.4049/jimmunol.0900609; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lin YC, 2009, J IMMUNOL, V182, P6095, DOI 10.4049/jimmunol.0803829; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Lyman MA, 2005, J IMMUNOL, V174, P2563, DOI 10.4049/jimmunol.174.5.2563; Machiels JPH, 2001, CANCER RES, V61, P3689; Manning EA, 2007, CLIN CANCER RES, V13, P3951, DOI 10.1158/1078-0432.CCR-07-0374; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Mattei F, 2009, EUR J IMMUNOL, V39, P1807, DOI 10.1002/eji.200939233; McMahan RH, 2007, SEMIN CANCER BIOL, V17, P317, DOI 10.1016/j.semcancer.2007.06.006; Mittendorf EA, 2010, EXPERT REV VACCINES, V9, P89, DOI [10.1586/erv.09.144, 10.1586/ERV.09.144]; Murata S, 2006, J IMMUNOL, V176, P974, DOI 10.4049/jimmunol.176.2.974; Nakahara T, 2010, BLOOD, V115, P4384, DOI 10.1182/blood-2009-11-251231; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; NIKULA TK, 1995, NUCL MED BIOL, V22, P387, DOI 10.1016/0969-8051(94)00126-5; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Ohtani H, 2009, J PATHOL, V217, P21, DOI 10.1002/path.2448; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Radojcic V, 2010, CANCER IMMUNOL IMMUN, V59, P137, DOI 10.1007/s00262-009-0734-3; Reilly RT, 2000, CANCER RES, V60, P3569; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sasaki K, 2008, J IMMUNOL, V181, P104, DOI 10.4049/jimmunol.181.1.104; Schiavoni G, 2000, BLOOD, V95, P2024, DOI 10.1182/blood.V95.6.2024; SCHULZ M, 1991, EUR J IMMUNOL, V21, P1181, DOI 10.1002/eji.1830210513; Shafer-Weaver KA, 2009, CANCER RES, V69, P6256, DOI 10.1158/0008-5472.CAN-08-4516; Shi MQ, 2007, BIOCHEM BIOPH RES CO, V360, P702, DOI 10.1016/j.bbrc.2007.06.126; Singh NJ, 2006, NAT CLIN PRACT RHEUM, V2, P44, DOI 10.1038/ncprheum0049; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; SPRENT J, 1995, CURR OPIN IMMUNOL, V7, P196, DOI 10.1016/0952-7915(95)80004-2; Strauss L, 2008, J IMMUNOL, V180, P2967, DOI 10.4049/jimmunol.180.5.2967; Viaud S, 2011, CANCER RES, V71, P661, DOI 10.1158/0008-5472.CAN-10-1259; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wong SBJ, 2008, J IMMUNOL, V180, P3122, DOI 10.4049/jimmunol.180.5.3122; Yi HF, 2006, CELL MOL IMMUNOL, V3, P189; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001; Zelenay S, 2005, P NATL ACAD SCI USA, V102, P4091, DOI 10.1073/pnas.0408679102	73	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31962	10.1371/journal.pone.0031962	http://dx.doi.org/10.1371/journal.pone.0031962			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359647	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200116
J	Yang, LJ; Shen, JQ; He, SS; Hu, GY; Shen, J; Wang, F; Xu, L; Dai, WQ; Xiong, J; Ni, JB; Guo, CY; Wan, R; Wang, XP				Yang, LiJuan; Shen, JiaQing; He, ShanShan; Hu, GuoYong; Shen, Jie; Wang, Feng; Xu, Ling; Dai, WeiQi; Xiong, Jie; Ni, JianBo; Guo, ChuanYong; Wan, Rong; Wang, XingPeng			L-Cysteine Administration Attenuates Pancreatic Fibrosis Induced by TNBS in Rats by Inhibiting the Activation of Pancreatic Stellate Cell	PLOS ONE			English	Article							LIVER FIBROSIS; TGF-BETA; GROWTH; EXPRESSION; MICE; OVEREXPRESSION; NRF2; PROLIFERATION; MEDIATORS; CYTOKINES	Background and Aims: Recent studies have shown that activated pancreatic stellate cells (PSCs) play a major role in pancreatic fibrogenesis. We aimed to study the effect of L-cysteine administration on fibrosis in chronic pancreatitis (CP) induced by trinitrobenzene sulfonic acid (TNBS) in rats and on the function of cultured PSCs. Methods: CP was induced by TNBS infusion into rat pancreatic ducts. L-cysteine was administrated for the duration of the experiment. Histological analysis and the contents of hydroxyproline were used to evaluate pancreatic damage and fibrosis. Immunohistochemical analysis of alpha-SMA in the pancreas was performed to detect the activation of PSCs in vivo. The collagen deposition related proteins and cytokines were determined by western blot analysis. DNA synthesis of cultured PSCs was evaluated by BrdU incorporation. We also evaluated the effect of L-cysteine on the cell cycle and cell activation by flow cytometry and immunocytochemistry. The expression of PDGFR beta, TGF beta RII, collagen 1 alpha 1 and alpha-SMA of PSCs treated with different concentrations of L-cysteine was determined by western blot. Parameters of oxidant stress were evaluated in vitro and in vivo. Nrf2, NQO1, HO-1, IL-1 beta expression were evaluated in pancreas tissues by qRT-PCR. Results: The inhibition of pancreatic fibrosis by L-cysteine was confirmed by histological observation and hydroxyproline assay. alpha-SMA, TIMP1, IL-1 beta and TGF-beta 1 production decreased compared with the untreated group along with an increase in MMP2 production. L-cysteine suppressed the proliferation and extracellular matrix production of PSCs through down-regulating of PDGFR beta and TGF beta RII. Concentrations of MDA+4-HNE were decreased by L-cysteine administration along with an increase in GSH levels both in tissues and cells. In addition, L-cysteine increased the mRNA expression of Nrf2, NQO1 and HO-1 and reduced the expression of IL-1 beta in L-cysteine treated group when compared with control group. Conclusion: L-cysteine treatment attenuated pancreatic fibrosis in chronic pancreatitis in rats.	[Yang, LiJuan; Shen, JiaQing; Wang, XingPeng] Shanghai Jiao Tong Univ, Dept Gastroenterol, Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [He, ShanShan; Hu, GuoYong; Shen, Jie; Wang, Feng; Xu, Ling; Dai, WeiQi; Xiong, Jie; Ni, JianBo; Guo, ChuanYong; Wan, Rong; Wang, XingPeng] Tongji Univ, Dept Gastroenterol, Peoples Hosp Shanghai 10, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Tongji University	Yang, LJ (corresponding author), Shanghai Jiao Tong Univ, Dept Gastroenterol, Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	wangxingpeng@hotmail.com	He, Shanshan/P-5691-2014	Guo, Chuanyong/0000-0002-6527-4673	National High Technology Research and Development Program of China (863 Program) [2009AA02Z116]; National Natural Science Foundation of China [30971359]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by a grant from the National High Technology Research and Development Program of China (863 Program) (no. 2009AA02Z116) and by the National Natural Science Foundation of China (no. 30971359). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Apte MV, 2004, DIGEST DIS, V22, P273, DOI 10.1159/000082799; Apte MV, 2000, GASTROENTEROLOGY, V118, P780, DOI 10.1016/S0016-5085(00)70148-X; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bentrem DJ, 2003, CRIT CARE MED, V31, pS582, DOI 10.1097/01.CCM.0000081428.35729.73; Bhardwaj P, 2009, GASTROENTEROLOGY, V136, P149, DOI 10.1053/j.gastro.2008.09.028; Bottinger EP, 1997, EMBO J, V16, P2621, DOI 10.1093/emboj/16.10.2621; Buchholz M, 2005, J MOL MED, V83, P795, DOI 10.1007/s00109-005-0680-2; Casini A, 2000, J PATHOL, V192, P81; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Clain JE, 1999, SURG CLIN N AM, V79, P829, DOI 10.1016/S0039-6109(05)70046-3; Ebert M, 1998, DIGEST DIS SCI, V43, P567, DOI 10.1023/A:1018867209170; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Friess H, 2002, EUR J GASTROEN HEPAT, V14, P971, DOI 10.1097/00042737-200209000-00007; Girish BN, 2011, J PANCREAS, V12, P11; Gukovskaya AS, 1997, J CLIN INVEST, V100, P1853, DOI 10.1172/JCI119714; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Horie T, 2003, BIOCHEM BIOPH RES CO, V305, P94, DOI 10.1016/S0006-291X(03)00691-0; Hu GY, 2011, GUT, V60, P820, DOI 10.1136/gut.2010.215178; Jaster R, 2002, GUT, V51, P579, DOI 10.1136/gut.51.4.579; Jesnowski R, 2005, LAB INVEST, V85, P1276, DOI 10.1038/labinvest.3700329; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; Khalid A, 2002, EUR J GASTROEN HEPAT, V14, P943, DOI 10.1097/00042737-200209000-00004; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kirk GR, 2006, J GASTROINTEST SURG, V10, P499, DOI 10.1016/j.gassur.2005.08.035; Kruse ML, 2000, REGUL PEPTIDES, V90, P47, DOI 10.1016/S0167-0115(00)00104-X; Laugier R, 2002, EUR J GASTROEN HEPAT, V14, P951, DOI 10.1097/00042737-200209000-00005; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lemke M, 2006, PANCREATOLOGY, V6, P486, DOI 10.1159/000094666; Levy MJ, 2003, GASTROINTEST ENDOSC, V57, P923, DOI 10.1016/S0016-5107(03)70036-4; Luttenberger T, 2000, LAB INVEST, V80, P47, DOI 10.1038/labinvest.3780007; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Marrache F, 2008, GASTROENTEROLOGY, V135, P1277, DOI 10.1053/j.gastro.2008.06.078; MARTENSSON J, 1986, AM J GASTROENTEROL, V81, P1179; Matsui H, 2004, J HEPATOL, V40, P917, DOI 10.1016/j.jhep.2004.02.011; Mews P, 2002, GUT, V50, P535, DOI 10.1136/gut.50.4.535; Morimitsu Y, 2002, J BIOL CHEM, V277, P3456, DOI 10.1074/jbc.M110244200; Neuschwander-Tetri BA, 2000, LAB INVEST, V80, P143, DOI 10.1038/labinvest.3780018; Ohashi S, 2006, ANTIOXID REDOX SIGN, V8, P1835, DOI 10.1089/ars.2006.8.1835; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Phillips PA, 2003, GUT, V52, P275, DOI 10.1136/gut.52.2.275; Puig-Divi V, 1999, DIGESTION, V60, P166, DOI 10.1159/000007643; PuigDivi V, 1996, PANCREAS, V13, P417, DOI 10.1097/00006676-199611000-00012; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; REED DJ, 1977, BIOCHEM BIOPH RES CO, V77, P1257, DOI 10.1016/S0006-291X(77)80115-0; Schneider E, 2001, AM J PHYSIOL-CELL PH, V281, pC532, DOI 10.1152/ajpcell.2001.281.2.C532; Shek FWT, 2002, AM J PATHOL, V160, P1787, DOI 10.1016/S0002-9440(10)61125-X; Shimizu K, 2008, J GASTROEN HEPATOL, V23, pS119, DOI 10.1111/j.1440-1746.2007.05296.x; Talukdar R, 2008, J GASTROEN HEPATOL, V23, P34, DOI 10.1111/j.1440-1746.2007.05206.x; Tasci I, 2007, PANCREAS, V35, P366, DOI 10.1097/mpa.0b013e31806dbaaa; TATEISHI N, 1974, J BIOCHEM, V75, P93, DOI 10.1093/oxfordjournals.jbchem.a130387; VanLaethem JL, 1996, GASTROENTEROLOGY, V110, P576, DOI 10.1053/gast.1996.v110.pm8566606; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Vogelmann R, 2001, AM J PHYSIOL-GASTR L, V280, pG164, DOI 10.1152/ajpgi.2001.280.1.G164; Yan MX, 2006, BIOCHEM BIOPH RES CO, V347, P192, DOI 10.1016/j.bbrc.2006.06.063; Yoo BM, 2005, PANCREATOLOGY, V5, P165, DOI 10.1159/000085268; Yoo BM, 2005, PANCREAS, V30, pE71, DOI 10.1097/01.mpa.0000157388.54016.0a; Zeki S, 2002, J GASTROEN HEPATOL, V17, P606, DOI 10.1046/j.1440-1746.2002.02733.x; Zhang W, 2010, PANCREAS, V39, P293, DOI 10.1097/MPA.0b013e3181bb90b5	60	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31807	10.1371/journal.pone.0031807	http://dx.doi.org/10.1371/journal.pone.0031807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359633	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200102
J	Zakas, C; Schult, N; McHugh, D; Jones, KL; Wares, JP				Zakas, Christina; Schult, Nancy; McHugh, Damhnait; Jones, Kenneth L.; Wares, John P.			Transcriptome Analysis and SNP Development Can Resolve Population Differentiation of Streblospio benedicti, a Developmentally Dimorphic Marine Annelid	PLOS ONE			English	Article							DEVELOPING SEA-URCHIN; NONSYNONYMOUS SUBSTITUTIONS; BENTHIC INVERTEBRATES; GENE-EXPRESSION; LARVAL ECOLOGY; EVOLUTION; PATTERNS; MODES; RECRUITMENT; DISPERSAL	Next-generation sequencing technology is now frequently being used to develop genomic tools for non-model organisms, which are generally important for advancing studies of evolutionary ecology. One such species, the marine annelid Streblospio benedicti, is an ideal system to study the evolutionary consequences of larval life history mode because the species displays a rare offspring dimorphism termed poecilogony, where females can produce either many small offspring or a few large ones. To further develop S. benedicti as a model system for studies of life history evolution, we apply 454 sequencing to characterize the transcriptome for embryos, larvae, and juveniles of this species, for which no genomic resources are currently available. Here we performed a de novo alignment of 336,715 reads generated by a quarter GS-FLX (Roche 454) run, which produced 7,222 contigs. We developed a novel approach for evaluating the site frequency spectrum across the transcriptome to identify potential signatures of selection. We also developed 84 novel single nucleotide polymorphism (SNP) markers for this species that are used to distinguish coastal populations of S. benedicti. We validated the SNPs by genotyping individuals of different developmental modes using the BeadXPress Golden Gate assay (Illumina). This allowed us to evaluate markers that may be associated with life-history mode.	[Zakas, Christina; Wares, John P.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Schult, Nancy; McHugh, Damhnait] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Jones, Kenneth L.] Univ Colorado, Dept Biochem & Mol Genet, Sch Med, Aurora, CO USA	University System of Georgia; University of Georgia; Colgate University; University of Colorado System; University of Colorado Anschutz Medical Campus	Zakas, C (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	christinazakas@gmail.com	Jones, Kenneth/GXF-4945-2022	Wares, John/0000-0003-1827-0669; Zakas, Christina/0000-0002-9998-848X	Picker Interdisciplinary Science Institute at Colgate University; University of Georgia Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007103] Funding Source: NIH RePORTER; Directorate For Geosciences [1029526] Funding Source: National Science Foundation	Picker Interdisciplinary Science Institute at Colgate University; University of Georgia Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funds from the Picker Interdisciplinary Science Institute at Colgate University to DM, and the University of Georgia Research Foundation to JPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto FS, 2011, MOL ECOL, V20, P560, DOI 10.1111/j.1365-294X.2010.04963.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Boyle MJ, 2008, EVOL DEV, V10, P89, DOI 10.1111/j.1525-142X.2007.00216.x; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Collin R, 2001, MOL ECOL, V10, P2249, DOI 10.1046/j.1365-294X.2001.01372.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; EMLET RB, 1995, DEV BIOL, V167, P405, DOI 10.1006/dbio.1995.1037; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foltz DW, 2010, EVOL DEV, V12, P222, DOI 10.1111/j.1525-142X.2010.00406.x; Foltz DW, 2004, GENETICA, V122, P115, DOI 10.1023/B:GENE.0000041002.97173.1e; Foltz DW, 2003, J MOL EVOL, V57, P607, DOI 10.1007/s00239-003-2495-5; Frobius AC, 2006, DEV GENES EVOL, V216, P81, DOI 10.1007/s00427-005-0049-0; FU YX, 1993, GENETICS, V133, P693; Giard MA, 1905, COMP REND 6 C INT ZO, P617; Gibson G, 2010, INVERTEBR BIOL, V129, P328, DOI 10.1111/j.1744-7410.2010.00213.x; Grosberg R, 2001, MARINE COMMUNITY ECOLOGY, P61; Haag ES, 1999, DEV BIOL, V211, P77, DOI 10.1006/dbio.1999.9283; Hart M, 2000, SEMIN CELL DEV BIOL, V11, P411, DOI 10.1006/scdb.2000.0194; Hellberg ME, 1996, EVOLUTION, V50, P1167, DOI 10.1111/j.1558-5646.1996.tb02357.x; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; HENRY JJ, 1990, DEV BIOL, V141, P55, DOI 10.1016/0012-1606(90)90101-N; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; JABLONSKI D, 1986, B MAR SCI, V39, P565; JABLONSKI D, 1983, BIOL REV, V58, P21, DOI 10.1111/j.1469-185X.1983.tb00380.x; Krug PJ, 2011, AM MALACOL BULL, V29, P169, DOI 10.4003/006.029.0210; LEVIN LA, 1991, EVOLUTION, V45, P380, DOI 10.1111/j.1558-5646.1991.tb04412.x; LEVIN LA, 1984, BIOL BULL, V166, P494, DOI 10.2307/1541157; LEVIN LA, 1990, ECOLOGY, V71, P2191, DOI 10.2307/1938632; Levin Lisa A., 1995, P1; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Lynch M, 2009, GENETICS, V182, P295, DOI 10.1534/genetics.109.100479; Mahon AR, 2009, MAR BIOL RES, V5, P172, DOI 10.1080/17451000802317683; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marsh AG, 2005, J EXP ZOOL PART B, V304B, P238, DOI 10.1002/jez.b.21037; McEdward LR, 2000, SEMIN CELL DEV BIOL, V11, P403, DOI 10.1006/scdb.2000.0193; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Palumbi Stephen R., 1995, P369; Pannell JR, 2003, EVOLUTION, V57, P949; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Pernet B, 2006, MAR BIOL, V149, P803, DOI 10.1007/s00227-006-0266-8; Pernet B, 2010, EVOL DEV, V12, P618, DOI 10.1111/j.1525-142X.2010.00446.x; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; Raff RA, 2000, EVOL DEV, V2, P102, DOI 10.1046/j.1525-142x.2000.00035.x; Schulze SR, 2000, EVOLUTION, V54, P1247; Skibinski DOF, 2004, MOL BIOL EVOL, V21, P1753, DOI 10.1093/molbev/msh193; Sotka EE, 2005, ECOL LETT, V8, P448, DOI 10.1111/j.1461-0248.2004.00719.x; Stadler T, 2009, GENETICS, V182, P205, DOI 10.1534/genetics.108.094904; STRATHMANN RR, 1990, AM ZOOL, V30, P197; STRATHMANN RR, 1978, EVOLUTION, V32, P894, DOI 10.1111/j.1558-5646.1978.tb04642.x; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; TAJIMA F, 1989, GENETICS, V123, P585; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Todd CD, 1998, HYDROBIOLOGIA, V375-76, P1, DOI 10.1023/A:1017007527490; Todd CD, 1998, J EXP MAR BIOL ECOL, V228, P1, DOI 10.1016/S0022-0981(98)00005-7; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wakeley J, 2008, MOL BIOL EVOL, V25, P2615, DOI 10.1093/molbev/msn209; Wares JP, 2010, EVOLUTION, V64, P1136, DOI 10.1111/j.1558-5646.2009.00870.x; WRAY GA, 1989, DEV BIOL, V132, P458, DOI 10.1016/0012-1606(89)90242-X; Wray Gregory A., 1995, P413	63	17	17	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31613	10.1371/journal.pone.0031613	http://dx.doi.org/10.1371/journal.pone.0031613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359608	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200077
J	Dacheux, D; Landrein, N; Thonnus, M; Gilbert, G; Sahin, A; Wodrich, H; Robinson, DR; Bonhivers, M				Dacheux, Denis; Landrein, Nicolas; Thonnus, Magali; Gilbert, Guillaume; Sahin, Annelise; Wodrich, Harald; Robinson, Derrick R.; Bonhivers, Melanie			A MAP6-Related Protein Is Present in Protozoa and Is Involved in Flagellum Motility	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; COLD-STABLE MICROTUBULES; INDUCIBLE EXPRESSION SYSTEM; IPG STRIP PREFRACTIONATION; TRYPANOSOMA-BRUCEI-BRUCEI; LC-MS/MS IDENTIFICATION; PARAFLAGELLAR ROD; STOP PROTEINS; CELL-CYCLE; AFRICAN TRYPANOSOMES	In vertebrates the microtubule-associated proteins MAP6 and MAP6d1 stabilize cold-resistant microtubules. Cilia and flagella have cold-stable microtubules but MAP6 proteins have not been identified in these organelles. Here, we describe TbSAXO as the first MAP6-related protein to be identified in a protozoan, Trypanosoma brucei. Using a heterologous expression system, we show that TbSAXO is a microtubule stabilizing protein. Furthermore we identify the domains of the protein responsible for microtubule binding and stabilizing and show that they share homologies with the microtubule-stabilizing Mn domains of the MAP6 proteins. We demonstrate, in the flagellated parasite, that TbSAXO is an axonemal protein that plays a role in flagellum motility. Lastly we provide evidence that TbSAXO belongs to a group of MAP6-related proteins (SAXO proteins) present only in ciliated or flagellated organisms ranging from protozoa to mammals. We discuss the potential roles of the SAXO proteins in cilia and flagella function.	[Dacheux, Denis; Landrein, Nicolas; Thonnus, Magali; Gilbert, Guillaume; Sahin, Annelise; Wodrich, Harald; Robinson, Derrick R.; Bonhivers, Melanie] Univ Bordeaux, UMR 5234, Bordeaux, France; [Dacheux, Denis; Landrein, Nicolas; Thonnus, Magali; Gilbert, Guillaume; Sahin, Annelise; Wodrich, Harald; Robinson, Derrick R.; Bonhivers, Melanie] CNRS, UMR 5234, Bordeaux, France; [Dacheux, Denis] Inst Polytech Bordeaux, UMR 5234, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Dacheux, D (corresponding author), Univ Bordeaux, UMR 5234, Bordeaux, France.	melanie.bonhivers@u-bordeaux2.fr	Wodrich, Harald/P-1777-2019; Dacheux, Denis/AGF-5359-2022; Bonhivers, Melanie/Z-5889-2019	Wodrich, Harald/0000-0002-4764-1708; Bonhivers, Melanie/0000-0001-9179-8473; LANDREIN, Nicolas/0000-0001-8875-4242; DACHEUX, Denis/0000-0002-9956-4839	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR) Blanc [ANR-09-BLAN-0074]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR) Blanc(French National Research Agency (ANR))	Work in the lab was supported by Centre National de la Recherche Scientifique (CNRS) Projets Exploratoires/Premier Soutien (PEPS) 2009 and Agence Nationale de la Recherche (ANR) Blanc (ANR-09-BLAN-0074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Amos LA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-229; Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; BAAS PW, 1994, J CELL SCI, V107, P135; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Baker MA, 2008, PROTEOMICS, V8, P1720, DOI 10.1002/pmic.200701020; Baker MA, 2008, PROTEOMICS, V8, P2312, DOI 10.1002/pmic.200700876; BALABAN N, 1989, CELL MOTIL CYTOSKEL, V14, P393, DOI 10.1002/cm.970140309; Baratier J, 2006, J BIOL CHEM, V281, P19561, DOI 10.1074/jbc.M509602200; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Bastin P, 1999, J CELL SCI, V112, P3769; Bastin P, 1996, PARASITOL TODAY, V12, P302, DOI 10.1016/0169-4758(96)10031-4; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Bastin P, 2000, J CELL SCI, V113, P3321; BEHNKE O, 1967, J CELL SCI, V2, P169; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bonhivers M, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-21; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Bosc C, 2001, J BIOL CHEM, V276, P30904, DOI 10.1074/jbc.M011614200; Boucher N, 2007, J BIOL CHEM, V282, P13780, DOI 10.1074/jbc.M700780200; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Chen YL, 2003, MOL BIOCHEM PARASIT, V126, P275, DOI 10.1016/S0166-6851(02)00276-1; Dehmelt L, 2003, J NEUROSCI, V23, P9479; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; Detmer E, 1997, EUR J CELL BIOL, V72, P378; Dorus S, 2006, NAT GENET, V38, P1440, DOI 10.1038/ng1915; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; DYE RB, 1993, J BIOL CHEM, V268, P6847; Emmer BT, 2011, EUKARYOT CELL, V10, P455, DOI 10.1128/EC.00248-10; Felgner H, 1997, J CELL BIOL, V138, P1067, DOI 10.1083/jcb.138.5.1067; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gory-Faure S, 2006, J BIOL CHEM, V281, P28387, DOI 10.1074/jbc.M603380200; Guerrero K, 2010, MOL CELL BIOCHEM, V337, P239, DOI 10.1007/s11010-009-0304-1; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hall N, 2003, NUCLEIC ACIDS RES, V31, P4864, DOI 10.1093/nar/gkg674; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; HEMPHILL A, 1992, J CELL BIOL, V117, P95, DOI 10.1083/jcb.117.1.95; HESKETH JE, 1984, NEUROSCI LETT, V51, P155, DOI 10.1016/0304-3940(84)90543-3; Hill KL, 2010, CURR OPIN MICROBIOL, V13, P459, DOI 10.1016/j.mib.2010.05.015; Hinchcliffe EH, 1998, J CELL SCI, V111, P585; Ikegami K, 2010, CELL STRUCT FUNCT, V35, P15, DOI 10.1247/csf.09027; IMBODEN M, 1995, PARASITOLOGY, V110, P249, DOI 10.1017/S0031182000080835; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; KOSIK KS, 1994, CELL MOTIL CYTOSKEL, V28, P195, DOI 10.1002/cm.970280302; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Linck RW, 2003, PROTIST, V154, P299, DOI 10.1078/143446103322454086; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; MACRAE TH, 1990, BIOCHEM J, V265, P87, DOI 10.1042/bj2650087; Maga JA, 1999, J CELL SCI, V112, P2753; MARGOLIS RL, 1986, P NATL ACAD SCI USA, V83, P639, DOI 10.1073/pnas.83.3.639; Maric D, 2010, CURR OPIN MICROBIOL, V13, P466, DOI 10.1016/j.mib.2010.06.001; MULLER N, 1992, PARASITOLOGY, V104, P111, DOI 10.1017/S0031182000060856; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Norrander JM, 2000, MOL BIOL CELL, V11, P201, DOI 10.1091/mbc.11.1.201; Oberholzer M, 2009, METHOD CELL BIOL, V93, P21, DOI 10.1016/S0091-679X(08)93002-8; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; PIROLLET F, 1989, BIOCHEMISTRY-US, V28, P835, DOI 10.1021/bi00428a064; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Pradel LC, 2006, J CELL SCI, V119, P1852, DOI 10.1242/jcs.02900; Ralston KS, 2006, PLOS PATHOG, V2, P873, DOI 10.1371/journal.ppat.0020101; Ralston KS, 2011, EUKARYOT CELL, V10, P884, DOI 10.1128/EC.00298-10; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Santrich C, 1997, MOL BIOCHEM PARASIT, V90, P95, DOI 10.1016/S0166-6851(97)00149-7; SASSE R, 1988, J CELL SCI, V90, P577; Schneider A, 1997, J CELL SCI, V110, P431; SCHNEIDER A, 1987, J CELL BIOL, V104, P431, DOI 10.1083/jcb.104.3.431; SCHNEIDER A, 1988, SCIENCE, V241, P459, DOI 10.1126/science.3393912; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; SEEBECK T, 1983, MOL BIOCHEM PARASIT, V9, P197, DOI 10.1016/0166-6851(83)90097-X; Setter PW, 2006, EXP CELL RES, V312, P2880, DOI 10.1016/j.yexcr.2006.05.014; SHERWIN T, 1989, CELL, V57, P211, DOI 10.1016/0092-8674(89)90959-8; Smith EF, 1997, CELL MOTIL CYTOSKEL, V38, P1; SOUTOPADRON T, 1993, MEM I OSWALDO CRUZ, V88, P517, DOI 10.1590/S0074-02761993000400004; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; TORRES A, 1989, J PROTOZOOL, V36, P113, DOI 10.1111/j.1550-7408.1989.tb01056.x; Vedrenne C, 2002, MOL BIOL CELL, V13, P1058, DOI 10.1091/mbc.01-06-0298; WALLIN M, 1995, INT REV CYTOL, V157, P1, DOI 10.1016/S0074-7696(08)62155-5; Wickstead B, 2004, GENOME RES, V14, P1014, DOI 10.1101/gr.2227704; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1989, J CELL SCI, V93, P491; Yi P, 2010, J CELL SCI, V123, P1060, DOI 10.1242/jcs.059717; Yoshida T, 1996, CELL MOTIL CYTOSKEL, V33, P252, DOI 10.1002/(SICI)1097-0169(1996)33:4<252::AID-CM2>3.0.CO;2-B	108	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31344	10.1371/journal.pone.0031344	http://dx.doi.org/10.1371/journal.pone.0031344			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355359	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300059
J	Lammens, T; Swerts, K; Derycke, L; De Craemer, A; De Brouwer, S; De Preter, K; Van Roy, N; Vandesompele, J; Speleman, F; Philippe, J; Benoit, Y; Beiske, K; Bracke, M; Laureys, G				Lammens, Tim; Swerts, Katrien; Derycke, Lara; De Craemer, Annemie; De Brouwer, Sara; De Preter, Katleen; Van Roy, Nadine; Vandesompele, Jo; Speleman, Frank; Philippe, Jan; Benoit, Yves; Beiske, Klaus; Bracke, Marc; Laureys, Genevieve			N-Cadherin in Neuroblastoma Disease: Expression and Clinical Significance	PLOS ONE			English	Article							CELL-ADHESION; TUMOR PROGRESSION; METASTASIS; INVASION; SUPPRESSES; PEPTIDE; ADH-1; GENE; DIFFERENTIATION; OSTEOSARCOMA	One of the first and most important steps in the metastatic cascade is the loss of cell-cell and cell-matrix interactions. N-cadherin, a crucial mediator of homotypic and heterotypic cell-cell interactions, might play a central role in the metastasis of neuroblastoma (NB), a solid tumor of neuroectodermal origin. Using Reverse Transcription Quantitative PCR (RT-qPCR), Western blot, immunocytochemistry and Tissue MicroArrays (TMA) we demonstrate the expression of N-cadherin in neuroblastoma tumors and cell lines. All neuroblastic tumors (n = 356) and cell lines (n = 10) expressed various levels of the adhesion protein. The N-cadherin mRNA expression was significantly lower in tumor samples from patients suffering metastatic disease. Treatment of NB cell lines with the N-cadherin blocking peptide ADH-1 (Exherin, Adherex Technologies Inc.), strongly inhibited tumor cell proliferation in vitro by inducing apoptosis. Our results suggest that N-cadherin signaling may play a role in neuroblastoma disease, marking involvement of metastasis and determining neuroblastoma cell viability.	[Lammens, Tim; Swerts, Katrien; De Craemer, Annemie; Benoit, Yves; Laureys, Genevieve] Ghent Univ Hosp, Dept Pediat Hematol Oncol, Ghent, Belgium; [Derycke, Lara; Bracke, Marc] Ghent Univ Hosp, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium; [De Brouwer, Sara; De Preter, Katleen; Van Roy, Nadine; Vandesompele, Jo; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Philippe, Jan] Ghent Univ Hosp, Dept Clin Chem Microbiol & Immunol, Ghent, Belgium; [Beiske, Klaus] Univ Oslo, Rikshosp, Dept Pathol, N-0027 Oslo, Norway	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; University of Oslo; National Hospital Norway	Lammens, T (corresponding author), Ghent Univ Hosp, Dept Pediat Hematol Oncol, Ghent, Belgium.	tim.lammens@ugent.be	philippé, jan/AAG-8964-2019; De Preter, Katleen/I-7135-2013; Philippé, Jan/A-1027-2008; Vandesompele, Jo/W-3411-2018; laureys, genevieve/AAG-2390-2021; speleman, frank/AAR-5184-2020	philippé, jan/0000-0003-4857-5746; De Preter, Katleen/0000-0002-7726-5096; Philippé, Jan/0000-0003-4857-5746; Vandesompele, Jo/0000-0001-6274-0184; speleman, frank/0000-0002-6628-8559; Lammens, Tim/0000-0001-8733-4027	Kinderkankerfonds; Foundation against Cancer; "Emmanuel Van Der Schueren" from the Flemish League against Cancer; Belgian program of Interuniversity Poles of Attraction	Kinderkankerfonds; Foundation against Cancer; "Emmanuel Van Der Schueren" from the Flemish League against Cancer; Belgian program of Interuniversity Poles of Attraction	This work was supported by the Kinderkankerfonds, the Foundation against Cancer, an "Emmanuel Van Der Schueren" grant from the Flemish League against Cancer and the Belgian program of Interuniversity Poles of Attraction, initiated by the Belgian State, Prime Minister's Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amitay R, 2001, AM J PATHOL, V159, P43, DOI 10.1016/S0002-9440(10)61671-9; Ara T, 2006, CANCER METAST REV, V25, P645, DOI 10.1007/s10555-006-9028-9; Augustine CK, 2008, CANCER RES, V68, P3777, DOI 10.1158/0008-5472.CAN-07-5949; Beasley GM, 2009, CANCER-AM CANCER SOC, V115, P4766, DOI 10.1002/cncr.24509; Berger JC, 2005, CANCER BIOL THER, V4, P805, DOI 10.4161/cbt.4.8.1865; Blaschuk OW, 2009, EUR J PHARMACOL, V625, P195, DOI 10.1016/j.ejphar.2009.05.033; BRODEUR GM, 1988, J CLIN ONCOL, V6, P1874, DOI 10.1200/JCO.1988.6.12.1874; Brodeur GM, 1993, PRINCIPLES PRACTICE, P739; Burden-gulley SM, 1999, PEPTIDES, V31, P842; Cavallaro U, 2002, CANCER LETT, V176, P123, DOI 10.1016/S0304-3835(01)00759-5; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Erez N, 2004, EXP CELL RES, V294, P366, DOI 10.1016/j.yexcr.2003.11.033; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; Kashima T, 2003, INT J CANCER, V104, P147, DOI 10.1002/ijc.10931; Kashima T, 1999, AM J PATHOL, V155, P1549, DOI 10.1016/S0002-9440(10)65471-5; Li G, 2001, CANCER RES, V61, P3819; Makrigiannakis A, 1999, AM J PATHOL, V154, P1391, DOI 10.1016/S0002-9440(10)65393-X; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nevo I, 2010, INT J CANCER, V126, P1570, DOI 10.1002/ijc.24889; Nieto MA, 2001, MECH DEVELOP, V105, P27, DOI 10.1016/S0925-4773(01)00394-X; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Peluso JJ, 1997, BIOCHEM PHARMACOL, V54, P847, DOI 10.1016/S0006-2952(97)00118-4; Peluso JJ, 1996, ENDOCRINOLOGY, V137, P1196, DOI 10.1210/en.137.4.1196; Perotti A, 2009, ANN ONCOL, V20, P741, DOI 10.1093/annonc/mdn695; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PULLMAN WE, 1992, NATURE, V356, P529, DOI 10.1038/356529a0; Qiao JB, 2008, P NATL ACAD SCI USA, V105, P12891, DOI 10.1073/pnas.0711861105; Shintani Y, 2008, INT J CANCER, V122, P71, DOI 10.1002/ijc.23027; Soler AP, 1997, HUM PATHOL, V28, P734, DOI 10.1016/S0046-8177(97)90184-2; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Swerts K, 2005, J HISTOCHEM CYTOCHEM, V53, P1433, DOI 10.1369/jhc.5C6661.2005; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tran NL, 1999, AM J PATHOL, V155, P787, DOI 10.1016/S0002-9440(10)65177-2; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Zeng Y, 2007, CANCER RES, V67, P2331, DOI 10.1158/0008-5472.CAN-06-3041	41	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31206	10.1371/journal.pone.0031206	http://dx.doi.org/10.1371/journal.pone.0031206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355346	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300046
J	Otten, C; van der Ven, PF; Lewrenz, I; Paul, S; Steinhagen, A; Busch-Nentwich, E; Eichhorst, J; Wiesner, B; Stemple, D; Strahle, U; Furst, DO; Abdelilah-Seyfried, S				Otten, Cecile; van der Ven, Peter F.; Lewrenz, Ilka; Paul, Sandeep; Steinhagen, Almut; Busch-Nentwich, Elisabeth; Eichhorst, Jenny; Wiesner, Burkhard; Stemple, Derek; Straehle, Uwe; Fuerst, Dieter O.; Abdelilah-Seyfried, Salim			Xirp Proteins Mark Injured Skeletal Muscle in Zebrafish	PLOS ONE			English	Article							INTERCALATED DISK PROTEIN; HEART REGENERATION; CARDIAC MORPHOGENESIS; CONDUCTION DEFECTS; REGULATORY FACTORS; XIN-REPEATS; MXIN-ALPHA; GENE; LOCALIZATION; EXPRESSION	Myocellular regeneration in vertebrates involves the proliferation of activated progenitor or dedifferentiated myogenic cells that have the potential to replenish lost tissue. In comparison little is known about cellular repair mechanisms within myocellular tissue in response to small injuries caused by biomechanical or cellular stress. Using a microarray analysis for genes upregulated upon myocellular injury, we identified zebrafish Xin-actin-binding repeat-containing protein1 (Xirp1) as a marker for wounded skeletal muscle cells. By combining laser-induced micro-injury with proliferation analyses, we found that Xirp1 and Xirp2a localize to nascent myofibrils within wounded skeletal muscle cells and that the repair of injuries does not involve cell proliferation or Pax7(+) cells. Through the use of Xirp1 and Xirp2a as markers, myocellular injury can now be detected, even though functional studies indicate that these proteins are not essential in this process. Previous work in chicken has implicated Xirps in cardiac looping morphogenesis. However, we found that zebrafish cardiac morphogenesis is normal in the absence of Xirp expression, and animals deficient for cardiac Xirp expression are adult viable. Although the functional involvement of Xirps in developmental and repair processes currently remains enigmatic, our findings demonstrate that skeletal muscle harbours a rapid, cell-proliferation-independent response to injury which has now become accessible to detailed molecular and cellular characterizations.	[Otten, Cecile; Abdelilah-Seyfried, Salim] Max Delbruck Ctr MDC Mol Med, Berlin, Germany; [van der Ven, Peter F.; Lewrenz, Ilka; Steinhagen, Almut; Fuerst, Dieter O.] Univ Bonn, Dept Mol Cell Biol, Inst Cell Biol, Bonn, Germany; [Paul, Sandeep; Straehle, Uwe] Inst Toxicol & Genet, Karlsruhe, Germany; [Paul, Sandeep] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Busch-Nentwich, Elisabeth; Stemple, Derek] Wellcome Trust Sanger Inst, Cambridge, England; [Eichhorst, Jenny; Wiesner, Burkhard] Leibniz Inst Mol Pharmacol, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Bonn; University of Southern California; Wellcome Trust Sanger Institute; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Otten, C (corresponding author), Max Delbruck Ctr MDC Mol Med, Berlin, Germany.	salim@mdc-berlin.de	Otten, Cecile/HGC-9281-2022; Paul, Sandeep/F-6824-2010; Straehle, Uwe/K-7054-2013; Fürst, Dieter O./H-8561-2013	Fürst, Dieter O./0000-0001-8805-6444; Paul, Sandeep/0000-0002-2721-1874; van der Ven, Peter/0000-0002-9750-8913; Otten, Cecile/0000-0002-8230-7350				Barash IA, 2004, AM J PHYSIOL-CELL PH, V286, pC355, DOI 10.1152/ajpcell.00211.2003; Beatham J, 2006, NEUROMUSCULAR DISORD, V16, P437, DOI 10.1016/j.nmd.2006.05.013; Behra M, 2004, TOXICOL SCI, V77, P325, DOI 10.1093/toxsci/kfh020; Bit-Avragim N, 2008, DEV DYNAM, V237, P83, DOI 10.1002/dvdy.21389; Cherepanova O, 2006, J MOL BIOL, V356, P714, DOI 10.1016/j.jmb.2005.11.082; Choi SJ, 2007, J BIOL CHEM, V282, P36024, DOI 10.1074/jbc.M707639200; Duka A, 2006, AM J HYPERTENS, V19, P275, DOI 10.1016/j.amjhyper.2005.08.017; Grosskurth SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002857; Gustafson-Wagner EA, 2007, AM J PHYSIOL-HEART C, V293, pH2680, DOI 10.1152/ajpheart.00806.2007; Hammond CL, 2007, DEV BIOL, V302, P504, DOI 10.1016/j.ydbio.2006.10.009; Hawke TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1636, DOI 10.1152/ajpcell.00124.2007; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Huang HT, 2006, J BIOL CHEM, V281, P39370, DOI 10.1074/jbc.M603244200; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Lowe T, 2007, HUM MOL GENET, V16, P1351, DOI 10.1093/hmg/ddm085; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; Murphey RD, 2006, CHEM BIOL DRUG DES, V68, P213, DOI 10.1111/j.1747-0285.2006.00439.x; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441; Otten J, 2010, CARDIOVASC RES, V85, P739, DOI 10.1093/cvr/cvp345; Pacholsky D, 2004, J CELL SCI, V117, P5257, DOI 10.1242/jcs.01406; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Rohr S, 2006, DEVELOPMENT, V133, P107, DOI 10.1242/dev.02182; Sinn HW, 2002, DEV DYNAM, V225, P1, DOI 10.1002/dvdy.10131; Steffen LS, 2007, DEV BIOL, V309, P180, DOI 10.1016/j.ydbio.2007.06.015; Stellabotte F, 2007, DEVELOPMENT, V134, P1253, DOI 10.1242/dev.000067; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; THISSE C, 1993, DEVELOPMENT, V119, P1203; van der Ven PFM, 2006, EXP CELL RES, V312, P2154, DOI 10.1016/j.yexcr.2006.03.015; van der Ven PFM, 2000, CELL MOTIL CYTOSKEL, V45, P149, DOI 10.1002/(SICI)1097-0169(200002)45:2<149::AID-CM6>3.0.CO;2-G; Walker Michael G., 2001, Mini-Reviews in Medicinal Chemistry, V1, P197, DOI 10.2174/1389557013407034; Wang DZ, 1999, DEVELOPMENT, V126, P1281; Wang QC, 2010, CIRC RES, V106, P1468, DOI 10.1161/CIRCRESAHA.109.212787; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227	35	27	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31041	10.1371/journal.pone.0031041	http://dx.doi.org/10.1371/journal.pone.0031041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355335	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300035
J	Tapanila, L; Roberts, EM				Tapanila, Leif; Roberts, Eric M.			The Earliest Evidence of Holometabolan Insect Pupation in Conifer Wood	PLOS ONE			English	Article							FOREST NATIONAL-PARK; CHINLE FORMATION; EVOLUTION; ARIZONA; ICHNOFOSSILS; TERRESTRIAL; UTAH; USA	Background: The pre-Jurassic record of terrestrial wood borings is poorly resolved, despite body fossil evidence of insect diversification among xylophilic clades starting in the late Paleozoic. Detailed analysis of borings in petrified wood provides direct evidence of wood utilization by invertebrate animals, which typically comprises feeding behaviors. Methodology/Principal Findings: We describe a U-shaped boring in petrified wood from the Late Triassic Chinle Formation of southern Utah that demonstrates a strong linkage between insect ontogeny and conifer wood resources. Xylokrypta durossi new ichnogenus and ichnospecies is a large excavation in wood that is backfilled with partially digested xylem, creating a secluded chamber. The tracemaker exited the chamber by way of a small vertical shaft. This sequence of behaviors is most consistent with the entrance of a larva followed by pupal quiescence and adult emergence - hallmarks of holometabolous insect ontogeny. Among the known body fossil record of Triassic insects, cupedid beetles (Coleoptera: Archostemata) are deemed the most plausible tracemakers of Xylokrypta, based on their body size and modern xylobiotic lifestyle. Conclusions/Significance: This oldest record of pupation in fossil wood provides an alternative interpretation to borings once regarded as evidence for Triassic bees. Instead Xylokrypta suggests that early archostematan beetles were leaders in exploiting wood substrates well before modern clades of xylophages arose in the late Mesozoic.	[Tapanila, Leif] Idaho State Univ, Dept Geosci, Pocatello, ID 83209 USA; [Tapanila, Leif] Idaho Museum Nat Hist, Div Earth Sci, Pocatello, ID USA; [Roberts, Eric M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia	Idaho; Idaho State University; James Cook University	Tapanila, L (corresponding author), Idaho State Univ, Dept Geosci, Pocatello, ID 83209 USA.	tapaleif@isu.edu	Roberts, Eric/J-1836-2014	Roberts, Eric/0000-0002-8583-7437	Idaho State University Research Committee [AS11-3U]	Idaho State University Research Committee	This study received partial funding support from Idaho State University Research Committee grant #AS11-3U. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alexeev AV, 1999, AMBA PROJECTS, P5; Ash S.R., 2003, UTAH GEOLOGICAL SURV, V35, P3; Beutel RG, 2002, SYST ENTOMOL, V27, P169, DOI 10.1046/j.1365-3113.2002.00172.x; Blakey R. C., 2009, REGIONAL PALEOGEOGRA; Bromley RG, 2007, SEDIMENT GEOL, V200, P141, DOI 10.1016/j.sedgeo.2006.11.007; BROWN ROLAND W., 1934, JOUR WASHINGTON ACAD SCI, V24, P532; Crowson R. A, 1975, ATT 10 C NAZ IT ENT, P47; Farrell BD, 2001, EVOLUTION, V55, P2011, DOI 10.1111/j.0014-3820.2001.tb01318.x; Genise J.F., 1995, ICHNOS, V3, P287, DOI DOI 10.1080/10420949509386399; Genise JF, 2004, GEOL SOC SPEC PUBL, V228, P419, DOI 10.1144/GSL.SP.2004.228.01.19; Genise JF, 2007, CRETACEOUS RES, V28, P545, DOI 10.1016/j.cretres.2006.08.007; Genise Jorge F., 1996, Ichnos, V4, P199; Genise Jorge F., 2000, Ichnos, V7, P267; Genise Jorge F., 2000, Ichnos, V7, P115; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Grimaldi David, 2005, pi; Haack R. A., 1986, NUTR ECOLOGY INSECTS, P449; HAMILTON WD, 1978, S R ENTOMOL SOC LOND, V9, P154; Hasiotis ST, 2003, PALAEOGEOGR PALAEOCL, V192, P259, DOI 10.1016/S0031-0182(02)00689-2; Hasiotis ST, 1997, PLATEAU J MUSEUM NO, V1, P20; Hasiotis ST, 1998, NATL PARK SERVICE PA, P116; Labandeira CC, 1997, PALAIOS, V12, P319, DOI 10.2307/3515334; Labandeira Conrad C., 2002, Paleontological Society Papers, V8, P211; Lawrence IF, 1982, ANNU REV ECOL SYST, V12, P261; Leymerie M.A., 1842, B SOC GEOL FR, V5, P1; Linck O., 1949, Neues Jahrbuch fuer Mineralogie Geologie und Palaeontologie Stuttgart B, V4-6, P180; Linsley E. Gorton, 1942, PROC NEW ENGLAND ZOOL CLUB, V21, P17; Lucas SG, 2010, PALAEOGEOGR PALAEOCL, V286, P194, DOI 10.1016/j.palaeo.2010.01.010; Martz JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009329; Miller DG, 2009, ENTOMOL EXP APPL, V132, P126, DOI 10.1111/j.1570-7458.2009.00880.x; Moore I., 1976, MEMOIRS NATL MUSEUM, P521; PONOMARENKO AG, 1966, PALEONTOL ZH, P47; Ponomarenko Alexandr G., 2003, Acta Zoologica Cracoviensia, V46, P319; Prochnow SJ, 2006, PALAEOGEOGR PALAEOCL, V232, P53, DOI 10.1016/j.palaeo.2005.08.011; Ramezani J, 2011, GEOL SOC AM BULL, V123, P2142, DOI 10.1130/B30433.1; Roberts EM, 2007, J PALEONTOL, V81, P201, DOI 10.1666/0022-3360(2007)81[201:CIBIDB]2.0.CO;2; Roselli F.L., 1939, B SOC AMIGOS CIENC N, V1, P72; Roselli F.L., 1987, PUBLICACIONES MUSEO, V1, P1; SS Beus, 1987, CENTENNIAL FIELD GUI, V2, P405; STATZ GEORG, 1952, PALAEONTOGRAPHICA, V102A, P1; Thenius E., 1979, ANN NATURHISTORISCHE, V82, P177; Tillyard R.J., 1916, PUBLICATIONS GEOLOGI, V253, P1; WALKER M. V., 1938, PROC U S NATION MUS, V85, P137; Zeuner F. E., 1961, Verhandlungen XI Internationaler Kongress fuer Entomologie Wien 1960, V1, P304	44	25	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31668	10.1371/journal.pone.0031668	http://dx.doi.org/10.1371/journal.pone.0031668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355387	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000302741300087
J	Weiss, WR; Jiang, CG				Weiss, Walter R.; Jiang, Chengyong George			Protective CD8+T lymphocytes in Primates Immunized with Malaria Sporozoites	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; T-CELLS; CIRCUMSPOROZOITE PROTEIN; STERILE PROTECTION; RHESUS-MONKEYS; LIVER STAGES; RESPONSES; YOELII; INDUCTION; INJECTION	Live attenuated malaria vaccines are more potent than the recombinant protein, bacterial or viral platform vaccines that have been tested, and an attenuated sporozoite vaccine against falciparum malaria is being developed for humans. In mice, attenuated malaria sporozoite vaccines induce CD8(+) T cells that kill parasites developing in the liver. We were curious to know if CD8(+) T cells were also important in protecting primates against malaria. We immunized 9 rhesus monkeys with radiation attenuated Plasmodium knowlesi sporozoites, and found that 5 did not develop blood stage infections after challenge with live sporozoites. We then injected 4 of these protected monkeys with cM-T807, a monoclonal antibody to the CD8 molecule which depletes T cells. The fifth monkey received equivalent doses of normal IgG. In 3 of the 4 monkeys receiving cM-T807 circulating CD8(+) T cells were profoundly depleted. When re-challenged with live sporozoites all 3 of these depleted animals developed blood stage malaria. The fourth monkey receiving cM-T807 retained many circulating CD8(+) T cells. This monkey, and the vaccinated monkey receiving normal IgG, did not develop blood stage malaria at re-challenge with live sporozoites. Animals were treated with antimalarial drugs and rested for 4 months. During this interval CD8(+) T cells re-appeared in the circulation of the depleted monkeys. When all vaccinated animals received a third challenge with live sporozoites, all 5 monkeys were once again protected and did not develop blood stage malaria infections. These data indicate that CD8(+) T cells are important effector cells protecting monkeys against malaria sporozoite infection. We believe that malaria vaccines which induce effector CD8+ T cells in humans will have the best chance of protecting against malaria.	[Weiss, Walter R.; Jiang, Chengyong George] USN, Med Res Ctr, Dept Infect Dis, Silver Spring, MD USA	United States Department of Defense; United States Navy	Weiss, WR (corresponding author), USN, Med Res Ctr, Dept Infect Dis, Silver Spring, MD USA.	walter.weiss@verizon.net			U.S. Army Medical Research Materiel Command [6000.RAD1.F.A0309]	U.S. Army Medical Research Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by funds allocated to the Naval Medical Research Center by the U.S. Army Medical Research Materiel Command (work unit 6000.RAD1.F.A0309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL A, 1990, J EXP MED, V172, P1083, DOI 10.1084/jem.172.4.1083; Belmonte M, 2003, J PARASITOL, V89, P602, DOI 10.1645/0022-3395(2003)089[0602:TIOPYI]2.0.CO;2; CHAROENVIT Y, 1987, INFECT IMMUN, V55, P604, DOI 10.1128/IAI.55.3.604-608.1987; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; Epstein JE, 2011, SCIENCE; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Gwadz R W, 1979, Bull World Health Organ, V57 Suppl 1, P165; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; JAFFE RI, 1990, AM J TROP MED HYG, V42, P309, DOI 10.4269/ajtmh.1990.42.309; Jiang G, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-135; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; MALIK A, 1991, P NATL ACAD SCI USA, V88, P3300, DOI 10.1073/pnas.88.8.3300; Mauduit M, 2010, INFECT IMMUN, V78, P2182, DOI 10.1128/IAI.01415-09; Mauduit M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007717; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Rodriguez A, 2009, VACCINE, V27, P6226, DOI 10.1016/j.vaccine.2009.07.106; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Vanderberg J, 2007, AM J PATHOL, V171, P1405, DOI 10.2353/ajpath.2007.070661; Weiss WR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001063; WEISS WR, 1989, J IMMUNOL, V143, P4263; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573	27	84	86	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31247	10.1371/journal.pone.0031247	http://dx.doi.org/10.1371/journal.pone.0031247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355349	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300049
J	Senavirathne, G; Jaszczur, M; Auerbach, PA; Upton, TG; Chelico, L; Goodman, MF; Rueda, D				Senavirathne, Gayan; Jaszczur, Malgorzata; Auerbach, Paul A.; Upton, Thomas G.; Chelico, Linda; Goodman, Myron F.; Rueda, David			Single-stranded DNA Scanning and Deamination by APOBEC3G Cytidine Deaminase at Single Molecule Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 DNA; SOMATIC HYPERMUTATION; FRET; REPAIR; POLYMERASES; SPECIFICITY; DYNAMICS; DOMAIN; BASES	APOBEC3G (Apo3G) is a single-stranded (ss) DNA cytosine deaminase that eliminates HIV-1 infectivity by converting C -> U in numerous small target motifs on the minus viral cDNA. Apo3G deaminates linear ssDNA in vitro with pronounced spatial asymmetry favoring the 3' -> 5' direction. A similar polarity observed in vivo is believed responsible for initiating localized C -> T mutational gradients that inactivate the virus. When compared with double-stranded (ds) DNA scanning enzymes, e.g. DNA glycosylases that excise rare aberrant bases, there is a paucity of mechanistic studies on ssDNA scanning enzymes. Here, we investigate ssDNA scanning and motif-targeting mechanisms for Apo3G using single molecule Forster resonance energy transfer. We address the specific issue of deamination asymmetry within the general context of ssDNA scanning mechanisms and show that Apo3G scanning trajectories, ssDNA contraction, and deamination efficiencies depend on motif sequence, location, and ionic strength. Notably, we observe the presence of bidirectional quasi-localized scanning of Apo3G occurring proximal to a 5' hot motif, a motif-dependent DNA contraction greatest for 5' hot > 3' hot > 5' cold motifs, and diminished mobility at low salt. We discuss the single molecule Forster resonance energy transfer data in terms of a model in which deamination polarity occurs as a consequence of Apo3G binding to ssDNA in two orientations, one that is catalytically favorable, with the other disfavorable.	[Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; [Jaszczur, Malgorzata; Auerbach, Paul A.; Upton, Thomas G.; Chelico, Linda; Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Senavirathne, Gayan; Rueda, David] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	University of Southern California; University of Southern California; Wayne State University	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, 1050 Childs Way, Los Angeles, CA 90089 USA.	mgoodman@usc.edu; david.rueda@wayne.edu	Rueda, David S./F-9065-2014	Rueda, David S./0000-0003-4657-6323; Senavirathne, Gayan/0000-0002-9113-4201; Chelico, Linda/0000-0003-4673-8978	National Institutes of Health [GM085116, ES13192, GM2142]; National Science Foundation [MCB-0747285]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013192, R56ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085116, R01GM021422, R37GM021422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM085116 (to D. R.) and ES13192 and GM21422 (to M. F. G.). This work was also supported by National Science Foundation Grant MCB-0747285 (to D. R.).	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chelico L, 2009, J BIOL CHEM, V284, P27761, DOI 10.1074/jbc.R109.052449; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Lamichhane R, 2010, METHODS, V52, P192, DOI 10.1016/j.ymeth.2010.06.010; Lamichhane R, 2010, P NATL ACAD SCI USA, V107, P4105, DOI 10.1073/pnas.0907072107; Lasken RS, 1996, J BIOL CHEM, V271, P17692, DOI 10.1074/jbc.271.30.17692; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; PETRUSKA J, 1995, J BIOL CHEM, V270, P746, DOI 10.1074/jbc.270.2.746; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2011, J BIOL CHEM, V286, P24931, DOI 10.1074/jbc.M111.241208; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Torella JP, 2011, BIOPHYS J, V100, P1568, DOI 10.1016/j.bpj.2011.01.066; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhao R, 2009, METHODS, V49, P112, DOI 10.1016/j.ymeth.2009.04.017	34	49	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15826	15835		10.1074/jbc.M112.342790	http://dx.doi.org/10.1074/jbc.M112.342790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22362763	Green Published, hybrid			2022-12-25	WOS:000304006300062
J	Kamath-Loeb, AS; Shen, JC; Schmitt, MW; Loeb, LA				Kamath-Loeb, Ashwini S.; Shen, Jiang-Cheng; Schmitt, Michael W.; Loeb, Lawrence A.			The Werner Syndrome Exonuclease Facilitates DNA Degradation and High Fidelity DNA Polymerization by Human DNA Polymerase delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME PROTEIN; REPLICATION FORK; P12 SUBUNIT; FUNCTIONAL INTERACTION; REPEAT SEQUENCE; IN-VITRO; HELICASE; DAMAGE; WRN; MUTATIONS	DNA Polymerase delta (Pol delta) and the Werner syndrome protein, WRN, are involved in maintaining cellular genomic stability. Pol delta synthesizes the lagging strand during replication of genomic DNA and also functions in the synthesis steps of DNA repair and recombination. WRN is a member of the RecQ helicase family, loss of which results in the premature aging and cancer-prone disorder, Werner syndrome. Both Pol delta and WRN encode 3' -> 5' DNA exonuclease activities. Pol delta exonuclease removes 3'-terminal mismatched nucleotides incorporated during replication to ensure high fidelity DNA synthesis. WRN exonuclease degrades DNA containing alternate secondary structures to prevent formation and enable resolution of stalled replication forks. We now observe that similarly to WRN, Pol delta degrades alternate DNA structures including bubbles, four-way junctions, and D-loops. Moreover, WRN and Pol delta form a complex with enhanced ability to hydrolyze these structures. We also present evidence that WRN can proofread for Pol delta; WRN excises 3'-terminal mismatches to enable primer extension by Pol delta. Consistent with our in vitro observations, we show that WRN contributes to the maintenance of DNA synthesis fidelity in vivo. Cells expressing limiting amounts (similar to 10% of normal) of WRN have elevated mutation frequencies compared with wildtype cells. Together, our data highlight the importance of WRN exonuclease activity and its cooperativity with Pol delta -in preserving genome stability, which is compromised by the loss of WRN in Werner syndrome.	[Schmitt, Michael W.; Loeb, Lawrence A.] Univ Washington, Dept Pathol & Biochem, Seattle, WA 98195 USA; [Kamath-Loeb, Ashwini S.; Shen, Jiang-Cheng] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Loeb, LA (corresponding author), Univ Washington, Dept Pathol & Biochem, 1959 NE Pacific St, Seattle, WA 98195 USA.	laloeb@uw.edu			National Institutes of Health [P01-CA77852, R01-CA102029, P01-AG0751]; NATIONAL CANCER INSTITUTE [P01CA077852, R01CA102029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-CA77852, R01-CA102029, and P01-AG0751 (to L. A. L.).	Bacolla A, 2011, J BIOL CHEM, V286, P10017, DOI 10.1074/jbc.M110.176636; Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751; Brosh RM, 2001, J BIOL CHEM, V276, P3024, DOI 10.1074/jbc.M006784200; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Fazlieva R, 2009, NUCLEIC ACIDS RES, V37, P2854, DOI 10.1093/nar/gkp155; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Harrigan JA, 2006, NUCLEIC ACIDS RES, V34, P745, DOI 10.1093/nar/gkj475; Hsu JJ, 2010, MOL CARCINOGEN, V49, P166, DOI 10.1002/mc.20586; Hubscher U., 2010, DNA POLYM DISCOVERY; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kamath-Loeb AS, 2001, J BIOL CHEM, V276, P16439, DOI 10.1074/jbc.M100253200; Kamath-Loeb AS, 2007, P NATL ACAD SCI USA, V104, P10394, DOI 10.1073/pnas.0702513104; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; Li BM, 2001, J BIOL CHEM, V276, P9896, DOI 10.1074/jbc.M008575200; Machwe A, 2007, NUCLEIC ACIDS RES, V35, P5729, DOI 10.1093/nar/gkm561; Machwe A, 2011, BIOCHEMISTRY-US, V50, P6774, DOI 10.1021/bi2001054; Maloisel L, 2004, GENETICS, V167, P1133, DOI 10.1534/genetics.104.026260; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; Orren DK, 2002, BIOCHEMISTRY-US, V41, P13483, DOI 10.1021/bi0266986; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011; Sambrook J, 2001, MOL CLONING LAB MANU; Schmitt MW, 2009, BIOCHIMIE, V91, P1163, DOI 10.1016/j.biochi.2009.06.007; Shah SN, 2010, NUCLEIC ACIDS RES, V38, P1149, DOI 10.1093/nar/gkp1131; Shen JC, 2000, NUCLEIC ACIDS RES, V28, P3260, DOI 10.1093/nar/28.17.3260; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Szekely AM, 2000, P NATL ACAD SCI USA, V97, P11365, DOI 10.1073/pnas.97.21.11365; Wright JH, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr142; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200	46	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12480	12490		10.1074/jbc.M111.332577	http://dx.doi.org/10.1074/jbc.M111.332577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351772	Green Published, hybrid			2022-12-25	WOS:000302782200087
J	Bansal, P; Banga, S; Banga, SS				Bansal, Payal; Banga, Shashi; Banga, S. S.			Heterosis as Investigated in Terms of Polyploidy and Genetic Diversity Using Designed Brassica juncea Amphiploid and Its Progenitor Diploid Species	PLOS ONE			English	Article							MAIZE; EXPRESSION; HYBRID; LINES; MARKER; RICE; MICROSATELLITES; BIOMASS; LOCI; RAPA	Fixed heterosis resulting from favorable interactions between the genes on their homoeologous genomes in an allopolyploid is considered analogous to classical heterosis accruing from interactions between homologous chromosomes in heterozygous plants of a diploid species. It has been hypothesized that fixed heterosis may be one of the causes of low classical heterosis in allopolyploids. We used Indian mustard (Brassica juncea, 2n = 36; AABB) as a model system to analyze this hypothesis due to ease of its resynthesis from its diploid progenitors, B. rapa (2n = 20; AA) and B. nigra (2n = 16; BB). Both forms of heterosis were investigated in terms of ploidy level, gene action and genetic diversity. To facilitate this, eleven B. juncea genotypes were resynthesized by hybridizing ten near inbred lines of B. rapa and nine of B. nigra. Three half diallel combinations involving resynthesized B. juncea (11x11) and the corresponding progenitor genotypes of B. rapa (10x10) and B. nigra (9x9) were evaluated. Genetic diversity was estimated based on DNA polymorphism generated by SSR primers. Heterosis and genetic diversity in parental diploid species appeared not to predict heterosis and genetic diversity at alloploid level. There was also no association between combining ability, genetic diversity and heterosis across ploidy. Though a large proportion (0.47) of combinations showed positive values, the average fixed heterosis was low for seed yield but high for biomass yield. The genetic diversity was a significant contributor to fixed heterosis for biomass yield, due possibly to adaptive advantage it may confer on de novo alloploids during evolution. Good general/specific combiners at diploid level did not necessarily produce good general/specific combiners at amphiploid level. It was also concluded that polyploidy impacts classical heterosis indirectly due to the negative association between fixed heterosis and classical heterosis.	[Bansal, Payal; Banga, Shashi; Banga, S. S.] Punjab Agr Univ, Dept Plant Breeding & Genet, Ludhiana 141004, Punjab, India	Punjab Agricultural University	Bansal, P (corresponding author), Punjab Agr Univ, Dept Plant Breeding & Genet, Ludhiana 141004, Punjab, India.	nppbg@pau.edu	BANSAL, Dr PAYAL/AGO-3537-2022; Banga, Surinder Singh/A-2753-2011	Banga, Surinder Singh/0000-0001-8209-7341	All India Coordinated Research Project on Rapesee-Mustard	All India Coordinated Research Project on Rapesee-Mustard	This work was supported by the All India Coordinated Research Project on Rapesee-Mustard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2007, PLANT BREEDING, V126, P642, DOI 10.1111/j.1439-0523.2007.01405.x; Abel S, 2005, EUPHYTICA, V146, P157, DOI 10.1007/s10681-005-3364-7; BERNARDO R, 1992, THEOR APPL GENET, V83, P628, DOI 10.1007/BF00226908; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; CHARCOSSET A, 1991, THEOR APPL GENET, V81, P571, DOI 10.1007/BF00226720; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; DOBZHANSKY T, 1950, GENETICS, V35, P288; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Duvick DN, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P19; East EM, 1936, GENETICS, V21, P375; Falconer D., INTRO QUANTITATIVE G, V4th; Falconer D. S., 1981, INTRO QUANTITATIVE G; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; Guo M, 2006, THEOR APPL GENET, V113, P831, DOI 10.1007/s00122-006-0335-x; HAYMAN BI, 1954, GENETICS, V39, P789; Huang Y, 2006, PLANT MOL BIOL, V62, P579, DOI 10.1007/s11103-006-9040-z; JINKS J. L., 1955, HEREDITY, V9, P223, DOI 10.1038/hdy.1955.21; JINKS JL, 1954, GENETICS, V39, P767; Lamkey KR, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P31; Li ZK, 2001, GENETICS, V158, P1737; Lippman ZB, 2006, TRENDS GENET, V23, P47; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Lu H, 2003, THEOR APPL GENET, V107, P494, DOI 10.1007/s00122-003-1271-7; MATZINGER D. F., 1962, CROP SCI, V2, P383, DOI 10.2135/cropsci1962.0011183X000200050006x; MELCHINGER AE, 1994, THEOR APPL GENET, V88, P343, DOI 10.1007/BF00223643; Meyer S, 2007, PLANT MOL BIOL, V63, P381, DOI 10.1007/s11103-006-9095-x; Omholt SW, 2000, GENETICS, V155, P969; Pruitt RE, 2003, NAT GENET, V33, P294, DOI 10.1038/ng1108; Rholf F. J., 1998, NTSYS PC NUMERICAL T; Riddle NC, 2008, THEOR APPL GENET, V116, P563, DOI 10.1007/s00122-007-0691-1; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Shokeen B, 2007, PLANT SCI, V172, P441, DOI 10.1016/j.plantsci.2006.10.010; Shyam Prakash, 2004, Brassica, V6, P1; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; STUBER CW, 1992, GENETICS, V132, P823; Stupar RM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-33; Suwabe K, 2002, THEOR APPL GENET, V104, P1092, DOI 10.1007/s00122-002-0875-7; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Wright S., 1978, EVOLUTION GENETICS P, V4	42	26	26	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e29607	10.1371/journal.pone.0029607	http://dx.doi.org/10.1371/journal.pone.0029607			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363404	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700003
J	Schat, KA; Bingham, J; Butler, JM; Chen, LM; Lowther, S; Crowley, TM; Moore, RJ; Donis, RO; Lowenthal, JW				Schat, Karel A.; Bingham, John; Butler, Jeff M.; Chen, Li-Mei; Lowther, Sue; Crowley, Tamsyn M.; Moore, Robert J.; Donis, Ruben O.; Lowenthal, John W.			Role of Position 627 of PB2 and the Multibasic Cleavage Site of the Hemagglutinin in the Virulence of H5N1 Avian Influenza Virus in Chickens and Ducks	PLOS ONE			English	Article							FOWL PLAGUE VIRUS; A-VIRUS; ANAS-PLATYRHYNCHOS; HIGH-PATHOGENICITY; AMINO-ACID; CLINICAL-DISEASE; GENES CONTRIBUTE; THROMBOCYTES; PATHOGENESIS; REPLICATION	Highly pathogenic H5N1 avian influenza viruses have caused major disease outbreaks in domestic and free-living birds with transmission to humans resulting in 59% mortality amongst 564 cases. The mutation of the amino acid at position 627 of the viral polymerase basic-2 protein (PB2) from glutamic acid (E) in avian isolates to lysine (K) in human isolates is frequently found, but it is not known if this change affects the fitness and pathogenicity of the virus in birds. We show here that horizontal transmission of A/Vietnam/1203/2004 H5N1 (VN/1203) virus in chickens and ducks was not affected by the change of K to E at PB2-627. All chickens died between 21 to 48 hours post infection (pi), while 70% of the ducks survived infection. Virus replication was detected in chickens within 12 hours pi and reached peak titers in spleen, lung and brain between 18 to 24 hours for both viruses. Viral antigen in chickens was predominantly in the endothelium, while in ducks it was present in multiple cell types, including neurons, myocardium, skeletal muscle and connective tissues. Virus replicated to a high titer in chicken thrombocytes and caused upregulation of TLR3 and several cell adhesion molecules, which may explain the rapid virus dissemination and location of viral antigen in endothelium. Virus replication in ducks reached peak values between 2 and 4 days pi in spleen, lung and brain tissues and in contrast to infection in chickens, thrombocytes were not involved. In addition, infection of chickens with low pathogenic VN/1203 caused neuropathology, with E at position PB2-627 causing significantly higher infection rates than K, indicating that it enhances virulence in chickens.	[Schat, Karel A.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Bingham, John; Butler, Jeff M.; Lowther, Sue; Crowley, Tamsyn M.; Moore, Robert J.; Lowenthal, John W.] Australian Anim Hlth Lab, Commonwealth Sci & Ind Res Org, Geelong, Vic, Australia; [Chen, Li-Mei; Donis, Ruben O.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Crowley, Tamsyn M.] Deakin Univ, Ctr Biotechnol Chem & Syst Biol, Geelong, Vic 3217, Australia	Cornell University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centers for Disease Control & Prevention - USA; Deakin University	Schat, KA (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	john.lowenthal@csiro.au	Bingham, John/H-8591-2013; Moore, Robert J/D-8352-2011; lowenthal, john w/G-4459-2010	Bingham, John/0000-0003-2360-3827; Moore, Robert J/0000-0002-0776-5861; lowenthal, john w/0000-0002-0548-2497; Crowley, Tamsyn/0000-0002-3698-8917	Commonwealth Scientific and Industrial Research Organisation	Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	Funding was provided by the Commonwealth Scientific and Industrial Research Organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiki-Raji CO, 2008, EMERG INFECT DIS, V14, P1753, DOI 10.3201/eid1411.080557; Al-Azemi A, 2008, EMERG INFECT DIS, V14, P958, DOI 10.3201/eid1406.080056; Aldous EW, 2010, AVIAN PATHOL, V39, P265, DOI 10.1080/03079457.2010.492825; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Bertram EM, 1998, RES VET SCI, V64, P267, DOI 10.1016/S0034-5288(98)90139-4; Bingham J, 2009, AVIAN PATHOL, V38, P267, DOI 10.1080/03079450903055371; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; CARLSON HC, 1968, AVIAN DIS, V12, P700, DOI 10.2307/1588457; Chakrabarti AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007846; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; de Wit E, 2008, J CLIN VIROL, V41, P1, DOI 10.1016/j.jcv.2007.10.017; Ferdous F, 2008, POULTRY SCI, V87, P61, DOI 10.3382/ps.2007-00356; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; GLICK B, 1964, J RETICULOENDOTH SOC, V1, P442; Gowthaman V, 2010, AVIAN DIS, V54, P576, DOI 10.1637/8695-031509-ResNote.1; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Heine HG, 2007, AVIAN DIS, V51, P370, DOI 10.1637/7587-040206R.1; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Isoda N, 2006, ARCH VIROL, V151, P1267, DOI 10.1007/s00705-005-0723-6; Karpala AJ, 2011, J INTERF CYTOK RES, V31, P393, DOI 10.1089/jir.2010.0069; Kishida N, 2005, ARCH VIROL, V150, P1383, DOI 10.1007/s00705-004-0473-x; Kiss I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-113; Kuiken T, 2010, VET PATHOL, V47, P893, DOI 10.1177/0300985810378651; Le Gall-Recule G, 2008, AVIAN PATHOL, V37, P15, DOI 10.1080/03079450701774835; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Lee CW, 2005, J VIROL, V79, P3692, DOI 10.1128/JVI.79.6.3692-3702.2005; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Londt BZ, 2010, INFLUENZA OTHER RESP, V4, P17, DOI 10.1111/j.1750-2659.2009.00116.x; Londt B, 2008, AVIAN PATHOL, V37, P619, DOI 10.1080/03079450802499126; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Marjuki H, 2009, ADV VIROL, V2009, DOI 10.1155/2009/294520; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Muller T, 2009, AVIAN DIS, V53, P578, DOI 10.1637/8851-040909-Reg.1; Mundt E, 2009, ARCH VIROL, V154, P1241, DOI 10.1007/s00705-009-0437-2; Nagy A, 2009, VET MICROBIOL, V133, P257, DOI 10.1016/j.vetmic.2008.07.013; *OIE, 2009, MAN DIAGN TESTS VACC; Pantin-Jackwood MJ, 2007, VIRUS RES, V130, P151, DOI 10.1016/j.virusres.2007.06.006; Pantin-Jackwood MJ, 2007, AVIAN DIS, V51, P250, DOI 10.1637/7710-090606R.1; Perkins LEL, 2003, AVIAN DIS, V47, P956, DOI 10.1637/0005-2086-47.s3.956; Pfeiffer J, 2009, VIRUS RES, V142, P108, DOI 10.1016/j.virusres.2009.01.019; Pillai SPS, 2010, ARCH VIROL, V155, P1439, DOI 10.1007/s00705-010-0727-8; Prele CM, 2008, J IMMUNOL, V181, P8018, DOI 10.4049/jimmunol.181.11.8018; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Ray K, 2008, VIRUS GENES, V36, P345, DOI 10.1007/s11262-007-0195-8; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Savic V, 2010, VECTOR-BORNE ZOONOT, V10, P915, DOI 10.1089/vbz.2009.0107; Scott T, 2008, MOL IMMUNOL, V45, P1001, DOI 10.1016/j.molimm.2007.07.035; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Song JS, 2011, J VIROL, V85, P2180, DOI 10.1128/JVI.01975-10; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; STERZ I, 1974, MED MICROBIOL IMMUN, V159, P151, DOI 10.1007/BF02123728; STERZ I, 1973, ZBL VET MED B, V20, P613; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Suguitan AL, 2009, VIROLOGY, V395, P280, DOI 10.1016/j.virol.2009.09.017; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Tada T, 2011, J VIROL, V85, P1834, DOI 10.1128/JVI.01648-10; Tang YH, 2009, AVIAN PATHOL, V38, P457, DOI 10.1080/03079450903349147; Tran TT, 2008, INT J BIOCHEM CELL B, V40, P2671, DOI 10.1016/j.biocel.2008.05.019; Tregaskes CA, 2005, DEV COMP IMMUNOL, V29, P361, DOI 10.1016/j.dci.2004.09.001; Wasilenko JL, 2011, ARCH VIROL, V156, P37, DOI 10.1007/s00705-010-0813-y; Wasilenko JL, 2008, J VIROL, V82, P4544, DOI 10.1128/JVI.02642-07; Wasilenko JL, 2009, ARCH VIROL, V154, P969, DOI 10.1007/s00705-009-0399-4; WHO, 2007, UN NOM SYST HIGHL PA; WHO, 2012, CUM NUMB CONF HUM CA; Zhou JY, 2006, J GEN VIROL, V87, P1823, DOI 10.1099/vir.0.81800-0	74	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30960	10.1371/journal.pone.0030960	http://dx.doi.org/10.1371/journal.pone.0030960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363523	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700016
J	Huang, Y; Gou, JQ; Jia, ZC; Yang, L; Sun, YM; Xiao, XY; Song, F; Luo, KM				Huang, Yan; Gou, Jiqing; Jia, Zhichun; Yang, Li; Sun, Yimin; Xiao, Xunyan; Song, Feng; Luo, Keming			Molecular Cloning and Characterization of Two Genes Encoding Dihydroflavonol-4-Reductase from Populus trichocarpa	PLOS ONE			English	Article							FLAVONOID BIOSYNTHESIS; MEDICAGO-TRUNCATULA; CHEMICAL DEFENSE; TREMBLING ASPEN; EXPRESSION; 4-REDUCTASE; REDUCTASE; TANNIN; ARABIDOPSIS; METABOLISM	Dihydroflavonol 4-reductase (DFR, EC 1.1.1.219) is a rate-limited enzyme in the biosynthesis of anthocyanins and condensed tannins (proanthocyanidins) that catalyzes the reduction of dihydroflavonols to leucoanthocyanins. In this study, two full-length transcripts encoding for PtrDFR1 and PtrDFR2 were isolated from Populus trichocarpa. Sequence alignment of the two PtrDFRs with other known DFRs reveals the homology of these genes. The expression profile of PtrDFRs was investigated in various tissues of P. trichocarpa. To determine their functions, two PtrDFRs were overexpressed in tobacco (Nicotiana tabacum) via Agrobacterium-mediated transformation. The associated color change in the flowers was observed in all 35S:PtrDFR1 lines, but not in 35S: PtrDFR2 lines. Compared to the wild-type control, a significantly higher accumulation of anthocyanins was detected in transgenic plants harboring the PtrDFR1. Furthermore, overexpressing PtrDFR1 in Chinese white poplar (P. tomentosa Carr.) resulted in a higher accumulation of both anthocyanins and condensed tannins, whereas constitutively expressing PtrDFR2 only improved condensed tannin accumulation, indicating the potential regulation of condensed tannins by PtrDFR2 in the biosynthetic pathway in poplars.	[Huang, Yan; Jia, Zhichun; Yang, Li; Sun, Yimin; Xiao, Xunyan; Song, Feng; Luo, Keming] Southwest Univ, Sch Life Sci, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Inst Resources Bot, Chongqing, Peoples R China; [Huang, Yan; Luo, Keming] Southwest Univ, Chongqing Key Lab Transgen Plant & Safety Control, Chongqing, Peoples R China; [Gou, Jiqing] Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK USA	Southwest University - China; Southwest University - China; Noble Research Institute	Huang, Y (corresponding author), Southwest Univ, Sch Life Sci, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Inst Resources Bot, Chongqing, Peoples R China.	kemingl@swu.edu.cn		Yan, Huang/0000-0002-9899-9443	National Natural Science Foundation of China [3081576]; National Key Project for Research on Transgenic Plant [2008ZX08010-003]; Natural Science Foundation (CSTC) [2009BA1004, 2009BB0004]; Fundamental Research Funds for the Central Universities [XDJK2009B018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project for Research on Transgenic Plant; Natural Science Foundation (CSTC)(National Natural Science Foundation of China (NSFC)Natural Science Foundation Project of CQ CSTC); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (3081576), the National Key Project for Research on Transgenic Plant (2008ZX08010-003), the Natural Science Foundation Project of CQ CSTC (CSTC, 2009BA1004, 2009BB0004), and the Fundamental Research Funds for the Central Universities (XDJK2009B018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida R, 2000, PLANT SCI, V160, P49, DOI 10.1016/S0168-9452(00)00364-2; Bavage AD, 1997, PLANT MOL BIOL, V35, P443, DOI 10.1023/A:1005841214470; BELD M, 1989, PLANT MOL BIOL, V13, P491, DOI 10.1007/BF00027309; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; CHEN C, 1990, BIOTECHNOL BIOENG, V36, P993, DOI 10.1002/bit.260361004; Davies KM, 2003, EUPHYTICA, V131, P259, DOI 10.1023/A:1024018729349; Devic M, 1999, PLANT J, V19, P387, DOI 10.1046/j.1365-313X.1999.00529.x; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Dixon RA, 1999, TRENDS PLANT SCI, V4, P394, DOI 10.1016/S1360-1385(99)01471-5; Donaldson JR, 2007, ECOLOGY, V88, P729, DOI 10.1890/06-0064; Driebe EM, 2000, OECOLOGIA, V123, P99, DOI 10.1007/s004420050994; Fischer TC, 2003, ARCH BIOCHEM BIOPHYS, V412, P223, DOI 10.1016/S0003-9861(03)00013-4; Gou JQ, 2011, NEW PHYTOL, V192, P626, DOI 10.1111/j.1469-8137.2011.03837.x; Gou JQ, 2010, PLANT CELL, V22, P623, DOI 10.1105/tpc.109.073239; HORSCH RB, 1988, PLANT MOL BIOL MAN A, V5, P1; Inagaki Y, 1999, GENE, V226, P181, DOI 10.1016/S0378-1119(98)00571-X; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Jia Z, 2011, TREE PHYSIOL, V30, P1599; Johnson ET, 1999, PLANT J, V19, P81, DOI 10.1046/j.1365-313X.1999.00502.x; KRISTIANSEN KN, 1991, MOL GEN GENET, V230, P49, DOI 10.1007/BF00290650; Lacombe E, 1997, PLANT J, V11, P429, DOI 10.1046/j.1365-313X.1997.11030429.x; Li XX, 2010, BIOTECHNOL LETT, V32, P1333, DOI [10.1007/s10529-010-0297-6, 10.1007/s10529-010-0281-1]; Liew CF, 1998, PLANT SCI, V135, P161, DOI 10.1016/S0168-9452(98)00071-5; Lindroth RL, 1996, RECENT ADV PHYTOCHEM, V30, P25; Lloyd G., 1980, Combined Proceedings, International Plant Propagators' Society, V30, P421; Lo Piero AR, 2006, PHYTOCHEMISTRY, V67, P684, DOI 10.1016/j.phytochem.2006.01.025; Luo KM, 2006, PLANT CELL REP, V25, P403, DOI 10.1007/s00299-005-0051-z; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Martens S, 2003, BIOCHEM ENG J, V14, P227, DOI 10.1016/S1369-703X(02)00224-3; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; OLSEN O, 1993, P NATL ACAD SCI USA, V90, P8043, DOI 10.1073/pnas.90.17.8043; Ostergaard L, 2001, PLANT SCI, V160, P463, DOI 10.1016/S0168-9452(00)00407-6; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Polashock JJ, 2002, PLANT SCI, V163, P241, DOI 10.1016/S0168-9452(02)00087-0; PRICE ML, 1978, J AGR FOOD CHEM, V26, P1214, DOI 10.1021/jf60219a031; Robbins MP, 1998, PLANT PHYSIOL, V116, P1133, DOI 10.1104/pp.116.3.1133; SCHULTZ JC, 1982, SCIENCE, V217, P149, DOI 10.1126/science.217.4555.149; Shimada N, 2005, J EXP BOT, V56, P2573, DOI 10.1093/jxb/eri251; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; Sterky F, 2004, P NATL ACAD SCI USA, V101, P13951, DOI 10.1073/pnas.0401641101; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Taylor G, 2002, ANN BOT-LONDON, V90, P681, DOI 10.1093/aob/mcf255; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Waterman P.G., 1994, OXF BLACKWELL SCI PU, V8, P73; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Winkel-Shirley B, 2001, PLANT PHYSIOL, V127, P1399, DOI 10.1104/pp.127.4.1399; Xie DY, 2004, PLANT PHYSIOL, V134, P979, DOI 10.1104/pp.103.030221	50	41	54	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30364	10.1371/journal.pone.0030364	http://dx.doi.org/10.1371/journal.pone.0030364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363429	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600023
J	Molina-Pena, R; Alvarez, MM				Molina-Pena, Rodolfo; Moises Alvarez, Mario			A Simple Mathematical Model Based on the Cancer Stem Cell Hypothesis Suggests Kinetic Commonalities in Solid Tumor Growth	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; INITIATING CELLS; DIFFERENTIATION THERAPY; COLORECTAL-CANCER; PROGENITOR CELLS; DYNAMICS; BIOLOGY; TARGET; LINES; SUBPOPULATION	Background: The Cancer Stem Cell (CSC) hypothesis has gained credibility within the cancer research community. According to this hypothesis, a small subpopulation of cells within cancerous tissues exhibits stem-cell-like characteristics and is responsible for the maintenance and proliferation of cancer. Methodologies/Principal Findings: We present a simple compartmental pseudo-chemical mathematical model for tumor growth, based on the CSC hypothesis, and derived using a "chemical reaction" approach. We defined three cell subpopulations: CSCs, transit progenitor cells, and differentiated cells. Each event related to cell division, differentiation, or death is then modeled as a chemical reaction. The resulting set of ordinary differential equations was numerically integrated to describe the time evolution of each cell subpopulation and the overall tumor growth. The parameter space was explored to identify combinations of parameter values that produce biologically feasible and consistent scenarios. Conclusions/Significance: Certain kinetic relationships apparently must be satisfied to sustain solid tumor growth and to maintain an approximate constant fraction of CSCs in the tumor lower than 0.01 (as experimentally observed): (a) the rate of symmetrical and asymmetrical CSC renewal must be in the same order of magnitude; (b) the intrinsic rate of renewal and differentiation of progenitor cells must be half an order of magnitude higher than the corresponding intrinsic rates for cancer stem cells; (c) the rates of apoptosis of the CSC, transit amplifying progenitor (P) cells, and terminally differentiated (D) cells must be progressively higher by approximately one order of magnitude. Simulation results were consistent with reports that have suggested that encouraging CSC differentiation could be an effective therapeutic strategy for fighting cancer in addition to selective killing or inhibition of symmetric division of CSCs.	[Molina-Pena, Rodolfo; Moises Alvarez, Mario] Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico	Tecnologico de Monterrey	Molina-Pena, R (corresponding author), Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico.	Mario.alvarez@itesm.mx		Alvarez, Mario Moises/0000-0002-9131-5344	Tecnologico de Monterrey [CAT122]; Mexican Council for Science and Technology (CONACYT)	Tecnologico de Monterrey; Mexican Council for Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors gratefully acknowledge the financial support provided by the Tecnologico de Monterrey through the research chair CAT122, by the Mexican Council for Science and Technology (CONACYT) in the form of a scholarship awarded to Rodolfo Molina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Ashkenazi R, 2008, NEOPLASIA, V10, P1170, DOI 10.1593/neo.08572; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Boman BM, 2007, CLIN PHARMACOL THER, V81, P893, DOI 10.1038/sj.clpt.6100202; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Cocciadiferro L, 2009, ANN NY ACAD SCI, V1155, P257, DOI 10.1111/j.1749-6632.2009.03696.x; Collins AT, 2006, EUR J CANCER, V42, P1213, DOI 10.1016/j.ejca.2006.01.037; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Daukste L, 2009, J THEOR BIOL, V260, P563, DOI 10.1016/j.jtbi.2009.06.019; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dingli D, 2007, PLOS COMPUT BIOL, V3, P482, DOI 10.1371/journal.pcbi.0030053; Dingli D, 2007, CELL CYCLE, V6, P461, DOI 10.4161/cc.6.4.3853; Dingli D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000345; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Ellis WJ, 1996, CLIN CANCER RES, V2, P1039; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Foo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000503; Friel AM, 2008, CELL CYCLE, V7, P242, DOI 10.4161/cc.7.2.5207; Galle J, 2009, J MATH BIOL, V58, P261, DOI 10.1007/s00285-008-0172-4; Ganguly R, 2007, CELL PROLIFERAT, V40, P338, DOI 10.1111/j.1365-2184.2007.00434.x; Gao JX, 2008, J CELL MOL MED, V12, P67, DOI 10.1111/j.1582-4934.2007.00170.x; Giebel B, 2008, CURR STEM CELL RES T, V3, P9, DOI 10.2174/157488808783489444; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gudjonsson T, 2005, APMIS, V113, P922, DOI 10.1111/j.1600-0463.2005.apm_371.x; Hermann PC, 2008, CELL CYCLE, V7, P188, DOI 10.4161/cc.7.2.5326; Jagani Z, 2008, ADV EXP MED BIOL, V615, P331, DOI 10.1007/978-1-4020-6554-5_15; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Kai K, 2009, CANCER SCI, V100, P2275, DOI 10.1111/j.1349-7006.2009.01318.x; Kang MK, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-15; Kern SE, 2007, CANCER RES, V67, P8985, DOI 10.1158/0008-5472.CAN-07-1971; Kim PS, 2008, B MATH BIOL, V70, P1994, DOI 10.1007/s11538-008-9336-z; Komarova NL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000990; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lodish H., 2004, MOL CELL BIOL; Loebinger MR, 2008, BRIT J CANCER, V98, P380, DOI 10.1038/sj.bjc.6604185; Los M, 2009, EUR J PHARMACOL, V625, P1, DOI 10.1016/j.ejphar.2009.10.008; Mackenzie IC, 2008, ANN ONCOL, V19, P40, DOI 10.1093/annonc/mdn306; Maitland NJ, 2007, ERNST SCHERING FOUND, V5, P155, DOI 10.1007/2789_2007_050; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Michor F, 2008, J CLIN ONCOL, V26, P2854, DOI 10.1200/JCO.2007.15.2421; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Pacheco JM, 2009, J THEOR BIOL, V259, P635, DOI 10.1016/j.jtbi.2009.04.003; Pan YY, 2008, INT J CLIN EXP MED, V1, P260; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pfeiffer MJ, 2010, EUR UROL, V57, P246, DOI 10.1016/j.eururo.2009.01.015; Rapp UR, 2008, CELL CYCLE, V7, P45, DOI 10.4161/cc.7.1.5203; Rappa G, 2008, EXP CELL RES, V314, P2110, DOI 10.1016/j.yexcr.2008.03.008; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roose T, 2007, SIAM REV, V49, P179, DOI 10.1137/S0036144504446291; Sagar J, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-9; Saini V, 2010, CANCER SCI, V101, P16, DOI 10.1111/j.1349-7006.2009.01371.x; Scatena R, 2011, EXPERT OPIN BIOL TH, V11, P875, DOI 10.1517/14712598.2011.573780; Schmidt C, 2008, NAT BIOTECHNOL, V26, P366, DOI 10.1038/nbt0408-366c; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sell S, 2005, STEM CELL REV, V1, P197, DOI 10.1385/SCR:1:3:197; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Soltysova A, 2005, NEOPLASMA, V52, P435; Tan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023383; Turner C, 2009, CELL PROLIFERAT, V42, P529, DOI 10.1111/j.1365-2184.2009.00619.x; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Winquist RJ, 2009, BIOCHEM PHARMACOL, V78, P326, DOI 10.1016/j.bcp.2009.03.020; Yanamoto S, 2011, ORAL ONCOLO IN PRESS	75	39	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e26233	10.1371/journal.pone.0026233	http://dx.doi.org/10.1371/journal.pone.0026233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363395	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600001
J	Antony, ML; Kim, SH; Singh, SV				Antony, Marie Lue; Kim, Su-Hyeong; Singh, Shivendra V.			Critical Role of p53 Upregulated Modulator of Apoptosis in Benzyl Isothiocyanate-Induced Apoptotic Cell Death	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; BREAST-CANCER; PUMA; BAX; GROWTH; PHOSPHORYLATION; CONSTITUENT; INHIBITION; PROTEINS; ARREST	Benzyl isothiocyanate (BITC), a constituent of edible cruciferous vegetables, decreases viability of cancer cells by causing apoptosis but the mechanism of cell death is not fully understood. The present study was undertaken to determine the role of Bcl-2 family proteins in BITC-induced apoptosis using MDA-MB-231 (breast), MCF-7 (breast), and HCT-116 (colon) human cancer cells. The B-cell lymphoma 2 interacting mediator of cell death (Bim) protein was dispensable for proapoptotic response to BITC in MCF-7 and MDA-MB-231 cells as judged by RNA interference studies. Instead, the BITC-treated MCF-7 and MDA-MB-231 cells exhibited upregulation of p53 upregulated modulator of apoptosis (PUMA) protein. The BITC-mediated induction of PUMA was relatively more pronounced in MCF-7 cells due to the presence of wild-type p53 compared with MDA-MB-231 with mutant p53. The BITC-induced apoptosis was partially but significantly attenuated by RNA interference of PUMA in MCF-7 cells. The PUMA knockout variant of HCT-116 cells exhibited significant resistance towards BITC-induced apoptosis compared with wild-type HCT-116 cells. Attenuation of BITC-induced apoptosis in PUMA knockout HCT-116 cells was accompanied by enhanced G2/M phase cell cycle arrest due to induction of p21 and down regulation of cyclin-dependent kinase 1 protein. The BITC treatment caused a decrease in protein levels of Bcl-xL (MCF-7 and MDA-MB-231 cells) and Bcl-2 (MCF-7 cells). Ectopic expression of Bcl-xL in MCF-7 and MDA-MB-231 cells and that of Bcl-2 in MCF-7 cells conferred protection against proapoptotic response to BITC. Interestingly, the BITC-treated MDA-MB-231 cells exhibited induction of Bcl-2 protein expression, and RNA interference of Bcl-2 in this cell line resulted in augmentation of BITC-induced apoptosis. The BITC-mediated inhibition of MDA-MB-231 xenograft growth in vivo was associated with the induction of PUMA protein in the tumor. In conclusion, the results of the present study indicate that Bim-independent apoptosis by BITC in cancer cells is mediated by PUMA.	[Antony, Marie Lue] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Antony, ML (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	singhs@upmc.edu	Antony, Marie Lue/AAB-3952-2019		National Cancer Institute at the National Institutes of Health [RO1 CA129347-05, P30 CA047904]; NATIONAL CANCER INSTITUTE [R01CA129347, P30CA047904] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by a research grant from the National Cancer Institute at the National Institutes of Health [RO1 CA129347-05 (SVS)]. This research project used the Tissue and Research Pathology Facility supported by a grant from the National Cancer Institute at the National Institutes of Health (P30 CA047904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gillings AS, 2009, FEBS J, V276, P6050, DOI 10.1111/j.1742-4658.2009.07329.x; Herman-Antosiewicz A, 2005, J BIOL CHEM, V280, P28519, DOI 10.1074/jbc.M501443200; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kim EJ, 2011, BREAST CANCER RES TR, V130, P61, DOI 10.1007/s10549-010-1299-8; Kim SH, 2011, CARCINOGENESIS, V32, P359, DOI 10.1093/carcin/bgq267; Kim SH, 2010, CANCER PREV RES, V3, P718, DOI 10.1158/1940-6207.CAPR-10-0048; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Liu ZH, 2005, CANCER RES, V65, P1647, DOI 10.1158/0008-5472.CAN-04-1754; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Park K, 2009, EXP MOL MED, V41, P371, DOI 10.3858/emm.2009.41.6.042; Powolny AA, 2011, JNCI-J NATL CANCER I, V103, P571, DOI 10.1093/jnci/djr029; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Qiao SL, 2012, NEUROCHEM RES, V37, P417, DOI 10.1007/s11064-011-0628-6; Sahin K, 2011, NUTR CANCER, V63, P1279, DOI 10.1080/01635581.2011.606955; Sakata M, 2011, ASIAN PAC J CANCER P, V12, P567; Sehrawat A, 2011, CANCER PREV RES, V4, P1107, DOI 10.1158/1940-6207.CAPR-10-0306; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; Tseng E, 2004, EXP BIOL MED, V229, P835, DOI 10.1177/153537020422900817; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Warin R, 2010, MOL CARCINOGEN, V49, P500, DOI 10.1002/mc.20600; Warin R, 2009, CANCER RES, V69, P9473, DOI 10.1158/0008-5472.CAN-09-2960; WATTENBERG LW, 1977, J NATL CANCER I, V58, P395, DOI 10.1093/jnci/58.2.395; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xiao D, 2004, ONCOGENE, V23, P5594, DOI 10.1038/sj.onc.1207747; Xiao D, 2008, J BIOL CHEM, V283, P30151, DOI 10.1074/jbc.M802529200; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Xiao D, 2006, CLIN CANCER RES, V12, P6836, DOI 10.1158/1078-0432.CCR-06-1273; Xiao D, 2011, MOL PHARMACOL, V79, P499, DOI 10.1124/mol.110.068551; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhang YS, 2003, MOL CANCER THER, V2, P1045	48	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32267	10.1371/journal.pone.0032267	http://dx.doi.org/10.1371/journal.pone.0032267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359675	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000302796200144
J	Chen, CR; Salazar, LM; McLachlan, SM; Rapoport, B				Chen, Chun-Rong; Salazar, Larry M.; McLachlan, Sandra M.; Rapoport, Basil			Novel Information on the Epitope of an Inverse Agonist Monoclonal Antibody Provides Insight into the Structure of the TSH Receptor	PLOS ONE			English	Article							GLYCOPROTEIN HORMONE-RECEPTORS; THYROTROPIN RECEPTOR; CRYSTAL-STRUCTURE; HINGE REGION; CONSTITUTIVE ACTIVITY; STIMULATING-HORMONE; GRAVES-DISEASE; BINDING-SITE; DOMAIN; RESIDUES	The TSH receptor (TSHR) comprises an extracellular leucine-rich domain (LRD) linked by a hinge region to the transmembrane domain (TMD). Insight into the orientation of these components to each other is required for understanding how ligands activate the receptor. We previously identified residue E251 at the LRD-hinge junction as contributing to coupling TSH binding with receptor activation. However, a single residue cannot stabilize the LRD-hinge unit. Therefore, based on the LRD crystal structure we selected for study four other potential LRD-hinge interface charged residues. Alanine substitutions of individual residues K244, E247, K250 and R255 (as well as previously known E251A) did not affect TSH binding or function. However, the cumulative mutation of these residues in varying permutations, primarily K250A and R255A when associated with E251A, partially uncoupled TSH binding and function. These data suggest that these three residues, spatially very close to each other at the LRD base, interact with the hinge region. Unexpectedly and most important, monoclonal antibody CS-17, a TSHR inverse agonist whose epitope straddles the LRD-hinge, was found to interact with residues K244 and E247 at the base of the convex LRD surface. These observations, together with the functional data, exclude residues K244 and E247 from the TSHR LRD-hinge interface. Further, for CS-17 accessibility to K244 and E247, the concave surface of the TSHR LRD must be tilted forwards towards the hinge region and plasma membrane. Overall, these data provide insight into the mechanism by which ligands either activate the TSHR or suppress its constitutive activity.	[Chen, Chun-Rong; Salazar, Larry M.; McLachlan, Sandra M.; Rapoport, Basil] Cedars Sinai Med Ctr, Thyroid Autoimmune Dis Unit, Los Angeles, CA 90048 USA; [Chen, Chun-Rong; McLachlan, Sandra M.; Rapoport, Basil] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chen, CR (corresponding author), Cedars Sinai Med Ctr, Thyroid Autoimmune Dis Unit, Los Angeles, CA 90048 USA.	rapoportb@cshs.org			National Institutes of Health [DK 19289, DK 54684]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019289, R01DK054684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grants DK 19289 (to BR) and DK 54684 (to SMM) and donations from Dr. Boris Catz (private clinical practioner, Los Angeles, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chazenbalk GD, 1996, ENDOCRINOLOGY, V137, P4586, DOI 10.1210/en.137.11.4586; Chazenbalk GD, 2002, J CLIN INVEST, V110, P209, DOI 10.1172/JCI200215745; Chen CR, 2008, ENDOCRINOLOGY, V149, P3427, DOI 10.1210/en.2008-0207; Chen CR, 2007, ENDOCRINOLOGY, V148, P2375, DOI 10.1210/en.2006-1754; Chen CR, 2011, J BIOL CHEM, V286, P6219, DOI 10.1074/jbc.M110.211003; Chen CR, 2010, ENDOCRINOLOGY, V151, P1940, DOI 10.1210/en.2009-1430; Chen CR, 2009, ENDOCRINOLOGY, V150, P3401, DOI 10.1210/en.2008-1800; Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Costagliola S, 1998, FEBS LETT, V436, P427, DOI 10.1016/S0014-5793(98)01177-6; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Johnstone AP, 2003, CLIN ENDOCRINOL, V59, P437, DOI 10.1046/j.1365-2265.2003.01864.x; Kleinau G, 2011, J BIOL CHEM, V286, P22622, DOI 10.1074/jbc.M110.211193; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; KOSUGI S, 1991, BIOCHEM BIOPH RES CO, V180, P1118, DOI 10.1016/S0006-291X(05)81182-9; Miguel RN, 2008, J MOL ENDOCRINOL, V41, P145, DOI 10.1677/JME-08-0040; Miguel RN, 2009, J MOL ENDOCRINOL, V42, P381, DOI 10.1677/JME-08-0152; Miguel RN, 2004, THYROID, V14, P991, DOI 10.1089/thy.2004.14.991; Mizutori Y, 2008, J CLIN ENDOCR METAB, V94, P935; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Moyle WR, 2005, ENDOCRINE, V26, P189, DOI 10.1385/ENDO:26:3:189; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1989, BIOCHEM BIOPH RES CO, V165, P1184, DOI 10.1016/0006-291X(89)92727-7; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Sanders J, 2003, LANCET, V362, P126, DOI 10.1016/S0140-6736(03)13866-4; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Smits G, 2003, EMBO J, V22, P2692, DOI 10.1093/emboj/cdg260; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31973	10.1371/journal.pone.0031973	http://dx.doi.org/10.1371/journal.pone.0031973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359649	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200118
J	Khurana, S; Raina, H; Pappas, V; Raufman, JP; Pallone, TL				Khurana, Sandeep; Raina, Hema; Pappas, Valeria; Raufman, Jean-Pierre; Pallone, Thomas L.			Effects of Deoxycholylglycine, a Conjugated Secondary Bile Acid, on Myogenic Tone and Agonist-Induced Contraction in Rat Resistance Arteries	PLOS ONE			English	Article							FXR-MEDIATED REGULATION; FARNESOID-X-RECEPTOR; SMOOTH-MUSCLE; EXPRESSION; CHANNELS; HYPERTENSION; SENSITIVITY; ACTIVATION; CONTRIBUTE; PREGNANCY	Background: Bile acids (BAs) regulate cardiovascular function via diverse mechanisms. Although in both health and disease serum glycine-conjugated BAs are more abundant than taurine-conjugated BAs, their effects on myogenic tone (MT), a key determinant of systemic vascular resistance (SVR), have not been examined. Methodology/Principal Findings: Fourth-order mesenteric arteries (170-250 mu m) isolated from Sprague-Dawley rats were pressurized at 70 mmHg and allowed to develop spontaneous constriction, i.e., MT. Deoxycholylglycine (DCG; 0.1-100 mu M), a glycine-conjugated major secondary BA, induced reversible, concentration-dependent reduction of MT that was similar in endothelium-intact and -denuded arteries. DCG reduced the myogenic response to stepwise increase in pressure (20 to 100 mmHg). Neither atropine nor the combination of L-NAME (a NOS inhibitor) plus indomethacin altered DCG-mediated reduction of MT. K+ channel blockade with glibenclamide (K-ATP), 4-aminopyradine (K-V), BaCl2 (K-IR) or tetraethylammonium (TEA, K-Ca) were also ineffective. In Fluo-2-loaded arteries, DCG markedly reduced vascular smooth muscle cell (VSM) Ca2+ fluorescence (similar to 50%). In arteries incubated with DCG, physiological salt solution (PSS) with high Ca2+ (4 mM) restored myogenic response. DCG reduced vascular tone and VSM cytoplasmic Ca2+ responses (similar to 50%) of phenylephrine (PE)- and Ang II-treated arteries, but did not affect KCl-induced vasoconstriction. Conclusion: In rat mesenteric resistance arteries DCG reduces pressure- and agonist-induced vasoconstriction and VSM cytoplasmic Ca2+ responses, independent of muscarinic receptor, NO or K+ channel activation. We conclude that BAs alter vasomotor responses, an effect favoring reduced SVR. These findings are likely pertinent to vascular dysfunction in cirrhosis and other conditions associated with elevated serum BAs.	[Khurana, Sandeep; Raufman, Jean-Pierre] VA Maryland Hlth Care Syst, Div Gastroenterol & Hepatol, Baltimore, MD USA; [Raina, Hema] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Pappas, Valeria; Pallone, Thomas L.] Univ Maryland Hosp, Dept Med, Div Nephrol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Khurana, S (corresponding author), VA Maryland Hlth Care Syst, Div Gastroenterol & Hepatol, Baltimore, MD USA.	skhurana@medicine.umaryland.edu			National Instituters of Health (NIH) [K08 DK081479, R01DK067621, R37DK042495, P01HL078870, R01CA107345, R01CA120407]; Baltimore Research and Education Foundation; NATIONAL CANCER INSTITUTE [R01CA120407, R01CA107345] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081479, R37DK042495, R01DK067621] Funding Source: NIH RePORTER	National Instituters of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baltimore Research and Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SK is supported by National Instituters of Health (NIH) grant K08 DK081479 and the Baltimore Research and Education Foundation. TLP is supported by NIH grants R01DK067621, R37DK042495 and P01HL078870. JPR is supported by NIH grants R01CA107345 and R01CA120407. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azer SA, 1996, J GASTROEN HEPATOL, V11, P208, DOI 10.1111/j.1440-1746.1996.tb00064.x; Bishop-Bailey D, 2004, P NATL ACAD SCI USA, V101, P3668, DOI 10.1073/pnas.0400046101; Brophy CM, 2000, AM J PHYSIOL-HEART C, V278, pH991, DOI 10.1152/ajpheart.2000.278.3.H991; Bukiya AN, 2007, MOL PHARMACOL, V72, P359, DOI 10.1124/mol.107.034330; CHRISTENSEN KL, 1993, J VASC RES, V30, P73, DOI 10.1159/000158978; Dopico AM, 2002, J GEN PHYSIOL, V119, P251, DOI 10.1085/jgp.119.3.251; FENGERGRON J, 1995, J PHYSIOL-LONDON, V488, P753, DOI 10.1113/jphysiol.1995.sp021006; Fiorucci S, 2009, TRENDS PHARMACOL SCI, V30, P570, DOI 10.1016/j.tips.2009.08.001; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Goto K, 2004, J PHYSIOL-LONDON, V561, P215, DOI 10.1113/jphysiol.2004.070458; Hagedorn KA, 2007, HYPERTENSION, V49, P328, DOI 10.1161/01.HYP.0000253478.51950.27; He FT, 2006, CIRC RES, V98, P192, DOI 10.1161/01.RES.0000200400.55539.85; Hilgers RHP, 2006, AM J PHYSIOL-HEART C, V291, pH216, DOI 10.1152/ajpheart.01383.2005; Hill MA, 2001, J APPL PHYSIOL, V91, P973, DOI 10.1152/jappl.2001.91.2.973; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Kadir SHSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009689; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Khurana S, 2005, EUR J PHARMACOL, V517, P103, DOI 10.1016/j.ejphar.2005.05.037; Khurana S, 2011, CTS-CLIN TRANSL SCI, V4, P210, DOI 10.1111/j.1752-8062.2011.00272.x; Koenigsberger M, 2008, BIOPHYS J, V95, P2728, DOI 10.1529/biophysj.108.131136; KOWALSKI HJ, 1953, J CLIN INVEST, V32, P1025, DOI 10.1172/JCI102813; Kutluay E, 2005, BIOPHYS J, V88, P1018, DOI 10.1529/biophysj.104.052043; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; Li J, 2008, CARDIOVASC RES, V77, P169, DOI 10.1093/cvr/cvm016; LINNET K, 1983, GUT, V24, P249, DOI 10.1136/gut.24.3.249; Mathew S, 2008, J AM SOC NEPHROL, V19, P1509, DOI 10.1681/ASN.2007080902; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Nakajima T, 2000, BRIT J PHARMACOL, V130, P1457, DOI 10.1038/sj.bjp.0703471; NEALE G, 1971, GUT, V12, P145, DOI 10.1136/gut.12.2.145; OHKUBO H, 1984, GASTROENTEROLOGY, V86, P514; Osborn JW, 2011, CURR HYPERTENS REP, V13, P221, DOI 10.1007/s11906-011-0188-9; PAK JM, 1993, HEPATOLOGY, V18, P1175; PAK JM, 1994, BRIT J PHARMACOL, V112, P1209, DOI 10.1111/j.1476-5381.1994.tb13212.x; Pazzi P, 2002, ALIMENT PHARM THER, V16, P1547, DOI 10.1046/j.1365-2036.2002.01314.x; Plane F, 2005, CIRC RES, V96, P216, DOI 10.1161/01.RES.0000154070.06421.25; Ploug KB, 2010, EUR J PHARMACOL, V637, P109, DOI 10.1016/j.ejphar.2010.03.027; Raina H, 2010, AM J PHYSIOL-HEART C, V298, pH2093, DOI 10.1152/ajpheart.01045.2009; Raufman JP, 2002, EUR J PHARMACOL, V457, P77, DOI 10.1016/S0014-2999(02)02690-0; Raufman JP, 2002, PHARMACOLOGY, V65, P215, DOI 10.1159/000064347; Raufman JP, 1998, AM J PHYSIOL-GASTR L, V274, pG997, DOI 10.1152/ajpgi.1998.274.6.G997; Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1715, DOI 10.1053/j.gastro.2008.03.007; Schubert R, 2008, CARDIOVASC RES, V77, P8, DOI 10.1016/j.cardiores.2007.07.018; Song JG, 2009, ANESTHESIOLOGY, V111, P561, DOI 10.1097/ALN.0b013e3181adf49f; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Zhang QH, 2008, CARDIOVASC RES, V77, P560, DOI 10.1093/cvr/cvm068; Zhang Z, 2010, AM J PHYSIOL-RENAL, V299, pF862, DOI 10.1152/ajprenal.00321.2010	47	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32006	10.1371/journal.pone.0032006	http://dx.doi.org/10.1371/journal.pone.0032006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359652	Green Submitted, gold, Green Published			2022-12-25	WOS:000302796200121
J	Nikdin, H; Olsson, ML; Hultenby, K; Sugars, RV				Nikdin, Hero; Olsson, Marie-Louise; Hultenby, Kjell; Sugars, Rachael V.			Osteoadherin Accumulates in the Predentin towards the Mineralization Front in the Developing Tooth	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; KERATAN SULFATE PROTEOGLYCAN; COLLAGEN FIBRILLOGENESIS; EXTRACELLULAR-MATRIX; TARGETED DISRUPTION; RAT INCISOR; IMMUNOHISTOCHEMICAL LOCALIZATION; DENTIN MINERALIZATION; DECORIN-BINDING; DEFICIENT MICE	Background: Proteoglycans (PG) are known to be involved in the organization and assembly of the extracellular matrix (ECM) prior to mineral deposition. Osteoadherin (OSAD), a keratan sulphate PG is a member of the small leucine-rich (SLRP) family of PGs and unlike other SLRPs, OSAD expression is restricted to mineralized tissues. It is proposed to have a high affinity for hydroxyapatite and has been shown to be expressed by mature osteoblasts but its exact role remains to be elucidated. Methodology/Principal Findings: We investigated the protein distribution of OSAD in the developing mouse tooth using immunohistochemistry and compared its expression with other SLRPs, biglycan (BGN), decorin (DCN) and fibromodulin (FMD). OSAD was found to be specifically localized in the predentin layer of the tooth and focused at the mineralization front. These studies were confirmed at the ultrastructural level using electron microscopy (iEM), where the distribution of immunogold labeled OSAD particles were quantified and significant amounts were found in the predentin, forming a gradient towards the mineralization front. In addition, iEM results revealed OSAD to lie in close association with collagen fibers, further suggesting an important role for OSAD in the organization of the ECM. The expression profile of mineralization-related SLRP genes by rat dental pulp cells exposed to mineralization inducing factors, showed an increase in all SLRP genes. Indeed, OSAD expression was significantly increased during the mineralization process, specifically following, matrix maturation, and finally mineral deposition. Alizarin Red S staining for calcium deposition showed clear bone-like nodules, which support matrix maturation and mineralization. Conclusions: These studies provide new evidence for the role of OSAD in the mineralization process and its specific localization in the predentin layer accumulating at the mineralization front highlighting its role in tooth development.	[Nikdin, Hero; Olsson, Marie-Louise; Sugars, Rachael V.] Karolinska Inst, Dept Dent Med, Huddinge, Sweden; [Hultenby, Kjell] Karolinska Inst, Huddinge Univ Hosp, Clin Res Ctr, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Nikdin, H (corresponding author), Karolinska Inst, Dept Dent Med, Huddinge, Sweden.	Rachael.Sugars@ki.se	Sugars, Rachael/O-9423-2019	Sugars, Rachael/0000-0003-4843-6260	Stockholm County Council; Karolinska Institutet; Swedish Graduate School in Odontological Science	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Graduate School in Odontological Science	The study was supported by funds from Stockholm County Council, research funds of Karolinska Institutet, and the Swedish Graduate School in Odontological Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allori AC, 2008, TISSUE ENG PART B-RE, V14, P275, DOI 10.1089/ten.teb.2008.0083; [Anonymous], 1979, STEREOLOGICAL METHOD; Buchaille R, 2000, BONE, V27, P265, DOI 10.1016/S8756-3282(00)00310-0; Chen XD, 2002, J BONE MINER RES, V17, P331, DOI 10.1359/jbmr.2002.17.2.331; Couble ML, 2004, HISTOCHEM CELL BIOL, V121, P47, DOI 10.1007/s00418-003-0608-2; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Embery G, 2001, CRIT REV ORAL BIOL M, V12, P331, DOI 10.1177/10454411010120040401; FISHER LW, 1983, J BIOL CHEM, V258, P2723; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; FUKAE M, 1994, CALCIFIED TISSUE INT, V55, P426, DOI 10.1007/BF00298556; GOLDBERG M, 1993, HISTOCHEM J, V25, P781; Goldberg M, 2006, J HISTOCHEM CYTOCHEM, V54, P525, DOI 10.1369/jhc.5A6650.2005; GOLDBERG M, 1995, INT J DEV BIOL, V39, P93; Goldberg M, 2005, CALCIFIED TISSUE INT, V77, P297, DOI 10.1007/s00223-005-0026-7; Goldberg M, 2003, CONNECT TISSUE RES, V44, P143, DOI 10.1080/03008200390223927; GORSKI JP, 1992, CALCIFIED TISSUE INT, V50, P391, DOI 10.1007/BF00296767; Hall RC, 1997, ARCH ORAL BIOL, V42, P783, DOI 10.1016/S0003-9969(97)00024-1; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; Hocking AM, 1998, MATRIX BIOL, V17, P1; HULTENBY K, 1991, MATRIX, V11, P206, DOI 10.1016/S0934-8832(11)80160-5; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Lillesaar C, 2003, NEUROSCIENCE, V119, P443, DOI 10.1016/S0306-4522(02)00938-7; Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679; Mochida Y, 2009, MATRIX BIOL, V28, P44, DOI 10.1016/j.matbio.2008.11.003; Neame PJ, 2000, CELL MOL LIFE SCI, V57, P859, DOI 10.1007/s000180050048; Patel M, 2009, ARCH ORAL BIOL, V54, P898, DOI 10.1016/j.archoralbio.2009.06.008; Petersson U, 2003, EUR J ORAL SCI, V111, P128, DOI 10.1034/j.1600-0722.2003.00027.x; Ramstad VE, 2003, CALCIFIED TISSUE INT, V72, P57, DOI 10.1007/s00223-002-2047-9; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Rehn AP, 2008, CALCIFIED TISSUE INT, V82, P454, DOI 10.1007/s00223-008-9138-1; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; Septier D, 1998, HISTOCHEM J, V30, P275, DOI 10.1023/A:1003216024158; Septier D, 2001, CALCIFIED TISSUE INT, V69, P38, DOI 10.1007/s002230020047; Sommarin Y, 1998, J BIOL CHEM, V273, P16723, DOI 10.1074/jbc.273.27.16723; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; TAKAGI M, 1990, J HISTOCHEM CYTOCHEM, V38, P319, DOI 10.1177/38.3.1689334; Tillgren V, 2009, J BIOL CHEM, V284, P28543, DOI 10.1074/jbc.M109.047076; Waddington RJ, 2003, MATRIX BIOL, V22, P153, DOI 10.1016/S0945-053X(03)00019-2; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; Wendel M, 1998, J CELL BIOL, V141, P839, DOI 10.1083/jcb.141.3.839; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Zhou HY, 2007, ANN NY ACAD SCI, V1116, P323, DOI 10.1196/annals.1402.023	46	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31525	10.1371/journal.pone.0031525	http://dx.doi.org/10.1371/journal.pone.0031525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355375	gold, Green Published, Green Submitted			2022-12-25	WOS:000302741300075
J	Tollefsen, S; Hotta, K; Chen, X; Simonsen, B; Swaminathan, K; Mathews, II; Sollid, LM; Kim, CY				Tollefsen, Stig; Hotta, Kinya; Chen, Xi; Simonsen, Bjorg; Swaminathan, Kunchithapadam; Mathews, Irimpan I.; Sollid, Ludvig M.; Kim, Chu-Young			Structural and Functional Studies of trans-Encoded HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) Protein Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 DIABETES RISK; CLASS-II MOLECULES; CELIAC-DISEASE; MAXIMUM-LIKELIHOOD; SURFACE EXPRESSION; BINDING; PEPTIDE; SUSCEPTIBILITY; ASSOCIATIONS; REFINEMENT	MHC class II molecules are composed of one alpha-chain and one beta-chain whose membrane distal interface forms the peptide binding groove. Most of the existing knowledge on MHC class II molecules comes from the cis-encoded variants where the alpha- and beta-chain are encoded on the same chromosome. However, trans-encoded class II MHC molecules, where the alpha- and beta-chain are encoded on opposite chromosomes, can also be expressed. We have studied the trans-encoded class II HLA molecule DQ2.3 (DQA1*03:01/DQB1*02:01) that has received particular attention as it may explain the increased risk of certain individuals to type 1 diabetes. We report the x-ray crystal structure of this HLA molecule complexed with a gluten epitope at 3.05 angstrom resolution. The gluten epitope, which is the only known HLA-DQ2.3-restricted epitope, is preferentially recognized in the context of the DQ2.3 molecule by T-cell clones of a DQ8/DQ2.5 heterozygous celiac disease patient. This preferential recognition can be explained by improved HLA binding as the epitope combines the peptide-binding motif of DQ2.5 (negative charge at P4) and DQ8 (negative charge at P1). The analysis of the structure of DQ2.3 together with all other available DQ crystal structures and sequences led us to categorize DQA1 and DQB1 genes into two groups where any alpha-chain and beta-chain belonging to the same group are expected to form a stable heterodimer.	[Tollefsen, Stig; Simonsen, Bjorg; Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, N-0027 Oslo, Norway; [Tollefsen, Stig; Simonsen, Bjorg; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, N-0027 Oslo, Norway; [Tollefsen, Stig; Simonsen, Bjorg; Sollid, Ludvig M.] Oslo Univ Hosp, Rikshosp, N-0027 Oslo, Norway; [Hotta, Kinya; Chen, Xi; Swaminathan, Kunchithapadam; Kim, Chu-Young] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Mathews, Irimpan I.] Stanford Linear Accelerator Ctr, Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 95124 USA	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; National University of Singapore; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Sollid, LM (corresponding author), Univ Oslo, Ctr Immune Regulat, N-0027 Oslo, Norway.	l.m.sollid@medisin.uio.no; chuyoung@nus.edu.sg	Sollid, Ludvig/N-9691-2015; Kim, Chu-Young/D-8849-2012; Hotta, Kinya/A-2574-2009	Sollid, Ludvig/0000-0001-8860-704X; Kim, Chu-Young/0000-0003-3744-7802; Hotta, Kinya/0000-0002-9427-0081	Novo Nordisk Foundation; Juvenile Diabetes Research Foundation; Research Council of Norway; Singapore Biomedical Research Council [07/1/21/19/546]; Norwegian Extra Foundation for Health and Rehabilitation; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; NIGMS; Biomedical Technology Program	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Research Council of Norway(Research Council of Norway); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Norwegian Extra Foundation for Health and Rehabilitation; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biomedical Technology Program	This work was supported by grants from the Novo Nordisk Foundation, the Juvenile Diabetes Research Foundation, and the Research Council of Norway (to L. M. S.) and by Singapore Biomedical Research Council Grant 07/1/21/19/546 (to C. Y. K.).; Present address: Norwegian Veterinary Institute, 0106 Oslo, Norway. Supported by a postdoctoral grant from the Norwegian Extra Foundation for Health and Rehabilitation.; We thank Marit Sandvik for technical assistance and Elizabeth Mellins for providing the pRmHa3 plasmid. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and NIGMS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BRAUNSTEIN NS, 1987, P NATL ACAD SCI USA, V84, P2921, DOI 10.1073/pnas.84.9.2921; CHARRON DJ, 1984, NATURE, V312, P157, DOI 10.1038/312157a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Fallang LE, 2009, NAT IMMUNOL, V10, P1096, DOI 10.1038/ni.1780; Helmberg W, 2004, NUCLEIC ACIDS RES, V32, pW173, DOI 10.1093/nar/gkh424; Juse U, 2009, IMMUNOGENETICS, V61, P81, DOI 10.1007/s00251-008-0338-7; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Koeleman BPC, 2004, GENES IMMUN, V5, P381, DOI 10.1038/sj.gene.6364106; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; KWOK WW, 1993, J IMMUNOL, V150, P2263; KWOK WW, 1988, J IMMUNOL, V141, P3123; KWOK WW, 1991, BAILLIERE CLIN ENDOC, V5, P375, DOI 10.1016/S0950-351X(05)80137-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LECHLER RI, 1990, J IMMUNOL, V144, P329; LOTTEAU V, 1987, NATURE, V329, P339, DOI 10.1038/329339a0; MAGALHAES A, 1994, J PROTEIN CHEM, V13, P195, DOI 10.1007/BF01891978; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McFarland BJ, 2002, MED RES REV, V22, P168, DOI 10.1002/med.10006; Molberg O, 2003, GASTROENTEROLOGY, V125, P337, DOI 10.1016/S0016-5085(03)00890-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; Noble JA, 2011, TISSUE ANTIGENS, V78, P348, DOI 10.1111/j.1399-0039.2011.01772.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quarsten H, 2001, J IMMUNOL, V167, P4861, DOI 10.4049/jimmunol.167.9.4861; Reichstetter S, 1999, TISSUE ANTIGENS, V53, P101, DOI 10.1034/j.1399-0039.1999.530111.x; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; SPENCER JS, 1993, J IMMUNOL, V151, P6822; Thorsby E, 1997, HUM IMMUNOL, V53, P1, DOI 10.1016/S0198-8859(97)00024-4; TODD JA, 1989, NATURE, V338, P587, DOI 10.1038/338587a0; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Vartdal F, 1996, EUR J IMMUNOL, V26, P2764, DOI 10.1002/eji.1830261132; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7	40	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13611	13619		10.1074/jbc.M111.320374	http://dx.doi.org/10.1074/jbc.M111.320374			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22362761	Green Published, hybrid			2022-12-25	WOS:000303996300017
J	Chung, JH; Jeon, HJ; Hong, SY; Lee, DL; Lee, KH; Kim, SH; Han, YS; Manabe, I; Miller, YI; Lee, SH				Chung, Ji Hyung; Jeon, Hyun Ju; Hong, Sung-Yu; Lee, Da Lyung; Lee, Kyung Hye; Kim, Soo Hyuk; Han, Ye Sun; Manabe, Ichiro; Miller, Yury I.; Lee, Sang-Hak			Palmitate Promotes the Paracrine Effects of Macrophages on Vascular Smooth Muscle Cells: The Role of Bone Morphogenetic Proteins	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; HYPOXIC PULMONARY-HYPERTENSION; ENDOTHELIAL-CELLS; KAPPA-B; PROLIFERATION; EXPRESSION; ACTIVATION; BMP4	Saturated fatty acids are known to activate macrophages and induce vascular inflammation. Although cytokines from activated macrophage influence other vascular cells, the influence of saturated fatty acids on the paracrine effect of macrophages is not fully understood yet. Here we examined the impact of palmitate on the effect of macrophages on vascular smooth muscle cells (SMCs) and their mediators. SMCs proliferation increased significantly after treatment with conditioned media from palmitate-stimulated RAW264.7 cells. SMC migration was found to be greater after treatment with palmitate-conditioned media. SM alpha-actin and SM22 alpha were decreased in SMCs treated with palmitate-conditioned media. When stimulated with palmitate, RAW264.7 cells secreted more bone morphogenetic protein (BMP)2 and BMP4 into the cell culture media. SMC proliferation, migration, and phenotypic changes were attenuated after treatment of neutralizing antibodies against BMPs or knockdown of BMPs with siRNA. The influences of these proteins were further confirmed by direct treatment of recombinant BMP2 and BMP4 on SMCs. Particularly, the effects of BMPs on SMC migration on phenotypic change were obvious, whereas their effect on SMC proliferation seemed not significant or modest. In conclusion, palmitate promoted macrophages' paracrine effects on SMC proliferation, migration, and phenotypic change. The effect of stimulated macrophages was mediated, at least in part, by BMP2 and BMP4. These results suggest a novel mechanism linking saturated fatty acids and the progression of vascular diseases that is possibly mediated by BMPs from macrophages.	[Chung, Ji Hyung; Hong, Sung-Yu] Yonsei Univ Hlth Syst, Cardiovasc Res Inst, Cardiovasc Prod Evaluat Ctr, Seoul, South Korea; [Jeon, Hyun Ju; Kim, Soo Hyuk] Yonsei Univ, Grad Sch, Interdisciplinary Course Sci Aging, Seoul 120749, South Korea; [Lee, Da Lyung] Biobud Inc, Natl Res Lab Cardiovasc Therapy, Seoul, South Korea; [Lee, Kyung Hye] Yonsei Univ, Yonsei Res Inst Aging Sci, Seoul 120749, South Korea; [Han, Ye Sun] Konkuk Univ, Dept Adv Technol Fus, Seoul, South Korea; [Manabe, Ichiro] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Miller, Yury I.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lee, Sang-Hak] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Konkuk University; University of Tokyo; University of California System; University of California San Diego; Yonsei University; Yonsei University Health System	Chung, JH (corresponding author), Yonsei Univ Hlth Syst, Cardiovasc Res Inst, Cardiovasc Prod Evaluat Ctr, Seoul, South Korea.	shl1106@yuhs.ac	Manabe, Ichiro/AAE-5105-2021; Manabe, Ichiro/E-1529-2014		Departmet of Internal Medicine, Yonsei University College of Medicine; Yonsei University College of Medicine [6-2011-0162]	Departmet of Internal Medicine, Yonsei University College of Medicine; Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from the Departmet of Internal Medicine, Yonsei University College of Medicine for 2007 and a faculty research grant from Yonsei University College of Medicine for 2011 (6-2011-0162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2010, AM J PHYSIOL-REG I, V298, pR833, DOI 10.1152/ajpregu.00534.2009; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Chen CN, 2006, P NATL ACAD SCI USA, V103, P2665, DOI 10.1073/pnas.0510973103; Corriere MA, 2008, J SURG RES, V145, P142, DOI 10.1016/j.jss.2007.03.077; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; Nakaoka T, 1997, J CLIN INVEST, V100, P2824, DOI 10.1172/JCI119830; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P2542, DOI 10.1210/jc.2006-0195; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sorescu GP, 2003, J BIOL CHEM, V278, P31128, DOI 10.1074/jbc.M300703200; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68	22	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e29100	10.1371/journal.pone.0029100	http://dx.doi.org/10.1371/journal.pone.0029100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363399	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700002
J	Mandalia, S; Westrop, SJ; Beck, EJ; Nelson, M; Gazzard, BG; Imami, N				Mandalia, Sundhiya; Westrop, Samantha J.; Beck, Eduard J.; Nelson, Mark; Gazzard, Brian G.; Imami, Nesrina			Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988-2010	PLOS ONE			English	Article							REFERENCE RANGES; INDIVIDUALS; REPLICATION; CONTROLLERS; RESPONSES; SURVIVORS	Define and identify long-term non-progressors (LTNP) and HIV controllers (HIC), and estimate time until disease progression. LTNP are HIV-1(+) patients who maintain stable CD4(+) T-cell counts, with no history of opportunistic infection or antiretroviral therapy (ART). HIC are a subset of LTNP who additionally have undetectable viraemia. These individuals may provide insights for prophylactic and therapeutic development. Records of HIV-1(+) individuals attending Chelsea and Westminster Hospital (1988-2010), were analysed. LTNP were defined as: HIV-1(+) for > 7 years; ART-naive; no history of opportunistic infection and normal, stable CD4(+) T-cell counts. MIXED procedure in SAS using random intercept model identified long-term stable CD4(+) T-cell counts. Survival analysis estimated time since diagnosis until disease progression. Subjects exhibiting long-term stable CD4(+) T-cell counts with history below the normal range (< 450 cells/mu l blood) were compared to LTNP whose CD4(+) T-cell count always remained normal. Within these two groups subjects with HIV-1 RNA load below limit of detection (BLD) were identified. Of 14,227 patients, 1,204 were diagnosed HIV-1(+) over 7 years ago and were ART-naive. Estimated time until disease progression for the 20% (239) whose CD4(+) T-cell counts remained within the normal range, was 6.2 years (IQR: 2.0 to 9.6); significantly longer than 4.0 years (IQR: 1.0 to 7.3) for patients with historical CD4(+) T-cell count below normal (Logrank chi-squared = 21.26; p < 0.001). Within a subpopulation of 312 asymptomatic patients, 50 exhibited long-term stable CD4(+) T-cell counts. Of these, 13 were LTNP, one of whom met HIC criteria. Of the remaining 37 patients with long-term stable low CD4(+) T-cell counts, 3 controlled HIV-1 RNA load BLD. Individuals with stable, normal CD4(+) T-cell counts progressed less rapidly than those with low CD4(+) T-cell counts. Few LTNP and HIC identified in this and other studies, endorse the need for universal definitions to facilitate comparison.	[Mandalia, Sundhiya; Westrop, Samantha J.; Nelson, Mark; Gazzard, Brian G.; Imami, Nesrina] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Med, London, England; [Beck, Eduard J.] London Sch Hyg & Trop Med, London WC1, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Mandalia, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Med, London, England.	n.imami@imperial.ac.uk		Imami, Nesrina/0000-0001-9673-2895; Westrop, Samantha/0000-0002-6836-4471	St Stephen's AIDS Trust; Westminster Medical School Research Trust; EC [LSHP-CT-2004-503487, LSHP-CT-2007-037616]; MRC [G0501957]; Medical Research Council [G0501957] Funding Source: researchfish	St Stephen's AIDS Trust; Westminster Medical School Research Trust; EC(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by St Stephen's AIDS Trust and the Westminster Medical School Research Trust. NI was also funded by EC (grant nos. LSHP-CT-2004-503487 and LSHP-CT-2007-037616), and MRC (grant no. G0501957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti F, 1995, J BIOL REG HOMEOS AG, V9, P82; [Anonymous], 1993, JAMA, V269, P729; Barre-Sinoussi F, 2011, NY TIMES        0603; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Diggle PJ, 2002, ANAL LONGITUDINAL DA; EASTERBROOK PJ, 1994, AIDS, V8, P1179, DOI 10.1097/00002030-199408000-00023; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Han YF, 2008, AIDS, V22, P541, DOI 10.1097/QAD.0b013e3282f470e4; HULSTAERT F, 1994, CLIN IMMUNOL IMMUNOP, V70, P152, DOI 10.1006/clin.1994.1023; Imami N, 2002, J VIROL, V76, P9011, DOI 10.1128/JVI.76.18.9011-9023.2002; Imami N, 2001, IMMUNOL LETT, V79, P63, DOI 10.1016/S0165-2478(01)00267-X; Kincaid C, 2005, SUGI 30 P; KLEIN MR, 1995, TRENDS MICROBIOL, V3, P386, DOI 10.1016/S0966-842X(00)88984-2; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lefrere JJ, 1997, BLOOD, V90, P1133, DOI 10.1182/blood.V90.3.1133.1133_1133_1140; Maini MK, 1996, GENITOURIN MED, V72, P27; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2010, JAMA-J AM MED ASSOC, V304, P194, DOI 10.1001/jama.2010.925; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Pantaleo G, 1996, ANNU REV MICROBIOL, V50, P825, DOI 10.1146/annurev.micro.50.1.825; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995; Walker Bruce D, 2007, Top HIV Med, V15, P134; Westrop SJ, 2011, INT J STD AIDS, V22, P690, DOI 10.1258/ijsa.2009.009045; Westrop SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005474; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	28	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e29844	10.1371/journal.pone.0029844	http://dx.doi.org/10.1371/journal.pone.0029844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363409	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500003
J	Bhaskara, VK; Mohanam, I; Rao, JS; Mohanam, S				Bhaskara, Vasantha Kumar; Mohanam, Indra; Rao, Jasti S.; Mohanam, Sanjeeva			Intermittent Hypoxia Regulates Stem-like Characteristics and Differentiation of Neuroblastoma Cells	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; TUMOR-CELLS; CANCER-CELLS; INDUCED DEDIFFERENTIATION; CYCLING HYPOXIA; GENE-EXPRESSION; SOLID TUMORS; REOXYGENATION; ANGIOGENESIS; HIF-1-ALPHA	Background: Neuroblastomas are the most common extracranial solid tumors in children. Neuroblastomas are derived from immature cells of the sympathetic nervous system and are characterized by clinical and biological heterogeneity. Hypoxia has been linked to tumor progression and increased malignancy. Intermittent hypoxia or repeated episodes of hypoxia followed by re-oxygenation is a common phenomenon in solid tumors including neuroblastoma and it has a significant influence on the outcome of therapies. The present study focuses on how intermittent hypoxia modulates the stem-like properties and differentiation in neuroblastoma cells. Methods and Findings: Cell survival was assessed by clonogenic assay and cell differentiation was determined by morphological characterization. Hypoxia-inducible genes were analyzed by real-time PCR and Western blotting. Immunofluorescence, real-time PCR and Western blotting were utilized to study stem cell markers. Analysis of neural crest / sympathetic nervous system (SNS) markers and neuronal differentiation markers were done by real-time PCR and Western blotting, respectively. Intermittent hypoxia stimulated the levels of HIF-1 alpha and HIF-2 alpha proteins and enhanced stem-like properties of neuroblastoma cells. In intermittent hypoxia-conditioned cells, downregulation of SNS marker genes and upregulation of genes expressed in the neural crest were observed. Intermittent hypoxia suppressed the retinoic acid-induced differentiation of neuroblastoma cells. Conclusions: Our results suggest that intermittent hypoxia enhances stem-like characteristics and suppresses differentiation propensities in neuroblastoma cells.	[Bhaskara, Vasantha Kumar; Mohanam, Indra; Rao, Jasti S.; Mohanam, Sanjeeva] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria	Bhaskara, VK (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	smohanam@uic.edu			National Cancer Institute [CA138466]; NATIONAL CANCER INSTITUTE [R01CA138466] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from the National Cancer Institute CA138466 to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinucci C, 2010, NEUROCHEM RES, V35, P1691, DOI 10.1007/s11064-010-0231-2; Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Cairns RA, 2001, CANCER RES, V61, P8903; Chang HH, 2010, CLIN CANCER RES, V16, P4411, DOI 10.1158/1078-0432.CCR-09-3360; Chaudary N, 2009, LAB INVEST, V89, P587, DOI 10.1038/labinvest.2009.16; Daneau G, 2010, CLIN CANCER RES, V16, P410, DOI 10.1158/1078-0432.CCR-09-0583; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dewhirst MW, 2007, CANCER RES, V67, P854, DOI 10.1158/0008-5472.CAN-06-4744; Dong Z, 2004, J BIOL CHEM, V279, P9215, DOI 10.1074/jbc.M312225200; Durand RE, 2001, ACTA ONCOL, V40, P929; Ezhilarasan R, 2009, INT J CANCER, V124, P306, DOI 10.1002/ijc.23951; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Grimmer MR, 2006, CURR OPIN PEDIATR, V18, P634, DOI 10.1097/MOP.0b013e32801080fe; Grynfeld A, 2000, INT J CANCER, V88, P401, DOI 10.1002/1097-0215(20001101)88:3<401::AID-IJC12>3.3.CO;2-M; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Holmquist L, 2005, INT J CANCER, V116, P218, DOI 10.1002/ijc.21024; Holmquist L, 2006, ADV EXP MED BIOL, V587, P179; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hsieh CH, 2010, ONCOL REP, V24, P1629, DOI 10.3892/or_00001027; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jogi A, 2003, CANCER LETT, V197, P145, DOI 10.1016/S0304-3835(03)00095-8; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Joshi S, 2007, BBA-MOL BASIS DIS, V1772, P1093, DOI 10.1016/j.bbadis.2007.05.009; Kim Y, 2009, CANCER RES, V69, P9271, DOI 10.1158/0008-5472.CAN-09-1605; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu YL, 2010, J CELL BIOCHEM, V111, P554, DOI 10.1002/jcb.22739; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Louie E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2773; Lu HM, 2009, FEBS J, V276, P7291, DOI 10.1111/j.1742-4658.2009.07441.x; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Malec V, 2010, FREE RADICAL BIO MED, V48, P1626, DOI 10.1016/j.freeradbiomed.2010.03.008; Maris JM, 2005, CURR OPIN PEDIATR, V17, P7, DOI 10.1097/01.mop.0000150631.60571.89; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; McPake CR, 1998, ONCOL RES, V10, P235; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nilsson MB, 2010, ONCOGENE, V29, P2938, DOI 10.1038/onc.2010.60; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Pietras A, 2008, J PATHOL, V214, P482, DOI 10.1002/path.2304; Reynolds CP, 2001, HEMATOL ONCOL CLIN N, V15, P867, DOI 10.1016/S0889-8588(05)70256-2; Rofstad EK, 2010, INT J CANCER, V127, P1535, DOI 10.1002/ijc.25176; Ross RA, 2007, SEMIN CANCER BIOL, V17, P241, DOI 10.1016/j.semcancer.2006.04.006; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Toffoli S, 2008, FEBS J, V275, P2991, DOI 10.1111/j.1742-4658.2008.06454.x; Toffoli S, 2007, BBA-MOL CELL RES, V1773, P1558, DOI 10.1016/j.bbamcr.2007.06.002; Tong QS, 2008, WORLD J PEDIATR, V4, P58, DOI 10.1007/s12519-008-0012-z; Weinmann M, 2004, FASEB J, V18, P1906, DOI 10.1096/fj.04-1918fje; Zamboni WC, 1998, J NATL CANCER I, V90, P505, DOI 10.1093/jnci/90.7.505; Zhao F, 2009, FREE RADICAL BIO MED, V47, P867, DOI 10.1016/j.freeradbiomed.2009.06.029	59	53	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30905	10.1371/journal.pone.0030905	http://dx.doi.org/10.1371/journal.pone.0030905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363512	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600085
J	Matthews, JE; Stephenson, R; Sullivan, PS				Matthews, Jonathan E.; Stephenson, Rob; Sullivan, Patrick S.			Factors Associated with Self-Reported HBV Vaccination among HIV-Negative MSM Participating in an Online Sexual Health Survey: A Cross-Sectional Study	PLOS ONE			English	Article							HEPATITIS-B VACCINATION; BEHAVIORAL SURVEILLANCE SYSTEM; YOUNG MEN; UNITED-STATES; TESTING BEHAVIORS; HOMOSEXUAL-MEN; INFECTION; RISK; IMMUNIZATION; POPULATION	Background: A substantial proportion of men who have sex with men (MSM) in the United States remain unvaccinated against hepatitis B. We sought to understand which factors are associated with vaccination among HIV-negative MSM. Methodology/Principal Findings: Data were from a 2010 web-based survey of adult MSM. We calculated the prevalence of self-reported hepatitis B vaccination among 1,052 HIV-negative or HIV-untested men who knew their hepatitis B vaccination status, and used multivariate logistic regression to determine associated factors. 679 (64.5%) MSM reported being vaccinated. Younger men were more likely to report being vaccinated than older men, and there was a significant interaction between age and history of hepatitis B testing. Men with at least some college education were at least 2.1 times as likely to be vaccinated as men with a high school education or less (95% CI = 1.4-3.1). Provider recommendation for vaccination (aOR = 4.2, 95% CI = 2.4-7.4) was also significantly associated with receipt of vaccination. Conclusions/Significance: Providers should assess sexual histories of male patients and offer those patients with male sex partners testing for hepatitis infection and vaccinate susceptible patients. There may be particular opportunities for screening and vaccination among older and more socioeconomically disadvantaged MSM.	[Matthews, Jonathan E.; Sullivan, Patrick S.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Stephenson, Rob] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Matthews, JE (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	pssulli@emory.edu	Stephenson, Rob/J-9876-2012	Sullivan, Patrick Sean/0000-0002-7728-0587	Emory Center for AIDS Research [P30 AI050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	Emory Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Emory Center for AIDS Research (http://www.sph.emory.edu/cms/departments_centers/centers/cfar/, P30 AI050409) [to RS and PSS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, MMWR Recomm Rep, V40, P1; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P215; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P33; Centers for Disease Control and Prevention (CDC), 1982, MMWR-MORBID MORTAL W, V31, P327; Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V31, P317; Choi KH, 2005, SEX TRANSM DIS, V32, P44, DOI 10.1097/01.olq.0000148296.93945.53; Davis CE, 1986, MODERN STAT METHODS, P140; Diamond C, 2003, SEX TRANSM DIS, V30, P425, DOI 10.1097/00007435-200305000-00009; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Gilbert LK, 2010, INT J STD AIDS, V21, P400, DOI 10.1258/ijsa.2009.009010; MacKellar DA, 2001, AM J PUBLIC HEALTH, V91, P965, DOI 10.2105/AJPH.91.6.965; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; MCCUSKER J, 1990, PUBLIC HEALTH REP, V105, P59; Neighbors K, 1999, J AM COLL HEALTH, V47, P173, DOI 10.1080/07448489909595643; Rhodes SD, 2000, SEX TRANSM INFECT, V76, P408, DOI 10.1136/sti.76.5.408-a; Rhodes SD, 2002, AIDS PATIENT CARE ST, V16, P519, DOI 10.1089/108729102761041074; Rhodes SD, 2001, AM J MED, V110, P628, DOI 10.1016/S0002-9343(01)00706-9; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; SCHREEDER MT, 1982, J INFECT DIS, V146, P7, DOI 10.1093/infdis/146.1.7; Siconolfi DE, 2009, AM J MENS HEALTH, V3, P141, DOI 10.1177/1557988308315151; SILVESTRE AJ, 1993, AM J PUBLIC HEALTH, V83, P578, DOI 10.2105/AJPH.83.4.578; SZMUNESS W, 1975, ANN INTERN MED, V83, P489, DOI 10.7326/0003-4819-83-4-489; Wall Kristin M, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P284, DOI 10.1177/1545109710379051; Weinbaum CM, 2008, AM J PUBLIC HEALTH, V98, P839, DOI 10.2105/AJPH.2006.101915; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	25	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30609	10.1371/journal.pone.0030609	http://dx.doi.org/10.1371/journal.pone.0030609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363453	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600040
J	Braunschweig, M; Jagannathan, V; Gutzwiller, A; Bee, G				Braunschweig, Martin; Jagannathan, Vidhya; Gutzwiller, Andreas; Bee, Giuseppe			Investigations on Transgenerational Epigenetic Response Down the Male Line in F2 Pigs	PLOS ONE			English	Article							GENE-EXPRESSION; DNA METHYLATION; INHERITANCE; ALLELE	We investigated the nutritional effects on carcass traits, gene expression and DNA methylation in a three generation Large White pig feeding experiment. A group of experimental (E) F0 boars were fed a standard diet supplemented with high amounts of methylating micronutrients whereas a control group (C) of F0 boars received a standard diet. These differentially fed F0 boars sired F1 boars which then sired 60 F2 pigs. Carcass traits were compared between 36 F2 descendants of E F0 boars and 24 F2 descendants of C F0 boars. The two F2 offspring groups differed with respect to backfat percentage (P = 0.03) and tended to differ with respect to adipose tissue (P = 0.09), fat thickness at the 10th rib (P = 0.08) and at the croup (P = 0.09) as well as percentages of shoulder (P = 0.07). Offspring from the experimental F0 boars had a higher percentage of shoulder and were leaner compared to the control group. Gene expression profiles showed significant twofold differences in mRNA level between 8 C F2 offspring and 8 E F2 offspring for 79, 64 and 53 genes for muscle, liver and kidney RNA, respectively. We found that in liver and muscle respective pathways of lipid metabolism and metabolic pathway were over-represented for the differentially expressed genes between these groups. A DNA methylation analysis in promoters of differentially expressed genes indicated a significant difference in DNA methylation at the IYD gene. If these responses on carcass traits, gene expression and DNA methylation withstand verification and can indeed be attributed to transgenerational epigenetic inheritance, it would open up pioneering application in pork production and would have implications for human health.	[Braunschweig, Martin; Jagannathan, Vidhya] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Gutzwiller, Andreas; Bee, Giuseppe] Agroscope Liebefeld Posieux, Fed Res Stn Anim Prod, Posieux, Switzerland	University of Bern; Swiss Federal Research Station Agroscope	Braunschweig, M (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	martin.braunschweig@vetsuisse.unibe.ch	Jagannathan, Vidhya/P-1055-2019	Jagannathan, Vidhya/0000-0002-8155-0041	European Commission [FOOD-CT-2006-016250]	European Commission(European CommissionEuropean Commission Joint Research Centre)	These results are part of the SABRE research project that has been co-financed by the European Commission, within the 6th Framework Programme, contract No. FOOD-CT-2006-016250. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The text represents the authors' views and does not necessarily represent a position of the Commission, who will not be liable for the use made of such information.	ALP (Agroscope Liebefeld-Posieux), 2005, APP AL REC TABL VAL; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Baker DH, 2006, J NUTR, V136, p1670S, DOI 10.1093/jn/136.6.1670S; Bee G, 2004, J ANIM SCI, V82, P826; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Braunschweig MH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-47; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gutzwiller A, 2009, VET REC, V165, P598, DOI 10.1136/vr.165.20.598; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; National Research Council (NRC), 1987, VIT TOL AN; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	28	81	84	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30583	10.1371/journal.pone.0030583	http://dx.doi.org/10.1371/journal.pone.0030583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359544	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200013
J	Sabat, R; Chanwangpong, A; Schneider-Burrus, S; Metternich, D; Kokolakis, G; Kurek, A; Philipp, S; Uribe, D; Wolk, K; Sterry, W				Sabat, Robert; Chanwangpong, Akewit; Schneider-Burrus, Sylke; Metternich, Deborah; Kokolakis, Georgios; Kurek, Agata; Philipp, Sandra; Uribe, Daniela; Wolk, Kerstin; Sterry, Wolfram			Increased Prevalence of Metabolic Syndrome in Patients with Acne Inversa	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; HIDRADENITIS SUPPURATIVA; CARDIOVASCULAR-DISEASE; PSORIASIS; RISK; KERATINOCYTES; INFLIXIMAB; ADALIMUMAB; PRECURSOR; IMMUNITY	Background: Acne inversa (AI; also designated as Hidradenitis suppurativa) is a common chronic inflammatory skin disease, localized in the axillary, inguinal and perianal skin areas that causes painful, fistulating sinuses with malodorous purulence and scars. Several chronic inflammatory diseases are associated with the metabolic syndrome and its consequences including arteriosclerosis, coronary heart disease, myocardial infraction, and stroke. So far, the association of AI with systemic metabolic alterations is largely unexplored. Methods and Findings: A hospital-based case-control study in 80 AI patients and 100 age- and sex-matched control participants was carried out. The prevalence of central obesity (odds ratio 5.88), hypertriglyceridemia (odds ratio 2.24), hypo-HDL-cholesterolemia (odds ratio 4.56), and hyperglycemia (odds ratio 4.09) in AI patients was significantly higher than in controls. Furthermore, the metabolic syndrome, previously defined as the presence of at least three of the five alterations listed above, was more common in those patients compared to controls (40.0% versus 13.0%; odds ratio 4.46, 95% confidence interval 2.02 to 9.96; P < 0.001). AI patients with metabolic syndrome also had more pronounced metabolic alterations than controls with metabolic syndrome. Interestingly, there was no correlation between the severity or duration of the disease and the levels of respective parameters or the number of criteria defining the metabolic syndrome. Rather, the metabolic syndrome was observed in a disproportionately high percentage of young AI patients. Conclusions: This study shows for the first time that AI patients have a high prevalence of the metabolic syndrome and all of its criteria. It further suggests that the inflammation present in AI patients does not have a major impact on the development of metabolic alterations. Instead, evidence is given for a role of metabolic alterations in the development of AI. We recommend monitoring of AI patients in order to correct their modifiable cardiovascular risk factors.	[Sabat, Robert; Chanwangpong, Akewit; Schneider-Burrus, Sylke; Kurek, Agata; Uribe, Daniela; Sterry, Wolfram] Univ Hosp Charite, Dept Dermatol & Allergy, Berlin, Germany; [Sabat, Robert; Metternich, Deborah; Kokolakis, Georgios; Philipp, Sandra; Wolk, Kerstin] Univ Hosp Charite, Interdisciplinary Grp Mol Immunopathol, Berlin, Germany; [Sabat, Robert; Kokolakis, Georgios; Philipp, Sandra; Wolk, Kerstin] Univ Hosp Charite, Psoriasis Res & Treatment Ctr, Dept Dermatol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sabat, R (corresponding author), Univ Hosp Charite, Dept Dermatol & Allergy, Berlin, Germany.	robert.sabat@charite.de	Wolk, Kerstin/O-1205-2013	Kokolakis, Georgios/0000-0002-8042-7885; Wolk, Kerstin/0000-0002-7689-4130				Alikhan A, 2009, J AM ACAD DERMATOL, V60, P539, DOI 10.1016/j.jaad.2008.11.911; Arenbergerova M, 2010, INT J DERMATOL, V49, P1445, DOI 10.1111/j.1365-4632.2010.04638.x; Bieniek A, 2010, DERMATOL SURG, V36, P1998, DOI 10.1111/j.1524-4725.2010.01763.x; Boehncke WH, 2009, J DTSCH DERMATOL GES; Chung CP, 2008, ATHEROSCLEROSIS, V196, P756, DOI 10.1016/j.atherosclerosis.2007.01.004; Cohen AD, 2008, DERMATOLOGY, V216, P152, DOI 10.1159/000111512; Dziurla R, 2010, IMMUNOL LETT, V131, P97, DOI 10.1016/j.imlet.2010.02.008; Esmann S, 2011, ACTA DERM VENEREOL; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gener G, 2009, DERMATOLOGY, V219, P148, DOI 10.1159/000228334; Gisondi P, 2007, BRIT J DERMATOL, V157, P68, DOI 10.1111/j.1365-2133.2007.07986.x; Grant A, 2010, J AM ACAD DERMATOL, V62, P205, DOI 10.1016/j.jaad.2009.06.050; Harde V, 2009, J DTSCH DERMATOL GES, V7, P139, DOI 10.1111/j.1610-0387.2008.06918.x; Haslund P, 2009, ACTA DERM-VENEREOL, V89, P595, DOI 10.2340/00015555-0747; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Jemec GBE, 1996, J AM ACAD DERMATOL, V35, P191, DOI 10.1016/S0190-9622(96)90321-7; Kurzen H, 2008, EXP DERMATOL, V17, P455, DOI [10.1111/j.1600-0625.2008.00712.x, 10.1111/j.1600-0625.2008.00712_1.x]; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Love TJ, 2010, ARCH DERMATOL; Matusiak L, 2010, ACTA DERM-VENEREOL, V90, P264, DOI 10.2340/00015555-0866; Meixner D, 2008, J DTSCH DERMATOL GES, V6, P189, DOI 10.1111/j.1610-0387.2007.06492.x; Mekkes JR, 2008, BRIT J DERMATOL, V158, P370, DOI 10.1111/j.1365-2133.2007.08332.x; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Revuz JE, 2008, J AM ACAD DERMATOL, V59, P596, DOI 10.1016/j.jaad.2008.06.020; Rompel R, 2000, DERMATOL SURG, V26, P638, DOI 10.1046/j.1524-4725.2000.00043.x; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001; Sartorius K, 2009, BRIT J DERMATOL, V161, P831, DOI 10.1111/j.1365-2133.2009.09198.x; van Rappard DC, 2011, J EUR ACAD DERMATOL; von Laffert M, 2011, BRIT J DERMATOL, V164, P367, DOI 10.1111/j.1365-2133.2010.10034.x; von Laffert M, 2010, EXP DERMATOL, V19, P533, DOI 10.1111/j.1600-0625.2009.00915.x; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Wegenka UM, 2010, CYTOKINE GROWTH F R, V21, P353, DOI 10.1016/j.cytogfr.2010.08.001; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2011, J IMMUNOL, V186, P1228, DOI 10.4049/jimmunol.0903907; Wolk K, 2009, EUR J IMMUNOL, V39, P3570, DOI 10.1002/eji.200939687; 2001, JAMA, V285, P2486	41	154	156	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31810	10.1371/journal.pone.0031810	http://dx.doi.org/10.1371/journal.pone.0031810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359634	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200103
J	Valtonen, TM; Kangassalo, K; Polkki, M; Rantala, MJ				Valtonen, Terhi M.; Kangassalo, Katariina; Polkki, Mari; Rantala, Markus J.			Transgenerational Effects of Parental Larval Diet on Offspring Development Time, Adult Body Size and Pathogen Resistance in Drosophila melanogaster	PLOS ONE			English	Article							MATING SUCCESS; LIFE-HISTORY; EGG SIZE; GENERATION; EVOLUTION; TRAITS; ENVIRONMENT; MECHANISMS; NUTRITION; BENEFITS	Environmental conditions experienced by parents are increasingly recognized to affect offspring performance. We set out to investigate the effect of parental larval diet on offspring development time, adult body size and adult resistance to the bacterium Serratia marcescens in Drosophila melanogaster. Flies for the parental generation were raised on either poor or standard diet and then mated in the four possible sex-by-parental diet crosses. Females that were raised on poor food produced larger offspring than females that were raised on standard food. Furthermore, male progeny sired by fathers that were raised on poor food were larger than male progeny sired by males raised on standard food. Development times were shortest for offspring whose one parent (mother or the father) was raised on standard and the other parent on poor food and longest for offspring whose parents both were raised on poor food. No evidence for transgenerational effects of parental diet on offspring disease resistance was found. Although paternal effects have been previously demonstrated in D. melanogaster, no earlier studies have investigated male-mediated transgenerational effects of diet in this species. The results highlight the importance of not only considering the relative contribution each parental sex has on progeny performance but also the combined effects that the two sexes may have on offspring performance.	[Valtonen, Terhi M.; Kangassalo, Katariina; Polkki, Mari; Rantala, Markus J.] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland	University of Turku	Valtonen, TM (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	terval@utu.fi			Finnish Cultural Foundation; Academy of Finland	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland)	This study was supported by the Finnish Cultural Foundation to TMV and by the Academy of Finland to MJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2004, ANIM BEHAV, V68, P1443, DOI 10.1016/j.anbehav.2004.05.005; Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; Andersen LH, 2010, J INSECT PHYSIOL, V56, P336, DOI 10.1016/j.jinsphys.2009.11.006; Azevedo RBR, 1997, AM NAT, V150, P250, DOI 10.1086/286065; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; Bonduriansky R, 2007, J EVOLUTION BIOL, V20, P2379, DOI 10.1111/j.1420-9101.2007.01419.x; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Bubli OA, 1998, EVOLUTION, V52, P619, DOI [10.2307/2411097, 10.1111/j.1558-5646.1998.tb01661.x]; Bubliy OA, 2000, HEREDITAS, V133, P59, DOI 10.1111/j.1601-5223.2000.00059.x; Burger JMS, 2007, AGING CELL, V6, P63, DOI 10.1111/j.1474-9726.2006.00261.x; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Crill WD, 1996, EVOLUTION, V50, P1205, DOI [10.2307/2410661, 10.1111/j.1558-5646.1996.tb02361.x]; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Devevey G, 2010, FUNCT ECOL, V24, P178, DOI 10.1111/j.1365-2435.2009.01609.x; Donelson JM, 2009, BIOL LETTERS, V5, P262, DOI 10.1098/rsbl.2008.0642; DUSSOURD DE, 1988, P NATL ACAD SCI USA, V85, P5992, DOI 10.1073/pnas.85.16.5992; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Friberg U, 2012, BIOL LETTERS, V8, P71, DOI 10.1098/rsbl.2011.0608; Fricke C, 2010, J EVOLUTION BIOL, V23, P157, DOI 10.1111/j.1420-9101.2009.01882.x; Frost PC, 2010, OECOLOGIA, V162, P865, DOI 10.1007/s00442-009-1517-4; Garcia-Gonzalez F, 2005, J EVOLUTION BIOL, V18, P1097, DOI 10.1111/j.1420-9101.2005.00889.x; Garcia-Gonzalez F, 2007, CURR BIOL, V17, P32, DOI 10.1016/j.cub.2006.10.054; GIESEL JT, 1988, EVOLUTION, V42, P1348, DOI 10.1111/j.1558-5646.1988.tb04194.x; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Grech K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-130; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Guzman-Novoa E, 2005, J HERED, V96, P376, DOI 10.1093/jhered/esi038; HUEY RB, 1995, HEREDITY, V74, P216, DOI 10.1038/hdy.1995.30; Hunt J, 2000, EVOLUTION, V54, P936, DOI 10.1111/j.0014-3820.2000.tb00093.x; Ivy TM, 2007, J EVOLUTION BIOL, V20, P479, DOI 10.1111/j.1420-9101.2006.01269.x; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Joshi A, 2004, J GENET, V83, P13, DOI 10.1007/BF02715824; KARR TL, 1991, MECH DEVELOP, V34, P101, DOI 10.1016/0925-4773(91)90047-A; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Lazzaro BP, 2006, GENETICS, V174, P1539, DOI 10.1534/genetics.105.054593; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Loppin B, 2005, CURR BIOL, V15, P87, DOI 10.1016/j.cub.2004.12.071; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; Magiafoglou A, 2003, FUNCT ECOL, V17, P664, DOI 10.1046/j.1365-2435.2003.00774.x; MARKOW TA, 1984, SCIENCE, V224, P302, DOI 10.1126/science.224.4646.302; McGraw LA, 2007, BIOL LETTERS, V3, P607, DOI 10.1098/rsbl.2007.0334; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Miller CW, 2007, P ROY SOC B-BIOL SCI, V274, P1279, DOI 10.1098/rspb.2006.0413; Miller GA, 2009, BIOL LETTERS, V5, P845, DOI 10.1098/rsbl.2009.0495; Mitchell SE, 2005, P ROY SOC B-BIOL SCI, V272, P2601, DOI 10.1098/rspb.2005.3253; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; PARTRIDGE L, 1987, ANIM BEHAV, V35, P468, DOI 10.1016/S0003-3472(87)80272-5; PARTRIDGE L, 1987, ANIM BEHAV, V35, P555, DOI 10.1016/S0003-3472(87)80281-6; PARTRIDGE L, 1983, ANIM BEHAV, V31, P871, DOI 10.1016/S0003-3472(83)80242-5; PARTRIDGE L, 1993, EVOLUTION, V47, P213, DOI 10.1111/j.1558-5646.1993.tb01211.x; Pischedda A, 2011, P ROY SOC B-BIOL SCI, V278, P2165, DOI 10.1098/rspb.2010.2272; Prasad NG, 2003, EVOL ECOL RES, V5, P903; RIDLEY M, 1978, ANIM BEHAV, V26, P904, DOI 10.1016/0003-3472(78)90156-2; Roff Derek, 2002, pi; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Roth O, 2010, J ANIM ECOL, V79, P403, DOI 10.1111/j.1365-2656.2009.01617.x; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; SANTOS M, 1988, HEREDITY, V61, P255, DOI 10.1038/hdy.1988.113; Smedley SR, 1996, P NATL ACAD SCI USA, V93, P809, DOI 10.1073/pnas.93.2.809; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Smith EM, 2007, J NUTR, V137, P2006, DOI 10.1093/jn/137.9.2006; Taborsky B, 2006, P ROY SOC B-BIOL SCI, V273, P741, DOI 10.1098/rspb.2005.3347; TALLAMY DW, 1984, BIOSCIENCE, V34, P20, DOI 10.2307/1309421; Valtonen TM, 2011, J EVOLUTION BIOL, V24, P196, DOI 10.1111/j.1420-9101.2010.02157.x; Valtonen TM, 2010, EVOL BIOL, V37, P49, DOI 10.1007/s11692-009-9078-3; Vijendravarma RK, 2010, BIOL LETTERS, V6, P238, DOI 10.1098/rsbl.2009.0754; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; WATSON MJO, 1995, AUST J ZOOL, V43, P51, DOI 10.1071/ZO9950051; Wenzel U, 2006, GENES NUTR, V1, P85, DOI 10.1007/BF02829950; West-Eberhard Mary Jane, 2003, pi; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; ZEH DW, 1985, AM ZOOL, V25, P785	81	69	71	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31611	10.1371/journal.pone.0031611	http://dx.doi.org/10.1371/journal.pone.0031611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359607	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200076
J	De Franceschi, L; Scardoni, G; Tomelleri, C; Danek, A; Walker, RH; Jung, HH; Bader, B; Mazzucco, S; Dotti, MT; Siciliano, A; Pantaleo, A; Laudanna, C				De Franceschi, Lucia; Scardoni, Giovanni; Tomelleri, Carlo; Danek, Adrian; Walker, Ruth H.; Jung, Hans H.; Bader, Benedikt; Mazzucco, Sara; Dotti, Maria Teresa; Siciliano, Angela; Pantaleo, Antonella; Laudanna, Carlo			Computational Identification of Phospho-Tyrosine Sub-Networks Related to Acanthocyte Generation in Neuroacanthocytosis	PLOS ONE			English	Article							ANION TRANSPORT ACTIVITY; CHOREA-ACANTHOCYTOSIS; BIOLOGICAL NETWORKS; MCLEOD-SYNDROME; GENE ONTOLOGY; PROTEIN; MEMBRANE; CYTOSCAPE; PHOSPHORYLATION; ORGANIZATION	Acanthocytes, abnormal thorny red blood cells (RBC), are one of the biological hallmarks of neuroacanthocytosis syndromes (NA), a group of rare hereditary neurodegenerative disorders. Since RBCs are easily accessible, the study of acanthocytes in NA may provide insights into potential mechanisms of neurodegeneration. Previous studies have shown that changes in RBC membrane protein phosphorylation state affect RBC membrane mechanical stability and morphology. Here, we coupled tyrosine-phosphoproteomic analysis to topological network analysis. We aimed to predict signaling sub-networks possibly involved in the generation of acanthocytes in patients affected by the two core NA disorders, namely McLeod syndrome (MLS, XK-related, Xk protein) and chorea-acanthocytosis (ChAc, VPS13A-related, chorein protein). The experimentally determined phosphoproteomic data-sets allowed us to relate the subsequent network analysis to the pathogenetic background. To reduce the network complexity, we combined several algorithms of topological network analysis including cluster determination by shortest path analysis, protein categorization based on centrality indexes, along with annotation-based node filtering. We first identified XK- and VPS13A-related protein-protein interaction networks by identifying all the interactomic shortest paths linking Xk and chorein to the corresponding set of proteins whose tyrosine phosphorylation was altered in patients. These networks include the most likely paths of functional influence of Xk and chorein on phosphorylated proteins. We further refined the analysis by extracting restricted sets of highly interacting signaling proteins representing a common molecular background bridging the generation of acanthocytes in MLS and ChAc. The final analysis pointed to a novel, very restricted, signaling module of 14 highly interconnected kinases, whose alteration is possibly involved in generation of acanthocytes in MLS and ChAc.	[De Franceschi, Lucia; Tomelleri, Carlo; Siciliano, Angela] Univ Verona, Dept Med, I-37100 Verona, Italy; [Scardoni, Giovanni; Laudanna, Carlo] Univ Verona, Dept Pathol & Diag, I-37100 Verona, Italy; [Scardoni, Giovanni; Laudanna, Carlo] Univ Verona, Ctr Biomed Comp, I-37100 Verona, Italy; [Danek, Adrian; Bader, Benedikt] Klinicum Univ Munchen, Neurol Klin & Poliklin, Munich, Germany; [Walker, Ruth H.] James J Peters Vet Affairs Med Ctr, Dept Neurol, New York, NY USA; [Walker, Ruth H.] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Jung, Hans H.] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Mazzucco, Sara] Univ Verona, Dept Neurosci, I-37100 Verona, Italy; [Dotti, Maria Teresa] Univ Siena, Dept Neurol, I-53100 Siena, Italy; [Pantaleo, Antonella] Univ Turin, Dept Biol Mol & Med Chem, Turin, Italy	University of Verona; University of Verona; University of Verona; University of Hamburg; University Medical Center Hamburg-Eppendorf; Icahn School of Medicine at Mount Sinai; University of Zurich; University Zurich Hospital; University of Verona; University of Siena; University of Turin	De Franceschi, L (corresponding author), Univ Verona, Dept Med, I-37100 Verona, Italy.	lucia.defranceschi@univr.it	DE FRANCESCHI, Lucia/AAB-8652-2022; Pantaleo, Antonella/ABA-5190-2020; Danek, Adrian/G-7339-2011	DE FRANCESCHI, Lucia/0000-0001-7093-777X; Danek, Adrian/0000-0001-8857-5383	Telethon [GP07007]; Advocacy on Neuro-acanthocytosis; AIRC (Associazione Italiana per la Ricerca sul Cancro) e Fondazione Cariverona	Telethon(Fondazione Telethon); Advocacy on Neuro-acanthocytosis; AIRC (Associazione Italiana per la Ricerca sul Cancro) e Fondazione Cariverona(Fondazione AIRC per la ricerca sul cancro)	Grants from Telethon grant (GP07007, LDF) and Advocacy on Neuro-acanthocytosis (LDF, AD, BB, RW) and AIRC (Associazione Italiana per la Ricerca sul Cancro) e Fondazione Cariverona (CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittokallio T, 2006, BRIEF BIOINFORM, V7, P243, DOI 10.1093/bib/bbl022; Bader B, 2011, MOVEMENT DISORD, V25, P127; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Brunati AM, 2000, BLOOD, V96, P1550, DOI 10.1182/blood.V96.4.1550.h8001550_1550_1557; Candiano G, 2002, ELECTROPHORESIS, V23, P292, DOI 10.1002/1522-2683(200202)23:2<292::AID-ELPS292>3.0.CO;2-5; Chautard E, 2009, PATHOL BIOL, V57, P324, DOI 10.1016/j.patbio.2008.10.004; Chiarugi P, 2000, J BIOL CHEM, V275, P4640, DOI 10.1074/jbc.275.7.4640; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Danek A, 2005, CURR OPIN NEUROL, V18, P386, DOI 10.1097/01.wco.0000173464.01888.e9; Danek A, 2005, J NEUROL SCI, V229, P171, DOI 10.1016/j.jns.2004.11.024; De Franceschi L, 1998, EXP HEMATOL, V26, P869; de Franceschi L, 2008, NEUROACANTHOCYTOSIS, VII; De Franceschi L, 2011, BLOOD, V118, P5652, DOI 10.1182/blood-2011-05-355339; De Franceschi L, 2008, PROTEOMICS, V8, P4695, DOI 10.1002/pmic.200700596; Dijkstra E, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dobson-Stone C, 2004, ANN NEUROL, V56, P299, DOI 10.1002/ana.20200; Dobson-Stone C, 2002, EUR J HUM GENET, V10, P773, DOI 10.1038/sj.ejhg.5200866; Faggioni G, 2006, MOL CELL PROBE, V20, P27, DOI 10.1016/j.mcp.2005.08.003; Gan JJ, 2011, NEUROLOGY, V76, pA590; Hsu KL, 2009, INT J BIOCHEM CELL B, V41, P1536, DOI 10.1016/j.biocel.2008.12.016; Jung HH, 2001, ANN NEUROL, V49, P384, DOI 10.1002/ana.76; Kalfa TA, 2006, BLOOD, V108, P3637, DOI 10.1182/blood-2006-03-005942; Karur VG, 2006, BLOOD, V108, P1524, DOI 10.1182/blood-2005-09-008243; Kruger M, 2011, J BIOL CHEM; Kwoh CK, 2007, CELL MOL LIFE SCI, V64, P1739, DOI 10.1007/s00018-007-7053-7; Li XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S3; Ma'ayan A, 2009, J BIOL CHEM, V284, P5451, DOI 10.1074/jbc.R800056200; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; OLIVIERI O, 1994, BLOOD, V84, P315; Olivieri O, 1997, HAEMATOLOGICA, V82, P648; Pantaleo A, 2010, J PROTEOMICS, V73, P445, DOI 10.1016/j.jprot.2009.08.011; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Pasini EM, 2010, J PROTEOMICS, V73, P403, DOI 10.1016/j.jprot.2009.06.005; Pasini EM, 2010, J PROTEOMICS, V73, P421, DOI 10.1016/j.jprot.2009.07.004; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pieroni E, 2008, PROTEOMICS, V8, P799, DOI 10.1002/pmic.200700767; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Rampoldi L, 2002, J MOL MED-JMM, V80, P475, DOI 10.1007/s00109-002-0349-z; Rubio JP, 1997, AM J HUM GENET, V61, P899, DOI 10.1086/514876; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siciliano A, BLOOD CELLS MOL DIS, V44, P233; Walker RHSV, 2011, MOVEMENT DI IN PRESS; Walker RH, 2007, MOVEMENT DISORD, V22, P244, DOI 10.1002/mds.21224; Walker RH, 2007, TRANSFUSION, V47, P299, DOI 10.1111/j.1537-2995.2007.01106.x; Walker RH, 2006, MOVEMENT DISORD, V21, P1794, DOI 10.1002/mds.21108; zurHausen JD, 1997, EUR J IMMUNOL, V27, P2643, DOI 10.1002/eji.1830271025	49	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31015	10.1371/journal.pone.0031015	http://dx.doi.org/10.1371/journal.pone.0031015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355334	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000302741300034
J	McCluskey, AJ; Bolewska-Pedyczak, E; Jarvik, N; Chen, G; Sidhu, SS; Gariepy, J				McCluskey, Andrew J.; Bolewska-Pedyczak, Eleonora; Jarvik, Nick; Chen, Gang; Sidhu, Sachdev S.; Gariepy, Jean			Charged and Hydrophobic Surfaces on the A Chain of Shiga-Like Toxin 1 Recognize the C-Terminal Domain of Ribosomal Stalk Proteins	PLOS ONE			English	Article							N-GLYCOSIDASE ACTIVITY; ESCHERICHIA-COLI O157-H7; GTPASE-ASSOCIATED CENTER; RICIN A-CHAIN; SACCHAROMYCES-CEREVISIAE; P-PROTEINS; ENDOPLASMIC-RETICULUM; SHIGELLA-DYSENTERIAE; STRUCTURAL-CHARACTERIZATION; INACTIVATING PROTEIN	Shiga-like toxins are ribosome-inactivating proteins (RIP) produced by pathogenic E. coli strains that are responsible for hemorrhagic colitis and hemolytic uremic syndrome. The catalytic A(1) chain of Shiga-like toxin 1 (SLT-1), a representative RIP, first docks onto a conserved peptide SD[D/E]DMGFGLFD located at the C-terminus of all three eukaryotic ribosomal stalk proteins and halts protein synthesis through the depurination of an adenine base in the sarcin-ricin loop of 28S rRNA. Here, we report that the A(1) chain of SLT-1 rapidly binds to and dissociates from the C-terminal peptide with a monomeric dissociation constant of 13 mu M. An alanine scan performed on the conserved peptide revealed that the SLT-1 A(1) chain interacts with the anionic tripeptide DDD and the hydrophobic tetrapeptide motif FGLF within its sequence. Based on these 2 peptide motifs, SLT-1 A(1) variants were generated that displayed decreased affinities for the stalk protein C-terminus and also correlated with reduced ribosome-inactivating activities in relation to the wild-type A(1) chain. The toxin-peptide interaction and subsequent toxicity were shown to be mediated by cationic and hydrophobic docking surfaces on the SLT-1 catalytic domain. These docking surfaces are located on the opposite face of the catalytic cleft and suggest that the docking of the A(1) chain to SDDDMGFGLFD may reorient its catalytic domain to face its RNA substrate. More importantly, both the delineated A(1) chain ribosomal docking surfaces and the ribosomal peptide itself represent a target and a scaffold, respectively, for the design of generic inhibitors to block the action of RIPs.	[McCluskey, Andrew J.; Gariepy, Jean] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Bolewska-Pedyczak, Eleonora; Gariepy, Jean] Sunnybrook Res Inst, Toronto, ON, Canada; [Jarvik, Nick; Chen, Gang; Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Gariepy, Jean] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto	McCluskey, AJ (corresponding author), Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada.	gariepy@sri.utoronto.ca		Chen, Gang/0000-0002-6304-9173	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This project was supported by an operation grant to J.G. from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayub MJ, 2008, BIOCHEM BIOPH RES CO, V369, P314, DOI 10.1016/j.bbrc.2008.01.170; Bai Y, 2010, TOXICON, V56, P526, DOI 10.1016/j.toxicon.2010.05.009; Bargis-Surgey P, 1999, EUR J BIOCHEM, V262, P606, DOI 10.1046/j.1432-1327.1999.00434.x; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Brigotti M, 1997, TOXICON, V35, P1431, DOI 10.1016/S0041-0101(96)00225-5; Chan DSB, 2007, NUCLEIC ACIDS RES, V35, P1660, DOI 10.1093/nar/gkm065; Chan SH, 2001, EUR J BIOCHEM, V268, P2107, DOI 10.1046/j.1432-1327.2001.02091.x; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; Datta PP, 2005, MOL CELL, V20, P723, DOI 10.1016/j.molcel.2005.10.028; Di R, 2011, TOXICON, V57, P525, DOI 10.1016/j.toxicon.2010.12.006; Endo Y, 1988, Nucleic Acids Symp Ser, P139; ENDO Y, 1988, J BIOL CHEM, V263, P8735; ENDO Y, 1987, J BIOL CHEM, V262, P5908; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Frank C, 2011, N ENGL J MED; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; GARRED O, 1995, J BIOL CHEM, V270, P10817; Gonzalo P, 2001, J BIOL CHEM, V276, P19762, DOI 10.1074/jbc.M101398200; Grela P, 2007, BIOCHEMISTRY-US, V46, P1988, DOI 10.1021/bi0616450; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Helgstrand M, 2007, J MOL BIOL, V365, P468, DOI 10.1016/j.jmb.2006.10.025; HOVDE CJ, 1988, P NATL ACAD SCI USA, V85, P2568, DOI 10.1073/pnas.85.8.2568; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; JACKSON MP, 1987, FEMS MICROBIOL LETT, V44, P109, DOI 10.1016/0378-1097(87)90210-2; Johannes L, 1998, TRENDS CELL BIOL, V8, P158, DOI 10.1016/S0962-8924(97)01209-9; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; Korennykh AV, 2007, RNA, V13, P1391, DOI 10.1261/rna.619707; Korennykh AV, 2006, NAT STRUCT MOL BIOL, V13, P436, DOI 10.1038/nsmb1082; KOZLOV YV, 1993, J MOL BIOL, V232, P704, DOI 10.1006/jmbi.1993.1421; Krokowski D, 2006, MOL MICROBIOL, V60, P386, DOI 10.1111/j.1365-2958.2006.05117.x; Kupferschmidt K, 2011, SCIENCE, V333, P27, DOI 10.1126/science.333.6038.27; LaPointe P, 2005, J BIOL CHEM, V280, P23310, DOI 10.1074/JBC.m414193200; Lea N, 1999, MICROBIOL-UK, V145, P999, DOI 10.1099/13500872-145-5-999; Li XP, 2010, J BIOL CHEM, V285, P41463, DOI 10.1074/jbc.M110.171793; Li XP, 2009, BIOCHEMISTRY-US, V48, P3853, DOI 10.1021/bi802371h; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; McCluskey AJ, 2008, J MOL BIOL, V378, P375, DOI 10.1016/j.jmb.2008.02.014; McCluskey AJ, 2007, PROTEIN SCI, V16, P2726, DOI 10.1110/ps.072894407; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; MONTANARO L, 1975, BIOCHEM J, V146, P127, DOI 10.1042/bj1460127; Naganuma T, 2007, GENES CELLS, V12, P501, DOI 10.1111/j.1365-2443.2007.01067.x; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; Pang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017883; Perez-Fernandez J, 2005, BIOCHEMISTRY-US, V44, P5532, DOI 10.1021/bi047332r; Qin SB, 2009, P NATL ACAD SCI USA, V106, P6974, DOI 10.1073/pnas.0900291106; RILEY LW, 1987, ANNU REV MICROBIOL, V41, P383, DOI 10.1146/annurev.micro.41.1.383; Roxas-Duncan V, 2009, ANTIMICROB AGENTS CH, V53, P3478, DOI 10.1128/AAC.00141-09; Santos C, 2005, MOL MICROBIOL, V58, P217, DOI 10.1111/j.1365-2958.2005.04816.x; Sturm MB, 2009, ANAL CHEM, V81, P2847, DOI 10.1021/ac8026433; Tam PJ, 2007, MICROBIOL-SGM, V153, P2700, DOI 10.1099/mic.0.2007/006858-0; Tchorzewski M, 2000, INT J BIOCHEM CELL B, V32, P737, DOI 10.1016/S1357-2725(00)00017-0; Tchorzewski M, 2003, BIOCHEMISTRY-US, V42, P3399, DOI 10.1021/bi0206006; Too PHM, 2009, NUCLEIC ACIDS RES, V37, P602, DOI 10.1093/nar/gkn922; Voelker R, 2011, JAMA-J AM MED ASSOC, V306, P29, DOI 10.1001/jama.2011.889; YAMASAKI S, 1991, MICROB PATHOGENESIS, V11, P1, DOI 10.1016/0882-4010(91)90088-R; Yang YH, 2010, J MOL BIOL, V395, P897, DOI 10.1016/j.jmb.2009.10.051	60	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31191	10.1371/journal.pone.0031191	http://dx.doi.org/10.1371/journal.pone.0031191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355345	gold, Green Published, Green Submitted			2022-12-25	WOS:000302741300045
J	Ortiz-Pelaez, A; Ashenafi, G; Roger, F; Waret-Szkuta, A				Ortiz-Pelaez, Angel; Ashenafi, Getaneh; Roger, Francois; Waret-Szkuta, Agnes			Can Geographical Factors Determine the Choices of Farmers in the Ethiopian Highlands to Trade in Livestock Markets?	PLOS ONE			English	Article							SOCIAL NETWORKS; MOUTH-DISEASE; EXPONENTIAL FAMILY; GREAT-BRITAIN; MARKOV GRAPHS; MODELS; WATER; SHEEP	Proximity and affiliation to the local market appear to be two of the most relevant factors to explain farmer's choices to select a particular trading point. Physical barriers may limit the options, especially in developing countries. A network of villages linked by traders/farmer-traders sharing livestock markets was built with field data collected in 75 villages from 8 kebelles in the Wassona Werna wereda of the Ethiopian Highlands. Two exponential random graph models were fitted with various geographical and demographic attributes of the nodes (dyadic independent model) and three internal network structures (dyadic dependent model). Several diagnostic methods were applied to assess the goodness of fit of the models. The odds of an edge where the distance to the main market Debre Behran and the difference in altitude between two connected villages are both large increases significantly so that villages far away from the main market and at different altitude are more likely to be linked in the network than randomly. The odds of forming an edge between two villages in Abamote or Gudoberet kebelles are approximately 75% lower than an edge between villages in any other kebelles (p<0.05). The conditional log-odds of two villages forming a tie that is not included in a triangle, a 2-star or a 3-star is extremely low, increasing the odds significantly (p<0.05) each time a node is in a 2-star structure and decreasing it when a node is in a 3-star (p<0.05) or in a triangle formation (p<0.05)), conditional on the rest of the network. Two major constraining factors, namely distance and altitude, are not deterrent for the potential contact of susceptible small ruminant populations in the Highlands of Ethiopia.	[Ashenafi, Getaneh] NVI, Debre Zeit, Ethiopia; [Roger, Francois] CIRAD, AGIRs Unit, Montpellier, France; [Waret-Szkuta, Agnes] Univ London Royal Vet Coll, Hawkshead, Herts, England	CIRAD; University of London; University of London Royal Veterinary College		angortpel@yahoo.com	Ortiz-Pelaez, Angel/I-8657-2014	ROGER, FRANCOIS/0000-0002-1573-6833; Waret-Szkuta, Agnes/0000-0002-6175-4418	EU [INCO-CT-2004-003670 RP/PPR MARKVAC]	EU(European Commission)	This study was carried out as part of the EU funded INCO-CT-2004-003670 RP/PPR MARKVAC project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklilu Y., 2002, AUDIT LIVESTOCK MARK, VI; Belachew H, 2005, ASSESSMENT LIVESTOCK; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Bronsvoort BMD, 2004, PREV VET MED, V66, P127, DOI 10.1016/j.prevetmed.2004.09.010; FAO, FAOTAT DAT; Fevre EM, 2001, LANCET, V358, P625, DOI 10.1016/S0140-6736(01)05778-6; FRANK O, 1986, J AM STAT ASSOC, V81, P832, DOI 10.2307/2289017; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Goodreau S., 2008, J STAT SOFTWARE, V24; Goodreau SM, 2009, DEMOGRAPHY, V46, P103, DOI 10.1353/dem.0.0045; Handcock M.S., 2008, J STAT SOFTWARE, V24; Handcock Mark S., 2003, STATNET SOFTWARE TOO; HOLLAND PW, 1981, J AM STAT ASSOC, V76, P33, DOI 10.2307/2287037; Hunter D. R., 2008, J STAT SOFTWARE, V24, DOI [10.18637/jss.v024.i08, DOI 10.18637/JSS.V024.I08]; Hunter DR, 2007, SOC NETWORKS, V29, P216, DOI 10.1016/j.socnet.2006.08.005; Kolaczyk ED, 2009, STAT ANAL NETWORK DA; Magalhaes RJS, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-10; Malm A, 2010, SECUR J, V23, P52, DOI 10.1057/sj.2009.18; Mansley LM, 2003, VET REC, V153, P43, DOI 10.1136/vr.153.2.43; MLCSL, 2010, LIV MARK 21 CENT REV; MUKASAMUGERWA E, 1995, SMALL RUMINANT RES, V17, P167, DOI 10.1016/0921-4488(95)00663-6; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Robins G, 2007, SOC NETWORKS, V29, P215; Robins G, 2007, SOC NETWORKS, V29, P192, DOI 10.1016/j.socnet.2006.08.003; Robinson SE, 2007, PREV VET MED, V81, P21, DOI 10.1016/j.prevetmed.2007.04.011; Snijders T. A. B., 2002, J SOCIAL STRUCTURE, V3, P2; Tibbo M., 2006, PRODUCTIVITY HLTH IN; Tranmer M, 2010, STAT MODELS SOCIAL N; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Van Kerkhove MD, 2009, VACCINE, V27, P6345, DOI 10.1016/j.vaccine.2009.05.004; Waret-Szkuta A, 2011, EPIDEMIOL INFECT, V139, P875, DOI 10.1017/S0950268810001718; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Wasserman S., 2005, MODELS METHODS SOCIA, P148, DOI DOI 10.1017/CBO9780511811395.008; Wasserman S., 1994, SOCIAL NETWORK ANAL	34	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30710	10.1371/journal.pone.0030710	http://dx.doi.org/10.1371/journal.pone.0030710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925DP	22355324	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300024
J	Manque, PA; Woehlbier, U; Lara, AM; Tenjo, F; Alves, JM; Buck, GA				Manque, Patricio A.; Woehlbier, Ute; Lara, Ana M.; Tenjo, Fernando; Alves, Joao M.; Buck, Gregory A.			Identification and Characterization of a Novel Calcium-Activated Apyrase from Cryptosporidium Parasites and Its Potential Role in Pathogenesis	PLOS ONE			English	Article							ECTO-ATPASE ACTIVITY; TRIPHOSPHATE DIPHOSPHOHYDROLASE ACTIVITIES; INTESTINAL EPITHELIAL-CELLS; TRYPANOSOMA-CRUZI; BIOCHEMICAL-CHARACTERIZATION; LEISHMANIA-AMAZONENSIS; EXTRACELLULAR ATP; PARVUM INFECTION; INSULIN-RECEPTOR; TYROSINE KINASE	Herein, we report the biochemical and functional characterization of a novel Ca2+-activated nucleoside diphosphatase (apyrase), CApy, of the intracellular gut pathogen Cryptosporidium. The purified recombinant CApy protein displayed activity, substrate specificity and calcium dependency strikingly similar to the previously described human apyrase, SCAN-1 (soluble calcium-activated nucleotidase 1). CApy was found to be expressed in both Cryptosporidium parvum oocysts and sporozoites, and displayed a polar localization in the latter, suggesting a possible co-localization with the apical complex of the parasite. In vitro binding experiments revealed that CApy interacts with the host cell in a dose-dependent fashion, implying the presence of an interacting partner on the surface of the host cell. Antibodies directed against CApy block Cryptosporidium parvum sporozoite invasion of HCT-8 cells, suggesting that CApy may play an active role during the early stages of parasite invasion. Sequence analyses revealed that the capy gene shares a high degree of homology with apyrases identified in other organisms, including parasites, insects and humans. Phylogenetic analysis argues that the capy gene is most likely an ancestral feature that has been lost from most apicomplexan genomes except Cryptosporidium, Neospora and Toxoplasma.	[Manque, Patricio A.; Woehlbier, Ute; Lara, Ana M.; Tenjo, Fernando; Alves, Joao M.; Buck, Gregory A.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Manque, Patricio A.; Woehlbier, Ute; Lara, Ana M.; Tenjo, Fernando; Alves, Joao M.; Buck, Gregory A.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Tenjo, Fernando] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Manque, PA (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	gabuck@vcu.edu	Alves, Joao M.P./G-8927-2011	Alves, Joao M.P./0000-0001-5914-2087; manque, patricio/0000-0002-6606-0896; Woehlbier, Ute/0000-0003-3114-9708	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U54 AI057168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant U54 AI057168 from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barros FS, 2000, ARCH BIOCHEM BIOPHYS, V375, P304, DOI 10.1006/abbi.1999.1592; Berredo-Pinho M, 2001, ARCH BIOCHEM BIOPHYS, V391, P16, DOI 10.1006/abbi.2001.2384; Bisaggio DFR, 2003, PARASITOL RES, V91, P273, DOI 10.1007/s00436-003-0965-8; Cavalier-Smith T, 2003, INT J SYST EVOL MICR, V53, P1741, DOI 10.1099/ijs.0.02548-0; Charlab R, 1999, P NATL ACAD SCI USA, V96, P15155, DOI 10.1073/pnas.96.26.15155; Clifford EE, 1997, AM J PHYSIOL-CELL PH, V273, pC973, DOI 10.1152/ajpcell.1997.273.3.C973; Dai JY, 2004, CELL, V116, P649, DOI 10.1016/S0092-8674(04)00172-2; Leite MDS, 2007, EXP PARASITOL, V115, P315, DOI 10.1016/j.exppara.2006.09.002; Devader C, 2006, GENE, V367, P135, DOI 10.1016/j.gene.2005.10.014; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Failer BU, 2002, J BIOL CHEM, V277, P36978, DOI 10.1074/jbc.M201656200; Fietto JLR, 2004, BIOCHEM BIOPH RES CO, V316, P454, DOI 10.1016/j.bbrc.2004.02.071; FILIPPINI A, 1990, J BIOL CHEM, V265, P334; Goodgame RW, 1996, ANN INTERN MED, V124, P429, DOI 10.7326/0003-4819-124-4-199602150-00008; Guerrant RL, 1997, EMERG INFECT DIS, V3, P51, DOI 10.3201/eid0301.970106; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hillis David M., 1996; Jesus JB, 2002, VET PARASITOL, V103, P29, DOI 10.1016/S0304-4017(01)00576-3; Joe A, 1998, INFECT IMMUN, V66, P3429, DOI 10.1128/IAI.66.7.3429-3432.1998; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kirley TL, 1997, J BIOL CHEM, V272, P1076, DOI 10.1074/jbc.272.2.1076; KNOWLES AF, 1995, BIOCHEM BIOPH RES CO, V207, P529, DOI 10.1006/bbrc.1995.1220; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurent F, 1997, INFECT IMMUN, V65, P5067, DOI 10.1128/IAI.65.12.5067-5073.1997; Laurent F, 1999, MICROBES INFECT, V1, P141, DOI 10.1016/S1286-4579(99)80005-7; Luttikhuizen DT, 2004, CELL TISSUE RES, V317, P289, DOI 10.1007/s00441-004-0939-x; MALISZEWSKI CR, 1994, J IMMUNOL, V153, P3574; Manque PA, 2011, CLIN VACCINE IMMUNOL; Manque PM, 2000, INFECT IMMUN, V68, P478, DOI 10.1128/IAI.68.2.478-484.2000; MARGOLIS RN, 1990, BIOCHEM BIOPH RES CO, V166, P562, DOI 10.1016/0006-291X(90)90845-E; Meyer-Fernandes JR, 2002, PARASITOL INT, V51, P299, DOI 10.1016/S1383-5769(02)00017-X; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Murphy DM, 2003, BIOCHEMISTRY-US, V42, P2412, DOI 10.1021/bi026763b; NAJJAR SM, 1993, J BIOL CHEM, V268, P1201; Peres-Sampaio CE, 2001, Z NATURFORSCH C, V56, P820; Pinheiro CM, 2006, EXP PARASITOL, V114, P16, DOI 10.1016/j.exppara.2006.02.007; PLESNER L, 1995, INT REV CYTOL, V158, P141; Sansom FM, 2007, CELL MICROBIOL, V9, P1922, DOI 10.1111/j.1462-5822.2007.00924.x; Sansom FM, 2008, MICROBIOL MOL BIOL R, V72, P765, DOI 10.1128/MMBR.00013-08; Santos RF, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000387; Silverman JA, 1998, J BIOL CHEM, V273, P12352, DOI 10.1074/jbc.273.20.12352; Smith HV, 2005, TRENDS PARASITOL, V21, P133, DOI 10.1016/j.pt.2005.01.007; Smith TM, 2002, ARCH BIOCHEM BIOPHYS, V406, P105, DOI 10.1016/S0003-9861(02)00420-4; STEINBERG TH, 1991, CURR OPIN IMMUNOL, V3, P71, DOI 10.1016/0952-7915(91)90080-K; STOUT JG, 1995, J BIOL CHEM, V270, P11845, DOI 10.1074/jbc.270.20.11845; Uccelletti D, 2008, MOL BIOL CELL, V19, P1337, DOI 10.1091/mbc.E07-06-0547; Valenzuela JG, 1998, J BIOL CHEM, V273, P30583, DOI 10.1074/jbc.273.46.30583; Valenzuela JG, 2001, J EXP BIOL, V204, P229; Wang TF, 1998, BRAIN RES, V790, P318, DOI 10.1016/S0006-8993(97)01562-X; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977	56	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31030	10.1371/journal.pone.0031030	http://dx.doi.org/10.1371/journal.pone.0031030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22363541	Green Published, Green Submitted, gold			2022-12-25	WOS:000302180600024
J	Villarreal, MF; Fridman, EA; Leiguarda, RC				Villarreal, Mirta F.; Fridman, Esteban A.; Leiguarda, Ramon C.			The Effect of the Visual Context in the Recognition of Symbolic Gestures	PLOS ONE			English	Article							SOCIAL COGNITION; BRAIN; INTENTIONS; NETWORK; MIRROR; OTHERS; CORTEX; FMRI; TEMPOROPARIETAL; REPRESENTATION	Background: To investigate, by means of fMRI, the influence of the visual environment in the process of symbolic gesture recognition. Emblems are semiotic gestures that use movements or hand postures to symbolically encode and communicate meaning, independently of language. They often require contextual information to be correctly understood. Until now, observation of symbolic gestures was studied against a blank background where the meaning and intentionality of the gesture was not fulfilled. Methodology/Principal Findings: Normal subjects were scanned while observing short videos of an individual performing symbolic gesture with or without the corresponding visual context and the context scenes without gestures. The comparison between gestures regardless of the context demonstrated increased activity in the inferior frontal gyrus, the superior parietal cortex and the temporoparietal junction in the right hemisphere and the precuneus and posterior cingulate bilaterally, while the comparison between context and gestures alone did not recruit any of these regions. Conclusions/Significance: These areas seem to be crucial for the inference of intentions in symbolic gestures observed in their natural context and represent an interrelated network formed by components of the putative human neuron mirror system as well as the mentalizing system.	[Villarreal, Mirta F.; Fridman, Esteban A.; Leiguarda, Ramon C.] Inst Neurol Res FLENI, Dept Cognit Neurol, Buenos Aires, DF, Argentina; [Villarreal, Mirta F.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Villarreal, MF (corresponding author), Inst Neurol Res FLENI, Dept Cognit Neurol, Buenos Aires, DF, Argentina.	mvillarreal@fleni.org.ar		Fridman, Esteban A./0000-0001-7879-8874	National Council for Scientific Research (CONICET); Foundation for the Fight against the Neurological Diseases of Childhood (FLENI); Perez Companc Foundation	National Council for Scientific Research (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Foundation for the Fight against the Neurological Diseases of Childhood (FLENI); Perez Companc Foundation	This work was supported by the National Council for Scientific Research (CONICET) (www.conicet.gov.ar), the Foundation for the Fight against the Neurological Diseases of Childhood (FLENI) (www.fleni.org.ar), and the Perez Companc Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Burgess N, 2001, NEUROIMAGE, V14, P439, DOI 10.1006/nimg.2001.0806; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2004, NEUROPSYCHOLOGIA, V42, P1725, DOI 10.1016/j.neuropsychologia.2004.05.006; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassin Ran R., 2005, NEW UNCONSCIOUS; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Joly JF, 2008, PERS SOC PSYCHOL B, V34, P1047, DOI 10.1177/0146167208318401; Kukolja J, 2006, NEUROPSYCHOLOGIA, V44, P2846, DOI 10.1016/j.neuropsychologia.2006.06.029; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Lotze M, 2006, NEUROPSYCHOLOGIA, V44, P1787, DOI 10.1016/j.neuropsychologia.2006.03.016; McNeill David, 1996, HAND MIND WHAT GESTU; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Samson D, 2004, NAT NEUROSCI, V7, P499, DOI 10.1038/nn1223; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Speer NK, 2007, PSYCHOL SCI, V18, P449, DOI 10.1111/j.1467-9280.2007.01920.x; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Spunt RP, 2011, J COGNITIVE NEUROSCI, V23, P63, DOI 10.1162/jocn.2010.21446; Talairach J., 1988, COPLANAR STEREOTAXIC; Thioux M, 2008, CURR BIOL, V18, pR431, DOI 10.1016/j.cub.2008.03.018; Tylen K, 2009, BRAIN LANG, V108, P159, DOI 10.1016/j.bandl.2008.07.002; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Villarrea M, 2008, NEUROPSYCHOLOGIA, V46, P2371, DOI 10.1016/j.neuropsychologia.2008.03.004; Wheatley T, 2007, PSYCHOL SCI, V18, P469, DOI 10.1111/j.1467-9280.2007.01923.x	41	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e29644	10.1371/journal.pone.0029644	http://dx.doi.org/10.1371/journal.pone.0029644			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363406	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700004
J	Botella-Soler, V; Valderrama, M; Crepon, B; Navarro, V; Le Van Quyen, M				Botella-Soler, Vicente; Valderrama, Mario; Crepon, Benoit; Navarro, Vincent; Le Van Quyen, Michel			Large-Scale Cortical Dynamics of Sleep Slow Waves	PLOS ONE			English	Article							LESS-THAN-1 HZ OSCILLATION; NEOCORTICAL NEURONS; LOW-FREQUENCY; SYNCHRONIZATION; HOMEOSTASIS; ELECTROENCEPHALOGRAM; NETWORKS; RHYTHMS; HUMANS; STATES	Slow waves constitute the main signature of sleep in the electroencephalogram (EEG). They reflect alternating periods of neuronal hyperpolarization and depolarization in cortical networks. While recent findings have demonstrated their functional role in shaping and strengthening neuronal networks, a large-scale characterization of these two processes remains elusive in the human brain. In this study, by using simultaneous scalp EEG and intracranial recordings in 10 epileptic subjects, we examined the dynamics of hyperpolarization and depolarization waves over a large extent of the human cortex. We report that both hyperpolarization and depolarization processes can occur with two different characteristic time durations which are consistent across all subjects. For both hyperpolarization and depolarization waves, their average speed over the cortex was estimated to be approximately 1 m/s. Finally, we characterized their propagation pathways by studying the preferential trajectories between most involved intracranial contacts. For both waves, although single events could begin in almost all investigated sites across the entire cortex, we found that the majority of the preferential starting locations were located in frontal regions of the brain while they had a tendency to end in posterior and temporal regions.	[Botella-Soler, Vicente] Univ Valencia, Dept Fis Teor, CSIC, Valencia, Spain; [Botella-Soler, Vicente] Univ Valencia, Inst Fis Corpuscular IFIC, CSIC, Valencia, Spain; [Crepon, Benoit; Navarro, Vincent] Hop La Pitie Salpetriere, AP HP, Epilepsy Unit, Paris, France; [Valderrama, Mario; Crepon, Benoit; Navarro, Vincent; Le Van Quyen, Michel] Univ Paris 06, Hop La Pitie Salpetriere, Ctr Rech Inst Cerveau & Moelle Epiniere CRICM, INSERM,CNRS,UMR 7225,UMRS 975, Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); University of Valencia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Botella-Soler, V (corresponding author), Univ Valencia, Dept Fis Teor, CSIC, Valencia, Spain.	quyen@t-online.de	Botella-Soler, Vicente/C-6702-2012	Navarro, Vincent/0000-0003-0077-8114; Valderrama, Mario/0000-0001-8791-6078; Botella-Soler, Vicente/0000-0002-8790-1914	European Union [211713]; (MCyT/FEDER, Spain) [FIS2007-60133]; MICINN, Spain [AYA2010-22111-C03-02]; Generalitat Valenciana	European Union(European Commission); (MCyT/FEDER, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by the European Union-FP7 Project EPILEPSIAE (Evolving Platform for Improving Living Expectation of Subjects Suffering from IctAl Events, Grant No 211713) and by contracts FIS2007-60133 (MCyT/FEDER, Spain) and AYA2010-22111-C03-02 (MICINN, Spain). VBS thanks Generalitat Valenciana for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Csercsa R, 2010, BRAIN, V133, P2814, DOI 10.1093/brain/awq169; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Ferri R, 2005, CLIN NEUROPHYSIOL, V116, P2783, DOI 10.1016/j.clinph.2005.08.013; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Mohajerani MH, 2010, J NEUROSCI, V30, P3745, DOI 10.1523/JNEUROSCI.6437-09.2010; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rigas P, 2007, J NEUROSCI, V27, P4261, DOI 10.1523/JNEUROSCI.0003-07.2007; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Talairach J., 1988, COPLANAR STEREOTAXIC; Terzano MG, 2001, SLEEP MED, V2, P537, DOI 10.1016/S1389-9457(01)00149-6; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 1996, J NEUROPHYSIOL, V76, P4152, DOI 10.1152/jn.1996.76.6.4152; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006	33	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30757	10.1371/journal.pone.0030757	http://dx.doi.org/10.1371/journal.pone.0030757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363484	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600065
J	Du, R; Sun, WJ; Xia, L; Zhao, A; Yu, Y; Zhao, LJ; Wang, HM; Huang, C; Sun, SR				Du, Rui; Sun, Wenjuan; Xia, Lin; Zhao, Ali; Yu, Yan; Zhao, Lijuan; Wang, Hanmin; Huang, Chen; Sun, Shiren			Hypoxia-Induced Down-Regulation of microRNA-34a Promotes EMT by Targeting the Notch Signaling Pathway in Tubular Epithelial Cells	PLOS ONE			English	Article							E-CADHERIN; MESENCHYMAL TRANSITION; HEPATOCELLULAR-CARCINOMA; RENAL FIBROGENESIS; EXPRESSION; CANCER; FAMILY; GROWTH; TRANSCRIPTION; REPRESSION	Background: Hypoxia-induced renal tubular cell epithelial-mesenchymal transition (EMT) is an important event leading to renal fibrosis. MicroRNAs (miRNAs) are small non-coding RNA molecules that bind to their mRNA targets, thereby leading to translational repression. The role of miRNA in hypoxia-induced EMT is largely unknown. Methodology/Principal Findings: miRNA profiling was performed for the identification of differentially expressed miRNAs in HK-2 cells under normal and low oxygen, and the results were then verified by quantitative real time RT-PCR (qRT-PCR). The function of miRNAs in hypoxia-induced renal tubular cell EMT was assessed by the transfection of specific miRNA inhibitors and mimics. Luciferase reporter gene assays and western blot analysis were performed to validate the target genes of miR-34a. siRNA against Jagged1 was designed to investigate the role of the miR-34a-Notch pathway in hypoxia induced renal tubular cell EMT. miRNA-34a was identified as being downregulated in hypoxic renal tubular epithelial cells. Inhibition of miR-34a expression in HK-2 cells, which highly express endogenous miR-34a, promoted a mesenchymal phenotype accompanied by reduced expression of the epithelial marker Z0-1, E-cadherin and increased expression of the mesenchymal markers alpha-SMA and vimentin. Conversely, miR-34a mimics effectively prevented hypoxia-induced EMT. Transfection of miRNA-34a in HK-2 cells under hypoxia abolished hypoxia-induced expression of Notch1 and Jagged1 as well as Notch downstream signals, such as snail. Western blot analysis and luciferase reporter gene assays showed direct evidence for miR-34a targeting Notch1 and Jagged1. siRNAs against Jagged1 or Notch1 effectively prevented miR-34a inhibitor-induced tubular epithelial cell EMT. Conclusions/Significance: Our study provides evidence that the hypoxia-induced decrease of miR-34a expression could promote EMT in renal tubular epithelial cells by directly targeting Notch1 and Jagged1, and subsequently, Notch downstream signaling.	[Du, Rui; Sun, Wenjuan; Zhao, Ali; Yu, Yan; Zhao, Lijuan; Wang, Hanmin; Huang, Chen; Sun, Shiren] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China; [Xia, Lin] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Xia, Lin] Fourth Mil Med Univ, Xijing Digest Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Du, R (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China.	Chenhuang@fmmu.edu.cn; Sunshiren@fmmu.edu.cn			National Nature Science Foundation of China [81070570, 81000988, 81100525]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Nature Science Foundation of China (No. 81070570, 81000988, and 81100525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Chen YB, 2007, CANCER RES, V67, P7954, DOI 10.1158/0008-5472.CAN-07-1229; Das I, 2004, J BIOL CHEM, V279, P30771, DOI 10.1074/jbc.M309252200; Du B, 2010, FEBS LETT, V584, P811, DOI 10.1016/j.febslet.2009.12.053; Du R, 2010, BIOCHEM BIOPH RES CO, V391, P135, DOI 10.1016/j.bbrc.2009.11.019; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Fabbri M, 2011, JAMA-J AM MED ASSOC, V305, P59, DOI 10.1001/jama.2010.1919; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Haase VH, 2009, ANN NY ACAD SCI, V1177, P57, DOI 10.1111/j.1749-6632.2009.05030.x; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Higgins DF, 2008, CELL CYCLE, V7, P1128, DOI 10.4161/cc.7.9.5804; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hiyama A, 2011, ARTHRITIS RHEUM-US, V63, P1355, DOI 10.1002/art.30246; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Kulshreshtha R, 2007, CELL CYCLE, V6, P1426; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morissey J, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017905.77985.4A; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Muth M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-24; NAGAI H, 1995, CANCER RES, V55, P1752; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Oba S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013614; Paterson EL, 2008, THESCIENTIFICWORLDJO, V8, P901, DOI 10.1100/tsw.2008.115; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wang G, 2010, AM J HYPERTENS, V23, P78, DOI 10.1038/ajh.2009.208; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yanada M, 2005, ONCOL REP, V14, P817; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	60	140	162	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30771	10.1371/journal.pone.0030771	http://dx.doi.org/10.1371/journal.pone.0030771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363487	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600067
J	Liu, YK; Chen, XJ; Zhang, L; Wang, L; Perc, M				Liu, Yongkui; Chen, Xiaojie; Zhang, Lin; Wang, Long; Perc, Matjaz			Win-Stay-Lose-Learn Promotes Cooperation in the Spatial Prisoner's Dilemma Game	PLOS ONE			English	Article							SCALE-FREE NETWORKS; TIT-FOR-TAT; EVOLUTIONARY GAMES; SOCIAL DILEMMAS; ASPIRATION; EMERGENCE; SHIFT; STRATEGIES; DYNAMICS; RULES	Holding on to one's strategy is natural and common if the later warrants success and satisfaction. This goes against widespread simulation practices of evolutionary games, where players frequently consider changing their strategy even though their payoffs may be marginally different than those of the other players. Inspired by this observation, we introduce an aspiration-based win-stay-lose-learn strategy updating rule into the spatial prisoner's dilemma game. The rule is simple and intuitive, foreseeing strategy changes only by dissatisfied players, who then attempt to adopt the strategy of one of their nearest neighbors, while the strategies of satisfied players are not subject to change. We find that the proposed win-stay-lose-learn rule promotes the evolution of cooperation, and it does so very robustly and independently of the initial conditions. In fact, we show that even a minute initial fraction of cooperators may be sufficient to eventually secure a highly cooperative final state. In addition to extensive simulation results that support our conclusions, we also present results obtained by means of the pair approximation of the studied game. Our findings continue the success story of related win-stay strategy updating rules, and by doing so reveal new ways of resolving the prisoner's dilemma.	[Liu, Yongkui; Zhang, Lin] Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China; [Liu, Yongkui] Changan Univ, Sch Elect & Control Engn, Xian, Peoples R China; [Liu, Yongkui] Changan Univ, Ctr Rd Traff Intelligent Detect & Equipment Engn, Xian, Peoples R China; [Chen, Xiaojie] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; [Wang, Long] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China; [Perc, Matjaz] Univ Maribor, Dept Phys, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia	Beihang University; Chang'an University; Chang'an University; International Institute for Applied Systems Analysis (IIASA); Peking University; University of Maribor	Liu, YK (corresponding author), Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China.	ykliu@chd.edu.cn; chenx@iiasa.ac.at; matjaz.perc@uni-mb.si	Liu, Yongkui/R-9307-2017; Gao, Y./GWZ-3665-2022; Perc, Matjaz/A-5148-2009; Wang, Long/A-7798-2010	Liu, Yongkui/0000-0003-2165-775X; Perc, Matjaz/0000-0002-3087-541X; Wang, Long/0000-0001-5600-8157	Chang'an University [CHD2010JC134]; National Natural Science Foundation of China (NSFC) [60736022, 10972002, 61074144, 51005012, 61103096]; Slovenian Research Agency (ARRS) [J1-4055]	Chang'an University; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	YL acknowledges financial support from the Special Fund for the Basic Scientific Research of Central Colleges of Chang'an University (Grant CHD2010JC134). LW acknowledges financial support from the National Natural Science Foundation of China (NSFC) (Grants 60736022 and 10972002). MP acknowledges financial support from the Slovenian Research Agency (ARRS) (Grant J1-4055). This work was additionally supported by the National Natural Science Foundation of China (NSFC) (Grants 61074144, 51005012 and 61103096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Chen XJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.017103; Chen X, 2008, PHYS LETT A, V372, P1161, DOI 10.1016/j.physleta.2007.09.044; Chen XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046109; Chen X, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051120; Cho IK, 2005, J ECON THEORY, V124, P171, DOI 10.1016/j.jet.2004.12.001; Dai QL, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011103; Dai QL, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113015; Droz M, 2009, EUR PHYS J B, V71, P579, DOI 10.1140/epjb/e2009-00160-1; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036101; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Guan JY, 2006, EUROPHYS LETT, V76, P1214, DOI 10.1209/epl/i2006-10381-4; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Hu MB, 2007, PHYSICA A, V381, P467, DOI 10.1016/j.physa.2007.03.021; Imhof LA, 2007, J THEOR BIOL, V247, P574, DOI 10.1016/j.jtbi.2007.03.027; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; Lee S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028702; Liu RR, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/20002; Liu YK, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/60002; Liu YK, 2010, PHYSICA A, V389, P2390, DOI 10.1016/j.physa.2010.02.008; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7229, DOI 10.1073/pnas.092080099; Matsen FA, 2004, P NATL ACAD SCI USA, V101, P18053, DOI 10.1073/pnas.0406608102; Maynard Smith J., 1982, pi; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2007, J THEOR BIOL, V246, P681, DOI 10.1016/j.jtbi.2007.01.024; Pacheco JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000596; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Platkowski T, 2009, APPL MATH LETT, V22, P1161, DOI 10.1016/j.aml.2008.09.005; Platkowski T, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036103; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38003; Poncela J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.057101; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Posch M, 1999, J THEOR BIOL, V198, P183, DOI 10.1006/jtbi.1999.0909; Roca CP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.158701; Roca CP, 2011, P NATL ACAD SCI USA, V108, P11370, DOI 10.1073/pnas.1101044108; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026101; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Sigmund K, 2010, CALCULUS SELSHNESS; Sigmund K., 1993, GAMES LIFE EXPLORATI; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18007; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szabo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016106; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tomassini M, 2007, INT J MOD PHYS C, V18, P1173, DOI 10.1142/S0129183107011212; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Vukov J, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036133; Vukov J, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.067103; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Wardil L, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/38001; Wu Z.-X., 2009, PHYS REV E, V80; Wu ZX, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041114; Wu ZX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021107; Wu ZX, 2007, PHYSICA A, V379, P672, DOI 10.1016/j.physa.2007.02.085; Wu ZX, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026108; Yang HX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.065101; Zhang HF, 2010, PHYSICA A, V389, P4734, DOI 10.1016/j.physa.2010.06.023	85	51	52	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30689	10.1371/journal.pone.0030689	http://dx.doi.org/10.1371/journal.pone.0030689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363470	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000302853600054
J	Ovadje, P; Hamm, C; Pandey, S				Ovadje, Pamela; Hamm, Caroline; Pandey, Siyaram			Efficient Induction of Extrinsic Cell Death by Dandelion Root Extract in Human Chronic Myelomonocytic Leukemia (CMML) Cells	PLOS ONE			English	Article							HUMAN T-CELLS; APOPTOSIS PATHWAYS; OXIDATIVE STRESS; IN-VITRO; AUTOPHAGY; CANCER; ACTIVATION; CASPASE-8; DISEASE; VIVO	Background: Chronic Myelomonocytic Leukemia (CMML) is a heterogeneous disease that is not only hard to diagnose and classify, but is also highly resistant to treatment. Available forms of therapy for this disease have not shown significant effects and patients rapidly develop resistance early on in therapy. These factors lead to the very poor prognosis observed with CMML patients, with median survival duration between 12 and 24 months after diagnosis. This study is therefore centered around evaluating the selective efficacy of a natural extract from dandelion roots, in inducing programmed cell death in aggressive and resistant CMML cell lines. Methodology/Principal Findings: To confirm the induction of programmed cell death in three human CMML cell lines, nuclear condensation and externalization of the phosphatidylserine, two main characteristics of apoptosis, were detected using Hoechst staining and annexin-V binding assay. The induction of another mode of cell death, autophagy, was determined using a monodansylcadaverine (MDC) stain, to detect the formation of autophagy vacuoles. The results from this study indicate that Dandelion Root Extract (DRE) is able to efficiently and selectively induce apoptosis and autophagy in these cell lines in a dose and time dependent manner, with no significant toxicity on non-cancerous peripheral blood mononuclear cells. More importantly, we observed early activation of initiator caspase-8, which led to mitochondrial destabilization and the induction of autophagy, suggesting that DRE acts through the extrinsic pathway of apoptosis. The inability of DRE to induce apoptosis in dominant-negative FADD cells, confirms the mechanism of action of DRE in in vitro models of CMML. Conclusion: The results from this study indicate that natural products, in particular Dandelion Root Extract, have great potential, as non-toxic and effective alternatives to conventional modes of chemotherapy available today.	[Ovadje, Pamela; Pandey, Siyaram] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada; [Hamm, Caroline] Windsor Reg Canc Ctr, Windsor, ON, Canada	University of Windsor	Ovadje, P (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	spandey@uwindsor.ca	Pandey, Siyaram/AAI-5491-2020; Hamm, Christian W./I-3155-2017	Hamm, Christian W./0000-0001-6763-4161	Seeds4Hope [810257]; Knights of columbus [850285]; Kevin Couvillion Memorial grant [810340]; Seeds4hope Windsor; Essex county Cancer Centre Foundation	Seeds4Hope; Knights of columbus; Kevin Couvillion Memorial grant; Seeds4hope Windsor; Essex county Cancer Centre Foundation	This work was supported by Seeds4Hope: Grant #: 810257, Knights of columbus: Grant #: 850285, and a Kevin Couvillion Memorial grant: 810340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Seeds4hope Windsor and Essex county Cancer Centre Foundation for the seeds4hope grant, the Knights of Columbus, Windsor Council 9671 and the Couvillion family, for their generous donations. We dedicate this work to the memory of Kevin Couvillion.	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Attia RR, 2008, J BIOL CHEM, V283, P30788, DOI 10.1074/jbc.M804159200; Chatterjee SJ, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/129045; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; DWYER JM, 1981, CLIN EXP IMMUNOL, V46, P237; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Foucar K, 2009, AM J CLIN PATHOL, V132, P281, DOI 10.1309/AJCPJ71PTVIKGEVT; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fuss IJ, 2009, CURR PROTOC IMMUNOL, V85, DOI DOI 10.1002/0471142735.IM0701S85; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gordaliza M, 2007, CLIN TRANSL ONCOL, V9, P767, DOI 10.1007/s12094-007-0138-9; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Griffin C, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-6; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Liu ZH, 2007, DEV CELL, V12, P484, DOI 10.1016/j.devcel.2007.03.016; Naderi J, 2003, APOPTOSIS, V8, P91, DOI 10.1023/A:1021657220843; Negoescu A, 1996, J HISTOCHEM CYTOCHEM, V44, P959, DOI 10.1177/44.9.8773561; Ngamwongsatit P, 2008, J MICROBIOL METH, V73, P211, DOI 10.1016/j.mimet.2008.03.002; Ovadje P, 2011, J ETHNOPHARMACOL, V133, P86, DOI 10.1016/j.jep.2010.09.005; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Ramshaw HS, 2002, EXP HEMATOL, V30, P1124, DOI 10.1016/S0301-472X(02)00903-7; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Schutz K, 2006, J ETHNOPHARMACOL, V107, P313, DOI 10.1016/j.jep.2006.07.021; Shakibaei M, 2010, ANTIOXID REDOX SIGN, V13, P821, DOI 10.1089/ars.2009.3036; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Somayajulu-Nitu M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-88; Steensma DP, 2006, MAYO CLIN PROC, V81, P104, DOI 10.4065/81.1.104; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Yarnell E., 2009, INTEGR MED, V8, P35; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhivotovsky B, 2010, EXP CELL RES, V316, P1374, DOI 10.1016/j.yexcr.2010.02.037; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004	34	27	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30604	10.1371/journal.pone.0030604	http://dx.doi.org/10.1371/journal.pone.0030604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363452	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600039
J	van Gennip, RGP; van de Water, SGP; Potgieter, CA; Wright, IM; Veldman, D; van Rijn, PA				van Gennip, Rene G. P.; van de Water, Sandra G. P.; Potgieter, Christiaan A.; Wright, Isabel M.; Veldman, Daniel; van Rijn, Piet A.			Rescue of Recent Virulent and Avirulent Field Strains of Bluetongue Virus by Reverse Genetics	PLOS ONE			English	Article							PROTEIN; TRAFFICKING; SEROTYPE-8; EPIDEMIC; VECTOR	Since 1998, Bluetongue virus (BTV)-serotypes 1, 2, 4, 9, and 16 have invaded European countries around the Mediterranean Basin. In 2006, a huge BT-outbreak started after incursion of BTV-serotype 8 (BTV8) in North-Western Europe. More recently, BTV6 and BTV11 were reported in North-Western Europe in 2008. These latter strains are closely related to live-attenuated vaccine, whereas BTV8 is virulent and can induce severe disease in ruminants, including cattle. In addition, Toggenburg orbivirus (TOV) was detected in 2008 in Swiss goats, which was recognized as a new serotype of BTV (BTV25). The (re) emergency of known and unknown BTV-serotypes needs a rapid response to supply effective vaccines, and research to study this phenomenon. Recently, orbivirus research achieved an important breakthrough by the establishment of reverse genetics for BTV1. Here, reverse genetics for two recent BTV strains representing virulent BTV8 and avirulent BTV6 was developed. For this purpose, extensive sequencing of full-genomes was performed, resulting in the consensus sequences of BTV8/net07 and BTV6/net08. The recovery of 'synthetic BTV', respectively rgBTV8 and rgBTV6, completely from T7-derived RNA transcripts was confirmed by silent mutations by which these 'synthetic BTVs' could be genetically distinguished from wild type BTV, respectively wtBTV6 and wtBTV8. The in vitro and in vivo properties of rgBTV6 or rgBTV8 were comparable to the properties of their parent strains. The asymptomatic or avirulent properties of rgBTV6 and the virulence of rgBTV8 were confirmed by experimental infection of sheep. Reverse genetics of the vaccine-related BTV6 provides a perfect start to develop new generations of BT-vaccines. Reverse genetics of the virulent BTV8 will accelerate research on the special features of BTV8, like transmission by species of Culicoides in a moderate climate, transplacental transmission, and pathogenesis in cattle.	[van Gennip, Rene G. P.; van de Water, Sandra G. P.; Veldman, Daniel; van Rijn, Piet A.] Cent Vet Inst Wageningen UR CVI, Dept Virol, Lelystad, Netherlands; [Potgieter, Christiaan A.; Wright, Isabel M.] Onderstepoort Vet Inst, Onderstepoort, South Africa	Wageningen University & Research; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council	van Gennip, RGP (corresponding author), Cent Vet Inst Wageningen UR CVI, Dept Virol, Lelystad, Netherlands.	rene.vangennip@wur.nl	van Rijn, Piet A/C-1163-2017; van Rijn, Piet A./AAG-7398-2019	van Rijn, Piet A/0000-0002-2594-1232; van Rijn, Piet A./0000-0002-2594-1232; van Gennip, Rene/0000-0002-5450-3493	Dutch Ministry of Economics, Agriculture and Innovation	Dutch Ministry of Economics, Agriculture and Innovation	This project was funded by the Dutch Ministry of Economics, Agriculture and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Backx A, 2009, VET MICROBIOL, V138, P235, DOI 10.1016/j.vetmic.2009.04.003; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Celma CCP, 2011, J VIROL, V85, P4783, DOI 10.1128/JVI.02352-10; Celma CCP, 2009, J VIROL, V83, P6806, DOI 10.1128/JVI.00263-09; De Clercq K, 2009, TRANSBOUND EMERG DIS, V56, P355, DOI 10.1111/j.1865-1682.2009.01092.x; Dijkstra E, 2008, VET REC, V162, P422, DOI 10.1136/vr.162.13.422-a; DURBIN R, 1991, VIROLOGY, V183, P306, DOI 10.1016/0042-6822(91)90143-Y; EFSA, 2011, EFSA J, V9, p[5175, 51]; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; Eschbaumer M, 2010, VET MICROBIOL, V143, P189, DOI 10.1016/j.vetmic.2009.11.040; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HUISMANS H, 1987, VIROLOGY, V157, P172, DOI 10.1016/0042-6822(87)90326-6; ISID Promed mail, 2006, BLUET EUR 1 BLUET OV; ISID Promed mail, 2007, BLUET EUR 19 BTV 8 N; ISID Promed mail, 2008, BLUET EUROPE 69 NETH; Kar AK, 2003, J VIROL, V77, P11347, DOI 10.1128/JVI.77.21.11347-11356.2003; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Meiswinkel R, 2007, VET REC, V161, P564, DOI 10.1136/vr.161.16.564; Mertens PPC, VIRUS TAXONOMY 8 REP, P466; MERTENS PPC, 2007, CONSERVED RNA TERMIN; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; OIE, 2022, NUMB NEW H5 OUTBR; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; Roy P, 2005, ADV VIRUS RES, V64, P69, DOI 10.1016/S0065-3527(05)64004-3; Roy P, 2008, CELL BIOCHEM BIOPHYS, V50, P143, DOI 10.1007/s12013-008-9009-4; SATO M, 1977, ARCH VIROL, V54, P333, DOI 10.1007/BF01314778; van Gennip RGP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-261; van Rijn PA, 2009, ANIMAL TRIALS BLUE T; WECHSLER SJ, 1988, J CLIN MICROBIOL, V26, P2324, DOI 10.1128/JCM.26.11.2324-2327.1988	33	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30540	10.1371/journal.pone.0030540	http://dx.doi.org/10.1371/journal.pone.0030540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363444	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600034
J	van Loggerenberg, F; Dieter, AA; Sobieszczyk, ME; Werner, L; Grobler, A; Mlisana, K				van Loggerenberg, Francois; Dieter, Alexis A.; Sobieszczyk, Magdalena E.; Werner, Lise; Grobler, Anneke; Mlisana, Koleka		CAPRISA 002 Acute Infection Study Team	HIV Prevention in High-Risk Women in South Africa: Condom Use and the Need for Change	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; REPRODUCTIVE HEALTH; YOUNG-ADULTS; INFECTION; HIV/AIDS; PREVALENCE; CONTEXT; NEGOTIATION; PERCEPTION; EPIDEMIC	Introduction: Young women are at disproportionate risk of HIV infection in South Africa. Understanding risk behaviors and factors associated with ability to negotiate safe sex and condom use is likely to be key in curbing the spread of HIV. Traditionally prevention efforts have focused on creating behavioral changes by increasing knowledge about HIV/AIDS. Methods: This was a cross-sectional analysis from a prospective observational cohort study of 245 women at a high-risk of HIV infection in KwaZulu-Natal, South Africa. Results: Participants demonstrated a high level of HIV/AIDS knowledge. Overall, 60.3% of participants reported condom use. Reported condom use at last sexual encounter varied slightly by partner type (57.0% with steady versus 64.4% with casual partners), and self-perceived ability to choose to use a condom was significantly lower with steady partners compared to casual partners (p<0.01). In multivariate analysis, women who had high school education were more likely to use condoms at their last sex encounter compared to those with only primary school education (RR of 1.36 (95% Confidence Interval (CI) 1.06-1.75) and 1.46 (95% CI 1.13-1.88) for grades 8-10 and 11-12, respectively). Those who used condoms as a contraceptive method were twice as likely to use condoms compared to women who did not report using them as a contraceptive method. Greater perceived ability to choose to use condoms was associated with higher self-reported condom use at last encounter, irrespective of partner type (RR = 2.65 (95% CI 2.15-32.5). Discussion: Self-perceived ability to use condoms, level of formal education and condom use as a contraceptive were all significantly associated with self-reported condom use at last sexual encounter. These findings suggest that that gender inequality and access to formal education, as opposed to lack of HIV/AIDS knowledge, prevent safer sexual practices in South Africa.	[van Loggerenberg, Francois; Werner, Lise; Grobler, Anneke; Mlisana, Koleka] Univ KwaZulu Natal, Ctr AIDS Programme Res S African CAPRISA, Durban, South Africa; [Sobieszczyk, Magdalena E.] Columbia Univ Coll Phys & Surg, Columbia Univ Med Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA	University of Kwazulu Natal; Columbia University	van Loggerenberg, F (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res S African CAPRISA, Durban, South Africa.	loggerenbergf@ukzn.ac.za	Dieter, Alexis/AAE-2127-2019; Mlisana, Koleka/N-6204-2013	Dieter, Alexis/0000-0003-0850-3289; van Loggerenberg, Francois/0000-0001-5317-7983; Mlisana, Koleka/0000-0002-8436-3268; Grobler, Anneke/0000-0002-7809-7688	Comprehensive International Program of Research on AIDS (CIPRA); National Institute of Allergy and Infectious Disease (NIAID); National Institutes of Health (NIH); US Department of Health and Human Services (DHHS) [1 U19 AI51794]; Columbia University-Southern African Fogarty; Fogarty International Center, National Institutes of Health [D43TW00231]; Doris Duke Charitable Foundation; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794] Funding Source: NIH RePORTER	Comprehensive International Program of Research on AIDS (CIPRA); National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services (DHHS); Columbia University-Southern African Fogarty; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CAPRISA received support for the CAPRISA 002 Acute Infection Study from the Comprehensive International Program of Research on AIDS (CIPRA) funded by the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) and the US Department of Health and Human Services (DHHS) (grant #1 U19 AI51794). The funders supported the initial development of the protocol but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Francois van Loggerenberg was supported by a pre-doctoral fellowship from the Columbia University-Southern African Fogarty AIDS International Training and Research Programme (AITRP) funded by the Fogarty International Center, National Institutes of Health (grant #D43TW00231). Alexis A. Dieter received support from the Doris Duke Charitable Foundation Clinical Research Fellowship Program for Medical Students at Columbia University College of Physicians and Surgeons.	Abdool Q, 2001, J Am Med Womens Assoc (1972), V56, P193; Ackermann Leane, 2002, Health Care Women Int, V23, P163, DOI 10.1080/073993302753429031; Booysen FL, 2002, J HEALTH POPUL NUTR, V20, P285; Boulle A, 2008, AIDS CARE, V20, P771, DOI 10.1080/09540120701660387; Cleland J, 2006, LANCET, V368, P1788, DOI 10.1016/S0140-6736(06)69738-9; Crepaz N, 2002, AIDS, V16, P135, DOI 10.1097/00002030-200201250-00002; Gilbert L, 2002, SOC SCI MED, V54, P1093, DOI 10.1016/S0277-9536(01)00083-1; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Hargreaves JR, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000300534.97601.d6; Hargreaves JR, 2009, AIDS CARE, V21, P1058, DOI 10.1080/09540120802657480; Harrison A, 2006, J URBAN HEALTH, V83, P709, DOI 10.1007/s11524-006-9077-y; Hartung TK, 2002, INT J STD AIDS, V13, P829, DOI 10.1258/095646202321020107; Hendriksen ES, 2007, AM J PUBLIC HEALTH, V97, P1241, DOI 10.2105/AJPH.2006.086009; Janssen RS, 2001, AM J PUBLIC HEALTH, V91, P1019, DOI 10.2105/AJPH.91.7.1019; KARIM QA, 1995, AM J PUBLIC HEALTH, V85, P1521, DOI 10.2105/AJPH.85.11.1521; Lurie M, 2008, JAIDS-J ACQ IMM DEF, V47, P484, DOI 10.1097/QAI.0b013e3181648de8; MacPhail C, 2009, CULT HEALTH SEX, V11, P485, DOI 10.1080/13691050902803537; Maharaj P, 2008, AIDS CARE, V20, P838, DOI 10.1080/09540120701742284; Maharaj P, 2005, INT FAM PLAN PERSPEC, V31, P24, DOI 10.1363/3102405; Mantell JE, 2009, CULT HEALTH SEX, V11, P139, DOI 10.1080/13691050802521155; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Ndinda C, 2007, AIDS CARE, V19, P844, DOI 10.1080/09540120701203923; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Ragnarsson A, 2009, AIDS CARE, V21, P1253, DOI 10.1080/09540120902814361; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Saleh-Onoya D, 2009, AIDS CARE, V21, P817, DOI 10.1080/09540120802537823; Sawyer KM, 2006, WOMEN HEALTH, V43, P73, DOI 10.1300/J013v43n02_05; Sayles JN, 2006, JAIDS-J ACQ IMM DEF, V43, P226, DOI 10.1097/01.qai.0000230527.17459.5c; Shisana O, 2009, S AFRICAN NATL HIV P; Shisana O, 2005, S AFRICA NATL HIV PR; Simbayi LC, 2004, AIDS CARE, V16, P605, DOI 10.1080/09540120410001716405; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Varga C A, 1997, Afr J Reprod Health, V1, P74, DOI 10.2307/3583277; Varga CA, 2001, AIDS CARE, V13, P351, DOI 10.1080/09540120120044008; Wechsberg WM, 2010, J PREV INTERV COMMUN, V38, P132, DOI 10.1080/10852351003640799	35	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30669	10.1371/journal.pone.0030669	http://dx.doi.org/10.1371/journal.pone.0030669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363467	gold, Green Published			2022-12-25	WOS:000302853600051
J	Yasugi, M; Nakamura, S; Daidoji, T; Kawashita, N; Ramadhany, R; Yang, CS; Yasunaga, T; Iida, T; Horii, T; Ikuta, K; Takahashi, K; Nakaya, T				Yasugi, Mayo; Nakamura, Shota; Daidoji, Tomo; Kawashita, Norihito; Ramadhany, Ririn; Yang, Cheng-Song; Yasunaga, Teruo; Iida, Tetsuya; Horii, Toshihiro; Ikuta, Kazuyoshi; Takahashi, Kazuo; Nakaya, Takaaki			Frequency of D222G and Q223R Hemagglutinin Mutants of Pandemic (H1N1) 2009 Influenza Virus in Japan between 2009 and 2010	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; BACTERIAL-INFECTIONS; SEVERE DISEASE; SUBSTITUTION; CELLS	Background: In April 2009, a novel swine-derived influenza A virus (H1N1pdm) emerged and rapidly spread around the world, including Japan. It has been suggested that the virus can bind to both 2,3- and 2,6-linked sialic acid receptors in infected mammals, in contrast to contemporary seasonal H1N1 viruses, which have a predilection for 2,6-linked sialic acid. Methods/Results: To elucidate the existence and transmissibility of alpha 2,3 sialic acid-specific viruses in H1N1pdm, amino acid substitutions within viral hemagglutinin molecules were investigated, especially D187E, D222G, and Q223R, which are related to a shift from human to avian receptor specificity. Samples from individuals infected during the first and second waves of the outbreak in Japan were examined using a high-throughput sequencing approach. In May 2009, three specimens from mild cases showed D222G and/or Q223R substitutions in a minor subpopulation of viruses infecting these individuals. However, the substitutions almost disappeared in the samples from five mild cases in December 2010. The D187E substitution was not widespread in specimens, even in May 2009. Conclusions: These results suggest that alpha 2,3 sialic acid-specific viruses, including G222 and R223, existed in humans as a minor population in the early phase of the pandemic, and that D222 and Q223 became more dominant through human-to-human transmission during the first and second waves of the epidemic. These results are consistent with the low substitution rates identified in seasonal H1N1 viruses in 2008.	[Yasugi, Mayo; Daidoji, Tomo; Ramadhany, Ririn; Yang, Cheng-Song; Iida, Tetsuya; Horii, Toshihiro; Nakaya, Takaaki] Osaka Univ, RIMD, Int Res Ctr Infect Dis, Suita, Osaka, Japan; [Yasugi, Mayo; Ramadhany, Ririn; Yang, Cheng-Song; Ikuta, Kazuyoshi] Osaka Univ, Dept Virol, RIMD, Suita, Osaka, Japan; [Nakamura, Shota; Kawashita, Norihito; Yasunaga, Teruo] Osaka Univ, RIMD, Dept Genome Informat, Suita, Osaka, Japan; [Nakamura, Shota; Iida, Tetsuya; Horii, Toshihiro; Nakaya, Takaaki] Osaka Univ, RIMD, Dept Infect Metagen, Suita, Osaka, Japan; [Kawashita, Norihito] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Environm Pharmacometr, Suita, Osaka, Japan; [Horii, Toshihiro] Osaka Univ, RIMD, Dept Mol Protozool, Suita, Osaka, Japan; [Takahashi, Kazuo] Osaka Prefectural Inst Publ Hlth, Higashinari Ku, Osaka 537, Japan; [Daidoji, Tomo; Nakaya, Takaaki] Kyoto Prefectural Univ Med, Dept Infect Dis, Kamigyo Ku, Kyoto, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka Prefectural Institute of Public Health; Kyoto Prefectural University of Medicine	Yasugi, M (corresponding author), Osaka Univ, RIMD, Int Res Ctr Infect Dis, Suita, Osaka, Japan.	tnakaya@biken.osaka-u.ac.jp	Nakamura, Shota/E-3033-2010	Nakamura, Shota/0000-0003-2058-5942; Horii, Toshihiro/0000-0002-3000-2045; Ramadhany, Ririn/0000-0003-1879-2440	Ministry of Education, Science, Sports, Culture, and Technology (MEXT); Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [23406017] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture, and Technology (MEXT) to TN; and a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (JSPS) to TD and MY. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan PKS, 2011, J CLIN VIROL, V50, P320, DOI 10.1016/j.jcv.2011.01.013; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Daidoji T, 2008, J VIROL, V82, P11294, DOI 10.1128/JVI.01192-08; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; Ledesma J, 2011, J CLIN VIROL, V51, P75, DOI 10.1016/j.jcv.2011.01.020; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mochalova L, 2003, VIROLOGY, V313, P473, DOI 10.1016/S0042-6822(03)00377-5; Nakamura S, 2008, EMERG INFECT DIS, V14, P1784, DOI 10.3201/eid1411.080589; Nakamura S, 2011, EXP BIOL MED, V236, P968, DOI 10.1258/ebm.2011.010378; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nunthaboot N, 2010, J CHEM INF MODEL, V50, P1410, DOI 10.1021/ci100038g; Puzelli S, 2010, EMERG INFECT DIS, V16, P863, DOI [10.3201/eid1605.091858, 10.3201/eid1605.091815]; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; Valli MB, 2011, EMERG INFECT DIS, V17, P749, DOI [10.3201/eid1706.100784, 10.3201/eid1704.100784]; Viswanathan K, 2010, GLYCOCONJUGATE J, V27, P561, DOI 10.1007/s10719-010-9303-4	25	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30946	10.1371/journal.pone.0030946	http://dx.doi.org/10.1371/journal.pone.0030946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363521	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600093
J	Chiu, PH; Hsieh, HY; Wang, SC				Chiu, Pei-Hsun; Hsieh, Hsin-Ying; Wang, Sun-Chong			Prescriptions of Traditional Chinese Medicine Are Specific to Cancer Types and Adjustable to Temperature Changes	PLOS ONE			English	Article							DIAGNOSIS; SUBTYPE	Targeted cancer therapies, with specific molecular targets, ameliorate the side effect issue of radiation and chemotherapy and also point to the development of personalized medicine. Combination of drugs targeting multiple pathways of carcinogenesis is potentially more fruitful. Traditional Chinese medicine (TCM) has been tailoring herbal mixtures for individualized healthcare for two thousand years. A systematic study of the patterns of TCM formulas and herbs prescribed to cancers is valuable. We analysed a total of 187,230 TCM prescriptions to 30 types of cancer in Taiwan in 2007, a year's worth of collection from the National Health Insurance reimbursement database (Taiwan). We found that a TCM cancer prescription consists on average of two formulas and four herbs. We show that the percentage weights of TCM formulas and herbs in a TCM prescription follow Zipf's law with an exponent around 0.6. TCM prescriptions to benign neoplasms have a larger Zipf's exponent than those to malignant cancers. Furthermore, we show that TCM prescriptions, via weighted combination of formulas and herbs, are specific to not only the malignancy of neoplasms but also the sites of origins of malignant cancers. From the effects of formulas and natures of herbs that were heavily prescribed to cancers, that cancers are a 'warm and stagnant' syndrome in TCM can be proposed, suggesting anti-inflammatory regimens for better prevention and treatment of cancers. We show that TCM incorporated relevant formulas to the prescriptions to cancer patients with a secondary morbidity. We compared TCM prescriptions made in different seasons and identified temperatures as the environmental factor that correlates with changes in TCM prescriptions in Taiwan. Lung cancer patients were among the patients whose prescriptions were adjusted when temperatures drop. The findings of our study provide insight to TCM cancer treatment, helping dialogue between modern western medicine and TCM for better cancer care.	[Chiu, Pei-Hsun; Hsieh, Hsin-Ying; Wang, Sun-Chong] Natl Cent Univ, Inst Syst Biol & Bioinformat, Chungli Taoyuan, Taiwan; [Wang, Sun-Chong] Ctr Addict & Mental Hlth, Epigenet Lab, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Chiu, PH (corresponding author), Natl Cent Univ, Inst Syst Biol & Bioinformat, Chungli Taoyuan, Taiwan.	scwang@ncu.edu.tw			National Science Council, Taiwan (Republic of China) [97-2112-M-008-003-MY3]	National Science Council, Taiwan (Republic of China)(Ministry of Science and Technology, Taiwan)	This work was funded in part by the National Science Council, Taiwan (Republic of China) grant # 97-2112-M-008-003-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adamic L, 2011, NATURE, V474, P164, DOI 10.1038/474164a; Aggarwal S, 2010, NAT REV DRUG DISCOV, V9, P427, DOI 10.1038/nrd3186; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Benz RW, 2008, J CHEM INF MODEL, V48, P1138, DOI 10.1021/ci700353m; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Furusawa C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088102; Gerber DE, 2008, AM FAM PHYSICIAN, V77, P311; Ha LQ, 2003, P 19 INT C COMP LING, P315; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris ESJ, 2011, SCI TOTAL ENVIRON, V409, P4297, DOI 10.1016/j.scitotenv.2011.07.032; Hsieh HY, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/neq050; Hsieh SC, 2008, PHARMACOEPIDEM DR S, V17, P609, DOI 10.1002/pds.1611; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; Li S.Z, 1982, BEN CAO GANG MU; LI WT, 1992, IEEE T INFORM THEORY, V38, P1842, DOI 10.1109/18.165464; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Miller VA, 2004, J CLIN ONCOL, V22, P1103, DOI 10.1200/JCO.2004.08.158; Patwardhan B, 2005, EVID-BASED COMPL ALT, V2, P465, DOI 10.1093/ecam/neh140; R Development Core Team, 2009, R FDN STAT COMP; Sawyers CL, 2007, NATURE, V449, P993, DOI 10.1038/449993a; Sung JJY, 2004, ALIMENT PHARM THER, V20, P1205, DOI 10.1111/j.1365-2036.2004.02242.x; Unschuld PU, 2003, HUANG DI NEI JING SU WEN: NATURE, KNOWLEDGE, IMAGERY IN AN ANCIENT CHINESE MEDICAL TEXT, P1, DOI 10.1525/california/9780520233225.001.0001; Wang S-C, 2008, DNA METHYLATION MICR; Wiseman N, 2009, JIN GUI YAO LUE ESSE; Wu FM, 2001, COLLECTED EXEGESIS R; Yang S, 1998, DIVINE FARMERS MAT M; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; Zhang GG, 2004, ALTERN THER HEALTH M, V10, P58; Zhang Zhogjing, 1999, SHANG HAN LUN COLD D	30	15	16	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31648	10.1371/journal.pone.0031648	http://dx.doi.org/10.1371/journal.pone.0031648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359613	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200082
J	Gergalova, G; Lykhmus, O; Kalashnyk, O; Koval, L; Chernyshov, V; Kryukova, E; Tsetlin, V; Komisarenko, S; Skok, M				Gergalova, Galyna; Lykhmus, Olena; Kalashnyk, Olena; Koval, Lyudmyla; Chernyshov, Volodymyr; Kryukova, Elena; Tsetlin, Victor; Komisarenko, Sergiy; Skok, Maryna			Mitochondria Express alpha 7 Nicotinic Acetylcholine Receptors to Regulate Ca2+ Accumulation and Cytochrome c Release: Study on Isolated Mitochondria	PLOS ONE			English	Article							OUTER-MEMBRANE; IONIC EVENTS; CHANNEL; VDAC; ACTIVATION; CHOLINE; LIVER; ANTIBODIES; DEFICIENT; SUBUNIT	Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that mediate synaptic transmission in the muscle and autonomic ganglia and regulate transmitter release in the brain. The nAChRs composed of alpha 7 subunits are also expressed in non-excitable cells to regulate cell survival and proliferation. Up to now, functional alpha 7 nAChRs were found exclusively on the cell plasma membrane. Here we show that they are expressed in mitochondria and regulate early proapoptotic events like cytochrome c release. The binding of alpha 7-specific antibody with mouse liver mitochondria was revealed by electron microscopy. Outer membranes of mitochondria from the wild-type and beta 2-/- but not alpha 7-/- mice bound alpha 7 nAChR-specific antibody and toxins: FITC-labeled alpha-cobratoxin or Alexa 555-labeled alpha-bungarotoxin. alpha 7 nAChR agonists (1 mu M acetylcholine, 10 mu M choline or 30 nM PNU-282987) impaired intramitochondrial Ca2+ accumulation and significantly decreased cytochrome c release stimulated with either 90 mu M CaCl2 or 0.5 mM H2O2. alpha 7-specific antagonist methyllicaconitine (50 nM) did not affect Ca2+ accumulation in mitochondria but attenuated the effects of agonists on cytochrome c release. Inhibitor of voltage-dependent anion channel (VDAC) 4,4'-diisothio-cyano-2,2'-stilbene disulfonic acid (0.5 mu M) decreased cytochrome c release stimulated with apoptogens similarly to alpha 7 nAChR agonists, and VDAC was co-captured with the alpha 7 nAChR from mitochondria outer membrane preparation in both direct and reverse sandwich ELISA. It is concluded that alpha 7 nAChRs are expressed in mitochondria outer membrane to regulate the VDAC-mediated Ca2+ transport and mitochondrial permeability transition.	[Gergalova, Galyna; Lykhmus, Olena; Kalashnyk, Olena; Koval, Lyudmyla; Chernyshov, Volodymyr; Komisarenko, Sergiy; Skok, Maryna] Palladin Inst Biochem, Dept Mol Immunol, Kiev, Ukraine; [Kryukova, Elena; Tsetlin, Victor] Russian Acad Sci, Dept Mol Bases Neurosignaling, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	National Academy of Sciences Ukraine; Palladin Institute of Biochemistry of NASU; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Gergalova, G (corresponding author), Palladin Inst Biochem, Dept Mol Immunol, Kiev, Ukraine.	skok@biochem.kiev.ua	Skok, Maryna/AAQ-9939-2020; Komisarenko, Sergiy/AAT-3457-2020; Tsetlin, Victor/X-2491-2018	Komisarenko, Serhiy/0000-0002-3244-3194; Skok, Maryna/0000-0002-5816-605X	European Molecular Biology Organization; Alzheimer Association; Russian Academy of Sciences	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the short-term fellowship of European Molecular Biology Organization, the Investigator Initiated Research Grant of Alzheimer Association and the grant P5 "Fundamental Sciences to Medicine" of Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alkondon M, 2006, J PHARMACOL EXP THER, V318, P268, DOI 10.1124/jpet.106.103135; Bathori G, 2006, J BIOL CHEM, V281, P17347, DOI 10.1074/jbc.M600906200; Bencherif M, 2009, ACTA PHARMACOL SIN, V30, P702, DOI 10.1038/aps.2009.37; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chernyavsky AI, 2004, J CELL SCI, V117, P5665, DOI 10.1242/jcs.01492; Chernyavsky AI, 2010, AM J PHYSIOL-CELL PH, V299, pC903, DOI 10.1152/ajpcell.00216.2010; Chernyavsky AI, 2009, J BIOL CHEM, V284, P22140, DOI 10.1074/jbc.M109.011395; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Conti-Fine BM, 2000, EUR J PHARMACOL, V393, P279, DOI 10.1016/S0014-2999(00)00036-4; Cormier A, 2001, BRAIN RES, V900, P72, DOI 10.1016/S0006-8993(01)02254-5; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; Danne O, 2010, EXPERT REV MOL DIAGN, V10, P159, DOI 10.1586/ERM.10.2; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gergalova G, 2011, NEIROFIZIOLOGIA NEUR, V43, P225; Gergalova G L, 2011, Ukr Biokhim Zh (1999), V83, P13; Hampl V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001383; Ichimura T., 2011, J BIOPHYS CHEM, V2, P10, DOI [10.4236/jbpc.2011.21002, DOI 10.4236/JBPC.2011.21002]; Jones IW, 2005, TRENDS NEUROSCI, V28, P343, DOI 10.1016/j.tins.2005.04.010; Kawamata J, 2011, J ALZHEIMERS DIS, V24, P95, DOI 10.3233/JAD-2011-110173; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Koval L, 2011, INT J BIOCHEM CELL B, V43, P516, DOI 10.1016/j.biocel.2010.12.003; Koval LA, 2008, INT J BIOCHEM CELL B, V40, P980, DOI 10.1016/j.biocel.2007.11.006; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Li YX, 2002, J NEUROCHEM, V81, P853, DOI 10.1046/j.1471-4159.2002.00891.x; Liu Q, 2009, J NEUROSCI, V29, P918, DOI 10.1523/JNEUROSCI.3952-08.2009; Lykhmus O, 2010, IMMUNOL LETT, V128, P68, DOI 10.1016/j.imlet.2009.11.006; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; Oloris SCS, 2010, TOXICOL APPL PHARM, V242, P299, DOI 10.1016/j.taap.2009.10.020; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; RATINAUD MH, 1988, CYTOMETRY, V9, P206, DOI 10.1002/cyto.990090304; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Sharples Christopher G.V., 2001, NEURONAL NICOTINIC R, P1; Shelukhina IV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P749, DOI 10.1134/S0006297906070078; Shelukhina IV, 2009, J NEUROCHEM, V109, P1087, DOI 10.1111/j.1471-4159.2009.06033.x; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Singhal S, 2011, J NANOTECHNOL, V2011, DOI [10.1155/2011/930243, 10.1155/2011/456743]; Skok M, 2006, J NEUROIMMUNOL, V171, P86, DOI 10.1016/j.jneuroim.2005.09.011; Skok MV, 2009, J LEUKOCYTE BIOL, V86, P1, DOI 10.1189/JLB.0209106; Skok MV, 1999, NEUROSCIENCE, V93, P1427, DOI 10.1016/S0306-4522(99)00160-8; Song P, 2008, J PHARMACOL SCI, V106, P180, DOI 10.1254/jphs.FM0070091; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Teodoro JS, 2008, MITOCHONDRION, V8, P367, DOI 10.1016/j.mito.2008.07.008; Tsetlin V, 2007, LIFE SCI, V80, P2202, DOI 10.1016/j.lfs.2007.01.007; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Ward MW, 2010, METHODS MOL BIOL, V591, P335, DOI 10.1007/978-1-60761-404-3_20	50	105	107	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31361	10.1371/journal.pone.0031361	http://dx.doi.org/10.1371/journal.pone.0031361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359587	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200056
J	Honnen, SJ; Buchter, C; Schroder, V; Hoffmann, M; Kohara, Y; Kampkotter, A; Bossinger, O				Honnen, Sebastian J.; Buechter, Christian; Schroeder, Verena; Hoffmann, Michael; Kohara, Yuji; Kampkoetter, Andreas; Bossinger, Olaf			C. elegans VANG-1 Modulates Life Span via Insulin/IGF-1-Like Signaling	PLOS ONE			English	Article							TRANSCRIPTION FACTOR DAF-16; OOCYTE MEIOTIC MATURATION; AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; CELL POLARITY; OXIDATIVE STRESS; PLANAR POLARITY; FAMILY-MEMBER; GENE; WNT	The planar cell polarity (PCP) pathway is highly conserved from Drosophila to humans and a PCP-like pathway has recently been described in the nematode Caenorhabditis elegans. The developmental function of this pathway is to coordinate the orientation of cells or structures within the plane of an epithelium or to organize cell-cell intercalation required for correct morphogenesis. Here, we describe a novel role of VANG-1, the only C. elegans ortholog of the conserved PCP component Strabismus/Van Gogh. We show that two alleles of vang-1 and depletion of the protein by RNAi cause an increase of mean life span up to 40%. Consistent with the longevity phenotype vang-1 animals also show enhanced resistance to thermal- and oxidative stress and decreased lipofuscin accumulation. In addition, vang-1 mutants show defects like reduced brood size, decreased ovulation rate and prolonged reproductive span, which are also related to gerontogenes. The germline, but not the intestine or neurons, seems to be the primary site of vang-1 function. Life span extension in vang-1 mutants depends on the insulin/IGF-1-like receptor DAF-2 and DAF-16/FoxO transcription factor. RNAi against the phase II detoxification transcription factor SKN-1/Nrf2 also reduced vang-1 life span that might be explained by gradual inhibition of insulin/IGF-1-like signaling in vang-1. This is the first time that a key player of the PCP pathway is shown to be involved in the insulin/IGF-1-like signaling dependent modulation of life span in C. elegans.	[Honnen, Sebastian J.; Bossinger, Olaf] Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, Sch Med, Aachen, Germany; [Honnen, Sebastian J.; Buechter, Christian; Schroeder, Verena; Kampkoetter, Andreas] Univ Dusseldorf, Inst Toxicol, D-40225 Dusseldorf, Germany; [Hoffmann, Michael] Univ Dusseldorf, Dept Gen Pediat, Univ Childrens Hosp, D-40225 Dusseldorf, Germany; [Kohara, Yuji] Natl Inst Genet, Genome Biol Lab, Mishima, Shizuoka 411, Japan; [Kampkoetter, Andreas] Bayer Anim Hlth GmbH, Res & Dev, Leverkusen, Germany	RWTH Aachen University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Bayer AG	Honnen, SJ (corresponding author), Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, Sch Med, Aachen, Germany.	olaf.bossinger@rwth-aachen.de		Honnen, Sebastian/0000-0002-7845-7807; Hoffmann, Michael/0000-0001-8677-5031	Deutsche Forschungsgemeinschaft [SFB590 TP B3]; NIH National Center for Research Resources (NCRR)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Deutsche Forschungsgemeinschaft (SFB590 TP B3) to OB. SH is a fellow of the Jurgen Manchot Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank: C. Cowan, A. Wodarz, A. Muller and J. Nelson for critical reading of the manuscript, N.J. Storm for sharing data, A. Dillin for providing daf-2 RNAi "feeding"-clone, the Mitani lab and the C. elegans Knockout Consortium for providing tm1422 and ok1142, respectively. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Braeckman BP, 2002, AGING CELL, V1, P82, DOI 10.1046/j.1474-9728.2002.00021.x; BRENNER S, 1974, GENETICS, V77, P71; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Darken RS, 2002, EMBO J, V21, P976, DOI 10.1093/emboj/21.5.976; De Castro E, 2004, FREE RADICAL BIO MED, V37, P139, DOI 10.1016/j.freeradbiomed.2004.04.021; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FRIEDMAN DB, 1988, GENETICS, V118, P75; Garigan D, 2002, GENETICS, V161, P1101; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Gill MS, 2003, FREE RADICAL BIO MED, V35, P558, DOI 10.1016/S0891-5849(03)00328-9; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; GOTTLIEB S, 1994, GENETICS, V137, P107; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; GREENSTEIN D, 1994, GENE DEV, V8, P1935, DOI 10.1101/gad.8.16.1935; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hekimi S, 2011, TRENDS CELL BIOL; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hoffmann M, 2010, DEV BIOL, V339, P268, DOI 10.1016/j.ydbio.2009.12.002; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hu PJ, 2006, PLOS GENET, V2, P930, DOI 10.1371/journal.pgen.0020099; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; Jenny A, 2010, CURR TOP DEV BIOL, V93, P189, DOI [10.1016/B978-0-12-385044-7.00007-2, 10.1016/S0070-2153(10)93007-X]; Johnson TE, 2002, J INHERIT METAB DIS, V25, P197, DOI 10.1023/A:1015677828407; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kampkotter A, 2007, PHARMACOL RES, V55, P139, DOI 10.1016/j.phrs.2006.11.006; Kampkotter A, 2007, ARCH TOXICOL, V81, P849, DOI 10.1007/s00204-007-0215-4; Kampkotter A, 2007, TOXICOLOGY, V234, P113, DOI 10.1016/j.tox.2007.02.006; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keller R, 2008, PHILOS T R SOC B, V363, P1317, DOI 10.1098/rstb.2007.2250; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Landis JN, 2010, DEV DYN; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Luo SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000789; Luscombe NM, 2002, GENOME BIOL, V3; McCarter J, 1997, DEV BIOL, V181, P121, DOI 10.1006/dbio.1996.8429; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Michaelson D, 2010, DEVELOPMENT, V137, P671, DOI 10.1242/dev.042523; Miller MA, 2003, GENE DEV, V17, P187, DOI 10.1101/gad.1028303; Mirkovic I, 2011, NATURE STRUCTURAL MO; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Mukhopadhyay A, 2005, CELL METAB, V2, P35, DOI 10.1016/j.cmet.2005.06.004; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Okuyama T, 2010, J BIOL CHEM; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Pilipiuk J, 2009, DEV BIOL, V327, P34, DOI 10.1016/j.ydbio.2008.11.025; Rose KL, 1997, DEV BIOL, V192, P59, DOI 10.1006/dbio.1997.8728; Samuelson AV, 2007, GENE DEV, V21, P2976, DOI 10.1101/gad.1588907; Sanchez-Alvarez L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002257; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215; Vandenberg AL, 2009, DEVELOPMENT, V136, P1559, DOI 10.1242/dev.034066; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wolff S, 2006, EXP GERONTOL, V41, P894, DOI 10.1016/j.exger.2006.06.054; Wolkow CA, 2002, J BIOL CHEM, V277, P49591, DOI 10.1074/jbc.M207866200; Woolson RFC., 2002, STAT METHODS ANAL BI, Ved 2; Wu J, 2009, TRENDS CELL BIOL, V19, P295, DOI 10.1016/j.tcb.2009.04.003; Wu MF, 2006, DEV BIOL, V293, P316, DOI 10.1016/j.ydbio.2005.12.024	86	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32183	10.1371/journal.pone.0032183	http://dx.doi.org/10.1371/journal.pone.0032183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359667	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200136
J	Poreba, M; McGowan, S; Skinner-Adams, TS; Trenholme, KR; Gardiner, DL; Whisstock, JC; To, J; Salvesen, GS; Dalton, JP; Drag, M				Poreba, Marcin; McGowan, Sheena; Skinner-Adams, Tina S.; Trenholme, Katharine R.; Gardiner, Donald L.; Whisstock, James C.; To, Joyce; Salvesen, Guy S.; Dalton, John P.; Drag, Marcin			Fingerprinting the Substrate Specificity of M1 and M17 Aminopeptidases of Human Malaria, Plasmodium falciparum	PLOS ONE			English	Article							LEUCINE AMINOPEPTIDASE; LEUCYL AMINOPEPTIDASE; ANTIMALARIAL ACTIVITY; PARASITES; INHIBITORS; IDENTIFICATION; DEGRADATION; BESTATIN; STRATEGY; DESIGN	Background: Plasmodium falciparum, the causative agent of human malaria, expresses two aminopeptidases, PfM1AAP and PfM17LAP, critical to generating a free amino acid pool used by the intraerythrocytic stage of the parasite for proteins synthesis, growth and development. These exopeptidases are potential targets for the development of a new class of anti-malaria drugs. Methodology/Principal Findings: To define the substrate specificity of recombinant forms of these two malaria aminopeptidases we used a new library consisting of 61 fluorogenic substrates derived both from natural and unnatural amino acids. We obtained a detailed substrate fingerprint for recombinant forms of the enzymes revealing that PfM1AAP exhibits a very broad substrate tolerance, capable of efficiently hydrolyzing neutral and basic amino acids, while PfM17LAP has narrower substrate specificity and preferentially cleaves bulky, hydrophobic amino acids. The substrate library was also exploited to profile the activity of the native aminopeptidases in soluble cell lysates of P. falciparum malaria. Conclusions/Significance: This data showed that PfM1AAP and PfM17LAP are responsible for majority of the aminopeptidase activity in these extracts. These studies provide specific substrate and mechanistic information important for understanding the function of these aminopeptidases and could be exploited in the design of new inhibitors to specifically target these for anti-malaria treatment.	[Poreba, Marcin; Drag, Marcin] Wroclaw Univ Technol, Div Med Chem & Microbiol, Fac Chem, PL-50370 Wroclaw, Poland; [McGowan, Sheena; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [McGowan, Sheena; Whisstock, James C.] Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic, Australia; [Skinner-Adams, Tina S.; Trenholme, Katharine R.; Gardiner, Donald L.] Queensland Inst Med Res, Malaria Biol Lab, Brisbane, Qld 4006, Australia; [Skinner-Adams, Tina S.; Trenholme, Katharine R.; Gardiner, Donald L.] Griffith Univ, Joint Program, Griffith Med Res Coll, Brisbane, Qld 4111, Australia; [Skinner-Adams, Tina S.; Trenholme, Katharine R.; Gardiner, Donald L.] Univ Queensland, Sch Med, Royal Brisbane Hosp, Brisbane, Qld, Australia; [To, Joyce; Dalton, John P.] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ, Canada; [Salvesen, Guy S.; Drag, Marcin] Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, La Jolla, CA USA	Wroclaw University of Science & Technology; Monash University; Monash University; QIMR Berghofer Medical Research Institute; Griffith University; Royal Brisbane & Women's Hospital; University of Queensland; McGill University; Sanford Burnham Prebys Medical Discovery Institute	Poreba, M (corresponding author), Wroclaw Univ Technol, Div Med Chem & Microbiol, Fac Chem, PL-50370 Wroclaw, Poland.	john.dalton@mcgill.ca; marcin.drag@pwr.wroc.pl	Dalton, John/K-4457-2014; Skinner-Adams, Tina S/A-9798-2012; Trenholme, Katharine/C-9244-2013; Gardiner, Don/G-4717-2010; McGowan, Sheena/C-4797-2014	Skinner-Adams, Tina S/0000-0001-7011-3850; Whisstock, James/0000-0003-4200-5611; McGowan, Sheena/0000-0001-6863-1106; To, Joyce/0000-0003-3482-4369	Foundation for Polish Science; Canadian Institute for Health Research	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	The source of funds are Foundation for Polish Science (www.fnp.org.pl) and Canadian Institute for Health Research (www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimzadeh O, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-189; Cunningham E, 2008, ANTIMICROB AGENTS CH, V52, P3221, DOI 10.1128/AAC.01327-07; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Dev V, 2006, J INFECTION, V52, P131, DOI 10.1016/j.jinf.2005.02.033; Drag M, 2010, J BIOL CHEM, V285, P3310, DOI 10.1074/jbc.M109.060418; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Enserink M, 2008, SCIENCE, V321, P1620, DOI 10.1126/science.321.5896.1620b; Fidock DA, 2008, TRENDS PARASITOL, V24, P537, DOI 10.1016/j.pt.2008.09.005; Flipo M, 2003, BIOORG MED CHEM LETT, V13, P2659, DOI 10.1016/S0960-894X(03)00550-X; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gavigan CS, 2001, MOL BIOCHEM PARASIT, V117, P37, DOI 10.1016/S0166-6851(01)00327-9; Harbut MB, 2011, P NATL ACAD SCI USA, V108, pE526, DOI 10.1073/pnas.1105601108; Lew VL, 2004, BLOOD CELL MOL DIS, V32, P353, DOI 10.1016/j.bcmd.2004.01.006; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; Maly DJ, 2002, J ORG CHEM, V67, P910, DOI 10.1021/jo016140o; Maric S, 2009, BIOCHEMISTRY-US, V48, P5435, DOI 10.1021/bi9003638; Martin RE, 2007, BLOOD, V109, P2217, DOI 10.1182/blood-2005-11-026963; McGowan S, 2010, P NATL ACAD SCI USA, V107, P2449, DOI 10.1073/pnas.0911813107; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; Ragheb D, 2011, J BIOL CHEM     0609; Rosenthal PJ, 2002, CURR OPIN HEMATOL, V9, P140, DOI 10.1097/00062752-200203000-00010; Skinner-Adams TS, 2007, J MED CHEM, V50, P6024, DOI 10.1021/jm070733v; Skinner-Adams TS, 2010, TRENDS BIOCHEM SCI, V35, P53, DOI 10.1016/j.tibs.2009.08.004; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Velmourougane G, 2011, J MED CHEM, V54, P1655, DOI 10.1021/jm101227t	29	58	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31938	10.1371/journal.pone.0031938	http://dx.doi.org/10.1371/journal.pone.0031938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359643	Green Published, gold			2022-12-25	WOS:000302796200112
J	Scotti, ML; Smith, KE; Butler, AM; Calcagno, SR; Crawford, HC; Leitges, M; Fields, AP; Murray, NR				Scotti, Michele L.; Smith, Kristin E.; Butler, Amanda M.; Calcagno, Shelly R.; Crawford, Howard C.; Leitges, Michael; Fields, Alan P.; Murray, Nicole R.			Protein Kinase C Iota Regulates Pancreatic Acinar-to-Ductal Metaplasia	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; EPITHELIAL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; TRANSGENIC MICE; TGF-ALPHA; CANCER; NESTIN; CARCINOGENESIS; PROGRESSION; EXPRESSION	Pancreatic acinar-to-ductal metaplasia (ADM) is associated with an increased risk of pancreatic cancer and is considered a precursor of pancreatic ductal adenocarcinoma. Transgenic expression of transforming growth factor alpha (TGF-alpha) or K-ras(G12D) in mouse pancreatic epithelium induces ADM in vivo. Protein kinase C iota (PKCi) is highly expressed in human pancreatic cancer and is required for the transformed growth and tumorigenesis of pancreatic cancer cells. In this study, PKCi expression was assessed in a mouse model of K-ras(G12D)-induced pancreatic ADM and pancreatic cancer. The ability of K-ras(G12D) to induce pancreatic ADM in explant culture, and the requirement for PKCi, was investigated. PKCi is elevated in human and mouse pancreatic ADM and intraepithelial neoplastic lesions in vivo. We demonstrate that K-ras(G12D) is sufficient to induce pancreatic ADM in explant culture, exhibiting many of the same morphologic and biochemical alterations observed in TGF-alpha-induced ADM, including a dependence on Notch activation. PKCi is highly expressed in both TGF-alpha- and K-ras(G12D)-induced pancreatic ADM and inhibition of PKCi significantly reduces TGF-alpha- and K-ras(G12D)-mediated ADM. Inhibition of PKCi suppresses K-ras(G12D)-induced MMP-7 expression and Notch activation, and exogenous MMP-7 restores K-ras(G12D)-mediated ADM in PKCi-depleted cells, implicating a K-ras(G12D)-PKCi-MMP-7 signaling axis that likely induces ADM through Notch activation. Our results indicate that PKCi is an early marker of pancreatic neoplasia and suggest that PKCi is a potential downstream target of K-ras(G12D) in pancreatic ductal metaplasia in vivo.	[Scotti, Michele L.; Smith, Kristin E.; Butler, Amanda M.; Calcagno, Shelly R.; Fields, Alan P.; Murray, Nicole R.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Crawford, Howard C.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway	Mayo Clinic; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Oslo	Scotti, ML (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	murray.nicole@mayo.edu	Leitges, Michael/AAN-1953-2021; Crawford, Howard/A-2874-2008	Saravia-Butler, Amanda M./0000-0001-7505-2743; Leitges, Michael/0000-0003-4203-6995	Mayo Clinic SPORE in Pancreatic Cancer [P50 CA102701]; NIH/NCI [R01CA140290-1, R01CA081436-13]; Fraternal Order of Eagles Cancer Research Fund Pilot Program; Daniel Foundation of Alabama; Mayo Clinic Foundation; NICHD; Lustgarten Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [R01CA140290, R01CA081436, P50CA102701, R01CA159222] Funding Source: NIH RePORTER	Mayo Clinic SPORE in Pancreatic Cancer; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fraternal Order of Eagles Cancer Research Fund Pilot Program; Daniel Foundation of Alabama; Mayo Clinic Foundation; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Lustgarten Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Mayo Clinic SPORE in Pancreatic Cancer Career Development award P50 CA102701 (N.R. Murray), NIH/NCI R01CA140290-1 (N.R. Murray), NIH/NCI R01CA081436-13 (A.P. Fields), Fraternal Order of Eagles Cancer Research Fund Pilot Program (N.R. Murray), Daniel Foundation of Alabama Postdoctoral Fellowship (M.L. Scotti) and The Mayo Clinic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Brandy Edenfield, Shuhua Li, and Justin Weems of the Mayo Clinic, for excellent technical support and Dr. Pinku Mukherjee, University of North Carolina, for providing the P48-Cre mice. The CK-19 antibody (TROMAIII) was developed by Dr. Rolf Kemler, Max-Planck Institute, and obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. We acknowledge the Mayo Clinic SPORE in Pancreatic Cancer Patient Registry and Tissue Core (supported by P50 CA102701 (Gloria Petersen, PI) and the Lustgarten Foundation for Pancreatic Cancer Research) for providing the biospecimens used in this study.	BOCKMAN DE, 1992, GASTROENTEROLOGY, V103, P1883, DOI 10.1016/0016-5085(92)91448-D; Calcagno SR, 2008, INT J CANCER, V122, P2462, DOI 10.1002/ijc.23383; Calcagno SR, 2011, INFLAMM BOWEL DIS, V17, P1685, DOI 10.1002/ibd.21547; Carriere C, 2007, P NATL ACAD SCI USA, V104, P4437, DOI 10.1073/pnas.0701117104; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; Crawford HC, 2002, J CLIN INVEST, V109, P1437, DOI 10.1172/JCI200215051; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Erdogan E, 2006, J BIOL CHEM, V281, P28450, DOI 10.1074/jbc.M606054200; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; del Pulgar TG, 2007, INT J BIOCHEM CELL B, V39, P2289, DOI 10.1016/j.biocel.2007.06.014; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hanlon L, 2010, CANCER RES, V70, P4280, DOI 10.1158/0008-5472.CAN-09-4645; Heid I, 2011, GASTROENTEROLOGY; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2008, INT J CLIN EXP PATHO, V1, P306; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; KLIMSTRA DS, 1994, AM J PATHOL, V145, P1547; Leach SD, 2005, J CLIN GASTROENTEROL, V39, pS78, DOI 10.1097/01.mcg.0000155547.83901.a3; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Meszoely IM, 2001, CANCER J, V7, P242; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Murray NR, 2009, CANCER RES, V69, P656, DOI 10.1158/0008-5472.CAN-08-3001; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; Plentz R, 2009, GASTROENTEROLOGY, V136, P1741, DOI 10.1053/j.gastro.2009.01.008; Regala RP, 2008, CANCER RES, V68, P5888, DOI 10.1158/0008-5472.CAN-08-0438; Regala RP, 2009, CANCER RES, V69, P7603, DOI 10.1158/0008-5472.CAN-09-2066; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Scotti ML, 2010, CANCER RES, V70, P2064, DOI 10.1158/0008-5472.CAN-09-2684; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shi GL, 2009, GASTROENTEROLOGY, V136, P1368, DOI 10.1053/j.gastro.2008.12.066; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Stallings-Mann M, 2006, CANCER RES, V66, P1767, DOI 10.1158/0008-5472.CAN-05-3405; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wagner M, 1998, GASTROENTEROLOGY, V115, P1254, DOI 10.1016/S0016-5085(98)70098-8; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	41	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30509	10.1371/journal.pone.0030509	http://dx.doi.org/10.1371/journal.pone.0030509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359542	gold, Green Submitted, Green Published			2022-12-25	WOS:000302796200011
J	Sugiura, M; Ogami, S; Kusumi, M; Un, S; Rappaport, F; Boussac, A				Sugiura, Miwa; Ogami, Shogo; Kusumi, Mai; Un, Sun; Rappaport, Fabrice; Boussac, Alain			Environment of Tyr(Z) in Photosystem II from Thermosynechococcus elongatus in which PsbA2 Is the D1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC WATER OXIDATION; SITE-DIRECTED MUTAGENESIS; OXYGEN-EVOLVING COMPLEX; HIGH-FIELD EPR; TYROSINE Y-Z; THERMOPHILIC CYANOBACTERIUM; ELECTRON-TRANSFER; PROTON RELEASE; P680(+CENTER-DOT) REDUCTION; TEMPERATURE-DEPENDENCE	The main cofactors that determine the photosystem II (PSII) oxygen evolution activity are borne by the D1 and D2 subunits. In the cyanobacterium Thermosynechococcus elongatus, there are three psbA genes coding for D1. Among the 344 residues constituting D1, there are 21 substitutions between PsbA1 and PsbA3, 31 between PsbA1 and PsbA2, and 27 between PsbA2 and PsbA3. Here, we present the first study of PsbA2-PSII. Using EPR and UV-visible time-resolved absorption spectroscopy, we show that: (i) the time-resolved EPR spectrum of Tyr(Z)(center dot) in the (S(3)Tyr(Z)(center dot))' is slightly modified; (ii) the split EPR signal arising from Tyr(Z)(center dot) in the (S(2)Tyr(Z)(center dot))' state induced by near-infrared illumination at 4.2 K of the S(3)Tyr(Z) state is significantly modified; and (iii) the slow phases of P-680(+). reduction by Tyr(Z) are slowed down from the hundreds of mu s time range to the ms time range, whereas both the S(1)Tyr(Z)(center dot) -> S(2)Tyr(Z) and the S(3)Tyr(Z)(center dot) -> 3 S(0)Tyr(Z) + O-2 transition kinetics remained similar to those in PsbA(1/3)-PSII. These results show that the geometry of the Tyr(Z) phenol and its environment, likely the Tyr-O center dot center dot center dot H center dot center dot center dot N epsilon-His bonding, are modified in PsbA2-PSII when compared with PsbA(1/3)-PSII. They also point to the dynamics of the proton-coupled electron transfer processes associated with the oxidation of Tyr(Z) being affected. From sequence comparison, we propose that the C144P and P173M substitutions in PsbA2-PSII versus PsbA(1/3)-PSII, respectively located upstream of the alpha-helix bearing Tyr(Z) and between the two alpha-helices bearing Tyr(Z) and its hydrogen-bonded partner, His-190, are responsible for these changes.	[Sugiura, Miwa] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan; [Sugiura, Miwa] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Sugiura, Miwa; Ogami, Shogo; Kusumi, Mai] Ehime Univ, Dept Chem, Grad Sch Sci & Technol, Matsuyama, Ehime 7908577, Japan; [Un, Sun; Boussac, Alain] CEA Saclay, CNRS, UMR 8221, iBiTec S, F-91191 Gif Sur Yvette, France; [Rappaport, Fabrice] CNRS, Inst Biol Physicochim, UMR 7141, F-75005 Paris, France; [Rappaport, Fabrice] Univ Paris 06, F-75005 Paris, France	Ehime University; Japan Science & Technology Agency (JST); Ehime University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Sugiura, M (corresponding author), Ehime Univ, Cell Free Sci & Technol Res Ctr, Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	miwa.sugiura@ehime-u.ac.jp; alain.boussac@cea.fr		Rappaport, Fabrice/0000-0001-9377-4934	JST [4018]; Ministry of Education, Science, Sports, Culture and Technology [21612007]	JST(Japan Science & Technology Agency (JST)); Ministry of Education, Science, Sports, Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by the JST-PRESTO program (4018) and Grant-in-aid for Scientific Research 21612007 from the Ministry of Education, Science, Sports, Culture and Technology. To whom correspondence may be addressed: Cell-Free Science and Technology Research Center, Ehime University, Bunkyo-cho, Matsuyama Ehime 790- 8577, Japan. E-mail: miwa.sugiura@ehime-u.ac.jp.	Beal D, 1999, REV SCI INSTRUM, V70, P202, DOI 10.1063/1.1149566; Boussac A, 2005, PLANT CELL PHYSIOL, V46, P837, DOI 10.1093/pcp/pci088; Boussac A, 2008, PHILOS T R SOC B, V363, P1203, DOI 10.1098/rstb.2007.2216; Boussac A, 2011, BBA-BIOENERGETICS, V1807, P119, DOI 10.1016/j.bbabio.2010.10.004; Boussac A, 2009, J AM CHEM SOC, V131, P5050, DOI 10.1021/ja900680t; Christen G, 1999, BIOCHEMISTRY-US, V38, P6082, DOI 10.1021/bi9827520; Christen G, 1999, BIOCHEMISTRY-US, V38, P2068, DOI 10.1021/bi982188t; CLARKE AK, 1993, P NATL ACAD SCI USA, V90, P9973, DOI 10.1073/pnas.90.21.9973; Cox N, 2011, J AM CHEM SOC, V133, P3635, DOI 10.1021/ja110145v; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V726, P149, DOI 10.1016/0304-4173(83)90004-6; Cuni A, 2004, PHYS CHEM CHEM PHYS, V6, P4825, DOI 10.1039/b407511k; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; de Wijn R, 2002, BBA-BIOENERGETICS, V1553, P302, DOI 10.1016/S0005-2728(02)00183-4; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Dorlet P, 1999, J PHYS CHEM B, V103, P10945, DOI 10.1021/jp992420k; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FORSTER V, 1985, PHOTOCHEM PHOTOBIOL, V41, P183, DOI 10.1111/j.1751-1097.1985.tb03469.x; Gerencser L, 2010, BIOCHEMISTRY-US, V49, P10098, DOI 10.1021/bi101198n; GOLDEN SS, 1995, J BACTERIOL, V177, P1651, DOI 10.1128/jb.177.7.1651-1654.1995; Groot ML, 2005, P NATL ACAD SCI USA, V102, P13087, DOI 10.1073/pnas.0503483102; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Hays AMA, 1999, BIOCHEMISTRY-US, V38, P11851, DOI 10.1021/bi990716a; Holzwarth AR, 2006, P NATL ACAD SCI USA, V103, P6895, DOI 10.1073/pnas.0505371103; Ioannidis N, 2000, BIOCHEMISTRY-US, V39, P5246, DOI 10.1021/bi000131c; Ishida N, 2008, J BIOL CHEM, V283, P13330, DOI 10.1074/jbc.M710583200; JAHNS P, 1991, BIOCHIM BIOPHYS ACTA, V1057, P313, DOI 10.1016/S0005-2728(05)80142-2; Joliot P., 1975, BIOENERG PHOTOSYNTH, P387; Kato Y, 2009, P NATL ACAD SCI USA, V106, P17365, DOI 10.1073/pnas.0905388106; KOIKE H, 1987, BIOCHIM BIOPHYS ACTA, V893, P524, DOI 10.1016/0005-2728(87)90104-6; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Komenda J, 2000, PLANT MOL BIOL, V42, P635, DOI 10.1023/A:1006305308196; Kos PB, 2008, BBA-BIOENERGETICS, V1777, P74, DOI 10.1016/j.bbabio.2007.10.015; Koulougliotis D, 2004, PHYS CHEM CHEM PHYS, V6, P4859, DOI 10.1039/b407355j; Kuhn P, 2004, PHYS CHEM CHEM PHYS, V6, P4838, DOI 10.1039/b407656g; Lavergne J, 1998, BIOCHEMISTRY-US, V37, P7899, DOI 10.1021/bi9801210; LAVERGNE J, 1984, FEBS LETT, V173, P9, DOI 10.1016/0014-5793(84)81006-6; LAVERGNE J, 1991, BIOCHIM BIOPHYS ACTA, V1060, P175, DOI 10.1016/S0005-2728(09)91005-2; LAVERGNE J, 1993, PHOTOSYNTH RES, V38, P279, DOI 10.1007/BF00046752; Loll B, 2008, BIOL CHEM, V389, P609, DOI 10.1515/BC.2008.058; Matsuoka H, 2011, J AM CHEM SOC, V133, P4655, DOI 10.1021/ja2000566; Merry SAP, 1998, BIOCHEMISTRY-US, V37, P17439, DOI 10.1021/bi980502d; MINO H, 1994, BBA-BIOENERGETICS, V1185, P213, DOI 10.1016/0005-2728(94)90212-7; Mulo P, 2009, CELL MOL LIFE SCI, V66, P3697, DOI 10.1007/s00018-009-0103-6; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Ogami S, 2012, BBA-BIOENERGETICS, V1817, P1322, DOI 10.1016/j.bbabio.2012.01.015; Petrouleas V, 2005, BIOCHEMISTRY-US, V44, P6723, DOI 10.1021/bi0503201; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; RAPPAPORT F, 1994, BBA-BIOENERGETICS, V1184, P178, DOI 10.1016/0005-2728(94)90222-4; Rappaport F, 2001, BBA-BIOENERGETICS, V1503, P246, DOI 10.1016/S0005-2728(00)00228-0; RAPPAPORT F, 1991, BIOCHEMISTRY-US, V30, P10004, DOI 10.1021/bi00105a027; Rappaport F, 2011, ENERG ENVIRON SCI, V4, P2520, DOI 10.1039/c1ee01408k; Rappaport F, 2009, J AM CHEM SOC, V131, P4425, DOI 10.1021/ja808604h; Razeghifard MR, 1999, BIOCHEMISTRY-US, V38, P1252, DOI 10.1021/bi9811765; Renger G, 2011, J PHOTOCH PHOTOBIO B, V104, P35, DOI 10.1016/j.jphotobiol.2011.01.023; Saito K, 2011, BIOCHEMISTRY-US, V50, P9836, DOI 10.1021/bi201366j; Sanakis Y, 2001, J AM CHEM SOC, V123, P10766, DOI 10.1021/ja016418u; Sander J, 2010, J BIOL CHEM, V285, P29851, DOI 10.1074/jbc.M110.127142; Schilstra MJ, 1998, BIOCHEMISTRY-US, V37, P3974, DOI 10.1021/bi9713815; SHINKAREV VP, 1993, P NATL ACAD SCI USA, V90, P1834, DOI 10.1073/pnas.90.5.1834; Sicora CI, 2006, BBA-BIOENERGETICS, V1757, P47, DOI 10.1016/j.bbabio.2005.11.002; Sicora CI, 2009, BBA-BIOENERGETICS, V1787, P105, DOI 10.1016/j.bbabio.2008.12.002; Sproviero EM, 2008, J AM CHEM SOC, V130, P3428, DOI 10.1021/ja076130q; STYRING S, 1987, BIOCHEMISTRY-US, V26, P2401, DOI 10.1021/bi00383a001; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219, DOI 10.1093/oxfordjournals.pcp.a029510; Sugiura M, 2004, BIOCHEMISTRY-US, V43, P13549, DOI 10.1021/bi048732h; Sugiura M, 2008, BBA-BIOENERGETICS, V1777, P331, DOI 10.1016/j.bbabio.2008.01.007; Sugiura M, 2010, J BIOL CHEM, V285, P30008, DOI 10.1074/jbc.M110.136945; Sugiura M, 2010, BBA-BIOENERGETICS, V1797, P1491, DOI 10.1016/j.bbabio.2010.03.022; TOMMOS C, 1995, J AM CHEM SOC, V117, P10325, DOI 10.1021/ja00146a017; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Un S, 2001, APPL MAGN RESON, V21, P341, DOI 10.1007/BF03162413; Un S, 2007, BIOCHEMISTRY-US, V46, P3138, DOI 10.1021/bi062084f; VELTHUYS BR, 1974, BIOCHIM BIOPHYS ACTA, V333, P85, DOI 10.1016/0005-2728(74)90165-0; Westphal KL, 2000, CURR OPIN PLANT BIOL, V3, P236, DOI 10.1016/S1369-5266(00)80071-0; Zhang MT, 2011, J AM CHEM SOC, V133, P13224, DOI 10.1021/ja203483j	77	19	19	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13336	13347		10.1074/jbc.M112.340323	http://dx.doi.org/10.1074/jbc.M112.340323			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362776	hybrid, Green Published			2022-12-25	WOS:000302903700069
J	Mei, S; Gu, HH; Ward, A; Yang, XF; Guo, HL; He, K; Liu, ZQ; Cao, WH				Mei, Shuang; Gu, Haihua; Ward, Adam; Yang, Xuefeng; Guo, Huailan; He, Ka; Liu, Zhenqi; Cao, Wenhong			p38 Mitogen-activated Protein Kinase (MAPK) Promotes Cholesterol Ester Accumulation in Macrophages through Inhibition of Macroautophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-CHEMOATTRACTANT PROTEIN-1; SIGNAL-TRANSDUCTION PATHWAY; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; TRANSGENIC EXPRESSION; CHEMOKINE PRODUCTION; FOAM CELLS; AUTOPHAGY; ATHEROSCLEROSIS; MIGRATION	p38 MAPK has been strongly implicated in the development of atherosclerosis, but its role in cholesterol ester accumulation in macrophages and formation of foam cells, an early step in the development of atherosclerosis, has not been investigated. We addressed this issue and made some brand new observations. First, elevated intracellular cholesterol level induced by the exposure to LDL-activated p38 MAPK and activation of p38 MAPK with anisomycin increased the ratio of cholesterol esters over free cholesterol, whereas inhibition of p38 MAPK with SB203580 or siRNA reduced the LDL loading-induced intracellular accumulation of free cholesterol and cholesterol esters in macrophages. Second, exposure to LDL cholesterol inhibited autophagy in macrophages, and inhibition of autophagy with 3-methyladenine increased intracellular accumulation of cholesterol (free cholesterol and cholesterol esters), whereas activation of autophagy with rapamycin decreased intracellular accumulation of free cholesterol and cholesterol esters induced by the exposure to LDL cholesterol. Third, LDL cholesterol loading-induced inhibition of autophagy was prevented by blockade of p38 MAPK with SB203580 or siRNA. Neutral cholesterol ester hydrolase was co-localized with autophagosomes. Finally, LDL cholesterol loading and p38 activation suppressed expression of the key autophagy gene, ulk1, in macrophages. Together, our results provide brand new insight about cholesterol ester accumulation in macrophages and foam cell formation.	[Mei, Shuang; Gu, Haihua; Ward, Adam; Yang, Xuefeng; Guo, Huailan; He, Ka; Cao, Wenhong] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27559 USA; [Yang, Xuefeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Nutr & Food Hyg, Wuhan 430030, Hubei, Peoples R China; [Guo, Huailan] Hubei Univ Med, Dept Prevent Med, Shiyan 442000, Hubei, Peoples R China; [Liu, Zhenqi] Univ Virginia Hlth Syst, Dept Med Endocrinol, Charlottesville, VA 22908 USA; [Cao, Wenhong] Duke Univ, Sch Med, Dept Med Endocrinol & Metab, Durham, NC 27705 USA	University of North Carolina; University of North Carolina Chapel Hill; Huazhong University of Science & Technology; Hubei University of Medicine; University of Virginia; Duke University	Cao, WH (corresponding author), Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27559 USA.	caow@unc.edu		Ward, Adam/0000-0002-7038-5597	National Institutes of Health [R01DK076039]; American Diabetes Association [7-09-BS-27]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK076039 (to W. C.). This work was also supported by the American Diabetes Association (7-09-BS-27) (to W. C.).	Ashida N, 2001, J BIOL CHEM, V276, P16555, DOI 10.1074/jbc.M009068200; Ayala JM, 2000, J LEUKOCYTE BIOL, V67, P869, DOI 10.1002/jlb.67.6.869; Bie JH, 2010, J BIOL CHEM, V285, P13630, DOI 10.1074/jbc.M109.069781; Cambien B, 2001, BLOOD, V97, P359, DOI 10.1182/blood.V97.2.359; Cao Wen-Hong, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P1; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; Dobreva I, 2005, BIOL CHEM, V386, P909, DOI 10.1515/BC.2005.106; Domoto K, 2003, ATHEROSCLEROSIS, V171, P193, DOI 10.1016/j.atherosclerosis.2003.08.016; Dubois PM, 1996, J IMMUNOL, V156, P1356; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghosh S, 2010, VASC PHARMACOL, V52, P1, DOI 10.1016/j.vph.2009.10.002; Goebeler M, 1999, BLOOD, V93, P857, DOI 10.1182/blood.V93.3.857.403k03_857_865; Griffin EE, 2005, J LIPID RES, V46, P2052, DOI 10.1194/jlr.M500059-JLR200; Hayama M, 2002, AM J PHYSIOL-RENAL, V282, pF485, DOI 10.1152/ajprenal.00210.2001; Hong T, 2011, AM J PHYSIOL-ENDOC M, V300, pE500, DOI 10.1152/ajpendo.00225.2010; Igarashi M, 1997, HORM METAB RES, V29, P444, DOI 10.1055/s-2007-979074; Kuki S, 2006, CIRC J, V70, P1076, DOI 10.1253/circj.70.1076; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Marin V, 2001, BLOOD, V98, P667, DOI 10.1182/blood.V98.3.667; Martinet W, 2008, CURR ATHEROSCLER REP, V10, P216, DOI 10.1007/s11883-008-0034-y; Martinet W, 2009, CIRC RES, V104, P304, DOI 10.1161/CIRCRESAHA.108.188318; Matsuyama W, 2004, J IMMUNOL, V172, P2332, DOI 10.4049/jimmunol.172.4.2332; McGinn S, 2003, AM J PHYSIOL-ENDOC M, V285, pE708, DOI 10.1152/ajpendo.00572.2002; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nagelin MH, 2009, J BIOL CHEM, V284, P31303, DOI 10.1074/jbc.M109.028910; Nakagami H, 2001, DIABETES, V50, P1472, DOI 10.2337/diabetes.50.6.1472; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Seeger FH, 2005, CIRCULATION, V111, P1184, DOI 10.1161/01.CIR.0000157156.85397.A1; Sekiya M, 2009, CELL METAB, V10, P219, DOI 10.1016/j.cmet.2009.08.004; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Srinivasan S, 2004, J BIOL CHEM, V279, P31930, DOI 10.1074/jbc.M400753200; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; Suzuki E, 2004, CIRC RES, V95, P42, DOI 10.1161/01.RES.0000134631.75684.4A; Vitale S, 2004, J IMMUNOL, V172, P585, DOI 10.4049/jimmunol.172.1.585; Wang XL, 2006, DIABETES, V55, P2301, DOI 10.2337/db05-1574; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Yamaguchi H, 2004, ARTERIOSCL THROM VAS, V24, P2095, DOI 10.1161/01.ATV.0000144009.35400.65; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146; Zeng XK, 2003, CIRC RES, V93, P311, DOI 10.1161/01.RES.0000087642.01082.E4; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485	51	54	55	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11761	11768		10.1074/jbc.M111.333575	http://dx.doi.org/10.1074/jbc.M111.333575			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354961	Green Published, hybrid			2022-12-25	WOS:000302782200015
J	Zhang, W; Zhao, Y; Guo, Y; Ye, KQ				Zhang, Wei; Zhao, Yang; Guo, Yan; Ye, Keqiong			Plant Actin-binding Protein SCAB1 Is Dimeric Actin Cross-linker with Atypical Pleckstrin Homology Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS VILLIN1; BUNDLING PROTEIN; COILED COILS; CYTOSKELETON; WLIM1	SCAB1 is a novel plant-specific actin-binding protein that binds, bundles, and stabilizes actin filaments and regulates stomatal movement. Here, we dissected the structure and function of SCAB1 by structural and biochemical approaches. We show that SCAB1 is composed of an actin-binding domain, two coiled-coil (CC) domains, and a fused immunoglobulin and pleckstrin homology (Ig-PH) domain. We determined crystal structures for the CC1 and Ig-PH domains at 1.9 and 1.7 angstrom resolution, respectively. The CC1 domain adopts an antiparallel helical hairpin that further dimerizes into a four-helix bundle. The CC2 domain also mediates dimerization. At least one of the coiled coils is required for actin binding, indicating that SCAB1 is a bivalent actin cross-linker. The key residues required for actin binding were identified. The PH domain lacks a canonical basic phosphoinositide-binding pocket but can bind weakly to inositol phosphates via a basic surface patch, implying the involvement of inositol signaling in SCAB1 regulation. Our results provide novel insights into the functional organization of SCAB1.	[Zhang, Wei; Ye, Keqiong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhang, Wei; Zhao, Yang; Guo, Yan] China Agr Univ, Coll Biol Sci, Beijing 100193, Peoples R China	National Institute of Biological Sciences, Beijing; China Agricultural University	Ye, KQ (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd, Beijing 102206, Peoples R China.	yekeqiong@nibs.ac.cn	Guo, Yan/X-1245-2019; Zhao, Yang/H-2827-2014	Zhao, Yang/0000-0003-0302-3470	Chinese Ministry of Science and Technology [2010CB835402, 2008AA022310]; Beijing Municipal Government; China National Funds for Distinguished Young Scientists [31025003]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Municipal Government; China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Ministry of Science and Technology 973 Project 2010CB835402 and 863 Project 2008AA022310 and the Beijing Municipal Government (to K. Y.) and by China National Funds for Distinguished Young Scientists Grant 31025003 (to Y. G.).	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Banuelos S, 1998, STRUCTURE, V6, P1419, DOI 10.1016/S0969-2126(98)00141-5; Blanchoin L, 2010, CURR OPIN PLANT BIOL, V13, P714, DOI 10.1016/j.pbi.2010.09.013; Blanchoin L, 2010, BBA-MOL CELL RES, V1803, P201, DOI 10.1016/j.bbamcr.2008.09.015; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; George SP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703617200; Higaki T, 2007, CURR OPIN PLANT BIOL, V10, P549, DOI 10.1016/j.pbi.2007.08.012; Higaki T, 2010, PLANT SIGNAL BEHAV, V5, P484, DOI 10.4161/psb.10947; Higaki T, 2010, PLANT J, V61, P156, DOI 10.1111/j.1365-313X.2009.04032.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang S, 2005, PLANT CELL, V17, P486, DOI 10.1105/tpc.104.028555; Hussey PJ, 2006, ANNU REV PLANT BIOL, V57, P109, DOI 10.1146/annurev.arplant.57.032905.105206; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Khurana P, 2010, PLANT CELL, V22, P2727, DOI 10.1105/tpc.110.076240; Klahre U, 2000, PLANT PHYSIOL, V122, P35, DOI 10.1104/pp.122.1.35; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Kovar DR, 2000, PLANT J, V24, P625, DOI 10.1046/j.1365-313x.2000.00907.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Michelot A, 2006, CURR BIOL, V16, P1924, DOI 10.1016/j.cub.2006.07.054; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papuga J, 2010, PLANT CELL, V22, P3034, DOI 10.1105/tpc.110.075960; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Thomas C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703691200; Thomas C, 2006, PLANT CELL, V18, P2194, DOI 10.1105/tpc.106.040956; Thomas C, 2009, CELL MOTIL CYTOSKEL, V66, P940, DOI 10.1002/cm.20389; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Willis MA, 2000, STRUCTURE, V8, P1319, DOI 10.1016/S0969-2126(00)00544-X; Wu YJ, 2010, PLANT CELL, V22, P3745, DOI 10.1105/tpc.110.080283; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Yokota E, 1998, PLANT PHYSIOL, V116, P1421, DOI 10.1104/pp.116.4.1421; Yokota E, 2003, PLANT CELL PHYSIOL, V44, P1088, DOI 10.1093/pcp/pcg132; Zhang H, 2010, PLANT CELL, V22, P2749, DOI 10.1105/tpc.110.076257; Zhao Y, 2011, PLANT CELL, V23, P2314, DOI 10.1105/tpc.111.086546	49	14	17	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11981	11990		10.1074/jbc.M111.338525	http://dx.doi.org/10.1074/jbc.M111.338525			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22356912	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000302782200036
J	Mahavanakul, W; Nickerson, EK; Srisomang, P; Teparrukkul, P; Lorvinitnun, P; Wongyingsinn, M; Chierakul, W; Hongsuwan, M; West, TE; Day, NP; Limmathurotsakul, D; Peacock, SJ				Mahavanakul, Weera; Nickerson, Emma K.; Srisomang, Pramot; Teparrukkul, Prapit; Lorvinitnun, Pichet; Wongyingsinn, Mingkwan; Chierakul, Wirongrong; Hongsuwan, Maliwan; West, T. Eoin; Day, Nicholas P.; Limmathurotsakul, Direk; Peacock, Sharon J.			Feasibility of Modified Surviving Sepsis Campaign Guidelines in a Resource-Restricted Setting Based on a Cohort Study of Severe S. Aureus Sepsis	PLOS ONE			English	Article							SEPTIC SHOCK; CARE; EPIDEMIOLOGY; MANAGEMENT; BACTEREMIA; INFECTION; MORTALITY; CHILDREN; THERAPY; PROGRAM	Background: The Surviving Sepsis Campaign (SSC) guidelines describe best practice for the management of severe sepsis and septic shock in developed countries, but most deaths from sepsis occur where healthcare is not sufficiently resourced to implement them. Our objective was to define the feasibility and basis for modified guidelines in a resource-restricted setting. Methods and Findings: We undertook a detailed assessment of sepsis management in a prospective cohort of patients with severe sepsis caused by a single pathogen in a 1,100-bed hospital in lower-middle income Thailand. We compared their management with the SSC guidelines to identify care bundles based on existing capabilities or additional activities that could be undertaken at zero or low cost. We identified 72 patients with severe sepsis or septic shock associated with S. aureus bacteraemia, 38 (53%) of who died within 28 days. One third of patients were treated in intensive care units (ICUs). Numerous interventions described by the SSC guidelines fell within existing capabilities, but their implementation was highly variable. Care available to patients on general wards covered the fundamental principles of sepsis management, including non-invasive patient monitoring, antimicrobial administration and intravenous fluid resuscitation. We described two additive care bundles, one for general wards and the second for ICUs, that if consistently performed would be predicted to improve outcome from severe sepsis. Conclusion: It is feasible to implement modified sepsis guidelines that are scaled to resource availability, and that could save lives prior to the publication of international guidelines for developing countries.	[Mahavanakul, Weera; Teparrukkul, Prapit; Lorvinitnun, Pichet] Sappasithiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand; [Nickerson, Emma K.; Chierakul, Wirongrong; Hongsuwan, Maliwan; Day, Nicholas P.; Limmathurotsakul, Direk; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Nickerson, Emma K.; Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Srisomang, Pramot] Sappasithiprasong Hosp, Dept Pediat, Ubon Ratchathani, Thailand; [Wongyingsinn, Mingkwan] Siriraj Hosp, Fac Med, Dept Anesthesiol, Bangkok, Thailand; [Chierakul, Wirongrong] Mahidol Univ, Fac Trop Med, Dept Trop Med, Bangkok, Thailand; [West, T. Eoin] Univ Washington, Harborview Med Ctr, Dept Med, Seattle, WA 98104 USA; [West, T. Eoin] Univ Washington, Harborview Med Ctr, Int Resp & Severe Illness Ctr, Seattle, WA 98104 USA; [Day, Nicholas P.] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Mahidol University; Mahidol University; Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Oxford; Mahidol University; Mahidol University	Mahavanakul, W (corresponding author), Sappasithiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand.	direk@tropmedres.ac; sjp97@medschl.cam.ac.uk	Peacock, Sharon J/ABE-6331-2020	Limmathurotsakul, Direk/0000-0001-7240-5320; Wongyingsinn, Mingkwan/0000-0003-4508-5661; West, T Eoin/0000-0001-5503-7204; Peacock, Sharon/0000-0002-1718-2782; /0000-0002-1075-4135; Chierakul, Wirongrong/0000-0003-2103-9425	Wellcome Trust; NIHR Cambridge Biomedical Research Centre	Wellcome Trust(Wellcome Trust); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR))	The study was funded by the Wellcome Trust. SP is supported by the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2009, CHEST; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705; Carcillo Joseph A, 2005, Pediatr Crit Care Med, V6, pS157, DOI 10.1097/01.PCC.0000161574.36857.CA; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dunser MW, 2006, CRIT CARE MED, V34, P1234, DOI 10.1097/01.CCM.0000208360.70835.87; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Gupta S, 2007, INFECT DIS CLIN N AM, V21, P617, DOI 10.1016/j.idc.2007.07.003; Hatherill Mark, 2005, Pediatr Crit Care Med, V6, pS92, DOI 10.1097/01.PCC.0000161579.39050.6B; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Moore CC, 2008, CLIN INFECT DIS, V46, P215, DOI 10.1086/524665; Nickerson EK, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004308, 10.1371/journal.pone.0006512]; Phu NH, 2002, NEW ENGL J MED, V347, P895, DOI 10.1056/NEJMoa020074; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Rice TW, 2007, CHEST, V132, P410, DOI 10.1378/chest.07-0617; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Siddiqui Shahla, 2007, J Indian Med Assoc, V105, P221; Silva E, 2004, CRIT CARE, V8, pR251, DOI 10.1186/cc2892; SMITH C, 1991, S AFR MED J, V80, P181; Tanriover MD, 2006, EPIDEMIOL INFECT, V134, P315, DOI 10.1017/S0950268805004978; Vincent JL, 2003, INTENS CARE MED, V29, pS74; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; World Health Organization, WORLD HLTH REP 1996; World Health Organization, 2004, GLOB BURD DIS 2004 U; World Health Organization, 2011, CLIN MAN AD PAT COMP; WRIGHT JP, 1995, TROP DOCT, V25, P5, DOI 10.1177/004947559502500102	36	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e29858	10.1371/journal.pone.0029858	http://dx.doi.org/10.1371/journal.pone.0029858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363410	Green Submitted, gold, Green Published			2022-12-25	WOS:000302873700005
J	Zhong, R; Tian, Y; Liu, L; Qiu, Q; Wang, Y; Rui, R; Yang, BF; Duan, SY; Shi, JX; Miao, XP; Wang, L; Li, H				Zhong, Rong; Tian, Yao; Liu, Li; Qiu, Qian; Wang, Ying; Rui, Rui; Yang, Bei-Fang; Duan, Sheng-Yu; Shi, Jun-Xin; Miao, Xiao-Ping; Wang, Li; Li, Hui			HBV-Related Hepatocellular Carcinoma Susceptibility Gene KIF1B Is Not Associated with Development of Chronic Hepatitis B	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VIRUS INFECTION; LOCUS; CHINA; VISUALIZATION; MANAGEMENT; ALPHA	Background: A recent genome-wide association study has identified a new susceptibility locus, kinesin family member 1B gene (KIF1B), strongly associated with progression from chronic hepatitis B (CHB) to hepatitis B virus-related hepatocellular carcinoma (HCC) in Chinese population, this study was carried out to explore the role of the genetic variants in KIF1B in the development of chronic hepatitis B. Methodology/Principal Findings: Three KIF1B polymorphisms (rs8019, rs17401924, and rs17401966) were selected and genotyped in 473 CHB patients and 580 controls with no history of CHB. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by logistic regression model. None of these three SNPs showed association with CHBs after adjusting for age and gender. Equivalence-based method analysis confirmed the absence of association. In the further haplotype analysis, three common haplotypes were observed in this study population, but no significant effect was also found for haplotypes in the progression to CHB. Conclusions/Significance: This study showed the new locus identified for HCC, KIF1B, was not associated with progression to CHB, implying distinct genetic susceptibility factor contributes to the progression from hepatitis B virus infection to HCC. Nevertheless, further comprehensive analyses are warranted to dissect the mechanism.	[Zhong, Rong; Rui, Rui; Yang, Bei-Fang; Duan, Sheng-Yu; Shi, Jun-Xin; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Epidemiol & Biostat & Minist, Educ Key Lab Environm & Hlth,Sch Publ Hlth, Wuhan 430074, Hubei, Peoples R China; [Tian, Yao; Qiu, Qian; Wang, Li; Li, Hui] Chinese Acad Med Sci, Dept Epidemiol & Biostat, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Tian, Yao; Qiu, Qian; Wang, Li; Li, Hui] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Wang, Ying] Wuhan Ctr Dis Prevent & Control, Dept Virol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Guangdong Pharmaceutical University	Zhong, R (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Epidemiol & Biostat & Minist, Educ Key Lab Environm & Hlth,Sch Publ Hlth, Wuhan 430074, Hubei, Peoples R China.	miaoxp@mail.hust.edu.cn; liwang@ibms.pumc.edu.cn	Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Zhong, Rong/0000-0002-5060-895X	National Key Project of Infectious Disease [2009ZX10004-903, 2008ZX10002-001]; Science Fund for Creative Research Groups [30721063]; Foundation of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences [2009PY16]; fundamental research funds for the central universities (HUST) [2011TS019]	National Key Project of Infectious Disease; Science Fund for Creative Research Groups(Science Fund for Creative Research Groups); Foundation of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences; fundamental research funds for the central universities (HUST)(Fundamental Research Funds for the Central Universities)	This work was supported by National Key Project of Infectious Disease (Grant number: 2009ZX10004-903 and 2008ZX10002-001), Science Fund for Creative Research Groups (Grant number: 30721063), Foundation of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (Grant number: 2009PY16), the fundamental research funds for the central universities (HUST: NO.2011TS019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott W, 2007, IMMUNOGENETICS, V59, P187, DOI 10.1007/s00251-006-0184-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Carroll MB, 2010, CLIN RHEUMATOL, V29, P1021, DOI 10.1007/s10067-010-1523-2; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Gourraud PA, 2011, GENET EPIDEMIOL, V35, P568, DOI 10.1002/gepi.20592; Guo X, 2010, HEPATOLOGY; Hann HWL, 2010, CURR CLIN ONCOL, P235, DOI 10.1007/978-1-60327-376-3_7; Hohler T, 1997, J HEPATOL, V26, P503, DOI 10.1016/S0168-8278(97)80414-X; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Li SP, 2001, J HEPATOL, V34, P840, DOI 10.1016/S0168-8278(01)00047-2; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; LIN TM, 1989, ANTICANCER RES, V9, P737; Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001; Munirajan AK, 2008, J BIOL CHEM, V283, P24426, DOI 10.1074/jbc.M802316200; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sun ZT, 2002, J MED VIROL, V67, P447, DOI 10.1002/jmv.10094; Suneetha PV, 2006, J HEPATOL, V44, P856, DOI 10.1016/j.jhep.2006.01.028; Wang FS, 2003, WORLD J GASTROENTERO, V9, P641, DOI 10.3748/wjg.v9.i4.641; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Yang CH, 2008, OMICS, V12, P217, DOI 10.1089/omi.2008.0026; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	26	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e28839	10.1371/journal.pone.0028839	http://dx.doi.org/10.1371/journal.pone.0028839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363396	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700001
J	Geisberger, R; Huemer, M; Gassner, FJ; Zaborsky, N; Egle, A; Greil, R				Geisberger, Roland; Huemer, Michael; Gassner, Franz J.; Zaborsky, Nadja; Egle, Alexander; Greil, Richard			Lysine Residue at Position 22 of the AID Protein Regulates Its Class Switch Activity	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; ACTIVATION-INDUCED DEAMINASE; ANTIBODY DIVERSIFICATION ENZYME; CENTER B-CELLS; SOMATIC HYPERMUTATION; DNA DEAMINATION; NUCLEAR-EXPORT; PHOSPHORYLATION; RECOMBINATION; EXPRESSION	Background: Activation induced deaminase (AID) mediates class switch recombination and somatic hypermutation of immunoglobulin (Ig) genes in germinal centre B cells. In order to regulate its specific activity and as a means to keep off-target mutations low, several mechanisms have evolved, including binding to specific cofactors, phosphorylation and destabilization of nuclear AID protein. Although ubiquitination at lysine residues of AID is recognized as an essential step in initiating degradation of nuclear AID, any functional relevance of lysine modifications has remained elusive. Methodology/Principal Findings: Here, we report functional implications of lysine modifications of the human AID protein by generating a panel of lysine to arginine mutants of AID and assessment of their catalytic class switch activity. We found that only mutation of Lys22 to Arg resulted in a significant reduction of class switching to IgG1 in transfected primary mouse B cells. This decrease in activity was neither reflected in reduced hypermutation of Ig genes in AID-mutant transfected DT40 B cell lines nor recapitulated in bacterial deamination assays, pointing to involvement of post-translational modification of Lys22 for AID activity in B cells. Conclusions/Significance: Our results imply that lysine modification may represent a novel level of AID regulation and that Lys22 is important for effective AID activity.	[Geisberger, Roland; Huemer, Michael; Gassner, Franz J.; Zaborsky, Nadja; Egle, Alexander; Greil, Richard] Paracelsus Med Univ Salzburg, Lab Immunol & Mol Canc Res, Med Dept Hematol Med Oncol Hemostaseol Rheumatol, Salzburg, Austria	Paracelsus Private Medical University	Geisberger, R (corresponding author), Paracelsus Med Univ Salzburg, Lab Immunol & Mol Canc Res, Med Dept Hematol Med Oncol Hemostaseol Rheumatol, Salzburg, Austria.	r.geisberger@salk.at	Gassner, Franz/AAN-1735-2021; Greil, Richard F/C-7673-2017; Egle, Alexander/AAC-3787-2020	Greil, Richard F/0000-0002-4462-3694; Egle, Alexander/0000-0003-0648-4416; Zaborsky, Nadja/0000-0002-9775-185X; Geisberger, Roland/0000-0002-0131-2191; Gassner, Franz J/0000-0001-9894-0313	FWF [SFB021, L488-B13, T516-B13]; Paracelsus Medical University Salzburg [E-09/09/047-GRE]; Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH; province of Salzburg	FWF(Austrian Science Fund (FWF)); Paracelsus Medical University Salzburg; Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH; province of Salzburg	This work was supported by the Austrian science fund FWF (SFB021 to R.Greil; L488-B13 to A.E.; Hertha Firnberg T516-B13 to N.Z.; www.fwf.ac.at), a grant from the Paracelsus Medical University Salzburg (PMU grant E-09/09/047-GRE to R.Greil and R.Geisberger; www.pmu.ac.at), the Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH, and the province of Salzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Arakawa H, 2004, PLOS BIOL, V2, P967, DOI 10.1371/journal.pbio.0020179; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; KIM KM, 1993, EUR J IMMUNOL, V23, P911, DOI 10.1002/eji.1830230422; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Maeda K, 2010, J BIOL CHEM, V285, P23945, DOI 10.1074/jbc.M110.131441; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; Nowak U, 2011, NAT IMMUNOL, V12, P160, DOI 10.1038/ni.1977; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sena-Esteves M, 1999, J VIROL, V73, P10426, DOI 10.1128/JVI.73.12.10426-10439.1999; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556	42	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30667	10.1371/journal.pone.0030667	http://dx.doi.org/10.1371/journal.pone.0030667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363466	gold, Green Published, Green Submitted			2022-12-25	WOS:000302871500013
J	Heegaard, NHH; West-Norager, M; Tanassi, JT; Houen, G; Nedergaard, L; Hogdall, C; Hogdall, E				Heegaard, Niels H. H.; West-Norager, Mikkel; Tanassi, Julia T.; Houen, Gunnar; Nedergaard, Lotte; Hogdall, Claus; Hogdall, Estrid			Circulating Antinuclear Antibodies in Patients with Pelvic Masses Are Associated with Malignancy and Decreased Survival	PLOS ONE			English	Article							OVARIAN-CANCER; AUTOANTIBODIES	Background: Circulating autoantibodies occur more frequently in cancer patients than in patients without cancer. Methods and Findings: We examined sera from patients referred for pelvic mass symptoms to a tertiary university clinic. A total of 127 were diagnosed with epithelial ovarian cancer while 386 had a benign condition. A screen for IgG anti-nuclear antibodies (ANA) by indirect immunofluorescence on HEp-2 cells confirmed a highly significant overrepresentation of ANA in the cancer group where 40% had detectable (i.e., a titer >= 160) ANA compared with less than 12% in the benign group. The overrepresentation of ANA in the cancer group persisted (p<0.0001) after matching the age-profile of the benign group with the ovarian cancer group. Only 19 out of 127 patients in the age-matched benign subgroup were positive for ANA corresponding to an 85% specificity at 40% sensitivity of ANA as the only marker for malignancy. No correlation of ANA positivity in either group with specific bands in immunoblots could be demonstrated even though immunoblot positivity was clearly increased in the malignant group (41% vs. 3%). The presence, strength, and type of ANA did not correlate with serum CA-125 values or with staging, and ANA outcome did not contribute with independent diagnostic information. However, survival was significantly shorter in ANA-positive compared with ANA-negative cancer patients and patients with CA-125 below the median CA-125 value in the cancer group had a significantly decreased survival when positive for ANA. ANA status made no difference in the group with CA-125 values above the median. Also, there was a significant correlation between speckled ANA-strength and histological tumor grade. Conclusions: Circulating antibodies are a promising source for new biomarkers in cancer. Characterization of epitope specificities and measurements of consecutive samples will be important for further elucidating the role of ANA in evaluating ovarian cancer patients.	[Heegaard, Niels H. H.; West-Norager, Mikkel; Tanassi, Julia T.; Houen, Gunnar] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Nedergaard, Lotte] Univ Copenhagen, Rigshosp, Dept Pathol, Copenhagen, Denmark; [Hogdall, Claus] Univ Copenhagen, Juliane Marie Ctr, Gynecol Clin, Rigshosp, Copenhagen, Denmark; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, DK-2730 Herlev, Denmark	Statens Serum Institut; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Heegaard, NHH (corresponding author), Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark.	nhe@ssi.dk		Hogdall, Estrid/0000-0003-4689-5658; Houen, Gunnar/0000-0002-5948-4156; Hogdall, Claus/0000-0002-5959-8874				Andersen-Ranberg K, 2004, CLIN EXP IMMUNOL, V138, P158, DOI 10.1111/j.1365-2249.2004.02575.x; COX DR, 1972, J R STAT SOC B, V34, P187; Dahle C, 2004, J AUTOIMMUN, V22, P241, DOI 10.1016/j.jaut.2003.12.004; Desmetz C, 2009, EXPERT REV PROTEOMIC, V6, P377, DOI 10.1586/EPR.09.56; Hatpio R, 2004, CLIN BIOCHEM, V37, P512, DOI 10.1016/j.clinbiochem.2004.05.012; HIJMANS W, 1984, MECH AGEING DEV, V26, P83, DOI 10.1016/0047-6374(84)90167-2; Hudson ME, 2007, P NATL ACAD SCI USA, V104, P17494, DOI 10.1073/pnas.0708572104; IMAI H, 1992, AM J PATHOL, V140, P859; Karam AK, 2010, NAT REV CLIN ONCOL, V7, P335, DOI 10.1038/nrclinonc.2010.44; KENEMANS P, 1993, CLIN CHEM, V39, P2509; MOORE AE, 1955, CANCER RES, V15, P598; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; TAN EM, 1988, CLIN IMMUNOL IMMUNOP, V47, P121, DOI 10.1016/0090-1229(88)90066-9; Tan EM, 2001, J CLIN INVEST, V108, P1411, DOI 10.1172/JCI200114451; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; West-Hielsen M, 2005, ANAL CHEM, V77, P5114, DOI 10.1021/ac050253g; West-Norager M, 2009, ANAL CHEM, V81, P1907, DOI 10.1021/ac802293g	17	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30997	10.1371/journal.pone.0030997	http://dx.doi.org/10.1371/journal.pone.0030997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363532	Green Submitted, gold, Green Published			2022-12-25	WOS:000302853600095
J	Wong, M; Ohrmalm, L; Broliden, K; Aust, C; Hibberd, M; Tolfvenstam, T				Wong, Michelle; Ohrmalm, Lars; Broliden, Kristina; Aust, Carl; Hibberd, Martin; Tolfvenstam, Thomas			Mannose-Binding Lectin 2 Polymorphisms Do Not Influence Frequency or Type of Infection in Adults with Chemotherapy Induced Neutropaenia	PLOS ONE			English	Article							REAL-TIME PCR; ACUTE MYELOID-LEUKEMIA; GENE; DEFICIENCY; PROTEIN; MBL; MUTATIONS; PROMOTER; VIRUSES; FEVER	Background: Mannose-binding Lectin protein (MBL) has been suggested to be relevant in the defence against infections in immunosuppressed individuals. In a Swedish adult cohort immunosuppressed from both the underlying disease and from iatrogenic treatments for their underlying disease we investigated the role of MBL in susceptibility to infection. Methods: In this cross sectional, prospective study, blood samples obtained from 96 neutropaenic febrile episodes, representing 82 individuals were analysed for single nucleotide polymorphism (SNP) in the MBL2 gene. Concurrent measurement of plasma MBL protein concentrations was also performed for observation of acute response during febrile episodes. Findings: No association was observed between MBL2 genotype or plasma MBL concentrations, and the type or frequency of infection. Adding to the literature, we found no evidence that viral infections or co-infections with virus and bacteria would be predisposed by MBL deficiency. We further saw no correlation between MBL2 genotype and the risk of fever. However, fever duration in febrile neutropaenic episodes was negatively associated with MBL2 SNP mutations (p<0.05). Patients with MBL2 SNP mutations presented a median febrile duration of 1.8 days compared with 3 days amongst patients with wildtype MBL2 genotype. Interpretation: We found no clear association between infection, or infection type to MBL2 genotypes or plasma MBL concentration, and add to the reports casting doubts on the benefit of recombinant MBL replacement therapy use during iatrogenic neutropaenia.	[Wong, Michelle; Ohrmalm, Lars; Broliden, Kristina; Aust, Carl; Tolfvenstam, Thomas] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden; [Hibberd, Martin] Genome Inst Singapore, Singapore, Singapore	Karolinska Institutet; Karolinska University Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Wong, M (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden.	michelle.wong@ki.se	Hibberd, Martin L/D-5050-2009	Tolfvenstam, Thomas/0000-0003-3549-8083; Hibberd, Martin/0000-0001-8587-1849	Swedish society of Medicine; Stockholm county council; Swedish childhood cancer foundation; Groschinsky foundation	Swedish society of Medicine; Stockholm county council(Stockholm County Council); Swedish childhood cancer foundation(European Commission); Groschinsky foundation	This work was supported by grants from the Swedish society of Medicine, Stockholm county council, Swedish childhood cancer foundation and the Groschinsky foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittoniemi J, 1997, APMIS, V105, P617, DOI 10.1111/j.1699-0463.1997.tb05062.x; ARAI T, 1993, Q J MED, V86, P575; Bergmann OJ, 2003, EUR J HAEMATOL, V70, P91, DOI 10.1034/j.1600-0609.2003.00012.x; Bernig T, 2004, GENES IMMUN, V5, P461, DOI 10.1038/sj.gene.6364116; Boldt ABW, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-38; Bossuyt X, 2007, CLIN CHEM, V53, P124, DOI 10.1373/clinchem.2007.075861; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Dahl M, 2004, J EXP MED, V199, P1391, DOI 10.1084/jem.20040111; Gustafsson I, MULTIPLEX REAL TIME; Hart ML, 2002, AIDS RES HUM RETROV, V18, P1311, DOI 10.1089/088922202320886352; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Kilpatrick DC, 2003, CLIN EXP IMMUNOL, V134, P279, DOI 10.1046/j.1365-2249.2003.02284.x; Klostergaard A, 2010, EUR J HAEMATOL, V85, P58, DOI 10.1111/j.1600-0609.2010.01443.x; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Martinez-Lopez J, 2009, LEUKEMIA LYMPHOMA, V50, P1283, DOI 10.1080/10428190903040006; Michelow IC, 2010, J BIOL CHEM, V285, P24729, DOI 10.1074/jbc.M110.106260; Muto S, 1999, BIOL PHARM BULL, V22, P347; Nauta AJ, 2003, EUR J HAEMATOL, V33, P2583; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Neth O, 2001, LANCET, V358, P614, DOI 10.1016/S0140-6736(01)05776-2; Nijhuis M, 2002, J CLIN MICROBIOL, V40, P3666, DOI 10.1128/JCM.40.10.3666-3670.2002; Ohrmalm L, VIRUS ASS FEVE UNPUB; Petersen KA, 2006, J CLIN IMMUNOL, V26, P465, DOI 10.1007/s10875-006-9037-z; Peterslund NA, 2001, LANCET, V358, P637, DOI 10.1016/S0140-6736(01)05785-3; Pizzo PA, 1999, NEW ENGL J MED, V341, P893, DOI 10.1056/NEJM199909163411207; Schejbel L, 2007, CLIN CHEM, V53, P159, DOI 10.1373/clinchem.2006.081224; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; Terlizzi ME, 2009, J VIROL METHODS, V160, P172, DOI 10.1016/j.jviromet.2009.04.039; Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368; Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X; Vekemans M, 2007, CLIN INFECT DIS, V44, P1593, DOI 10.1086/518171; World Health Organization, 2009, CDC PROT REALT RTPCR	34	12	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30819	10.1371/journal.pone.0030819	http://dx.doi.org/10.1371/journal.pone.0030819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363494	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000302853600071
J	Chen, SF; Chang, YC; Nieh, S; Liu, CL; Yang, CY; Lin, YS				Chen, Su-Feng; Chang, Yun-Ching; Nieh, Shin; Liu, Chia-Lin; Yang, Chin-Yuh; Lin, Yaoh-Shiang			Nonadhesive Culture System as a Model of Rapid Sphere Formation with Cancer Stem Cell Properties	PLOS ONE			English	Article							PUTATIVE MARKER; E-CADHERIN; CARCINOMA; HEAD; IDENTIFICATION; MECHANISMS; POPULATION; THERAPY; CD133; LINE	Background: Cancer stem cells (CSCs) play an important role in tumor initiation, progression, and metastasis and are responsible for high therapeutic failure rates. Identification and characterization of CSC are crucial for facilitating the monitoring, therapy, or prevention of cancer. Great efforts have been paid to develop a more effective methodology. Nevertheless, the ideal model for CSC research is still evolving. In this study, we created a nonadhesive culture system to enrich CSCs from human oral squamous cell carcinoma cell lines with sphere formation and to characterize their CSC properties further. Methods: A nonadhesive culture system was designed to generate spheres from the SAS and OECM-1 cell lines. A subsequent investigation of their CSC properties, including stemness, self-renewal, and chemo- and radioresistance in vitro, as well as tumor initiation capacity in vivo, was also performed. Results: Spheres were formed cost-effectively and time-efficiently within 5 to 7 days. Moreover, we proved that these spheres expressed putative stem cell markers and exhibited chemoradiotherapeutic resistance, in addition to tumor-initiating and self-renewal capabilities. Conclusions: Using this nonadhesive culture system, we successfully established a rapid and cost-effective model that exhibits the characteristics of CSCs and can be used in cancer research.	[Chen, Su-Feng] China Med Univ, Dept Dent Hyg, Taichung, Taiwan; [Chang, Yun-Ching; Liu, Chia-Lin] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chang, Yun-Ching; Nieh, Shin] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Chang, Yun-Ching; Nieh, Shin; Yang, Chin-Yuh; Lin, Yaoh-Shiang] Tri Serv Gen Hosp, Taipei, Taiwan; [Yang, Chin-Yuh] Natl Def Med Ctr, Dept Dent, Taipei, Taiwan; [Lin, Yaoh-Shiang] Natl Def Med Ctr, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan	China Medical University Taiwan; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Chen, SF (corresponding author), China Med Univ, Dept Dent Hyg, Taichung, Taiwan.	yaohshiang@gmail.com		mou, wenjun/0000-0002-7781-7671	Tri-Service General Hospital and National Defense Medical Centre [TSGH-C100-007-009-10-S02, TSGH-C100-161, TSGH-C100-155, I-29]; Department of Dental Hygiene, China Medical University [CMU99-N1-04-1]; National Science Council, Republic of China (Taiwan) [NSC 99-2320-B-039-028-MY3, NSC 100-2320-B-016-009]; Department of Health, Executive Yuan, Republic of China (Taiwan) [DOH100-TD-PB-111-TM007-22]	Tri-Service General Hospital and National Defense Medical Centre; Department of Dental Hygiene, China Medical University; National Science Council, Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Republic of China (Taiwan)	This study was partly supported by the Tri-Service General Hospital and National Defense Medical Centre: Grant No. TSGH-C100-007-009-10-S02, TSGH-C100-161, TSGH-C100-155 and I-29; Department of Dental Hygiene, China Medical University: Grant No. CMU99-N1-04-1; National Science Council, Republic of China (Taiwan): Grants No. NSC 99-2320-B-039-028-MY3 and NSC 100-2320-B-016-009; Department of Health, Executive Yuan, Republic of China (Taiwan): DOH100-TD-PB-111-TM007-22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Swiahb JN, 2010, FUTURE ONCOL, V6, P837, DOI 10.2217/fon.10.35; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Costea DE, 2006, ORAL DIS, V12, P443, DOI 10.1111/j.1601-0825.2006.01264.x; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dubessy C, 2000, CRIT REV ONCOL HEMAT, V36, P179, DOI 10.1016/S1040-8428(00)00085-8; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hueng DY, 2011, J NEURO-ONCOL, V104, P45, DOI 10.1007/s11060-010-0469-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jordan CT, 2004, ONCOGENE, V23, P7178, DOI 10.1038/sj.onc.1207935; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Le Tourneau C, 2010, B CANCER, V97, P1453, DOI 10.1684/bdc.2010.1226; Lee CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-64; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Lippman SM, 2005, J CLIN ONCOL, V23, P346, DOI 10.1200/JCO.2005.09.128; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; OLASZ L, 1988, CANCER, V62, P1267, DOI 10.1002/1097-0142(19881001)62:7<1267::AID-CNCR2820620704>3.0.CO;2-G; Ouyang GL, 2010, CELL MOL LIFE SCI, V67, P2605, DOI 10.1007/s00018-010-0338-2; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shen SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023282; Song J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011456; Sung JM, 2008, BIOCHEM BIOPH RES CO, V371, P163, DOI 10.1016/j.bbrc.2008.04.038; Timmins Nicholas E., 2004, Angiogenesis, V7, P97, DOI 10.1007/s10456-004-8911-7; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Wei XD, 2009, HEAD NECK-J SCI SPEC, V31, P94, DOI 10.1002/hed.20935; Yanamoto S, 2011, ORAL ONCOL, V47, P855, DOI 10.1016/j.oraloncology.2011.06.501; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zhang QZ, 2010, CANCER LETT, V289, P151, DOI 10.1016/j.canlet.2009.08.010; Zhong Y, 2010, CANCER LETT, V299, P150, DOI 10.1016/j.canlet.2010.08.013; Zhou L, 2007, LARYNGOSCOPE, V117, P455, DOI 10.1097/01.mlg.0000251586.15299.35	47	100	102	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31864	10.1371/journal.pone.0031864	http://dx.doi.org/10.1371/journal.pone.0031864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359637	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200106
J	Jaworski, JP; Krebs, SJ; Trovato, M; Kovarik, DN; Brower, Z; Sutton, WF; Waagmeester, G; Sartorius, R; D'Apice, L; Caivano, A; Doria-Rose, NA; Malherbe, D; Montefiori, DC; Barnett, S; De Berardinis, P; Haigwood, NL				Jaworski, Juan Pablo; Krebs, Shelly J.; Trovato, Maria; Kovarik, Dina N.; Brower, Zachary; Sutton, William F.; Waagmeester, Garrett; Sartorius, Rossella; D'Apice, Luciana; Caivano, Antonella; Doria-Rose, Nicole A.; Malherbe, Delphine; Montefiori, David C.; Barnett, Susan; De Berardinis, Piergiuseppe; Haigwood, Nancy L.			Co-Immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8(+) T Cells	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; CELLULAR IMMUNE-RESPONSES; SIMIAN IMMUNODEFICIENCY; MONOCLONAL-ANTIBODIES; RHESUS-MONKEYS; MULTIENZYME COMPLEX; MUCOSAL CHALLENGE; GERMINAL-CENTERS; CHIMERIC VIRUS; HIGH-FREQUENCY	To obtain proof of concept for HIV vaccines, we generated recombinant multimeric particles displaying the HIV-1 Envelope (Env) third hypervariable region (V3) as an N-terminal fusion protein on the E2 subunit of the pyruvate dehydrogenase complex of Geobacillus stearothermophilus. The E2 scaffold self-assembles into a 60-mer core that is 24 nm in diameter, with a molecular weight of 1.5 MDa, similar to a virus like particle with up to 60 copies of a heterologous protein accessible on the surface. Env(V3)-E2 multimers were tested alone and in combination with Env(gp160) DNA in mice and rabbits. Following two or more co-immunizations with Env(V3)-E2 and Env gp160 DNA, all 18 rabbits developed potent autologous neutralizing antibodies specific for V3 in six weeks. These neutralizing antibodies were sustained for 16 weeks without boosting, and comparable responses were obtained when lipopolysaccharide, a contaminant from expression in E. coli, was removed. Co-immunizations of Env(V3)-E2 and DNA expressing gp160 elicited moderate CD8-specific responses and Env-specific antibodies in mice. Co-immunization with DNA and E2 was superior to individual or sequential vaccination with these components in eliciting both neutralizing antibodies in rabbits and CD8(+) T cell responses in mice. Co-immunization with DNA and multimeric E2 scaffolds appears to offer a highly effective means of eliciting rapid, specific, and sustained immune responses that may be a useful approach for other vaccine targets.	[Jaworski, Juan Pablo; Krebs, Shelly J.; Brower, Zachary; Sutton, William F.; Waagmeester, Garrett; Malherbe, Delphine; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA; [Trovato, Maria; Sartorius, Rossella; D'Apice, Luciana; Caivano, Antonella; De Berardinis, Piergiuseppe] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Kovarik, Dina N.; Haigwood, Nancy L.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Doria-Rose, Nicole A.] Seattle Biomed Res Inst, Viral Vaccines Program, Seattle, WA 98109 USA; [Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC USA; [Barnett, Susan] Novartis, Cambridge, MA USA	Oregon Health & Science University; Oregon National Primate Research Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Washington; University of Washington Seattle; Center for Infectious Disease Research; Duke University; Novartis	Jaworski, JP (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA.	haigwoon@ohsu.edu	De Berardinis, Piergiuseppe/HCI-0893-2022; SARTORIUS, ROSSELLA/G-8559-2016; sartorius, rossella/AAF-1623-2021; De Berardinis, Piergiuseppe/AAX-1049-2020; Haigwood, Nancy Logan/AAV-7484-2020; Jaworski, Juan/ABA-4503-2020; CAIVANO, ANTONELLA/J-8120-2018	sartorius, rossella/0000-0003-0153-9377; De Berardinis, Piergiuseppe/0000-0001-6579-1729; Jaworski, Juan/0000-0002-1311-060X; CAIVANO, ANTONELLA/0000-0003-2502-4060; Trovato, Maria/0000-0002-3831-6073; Haigwood, Nancy/0000-0002-1477-9575; D'Apice, Luciana/0000-0002-6513-2237	PHS [AI30034, R01-AI074379, R21-AI062418, P51-RR-000163, T32-A1074494]; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074379, R21AI062418] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by PHS grants AI30034 (to DM), R01-AI074379 and R21-AI062418 (to NLH and PDB), P51-RR-000163 (to NLH), and T32-A1074494 (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; Barnett SW, 1997, VACCINE, V15, P869, DOI 10.1016/S0264-410X(96)00264-2; Barouch DH, 2001, J VIROL, V75, P2462, DOI 10.1128/JVI.75.5.2462-2467.2001; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buonaguro L, 2005, J VIROL, V79, P7059, DOI 10.1128/JVI.79.11.7059-7067.2005; Caivano A, 2010, VIROLOGY, V407, P296, DOI 10.1016/j.virol.2010.08.026; Cruz LJ, 2004, BIOCONJUGATE CHEM, V15, P112, DOI 10.1021/bc034119j; De Berardinis P, 2003, CURR HIV RES, V1, P441; Derby NR, 2006, J VIROL, V80, P8745, DOI 10.1128/JVI.00956-06; Domingo GJ, 2003, VACCINE, V21, P1502, DOI 10.1016/S0264-410X(02)00664-3; Domingo GJ, 2001, J MOL BIOL, V305, P259, DOI 10.1006/jmbi.2000.4311; Doria-Rose NA, 2005, J VIROL, V79, P11214, DOI 10.1128/JVI.79.17.11214-11224.2005; Doria-Rose NA, 2003, J VIROL, V77, P11563, DOI 10.1128/JVI.77.21.11563-11577.2003; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Graham BS, 2002, ANNU REV MED, V53, P207, DOI 10.1146/annurev.med.53.082901.104035; Greenland JR, 2007, VACCINE, V25, P3731, DOI 10.1016/j.vaccine.2007.01.120; HAFFAR OK, 1991, VIROLOGY, V183, P487, DOI 10.1016/0042-6822(91)90978-K; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; HU SL, 1987, NATURE, V328, P721, DOI 10.1038/328721a0; Huang KHG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1100; Humbert M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003937; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Iglesias E, 2005, MOL IMMUNOL, V42, P99, DOI 10.1016/j.molimm.2004.06.038; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Lifson JD, 2004, AIDS RES HUM RETROV, V20, P772, DOI 10.1089/0889222041524661; Margolin DH, 2002, J VIROL, V76, P3965, DOI 10.1128/JVI.76.8.3965-3973.2002; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Montefiori DM, 2004, CURRENT PRO IN PRESS; Mossman SP, 2004, AIDS RES HUM RETROV, V20, P425, DOI 10.1089/088922204323048177; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Patterson LJ, 2004, J VIROL, V78, P2212, DOI 10.1128/JVI.78.5.2212-2221.2004; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Quan FS, 2007, VACCINE, V25, P3841, DOI 10.1016/j.vaccine.2007.01.107; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Totrov M, 2010, VIROLOGY, V405, P513, DOI 10.1016/j.virol.2010.06.027; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; Vaine M, 2010, VACCINE, V28, P2999, DOI 10.1016/j.vaccine.2010.02.006; Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801; Zolla-Pazner S, 2009, VIROLOGY, V392, P82, DOI 10.1016/j.virol.2009.05.039	55	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31464	10.1371/journal.pone.0031464	http://dx.doi.org/10.1371/journal.pone.0031464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359593	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200062
J	Kaur, H; Yung, LYL				Kaur, Harleen; Yung, Lin-Yue Lanry			Probing High Affinity Sequences of DNA Aptamer against VEGF(165)	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR VEGF; IN-VITRO; SYSTEMATIC EVOLUTION; RNA INHIBITORS; SELECTION; HYPOXIA; MOLECULES; LIGANDS; BINDING	Vascular endothelial growth factor (VEGF(165)) is a potent angiogenic mitogen commonly overexpressed in cancerous cells. It contains two main binding domains, the receptor-binding domain (RBD) and the heparin-binding domain (HBD). This study attempted to identify the specific sequences of the VEa5 DNA aptamer that exhibit high binding affinity towards the VEGF(165) protein by truncating the original VEa5 aptamer into different segments. Using surface plasmon resonance (SPR) spectroscopy for binding affinity analysis, one of the truncated aptamers showed a >200-fold increase in the binding affinity for HBD. This truncated aptamer also exhibited high specificity to HBD with negligible binding affinity for VEGF(121), an isoform of VEGF lacking HBD. Exposing colorectal cancer cells to the truncated aptamer sequence further confirmed the binding affinity and specificity of the aptamer to the target VEGF(165) protein. Hence, our approach of aptamer truncation can potentially be useful in identifying high affinity aptamer sequences for the biological molecules and targeting them as antagonist for cancer cell detection.	[Kaur, Harleen; Yung, Lin-Yue Lanry] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore	National University of Singapore	Kaur, H (corresponding author), Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117548, Singapore.	cheyly@nus.edu.sg	Kaur, Harleen/AAJ-8789-2020; Yung, Lanry/B-6515-2009; K, Harleen/T-2613-2019	Yung, Lanry/0000-0001-7579-6347; 	Singapore Ministry of Education [MOE2008-T2-1-046, R279000282112]	Singapore Ministry of Education(Ministry of Education, Singapore)	This work was supported by research funding from the Singapore Ministry of Education Academic Research Fund Tier 2 grant MOE2008-T2-1-046 and Tier 1 grant R279000282112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Berezovski M, 2005, J AM CHEM SOC, V127, P3165, DOI 10.1021/ja042394q; Bernimoulin M, 2009, J THROMB HAEMOST, V7, P1019, DOI 10.1111/j.1538-7836.2009.03434.x; Biesecker G, 1999, IMMUNOPHARMACOLOGY, V42, P219, DOI 10.1016/S0162-3109(99)00020-X; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Boomer RM, 2005, OLIGONUCLEOTIDES, V15, P183, DOI 10.1089/oli.2005.15.183; Calvani M, 2008, CANCER RES, V68, P285, DOI 10.1158/0008-5472.CAN-07-5564; Chan MY, 2008, CIRCULATION, V117, P2865, DOI 10.1161/CIRCULATIONAHA.107.745687; Chelliserrykattil J, 2004, NAT BIOTECHNOL, V22, P1155, DOI 10.1038/nbt1001; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Davis JH, 2002, P NATL ACAD SCI USA, V99, P11616, DOI 10.1073/pnas.182095699; Davis KA, 1998, NUCLEIC ACIDS RES, V26, P3915, DOI 10.1093/nar/26.17.3915; Diener JL, 2009, J THROMB HAEMOST, V7, P1155, DOI 10.1111/j.1538-7836.2009.03459.x; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Green LS, 1996, BIOCHEMISTRY-US, V35, P14413, DOI 10.1021/bi961544+; Hasegawa H, 2008, BIOTECHNOL LETT, V30, P829, DOI 10.1007/s10529-007-9629-6; Hasegawa H, 2008, SENSORS-BASEL, V8, P1090, DOI 10.3390/s8021090; Hernandez FJ, 2009, BIOORG MED CHEM LETT, V19, P6585, DOI 10.1016/j.bmcl.2009.10.039; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Jayasena SD, 1999, CLIN CHEM, V45, P1628; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; Katilius E, 2007, NUCLEIC ACIDS RES, V35, P7626, DOI 10.1093/nar/gkm922; Kato T, 2000, NUCLEIC ACIDS RES, V28, P1963, DOI 10.1093/nar/28.9.1963; KAWASAKI AM, 1993, J MED CHEM, V36, P831, DOI 10.1021/jm00059a007; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; MINCHENKO A, 1994, LAB INVEST, V71, P374; Misono TS, 2005, ANAL BIOCHEM, V342, P312, DOI 10.1016/j.ab.2005.04.013; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Ninichuk V, 2008, AM J PATHOL, V172, P628, DOI 10.2353/ajpath.2008.070601; Oswald J, 2007, CANCER LETT, V254, P102, DOI 10.1016/j.canlet.2007.02.016; Pagratis NC, 1997, NAT BIOTECHNOL, V15, P68, DOI 10.1038/nbt0197-68; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Potty ASR, 2009, BIOPOLYMERS, V91, P145, DOI 10.1002/bip.21097; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Sayer NM, 2004, J BIOL CHEM, V279, P13102, DOI 10.1074/jbc.M310928200; Sayyed SG, 2009, DIABETOLOGIA, V52, P2445, DOI 10.1007/s00125-009-1493-6; Schmidt KS, 2004, NUCLEIC ACIDS RES, V32, P5757, DOI 10.1093/nar/gkh862; Shangguan D, 2007, CHEMBIOCHEM, V8, P603, DOI 10.1002/cbic.200600532; SHIMA DT, 1995, FEBS LETT, V370, P203, DOI 10.1016/0014-5793(95)00831-S; Somasunderam A, 2005, BIOCHEMISTRY-US, V44, P10388, DOI 10.1021/bi0507074; Tok JBH, 2008, CHEM COMMUN, P1883, DOI 10.1039/b717936g; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; WALEH NS, 1995, CANCER RES, V55, P6222; Wrzesinski J, 2005, BIOCHEMISTRY-US, V44, P6257, DOI 10.1021/bi047397u; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	97	102	4	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31196	10.1371/journal.pone.0031196	http://dx.doi.org/10.1371/journal.pone.0031196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359573	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200042
J	Liu, Z; Xing, MZ				Liu, Zhi; Xing, Mingzhao			Induction of Sodium/Iodide Symporter (NIS) Expression and Radioiodine Uptake in Non-Thyroid Cancer Cells	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; DIFFERENTIATED THYROID-CARCINOMA; HISTONE DEACETYLASE INHIBITOR; GENE-EXPRESSION; NA+/I-SYMPORTER; THERAPEUTIC IMPLICATIONS; MELANOMA-CELLS; BREAST-CANCER; ACETYLATION; PATHWAYS	Background: This study was designed to explore the therapeutic potential of suppressing MAP kinase and PI3K/Akt pathways and histone deacetylase (HDAC) to induce the expression of sodium/iodide symporter (NIS) and radioiodine uptake in non-thyroid cancer cells. Methods: We tested the effects of the MEK inhibitor RDEA119, the Akt inhibitor perifosine, and the HDAC inhibitor SAHA on NIS expression in thirteen human cancer cell lines derived from melanoma, hepatic carcinoma, gastric carcinoma, colon carcinoma, breast carcinoma, and brain cancers. We also examined radioiodine uptake and histone acetylation at the NIS promoter in selected cells. Results: Overall, the three inhibitors could induce NIS expression, to various extents, in melanoma and all the epithelial carcinoma-derived cells but not in brain cancer-derived cells. SAHA was most effective and its effect could be significantly enhanced by RDEA119 and perifosine. The expression of NIS, at both mRNA and protein levels, was most robust in the melanoma cell M14, hepatic carcinoma cell HepG2, and the gastric carcinoma cell MKN-7 cell. Radioiodine uptake was correspondingly induced, accompanied by robust increase in histone acetylation at the NIS promoter, in these cells when treated with the three inhibitors. Conclusions: This is the first demonstration that simultaneously suppressing the MAP kinase and PI3K/Akt pathways and HDAC could induce robust NIS expression and radioiodine uptake in certain non-thyroid human cancer cells, providing novel therapeutic implications for adjunct radioiodine treatment of these cancers.	[Liu, Zhi; Xing, Mingzhao] Johns Hopkins Univ, Sch Med, Lab Cellular & Mol Thyroid Res, Div Endocrinol & Metab, Baltimore, MD 21218 USA	Johns Hopkins University	Liu, Z (corresponding author), Johns Hopkins Univ, Sch Med, Lab Cellular & Mol Thyroid Res, Div Endocrinol & Metab, Baltimore, MD 21218 USA.	mxing1@jhmi.edu	Liu, Zhi/D-2759-2012		National Institute of Health [CA134225]; NATIONAL CANCER INSTITUTE [R01CA134225] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institute of Health R01 grant CA134225 to Dr. Xing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arturi F, 1998, J CLIN ENDOCR METAB, V83, P2493, DOI 10.1210/jc.83.7.2493; Baker C. H., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P167, DOI 10.2174/1568008043339839; BAKHEET SM, 1994, EUR J NUCL MED, V21, P604, DOI 10.1007/BF00285581; Caillou B, 1998, J CLIN ENDOCR METAB, V83, P4102, DOI 10.1210/jc.83.11.4102; Carafa V, 2011, RECENT PAT ANTI-CANC, V6, P131, DOI 10.2174/157489211793980088; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Cho Je-Yoel, 2002, Current Gene Therapy, V2, P393, DOI 10.2174/1566523023347599; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Ellerhorst JA, 2006, ENDOCR-RELAT CANCER, V13, P1269, DOI 10.1677/erc.1.01239; GREENLER DP, 1989, CLIN NUCL MED, V14, P111, DOI 10.1097/00003072-198902000-00009; Hingorani M, 2010, CURR CANCER DRUG TAR, V10, P242, DOI 10.2174/156800910791054194; Hou P, 2010, J CLIN ENDOCR METAB, V95, P820, DOI 10.1210/jc.2009-1888; Hou P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006200; Jhiang S M, 2000, Rev Endocr Metab Disord, V1, P205, DOI 10.1023/A:1010083132071; Jhiang SM, 1998, ENDOCRINOLOGY, V139, P4416, DOI 10.1210/en.139.10.4416; Kang DY, 2009, PATHOL INT, V59, P73, DOI 10.1111/j.1440-1827.2008.02331.x; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kitazono M, 2001, J CLIN ENDOCR METAB, V86, P3430, DOI 10.1210/jc.86.7.3430; Kogai T, 2000, P NATL ACAD SCI USA, V97, P8519, DOI 10.1073/pnas.140217197; Li W, 2007, J CLIN ENDOCR METAB, V92, P1080, DOI 10.1210/jc.2006-2106; Liu Z, 2010, CLIN CANCER RES, V16, P6009, DOI 10.1158/1078-0432.CCR-10-1627; MacDonald VE, 2009, EPIGENETICS-US, V4, P139, DOI 10.4161/epi.4.3.8484; McCubrey JA, 2010, EXPERT OPIN EMERG DR, V15, P203, DOI 10.1517/14728210903282760; MCDOUGALL IR, 1995, CLIN NUCL MED, V20, P869, DOI 10.1097/00003072-199510000-00002; Morgenstern KE, 2005, OPHTHAL PLAST RECONS, V21, P337, DOI 10.1097/01.iop.0000179369.75569.a8; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Park HJ, 2000, THYROID, V10, P211, DOI 10.1089/thy.2000.10.211; Puppin C, 2005, ENDOCRINOLOGY, V146, P3967, DOI 10.1210/en.2005-0128; ROSENBAUM RC, 1988, CLIN NUCL MED, V13, P657, DOI 10.1097/00003072-198809000-00011; Slominski A, 2002, J INVEST DERMATOL, V119, P1449, DOI 10.1046/j.1523-1747.2002.19617.x; Smanik PA, 1997, ENDOCRINOLOGY, V138, P3555, DOI 10.1210/en.138.8.3555; Spitzweg C, 1999, J CLIN ENDOCR METAB, V84, P4178, DOI 10.1210/jc.84.11.4178; Spitzweg C, 2002, CLIN ENDOCRINOL, V57, P559, DOI 10.1046/j.1365-2265.2002.01640.x; Spitzweg C, 2001, KIDNEY INT, V59, P1013, DOI 10.1046/j.1523-1755.2001.00584.x; Tazebay UH, 2000, NAT MED, V6, P871, DOI 10.1038/78630; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Zarnegar R, 2002, SURGERY, V132, P984, DOI 10.1067/msy.2002.128690	37	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31729	10.1371/journal.pone.0031729	http://dx.doi.org/10.1371/journal.pone.0031729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359623	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200092
J	Nie, Y; Tang, YQ; Li, Y; Chi, CQ; Cai, M; Wu, XL				Nie, Yong; Tang, Yue-Qin; Li, Yan; Chi, Chang-Qiao; Cai, Man; Wu, Xiao-Lei			The Genome Sequence of Polymorphum gilvum SL003B-26A1(T) Reveals Its Genetic Basis for Crude Oil Degradation and Adaptation to the Saline Soil	PLOS ONE			English	Article							GUDAONENSIS SP NOV.; ALKANE HYDROXYLASES; SYSTEM; BIODEGRADATION; BACTERIUM; CHEMOTAXIS; FAMILY; IDENTIFICATION; HYDROCARBONS; SURFACTANTS	Polymorphum gilvum SL003B-26A1(T) is the type strain of a novel species in the recently published novel genus Polymorphum isolated from saline soil contaminated with crude oil. It is capable of using crude oil as the sole carbon and energy source and can adapt to saline soil at a temperature of 45 degrees C. The Polymorphum gilvum genome provides a genetic basis for understanding how the strain could degrade crude oil and adapt to a saline environment. Genome analysis revealed the versatility of the strain for emulsifying crude oil, metabolizing aromatic compounds ( a characteristic specific to the Polymorphum gilvum genome in comparison with other known genomes of oil-degrading bacteria), as well as possibly metabolizing n-alkanes through the LadA pathway. In addition, COG analysis revealed Polymorphum gilvum SL003B-26A1(T) has significantly higher abundances of the proteins responsible for cell motility, lipid transport and metabolism, and secondary metabolite biosynthesis, transport and catabolism than the average levels found in all other genomes sequenced thus far, but lower abundances of the proteins responsible for carbohydrate transport and metabolism, defense mechanisms, and translation than the average levels. These traits support the adaptability of Polymorphum gilvum to a crude oil-contaminated saline environment. The Polymorphum gilvum genome could serve as a platform for further study of oil-degrading microorganisms for bioremediation and microbial-enhanced oil recovery in harsh saline environments.	[Nie, Yong; Tang, Yue-Qin; Li, Yan; Chi, Chang-Qiao; Cai, Man; Wu, Xiao-Lei] Peking Univ, Coll Engn, Dept Energy & Resources Engn, Beijing 100871, Peoples R China	Peking University	Nie, Y (corresponding author), Peking Univ, Coll Engn, Dept Energy & Resources Engn, Beijing 100871, Peoples R China.	xiaolei_wu@pku.edu.cn	Wu, Xiao-Lei/G-6882-2011	Wu, Xiao-Lei/0000-0002-9897-6903	National Natural Science Foundation of China [30870086, 31070107, 40821140541]; National High Technology Research and Development Program of China [2009AA063501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by the National Natural Science Foundation of China (30870086, 31070107 and 40821140541, http://www.nsfc.gov.cn) and the National High Technology Research and Development Program of China (2009AA063501, http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; BENSON S, 1979, J BACTERIOL, V140, P754, DOI 10.1128/JB.140.3.754-762.1979; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brown LR, 2010, CURR OPIN MICROBIOL, V13, P316, DOI 10.1016/j.mib.2010.01.011; Cai M, 2011, INT J SYST EVOL MICR, V61, P1767, DOI 10.1099/ijs.0.025932-0; Cai M, 2011, SYST APPL MICROBIOL, V34, P321, DOI 10.1016/j.syapm.2011.03.004; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Callaghan AV, 2008, BIOCHEM BIOPH RES CO, V366, P142, DOI 10.1016/j.bbrc.2007.11.094; Callaghan AV, 2011, ENV MICROBI IN PRESS; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Cock PJA, 2007, MOL BIOL EVOL, V24, P2355, DOI 10.1093/molbev/msm170; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Desai JD, 1997, MICROBIOL MOL BIOL R, V61, P47, DOI 10.1128/.61.1.47-64.1997; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Drepper T, 2006, FEMS MICROBIOL LETT, V258, P250, DOI 10.1111/j.1574-6968.2006.00228.x; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Feng L, 2007, P NATL ACAD SCI USA, V104, P5602, DOI 10.1073/pnas.0609650104; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Funhoff EG, 2006, J BACTERIOL, V188, P5220, DOI 10.1128/JB.00286-06; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gerischer U, 2002, J MOL MICROB BIOTECH, V4, P111; Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Grundmann O, 2008, ENVIRON MICROBIOL, V10, P376, DOI 10.1111/j.1462-2920.2007.01458.x; Gu J, 2007, INT J SYST EVOL MICR, V57, P250, DOI 10.1099/ijs.0.64522-0; Heermann R, 2004, CURR OPIN MICROBIOL, V7, P168, DOI 10.1016/j.mib.2004.02.008; Heermann R, 2010, FEMS MICROBIOL LETT, V304, P97, DOI 10.1111/j.1574-6968.2010.01906.x; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; HULTGREN SJ, 1991, ANNU REV MICROBIOL, V45, P383, DOI 10.1146/annurev.micro.45.1.383; Johnsborg O, 2007, RES MICROBIOL, V158, P767, DOI 10.1016/j.resmic.2007.09.004; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kleinsteuber S, 2006, APPL ENVIRON MICROB, V72, P3531, DOI 10.1128/AEM.72.5.3531-3542.2006; Kramer R, 2010, CHEM REC, V10, P217, DOI 10.1002/tcr.201000005; Kramer R, 2009, AMINO ACIDS, V37, P487, DOI 10.1007/s00726-009-0271-6; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Li SG, 2011, J BACTERIOL, V193, P2894, DOI 10.1128/JB.00333-11; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Maier RM, 2000, APPL MICROBIOL BIOT, V54, P625, DOI 10.1007/s002530000443; Maier T, 2001, BIOCHEM BIOPH RES CO, V286, P652, DOI 10.1006/bbrc.2001.5449; Margesin R, 2001, APPL MICROBIOL BIOT, V56, P650, DOI 10.1007/s002530100701; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; MCFARLAND N, 1981, P NATL ACAD SCI-BIOL, V78, P2135, DOI 10.1073/pnas.78.4.2135; Nicholson CA, 2004, APPL ENVIRON MICROB, V70, P1222, DOI 10.1128/AEM.70.2.1222-1225.2004; Nie Y, 2011, APPL ENVIRON MICROB, V77, P7279, DOI 10.1128/AEM.00203-11; PAWLOWSKI K, 1991, MOL GEN GENET, V231, P124, DOI 10.1007/BF00293830; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Rojo F, 2009, ENVIRON MICROBIOL, V11, P2477, DOI 10.1111/j.1462-2920.2009.01948.x; ROWSELL EH, 1995, J BACTERIOL, V177, P6011, DOI 10.1128/jb.177.20.6011-6014.1995; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sambrook J., 2001, MOL CLONING LAB MANU; Satpute SK, 2010, ADV EXP MED BIOL, V672, P14; Schneiker S, 2006, NAT BIOTECHNOL, V24, P997, DOI 10.1038/nbt1232; Singh A, 2007, BIOTECHNOL ADV, V25, P99, DOI 10.1016/j.biotechadv.2006.10.004; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Tondervik A, 2006, J BACTERIOL, V188, P4218, DOI 10.1128/JB.00513-05; Toren A, 2002, J BACTERIOL, V184, P165, DOI 10.1128/JB.184.1.165-170.2002; van Beilen JB, 2007, APPL MICROBIOL BIOT, V74, P13, DOI 10.1007/s00253-006-0748-0; van Beilen JB, 2006, APPL ENVIRON MICROB, V72, P59, DOI 10.1128/AEM.72.1.59-65.2006; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Walzer G, 2006, ENVIRON MICROBIOL, V8, P1026, DOI 10.1111/j.1462-2920.2006.00994.x; Wang XB, 2011, BIORESOURCE TECHNOL, V102, P7755, DOI 10.1016/j.biortech.2011.06.009; Wang YN, 2007, INT J SYST EVOL MICR, V57, P1222, DOI 10.1099/ijs.0.64973-0; Wang YN, 2007, INT J SYST EVOL MICR, V57, P911, DOI 10.1099/ijs.0.64826-0; WARD DM, 1978, APPL ENVIRON MICROB, V35, P353, DOI 10.1128/AEM.35.2.353-359.1978; Widdel F, 2001, CURR OPIN BIOTECH, V12, P259, DOI 10.1016/S0958-1669(00)00209-3; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Williams RHN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-720; Wu XL, 2009, INT J SYST EVOL MICR, V59, P300, DOI 10.1099/ijs.0.65758-0; Yu SL, 2011, J ENVIRON SCI, V23, P1533, DOI 10.1016/S1001-0742(10)60585-2; Yuan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023701; Yura T, 1999, CURR OPIN MICROBIOL, V2, P153, DOI 10.1016/S1369-5274(99)80027-7	78	36	37	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31261	10.1371/journal.pone.0031261	http://dx.doi.org/10.1371/journal.pone.0031261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359583	Green Submitted, gold, Green Published			2022-12-25	WOS:000302796200052
J	Roberts, DM; Pronobis, MI; Alexandre, KM; Rogers, GC; Poulton, JS; Schneider, DE; Jung, KC; Mckay, DJ; Peifer, M				Roberts, David M.; Pronobis, Mira I.; Alexandre, Kelly M.; Rogers, Gregory C.; Poulton, John S.; Schneider, Daniel E.; Jung, Kuo-Chen; Mckay, Daniel J.; Peifer, Mark			Defining Components of the beta catenin Destruction Complex and Exploring Its Regulation and Mechanisms of Action during Development	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; TUMOR-SUPPRESSOR PROTEIN; SEGMENT POLARITY GENE; NEGATIVE REGULATION; UBIQUITIN LIGASES; DROSOPHILA-MELANOGASTER; ADHERENS JUNCTION; TRANSGENIC RNAI; WINGLESS SIGNAL; ARMADILLO	Background: A subset of signaling pathways play exceptionally important roles in embryonic and post-embryonic development, and mis-regulation of these pathways occurs in most human cancers. One such pathway is the Wnt pathway. The primary mechanism keeping Wnt signaling off in the absence of ligand is regulated proteasomal destruction of the canonical Wnt effector beta catenin (or its fly homolog Armadillo). A substantial body of evidence indicates that SCF beta TrCP mediates beta cat destruction, however, an essential role for Roc1 has not been demonstrated in this process, as would be predicted. In addition, other E3 ligases have also been proposed to destroy bcat, suggesting that beta cat destruction may be regulated differently in different tissues. Methodology/Principal Findings: Here we used cultured Drosophila cells, human colon cancer cells, and Drosophila embryos and larvae to explore the machinery that targets Armadillo for destruction. Using RNAi in Drosophila S2 cells to examine which SCF components are essential for Armadillo destruction, we find that Roc1/Roc1a is essential for regulating Armadillo stability, and that in these cells the only F-box protein playing a detectable role is Slimb. Second, we find that while embryonic and larval Drosophila tissues use the same destruction complex proteins, the response of these tissues to destruction complex inactivation differs, with Armadillo levels more elevated in embryos. We provide evidence consistent with the possibility that this is due to differences in armadillo mRNA levels. Third, we find that there is no correlation between the ability of different APC2 mutant proteins to negatively regulate Armadillo levels, and their recently described function in positively-regulating Wnt signaling. Finally, we demonstrate that APC proteins lacking the N-terminal Armadillo-repeat domain cannot restore Armadillo destruction but retain residual function in negatively-regulating Wnt signaling. Conclusions/Significance: We use these data to refine our model for how Wnt signaling is regulated during normal development.	[Roberts, David M.; Alexandre, Kelly M.; Poulton, John S.; Schneider, Daniel E.; Jung, Kuo-Chen; Mckay, Daniel J.; Peifer, Mark] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Roberts, David M.; Poulton, John S.; Peifer, Mark] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Roberts, David M.] Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA; [Pronobis, Mira I.; Peifer, Mark] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Rogers, Gregory C.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Franklin & Marshall College; University of North Carolina; University of North Carolina Chapel Hill; University of Arizona	Roberts, DM (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	david.roberts@fandm.edu; peifer@unc.edu		Pronobis, Mira/0000-0002-9861-6596; Peifer, Mark/0000-0003-1412-3987	National Institutes of Health [RO1 GM67236, NRSA F32 GM076898, T32 CA 009156, NRSA F32 GM095127]; Franklin and Marshall College; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076898, F32GM095127, R01GM067236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin and Marshall College; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health RO1 GM67236 to M. P. [www.nih.gov], and by start-up funds from Franklin and Marshall College to D.M.R. [www.fandm.edu]. D.M.R was supported in part by National Institutes of Health NRSA F32 GM076898, J.S.P. by National Institutes of Health T32 CA 009156 and National Institutes of Health NRSA F32 GM095127 [all www.nih.gov], and M.P. supported in part by the Hooker Distinguished Professorship from the University of North Carolina at Chapel Hill [www.unc.edu]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Y, 1998, CELL, V93, P1171, DOI 10.1016/S0092-8674(00)81461-0; Ahmed Y, 2002, DEVELOPMENT, V129, P1751; Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; BAKER NE, 1988, DEVELOPMENT, V103, P289; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Donaldson TD, 2004, MOL BIOL CELL, V15, P4892, DOI 10.1091/mbc.E04-03-0180; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hayden MA, 2007, DEV BIOL, V305, P358, DOI 10.1016/j.ydbio.2007.02.018; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; LaFave MC, 2011, GENETICS, V188, P749, DOI 10.1534/genetics.111.129825; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; McCartney BM, 2006, DEVELOPMENT, V133, P2407, DOI 10.1242/dev.02398; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Murphy TD, 2003, J CELL SCI, V116, P2321, DOI 10.1242/jcs.00463; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Noureddine MA, 2002, DEV CELL, V2, P757, DOI 10.1016/S1534-5807(02)00164-8; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Pai LM, 1997, DEVELOPMENT, V124, P2255; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1993, J CELL SCI, V105, P993; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Peifer M, 2009, CSH PERSPECT BIOL, V1; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Reynolds PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002918; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Rubinfeld B, 1997, CANCER RES, V57, P4624; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; Takacs CM, 2008, SCIENCE, V319, P333, DOI 10.1126/science.1151232; Tripathi R, 2007, J BIOSCIENCES, V32, P1133, DOI 10.1007/s12038-007-0114-0; Widmann TJ, 2009, DEV BIOL, V334, P161, DOI 10.1016/j.ydbio.2009.07.013; Wieschaus E., 1986, P199; Willert K, 1999, DEVELOPMENT, V126, P4165; Zimmerman SG, 2010, DEV BIOL, V340, P54, DOI 10.1016/j.ydbio.2010.01.021; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	46	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31284	10.1371/journal.pone.0031284	http://dx.doi.org/10.1371/journal.pone.0031284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359584	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200053
J	Rolf, HJ; Niebert, S; Niebert, M; Gaus, L; Schliephake, H; Wiese, KG				Rolf, Hans J.; Niebert, Sabine; Niebert, Marcus; Gaus, Lena; Schliephake, Henning; Wiese, K. Guenter			Intercellular Transport of Oct4 in Mammalian Cells: A Basic Principle to Expand a Stem Cell Niche?	PLOS ONE			English	Article							TUNNELING NANOTUBES; MEMBRANE NANOTUBES; DEFINED FACTORS; RECOMBINANT PROTEINS; INDUCED PLURIPOTENCY; HUMAN FIBROBLASTS; PROGENITOR CELLS; SOMATIC-CELLS; ANIMAL-CELLS; EXPRESSION	Background: The octamer-binding transcription factor 4 (Oct4) was originally described as a marker of embryonic stem cells. Recently, the role of Oct4 as a key regulator in pluripotency was shown by its ability to reprogram somatic cells in vitro, either alone or in concert with other factors. While artificial induction of pluripotency using transcription factors is possible in mammalian cell culture, it remains unknown whether a potential natural transfer mechanism might be of functional relevance in vivo. The stem cell based regeneration of deer antlers is a unique model for rapid and complete tissue regeneration in mammals and therefore most suitable to study such mechanisms. Here, the transfer of pluripotency factors from resident stem cell niche cells to differentiated cells could recruit more stem cells and start rapid tissue regeneration. Methodology/Principal Findings: We report on the ability of STRO-1(+) deer antlerogenic mesenchymal stem cells (DaMSCs) to transport Oct4 via direct cell-to-cell connections. Upon cultivation in stem cell expansion medium, we observed nuclear Oct4 expression in nearly all cells. A number of these cells exhibit Oct4 expression not only in the nucleus, but also with perinuclear localisation and within far-ranging intercellular connections. Furthermore, many cells showed intercellular connections containing both F-actin and alpha-tubulin and through which transport could be observed. To proof that intercellular Oct4-transfer has functional consequences in recipient cells we used a co-culture approach with STRO-1(+) DaMSCs and a murine embryonic fibroblast indicator cell line (Oct4-GFP MEF). In this cell line a reporter gene (GFP) under the control of an Oct4 responsive element is only expressed in the presence of Oct4. GFP expression in Oct4-GFP cells started after 24 hours of co-culture providing evidence of Oct4 transfer from STRO-1(+) DaMSCs to Oct4-GFP MEF target cells. Conclusions: Our findings indicate a possible mechanism for the expansion of a resident stem cell niche by induction of pluripotency in surrounding non-niche cells via transfer of transcription factors through intercellular connections. This provides a new approach to explain the rapid annual antler regrowth.	[Rolf, Hans J.; Niebert, Sabine; Gaus, Lena; Schliephake, Henning; Wiese, K. Guenter] Univ Goettingen, Res Grp Expt Osteol, Dept Maxillofacial Surg, Univ Med Ctr, Gottingen, Germany; [Niebert, Marcus] Univ Goettingen, Dept Neuro & Sensory Physiol, Univ Med Ctr, Gottingen, Germany	University of Gottingen; University of Gottingen	Rolf, HJ (corresponding author), Univ Goettingen, Res Grp Expt Osteol, Dept Maxillofacial Surg, Univ Med Ctr, Gottingen, Germany.	hrolf@uni-goettingen.de	Schliephake, Henning/I-8911-2019	Wiese, K. Gunter/0000-0001-6436-0468	German Research Society (DFG) [RO 2520/1-1/1-3]; German Research Society [DFG/RO 2520/1-1/1-3]	German Research Society (DFG)(German Research Foundation (DFG)); German Research Society(German Research Foundation (DFG))	The work was funded by the German Research Society (DFG/grant numbers: RO 2520/1-1/1-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank J. Schulz and S. Ahlborn for technical assistance with cell cultures. We would like to thank H. Reinecke and co-workers of the Wildlife Biology and Game Management, University of Goettingen, for keeping of animals and assistance with tissue sampling. We are indebted to Erika Kuzmova, Research Institute of Animal Production, University of Praha, for providing red deer tissue samples. Many thanks go to D. Raab, head of the forest district of the city of Goettingen, and his colleagues for providing pedicles of fallow deer kept in a forest enclosure in Goettingen. Special thanks go to Uwe and Horst Kierdorf, Department of Biology, University of Hildesheim, for their invaluable discussions. H. J. R. and co-workers are funded by the German Research Society (DFG/RO 2520/1-1/1-3).	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Domhan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021283; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gerdes HH, 2009, NAT CELL BIOL, V11, P235, DOI 10.1038/ncb0309-235; Goss R.J., 1983, DEER ANTLERS REGENER; Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0; Gurke S, 2008, EXP CELL RES, V314, P3669, DOI 10.1016/j.yexcr.2008.08.022; Ho R, 2011, J CELL PHYSIOL, V226, P868, DOI 10.1002/jcp.22450; Ji KH, 2008, ANN HEMATOL, V87, P431, DOI 10.1007/s00277-008-0470-3; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kierdorf U, 2010, DEER ANTLERS MODEL M; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Koga K, 2005, ANTICANCER RES, V25, P3703; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Niu XL, 2009, J CELL SCI, V122, P600, DOI 10.1242/jcs.031427; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Pan CY, 2010, MOL BIOL REP, V37, P2117, DOI 10.1007/s11033-009-9680-6; Panagopoulos I, 2008, ONCOL REP, V20, P1029, DOI 10.3892/or_00000105; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pochampally RR, 2004, BLOOD, V103, P1647, DOI 10.1182/blood-2003-06-1967; Ralston A, 2010, REPRODUCTION, V139, P35, DOI 10.1530/REP-09-0024; Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9; Rolf HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002064; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Tsai SY, 2010, STEM CELLS, V28, P221, DOI 10.1002/stem.281; Veranic P, 2008, BIOPHYS J, V95, P4416, DOI 10.1529/biophysj.108.131375; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Welstead GG, 2008, J VIS EXP; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yuan X, 2011, STEM CELLS, V29, P549, DOI 10.1002/stem.594; Zani Brett G, 2010, Commun Integr Biol, V3, P215; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	53	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32287	10.1371/journal.pone.0032287	http://dx.doi.org/10.1371/journal.pone.0032287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359678	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200147
J	Shapira, A; Shapira, S; Gal-Tanamy, M; Zemel, R; Tur-Kaspa, R; Benhar, I				Shapira, Assaf; Shapira, Shiran; Gal-Tanamy, Meital; Zemel, Romy; Tur-Kaspa, Ran; Benhar, Itai			Removal of Hepatitis C Virus-Infected Cells by a Zymogenized Bacterial Toxin	PLOS ONE			English	Article							MESSENGER-RNA INTERFERASES; VIRAL REPLICATION COMPLEX; N-END-RULE; RECOMBINANT ADENOVIRUSES; MEMBRANE ASSOCIATION; ANTITOXIN SYSTEMS; SERINE-PROTEASE; DEATH; ACTIVATION; PROTEINS	Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and has become a global health threat. No HCV vaccine is currently available and treatment with antiviral therapy is associated with adverse side effects. Moreover, there is no preventive therapy for recurrent hepatitis C post liver transplantation. The NS3 serine protease is necessary for HCV replication and represents a prime target for developing anti HCV therapies. Recently we described a therapeutic approach for eradication of HCV infected cells that is based on protein delivery of two NS3 protease-activatable recombinant toxins we named "zymoxins". These toxins were inactivated by fusion to rationally designed inhibitory peptides via NS3-cleavable linkers. Once delivered to cells where NS3 protease is present, the inhibitory peptide is removed resulting in re-activation of cytotoxic activity. The zymoxins we described suffered from two limitations: they required high levels of protease for activation and had basal activities in the un-activated form that resulted in a narrow potential therapeutic window. Here, we present a solution that overcame the major limitations of the "first generation zymoxins" by converting MazF ribonuclease, the toxic component of the E. coli chromosomal MazEF toxin-antitoxin system, into an NS3-activated zymoxin that is introduced to cells by means of gene delivery. We constructed an expression cassette that encodes for a single polypeptide that incorporates both the toxin and a fragment of its potent natural antidote, MazE, linked via an NS3-cleavable linker. While covalently paired to its inhibitor, the ribonuclease is well tolerated when expressed in naive, healthy cells. In contrast, activating proteolysis that is induced by even low levels of NS3, results in an eradication of NS3 expressing model cells and HCV infected cells. Zymoxins may thus become a valuable tool in eradicating cells infected by intracellular pathogens that express intracellular proteases.	[Shapira, Assaf; Benhar, Itai] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel; [Shapira, Assaf; Gal-Tanamy, Meital; Zemel, Romy; Tur-Kaspa, Ran] Tel Aviv Univ, Felsenstein Med Res Ctr, Sackler Sch Med, Mol Hepatol Res Lab, Petah Tiqwa, Israel; [Shapira, Shiran] Tel Aviv Med Ctr & Sch Med, Integrated Canc Prevent Ctr, Tel Aviv, Israel; [Shapira, Shiran] Tel Aviv Univ, Sackler Sch Med, Ramat Aviv, Israel; [Tur-Kaspa, Ran] Rabin Med Ctr, Liver Inst, Petah Tiqwa, Israel; [Tur-Kaspa, Ran] Rabin Med Ctr, Dept Med D, Petah Tiqwa, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center	Shapira, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel.	benhar@post.tau.ac.il		Benhar, Itai/0000-0002-0824-7177	Israel Science Foundation (ISF) [397/08]; Israel Ministry of Health [3-3981]	Israel Science Foundation (ISF)(Israel Science Foundation); Israel Ministry of Health	This research was supported by the Israel Science Foundation (ISF) (grant no. 397/08) (http://www.isf.org.il) and grant no. 3-3981 from the Israel Ministry of Health (http://www.health.gov.il/pages/default.asp?maincat = 14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderie I, 2007, EXP CELL RES, V313, P3189, DOI 10.1016/j.yexcr.2007.05.025; Bartenschlager R, 1999, J VIRAL HEPATITIS, V6, P165, DOI 10.1046/j.1365-2893.1999.00152.x; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0; Davie EW, 2003, J BIOL CHEM, V278, P50819, DOI 10.1074/jbc.X300009200; De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016; Donepudi M, 2002, BIOPHYS CHEM, V101, P145, DOI 10.1016/S0301-4622(02)00151-5; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Falnes PO, 1999, BIOCHEM J, V343, P199, DOI 10.1042/0264-6021:3430199; Gal-Tanamy M, 2005, J MOL BIOL, V347, P991, DOI 10.1016/j.jmb.2005.02.020; Gal-Tanamy M, 2010, ANTIVIR RES, V88, P95, DOI 10.1016/j.antiviral.2010.08.001; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2004, CELL, V116, P359, DOI 10.1016/S0092-8674(04)00116-3; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hsu EC, 2003, NAT BIOTECHNOL, V21, P519, DOI 10.1038/nbt817; Hsu JTA, 2006, CURR PHARM DESIGN, V12, P1301, DOI 10.2174/138161206776361110; Inouye M, 2006, J CELL PHYSIOL, V209, P670, DOI 10.1002/jcp.20801; Johnson RJ, 2006, FEBS J, V273, P5457, DOI 10.1111/j.1742-4658.2006.05536.x; Jucovic M, 2008, PROTEIN ENG DES SEL, V21, P631, DOI 10.1093/protein/gzn038; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Law SK, 2010, NUCL ACIDS RES; Li GY, 2006, J MOL BIOL, V357, P139, DOI 10.1016/j.jmb.2005.12.035; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Mittenhuber Gerhard, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P295; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Patick AK, 1998, CLIN MICROBIOL REV, V11, P614, DOI 10.1128/CMR.11.4.614; Pawlotsky JM, 2011, HEPATOLOGY, V53, P1742, DOI 10.1002/hep.24262; Plainkum P, 2003, NAT STRUCT BIOL, V10, P115, DOI 10.1038/nsb884; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Richter C, 1998, BIOCHEM J, V335, P481, DOI 10.1042/bj3350481; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shapira A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015916; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Suzuki T, 2007, ADV DRUG DELIV REV; Tellinghuisen TL, 2007, J VIROL, V81, P8853, DOI 10.1128/JVI.00753-07; Teramoto S, 1999, EUR RESPIR J, V13, P1125, DOI 10.1034/j.1399-3003.1999.13e31.x; TERAMOTO S, 1995, HUM GENE THER, V6, P1045, DOI 10.1089/hum.1995.6.8-1045; Thompson AJV, 2009, ALIMENT PHARM THER, V29, P689, DOI 10.1111/j.1365-2036.2009.03927.x; Trahtenherts A, 2008, ANTIVIR RES, V77, P195, DOI 10.1016/j.antiviral.2007.12.013; Turcotte RF, 2008, AIDS RES HUM RETROVI; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Varshavsky A, 1995, COLD SPRING HARB SYM, V60, P461, DOI 10.1101/SQB.1995.060.01.051; Wainberg MA, 2009, ANTIVIR RES, V81, P1, DOI 10.1016/j.antiviral.2008.09.003; Wersto RP, 1998, J VIROL, V72, P9491, DOI 10.1128/JVI.72.12.9491-9502.1998; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Yamaguchi Y, 2009, PROG MOL BIOL TRANSL, V85, P467, DOI 10.1016/S0079-6603(08)00812-X; Yan N, 2006, J BIOL CHEM, V281, P8667, DOI 10.1074/jbc.M513232200; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yi MK, 2004, J VIROL, V78, P7904, DOI 10.1128/JVI.78.15.7904-7915.2004; Zheng CY, 2000, BIOCHEM BIOPH RES CO, V274, P767, DOI 10.1006/bbrc.2000.3213	67	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32320	10.1371/journal.pone.0032320	http://dx.doi.org/10.1371/journal.pone.0032320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359682	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200151
J	Slater, H; Michael, E				Slater, Hannah; Michael, Edwin			Predicting the Current and Future Potential Distributions of Lymphatic Filariasis in Africa Using Maximum Entropy Ecological Niche Modelling	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; BANCROFTIAN FILARIASIS; GEOGRAPHIC-DISTRIBUTION; SPATIAL-ANALYSIS; VECTOR-BORNE; MALARIA; RISK; PREVALENCE; SCHISTOSOMIASIS	Modelling the spatial distributions of human parasite species is crucial to understanding the environmental determinants of infection as well as for guiding the planning of control programmes. Here, we use ecological niche modelling to map the current potential distribution of the macroparasitic disease, lymphatic filariasis (LF), in Africa, and to estimate how future changes in climate and population could affect its spread and burden across the continent. We used 508 community-specific infection presence data collated from the published literature in conjunction with five predictive environmental/climatic and demographic variables, and a maximum entropy niche modelling method to construct the first ecological niche maps describing potential distribution and burden of LF in Africa. We also ran the best-fit model against climate projections made by the HADCM3 and CCCMA models for 2050 under A2a and B2a scenarios to simulate the likely distribution of LF under future climate and population changes. We predict a broad geographic distribution of LF in Africa extending from the west to the east across the middle region of the continent, with high probabilities of occurrence in the Western Africa compared to large areas of medium probability interspersed with smaller areas of high probability in Central and Eastern Africa and in Madagascar. We uncovered complex relationships between predictor ecological niche variables and the probability of LF occurrence. We show for the first time that predicted climate change and population growth will expand both the range and risk of LF infection (and ultimately disease) in an endemic region. We estimate that populations at risk to LF may range from 543 and 804 million currently, and that this could rise to between 1.65 to 1.86 billion in the future depending on the climate scenario used and thresholds applied to signify infection presence.	[Slater, Hannah; Michael, Edwin] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	Imperial College London	Slater, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	emichael@nd.edu	Michael, Edwin/D-3388-2014	Slater, Hannah/0000-0003-4291-7899	Natural Environment Research Council, UK; Grantham Institute for Climate Change at Imperial College London; National Institutes of Health, USA [RO1 AI069387-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069387] Funding Source: NIH RePORTER	Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Grantham Institute for Climate Change at Imperial College London; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge the Natural Environment Research Council, UK, for a NERC/ESRC Interdisciplinary Research Studentship to HS. The authors also acknowledge the Grantham Institute for Climate Change at Imperial College London and the National Institutes of Health, USA (under grant number RO1 AI069387-01A1), for partial financial support of this work. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301; Boko M, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P433; Brinkmann UK, 1976, PARASITOLOGY, V28, P71; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Brooker S, 2007, T ROY SOC TROP MED H, V101, P1, DOI 10.1016/j.trstmh.2006.08.004; Casaca V M, 1966, An Inst Med Trop (Lisb), V23, P127; Clements ACA, 2008, INT J PARASITOL, V38, P401, DOI 10.1016/j.ijpara.2007.08.001; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gyapong JO, 2002, ANN TROP MED PARASIT, V96, P695, DOI 10.1179/000349802125001735; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hartley S, 2006, ECOL LETT, V9, P1068, DOI 10.1111/j.1461-0248.2006.00954.x; Hay SI, 2000, ADV PARASIT, V47, P173, DOI 10.1016/S0065-308X(00)47009-0; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt AC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-38; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Juminer B, 1971, Archs Inst Pasteur Tunis, V48, P231; Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lamontellerie M, 1972, ANN PARASITOLOGIE HU, V47, P743; Lardeux F, 1997, PARASITOLOGY, V114, P123, DOI 10.1017/S0031182096008359; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Levine RS, 2004, AM J TROP MED HYG, V70, P105, DOI 10.4269/ajtmh.2004.70.105; Lindsay SW, 2000, T ROY SOC TROP MED H, V94, P37, DOI 10.1016/S0035-9203(00)90431-0; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Manga L, 2002, ANN TROP MED PARASIT, V96, pS129, DOI 10.1179/000349802125002473; Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932; McMichael AJ, 2003, INTERN MED J, V33, P554, DOI 10.1111/j.1445-5994.2003.00492.x; Meyrowitsch DW, 1998, ACTA TROP, V70, P335, DOI 10.1016/S0001-706X(98)00037-0; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; Michael E, 1997, PARASITOL TODAY, V13, P472, DOI 10.1016/S0169-4758(97)01151-4; Michael E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002936; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Ngwira Bagrey Mm, 2007, Filaria J, V6, P12, DOI 10.1186/1475-2883-6-12; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Onapa AW, 2005, ANN TROP MED PARASIT, V99, P141, DOI 10.1179/136485905X19829; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Richards F O Jr, 1993, Bull Pan Am Health Organ, V27, P52; Robinson TP, 1998, PARASITOL TODAY, V14, P457, DOI 10.1016/S0169-4758(98)01336-2; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; ROGERS DJ, 1993, PARASITOL TODAY, V9, P266, DOI 10.1016/0169-4758(93)90074-P; Roura-Pascual Nuria, 2008, Myrmecological News, V11, P67; Sabesan S, 2000, ANN TROP MED PARASIT, V94, P591, DOI 10.1080/00034983.2000.11813582; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sowilem Mohamed M., 2006, Journal of the Egyptian Society of Parasitology, V36, P373; Srividya A, 2002, AM J TROP MED HYG, V67, P480, DOI 10.4269/ajtmh.2002.67.480; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Thompson DF, 1996, EMERG INFECT DIS, V2, P234, DOI 10.3201/eid0203.960313; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; WHO, 1992, LYMPH FIL DIS ITS CO; WHO, 2004, LYMPH FIL EL AFR REG; WHO/Department of Control of Neglected Tropical Diseases, 2009, WKLY EPIDEMIOL REC, V42, P437; WIJERS DJB, 1977, ANN TROP MED PARASIT, V71, P313, DOI 10.1080/00034983.1977.11687193; World Health Organization, 2005, WORLD HEALTH, P202; ZWEIG MH, 1993, CLIN CHEM, V39, P561	79	84	93	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32202	10.1371/journal.pone.0032202	http://dx.doi.org/10.1371/journal.pone.0032202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359670	gold, Green Submitted, Green Published			2022-12-25	WOS:000302796200139
J	Baryshyan, AL; Woods, W; Trimmer, BA; Kaplan, DL				Baryshyan, Amanda L.; Woods, William; Trimmer, Barry A.; Kaplan, David L.			Isolation and Maintenance-Free Culture of Contractile Myotubes from Manduca sexta Embryos	PLOS ONE			English	Article							TOBACCO HORNWORM; SKELETAL-MUSCLE; FLIGHT-MUSCLE; ENERGY-METABOLISM; JUVENILE-HORMONE; BOMBYX-MORI; CELL LINES; DROSOPHILA; TISSUE; DIFFERENTIATION	Skeletal muscle tissue engineering has the potential to treat tissue loss and degenerative diseases. However, these systems are also applicable for a variety of devices where actuation is needed, such as microelectromechanical systems (MEMS) and robotics. Most current efforts to generate muscle bioactuators are focused on using mammalian cells, which require exacting conditions for survival and function. In contrast, invertebrate cells are more environmentally robust, metabolically adaptable and relatively autonomous. Our hypothesis is that the use of invertebrate muscle cells will obviate many of the limitations encountered when mammalian cells are used for bioactuation. We focus on the tobacco hornworm, Manduca sexta, due to its easy availability, large size and well-characterized muscle contractile properties. Using isolated embryonic cells, we have developed culture conditions to grow and characterize contractile M. sexta muscles. The insect hormone 20-hydroxyecdysone was used to induce differentiation in the system, resulting in cells that stained positive for myosin, contract spontaneously for the duration of the culture, and do not require media changes over periods of more than a month. These cells proliferate under normal conditions, but the application of juvenile hormone induced further proliferation and inhibited differentiation. Cellular metabolism under normal and low glucose conditions was compared for C2C12 mouse and M. sexta myoblast cells. While differentiated C2C12 cells consumed glucose and produced lactate over one week as expected, M. sexta muscle did not consume significant glucose, and lactate production exceeded mammalian muscle production on a per cell basis. Contractile properties were evaluated using index of movement analysis, which demonstrated the potential of these cells to perform mechanical work. The ability of cultured M. sexta muscle to continuously function at ambient conditions without medium replenishment, combined with the interesting metabolic properties, suggests that this cell source is a promising candidate for further investigation toward bioactuator applications.	[Baryshyan, Amanda L.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Woods, William; Trimmer, Barry A.] Tufts Univ, Dept Biol, Medford, MA 02155 USA	Tufts University; Tufts University	Baryshyan, AL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	David.Kaplan@tufts.edu		Trimmer, Barry/0000-0003-1782-7373	DARPA [DARPA - W911NF-11-1-0079]; Direct For Biological Sciences [1050908] Funding Source: National Science Foundation	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by DARPA (DARPA - W911NF-11-1-0079), as part of the ChemBots and M3 programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2008, J BIOTECHNOL, V133, P261, DOI 10.1016/j.jbiotec.2007.08.042; Akiyama Y, 2009, LAB CHIP, V9, P140, DOI 10.1039/b809299k; Auerswald L, 2000, J INSECT PHYSIOL, V46, P343, DOI 10.1016/S0022-1910(99)00187-0; BERNSTEIN SI, 1978, J CELL BIOL, V78, P856, DOI 10.1083/jcb.78.3.856; BROADIE K, 1992, ROUX ARCH DEV BIOL, V201, P364, DOI 10.1007/BF00365124; Buttgereit D, 1996, INT J DEV BIOL, V40, P189; Champlin DT, 1999, DEV GENES EVOL, V209, P265, DOI 10.1007/s004270050252; Chapman RF, 1998, INSECTS STRUCTURE FU; Das M, 2007, NAT PROTOC, V2, P1795, DOI 10.1038/nprot.2007.229; Dorfmann A, 2007, J R SOC INTERFACE, V4, P257, DOI 10.1098/rsif.2006.0163; DORN A, 1987, INT J INVER REP DEV, V11, P137, DOI 10.1080/01688170.1987.10510274; EIDE PE, 1975, IN VITRO CELL DEV B, V11, P395; FAUSTO AM, 1994, DEV GROWTH DIFFER, V36, P197; Feala JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100139; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Foe V. E., 1993, DEV DROSOPHILA MELAN, pCh 3; Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002; Gawlitta D, 2007, J APPL PHYSIOL, V103, P464, DOI 10.1152/japplphysiol.01374.2006; Harrison JF, 2001, ANNU REV ENTOMOL, V46, P221, DOI 10.1146/annurev.ento.46.1.221; Haunerland NH, 1997, COMP BIOCHEM PHYS B, V117, P475, DOI 10.1016/S0305-0491(97)00185-5; Hegstrom CD, 1996, J NEUROBIOL, V29, P535; Herr H., 2004, J NEUROENG REHABIL, V1, P1; Horiguchi H, 2009, IEEE T NANOBIOSCI, V8, P349, DOI 10.1109/TNB.2009.2035282; Hull-Thompson J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000460; Josephson RK, 2000, J EXP BIOL, V203, P2667; JOSEPHSON RK, 1991, J PHYSIOL-LONDON, V442, P413, DOI 10.1113/jphysiol.1991.sp018800; Konig A, 2011, EMBO J, V30, P1549, DOI 10.1038/emboj.2011.73; LAW JH, 1989, J BIOL CHEM, V264, P16335; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Luedeman R, 1996, DEV BIOL, V173, P51, DOI 10.1006/dbio.1996.0006; Lynn DE, 1996, CYTOTECHNOLOGY, V20, P3, DOI 10.1007/BF00350384; Patel RT, 2006, ARCH INSECT BIOCHEM, V63, P73, DOI 10.1002/arch.20143; RHEUBEN MB, 1980, J EXP BIOL, V84, P103; Siaussat D, 2007, CELL MOL LIFE SCI, V64, P365, DOI 10.1007/s00018-007-6452-0; Sonobe H, 2004, ZOOL SCI, V21, P503, DOI 10.2108/zsj.21.503; Suarez RK, 2005, J EXP BIOL, V208, P3573, DOI 10.1242/jeb.01775; Tanaka Y, 2007, LAB CHIP, V7, P207, DOI 10.1039/b612082b; Tian L, 2010, J MOL CELL BIOL, V2, P255, DOI 10.1093/jmcb/mjq020; Truman JW, 2007, INSECT BIOCHEM MOLEC, V37, P761, DOI 10.1016/j.ibmb.2007.05.011; WOLFGANG WJ, 1986, DEV BIOL, V113, P305, DOI 10.1016/0012-1606(86)90166-1; Woods WA, 2008, J EXP BIOL, V211, P873, DOI 10.1242/jeb.006031	41	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31598	10.1371/journal.pone.0031598	http://dx.doi.org/10.1371/journal.pone.0031598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355379	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300079
J	Marcombe, S; Mathieu, RB; Pocquet, N; Riaz, MA; Poupardin, R; Selior, S; Darriet, F; Reynaud, S; Yebakima, A; Corbel, V; David, JP; Chandre, F				Marcombe, Sebastien; Mathieu, Romain Blanc; Pocquet, Nicolas; Riaz, Muhammad-Asam; Poupardin, Rodolphe; Selior, Serge; Darriet, Frederic; Reynaud, Stephane; Yebakima, Andre; Corbel, Vincent; David, Jean-Philippe; Chandre, Fabrice			Insecticide Resistance in the Dengue Vector Aedes aegypti from Martinique: Distribution, Mechanisms and Relations with Environmental Factors	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; DETOXIFICATION GENES; PYRETHROID RESISTANCE; CYTOCHROME P450S; MOLECULAR-BASIS; MUTATIONS; POPULATIONS; EXPRESSION; TOLERANCE; EVOLUTION	Dengue is an important mosquito borne viral disease in Martinique Island (French West Indies). The viruses responsible for dengue are transmitted by Aedes aegypti, an indoor day-biting mosquito. The most effective proven method for disease prevention has been by vector control by various chemical or biological means. Unfortunately insecticide resistance has already been observed on the Island and recently showed to significantly reduce the efficacy of vector control interventions. In this study, we investigated the distribution of resistance and the underlying mechanisms in nine Ae. aegypti populations. Statistical multifactorial approach was used to investigate the correlations between insecticide resistance levels, associated mechanisms and environmental factors characterizing the mosquito populations. Bioassays revealed high levels of resistance to temephos and deltamethrin and susceptibility to Bti in the 9 populations tested. Biochemical assays showed elevated detoxification enzyme activities of monooxygenases, carboxylesterases and glutathione S-tranferases in most of the populations. Molecular screening for common insecticide target-site mutations, revealed the presence of the "knockdown resistance'' V1016I Kdr mutation at high frequency (> 87%). Real time quantitative RT-PCR showed the potential involvement of several candidate detoxification genes in insecticide resistance. Principal Component Analysis (PCA) performed with variables characterizing Ae. aegypti from Martinique permitted to underline potential links existing between resistance distribution and other variables such as agriculture practices, vector control interventions and urbanization. Insecticide resistance is widespread but not homogeneously distributed across Martinique. The influence of environmental and operational factors on the evolution of the resistance and mechanisms are discussed.	[Marcombe, Sebastien; Pocquet, Nicolas; Darriet, Frederic; Chandre, Fabrice] IRD, IRD 224, CNRS 5290, Unite Mixte Rech MIVEGEC,UM1, Montpellier, France; [Mathieu, Romain Blanc; Riaz, Muhammad-Asam; Poupardin, Rodolphe; Reynaud, Stephane; David, Jean-Philippe] Univ Grenoble, UMR CNRS 5553, Lab Ecol Alpine LECA, Grenoble, France; [Yebakima, Andre] Conseil Gen Martinique, Ctr Demousticat, Martinique, Martinique, France; [Selior, Serge; Corbel, Vincent] IRD, CREC, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD)	Marcombe, S (corresponding author), IRD, IRD 224, CNRS 5290, Unite Mixte Rech MIVEGEC,UM1, Montpellier, France.	sebastien.marcombe@ird.fr; fabrice.chandre@ird.fr	Corbel, VIncent/G-9576-2016; DAVID, jean-philippe/F-3077-2012; Chandre, Fabrice/Q-3429-2019; Reynaud, Stephane/H-5493-2013; Poupardin, Rodolphe/K-3138-2014	DAVID, jean-philippe/0000-0002-3950-5909; Chandre, Fabrice/0000-0002-1994-9705; Reynaud, Stephane/0000-0003-0248-0602; Blanc-Mathieu, Romain/0000-0002-9485-6330; Poupardin, Rodolphe/0000-0001-5195-5155; Pocquet, Nicolas/0000-0003-3928-6803; Darriet, Frederic/0000-0003-2486-5968; corbel, vincent/0000-0003-0995-3257	French agency Agence Nationale de Securite sanitaire, de l'almentation, de l'environnement et du travail	French agency Agence Nationale de Securite sanitaire, de l'almentation, de l'environnement et du travail	The experiment was funded by the French agency Agence Nationale de Securite sanitaire, de l'almentation, de l'environnement et du travail (www.anses.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Akogbeto M C, 2005, Bull Soc Pathol Exot, V98, P400; Alout H, 2009, INSECT BIOCHEM MOLEC, V39, P884, DOI 10.1016/j.ibmb.2009.10.005; Bocquene G, 2005, MAR POLLUT BULL, V51, P612, DOI 10.1016/j.marpolbul.2005.06.026; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233; BROWN AWA, 1986, J AM MOSQUITO CONTR, V2, P123; Chiu TL, 2008, P NATL ACAD SCI USA, V105, P8855, DOI 10.1073/pnas.0709249105; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; CORRIVEAU R, 2003, DENGUE DEP FRANCAIS; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; FINNEY D J, 1971, P333; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; INVS, 2010, SURV DENG MART; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Lycett GJ, 2006, INSECT MOL BIOL, V15, P321, DOI 10.1111/j.1365-2583.2006.00647.x; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745; Mclaughlin LA, 2008, INSECT MOL BIOL, V17, P125, DOI 10.1111/j.1365-2583.2007.00788.x; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Oakeshott JG, 2005, CHEM-BIOL INTERACT, V157, P269, DOI 10.1016/j.cbi.2005.10.041; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Paris M, 2010, PEST MANAG SCI; Paul A, 2006, J MED ENTOMOL, V43, P55, DOI 10.1603/0022-2585(2006)043[0055:EONIFC]2.0.CO;2; Poupardin R, 2010, INSECT MOL BIOL, V19, P185, DOI 10.1111/j.1365-2583.2009.00967.x; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; R Core Team, 2021, R LANG ENV STAT COMP; Rajatileka S, 2008, ACTA TROP, V108, P54, DOI 10.1016/j.actatropica.2008.08.004; Ranson H, 2010, TROPIKANET J, V1; Raymond M, 1998, PHILOS T R SOC B, V353, P1707, DOI 10.1098/rstb.1998.0322; Raymond M, 1995, PROBIT SOFTWARE; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; Rodriguez MM, 2005, J AM MOSQUITO CONTR, V21, P437, DOI 10.2987/8756-971X(2006)21[437:PISOAA]2.0.CO;2; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Rosine J, 1999, THESIS U P M CURIE P; Rousset F, 1997, TRENDS ECOL EVOL, V12, P313, DOI 10.1016/S0169-5347(97)01104-X; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Saavedra-Rodriguez K, 2008, GENETICS, V180, P1137, DOI 10.1534/genetics.108.087924; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; WHO, 2005, GUID LAB FIELD TEST; WHO, 2006, WHOCDSNTDWHOPESGCDDP; World Health Organization, 1998, WHOCDSCPCMAL98; Yanola J, 2010, PESTIC BIOCHEM PHYS, V96, P127, DOI 10.1016/j.pestbp.2009.10.005; Yebakima A, 1991, THESIS U MONTPELLIER, P210	54	150	156	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30989	10.1371/journal.pone.0030989	http://dx.doi.org/10.1371/journal.pone.0030989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363529	Green Published, gold			2022-12-25	WOS:000302873700019
J	McLaughlin, HP; Xiao, QB; Rea, RB; Pi, HL; Casey, PG; Darby, T; Charbit, A; Sleator, RD; Joyce, SA; Cowart, RE; Hill, C; Klebba, PE; Gahan, CGM				McLaughlin, Heather P.; Xiao, Qiaobin; Rea, Rosemarie B.; Pi, Hualiang; Casey, Pat G.; Darby, Trevor; Charbit, Alain; Sleator, Roy D.; Joyce, Susan A.; Cowart, Richard E.; Hill, Colin; Klebba, Phillip E.; Gahan, Cormac G. M.			A Putative P-Type ATPase Required for Virulence and Resistance to Haem Toxicity in Listeria monocytogenes	PLOS ONE			English	Article							IRON ACQUISITION-SYSTEMS; STAPHYLOCOCCUS-AUREUS; BACTERIAL PATHOGENS; LACTOCOCCUS-LACTIS; GENE-EXPRESSION; FUR; TRANSPORT; PROTEIN; PERR; IDENTIFICATION	Regulation of iron homeostasis in many pathogens is principally mediated by the ferric uptake regulator, Fur. Since acquisition of iron from the host is essential for the intracellular pathogen Listeria monocytogenes, we predicted the existence of Fur-regulated systems that support infection. We examined the contribution of nine Fur-regulated loci to the pathogenicity of L. monocytogenes in a murine model of infection. While mutating the majority of the genes failed to affect virulence, three mutants exhibited a significantly compromised virulence potential. Most striking was the role of the membrane protein we designate FrvA (Fur regulated virulence factor A; encoded by frvA [lmo0641]), which is absolutely required for the systemic phase of infection in mice and also for virulence in an alternative infection model, the Wax Moth Galleria mellonella. Further analysis of the Delta frvA mutant revealed poor growth in iron deficient media and inhibition of growth by micromolar concentrations of haem or haemoglobin, a phenotype which may contribute to the attenuated growth of this mutant during infection. Uptake studies indicated that the Delta frvA mutant is unaffected in the uptake of ferric citrate but demonstrates a significant increase in uptake of haem and haemin. The data suggest a potential role for FrvA as a haem exporter that functions, at least in part, to protect the cell against the potential toxicity of free haem.	[McLaughlin, Heather P.; Rea, Rosemarie B.; Casey, Pat G.; Darby, Trevor; Joyce, Susan A.; Hill, Colin; Gahan, Cormac G. M.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Alimentary Pharmabiot Ctr, Cork, Ireland; [Gahan, Cormac G. M.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland; [Xiao, Qiaobin; Pi, Hualiang; Klebba, Phillip E.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Rea, Rosemarie B.; Sleator, Roy D.] Cork Inst Technol, Dept Biol Sci, Cork, Ireland; [Charbit, Alain] Univ Paris 05, Fac Med Necker Enfants Malad, Paris, France; [Charbit, Alain] INSERM, U1002, Unite Pathogenie Infect Syst, Paris, France; [Cowart, Richard E.] Univ Dubuque, Dept Nat & Appl Sci, Div Biol Sci, Dubuque, IA USA	University College Cork; University College Cork; University of Oklahoma System; University of Oklahoma - Norman; Cork Institute of Technology; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	McLaughlin, HP (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Alimentary Pharmabiot Ctr, Cork, Ireland.	c.hill@ucc.ie	Gahan, Cormac G/AAE-9346-2019; Hill, Colin/A-5611-2012; Joyce, Susan/ABE-2616-2020	Gahan, Cormac G/0000-0003-2385-8192; Hill, Colin/0000-0002-8527-1445; Joyce, Susan/0000-0003-4771-3123; Sleator, Roy/0000-0001-5846-3938; Darby, Trevor/0000-0002-7379-3836; charbit, alain/0000-0001-5243-4861	Science Foundation Ireland through the Centers for Science Engineering and Technology (CSET); Irish Research Council for Science, Engineering & Technology (IRCSET) [ID1773]; National Institutes of Health (NIH) [GM53836]; National Science Foundation (NSF) [MCB0417694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053836] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1316251] Funding Source: National Science Foundation	Science Foundation Ireland through the Centers for Science Engineering and Technology (CSET)(Science Foundation Ireland); Irish Research Council for Science, Engineering & Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors acknowledge funding received from Science Foundation Ireland (www.sfi.ie) through the Centers for Science Engineering and Technology (CSET) programme for the Alimentary Pharmabiotic Centre. HM was funded by the Irish Research Council for Science, Engineering & Technology (IRCSET) through the Embark postgraduate scholarship programme (IRCSET ID1773). The research was also supported by National Institutes of Health (NIH) grant GM53836 and National Science Foundation (NSF) grant MCB0417694 to PEK and SMN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TJ, 1990, INFECT IMMUN, V58, P2715, DOI 10.1128/IAI.58.8.2715-2718.1990; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; Autret N, 2001, INFECT IMMUN, V69, P2054, DOI 10.1128/IAI.69.4.2054-2065.2001; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Bockmann R, 1996, MOL MICROBIOL, V22, P643, DOI 10.1046/j.1365-2958.1996.d01-1722.x; Braun Volkmar, 2005, V12, P210, DOI 10.1159/000081697; BULLEN JJ, 1974, BRIT J HAEMATOL, V28, P139; Calder KM, 1998, MICROB PATHOGENESIS, V24, P133, DOI 10.1006/mpat.1997.9999; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Conte MP, 2000, J MED MICROBIOL, V49, P681, DOI 10.1099/0022-1317-49-8-681; CORNELISSEN CN, 1994, MOL MICROBIOL, V14, P843, DOI 10.1111/j.1365-2958.1994.tb01320.x; Cowart RE, 2002, ARCH BIOCHEM BIOPHYS, V400, P273, DOI 10.1016/S0003-9861(02)00012-7; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; DENEER HG, 1995, MICROBIOL-UK, V141, P1985, DOI 10.1099/13500872-141-8-1985; Dubail I, 2000, INFECT IMMUN, V68, P3242, DOI 10.1128/IAI.68.6.3242-3250.2000; Dussurget O, 2005, FEMS MICROBIOL LETT, V250, P253, DOI 10.1016/j.femsle.2005.07.015; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Francis MS, 1997, MICROB PATHOGENESIS, V22, P67, DOI 10.1006/mpat.1996.0092; Francis MS, 1997, MOL GEN GENET, V253, P484, DOI 10.1007/s004380050347; Gahan CGM, 2000, MOL MICROBIOL, V36, P498, DOI 10.1046/j.1365-2958.2000.01869.x; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Horsburgh MJ, 2001, J BACTERIOL, V183, P468, DOI 10.1128/JB.183.2.468-475.2001; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jin B, 2006, MOL MICROBIOL, V59, P1185, DOI 10.1111/j.1365-2958.2005.05015.x; Joyce SA, 2010, MICROBIOL-SGM, V156, P3456, DOI 10.1099/mic.0.040782-0; Latunde-Dada GO, 2009, BIOESSAYS, V31, P1309, DOI 10.1002/bies.200900101; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Ledala N, 2010, APPL ENVIRON MICROB, V76, P406, DOI 10.1128/AEM.01389-09; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lungu B, 2009, ANAEROBE, V15, P7, DOI 10.1016/j.anaerobe.2008.08.001; McLaughlin HP, 2011, CURR OPIN BIOTECH, V22, P194, DOI 10.1016/j.copbio.2010.10.005; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Olsen KN, 2005, MICROBIOL-SGM, V151, P925, DOI 10.1099/mic.0.27552-0; Payne SM, 2006, BIOMETALS, V19, P173, DOI 10.1007/s10534-005-4577-x; Raya R, 1998, J BACTERIOL, V180, P3174, DOI 10.1128/JB.180.12.3174-3180.1998; Rea R, 2005, APPL ENVIRON MICROB, V71, P8314, DOI 10.1128/AEM.71.12.8314-8322.2005; Rea RB, 2004, INFECT IMMUN, V72, P717, DOI 10.1128/IAI.72.2.717-727.2004; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SIMON N, 1995, APPL ENVIRON MICROB, V61, P1643, DOI 10.1128/AEM.61.4.1643-1645.1995; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Stauff DL, 2008, J BACTERIOL, V190, P3588, DOI 10.1128/JB.01921-07; Stauff DL, 2009, MOL MICROBIOL, V72, P763, DOI 10.1111/j.1365-2958.2009.06684.x; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x	52	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30928	10.1371/journal.pone.0030928	http://dx.doi.org/10.1371/journal.pone.0030928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363518	Green Published, Green Submitted, gold			2022-12-25	WOS:000302873700015
J	Ahmed, A; Rabbitt, E; Brady, T; Brown, C; Guest, P; Bujalska, IJ; Doig, C; Newsome, PN; Hubscher, S; Elias, E; Adams, DH; Tomlinson, JW; Stewart, PM				Ahmed, Adeeba; Rabbitt, Elizabeth; Brady, Theresa; Brown, Claire; Guest, Peter; Bujalska, Iwona J.; Doig, Craig; Newsome, Philip N.; Hubscher, Stefan; Elias, Elwyn; Adams, David H.; Tomlinson, Jeremy W.; Stewart, Paul M.			A Switch in Hepatic Cortisol Metabolism across the Spectrum of Non Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; 5-ALPHA-REDUCTASE ACTIVITY; GLUCOCORTICOID METABOLISM; SEVERE STEATOHEPATITIS; PREDNISOLONE THERAPY; COMPUTED-TOMOGRAPHY; ADIPOSE-TISSUE; INSULIN; OBESITY; MICE	Context: Non alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. NAFLD represents a spectrum of liver disease ranging from reversible hepatic steatosis, to non alcoholic steato-hepatitis (NASH) and cirrhosis. The potential role of glucocorticoids (GC) in the pathogenesis of NAFLD is highlighted in patients with GC excess, Cushing's syndrome, who develop central adiposity, insulin resistance and in 20% of cases, NAFLD. Although in most cases of NAFLD, circulating cortisol levels are normal, hepatic cortisol availability is controlled by enzymes that regenerate cortisol (F) from inactive cortisone (E) (11 beta-hydroxysteroid dehydrogenase type 1, 11 beta-HSD1), or inactivate cortisol through A-ring metabolism (5 alpha- and 5 beta-reductase, 5 alpha R and 5 beta R). Objective and Methods: In vitro studies defined 11 beta-HSD1 expression in normal and NASH liver samples. We then characterised hepatic cortisol metabolism in 16 patients with histologically proven NAFLD compared to 32 obese controls using gas chromatographic analysis of 24 hour urine collection and plasma cortisol generation profile following oral cortisone. Results: In patients with steatosis 5 alpha R activity was increased, with a decrease in hepatic 11 beta-HSD1 activity. Total cortisol metabolites were increased in this group consistent with increased GC production rate. In contrast, in patients with NASH, 11 beta-HSD1 activity was increased both in comparison to patients with steatosis, and controls. Endorsing these findings, 11 beta-HSD1 mRNA and immunostaining was markedly increased in NASH patients in peri septal hepatocytes and within CD68 positive macrophages within inflamed cirrhotic septa. Conclusion: Patients with hepatic steatosis have increased clearance and decreased hepatic regeneration of cortisol and we propose that this may represent a protective mechanism to decrease local GC availability to preserve hepatic metabolic phenotype. With progression to NASH, increased 11 beta-HSD1 activity and consequent cortisol regeneration may serve to limit hepatic inflammation.	[Ahmed, Adeeba; Rabbitt, Elizabeth; Bujalska, Iwona J.; Doig, Craig; Tomlinson, Jeremy W.; Stewart, Paul M.] Univ Birmingham, Sch Clin & Expt Med, Ctr Endocrinol Diabet & Metab, Inst Biomed Res, Birmingham, W Midlands, England; [Brady, Theresa; Brown, Claire] Univ Hosp Birmingham NHS Fdn Trust, Wellcome Trust Clin Res Facil, Birmingham, W Midlands, England; [Newsome, Philip N.; Elias, Elwyn; Adams, David H.] Univ Hosp Birmingham NHS Fdn Trust, Liver Res Ctr, Birmingham, W Midlands, England; [Newsome, Philip N.; Elias, Elwyn; Adams, David H.] Univ Hosp Birmingham NHS Fdn Trust, NIHR Biomed Res Unit Liver Dis, Birmingham, W Midlands, England; [Guest, Peter] Univ Hosp Birmingham NHS Fdn, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Ahmed, A (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Ctr Endocrinol Diabet & Metab, Inst Biomed Res, Birmingham, W Midlands, England.	p.m.stewart@bham.ac.uk	Adams, David H/C-9092-2009; Doig, Craig/D-6948-2012; Doig, Craig L./HHZ-0266-2022; Doig, Craig/AAU-7601-2021; Newsome, Philip N/D-4495-2018	Adams, David H/0000-0001-6776-0336; Doig, Craig L./0000-0001-9694-4230; Doig, Craig/0000-0001-9694-4230; Newsome, Philip N/0000-0001-6085-3652; Tomlinson, Jeremy/0000-0002-3170-8533	Wellcome Trust [082809/Z/07/Z]; Medical Research Council [G84/6638]; Medical Research Council [G9818340B, G0802765] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10356] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by grants from the Wellcome Trust (Programme Grant reference number is 082809/Z/07/Z) (to P.M.S.) Medical Research Council G84/6638 (to A.A.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2008, CLIN ENDOCRINOL, V68, P898, DOI 10.1111/j.1365-2265.2007.03125.x; ANTAKLY T, 1984, ENDOCRINOLOGY, V115, P1984, DOI 10.1210/endo-115-5-1984; BAXTER JD, 1972, AM J MED, V53, P573, DOI 10.1016/0002-9343(72)90154-4; Berthiaume M, 2009, METABOLISM; BORKAN GA, 1982, AM J CLIN NUTR, V36, P172, DOI 10.1093/ajcn/36.1.172; Bujalska IJ, 2008, J ENDOCRINOL, V197, P297, DOI 10.1677/JOE-08-0050; BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chapman KE, 2009, MOL CELL ENDOCRINOL, V301, P123, DOI 10.1016/j.mce.2008.09.031; Cooper MS, 2001, J BONE MINER RES, V16, P1037, DOI 10.1359/jbmr.2001.16.6.1037; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Dolinsky VW, 2004, BIOCHEM J, V378, P967, DOI 10.1042/BJ20031320; Dourakis SP, 2002, AM J GASTROENTEROL, V97, P1074; Dover AR, 2007, ENDOCRINOLOGY, V148, P166, DOI 10.1210/en.2006-0996; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Gilmour JS, 2006, J IMMUNOL, V176, P7605, DOI 10.4049/jimmunol.176.12.7605; Hardy R, 2008, ANN RHEUM DIS, V67, P1204, DOI 10.1136/ard.2008.090662; Hellerstein MK, 1999, EUR J CLIN NUTR, V53, pS53, DOI 10.1038/sj.ejcn.1600744; Heydtmann M, 2009, J VIROL, V83, P2796, DOI 10.1128/JVI.00996-08; Ishii T, 2007, FEBS LETT, V581, P349, DOI 10.1016/j.febslet.2006.11.032; Konopelska S, 2009, CLIN ENDOCRINOL, V70, P554, DOI 10.1111/j.1365-2265.2008.03358.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavery GG, 2006, J BIOL CHEM, V281, P6546, DOI 10.1074/jbc.M512635200; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Nanki T, 1999, AM J GASTROENTEROL, V94, P3379, DOI 10.1111/j.1572-0241.1999.03379.x; NORRHEIM L, 1990, BIOCHIM BIOPHYS ACTA, V1051, P319, DOI 10.1016/0167-4889(90)90141-Y; Palermo M, 1996, CLIN ENDOCRINOL, V45, P605, DOI 10.1046/j.1365-2265.1996.00853.x; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Rae MT, 2004, J ENDOCRINOL, V183, P19, DOI 10.1677/joe.1.05754; Ricketts ML, 1998, J CLIN ENDOCR METAB, V83, P1325, DOI 10.1210/jc.83.4.1325; Rockall AG, 2003, EUR J ENDOCRINOL, V149, P543, DOI 10.1530/eje.0.1490543; Rosenstock J, 2010, DIABETES CARE, V33, P1516, DOI 10.2337/dc09-2315; SHACKLETON CHL, 1993, J STEROID BIOCHEM, V45, P127, DOI 10.1016/0960-0760(93)90132-G; Stewart PM, 1999, J CLIN ENDOCR METAB, V84, P1022, DOI 10.1210/jc.84.3.1022; STEWART PM, 1990, CLIN SCI, V78, P49, DOI 10.1042/cs0780049; Targher G, 2006, CLIN ENDOCRINOL, V64, P337, DOI 10.1111/j.1365-2265.2006.02466.x; Tomlinson JW, 2008, DIABETES, V57, P1536, DOI 10.2337/db08-0094; Tomlinson JW, 2005, NAT CLIN PRACT ENDOC, V1, P92, DOI 10.1038/ncpendmet0023; Vassiliadi DA, 2009, J CLIN ENDOCR METAB, V94, P3558, DOI 10.1210/jc.2009-0837; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westerbacka J, 2003, J CLIN ENDOCR METAB, V88, P4924, DOI 10.1210/jc.2003-030596; Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200; Zbankova S, 2007, J GASTROEN HEPATOL, V22, P1019, DOI 10.1111/j.1440-1746.2006.04529.x	44	62	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e29531	10.1371/journal.pone.0029531	http://dx.doi.org/10.1371/journal.pone.0029531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363403	Green Published, gold			2022-12-25	WOS:000302871500001
J	Liang, D; Jia, WS; Li, JY; Li, K; Zhao, QS				Liang, Dong; Jia, Wenshuang; Li, Jingyun; Li, Kui; Zhao, Qingshun			Retinoic Acid Signaling Plays a Restrictive Role in Zebrafish Primitive Myelopoiesis	PLOS ONE			English	Article							HEMATOPOIETIC STEM; CELL DEVELOPMENT; ACTS DOWNSTREAM; HEART FIELD; CLOCHE; SCL; ENDODERM; DIFFERENTIATION; IDENTIFICATION; PROGENITORS	Retinoic acid (RA) is known to regulate definitive myelopoiesis but its role in vertebrate primitive myelopoiesis remains unclear. Here we report that zebrafish primitive myelopoiesis is restricted by RA in a dose dependent manner mainly before 11 hpf (hours post fertilization) when anterior hemangioblasts are initiated to form. RA treatment significantly reduces expressions of anterior hemangioblast markers scl, lmo2, gata2 and etsrp in the rostral end of ALPM (anterior lateral plate mesoderm) of the embryos. The result indicates that RA restricts primitive myelopoiesis by suppressing formation of anterior hemangioblasts. Analyses of ALPM formation suggest that the defective primitive myelopoiesis resulting from RA treatment before late gastrulation may be secondary to global loss of cells for ALPM fate whereas the developmental defect resulting from RA treatment during 10-11 hpf should be due to ALPM patterning shift. Overexpressions of scl and lmo2 partially rescue the block of primitive myelopoiesis in the embryos treated with 250 nM RA during 10-11 hpf, suggesting RA acts upstream of scl to control primitive myelopoiesis. However, the RA treatment blocks the increased primitive myelopoiesis caused by overexpressing gata4/6 whereas the abolished primitive myelopoiesis in gata4/5/6 depleted embryos is well rescued by 4-diethylamino-benzaldehyde, a retinal dehydrogenase inhibitor, or partially rescued by knocking down aldh1a2, the major retinal dehydrogenase gene that is responsible for RA synthesis during early development. Consistently, overexpressing gata4/6 inhibits aldh1a2 expression whereas depleting gata4/5/6 increases aldh1a2 expression. The results reveal that RA signaling acts downstream of gata4/5/6 to control primitive myelopoiesis. But, 4-diethylamino-benzaldehyde fails to rescue the defective primitive myelopoiesis in either cloche embryos or lycat morphants. Taken together, our results demonstrate that RA signaling restricts zebrafish primitive myelopoiesis through acting downstream of gata4/5/6, upstream of, or parallel to, cloche, and upstream of scl.	[Liang, Dong; Jia, Wenshuang; Li, Jingyun; Li, Kui; Zhao, Qingshun] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Zhao, Qingshun] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Peoples R China	Nanjing University; Wenzhou Medical University	Liang, D (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China.	qingshun@nju.edu.cn			Ministry of Science and Technology of China [2011CB943804, 2007CB947101]; National Natural Science Foundation of China [30871439]; Natural Science Foundation of Jiangsu Province [BK2010390]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the Ministry of Science and Technology of China (2011CB943804 and 2007CB947101), the National Natural Science Foundation of China (30871439) and the Natural Science Foundation of Jiangsu Province (BK2010390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Babuska V, 2010, Prague Med Rep, V111, P289; Begemann G, 2001, DEVELOPMENT, V128, P3081; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Capo-chichi CD, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/602068; Capo-chichi CD, 2005, DEV BIOL, V286, P574, DOI 10.1016/j.ydbio.2005.07.037; Collins SJ, 2002, LEUKEMIA, V16, P1896, DOI 10.1038/sj.leu.2402718; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; de Jong JL, 2010, BLOOD, V54, P1139; Drumea K, 2008, CURR OPIN HEMATOL, V15, P37, DOI 10.1097/MOH.0b013e3282f20a9c; Galloway JL, 2003, CURR TOP DEV BIOL, V53, P139, DOI 10.1016/S0070-2153(03)53004-6; Gering M, 2003, DEVELOPMENT, V130, P6187, DOI 10.1242/dev.00875; Grandel H, 2002, DEVELOPMENT, V129, P2851; Hartenstein V, 2006, ANNU REV CELL DEV BI, V22, P677, DOI 10.1146/annurev.cellbio.22.010605.093317; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hoshijima K, 2002, GENE DEV, V16, P2518, DOI 10.1101/gad.1001302; Hsia N, 2005, EXP HEMATOL, V33, P1007, DOI 10.1016/j.exphem.2005.06.013; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Jiang YM, 1999, DEV BIOL, V216, P57, DOI 10.1006/dbio.1999.9469; Kastner P, 2001, BLOOD, V97, P1314, DOI 10.1182/blood.V97.5.1314; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kostetskii I, 1999, DEV BIOL, V206, P206, DOI 10.1006/dbio.1998.9139; Kuwata T, 2000, BLOOD, V95, P3349, DOI 10.1182/blood.V95.11.3349; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Li X, 2009, BLOOD, V114, P5464, DOI 10.1182/blood-2009-06-227777; Liang D, 2008, GENE EXPR PATTERNS, V8, P248, DOI 10.1016/j.gep.2007.12.007; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Liao W, 1997, DEVELOPMENT, V124, P381; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Ma ACH, 2010, LEUKEMIA, V24, P2090, DOI 10.1038/leu.2010.206; Mauney JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011513; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087; Peterkin T, 2009, DEVELOPMENT, V136, P1465, DOI 10.1242/dev.032748; Purton LE, 1999, BLOOD, V94, P483, DOI 10.1182/blood.V94.2.483.414k12_483_495; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Ren X, 2010, BLOOD, V115, P5338, DOI 10.1182/blood-2009-09-244640; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rodaway A, 1999, DEVELOPMENT, V126, P3067; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; Serbedzija GN, 1998, DEVELOPMENT, V125, P1095; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Ward AC, 2003, BLOOD, V102, P3238, DOI 10.1182/blood-2003-03-0966; Waxman JS, 2009, DEV DYNAM, V238, P1207, DOI 10.1002/dvdy.21951; Waxman JS, 2008, DEV CELL, V15, P923, DOI 10.1016/j.devcel.2008.09.009; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907; Xu F, 2009, MECH DEVELOP, V126, P771, DOI 10.1016/j.mod.2009.09.001; Yeh JRJ, 2008, DEVELOPMENT, V135, P401, DOI 10.1242/dev.008904; Yelon D, 2000, DEVELOPMENT, V127, P2573; Yu C, 2010, BLOOD, V116, P4786, DOI 10.1182/blood-2010-01-263335	55	17	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30865	10.1371/journal.pone.0030865	http://dx.doi.org/10.1371/journal.pone.0030865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363502	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600078
J	Serang, O; Mollinari, M; Garcia, AAF				Serang, Oliver; Mollinari, Marcelo; Franco Garcia, Antonio Augusto			Efficient Exact Maximum a Posteriori Computation for Bayesian SNP Genotyping in Polyploids	PLOS ONE			English	Article							LINKAGE; MAP	The problem of genotyping polyploids is extremely important for the creation of genetic maps and assembly of complex plant genomes. Despite its significance, polyploid genotyping still remains largely unsolved and suffers from a lack of statistical formality. In this paper a graphical Bayesian model for SNP genotyping data is introduced. This model can infer genotypes even when the ploidy of the population is unknown. We also introduce an algorithm for finding the exact maximum a posteriori genotype configuration with this model. This algorithm is implemented in a freely available web-based software package SuperMASSA. We demonstrate the utility, efficiency, and flexibility of the model and algorithm by applying them to two different platforms, each of which is applied to a polyploid data set: Illumina GoldenGate data from potato and Sequenom MassARRAY data from sugarcane. Our method achieves state-of-the-art performance on both data sets and can be trivially adapted to use models that utilize prior information about any platform or species.	[Serang, Oliver] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Serang, Oliver] Childrens Hosp Boston, Dept Pathol, Boston, MA USA; [Mollinari, Marcelo; Franco Garcia, Antonio Augusto] Univ Sao Paulo ESALQ, Dept Genet, Sao Paulo, Brazil	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Serang, O (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	Oliver.Serang@Childrens.Harvard.edu	Garcia, Antonio A F/A-4538-2010; Mollinari, Marcelo/E-7678-2012	Garcia, Antonio A F/0000-0003-0634-3277; Mollinari, Marcelo/0000-0002-7001-8498	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/52197-4, 2008/54402-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant 2008/52197-4 and 2008/54402-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Alwala S, MOL GENETIC LINKAGE; Andersen SK, 1990, HUGIN SHELL BUILDING, P332; Anithakumari AM, 2010, MOL BREEDING, V26, P65, DOI 10.1007/s11032-009-9377-5; [Anonymous], SEQUENOM TYPER 4 0 M; ARNBORG S, 1987, SIAM J ALGEBRA DISCR, V8, P277, DOI 10.1137/0608024; Baker P, 2010, THEOR APPL GENET, V120, P1653, DOI 10.1007/s00122-010-1283-z; Bilmes J, 2002, INT CONF ACOUST SPEE, P3916; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fujisawa H, 2004, BIOINFORMATICS, V20, P718, DOI 10.1093/bioinformatics/btg475; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Garcia AAF, 2006, THEOR APPL GENET, V112, P298, DOI 10.1007/s00122-005-0129-6; Grivet L, 1996, GENETICS, V142, P987; Grivet L, 2002, CURR OPIN PLANT BIOL, V5, P122, DOI 10.1016/S1369-5266(02)00234-0; Hieter P, 1999, SCIENCE, V285, P210, DOI 10.1126/science.285.5425.210; Jannoo N, 2004, HEREDITY, V93, P460, DOI 10.1038/sj.hdy.6800524; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1989, GENETICS, V121, P185; Lewin HA, 2009, GENOME RES, V19, P1925, DOI 10.1101/gr.094557.109; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Oeth P, SINGLE NUCLEOTIDE PO, P307; Oliveira KM, 2007, MOL BREEDING, V20, P189, DOI 10.1007/s11032-007-9082-1; Pastina MM, 2010, MOL MAPPING COMPLEX; Ripol MI, 1999, GENE, V235, P31, DOI 10.1016/S0378-1119(99)00218-8; ROBERTSON N, 1984, J COMB THEORY B, V36, P49, DOI 10.1016/0095-8956(84)90013-3; Serang O, 2010, J PROTEOME RES, V9, P5346, DOI 10.1021/pr100594k; Singh R.J., 2002, PLANT CYTOGENETICS; Storm N, CP R SINGLE NUCLEOTI, P241; Voorrips R, 2011, FITTETRA FITTETRA IS; Voorrips RE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-172; Wang J, 2010, MICROCOLLINEARITY AU, DOI [10.1186/1471-2164-11-261, DOI 10.1186/1471-2164-11-261]; WU KK, 1992, THEOR APPL GENET, V83, P294, DOI 10.1007/BF00224274; Zeng ZB, 1999, GENET RES, V74, P279, DOI 10.1017/S0016672399004255	33	74	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30906a	10.1371/journal.pone.0030906	http://dx.doi.org/10.1371/journal.pone.0030906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363513	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600086
J	Tomppo, L; Ekelund, J; Lichtermann, D; Veijola, J; Jarvelin, MR; Hennah, W				Tomppo, Liisa; Ekelund, Jesper; Lichtermann, Dirk; Veijola, Juha; Jaervelin, Marjo-Riitta; Hennah, William			DISC1 Conditioned GWAS for Psychosis Proneness in a Large Finnish Birth Cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SCHIZOPHRENIA; SCALES; EXPRESSION; PROTEIN; RISK; GENE; ACTIVATION; SCHIZOTYPY; PATHWAY	Background: Genetic evidence implicates the DISC1 gene in the etiology of a number of mental illnesses. Previously, we have reported association between DISC1 and measures of psychosis proneness, the Revised Social Anhedonia Scale (RSAS) and Revised Physical Anhedonia Scale (RPAS), in the Northern Finland Birth Cohort 1966 (NFBC66). As part of the studies of this Finnish birth cohort genome-wide association analysis has recently been performed. Methodology: In the present study, we re-analyzed the genome-wide association data with regard to these two measures of psychosis proneness, conditioning on our previous DISC1 observation. From the original NFBC66 sample (N = 12 058), 4 561 individuals provided phenotype and genotype data. No markers were significant at the genome-wide level. However, several genes with biological relevance to mental illnesses were highlighted through loci displaying suggestive evidence for association (>= 3 SNP with P<10E-4). These included the protein coding genes, CXCL3, KIAA1128, LCT, MED13L, TMCO7, TTN, and the micro RNA MIR620. Conclusions: By conditioning a previous genome-wide association study on DISC1, we have been able to identify eight genes as associating to psychosis proneness. Further, these molecules predominantly link to the DISC1 pathway, strengthening the evidence for the role of this gene network in the etiology of mental illness. The use of quantitative measures of psychosis proneness in a large population cohort will make these findings, once verified; more generalized to a broad selection of disorders related to psychoses and psychosis proneness.	[Tomppo, Liisa; Hennah, William] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Ekelund, Jesper] Univ Helsinki, Dept Psychiat, SF-00180 Helsinki, Finland; [Tomppo, Liisa; Ekelund, Jesper; Hennah, William] Natl Inst Hlth & Welf, Helsinki, Finland; [Ekelund, Jesper] Vaasa Hosp Dist, Vaasa, Finland; [Lichtermann, Dirk] Cafe Ersatz, Bonn, Germany; [Veijola, Juha] Univ Oulu, Dept Psychiat, Oulu, Finland; [Jaervelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Hennah, William] Univ Edinburgh, Med Genet Sect, Edinburgh, Midlothian, Scotland	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Oulu; Imperial College London; University of Edinburgh	Tomppo, L (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland.	William.Hennah@helsinki.fi	Ekelund, Jesper/D-6655-2013	Tomppo, Liisa/0000-0002-9369-5846; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Hennah, William/0000-0002-4462-4208	Jalmari and Rauha Ahokas Foundation; Academy of Finland [128504]; Medical Research Council [G0801056B] Funding Source: researchfish	Jalmari and Rauha Ahokas Foundation; Academy of Finland(Academy of Finland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	LT is supported by the Jalmari and Rauha Ahokas Foundation. WH is supported by the Academy of Finland postdoctoral fellowship (Number 128504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; [Anonymous], 1991, SCHIZOPHRENIA GENESI; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blanchard JJ, 2000, J ABNORM PSYCHOL, V109, P87, DOI 10.1037/0021-843X.109.1.87; Bradshaw NJ, 2010, DISC1 BINDING PROTEI; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Chapman L. J., 1978, REVISED PHYS A UNPUB; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Eckblad M.L., 1982, REVISED SOCIAL UNPUB; Fonseca-Pedrero E, 2009, SPAN J PSYCHOL, V12, P815, DOI 10.1017/S1138741600002183; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Hennah W, 2007, HUM MOL GENET, V16, P453, DOI 10.1093/hmg/ddl462; Hennah W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004906; Horan WP, 2008, SCHIZOPHR RES, V100, P224, DOI 10.1016/j.schres.2007.12.469; Hunsberger JG, 2009, NEUROMOL MED, V11, P173, DOI 10.1007/s12017-009-8070-5; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kalovidouris SA, 2005, J AM CHEM SOC, V127, P1340, DOI 10.1021/ja044631v; LeWinter MM, 2010, CIRCULATION, V121, P2137, DOI 10.1161/CIRCULATIONAHA.109.860171; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Miettunen J, 2008, SCHIZOPHR B; Miettunen J, 2011, J NERV MENT DIS, V199, P230, DOI 10.1097/NMD.0b013e3182125d2c; Miettunen J, 2010, PSYCHIAT RES, V178, P408, DOI 10.1016/j.psychres.2008.07.022; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Muncke N, 2003, CIRCULATION, V108, P2843, DOI 10.1161/01.CIR.0000103684.77636.CD; Murrey HE, 2006, P NATL ACAD SCI USA, V103, P21, DOI 10.1073/pnas.0503381102; Murrey HE, 2009, BIOCHEMISTRY-US, V48, P7261, DOI 10.1021/bi900640x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rantakallio P, 1969, ACTA PAEDIAT SC S193, V193, P11; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Tomppo L, 2009, ARCH GEN PSYCHIAT, V66, P134, DOI 10.1001/archgenpsychiatry.2008.524; Tskhovrebova L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/612482; Walker DG, 2006, J LEUKOCYTE BIOL, V79, P596, DOI 10.1189/jlb.0705377	40	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30643	10.1371/journal.pone.0030643	http://dx.doi.org/10.1371/journal.pone.0030643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363459	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600046
J	Garavaglia, M; Rossi, E; Landini, P				Garavaglia, Marco; Rossi, Elio; Landini, Paolo			The Pyrimidine Nucleotide Biosynthetic Pathway Modulates Production of Biofilm Determinants in Escherichia coli	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SALMONELLA-TYPHIMURIUM; GENE-EXPRESSION; MULTICELLULAR BEHAVIOR; AGGREGATIVE BEHAVIOR; CELLULOSE PRODUCTION; RDAR MORPHOTYPE; PROTEIN; AGFD; COLONIZATION	Bacteria are often found in multicellular communities known as biofilms, which constitute a resistance form against environmental stresses. Extracellular adhesion and cell aggregation factors, responsible for bacterial biofilm formation and maintenance, are tightly regulated in response to physiological and environmental cues. We show that, in Escherichia coli, inactivation of genes belonging to the de novo uridine monophosphate (UMP) biosynthetic pathway impairs production of curli fibers and cellulose, important components of the bacterial biofilm matrix, by inhibiting transcription of the csgDEFG operon, thus preventing production of the biofilm master regulator CsgD protein. Supplementing growth media with exogenous uracil, which can be converted to UMP through the pyrimidine nucleotide salvage pathway, restores csgDEFG transcription and curli production. In addition, however, exogenous uracil triggers cellulose production, particularly in strains defective in either carB or pyrB genes, which encode enzymes catalyzing the first steps of de novo UMP biosynthesis. Our results indicate the existence of tight and complex links between pyrimidine metabolism and curli/cellulose production: transcription of the csgDEFG operon responds to pyrimidine nucleotide availability, while cellulose production is triggered by exogenous uracil in the absence of active de novo UMP biosynthesis. We speculate that perturbations in the UMP biosynthetic pathways allow the bacterial cell to sense signals such as starvation, nucleic acids degradation, and availability of exogenous pyrimidines, and to adapt the production of the extracellular matrix to the changing environmental conditions.	[Garavaglia, Marco; Rossi, Elio; Landini, Paolo] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy	University of Milan	Garavaglia, M (corresponding author), Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy.	paolo.landini@unimi.it	Landini, Paolo/B-7859-2017; Rossi, Elio/N-4802-2015	Landini, Paolo/0000-0003-0999-426X; Rossi, Elio/0000-0002-2042-608X	Italian Ministry for University and Research [RBPR05NWWC_004, 2008K37RHP]	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by the CHEM-PROFARMA-NET (Project RBPR05NWWC_004) and PRIN (Project 2008K37RHP) Research Programs of the Italian Ministry for University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; Antoniani D, 2010, APPL MICROBIOL BIOT, V85, P1095, DOI 10.1007/s00253-009-2199-x; Attila C, 2009, APPL MICROBIOL BIOT, V82, P525, DOI 10.1007/s00253-009-1860-8; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Da Re S, 2006, J BACTERIOL, V188, P3073, DOI 10.1128/JB.188.8.3073-3087.2006; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; Delannay S, 1999, J MOL BIOL, V286, P1217, DOI 10.1006/jmbi.1999.2561; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Durand JMB, 2009, MICROBIOL-SGM, V155, P2498, DOI 10.1099/mic.0.028191-0; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Gerstel U, 2003, MOL MICROBIOL, V49, P639, DOI 10.1046/j.1365-2958.2003.03594.x; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x; Gualdi L, 2008, MICROBIOL-SGM, V154, P2017, DOI 10.1099/mic.0.2008/018093-0; Gualdi L, 2007, J BACTERIOL, V189, P8034, DOI 10.1128/JB.00900-07; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Harrison JJ, 2007, NAT REV MICROBIOL, V5, P928, DOI 10.1038/nrmicro1774; Haugo AJ, 2002, MOL MICROBIOL, V45, P471, DOI 10.1046/j.1365-2958.2002.03023.x; Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Latasa C, 2005, MOL MICROBIOL, V58, P1322, DOI 10.1111/j.1365-2958.2005.04907.x; Le Minh PN, 2010, NUCLEIC ACIDS RES, V38, P6286, DOI 10.1093/nar/gkq385; Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x; Mendez-Ortiz MM, 2006, J BIOL CHEM, V281, P8090, DOI 10.1074/jbc.M510701200; Miller JH, EXPT MOL GENETICS; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Perrin C, 2009, APPL ENVIRON MICROB, V75, P1723, DOI 10.1128/AEM.02171-08; Pratt LA, 1998, MOL MICROBIOL, V29, P1225, DOI 10.1046/j.1365-2958.1998.01007.x; Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001; Robbe-Saule V, 2006, J BACTERIOL, V188, P3983, DOI 10.1128/JB.00033-06; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Romling U, 2000, MOL MICROBIOL, V36, P10, DOI 10.1046/j.1365-2958.2000.01822.x; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Sitaras C, 2011, ANAL BIOCHEM, V408, P328, DOI 10.1016/j.ab.2010.09.038; Tagliabue L, 2010, MICROBIOL-SGM, V156, P2901, DOI 10.1099/mic.0.041350-0; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Ueda A, 2009, MICROB BIOTECHNOL, V2, P62, DOI 10.1111/j.1751-7915.2008.00060.x; ValentinHansen P, 1996, MOL MICROBIOL, V20, P461, DOI 10.1046/j.1365-2958.1996.5341056.x; Wang X, 2006, CELL MOL LIFE SCI, V63, P2352, DOI 10.1007/s00018-006-6222-4; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	52	57	58	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31252	10.1371/journal.pone.0031252	http://dx.doi.org/10.1371/journal.pone.0031252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359582	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200051
J	Ymele-Leki, P; Cao, SG; Sharp, J; Lambert, KG; McAdam, AJ; Husson, RN; Tamayo, G; Clardy, J; Watnick, PI				Ymele-Leki, Patrick; Cao, Shugeng; Sharp, Jared; Lambert, Kathleen G.; McAdam, Alexander J.; Husson, Robert N.; Tamayo, Giselle; Clardy, Jon; Watnick, Paula I.			A High-Throughput Screen Identifies a New Natural Product with Broad-Spectrum Antibacterial Activity	PLOS ONE			English	Article							VIBRIO-CHOLERAE; ANTIBIOTICS; INHIBITORS; QUINONES; SYSTEM; AGAR	Due to the inexorable invasion of our hospitals and communities by drug-resistant bacteria, there is a pressing need for novel antibacterial agents. Here we report the development of a sensitive and robust but low-tech and inexpensive high-throughput metabolic screen for novel antibiotics. This screen is based on a colorimetric assay of pH that identifies inhibitors of bacterial sugar fermentation. After validation of the method, we screened over 39,000 crude extracts derived from organisms that grow in the diverse ecosystems of Costa Rica and identified 49 with reproducible antibacterial effects. An extract from an endophytic fungus was further characterized, and this led to the discovery of three novel natural products. One of these, which we named mirandamycin, has broad-spectrum antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Vibrio cholerae, methicillin-resistant Staphylococcus aureus, and Mycobacterium tuberculosis. This demonstrates the power of simple high throughput screens for rapid identification of new antibacterial agents from environmental samples.	[Ymele-Leki, Patrick; Sharp, Jared; Husson, Robert N.; Watnick, Paula I.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Cao, Shugeng; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lambert, Kathleen G.; McAdam, Alexander J.] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; [Tamayo, Giselle] Univ Costa Rica, Inst Nacl Biodiversidad INBio, Unidad Estrateg Bioprospecc, San Jose, Costa Rica; [Tamayo, Giselle] Univ Costa Rica, Escuela Quim, San Jose, Costa Rica	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Universidad Costa Rica; Universidad Costa Rica	Ymele-Leki, P (corresponding author), Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA.	paula.watnick@childrens.harvard.edu	Husson, Robert/Y-7288-2019; Tamayo, Giselle/J-3609-2015	Tamayo, Giselle/0000-0002-4912-8895	National Institutes of Health [U54 AI057159, NIHU01 TW007404, AI50032, AHA 09GRNT2280096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055148] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [U01TW007404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050032, N01AI050032, R56AI050032, R01AI037901, U54AI057159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by a National Institutes of Health U54 AI057159 to the Harvard NERCE facility, by NIHU01 TW007404 to JC and GT, and by AI50032 and AHA 09GRNT2280096 to PIW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Campbell J, 2010, CURR PROTOC CHEM BIO, V3; Cao SG, 2010, ORG LETT, V12, P4661, DOI 10.1021/ol101972g; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Fernandes P, 2006, NAT BIOTECHNOL, V24, P1497, DOI 10.1038/nbt1206-1497; Ferrand S, 2011, J BIOMOL SCREEN, V16, P637, DOI 10.1177/1087057111403927; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Houot L, 2008, J BACTERIOL, V190, P311, DOI 10.1128/JB.01410-07; Houot L, 2010, J BACTERIOL, V192, P3055, DOI 10.1128/JB.00213-10; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Levine DP, 2006, CLIN INFECT DIS, V42, pS5, DOI 10.1086/491709; Liebeke M, 2008, MOL MICROBIOL, V69, P1513, DOI 10.1111/j.1365-2958.2008.06382.x; Mandal S, 2011, ASIAN PAC J TROP MED, V4, P573, DOI 10.1016/S1995-7645(11)60149-1; MCCORMACK WM, 1974, J INFECT DIS, V129, P497, DOI 10.1093/infdis/129.5.497; Mohamad S, 2011, J ETHNOPHARMACOL, V133, P1021, DOI 10.1016/j.jep.2010.11.037; Muh U, 2006, ANTIMICROB AGENTS CH, V50, P3674, DOI 10.1128/AAC.00665-06; Parish CA, 2009, J NAT PROD, V72, P59, DOI 10.1021/np800528a; Pereira MP, 2009, ANTIMICROB AGENTS CH, V53, P2306, DOI 10.1128/AAC.01572-08; Pfeffer C, 2003, LETT APPL MICROBIOL, V36, P150, DOI 10.1046/j.1472-765X.2003.01280.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WALDOR MK, 1994, P NATL ACAD SCI USA, V91, P11388, DOI 10.1073/pnas.91.24.11388; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	26	32	32	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31307	10.1371/journal.pone.0031307	http://dx.doi.org/10.1371/journal.pone.0031307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359585	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200054
J	Cakir, B; Dagliyan, O; Dagyildiz, E; Baris, I; Kavakli, IH; Kizilel, S; Turkay, M				Cakir, Bilal; Dagliyan, Onur; Dagyildiz, Ezgi; Baris, Ibrahim; Kavakli, Ibrahim Halil; Kizilel, Seda; Turkay, Metin			Structure Based Discovery of Small Molecules to Regulate the Activity of Human Insulin Degrading Enzyme	PLOS ONE			English	Article							AMYLOID BETA-PROTEIN; BINDING FREE-ENERGY; SUBSTRATE RECOGNITION; IN-VIVO; DEGRADATION; INHIBITORS; NEPRILYSIN; DYNAMICS; DOCKING; DESIGN	Background: Insulin-degrading enzyme (IDE) is an allosteric Zn+2 metalloprotease involved in the degradation of many peptides including amyloid-beta, and insulin that play key roles in Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM), respectively. Therefore, the use of therapeutic agents that regulate the activity of IDE would be a viable approach towards generating pharmaceutical treatments for these diseases. Crystal structure of IDE revealed that N-terminal has an exosite which is similar to 30 angstrom away from the catalytic region and serves as a regulation site by orientation of the substrates of IDE to the catalytic site. It is possible to find small molecules that bind to the exosite of IDE and enhance its proteolytic activity towards different substrates. Methodology/Principal Findings: In this study, we applied structure based drug design method combined with experimental methods to discover four novel molecules that enhance the activity of human IDE. The novel compounds, designated as D3, D4, D6, and D10 enhanced IDE mediated proteolysis of substrate V, insulin and amyloid-b, while enhanced degradation profiles were obtained towards substrate V and insulin in the presence of D10 only. Conclusion/Significance: This paper describes the first examples of a computer-aided discovery of IDE regulators, showing that in vitro and in vivo activation of this important enzyme with small molecules is possible.	[Cakir, Bilal; Dagliyan, Onur; Dagyildiz, Ezgi; Baris, Ibrahim; Kavakli, Ibrahim Halil; Kizilel, Seda] Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey; [Kavakli, Ibrahim Halil] Koc Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Turkay, Metin] Koc Univ, Dept Ind Engn, Istanbul, Turkey	Koc University; Koc University; Koc University	Cakir, B (corresponding author), Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey.	hkavakli@ku.edu.tr; skizilel@ku.edu.tr; mturkay@ku.edu.tr	Turkay, Metin/F-9769-2011; Dagliyan, Onur/N-5683-2019; cakir, bilal/AAM-9147-2021; Kizilel, Seda/P-3959-2014; Kavakli, Ibrahim/AAF-5468-2020	Turkay, Metin/0000-0003-4769-6714; Dagliyan, Onur/0000-0003-1825-1011; cakir, bilal/0000-0003-4610-0317; Kizilel, Seda/0000-0001-9092-2698; Kavakli, Ibrahim/0000-0001-6624-3505; baris, ibrahim/0000-0003-2185-3259				[Anonymous], 2001, MOL CLONING LAB MANU; Armutlu P, 2009, LETT DRUG DES DISCOV, V6, P337, DOI 10.2174/1570180810906050337; Armutlu P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-411; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Cabrol C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005274; Camberos MC, 2001, EXP BIOL MED, V226, P334, DOI 10.1177/153537020122600411; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Dagliyan O, 2009, J CHEM INF MODEL, V49, P2403, DOI 10.1021/ci900247t; Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w; DUCKWORTH WC, 1988, ENDOCR REV, V9, P319, DOI 10.1210/edrv-9-3-319; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GARCIA JV, 1989, J CELL BIOL, V109, P1301, DOI 10.1083/jcb.109.3.1301; HAMEL FG, 1991, DIABETES, V40, P436, DOI 10.2337/diabetes.40.4.436; Hentz NG, 1997, ANAL CHEM, V69, P4994, DOI 10.1021/ac970726m; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Kavakli IH, 2001, J BIOL CHEM, V276, P40834, DOI 10.1074/jbc.M106310200; Kruger DM, 2010, CHEMMEDCHEM, V5, P148, DOI 10.1002/cmdc.200900314; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Li P, 2006, BIOCHEM BIOPH RES CO, V343, P1032, DOI 10.1016/j.bbrc.2006.03.083; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mosmann T., 1983, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; ROSE K, 1988, BIOCHEM J, V256, P847, DOI 10.1042/bj2560847; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; Woodward PW, 2006, J BIOMOL SCREEN, V11, P5, DOI 10.1177/1087057105280779	37	26	29	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31787	10.1371/journal.pone.0031787	http://dx.doi.org/10.1371/journal.pone.0031787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355395	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300095
J	Engler, DA; Gupta, S; Growdon, WB; Drapkin, RI; Nitta, M; Sergent, PA; Allred, SF; Gross, J; Deavers, MT; Kuo, WL; Karlan, BY; Rueda, BR; Orsulic, S; Gershenson, DM; Birrer, MJ; Gray, JW; Mohapatra, G				Engler, David A.; Gupta, Sumeet; Growdon, Whitfield B.; Drapkin, Ronny I.; Nitta, Mai; Sergent, Petra A.; Allred, Serena F.; Gross, Jenny; Deavers, Michael T.; Kuo, Wen-Lin; Karlan, Beth Y.; Rueda, Bo R.; Orsulic, Sandra; Gershenson, David M.; Birrer, Michael J.; Gray, Joe W.; Mohapatra, Gayatry			Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical Outcome	PLOS ONE			English	Article							HIGH-RESOLUTION ANALYSIS; TUMOR-SUPPRESSOR; LOW-GRADE; EXPRESSION PROFILES; CYCLIN-E; C-MYC; ADVANCED-STAGE; HUMAN-BREAST; PHASE-III; IN-VIVO	Ovarian cancer is the fifth leading cause of cancer death in women. Ovarian cancers display a high degree of complex genetic alterations involving many oncogenes and tumor suppressor genes. Analysis of the association between genetic alterations and clinical endpoints such as survival will lead to improved patient management via genetic stratification of patients into clinically relevant subgroups. In this study, we aim to define subgroups of high-grade serous ovarian carcinomas that differ with respect to prognosis and overall survival. Genome-wide DNA copy number alterations (CNAs) were measured in 72 clinically annotated, high-grade serous tumors using high-resolution oligonucleotide arrays. Two clinically annotated, independent cohorts were used for validation. Unsupervised hierarchical clustering of copy number data derived from the 72 patient cohort resulted in two clusters with significant difference in progression free survival (PFS) and a marginal difference in overall survival (OS). GISTIC analysis of the two clusters identified altered regions unique to each cluster. Supervised clustering of two independent large cohorts of high-grade serous tumors using the classification scheme derived from the two initial clusters validated our results and identified 8 genomic regions that are distinctly different among the subgroups. These 8 regions map to 8p21.3, 8p23.2, 12p12.1, 17p11.2, 17p12, 19q12, 20q11.21 and 20q13.12; and harbor potential oncogenes and tumor suppressor genes that are likely to be involved in the pathogenesis of ovarian carcinoma. We have identified a set of genetic alterations that could be used for stratification of high-grade serous tumors into clinically relevant treatment subgroups.	[Engler, David A.; Allred, Serena F.] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA; [Nitta, Mai; Mohapatra, Gayatry] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Gupta, Sumeet] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Growdon, Whitfield B.; Sergent, Petra A.; Rueda, Bo R.] Massachusetts Gen Hosp, Dept Vincent Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [Drapkin, Ronny I.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kuo, Wen-Lin; Gray, Joe W.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Gross, Jenny; Karlan, Beth Y.; Orsulic, Sandra] Cedars Sinai Med Ctr, Womens Canc Res Inst, Los Angeles, CA 90048 USA; [Deavers, Michael T.; Gershenson, David M.] Univ Texas MD Anderson Canc Ctr, Dept Pathol & Gynecol Oncol, Houston, TX 77030 USA; [Birrer, Michael J.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA	Brigham Young University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Cedars Sinai Medical Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital	Engler, DA (corresponding author), Brigham Young Univ, Dept Stat, Provo, UT 84602 USA.	gmohapatra@partners.org	Gray, Joe/AAX-9549-2020; Drapkin, Ronny/E-9944-2016	Sergent, Petra/0000-0002-8244-8209; Drapkin, Ronny/0000-0002-6912-6977	Office of Science, Office of Biological & Environmental Research, of the U. S. Department of Energy [DE-AC02-05CH11231]; National Cancer Institute [P50 CA 83639, RC4 CA 156551]; Dana Farber/Harvard Cancer Center Ovarian SPORE [P50 CA105009]; Ovarian Cancer Research Fund; Michael Wall Gynecologic Oncology Research Fund; NATIONAL CANCER INSTITUTE [RC4CA156551, P50CA105009, P50CA083639, U10CA027469, U10CA037517] Funding Source: NIH RePORTER	Office of Science, Office of Biological & Environmental Research, of the U. S. Department of Energy(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dana Farber/Harvard Cancer Center Ovarian SPORE; Ovarian Cancer Research Fund; Michael Wall Gynecologic Oncology Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Director, Office of Science, Office of Biological & Environmental Research, of the U. S. Department of Energy under Contract No. DE-AC02-05CH11231, the National Cancer Institute grant P50 CA 83639 (JWG), the National Cancer Institute grant RC4 CA 156551 (MJB), Dana Farber/Harvard Cancer Center Ovarian SPORE P50 CA105009 (SO and BRR), Ovarian Cancer Research Fund (SO and BRR), and by the Michael Wall Gynecologic Oncology Research Fund (GM). The GOG component was supported by the National Cancer Institute grants to the Gynecologic Oncology Group (GOG) Administrative Office (Philip DiSaia U10 CA027469), GOG Tissue Bank (Philip DiSaia U10CA027469 and U24 CA011479), and the GOG Statistical Data Center (John Blessing U10 CA037517). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Arnold N, 1996, GENE CHROMOSOME CANC, V16, P46, DOI 10.1002/(SICI)1098-2264(199605)16:1<46::AID-GCC7>3.0.CO;2-3; BAKER VV, 1990, GYNECOL ONCOL, V38, P340, DOI 10.1016/0090-8258(90)90069-W; BALVERTLOCHT HR, 1991, GYNECOL ONCOL, V42, P3, DOI 10.1016/0090-8258(91)90222-Q; Berchuck A, 2009, CLIN CANCER RES, V15, P2448, DOI 10.1158/1078-0432.CCR-08-2430; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Biagi JJ, 2003, INT J GYNECOL CANCER, V13, P231, DOI 10.1111/j.1525-1438.2003.13356.x; Bodmer W, 2003, GYNECOL ONCOL, V88, pS22, DOI 10.1006/gyno.2002.6678; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; Brown LA, 2006, GYNECOL ONCOL, V100, P264, DOI 10.1016/j.ygyno.2005.08.026; Bruening W, 1999, CANCER RES, V59, P4973; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Caserta D, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-10; Cazillis M, 2004, ONCOGENE, V23, P4735, DOI 10.1038/sj.onc.1207619; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Clauss A, 2010, NEOPLASIA, V12, P161, DOI 10.1593/neo.91542; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Cuenda A, 2000, INT J BIOCHEM CELL B, V32, P581, DOI 10.1016/S1357-2725(00)00003-0; Dimitriadou E, 2006, E1071 MISC FUNCTIONS, pe1071; Dinh P, 2008, CRIT REV ONCOL HEMAT, V67, P103, DOI 10.1016/j.critrevonc.2008.01.012; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; du Bois A, 1999, ANN ONCOL, V10, P35, DOI 10.1023/A:1008355317514; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Farley J, 2003, CANCER RES, V63, P1235; Farley J, 2009, GYNECOL ONCOL, V113, P341, DOI 10.1016/j.ygyno.2009.02.009; Feller SM, 2006, CURR PHARM DESIGN, V12, P529, DOI 10.2174/138161206775474369; FIGO cancer committee, 1986, GYNECOL ONCOL, V25, P383; Gabeau-Lacet D, 2009, J NEUROPATH EXP NEUR, V68, P1155, DOI 10.1097/NEN.0b013e3181ba3952; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Gorringe KL, 2009, GENE CHROMOSOME CANC, V48, P931, DOI 10.1002/gcc.20694; Gray JW, 2003, GYNECOL ONCOL, V88, pS16, DOI 10.1006/gyno.2002.6677; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Griffiths C T, 1975, Natl Cancer Inst Monogr, V42, P101; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Huang DY, 2008, J PATHOL, V214, P445, DOI 10.1002/path.2299; IWABUCHI H, 1995, CANCER RES, V55, P6172; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang C, 2004, J BIOL CHEM, V279, P27781, DOI 10.1074/jbc.M401809200; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Ju W, 2009, ONCOL RES, V18, P47, DOI 10.3727/096504009789954672; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Katoh M, 2008, INT J ONCOL, V33, P233, DOI 10.3892/ijo_00000001; Kawamura K, 2004, CANCER RES, V64, P4800, DOI 10.1158/0008-5472.CAN-03-3908; Kim SW, 2007, GENE CHROMOSOME CANC, V46, P1, DOI 10.1002/gcc.20384; KOHLER MF, 1993, J NATL CANCER I, V85, P1513, DOI 10.1093/jnci/85.18.1513; Korkola JE, 2008, GENE CHROMOSOME CANC, V47, P43, DOI 10.1002/gcc.20504; KRAG KJ, 1989, GYNECOL ONCOL, V34, P88, DOI 10.1016/0090-8258(89)90114-5; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Lin BY, 2009, PROTEOM CLIN APPL, V3, P853, DOI 10.1002/prca.200800141; Lin CQ, 2000, CANCER RES, V60, P1332; Liu PY, 2006, NAT GENET, V38, P888, DOI 10.1038/ng1849; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mok SC, 1996, ONCOGENE, V12, P1895; Mutch DG, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.31589; Nakayama N, 2010, CANCER-AM CANCER SOC, V116, P2621, DOI 10.1002/cncr.24987; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Neijt JP, 2000, J CLIN ONCOL, V18, P3084, DOI 10.1200/JCO.2000.18.17.3084; Niedner H, 2001, MOL PHARMACOL, V60, P1153, DOI 10.1124/mol.60.6.1153; Nowee ME, 2007, J PATHOL, V213, P46, DOI 10.1002/path.2217; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Perez RP, 1998, EUR J CANCER, V34, P1535, DOI 10.1016/S0959-8049(98)00227-5; Peterson D, 2010, CANCER RES, V70, P6325, DOI 10.1158/0008-5472.CAN-10-0015; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Qian YJ, 2008, J BIOL CHEM, V283, P22410, DOI 10.1074/jbc.M800643200; Ramaswamy S, 2002, J CLIN ONCOL, V20, P1932, DOI 10.1200/JCO.2002.20.7.1932; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; Sandercock J, 2002, BRIT J CANCER, V87, P815, DOI 10.1038/sj.bjc.6600567; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schindl M, 2003, CLIN CANCER RES, V9, P779; Schoppmann SF, 2003, INT J CANCER, V104, P677, DOI 10.1002/ijc.11009; Schuldiner O, 1996, P NATL ACAD SCI USA, V93, P7143, DOI 10.1073/pnas.93.14.7143; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sonoda G, 1997, GENE CHROMOSOME CANC, V20, P320; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Straehle C, 2009, CRIT CARE MED, V37, pS22, DOI 10.1097/CCM.0b013e3181921598; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; van de Wiel MA, 2007, CANCER INFORM, V3, P55; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Yamada SD, 2002, CANCER RES, V62, P6717; Yoshihara K, 2009, CANCER SCI, V100, P1421, DOI 10.1111/j.1349-7006.2009.01204.x; Yoshikawa R, 2006, WORLD J GASTROENTERO, V12, P5884, DOI 10.3748/wjg.v12.i36.5884; Yu YH, 1999, P NATL ACAD SCI USA, V96, P214, DOI 10.1073/pnas.96.1.214; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527; Zhou W, 2007, ONCOL RES, V16, P405, DOI 10.3727/000000007783980873; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	106	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30996	10.1371/journal.pone.0030996	http://dx.doi.org/10.1371/journal.pone.0030996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355333	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300033
J	Janse, I; Bok, JM; Hamidjaja, RA; Hodemaekers, HM; van Rotterdam, BJ				Janse, Ingmar; Bok, Jasper M.; Hamidjaja, Raditijo A.; Hodemaekers, Hennie M.; van Rotterdam, Bart J.			Development and Comparison of Two Assay Formats for Parallel Detection of Four Biothreat Pathogens by Using Suspension Microarrays	PLOS ONE			English	Article							REAL-TIME PCR; THE-EXPONENTIAL (LATE)-PCR; BACILLUS-ANTHRACIS; YERSINIA-PESTIS; FRANCISELLA-TULARENSIS; ASYMMETRIC PCR; IDENTIFICATION; GENES; PANEL; SYSTEM	Microarrays provide a powerful analytical tool for the simultaneous detection of multiple pathogens. We developed diagnostic suspension microarrays for sensitive and specific detection of the biothreat pathogens Bacillus anthracis, Yersinia pestis, Francisella tularensis and Coxiella burnetii. Two assay chemistries for amplification and labeling were developed, one method using direct hybridization and the other using target-specific primer extension, combined with hybridization to universal arrays. Asymmetric PCR products for both assay chemistries were produced by using a multiplex asymmetric PCR amplifying 16 DNA signatures (16-plex). The performances of both assay chemistries were compared and their advantages and disadvantages are discussed. The developed microarrays detected multiple signature sequences and an internal control which made it possible to confidently identify the targeted pathogens and assess their virulence potential. The microarrays were highly specific and detected various strains of the targeted pathogens. Detection limits for the different pathogen signatures were similar or slightly higher compared to real-time PCR. Probit analysis showed that even a few genomic copies could be detected with 95% confidence. The microarrays detected DNA from different pathogens mixed in different ratios and from spiked or naturally contaminated samples. The assays that were developed have a potential for application in surveillance and diagnostics.	[Janse, Ingmar; Bok, Jasper M.; Hamidjaja, Raditijo A.; van Rotterdam, Bart J.] Natl Inst Publ Hlth & Environm RIVM, Lab Zoonoses & Environm Microbiol, Bilthoven, Netherlands; [Hodemaekers, Hennie M.] Natl Inst Publ Hlth & Environm RIVM, Lab Toxicol Pathol & Genet, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Janse, I (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Zoonoses & Environm Microbiol, Bilthoven, Netherlands.	Ingmar.Janse@rivm.nl		van Rotterdam, Bart/0000-0003-2837-9465; Hamidjaja, Raditijo/0000-0002-5655-2299	National Institute for Public Health and the Environment (RIVM)	National Institute for Public Health and the Environment (RIVM)	The work was funded by a strategic research grant (SOR) from the National Institute for Public Health and the Environment (RIVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boving MK, 2009, J CLIN MICROBIOL, V47, P908, DOI 10.1128/JCM.01966-08; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; Cirino NM, 2004, EXPERT REV MOL DIAGN, V4, P841, DOI 10.1586/14737159.4.6.841; Coker PR, 2003, J CLIN MICROBIOL, V41, P1212, DOI 10.1128/JCM.41.3.1212-1218.2003; de Bruin A, 2011, APPL ENVIRON MICROB, V77, P6516, DOI 10.1128/AEM.05097-11; Deshpande A, 2010, J MICROBIOL METH, V80, P155, DOI 10.1016/j.mimet.2009.12.001; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Gadsby NJ, 2010, J CLIN MICROBIOL, V48, P2213, DOI 10.1128/JCM.02446-09; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Janse I, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-314; Kuske CR, 2006, J FORENSIC SCI, V51, P548, DOI 10.1111/j.1556-4029.2006.00131.x; Li H, 2007, J CLIN MICROBIOL, V45, P2105, DOI 10.1128/JCM.00210-07; Lim DV, 2005, CLIN MICROBIOL REV, V18, P583, DOI 10.1128/CMR.18.4.583-607.2005; Luna VA, 2006, J CLIN MICROBIOL, V44, P2367, DOI 10.1128/JCM.00154-06; Merante F, 2007, J CLIN VIROL, V40, pS31, DOI 10.1016/S1386-6532(07)70007-0; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; Olschlager S, 2010, J CLIN MICROBIOL, V48, P2009, DOI 10.1128/JCM.02351-09; Pierce KE, 2005, P NATL ACAD SCI USA, V102, P8609, DOI 10.1073/pnas.0501946102; Reddington K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023481; Regan JF, 2008, ANAL CHEM, V80, P7422, DOI 10.1021/ac801125x; Rutjes SA, 2005, APPL ENVIRON MICROB, V71, P3734, DOI 10.1128/AEM.71.7.3734-3740.2005; Sanchez JA, 2004, P NATL ACAD SCI USA, V101, P1933, DOI 10.1073/pnas.0305476101; Smieja M, 2001, J CLIN MICROBIOL, V39, P1796, DOI 10.1128/JCM.39.5.1796-1801.2001; Stewart A, 2008, J MED MICROBIOL, V57, P324, DOI 10.1099/jmm.0.47485-0; Tomaso H, 2003, FEMS IMMUNOL MED MIC, V38, P117, DOI 10.1016/S0928-8244(03)00184-6; Tomaso H, 2007, MOL CELL PROBE, V21, P12, DOI 10.1016/j.mcp.2006.06.001; Wilson WJ, 2005, MOL CELL PROBE, V19, P137, DOI 10.1016/j.mcp.2004.10.005; Zhu LX, 2007, ANTIMICROB AGENTS CH, V51, P3707, DOI 10.1128/AAC.01461-06	28	20	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31958	10.1371/journal.pone.0031958	http://dx.doi.org/10.1371/journal.pone.0031958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355407	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300107
J	Lundgren, TK; Nakahata, K; Fritz, N; Rebellato, P; Zhang, SB; Uhlen, P				Lundgren, T. Kalle; Nakahata, Katsutoshi; Fritz, Nicolas; Rebellato, Paola; Zhang, Songbai; Uhlen, Per			RET PLC gamma Phosphotyrosine Binding Domain Regulates Ca2+ Signaling and Neocortical Neuronal Migration	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; GDNF FAMILY; CELL-PROLIFERATION; CALCIUM; ACTIVATION; GFR-ALPHA-1; EXPRESSION; MUTATION; DIFFERENTIATION; DYSFUNCTION	The receptor tyrosine kinase RET plays an essential role during embryogenesis in regulating cell proliferation, differentiation, and migration. Upon glial cell line-derived neurotrophic factor (GDNF) stimulation, RET can trigger multiple intracellular signaling pathways that in concert activate various downstream effectors. Here we report that the RET receptor induces calcium (Ca2+) signaling and regulates neocortical neuronal progenitor migration through the Phospholipase-C gamma (PLC gamma) binding domain Tyr1015. This signaling cascade releases Ca2+ from the endoplasmic reticulum through the inositol 1,4,5-trisphosphate receptor and stimulates phosphorylation of ERK1/2 and CaMKII. A point mutation at Tyr1015 on RET or small interfering RNA gene silencing of PLC gamma block the GDNF-induced signaling cascade. Delivery of the RET mutation to neuronal progenitors in the embryonic ventricular zone using in utero electroporation reveal that Tyr1015 is necessary for GDNF-stimulated migration of neurons to the cortical plate. These findings demonstrate a novel RET mediated signaling pathway that elevates cytosolic Ca2+ and modulates neuronal migration in the developing neocortex through the PLC gamma binding domain Tyr1015.	[Lundgren, T. Kalle; Nakahata, Katsutoshi; Fritz, Nicolas; Rebellato, Paola; Zhang, Songbai; Uhlen, Per] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Lundgren, T. Kalle] Karolinska Univ Hosp, Dept Reconstruct Plast Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Lundgren, TK (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	per.uhlen@ki.se	Fritz, Nicolas/P-1290-2019; Lundgren, Kalle/E-9056-2015; Fritz, Nicolas/N-1030-2013	Fritz, Nicolas/0000-0002-9722-7425; Lundgren, Kalle/0000-0001-6781-762X; Fritz, Nicolas/0000-0002-9722-7425; Uhlen, Per/0000-0003-1446-1062; Zhang, Songbai/0000-0002-2033-8389	Swedish Research Council [Dnr 2005-6682, 2007-5977, 2009-3364, 2010-4392]; Foundation for Strategic Research (CEDB); Knut and Alice Wallenberg Foundation (CLICK); Royal Swedish Academy of Sciences; Ake Wiberg's Foundation; Magnus Bergvall's Foundation; Fredrik and Ingrid Thuring's Foundation; Swedish Society for Medical Research; Uehara Memorial Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation for Strategic Research (CEDB); Knut and Alice Wallenberg Foundation (CLICK)(Knut & Alice Wallenberg Foundation); Royal Swedish Academy of Sciences; Ake Wiberg's Foundation; Magnus Bergvall's Foundation; Fredrik and Ingrid Thuring's Foundation; Swedish Society for Medical Research; Uehara Memorial Foundation(Uehara Memorial Foundation)	This study was supported by the Swedish Research Council (www.vr.se, Dnr 2005-6682, 2007-5977, 2009-3364, 2010-4392, DBRM), the Foundation for Strategic Research (CEDB), the Knut and Alice Wallenberg Foundation (CLICK and Research Fellow to PU), The Royal Swedish Academy of Sciences (PU), Ake Wiberg's Foundation (PU), Magnus Bergvall's Foundation (PU), Fredrik and Ingrid Thuring's Foundation (PU), the Swedish Society for Medical Research (PU and TKL), and the Uehara Memorial Foundation (KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Anders J, 2001, J BIOL CHEM, V276, P35808, DOI 10.1074/jbc.M104968200; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Asai N, 1996, J BIOL CHEM, V271, P17644, DOI 10.1074/jbc.271.30.17644; Asai N, 2006, DEVELOPMENT, V133, P4507, DOI 10.1242/dev.02616; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Borodinsky Laura N, 2006, Sci STKE, V2006, ppe22, DOI 10.1126/stke.3362006pe22; Borrello MG, 1996, MOL CELL BIOL, V16, P2151; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Canibano C, 2007, EMBO J, V26, P2015, DOI 10.1038/sj.emboj.7601636; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; Coulpier M, 2002, J BIOL CHEM, V277, P1991, DOI 10.1074/jbc.M107992200; Daza RAM, 2007, COLD SPRING HARB PRO; Desfrere L, 2009, P NATL ACAD SCI USA, V106, P2212, DOI 10.1073/pnas.0809253106; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; Fukuda T, 2002, J BIOL CHEM, V277, P19114, DOI 10.1074/jbc.M200643200; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Jain S, 2006, GENE DEV, V20, P321, DOI 10.1101/gad.1387206; Jiao L, 2011, CELL RES, V21, P327, DOI 10.1038/cr.2010.139; Jijiwa M, 2004, MOL CELL BIOL, V24, P8026, DOI 10.1128/MCB.24.18.8026-8036.2004; Kjaer S, 2003, J BIOL CHEM, V278, P47898, DOI 10.1074/jbc.M309772200; Leppanen VM, 2004, EMBO J, V23, P1452, DOI 10.1038/sj.emboj.7600174; Lundgren TK, 2008, J CELL BIOCHEM, V104, P879, DOI 10.1002/jcb.21671; Malmersjo S, 2010, STEM CELLS DEV, V19, P1355, DOI 10.1089/scd.2009.0436; Manie S, 2001, TRENDS GENET, V17, P580, DOI 10.1016/S0168-9525(01)02420-9; Mijatovic J, 2007, J NEUROSCI, V27, P4799, DOI 10.1523/JNEUROSCI.5647-06.2007; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Paratcha G, 2008, TRENDS NEUROSCI, V31, P384, DOI 10.1016/j.tins.2008.05.003; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; Richardson DS, 2009, CANCER RES, V69, P4861, DOI 10.1158/0008-5472.CAN-08-4425; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Runeberg-Roos P, 2007, ANN MED, V39, P572, DOI 10.1080/07853890701646256; Rusciano MR, 2010, ENDOCR-RELAT CANCER, V17, P113, DOI 10.1677/ERC-09-0214; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Santoro M, 2004, CELL MOL LIFE SCI, V61, P2954, DOI 10.1007/s00018-004-4276-8; Schmutzler BS, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-22; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; Uchida M, 2006, J CELL SCI, V119, P3067, DOI 10.1242/jcs.03043; Uhlen P, 2010, BIOCHEM BIOPH RES CO, V396, P28, DOI 10.1016/j.bbrc.2010.02.117; Watanabe T, 2002, AM J PATHOL, V161, P249, DOI 10.1016/S0002-9440(10)64176-4; Yu T, 1998, J NEUROSCI, V18, P4684; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; Zhou RY, 2009, CELL, V139, P802, DOI 10.1016/j.cell.2009.10.023	51	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31258	10.1371/journal.pone.0031258	http://dx.doi.org/10.1371/journal.pone.0031258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355350	Green Submitted, gold, Green Published			2022-12-25	WOS:000302741300050
J	Zhang, X; You, XN; Wang, Q; Zhang, T; Du, YM; Lv, N; Zhang, Z; Zhang, S; Shan, CL; Ye, LH; Zhang, XD				Zhang, Xuan; You, Xiaona; Wang, Qi; Zhang, Tao; Du, Yumei; Lv, Na; Zhang, Zhao; Zhang, Shuai; Shan, Changliang; Ye, Lihong; Zhang, Xiaodong			Hepatitis B Virus X Protein Drives Multiple Cross-Talk Cascade Loops Involving NF-kappa B, 5-LOX, OPN and Capn4 to Promote Cell Migration	PLOS ONE			English	Article							ARACHIDONIC-ACID METABOLISM; CALPAIN SMALL-SUBUNIT; HBX PROTEIN; INCREASES MIGRATION; UP-REGULATION; OSTEOPONTIN; EXPRESSION; METASTASIS; ACTIVATION; OVEREXPRESSION	Hepatitis B virus X protein (HBx) plays an important role in the development of hepatocellular carcinoma (HCC). However, the mechanism remains unclear. Recently, we have reported that HBx promotes hepatoma cell migration through the upregulation of calpain small subunit 1 (Capn4). In addition, several reports have revealed that osteopontin (OPN) plays important roles in tumor cell migration. In this study, we investigated the signaling pathways involving the promotion of cell migration mediated by HBx. We report that HBx stimulates several factors in a network manner to promote hepatoma cell migration. We showed that HBx was able to upregulate the expression of osteopontin (OPN) through 5-lipoxygenase (5-LOX) in HepG2-X/H7402-X (stable HBx-transfected cells) cells. Furthermore, we identified that HBx could increase the expression of 5-LOX through nuclear factor-kappa B (NF-kappa B). We also found that OPN could upregulate Capn4 through NF-kappa B. Interestingly, we showed that Capn4 was able to upregulate OPN through NF-kappa B in a positive feedback manner, suggesting that the OPN and Capn4 proteins involving cell migration affect each other in a network through NF-kappa B. Importantly, NF-kappa B plays a crucial role in the regulation of 5-LOX, OPN and Capn4. Thus, we conclude that HBx drives multiple cross-talk cascade loops involving NF-kappa B, 5-LOX, OPN and Capn4 to promote cell migration. This finding provides new insight into the mechanism involving the promotion of cell migration by HBx.	[Zhang, Xuan; You, Xiaona; Wang, Qi; Zhang, Tao; Du, Yumei; Lv, Na; Zhang, Shuai; Shan, Changliang; Zhang, Xiaodong] Nankai Univ, Dept Canc Res, Key Lab Mol Microbiol & Technol, Minist Educ,Inst Mol Biol,Coll Life Sci, Tianjin 300071, Peoples R China; [Zhang, Zhao; Ye, Lihong] Nankai Univ, Dept Biochem, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, X (corresponding author), Nankai Univ, Dept Canc Res, Key Lab Mol Microbiol & Technol, Minist Educ,Inst Mol Biol,Coll Life Sci, Tianjin 300071, Peoples R China.	yelihong@nankai.edu.cn; zhangxd@nankai.edu.cn	Zhang, Tao/F-4366-2018	Zhang, Tao/0000-0002-4749-6774; You, Xiaona/0000-0001-9996-1466; Zhang, Shuai/0000-0003-0272-0856	National Basic Research Program of China (973 Program) [2007CB914804, 2007CB914802, 2009CB521702]; National Natural Science Foundation of China [81071624]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was funded by National Basic Research Program of China (973 Program, No. 2007CB914804, No. 2007CB914802, No. 2009CB521702) and National Natural Science Foundation of China (No. 81071624). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D, 2002, J NATL CANCER I, V94, P513; Bai DS, 2009, HEPATOLOGY, V49, P460, DOI 10.1002/hep.22638; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chiao PJ, 2002, CANCER, V95, P1696, DOI 10.1002/cncr.10829; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Covey TM, 2007, ONCOGENE, V26, P5784, DOI 10.1038/sj.onc.1210391; Das R, 2005, IUBMB LIFE, V57, P441, DOI 10.1080/15216540500159424; Demarchi F, 2005, CELL DEATH DIFFER, V12, P512, DOI 10.1038/sj.cdd.4401592; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dwarakanath RS, 2004, J MOL CELL CARDIOL, V36, P585, DOI 10.1016/j.yjmcc.2004.02.007; Feitelson MA, 2002, ONCOGENE, V21, P2593, DOI 10.1038/sj.onc.1205434; Gotoh M, 2002, PATHOL INT, V52, P19, DOI 10.1046/j.1440-1827.2002.01316.x; Jessen KA, 2004, BREAST CANCER RES, V6, pR157, DOI 10.1186/bcr768; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kreunin P, 2004, PROTEOMICS, V4, P2754, DOI 10.1002/pmic.200300767; Lara-Pezzi E, 2002, J CLIN INVEST, V110, P1831, DOI 10.1172/JCI200215887; Lara-Pezzi E, 2001, HEPATOLOGY, V33, P1270, DOI 10.1053/jhep.2001.1270; Lara-Pezzi E, 2001, J HEPATOL, V34, P409, DOI 10.1016/S0168-8278(00)00090-8; Lee YM, 2010, VIRUS GENES, V40, P37, DOI 10.1007/s11262-009-0416-4; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Melstrom LG, 2008, CLIN CANCER RES, V14, P6525, DOI 10.1158/1078-0432.CCR-07-4631; Mi ZY, 2006, CARCINOGENESIS, V27, P1134, DOI 10.1093/carcin/bgi352; Ou DP, 2007, INT J CANCER, V120, P1208, DOI 10.1002/ijc.22452; Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487; Park SG, 2006, J BIOL CHEM, V281, P31770, DOI 10.1074/jbc.M603194200; Philip S, 2001, J BIOL CHEM, V276, P44926, DOI 10.1074/jbc.M103334200; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Qin XR, 2007, TRANSL RES, V150, P281, DOI 10.1016/j.trsl.2007.06.005; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Shimada M, 2008, J BIOL CHEM, V283, P21002, DOI 10.1074/jbc.M710354200; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Wang Q, 2010, NEOPLASIA, V12, P103, DOI 10.1593/neo.91298; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wise GE, 2008, J DENT RES, V87, P414, DOI 10.1177/154405910808700509; Wu CY, 2007, GUT, V56, P782, DOI 10.1136/gut.2006.109868; Xia LM, 2009, VIROLOGY, V385, P335, DOI 10.1016/j.virol.2008.11.042; You JC, 2009, ENDOCRINOLOGY, V150, P1607, DOI 10.1210/en.2008-0616; Zhang F, 2010, J MED VIROL, V82, P920, DOI 10.1002/jmv.21753; Zhang H, 2008, ACTA PHARMACOL SIN, V29, P473, DOI 10.1111/j.1745-7254.2008.00764.x; Zhang JL, 2005, ARCH VIROL, V150, P721, DOI 10.1007/s00705-004-0446-0; Zhang X, 2010, ACTA PHARMACOL SIN, V31, P593, DOI 10.1038/aps.2010.36; Zhou Y, 2010, J BIOL CHEM, V285, P12159, DOI 10.1074/jbc.M109.067629	46	17	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31458	10.1371/journal.pone.0031458	http://dx.doi.org/10.1371/journal.pone.0031458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355367	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300067
J	Burkinshaw, BJ; Prehna, G; Worrall, LJ; Strynadka, NCJ				Burkinshaw, Brianne J.; Prehna, Gerd; Worrall, Liam J.; Strynadka, Natalie C. J.			Structure of Salmonella Effector Protein SopB N-terminal Domain in Complex with Host Rho GTPase Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; BINDING DOMAIN; GLOBAL BURDEN; TYPHIMURIUM; MEMBRANE; CELL; IDENTIFICATION; PHOSPHATASE; ACTIVATION; INVASION	SopB is a type III secreted Salmonella effector protein with phosphoinositide phosphatase activity and a distinct GTPase binding domain. The latter interacts with host Cdc42, an essential Rho GTPase that regulates critical events in eukaryotic cytoskeleton organization and membrane trafficking. Structural and biochemical analysis of the SopB GTPase binding domain in complex with Cdc42 shows for the first time that SopB structurally and functionally mimics a host guanine nucleotide dissociation inhibitor (GDI) by contacting key residues in the regulatory switch regions of Cdc42 and slowing Cdc42 nucleotide exchange.	[Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca		Prehna, Gerd/0000-0001-5539-7533	Canadian Institute for Health Research; Canadian Foundation of Innovation; British Columbia Knowledge Development Fund; Natural Sciences and Engineering Research Council of Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation of Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Canadian Institute for Health Research, the Canadian Foundation of Innovation, and the British Columbia Knowledge Development Fund. G. P. and L. J. W. are Michael Smith Foundation for Health Research (MSFHR) postdoctoral fellows.; Recipient of a Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada graduate scholarship.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Afonine P. V., 2005, COLLABORATIVE COMPUT, V42; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Aleman A, 2005, CELL MICROBIOL, V7, P1432, DOI 10.1111/j.1462-5822.2005.00568.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakowski MA, 2010, CELL HOST MICROBE, V7, P453, DOI 10.1016/j.chom.2010.05.011; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Knodler LA, 2009, CELL MICROBIOL, V11, P1652, DOI 10.1111/j.1462-5822.2009.01356.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Patel JC, 2009, CELL, V137, P283, DOI 10.1016/j.cell.2009.01.056; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Rodiguez-Escudero I, 2006, MICROBIOL-SGM, V152, P3437, DOI 10.1099/mic.0.29186-0; Rodriguez-Escudero I, 2011, MOL MICROBIOL, V80, P1220, DOI 10.1111/j.1365-2958.2011.07639.x; Rogers LD, 2008, J PROTEOMICS, V71, P97, DOI 10.1016/j.jprot.2008.01.011; Sinha S, 2008, CELL SIGNAL, V20, P1927, DOI 10.1016/j.cellsig.2008.05.002; Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	39	15	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13348	13355		10.1074/jbc.M111.331330	http://dx.doi.org/10.1074/jbc.M111.331330			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362774	Green Published, hybrid			2022-12-25	WOS:000302903700070
J	Zoufaly, S; Frobel, J; Rose, P; Flecken, T; Maurer, C; Moser, M; Muller, M				Zoufaly, Stefan; Froebel, Julia; Rose, Patrick; Flecken, Tobias; Maurer, Carlo; Moser, Michael; Mueller, Matthias			Mapping Precursor-binding Site on TatC Subunit of Twin Arginine-specific Protein Translocase by Site-specific Photo Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE BINDING; ESCHERICHIA-COLI; TRANSPORT SYSTEM; IN-VITRO; SUBSTRATE-BINDING; MEMBRANE-BINDING; FOLDED PROTEINS; COMPONENT; PATHWAY; COMPLEXES	A number of secreted precursor proteins of bacteria, archaea, and plant chloroplasts stand out by a conserved twin arginine-containing sequence motif in their signal peptides. Many of these precursor proteins are secreted in a completely folded conformation by specific twin arginine translocation (Tat) machineries. Tat machineries are high molecular mass complexes consisting of two types of membrane proteins, a hexahelical TatC protein, and usually one or two single-spanning membrane proteins, called TatA and TatB. TatC has previously been shown to be involved in the recognition of twin arginine signal peptides. We have performed an extensive site-specific cross-linking analysis of the Escherichia coli TatC protein under resting and translocating conditions. This strategy allowed us to map the recognition site for twin arginine signal peptides to the cytosolic N-terminal region and first cytosolic loop of TatC. In addition, discrete contact sites between TatC, TatB, and TatA were revealed. We discuss a tentative model of how a twin arginine signal sequence might be accommodated in the Tat translocase.	[Zoufaly, Stefan; Froebel, Julia; Rose, Patrick; Flecken, Tobias; Maurer, Carlo; Moser, Michael; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Froebel, Julia; Rose, Patrick] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Muller, M (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, Stefan Meier Str 17, D-79104 Freiburg, Germany.	matthias.mueller@biochemie.uni-freiburg.de	Flecken, Tobias/AAH-6351-2019	Flecken, Tobias/0000-0001-5095-8493; Maurer, H. Carlo/0000-0002-2193-6014	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 746, Forschergruppe 929]; University of Freiburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Freiburg	This work was supported by Sonderforschungsbereich 746 and Forschergruppe 929 of the Deutsche Forschungsgemeinschaft and an F. F. Nord grant by the University of Freiburg (to S. Z.).	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Alder NN, 2003, FEBS LETT, V540, P96, DOI 10.1016/S0014-5793(03)00231-X; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Baglieri J, 2012, J BIOL CHEM, V287, P7335, DOI 10.1074/jbc.M111.326355; Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Behrendt J, 2007, FEBS LETT, V581, P4085, DOI 10.1016/j.febslet.2007.07.045; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; Fincher V, 1998, FEBS LETT, V423, P66, DOI 10.1016/S0014-5793(98)00066-0; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Jeong KJ, 2004, J MOL BIOL, V341, P901, DOI 10.1016/j.jmb.2004.05.078; Kostecki JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009225; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; LESLEY SA, 1991, J BIOL CHEM, V266, P2632; Ma XY, 2010, EMBO J, V29, P1477, DOI 10.1038/emboj.2010.44; Maldonado B, 2011, J MOL MICROB BIOTECH, V20, P168, DOI 10.1159/000329076; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; McDevitt CA, 2005, BIOCHEM BIOPH RES CO, V329, P693, DOI 10.1016/j.bbrc.2005.02.038; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Moser Michael, 2007, V390, P63; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Palmer T., 2010, ECOSAL ESCHERICHIA C; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Schlesier R, 2010, BIOL CHEM, V391, P1411, DOI 10.1515/BC.2010.138; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; White GF, 2010, J BIOL CHEM, V285, P2294, DOI 10.1074/jbc.M109.065458; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472	49	53	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13430	13441		10.1074/jbc.M112.343798	http://dx.doi.org/10.1074/jbc.M112.343798			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362773	Green Published, hybrid			2022-12-25	WOS:000302903700077
J	Duverger, O; Zah, A; Isaac, J; Sun, HW; Bartels, AK; Lian, JB; Berdal, A; Hwang, J; Morasso, MI				Duverger, Olivier; Zah, Angela; Isaac, Juliane; Sun, Hong-Wei; Bartels, Anne K.; Lian, Jane B.; Berdal, Ariane; Hwang, Joonsung; Morasso, Maria I.			Neural Crest Deletion of Dlx3 Leads to Major Dentin Defects through Down-regulation of Dspp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHIP-SEQ DATA; TRICHODENTOOSSEOUS SYNDROME; SIALOPHOSPHOPROTEIN EXPRESSION; TOOTH DEVELOPMENT; MURINE DENTITION; GENE-EXPRESSION; HOMEOBOX GENES; ENAMEL DEFECTS; DIFFERENTIATION; MUTATION	During development, Dlx3 is expressed in ectodermal appendages such as hair and teeth. Thus far, the evidence that Dlx3 plays a crucial role in tooth development comes from reports showing that autosomal dominant mutations in DLX3 result in severe enamel and dentin defects leading to abscesses and infections. However, the normal function of DLX3 in odontogenesis remains unknown. Here, we use a mouse model to demonstrate that the absence of Dlx3 in the neural crest results in major impairment of odontoblast differentiation and dentin production. Mutant mice develop brittle teeth with hypoplastic dentin and molars with an enlarged pulp chamber and underdeveloped roots. Using this mouse model, we found that dentin sialophosphoprotein (Dspp), a major component of the dentin matrix, is strongly down-regulated in odontoblasts lacking Dlx3. Using ChIP-seq, we further demonstrate the direct binding of Dlx3 to the Dspp promoter in vivo. Luciferase reporter assays determined that Dlx3 positively regulates Dspp expression. This establishes a regulatory pathway where the transcription factor Dlx3 is essential in dentin formation by directly regulating a crucial matrix protein.	[Duverger, Olivier; Zah, Angela; Isaac, Juliane; Bartels, Anne K.; Hwang, Joonsung; Morasso, Maria I.] NIAMS, Dev Skin Biol Sect, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMS, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Lian, Jane B.] Univ Massachusetts, Dept Cell Biol, Sch Med, Worcester, MA 01655 USA; [Lian, Jane B.] Univ Massachusetts, Dept Orthoped Surg, Sch Med, Worcester, MA 01655 USA; [Berdal, Ariane] Univ Paris 05, INSERM, UMRS 872, Team 5, F-75006 Paris, France; [Berdal, Ariane] Univ Paris 06, INSERM, UMRS 872, Team 5, F-75006 Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Morasso, MI (corresponding author), NIAMS, Dev Skin Biol Sect, NIH, 50 South Dr,Room 1523, Bethesda, MD 20892 USA.	morasso@nih.gov	Berdal, Ariane/AAC-8745-2022; Isaac, Juliane/AAV-5765-2021; Isaac, Juliane/AAD-8395-2022; Isaac, Juliane/G-4944-2017	Berdal, Ariane/0000-0001-5833-5813; Isaac, Juliane/0000-0001-7898-022X; Isaac, Juliane/0000-0001-7898-022X	NIAMS, National Institutes of Health; National Institutes of Health [R37 DE012528]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041186, ZIHAR041173, ZIAAR041171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program of the NIAMS, National Institutes of Health.; Supported by National Institutes of Health Grant R37 DE012528.	Bartlett JD, 2004, J DENT RES, V83, P909, DOI 10.1177/154405910408301204; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chen S, 2004, J BIOL CHEM, V279, P42182, DOI 10.1074/jbc.M402476200; Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200; Cho YD, 2010, J BIOL CHEM, V285, P36369, DOI 10.1074/jbc.M110.103093; Choi SJ, 2010, DEV BIOL, V344, P682, DOI 10.1016/j.ydbio.2010.05.499; Choi SJ, 2009, DEV BIOL, V325, P129, DOI 10.1016/j.ydbio.2008.10.014; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Dong J, 2005, AM J MED GENET A, V133A, P138, DOI 10.1002/ajmg.a.30521; Duverger O, 2008, J BIOL CHEM, V283, P20198, DOI 10.1074/jbc.M709562200; Duverger O, 2011, J CELL BIOCHEM, V112, P445, DOI 10.1002/jcb.22891; Feledy JA, 1999, NUCLEIC ACIDS RES, V27, P764, DOI 10.1093/nar/27.3.764; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; He PP, 2010, MATRIX BIOL, V29, P411, DOI 10.1016/j.matbio.2010.03.001; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Hu JCC, 2002, EUR J ORAL SCI, V110, P307, DOI 10.1034/j.1600-0722.2002.21301.x; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Hwang J, 2011, P NATL ACAD SCI USA, V108, P11566, DOI 10.1073/pnas.1019658108; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kim JW, 2005, HUM GENET, V116, P186, DOI 10.1007/s00439-004-1223-6; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SK, 2008, J DENT RES, V87, P354, DOI 10.1177/154405910808700402; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lezot F, 2008, J CELL PHYSIOL, V216, P688, DOI 10.1002/jcp.21448; Mayer DEY, 2010, J DTSCH DERMATOL GES, V8, P102, DOI [10.1111/j.1610-0387.2009.07125_supp.x, 10.1111/j.1610-0387.2009.07159.x]; McGuinness T, 1996, GENOMICS, V35, P473, DOI 10.1006/geno.1996.0387; Morasso MI, 2010, METHODS MOL BIOL, V585, P253, DOI 10.1007/978-1-60761-380-0_17; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Nakamura S, 1996, GENOMICS, V38, P314, DOI 10.1006/geno.1996.0634; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Nieminen P, 2011, CELLS TISSUES ORGANS, V194, P49, DOI 10.1159/000322561; Ogbureke KUE, 2004, J DENT RES, V83, P664, DOI 10.1177/154405910408300902; Opsahl S, 2005, ARCH ORAL BIOL, V50, P279, DOI 10.1016/j.archoralbio.2004.09.009; Park JC, 2007, J PERIODONTOL, V78, P1795, DOI 10.1902/jop.2007.060363; Price JA, 1998, HUM MOL GENET, V7, P563, DOI 10.1093/hmg/7.3.563; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; ROBINSON GW, 1994, MECH DEVELOP, V48, P199, DOI 10.1016/0925-4773(94)90060-4; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Thesleff I, 2006, AM J MED GENET A, V140A, P2530, DOI 10.1002/ajmg.a.31360; Thomas BL, 1997, DEVELOPMENT, V124, P4811; Wright JT, 2008, AM J MED GENET A, V146A, P343, DOI 10.1002/ajmg.a.32132; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhao ZY, 2000, DEV GENES EVOL, V210, P270, DOI 10.1007/s004270050314	51	49	51	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12230	12240		10.1074/jbc.M111.326900	http://dx.doi.org/10.1074/jbc.M111.326900			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351765	Green Published, hybrid			2022-12-25	WOS:000302782200064
J	Xiao, X; Wang, P; Chou, KC				Xiao, Xuan; Wang, Pu; Chou, Kuo-Chen			iNR-PhysChem: A Sequence-Based Predictor for Identifying Nuclear Receptors and Their Subfamilies via Physical-Chemical Property Matrix	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINES; MODIFIED MAHALANOBIS DISCRIMINANT; SUBCELLULAR-LOCALIZATION; APPROXIMATE ENTROPY; APOPTOSIS PROTEINS; WEB-SERVER; LOCATION; SUPERFAMILY; ALGORITHM	Nuclear receptors (NRs) form a family of ligand-activated transcription factors that regulate a wide variety of biological processes, such as homeostasis, reproduction, development, and metabolism. Human genome contains 48 genes encoding NRs. These receptors have become one of the most important targets for therapeutic drug development. According to their different action mechanisms or functions, NRs have been classified into seven subfamilies. With the avalanche of protein sequences generated in the postgenomic age, we are facing the following challenging problems. Given an uncharacterized protein sequence, how can we identify whether it is a nuclear receptor? If it is, what subfamily it belongs to? To address these problems, we developed a predictor called iNR-PhysChem in which the protein samples were expressed by a novel mode of pseudo amino acid composition ( PseAAC) whose components were derived from a physical-chemical matrix via a series of auto-covariance and cross-covariance transformations. It was observed that the overall success rate achieved by iNR-PhysChem was over 98% in identifying NRs or non-NRs, and over 92% in identifying NRs among the following seven subfamilies: NR1-thyroid hormone like, NR2-HNF4-like, NR3-estrogen like, NR4-nerve growth factor IB-like, NR5-fushi tarazu-F1 like, NR6-germ cell nuclear factor like, and NR0-knirps like. These rates were derived by the jackknife tests on a stringent benchmark dataset in which none of protein sequences included has >= 60% pairwise sequence identity to any other in a same subset. As a user-friendly web-server, iNR-PhysChem is freely accessible to the public at either http://www.jci-bioinfo.cn/iNR-PhysChem or http://icpr.jci.edu.cn/bioinfo/iNR-PhysChem. Also a step-by-step guide is provided on how to use the web-server to get the desired results without the need to follow the complicated mathematics involved in developing the predictor. It is anticipated that iNR-PhysChem may become a useful high throughput tool for both basic research and drug design.	[Xiao, Xuan; Wang, Pu] Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China; [Xiao, Xuan; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Jingdezhen Ceramic Institute	Xiao, X (corresponding author), Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China.	xiaoxuan0326@yahoo.com.cn; kcchou@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [60961003]; Chinese Ministry of Education [210116]; Province National Natural Science Foundation of JiangXi [2010GQS0127, 2010GZS0122]; Department of Education of JiangXi Province [GJJ11557]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Province National Natural Science Foundation of JiangXi; Department of Education of JiangXi Province	This work was supported by the grants from the National Natural Science Foundation of China (No. 60961003), the Key Project of Chinese Ministry of Education (No. 210116), the Province National Natural Science Foundation of JiangXi (2010GQS0127 and 2010GZS0122), and the Department of Education of JiangXi Province (No. GJJ11557). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Altucci L, 2001, TRENDS ENDOCRIN MET, V12, P460, DOI 10.1016/S1043-2760(01)00502-1; Auwerx J, 1999, CELL, V97, P161; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bhasin M, 2004, J BIOL CHEM, V279, P23262, DOI 10.1074/jbc.M401932200; Cai YD, 2003, BIOPHYS J, V84, P3257, DOI 10.1016/S0006-3495(03)70050-2; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1994, J BIOL CHEM, V269, P22014; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dawson Rex M.C., 1986, DATA BIOCH RES; Ding H, 2011, PROTEIN PEPTIDE LETT, V18, P58, DOI 10.2174/092986611794328708; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007; Ding YS, 2007, PROTEIN PEPTIDE LETT, V14, P811; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Gao QB, 2009, ANAL BIOCHEM, V387, P54, DOI 10.1016/j.ab.2009.01.018; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gronemeyer H, 1995, PROTEIN PROFILE, V2, P1173; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Guo JX, 2011, J COMPUT CHEM, V32, P1612, DOI 10.1002/jcc.21740; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Horn F, 2001, NUCLEIC ACIDS RES, V29, P346, DOI 10.1093/nar/29.1.346; Hu LL, 2011, PROTEIN PEPTIDE LETT, V18, P552, DOI 10.2174/092986611795222795; Jiang XY, 2008, AMINO ACIDS, V34, P669, DOI 10.1007/s00726-008-0034-9; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; Laudet V, 2002, NUCL RECEPTORS FACTS; Li DD, 2010, PROTEIN PEPTIDE LETT, V17, P1566, DOI 10.2174/0929866511009011566; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Li YX, 2011, PROTEIN PEPTIDE LETT, V18, P186, DOI 10.2174/092986611794475084; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Mohammad Beigi Majid, 2011, J Struct Funct Genomics, V12, P191, DOI 10.1007/s10969-011-9120-4; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Nanni L, 2011, IEEE ACM T COMPUT BI, DOI [10.1109/TCBB.2011.1117, DOI 10.1109/TCBB.2011.1117]; Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1; Novac Natalia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P335; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Qiu JD, 2011, J MOL GRAPH MODEL, V30, P129, DOI 10.1016/j.jmgm.2011.06.014; Qiu JD, 2010, PROTEIN PEPTIDE LETT, V17, P715, DOI 10.2174/092986610791190372; Qiu JD, 2009, ANAL BIOCHEM, V390, P68, DOI 10.1016/j.ab.2009.04.009; Robert CW, 1985, CRC HDB CHEM PHYS; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Wang YC, 2010, PROTEIN PEPTIDE LETT, V17, P1441, DOI 10.2174/0929866511009011441; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang GY, 2008, PROTEIN PEPTIDE LETT, V15, P1132, DOI 10.2174/092986608786071184; Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou GP, 1998, J PROTEIN CHEM, V17, P729, DOI 10.1023/A:1020713915365; Zhou GP, 2001, PROTEINS, V44, P57, DOI 10.1002/prot.1071; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001; Zou DS, 2011, J COMPUT CHEM, V32, P271, DOI 10.1002/jcc.21616	79	79	79	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30869	10.1371/journal.pone.0030869	http://dx.doi.org/10.1371/journal.pone.0030869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363503	Green Submitted, gold, Green Published			2022-12-25	WOS:000302873700013
J	Cawthorn, TR; Moreno, JC; Dharsee, M; Danh, TT; Ackloo, S; Zhu, PH; Sardana, G; Chen, J; Kupchak, P; Jacks, LM; Miller, NA; Youngson, BJ; Iakovlev, V; Guidos, CJ; Vallis, KA; Evans, KR; McCready, D; Leong, WL; Done, SJ				Cawthorn, Thomas R.; Moreno, Juan C.; Dharsee, Moyez; Danh Tran-Thanh; Ackloo, Suzanne; Zhu, Pei Hong; Sardana, Girish; Chen, Jian; Kupchak, Peter; Jacks, Lindsay M.; Miller, Naomi A.; Youngson, Bruce J.; Iakovlev, Vladimir; Guidos, Cynthia J.; Vallis, Katherine A.; Evans, Kenneth R.; McCready, David; Leong, Wey L.; Done, Susan J.			Proteomic Analyses Reveal High Expression of Decorin and Endoplasmin (HSP90B1) Are Associated with Breast Cancer Metastasis and Decreased Survival	PLOS ONE			English	Article							TUMOR-MARKERS CA-15-3; B-RAF; PROTEIN; MODULATION; RECEPTOR; ACTIVATION; INDUCTION; APOPTOSIS; SEQUENCE; ISOFORMS	Background: Breast cancer is the most common malignancy among women worldwide in terms of incidence and mortality. About 10% of North American women will be diagnosed with breast cancer during their lifetime and 20% of those will die of the disease. Breast cancer is a heterogeneous disease and biomarkers able to correctly classify patients into prognostic groups are needed to better tailor treatment options and improve outcomes. One powerful method used for biomarker discovery is sample screening with mass spectrometry, as it allows direct comparison of protein expression between normal and pathological states. The purpose of this study was to use a systematic and objective method to identify biomarkers with possible prognostic value in breast cancer patients, particularly in identifying cases most likely to have lymph node metastasis and to validate their prognostic ability using breast cancer tissue microarrays. Methods and Findings: Differential proteomic analyses were employed to identify candidate biomarkers in primary breast cancer patients. These analyses identified decorin (DCN) and endoplasmin (HSP90B1) which play important roles regulating the tumour microenvironment and in pathways related to tumorigenesis. This study indicates that high expression of Decorin is associated with lymph node metastasis (p < 0.001), higher number of positive lymph nodes (p < 0.0001) and worse overall survival (p = 0.01). High expression of HSP90B1 is associated with distant metastasis (p < 0.0001) and decreased overall survival (p < 0.0001) these patients also appear to benefit significantly from hormonal treatment. Conclusions: Using quantitative proteomic profiling of primary breast cancers, two new promising prognostic and predictive markers were found to identify patients with worse survival. In addition HSP90B1 appears to identify a group of patients with distant metastasis with otherwise good prognostic features.	[Cawthorn, Thomas R.; Moreno, Juan C.; Danh Tran-Thanh; Done, Susan J.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Moreno, Juan C.; Danh Tran-Thanh; Miller, Naomi A.; Youngson, Bruce J.; Done, Susan J.] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Dharsee, Moyez; Ackloo, Suzanne; Zhu, Pei Hong; Sardana, Girish; Chen, Jian; Kupchak, Peter; Evans, Kenneth R.] Ontario Canc Biomarker Network, Toronto, ON, Canada; [Jacks, Lindsay M.] Univ Hlth Network, Dept Biostat, Toronto, ON, Canada; [Cawthorn, Thomas R.; Done, Susan J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Miller, Naomi A.; Youngson, Bruce J.; Iakovlev, Vladimir; Done, Susan J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Iakovlev, Vladimir] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada; [Guidos, Cynthia J.] Univ Toronto, Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Guidos, Cynthia J.] Univ Toronto, Dept Immunol, Toronto, ON M5G 1X8, Canada; [Vallis, Katherine A.] Univ Oxford, MRC CRUK Gray Inst Radiat Oncol & Biol, Oxford, England; [McCready, David; Leong, Wey L.] Univ Hlth Network, Dept Surg Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Oxford; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Cawthorn, TR (corresponding author), Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada.	sdone@uhnres.utoronto.ca	Iakovlev, Vladimir/AAM-1822-2021; Evans, Kenneth/I-5161-2015	Iakovlev, Vladimir/0000-0002-0765-3034; Cawthorn, Thomas/0000-0001-9069-7857; Evans, Kenneth/0000-0002-6856-8423; Dharsee, Moyez/0000-0002-4175-0719; Ackloo, Suzanne/0000-0002-9696-1839; Done, Susan/0000-0002-1770-988X; Vallis, Katherine/0000-0003-4672-5683; Youngson, Bruce/0000-0001-6526-8081	Genome Canada through the Ontario Genomics Institute; Princess Margaret Hospital Foundation; Canadian Institutes of Health Research [STP-53912]; Ontario institute for Cancer Research [TSAO-OICR-RF-007]	Genome Canada through the Ontario Genomics Institute(Genome Canada); Princess Margaret Hospital Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario institute for Cancer Research	Funding for this project was provided by: Genome Canada through the Ontario Genomics Institute, Princess Margaret Hospital Foundation, Canadian Institutes of Health Research - STP-53912 and The Ontario institute for Cancer Research - TSAO-OICR-RF-007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-81; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Cox C, 2006, ANN SURG ONCOL, V13, P708, DOI 10.1245/ASO.2006.05.017; Dias S, 2002, BLOOD, V99, P2532, DOI 10.1182/blood.V99.7.2532; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Feugaing DDS, 2007, BIOCHIMIE, V89, P637, DOI 10.1016/j.biochi.2006.12.012; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; Fiedler LR, 2009, CELL ADHES MIGR, V3, P3, DOI 10.4161/cam.3.1.7275; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Griffiths SD, 2007, MOL BIOTECHNOL, V36, P81, DOI 10.1007/s12033-007-0005-5; Hacihanefioglu A, 2010, MED ONCOL; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Kell MR, 2000, BRIT J SURG, V87, P1629, DOI 10.1046/j.1365-2168.2000.01606.x; Kuijt GP, 2007, EJSO-EUR J SURG ONC, V33, P832, DOI 10.1016/j.ejso.2006.11.017; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Li CF, 2008, CLIN CANCER RES, V14, P7822, DOI 10.1158/1078-0432.CCR-08-1369; Liu XL, 1999, CHINESE MED J-PEKING, V112, P1133; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; O'Hea BJ, 1998, J AM COLL SURGEONS, V186, P423, DOI 10.1016/S1072-7515(98)00060-X; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simmons RM, 2001, J AM COLL SURGEONS, V193, P206, DOI 10.1016/S1072-7515(01)00998-X; Soletormos G, 2004, EUR J CANCER, V40, P481, DOI 10.1016/j.ejca.2003.10.015; Song XM, 2008, J PROTEOME RES, V7, P2952, DOI 10.1021/pr800072x; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Sreedhar AS, 2004, FEBS LETT, V562, P11; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Xu M, 1998, J BIOL CHEM, V273, P13918, DOI 10.1074/jbc.273.22.13918; Zafiropoulos A, 2008, CONNECT TISSUE RES, V49, P244, DOI 10.1080/03008200802147746; Zafiropoulos A, 2008, MOL CANCER RES, V6, P785, DOI 10.1158/1541-7786.MCR-07-0165	40	68	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30992	10.1371/journal.pone.0030992	http://dx.doi.org/10.1371/journal.pone.0030992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363530	Green Published, Green Submitted, gold			2022-12-25	WOS:000302871500024
J	Schley, D; Tanaka, RJ; Leungchavaphongse, K; Shahrezaei, V; Ward, J; Grant, C; Charleston, B; Rhodes, CJ				Schley, David; Tanaka, Reiko J.; Leungchavaphongse, Kritsada; Shahrezaei, Vahid; Ward, John; Grant, Clare; Charleston, Bryan; Rhodes, Christopher J.			Modelling the Influence of Foot-and-Mouth Disease Vaccine Antigen Stability and Dose on the Bovine Immune Response	PLOS ONE			English	Article							TRANSMISSION	Foot and mouth disease virus causes a livestock disease of significant global socio-economic importance. Advances in its control and eradication depend critically on improvements in vaccine efficacy, which can be best achieved by better understanding the complex within-host immunodynamic response to inoculation. We present a detailed and empirically parametrised dynamical mathematical model of the hypothesised immune response in cattle, and explore its behaviour with reference to a variety of experimental observations relating to foot and mouth immunology. The model system is able to qualitatively account for the observed responses during in-vivo experiments, and we use it to gain insight into the incompletely understood effect of single and repeat inoculations of differing dosage using vaccine formulations of different structural stability.	[Schley, David; Grant, Clare; Charleston, Bryan] Inst Anim Hlth, Woking, Surrey, England; [Tanaka, Reiko J.; Leungchavaphongse, Kritsada] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Shahrezaei, Vahid] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Ward, John] Univ Loughborough, Dept Math Sci, Loughborough, Leics, England; [Rhodes, Christopher J.] Univ London Imperial Coll Sci Technol & Med, Inst Math Sci, London, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Imperial College London; Imperial College London; Loughborough University; Imperial College London	Schley, D (corresponding author), Inst Anim Hlth, Woking, Surrey, England.	David.Schley@iah.ac.uk	Ward, John/B-6188-2018	Ward, John/0000-0003-0570-2725; Charleston, Bryan/0000-0002-6952-9338; Shahrezaei, Vahid/0000-0002-4013-5458	Research Councils United Kingdom; Imperial College London; Biotechnology and Biological Sciences Research Council [IAH1444]; Engineering and Physical Sciences Research Council; BBSRC [BBS/E/I/00001715, BBS/E/I/00001447, BBS/E/I/00001615, BBS/E/I/00001444] Funding Source: UKRI; EPSRC [EP/H00162X/1, EP/H000755/1, EP/G007446/1, EP/H000542/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001715, BBS/E/I/00001444, BBS/E/I/00001615, BBS/E/I/00001447] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G007446/1, EP/H000755/1, EP/H00162X/1, EP/H000542/1] Funding Source: researchfish	Research Councils United Kingdom; Imperial College London(General Electric); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	CJR is funded by Research Councils United Kingdom and Imperial College London. DS is funded by the Biotechnology and Biological Sciences Research Council [IAH1444]. RJT is funded by the Engineering and Physical Sciences Research Council. The 9th United Kingdom Mathematics in Medicine Study Group (Imperial College London; September 2009) was funding by the Engineering and Physical Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Bankowski BM, 2006, 2006 SESS RES GROUP; Beverley PCL, 2010, J COMP PATHOL, V141, pS91, DOI 10.1016/j.jcpa.2009.09.008; BLACK L, 1984, J COMP PATHOL, V94, P417, DOI 10.1016/0021-9975(84)90028-8; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Buckee CO, 2004, P NATL ACAD SCI USA, V101, P10839, DOI 10.1073/pnas.0402000101; Charleston B, 2011, SCIENCE, V332, P726, DOI 10.1126/science.1199884; Defrance T, 2011, CURR OPIN IMMUNOL, V23, P330, DOI 10.1016/j.coi.2011.03.004; DOEL TR, 1981, ARCH VIROL, V70, P21, DOI 10.1007/BF01320790; Doel TR, 1999, VACCINE, V17, P1767, DOI 10.1016/S0264-410X(98)00444-7; Follett B, 2002, 1502 ROYAL SOC; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Grant C, 2010, 2010 OP SESS EUFMD S; Guay HM, 2009, J IMMUNOL, V183, P518, DOI 10.4049/jimmunol.0900068; HARKISS GD, 1981, IMMUNOLOGY, V42, P297; Juleff N, 2009, J VIROL, V83, P3626, DOI 10.1128/JVI.02613-08; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Kelly DF, 2006, BLOOD, V108, P2642, DOI 10.1182/blood-2006-01-009282; Kostova K, 2004, USE MODELS ASSESS FO; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Paton DJ, 2009, PHILOS T R SOC B, V364, P2657, DOI 10.1098/rstb.2009.0100; Perry B. D, 2002, INVESTING ANIMAL HLT; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Schley D., 2007, 37 GEN SESS EUR COMM; Shampine LF, 2001, APPL NUMER MATH, V37, P441, DOI 10.1016/S0168-9274(00)00055-6; Thompson D, 2002, REV SCI TECH, V21; Wodarz D, 2005, KILLER CELL DYNAMICS	29	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30435	10.1371/journal.pone.0030435	http://dx.doi.org/10.1371/journal.pone.0030435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363437	Green Submitted, gold, Green Published			2022-12-25	WOS:000302853600030
J	Claes, IJJ; Schoofs, G; Regulski, K; Courtin, P; Chapot-Chartier, MP; Rolain, T; Hols, P; von Ossowski, I; Reunanen, J; de Vos, WM; Palva, A; Vanderleyden, J; De Keersmaecker, SCJ; Lebeer, S				Claes, Ingmar J. J.; Schoofs, Geert; Regulski, Krzysztof; Courtin, Pascal; Chapot-Chartier, Marie-Pierre; Rolain, Thomas; Hols, Pascal; von Ossowski, Ingemar; Reunanen, Justus; de Vos, Willem M.; Palva, Airi; Vanderleyden, Jos; De Keersmaecker, Sigrid C. J.; Lebeer, Sarah			Genetic and Biochemical Characterization of the Cell Wall Hydrolase Activity of the Major Secreted Protein of Lactobacillus rhamnosus GG	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; FUNCTIONAL-ANALYSIS; PEPTIDOGLYCAN; REVEALS; GROWTH; ENZYME; BL23	Lactobacillus rhamnosus GG (LGG) produces two major secreted proteins, designated here Msp1 (LGG_00324 or p75) and Msp2 (LGG_00031 or p40), which have been reported to promote the survival and growth of intestinal epithelial cells. Intriguingly, although each of these proteins shares homology with cell wall hydrolases, a physiological function that correlates with such an enzymatic activity remained to be substantiated in LGG. To investigate the bacterial function, we constructed knock-out mutants in the corresponding genes aiming to establish a genotype to phenotype relation. Microscopic examination of the msp1 mutant showed the presence of rather long and overly extended cell chains, which suggests that normal daughter cell separation is hampered. Subsequent observation of the LGG wild-type cells by immunofluorescence microscopy revealed that the Msp1 protein accumulates at the septum of exponential-phase cells. The cell wall hydrolyzing activity of the Msp1 protein was confirmed by zymogram analysis. Subsequent analysis by RP-HPLC and mass spectrometry of the digestion products of LGG peptidoglycan (PG) by Msp1 indicated that the Msp1 protein has D-glutamyl-L-lysyl endopeptidase activity. Immunofluorescence microscopy and the failure to construct a knock-out mutant suggest an indispensable role for Msp2 in priming septum formation in LGG.	[Claes, Ingmar J. J.; Schoofs, Geert; Vanderleyden, Jos; De Keersmaecker, Sigrid C. J.; Lebeer, Sarah] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Louvain, Belgium; [Regulski, Krzysztof; Courtin, Pascal; Chapot-Chartier, Marie-Pierre] INRA, UMR1319 Micalis, F-78350 Jouy En Josas, France; [Regulski, Krzysztof; Courtin, Pascal; Chapot-Chartier, Marie-Pierre] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France; [Rolain, Thomas; Hols, Pascal] UCL, Inst Sci Vie, Louvain, Belgium; [von Ossowski, Ingemar; Reunanen, Justus; de Vos, Willem M.; Palva, Airi] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Lebeer, Sarah] Univ Antwerp, Dept Biosci Engn, B-2020 Antwerp, Belgium	KU Leuven; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Universite Catholique Louvain; University of Helsinki; Wageningen University & Research; University of Antwerp	Claes, IJJ (corresponding author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Louvain, Belgium.	sarah.lebeer@biw.kuleuven.be	Lebeer, Sarah/S-9951-2019; Lebeer, Sarah/D-5156-2014; Claes, Ingmar/AAI-1910-2019; De Keersmaecker, Sigrid/ABB-5332-2021	Lebeer, Sarah/0000-0002-9400-6918; Lebeer, Sarah/0000-0002-9400-6918; Claes, Ingmar/0000-0003-4209-4116; De Keersmaecker, Sigrid/0000-0003-4198-4133; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519; von Ossowski, Ingemar Eric/0000-0002-9899-671X	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Research Department of the Communaute francaise de Belgique; Le Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture; Institut nationale de la recherche agronomique (INRA); French National Institut for Agricultural Research; Marie Curie FP7 Initial Training Network Cross Talk [21553-2]; Academy of Finland [118165]	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Department of the Communaute francaise de Belgique; Le Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture; Institut nationale de la recherche agronomique (INRA); French National Institut for Agricultural Research; Marie Curie FP7 Initial Training Network Cross Talk; Academy of Finland(Academy of Finland)	At the time of experiments, IJJC held a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) and SL was a postdoctoral researcher of the Fund for scientific research Vlaanderen, Belgium. Work of PH was supported by the Research Department of the Communaute francaise de Belgique (Concerted Research Action), and PH is Research Associate of the National fund for scientific research, Walloon, Belgium. TR held a doctoral fellowship from Le Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture. Work of MPCC was supported by Institut nationale de la recherche agronomique (INRA) or French National Institut for Agricultural Research. KR was the recipient of a fellowship from INRA and its PhD project received financial support from the Marie Curie FP7 Initial Training Network Cross Talk (grant agreement no21553-2). The work conducted in the group of AP is supported by the Academy of Finland (118165) and was part of the Center of Excellence in Microbial Food Safety Research at the University of Helsinki and the Academy of 377 Finland funded Research Program on Nutrition, Foods, and Health (ELVIRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; De Keersmaecker SCJ, 2006, APPL ENVIRON MICROB, V72, P4923, DOI 10.1128/AEM.02605-05; Goffin E, 2004, PERITON DIALYSIS INT, V24, P433; Harlow E., 1988, ANTIBODIES LAB MANUA; JOSSON K, 1989, PLASMID, V21, P9, DOI 10.1016/0147-619X(89)90082-6; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Layec S, 2008, RES MICROBIOL, V159, P507, DOI 10.1016/j.resmic.2008.06.008; Lebeer S, 2011, MICROBIAL CELL FACTO; Lebeer S, 2007, J BACTERIOL, V189, P860, DOI 10.1128/JB.01394-06; Lepeuple AS, 1998, APPL ENVIRON MICROB, V64, P4142; Maze A, 2010, J BACTERIOL, V192, P2647, DOI 10.1128/JB.00076-10; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Acosta MP, 2008, APPL ENVIRON MICROB, V74, P7824, DOI 10.1128/AEM.01712-08; Redko Y, 2007, APPL ENVIRON MICROB, V73, P5825, DOI 10.1128/AEM.00705-07; Sambrook J., 2002, MOL CLONING LAB MANU; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; WEIDEL W, 1964, ADV ENZYMOL REL S BI, V26, P193; Yan F, 2002, J BIOL CHEM, V277, P50959, DOI 10.1074/jbc.M207050200; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031	22	56	60	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31588	10.1371/journal.pone.0031588	http://dx.doi.org/10.1371/journal.pone.0031588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359601	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200070
J	Garcia-Olmos, L; Salvador, CH; Alberquilla, A; Lora, D; Carmona, M; Garcia-Sagredo, P; Pascual, M; Munoz, A; Monteagudo, JL; Garcia-Lopez, F				Garcia-Olmos, Luis; Salvador, Carlos H.; Alberquilla, Angel; Lora, David; Carmona, Montserrat; Garcia-Sagredo, Pilar; Pascual, Mario; Munoz, Adolfo; Monteagudo, Jose Luis; Garcia-Lopez, Fernando			Comorbidity Patterns in Patients with Chronic Diseases in General Practice	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; MULTIPLE CHRONIC CONDITIONS; EXTERNAL VALIDITY; PRIMARY-CARE; FAMILY-PRACTICE; MULTIMORBIDITY; PREVALENCE; QUALITY; CONSEQUENCES; MORBIDITY	Introduction: Healthcare management is oriented toward single diseases, yet multimorbidity is nevertheless the rule and there is a tendency for certain diseases to occur in clusters. This study sought to identify comorbidity patterns in patients with chronic diseases, by reference to number of comorbidities, age and sex, in a population receiving medical care from 129 general practitioners in Spain, in 2007. Methods: A cross-sectional study was conducted in a health-area setting of the Madrid Autonomous Region (Comunidad Autonoma), covering a population of 198,670 individuals aged over 14 years. Multiple correspondences were analyzed to identify the clustering patterns of the conditions targeted. Results: Forty-two percent (95% confidence interval [CI]: 41.8-42.2) of the registered population had at least one chronic condition. In all, 24.5% (95% CI: 24.3-24.6) of the population presented with multimorbidity. In the correspondence analysis, 98.3% of the total information was accounted for by three dimensions. The following four, age- and sex-related comorbidity patterns were identified: pattern B, showing a high comorbidity rate; pattern C, showing a low comorbidity rate; and two patterns, A and D, showing intermediate comorbidity rates. Conclusions: Four comorbidity patterns could be identified which grouped diseases as follows: one showing diseases with a high comorbidity burden; one showing diseases with a low comorbidity burden; and two showing diseases with an intermediate comorbidity burden.	[Garcia-Olmos, Luis] Multiprofess Educ Unit Family & Community Care SW, Madrid, Spain; [Salvador, Carlos H.; Garcia-Sagredo, Pilar; Pascual, Mario; Munoz, Adolfo; Monteagudo, Jose Luis] Carlos III Inst Hlth, Telemed & E Hlth Unit, Madrid, Spain; [Alberquilla, Angel] Multiprofess Educ Unit Family & Community Care Ct, Madrid, Spain; [Lora, David] 12 Octubre Hosp Biomed Res Inst Imas12, Clin Epidemiol Unit, Octubre Univ Teaching Hosp 12, Madrid, Spain; [Carmona, Montserrat] Puerta Hierro Univ Teaching Hosp, Bioengn & Telemed Unit, Madrid, Spain; [Garcia-Lopez, Fernando] Puerta Hierro Univ Teaching Hosp, Clin Epidemiol Unit, Madrid, Spain	Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre	Garcia-Olmos, L (corresponding author), Multiprofess Educ Unit Family & Community Care SW, Madrid, Spain.	lgarcia.gapm02@salud.madrid.org	Carmona, Montserrat/F-7593-2010; Carrero, Adolfo Muñoz/M-7801-2016; Carmona, Montserrat/AAD-7263-2019; García López, Fernando/F-8504-2010; Pascual Carrasco, Mario/E-8566-2016	Carmona, Montserrat/0000-0002-4680-7745; Carrero, Adolfo Muñoz/0000-0002-0141-7751; Carmona, Montserrat/0000-0002-4680-7745; García López, Fernando/0000-0002-4802-2650; Pascual Carrasco, Mario/0000-0003-0893-2841	CENIT (MICINN-CDTI) [CEN-2007-1010]; Ministry of Health & Consumer Affairs [FIS PI08-0435]; MOBIS of the Spanish Vodafone Foundation; Madrid's Area 11 Primary Health Care Authority	CENIT (MICINN-CDTI); Ministry of Health & Consumer Affairs; MOBIS of the Spanish Vodafone Foundation; Madrid's Area 11 Primary Health Care Authority	This study was partially supported by the CENIT Program (MICINN-CDTI) [CEN-2007-1010 "Digital personal environment for health and wellbeing - AmiVital" project], a grant from the Ministry of Health & Consumer Affairs [FIS PI08-0435], and the MOBIS Program of the Spanish Vodafone Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Drs. Juan Jose Munoz (Managing Director) and Maria Teresa Alonso (Medical Director) of Madrid's Area 11 Primary Health Care Authority for the support received.	Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4; Beasley JW, 2004, ANN FAM MED, V2, P405, DOI 10.1370/afm.94; Black, 2005, CHRONIC CONDITIONS C; Bogner HR, 2008, ANN FAM MED, V6, P295, DOI 10.1370/afm.843; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Carmona M, 2011, FAM PRACT, V28, P128, DOI 10.1093/fampra/cmq084; Cornell JE, 2007, APPL MULTIVARIATE RE, V2007, P163, DOI [10.22329/amr.v12i3.658, DOI 10.22329/AMR.V12I3.658]; De Maeseneer Jan M, 2003, Ann Fam Med, V1, P144, DOI 10.1370/afm.75; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2010, BMC HEALTH SERV RES, V10, P14; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Fortin Martin, 2005, Can Fam Physician, V51, P244; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Greenacre M, 1992, Stat Methods Med Res, V1, P97, DOI 10.1177/096228029200100106; Greenacre MJ, 1984, THEORY APPL CORRES A, P137; Grumbach Kevin, 2003, Ann Fam Med, V1, P4, DOI 10.1370/afm.47; Jordan K, 2004, FAM PRACT, V21, P396, DOI 10.1093/fampra/cmh409; Kadam UT, 2007, FAM PRACT, V24, P412, DOI 10.1093/fampra/cmm049; Laux G, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-14; Loza E, 2009, SEMIN ARTHRITIS RHEU, V38, P312, DOI 10.1016/j.semarthrit.2008.01.004; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020; O'Halloran J, 2004, FAM PRACT, V21, P381, DOI 10.1093/fampra/cmh407; O'Kelly S, 2011, RESP MED, V105, P236, DOI 10.1016/j.rmed.2010.07.019; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Schram MT, 2008, J CLIN EPIDEMIOL, V61, P1104, DOI 10.1016/j.jclinepi.2007.11.021; Starfield B, 2006, ANN FAM MED, V4, P101, DOI 10.1370/afm.524; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; Steckler A, 2008, AM J PUBLIC HEALTH, V98, P9, DOI 10.2105/AJPH.2007.126847; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van den Akker M, 2001, J CLIN EPIDEMIOL, V54, P675, DOI 10.1016/S0895-4356(00)00358-9; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Weiner JP, 2005, J HOPKINS ACGH CASE, P163; Westert GP, 2001, EUR J PUBLIC HEALTH, V11, P365, DOI 10.1093/eurpub/11.4.365; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	39	70	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32141	10.1371/journal.pone.0032141	http://dx.doi.org/10.1371/journal.pone.0032141			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359665	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200134
J	Koyama, H; Umeda, T; Nakamura, K; Higuchi, T; Kimura, A				Koyama, Hiroshi; Umeda, Tamiki; Nakamura, Kazuyuki; Higuchi, Tomoyuki; Kimura, Akatsuki			A High-Resolution Shape Fitting and Simulation Demonstrated Equatorial Cell Surface Softening during Cytokinesis and Its Promotive Role in Cytokinesis	PLOS ONE			English	Article							ANIMAL CYTOKINESIS; ADHERENT CELLS; MYOSIN-II; CONTRACTILE; MECHANISMS; DIVISION; CLEAVAGE; FORCES	Different models for animal cell cytokinesis posit that the stiffness of the equatorial cortex is either increased or decreased relative to the stiffness of the polar cortex. A recent work has suggested that the critical cytokinesis signaling complex centralspindlin may reduce the stiffness of the equatorial cortex by inactivating the small GTPase Rac. To determine if such a reduction occurs and if it depends on centralspindlin, we devised a method to estimate cortical bending stiffness with high spatio-temporal resolution from in vivo cell shapes. Using the early Caenorhabditis elegans embryo as a model, we show that the stiffness of the equatorial cell surface is reduced during cytokinesis, whereas the stiffness of the polar cell surface remains stiff. The equatorial reduction of stiffness was compromised in cells with a mutation in the gene encoding the ZEN-4/kinesin-6 subunit of centralspindlin. Theoretical modeling showed that the absence of the equatorial reduction of stiffness could explain the arrest of furrow ingression in the mutant. By contrast, the equatorial reduction of stiffness was sufficient to generate a cleavage furrow even without the constriction force of the contractile ring. In this regime, the contractile ring had a supportive contribution to furrow ingression. We conclude that stiffness is reduced around the equator in a centralspindlin-dependent manner. In addition, computational modeling suggests that proper regulation of stiffness could be sufficient for cleavage furrow ingression.	[Koyama, Hiroshi; Kimura, Akatsuki] Natl Inst Genet, Frontier Res Ctr, Cell Architecture Lab, Mishima, Shizuoka 411, Japan; [Koyama, Hiroshi; Higuchi, Tomoyuki; Kimura, Akatsuki] Res Org Informat & Syst, Transdisciplinary Res Intergrat Ctr, Tokyo, Japan; [Umeda, Tamiki] Kobe Univ, Grad Sch Maritime Sci, Kobe, Hyogo 657, Japan; [Nakamura, Kazuyuki] Meiji Univ, Kawasaki, Kanagawa, Japan; [Higuchi, Tomoyuki] Inst Stat Math, Tokyo, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); Kobe University; Meiji University; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan	Koyama, H (corresponding author), Natl Inst Basic Biol, Div Embryol, Higashiyama 5-1, Okazaki, Aichi 444, Japan.	akkimura@lab.nig.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Transdisciplinary Research Integration Center of the Research Organization of Information and Systems, Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Transdisciplinary Research Integration Center of the Research Organization of Information and Systems, Japan	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by the Transdisciplinary Research Integration Center of the Research Organization of Information and Systems, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canman JC, 2008, SCIENCE, V322, P1543, DOI 10.1126/science.1163086; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; DEULING HJ, 1976, BIOPHYS J, V16, P861, DOI 10.1016/S0006-3495(76)85736-0; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Hiramoto Y, 1990, ANN N Y ACAD SCI, V582, P22; Hotani H, 2003, BIOSYSTEMS, V71, P93, DOI 10.1016/S0303-2647(03)00113-8; Kanada M, 2005, MOL BIOL CELL, V16, P3865, DOI 10.1091/mbc.E05-03-0233; Matzke R, 2001, NAT CELL BIOL, V3, P607, DOI 10.1038/35078583; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Miyoshi H, 2006, CELL MOTIL CYTOSKEL, V63, P208, DOI 10.1002/cm.20118; Noguchi H, 2005, P NATL ACAD SCI USA, V102, P14159, DOI 10.1073/pnas.0504243102; O'Connell CB, 2001, CURR BIOL, V11, P702, DOI 10.1016/S0960-9822(01)00181-6; Oegema Karen, 2006, WormBook, P1, DOI 10.1895/wormbook.1.72.1; Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9; Reichl EM, 2005, TRENDS CELL BIOL, V15, P200, DOI 10.1016/j.tcb.2005.02.004; Robinson DN, 2000, TRENDS CELL BIOL, V10, P228, DOI 10.1016/S0962-8924(00)01747-5; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; Shelton CA, 1996, DEVELOPMENT, V122, P2043; Umeda T, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011913; Uyeda TQP, 2000, CELL STRUCT FUNCT, V25, P1; Wang YL, 2001, CELL STRUCT FUNCT, V26, P633, DOI 10.1247/csf.26.633; WHITE JG, 1983, J THEOR BIOL, V101, P289, DOI 10.1016/0022-5193(83)90342-9; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zhang WD, 2005, P NATL ACAD SCI USA, V102, P7186, DOI 10.1073/pnas.0502545102	28	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31607	10.1371/journal.pone.0031607	http://dx.doi.org/10.1371/journal.pone.0031607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359606	gold, Green Submitted, Green Published			2022-12-25	WOS:000302796200075
J	Mackenzie, NCW; Zhu, DX; Milne, EM; van 't Hof, R; Martin, A; Quarles, DL; Millan, JL; Farquharson, C; MacRae, VE				Mackenzie, Neil Charles Wallace; Zhu, Dongxing; Milne, Elspeth M.; van 't Hof, Rob; Martin, Aline; Quarles, Darryl Leigh; Millan, Jose Luis; Farquharson, Colin; MacRae, Vicky Elisabeth			Altered Bone Development and an Increase in FGF-23 Expression in Enpp1(-/-) Mice	PLOS ONE			English	Article							NONSPECIFIC ALKALINE-PHOSPHATASE; POSTERIOR LONGITUDINAL LIGAMENT; CELL MEMBRANE GLYCOPROTEIN-1; INORGANIC PYROPHOSPHATE; PATHOLOGICAL CALCIFICATION; VASCULAR CALCIFICATION; PATHOGENIC ROLE; MOUSE MODEL; CALCIUM; ANK	Nucleotide pyrophosphatase phosphodiesterase 1 (NPP1) is required for the conversion of extracellular ATP into inorganic pyrophosphate (PPi), a recognised inhibitor of hydroxyapatite (HA) crystal formation. A detailed phenotypic assessment of a mouse model lacking NPP1 (Enpp1(-/-)) was completed to determine the role of NPP1 in skeletal and soft tissue mineralization in juvenile and adult mice. Histopathological assessment of Enpp1(-/-) mice at 22 weeks of age revealed calcification in the aorta and kidney and ectopic cartilage formation in the joints and spine. Radiographic assessment of the hind-limb showed hyper-mineralization in the talocrural joint and hypo-mineralization in the femur and tibia. MicroCT analysis of the tibia and femur disclosed altered trabecular architecture and bone geometry at 6 and 22 weeks of age in Enpp1(-/-) mice. Trabecular number, trabecular bone volume, structure model index, trabecular and cortical thickness were all significantly reduced in tibiae and femurs from Enpp1(-/-) mice (P<0.05). Bone stiffness as determined by 3-point bending was significantly reduced in Enpp1(-/-) tibiae and femurs from 22-week-old mice (P<0.05). Circulating phosphate and calcium levels were reduced (P<0.05) in the Enpp1(-/-) null mice. Plasma levels of osteocalcin were significantly decreased at 6 weeks of age (P<0.05) in Enpp1(-/-) mice, with no differences noted at 22 weeks of age. Plasma levels of CTx (Ratlaps (TM)) and the phosphaturic hormone FGF-23 were significantly increased in the Enpp1(-/-) mice at 22 weeks of age (P<0.05). Fgf-23 messenger RNA expression in cavarial osteoblasts was increased 12-fold in Enpp1(-/-) mice compared to controls. These results indicate that Enpp1(-/-) mice are characterized by severe disruption to the architecture and mineralization of long-bones, dysregulation of calcium/phosphate homeostasis and changes in Fgf-23 expression. We conclude that NPP1 is essential for normal bone development and control of physiological bone mineralization.	[Mackenzie, Neil Charles Wallace; Zhu, Dongxing; Milne, Elspeth M.; Farquharson, Colin; MacRae, Vicky Elisabeth] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Mackenzie, Neil Charles Wallace; Zhu, Dongxing; Milne, Elspeth M.; Farquharson, Colin; MacRae, Vicky Elisabeth] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland; [van 't Hof, Rob] Univ Edinburgh, Rheumat Dis Unit, Mol Med Ctr, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Millan, Jose Luis] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA USA; [Martin, Aline; Quarles, Darryl Leigh] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; Sanford Burnham Prebys Medical Discovery Institute; University of Tennessee System; University of Tennessee Health Science Center	Mackenzie, NCW (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland.	vicky.macrae@roslin.ed.ac.uk	farquharson, colin/C-2956-2011; Zhu, Dongxing/N-5059-2014; zhu, dongxing/AAM-4330-2020	farquharson, colin/0000-0002-4970-4039; zhu, dongxing/0000-0001-5419-438X; MacRae, Vicky/0000-0001-6306-7040; van 't Hof, Rob/0000-0002-8193-6788; Quarles, L. Darryl/0000-0002-5082-7896	Institute Strategic Programme Grant; Institute Career Path Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/E/D/20221657, BB/F023928/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053102, R01AR045955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012889] Funding Source: NIH RePORTER; BBSRC [BB/F023928/1, BBS/E/D/20221657] Funding Source: UKRI	Institute Strategic Programme Grant; Institute Career Path Fellowship; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an Institute Strategic Programme Grant and Institute Career Path Fellowship funding from the Biotechnology and Biological Sciences Research Council (BBSRC; www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abate N, 2006, NAT CLIN PRACT ENDOC, V2, P694, DOI 10.1038/ncpendmet0367; Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z; Anderson HC, 2005, AM J PATHOL, V166, P1711, DOI 10.1016/S0002-9440(10)62481-9; ANDERSON HC, 1990, AM J PATHOL, V136, P391; Baba H, 1997, EUR J HISTOCHEM, V41, P191; Babij P, 2009, J BONE MINER RES, V24, P1552, DOI [10.1359/JBMR.090417, 10.1359/jbmr.090417]; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; CECIL RNA, 1978, METAB BONE DIS RELAT, V1, P89, DOI 10.1016/0221-8747(78)90043-7; CHAMBERS TJ, 1982, J PATHOL, V136, P27, DOI 10.1002/path.1711360104; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Chen IP, 2011, HUM MOL GENET, V20, P948, DOI 10.1093/hmg/ddq541; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Dong HJ, 2005, DIABETES, V54, P367, DOI 10.2337/diabetes.54.2.367; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Furusawa N, 1996, EUR J HISTOCHEM, V40, P199; HAKIM FT, 1984, ARTHRITIS RHEUM, V27, P1411, DOI 10.1002/art.1780271212; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Harmey D, 2006, J BONE MINER RES, V21, P1377, DOI 10.1359/JBMR.060619; HENTHORN PS, 1992, P NATL ACAD SCI USA, V89, P9924, DOI 10.1073/pnas.89.20.9924; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hessle L, 2002, J BONE MINER RES, V17, pS128; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Huesa C, 2011, BONE, V48, P1066, DOI 10.1016/j.bone.2011.01.010; Johnson K, 2005, FRONT BIOSCI-LANDMRK, V10, P988, DOI 10.2741/1593; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Johnson K, 2005, ARTERIOSCL THROM VAS, V25, P686, DOI 10.1161/01.ATV.0000154774.71187.f0; Johnson K, 2001, J RHEUMATOL, V28, P2681; Johnson KA, 2000, AM J PHYSIOL-REG I, V279, pR1365, DOI 10.1152/ajpregu.2000.279.4.R1365; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010; Liu SG, 2008, AM J PHYSIOL-ENDOC M, V295, pE254, DOI 10.1152/ajpendo.90201.2008; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; MAJESKA RJ, 1975, BIOCHIM BIOPHYS ACTA, V391, P51, DOI 10.1016/0005-2744(75)90151-5; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4; MOSS DW, 1967, BIOCHEM J, V102, P53, DOI 10.1042/bj1020053; Mulari MTK, 2003, TRAFFIC, V4, P113, DOI 10.1034/j.1600-0854.2003.40206.x; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Nam HK, 2011, J BIOL CHEM, V286, P39059, DOI 10.1074/jbc.M111.221689; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Okawa A, 1999, CALCIFIED TISSUE INT, V64, P239, DOI 10.1007/s002239900610; Orriss IR, 2010, CURR OPIN PHARMACOL, V10, P322, DOI 10.1016/j.coph.2010.01.003; Owen HC, 2009, CALCIFIED TISSUE INT, V85, P326, DOI 10.1007/s00223-009-9276-0; Petersen CB, 2007, DEV COMP IMMUNOL, V31, P618, DOI 10.1016/j.dci.2006.08.012; Prosdocimo DA, 2009, AM J PHYSIOL-CELL PH, V296, pC828, DOI 10.1152/ajpcell.00619.2008; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; SAKAMOTO M, 1994, PATHOL INT, V44, P420, DOI 10.1111/j.1440-1827.1994.tb01705.x; Sali A.F.J.M., 1999, ECTO ATPASES RELATED, P267; Sekrecka-Belniak A, 2010, BIOCHEM BIOPH RES CO, V391, P1432, DOI 10.1016/j.bbrc.2009.12.083; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624	61	105	106	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32177	10.1371/journal.pone.0032177	http://dx.doi.org/10.1371/journal.pone.0032177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359666	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200135
J	Shin, YJ; Sayed, AH; Shen, XL				Shin, Yong-Jun; Sayed, Ali H.; Shen, Xiling			Adaptive Models for Gene Networks	PLOS ONE			English	Article							FEEDBACK LOOP; P53; EXPRESSION; IDENTIFICATION; STRATEGIES; CIRCUIT; SYSTEMS	Biological systems are often treated as time-invariant by computational models that use fixed parameter values. In this study, we demonstrate that the behavior of the p53-MDM2 gene network in individual cells can be tracked using adaptive filtering algorithms and the resulting time-variant models can approximate experimental measurements more accurately than time-invariant models. Adaptive models with time-variant parameters can help reduce modeling complexity and can more realistically represent biological systems.	[Shin, Yong-Jun; Shen, Xiling] Cornell Univ, Ithaca, NY 14853 USA; [Sayed, Ali H.] Univ Calif Los Angeles, Los Angeles, CA USA	Cornell University; University of California System; University of California Los Angeles	Shin, YJ (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	xs66@cornell.edu	Sayed, Ali H/D-6251-2012	Sayed, Ali H/0000-0002-5125-5519	Cornell Stem Cell Program; National Institutes of Health [R01GM95990]; National Science Foundation [CCF-1011918, CCF-0942936]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095990] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [0942936, 1011918] Funding Source: National Science Foundation	Cornell Stem Cell Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by Cornell Stem Cell Program, National Institutes of Health grant R01GM95990 and National Science Foundation grants CCF-1011918 and CCF-0942936. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Cattivelli FS, 2010, IEEE T AUTOMAT CONTR, V55, P2069, DOI 10.1109/TAC.2010.2042987; Cattivelli FS, 2010, IEEE T SIGNAL PROCES, V58, P1035, DOI 10.1109/TSP.2009.2033729; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Gennemark P, 2007, IET SYST BIOL, V1, P120, DOI 10.1049/iet-syb:20050098; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Geva-Zatorsky N, 2010, P NATL ACAD SCI USA, V107, P13550, DOI 10.1073/pnas.1001107107; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Landau R.H., 2007, COMPUTATIONAL PHYS P; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; Ljung L., 1999, SYSTEM IDENTIFICATIO; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Milias-Argeitis A, 2011, NAT BIOTECHNOL, V29, P1114, DOI 10.1038/nbt.2018; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Proakis J. G., 2007, DIGITAL SIGNAL PROCE; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; REGALIA PA, 1995, ADAPTIVE IIR FILTERI; Sayed A. H., 2008, ADAPTIVE FILTERS, DOI 10.1002/9780470374122; Sun XD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003758; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	22	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31657	10.1371/journal.pone.0031657	http://dx.doi.org/10.1371/journal.pone.0031657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359614	Green Submitted, gold, Green Published			2022-12-25	WOS:000302796200083
J	Guerrero-Vargas, JA; Mourao, CBF; Quintero-Hernandez, V; Possani, LD; Schwartz, EF				Guerrero-Vargas, Jimmy A.; Mourao, Caroline B. F.; Quintero-Hernandez, Veronica; Possani, Lourival D.; Schwartz, Elisabeth F.			Identification and Phylogenetic Analysis of Tityus pachyurus and Tityus obscurus Novel Putative Na+-Channel Scorpion Toxins	PLOS ONE			English	Article							ANDROCTONUS-AUSTRALIS-HECTOR; MAMMALIAN SODIUM-CHANNELS; AMINO-ACID-SEQUENCE; SERRULATUS SCORPION; MASS-SPECTROMETRY; ALPHA-TOXINS; BETA-TOXINS; K+-CHANNELS; TRANSCRIPTOME ANALYSIS; VENEZUELAN SCORPION	Background: Colombia and Brazil are affected by severe cases of scorpionism. In Colombia the most dangerous accidents are caused by Tityus pachyurus that is widely distributed around this country. In the Brazilian Amazonian region scorpion stings are a common event caused by Tityus obscurus. The main objective of this work was to perform the molecular cloning of the putative Na+-channel scorpion toxins (NaScTxs) from T. pachyurus and T. obscurus venom glands and to analyze their phylogenetic relationship with other known NaScTxs from Tityus species. Methodology/Principal Findings: cDNA libraries from venom glands of these two species were constructed and five nucleotide sequences from T. pachyurus were identified as putative modulators of Na+-channels, and were named Tpa4, Tpa5, Tpa6, Tpa7 and Tpa8; the latter being the first anti-insect excitatory beta-class NaScTx in Tityus scorpion venom to be described. Fifteen sequences from T. obscurus were identified as putative NaScTxs, among which three had been previously described, and the others were named To4 to To15. The peptides Tpa4, Tpa5, Tpa6, To6, To7, To9, To10 and To14 are closely related to the alpha-class NaScTxs, whereas Tpa7, Tpa8, To4, To8, To12 and To15 sequences are more related to the beta-class NaScTxs. To5 is possibly an arthropod specific toxin. To11 and To13 share sequence similarities with both alpha and beta NaScTxs. By means of phylogenetic analysis using the Maximum Parsimony method and the known NaScTxs from Tityus species, these toxins were clustered into 14 distinct groups. Conclusions/Significance: This communication describes new putative NaScTxs from T. pachyurus and T. obscurus and their phylogenetic analysis. The results indicate clear geographic separation between scorpions of Tityus genus inhabiting the Amazonian and Mountain Andes regions and those distributed over the Southern of the Amazonian rainforest. Based on the consensus sequences for the different clusters, a new nomenclature for the NaScTxs is proposed.	[Guerrero-Vargas, Jimmy A.; Mourao, Caroline B. F.; Schwartz, Elisabeth F.] Univ Brasilia, Dept Ciencias Fisiol, Lab Toxinol, Brasilia, DF, Brazil; [Quintero-Hernandez, Veronica; Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico	Universidade de Brasilia; Universidad Nacional Autonoma de Mexico	Guerrero-Vargas, JA (corresponding author), Univ Brasilia, Dept Ciencias Fisiol, Lab Toxinol, Brasilia, DF, Brazil.	efschwa@unb.br	Mourao, Caroline B F/A-2277-2013; Schwartz, Elisabeth Ferroni/AGE-4234-2022; Schwartz, Elisabeth/G-4531-2012; Possani, Lourival D/J-2397-2013; Guerrero-Vargas, Jimmy Alexander/AAC-1367-2019	Mourao, Caroline B F/0000-0003-3795-6025; Schwartz, Elisabeth Ferroni/0000-0001-8239-4055; Schwartz, Elisabeth/0000-0001-8239-4055; Guerrero-Vargas, Jimmy Alexander/0000-0002-0193-5508; Quintero-Hernandez, Veronica/0000-0002-1856-8134	National Council for Scientific and Technological Development Brazil/Consejo Nacional de Ciencia y Tecnologia (CNPq/CONACyT) [490068/2009-0]; CNPq [303003/2009-0, 472731/2008-4, 472533/2010-0, 553137/2007-7]; Foundation for Research Support of the Federal District (FAPDF) [193.000.472/2008]; Direcion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) [IN204110]; CAPES	National Council for Scientific and Technological Development Brazil/Consejo Nacional de Ciencia y Tecnologia (CNPq/CONACyT); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of the Federal District (FAPDF)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Direcion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by National Council for Scientific and Technological Development Brazil/Consejo Nacional de Ciencia y Tecnologia (CNPq/CONACyT; www.conacyt.mx) (490068/2009-0) to EFS and LDP, CNPq (303003/2009-0; 472731/2008-4, 472533/2010-0) and Foundation for Research Support of the Federal District (FAPDF; www.fap.df.gov.br) (193.000.472/2008) to EFS, and Direcion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) IN204110 to LDP. JAGV and CBFM are students supported respectively by the Brazilian agencies CNPq (www.cnpq.br) (553137/2007-7) and CAPES (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MA, 2009, TOXICON, V53, P349, DOI 10.1016/j.toxicon.2008.12.007; Amaro I, 2011, IMMUNOL LETT, V139, P73, DOI 10.1016/j.imlet.2011.05.002; Asano ME, 1996, REV SOC BRASILEIRA M, V29, P243; Barona J, 2006, BBA-PROTEINS PROTEOM, V1764, P76, DOI 10.1016/j.bbapap.2005.08.010; Barona Jacqueline, 2004, Biomed., V24, P42; Batista CVF, 2004, J CHROMATOGR B, V803, P55, DOI 10.1016/j.jchromb.2003.09.002; Batista CVF, 2002, TOXICON, V40, P557, DOI 10.1016/S0041-0101(01)00252-5; Batista CVF, 2002, BBA-PROTEINS PROTEOM, V1601, P123, DOI 10.1016/S1570-9639(02)00458-2; Batista CVF, 2000, FEBS LETT, V486, P117, DOI 10.1016/S0014-5793(00)02253-5; Becerril B, 1997, TOXICON, V35, P821, DOI 10.1016/S0041-0101(96)00198-5; Becerril B, 1996, BIOCHEM J, V313, P753, DOI 10.1042/bj3130753; Ben Othmen A, 2009, ACTA TROP, V112, P77, DOI 10.1016/j.actatropica.2009.07.001; Blanc E, 1997, EUR J BIOCHEM, V247, P1118, DOI 10.1111/j.1432-1033.1997.01118.x; Borges A, 2006, COMP BIOCHEM PHYS C, V142, P240, DOI 10.1016/j.cbpc.2005.10.011; Borges A, 2004, TOXICON, V43, P671, DOI 10.1016/j.toxicon.2004.02.022; Borges A, 1999, TOXICON, V37, P867, DOI 10.1016/S0041-0101(98)00201-3; Borges A, 2005, ACTA CIENT VENEZ, V5, P56; Borges A, 2007, TOXICON, V50, P1005, DOI 10.1016/j.toxicon.2007.07.019; Borges A, 2010, WILD ENVIRON MED, V21, P282, DOI 10.1016/j.wem.2010.06.008; Borges A, 2010, TOXICON, V55, P436, DOI 10.1016/j.toxicon.2009.09.011; Bosmans F, 2007, TOXICON, V49, P142, DOI 10.1016/j.toxicon.2006.09.023; Bucaretchi Fabio, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P331, DOI 10.1590/S0036-46651995000400008; Caliskan F, 2006, TOXICON, V48, P12, DOI 10.1016/j.toxicon.2006.04.003; Cao ZJ, 2006, TOXICON, V47, P348, DOI 10.1016/j.toxicon.2005.11.013; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cologna CT, 2009, PROTEIN PEPTIDE LETT, V16, P920, DOI 10.2174/092986609788923329; Corona M, 1996, TOXICON, V34, P251, DOI 10.1016/0041-0101(95)00129-8; Cupo Palmira, 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P67, DOI 10.1590/S0036-46651994000100011; D'Suze G, 2004, TOXICON, V43, P263, DOI 10.1016/j.toxicon.2003.12.004; D'Suze G, 2009, BIOCHIMIE, V91, P1010, DOI 10.1016/j.biochi.2009.05.005; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de la Vega RCR, 2007, TOXICON, V49, P171, DOI 10.1016/j.toxicon.2006.09.016; De Sousa L, 2007, REV SOC BRAS MED TRO, V40, P681, DOI 10.1590/S0037-86822007000600017; Demeure K, 2010, J AM SOC MASS SPECTR, V21, P1906, DOI 10.1016/j.jasms.2010.07.009; Escoubas P, 2008, J MASS SPECTROM, V43, P279, DOI 10.1002/jms.1389; Escoubas P, 2006, TOXICON, V47, P609, DOI 10.1016/j.toxicon.2006.01.013; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Florez D.E., 2001, BIOTA COLOMB, V2, P25; Froy O, 2003, TOXICON, V42, P549, DOI 10.1016/S0041-0101(03)00236-8; Froy O, 1999, J MOL EVOL, V48, P187, DOI 10.1007/PL00006457; Garcia-Gomez BI, 2009, TOXICON, V53, P770, DOI 10.1016/j.toxicon.2009.02.011; Gómez C Juan Pablo, 2007, Rev. Fac. Nac. Salud Pública, V25, P50; Gonzalez-Sponga MA, 2002, B ACAD CIEN FIS MAT, VIXII, P49; Gordon D, 2003, EUR J BIOCHEM, V270, P2663, DOI 10.1046/j.1432-1033.2003.03643.x; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Gurevitz M, 2001, FASEB J, V15, P1201, DOI 10.1096/fj.00-0571hyp; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Inceoglu B, 2001, EUR J BIOCHEM, V268, P5407, DOI 10.1046/j.0014-2956.2001.02479.x; JOVER E, 1980, BIOCHEM BIOPH RES CO, V95, P1607, DOI 10.1016/S0006-291X(80)80082-9; Junqueira-de-Azevedo ILM, 2006, GENETICS, V173, P877, DOI 10.1534/genetics.106.056515; Kalapothakis E, 2001, TOXICON, V39, P679, DOI 10.1016/S0041-0101(00)00194-X; Karbat I, 2004, J BIOL CHEM, V279, P31679, DOI 10.1074/jbc.M402048200; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Lazo GR, 2001, BIOTECHNIQUES, V30, P1300, DOI 10.2144/01306bc03; LORET EP, 1991, BIOCHEMISTRY-US, V30, P633, DOI 10.1021/bi00217a007; Lourenco W, 2001, SCORPION BIOLOGY AND RESEARCH, P406; Lourenco Wilson R., 1994, Biogeographica (Paris), V70, P155; Lourengo W. R., 2008, EUSCORPIUS, V75, P1; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; Mansuelle Pascal, 1992, Natural Toxins, V1, P119, DOI 10.1002/nt.2620010211; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Murgia AR, 2004, TOXICON, V43, P737, DOI 10.1016/j.toxicon.2004.02.014; Nei M., 2000, MOL EVOLUTION PHYLOG; Otero R, 2004, T ROY SOC TROP MED H, V98, P742, DOI 10.1016/j.trstmh.2003.12.018; Pardal Pedro Pereira de Oliveira, 2003, Rev Soc Bras Med Trop, V36, P349; Pimenta AMC, 2001, TOXICON, V39, P1009, DOI 10.1016/S0041-0101(00)00240-3; POSSANI LD, 1991, J BIOL CHEM, V266, P3178; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; Roberts JL, 2006, MOL PHYLOGENET EVOL, V41, P149, DOI 10.1016/j.ympev.2006.05.005; Sanz L, 2008, J PROTEOMICS, V71, P46, DOI 10.1016/j.jprot.2007.10.004; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Silva ECN, 2009, TOXICON, V54, P252, DOI 10.1016/j.toxicon.2009.04.010; Soares Marcely Regina Martins, 2002, Rev. Soc. Bras. Med. Trop., V35, P359, DOI 10.1590/S0037-86822002000400013; Srairi-Abid N, 2005, BIOCHEM J, V388, P455, DOI 10.1042/BJ20041407; Tamura K, 2011, MOL BIOL EV IN PRESS; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Wilson E. O., BIODIVERSITY; Yao J, 2005, J BIOL CHEM, V280, P14819, DOI 10.1074/jbc.M412735200; Zeng XC, 2005, IUBMB LIFE, V57, P13, DOI 10.1080/15216540500058899; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452	84	44	111	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30478	10.1371/journal.pone.0030478	http://dx.doi.org/10.1371/journal.pone.0030478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355312	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300012
J	Nagpal, I; Raj, I; Subbarao, N; Gourinath, S				Nagpal, Isha; Raj, Isha; Subbarao, Naidu; Gourinath, Samudrala			Virtual Screening, Identification and In Vitro Testing of Novel Inhibitors of O-Acetyl-L-Serine Sulfhydrylase of Entamoeba histolytica	PLOS ONE			English	Article							VALIDATION; AMEBIASIS; CYSTEINE; BINDING; DOCKING; COMPLEX	The explosive epidemicity of amoebiasis caused by the facultative gastrointestinal protozoan parasite Entamoeba histolytica is a major public health problem in developing countries. Multidrug resistance and side effects of various available antiamoebic drugs necessitate the design of novel antiamobeic agents. The cysteine biosynthetic pathway is the critical target for drug design due to its significance in the growth, survival and other cellular activities of E. histolytica. Here, we have screened 0.15 million natural compounds from the ZINC database against the active site of the EhOASS enzyme (PDB ID. 3BM5, 2PQM), whose structure we previously determined to 2.4 A and 1.86 angstrom resolution. For this purpose, the incremental construction algorithm of GLIDE and the genetic algorithm of GOLD were used. We analyzed docking results for top ranking compounds using a consensus scoring function of X-Score to calculate the binding affinity and using ligplot to measure protein-ligand interactions. Fifteen compounds that possess good inhibitory activity against EhOASS active site were identified that may act as potential high affinity inhibitors. In vitro screening of a few commercially available compounds established their biological activity. The first ranked compound ZINC08931589 had a binding affinity of similar to 8.05 mu M and inhibited about 73% activity at 0.1 mM concentration, indicating good correlation between in silico prediction and in vitro inhibition studies. This compound is thus a good starting point for further development of strong inhibitors.	[Nagpal, Isha; Raj, Isha; Gourinath, Samudrala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Nagpal, I (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	nsrao@mail.jnu.ac.in; sgourinath@mail.jnu.ac.in	Subbarao, Prof Naidu/AAZ-1832-2020	Subbarao, Prof Naidu/0000-0002-1720-2165; Raj, Isha/0000-0003-4686-0498	DBT; CSIR; Department of Biotechnology, Government of India, UGC; JNU	DBT(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India, UGC; JNU	I.N. and I. R. thank DBT and CSIR for fellowships. The authors thank Programme Support on Molecular Parasitology by the Department of Biotechnology, Government of India, UGC resource networking and JNU capacity build-up grant for funding. The funders or funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinthalapudi K, 2008, PROTEINS, V72, P1222, DOI 10.1002/prot.22013; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Cudmore SL, 2004, CLIN MICROBIOL REV, V17, P783, DOI 10.1128/CMR.17.4.783-793.2004; DeLano W, 2002, PYMOL 0 99; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Krishna C, 2007, ACTA CRYSTALLOGR F, V63, P512, DOI 10.1107/S1744309107022154; Kumar S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197376; Olivos-Garcia A, 2009, INFECT GENET EVOL, V9, P1033, DOI 10.1016/j.meegid.2009.04.005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salles JM, 2007, EXPERT REV ANTI-INFE, V5, P893, DOI 10.1586/14787210.5.5.893; Stanley SL, 2006, PARASITOLOGY, V133, pS81, DOI [10.1017/S003118200600182X, 10.1017/S003118200600182x]; TAKEUCHI T, 1979, COMP BIOCHEM PHYS B, V62, P281, DOI 10.1016/0305-0491(79)90214-1; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882	17	58	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30305	10.1371/journal.pone.0030305	http://dx.doi.org/10.1371/journal.pone.0030305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355310	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300010
J	Sati, S; Tanwar, VS; Kumar, KA; Patowary, A; Jain, V; Ghosh, S; Ahmad, S; Singh, M; Reddy, SU; Chandak, GR; Raghunath, M; Sivasubbu, S; Chakraborty, K; Scaria, V; Sengupta, S				Sati, Satish; Tanwar, Vinay Singh; Kumar, K. Anand; Patowary, Ashok; Jain, Vaibhav; Ghosh, Sourav; Ahmad, Shadab; Singh, Meghna; Reddy, S. Umakar; Chandak, Giriraj Ratan; Raghunath, Manchala; Sivasubbu, Sridhar; Chakraborty, Kausik; Scaria, Vinod; Sengupta, Shantanu			High Resolution Methylome Map of Rat Indicates Role of Intragenic DNA Methylation in Identification of Coding Region	PLOS ONE			English	Article							EPIGENETIC MODIFICATIONS; TRANSCRIPTIONAL REGULATION; CHROMATIN-STRUCTURE; GENOME; DIFFERENTIATION; EPIGENOME; INSTABILITY; CHALLENGES; DATABASE; REPEATS	DNA methylation is crucial for gene regulation and maintenance of genomic stability. Rat has been a key model system in understanding mammalian systemic physiology, however detailed rat methylome remains uncharacterized till date. Here, we present the first high resolution methylome of rat liver generated using Methylated DNA immunoprecipitation and high throughput sequencing (MeDIP-Seq) approach. We observed that within the DNA/RNA repeat elements, simple repeats harbor the highest degree of methylation. Promoter hypomethylation and exon hypermethylation were common features in both RefSeq genes and expressed genes (as evaluated by proteomic approach). We also found that although CpG islands were generally hypomethylated, about 6% of them were methylated and a large proportion (37%) of methylated islands fell within the exons. Notably, we obeserved significant differences in methylation of terminal exons (UTRs); methylation being more pronounced in coding/partially coding exons compared to the non-coding exons. Further, events like alternate exon splicing (cassette exon) and intron retentions were marked by DNA methylation and these regions are retained in the final transcript. Thus, we suggest that DNA methylation could play a crucial role in marking coding regions thereby regulating alternative splicing. Apart from generating the first high resolution methylome map of rat liver tissue, the present study provides several critical insights into methylome organization and extends our understanding of interplay between epigenome, gene expression and genome stability.	[Sati, Satish; Tanwar, Vinay Singh; Patowary, Ashok; Jain, Vaibhav; Ghosh, Sourav; Ahmad, Shadab; Singh, Meghna; Sivasubbu, Sridhar; Chakraborty, Kausik; Scaria, Vinod; Sengupta, Shantanu] CSIR Inst Genom & Integrat Biol, Delhi, India; [Kumar, K. Anand; Raghunath, Manchala] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India; [Reddy, S. Umakar; Chandak, Giriraj Ratan] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sati, S (corresponding author), CSIR Inst Genom & Integrat Biol, Delhi, India.	vinods@igib.in; shantanus@igib.res.in	Patowary, Ashok/AAT-5305-2020; Sati, Satish/F-3531-2012; Scaria, Vinod/B-2819-2008; Scaria, Vinod/AAS-3151-2021; Chakraborty, Kausik/AAL-5748-2021; Sati, Satish/Q-6951-2019; Tanwar, Vinay Singh/AAJ-5017-2021; Singh, Meghna/AAV-5262-2020; ghosh, sourav/H-8412-2012	Patowary, Ashok/0000-0001-7507-3907; Sati, Satish/0000-0001-8236-9466; Chandak, Giriraj Ratan/0000-0002-3095-9453; Scaria, Vinod/0000-0001-7644-7181; Singh, Meghna/0000-0002-7907-6571; chakraborty, kausik/0000-0001-6000-8379; Tanwar, Vinay/0000-0001-6168-2752	Department of Biotechnology, India [BT/PR4525/MED/14/533/2003]	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This study was supported by the Department of Biotechnology, India (BT/PR4525/MED/14/533/2003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta D, 2011, MAMM GENOME, V22, P249, DOI 10.1007/s00335-011-9318-6; Anastasiadou C, 2011, DNA CELL BIOL, V30, P267, DOI 10.1089/dna.2010.1094; Backdahl L, 2009, EPIGENETICS-US, V4, P248; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Brodsky AS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r64; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Choi JK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r89; Dion V, 2009, TRENDS GENET, V25, P288, DOI 10.1016/j.tig.2009.04.007; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Esteller M, 2005, EMBO REP, V6, P624, DOI 10.1038/sj.embor.7400456; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; Koul Sanjay, 2002, Mol Cancer, V1, P8, DOI 10.1186/1476-4598-1-8; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Mandal PK, 2008, CELL, V135, DOI 10.1016/j.cell.2008.09.028; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rosenfeld CS, 2010, BIOL REPROD, V82, P473, DOI 10.1095/biolreprod.109.080952; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Szyf M, 2007, TOXICOL SCI, V100, P7, DOI 10.1093/toxsci/kfm177; Thompson RF, 2010, J BIOL CHEM, V285, P15111, DOI 10.1074/jbc.M109.095133; Tomazou EM, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-19; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang YM, 2010, GENOME RES, V20, P19, DOI 10.1101/gr.100073.109; Yadav AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024442; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	48	69	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31621	10.1371/journal.pone.0031621	http://dx.doi.org/10.1371/journal.pone.0031621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355382	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300082
J	Dastidar, SG; Narayanan, S; Stifani, S; D'Mello, SR				Dastidar, Somasish Ghosh; Narayanan, Sriram; Stifani, Stefano; D'Mello, Santosh R.			Transducin-like Enhancer of Split-1 (TLE1) Combines with Forkhead Box Protein G1 (FoxG1) to Promote Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEACETYLASE-RELATED PROTEIN; HELIX TRANSCRIPTION FACTOR; HEAD GENE FAMILY; CEREBRAL HEMISPHERES; POSTMITOTIC NEURONS; DROSOPHILA GROUCHO; FACTOR-I; Q-DOMAIN; DIFFERENTIATION; REPRESSOR	Transducin-like enhancer of split-1 (TLE1) plays a critical role in the regulation of neurogenesis by inhibiting the differentiation of neural progenitor cells into neurons. Although TLE1 is also expressed highly in the postnatal brain and through adulthood, its role in postmitotic neurons is not clear. Using cultures of cerebellar granule neurons, we show that expression of TLE1 is reduced in neurons primed to die. Reestablishment of elevated TLE1 levels by ectopic expression protects neurons from death, whereas suppression of TLE1 expression in otherwise healthy neurons induces cell death. These results show that TLE1 is necessary for the maintenance of neuronal survival. Experiments using pharmacological inhibitors as well as expression of point mutants indicate that phosphorylation of TLE1 by casein kinase-2 (CK2) at Ser-239 and Ser-253 is necessary for its survival-promoting activity. TLE1-mediated survival is also inhibited by pharmacological inhibition of PI3K-Akt signaling but not by inhibitors of Raf-MEK-ERK signaling or other molecules, including histone deacetylases, calcium calmodulin kinase, or CK1. The survival-promoting activity of TLE1 depends critically on interaction with FoxG1, another protein involved in the regulation of neurogenesis and shown previously to promote survival of postmitotic neurons. Likewise, the ability of FoxG1 to promote neuronal survival depends on TLE1. Taken together, our study demonstrates that TLE1 cooperates with FoxG1 to promote neuronal survival in a CK2- and PI3K-Akt-dependent manner.	[Dastidar, Somasish Ghosh; Narayanan, Sriram; D'Mello, Santosh R.] Univ Texas Richardson, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [D'Mello, Santosh R.] Univ Texas Richardson, Sch Behav & Brain Sci, Richardson, TX 75080 USA; [Stifani, Stefano] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; McGill University	D'Mello, SR (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, 2601 N Floyd Rd, Richardson, TX 75083 USA.	dmello@utdallas.edu	D'Mello, Santosh/AAO-7192-2020; D'Mello, Santosh/AAM-3644-2020	D'Mello, Santosh/0000-0002-7652-1334; Stifani, Stefano/0000-0002-2376-7701; Ghosh Dastidar, Somasish/0000-0003-4123-1801	National Institutes of Health [NS40408, NS058462]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040408, R21NS058462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40408 and NS058462 (to S. R. D.).	Beagle B, 2010, DEV DYNAM, V239, P2795, DOI 10.1002/dvdy.22439; Borodezt K, 1998, J NEUROSCI RES, V53, P531, DOI 10.1002/(SICI)1097-4547(19980901)53:5<531::AID-JNR3>3.3.CO;2-0; Bourguignon C, 1998, DEVELOPMENT, V125, P4889; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Buscarlet M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008107; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Choi CY, 2005, J BIOL CHEM, V280, P21427, DOI 10.1074/jbc.M500496200; D'Mello SR, 2005, CNS NEUROL DISORD-DR, V4, P3, DOI 10.2174/1568007053005118; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dastidar SG, 2011, J NEUROSCI, V31, P402, DOI 10.1523/JNEUROSCI.2897-10.2011; DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Hanashima C, 2002, J NEUROSCI, V22, P6526; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Lepourcelet M, 2002, J BIOL CHEM, V277, P47732, DOI 10.1074/jbc.M208154200; LI J, 1995, CANCER RES, V55, P5540; Liu F, 2002, MOL CELL BIOCHEM, V232, P163, DOI 10.1023/A:1014880813692; Marcal N, 2005, MOL CELL BIOL, V25, P10916, DOI 10.1128/MCB.25.24.10916-10929.2005; Milili M, 2002, IMMUNOLOGY, V106, P447, DOI 10.1046/j.1365-2567.2002.01456.x; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; MURPHY DB, 1994, GENOMICS, V21, P551, DOI 10.1006/geno.1994.1313; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; Obendorf M, 2007, J STEROID BIOCHEM, V104, P195, DOI 10.1016/j.jsbmb.2007.03.012; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Regad T, 2007, NAT CELL BIOL, V9, P531, DOI 10.1038/ncb1573; Sonderegger CK, 2003, ONCOGENE, V22, P1749, DOI 10.1038/sj.onc.1206308; Stewart L, 2005, MOL BRAIN RES, V140, P106, DOI 10.1016/j.molbrainres.2005.06.016; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Yao J, 2001, MOL CELL BIOL, V21, P1962, DOI 10.1128/MCB.21.6.1962-1972.2001; Yao J, 2000, MECH DEVELOP, V93, P105, DOI 10.1016/S0925-4773(00)00278-1; Zhang XG, 2008, J NEUROSCI RES, V86, P2423, DOI 10.1002/jnr.21680	36	21	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14749	14759		10.1074/jbc.M111.328336	http://dx.doi.org/10.1074/jbc.M111.328336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22354967	hybrid, Green Published			2022-12-25	WOS:000304003200040
J	Chen, YY; Farquhar, ER; Chance, MR; Palczewski, K; Kiser, PD				Chen, Yuanyuan; Farquhar, Erik R.; Chance, Mark R.; Palczewski, Krzysztof; Kiser, Philip D.			Insights into Substrate Specificity and Metal Activation of Mammalian Tetrahedral Aspartyl Aminopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENIN-ANGIOTENSIN SYSTEM; RAY-ABSORPTION SPECTROSCOPY; CRYSTAL-STRUCTURE; CONVERTING ENZYME; MODEL; IDENTIFICATION; PROTEIN; INHIBITORS; EXPRESSION; CLASSIFICATION	Aminopeptidases are key enzymes involved in the regulation of signaling peptide activity. Here, we present a detailed biochemical and structural analysis of an evolutionary highly conserved aspartyl aminopeptidase called DNPEP. We show that this peptidase can cleave multiple physiologically relevant substrates, including angiotensins, and thus may play a key role in regulating neuron function. Using a combination of x-ray crystallography, x-ray absorption spectroscopy, and single particle electron microscopy analysis, we provide the first detailed structural analysis of DNPEP. We show that this enzyme possesses a binuclear zinc-active site in which one of the zinc ions is readily exchangeable with other divalent cations such as manganese, which strongly stimulates the enzymatic activity of the protein. The plasticity of this metal-binding site suggests a mechanism for regulation of DNPEP activity. We also demonstrate that DNPEP assembles into a functionally relevant tetrahedral complex that restricts access of peptide substrates to the active site. These structural data allow rationalization of the enzyme's preference for short peptide substrates with N-terminal acidic residues. This study provides a structural basis for understanding the physiology and bioinorganic chemistry of DNPEP and other M18 family aminopeptidases.	[Chen, Yuanyuan; Palczewski, Krzysztof; Kiser, Philip D.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Farquhar, Erik R.; Chance, Mark R.] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Ctr Synchrotron Biosci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu; pdk7@case.edu	Chen, Yuanyuan/E-1556-2013	Chen, Yuanyuan/0000-0001-9625-1610; Farquhar, Erik/0000-0002-6419-038X	National Institutes of Health [EY009339, P30 EY11373]; National Institute of Health from the NCRR [RR-15301]; United States Department of Energy, Office of Basic Energy Sciences [W-31-109-ENG-38]; National Institutes of Health NIBIB [P30-EB-009998]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373, R01EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health from the NCRR; United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants EY009339 and P30 EY11373.; We thank Drs. Andreas Engel, Vera Moiseenkova-Bell, Yaroslav Tsybovsky, David Lodowski at Case Western Reserve University and Steve Ludtke at Baylor Medical Institute for their advice on electron microscopy and single particle analysis. We thank Debarshi Mustafi for sharing RNA-seq data prior to publication and Dr. Marcin Golczak for assistance with mass spectrometry. This work is based upon research conducted at the Northeastern Collaborative Access Team beam lines of the Advanced Photon Source, supported by National Institute of Health Award RR-15301 from the NCRR. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences, under Contract W-31-109-ENG-38. XAS experiments were carried out at beamline X3B of the National Synchrotron Light Source at Brookhaven National Laboratory. Beamline X3B is operated by the Case Center for Synchrotron Biosciences, supported by National Institutes of Health NIBIB Grant P30-EB-009998. National Synchrotron Light Source is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRETT AJ, 1994, METHOD ENZYMOL, V244, P1; BERKA JL, 1995, INVEST OPHTH VIS SCI, V36, P1450; Borissenko L, 2005, J MOL BIOL, V346, P1207, DOI 10.1016/j.jmb.2004.12.056; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHEUNG HS, 1971, BIOCHIM BIOPHYS ACTA, V242, P190, DOI 10.1016/0005-2744(71)90098-2; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Costagliola C, 1995, Eur J Ophthalmol, V5, P19; Danser AHJ, 1996, MOL CELL BIOCHEM, V157, P211; DANSER AHJ, 1994, INVEST OPHTH VIS SCI, V35, P1008; DEINUM J, 1989, J HYPERTENS, V7, pS216, DOI 10.1097/00004872-198900076-00104; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Downie LE, 2009, NEUROSCIENCE, V161, P195, DOI 10.1016/j.neuroscience.2009.02.084; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans G, 2001, J APPL CRYSTALLOGR, V34, P82, DOI 10.1107/S0021889800014655; FERRARIDILEO G, 1988, INVEST OPHTH VIS SCI, V29, P876; Fletcher EL, 2010, PROG RETIN EYE RES, V29, P284, DOI 10.1016/j.preteyeres.2010.03.003; Franzetti B, 2002, EMBO J, V21, P2132, DOI 10.1093/emboj/21.9.2132; Goto Y, 2006, J BIOL CHEM, V281, P23503, DOI 10.1074/jbc.M603191200; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; GUYTON AC, 2000, TXB MED PHYSL, P195; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; JACOBI PC, 1994, INVEST OPHTH VIS SCI, V35, P973; Jacquamet L, 1998, BIOCHEMISTRY-US, V37, P2564, DOI 10.1021/bi9721344; JENSEN LL, 1989, BRAIN RES, V490, P48, DOI 10.1016/0006-8993(89)90429-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KELLY JA, 1983, J NEUROCHEM, V40, P1727, DOI 10.1111/j.1471-4159.1983.tb08148.x; Krause MW, 2011, KIDNEY INT, V80, P245, DOI 10.1038/ki.2011.142; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurihara T, 2006, INVEST OPHTH VIS SCI, V47, P5545, DOI 10.1167/iovs.06-0478; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lavoie JL, 2003, ENDOCRINOLOGY, V144, P2179, DOI 10.1210/en.2003-0150; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LIU WT, 1993, INORG CHEM, V32, P4102, DOI 10.1021/ic00071a023; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; METZ G, 1976, BIOCHIM BIOPHYS ACTA, V429, P933, DOI 10.1016/0005-2744(76)90338-7; Milenkovic VM, 2010, AM J PHYSIOL-RENAL, V299, pF396, DOI 10.1152/ajprenal.00576.2009; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Mustafi D, 2011, FASEB J, V25, P3157, DOI 10.1096/fj.11-186767; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P2925, DOI 10.1167/iovs.04-1476; Otani A, 1998, CIRC RES, V82, P619, DOI 10.1161/01.RES.82.5.619; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickering I. J., 2000, EXAFSPAK; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; Reaux A, 1999, P NATL ACAD SCI USA, V96, P13415, DOI 10.1073/pnas.96.23.13415; REID IA, 1978, ANNU REV PHYSIOL, V40, P377, DOI 10.1146/annurev.ph.40.030178.002113; Riggs-Gelasco P., 1995, THESIS U MICHIGAN; RIGGSGELASCO PJ, 1995, COORDIN CHEM REV, V144, P245, DOI 10.1016/0010-8545(95)01144-E; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Russo S, 2004, J BIOL CHEM, V279, P51275, DOI 10.1074/jbc.M409455200; Schu P, 2008, METHOD ENZYMOL, V451, P67, DOI 10.1016/S0076-6879(08)03206-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silva KC, 2009, DIABETES, V58, P1382, DOI 10.2337/db09-0166; Sim M K, 1994, Blood Press, V3, P260, DOI 10.3109/08037059409102267; Stemmler TL, 1997, BIOCHEMISTRY-US, V36, P9847, DOI 10.1021/bi9702795; Sukumar N, 2011, J INORG BIOCHEM, V105, P1638, DOI 10.1016/j.jinorgbio.2011.08.002; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Teuscher F, 2007, J BIOL CHEM, V282, P30817, DOI 10.1074/jbc.M704938200; Unger T, 2002, AM J CARDIOL, V89, p3A; Vaajanen A, 2011, BASIC CLIN PHARMACOL, V109, P217, DOI 10.1111/j.1742-7843.2011.00729.x; Vetro J.A., 2004, AMINOPEPTIDASES BIOL; Vettori MV, 1999, TOXICOL IN VITRO, V13, P931, DOI 10.1016/S0887-2333(99)00073-9; Wagner J, 1996, BRIT J OPHTHALMOL, V80, P159, DOI 10.1136/bjo.80.2.159; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wilk S, 2002, ARCH BIOCHEM BIOPHYS, V407, P176, DOI 10.1016/S0003-9861(02)00494-0; Wilk S, 1998, J BIOL CHEM, V273, P15961, DOI 10.1074/jbc.273.26.15961; Yokoyama R, 2006, FEBS J, V273, P192, DOI 10.1111/j.1742-4658.2005.05057.x; Yoshimoto T, 2004, J MOL BIOL, V337, P399, DOI 10.1016/j.jmb.2004.01.022; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	78	28	29	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13356	13370		10.1074/jbc.M112.347518	http://dx.doi.org/10.1074/jbc.M112.347518			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22356908	Green Published, hybrid			2022-12-25	WOS:000302903700071
J	Martinez-Antonio, A; Lomnitz, JG; Sandoval, S; Aldana, M; Savageau, MA				Martinez-Antonio, Agustino; Lomnitz, Jason G.; Sandoval, Santiago; Aldana, Maximino; Savageau, Michael A.			Regulatory Design Governing Progression of Population Growth Phases in Bacteria	PLOS ONE			English	Article							NUCLEOID-ASSOCIATED PROTEINS; SIGMA SUBUNIT SYNTHESIS; ESCHERICHIA-COLI; RNA-POLYMERASE; TRANSCRIPTIONAL REGULATION; INTRACELLULAR LEVELS; STATIONARY-PHASE; GENE-EXPRESSION; ORGANIZATION; NETWORK	It has long been noted that batch cultures inoculated with resting bacteria exhibit a progression of growth phases traditionally labeled lag, exponential, pre-stationary and stationary. However, a detailed molecular description of the mechanisms controlling the transitions between these phases is lacking. A core circuit, formed by a subset of regulatory interactions involving five global transcription factors (FIS, HNS, IHF, RpoS and GadX), has been identified by correlating information from the well- established transcriptional regulatory network of Escherichia coli and genome-wide expression data from cultures in these different growth phases. We propose a functional role for this circuit in controlling progression through these phases. Two alternative hypotheses for controlling the transition between the growth phases are first, a continuous graded adjustment to changing environmental conditions, and second, a discontinuous hysteretic switch at critical thresholds between growth phases. We formulate a simple mathematical model of the core circuit, consisting of differential equations based on the power-law formalism, and show by mathematical and computer-assisted analysis that there are critical conditions among the parameters of the model that can lead to hysteretic switch behavior, which - if validated experimentally - would suggest that the transitions between different growth phases might be analogous to cellular differentiation. Based on these provocative results, we propose experiments to test the alternative hypotheses.	[Martinez-Antonio, Agustino] CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico; [Lomnitz, Jason G.; Savageau, Michael A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Sandoval, Santiago; Aldana, Maximino] Univ Nacl Autonoma Mexico, Inst Fis, Cuernavaca 62191, Morelos, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of California System; University of California Davis; Universidad Nacional Autonoma de Mexico	Martinez-Antonio, A (corresponding author), CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico.	amartinez@ira.cinvestav.mx	Martínez-Antonio, Agustino/A-3881-2008; Aldana, Maximino/D-9372-2017; Martínez-Antonio, Agustino/GQQ-2363-2022; Antonio, Agustino Martínez/AAG-4309-2021	Martínez-Antonio, Agustino/0000-0003-2231-5014; Aldana, Maximino/0000-0002-3419-6641; Martínez-Antonio, Agustino/0000-0003-2231-5014; Antonio, Agustino Martínez/0000-0003-2231-5014; Lomnitz, Jason/0000-0001-6509-2194	CONACYT [102854]; United States Public Health Service [R01-GM30054]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030054] Funding Source: NIH RePORTER	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a Young Researcher Grant (102854) from CONACYT given to AM-A and United States Public Health Service Grant R01-GM30054 to MAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CN, 2001, J BACTERIOL, V183, P2178, DOI 10.1128/JB.183.7.2178-2186.2001; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Becker G, 1999, P NATL ACAD SCI USA, V96, P6439, DOI 10.1073/pnas.96.11.6439; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Chiancone E, 2010, BIOCH BIOPHYS ACTA; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chung YS, 2009, NUCLEIC ACIDS RES, V37, P3143, DOI 10.1093/nar/gkp151; COOPER S, 1969, J MOL BIOL, V43, P1, DOI 10.1016/0022-2836(69)90074-6; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Fasani RA, BIOINFORMATICS; Freire P, 2009, J MOL BIOL, V385, P1345, DOI 10.1016/j.jmb.2008.12.026; Frenkiel-Krispin D, 2001, EMBO J, V20, P1184, DOI 10.1093/emboj/20.5.1184; Gallardo-Madueno R, 1998, J BIOL CHEM, V273, P18382, DOI 10.1074/jbc.273.29.18382; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Haeusser DP, 2008, CURR OPIN MICROBIOL, V11, P94, DOI 10.1016/j.mib.2008.02.008; Janga SC, 2009, NUCLEIC ACIDS RES, V37, P3680, DOI 10.1093/nar/gkp231; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kirkpatrick C, 2001, J BACTERIOL, V183, P6466, DOI 10.1128/JB.183.21.6466-6477.2001; Klauck Eberhard, 2007, Science Progress, V90, P103, DOI 10.3184/003685007X215922; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Loewen PC, 1998, CAN J MICROBIOL, V44, P707, DOI 10.1139/cjm-44-8-707; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; MaalOe O, 1966, CONTROL MACROMOLECUL; Marr C, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-18; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Martinez-Antonio A, 2008, J MOL BIOL, V381, P238, DOI 10.1016/j.jmb.2008.05.054; Martinez-Antonio A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-247; Mates AK, 2007, J BACTERIOL, V189, P2759, DOI 10.1128/JB.01490-06; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Piper SE, 2009, MOL BIOSYST, V5, P1943, DOI [10.1039/b904955j, 10.1039/B904955j]; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Savageau MA, 2002, MATH BIOSCI, V180, P237, DOI 10.1016/S0025-5564(02)00113-X; Savageau MA, 2001, CHAOS, V11, P142, DOI 10.1063/1.1349892; SAVAGEAU MA, 1971, ARCH BIOCHEM BIOPHYS, V145, P612, DOI 10.1016/S0003-9861(71)80021-8; Savageau MA, 2011, ANN BIOMED ENG, V39, P1278, DOI 10.1007/s10439-010-0220-2; Savageau MA, 2009, FEBS LETT, V583, P3914, DOI 10.1016/j.febslet.2009.10.073; Savageau MA, 2009, P NATL ACAD SCI USA, V106, P6435, DOI 10.1073/pnas.0809869106; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tolla DA, 2011, MOL MICROBIOL, V79, P149, DOI 10.1111/j.1365-2958.2010.07437.x; Tramonti A, 2002, J BACTERIOL, V184, P2603, DOI 10.1128/JB.184.10.2603-2613.2002; Travers A, 2001, BIOCHIMIE, V83, P213, DOI 10.1016/S0300-9084(00)01217-7; Travers A, 1997, CURR BIOL, V7, pR252, DOI 10.1016/S0960-9822(06)00114-X; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Wilson GS, 1922, J BACTERIOL, V7, P405, DOI 10.1128/JB.7.4.405-446.1922; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	52	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30654	10.1371/journal.pone.0030654	http://dx.doi.org/10.1371/journal.pone.0030654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363461	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700009
J	Sarovich, DS; Price, EP; Von Schulze, AT; Cook, JM; Mayo, M; Watson, LM; Richardson, L; Seymour, ML; Tuanyok, A; Engelthaler, DM; Pearson, T; Peacock, SJ; Currie, BJ; Keim, P; Wagner, DM				Sarovich, Derek S.; Price, Erin P.; Von Schulze, Alex T.; Cook, James M.; Mayo, Mark; Watson, Lindsey M.; Richardson, Leisha; Seymour, Meagan L.; Tuanyok, Apichai; Engelthaler, David M.; Pearson, Talima; Peacock, Sharon J.; Currie, Bart J.; Keim, Paul; Wagner, David M.			Characterization of Ceftazidime Resistance Mechanisms in Clinical Isolates of Burkholderia pseudomallei from Australia	PLOS ONE			English	Article							PSEUDOMONAS-PSEUDOMALLEI; RECURRENT MELIOIDOSIS; BETA-LACTAMASE; SUSCEPTIBILITY; AMPLIFICATION; EXPRESSION; REGIONS; RELAPSE	Burkholderia pseudomallei is a Gram-negative bacterium that causes the serious human disease, melioidosis. There is no vaccine against melioidosis and it can be fatal if not treated with a specific antibiotic regimen, which typically includes the third-generation cephalosporin, ceftazidime (CAZ). There have been several resistance mechanisms described for B. pseudomallei, of which the best described are amino acid changes that alter substrate specificity in the highly conserved class A beta-lactamase, PenA. In the current study, we sequenced penA from isolates sequentially derived from two melioidosis patients with wild-type (1.5 mu g/mL) and, subsequently, resistant (16 or >= 256 mu g/mL) CAZ phenotypes. We identified two single-nucleotide polymorphisms (SNPs) that directly increased CAZ hydrolysis. One SNP caused an amino acid substitution (C69Y) near the active site of PenA, whereas a second novel SNP was found within the penA promoter region. In both instances, the CAZ resistance phenotype corresponded directly with the SNP genotype. Interestingly, these SNPs appeared after infection and under selection from CAZ chemotherapy. Through heterologous cloning and expression, and subsequent allelic exchange in the native bacterium, we confirmed the role of penA in generating both low-level and high-level CAZ resistance in these clinical isolates. Similar to previous studies, the amino acid substitution altered substrate specificity to other beta-lactams, suggesting a potential fitness cost associated with this mutation, a finding that could be exploited to improve therapeutic outcomes in patients harboring CAZ resistant B. pseudomallei. Our study is the first to functionally characterize CAZ resistance in clinical isolates of B. pseudomallei and to provide proven and clinically relevant signatures for monitoring the development of antibiotic resistance in this important pathogen.	[Sarovich, Derek S.; Price, Erin P.; Von Schulze, Alex T.; Cook, James M.; Watson, Lindsey M.; Seymour, Meagan L.; Tuanyok, Apichai; Pearson, Talima; Keim, Paul; Wagner, David M.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Mayo, Mark; Richardson, Leisha; Currie, Bart J.] Menzies Sch Hlth Res, Darwin, NT, Australia; [Engelthaler, David M.] Translat Genom Res Inst, Flagstaff, AZ USA; [Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Peacock, Sharon J.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	Northern Arizona University; Charles Darwin University; Menzies School of Health Research; Translational Genomics Research Institute; Mahidol University; University of Cambridge	Sarovich, DS (corresponding author), No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA.	Dave.Wagner@nau.edu	Peacock, Sharon J/ABE-6331-2020; Pearson, Talima/O-7840-2019; Pacific-Southwest, RCE/B-6155-2009; Price, Erin/N-2336-2013; Sarovich, Derek/H-5587-2019	Pearson, Talima/0000-0003-3696-041X; Price, Erin/0000-0002-1079-4882; Sarovich, Derek/0000-0002-6944-3980; Wagner, David/0000-0003-2684-6007; Von Schulze, Alex/0000-0001-5688-590X; Peacock, Sharon/0000-0002-1718-2782	Pacific-Southwest Regional Center of Excellence [AI065359]; NIH-NIAID [AI075568]; Australian National Health and Medical Research Council [383504, 605820]; NIHR Cambridge Biomedical Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, U01AI075568] Funding Source: NIH RePORTER	Pacific-Southwest Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NIHR Cambridge Biomedical Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Pacific-Southwest Regional Center of Excellence (AI065359), NIH-NIAID (AI075568) and the Australian National Health and Medical Research Council (383504, 605820). Sharon Peacock received support from the NIHR Cambridge Biomedical Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Bachmann HS, 2003, PHARMACOGENETICS, V13, P759, DOI 10.1097/00008571-200312000-00006; Burtnick MN, 1999, ANTIMICROB AGENTS CH, V43, P2648, DOI 10.1128/AAC.43.11.2648; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng AC, 2010, CURR OPIN INFECT DIS, V23, P554, DOI 10.1097/QCO.0b013e32833fb88c; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; DELAMBALLERIE X, 1992, RES MICROBIOL, V143, P785, DOI 10.1016/0923-2508(92)90107-Y; DESMARCHELIER PM, 1993, J CLIN MICROBIOL, V31, P1592, DOI 10.1128/JCM.31.6.1592-1596.1993; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P879, DOI 10.1111/j.1462-2920.2004.00640.x; Germer S, 1999, GENOME RES, V9, P72; GODFREY AJ, 1991, ANTIMICROB AGENTS CH, V35, P1635, DOI 10.1128/AAC.35.8.1635; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Hamad MA, 2009, GENE, V430, P123, DOI 10.1016/j.gene.2008.10.011; Hezard N, 1997, THROMB RES, V88, P59, DOI 10.1016/S0049-3848(97)00191-6; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Limmathurotsakul D, 2009, AM J TROP MED HYG, V81, P335, DOI 10.4269/ajtmh.2009.81.335; LIVERMORE DM, 1987, J ANTIMICROB CHEMOTH, V20, P313, DOI 10.1093/jac/20.3.313; Maharjan B, 2005, J CLIN MICROBIOL, V43, P6032, DOI 10.1128/JCM.43.12.6032-6034.2005; Moore RA, 1999, ANTIMICROB AGENTS CH, V43, P465, DOI 10.1128/AAC.43.3.465; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; OCALLAGHAN CH, 1980, ANTIMICROB AGENTS CH, V17, P876, DOI 10.1128/AAC.17.5.876; Phillpott R, 1991, COMMUNICABLE DIS INT, V15, P270; Price EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000725; Rholl DA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00139; Sam IC, 2009, J CLIN MICROBIOL, V47, P1556, DOI 10.1128/JCM.01657-08; Schweizer Herbert P, 2003, Genet Mol Res, V2, P48; Toohey M, 1994, LAB INVESTIGATIONS A, P1; Tribuddharat C, 2003, ANTIMICROB AGENTS CH, V47, P2082, DOI 10.1128/AAC.47.7.2082-2087.2003; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; U'Ren JM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-23; Viktorov Dimitry V, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS103, DOI 10.1016/S0035-9203(08)70025-7	34	56	57	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30789	10.1371/journal.pone.0030789	http://dx.doi.org/10.1371/journal.pone.0030789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363490	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700012
J	Babigumira, JB; Stergachis, A; Veenstra, DL; Gardner, JS; Ngonzi, J; Mukasa-Kivunike, P; Garrison, LP				Babigumira, Joseph B.; Stergachis, Andy; Veenstra, David L.; Gardner, Jacqueline S.; Ngonzi, Joseph; Mukasa-Kivunike, Peter; Garrison, Louis P.			Potential Cost-Effectiveness of Universal Access to Modern Contraceptives in Uganda	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; INDUCED-ABORTION; CARE	Background: Over two thirds of women who need contraception in Uganda lack access to modern effective methods. This study was conducted to estimate the potential cost-effectiveness of achieving universal access to modern contraceptives in Uganda by implementing a hypothetical new contraceptive program (NCP) from both societal and governmental (Ministry of Health (MoH)) perspectives. Methodology/Principal Findings: A Markov model was developed to compare the NCP to the status quo or current contraceptive program (CCP). The model followed a hypothetical cohort of 15-year old girls over a lifetime horizon. Data were obtained from the Uganda National Demographic and Health Survey and from published and unpublished sources. Costs, life expectancy, disability-adjusted life expectancy, pregnancies, fertility and incremental cost-effectiveness measured as cost per life-year (LY) gained, cost per disability-adjusted life-year (DALY) averted, cost per pregnancy averted and cost per unit of fertility reduction were calculated. Univariate and probabilistic sensitivity analyses were performed to examine the robustness of results. Mean discounted life expectancy and disability-adjusted life expectancy (DALE) were higher under the NCP vs. CCP (28.74 vs. 28.65 years and 27.38 vs. 27.01 respectively). Mean pregnancies and live births per woman were lower under the NCP (9.51 vs. 7.90 and 6.92 vs. 5.79 respectively). Mean lifetime societal costs per woman were lower for the NCP from the societal perspective ($1,949 vs. $1,987) and the MoH perspective ($636 vs. $685). In the incremental analysis, the NCP dominated the CCP, i.e. it was both less costly and more effective. The results were robust to univariate and probabilistic sensitivity analysis. Conclusion/Significance: Universal access to modern contraceptives in Uganda appears to be highly cost-effective. Increasing contraceptive coverage should be considered among Uganda's public health priorities.	[Babigumira, Joseph B.; Stergachis, Andy; Garrison, Louis P.] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Global Med Program, Seattle, WA 98195 USA; [Babigumira, Joseph B.; Stergachis, Andy; Veenstra, David L.; Gardner, Jacqueline S.; Garrison, Louis P.] Univ Washington, Sch Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Stergachis, Andy] Univ Washington, Dept Epidemiol, Sch Publ Hlth & Community Pharm, Seattle, WA 98195 USA; [Stergachis, Andy] Univ Washington, Dept Global Hlth, Sch Publ Hlth & Community Pharm, Seattle, WA 98195 USA; [Ngonzi, Joseph] Mbarara Univ Sci & Technol, Dept Obstet & Gynecol, Mbarara, Uganda; [Mukasa-Kivunike, Peter] Engender Hlth Fistula Care Project, Kampala, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mbarara University of Science & Technology	Babigumira, JB (corresponding author), Univ Washington, Sch Publ Hlth, Dept Global Hlth, Global Med Program, Seattle, WA 98195 USA.	babijo@uw.edu	Babigumira, Joseph/T-4208-2019		William and Flora Hewlett Foundation; Institute of International Education	William and Flora Hewlett Foundation; Institute of International Education	This study was funded by the William and Flora Hewlett Foundation and Institute of International Education Dissertation Fellowship in Population, Reproductive Health, and Economic Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, MACR HLTH INV HLTH E; Babigumira JB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-904; Babigumira JB, 2011, J INFECT DIS, V204, pS116, DOI 10.1093/infdis/jir132; Babigumira JB, 2009, PHARMACOECONOMICS, V27, P963, DOI 10.2165/11318230-000000000-00000; Bishai D, 2008, INJURY PREV, V14, P223, DOI 10.1136/ip.2008.018341; Blanc AK, 2009, INT PERSPECT SEX R H, V35, P63, DOI 10.1363/ipsrh.35.063.09; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Casterline JB, 2000, POPUL DEV REV, V26, P691, DOI 10.1111/j.1728-4457.2000.00691.x; CASTERLINE JB, 1989, STUD FAMILY PLANN, V20, P81, DOI 10.2307/1966462; Fiedler JL, 2010, FOOD NUTR BULL, V31, P193, DOI 10.1177/156482651003100202; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; KENNEDY KI, 1992, LANCET, V339, P227, DOI 10.1016/0140-6736(92)90018-X; Khan SM., 2008, UNMET NEED DEMAND FA; Levin A, 2003, INT J HEALTH PLAN M, V18, P3, DOI 10.1002/hpm.690; LISKIN LS, 1992, INT J GYNECOL OBSTET, V37, P77, DOI 10.1016/0020-7292(92)90486-3; Marseille E, 2009, APPL HEALTH ECON HEA, V7, P229, DOI 10.2165/11318740-000000000-00000; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Okonofua F, 2006, J OBSTET GYNAECOL CA, V28, P974, DOI 10.1016/S1701-2163(16)32307-6; Sedgh G, 2007, 37 GUTTM I; Singh S, 2005, INT FAM PLAN PERSPEC, V31, P183, DOI 10.1363/3118305; Siskind D, 2008, J MENT HEALTH POLICY, V11, P127; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Sundaram A., 2010, ISSUES BRIEF; Trussell J, 2009, BEST PRACT RES CL OB, V23, P199, DOI 10.1016/j.bpobgyn.2008.11.008; UBOS, 2007, UG DEM HLTH SURV 200; Vlassoff M, 2009, BENEFITS M CONTRACEP; Weissman E, 1999, SAFE MOTHERHOOD PROG; WHO, WORLD HLTH STAT 2011; World Health Organisation, DEATH DALY EST 2004; World Health Organization, LIF TABL COUNTR UG; [No title captured]	32	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30735	10.1371/journal.pone.0030735	http://dx.doi.org/10.1371/journal.pone.0030735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363480	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600063
J	Kocemba, KA; Groen, RWJ; van Andel, H; Kersten, MJ; Mahtouk, K; Spaargaren, M; Pals, ST				Kocemba, Kinga A.; Groen, Richard W. J.; van Andel, Harmen; Kersten, Marie Jose; Mahtouk, Karene; Spaargaren, Marcel; Pals, Steven T.			Transcriptional Silencing of the Wnt-Antagonist DKK1 by Promoter Methylation Is Associated with Enhanced Wnt Signaling in Advanced Multiple Myeloma	PLOS ONE			English	Article							FREQUENT EPIGENETIC INACTIVATION; BONE-MARROW MICROENVIRONMENT; BETA-CATENIN; COLORECTAL-CANCER; CELL-GROWTH; IN-VIVO; PATHWAY; DISEASE; DICKKOPF-1; EXPRESSION	The Wnt/beta-catenin pathway plays a crucial role in the pathogenesis of various human cancers. In multiple myeloma (MM), aberrant auto-and/or paracrine activation of canonical Wnt signaling promotes proliferation and dissemination, while overexpression of the Wnt inhibitor Dickkopf1 (DKK1) by MM cells contributes to osteolytic bone disease by inhibiting osteoblast differentiation. Since DKK1 itself is a target of TCF/beta-catenin mediated transcription, these findings suggest that DKK1 is part of a negative feedback loop in MM and may act as a tumor suppressor. In line with this hypothesis, we show here that DKK1 expression is low or undetectable in a subset of patients with advanced MM as well as in MM cell lines. This absence of DKK1 is correlated with enhanced Wnt pathway activation, evidenced by nuclear accumulation of beta-catenin, which in turn can be antagonized by restoring DKK1 expression. Analysis of the DKK1 promoter revealed CpG island methylation in several MM cell lines as well as in MM cells from patients with advanced MM. Moreover, demethylation of the DKK1 promoter restores DKK1 expression, which results in inhibition of beta-catenin/TCF-mediated gene transcription in MM lines. Taken together, our data identify aberrant methylation of the DKK1 promoter as a cause of DKK1 silencing in advanced stage MM, which may play an important role in the progression of MM by unleashing Wnt signaling.	[Kocemba, Kinga A.; Groen, Richard W. J.; van Andel, Harmen; Mahtouk, Karene; Spaargaren, Marcel; Pals, Steven T.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Kersten, Marie Jose] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kocemba, KA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	s.t.pals@amc.uva.nl	kocemba, kinga/AAE-2305-2019; Spaargaren, Marcel/AAU-1298-2021; Kocemba, Kinga/AAE-6520-2021	kocemba, kinga/0000-0002-7119-2412; Spaargaren, Marcel/0000-0002-3135-5109; Groen, Richard/0000-0002-5010-4604; Pals, Steven/0000-0002-1419-0939	Dutch Cancer Society	Dutch Cancer Society(KWF Kankerbestrijding)	Grant support was provided by the Dutch Cancer Society to M. Spaargaren and S.T. Pals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2004, BLOOD, V104, P2484, DOI 10.1182/blood-2003-11-3839; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Ashihara E, 2009, CLIN CANCER RES, V15, P2731, DOI 10.1158/1078-0432.CCR-08-1350; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chim CS, 2007, LEUKEMIA, V21, P2527, DOI 10.1038/sj.leu.2404939; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Derksen PWB, 2004, P NATL ACAD SCI USA, V101, P6122, DOI 10.1073/pnas.0305855101; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Dosen G, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-13; Dutta-Simmons J, 2009, BLOOD, V114, P2699, DOI 10.1182/blood-2008-12-194290; Edwards CM, 2008, BONE, V42, P1007, DOI 10.1016/j.bone.2008.01.027; Edwards CM, 2008, BLOOD, V111, P2833, DOI 10.1182/blood-2007-03-077685; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Esteller M, 2002, SCIENCE, V297, P1807; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Giuliani N, 2007, CANCER RES, V67, P7665, DOI 10.1158/0008-5472.CAN-06-4666; Groen RWJ, 2008, CANCER RES, V68, P6969, DOI 10.1158/0008-5472.CAN-08-1322; Haaber J, 2008, BRIT J HAEMATOL, V140, P25, DOI 10.1111/j.1365-2141.2007.06871.x; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Heath DJ, 2009, J BONE MINER RES, V24, P425, DOI 10.1359/JBMR.081104; Herman JG, 2005, COLD SH Q B, V70, P329, DOI 10.1101/sqb.2005.70.036; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kiziltepe T, 2007, MOL CANCER THER, V6, P1718, DOI 10.1158/1535-7163.MCT-07-0010; KLEIN B, 1989, BLOOD, V73, P517; Klein G, 2005, NATURE, V434, P150, DOI 10.1038/434150a; Le Gouill S, 2004, BLOOD, V104, P2886, DOI 10.1182/blood-2004-05-1760; Lescher B, 1998, DEV DYNAM, V213, P440, DOI 10.1002/(SICI)1097-0177(199812)213:4<440::AID-AJA9>3.0.CO;2-6; Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853; Mahtouk K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-198; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Oshima T, 2005, BLOOD, V106, P3160, DOI 10.1182/blood-2004-12-4940; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Polakis P, 2000, GENE DEV, V14, P1837; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Qiang YW, 2008, BONE, V42, P669, DOI 10.1016/j.bone.2007.12.006; Qiang YW, 2005, BLOOD, V106, P1786, DOI 10.1182/blood-2005-01-0049; Qiang YW, 2003, ONCOGENE, V22, P1536, DOI 10.1038/sj.onc.1206239; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Schmidt M, 2009, BRIT J HAEMATOL, V144, P796, DOI 10.1111/j.1365-2141.2008.07503.x; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Standal T, 2007, BLOOD, V109, P3024, DOI 10.1182/blood-2006-07-034884; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Suzuki R, 2007, BRIT J HAEMATOL, V138, P624, DOI 10.1111/j.1365-2141.2007.06702.x; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Timm A, 2005, CURR TOP MICROBIOL, V290, P225; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vibhakar R, 2007, NEURO-ONCOLOGY, V9, P135, DOI 10.1215/15228517-2006-038; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Yamaguchi Y, 2008, FASEB J, V22, P1009, DOI 10.1096/fj.07-9475com; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077	59	43	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30359	10.1371/journal.pone.0030359	http://dx.doi.org/10.1371/journal.pone.0030359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363428	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600022
J	Riehm, JM; Vergnaud, G; Kiefer, D; Damdindorj, T; Dashdavaa, O; Khurelsukh, T; Zoller, L; Wolfel, R; Le Fleche, P; Scholz, HC				Riehm, Julia M.; Vergnaud, Gilles; Kiefer, Daniel; Damdindorj, Tserennorov; Dashdavaa, Otgonbaatar; Khurelsukh, Tungalag; Zoeller, Lothar; Woelfel, Roman; Le Fleche, Philippe; Scholz, Holger C.			Yersinia pestis Lineages in Mongolia	PLOS ONE			English	Article							NUMBER TANDEM REPEATS; BACILLUS-ANTHRACIS; PHYLOGENETIC ANALYSIS; PLAGUE; GENOME; MICROEVOLUTION; DYNAMICS; INSIGHTS; TOOLS; DNA	Background: Whole genome sequencing allowed the development of a number of high resolution sequence based typing tools for Yersinia (Y.) pestis. The application of these methods on isolates from most known foci worldwide and in particular from China and the Former Soviet Union has dramatically improved our understanding of the population structure of this species. In the current view, Y. pestis including the non or moderate human pathogen Y. pestis subspecies microtus emerged from Yersinia pseudotuberculosis about 2,600 to 28,600 years ago in central Asia. The majority of central Asia natural foci have been investigated. However these investigations included only few strains from Mongolia. Methodology/Principal Findings: Clustered Regularly Interspaced Short Prokaryotic Repeats (CRISPR) analysis and Multiple-locus variable number of tandem repeats (VNTR) analysis (MLVA) with 25 loci was performed on 100 Y. pestis strains, isolated from 37 sampling areas in Mongolia. The resulting data were compared with previously published data from more than 500 plague strains, 130 of which had also been previously genotyped by single nucleotide polymorphism (SNP) analysis. The comparison revealed six main clusters including the three microtus biovars Ulegeica, Altaica, and Xilingolensis. The largest cluster comprises 78 isolates, with unique and new genotypes seen so far in Mongolia only. Typing of selected isolates by key SNPs was used to robustly assign the corresponding clusters to previously defined SNP branches. Conclusions/Significance: We show that Mongolia hosts the most recent microtus clade (Ulegeica). Interestingly no representatives of the ancestral Y. pestis subspecies pestis nodes previously identified in North-western China were identified in this study. This observation suggests that the subsequent evolution steps within Y. pestis pestis did not occur in Mongolia. Rather, Mongolia was most likely re-colonized by more recent clades coming back from China contemporary of the black death pandemic, or more recently in the past 600 years.	[Riehm, Julia M.; Kiefer, Daniel; Zoeller, Lothar; Woelfel, Roman; Scholz, Holger C.] Bundeswehr Inst Microbiol, Munich, Germany; [Vergnaud, Gilles; Le Fleche, Philippe] Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France; [Vergnaud, Gilles; Le Fleche, Philippe] CNRS, F-91405 Orsay, France; [Vergnaud, Gilles] DGA MRIS Mission Rech & Innovat Sci, Bagneux, France; [Dashdavaa, Otgonbaatar; Khurelsukh, Tungalag] Natl Ctr Infect Dis Nat Foci, Ulaanbaatar, Mongolia; [Le Fleche, Philippe] Direct Gen Armement DGA Maitrise NRBC, Div Analyt Microbiol, Vert Le Petit, France	Bundeswehr Institute of Microbiology (IMB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Riehm, JM (corresponding author), Bundeswehr Inst Microbiol, Munich, Germany.	juliariehm@bundeswehr.org	Wölfel, Roman/AAQ-3977-2021; Vergnaud, Gilles/AAC-1162-2020; Vergnaud, Gilles/P-1304-2015	Wölfel, Roman/0000-0002-8756-7821; Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X	European Defense Agency (EDA) [B-0060-GEM3-GC]	European Defense Agency (EDA)	This study was part of the European Biodefence Laboratory Network (EBLN). Coordination work supported by the European Defense Agency (EDA, B-0060-GEM3-GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Ciammaruconi A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-21; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Devignat R, 1951, B WORLD HEALTH ORGAN, V4, P241; Galdan B, 2010, VECTOR-BORNE ZOONOT, V10, P69, DOI 10.1089/vbz.2009.0047; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Grissa I, 2008, NUCLEIC ACIDS RES, V36, pW145, DOI 10.1093/nar/gkn228; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Grissa I, 2009, METHODS MOL BIOL, V551, P105, DOI 10.1007/978-1-60327-999-4_9; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Kingston JJ, 2009, ANTON LEEUW INT J G, V96, P303, DOI 10.1007/s10482-009-9347-2; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Le Fleche P, 2001, BMC Microbiol, V1, P2; Li YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006000; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Lowell JL, 2007, MICROBIOL-SGM, V153, P169, DOI 10.1099/mic.0.29059-0; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; PERRIN C, 1993, ETHOLOGY, V93, P21; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pourcel C, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-22; Ravenel MP, 1936, AM J PUBLIC HEALTH N, V26, P1049, DOI 10.2105/AJPH.26.10.1049; Riehm JM, 2011, MOL CELL PROBE, V25, P8, DOI 10.1016/j.mcp.2010.09.002; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Vergnaud G, 2007, ADV EXP MED BIOL, V603, P327; Vogler AJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001319; World Health Organization, 2003, WEEKLY EPIDEMIOLOGIC, V78, P129; Zhang XA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-205; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]	34	49	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30624	10.1371/journal.pone.0030624	http://dx.doi.org/10.1371/journal.pone.0030624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363455	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600042
J	Du, MF; Yin, XM; Zhang, SD; Zhu, B; Song, QS; An, SH				Du, Mengfang; Yin, Xinming; Zhang, Songdou; Zhu, Bin; Song, Qisheng; An, Shiheng			Identification of Lipases Involved in PBAN Stimulated Pheromone Production in Bombyx mori Using the DGE and RNAi Approaches	PLOS ONE			English	Article							ACTIVATING NEUROPEPTIDE PBAN; SIGNAL-TRANSDUCTION CASCADE; ADIPOSE-TISSUE; CDNA CLONING; BIOSYNTHESIS; SILKMOTH; HORMONE; EXPRESSION; SILKWORM; GENERATION	Background: Pheromone biosynthesis activating neuropeptide (PBAN) is a neurohormone that regulates sex pheromone synthesis in female moths. Bombyx mori is a model organism that has been used to explore the signal transduction pattern of PBAN, which is mediated by a G-protein coupled receptor (GPCR). Although significant progress has been made in elucidating PBAN-regulated lipolysis that releases the precursor of the sex pheromone, little is known about the molecular components involved in this step. To better elucidate the molecular mechanisms of PBAN-stimulated lipolysis of cytoplasmic lipid droplets (LDs), the associated lipase genes involved in PBAN-regulated sex pheromone biosynthesis were identified using digital gene expression (DGE) and subsequent RNA interference (RNAi). Results: Three DGE libraries were constructed from pheromone glands (PGs) at different developed stages, namely, 72 hours before eclosion (272 h), new emergence (0 h) and 72 h after eclosion (-72 h), to investigate the gene expression profiles during PG development. The DGE evaluated over 5.6 million clean tags in each PG sample and revealed numerous genes that were differentially expressed at these stages. Most importantly, seven lipases were found to be richly expressed during the key stage of sex pheromone synthesis and release (new emergence). RNAi-mediated knockdown confirmed for the first time that four of these seven lipases play important roles in sex pheromone synthesis. Conclusion: This study has identified four lipases directly involved in PBAN-stimulated sex pheromone biosynthesis, which improve our understanding of the lipases involved in releasing bombykol precursors from triacylglycerols (TAGs) within the cytoplasmic LDs.	[Du, Mengfang; Yin, Xinming; Zhang, Songdou; Zhu, Bin; An, Shiheng] Henan Agr Univ, Coll Plant Protect, Zhengzhou, Peoples R China; [Song, Qisheng] Univ Missouri, Div Plant Sci, Columbia, MO USA	Henan Agricultural University; University of Missouri System; University of Missouri Columbia	Du, MF (corresponding author), Henan Agr Univ, Coll Plant Protect, Zhengzhou, Peoples R China.	anshiheng@yahoo.com.cn			Distinguished Professor Foundation of Henan Agricultural University [30600022]; Natural Science Foundation of Henan Province [2011B180021]	Distinguished Professor Foundation of Henan Agricultural University; Natural Science Foundation of Henan Province	This study was supported by a Distinguished Professor Foundation of Henan Agricultural University (No: 30600022) and Natural Science Foundation of Henan Province (No: 2011B180021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Blow N, 2009, NATURE, V458, P239, DOI 10.1038/458239a; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Hull JJ, 2010, INSECT MOL BIOL, V19, P553, DOI 10.1111/j.1365-2583.2010.01013.x; Hull JJ, 2009, J BIOL CHEM, V284, P31200, DOI 10.1074/jbc.M109.044198; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; KITAMURA A, 1989, BIOCHEM BIOPH RES CO, V163, P520, DOI 10.1016/0006-291X(89)92168-2; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto S, 2002, INSECT BIOCHEM MOLEC, V32, P1447, DOI 10.1016/S0965-1748(02)00065-6; Matsumoto S, 2001, INSECT BIOCHEM MOLEC, V31, P603, DOI 10.1016/S0965-1748(00)00165-X; Matsumoto S, 2007, J INSECT PHYSIOL, V53, P752, DOI 10.1016/j.jinsphys.2007.02.014; Matsumoto S, 2010, VITAM HORM, V83, P425, DOI 10.1016/S0083-6729(10)83018-3; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Ohnishi A, 2011, J BIOL CHEM, V286, P24101, DOI 10.1074/jbc.M111.250555; Ohnishi A, 2009, J BIOL CHEM, V284, P5128, DOI 10.1074/jbc.M806072200; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Rafaeli Ada, 2003, P107, DOI 10.1016/B978-012107151-6/50007-4; Rafaeli A, 2009, GEN COMP ENDOCR, V162, P69, DOI 10.1016/j.ygcen.2008.04.004; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Tsfadia O, 2008, INSECT BIOCHEM MOLEC, V38, P552, DOI 10.1016/j.ibmb.2008.01.005; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Yoshiga T, 2000, GENE, V246, P339, DOI 10.1016/S0378-1119(00)00047-0; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	30	26	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31045	10.1371/journal.pone.0031045	http://dx.doi.org/10.1371/journal.pone.0031045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359564	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200033
J	Jayaraman, A; Chandrasekaran, A; Viswanathan, K; Raman, R; Fox, JG; Sasisekharan, R				Jayaraman, Akila; Chandrasekaran, Aarthi; Viswanathan, Karthik; Raman, Rahul; Fox, James G.; Sasisekharan, Ram			Decoding the Distribution of Glycan Receptors for Human-Adapted Influenza A Viruses in Ferret Respiratory Tract	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; TRANSMISSION; SPECIFICITY; INFECTION; CELLS; MODEL; HOST; HEMAGGLUTININ; PATHOGENESIS; CULTURES	Ferrets are widely used as animal models for studying influenza A viral pathogenesis and transmissibility. Human-adapted influenza A viruses primarily target the upper respiratory tract in humans (infection of the lower respiratory tract is observed less frequently), while in ferrets, upon intranasal inoculation both upper and lower respiratory tract are targeted. Viral tropism is governed by distribution of complex sialylated glycan receptors in various cells/tissues of the host that are specifically recognized by influenza A virus hemagglutinin (HA), a glycoprotein on viral surface. It is generally known that upper respiratory tract of humans and ferrets predominantly express alpha 2 -> 6 sialylated glycan receptors. However much less is known about the fine structure of these glycan receptors and their distribution in different regions of the ferret respiratory tract. In this study, we characterize distribution of glycan receptors going beyond terminal sialic acid linkage in the cranial and caudal regions of the ferret trachea (upper respiratory tract) and lung hilar region (lower respiratory tract) by multiplexing use of various plant lectins and human-adapted HAs to stain these tissue sections. Our findings show that the sialylated glycan receptors recognized by human-adapted HAs are predominantly distributed in submucosal gland of lung hilar region as a part of O-linked glycans. Our study has implications in understanding influenza A viral pathogenesis in ferrets and also in employing ferrets as animal models for developing therapeutic strategies against influenza.	[Jayaraman, Akila; Chandrasekaran, Aarthi; Viswanathan, Karthik; Raman, Rahul; Sasisekharan, Ram] Koch Inst Integrat Canc Res, Singapore Massachusetts Inst Technol Alliance Res, Dept Biol Engn, Harvard Massachusetts Inst Technol Div Hlth Sci &, Cambridge, MA USA; [Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Jayaraman, A (corresponding author), Koch Inst Integrat Canc Res, Singapore Massachusetts Inst Technol Alliance Res, Dept Biol Engn, Harvard Massachusetts Inst Technol Div Hlth Sci &, Cambridge, MA USA.	rams@mit.edu			Singapore-Massachusetts Institute of Technology Alliance for Research and Technology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	Singapore-Massachusetts Institute of Technology Alliance for Research and Technology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Singapore-Massachusetts Institute of Technology Alliance for Research and Technology. The confocal microscopy analysis of the tissue sections was performed at the W. M. Keck Imaging Facility in the Whitehead Institute at Massachusetts Institute of Technology (MIT). The authors would like to acknowledge Dr. Nicki Parry and Chakib Boussahmain from the Division of Comparative Medicine (MIT) for providing the ferret lung hilar tissue sections. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Blixt O, 2006, METHOD ENZYMOL, V415, P137, DOI 10.1016/S0076-6879(06)15009-0; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; GAMBARYAN AS, 1995, FEBS LETT, V366, P57, DOI 10.1016/0014-5793(95)00488-U; Garcia-Sastre A, 2010, AM J PATHOL, V176, P1584, DOI 10.2353/ajpath.2010.100066; HUSSEINI RH, 1983, J GEN VIROL, V64, P589, DOI 10.1099/0022-1317-64-3-589; Kirkeby S, 2009, VIRUS RES, V144, P225, DOI 10.1016/j.virusres.2009.05.004; LEIGH MW, 1995, VACCINE, V13, P1468, DOI 10.1016/0264-410X(95)00004-K; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mansfield KG, 2007, AM J PATHOL, V171, P1089, DOI 10.2353/ajpath.2007.070695; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Memoli MJ, 2011, J INFECT DIS, V203, P348, DOI 10.1093/infdis/jiq067; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; PERINI JM, 1991, EUR J BIOCHEM, V196, P321, DOI 10.1111/j.1432-1033.1991.tb15820.x; ROGERS DF, 1994, EUR RESPIR J, V7, P1690; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Triana-Baltzer GB, 2010, J ANTIMICROB CHEMOTH, V65, P275, DOI 10.1093/jac/dkp421; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; Viswanathan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013768; Viswanathan K, 2010, GLYCOCONJUGATE J, V27, P561, DOI 10.1007/s10719-010-9303-4; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P588, DOI 10.1073/pnas.0806959106; Xu Q, 2010, J VIROL, V84, P4936, DOI 10.1128/JVI.02489-09	30	49	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e27517	10.1371/journal.pone.0027517	http://dx.doi.org/10.1371/journal.pone.0027517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359533	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200002
J	Lawless, C; Jurk, D; Gillespie, CS; Shanley, D; Saretzki, G; von Zglinicki, T; Passos, JF				Lawless, Conor; Jurk, Diana; Gillespie, Colin S.; Shanley, Daryl; Saretzki, Gabriele; von Zglinicki, Thomas; Passos, Joao F.			A Stochastic Step Model of Replicative Senescence Explains ROS Production Rate in Ageing Cell Populations	PLOS ONE			English	Article							OXIDATIVE STRESS; LIFE-SPAN; HUMAN FIBROBLASTS; SUPEROXIDE-DISMUTASE; SHORTENS TELOMERES; LUNG FIBROBLASTS; DNA-DAMAGE; IN-VIVO; ACCUMULATION; MITOCHONDRIA	Increases in cellular Reactive Oxygen Species (ROS) concentration with age have been observed repeatedly in mammalian tissues. Concomitant increases in the proportion of replicatively senescent cells in ageing mammalian tissues have also been observed. Populations of mitotic human fibroblasts cultured in vitro, undergoing transition from proliferation competence to replicative senescence are useful models of ageing human tissues. Similar exponential increases in ROS with age have been observed in this model system. Tracking individual cells in dividing populations is difficult, and so the vast majority of observations have been cross-sectional, at the population level, rather than longitudinal observations of individual cells. One possible explanation for these observations is an exponential increase in ROS in individual fibroblasts with time (e.g. resulting from a vicious cycle between cellular ROS and damage). However, we demonstrate an alternative, simple hypothesis, equally consistent with these observations which does not depend on any gradual increase in ROS concentration: the Stochastic Step Model of Replicative Senescence (SSMRS). We also demonstrate that, consistent with the SSMRS, neither proliferation-competent human fibroblasts of any age, nor populations of hTERT overexpressing human fibroblasts passaged beyond the Hayflick limit, display high ROS concentrations. We conclude that longitudinal studies of single cells and their lineages are now required for testing hypotheses about roles and mechanisms of ROS increase during replicative senescence.	[Lawless, Conor] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lawless, Conor; Jurk, Diana; Gillespie, Colin S.; Shanley, Daryl; Saretzki, Gabriele; von Zglinicki, Thomas; Passos, Joao F.] Newcastle Univ, Ctr Integrated Syst Biol Ageing & Nutr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jurk, Diana; Shanley, Daryl; Saretzki, Gabriele; von Zglinicki, Thomas; Passos, Joao F.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gillespie, Colin S.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Lawless, C (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Joao.Passos@ncl.ac.uk	Saretzki, Gabriele Christine/I-7175-2019	Saretzki, Gabriele Christine/0000-0003-2100-8223; Shanley, Daryl/0000-0003-3096-6386; Lawless, Conor/0000-0002-4186-8506; Jurk, Diana/0000-0003-4486-0857; Gillespie, Colin/0000-0003-1787-0275; Passos, Joao/0000-0001-8765-1890; von Zglinicki, Thomas/0000-0002-5939-0248	Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom; BBSRC; BBSRC [BB/H022384/1, BB/F010966/1, BB/I020748/1] Funding Source: UKRI; MRC [G0900686] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I020748/1, BB/H022384/1, BB/F010966/1] Funding Source: researchfish; Medical Research Council [G0900686] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom. JFP is funded by a BBSRC David Phillips Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed EK, 2010, AGING CELL, V9, P252, DOI 10.1111/j.1474-9726.2010.00555.x; Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Allen RG, 1999, J CELL PHYSIOL, V180, P114, DOI 10.1002/(SICI)1097-4652(199907)180:1<114::AID-JCP13>3.0.CO;2-0; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Colavitti R, 2005, IUBMB LIFE, V57, P277, DOI 10.1080/15216540500091890; de Magalhaes JP, 2006, EXP GERONTOL, V41, P1, DOI 10.1016/j.exger.2005.09.002; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Lechel A, 2005, EMBO REP, V6, P275, DOI 10.1038/sj.embor.7400352; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; MITSUI Y, 1976, EXP CELL RES, V100, P147, DOI 10.1016/0014-4827(76)90336-0; Passes JF, 2007, BIOESSAYS, V29, P908, DOI 10.1002/bies.20634; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Saretzki G, 2003, AGING CELL, V2, P141, DOI 10.1046/j.1474-9728.2003.00040.x; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Serra V, 2003, J BIOL CHEM, V278, P6824, DOI 10.1074/jbc.M207939200; Sitte N, 2001, EXP GERONTOL, V36, P475, DOI 10.1016/S0531-5565(00)00253-9; Sitte N, 2000, FREE RADICAL BIO MED, V28, P701, DOI 10.1016/S0891-5849(99)00279-8; SMITH JR, 1980, SCIENCE, V207, P82; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132	42	37	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32117	10.1371/journal.pone.0032117	http://dx.doi.org/10.1371/journal.pone.0032117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359661	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200130
J	Morales, O; Richard, A; Martin, N; Mrizak, D; Senechal, M; Miroux, C; Pancre, V; Rommelaere, J; Caillet-Fauquet, P; de Launoit, Y; Delhem, N				Morales, Olivier; Richard, Audrey; Martin, Nathalie; Mrizak, Dhafer; Senechal, Magalie; Miroux, Celine; Pancre, Veronique; Rommelaere, Jean; Caillet-Fauquet, Perrine; de Launoit, Yvan; Delhem, Nadira			Activation of a Helper and Not Regulatory Human CD4+T Cell Response by Oncolytic H-1 Parvovirus	PLOS ONE			English	Article							RESTRICTED TUMOR-ANTIGENS; CD4(+) T-CELLS; MINUTE VIRUS; ANTITUMOR IMMUNITY; REPLICATIVE FUNCTIONS; FUTURE-DIRECTIONS; IN-VIVO; MICE; CANCER; VIROTHERAPY	Background: H-1 parvovirus (H-1 PV), a rodent autonomous oncolytic parvovirus, has emerged as a novel class of promising anticancer agents, because of its ability to selectively find and destroy malignant cells. However, to probe H-1 PV multimodal antitumor potential one of the major prerequisites is to decipher H-1 PV direct interplay with human immune system, and so prevent any risk of impairment. Methodology/Principal findings: Non activated peripheral blood mononuclear cells (PBMCs) are not sensitive to H-1 PV cytotoxic effect. However, the virus impairs both activated PBMC proliferation ability and viability. This effect is related to H-1 PV infection as evidenced by Western blotting detection of H-1 PV main protein NS1. However, TCID50 experiments did not allow newly generated virions to be detected. Moreover, flow cytometry has shown that H-1 PV preferentially targets B lymphocytes. Despite seeming harmful at first sight, H-1 PV seems to affect very few NK cells and CD8+ T lymphocytes and, above all, clearly does not affect human neutrophils and one of the major CD4+ T lymphocyte subpopulation. Very interestingly, flow cytometry analysis and ELISA assays proved that it even activates human CD4+ T cells by increasing activation marker expression (CD69 and CD30) and both effective Th1 and Th2 cytokine secretion (IL-2, IFN-gamma and IL-4). In addition, H-1 PV action does not come with any sign of immunosuppressive side effect. Finally, we have shown the efficiency of H-1 PV on xenotransplanted human nasopharyngeal carcinoma, in a SCID mouse model reconstituted with human PBMC. Conclusions/Significance: Our results show for the first time that a wild-type oncolytic virus impairs some immune cell subpopulations while directly activating a Helper CD4+ T cell response. Thus, our data open numerous gripping perspectives of investigation and strongly argue for the use of H-1 PV as an anticancer treatment.	[Morales, Olivier; Richard, Audrey; Martin, Nathalie; Mrizak, Dhafer; Senechal, Magalie; Miroux, Celine; Pancre, Veronique; Caillet-Fauquet, Perrine; de Launoit, Yvan; Delhem, Nadira] Univ Lille Nord France, Inst Biol Lille, CNRS, Inst Pasteur Lille,UMR 8161, Lille, France; [Rommelaere, Jean] Deutsch Krebsforschungszentrum, Res Program Infect & Canc, D-6900 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Helmholtz Association; German Cancer Research Center (DKFZ)	Morales, O (corresponding author), Univ Lille Nord France, Inst Biol Lille, CNRS, Inst Pasteur Lille,UMR 8161, Lille, France.	nadira.delhem@ibl.fr	Pancre, Véronique/L-8206-2018; MORALES, Olivier/AAR-5337-2020	de Launoit, Yvan/0000-0003-1837-9808; MORALES, Olivier/0000-0002-2135-3265				Angelova AL, 2009, CLIN CANCER RES, V15, P511, DOI 10.1158/1078-0432.CCR-08-1088; CAILLETFAUQUET P, 1990, EMBO J, V9, P2989, DOI 10.1002/j.1460-2075.1990.tb07491.x; CORNELIS JJ, 1988, J VIROL, V62, P3438, DOI 10.1128/JVI.62.9.3438-3444.1988; Daeffler L, 2003, J VIROL, V77, P12466, DOI 10.1128/JVI.77.23.12466-12478.2003; DEBEECK AO, 1995, CELL GROWTH DIFFER, V6, P781; Deleu L, 1999, J VIROL, V73, P3877, DOI 10.1128/JVI.73.5.3877-3885.1999; Depil S, 2007, J IMMUNOTHER, V30, P215, DOI 10.1097/01.cji.0000211338.99137.4f; FAISST S, 1995, J VIROL, V69, P4538, DOI 10.1128/JVI.69.7.4538-4543.1995; Geletneky K, 2010, NEURO-ONCOLOGY, V12, P804, DOI 10.1093/neuonc/noq023; Grekova S, 2010, CANCER BIOL THER, V10, P1280, DOI 10.4161/cbt.10.12.13455; Hristov G, 2010, J VIROL, V84, P5909, DOI 10.1128/JVI.01797-09; Kirn D, 2001, NAT MED, V7, P781, DOI 10.1038/89901; Kirn DH, 2009, NAT REV CANCER, V9, P64, DOI 10.1038/nrc2545; Lachmann S, 2003, J VIROL, V77, P8048, DOI 10.1128/JVI.77.14.8048-8060.2003; Moehler M, 2001, CANCER GENE THER, V8, P158, DOI 10.1038/sj.cgt.7700288; Moehler MH, 2005, HUM GENE THER, V16, P996, DOI 10.1089/hum.2005.16.996; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Muharram G, 2010, BREAST CANCER RES TR, V121, P23, DOI 10.1007/s10549-009-0451-9; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Nomura T, 2005, CURR TOP MICROBIOL, V293, P287, DOI 10.1007/3-540-27702-1_13; Nuesch JPF, 2003, J VIROL, V77, P433, DOI 10.1128/JVI.77.1.433-442.2003; Ostrand-Rosenberg S, 2005, CANCER INVEST, V23, P413, DOI 10.1081/CNV-200067428; Penault-Llorca F, 2002, Cancer Radiother, V6 Suppl 1, p24s; Raykov Z, 2007, ONCOL REP, V17, P1493; Reilly R T, 2001, Curr Opin Investig Drugs, V2, P133; RHODE SL, 1985, J VIROL, V55, P886, DOI 10.1128/JVI.55.3.886-889.1985; ROMMELAERE J, 1991, J VIROL METHODS, V33, P233, DOI 10.1016/0166-0934(91)90024-T; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Thorne SH, 2004, EXPERT OPIN BIOL TH, V4, P1307, DOI 10.1517/14712598.4.8.1307; Toda M, 1999, HUM GENE THER, V10, P385, DOI 10.1089/10430349950018832; Wan YSY, 2010, IMMUNOLOGY, V130, P166, DOI 10.1111/j.1365-2567.2010.03289.x; Wang RF, 2003, METHODS, V29, P227, DOI 10.1016/S1046-2023(02)00345-6; Wang RF, 2001, TRENDS IMMUNOL, V22, P269, DOI 10.1016/S1471-4906(01)01896-8; White CA, 2001, ANNU REV MED, V52, P125, DOI 10.1146/annurev.med.52.1.125; Wilczynski JR, 2008, FRONT BIOSCI-LANDMRK, V13, P2266, DOI 10.2741/2840; Wizla P, 2010, ARCH VIROL, V155, P771, DOI 10.1007/s00705-010-0637-9; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Zhang W, 2009, J IMMUNOTOXICOL; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	39	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32197	10.1371/journal.pone.0032197	http://dx.doi.org/10.1371/journal.pone.0032197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359669	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200138
J	Su, HR; Jiang, L; Carter-Su, C; Rui, LY				Su, Haoran; Jiang, Lin; Carter-Su, Christin; Rui, Liangyou			Glucose Enhances Leptin Signaling through Modulation of AMPK Activity	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DIET-INDUCED OBESITY; ENERGY-BALANCE; CELL-GROWTH; OB RECEPTOR; FOOD-INTAKE; LONG FORM; RESISTANCE; IDENTIFICATION; MICE	Leptin exerts its action by binding to and activating the long form of leptin receptors (LEPRb). LEPRb activates JAK2 that subsequently phosphorylates and activates STAT3. The JAK2/STAT3 pathway is required for leptin control of energy balance and body weight. Defects in leptin signaling lead to leptin resistance, a primary risk factor for obesity. Body weight is also regulated by nutrients, including glucose. Defects in glucose sensing also contribute to obesity. Here we report crosstalk between leptin and glucose. Glucose starvation blocked the ability of leptin to stimulate tyrosyl phosphorylation and activation of JAK2 and STAT3 in a variety of cell types. Glucose dose-dependently enhanced leptin signaling. In contrast, glucose did not enhance growth hormone-stimulated phosphorylation of JAK2 and STAT5. Glucose starvation or 2-deoxyglucose-induced inhibition of glycolysis activated AMPK and inhibited leptin signaling; pharmacological inhibition of AMPK restored the ability of leptin to stimulate STAT3 phosphorylation. Conversely, pharmacological activation of AMPK was sufficient to inhibit leptin signaling and to block the ability of glucose to enhance leptin signaling. These results suggest that glucose and/or its metabolites play a permissive role in leptin signaling, and that glucose enhances leptin sensitivity at least in part by attenuating the ability of AMPK to inhibit leptin signaling.	[Su, Haoran; Jiang, Lin; Carter-Su, Christin; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Su, HR (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu	Jiang, Lin/E-7468-2012		National Institutes of Health (NIH) [RO1-DK065122, RO1-DK073601, 5P60 DK20572, 5 P30 CA46592, P30AG013283, DK34933]; American Diabetes Association [1-09-RA-156]; Michigan Diabetes Research and Training Center; University of Michigan's Cancer Center; University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, R01DK065122, P30DK034933, R01DK073601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Michigan Diabetes Research and Training Center; University of Michigan's Cancer Center(University of Michigan System); University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants RO1-DK065122, RO1-DK073601, and RO1-DK073601 from the National Institutes of Health (NIH); and by a research award 1-09-RA-156 from the American Diabetes Association. This work utilized the cores supported by the Michigan Diabetes Research and Training Center (funded by NIH 5P60 DK20572), the University of Michigan's Cancer Center (funded by NIH 5 P30 CA46592), the University of Michigan Nathan Shock Center (funded by NIH P30AG013283), and the University of Michigan Gut Peptide Research Center (funded by NIH DK34933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Campfield LA, 2003, PHYSIOL REV, V83, P25, DOI 10.1152/physrev.00019.2002; Carpenter LR, 1998, P NATL ACAD SCI USA, V95, P6061, DOI 10.1073/pnas.95.11.6061; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Gong Y, 2007, J BIOL CHEM, V282, P31019, DOI 10.1074/jbc.M702838200; GONZALEZMANCHON C, 1991, NEUROENDOCRINOLOGY, V54, P373, DOI 10.1159/000125916; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hekerman P, 2005, FEBS J, V272, P109, DOI 10.1111/j.1432-1033.2004.04391.x; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jiang L, 2008, P NATL ACAD SCI USA, V105, P18619, DOI 10.1073/pnas.0804589105; Jiang L, 2008, J BIOL CHEM, V283, P28066, DOI 10.1074/jbc.M805545200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim HK, 2011, ENDOCRINOLOGY, V152, P4672, DOI 10.1210/en.2011-1221; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Li C, 1999, P NATL ACAD SCI USA, V96, P9677, DOI 10.1073/pnas.96.17.9677; Li MH, 2007, ENDOCRINOLOGY, V148, P1615, DOI 10.1210/en.2006-1010; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; MISELIS RR, 1975, AM J PHYSIOL, V229, P1438, DOI 10.1152/ajplegacy.1975.229.5.1438; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Morrison CD, 2007, ENDOCRINOLOGY, V148, P433, DOI 10.1210/en.2006-0672; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Routh VH, 2010, SENSORS-BASEL, V10, P9002, DOI 10.3390/s101009002; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Smit LS, 1997, ENDOCRINOLOGY, V138, P3426, DOI 10.1210/en.138.8.3426; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; White CL, 2008, AM J PHYSL ENDOCRINO; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhang H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001112; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	48	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31636	10.1371/journal.pone.0031636	http://dx.doi.org/10.1371/journal.pone.0031636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359610	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200079
J	Zhang, XM; Grusche, FA; Harvey, KF				Zhang, Xiaomeng; Grusche, Felix A.; Harvey, Kieran F.			Control of Tissue Growth and Cell Transformation by the Salvador/Warts/Hippo Pathway	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; HIPPO SIGNALING PATHWAY; TRANSCRIPTIONAL OUTPUT; CONTACT INHIBITION; TEAD/TEF FAMILY; ORGAN SIZE; YAP; DROSOPHILA; DOMAIN; YORKIE	The Salvador-Warts-Hippo (SWH) pathway is an important regulator of tissue growth that is frequently subverted in human cancer. The key oncoprotein of the SWH pathway is the transcriptional co-activator, Yes-associated protein (YAP). YAP promotes tissue growth and transformation of cultured cells by interacting with transcriptional regulatory proteins via its WW domains, or, in the case of the TEAD1-4 transcription factors, an N-terminal binding domain. YAP possesses a putative transactivation domain in its C-terminus that is necessary to stimulate transcription factors in vitro, but its requirement for YAP function has not been investigated in detail. Interestingly, whilst the WW domains and TEAD-binding domain are highly conserved in the Drosophila melanogaster YAP orthologue, Yorkie, the majority of the C-terminal region of YAP is not present in Yorkie. To investigate this apparent conundrum, we assessed the functional roles of the YAP and Yorkie C-termini. We found that these regions were not required for Yorkie's ability to drive tissue growth in vivo, or YAP's ability to promote anchorage-independent growth or resistance to contact inhibition. However, the YAP transactivation domain was required for YAP's ability to induce cell migration and invasion. Moreover, a role for the YAP transactivation domain in cell transformation was uncovered when the YAP WW domains were mutated together with the transactivation domain. This shows that YAP can promote cell transformation in a flexible manner, presumably by contacting transcriptional regulatory proteins either via its WW domains or its transactivation domain.	[Zhang, Xiaomeng; Grusche, Felix A.; Harvey, Kieran F.] Peter MacCallum Canc Ctr, Cell Growth & Proliferat Lab, Melbourne, Vic, Australia; [Zhang, Xiaomeng; Grusche, Felix A.; Harvey, Kieran F.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Zhang, Xiaomeng; Grusche, Felix A.; Harvey, Kieran F.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne	Zhang, XM (corresponding author), Peter MacCallum Canc Ctr, Cell Growth & Proliferat Lab, Melbourne, Vic, Australia.	kieran.harvey@petermac.org	Harvey, Kieran/AAD-5268-2022	Harvey, Kieran/0000-0001-7845-369X	Sylvia and Charles Viertel Senior Medical Research Fellowship; Cure Cancer Australia; National Breast Cancer Foundation; Cancer Council Victoria; National Health and Medical Research Council of Australia	Sylvia and Charles Viertel Senior Medical Research Fellowship; Cure Cancer Australia; National Breast Cancer Foundation; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Sylvia and Charles Viertel Senior Medical Research Fellowship to KFH, a Cure Cancer Australia and National Breast Cancer Foundation Fellowship to XZ, a Cancer Council Victoria Fellowship to FAG and a Project Grant from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hilman D, 2011, MOL BIOL EVOL, V28, P2403, DOI 10.1093/molbev/msr065; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Oh H, 2011, DEV CELL, V20, P109, DOI 10.1016/j.devcel.2010.12.002; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Sebe-Pedros A, 2012, CELL REP, V1, P13, DOI 10.1016/j.celrep.2011.11.004; SUDOL M, 1994, ONCOGENE, V9, P2145; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang X, 2011, CELL DEATH DIFFER, V18, P1346, DOI 10.1038/cdd.2011.6; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhang XM, 2009, CANCER RES, V69, P6033, DOI 10.1158/0008-5472.CAN-08-4592; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997	38	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31994	10.1371/journal.pone.0031994	http://dx.doi.org/10.1371/journal.pone.0031994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359650	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200119
J	Martin, F; Nunez, C; Marin, MT; Laorden, ML; Kovacs, KJ; Milanes, MV				Martin, Fatima; Nunez, Cristina; Teresa Marin, M.; Luisa Laorden, M.; Kovacs, Krisztina J.; Victoria Milanes, M.			Involvement of Noradrenergic Transmission in the PVN on CREB Activation, TORC1 Levels, and Pituitary-Adrenal Axis Activity during Morphine Withdrawal	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; ELEMENT-BINDING PROTEIN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; FACTOR GENE-EXPRESSION; MESSENGER-RNA; CATECHOLAMINERGIC PATHWAYS; SUPRAOPTIC NUCLEI; RAT HYPOTHALAMUS; BRAIN STRESS; PHOSPHORYLATION	Experimental and clinical findings have shown that administration of adrenoceptor antagonists alleviated different aspects of drug withdrawal and dependence. The present study tested the hypothesis that changes in CREB activation and phosphorylated TORC1 levels in the hypothalamic paraventricular nucleus (PVN) after naloxone-precipitated morphine withdrawal as well as the HPA axis activity arises from alpha(1)- and/or beta-adrenoceptor activation. The effects of morphine dependence and withdrawal on CREB phosphorylation (pCREB), phosphorylated TORC1 (pTORC1), and HPA axis response were measured by Western-blot, immunohistochemistry and radioimmunoassay in rats pretreated with prazosin (alpha(1)-adrenoceptor antagonist) or propranolol (beta-adrenoceptor antagonist). In addition, the effects of morphine withdrawal on MHPG (the main NA metabolite at the central nervous system) and NA content and turnover were evaluated by HPLC. We found an increase in MHPG and NA turnover in morphine-withdrawn rats, which were accompanied by increased pCREB immunoreactivity and plasma corticosterone concentrations. Levels of the inactive form of TORC1 (pTORC1) were decreased during withdrawal. Prazosin but not propranolol blocked the rise in pCREB level and the decrease in pTORC1 immunoreactivity. In addition, the HPA axis response to morphine withdrawal was attenuated in prazosin-pretreated rats. Present results suggest that, during acute morphine withdrawal, NA may control the HPA axis activity through CREB activation at the PVN level. We concluded that the combined increase in CREB phosphorylation and decrease in pTORC1 levels might represent, in part, two of the mechanisms of CREB activation at the PVN during morphine withdrawal.	[Martin, Fatima; Nunez, Cristina; Luisa Laorden, M.; Victoria Milanes, M.] Univ Murcia, Dept Pharmacol, Grp Cellular & Mol Pharmacol, Sch Med, Murcia, Spain; [Martin, Fatima; Nunez, Cristina; Luisa Laorden, M.; Victoria Milanes, M.] IMIB, Murcia, Spain; [Teresa Marin, M.] Univ Granada, Fac Pharm, Dept Pharm & Pharmaceut Technol, E-18071 Granada, Spain; [Kovacs, Krisztina J.] Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary	University of Murcia; University of Granada; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Martin, F (corresponding author), Univ Murcia, Dept Pharmacol, Grp Cellular & Mol Pharmacol, Sch Med, Murcia, Spain.	milanes@um.es	Núñez, Cristina/O-8288-2015; Milanés, M Victoria/K-6591-2017; Milanés, M. Victoria/AGB-4075-2022	Núñez, Cristina/0000-0002-0773-4950; Milanés, M Victoria/0000-0002-0984-2218; Milanés, M. Victoria/0000-0002-0984-2218	Ministerio de Ciencia e Innovacion [SAF2009-07178, SAF2010-17907]; Red de Trastornos Adictivos (RTA) [RD06/0001/1006]; Fundacion Seneca [15405/PI/10]; Agencia Regional de Ciencia y Tecnologia, Region de Murcia; University of Murcia	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red de Trastornos Adictivos (RTA); Fundacion Seneca(Fundacion Seneca); Agencia Regional de Ciencia y Tecnologia, Region de Murcia; University of Murcia	This work was supported by Ministerio de Ciencia e Innovacion (SAF2009-07178 and SAF2010-17907), Red de Trastornos Adictivos (RTA; RD06/0001/1006) and Fundacion Seneca (15405/PI/10), Agencia Regional de Ciencia y Tecnologia, Region de Murcia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fatima Martin was supported by a fellowship from the Ministerio de Ciencia e Innovacion. Cristina Nunez was supported by a postdoctoral fellowship from the University of Murcia.	BARABAN SC, 1995, BRAIN RES, V676, P245, DOI 10.1016/0006-8993(95)00097-A; Bittinger MA, 2004, CURR BIOL, V2156, P2161; Blendy JA, 1998, J MOL MED-JMM, V76, P104, DOI 10.1007/s001090050197; Briand LA, 2010, BRAIN RES, V1314, P219, DOI 10.1016/j.brainres.2009.11.002; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cecchi M, 2002, NEUROPHARMACOLOGY, V43, P1139, DOI 10.1016/S0028-3908(02)00292-7; Chen MJ, 2007, CELL SIGNAL, V19, P114, DOI 10.1016/j.cellsig.2006.05.028; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; COUCEYRO P, 1995, MOL PHARMACOL, V47, P29; CUNNINGHAM ET, 1988, J COMP NEUROL, V274, P60, DOI 10.1002/cne.902740107; Daftary SS, 2000, NEUROSCIENCE, V96, P743, DOI 10.1016/S0306-4522(00)00003-8; Day HEW, 1999, J NEUROSCI, V19, P10098; Deak T, 1999, ENDOCRINOLOGY, V140, P79, DOI 10.1210/en.140.1.79; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Dunn AJ, 2008, EUR J PHARMACOL, V583, P186, DOI 10.1016/j.ejphar.2007.11.069; Ferenczi S, 2010, NEUROCHEM INT, V57, P323, DOI 10.1016/j.neuint.2010.06.011; Forget B, 2010, NEUROPSYCHOPHARMACOL, V35, P1751, DOI 10.1038/npp.2010.42; FREEDMAN JE, 1985, J NEUROSCI, V5, P3016; GOLD MS, 1978, LANCET, V2, P599; Greenwell TN, 2009, PHARMACOL BIOCHEM BE, V91, P295, DOI 10.1016/j.pbb.2008.07.012; HARRIS GC, 1993, NEUROPSYCHOPHARMACOL, V9, P303, DOI 10.1038/npp.1993.66; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Itoi K, 1999, J NEUROSCI, V19, P5464; Itoi K, 1996, ENDOCRINOLOGY, V137, P2389, DOI 10.1210/en.137.6.2389; ITOI K, 1994, ENDOCRINOLOGY, V135, P2177, DOI 10.1210/en.135.5.2177; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; KATZ JL, 1986, PSYCHOPHARMACOLOGY, V88, P392; Kiss A, 2000, CELL MOL NEUROBIOL, V20, P683, DOI 10.1023/A:1007098724683; Kovacs KJ, 1996, J NEUROSCI, V16, P262; Laorden ML, 2002, BRIT J PHARMACOL, V136, P67, DOI 10.1038/sj.bjp.0704684; Laorden ML, 2002, J NEUROCHEM, V83, P132, DOI 10.1046/j.1471-4159.2002.01123.x; Laorden ML, 2000, J PHARMACOL EXP THER, V293, P578; LIPOSITS Z, 1986, HISTOCHEMISTRY, V85, P95, DOI 10.1007/BF00491754; Liu Y, 2008, ENDOCRINOLOGY, V149, P3512, DOI 10.1210/en.2008-0052; Liu Y, 2010, ENDOCRINOLOGY, V151, P1109, DOI 10.1210/en.2009-0963; Maldonado R, 1997, NEUROSCI BIOBEHAV R, V21, P91, DOI 10.1016/0149-7634(95)00061-5; Martin F, 2011, BRIT J PHARMACOL, V163, P857, DOI 10.1111/j.1476-5381.2011.01287.x; Martin F, 2009, J NEUROCHEM, V110, P1422, DOI 10.1111/j.1471-4159.2009.06234.x; Martin-Fardon R, 2010, BRAIN RES, V1314, P145, DOI 10.1016/j.brainres.2009.12.027; McClung CA, 2008, NEUROPSYCHOPHARMACOL, V33, P3, DOI 10.1038/sj.npp.1301544; Navarro-Zaragoza J, 2011, BRIT J PHARMACOL, V162, P851, DOI 10.1111/j.1476-5381.2010.01090.x; Navarro-Zaragoza J, 2010, MOL PHARMACOL, V77, P864, DOI 10.1124/mol.109.062463; Nunez C, 2007, ENDOCRINOLOGY, V148, P5780, DOI 10.1210/en.2007-0510; Nunez C, 2007, J NEUROCHEM, V101, P1060, DOI 10.1111/j.1471-4159.2006.04421.x; Nunez C, 2009, ENDOCRINOLOGY, V150, P3118, DOI 10.1210/en.2008-1732; Otis JM, 2011, NEUROPSYCHOPHARMACOL, V36, P1912, DOI 10.1038/npp.2011.77; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; PLOTSKY PM, 1987, ENDOCRINOLOGY, V121, P924, DOI 10.1210/endo-121-3-924; Rasmussen DD, 2011, ALCOHOLISMNO; SAWCHENKO PE, 1983, J COMP NEUROL, V218, P121, DOI 10.1002/cne.902180202; SAWCHENKO PE, 1982, BRAIN RES REV, V4, P275, DOI 10.1016/0165-0173(82)90010-8; Shepard JD, 2005, J NEUROSCI, V25, P4073, DOI 10.1523/JNEUROSCI.0122-05.2005; Simpson TL, 2009, ALCOHOL CLIN EXP RES, V33, P255, DOI 10.1111/j.1530-0277.2008.00807.x; Thonberg H, 2002, BIOCHEM J, V364, P73, DOI 10.1042/bj3640073; TILDERS FJH, 1985, FED PROC, V44, P155; Walker BM, 2008, ALCOHOL, V42, P91, DOI 10.1016/j.alcohol.2007.12.002; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198	57	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31119	10.1371/journal.pone.0031119	http://dx.doi.org/10.1371/journal.pone.0031119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355339	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300039
J	Schmitt, DM; O'Dee, DM; Horzempa, J; Carlson, PE; Russo, BC; Bales, JM; Brown, MJ; Nau, GJ				Schmitt, Deanna M.; O'Dee, Dawn M.; Horzempa, Joseph; Carlson, Paul E., Jr.; Russo, Brian C.; Bales, Jacqueline M.; Brown, Matthew J.; Nau, Gerard J.			A Francisella tularensis Live Vaccine Strain That Improves Stimulation of Antigen-Presenting Cells Does Not Enhance Vaccine Efficacy	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; TULAREMIA VACCINE; VIRULENCE; LVS; IMMUNIZATION; ACTIVATION; MICE; SECRETION; INFECTION; RESPONSES	Vaccination is a proven strategy to mitigate morbidity and mortality of infectious diseases. The methodology of identifying and testing new vaccine candidates could be improved with rational design and in vitro testing prior to animal experimentation. The tularemia vaccine, Francisella tularensis live vaccine strain (LVS), does not elicit complete protection against lethal challenge with a virulent type A Francisella strain. One factor that may contribute to this poor performance is limited stimulation of antigen-presenting cells. In this study, we examined whether the interaction of genetically modified LVS strains with human antigen-presenting cells correlated with effectiveness as tularemia vaccine candidates. Human dendritic cells infected with wild-type LVS secrete low levels of proinflammatory cytokines, fail to upregulate costimulatory molecules, and activate human T cells poorly in vitro. One LVS mutant, strain 13B47, stimulated higher levels of proinflammatory cytokines from dendritic cells and macrophages and increased costimulatory molecule expression on dendritic cells compared to wild type. Additionally, 13B47-infected dendritic cells activated T cells more efficiently than LVS-infected cells. A deletion allele of the same gene in LVS displayed similar in vitro characteristics, but vaccination with this strain did not improve survival after challenge with a virulent Francisella strain. In vivo, this mutant was attenuated for growth and did not stimulate T cell responses in the lung comparable to wild type. Therefore, stimulation of antigen-presenting cells in vitro was improved by genetic modification of LVS, but did not correlate with efficacy against challenge in vivo within this model system.	[Schmitt, Deanna M.; O'Dee, Dawn M.; Horzempa, Joseph; Carlson, Paul E., Jr.; Russo, Brian C.; Bales, Jacqueline M.; Brown, Matthew J.; Nau, Gerard J.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Horzempa, Joseph] W Liberty Univ, Dept Nat Sci & Math, W Liberty, WV USA; [Nau, Gerard J.] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA USA; [Nau, Gerard J.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schmitt, DM (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	gjnau@pitt.edu		Nau, Gerard/0000-0001-7921-8317	National Institutes of Health [AI074402, AI050018]; Department of Microbiology and Molecular Genetics of the University of Pittsburgh School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI074402, T32AI060525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology and Molecular Genetics of the University of Pittsburgh School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health grants AI074402 and AI050018 and institutional funding from the Department of Microbiology and Molecular Genetics of the University of Pittsburgh School of Medicine. DMS is a recipient of T32 AI060525, "Immunology of Infectious Disease." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Baron G S, 1995, Methods Mol Biol, V47, P149; Barrett ADT, 2009, VACCINE, V27, pD2, DOI 10.1016/j.vaccine.2009.07.094; Ben Nasr A, 2006, J LEUKOCYTE BIOL, V80, P774, DOI 10.1189/jlb.1205755; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; BURKE DS, 1977, J INFECT DIS, V135, P55, DOI 10.1093/infdis/135.1.55; Carlson PE, 2007, MICROB PATHOGENESIS, V42, P204, DOI 10.1016/j.micpath.2007.02.001; Carlson PE, 2009, J BACTERIOL, V191, P6855, DOI 10.1128/JB.00995-09; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; De Pascalis R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002494; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; El Sahly HM, 2009, VACCINE, V27, P4905, DOI 10.1016/j.vaccine.2009.06.036; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Elkins KL, 2010, MICROBES INFECT, V12, P28, DOI 10.1016/j.micinf.2009.09.012; FOSHAY L, 1950, ANNU REV MICROBIOL, V4, P313, DOI 10.1146/annurev.mi.04.100150.001525; Hazlett KRO, 2008, INFECT IMMUN, V76, P4479, DOI 10.1128/IAI.00610-08; Hinman AR, 1998, VACCINE, V16, P1116, DOI 10.1016/S0264-410X(98)80107-2; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; Horzempa J, 2008, APPL ENVIRON MICROB, V74, P2161, DOI 10.1128/AEM.02360-07; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; Jia QM, 2010, INFECT IMMUN, V78, P4341, DOI 10.1128/IAI.00192-10; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; KADULL PJ, 1950, J IMMUNOL, V65, P425; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Le Nouen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015017; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Loegering DJ, 2006, MICROB PATHOGENESIS, V41, P218, DOI 10.1016/j.micpath.2006.07.007; Markel G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011176; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Munir S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001336; Nau GJ, 1997, P NATL ACAD SCI USA, V94, P6414, DOI 10.1073/pnas.94.12.6414; Oyston PCF, 2008, J MED MICROBIOL, V57, P921, DOI 10.1099/jmm.0.2008/000653-0; Paranavitana C, 2010, J INTERF CYTOK RES, V30, P471, DOI 10.1089/jir.2009.0108; Parsa KVL, 2008, MOL IMMUNOL, V45, P3428, DOI 10.1016/j.molimm.2008.04.006; Pasetti MF, 2008, VACCINE, V26, P1773, DOI 10.1016/j.vaccine.2008.01.005; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Quill H, 2004, NAT IMMUNOL, V5, P765, DOI 10.1038/ni0804-765; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rubin EJ, 1999, P NATL ACAD SCI USA, V96, P1645, DOI 10.1073/pnas.96.4.1645; Russo BC, 2011, INFECT IMMUN, V79, P3665, DOI 10.1128/IAI.00135-11; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Shen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013349; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; SMALL PLC, 1987, INFECT IMMUN, V55, P1674, DOI 10.1128/IAI.55.7.1674-1679.1987; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Titball RW, 2003, EXPERT OPIN BIOL TH, V3, P645, DOI 10.1517/14712598.3.4.645; Torres VJ, 2007, J IMMUNOL, V179, P5433, DOI 10.4049/jimmunol.179.8.5433; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; West TE, 2008, MICROBES INFECT, V10, P773, DOI 10.1016/j.micinf.2008.04.008; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005; Zarrella TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022335	65	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31172	10.1371/journal.pone.0031172	http://dx.doi.org/10.1371/journal.pone.0031172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355343	Green Published, Green Accepted, gold			2022-12-25	WOS:000302741300043
J	Srividya, I; Tirupataiah, S; Mishra, K				Srividya, Indukuri; Tirupataiah, Sirupangi; Mishra, Krishnaveni			Yeast Transcription Termination Factor Rtt103 Functions in DNA Damage Response	PLOS ONE			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; KU; GENOME; REPAIR; TELOMERE; GENES; MAINTENANCE; INSTABILITY; COMPLEX	YKu70/YKu80 is a heterodimer that is essential for repair of DNA double strand breaks through non-homologous end joining pathway in the yeast Saccharomyces cerevisiae. Yku70/80 proteins are associated with telomeres and are important for maintaining the integrity of telomeres. These proteins protect telomeres from recombination events, nuclease attacks, support the formation of heterochromatin at telomeres and anchor telomeres to the nuclear periphery. To identify components in molecular networks involved in the multiple functions of Yku70/80 complex, we performed a genetic screen for suppressors of yku70 deletion. One of the suppressors identified was RTT103, which encodes a protein implicated in transcription termination. We show that rtt103 Delta are sensitive to multiple forms of genome insults and that RTT103 is essential for recovery from DNA double strand breaks in the chromosome. We further show that Rtt103 associates with sites of DNA breaks and hence is likely to play a direct role in response to DNA damage.	[Srividya, Indukuri; Tirupataiah, Sirupangi; Mishra, Krishnaveni] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Srividya, I (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	kmsl@uohyd.ernet.in			University Grants Commission (UGC), India [F.31-287/2005(SR)]; Department of Science and Technology (DST-FIST); UGC-SAP (UGC); UGC	University Grants Commission (UGC), India(University Grants Commission, India); Department of Science and Technology (DST-FIST)(Department of Science & Technology (India)); UGC-SAP (UGC); UGC(University Grants Commission, India)	Funds for this study were obtained from the University Grants Commission (UGC), India via grant number F.31-287/2005(SR) and Department of Science and Technology (DST-FIST); and UGC-SAP (UGC special assistance program) to the Department of Biochemistry. IS and ST acknowledge fellowship support from UGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Birrell GW, 2001, P NATL ACAD SCI USA, V98, P12608, DOI 10.1073/pnas.231366398; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Enyenihi AH, 2003, GENETICS, V163, P47; Feldmann H, 1996, J BIOL CHEM, V271, P27765, DOI 10.1074/jbc.271.44.27765; Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Fry RC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-313; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Hanway D, 2002, P NATL ACAD SCI USA, V99, P10605, DOI 10.1073/pnas.152264899; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; JSaP Russell, MOL CLONING LAB MANU; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Mages GJ, 1996, J BIOL CHEM, V271, P7910, DOI 10.1074/jbc.271.14.7910; Marcand S, 2008, GENE DEV, V22, P1153, DOI 10.1101/gad.455108; Milne GT, 1996, MOL CELL BIOL, V16, P4189; Mirkin N, 2008, NUCLEIC ACIDS RES, V36, P1792, DOI 10.1093/nar/gkn005; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; SANTOSROSA H, 1995, GENETICS, V139, P57; Scholes DT, 2001, GENETICS, V159, P1449; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Vodenicharov MD, 2010, EMBO J, V29, P3007, DOI 10.1038/emboj.2010.155; Waples WG, 2009, MOL BIOL CELL, V20, P245, DOI 10.1091/mbc.E08-08-0879; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011	41	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31288	10.1371/journal.pone.0031288	http://dx.doi.org/10.1371/journal.pone.0031288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355353	gold, Green Published, Green Submitted			2022-12-25	WOS:000302741300053
J	Takara, K; Yamamoto, K; Matsubara, M; Minegaki, T; Takahashi, M; Yokoyama, T; Okumura, K				Takara, Kohji; Yamamoto, Kazuhiro; Matsubara, Mika; Minegaki, Tetsuya; Takahashi, Minoru; Yokoyama, Teruyoshi; Okumura, Katsuhiko			Effects of alpha-Adrenoceptor Antagonists on ABCG2/BCRP-Mediated Resistance and Transport	PLOS ONE			English	Article							SELECTIVE ALPHA(1)-ADRENOCEPTOR ANTAGONIST; CANCER CELL APOPTOSIS; HUMAN PROSTATE-CANCER; MULTIDRUG-RESISTANCE; ALPHA-1-ADRENOCEPTOR ANTAGONIST; ANTICANCER DRUGS; P-GLYCOPROTEIN; GROWTH; NAFTOPIDIL; INDUCTION	Acquired resistance of cancer cells to various chemotherapeutic agents is known as multidrug resistance, and remains a critical factor in the success of cancer treatment. It is necessary to develop the inhibitors for multidrug resistance. The aim of this study was to examine the effects of eight alpha-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport. Previously established HeLa/SN100 cells, which overexpress ABCG2/BCRP but not ABCB1/MDR1, were used. The effects of the antagonists on sensitivity to mitoxantrone and the transport activity of Hoehst33342, both substrates for ABCG2/BCRP, were evaluated using the WST-1 assay and cellular kinetics, respectively. ABCG2/BCRP mRNA expression and the cell cycle were also examined by real-time RT-PCR and flow cytometry, respectively. Sensitivity to mitoxantrone was reversed by the alpha-adrenoceptor antagonists in a concentration-dependent manner, although such effects were also found in the parental HeLa cells. Levels of ABCG2/BCRP mRNA expression were not influenced by the antagonists. The transport activity of Hoechst33342 was decreased by doxazosin and prazosin, but unaffected by the other antagonists. In addition, doxazosin and prazosin increased the proportion of S phase cells in the cultures treated with mitoxantrone, whereas the other alpha-adrenoceptor antagonists increased the percentage of cells in G2/M phase. These findings suggested that doxazosin and prazosin reversed resistance mainly by inhibiting ABCG2/BCRP-mediated transport, but the others affected sensitivity to mitoxantrone via a different mechanism.	[Takara, Kohji; Takahashi, Minoru; Yokoyama, Teruyoshi; Okumura, Katsuhiko] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Dept Clin Pharmaceut, Himeji, Hyogo, Japan; [Yamamoto, Kazuhiro; Matsubara, Mika; Minegaki, Tetsuya] Kyoto Pharmaceut Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Kyoto 607, Japan	Himeji Dokkyo University; Kyoto Pharmaceutical University	Takara, K (corresponding author), Himeji Dokkyo Univ, Fac Pharmaceut Sci, Dept Clin Pharmaceut, Himeji, Hyogo, Japan.	takara@gm.himeji-du.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Benning CM, 2002, CANCER RES, V62, P597; CRUISE JL, 1985, SCIENCE, V227, P749, DOI 10.1126/science.2982212; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Harris AM, 2007, J UROLOGY, V178, P2176, DOI 10.1016/j.juro.2007.06.043; Hori Y, 2011, CANCER PREV RES, V4, P87, DOI 10.1158/1940-6207.CAPR-10-0189; Hu ZW, 1996, J BIOL CHEM, V271, P8977, DOI 10.1074/jbc.271.15.8977; Kanda H, 2008, INT J CANCER, V122, P444, DOI 10.1002/ijc.23095; Kim RB, 1999, PHARMACEUT RES, V16, P408; Koceva-Chyla A, 2005, APOPTOSIS, V10, P1497, DOI 10.1007/s10495-005-1540-9; Kojima Y, 2009, PROSTATE, V69, P1521, DOI 10.1002/pros.21003; Liao CH, 2011, PROSTATE, V71, P976, DOI 10.1002/pros.21313; Litman T, 2000, J CELL SCI, V113, P2011; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mulac D, 2011, TOXICOLOGY, V282, P112, DOI 10.1016/j.tox.2011.01.019; Noguchi K, 2009, ADV DRUG DELIVER REV, V61, P26, DOI 10.1016/j.addr.2008.07.003; Pan SL, 2003, J UROLOGY, V169, P724, DOI 10.1016/S0022-5347(05)64002-5; Partin JV, 2003, BRIT J CANCER, V88, P1615, DOI 10.1038/sj.bjc.6600961; Pool James L., 2001, International Urology and Nephrology, V33, P407, DOI 10.1023/A:1019504703485; Siddiqui EJ, 2005, ANTICANCER RES, V25, P4281; SIMON SM, 1994, P NATL ACAD SCI USA, V91, P3497, DOI 10.1073/pnas.91.9.3497; Tahmatzopoulos A, 2004, EXPERT OPIN PHARMACO, V5, P1279, DOI 10.1517/14656566.5.6.1279; Takara K, 2002, BIOL PHARM BULL, V25, P771, DOI 10.1248/bpb.25.771; Takara K, 2009, ONCOL RES, V17, P527, DOI 10.3727/096504009789745601; Takara K, 2009, CANCER LETT, V278, P88, DOI 10.1016/j.canlet.2008.12.033; Xiao YL, 2006, MOL PHARMACEUT, V3, P45, DOI 10.1021/mp050088t; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zhou L, 2009, DRUG METAB DISPOS, V37, P946, DOI 10.1124/dmd.108.024489	28	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30697	10.1371/journal.pone.0030697	http://dx.doi.org/10.1371/journal.pone.0030697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355323	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300023
J	Hayashi, H; Nakagami, H; Takeichi, M; Shimamura, M; Koibuchi, N; Oiki, E; Sato, N; Koriyama, H; Mori, M; Araujo, RG; Maeda, A; Morishita, R; Tamai, K; Kaneda, Y				Hayashi, Hiroki; Nakagami, Hironori; Takeichi, Makiko; Shimamura, Munehisa; Koibuchi, Nobutaka; Oiki, Eiji; Sato, Naoyuki; Koriyama, Hiroshi; Mori, Masaki; Araujo, Rodriguez Gerardo; Maeda, Akito; Morishita, Ryuichi; Tamai, Katsuto; Kaneda, Yasufumi			HIG1, a novel regulator of mitochondrial gamma-secretase, maintains normal mitochondrial function	FASEB JOURNAL			English	Article						Alzheimer's disease; hypoxia; neuron; oxidative stress; intracellular A beta	AMYLOID PRECURSOR PROTEIN; INSULIN-DEGRADING ENZYME; ALZHEIMERS-DISEASE; A-BETA; PEPTIDE PRODUCTION; OXIDATIVE STRESS; PRESENILIN; COMPLEX; NOTCH; INHIBITORS	The gamma-secretase complex (which contains presenilins, nicastrin, anterior pharynx defective-1, and presenilin enhancer-2) cleaves type I transmembrane proteins, including Notch and amyloid precursor protein. Dysregulated gamma-secretase activity has been implicated in the pathogenesis of Alzheimer's disease, stroke, atherosclerosis, and cancer. Tight regulation of gamma-secretase activity is required for normal physiology. Here, we isolated HIG1 (hypoxia inducible gene 1, domain member 1A) from a functional screen of gamma-secretase inhibitory genes. HIG1 was highly expressed in the brain. Interestingly, HIG1 was localized to the mitochondria and was directly bound to gamma-secretase components on the mitochondrial membrane in SK-N-SH neuroblastoma cells. Overexpresssion of HIG1 attenuated hypoxia-induced gamma-secretase activation on the mitochondrial membrane and the accumulation of intracellular amyloid beta. This accumulation was accompanied by hypoxia-induced mitochondrial dysfunction. The latter half domain of HIG1 was required for binding to the gamma-secretase complex and suppression of gamma-secretase activity. Moreover, depletion of HIG1 increased gamma-secretase activation and enhanced hypoxia-induced mitochondrial dysfunction. In summary, HIG1 is a novel modulator of the mitochondrial gamma-secretase complex, and may play a role in the maintenance of normal mitochondrial function.-Hayashi, H., Nakagami, H., Takeichi, M., Shimamura, M., Koibuchi, N., Oiki, E., Sato, N., Koriyama, H., Mori, M., Gerardo Araujo, R., Maeda, A., Morishita, R., Tamai, K., Kaneda, Y. HIG1, a novel regulator of mitochondrial gamma-secretase, maintains normal mitochondrial function. FASEB J. 26, 2306-2317 (2012). www.fasebj.org	[Hayashi, Hiroki; Nakagami, Hironori; Takeichi, Makiko; Mori, Masaki; Araujo, Rodriguez Gerardo; Tamai, Katsuto; Kaneda, Yasufumi] Osaka Univ, United Grad Sch Child Dev, Div Gene Therapy Sci, Suita, Osaka 5650871, Japan; [Nakagami, Hironori; Shimamura, Munehisa; Morishita, Ryuichi] Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Suita, Osaka 5650871, Japan; [Shimamura, Munehisa; Sato, Naoyuki; Koriyama, Hiroshi] Osaka Univ, Grad Sch Med, Div Clin Gene Therapy Sci, Suita, Osaka 5650871, Japan; [Oiki, Eiji] Osaka Univ, Grad Sch Med, Ctr Med Res & Educ, Suita, Osaka 5650871, Japan; [Maeda, Akito] Osaka Univ, PIAS Collaborat Res, Ctr Adv Sci & Innovat, Suita, Osaka 5650871, Japan; [Koibuchi, Nobutaka] Univ Tokyo, Grad Sch Med, Dept Adv Clin Sci & Therapeut, Tokyo, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; University of Tokyo	Nakagami, H (corresponding author), Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	nakagami@gts.med.osaka-u.ac.jp; kaneday@gts.med.osaka-u.ac.jp	Maeda, Akito/AAX-6252-2020; Nakagami, Hironori/GLU-0570-2022	Nakagami, Hironori/0000-0003-4494-3601	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Prof. Noriaki Mitsuda (Ehime University, Ehime, Japan) for providing the human neuroblastoma cell line, SK-N-SH. pCS2 + Notch1 ICV 6mt (6 myc-tagged Notch1 intracellular domain) and pCS2 + Notch1 Delta ETM 6mt (6 myc-tagged Notch1 extracellular transmembrane domain) were kind gifts from Dr. Raphael Kopan (Washington University, St. Louis, MO, USA). This work was supported, in part, by the Japan Society for the Promotion of Science.	Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Aoyama T, 2009, BIOCHEM BIOPH RES CO, V383, P216, DOI 10.1016/j.bbrc.2009.03.154; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen X, 2006, IUBMB LIFE, V58, P686, DOI 10.1080/15216540601047767; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Falkevall A, 2006, J BIOL CHEM, V281, P29096, DOI 10.1074/jbc.M602532200; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Hayashi H, 2007, BIOCHEM BIOPH RES CO, V363, P584, DOI 10.1016/j.bbrc.2007.09.003; Hayashi H, 2009, ARTERIOSCL THROM VAS, V29, P909, DOI 10.1161/ATVBAHA.108.178541; Hwang DY, 2005, NEUROCHEM RES, V30, P1171, DOI 10.1007/s11064-005-7952-7; Jendroska K, 1997, Ann N Y Acad Sci, V826, P401, DOI 10.1111/j.1749-6632.1997.tb48492.x; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.0000261693.13269.bf; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Meunier C, 2002, J BIOL CHEM, V277, P9139, DOI 10.1074/jbc.M105970200; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Mracek T, 2009, ARCH BIOCHEM BIOPHYS, V481, P30, DOI 10.1016/j.abb.2008.10.011; Nilsson R, 2006, CELL SIGNAL, V18, P1713, DOI 10.1016/j.cellsig.2006.01.010; Nishikawa T, 2006, HUM GENE THER, V17, P470, DOI 10.1089/hum.2006.17.470; SENDA T, 1991, HISTOCHEMISTRY, V96, P25, DOI 10.1007/BF00266757; Shaw RW, 2006, FASEB J, V20, pA898, DOI 10.1096/fj.05-4055fje; Sheng BY, 2009, FREE RADICAL BIO MED, V46, P1362, DOI 10.1016/j.freeradbiomed.2009.02.018; Shi J, 2000, BRAIN RES, V853, P1, DOI 10.1016/S0006-8993(99)02113-7; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Shimamura M, 2007, STROKE, V38, P3251, DOI 10.1161/STROKEAHA.107.485045; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Solenski NJ, 2002, STROKE, V33, P816, DOI 10.1161/hs0302.104541; Tanahashi H, 2008, NEUROSCI LETT, V439, P293, DOI 10.1016/j.neulet.2008.05.039; Wang J, 2006, P NATL ACAD SCI USA, V103, P10636, DOI 10.1073/pnas.0604194103; Wang RS, 2006, FASEB J, V20, P1275, DOI 10.1096/fj.06-5839fje; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Zhang J, 2006, NEUROSCIENCE, V143, P63, DOI 10.1016/j.neuroscience.2006.07.023; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	44	33	33	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2306	2317		10.1096/fj.11-196063	http://dx.doi.org/10.1096/fj.11-196063			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22355194				2022-12-25	WOS:000305017200009
J	Sharp, JD; Cruz, JW; Raman, S; Inouye, M; Husson, RN; Woychik, NA				Sharp, Jared D.; Cruz, Jonathan W.; Raman, Sahadevan; Inouye, Masayori; Husson, Robert N.; Woychik, Nancy A.			Growth and Translation Inhibition through Sequence-specific RNA Binding by Mycobacterium tuberculosis VapC Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; PIN-DOMAIN; CRYSTAL-STRUCTURE; PERSISTER CELLS; MESSENGER-RNAS; ANTITOXIN LOCI; PROTEIN; CLEAVAGE; INTERFERASES	The Mycobacterium tuberculosis genome harbors an unusually large number of toxin-antitoxin (TA) modules. Curiously, over half of these are VapBC (virulence-associated protein) family members. Nonetheless, the cellular target, precise mode of action, and physiological role of the VapC toxins in this important pathogen remain unclear. To better understand the function of this toxin family, we studied the features and biochemical properties of a prototype M. tuberculosis VapBC TA system, vapBC-mt4 (Rv0596c-Rv0595c). VapC-mt4 expression resulted in growth arrest, a hallmark of all TA toxins, in Escherichia coli, Mycobacterium smegmatis, and M. tuberculosis. Its expression led to translation inhibition accompanied by a gradual decrease in the steady-state levels of several mRNAs. VapC-mt4 exhibited sequence-specific endoribonuclease activity on mRNA templates at ACGC and AC(A/U)GC sequences. However, the cleavage activity of VapC-mt4 was comparatively weak relative to the TA toxin MazF-mt1 (Rv2801c). Unlike other TA toxins, translation inhibition and growth arrest preceded mRNA cleavage, suggesting that the RNA binding property of VapC-mt4, not RNA cleavage, initiates toxicity. In support of this hypothesis, expression of VapC-mt4 led to an increase in the recovery of total RNA with time in contrast to TA toxins that inhibit translation via direct mRNA cleavage. Additionally, VapC-mt4 exhibited stable, sequence-specific RNA binding in an electrophoretic mobility shift assay. Finally, VapC-mt4 inhibited protein synthesis in a cell-free system without cleaving the corresponding mRNA. Therefore, the activity of VapC-mt4 is mechanistically distinct from other TA toxins because it appears to primarily inhibit translation through selective, stable binding to RNA.	[Sharp, Jared D.; Raman, Sahadevan; Husson, Robert N.] Harvard Univ, Div Infect Dis, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA; [Sharp, Jared D.; Cruz, Jonathan W.; Woychik, Nancy A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Inouye, Masayori] Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Dept Biochem, Piscataway, NJ 08854 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Husson, RN (corresponding author), Harvard Univ, Div Infect Dis, Childrens Hosp Boston, Sch Med, 300 Longwood Ave, Boston, MA 02115 USA.	Robert.Husson@childrens.harvard.edu; nancy.woychik@umdnj.edu	Husson, Robert/Y-7288-2019	Raman, Sahadevan/0000-0001-5309-8169	National Institutes of Health from NIAID [AI072399]; T32 Training Grant [AI07403]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072399, T32AI007403, R01AI037901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095693] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); T32 Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI072399 from the NIAID R21 (to R. N. H. and N. A. W.) and T32 Training Grant AI07403, Virus-Host Interactions in Eukaryotic Cells, from the NIAID (to J. D. S. and J. W. C. (awarded to G. Brewer)).	Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Bunker RD, 2008, PROTEINS, V72, P510, DOI 10.1002/prot.22048; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; INOUYE S, 1985, NUCLEIC ACIDS RES, V13, P3101, DOI 10.1093/nar/13.9.3101; Jeyakanthan J, 2005, ACTA CRYSTALLOGR F, V61, P463, DOI 10.1107/S1744309105012406; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Levin I, 2004, PROTEINS, V56, P404, DOI 10.1002/prot.20090; Lewis K, 2005, BIOCHEMISTRY-MOSCOW+, V70, P267, DOI 10.1007/s10541-005-0111-6; MASUI Y, 1984, BIO-TECHNOL, V2, P81, DOI 10.1038/nbt0184-81; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Mwinga A, 2004, TROP MED INT HEALTH, V9, P827, DOI 10.1111/j.1365-3156.2004.01274.x; NAKANO ET, 1987, J VIROL, V61, P302, DOI 10.1128/JVI.61.2.302-307.1987; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; POWERS T, 1990, P NATL ACAD SCI USA, V87, P1042, DOI 10.1073/pnas.87.3.1042; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; RON EZ, 1966, SCIENCE, V153, P1119, DOI 10.1126/science.153.3740.1119; Russo E, 2005, SCIENTIST, V19, P22; Singh R, 2010, J BACTERIOL, V192, P1279, DOI 10.1128/JB.01285-09; Singletary LA, 2009, J BACTERIOL, V191, P7456, DOI 10.1128/JB.00963-09; Sisido M, 2005, METHODS, V36, P270, DOI 10.1016/j.ymeth.2005.04.009; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; Tai P C, 1979, Methods Enzymol, V59, P362; Takeshita D, 2006, ACTA CRYSTALLOGR F, V62, P656, DOI 10.1107/S1744309106020057; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Winther KS, 2009, MOL MICROBIOL, V72, P918, DOI 10.1111/j.1365-2958.2009.06694.x; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhu L, 2008, MOL MICROBIOL, V69, P559, DOI 10.1111/j.1365-2958.2008.06284.x; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200	52	43	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12835	12847		10.1074/jbc.M112.340109	http://dx.doi.org/10.1074/jbc.M112.340109			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22354968	hybrid, Green Published			2022-12-25	WOS:000302903700023
J	Noguchi, S; Mori, T; Otsuka, Y; Yamada, N; Yasui, Y; Iwasaki, J; Kumazaki, M; Maruo, K; Akao, Y				Noguchi, Shunsuke; Mori, Takashi; Otsuka, Yusami; Yamada, Nami; Yasui, Yuki; Iwasaki, Junya; Kumazaki, Minami; Maruo, Kohji; Akao, Yukihiro			Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 Protein in Human Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ZBP-89; MALIGNANT-MELANOMA; EMERGING ROLES; EXPRESSION; CANCER; APOPTOSIS; PROLIFERATION; PATHWAY; GROWTH; MECHANISM	MicroRNAs regulate gene expression by repressing translation or directing sequence-specific degradation of their complementary mRNA. We recently reported that miR-203 is down-regulated, and its exogenous expression inhibits cell growth in canine oral malignant melanoma tissue specimens as well as in canine and human malignant melanoma cells. A microRNA target database predicted E2F3 and ZBP-89 as putative targets of microRNA-203 (miR-203). The expression levels of E2F3a, E2F3b, and ZBP-89 were markedly up-regulated in human malignant melanoma Mewo cells compared with those in human epidermal melanocytes. miR-203 significantly suppressed the luciferase activity of reporter plasmids containing the 3'-UTR sequence of either E2F3 or ZBP-89 complementary to miR-203. The ectopic expression of miR-203 in melanoma cells reduced the levels of E2F3a, E2F3b, and ZBP-89 protein expression. At the same time, miR-203 induced cell cycle arrest and senescence phenotypes, such as elevated expression of hypophosphorylated retinoblastoma and other markers for senescence. Silencing of E2F3, but not of ZBP-89, inhibited cell growth and induced cell cycle arrest and senescence. These results demonstrate a novel role for miR-203 as a tumor suppressor acting by inducing senescence in melanoma cells.	[Noguchi, Shunsuke; Yamada, Nami; Yasui, Yuki; Iwasaki, Junya; Kumazaki, Minami; Akao, Yukihiro] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011193, Japan; [Noguchi, Shunsuke; Yamada, Nami] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan; [Mori, Takashi; Otsuka, Yusami; Maruo, Kohji] Gifu Univ, Fac Appl Biol Sci, Dept Vet Clin Oncol, Gifu 5011193, Japan; [Otsuka, Yusami; Maruo, Kohji; Akao, Yukihiro] Gifu Univ, Comparat Canc Ctr, Gifu 5011193, Japan; [Yasui, Yuki; Iwasaki, Junya; Kumazaki, Minami] Gifu Univ, Fac Engn, Dept Biomol Sci, Gifu 5011193, Japan	Gifu University; Gifu University; Gifu University; Gifu University; Gifu University	Akao, Y (corresponding author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, 1-1 Yanagido, Gifu 5011193, Japan.	yakao@gifu-u.ac.jp		Yamada, Nami/0000-0002-1220-0814				Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cannell IG, 2008, BIOCHEM SOC T, V36, P1224, DOI 10.1042/BST0361224; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Eggermont A. M., 2011, EUR J CANCER, V104, P397; Feng YP, 2009, FEBS J, V276, P4197, DOI 10.1111/j.1742-4658.2009.07128.x; Gorospe M, 2011, TRENDS GENET, V27, P233, DOI 10.1016/j.tig.2011.03.005; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Ho CK, 2005, BRIT J DERMATOL, V153, P900, DOI 10.1111/j.1365-2133.2005.06810.x; Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kaddar T, 2009, BIOL CELL, V101, P511, DOI 10.1042/BC20080213; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Liu FJ, 2012, AGEING RES REV, V11, P41, DOI 10.1016/j.arr.2011.06.001; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Macleod K, 1999, CURR OPIN GENET DEV, V9, P31, DOI 10.1016/S0959-437X(99)80005-7; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Noguchi S., 2012, VET COMP ON IN PRESS; Noguchi S, 2012, J VET MED SCI, V74, P1, DOI 10.1292/jvms.11-0264; Noguchi S, 2011, CANCER LETT, V307, P211, DOI 10.1016/j.canlet.2011.04.005; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pacheco I, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S146239941100202X; Russo AE, 2009, INT J ONCOL, V34, P1481, DOI 10.3892/ijo_00000277; Smedley D, 2000, GENE CHROMOSOME CANC, V28, P121, DOI 10.1002/(SICI)1098-2264(200005)28:1<121::AID-GCC14>3.0.CO;2-O; Sun BS, 2008, HEPATOLOGY, V48, P1834, DOI 10.1002/hep.22531; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Udelhoven M, 2010, J ENDOCRINOL, V204, P199, DOI 10.1677/JOE-09-0266; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Zhang CZY, 2010, BBA-REV CANCER, V1806, P36, DOI 10.1016/j.bbcan.2010.03.002; Zhang J, 2009, BLOOD, V113, P4586, DOI 10.1182/blood-2008-09-178186	37	92	97	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11769	11777		10.1074/jbc.M111.325027	http://dx.doi.org/10.1074/jbc.M111.325027			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354972	Green Published, hybrid			2022-12-25	WOS:000302782200016
J	Wu, D; Chapman, JR; Wang, LF; Harris, TE; Shabanowitz, J; Hunt, DF; Fu, Z				Wu, Di; Chapman, Jessica R.; Wang, Lifu; Harris, Thurl E.; Shabanowitz, Jeffrey; Hunt, Donald F.; Fu, Zheng			Intestinal Cell Kinase (ICK) Promotes Activation of mTOR Complex 1 (mTORC1) through Phosphorylation of Raptor Thr-908	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; MAP KINASE; CYCLE PROGRESSION; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; RAPAMYCIN MTOR; GENE-PRODUCTS; RAG GTPASES; GROWTH; INSULIN	Intestinal cell kinase (ICK), named after its cloning origin, the intestine, is actually a ubiquitously expressed and highly conserved serine/threonine protein kinase. Recently we reported that ICK supports cell proliferation and G(1) cell cycle progression. ICK deficiency significantly disrupted the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) signaling events. However, the biological substrates that mediate the downstream signaling effects of ICK in proliferation and the molecular mechanisms by which ICK interacts with mTORC1 are not well defined. Our prior studies also provided biochemical evidence that ICK interacts with the mTOR/Raptor complex in cells and phosphorylates Raptor in vitro. In this report, we investigated whether and how ICK targets Raptor to regulate the activity of mTORC1. Using the ICK substrate consensus sequence [R-P-X-S/T-P/A/T/S], we identified a putative phosphorylation site, RPGT908T, for ICK in human Raptor. By mass spectrometry and a phospho-specific antibody, we showed that Raptor Thr-908 is a novel in vivo phosphorylation site. ICK is able to phosphorylate Raptor Thr-908 both in vitro and in vivo and when Raptor exists in protein complexes with or without mTOR. Although expression of the Raptor T908A mutant did not affect the mTORC1 integrity, it markedly impaired the mTORC1 activation by insulin or by overexpression of the small GTP-binding protein RheB under nutrient starvation. Our findings demonstrate an important role for ICK in modulating the activity of mTORC1 through phosphorylation of Raptor Thr-908 and thus implicate a potential signaling mechanism by which ICK regulates cell proliferation and division.	[Wu, Di; Fu, Zheng] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Chapman, Jessica R.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22908 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; [Wang, Lifu; Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Fu, Zheng] Univ Virginia, Digest Hlth Res Ctr, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Fu, Z (corresponding author), Univ Virginia, Dept Med, POB 800708,2 Jefferson Pk Ave,Lee St,MSB 2091, Charlottesville, VA 22908 USA.	zf6n@virginia.edu	wang, lifu/E-1436-2012; Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368; /0000-0002-4080-8667	National Institutes of Health [DK082614, GM37537]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK082614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK082614 (to Z. F.) and GM37537 (to D. F. H.).	Abe S, 1995, ONCOGENE, V11, P2187; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Ekim B, 2011, MOL CELL BIOL, V31, P2787, DOI 10.1128/MCB.05437-11; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Fu Z, 2005, MOL CELL BIOL, V25, P6047, DOI 10.1128/MCB.25.14.6047-6064.2005; Fu Z, 2006, MOL CELL BIOL, V26, P8639, DOI 10.1128/MCB.00816-06; Fu Z, 2009, AM J PHYSIOL-GASTR L, V297, pG632, DOI 10.1152/ajpgi.00066.2009; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hanrahan J, 2006, METHOD ENZYMOL, V407, P542, DOI 10.1016/S0076-6879(05)07044-8; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2003, CURR TOP MICROBIOL, V279, P259; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Lahiry P, 2009, AM J HUM GENET, V84, P134, DOI 10.1016/j.ajhg.2008.12.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Liu Y, 2004, J BIOL CHEM, V279, P4507, DOI 10.1074/jbc.M309995200; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma AH, 2006, CANCER RES, V66, P8439, DOI 10.1158/0008-5472.CAN-06-1636; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MATSUSHIME H, 1990, MOL CELL BIOL, V10, P2261, DOI 10.1128/MCB.10.5.2261; Miyata Y, 1999, GENES CELLS, V4, P299, DOI 10.1046/j.1365-2443.1999.00261.x; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Nascimento Emmani B. M., 2009, Archives of Physiology and Biochemistry, V115, P163, DOI 10.1080/13813450902988580; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Shinkai Y, 2002, MOL CELL BIOL, V22, P3276, DOI 10.1128/MCB.22.10.3276-3280.2002; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Wohlbold L, 2006, CELL CYCLE, V5, P546, DOI 10.4161/cc.5.5.2541; Xia L, 2002, J BIOL CHEM, V277, P35422, DOI 10.1074/jbc.M203940200	50	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12510	12519		10.1074/jbc.M111.302117	http://dx.doi.org/10.1074/jbc.M111.302117			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22356909	hybrid, Green Published			2022-12-25	WOS:000302782200090
J	Trip, H; Mulder, NL; Lolkema, JS				Trip, Hein; Mulder, Niels L.; Lolkema, Juke S.			Improved Acid Stress Survival of Lactococcus lactis Expressing the Histidine Decarboxylation Pathway of Streptococcus thermophilus CHCC1524	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-MOTIVE FORCE; TRANSCRIPTIONAL ANALYSIS; LACTOBACILLUS-BUCHNERI; ESCHERICHIA-COLI; BIOGENIC-AMINES; RESISTANCE; MECHANISM; ARGININE; OPERON; GENERATION	Background: Degradative amino acid decarboxylation pathways in bacteria have diverse physiological functions. Results: A histidine decarboxylation pathway introduced in L. lactis improves acid stress survival, and synergy with the glycolytic pathway is demonstrated. Conclusion: The physiological benefit of the new pathway is strongly dependent on the properties of the host organism. Significance: Acquisition of the histidine decarboxylation pathway mimics successful horizontal gene transfer.	[Trip, Hein; Mulder, Niels L.; Lolkema, Juke S.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands	University of Groningen	Lolkema, JS (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands.	j.s.lolkema@rug.nl			European Community [211441-BIAMFOOD]; Netherlands Organization for Scientific Research (NWO-ALW)	European Community(European Commission); Netherlands Organization for Scientific Research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	This work was supported by European Community Seventh Framework Programme Grant Agreement No. 211441-BIAMFOOD and by The Netherlands Organization for Scientific Research (NWO-ALW).	Abe K, 2002, J BACTERIOL, V184, P2906, DOI 10.1128/JB.184.11.2906-2913.2002; Abe K, 1996, J BIOL CHEM, V271, P3079, DOI 10.1074/jbc.271.6.3079; Calles-Enriquez M, 2010, APPL ENVIRON MICROB, V76, P6231, DOI 10.1128/AEM.00827-10; Coton E, 2010, APPL ENVIRON MICROB, V76, P5570, DOI 10.1128/AEM.00441-10; Coton M, 2011, MICROBIOL-SGM, V157, P1841, DOI 10.1099/mic.0.046367-0; Cotter PD, 2001, MOL MICROBIOL, V40, P465, DOI 10.1046/j.1365-2958.2001.02398.x; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Fernandez M, 2006, CRIT REV MICROBIOL, V32, P155, DOI 10.1080/10408410600880643; Giles TN, 2007, J BACTERIOL, V189, P7376, DOI 10.1128/JB.00772-07; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Guimont C, 2002, INT DAIRY J, V12, P729, DOI 10.1016/S0958-6946(02)00068-7; GUIRARD BM, 1980, J BIOL CHEM, V255, P5960; Kieboom J, 2006, J BACTERIOL, V188, P5650, DOI 10.1128/JB.00323-06; Lucas PM, 2007, MICROBIOL-SGM, V153, P2221, DOI 10.1099/mic.0.2007/006320-0; Lucas PM, 2005, APPL ENVIRON MICROB, V71, P1417, DOI 10.1128/AEM.71.3.1417-1424.2005; Martin MC, 2005, MICROBIOL-SGM, V151, P1219, DOI 10.1099/mic.0.27459-0; MATSUMOTO T, 1984, ANAL BIOCHEM, V138, P133, DOI 10.1016/0003-2697(84)90780-2; MOLENAAR D, 1991, BIOCHIM BIOPHYS ACTA, V1115, P75, DOI 10.1016/0304-4165(91)90014-8; MOLENAAR D, 1993, J BACTERIOL, V175, P2864, DOI 10.1128/JB.175.10.2864-2870.1993; Pereira CI, 2009, J APPL MICROBIOL, V107, P1894, DOI 10.1111/j.1365-2672.2009.04371.x; Pereira CI, 2009, APPL ENVIRON MICROB, V75, P345, DOI 10.1128/AEM.01958-08; POOLMAN B, 1987, MICROBIOL REV, V51, P498, DOI 10.1128/MMBR.51.4.498-508.1987; Rossi F, 2011, APPL ENVIRON MICROB, V77, P2817, DOI 10.1128/AEM.02531-10; Sanders JW, 1998, MOL MICROBIOL, V27, P299, DOI 10.1046/j.1365-2958.1998.00676.x; Santos MHS, 1996, INT J FOOD MICROBIOL, V29, P213, DOI 10.1016/0168-1605(95)00032-1; SIP M, 1990, J PHOTOCH PHOTOBIO B, V4, P321, DOI 10.1016/1011-1344(90)85037-W; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Spano G, 2010, EUR J CLIN NUTR, V64, pS95, DOI 10.1038/ejcn.2010.218; Tanaka Y, 2008, J APPL MICROBIOL, V104, P1283, DOI 10.1111/j.1365-2672.2007.03652.x; Trip H, 2011, MOL MICROBIOL, V79, P861, DOI 10.1111/j.1365-2958.2010.07492.x; VANPOELJE PD, 1990, ANNU REV BIOCHEM, V59, P29, DOI 10.1146/annurev.bi.59.070190.000333; Wolken WAM, 2006, J BACTERIOL, V188, P2198, DOI 10.1128/JB.188.6.2198-2206.2006; Zhao BY, 2010, BIOCHEM CELL BIOL, V88, P301, DOI [10.1139/O09-182, 10.1139/o09-182]	33	35	39	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11195	11204		10.1074/jbc.M111.330704	http://dx.doi.org/10.1074/jbc.M111.330704			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22351775	Green Published, hybrid			2022-12-25	WOS:000302780100047
J	Santiago-Alarcon, D; Havelka, P; Schaefer, HM; Segelbacher, G				Santiago-Alarcon, Diego; Havelka, Peter; Schaefer, Hinrich Martin; Segelbacher, Gernot			Bloodmeal Analysis Reveals Avian Plasmodium Infections and Broad Host Preferences of Culicoides (Diptera: Ceratopogonidae) Vectors	PLOS ONE			English	Article							AFRICAN RAIN-FOREST; BITING MIDGES; PARASITES; MALARIA; ASSOCIATIONS; MOSQUITOS; PATTERNS	Changing environmental conditions and human encroachment on natural habitats bring human populations closer to novel sources of parasites, which might then develop into new emerging diseases. Diseases transmitted by host generalist vectors are of special interest due to their capacity to move pathogens into novel hosts. We hypothesize that humans using forests for recreation are exposed to a broad range of parasites from wild animals and their vectors. A corollary of this is that new vector-host, parasite-host, and vector-parasite associations could eventually develop. Thus, we expect to observe atypical vector-host associations. Using molecular bloodmeal analysis via amplification of the mtDNA COI gene we identified the vertebrate hosts of Culicoides (Diptera: Ceratopogonidae) species in a sub-urban forest of Southwestern Germany. Bloodmeals were also checked for haemosporidian infections by amplifying a fragment of the mtDNA cyt b gene. We identified a total of 20 Culicoides species, thirteen of which fed on humans. From 105 screened bloodmeals we obtained high quality sequences for 77 samples, 73 (94.8%) originated from humans, two from livestock (Bos taurus and Equus caballus), and two from wild birds (Sylvia atricapilla and Turdus merula). We found that four Culicoides species previously assumed to feed exclusively on either birds (C. kibunensis) or domestic mammals (C. chiopterus, C. deltus, C. scoticus) fed also on humans. A total of six Culicoides abdomens were infected with avian haemosporidian parasites (Plasmodium or Haemoproteus), four of those abdomens contained blood derived from humans. Our results suggest that parasites of wild animals may be transferred to humans through infectious bites of Culicoides vectors. Further, we show that Culicoides vectors believed to be a specialist on specific vertebrate groups can have plastic feeding preferences, and that Culicoides are susceptible to infection by Plasmodium parasites, though vector viability must still be experimentally demonstrated.	[Santiago-Alarcon, Diego] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Havelka, Peter] Staatliches Museum Nat Kunde, Dept Zool, Karlsruhe, Baden Wurttembe, Germany; [Santiago-Alarcon, Diego; Schaefer, Hinrich Martin] Univ Freiburg, Dept Ecol & Evolutionary Biol, D-79106 Freiburg, Baden Wurttembe, Germany; [Segelbacher, Gernot] Univ Freiburg, Dept Wildlife Ecol & Management, D-79106 Freiburg, Baden Wurttembe, Germany	Instituto de Ecologia - Mexico; University of Freiburg; University of Freiburg	Santiago-Alarcon, D (corresponding author), Inst Ecol AC, Xalapa, Veracruz, Mexico.	diego.santiago@inecol.edu.mx	Segelbacher, Gernot/F-3633-2011; Santiago-Alarcon, Diego/G-2485-2018; Santiago-Alarcon, Diego/AAF-3641-2020	Segelbacher, Gernot/0000-0002-8024-7008; Santiago-Alarcon, Diego/0000-0002-4914-5580; Santiago-Alarcon, Diego/0000-0002-4914-5580	Deutsche Forschungsgemeinschaft [1008/6-1]; Wissenschaftliche Gesellschaft Freiburg; Alexander von Humboldt Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wissenschaftliche Gesellschaft Freiburg; Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation)	This research was funded through an Alexander von Humboldt Stiftung (http://www.humboldt-foundation.de/web/start.html) postdoctoral grant to DS-A, Deutsche Forschungsgemeinschaft to HMS (1008/6-1), and by the Wissenschaftliche Gesellschaft Freiburg to HMS and GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; Bartsch S, 2009, PARASITOL RES, V105, P373, DOI 10.1007/s00436-009-1408-y; BENNETT GORDON F., 1960, CANADIAN JOUR ZOOL, V38, P377, DOI 10.1139/z60-042; BRAVERMAN Y, 1977, RHOD J AGR RES, V15, P101; BURYLOVA A M, 1975, Parazitologiya (St. Petersburg), V9, P197; BUTENKO O M, 1967, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V72, P132; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; Coggeshall L. T., 1940, J PARASITOL, V26, pS44; Delecolle J. C., 1985, THESIS U L PASTEUR S, P1; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Ewald PW, 1994, EVOLUTION INFECT DIS; Fritz H. G., 1982, THESIS TH DARMSTADT, P108; Gethmann J, 2010, TIERAERZTL UMSCHAU, V65, P4; HAVELKA P, 1976, Beitraege zur Entomologie, V26, P211; Hofmeister EK, 2011, INTEGR ZOOL, V6, P279, DOI 10.1111/j.1749-4877.2011.00251.x; HUFF CLAY G., 1929, ANN TROP MED & PARASIT [LIVERPOOL], V23, P427; Ishtiaq F, 2008, MOL ECOL, V17, P4545, DOI 10.1111/j.1365-294X.2008.03935.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; KITAOKA S., 1965, Japanese Journal of Sanitary Zoology, V16, P244; Kremer M., 1965, ENCY ENT A, V11, P3; Lefevre T, 2009, AM J TROP MED HYG, V81, P1023, DOI 10.4269/ajtmh.2009.09-0124; Martinez-de la Puente J, 2011, MOL ECOL, V20, P3275, DOI 10.1111/j.1365-294X.2011.05136.x; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; MAYNE BRUCE, 1928, INDIAN JOUR MED RES, V16, P557; MCGHEE RB, 1951, J INFECT DIS, V88, P86, DOI 10.1093/infdis/88.1.86; McLendon SB, 1943, AM J HYG, V37, P19, DOI 10.1093/oxfordjournals.aje.a118839; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Mehlhorn H, 2008, PARASITOL RES, V103, pS79, DOI 10.1007/s00436-008-1100-7; MICKS D. W., 1949, JOUR NATION MALARIA SOC, V8, P206; MINAR JAN, 1965, CESK PARAZITOL, V12, P197; NIELSEN B O, 1971, Entomologica Scandinavica, V2, P94; Nielsen B. O., 1964, ENTOMLOGISKE MEDDELE, VXXXII, P261; Njabo KY, 2011, MOL ECOL, V20, P1049, DOI 10.1111/j.1365-294X.2010.04904.x; Orszagh I., 1976, Acta Facultatis Rerum Naturalium Universitatis Comenianae Series Zoologia, V21, P1; PACLT J, 1970, Biologia (Bratislava), V25, P751; Quan M, 2008, J GEN VIROL, V89, P1159, DOI 10.1099/vir.0.83502-0; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Szadziewski R., 1984, POLSKIE PISMO ENTOMO, V53, P559; Trager William, 1942, JOUR PARASITOL, V28, P457, DOI 10.2307/3272906; Valkiunas G, AVIAN MALARIA PARASI; Valkiunas G, 2009, J PARASITOL, V95, P1512, DOI 10.1645/GE-2105.1; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN	43	75	78	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31098	10.1371/journal.pone.0031098	http://dx.doi.org/10.1371/journal.pone.0031098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363557	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500026
J	Amarnath, S; Kawli, T; Mohanty, S; Srinivasan, N; Nanjundiah, V				Amarnath, Smita; Kawli, Trupti; Mohanty, Smita; Srinivasan, Narayanaswamy; Nanjundiah, Vidyanand			Pleiotropic Roles of a Ribosomal Protein in Dictyostelium discoideum	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; DEVELOPMENTAL REGULATION; POLARITY ESTABLISHMENT; ACTIN CYTOSKELETON; DOSAGE SENSITIVITY; FOLD RECOGNITION; MESSENGER-RNA; GENE; YEAST	The cell cycle phase at starvation influences post-starvation differentiation and morphogenesis in Dictyostelium discoideum. We found that when expressed in Saccharomyces cerevisiae, a D. discoideum cDNA that encodes the ribosomal protein S4 (DdS4) rescues mutations in the cell cycle genes cdc24, cdc42 and bem1. The products of these genes affect morphogenesis in yeast via a coordinated moulding of the cytoskeleton during bud site selection. D. discoideum cells that over-or under-expressed DdS4 did not show detectable changes in protein synthesis but displayed similar developmental aberrations whose intensity was graded with the extent of over-or under-expression. This suggested that DdS4 might influence morphogenesis via a stoichiometric effect - specifically, by taking part in a multimeric complex similar to the one involving Cdc24p, Cdc42p and Bem1p in yeast. In support of the hypothesis, the S. cerevisiae proteins Cdc24p, Cdc42p and Bem1p as well as their D. discoideum cognates could be co-precipitated with antibodies to DdS4. Computational analysis and mutational studies explained these findings: a C-terminal domain of DdS4 is the functional equivalent of an SH3 domain in the yeast scaffold protein Bem1p that is central to constructing the bud site selection complex. Thus in addition to being part of the ribosome, DdS4 has a second function, also as part of a multi-protein complex. We speculate that the existence of the second role can act as a safeguard against perturbations to ribosome function caused by spontaneous variations in DdS4 levels.	[Amarnath, Smita; Kawli, Trupti; Nanjundiah, Vidyanand] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Mohanty, Smita; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Amarnath, S (corresponding author), Univ Texas Austin, Dept Mol Cellular & Dev Biol, Austin, TX 78712 USA.	smita-nms@mail.utexas.edu	Mohanty, Smita/AAP-2969-2021					Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; ANAND S, 1987, BIOCHEM INT, V14, P963; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; ATKINS JF, 1972, P NATL ACAD SCI USA, V69, P1192, DOI 10.1073/pnas.69.5.1192; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bates PA, 2001, PROTEINS, P39; BEACH D, 1982, NATURE, V300, P706, DOI 10.1038/300706a0; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bonner JT, 1967, CELLULAR SLIME MOLDS, p[x, 205]; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Boutet Emmanuel, 2007, V406, P89; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; CORNEY AJ, 1990, MOL MICROBIOL, V4, P613, DOI 10.1111/j.1365-2958.1990.tb00630.x; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichinger L, 1999, MICROSC RES TECHNIQ, V47, P124, DOI 10.1002/(SICI)1097-0029(19991015)47:2<124::AID-JEMT5>3.0.CO;2-8; Erijman A, 2011, BIOCHEMISTRY-US, V50, P602, DOI 10.1021/bi101563v; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Ferraro E, 2007, NUCLEIC ACIDS RES, V35, pW451, DOI 10.1093/nar/gkm296; Fields SD, 1998, J CELL SCI, V111, P1717; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; HIRASHIMA A, 1972, J MOL BIOL, V65, P43, DOI 10.1016/0022-2836(72)90490-1; Hodgkin J, 1998, INT J DEV BIOL, V42, P501; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; HUTTER KJ, 1979, J GEN MICROBIOL, V113, P369, DOI 10.1099/00221287-113-2-369; Ibarra N, 2006, CURR BIOL, V16, P717, DOI 10.1016/j.cub.2006.02.068; Inazu Y, 1999, DEV GENET, V25, P339, DOI 10.1002/(SICI)1520-6408(1999)25:4<339::AID-DVG8>3.0.CO;2-3; Irazoqui JE, 2004, J CELL SCI, V117, P2169, DOI 10.1242/jcs.00953; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kajan L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-304; KLEBE RJ, 1983, GENE, V25, P333, DOI 10.1016/0378-1119(83)90238-X; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973, DOI 10.1128/MCB.6.11.3973; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee E, 2001, EUR J CELL BIOL, V80, P399, DOI 10.1078/0171-9335-00177; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; MCDONALD SA, 1984, J CELL SCI, V66, P195; MICHAELIS C, 1993, BIOCHIM BIOPHYS ACTA, V1179, P117, DOI 10.1016/0167-4889(93)90132-9; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Mondal S, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-23; Moskow JJ, 2000, MOL CELL BIOL, V20, P7559, DOI 10.1128/MCB.20.20.7559-7571.2000; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Para A, 2009, MOL BIOL CELL, V20, P699, DOI 10.1091/mbc.E08-09-0899; Park KC, 2004, EMBO J, V23, P4177, DOI 10.1038/sj.emboj.7600368; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pikzack C, 2005, CELL MOTIL CYTOSKEL, V62, P210, DOI 10.1002/cm.20098; PODKOVYROV S, 1995, FEBS LETT, V368, P429, DOI 10.1016/0014-5793(95)00702-B; Pollitt AY, 2008, CURR BIOL, V18, P203, DOI 10.1016/j.cub.2008.01.026; PROFFITT JA, 1991, NUCLEIC ACIDS RES, V19, P3867, DOI 10.1093/nar/19.14.3867; Raper KB, 1984, DICTYOSTELIDS, p[x, 453]; Rivero F, 2001, NUCLEIC ACIDS RES, V29, P1068, DOI 10.1093/nar/29.5.1068; SARAN S, 1994, DIFFERENTIATION, V57, P163, DOI 10.1046/j.1432-0436.1994.5730163.x; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SLOAT BF, 1981, J CELL BIOL, V89, P395, DOI 10.1083/jcb.89.3.395; Souza GM, 1998, DEVELOPMENT, V125, P2291; Stansfield I, 1998, J MOL BIOL, V282, P13, DOI 10.1006/jmbi.1998.1976; Tapparo A, 1998, CURR GENET, V34, P410, DOI 10.1007/s002940050415; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037; Veitia RA, 2003, J THEOR BIOL, V220, P19, DOI 10.1006/jtbi.2003.3105; Wang S, 2010, NEOPLASIA, V12, P284, DOI 10.1593/neo.91610; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilkins A, 2001, TRENDS GENET, V17, P41, DOI 10.1016/S0168-9525(00)02181-8; Wilson D, 2007, NUCLEIC ACIDS RES, V35, pD308, DOI 10.1093/nar/gkl910; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; WRIGHT S, 1964, AM NAT, V98, P65, DOI 10.1086/282301; Yamaguchi Y, 2007, J BIOL CHEM, V282, P29, DOI 10.1074/jbc.M609308200	81	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30644	10.1371/journal.pone.0030644	http://dx.doi.org/10.1371/journal.pone.0030644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363460	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000302853600047
J	Kushki, A; Andrews, AJ; Power, SD; King, G; Chau, T				Kushki, Azadeh; Andrews, Alexander J.; Power, Sarah D.; King, Gillian; Chau, Tom			Classification of Activity Engagement in Individuals with Severe Physical Disabilities Using Signals of the Peripheral Nervous System	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; STUDENT ENGAGEMENT; COMMUNICATION; TECHNOLOGIES; AUTISM; STATE	Communication barriers often result in exclusion of children and youth with disabilities from activities and social settings that are essential to their psychosocial development. In particular, difficulties in describing their experiences of activities and social settings hinder our understanding of the factors that promote inclusion and participation of this group of individuals. To address this specific communication challenge, we examined the feasibility of developing a language-free measure of experience in youth with severe physical disabilities. To do this, we used the activity of the peripheral nervous system to detect patterns of psychological arousal associated with activities requiring different patterns of cognitive/affective and interpersonal involvement (activity engagement). We demonstrated that these signals can differentiate among patterns of arousal associated with these activities with high accuracy (two levels: 81%, three levels: 74%). These results demonstrate the potential for development of a real-time, motor-and language-free measure for describing the experiences of children and youth with disabilities.	[Kushki, Azadeh; Andrews, Alexander J.; Power, Sarah D.; King, Gillian; Chau, Tom] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Power, Sarah D.; Chau, Tom] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; University of Toronto	Kushki, A (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada.	tchau@hollandbloorview.ca	Chau, Tom TK/C-8426-2009; Power, Sarah/AAU-9422-2020	Chau, Tom TK/0000-0002-7486-0316; Power, Sarah/0000-0001-5132-2753	Canadian Institutes of Health Research [TWC-95045]; Ontario Ministry of Research and Innovations; Canada Research Chairs programs	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovations(Ministry of Research and Innovation, Ontario); Canada Research Chairs programs(Canada Research Chairs)	This work was financially supported by the Canadian Institutes of Health Research [TWC-95045] (http://www.cihr-irsc.gc.ca), the Ontario Ministry of Research and Innovations (http://www.mri.gov.on.ca/english/programs/PDF-Program.asp), and the Canada Research Chairs (http://www.chairs-chaires.gc.ca/) programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Beukelman D. R., 2020, AUGMENTATIVE ALTERNA; Blackstone S, 2009, PERSPECTIVES AUGMENT, V18, P78; Blain S, 2008, OPEN REHABILITATION, V1, P27, DOI DOI 10.2174/1874943700801010027; Cacioppo J.T., 1993, HDB EMOTION, P119; Carini RM, 2006, RES HIGH EDUC, V47, P1, DOI 10.1007/s11162-005-8150-9; DAWSON ME, 2000, HDB PSYCHOPHYSIOLOGY, P200; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Duda R.O., 2006, PATTERN CLASSIFICATI; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; Gazzaniga M.S., 2002, COGNITIVE NEUROSCIEN, V2nd ed.; Gibson BE, 2007, SOC SCI MED, V65, P505, DOI 10.1016/j.socscimed.2007.03.043; Haag A, 2004, LECT NOTES COMPUT SC, V3068, P36; Ito T, 1998, PERS SOC PSYCHOL B, V24, P855, DOI 10.1177/0146167298248006; King Gillian, 2003, Physical & Occupational Therapy in Pediatrics, V23, P63, DOI 10.1300/J006v23n01_05; Kingsnorth S, 2011, EVID BASED COMPLEMEN; Kistler A, 1998, INT J PSYCHOPHYSIOL, V29, P35, DOI 10.1016/S0167-8760(97)00087-1; Kreibig SD, 2007, PSYCHOPHYSIOLOGY, V44, P787, DOI 10.1111/j.1469-8986.2007.00550.x; Kushki A, 2011, PHYSL MEAS IN PRESS; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; Leary MR, 1996, MENT RETARD, V34, P39; Levenson R. W., 1988, SOCIAL PSYCHOPHYSIOL, P17; Light J, 2007, AUGMENT ALTERN COMM, V23, P204, DOI 10.1080/07434610701553635; Lund SK, 2007, AUGMENT ALTERN COMM, V23, P1, DOI 10.1080/07434610600720442; MAuller-Putz G, 2008, INT J BIOELECTROMAGN, V10, P52; Mauri M, 2010, IEEE ENG MED BIO, P3563, DOI 10.1109/IEMBS.2010.5627465; McCarthy A, 2011, AUGMENT ALT IN PRESS; MCWILLIAM RA, 1995, TOP EARLY CHILD SPEC, V15, P123, DOI 10.1177/027112149501500201; Moghimi S, 2011, J ASSIST TECHN UNPUB; Myrden AJB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024170; Picard RW, 2003, INT J HUM-COMPUT ST, V59, P55, DOI 10.1016/S1071-5819(03)00052-1; Picard RW, 2001, IEEE T PATTERN ANAL, V23, P1175, DOI 10.1109/34.954607; Poh MZ, 2010, IEEE T BIO-MED ENG, V57, P1243, DOI 10.1109/TBME.2009.2038487; Power SD, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026002; Reeve J, 2004, MOTIV EMOTION, V28, P147, DOI 10.1023/B:MOEM.0000032312.95499.6f; Ruble LA, 2007, J AUTISM DEV DISORD, V37, P1457, DOI 10.1007/s10803-006-0222-y; Ryan S, 1966, 22 INT SEAT S, P104; Schmidt S, 2000, J PARAPSYCHOL, V64, P250; Tai K, 2008, ASSIST TECHNOL, V20, P204, DOI 10.1080/10400435.2008.10131947; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	42	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30373	10.1371/journal.pone.0030373	http://dx.doi.org/10.1371/journal.pone.0030373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363432	Green Submitted, Green Published, gold			2022-12-25	WOS:000302853600026
J	Thriemer, K; Ley, B; Ame, S; Von Seidlein, L; Pak, GD; Chang, NY; Hashim, R; Schmied, WH; Busch, CJL; Nixon, S; Morrissey, A; Puri, MK; Ali, M; Ochiai, RL; Wierzba, T; Jiddawi, MS; Clemens, JD; Ali, SM; Deen, JL				Thriemer, Kamala; Ley, Benedikt; Ame, Shaali; Von Seidlein, Lorenz; Pak, Gi Deok; Chang, Na Yoon; Hashim, Ramadhan; Schmied, Wolfgang Hellmut; Busch, Clara Jana-Lui; Nixon, Shanette; Morrissey, Anne; Puri, Mahesh K.; Ali, Mohammad; Ochiai, R. Leon; Wierzba, Thomas; Jiddawi, Mohammad S.; Clemens, John D.; Ali, Said M.; Deen, Jaqueline L.			The Burden of Invasive Bacterial Infections in Pemba, Zanzibar	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; MALARIA; CHILDREN; BACTEREMIA; CULTURE; AFRICA; KENYA	Background: We conducted a surveillance study to determine the leading causes of bloodstream infection in febrile patients seeking treatment at three district hospitals in Pemba Island, Zanzibar, Tanzania, an area with low malaria transmission. Methods: All patients above two months of age presenting to hospital with fever were screened, and blood was collected for microbiologic culture and malaria testing. Bacterial sepsis and malaria crude incidence rates were calculated for a one-year period and were adjusted for study participation and diagnostic sensitivity of blood culture. Results: Blood culture was performed on 2,209 patients. Among them, 166 (8%) samples yielded bacterial growth; 87 (4%) were considered as likely contaminants; and 79 (4%) as pathogenic bacteria. The most frequent pathogenic bacteria isolated were Salmonella Typhi (n = 46; 58%), followed by Streptococcus pneumoniae (n = 12; 15%). The crude bacteremia rate was 6/100,000 but when adjusted for potentially missed cases the rate may be as high as 163/100,000. Crude and adjusted rates for S. Typhi infections and malaria were 4 and 110/100,000 and 4 and 47/100,000, respectively. Twenty three (51%), 22 (49%) and 22 (49%) of the S. Typhi isolates were found to be resistant toward ampicillin, chloramphenicol and cotrimoxazole, respectively. Multidrug resistance (MDR) against the three antimicrobials was detected in 42% of the isolates. Conclusions: In the presence of very low malaria incidence we found high rates of S. Typhi and S. pneumoniae infections on Pemba Island, Zanzibar. Preventive measures such as vaccination could reduce the febrile disease burden.	[Thriemer, Kamala; Ley, Benedikt; Pak, Gi Deok; Chang, Na Yoon; Hashim, Ramadhan; Schmied, Wolfgang Hellmut; Busch, Clara Jana-Lui; Puri, Mahesh K.; Ali, Mohammad; Ochiai, R. Leon; Wierzba, Thomas; Clemens, John D.; Deen, Jaqueline L.] Int Vaccine Inst, Seoul, South Korea; [Ley, Benedikt] Univ Vienna, Bioctr, Vienna, Austria; [Ame, Shaali; Ali, Said M.] Publ Hlth Lab Pemba Ivo de Carneri, Chake Chake, Tanzania; [Ame, Shaali; Jiddawi, Mohammad S.; Ali, Said M.] Minist Hlth & Social Welf, Zanzibar, Tanzania; [Von Seidlein, Lorenz; Deen, Jaqueline L.] Menzies Sch Hlth Res, Casuarina, NT, Australia; [Busch, Clara Jana-Lui] Inst Mol Biotechnol GmbH, Vienna, Austria; [Nixon, Shanette; Morrissey, Anne] Duke Univ KCMC Collaborat, Moshi, Tanzania	International Vaccine Institute; University of Vienna; Charles Darwin University; Menzies School of Health Research; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Thriemer, K (corresponding author), Int Vaccine Inst, Seoul, South Korea.	k.leythriemer@gmail.com	Schmied, Wolfgang/AAU-9961-2020; Ali, Mohammad/E-2365-2017	Schmied, Wolfgang/0000-0001-7625-0995; Ali, Mohammad/0000-0003-1410-388X; Ochiai, Leon/0000-0002-5079-6786; Thriemer, Kamala/0000-0001-7536-7497; Ley, Benedikt/0000-0002-5734-0845	Swedish International Development Cooperation Agency (SIDA)	Swedish International Development Cooperation Agency (SIDA)	This work has been supported by a grant from the Swedish International Development Cooperation Agency (SIDA) to the International Vaccine Institute (IV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Clinical and Laboratory Standards Institute, 2007, M100S16 CLIN LAB STA, V26, pM100; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Lee A, 2007, J CLIN MICROBIOL, V45, P3546, DOI 10.1128/JCM.01555-07; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; Mengo DM, 2010, J INFECT DEV COUNTR, V4, P393, DOI 10.3855/jidc.503; Mindy J., 2003, MANUAL LAB IDENTIFIC; National Bureau of Statistics, 2006, MIN PLANN EC EMP UN, VXII; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Saha S, 2011, J TROP PEDIATRICS, V57, P192, DOI 10.1093/tropej/fmq070; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Thriemer K, REPLACING PAPE UNPUB; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; Wain J, 2008, J INFECT DEV COUNTR, V2, P469, DOI 10.3855/jidc.164; WHO, 2010, WORLD MALARIA REPORT 2010, P1; ZAC-Zanzibar Aids Commission, 2008, UNGASS COUNTR PROGR; Zhou LQ, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-14	25	39	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30350	10.1371/journal.pone.0030350	http://dx.doi.org/10.1371/journal.pone.0030350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363426	Green Submitted, gold, Green Published			2022-12-25	WOS:000302853600020
J	Toulza, E; Tagliabue, A; Blain, S; Piganeau, G				Toulza, Eve; Tagliabue, Alessandro; Blain, Stephane; Piganeau, Gwenael			Analysis of the Global Ocean Sampling (GOS) Project for Trends in Iron Uptake by Surface Ocean Microbes	PLOS ONE			English	Article							ESCHERICHIA-COLI; DISSOLVED IRON; TRANSPORT; SIDEROPHORES; PROTEINS; GENES; BIOGEOGRAPHY; ADAPTATION; CHEMISTRY; GENOMICS	Microbial metagenomes are DNA samples of the most abundant, and therefore most successful organisms at the sampling time and location for a given cell size range. The study of microbial communities via their DNA content has revolutionized our understanding of microbial ecology and evolution. Iron availability is a critical resource that limits microbial communities' growth in many oceanic areas. Here, we built a database of 2319 sequences, corresponding to 140 gene families of iron metabolism with a large phylogenetic spread, to explore the microbial strategies of iron acquisition in the ocean's bacterial community. We estimate iron metabolism strategies from metagenome gene content and investigate whether their prevalence varies with dissolved iron concentrations obtained from a biogeochemical model. We show significant quantitative and qualitative variations in iron metabolism pathways, with a higher proportion of iron metabolism genes in low iron environments. We found a striking difference between coastal and open ocean sites regarding Fe2+ versus Fe3+ uptake gene prevalence. We also show that non-specific siderophore uptake increases in low iron open ocean environments, suggesting bacteria may acquire iron from natural siderophore-like organic complexes. Despite the lack of knowledge of iron uptake mechanisms in most marine microorganisms, our approach provides insights into how the iron metabolic pathways of microbial communities may vary with seawater iron concentrations.	[Toulza, Eve; Blain, Stephane; Piganeau, Gwenael] UPMC Univ Paris 06, Observ Oceanol, UMR 7232, Banyuls Sur Mer, France; [Toulza, Eve; Piganeau, Gwenael] CNRS, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France; [Tagliabue, Alessandro] IPSL Lab Sci Climat & Environnement, Gif Sur Yvette, France; [Blain, Stephane] CNRS, UMR 7621, Observ Oceanol, Banyuls Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Toulza, E (corresponding author), UPMC Univ Paris 06, Observ Oceanol, UMR 7232, Banyuls Sur Mer, France.	gwenael.piganeau@obs-banyuls.fr	blain, stéphane/F-6917-2010; Toulza, Eve/A-9919-2012; Piganeau, Gwenael V/C-7600-2011	blain, stéphane/0000-0002-5234-2446; Toulza, Eve/0000-0003-2049-2279; Piganeau, Gwenael V/0000-0002-9992-4187; Tagliabue, Alessandro/0000-0002-3572-3634	European network of excellence Marine Genomics Europe [GOGE-CT-505403]; Agence Nationale de la Recherche [ANR-08-BLAN-0309]; European Union [254619]	European network of excellence Marine Genomics Europe; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union(European Commission)	ET was funded by the European network of excellence Marine Genomics Europe (GOGE-CT-505403) and the Agence Nationale de la Recherche (ANR-08-BLAN-0309). GP is funded by European Union FP7 program under grant agreement 254619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; [Anonymous], 1932, STAT METHODS RES WOR; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Bibby TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004601; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Brochier-Armanet C, 2011, ISME J, V5, P1291, DOI 10.1038/ismej.2011.16; Butler A, 2005, BIOMETALS, V18, P369, DOI 10.1007/s10534-005-3711-0; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Chauhan D, 2011, BIOCHEMISTRY-US, V50, P686, DOI 10.1021/bi1009425; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Cornelis P, 2011, METALLOMICS; Daubin V, 2003, SCIENCE, V301, P829, DOI 10.1126/science.1086568; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Eisen JA, 1995, J MOL EVOL, V41, P1105; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Gulick AM, 2009, NAT CHEM BIOL, V5, P143, DOI 10.1038/nchembio0309-143; HARLE C, 1995, EMBO J, V14, P1430, DOI 10.1002/j.1460-2075.1995.tb07129.x; Hopkinson BM, 2008, APPL ENVIRON MICROB, V74, P6263, DOI 10.1128/AEM.00964-08; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kupper H, 2008, NEW PHYTOL, V179, P784, DOI 10.1111/j.1469-8137.2008.02497.x; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Longhurst AR, ECOLOGICAL GEOGRAPHY; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Monier A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r106; Moore JK, 2008, BIOGEOSCIENCES, V5, P631, DOI 10.5194/bg-5-631-2008; Morel FMM, 2008, LIMNOL OCEANOGR, V53, P400, DOI 10.4319/lo.2008.53.1.0400; Nwugo CC, 2010, J PROTEOMICS; Palenik B, 2006, P NATL ACAD SCI USA, V103, P13555, DOI 10.1073/pnas.0602963103; Patel PV, 2010, GENOME RES, V20, P960, DOI 10.1101/gr.102814.109; Pierre JL, 2000, BIOMETALS, V13, P91, DOI 10.1023/A:1009225701332; Piganeau G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r5; Raes J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.6; RAVEN JA, 1988, NEW PHYTOL, V109, P279, DOI 10.1111/j.1469-8137.1988.tb04196.x; Rivers AR, 2009, ENVIRON MICROBIOL, V11, P382, DOI 10.1111/j.1462-2920.2008.01778.x; Rue EL, 1997, LIMNOL OCEANOGR, V42, P901, DOI 10.4319/lo.1997.42.5.0901; Rusch DB, 2010, P NATL ACAD SCI USA, V107, P16184, DOI 10.1073/pnas.1009513107; Saito MA, 2011, P NATL ACAD SCI USA, V108, P2184, DOI 10.1073/pnas.1006943108; Sandy M, 2009, CHEM REV, V109, P4580, DOI 10.1021/cr9002787; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Tagliabue A, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003363; Tagliabue A, 2010, NAT GEOSCI, V3, P252, DOI 10.1038/NGEO818; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thioulouse J, 2007, J STAT SOFTW, V22, P1; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Tortell PD, 1999, FEMS MICROBIOL ECOL, V29, P1; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Volker C, 1999, MAR CHEM, V65, P227, DOI 10.1016/S0304-4203(99)00004-3; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811	57	45	45	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30931	10.1371/journal.pone.0030931	http://dx.doi.org/10.1371/journal.pone.0030931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363520	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600092
J	Wang, RH; Jin, Z; Liu, QX; van de Koppel, J; Alonso, D				Wang, Rong-Hua; Jin, Zhen; Liu, Quan-Xing; van de Koppel, Johan; Alonso, David			A Simple Stochastic Model with Environmental Transmission Explains Multi-Year Periodicity in Outbreaks of Avian Flu	PLOS ONE			English	Article							BORNE TRANSMISSION; INFLUENZA-VIRUSES; TIME-SERIES; DYNAMICS; EPIDEMICS; EVOLUTION; COEXISTENCE; PERSISTENCE; PATTERNS; NUMBER	Avian influenza virus reveals persistent and recurrent outbreaks in North American wild waterfowl, and exhibits major outbreaks at 2-8 years intervals in duck populations. The standard susceptible-infected-recovered (SIR) framework, which includes seasonal migration and reproduction, but lacks environmental transmission, is unable to reproduce the multi-periodic patterns of avian influenza epidemics. In this paper, we argue that a fully stochastic theory based on environmental transmission provides a simple, plausible explanation for the phenomenon of multi-year periodic outbreaks of avian flu. Our theory predicts complex fluctuations with a dominant period of 2 to 8 years which essentially depends on the intensity of environmental transmission. A wavelet analysis of the observed data supports this prediction. Furthermore, using master equations and van Kampen system-size expansion techniques, we provide an analytical expression for the spectrum of stochastic fluctuations, revealing how the outbreak period varies with the environmental transmission.	[Wang, Rong-Hua; Jin, Zhen] N Univ China, Dept Math, Taiyuan, Shanxi, Peoples R China; [Wang, Rong-Hua; Liu, Quan-Xing; van de Koppel, Johan] Netherlands Inst Ecol, Spatial Ecol Dept, Yerseke, Netherlands; [Alonso, David] Univ Groningen, Community & Conservat Ecol Grp, Groningen, Netherlands; [Alonso, David] Spanish Council Sci Res, Ctr Adv Studies, Blanes, Catalunya, Spain	North University of China; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Groningen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Wang, RH (corresponding author), N Univ China, Dept Math, Taiyuan, Shanxi, Peoples R China.	dalonso@ceab.csic.es	Liu, Quan-Xing/E-4892-2010; Alonso, David/A-5406-2008; Van de Koppel, Johan/E-7266-2010; jin, zhen/B-6563-2015; KNAW, NIOO-KNAW/A-4320-2012	Liu, Quan-Xing/0000-0002-8602-0154; Alonso, David/0000-0002-8888-1644; jin, zhen/0000-0002-9763-707X; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Institution for Scientific Research (NWO); Netherlands Institute of Ecology (NIOO-KNAW); National Natural Science Foundation of China [10901145]	Netherlands Institution for Scientific Research (NWO); Netherlands Institute of Ecology (NIOO-KNAW); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by The Netherlands Institution for Scientific Research (NWO), The Netherlands Institute of Ecology (NIOO-KNAW), and National Natural Science Foundation of China (Grant No. 10901145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2002, B MATH BIOL, V64, P913, DOI 10.1006/bulm.2002.0307; Alonso D, 2010, P ROYAL SOC B; Alonso D, 2007, J R SOC INTERFACE, V4, P575, DOI 10.1098/rsif.2006.0192; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; [Anonymous], INFECT DIS HUMANS DY; Batt B. D. J., 1992, ECOLOGY MANAGEMENT B; Black AJ, 2010, J THEOR BIOL, V267, P8594; Black AJ, 2010, J R SOC INTERFACE, V7, P1219, DOI 10.1098/rsif.2009.0514; Blanchong JA, 2006, J WILDLIFE DIS, V42, P33, DOI 10.7589/0090-3558-42.1.33; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011; Codeco CT, 2008, J R SOC INTERFACE, V5, P247, DOI 10.1098/rsif.2007.1135; Colijn C, 2010, J R SOC INTERFACE, V7, P905, DOI 10.1098/rsif.2009.0400; D'Souza DH, 2006, INT J FOOD MICROBIOL, V108, P84, DOI 10.1016/j.ijfoodmicro.2005.10.024; Dangerfield CE, 2009, J R SOC INTERFACE, V6, P761, DOI 10.1098/rsif.2008.0410; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Henning J, 2005, EPIDEMIOL INFECT, V133, P719, DOI 10.1017/S0950268805003766; Joh RI, 2009, B MATH BIOL, V71, P845, DOI 10.1007/s11538-008-9384-4; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Kamo M, 2005, ECOL LETT, V8, P378, DOI 10.1111/j.1461-0248.2005.00734.x; Kampen NGV, 2007, STOCHASTIC PROCESSES, V3; Keeling MJ, 2008, J R SOC INTERFACE, V5, P171, DOI 10.1098/rsif.2007.1106; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Koelle K, 2004, AM NAT, V163, P901, DOI 10.1086/420798; Koelle K, 2010, J R SOC INTERFACE, V7, P1257, DOI 10.1098/rsif.2010.0007; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Marion G, 2000, THEOR POPUL BIOL, V57, P197, DOI 10.1006/tpbi.2000.1450; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McKane AJ, 2007, J STAT PHYS, V128, P165, DOI 10.1007/s10955-006-9221-9; McKane AJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041902; McKane AJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218102; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Nguyen HTH, 2008, J R SOC INTERFACE, V5, P403, DOI 10.1098/rsif.2007.1168; Nisbet RM, 1982, MODELLING FLUCTUATIN; Pascual M, 2008, P ROY SOC B-BIOL SCI, V275, P123, DOI 10.1098/rspb.2007.1068; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Renshaw E., 1991, MODELLING BIOL POPUL, DOI 10.1017/CBO9780511624094; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Roche B, 2009, INFECT GENET EVOL, V9, P800, DOI 10.1016/j.meegid.2009.04.009; Rohani P, 2002, AM NAT, V159, P469, DOI 10.1086/339467; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Rozhnova G, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041906; SHARP GB, 1993, EPIDEMIOL INFECT, V110, P161, DOI 10.1017/S0950268800050780; Simoes M, 2008, J R SOC INTERFACE, V5, P555, DOI 10.1098/rsif.2007.1206; Thomas F., 2005, PARASITISM ECOSYSTEM; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Webb CT, 2006, P NATL ACAD SCI USA, V103, P6236, DOI 10.1073/pnas.0510090103; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x; Yang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001399; Zhang ZB, 2009, P ROY SOC B-BIOL SCI, V276, P823, DOI 10.1098/rspb.2008.1284	58	31	31	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e28873	10.1371/journal.pone.0028873	http://dx.doi.org/10.1371/journal.pone.0028873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363397	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600002
J	Butler, DL; Mattingley, JB; Cunnington, R; Suddendorf, T				Butler, David L.; Mattingley, Jason B.; Cunnington, Ross; Suddendorf, Thomas			Mirror, Mirror on the Wall, How Does My Brain Recognize My Image at All?	PLOS ONE			English	Article							VISUAL SELF-RECOGNITION; EMOTIONAL EXPRESSION; FACE RECOGNITION; FAMILIARITY; CHIMPANZEES; PERCEPTION; AWARENESS; MISIDENTIFICATION; REPRESENTATION; EVOLUTION	For decades researchers have used mirrors to study self-recognition. However, attempts to identify neural processes underlying this ability have used photographs instead. Here we used event related potentials (ERPs) to compare self-face recognition in photographs versus mirrors and found distinct neural signatures. Measures of visual self-recognition are therefore not independent of the medium employed.	[Butler, David L.; Mattingley, Jason B.; Cunnington, Ross; Suddendorf, Thomas] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Mattingley, Jason B.; Cunnington, Ross] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Butler, DL (corresponding author), Univ Queensland, Sch Psychol, McElwain Bldg, St Lucia, Qld, Australia.	davidbut@psy.uq.edu.au	Suddendorf, Thomas/A-1631-2017; Mattingley, Jason/J-1537-2014	Suddendorf, Thomas/0000-0003-3328-7442; Mattingley, Jason/0000-0003-0929-9216; Butler, David/0000-0002-7450-2121; Cunnington, Ross/0000-0002-7423-4809				American Clinical Neurophysiology Society, 2006, J Clin Neurophysiol, V23, P107; AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Bard KA, 2006, INFANCY, V9, P191, DOI 10.1207/s15327078in0902_6; Bentin S, 2002, COGNITION, V86, pB1, DOI 10.1016/S0010-0277(02)00124-5; BIGELOW AE, 1981, J GENET PSYCHOL, V139, P11, DOI 10.1080/00221325.1981.10533432; BIRINGER F, 1992, J GERONTOL, V47, pP385, DOI 10.1093/geronj/47.6.P385; Breen N, 2001, NEUROCASE, V7, P239, DOI 10.1093/neucas/7.3.239; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Caharel S, 2002, INT J NEUROSCI, V112, P1499, DOI 10.1080/00207450290158368; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; Caharel S, 2007, SCHIZOPHR RES, V95, P186, DOI 10.1016/j.schres.2007.06.015; Caharel S, 2006, INT J PSYCHOPHYSIOL, V62, P141, DOI 10.1016/j.ijpsycho.2006.03.002; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Darwin C., 1877, MIND, V2, P285, DOI [10.1093/mind/os-2.7.285, DOI 10.1093/MIND/OS-2.7.285]; Devue C, 2010, CONSCIOUSNE IN PRESS; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; EPSTEIN R, 1981, SCIENCE, V212, P695, DOI 10.1126/science.212.4495.695; Feusner JD, 2008, BODY IMAGE, V5, P3, DOI 10.1016/j.bodyim.2007.11.002; Friederich HC, 2010, NEUROPSYCHOLOGIA, V48, P2878, DOI 10.1016/j.neuropsychologia.2010.04.036; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; HARRINGTON A, 1989, COMPR PSYCHIAT, V30, P376, DOI 10.1016/0010-440X(89)90003-5; Herrmann MJ, 2005, J NEURAL TRANSM, V112, P1073, DOI 10.1007/s00702-004-0250-8; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Keyes H, 2010, BRAIN COGNITION, V72, P244, DOI 10.1016/j.bandc.2009.09.006; LETHMATE J, 1973, Zeitschrift fuer Tierpsychologie, V33, P248; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Marzi T, 2007, INT J PSYCHOPHYSIOL, V65, P182, DOI 10.1016/j.ijpsycho.2007.04.003; Miles H, 1994, ME CHANTEK DEV SELF; MOLCHAN SE, 1990, BRIT J PSYCHIAT, V157, P605, DOI 10.1192/bjp.157.4.605; Nielsen M, 2006, CHILD DEV, V77, P176, DOI 10.1111/j.1467-8624.2006.00863.x; Nielsen M, 2003, INFANT BEHAV DEV, V26, P213, DOI 10.1016/S0163-6383(03)00018-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phillips M L, 1996, Cogn Neuropsychiatry, V1, P153, DOI 10.1080/135468096396613; Platek SM, 2008, BRAIN RES, V1232, P173, DOI 10.1016/j.brainres.2008.07.010; Posada S, 2007, AM J PRIMATOL, V69, P576, DOI 10.1002/ajp.20355; Povinelli DJ, 1996, CHILD DEV, V67, P1540, DOI 10.2307/1131717; Povinelli DJ, 1997, ANIM BEHAV, V53, P1083, DOI 10.1006/anbe.1996.0303; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SPERRY RW, 1979, NEUROPSYCHOLOGIA, V17, P153, DOI 10.1016/0028-3932(79)90006-X; SUAREZ SD, 1981, J HUM EVOL, V10, P175, DOI 10.1016/S0047-2484(81)80016-4; Suddendorf T, 1999, J EXP CHILD PSYCHOL, V72, P157, DOI 10.1006/jecp.1998.2485; Suddendorf T, 2001, PSYCHOL BULL, V127, P629, DOI 10.1037//0033-2909.127.5.629; Suddendorf T, 2007, COGNITIVE DEV, V22, P185, DOI 10.1016/j.cogdev.2006.09.003; Suddendorf T, 2009, P R SOC B, V276, P1671, DOI 10.1098/rspb.2008.1754; Sui J, 2006, NEUROREPORT, V17, P423, DOI 10.1097/01.wnr.0000203357.65190.61; Tanaka JW, 2006, J COGNITIVE NEUROSCI, V18, P1488, DOI 10.1162/jocn.2006.18.9.1488; Villarejo A, 2011, NEUROCASE, V17, P276, DOI 10.1080/13554794.2010.498427	50	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31452	10.1371/journal.pone.0031452	http://dx.doi.org/10.1371/journal.pone.0031452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925XS	22359592	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200061
J	Gao, GP; Yin, DH; Chen, SJ; Xia, F; Yang, J; Li, Q; Wang, W				Gao, Guanpeng; Yin, Danhan; Chen, Shengju; Xia, Fei; Yang, Jie; Li, Qing; Wang, Wei			Effect of Biocontrol Agent Pseudomonas fluorescens 2P24 on Soil Fungal Community in Cucumber Rhizosphere Using T-RFLP and DGGE	PLOS ONE			English	Article							LENGTH-POLYMORPHISM ANALYSIS; BIOLOGICAL-CONTROL; BACTERIAL DIVERSITY; AGRICULTURAL SOILS; RIBOSOMAL-RNA; 2,4-DIACETYLPHLOROGLUCINOL; CARBON; IDENTIFICATION; FRAGMENTS; SURVIVAL	Fungi and fungal community play important roles in the soil ecosystem, and the diversity of fungal community could act as natural antagonists of various plant pathogens. Biological control is a promising method to protect plants as chemical pesticides may cause environment pollution. Pseudomonas fluorescens 2P24 had strong inhibitory on Rastonia solanacearum, Fusarium oxysporum and Rhizoctonia solani, etc., and was isolated from the wheat rhizosphere take-all decline soils in Shandong province, China. However, its potential effect on soil fungal community was still unknown. In this study, the gfp-labeled P. fluorescens 2P24 was inoculated into cucumber rhizosphere, and the survival of 2P24 was monitored weekly. The amount decreased from 10(8) to 10(5) CFU/g dry soils. The effect of 2P24 on soil fungal community in cucumber rhizosphere was investigated using T-RFLP and DGGE. In T-RFLP analysis, principle component analysis showed that the soil fungal community was greatly influenced at first, digested with restriction enzyme Hinf I and Taq I. However, there was little difference as digested by different enzymes. DGGE results demonstrated that the soil fungal community was greatly shocked at the beginning, but it recovered slowly with the decline of P. fluorescens 2P24. Four weeks later, there was little difference between the treatment and control. Generally speaking, the effect of P. fluorescens 2P24 on soil fungal community in cucumber rhizosphere was just transient.	[Gao, Guanpeng; Yin, Danhan; Chen, Shengju; Xia, Fei; Yang, Jie; Li, Qing; Wang, Wei] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	East China University of Science & Technology	Gao, GP (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	weiwang@ecust.edu.cn			National Science Foundation of China [30871664]; Open Project for the State Key Laboratory of Bioreactor Engineering [2060204]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project for the State Key Laboratory of Bioreactor Engineering	This work was supported by the National Science Foundation of China (30871664) and Open Project for the State Key Laboratory of Bioreactor Engineering (2060204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALABOUVETTE C, 1990, BIOLOGICAL CONTROL OF SOIL-BORNE PLANT PATHOGENS, P27; Arias-Estevez M, 2008, AGR ECOSYST ENVIRON, V123, P247, DOI 10.1016/j.agee.2007.07.011; Bailey K. L., 2006, Handbook of sustainable weed management, P431; Bailey KL, 2010, BIOL CONTROL, V52, P221, DOI 10.1016/j.biocontrol.2009.05.003; Bangera MG, 1996, MOL PLANT MICROBE IN, V9, P83, DOI 10.1094/MPMI-9-0083; Bernbom N, 2006, J MICROBIOL METH, V66, P87, DOI 10.1016/j.mimet.2005.10.014; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; Bruns TD, 1998, MOL ECOL, V7, P257, DOI 10.1046/j.1365-294X.1998.00337.x; Burke DJ, 2005, SOIL BIOL BIOCHEM, V37, P1683, DOI 10.1016/j.soilbio.2005.01.028; CARROLL H, 1995, APPL ENVIRON MICROB, V61, P3002, DOI 10.1128/AEM.61.8.3002-3007.1995; Cook RJ, 2000, ANNU REV PHYTOPATHOL, V38, P95, DOI 10.1146/annurev.phyto.38.1.95; Cronin D, 1997, APPL ENVIRON MICROB, V63, P1357, DOI 10.1128/AEM.63.4.1357-1361.1997; Cronin D, 1997, FEMS MICROBIOL ECOL, V23, P95, DOI 10.1111/j.1574-6941.1997.tb00394.x; Egert M, 2003, APPL ENVIRON MICROB, V69, P2555, DOI 10.1128/AEM.69.5.2555-2562.2003; Entry JA, 2004, ENVIRON MANAGE, V33, pS363, DOI 10.1007/s00267-003-9145-y; Enwall K, 2009, LETT APPL MICROBIOL, V48, P145, DOI 10.1111/j.1472-765X.2008.02498.x; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Hoshino YT, 2008, SOIL SCI PLANT NUTR, V54, P701, DOI 10.1111/j.1747-0765.2008.00289.x; Institute of Soil Science Chinese Academy of Sciences, 1978, SOIL PHYS CHEM AN SH; Jarosik V, 1996, MICROBIOL RES, V151, P177, DOI 10.1016/S0944-5013(96)80042-5; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; Johnsen K, 2001, BIOL FERT SOILS, V33, P443, DOI 10.1007/s003740100351; KEEL C, 1992, MOL PLANT MICROBE IN, V5, P4, DOI 10.1094/MPMI-5-004; Lueders T, 2003, APPL ENVIRON MICROB, V69, P320, DOI 10.1128/AEM.69.1.320-326.2003; Marsh TL, 2000, APPL ENVIRON MICROB, V66, P3616, DOI 10.1128/AEM.66.8.3616-3620.2000; May LA, 2001, CAN J MICROBIOL, V47, P829, DOI 10.1139/cjm-47-9-829; McSpadden Gardener BB, 2002, PLANT HLTH PROG, DOI [10.1094/PHP-2002-0510-01-RV, DOI 10.1094/PHP-2002-0510-01-RV]; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Natsch A, 1998, FEMS MICROBIOL ECOL, V27, P365, DOI 10.1111/j.1574-6941.1998.tb00552.x; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Prevost K, 2006, BIOCONTROL, V51, P533, DOI 10.1007/s10526-005-4240-z; Qing Y., 2009, MICROBIOLOGY, V155, P124; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Saravanakumar D, 2008, J APPL ENTOMOL, V132, P469, DOI 10.1111/j.1439-0418.2008.01278.x; Sarniguet A, 1995, P NATL ACAD SCI USA, V92, P12255, DOI 10.1073/pnas.92.26.12255; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Vahjen W, 1995, FEMS MICROBIOL ECOL, V18, P317; van Elsas JD, 1998, J MICROBIOL METH, V32, P133, DOI 10.1016/S0167-7012(98)00025-6; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; VANELSAS JD, 1992, BIOL FERT SOILS, V14, P14, DOI 10.1007/BF00336297; Wang JF, 2008, PLANT SOIL, V302, P45, DOI 10.1007/s11104-007-9453-8; Wei HL, 2006, ANTON LEEUW INT J G, V89, P267, DOI 10.1007/s10482-005-9028-8; Wei HaiLei, 2004, Acta Phytopathologica Sinica, V34, P80; WESSENDORF J, 1989, APPL MICROBIOL BIOT, V31, P97, DOI 10.1007/BF00252536; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wu XG, 2010, FEMS MICROBIOL LETT, V309, P16, DOI 10.1111/j.1574-6968.2010.02009.x	50	47	51	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31806	10.1371/journal.pone.0031806	http://dx.doi.org/10.1371/journal.pone.0031806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359632	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200101
J	Barrowman, J; Hamblet, C; Kane, MS; Michaelis, S				Barrowman, Jemima; Hamblet, Corinne; Kane, Megan S.; Michaelis, Susan			Requirements for Efficient Proteolytic Cleavage of Prelamin A by ZMPSTE24	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; PROTEASE INHIBITORS BLOCK; LAMIN-A PRECURSOR; RESTRICTIVE DERMOPATHY; MANDIBULOACRAL DYSPLASIA; ZINC METALLOPROTEINASE; NUCLEAR-LOCALIZATION; LMNA MUTATIONS; A/C GENE; LAMINOPATHIES	Background: The proteolytic maturation of the nuclear protein lamin A by the zinc metalloprotease ZMPSTE24 is critical for human health. The lamin A precursor, prelamin A, undergoes a multi-step maturation process that includes CAAX processing (farnesylation, proteolysis and carboxylmethylation of the C-terminal CAAX motif), followed by ZMPSTE24-mediated cleavage of the last 15 amino acids, including the modified C-terminus. Failure to cleave the prelamin A "tail", due to mutations in either prelamin A or ZMPSTE24, results in a permanently prenylated form of prelamin A that underlies the premature aging disease Hutchinson-Gilford Progeria Syndrome (HGPS) and related progeroid disorders. Methodology/Principal Findings: Here we have investigated the features of the prelamin A substrate that are required for efficient cleavage by ZMPSTE24. We find that the C-terminal 41 amino acids of prelamin A contain sufficient context to allow cleavage of the tail by ZMPSTE24. We have identified several mutations in amino acids immediately surrounding the cleavage site (between Y646 and L647) that interfere with efficient cleavage of the prelamin A tail; these mutations include R644C, L648A and N650A, in addition to the previously reported L647R. Our data suggests that 9 of the 15 residues within the cleaved tail that lie immediately upstream of the CAAX motif are not critical for ZMPSTE24-mediated cleavage, as they can be replaced by the 9 amino acid HA epitope. However, duplication of the same 9 amino acids (to increase the distance between the prenyl group and the cleavage site) impairs the ability of ZMPSTE24 to cleave prelamin A. Conclusions/Significance: Our data reveals amino acid preferences flanking the ZMPSTE24 cleavage site of prelamin A and suggests that spacing from the farnesyl-cysteine to the cleavage site is important for optimal ZMPSTE24 cleavage. These studies begin to elucidate the substrate requirements of an enzyme activity critical to human health and longevity.	[Barrowman, Jemima; Hamblet, Corinne; Kane, Megan S.; Michaelis, Susan] Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Barrowman, J (corresponding author), Johns Hopkins Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA.	michaelis@jhmi.edu			National Institutes of Health [GM41223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the National Institutes of Health (GM41223) to Susan Michaelis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Barrowman J, 2009, BIOL CHEM, V390, P761, DOI 10.1515/BC.2009.080; Barrowman J, 2008, MOL BIOL CELL, V19, P5398, DOI 10.1091/mbc.E08-07-0704; Barton RM, 1999, J BIOL CHEM, V274, P30008, DOI 10.1074/jbc.274.42.30008; BECK LA, 1990, J CELL BIOL, V110, P1489, DOI 10.1083/jcb.110.5.1489; Ben Yaou R, 2011, EUR J HUM GENET, V19, P647, DOI 10.1038/ejhg.2010.256; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Capell BC, 2007, CIRC RES, V101, P13, DOI 10.1161/CIRCRESAHA.107.153692; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197; Caron M, 2003, AIDS, V17, P2437, DOI 10.1097/00002030-200311210-00005; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Csoka AB, 2004, J MED GENET, V41, P304, DOI 10.1136/jmg.2003.015651; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Dutour A, 2011, HUM MOL GENET, V20, P3779, DOI 10.1093/hmg/ddr294; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Genschel J, 2001, Hum Mutat, V17, P154, DOI 10.1002/1098-1004(200102)17:2<154::AID-HUMU11>3.3.CO;2-I; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; HENNEKES H, 1994, J CELL SCI, V107, P1019; HOLTZ D, 1989, CELL, V59, P969, DOI 10.1016/0092-8674(89)90753-8; Hudon SE, 2008, BIOCHEM BIOPH RES CO, V374, P365, DOI 10.1016/j.bbrc.2008.07.033; Kieran MW, 2007, PEDIATRICS, V120, P834, DOI 10.1542/peds.2007-1356; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Mercuri E, 2005, MUSCLE NERVE, V31, P602, DOI 10.1002/mus.20293; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Moulson CL, 2007, HUM MUTAT, V28, P882, DOI 10.1002/humu.20536; Moulson CL, 2005, J INVEST DERMATOL, V125, P913, DOI 10.1111/j.0022-202X.2005.23846.x; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Rankin J, 2008, AM J MED GENET A, V146A, P1530, DOI 10.1002/ajmg.a.32331; Rodriguez Sofia, 2010, Curr Aging Sci, V3, P81; Scaffidi P, 2005, PLOS BIOL, V3, P1855, DOI 10.1371/journal.pbio.0030395; Schmidt WK, 1998, P NATL ACAD SCI USA, V95, P11175, DOI 10.1073/pnas.95.19.11175; Smigiel R, 2010, AM J MED GENET A, V152A, P447, DOI 10.1002/ajmg.a.33221; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200	49	38	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32120	10.1371/journal.pone.0032120	http://dx.doi.org/10.1371/journal.pone.0032120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355414	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300114
J	Huovinen, T; Brockmann, EC; Akter, S; Perez-Gamarra, S; Yla-Pelto, J; Liu, Y; Lamminmaki, U				Huovinen, Tuomas; Brockmann, Eeva-Christine; Akter, Sultana; Perez-Gamarra, Susan; Yla-Pelto, Jani; Liu, Yuan; Lamminmaki, Urpo			Primer Extension Mutagenesis Powered by Selective Rolling Circle Amplification	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; EXCISION-REPAIR PATHWAY; PHI-29 DNA-POLYMERASE; STRANDED PLASMID DNA; ESCHERICHIA-COLI; DEPURINATION; REPLICATION; LIBRARIES; DUTPASE; UNG	Primer extension mutagenesis is a popular tool to create libraries for in vitro evolution experiments. Here we describe a further improvement of the method described by T. A. Kunkel using uracil-containing single-stranded DNA as the template for the primer extension by additional uracil-DNA glycosylase treatment and rolling circle amplification (RCA) steps. It is shown that removal of uracil bases from the template leads to selective amplification of the nascently synthesized circular DNA strand carrying the desired mutations by phi29 DNA polymerase. Selective RCA (sRCA) of the DNA heteroduplex formed in Kunkel's mutagenesis increases the mutagenesis efficiency from 50% close to 100% and the number of transformants 300-fold without notable diversity bias. We also observed that both the mutated and the wild-type DNA were present in at least one third of the cells transformed directly with Kunkel's heteroduplex. In contrast, the cells transformed with sRCA product contained only mutated DNA. In sRCA, the complex cell-based selection for the mutant strand is replaced with the more controllable enzyme-based selection and less DNA is needed for library creation. Construction of a gene library of ten billion members is demonstrated with the described method with 240 nanograms of DNA as starting material.	[Huovinen, Tuomas; Brockmann, Eeva-Christine; Akter, Sultana; Perez-Gamarra, Susan; Yla-Pelto, Jani; Liu, Yuan; Lamminmaki, Urpo] Univ Turku, Dept Biochem & Food Chem, Turku, Finland	University of Turku	Huovinen, T (corresponding author), Univ Turku, Dept Biochem & Food Chem, Turku, Finland.	tuomas.huovinen@utu.fi		Huovinen, Tuomas/0000-0003-0960-3249; Akter, Sultana/0000-0002-1939-7963	Finnish Agency of Technology and Innovation [40366/06]; National Doctoral Programme of Advanced Diagnostic Technologies and Applications [129793]	Finnish Agency of Technology and Innovation; National Doctoral Programme of Advanced Diagnostic Technologies and Applications	This work was supported by the Finnish Agency of Technology and Innovation (40366/06) and the National Doctoral Programme of Advanced Diagnostic Technologies and Applications (129793 for T. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAAS PD, 1980, FEBS LETT, V110, P15, DOI 10.1016/0014-5793(80)80012-3; BLANCO L, 1989, J BIOL CHEM, V264, P8935; Brockmann EC, 2011, PROTEIN ENG DES SEL; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Fujii R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh147; GLICKMAN BW, 1980, P NATL ACAD SCI-BIOL, V77, P1063, DOI 10.1073/pnas.77.2.1063; Huovinena T, 2011, PLASMID, V66, P47, DOI 10.1016/j.plasmid.2011.03.004; Hutchison CA, 2005, P NATL ACAD SCI USA, V102, P17332, DOI 10.1073/pnas.0508809102; JUNG R, 1992, GENE, V121, P17, DOI 10.1016/0378-1119(92)90157-K; KUNKEL TA, 1984, P NATL ACAD SCI-BIOL, V81, P1494, DOI 10.1073/pnas.81.5.1494; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lari SU, 2006, DNA REPAIR, V5, P1407, DOI 10.1016/j.dnarep.2006.06.009; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; Li FS, 1999, BIOTECHNIQUES, V27, P734, DOI 10.2144/99274st03; MARKVARDSEN P, 1995, BIOTECHNIQUES, V18, P370; SAGHER D, 1985, NUCLEIC ACIDS RES, V13, P4285, DOI 10.1093/nar/13.12.4285; Sandigursky M, 1998, NUCLEIC ACIDS RES, V26, P1282, DOI 10.1093/nar/26.5.1282; SCHAAPER RM, 1981, P NATL ACAD SCI-BIOL, V78, P1773, DOI 10.1073/pnas.78.3.1773; Serrano-Heras G, 2008, P NATL ACAD SCI USA, V105, P19044, DOI 10.1073/pnas.0808797105; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; TYE BK, 1977, J MOL BIOL, V117, P293, DOI 10.1016/0022-2836(77)90128-0; WARNER HR, 1981, J BACTERIOL, V145, P687, DOI 10.1128/JB.145.2.687-695.1981; Yagodkin A, 2007, NUCLEOS NUCLEOT NUCL, V26, P473, DOI 10.1080/15257770701426260	27	17	24	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31817	10.1371/journal.pone.0031817	http://dx.doi.org/10.1371/journal.pone.0031817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355397	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300097
J	Phillips, KA; Hopkins, WD				Phillips, Kimberley A.; Hopkins, William D.			Topography of the Chimpanzee Corpus Callosum	PLOS ONE			English	Article							DIFFUSION-TENSOR; FIBER COMPOSITION; SIGNAL INTENSITY; SEX-DIFFERENCES; WHITE-MATTER; EVOLUTION; SIZE; MORPHOLOGY; AGE; CONNECTIVITY	The corpus callosum (CC) is the largest commissural white matter tract in mammalian brains, connecting homotopic and heterotopic regions of the cerebral cortex. Knowledge of the distribution of callosal fibers projecting into specific cortical regions has important implications for understanding the evolution of lateralized structures and functions of the cerebral cortex. No comparisons of CC topography in humans and great apes have yet been conducted. We investigated the topography of the CC in 21 chimpanzees using high-resolution magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI). Tractography was conducted based on fiber assignment by continuous tracking (FACT) algorithm. We expected chimpanzees to display topographical organization similar to humans, especially concerning projections into the frontal cortical regions. Similar to recent studies in humans, tractography identified five clusters of CC fibers projecting into defined cortical regions: prefrontal; premotor and supplementary motor; motor; sensory; parietal, temporal and occipital. Significant differences in fractional anisotropy (FA) were found in callosal regions, with highest FA values in regions projecting to higher-association areas of posterior cortical (including parietal, temporal and occipital cortices) and prefrontal cortical regions (p<0.001). The lowest FA values were seen in regions projecting into motor and sensory cortical areas. Our results indicate chimpanzees display similar topography of the CC as humans, in terms of distribution of callosal projections and microstructure of fibers as determined by anisotropy measures.	[Phillips, Kimberley A.] Trinity Univ, Dept Psychol, San Antonio, TX 78212 USA; [Phillips, Kimberley A.] SW Natl Primate Res Ctr, Texas Biomed Res Inst, San Antonio, TX USA; [Hopkins, William D.] Agnes Scott Coll, Dept Psychol, Decatur, GA 30030 USA; [Hopkins, William D.] Yerkes Natl Primate Res Ctr, Div Dev & Cognit Neurosci, Atlanta, GA USA	Trinity University; Texas Biomedical Research Institute	Phillips, KA (corresponding author), Trinity Univ, Dept Psychol, San Antonio, TX 78212 USA.	kimberley.phillips@trinity.edu	Phillips, Kimberley/P-1212-2016	Phillips, Kimberley/0000-0002-5517-3596	National Institute of Neurological Disorders and Stroke [NS070717, NS42867, HD60563]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD060563] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042867, R15NS070717] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke (grants NS070717 to KAP; NS42867 and HD60563 to WDH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders And Stroke or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2004, J COMPUTER ASSISTED, V28; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; ALLEN LS, 1991, J NEUROSCI, V11, P933; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Basser PJ, 1995, NMR BIOMED, V7-8, P583; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bonzano L, 2008, J NEUROSCI, V28, P3227, DOI 10.1523/JNEUROSCI.4076-07.2008; Brambilla P, 2004, J NEUROL NEUROSUR PS, V75, P221; Caminiti R, 2009, P NATL ACAD SCI USA, V106, P19551, DOI 10.1073/pnas.0907655106; Dorion AA, 2000, NEUROSCI RES, V36, P9, DOI 10.1016/S0168-0102(99)00102-9; DRIESEN NR, 1995, PSYCHOBIOLOGY, V23, P240; Dunham LA, 2006, BEHAV NEUROSCI, V120, P1025, DOI 10.1037/0735-7044.120.5.1025; Fabri M, 2011, BRAIN RES, V1370, P99, DOI 10.1016/j.brainres.2010.11.039; Fryer SL, 2008, BRAIN COGNITION, V67, P225, DOI 10.1016/j.bandc.2008.01.009; Hasan KM, 2009, BRAIN RES, V1249, P91, DOI 10.1016/j.brainres.2008.10.026; Highley JR, 1999, BRAIN, V122, P99, DOI 10.1093/brain/122.1.99; Hofer S, 2007, CEREB CORTEX; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hopkins WD, 2000, BEHAV NEUROSCI, V114, P739, DOI 10.1037//0735-7044.114.4.739; Hopkins WD, 2010, DEV PSYCHOBIOL, V52, P133, DOI 10.1002/dev.20421; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Innocenti GM, 2010, BRAIN STRUCT FUNCT, V215, P123, DOI 10.1007/s00429-010-0274-9; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Le Bihan D., 1995, DIFFUSION PERFUSION, V1st; Li LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012886; Olivares R, 2001, BRAIN BEHAV EVOLUT, V57, P98, DOI 10.1159/000047229; Ota M, 2006, NEUROIMAGE, V31, P1445, DOI 10.1016/j.neuroimage.2006.02.008; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Phillips KA, 2009, NEUROSCIENCE, V159, P1119, DOI 10.1016/j.neuroscience.2009.01.061; Phillips KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000792; Ramnani N, 2006, CEREB CORTEX, V16, P811, DOI 10.1093/cercor/bhj024; Rilling JK, 1999, NEUROREPORT, V10, P1453, DOI 10.1097/00001756-199905140-00012; Rilling JK, 1999, J HUM EVOL, V37, P191, DOI 10.1006/jhev.1999.0313; ROSEN GD, 1989, NEUROSCIENCE, V33, P525, DOI 10.1016/0306-4522(89)90404-1; Sakai T, 2011, CURR BIOL, V21, P1; Schoenemann PT, 2006, ANNU REV ANTHROPOL, V35, P379, DOI 10.1146/annurev.anthro.35.081705.123210; TOMASCH J, 1954, ANAT REC, V119, P119, DOI 10.1002/ar.1091190109; Wang F, 2008, BIOL PSYCHIAT, V64, P730, DOI 10.1016/j.biopsych.2008.06.001; WITELSON SF, 1985, SCIENCE, V229, P665, DOI 10.1126/science.4023705; WITELSON SF, 1991, BRAIN RES, V545, P175, DOI 10.1016/0006-8993(91)91284-8; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x	46	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31941	10.1371/journal.pone.0031941	http://dx.doi.org/10.1371/journal.pone.0031941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355406	gold, Green Published, Green Submitted			2022-12-25	WOS:000302741300106
J	Reynolds, JR; O'Reilly, RC; Cohen, JD; Braver, TS				Reynolds, Jeremy R.; O'Reilly, Randall C.; Cohen, Jonathan D.; Braver, Todd S.			The Function and Organization of Lateral Prefrontal Cortex: A Test of Competing Hypotheses	PLOS ONE			English	Article							INFERIOR FRONTAL JUNCTION; COGNITIVE CONTROL; WORKING-MEMORY; NEURAL MECHANISMS; TRANSIENT; CONTEXT; FMRI; SCHIZOPHRENIA; MAINTENANCE; DYSFUNCTION	The present experiment tested three hypotheses regarding the function and organization of lateral prefrontal cortex (PFC). The first account (the information cascade hypothesis) suggests that the anterior-posterior organization of lateral PFC is based on the timing with which cue stimuli reduce uncertainty in the action selection process. The second account (the levels-of-abstraction hypothesis) suggests that the anterior-posterior organization of lateral PFC is based on the degree of abstraction of the task goals. The current study began by investigating these two hypotheses, and identified several areas of lateral PFC that were predicted to be active by both the information cascade and levels-of-abstraction accounts. However, the pattern of activation across experimental conditions was inconsistent with both theoretical accounts. Specifically, an anterior area of mid-dorsolateral PFC exhibited sensitivity to experimental conditions that, according to both accounts, should have selectively engaged only posterior areas of PFC. We therefore investigated a third possible account (the adaptive context maintenance hypothesis) that postulates that both posterior and anterior regions of PFC are reliably engaged in task conditions requiring active maintenance of contextual information, with the temporal dynamics of activity in these regions flexibly tracking the duration of maintenance demands. Activity patterns in lateral PFC were consistent with this third hypothesis: regions across lateral PFC exhibited transient activation when contextual information had to be updated and maintained in a trial-by-trial manner, but sustained activation when contextual information had to be maintained over a series of trials. These findings prompt a reconceptualization of current views regarding the anterior-posterior organization of lateral PFC, but do support other findings regarding the active maintenance role of lateral PFC in sequential working memory paradigms.	[Reynolds, Jeremy R.] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [O'Reilly, Randall C.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Cohen, Jonathan D.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Cohen, Jonathan D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	University of Denver; University of Colorado System; University of Colorado Boulder; Princeton University; Princeton University; Washington University (WUSTL)	Reynolds, JR (corresponding author), Univ Denver, Dept Psychol, Denver, CO 80208 USA.	jeremy.reynolds@psy.du.edu		O'Reilly, Randall/0000-0003-0322-4600; Braver, Todd/0000-0002-2631-3393	National Institute of Mental Health [MH069597, 2 RO1 MH66078]; National Research Service Award [5F32MH07530002]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066078, R01MH069597] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by grants MH069597 and 2 RO1 MH66078 from the National Institute of Mental Health, and a National Research Service Award (5F32MH07530002). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Botvinick MM, 2007, PHILOS T R SOC B, V362, P1615, DOI 10.1098/rstb.2007.2056; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Braver T S, 1999, Prog Brain Res, V121, P327; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Burgess GC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012861; Christoff K, 2009, BRAIN RES, V1286, P94, DOI 10.1016/j.brainres.2009.05.096; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Conturo T. E., 1996, Society for Neuroscience Abstracts, V22, P7; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Fales CL, 2008, COGN AFFECT BEHAV NE, V8, P239, DOI 10.3758/CABN.8.3.239; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Holmes AJ, 2005, SCHIZOPHR RES, V76, P199, DOI 10.1016/j.schres.2005.01.021; Jimura K, 2010, CEREB CORTEX, V20, P1420, DOI 10.1093/cercor/bhp206; Kim C, 2011, J NEUROSCI, V31, P4771, DOI 10.1523/JNEUROSCI.5923-10.2011; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Lenartowicz A, 2010, COGN AFFECT BEHAV NE, V10, P298, DOI 10.3758/CABN.10.2.298; MacDonald AW, 2005, AM J PSYCHIAT, V162, P475, DOI 10.1176/appi.ajp.162.3.475; MacDonald AW, 2003, J ABNORM PSYCHOL, V112, P689, DOI 10.1037/0021-843X.112.4.689; Marklund P, 2007, NEUROIMAGE, V36, P1361, DOI 10.1016/j.neuroimage.2007.03.058; Marklund P, 2007, CORTEX, V43, P22, DOI 10.1016/S0010-9452(08)70443-X; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 1996, J NEUROSCI, V16, P5154; Mozer MC, 2009, ADV NEURAL INFORM PR, V21, P1353; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Perlstein WM, 2003, BIOL PSYCHIAT, V53, P25, DOI 10.1016/S0006-3223(02)01675-X; Reynolds JR, 2009, COGNITION, V113, P281, DOI 10.1016/j.cognition.2009.05.015; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Rowe JB, 2001, NEUROIMAGE, V14, P77, DOI 10.1006/nimg.2001.0784; Ruge H, 2009, NEUROPSYCHOLOGIA, V47, P1670, DOI 10.1016/j.neuropsychologia.2009.02.004; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; Talairach J., 1988, COPLANAR STEREOTAXIC; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006	55	55	55	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30284	10.1371/journal.pone.0030284	http://dx.doi.org/10.1371/journal.pone.0030284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355309	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300009
J	Kesanakurti, D; Chetty, C; Dinh, DH; Gujrati, M; Rao, JS				Kesanakurti, D.; Chetty, C.; Dinh, D. H.; Gujrati, M.; Rao, J. S.			Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with alpha 5 beta 1 integrin in glioma	ONCOGENE			English	Article						MMP-2; alpha 5 beta 1; glioma; IL-6; STAT3; CyclinD1	BREAST-CARCINOMA CELLS; MATRIX METALLOPROTEINASE-2; CANCER CELLS; ALPHA(5)BETA(1) INTEGRIN; STAT3 ACTIVATION; TUMOR INVASION; KAPPA-B; EXPRESSION; GROWTH; APOPTOSIS	Matrix metalloproteinase-2 (MMP-2) has pivotal role in the degradation of extracellular matrix, and thereby enhances the invasive, proliferative and metastatic potential in cancer. Knockdown of MMP-2 using MMP-2 small interfering RNA (pM) in human glioma xenograft cell lines 4910 and 5310 decreased cell proliferation compared with mock and pSV (scrambled vector) treatments, as determined by 5-bromo-2'-deoxyuridine incorporation, Ki-67 staining and clonogenic survival assay. Cytokine array and western blotting using tumor-conditioned media displayed modulated secretory levels of various cytokines including granulocyte-macrophage colony-stimulating factor, interleukin-6 (IL-6), IL-8, IL-10, tumor necrosis factor-alpha, angiogenin, vascular endothelial growth factor and PDGF-BB in MMP-2 knockdown cells. Further, cDNA PCR array indicated potential negative regulation of Janus kinase/Stat3 pathway in pM-treated cells. Mechanistically, MMP-2 is involved in complex formation with alpha 5 and beta 1 integrins and MMP-2 downregulation inhibited alpha 5 beta 1 integrin-mediated Stat3 phosphorylation and nuclear translocation. Electrophoretic mobility shift assay and chromatin immunoprecipitation assays showed inhibited Stat3 DNA-binding activity and recruitment at CyclinD1 and c-Myc promoters in pM-treated cells. In individual experiments, IL-6 or siRNA-insensitive MMP-2 overexpression by pM-FL-A141G counteracted and restored the pM-inhibited Stat3 DNA-binding activity, suggesting IL-6/Stat3 signaling suppression in pM-treated 4910 and 5310 cells. MMP-2/alpha 5 beta 1 binding is enhanced in human recombinant MMP-2 treatments, resulting in elevated Stat3 DNA-binding activity and recruitment on CyclinD1 and c-Myc promoters. Activation of alpha 5 beta 1 signaling by Fibronectin adhesion elevated pM-inhibited Stat3 phosphorylation whereas blocking alpha 5 beta 1 abrogated constitutive Stat3 activation. In vivo experiments with orthotropic tumor model revealed the decreased tumor size in pM treatment compared with mock or pSV treatments. Innmunofluorescence studies in tumor sections corroborated our in vitro findings evidencing high expression and co-localization of MMP-2/alpha 5 beta 1, which is decreased upon pM treatment along with significantly reduced IL-6, phospho-Stat3, CyclinD1, c-Myc, Ki-67 and PCNA expression levels. Our data indicate the possible role of MMP-2/alpha 5 beta 1 interaction in the regulation of alpha 5 beta 1-mediated IL-6/Stat3 signaling activation and signifies the therapeutic potential of blocking MMP-2/alpha 5 beta 1 interaction in glioma treatment. Oncogene (2013) 32, 327-340; doi:10.1038/onc.2012.52; published online 20 February 2012	[Kesanakurti, D.; Chetty, C.; Rao, J. S.] Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA; [Dinh, D. H.; Rao, J. S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL 61605 USA; [Gujrati, M.] Univ Illinois, Coll Med Peoria, Dept Pathol, Peoria, IL 61605 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Rao, JS (corresponding author), Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, 1 Illini Dr, Peoria, IL 61605 USA.	jsrao@uic.edu			National Institute of Neurological Disorders and Stroke [NS64535-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064535] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Shellee Abraham for manuscript preparation and Diana Meister and Sushma Jasti for manuscript review. This research was supported by award NS64535-01A2 (to JSR) from the National Institute of Neurological Disorders and Stroke.	Aoudjit F, 2001, ONCOGENE, V20, P4995, DOI 10.1038/sj.onc.1204554; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Badiga AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020614; Bhaskar V, 2008, INVEST NEW DRUG, V26, P7, DOI 10.1007/s10637-007-9078-z; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chetty C, 2006, MOL CANCER THER, V5, P2289, DOI 10.1158/1535-7163.MCT-06-0169; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Courter DL, 2005, J BIOL CHEM, V280, P12145, DOI 10.1074/jbc.M412555200; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Farber K, 2008, MOL CELL NEUROSCI, V39, P579, DOI 10.1016/j.mcn.2008.08.005; Galatioto J, 2010, J CELL SCI, V123, P3789, DOI 10.1242/jcs.073387; Ganji PCN, 2011, MOL CANCER RES, V9, P51, DOI 10.1158/1541-7786.MCR-10-0399; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Han X., 2010, EUR J CLIN MED ONCOL, V2, P59; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Hsu CP, 2011, EUR J CLIN INVEST, V41, P277, DOI 10.1111/j.1365-2362.2010.02405.x; Huang C, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-51; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Kesanakurti D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019341; Kesanakurti D, 2009, BIOCHEM BIOPH RES CO, V390, P427, DOI 10.1016/j.bbrc.2009.09.046; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khalili P, 2006, MOL CANCER THER, V5, P2271, DOI 10.1158/1535-7163.MCT-06-0100; Klein S, 2002, MOL CELL BIOL, V22, P5912, DOI 10.1128/MCB.22.16.5912-5922.2002; Korah R, 2004, CANCER RES, V64, P4514, DOI 10.1158/0008-5472.CAN-03-3853; Lee BH, 2005, J CELL BIOCHEM, V95, P1214, DOI 10.1002/jcb.20488; Levkau B, 2002, CELL DEATH DIFFER, V9, P1360, DOI 10.1038/sj.cdd.4401106; Levy DE, 2006, P NATL ACAD SCI USA, V103, P10151, DOI 10.1073/pnas.0604042103; Li RH, 2010, ONCOL REP, V23, P1553, DOI 10.3892/or_00000795; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Maglott A, 2006, CANCER RES, V66, P6002, DOI 10.1158/0008-5472.CAN-05-4105; Martinkova E, 2010, INT J CANCER, V127, P1240, DOI 10.1002/ijc.25187; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; Melet A, 2008, ADV EXP MED BIOL, V615, P47, DOI 10.1007/978-1-4020-6554-5_4; Mino K, 2011, CANCER SCI, V102, P1052, DOI 10.1111/j.1349-7006.2011.01901.x; Mitra Aparna, 2003, Journal of Environmental Pathology Toxicology and Oncology, V22, P167, DOI 10.1615/JEnvPathToxOncol.v22.i3.20; Morgan MR, 2004, J BIOL CHEM, V279, P26533, DOI 10.1074/jbc.M401736200; Morozevich GE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P791, DOI 10.1134/S0006297908070079; Morozevich G, 2009, CELL CYCLE, V8, P2219, DOI 10.4161/cc.8.14.8980; Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Rahaman SO, 2002, ONCOGENE, V21, P8404, DOI 10.1038/sj.onc.1206047; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rojas A, 2011, ONCOGENE, V30, P2345, DOI 10.1038/onc.2010.605; Salgado R, 2003, INT J CANCER, V103, P642, DOI 10.1002/ijc.10833; Senft C, 2011, J NEURO-ONCOL, V101, P393, DOI 10.1007/s11060-010-0273-y; Shain KH, 2009, CANCER RES, V69, P1009, DOI 10.1158/0008-5472.CAN-08-2419; Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298; Song LX, 2011, MOL CANCER THER, V10, P481, DOI 10.1158/1535-7163.MCT-10-0502; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Weissenberger J, 2004, ONCOGENE, V23, P3308, DOI 10.1038/sj.onc.1207455; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Zhang XY, 2009, ANTICANCER RES, V29, P4497	59	83	88	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2013	32	3					327	340		10.1038/onc.2012.52	http://dx.doi.org/10.1038/onc.2012.52			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	087BP	22349830	Green Accepted			2022-12-25	WOS:000314736600007
J	Kuhbacher, A; Dambournet, D; Echard, A; Cossart, P; Pizarro-Cerda, J				Kuehbacher, Andreas; Dambournet, Daphne; Echard, Arnaud; Cossart, Pascale; Pizarro-Cerda, Javier			Phosphatidylinositol 5-Phosphatase Oculocerebrorenal Syndrome of Lowe Protein (OCRL) Controls Actin Dynamics during Early Steps of Listeria monocytogenes Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE METABOLISM; MEMBRANE TRAFFICKING; BACTERIAL PATHOGENS; MET RECEPTOR; INVASION; 3-KINASE; BINDING; CELLS; PATHWAY; KINASE	Listeria monocytogenes is a bacterial pathogen that induces its own entry into a broad range of mammalian cells through interaction of the bacterial surface protein InlB with the cellular receptor Met, promoting an actin polymerization/depolymerization process that leads to pathogen engulfment. Phosphatidylinositol bisphosphate (PI[4,5]P-2) and trisphosphate (PI[3,4,5]P-3) are two major phosphoinositide species that function as molecular scaffolds, recruiting cellular effectors that regulate actin dynamics during L. monocytogenes infection. Because the phosphatidylinositol 5'-phosphatase OCRL dephosphorylates PI(4,5)P-2 and to a lesser extent PI(3,4,5)P-3, we investigated whether this phosphatase modulates cell invasion by L. monocytogenes. Inactivation of OCRL by small interfering RNA( siRNA) leads to an increase in the internalization levels of L. monocytogenes in HeLa cells. Interestingly, OCRL depletion does not increase but rather decreases the surface expression of the receptor Met, suggesting that OCRL controls bacterial internalization by modulating signaling cascades downstream of Met. Immuno-fluorescence microscopy reveals that endogenous and overexpressed OCRL are present at L. monocytogenes invasion foci; live-cell imaging additionally shows that actin depolymerization coincides with EGFP-OCRL-a accumulation around invading bacteria. Together, these observations suggest that OCRL promotes actin depolymerization during L. monocytogenes infection; in agreement with this hypothesis, OCRL depletion leads to an increase in actin, PI(4,5)P-2, and PI(3,4,5)P3 levels at bacterial internalization foci. Furthermore, in cells knocked down for OCRL, transfection of enzymatically active EGFP-OCRL-a (but not of a phosphatase-dead enzyme) decreases the levels of intracellular L. monocytogenes and of actin associated with invading bacteria. These results demonstrate that through its phosphatase activity, OCRL restricts L. monocytogenes invasion by modulating actin dynamics at bacterial internalization sites.	[Kuehbacher, Andreas; Cossart, Pascale; Pizarro-Cerda, Javier] Inst Pasteur, INSERM, U604, Unite Interact Bacteries Cellules,INRA,USC2020, F-75724 Paris 15, France; [Dambournet, Daphne] Univ Paris 06, Cellule Pasteur UPMC, F-75015 Paris, France; [Dambournet, Daphne; Echard, Arnaud] Inst Pasteur, Unite Traff Membranaire, F-75724 Paris 15, France; [Dambournet, Daphne; Echard, Arnaud] Inst Pasteur, Div Cellulaire, F-75724 Paris 15, France; [Dambournet, Daphne; Echard, Arnaud] CNRS, URA2582, F-75015 Paris, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Pizarro-Cerda, J (corresponding author), Inst Pasteur, INSERM, U604, Unite Interact Bacteries Cellules,INRA,USC2020, 28 Rue Docteur Roux, F-75724 Paris 15, France.	pizarroj@pasteur.fr		Echard, Arnaud/0000-0001-7402-1398	Pasteur Institute; European Research Council [233348]; INSERM; INRA; CNRS; Louis-Jeantet Foundation; La Fondation Le Roch-Les Mousquetaires; Agence Nationale de la Recherche [ANR-09-MIEN-020, ANR-07-JCJC-0089]; Schlumberger Foundation for Education and Research; Ministere de la Recherche et de l'Enseignement Superieur; Association pour la Recherche sur le Cancer; Institut Carnot Maladies Infectieuses	Pasteur Institute; European Research Council(European Research Council (ERC)European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; CNRS(Centre National de la Recherche Scientifique (CNRS)); Louis-Jeantet Foundation; La Fondation Le Roch-Les Mousquetaires; Agence Nationale de la Recherche(French National Research Agency (ANR)); Schlumberger Foundation for Education and Research(Schlumberger); Ministere de la Recherche et de l'Enseignement Superieur; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut Carnot Maladies Infectieuses	This work was supported by the Pasteur Institute, the European Research Council Grant 233348, INSERM, INRA, CNRS, the Louis-Jeantet Foundation, La Fondation Le Roch-Les Mousquetaires, Agence Nationale de la Recherche Grant ANR-09-MIEN-020 (to P. C.) and Grant ANR-07-JCJC-0089 (to A. E.), and the Schlumberger Foundation for Education and Research (to A. E.).; Recipient of a scholarship from the Pasteur-Paris University International Doctoral Program/Institut Carnot Maladies Infectieuses.; Supported by the Ministere de la Recherche et de l'Enseignement Superieur and by the Association pour la Recherche sur le Cancer.	Bierne H, 2005, J CELL SCI, V118, P1537, DOI 10.1242/jcs.02285; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Choudhury R, 2009, J BIOL CHEM, V284, P9965, DOI 10.1074/jbc.M807442200; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; El Kadhi KB, 2011, CURR BIOL, V21, P1074, DOI 10.1016/j.cub.2011.05.030; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Hou XM, 2011, EMBO J, V30, P1659, DOI 10.1038/emboj.2011.60; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Lawrence DW, 2012, IMMUNOL INVEST, V41, P129, DOI 10.3109/08820139.2011.595471; Loi M, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-16; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; Mao YX, 2009, EMBO J, V28, P1831, DOI 10.1038/emboj.2009.155; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Moorhead AM, 2010, INFECT IMMUN, V78, P1990, DOI 10.1128/IAI.01340-09; Noakes CJ, 2011, MOL BIOL CELL, V22, P606, DOI 10.1091/mbc.E10-08-0730; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Pizarro-Cerda J, 2002, METHOD MICROBIOL, V31, P161, DOI 10.1016/S0580-9517(02)31009-2; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Pizarro-Cerda J, 2009, ANNU REV CELL DEV BI, V25, P649, DOI 10.1146/annurev.cellbio.042308.113331; Seveau S, 2007, CELL MICROBIOL, V9, P790, DOI 10.1111/j.1462-5822.2006.00832.x; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Swan LE, 2010, P NATL ACAD SCI USA, V107, P3511, DOI 10.1073/pnas.0914658107; Vicinanza M, 2011, EMBO J, V30, P4970, DOI 10.1038/emboj.2011.354; Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	28	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13128	13136		10.1074/jbc.M111.315788	http://dx.doi.org/10.1074/jbc.M111.315788			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351770	Green Published, hybrid			2022-12-25	WOS:000302903700052
J	Whitham, M; Chan, MHS; Pal, M; Matthews, VB; Prelovsek, O; Lunk, S; El-Osta, A; Broenneke, H; Alber, J; Bruning, JC; Wunderlich, FT; Lancaster, GI; Febbraio, MA				Whitham, Martin; Chan, M. H. Stanley; Pal, Martin; Matthews, Vance B.; Prelovsek, Oja; Lunk, Sebastian; El-Osta, Assam; Broenneke, Hella; Alber, Jens; Bruening, Jens C.; Wunderlich, F. Thomas; Lancaster, Graeme I.; Febbraio, Mark A.			Contraction-induced Interleukin-6 Gene Transcription in Skeletal Muscle Is Regulated by c-Jun Terminal Kinase/Activator Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; HUMAN MONOCYTES; NH2-TERMINAL KINASE; EXERCISE; INDUCTION; CALCINEURIN; LIPOPOLYSACCHARIDE; ASSOCIATION; SPECIFICITY; ACTIVATION	Exercise increases the expression of the prototypical myokine IL-6, but the precise mechanism by which this occurs has yet to be identified. To mimic exercise conditions, C2C12 myotubes were mechanically stimulated via electrical pulse stimulation (EPS). We compared the responses of EPS with the pharmacological Ca2+ carrier calcimycin (A23187) because contraction induces marked increases in cytosolic Ca2+ levels or the classical I kappa B kinase/NF kappa B inflammatory response elicited by H2O2. We demonstrate that, unlike H2O2-stimulated increases in IL-6 mRNA, neither calcimycin- nor EPS-induced IL-6 mRNA expression is under the transcriptional control of NF kappa B. Rather, we show that EPS increased the phosphorylation of JNK and the reporter activity of the downstream transcription factor AP-1. Furthermore, JNK inhibition abolished the EPS-induced increase in IL-6 mRNA and protein expression. Finally, we observed an exercise-induced increase in both JNK phosphorylation and IL-6 mRNA expression in the skeletal muscles of mice after 30 min of treadmill running. Importantly, exercise did not increase IL-6 mRNA expression in skeletal muscle-specific JNK-deficient mice. These data identify a novel contraction-mediated transcriptional regulatory pathway for IL-6 in skeletal muscle.	[Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Div Obes & Metab, Melbourne, Vic 8008, Australia; [Lunk, Sebastian; El-Osta, Assam] Baker IDI Heart & Diabet Inst, Epigenet Human Hlth & Dis Lab, Melbourne, Vic 8008, Australia; [Pal, Martin; Bruening, Jens C.; Wunderlich, F. Thomas] Univ Cologne, Max Planck Inst Neurol Res, Inst Genet, D-50931 Cologne, Germany; [Pal, Martin; Bruening, Jens C.; Wunderlich, F. Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, CMMC, D-50931 Cologne, Germany; [Pal, Martin; Bruening, Jens C.; Wunderlich, F. Thomas] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, D-50931 Cologne, Germany; [Broenneke, Hella; Alber, Jens] CECAD, Phenotyping Facil, D-50674 Cologne, Germany	Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Febbraio, MA (corresponding author), Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Div Obes & Metab, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	mark.febbraio@bakeridi.edu.au	Febbraio, Mark/AAE-9632-2019; Whitham, Martin/L-1242-2019; Pal, Martin/AAL-8685-2020	Whitham, Martin/0000-0002-0254-762X; Pal, Martin/0000-0002-1563-5426; Chan, Stanley/0000-0002-4103-9441; Febbraio, Mark/0000-0002-9296-4418; El-Osta, Assam/0000-0001-7968-7375; El-Osta, Assam/0000-0003-2969-9137	National Health and Medical Research Council of Australia (NHMRC) [526606]; Victorian Government	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Grant 526606 and the Victorian Government Operational Infrastructure Support Program.	Allen DL, 2010, AM J PHYSIOL-REG I, V298, pR198, DOI 10.1152/ajpregu.00325.2009; Aronson D, 1997, J BIOL CHEM, V272, P25636, DOI 10.1074/jbc.272.41.25636; Aronson D, 1998, BIOCHEM BIOPH RES CO, V251, P106, DOI 10.1006/bbrc.1998.9435; BALON TW, 1994, J APPL PHYSIOL, V77, P2519, DOI 10.1152/jappl.1994.77.6.2519; Banzet S, 2005, J PHYSIOL-LONDON, V566, P839, DOI 10.1113/jphysiol.2005.089193; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Carey AL, 2004, DIABETOLOGIA, V47, P1029, DOI 10.1007/s00125-004-1403-x; Chan MHS, 2004, FASEB J, V18, P1785, DOI 10.1096/fj.03-1039fje; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Frost RA, 2003, AM J PHYSIOL-REG I, V285, pR1153, DOI 10.1152/ajpregu.00164.2003; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Holmes AG, 2004, METABOLISM, V53, P1492, DOI 10.1016/j.metabol.2004.05.015; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Keller C, 2006, CYTOKINE, V36, P141, DOI 10.1016/j.cyto.2006.10.014; Kramer HF, 2007, J APPL PHYSIOL, V103, P388, DOI 10.1152/japplphysiol.00085.2007; Kreutz M, 1997, IMMUNOLOGY, V92, P396, DOI 10.1046/j.1365-2567.1997.00365.x; MALEFYT RD, 1991, J EXP MED, V174, P1209; Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1; McGee SL, 2006, FASEB J, V20, P348, DOI 10.1096/fj.05-4671fje; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nedachi T, 2009, AM J PHYSIOL-ENDOC M, V297, pE866, DOI 10.1152/ajpendo.00104.2009; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Petersen AC, 2012, ACTA PHYSIOL, V204, P382, DOI 10.1111/j.1748-1716.2011.02344.x; Rohrbach S, 2007, MOL MED, V13, P605, DOI 10.2119/2007-00071.Rohrbach; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Steensberg A, 2007, FASEB J, V21, P2683, DOI 10.1096/fj.06-7477com; Tantiwong P, 2010, AM J PHYSIOL-ENDOC M, V299, pE794, DOI 10.1152/ajpendo.00776.2009	32	74	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10771	10779		10.1074/jbc.M111.310581	http://dx.doi.org/10.1074/jbc.M111.310581			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22351769	Green Published, hybrid			2022-12-25	WOS:000302780100006
J	Hall-Glenn, F; De Young, RA; Huang, BL; van Handel, B; Hofmann, JJ; Chen, TT; Choi, A; Ong, JR; Benya, PD; Mikkola, H; Iruela-Arispe, ML; Lyons, KM				Hall-Glenn, Faith; De Young, R. Andrea; Huang, Bau-Lin; van Handel, Ben; Hofmann, Jennifer J.; Chen, Tom T.; Choi, Aaron; Ong, Jessica R.; Benya, Paul D.; Mikkola, Hanna; Iruela-Arispe, M. Luisa; Lyons, Karen M.			CCN2/Connective Tissue Growth Factor Is Essential for Pericyte Adhesion and Endothelial Basement Membrane Formation during Angiogenesis	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PRODUCTION; FACTOR CTGF/CCN2; FACTOR CTGF; FACTOR CCN2; PDGF-B; INTEGRIN ALPHA(V)BETA(3); GENE-EXPRESSION; CELL-ADHESION; MIGRATION; MOUSE	CCN2/Connective Tissue Growth Factor (CTGF) is a matricellular protein that regulates cell adhesion, migration, and survival. CCN2 is best known for its ability to promote fibrosis by mediating the ability of transforming growth factor beta (TGF beta) to induce excess extracellular matrix production. In addition to its role in pathological processes, CCN2 is required for chondrogenesis. CCN2 is also highly expressed during development in endothelial cells, suggesting a role in angiogenesis. The potential role of CCN2 in angiogenesis is unclear, however, as both pro- and anti-angiogenic effects have been reported. Here, through analysis of Ccn2-deficient mice, we show that CCN2 is required for stable association and retention of pericytes by endothelial cells. PDGF signaling and the establishment of the endothelial basement membrane are required for pericytes recruitment and retention. CCN2 induced PDGF-B expression in endothelial cells, and potentiated PDGF-B mediated Akt signaling in mural (vascular smooth muscle/pericyte) cells. In addition, CCN2 induced the production of endothelial basement membrane components in vitro, and was required for their expression in vivo. Overall, these results highlight CCN2 as an essential mediator of vascular remodeling by regulating endothelial-pericyte interactions. Although most studies of CCN2 function have focused on effects of CCN2 overexpression on the interstitial extracellular matrix, the results presented here show that CCN2 is required for the normal production of vascular basement membranes.	[Hall-Glenn, Faith; van Handel, Ben; Hofmann, Jennifer J.; Chen, Tom T.; Ong, Jessica R.; Mikkola, Hanna; Iruela-Arispe, M. Luisa; Lyons, Karen M.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA; [De Young, R. Andrea; Choi, Aaron; Benya, Paul D.; Lyons, Karen M.] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA USA; [Huang, Bau-Lin] Univ Calif Los Angeles, Dept Oral Biol, Los Angeles, CA USA; [Hofmann, Jennifer J.; Iruela-Arispe, M. Luisa; Lyons, Karen M.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Iruela-Arispe, M. Luisa; Lyons, Karen M.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Hall-Glenn, F (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA.	klyons@mednet.ucla.edu	Iruela-Arispe, M. Luisa/AAJ-1297-2020; Huang, Bau-Lin/S-4133-2019; Huang, Bau-Lin/K-8317-2019; Benya, Paul/I-3449-2015	Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Huang, Bau-Lin/0000-0003-3747-6697; Benya, Paul/0000-0002-1060-7127; Ong, Jessica/0000-0001-5925-8047	NIH [AR052686, HL097766]; Scleroderma Foundation; Jonsson Comprehensive Cancer Center; UCLA [HL069766]; Ruth L. Kirschstein National Research Service [T32HL69766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097766, T32HL069766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR060687, R01AR052686] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Foundation; Jonsson Comprehensive Cancer Center; UCLA; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH AR052686, Scleroderma Foundation, and the Jonsson Comprehensive Cancer Center, UCLA (KML), UCLA Vascular Biology Training Grant HL069766 and Ruth L. Kirschstein National Research Service Award T32HL69766 (FHG), and NIH HL097766 (HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Arnott JA, 2007, J CELL PHYSIOL, V210, P843, DOI 10.1002/jcp.20917; Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Basciani S, 2002, J CLIN ENDOCR METAB, V87, P2310, DOI 10.1210/jc.87.5.2310; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Brigstock DR, 2010, J CELL COMMUN SIGNAL, V4, P1, DOI 10.1007/s12079-009-0071-5; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Brugger SM, 2004, DEVELOPMENT, V131, P5153, DOI 10.1242/dev.01390; Cattaruzza S, 2002, J BIOL CHEM, V277, P47626, DOI 10.1074/jbc.M206521200; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chen YJ, 2001, EXP CELL RES, V271, P109, DOI 10.1006/excr.2001.5364; Chen YL, 2004, MOL BIOL CELL, V15, P5635, DOI 10.1091/mbc.E04-06-0490; Chien WW, 2011, INT J ONCOL, V38, P1741, DOI 10.3892/ijo.2011.985; Choi J, 2011, DEVELOPMENT, V138, P1173, DOI 10.1242/dev.054049; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Favor J, 2007, GENETICS, V175, P725, DOI 10.1534/genetics.106.064733; Friedrichsen S, 2005, GROWTH FACTORS, V23, P43, DOI 10.1080/08977190512331340566; Friedrichsen S, 2003, CELL TISSUE RES, V312, P175, DOI 10.1007/s00441-003-0712-6; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gao R, 2006, GUT, V55, P856, DOI 10.1136/gut.2005.079178; Gao RP, 2005, GASTROENTEROLOGY, V129, P1019, DOI 10.1053/j.gastro.2005.06.067; Gao RP, 2004, J BIOL CHEM, V279, P8848, DOI 10.1074/jbc.M313204200; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Guha M, 2007, FASEB J, V21, P3355, DOI 10.1096/fj.06-6713com; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Heng ECK, 2006, J CELL BIOCHEM, V98, P409, DOI 10.1002/jcb.20810; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; Huang BL, 2010, J BIOL CHEM, V285, P27702, DOI 10.1074/jbc.M110.108498; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; Kale S, 2004, FASEB J, V18, P270, DOI 10.1096/fj.04-1604fje; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kuiper EJ, 2008, J HISTOCHEM CYTOCHEM, V56, P785, DOI 10.1369/jhc.2008.950980; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Nguyen TQ, 2008, J AM SOC NEPHROL, V19, P2098, DOI 10.1681/ASN.2007111261; Nishida T, 2007, J CELL COMMUN SIGNAL, V1, P45, DOI 10.1007/s12079-007-0005-z; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; RISAU W, 1988, DEV BIOL, V125, P441, DOI 10.1016/0012-1606(88)90225-4; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Shimo T, 2001, ONCOLOGY-BASEL, V61, P315, DOI 10.1159/000055339; Simon-Assmann P, 2011, INT J DEV BIOL, V55, P455, DOI 10.1387/ijdb.103223ps; Sonnylal S, 2010, ARTHRITIS RHEUM-US, V62, P1523, DOI 10.1002/art.27382; Steffen CL, 1998, GROWTH FACTORS, V15, P199, DOI 10.3109/08977199809002117; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Surveyor GA, 1999, GROWTH FACTORS, V17, P115, DOI 10.3109/08977199909103520; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; Van Handel B, 2010, BLOOD, V116, P3321, DOI 10.1182/blood-2010-04-279489; Vorwerk P, 2002, ENDOCRINOLOGY, V143, P1677, DOI 10.1210/en.143.5.1677; Wight TN, 2008, FRONT BIOSCI, V13, P4933, DOI 10.2741/3052; Yokoi H, 2002, AM J PHYSIOL-RENAL, V282, pF933, DOI 10.1152/ajprenal.00122.2001; Yoshida K, 2007, BBA-GEN SUBJECTS, V1770, P672, DOI 10.1016/j.bbagen.2006.11.010	70	91	97	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30562	10.1371/journal.pone.0030562	http://dx.doi.org/10.1371/journal.pone.0030562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363445	Green Submitted, Green Published, gold			2022-12-25	WOS:000302871500011
J	Zhang, AB; Feng, J; Ward, RD; Wan, P; Gao, Q; Wu, J; Zhao, WZ				Zhang, Ai-bing; Feng, Jie; Ward, Robert D.; Wan, Ping; Gao, Qiang; Wu, Jun; Zhao, Wei-zhong			A New Method for Species Identification via Protein-Coding and Non-Coding DNA Barcodes by Combining Machine Learning with Bioinformatic Methods	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; 2-D GRAPHICAL REPRESENTATION; PROPAGATION NEURAL-NETWORKS; CLASSIFICATION; TAXONOMY; LIFE; BACKPROPAGATION; OPTIMIZATION; DELIMITATION; LEPIDOPTERA	Species identification via DNA barcodes is contributing greatly to current bioinventory efforts. The initial, and widely accepted, proposal was to use the protein-coding cytochrome c oxidase subunit I (COI) region as the standard barcode for animals, but recently non- coding internal transcribed spacer (ITS) genes have been proposed as candidate barcodes for both animals and plants. However, achieving a robust alignment for non-coding regions can be problematic. Here we propose two new methods (DV-RBF and FJ-RBF) to address this issue for species assignment by both coding and non-coding sequences that take advantage of the power of machine learning and bioinformatics. We demonstrate the value of the new methods with four empirical datasets, two representing typical protein-coding COI barcode datasets (neotropical bats and marine fish) and two representing non- coding ITS barcodes (rust fungi and brown algae). Using two random sub-sampling approaches, we demonstrate that the new methods significantly outperformed existing Neighbor-joining (NJ) and Maximum likelihood (ML) methods for both coding and non- coding barcodes when there was complete species coverage in the reference dataset. The new methods also out-performed NJ and ML methods for non- coding sequences in circumstances of potentially incomplete species coverage, although then the NJ and ML methods performed slightly better than the new methods for protein-coding barcodes. A 100% success rate of species identification was achieved with the two new methods for 4,122 bat queries and 5,134 fish queries using COI barcodes, with 95% confidence intervals (CI) of 99.75-100%. The new methods also obtained a 96.29% success rate (95% CI: 91.62-98.40%) for 484 rust fungi queries and a 98.50% success rate (95% CI: 96.60-99.37%) for 1094 brown algae queries, both using ITS barcodes.	[Zhang, Ai-bing; Wan, Ping; Gao, Qiang; Wu, Jun] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Feng, Jie; Zhao, Wei-zhong] Capital Normal Univ, Sch Math Sci, Beijing, Peoples R China; [Ward, Robert D.] CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia	Capital Normal University; Capital Normal University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Zhang, AB (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	zhangab2008@mail.cnu.edu.cn	Ward, Robert D/A-2319-2012	zhang, ai bing/0000-0002-6580-5462; ZHANG, Ai-bing/0000-0003-3450-5421	Beijing Municipal Natural Science Foundation [KZ201010028028]; Natural Science Foundation of China [31071963]; Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality [PHR201107120]; Research Fund for the Doctoral Program of Higher Education [20101108120002]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This study was supported by Beijing Municipal Natural Science Foundation Key Projects (Grant No. KZ201010028028 to AZ), by Natural Science Foundation of China (Grant No. 31071963 to AZ), by Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality (Grant No. PHR201107120 to AZ), and by The Research Fund for the Doctoral Program of Higher Education (Grant No. 20101108120002 to AZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Babu AS, 2010, INT J COMPUT SCI ENG, V2, P80; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; Chu KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S8; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dopazo J, 1997, J MOL EVOL, V44, P226, DOI 10.1007/PL00006139; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Giribet G, 2001, CLADISTICS, V17, pS60, DOI 10.1111/j.1096-0031.2001.tb00105.x; Gladstein DS, 1997, POY OPTIMIZATION ALI; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Jolliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuksa P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Liao B, 2005, CHEM PHYS LETT, V414, P296, DOI 10.1016/j.cplett.2005.08.079; Lou M, 2010, MOL PHYLOGENET EVOL, V56, P187, DOI 10.1016/j.ympev.2010.01.002; Marshall E, 2005, SCIENCE, V307, P1037, DOI 10.1126/science.307.5712.1037; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Park J, 1991, NEURAL COMPUT, V3, P246, DOI 10.1162/neco.1991.3.2.246; Parker DB, 1987, P IEEE INT C NEUR NE, V2, P593; Prendini L, 2005, CAN J ZOOL, V83, P498, DOI 10.1139/Z05-025; Randic M, 2003, CHEM PHYS LETT, V368, P1, DOI 10.1016/S0009-2614(02)01784-0; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Seo TK, 2010, J MOL EVOL, V71, P250, DOI 10.1007/s00239-010-9380-9; Silva-Brandao KL, 2009, NEOTROP ENTOMOL, V38, P441, DOI 10.1590/S1519-566X2009000400001; Smith M, 1993, NEURAL NETWORKS STAT; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamhane AC, 2000, STAT DATA ANAL ELEME; Wang HC, 1998, PROTEIN SCI, V7, P2613; Wang WP, 2006, INT J QUANTUM CHEM, V106, P1998, DOI 10.1002/qua.21001; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Werbos P.J., 1974, THESIS HARVARD U CAM; Wheeler W, 1996, CLADISTICS, V12, P1, DOI 10.1111/j.1096-0031.1996.tb00189.x; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wu C, 1995, MATH COMPUT SIMULAT, V40, P23, DOI 10.1016/0378-4754(95)00016-4; WU C, 1994, NUCLEIC ACIDS RES, V22, P4291, DOI 10.1093/nar/22.20.4291; Wu C, 1997, APPL INTELL, V7, P27, DOI 10.1023/A:1008228603783; Wu CH, 1997, COMPUT CHEM, V21, P237, DOI 10.1016/S0097-8485(96)00038-1; Zhang AB, 2008, SYST BIOL, V57, P202, DOI 10.1080/10635150802032982; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014; Zhang AB, 2009, MOL ECOL RESOUR, V9, P104, DOI 10.1111/j.1755-0998.2008.02372.x; Zhang ZJ, 2009, BIOINFORMATICS, V25, P1112, DOI 10.1093/bioinformatics/btp130	82	17	22	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30986	10.1371/journal.pone.0030986	http://dx.doi.org/10.1371/journal.pone.0030986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363527	Green Published, gold, Green Submitted			2022-12-25	WOS:000302871500023
J	Amos, JN; Bennett, AF; Mac Nally, R; Newell, G; Pavlova, A; Radford, JQ; Thomson, JR; White, M; Sunnucks, P				Amos, J. Nevil; Bennett, Andrew F.; Mac Nally, Ralph; Newell, Graeme; Pavlova, Alexandra; Radford, James Q.; Thomson, James R.; White, Matt; Sunnucks, Paul			Predicting Landscape-Genetic Consequences of Habitat Loss, Fragmentation and Mobility for Multiple Species of Woodland Birds	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; EXTINCTION DEBT; SOUTHERN AUSTRALIA; CIRCUIT-THEORY; FLOW; DISPERSAL; MODELS; DIFFERENTIATION; THRESHOLDS; INFERENCE	Inference concerning the impact of habitat fragmentation on dispersal and gene flow is a key theme in landscape genetics. Recently, the ability of established approaches to identify reliably the differential effects of landscape structure (e. g. land-cover composition, remnant vegetation configuration and extent) on the mobility of organisms has been questioned. More explicit methods of predicting and testing for such effects must move beyond post hoc explanations for single landscapes and species. Here, we document a process for making a priori predictions, using existing spatial and ecological data and expert opinion, of the effects of landscape structure on genetic structure of multiple species across replicated landscape blocks. We compare the results of two common methods for estimating the influence of landscape structure on effective distance: least-cost path analysis and isolation-by-resistance. We present a series of alternative models of genetic connectivity in the study area, represented by different landscape resistance surfaces for calculating effective distance, and identify appropriate null models. The process is applied to ten species of sympatric woodland-dependant birds. For each species, we rank a priori the expectation of fit of genetic response to the models according to the expected response of birds to loss of structural connectivity and landscape-scale tree-cover. These rankings (our hypotheses) are presented for testing with empirical genetic data in a subsequent contribution. We propose that this replicated landscape, multi-species approach offers a robust method for identifying the likely effects of landscape fragmentation on dispersal.	[Amos, J. Nevil; Mac Nally, Ralph; Pavlova, Alexandra; Thomson, James R.; Sunnucks, Paul] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Amos, J. Nevil; Mac Nally, Ralph; Pavlova, Alexandra; Thomson, James R.; Sunnucks, Paul] Monash Univ, Australian Ctr Biodivers, Melbourne, Vic 3004, Australia; [Bennett, Andrew F.; Radford, James Q.] Deakin Univ, Landscape Ecol Res Grp, Sch Life & Environm Sci, Burwood, Vic, Australia; [Newell, Graeme; White, Matt] Arthur Rylah Inst Environm Res, Dept Sustainabil & Environm, Heidelberg, Vic, Australia	Monash University; Monash University; Deakin University; Arthur Rylah Institute for Environmental Research (ARI)	Amos, JN (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	nevil.amos@monash.edu	Pavlova, Alexandra/H-4749-2014; Thomson, Jim/W-2950-2019	Pavlova, Alexandra/0000-0001-9455-4124; Sunnucks, Paul/0000-0002-8139-7059	Australian Research Council [LP0776322]; Victorian Department of Sustainability and Environment; Museum of Victoria; Victorian Department of Primary Industries; Parks Victoria; North Central Catchment Management Authority; Goulburn Broken Catchment Management Authority; Monash University; Birds Australia; Holsworth Wildlife Research Endowment	Australian Research Council(Australian Research Council); Victorian Department of Sustainability and Environment; Museum of Victoria; Victorian Department of Primary Industries; Parks Victoria; North Central Catchment Management Authority; Goulburn Broken Catchment Management Authority; Monash University(Monash University); Birds Australia; Holsworth Wildlife Research Endowment	This project was funded by Australian Research Council Linkage Project LP0776322, the Victorian Department of Sustainability and Environment, Museum of Victoria, Victorian Department of Primary Industries, Parks Victoria, North Central Catchment Management Authority, and Goulburn Broken Catchment Management Authority. JA was funded by Monash University Dean of Science Scholarship and a stipend from Birds Australia, and travel funded by Monash University and the Holsworth Wildlife Research Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Balkenhol N, 2011, MOL ECOL, V20, P667, DOI 10.1111/j.1365-294X.2010.04967.x; Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Balkenhol N, 2009, LANDSCAPE ECOL, V24, P455, DOI 10.1007/s10980-009-9334-z; Bates D., 2011, IME4 LINEAR MIXED EF; Bennett AF, 2009, CONSERV BIOL SER, P161; Broquet T, 2006, LANDSCAPE ECOL, V21, P877, DOI 10.1007/s10980-005-5956-y; Bull RAS, 2011, MOL ECOL, V20, P1092, DOI 10.1111/j.1365-294X.2010.04944.x; Callens T, 2011, MOL ECOL, V20, P1829, DOI 10.1111/j.1365-294X.2011.05028.x; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; Coulon A, 2004, MOL ECOL, V13, P2841, DOI 10.1111/j.1365-294X.2004.02253.x; Crooks KR, CONNECTIVITY CONSERV; Cushman SA, 2011, LANDSCAPE ECOL, V26, P1137, DOI 10.1007/s10980-011-9645-8; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Cushman SA, 2010, MOL ECOL, V19, P3592, DOI 10.1111/j.1365-294X.2010.04656.x; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Czembor CA, 2011, J APPL ECOL, V48, P736, DOI 10.1111/j.1365-2664.2011.01971.x; Dept of Sustainability and Environment, 1990, TREE25 TREE COV; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Doerr VAJ, 2011, EMU, V111, P71, DOI 10.1071/MU09118; Driezen K, 2007, ECOL MODEL, V209, P314, DOI 10.1016/j.ecolmodel.2007.07.002; *ENV CONS COUNC, 1997, BOX IR FOR WOODL INV; Environmental Systems Research Institute, 1999, ARCGIS; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; Ford HA, 2001, BIOL CONSERV, V97, P71, DOI 10.1016/S0006-3207(00)00101-4; FORD HA, 1985, OIKOS, V44, P127, DOI 10.2307/3544053; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; Garrard GE, 2012, J ANIM ECOL, V81, P14, DOI 10.1111/j.1365-2656.2011.01891.x; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I, 1996, AM NAT, V147, P527, DOI 10.1086/285864; Hanski I, 2002, CONSERV BIOL, V16, P666, DOI 10.1046/j.1523-1739.2002.00342.x; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Higgins PJ, HDB AUSTR NZ ANTARCT, V6; Higgins PJ, HDB AUSTR NZ ANTARCT, V5; HILDEN J, 1991, MED DECIS MAKING, V11, P95, DOI 10.1177/0272989X9101100204; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Jaquiery J, 2011, MOL ECOL, V20, P692, DOI 10.1111/j.1365-294X.2010.04966.x; Jeness J, JEN J EXP CIRC TOOL; Koen EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011785; Lada H, 2008, CONSERV GENET, V9, P569, DOI 10.1007/s10592-007-9372-5; Landguth E, ECOGRAPHY IN PRESS; LEGENDRE P, 1988, LIMNOL OCEANOGR, V33, P1055, DOI 10.4319/lo.1988.33.5.1055; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Lindenmayer DB, 2007, TRENDS ECOL EVOL, V22, P127, DOI 10.1016/j.tree.2006.11.006; Liu C, 2011, SPECIES DISTRIBUTION; Loehle C, 1996, ECOL APPL, V6, P784, DOI 10.2307/2269483; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Mac Nally R, 1997, BIOL CONSERV, V82, P147, DOI 10.1016/S0006-3207(97)00028-1; Mac Nally R, 2009, DIVERS DISTRIB, V15, P720, DOI 10.1111/j.1472-4642.2009.00578.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Martin TG, 2005, J APPL ECOL, V42, P400, DOI 10.1111/j.1365-2664.2005.01012.x; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; McRae B.H., 2009, CIRCUITSCAPE USERS G; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; MULDER RA, 1995, J AVIAN BIOL, V26, P234, DOI 10.2307/3677324; Pinto N, 2009, LANDSCAPE ECOL, V24, P253, DOI 10.1007/s10980-008-9303-y; Radford JQ, 2007, J APPL ECOL, V44, P737, DOI 10.1111/j.1365-2664.2007.01327.x; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Robertson OJ, 2009, AUSTRAL ECOL, V34, P435, DOI 10.1111/j.1442-9993.2009.01945.x; ROBINSON D, 1996, CONSERVING WOODLAND; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Segelbacher G, 2010, CONSERV GENET, P1; Segelbacher G, 2008, MOL ECOL, V17, P2356, DOI 10.1111/j.1365-294X.2008.03767.x; Shanahan DF, 2011, LANDSCAPE ECOL, V26, P137, DOI 10.1007/s10980-010-9542-6; Shanahan DF, 2009, J APPL ECOL, V46, P1026, DOI 10.1111/j.1365-2664.2009.01694.x; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; Stevens VM, 2006, MOL ECOL, V15, P2333, DOI 10.1111/j.1365-294X.2006.02936.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Sunnucks P, 2011, EMU, V111, P19, DOI 10.1071/MU10008; Szabo JK, 2011, EMU, V111, P59, DOI 10.1071/MU09114; Taylor P. D., 2006, CONNECTIVITY CONSERV; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Theobald D.M, 2006, CONNECTIVITY CONSERV; Walker RS, 2007, LANDSCAPE ECOL, V22, P1303, DOI 10.1007/s10980-007-9118-2; Wasserman TN, 2011, LANDSCAPE ECOLOGY; Wasserman TN, 2010, LANDSCAPE ECOL, V25, P1601, DOI 10.1007/s10980-010-9525-7; Wright S, 1943, GENETICS, V28, P114	85	49	50	0	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30888	10.1371/journal.pone.0030888	http://dx.doi.org/10.1371/journal.pone.0030888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363508	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600083
J	de Regt, MJA; van Schaik, W; van Luit-Asbroek, M; Dekker, HAT; van Duijkeren, E; Koning, CJM; Bonten, MJM; Willems, RJL				de Regt, Marieke J. A.; van Schaik, Willem; van Luit-Asbroek, Miranda; Dekker, Huberta A. T.; van Duijkeren, Engeline; Koning, Catherina J. M.; Bonten, Marc J. M.; Willems, Rob J. L.			Hospital and Community Ampicillin-Resistant Enterococcus faecium Are Evolutionarily Closely Linked but Have Diversified through Niche Adaptation	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; INTESTINAL MICROBIOTA; SPECIES DISTRIBUTION; COLLAGEN ADHESIN; TYPING SCHEME; VANCOMYCIN; GENE; ESP; IDENTIFICATION	Background: Ampicillin-resistant Enterococcus faecium (ARE) has emerged as a nosocomial pathogen. Here, we quantified ARE carriage in different community sources and determined genetic relatedness with hospital ARE. Methods and Results: ARE was recovered from rectal swabs of 24 of 79 (30%) dogs, 11 of 85 (13%) cats and 0 of 42 horses and from 3 of 40 (8%) faecal samples of non-hospitalized humans receiving amoxicillin. Multi-locus Sequence Typing revealed 21 sequence types (STs), including 5 STs frequently associated with hospital-acquired infections. Genes previously found to be enriched in hospital ARE, such as IS16, orf903, orf905, orf907, were highly prevalent in community ARE (>= 79%), while genes with a proposed role in pathogenesis, such as esp, hyl and ecbA, were found rarely (<= 5%) in community isolates. Comparative genome analysis of 2 representative dog isolates revealed that the dog strain of ST192 was evolutionarily closely linked to two previously sequenced hospital ARE, but had, based on gene content, more genes in common with the other, evolutionarily more distantly related, dog strain (ST266). Conclusion: ARE were detected in dogs, cats and sporadically in healthy humans, with evolutionary linkage to hospital ARE. Yet, their accessory genome has diversified, probably as a result of niche adaptation.	[de Regt, Marieke J. A.; van Schaik, Willem; van Luit-Asbroek, Miranda; Dekker, Huberta A. T.; Bonten, Marc J. M.; Willems, Rob J. L.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [van Duijkeren, Engeline] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Koning, Catherina J. M.] Univ Hosp Maastricht, Dept Internal Med, Maastricht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Maastricht University; Maastricht University Medical Centre (MUMC)	de Regt, MJA (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	mjaderegt@gmail.com	Willems, Rob JL/E-3681-2010	Willems, Rob JL/0000-0002-7370-0812; van Schaik, Willem/0000-0001-5832-0988	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [NWO-VENI] [916.86.044]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [NWO-VENI]	Willem van Schaik was funded through the Nederlandse Organisatie voor Wetenschappelijk Onderzoek [NWO-VENI grant 916.86.044]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beres SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/pnas.0911295107; Biavasco F, 2007, APPL ENVIRON MICROB, V73, P3307, DOI 10.1128/AEM.02239-06; Billstrom H, 2009, J APPL MICROBIOL; Boerlin P, 2001, VET MICROBIOL, V82, P347, DOI 10.1016/S0378-1135(01)00396-0; Brilliantova AN, 2010, INT J ANTIMICROB AG, V35, P177, DOI 10.1016/j.ijantimicag.2009.10.006; Chassard C, 2007, FEMS MICROBIOL ECOL, V61, P121, DOI 10.1111/j.1574-6941.2007.00314.x; Council NR, 2006, NUTR REQ DOGS CATS; Damborg P, 2009, APPL ENVIRON MICROB, V75, P2360, DOI 10.1128/AEM.02035-08; de Regt MJA, 2008, J ANTIMICROB CHEMOTH, V62, P1401, DOI 10.1093/jac/dkn390; GRAYSON ML, 1991, ANTIMICROB AGENTS CH, V35, P2180, DOI 10.1128/AAC.35.11.2180; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Heikens E, 2008, APPL ENVIRON MICROB, V74, P7094, DOI 10.1128/AEM.01378-08; Heikens E, 2007, J BACTERIOL, V189, P8233, DOI 10.1128/JB.01205-07; Hendrickx APA, 2009, TRENDS MICROBIOL, V17, P423, DOI 10.1016/j.tim.2009.06.004; Hendrickx APA, 2009, INFECT IMMUN, V77, P5097, DOI 10.1128/IAI.00275-09; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Hsieh YC, 2010, EUR J CLIN MICROBIOL, V29, P25, DOI 10.1007/s10096-009-0810-9; Jackson CR, 2009, J APPL MICROBIOL, V107, P1269, DOI 10.1111/j.1365-2672.2009.04310.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khan MA, 2008, J ANTIMICROB CHEMOTH, V62, P279, DOI 10.1093/jac/dkn173; Klare I, 2005, EUR J CLIN MICROBIOL, V24, P815, DOI 10.1007/s10096-005-0056-0; Koning CJM, 2008, AM J GASTROENTEROL, V103, P178, DOI 10.1111/j.1572-0241.2007.01547.x; Leavis H, 2004, J BACTERIOL, V186, P672, DOI 10.1128/JB.186.3.672-682.2004; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; Leavis HL, 2006, J CLIN MICROBIOL, V44, P1059, DOI 10.1128/JCM.44.3.1059-1064.2006; Lee WG, 2006, LETT APPL MICROBIOL, V43, P274, DOI 10.1111/j.1472-765X.2006.01957.x; Leendertse M, 2009, J INFECT DIS, V200, P1162, DOI 10.1086/605609; Libisch B, 2008, SCAND J INFECT DIS, V40, P778, DOI 10.1080/00365540802165740; Moyaert H, 2006, RES VET SCI, V81, P1, DOI 10.1016/j.rvsc.2005.10.004; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Nallapareddy SR, 2008, INFECT IMMUN, V76, P4110, DOI 10.1128/IAI.00375-08; Olioso D, 2007, MICROB DRUG RESIST, V13, P171, DOI 10.1089/mdr.2007.739; Ossiprandi MC, 2008, COMP IMMUNOL MICROB, V31, P1, DOI 10.1016/j.cimid.2007.08.003; Panesso D, J CLIN MICROBIOL; Rice LB, 2004, ANTIMICROB AGENTS CH, V48, P3028, DOI 10.1128/AAC.48.8.3028-3032.2004; Rodrigues J, 2002, J VET MED B, V49, P278, DOI 10.1046/j.1439-0450.2002.00561.x; Sava IG, 2010, J MED MICROBIOL, V59, P1001, DOI 10.1099/jmm.0.020578-0; Sillanpaa J, 2009, J CLIN MICROBIOL, V47, P896, DOI 10.1128/JCM.02283-08; Sillapaa J, 2008, MICROBIOL-SGM, V154, P3199, DOI 10.1099/mic.0.2008/017319-0; Simjee S, 2002, J CLIN MICROBIOL, V40, P4659, DOI 10.1128/JCM.40.12.4659-4665.2002; Top J, 2007, CLIN MICROBIOL INFEC, V13, P316, DOI 10.1111/j.1469-0691.2006.01631.x; Top J, 2004, J CLIN MICROBIOL, V42, P4503, DOI 10.1128/JCM.42.10.4503-4511.2004; Top J, 2011, J BACTERIOL, V193, P1003, DOI 10.1128/JB.00952-10; van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239; Werner G, 2008, Euro Surveill, V13; Werner G, 2008, INT J MED MICROBIOL, V298, P515, DOI 10.1016/j.ijmm.2007.05.008; Werner G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-80; Willems RJL, 2001, LANCET, V357, P853, DOI 10.1016/S0140-6736(00)04205-7; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]; Zhu X, 2009, J HOSP INFECT, V72, P147, DOI 10.1016/j.jhin.2009.02.014	52	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30319	10.1371/journal.pone.0030319	http://dx.doi.org/10.1371/journal.pone.0030319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363425	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600019
J	Ketmaier, V; Marrone, F; Alfonso, G; Paulus, K; Wiemann, A; Tiedemann, R; Mura, G				Ketmaier, Valerio; Marrone, Federico; Alfonso, Giuseppe; Paulus, Kirsten; Wiemann, Annika; Tiedemann, Ralph; Mura, Graziella			Mitochondrial DNA Regionalism and Historical Demography in the Extant Populations of Chirocephalus kerkyrensis (Branchiopoda: Anostraca)	PLOS ONE			English	Article							CYST MORPHOMETRICS; ADDITIONAL REMARKS; CRUSTACEA; PHYLOGEOGRAPHY; DIVERSITY; COLONIZATION; BIOGEOGRAPHY; HAPLOTYPES; DISPERSAL; PHYLOGENY	Background: Mediterranean temporary water bodies are important reservoirs of biodiversity and host a unique assemblage of diapausing aquatic invertebrates. These environments are currently vanishing because of increasing human pressure. Chirocephalus kerkyrensis is a fairy shrimp typical of temporary water bodies in Mediterranean plain forests and has undergone a substantial decline in number of populations in recent years due to habitat loss. We assessed patterns of genetic connectivity and phylogeographic history in the seven extant populations of the species from Albania, Corfu Is. (Greece), Southern and Central Italy. Methodology/Principal Findings: We analyzed sequence variation at two mitochondrial DNA genes (Cytochrome Oxidase I and 16s rRNA) in all the known populations of C. kerkyrensis. We used multiple phylogenetic, phylogeographic and coalescence-based approaches to assess connectivity and historical demography across the whole distribution range of the species. C. kerkyrensis is genetically subdivided into three main mitochondrial lineages; two of them are geographically localized (Corfu Is. and Central Italy) and one encompasses a wide geographic area (Albania and Southern Italy). Most of the detected genetic variation (approximate to 81%) is apportioned among the aforementioned lineages. Conclusions/Significance: Multiple analyses of mismatch distributions consistently supported both past demographic and spatial expansions with the former predating the latter; demographic expansions were consistently placed during interglacial warm phases of the Pleistocene while spatial expansions were restricted to cold periods. Coalescence methods revealed a scenario of past isolation with low levels of gene flow in line with what is already known for other co-distributed fairy shrimps and suggest drift as the prevailing force in promoting local divergence. We recommend that these evolutionary trajectories should be taken in proper consideration in any effort aimed at protecting Mediterranean temporary water bodies.	[Ketmaier, Valerio; Paulus, Kirsten; Tiedemann, Ralph] Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, Potsdam, Germany; [Ketmaier, Valerio; Mura, Graziella] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Marrone, Federico] Univ Palermo, Dept Environm Biol & Biodivers, Palermo, Italy; [Alfonso, Giuseppe] Univ Salento, DiSTeBA, Lab Zoogeog & Fauna, Lecce, Italy; [Wiemann, Annika] State Off Criminal Invest, Inst Forens Sci, Dept Biol, Hannover, Germany	University of Potsdam; Sapienza University Rome; University of Palermo; University of Salento	Ketmaier, V (corresponding author), Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, Potsdam, Germany.	ketmaier@uni-potsdam.de	Marrone, Federico/M-3154-2015; Alfonso, Giuseppe/A-6252-2016	Marrone, Federico/0000-0002-4730-0452; Alfonso, Giuseppe/0000-0003-0016-7006; Tiedemann, Ralph/0000-0002-2604-6336	University of Potsdam (Germany)	University of Potsdam (Germany)	The study was funded by basic funding of the University of Potsdam (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2011, AQUAT SCI, V73, P15, DOI 10.1007/s00027-010-0155-6; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Beladjal L, 2009, J CRUSTACEAN BIOL, V29, P266, DOI 10.1651/08-3059R.1; BELK D, 1995, HYDROBIOLOGIA, V298, P315, DOI 10.1007/BF00033826; Bohonak AJ, 1998, CAN J ZOOL, V76, P2049, DOI 10.1139/cjz-76-11-2049; Brtek J., 1968, Annotationes Zoologicae et Botanicae Bratislava, VNo. 51, P1; BRTEK J, 1995, HYDROBIOLOGIA, V298, P263, DOI 10.1007/BF00033821; Brtek J., 1966, Annotationes Zoologicae et Botanicae Bratislava, VNo. 33, P1; Brtek J, 2006, CRUSTACEANA, V79, P89, DOI 10.1163/156854006776759707; Brtek Jan, 1995, Zbornik Slovenskeho Narodneho Muzea Prirodne Vedy, V41, P3; Cesari M, 2007, HYDROBIOLOGIA, V586, P249, DOI 10.1007/s10750-007-0645-2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; COTTARELLI V, 1979, Rivista di Idrobiologia, V18, P75; Cottarelli V., 1965, Rec Ist Lomb Sci Lett, V99B, P133; Cottarelli V, 1983, QUAD CNR, V18, P1; Cottarelli V, 2007, CRUSTACEANA, V80, P455, DOI 10.1163/156854007780440902; Daniels SR, 2004, BIOL J LINN SOC, V82, P313, DOI 10.1111/j.1095-8312.2004.00359.x; De Gelas K, 2005, MOL ECOL, V14, P753, DOI 10.1111/j.1365-294X.2004.02434.x; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; DUMONT HJ, 1995, HYDROBIOLOGIA, V298, P281, DOI 10.1007/BF00033822; DUMONT HJ, 2002, INTRO CLASS BRANCHIO; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fu YX, 1997, GENETICS, V147, P915; Gomez A, 2007, MOL ECOL, V16, P3228, DOI 10.1111/j.1365-294X.2007.03372.x; Green AJ, 2005, DIVERS DISTRIB, V11, P149, DOI 10.1111/j.1366-9516.2005.00147.x; Hebert PDN, 2002, EVOLUTION, V56, P909; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Ketmaier V, 2006, MOL PHYLOGENET EVOL, V39, P439, DOI 10.1016/j.ympev.2005.12.008; Ketmaier V, 2005, J ZOOL, V266, P401, DOI 10.1017/S0952836905007041; Ketmaier V, 2003, J ZOOL SYST EVOL RES, V41, P276, DOI 10.1046/j.1439-0469.2003.00222.x; Ketmaier V, 2008, AQUAT SCI, V70, P65, DOI 10.1007/s00027-007-7028-7; Ketmaier V, 2010, MALACOLOGIA, V52, P81, DOI 10.4002/040.052.0106; Korn M, 2010, ORG DIVERS EVOL, V10, P409, DOI 10.1007/s13127-010-0026-y; La Greca M, 1998, MEMORIE SOC ENTOMOLO, V77, P123; Marrone F., 2009, P INT C MED TEMP PON, P189; Marrone F, 2010, HYDROBIOLOGIA, V644, P115, DOI 10.1007/s10750-010-0101-6; Munoz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011932; Mura G, 1997, HYDROBIOLOGIA, V346, P11, DOI 10.1023/A:1002931606886; MURA G, 1987, Rivista di Idrobiologia, V26, P97; MURA G, 1989, Rivista di Idrobiologia, V28, P283; Mura G, 2004, CRUSTACEANA, V77, P1007, DOI 10.1163/1568540042781694; MURA G, 1984, Rivista di Idrobiologia, V23, P165; MURA G, 1986, Rivista di Idrobiologia, V25, P43; Mura G, 2003, HYDROBIOLOGIA, V495, P93, DOI 10.1023/A:1025406005367; Mura G, 2002, J CRUSTACEAN BIOL, V22, P162, DOI 10.1651/0278-0372(2002)022[0162:MVACDC]2.0.CO;2; MURA G, 1992, CRUSTACEANA, V63, P225, DOI 10.1163/156854092X00389; MURA G, 1986, HYDROBIOLOGIA, V134, P273, DOI 10.1007/BF00008496; Mura G, 1999, HYDROBIOLOGIA, V405, P57, DOI 10.1023/A:1003701004970; MURA G, 1991, CRUSTACEANA, V61, P241, DOI 10.1163/156854091X00137; Mura G, 1986, ATT CONV ASP FAUN PR, P109; Mura G, 2011, J BIOL RES-THESSALON, V15, P17; Mura Graziella, 2001, Journal of Limnology, V60, P45; Mura G, 2010, J BIOL RES-THESSALON, V14, P137; Nielsen R, 2001, GENETICS, V158, P885; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pesta D, 1936, ZOOL ANZ, V114, P241; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Remigio EA, 2003, J CRUSTACEAN BIOL, V23, P436, DOI 10.1651/0278-0372(2003)023[0436:PSOTAF]2.0.CO;2; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers D.C., 2003, ZOOTAXA, V257, P1, DOI DOI 10.11646/ZOOTAXA.257.1.1; Rogers DC, 2006, ZOOTAXA, P35, DOI 10.11646/zootaxa.1126.1.3; Rogers DC, 2002, HYDROBIOLOGIA, V486, P125, DOI 10.1023/A:1021390416256; Rogers DC, 2002, HYDROBIOLOGIA, V486, P57, DOI 10.1023/A:1021326129460; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sime LC, 2009, NATURE, V462, P342, DOI 10.1038/nature08564; Stella E, 1963, RENDIC ACCAD NAZ, V13, P1; Stephanides T., 1948, Praktika of the Hellenic Hydrobiological Institute, V2, P1; Swofford D, 2002, PAUP BETA VERSION 4; TEMPLETON AR, 1992, GENETICS, V132, P619; Tourenq C, 2001, BIOL CONSERV, V100, P335, DOI 10.1016/S0006-3207(01)00037-4; TZEDAKIS PC, 1993, NATURE, V364, P437, DOI 10.1038/364437a0; Weekers PHH, 2002, MOL PHYLOGENET EVOL, V25, P535, DOI 10.1016/S1055-7903(02)00289-0; Zierold T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-161	78	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30082	10.1371/journal.pone.0030082	http://dx.doi.org/10.1371/journal.pone.0030082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363417	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600012
J	Lopez-Vernaza, M; Yang, SX; Muller, R; Thorpe, F; de Leau, E; Goodrich, J				Lopez-Vernaza, Manuel; Yang, Suxin; Mueller, Ralf; Thorpe, Frazer; de Leau, Erica; Goodrich, Justin			Antagonistic Roles of SEPALLATA3, FT and FLC Genes as Targets of the Polycomb Group Gene CURLY LEAF	PLOS ONE			English	Article							FLOWERING-LOCUS-C; HISTONE METHYLTRANSFERASE ACTIVITY; FLORAL INDUCTION; ANTISENSE TRANSCRIPTS; EPIGENETIC REGULATION; ARABIDOPSIS; VERNALIZATION; PROTEIN; TIME; FCA	In Arabidopsis, mutations in the Pc-G gene CURLY LEAF (CLF) give early flowering plants with curled leaves. This phenotype is caused by mis-expression of the floral homeotic gene AGAMOUS (AG) in leaves, so that ag mutations largely suppress the clf phenotype. Here, we identify three mutations that suppress clf despite maintaining high AG expression. We show that the suppressors correspond to mutations in FPA and FT, two genes promoting flowering, and in SEPALLATA3 (SEP3) which encodes a co-factor for AG protein. The suppression of the clf phenotype is correlated with low SEP3 expression in all case and reveals that SEP3 has a role in promoting flowering in addition to its role in controlling floral organ identity. Genetic analysis of clf ft mutants indicates that CLF promotes flowering by reducing expression of FLC, a repressor of flowering. We conclude that SEP3 is the key target mediating the clf phenotype, and that the antagonistic effects of CLF target genes masks a role for CLF in promoting flowering.	[Lopez-Vernaza, Manuel; Yang, Suxin; Mueller, Ralf; Thorpe, Frazer; de Leau, Erica; Goodrich, Justin] Univ Edinburgh, Inst Mol Plant Sci, Sch Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Lopez-Vernaza, M (corresponding author), Univ Edinburgh, Inst Mol Plant Sci, Sch Biol, Edinburgh, Midlothian, Scotland.	Justin.Goodrich@ed.ac.uk		Lopez Vernaza, Manuel Augusto/0000-0002-9542-7028; Muller-Xing, Ralf/0000-0003-0024-4243; Yang, Suxin/0000-0001-8673-9428	BBSRC Biotechnology and Biological Sciences Research Council [BB/F007442/1, BB/H004319/1]; Darwin Trust of Edinburgh; Biotechnology and Biological Sciences Research Council [BB/F007442/1, BBS/B/05494, BB/H004319/1] Funding Source: researchfish; BBSRC [BB/H004319/1, BB/F007442/1] Funding Source: UKRI	BBSRC Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Darwin Trust of Edinburgh; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JG, RM, FT, EDL and SY were funded by grants BB/F007442/1 and BB/H004319/1 from BBSRC Biotechnology and Biological Sciences Research Council and ERA-PG, MLV by the Darwin Trust of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Bensmihen S, 2004, FEBS LETT, V561, P127, DOI 10.1016/S0014-5793(04)00148-6; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Bratzel F, 2010, CURR BIOL, V20, P1853, DOI 10.1016/j.cub.2010.09.046; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Cui RF, 2010, PLANT J, V61, P767, DOI 10.1111/j.1365-313X.2009.04101.x; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deng WW, 2011, P NATL ACAD SCI USA, V108, P6680, DOI 10.1073/pnas.1103175108; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Finnegan EJ, 2011, PLANT J, V65, P382, DOI 10.1111/j.1365-313X.2010.04428.x; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Hornyik C, 2010, DEV CELL, V18, P203, DOI 10.1016/j.devcel.2009.12.009; Ito T, 1997, PLANT CELL PHYSIOL, V38, P248, DOI 10.1093/oxfordjournals.pcp.a029160; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Kim DH, 2010, PLANT PHYSIOL, V154, P949, DOI 10.1104/pp.110.161083; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kwon CS, 2009, PLANT J, V60, P112, DOI 10.1111/j.1365-313X.2009.03938.x; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Moon YH, 2003, PLANT CELL, V15, P681, DOI 10.1105/tpc.007831; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Pazhouhandeh M, 2011, P NATL ACAD SCI USA, V108, P3430, DOI 10.1073/pnas.1018242108; Pelaz S, 2001, PLANT J, V26, P385, DOI 10.1046/j.1365-313X.2001.2641042.x; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Reeves PH, 2000, CURR OPIN PLANT BIOL, V3, P37, DOI 10.1016/S1369-5266(99)00041-2; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Serrano-Cartagena J, 2000, GENETICS, V156, P1363; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Sonmez C, 2011, P NATL ACAD SCI USA, V108, P8508, DOI 10.1073/pnas.1105334108; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129	62	53	61	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30715	10.1371/journal.pone.0030715	http://dx.doi.org/10.1371/journal.pone.0030715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363474	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600058
J	Vinther, TN; Norrman, M; Strauss, HM; Huus, K; Schlein, M; Pedersen, TA; Kjeldsen, T; Jensen, KJ; Hubalek, F				Vinther, Tine N.; Norrman, Mathias; Strauss, Holger M.; Huus, Kasper; Schlein, Morten; Pedersen, Thomas A.; Kjeldsen, Thomas; Jensen, Knud J.; Hubalek, Frantisek			Novel Covalently Linked Insulin Dimer Engineered to Investigate the Function of Insulin Dimerization	PLOS ONE			English	Article							INTERSUBUNIT DISULFIDE BRIDGE; FREE BOVINE INSULIN; GUINEA-PIG INSULIN; SELF-ASSOCIATION; INTRACELLULAR-TRANSPORT; STRUCTURAL SWITCH; DNA-BINDING; RECEPTOR; MODEL; BOND	An ingenious system evolved to facilitate insulin binding to the insulin receptor as a monomer and at the same time ensure sufficient stability of insulin during storage. Insulin dimer is the cornerstone of this system. Insulin dimer is relatively weak, which ensures dissociation into monomers in the circulation, and it is stabilized by hexamer formation in the presence of zinc ions during storage in the pancreatic beta-cell. Due to the transient nature of insulin dimer, direct investigation of this important form is inherently difficult. To address the relationship between insulin oligomerization and insulin stability and function, we engineered a covalently linked insulin dimer in which two monomers were linked by a disulfide bond. The structure of this covalent dimer was identical to the self-association dimer of human insulin. Importantly, this covalent dimer was capable of further oligomerization to form the structural equivalent of the classical hexamer. The covalently linked dimer neither bound to the insulin receptor, nor induced a metabolic response in vitro. However, it was extremely thermodynamically stable and did not form amyloid fibrils when subjected to mechanical stress, underlining the importance of oligomerization for insulin stability.	[Vinther, Tine N.; Norrman, Mathias; Strauss, Holger M.; Huus, Kasper; Schlein, Morten; Pedersen, Thomas A.; Kjeldsen, Thomas; Hubalek, Frantisek] Novo Nordisk A S, Diabet Res Unit, Malov, Denmark; [Vinther, Tine N.; Jensen, Knud J.] Univ Copenhagen, Fac Life Sci, IGM, Frederiksberg, Denmark	Novo Nordisk; University of Copenhagen	Vinther, TN (corresponding author), Novo Nordisk A S, Diabet Res Unit, Novo Nordisk Pk, Malov, Denmark.	fhub@novonordisk.com	Jensen, Knud J/D-1145-2016; Strauss, Holger Martin/I-8403-2012	Jensen, Knud J/0000-0003-3525-5452; Kjeldsen, Thomas/0000-0003-0094-9286; Hubalek, Frantisek/0000-0003-3983-7900	Danish Ministry of Science, Technology and Innovation; Novo Nordisk CORA Training and Research Program	Danish Ministry of Science, Technology and Innovation; Novo Nordisk CORA Training and Research Program	This work was supported by the Danish Ministry of Science, Technology and Innovation and the Novo Nordisk CORA Training and Research Program. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Andersen AS, 2010, J PEPT SCI, V16, P473, DOI 10.1002/psc.1264; Attri AK, 2010, BIOPHYS CHEM, V148, P23, DOI 10.1016/j.bpc.2010.02.001; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BENEZRA R, 1994, CELL, V79, P1057, DOI 10.1016/0092-8674(94)90036-1; Bjork A, 2003, J MOL BIOL, V334, P811, DOI 10.1016/j.jmb.2003.10.006; Blundell T., 1972, ADV PROTEIN CHEM, V26, P279; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1993, Pharm Biotechnol, V5, P315; Bunting KA, 2002, ARCH BIOCHEM BIOPHYS, V397, P69, DOI 10.1006/abbi.2001.2635; CHAN SJ, 1984, P NATL ACAD SCI-BIOL, V81, P5046, DOI 10.1073/pnas.81.16.5046; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; Diao JS, 2003, ACTA CRYSTALLOGR D, V59, P670, DOI 10.1107/S0907444903002208; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; EMDIN SO, 1980, DIABETOLOGIA, V19, P174, DOI 10.1007/BF00275265; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; GIVEN BD, 1980, NEW ENGL J MED, V302, P129, DOI 10.1056/NEJM198001173020301; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; GURSKY O, 1992, BIOPHYS J, V63, P1210, DOI 10.1016/S0006-3495(92)81697-1; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; Huus K, 2005, BIOCHEMISTRY-US, V44, P11171, DOI 10.1021/bi0507940; HVIDT S, 1991, BIOPHYS CHEM, V39, P205, DOI 10.1016/0301-4622(91)85023-J; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; Kjeldsen T, 1999, J BIOTECHNOL, V75, P195, DOI 10.1016/S0168-1656(99)00159-5; Kjeldsen T, 1996, GENE, V170, P107, DOI 10.1016/0378-1119(95)00822-5; Kjeldsen T, 2003, PROTEIN EXPRES PURIF, V27, P331, DOI 10.1016/S1046-5928(02)00640-X; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; MaAuley A, 2008, PROTEIN SCI, V17, P95, DOI 10.1110/ps.073134408; Madala PK, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900368a; MARK AE, 1990, BIOL CHEM H-S, V371, P1165, DOI 10.1515/bchm3.1990.371.2.1165; MARK AE, 1987, BIOPHYS CHEM, V27, P103, DOI 10.1016/0301-4622(87)80051-0; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; Markussen J., 1987, HUMAN INSULIN TRYPTI; MOODY AJ, 1974, HORM METAB RES, V6, P12, DOI 10.1055/s-0028-1093895; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; POSNER BI, 1974, ENDOCRINOLOGY, V95, P521, DOI 10.1210/endo-95-2-521; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; Richards JP, 1998, PHARMACEUT RES, V15, P1434, DOI 10.1023/A:1011961923870; Robinson CR, 2000, BIOCHEMISTRY-US, V39, P12494, DOI 10.1021/bi001484e; RODBELL M, 1964, J BIOL CHEM, V239, P375; SAUER RT, 1986, BIOCHEMISTRY-US, V25, P5992, DOI 10.1021/bi00368a024; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHMITZ A, 1995, EMBO J, V14, P1091, DOI 10.1002/j.1460-2075.1995.tb07092.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCRUTTON NS, 1988, FEBS LETT, V241, P46, DOI 10.1016/0014-5793(88)81028-7; Seabright PJ, 1996, BIOCHEM J, V320, P947, DOI 10.1042/bj3200947; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; STEINER DF, 1977, DIABETES, V26, P322, DOI 10.2337/diab.26.4.322; TAGER H, 1979, NATURE, V281, P122, DOI 10.1038/281122a0; TAKEDA A, 1977, J BIOCHEM-TOKYO, V82, P1025, DOI 10.1093/oxfordjournals.jbchem.a131773; TAMURA A, 1994, BIOCHEMISTRY-US, V33, P14512, DOI 10.1021/bi00252a018; Thorsoe KS, 2010, BIOCHEMISTRY-US, V49, P6234, DOI 10.1021/bi1000118; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vinther TN, 2011, CHEMBIOCHEM, V12, P2448, DOI 10.1002/cbic.201100464; VOLUND A, 1978, BIOMETRICS, V34, P357, DOI 10.2307/2530598; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003; ZIMMERMAN AE, 1974, J BIOL CHEM, V249, P4026; ZIMMERMAN AE, 1974, J BIOL CHEM, V249, P4021	67	24	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30882	10.1371/journal.pone.0030882	http://dx.doi.org/10.1371/journal.pone.0030882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363506	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600081
J	West, XZ; Meller, N; Malinin, NL; Deshmukh, L; Meller, J; Mahabeleshwar, GH; Weber, ME; Kerr, BA; Vinogradova, O; Byzova, TV				West, Xiaoxia Z.; Meller, Nahum; Malinin, Nikolay L.; Deshmukh, Lalit; Meller, Julia; Mahabeleshwar, Ganapati H.; Weber, Malory E.; Kerr, Bethany A.; Vinogradova, Olga; Byzova, Tatiana V.			Integrin beta(3) Crosstalk with VEGFR Accommodating Tyrosine Phosphorylation as a Regulatory Switch	PLOS ONE			English	Article							DEPENDENT ACTIVATION; CYTOPLASMIC DOMAIN; BINDING; ALPHA(IIB)BETA(3); ANGIOGENESIS; MODULATION; MECHANISM; ADHESION; SUBUNIT; COMPLEX	Integrins mediate cell adhesion, migration, and survival by connecting intracellular machinery with the surrounding extracellular matrix. Previous studies demonstrated the importance of the interaction between beta(3) integrin and VEGF type 2 receptor (VEGFR2) in VEGF-induced angiogenesis. Here we present in vitro evidence of the direct association between the cytoplasmic tails (CTs) of beta(3) and VEGFR2. Specifically, the membrane-proximal motif around (YLSI)-Y-801 in VEGFR2 mediates its binding to non-phosphorylated beta 3CT, accommodating an alpha-helical turn in integrin bound conformation. We also show that Y-747 phosphorylation of beta(3) enhances the above interaction. To demonstrate the importance of beta(3) phosphorylation in endothelial cell functions, we synthesized beta 3CT-mimicking Y-747 phosphorylated and unphosphorylated membrane permeable peptides. We show that a peptide containing phospho-Y-747 but not F-747 significantly inhibits VEGF-induced signaling and angiogenesis. Moreover, phospho-Y-747 peptide exhibits inhibitory effect only in WT but not in beta(3) integrin knock-out or beta(3) integrin knock-in cells expressing beta(3) with two tyrosines substituted for phenylalanines, demonstrating its specificity. Importantly, these peptides have no effect on fibroblast growth factor receptor signaling. Collectively these data provide novel mechanistic insights into phosphorylation dependent cross-talk between integrin and VEGFR2.	[West, Xiaoxia Z.; Meller, Nahum; Malinin, Nikolay L.; Meller, Julia; Mahabeleshwar, Ganapati H.; Weber, Malory E.; Kerr, Bethany A.; Byzova, Tatiana V.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Deshmukh, Lalit; Vinogradova, Olga] Univ Connecticut, Dept Pharmaceut Sci, Sch Pharm, Storrs, CT USA; [Deshmukh, Lalit] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Univ Hosp Harrington McLaughlin Heart & Vasc Inst, Cleveland, OH USA; [Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Case Cardiovasc Res Inst, Cleveland, OH USA	Cleveland Clinic Foundation; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Case Western Reserve University; Case Western Reserve University	West, XZ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	olga.vinogradova@uconn.edu; byzovat@ccf.org	Vinogradova, Olga/ABE-8367-2020; Deshmukh, Lalit/C-5073-2015; Kerr, Bethany/D-1644-2012; Malinin, Nikolay/J-4271-2012; Malinin, Nikolay/Z-5308-2019	Vinogradova, Olga/0000-0001-5101-7361; Kerr, Bethany/0000-0002-2995-7549; Malinin, Nikolay/0000-0002-2654-1783; Byzova, Tatiana/0000-0002-2615-875X	National Institute of Health (NIH); American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098777] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in parts by National Institute of Health (NIH) grants to TVB and American Heart Association and NIH grants to OV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Blystone SD, 1997, J BIOL CHEM, V272, P28757, DOI 10.1074/jbc.272.45.28757; Boettiger D, 2001, MOL BIOL CELL, V12, P1227, DOI 10.1091/mbc.12.5.1227; Butler B, 2003, J BIOL CHEM, V278, P5264, DOI 10.1074/jbc.M206997200; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Chandhoke SK, 2004, J CELL SCI, V117, P1431, DOI 10.1242/jcs.00987; Cowan KJ, 2000, J BIOL CHEM, V275, P36423, DOI 10.1074/jbc.M004068200; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshmukh L, 2011, J BIOL CHEM, V286, P40943, DOI 10.1074/jbc.M111.231951; Deshmukh L, 2010, J BIOL CHEM, V285, P34875, DOI 10.1074/jbc.M110.159087; Harris PA, 2005, J MED CHEM, V48, P1610, DOI 10.1021/jm049538w; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; Napione L, 2007, AUTOIMMUN REV, V7, P18, DOI 10.1016/j.autrev.2007.03.007; PASSANITI A, 1992, LAB INVEST, V67, P804; Phillips DR, 2001, THROMB HAEMOSTASIS, V86, P246; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Ward C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012543; Wuthrich K, 1986, NMR PROTEINS NUCL AC	40	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31071	10.1371/journal.pone.0031071	http://dx.doi.org/10.1371/journal.pone.0031071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363548	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600105
J	He, Z; Nguyen, CTO; Armitage, JA; Vingrys, AJ; Bui, BV				He, Zheng; Nguyen, Christine T. O.; Armitage, James A.; Vingrys, Algis J.; Bui, Bang V.			Blood Pressure Modifies Retinal Susceptibility to Intraocular Pressure Elevation	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OCULAR PERFUSION-PRESSURE; LASER-DOPPLER FLOWMETRY; NORMAL-TENSION GLAUCOMA; OPTIC-NERVE HEAD; SCOTOPIC THRESHOLD RESPONSE; CIRCADIAN FLUCTUATION; RISK-FACTORS; FLOW; ELECTRORETINOGRAM	Primary open angle glaucoma affects more than 67 million people. Elevated intraocular pressure (IOP) is a risk factor for glaucoma and may reduce nutrient availability by decreasing ocular perfusion pressure (OPP). An interaction between arterial blood pressure and IOP determines OPP; but the exact contribution that these factors have for retinal function is not fully understood. Here we sought to determine how acute modifications of arterial pressure will affect the susceptibility of neuronal function and blood flow to IOP challenge. Anaesthetized (ketamine:xylazine) Long-Evan rats with low (similar to 60 mmHg, sodium nitroprusside infusion), moderate (similar to 100 mmHg, saline), or high levels (similar to 160 mmHg, angiotensin II) of mean arterial pressure (MAP, n = 5-10 per group) were subjected to IOP challenge (10-120 mmHg, 5 mmHg steps every 3 minutes). Electroretinograms were measured at each IOP step to assess bipolar cell (b-wave) and inner retinal function (scotopic threshold response or STR). Ocular blood flow was measured using laser-Doppler flowmetry in groups with similar MAP level and the same IOP challenge protocol. Both b-wave and STR amplitudes decreased with IOP elevation. Retinal function was less susceptible to IOP challenge when MAP was high, whereas the converse was true for low MAP. Consistent with the effects on retinal function, higher IOP was needed to attenuated ocular blood flow in animals with higher MAP. The susceptibility of retinal function to IOP challenge can be ameliorated by acute high BP, and exacerbated by low BP. This is partially mediated by modifications in ocular blood flow.	[He, Zheng; Nguyen, Christine T. O.; Vingrys, Algis J.; Bui, Bang V.] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia; [Armitage, James A.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	University of Melbourne; Monash University	He, Z (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia.	bvb@unimelb.edu.au	Armitage, James A/A-8949-2012; Armitage, James/AAX-1294-2021; Bui, Bang/AAD-2679-2021	Bui, Bang/0000-0001-7298-1352; Nguyen, Christine/0000-0002-3298-3086; Armitage, James/0000-0002-3762-0911; Vingrys, Algis/0000-0001-5920-4604; He, Zheng/0000-0001-6496-3971	National Health and Medical Research Council (NHMRC) of Australia [566570]; Albert Shimmins Memorial Fund; National Heart Foundation	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Albert Shimmins Memorial Fund; National Heart Foundation(National Heart Foundation of Australia)	This study received funding support from the National Health and Medical Research Council (NHMRC grant 566570) of Australia and the Albert Shimmins Memorial Fund. JAA is a Monash Fellow and was supported by a National Heart Foundation Postgraduate Fellowship during the course of these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; Bui BV, 2005, INVEST OPHTH VIS SCI, V46, P202, DOI 10.1167/iovs.04-0421; Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; Choi J, 2006, INVEST OPHTH VIS SCI, V47, P831, DOI 10.1167/iovs.05-1053; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P104, DOI 10.1167/iovs.06-0615; Collignon N, 1998, INT OPHTHALMOL, V22, P19, DOI 10.1023/A:1006113109864; DEMAILLY P, 1984, OPHTHALMOLOGICA, V188, P65, DOI 10.1159/000309344; DIELEMANS I, 1995, OPHTHALMOLOGY, V102, P54; Fortune B, 2004, INVEST OPHTH VIS SCI, V45, P1854, DOI 10.1167/iovs.03-1411; Fredriksson I., 2007, LASER DOPPLER FLOWME; Fredriksson I, 2009, MICROVASC RES, V78, P4, DOI 10.1016/j.mvr.2009.02.008; Frishman LJ, 1996, INVEST OPHTH VIS SCI, V37, P125; GRAHAM SL, 1995, OPHTHALMOLOGY, V102, P61; Graham SL, 1999, SURV OPHTHALMOL, V43, pS10, DOI 10.1016/S0039-6257(99)00016-8; GREHN F, 1983, INVEST OPHTH VIS SCI, V24, P347; HAYREH SS, 1994, AM J OPHTHALMOL, V117, P603, DOI 10.1016/S0002-9394(14)70067-4; He Z, 2011, CLIN EXP OPTOM, V94, P133, DOI 10.1111/j.1444-0938.2010.00564.x; HOOD DC, 1990, VISUAL NEUROSCI, V5, P379, DOI 10.1017/S0952523800000468; Hulsman CAA, 2007, ARCH OPHTHALMOL-CHIC, V125, P805, DOI 10.1001/archopht.125.6.805; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; KAISER HJ, 1993, OPHTHALMOLOGICA, V207, P6, DOI 10.1159/000310398; KAISER HJ, 1993, GRAEF ARCH CLIN EXP, V231, P677, DOI 10.1007/BF00919280; KIEL JW, 1995, INVEST OPHTH VIS SCI, V36, P579; Kyhn MV, 2009, EXP EYE RES, V89, P1012, DOI 10.1016/j.exer.2009.08.014; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leske MC, 2002, ARCH OPHTHALMOL-CHIC, V120, P954, DOI 10.1001/archopht.120.7.954; Liang Y, 2009, INVEST OPHTH VIS SCI, V50, P2154, DOI 10.1167/iovs.08-2882; Memarzadeh F, 2010, INVEST OPHTH VIS SCI, V51, P2872, DOI 10.1167/iovs.08-2956; Meyer JH, 1996, BRIT J OPHTHALMOL, V80, P864, DOI 10.1136/bjo.80.10.864; Mitchell P, 2004, J GLAUCOMA, V13, P319, DOI 10.1097/00061198-200408000-00010; Naarendorp F, 2001, VISUAL NEUROSCI, V18, P641, DOI 10.1017/S0952523801184142; NAARENDORP F, 1991, VISION RES, V31, P1, DOI 10.1016/0042-6989(91)90068-G; Petrig BL, 1999, AM J OPHTHALMOL, V127, P413, DOI 10.1016/S0002-9394(98)00437-1; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; RIVA CE, 1994, INVEST OPHTH VIS SCI, V35, P608; Riva Charles E., 2001, International Ophthalmology, V23, P183, DOI 10.1023/A:1014433913240; SACHSENWEGER R, 1963, Klin Monbl Augenheilkd, V142, P625; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; Schmetterer L, 2007, SURV OPHTHALMOL, V52, pS134, DOI 10.1016/j.survophthal.2007.08.008; Schmidl D, 2011, EXP EYE RES, V93, P141, DOI 10.1016/j.exer.2010.09.002; Shepherd A.P, 1990, LASER DOPPLER BLOOD; SILIPRANDI R, 1988, INVEST OPHTH VIS SCI, V29, P558; Topouzis F, 2006, AM J OPHTHALMOL, V142, P60, DOI 10.1016/j.ajo.2006.02.055; YANCEY CM, 1988, INVEST OPHTH VIS SCI, V29, P700	45	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31104	10.1371/journal.pone.0031104	http://dx.doi.org/10.1371/journal.pone.0031104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359566	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200035
J	McClenahan, P; Troup, M; Scott, EK				McClenahan, Phil; Troup, Michael; Scott, Ethan K.			Fin-Tail Coordination during Escape and Predatory Behavior in Larval Zebrafish	PLOS ONE			English	Article							FAST-START PERFORMANCE; PECTORAL FIN; SPINAL INTERNEURONS; PREY CAPTURE; DANIO-RERIO; ELECTROMYOGRAPHIC ANALYSIS; LABRIFORM PROPULSION; SWIMMING MOVEMENTS; GOMPHOSUS-VARIUS; NEURAL-CONTROL	Larval zebrafish innately perform a suite of behaviors that are tightly linked to their evolutionary past, notably escape from threatening stimuli and pursuit and capture of prey. These behaviors have been carefully examined in the past, but mostly with regard to the movements of the trunk and tail of the larvae. Here, we employ kinematics analyses to describe the movements of the pectoral fins during escape and predatory behavior. In accord with previous studies, we find roles for the pectoral fins in slow swimming and immediately after striking prey. We find novel roles for the pectoral fins in long-latency, but not in short-latency C-bends. We also observe fin movements that occur during orienting J-turns and S-starts that drive high-velocity predatory strikes. Finally, we find that the use of pectoral fins following a predatory strike is scaled to the velocity of the strike, supporting a role for the fins in braking. The implications of these results for central control of coordinated movements are discussed, and we hope that these results will provide baselines for future analyses of cross-body coordination using mutants, morphants, and transgenic approaches.	[McClenahan, Phil; Troup, Michael; Scott, Ethan K.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia	University of Queensland	McClenahan, P (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	ethan.scott@uq.edu.au		Troup, Michael/0000-0002-8828-4735; Scott, Ethan/0000-0003-3150-9216	NARSAD, Brain and Behavior Research Foundation; University of Queensland; Australian Zebrafish Phenomics Facility (NHMRC) [455871]; Australian Research Council [DP110103612]	NARSAD, Brain and Behavior Research Foundation; University of Queensland(University of Queensland); Australian Zebrafish Phenomics Facility (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	ES is funded by a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation, the University of Queensland, the Australian Zebrafish Phenomics Facility (NHMRC Enabling Grant 455871), Australian Research Council Discovery Project Grant DP110103612, and an Australian Research Council Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley-Ross MA, 2002, J EXP ZOOL, V293, P561, DOI 10.1002/jez.10183; Bhatt DH, 2007, NEURON, V53, P91, DOI 10.1016/j.neuron.2006.11.011; Borla MA, 2002, BRAIN BEHAV EVOLUT, V60, P207, DOI 10.1159/000066699; Budick SA, 2000, J EXP BIOL, V203, P2565; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Danos N, 2007, J EXP BIOL, V210, P3374, DOI 10.1242/jeb.007484; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Drucker EG, 2003, J EXP BIOL, V206, P813, DOI 10.1242/jeb.00139; Drucker EG, 1997, J EXP BIOL, V200, P1709; Drucker EG, 2001, J EXP BIOL, V204, P431; Fontaine E, 2008, J EXP BIOL, V211, P1305, DOI 10.1242/jeb.010272; FOREMAN MB, 1993, J NEUROSCI, V13, P4101; Friedrich RW, 2010, CURRENT BIOL, V20; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Green MH, 2011, J EXP BIOL, V214, P3111, DOI 10.1242/jeb.057497; Hale ME, 1996, AM ZOOL, V36, P695; Hale ME, 1999, J EXP BIOL, V202, P1465; Hale ME, 2006, J EXP BIOL, V209, P3708, DOI 10.1242/jeb.02449; HALL DH, 1985, J NEUROCYTOL, V14, P825, DOI 10.1007/BF01170831; Kamata R, 2003, COMP BIOCHEM PHYS A, V135, P435, DOI 10.1016/S1095-6433(03)00110-7; KIMMEL CB, 1974, DEV PSYCHOBIOL, V7, P47, DOI 10.1002/dev.420070109; KIMMEL CB, 1980, J COMP PHYSIOL, V140, P343, DOI 10.1007/BF00606274; Koyama M, 2011, P NATL ACAD SCI USA, V108, P1170, DOI 10.1073/pnas.1012189108; LADICH F, 1992, BRAIN BEHAV EVOLUT, V39, P1, DOI 10.1159/000114099; Lauder GV, 2007, EXP FLUIDS, V43, P641, DOI 10.1007/s00348-007-0357-4; Liao JC, 2008, J NEUROSCI, V28, P12982, DOI 10.1523/JNEUROSCI.3330-08.2008; McElligott MB, 2005, BRAIN BEHAV EVOLUT, V66, P177, DOI 10.1159/000087158; McLean DL, 2011, CURR OPIN NEUROBIOL, V21, P110, DOI 10.1016/j.conb.2010.09.011; McLean DL, 2009, J NEUROSCI, V29, P13566, DOI 10.1523/JNEUROSCI.3277-09.2009; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; MYERS PZ, 1985, J COMP NEUROL, V236, P555, DOI 10.1002/cne.902360411; Nakae M, 2007, ICHTHYOL RES, V54, P333, DOI 10.1007/s10228-007-0409-z; OKAMOTO H, 1991, DEV BIOL, V146, P49, DOI 10.1016/0012-1606(91)90445-9; Patterson SE, 2008, DEV DYNAM, V237, P307, DOI 10.1002/dvdy.21400; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; Sankrithi NS, 2010, NEUROSCIENCE, V166, P970, DOI 10.1016/j.neuroscience.2010.01.003; Satou C, 2009, J NEUROSCI, V29, P6780, DOI 10.1523/JNEUROSCI.0801-09.2009; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Thorsen DH, 2007, J COMP NEUROL, V504, P168, DOI 10.1002/cne.21425; Thorsen DH, 2005, J MORPHOL, V266, P241, DOI 10.1002/jmor.10374; Thorsen DH, 2005, J MORPHOL, V263, P133, DOI 10.1002/jmor.10173; Thorsen DH, 2004, J EXP BIOL, V207, P4175, DOI 10.1242/jeb.01285; Walker JA, 1997, J EXP BIOL, V200, P1549; Walker JA, 2002, INTEGR COMP BIOL, V42, P1032, DOI 10.1093/icb/42.5.1032; Westneat MW, 2004, IEEE J OCEANIC ENG, V29, P674, DOI 10.1109/JOE.2004.833207; Westneat MW, 1997, J EXP BIOL, V200, P1881; Wilga CD, 1999, J EXP BIOL, V202, P2413; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323	52	36	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32295	10.1371/journal.pone.0032295	http://dx.doi.org/10.1371/journal.pone.0032295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359680	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200149
J	Hancock, T; Wicker, N; Takigawa, I; Mamitsuka, H				Hancock, Timothy; Wicker, Nicolas; Takigawa, Ichigaku; Mamitsuka, Hiroshi			Identifying Neighborhoods of Coordinated Gene Expression and Metabolite Profiles	PLOS ONE			English	Article							ESCHERICHIA-COLI; ROBUSTNESS; PROTEIN; IRON; INTEGRATION; PATHWAYS; NETWORK; SYSTEM; ENZYME; KNOWLEDGEBASE	In this paper we investigate how metabolic network structure affects any coordination between transcript and metabolite profiles. To achieve this goal we conduct two complementary analyses focused on the metabolic response to stress. First, we investigate the general size of any relationship between metabolic network gene expression and metabolite profiles. We find that strongly correlated transcript-metabolite profiles are sustained over surprisingly long network distances away from any target metabolite. Secondly, we employ a novel pathway mining method to investigate the structure of this transcript-metabolite relationship. The objective of this method is to identify a minimum set of metabolites which are the target of significantly correlated gene expression pathways. The results reveal that in general, a global regulation signature targeting a small number of metabolites is responsible for a large scale metabolic response. However, our method also reveals pathway specific effects that can degrade this global regulation signature and complicates the observed coordination between transcript-metabolite profiles.	[Hancock, Timothy; Takigawa, Ichigaku; Mamitsuka, Hiroshi] Kyoto Univ, Bioinformat Ctr, Kyoto, Japan; [Wicker, Nicolas] Univ Strasbourg, Lab Bioinformat & Genom Integrat, Inst Genet & Biol Mol & Cellulaire, Strasbourg, France	Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hancock, T (corresponding author), Kyoto Univ, Bioinformat Ctr, Kyoto, Japan.	timhancock@kuicr.kyoto-u.ac.jp	Takigawa, Ichigaku/B-3823-2012; Mamitsuka, Hiroshi/R-1110-2016	Takigawa, Ichigaku/0000-0001-5633-995X; Mamitsuka, Hiroshi/0000-0002-6607-5617	BIRD, JST (Japan Science and Technology Agency); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [23710233]	BIRD, JST (Japan Science and Technology Agency); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	H.M., T. H. and I. T. have been partially supported by BIRD, JST (Japan Science and Technology Agency). I. T. is also partially supported by the Grant-in-Aid for Scientificc Research 23710233 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akana J, 2006, BIOCHEMISTRY-US, V45, P2493, DOI 10.1021/bi052474m; Bradley PH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000270; Cakir T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100085; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Fischer D, 1998, J BACTERIOL, V180, P6203; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibon Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r76; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hancock T, 2010, BIOINFORMATICS, V26, P2128, DOI 10.1093/bioinformatics/btq344; Handorf T, 2005, J MOL EVOL, V61, P498, DOI 10.1007/s00239-005-0027-1; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Holme P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016605; IBM, 2008, IL CPLEX OPT VERS 11; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim PJ, 2007, P NATL ACAD SCI USA, V104, P13638, DOI 10.1073/pnas.0703262104; Koch D, 2007, BIOMETALS, V20, P759, DOI 10.1007/s10534-006-9039-6; Krin E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-273; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; Kupiec M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100146; MANDELSTAM J, 1957, NATURE, V179, P1179, DOI 10.1038/1791179a0; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Metzner M, 2004, MOL MICROBIOL, V51, P799, DOI 10.1046/j.1365-2958.2003.03867.x; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Smart AG, 2008, P NATL ACAD SCI USA, V105, P13223, DOI 10.1073/pnas.0803571105; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Spirin V, 2006, P NATL ACAD SCI USA, V103, P8774, DOI 10.1073/pnas.0510258103; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takigawa I, 2008, BIOINFORMATICS, V24, P250, DOI 10.1093/bioinformatics/btm575; van Vliet AHM, 2002, FEMS MICROBIOL REV, V26, P173, DOI 10.1111/j.1574-6976.2002.tb00609.x; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Vazirani V., 2001, APPROXIMATION ALGORI; WILLETTS NS, 1967, BIOCHEM J, V103, P453, DOI 10.1042/bj1030453	43	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31345	10.1371/journal.pone.0031345	http://dx.doi.org/10.1371/journal.pone.0031345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355360	gold, Green Published, Green Submitted			2022-12-25	WOS:000302741300060
J	Hoffmann, F; Kloas, W				Hoffmann, Frauke; Kloas, Werner			Estrogens Can Disrupt Amphibian Mating Behavior	PLOS ONE			English	Article							AFRICAN CLAWED FROGS; XENOPUS-LAEVIS; ENDOCRINE DISRUPTERS; SURFACE-WATER; WASTE-WATER; BISPHENOL-A; IN-VITRO; 17-ALPHA-ETHINYLESTRADIOL; PHARMACEUTICALS; GONADOTROPIN	The main component of classical contraceptives, 17 alpha-ethinylestradiol (EE2), has high estrogenic activity even at environmentally relevant concentrations. Although estrogenic endocrine disrupting compounds are assumed to contribute to the worldwide decline of amphibian populations by adverse effects on sexual differentiation, evidence for EE2 affecting amphibian mating behaviour is lacking. In this study, we demonstrate that EE2 exposure at five different concentrations (0.296 ng/L, 2.96 ng/L, 29.64 ng/L, 2.96 mu g/L and 296.4 mu g/L) can disrupt the mating behavior of adult male Xenopus laevis. EE2 exposure at all concentrations lowered male sexual arousal, indicated by decreased proportions of advertisement calls and increased proportions of the call type rasping, which characterizes a sexually unaroused state of a male. Additionally, EE2 at all tested concentrations affected temporal and spectral parameters of the advertisement calls, respectively. The classical and highly sensitive biomarker vitellogenin, on the other hand, was only induced at concentrations equal or higher than 2.96 mu g/L. If kept under control conditions after a 96 h EE2 exposure (2.96 mu g/L), alterations of male advertisement calls vanish gradually within 6 weeks and result in a lower sexual attractiveness of EE2 exposed males toward females as demonstrated by female choice experiments. These findings indicate that exposure to environmentally relevant EE2 concentrations can directly disrupt male mate calling behavior of X. laevis and can indirectly affect the mating behavior of females. The results suggest the possibility that EE2 exposure could reduce the reproductive success of EE2 exposed animals and these effects might contribute to the global problem of amphibian decline.	[Hoffmann, Frauke] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecophysiol & Aquaculture, Berlin, Germany; [Kloas, Werner] Humboldt Univ, Inst Biol, Dept Endocrinol, D-10099 Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin	Hoffmann, F (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecophysiol & Aquaculture, Berlin, Germany.	f.hoffmann@igb-berlin.de	Hoffmann, Frauke/H-5994-2015; Hoffmann, Frauke/F-9114-2017		German Environmental Foundation (Deutsche Bundesstiftung Umwelt, DBU, Osnabruck, Germany) [AZ 20009/987]	German Environmental Foundation (Deutsche Bundesstiftung Umwelt, DBU, Osnabruck, Germany)	The authors would like to thank the German Environmental Foundation (Deutsche Bundesstiftung Umwelt, DBU, Osnabruck, Germany, http://www.dbu.de/stipendien_20008/987_db.html) for awarding a doctoral scholarship to Frauke Hoffmann (grant no. AZ 20009/987). There are no further external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P, 2001, ACTA HYDROCH HYDROB, V29, P227, DOI 10.1002/1521-401X(200111)29:4<227::AID-AHEH227>3.0.CO;2-R; Arcand-Hoy LD, 1998, INT J TOXICOL, V17, P139, DOI 10.1080/109158198226675; BANCROFT J, 1974, BRIT J PSYCHIAT, V125, P310, DOI 10.1192/bjp.125.3.310; Belfroid AC, 1999, SCI TOTAL ENVIRON, V225, P101, DOI 10.1016/S0048-9697(98)00336-2; Bogi C, 2003, ENVIRON RES, V93, P195, DOI 10.1016/S0013-9351(03)00082-3; Brahic CJ, 2003, J COMP NEUROL, V464, P115, DOI 10.1002/cne.10772; Braun P, 2003, J CHROMATOGR A, V988, P41, DOI 10.1016/S0021-9673(02)02052-6; CAREY C, 1995, ENVIRON HEALTH PERSP, V103, P13, DOI 10.2307/3432406; Colman JR, 2009, AQUAT TOXICOL, V91, P346, DOI 10.1016/j.aquatox.2008.12.001; Desbrow C, 1998, ENVIRON SCI TECHNOL, V32, P1549, DOI 10.1021/es9707973; Emperaire J C, 1969, Gynecol Prat, V20, P327; GERHARDT HC, 1978, J EXP BIOL, V74, P59; Hoffmann F, 2010, HORM BEHAV, V58, P653, DOI 10.1016/j.yhbeh.2010.06.008; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Jones OAH, 2001, ENVIRON TECHNOL, V22, P1383, DOI 10.1080/09593332208618186; KELLEY DB, 1976, HORM BEHAV, V7, P159, DOI 10.1016/0018-506X(76)90045-3; Kelley DB, 1999, DESIGN OF ANIMAL COMMUNICATION, P9; Kloas W, 1999, SCI TOTAL ENVIRON, V225, P59, DOI 10.1016/S0048-9697(98)00332-5; Kloas W, 2002, INT REV CYTOL, V216, P1; KONISHI M, 1988, P NATL ACAD SCI USA, V85, P7006, DOI 10.1073/pnas.85.18.7006; Kuch HM, 2001, ENVIRON SCI TECHNOL, V35, P3201, DOI 10.1021/es010034m; Levy G, 2004, ENVIRON RES, V94, P102, DOI 10.1016/S0013-9351(03)00086-0; LOFTUSHI.JJ, 1971, COPEIA, P154; Lutz I, 2005, COMP BIOCHEM PHYS C, V141, P384, DOI 10.1016/j.cbpc.2005.08.003; MARIN ML, 1990, DEVELOPMENT, V110, P703; Markman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001674; MORRELL JI, 1975, J COMP NEUROL, V164, P63, DOI 10.1002/cne.901640106; MURRAY MAF, 1975, J ENDOCRINOL, V67, P179, DOI 10.1677/joe.0.0670179; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; ORME ML, 1983, CLIN PHARMACOKINET, V8, P95, DOI 10.2165/00003088-198308020-00001; Partridge C, 2010, HORM BEHAV, V58, P800, DOI 10.1016/j.yhbeh.2010.08.002; Pawlowski S, 2004, ECOTOX ENVIRON SAFE, V57, P330, DOI 10.1016/j.ecoenv.2003.07.019; Prasad PJ, 2010, CONCEPTUAL PHARM; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; RUSSELL W. M. S., 1960, BEHAVIOUR, V15, P253, DOI 10.1163/156853960X00269; Saaristo M, 2010, CHEMOSPHERE, V79, P541, DOI 10.1016/j.chemosphere.2010.02.019; Saaristo M, 2009, HORM BEHAV, V56, P315, DOI 10.1016/j.yhbeh.2009.06.010; Sanderson H, 2004, REGUL TOXICOL PHARM, V39, P158, DOI 10.1016/j.yrtph.2003.12.006; Shen JH, 2001, TOXICOLOGY, V166, P71, DOI 10.1016/S0300-483X(01)00439-5; Stebbins RC., 1997, NATURAL HIST AMPHIBI; STUMPF M, 1996, VOM WASSER, V87, P251; Ternes TA, 1999, SCI TOTAL ENVIRON, V225, P81, DOI 10.1016/S0048-9697(98)00334-9; Tobias ML, 2004, ANIM BEHAV, V67, P353, DOI 10.1016/j.anbehav.2003.03.016; Tobias ML, 1998, P NATL ACAD SCI USA, V95, P1870, DOI 10.1073/pnas.95.4.1870; Tobias ML, 1998, J NEUROBIOL, V37, P441, DOI 10.1002/(SICI)1097-4695(19981115)37:3<441::AID-NEU9>3.3.CO;2-X; Toppari J, 2002, SEMIN REPROD MED, V20, P305, DOI 10.1055/s-2002-35377; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; Urbatzka R, 2007, COMP BIOCHEM PHYS C, V144, P310, DOI 10.1016/j.cbpc.2006.10.008; van Heusden AM, 2002, HUM REPROD UPDATE, V8, P345, DOI 10.1093/humupd/8.4.345; Vignal C, 2007, P ROY SOC B-BIOL SCI, V274, P479, DOI 10.1098/rspb.2006.3744; Wade J, 1996, P NATL ACAD SCI USA, V93, P5264, DOI 10.1073/pnas.93.11.5264; Watson CS, 2011, J STEROID B IN PRESS; WETZEL DM, 1983, HORM BEHAV, V17, P388, DOI 10.1016/0018-506X(83)90048-X; Wu KH, 2001, NEUROENDOCRINOLOGY, V74, P22, DOI 10.1159/000054667; YAGER D, 1982, AM ZOOL, V22, P887; Yang EJ, 2007, P NATL ACAD SCI USA, V104, P2477, DOI 10.1073/pnas.0608391104	56	43	44	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e32097	10.1371/journal.pone.0032097	http://dx.doi.org/10.1371/journal.pone.0032097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355410	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300110
J	Maurer, LM; Annis, DS; Mosher, DF				Maurer, Lisa M.; Annis, Douglas S.; Mosher, Deane F.			IGD Motifs, Which Are Required for Migration Stimulatory Activity of Fibronectin Type I Modules, Do Not Mediate Binding in Matrix Assembly	PLOS ONE			English	Article							CELL-SURFACE FIBRONECTIN; PLASMA FIBRONECTIN; TERMINAL MODULES; SITES; SEQUENCES; FRAGMENT; PROTEIN; MARKER; F1	Picomolar concentrations of proteins comprising only the N-terminal 70-kDa region (70K) of fibronectin (FN) stimulate cell migration into collagen gels. The Ile-Gly-Asp (IGD) motifs in four of the nine FN type 1 (FNI) modules in 70K are important for such migratory stimulating activity. The 70K region mediates binding of nanomolar concentrations of intact FN to cell-surface sites where FN is assembled. Using baculovirus, we expressed wildtype 70K and 70K with Ile-to-Ala mutations in (FNI)-F-3 and (FNI)-F-5; (FNI)-F-7 and (FNI)-F-9; or (FNI)-F-3, (FNI)-F-5, (FNI)-F-7, and (FNI)-F-9. Wildtype 70K and 70K with Ile-to-Ala mutations were equally active in binding to assembly sites of FN-null fibroblasts. This finding indicates that IGD motifs do not mediate the interaction between 70K and the cell-surface that is important for FN assembly. Further, FN fragment N-(FNIII)-F-3, which does not stimulate migration, binds to assembly sites on FN-null fibroblast. The Ile-to-Ala mutations had effects on the structure of FNI modules as evidenced by decreases in abilities of 70K with Ile-to-Ala mutations to bind to monoclonal antibody 5C3, which recognizes an epitope in (FNI)-F-9, or to bind to FUD, a polypeptide based on the F1 adhesin of Streptococcus pyogenes that interacts with 70K by the beta-zipper mechanism. These results suggest that the picomolar interactions of 70K with cells that stimulate cell migration require different conformations of FNI modules than the nanomolar interactions required for assembly.	[Maurer, Lisa M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Maurer, LM (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.	dfmosher@wisc.edu		Maurer, Lisa/0000-0003-0492-9805	National Institutes of Health [R01 HL021644]; American Heart Association [0815362G]; National Institutes of Aging [T32 AG000213]; PI Sanjay Asthana;  [P01 HL088594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594, R01HL021644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PI Sanjay Asthana; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a National Institutes of Health Grant R01 HL021644 (to D. F. M.), an American Heart Association pre-doctoral training grant 0815362G (to L. M. M.), a National Institutes of Aging Grant T32 AG000213, PI Sanjay Asthana (to L. M. M.), and Program Project grant P01 HL088594. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Cho J, 2006, J THROMB HAEMOST, V4, P1461, DOI 10.1111/j.1538-7836.2006.01943.x; Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Ellis IR, 2010, CELL SIGNAL, V22, P1655, DOI 10.1016/j.cellsig.2010.06.005; Ellis IR, 2010, EXP CELL RES, V316, P2465, DOI 10.1016/j.yexcr.2010.04.003; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; Maurer LM, 2010, THROMB RES, V125, P287, DOI 10.1016/j.thromres.2009.12.017; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Millard CJ, 2007, J BIOL CHEM, V282, P35530, DOI 10.1074/jbc.M707532200; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Norris NC, 2011, J BIOL CHEM, V286, P38311, DOI 10.1074/jbc.M111.276592; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X; Schor SL, 2003, CANCER RES, V63, P8827; Schor SL, 1999, J CELL SCI, V112, P3879; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Xu JL, 2010, J BIOL CHEM, V285, P8563, DOI 10.1074/jbc.M109.062646; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113; ZERLAUTH G, 1984, AM J MED, V77, P685, DOI 10.1016/0002-9343(84)90366-8; ZHANG QH, 1994, J CELL BIOL, V127, P1447, DOI 10.1083/jcb.127.5.1447	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30615	10.1371/journal.pone.0030615	http://dx.doi.org/10.1371/journal.pone.0030615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355321	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300021
J	Schoolmeesters, A; Brown, DD; Fedorov, Y				Schoolmeesters, Angela; Brown, Daniel D.; Fedorov, Yuriy			Kinome-Wide Functional Genomics Screen Reveals a Novel Mechanism of TNF alpha-Induced Nuclear Accumulation of the HIF-1 alpha Transcription Factor in Cancer Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; KAPPA-B; REGULATOR; TRIB2	Hypoxia-inducible factor-1 (HIF-1) and its most important subunit, HIF-1 alpha, plays a central role in tumor progression by regulating genes involved in cancer cell survival, proliferation and metastasis. HIF-1 alpha activity is associated with nuclear accumulation of the transcription factor and regulated by several mechanisms including modulation of protein stability and degradation. Among recent advances are the discoveries that inflammation-induced cytokines and growth factors affect protein accumulation of HIF-1 alpha under normoxia conditions. TNF alpha, a major pro-inflammatory cytokine that promotes tumorigenesis is known as a stimulator of HIF-1 alpha activity. To improve our understanding of TNF alpha-mediated regulation of HIF-1 alpha nuclear accumulation we screened a kinase-specific siRNA library using a cell imaging-based HIF-1 alpha-eGFP chimera reporter assay. Interestingly, this systematic analysis determined that depletion of kinases involved in conventional TNF alpha signaling (IKK/NF kappa B and JNK pathways) has no detrimental effect on HIF-1 alpha accumulation. On the other hand, depletion of PRKAR2B, ADCK2, TRPM7, and TRIB2 significantly decreases the effect of TNF alpha on HIF-1 alpha stability in osteosarcoma and prostate cancer cell lines. These newly discovered regulators conveyed their activity through a non-conventional RELB-depended NF kappa B signaling pathway and regulation of superoxide activity. Taken together our data allow us to conclude that TNF alpha uses a distinct and complex signaling mechanism to induce accumulation of HIF-1 alpha in cancer cells. In summary, our results illuminate a novel mechanism through which cancer initiation and progression may be promoted by inflammatory cytokines, highlighting new potential avenues for fighting this disease.	[Schoolmeesters, Angela] Thermo Fisher Sci, Lafayette, CO USA; [Brown, Daniel D.; Fedorov, Yuriy] Thermo Fisher Sci, Pittsburgh, PA USA	Thermo Fisher Scientific; Thermo Fisher Scientific	Schoolmeesters, A (corresponding author), Thermo Fisher Sci, Lafayette, CO USA.	Yuriy.Fedorov@thermofisher.com			Thermo Fisher Scientific	Thermo Fisher Scientific	This work was funded by Thermo Fisher Scientific. There are no current external funding sources for this study.	Albina JE, 2001, AM J PHYSIOL-CELL PH, V281, pC1971, DOI 10.1152/ajpcell.2001.281.6.C1971; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Cash TP, 2007, FREE RADICAL BIO MED, V43, P1219, DOI 10.1016/j.freeradbiomed.2007.07.001; Chen RQ, 2009, J BIOL CHEM, V284, P16752, DOI 10.1074/jbc.M109.014316; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Frede S, 2007, METHOD ENZYMOL, V435, P405, DOI 10.1016/S0076-6879(07)35021-0; Grandinetti KB, 2011, ONCOGENE, V30, P3328, DOI 10.1038/onc.2011.57; Guilbert A, 2009, AM J PHYSIOL-CELL PH, V297, pC493, DOI 10.1152/ajpcell.00624.2008; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Han D, 2009, ANTIOXID REDOX SIGN, V11, P2245, DOI [10.1089/ars.2009.2611, 10.1089/ARS.2009.2611]; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Iorns E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005120; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jaspers I, 2001, AM J RESP CELL MOL, V24, P769, DOI 10.1165/ajrcmb.24.6.4344; Keeshan K, 2008, BLOOD CELL MOL DIS, V40, P119, DOI 10.1016/j.bcmd.2007.06.005; Kohl R, 2006, FREE RADICAL BIO MED, V40, P1430, DOI 10.1016/j.freeradbiomed.2005.12.012; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Sonenshein GE, 1997, SEMIN CANCER BIOL, V8, P113, DOI 10.1006/scbi.1997.0062; Tasken K, 1997, ADV SEC MESS PHOSPH, V31, P191; Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x; Yee NS, 2011, DIS MODEL MECH, V4, P240, DOI 10.1242/dmm.004564	26	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31270	10.1371/journal.pone.0031270	http://dx.doi.org/10.1371/journal.pone.0031270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355351	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300051
J	Srivastava, S; Kashiwaya, Y; King, MT; Baxa, U; Tam, J; Niu, G; Chen, XY; Clarke, K; Veech, RL				Srivastava, Shireesh; Kashiwaya, Yoshihiro; King, M. Todd; Baxa, Ulrich; Tam, Joseph; Niu, Gang; Chen, Xiaoyuan; Clarke, Kieran; Veech, Richard L.			Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet	FASEB JOURNAL			English	Article						brown fat; electron transport chain; sympathetic activity; insulin sensitivity; energy expenditure	HYPOTHALAMIC MALONYL-COA; KETOGENIC DIET; HIGH-FAT; SKELETAL-MUSCLE; GENE-EXPRESSION; INDUCED OBESITY; ADULT HUMANS; PPAR-GAMMA; RAT; METABOLISM	We measured the effects of a diet in which D-beta-hydroxybutyrate-(R)-1,3 butanediol monoester [ketone ester (KE)] replaced equicaloric amounts of carbohydrate on 8-wk-old male C57BL/6J mice. Diets contained equal amounts of fat, protein, and micronutrients. The KE group was fed ad libitum, whereas the control (Ctrl) mice were pair-fed to the KE group. Blood D-beta-hydroxybutyrate levels in the KE group were 3-5 times those reported with high-fat ketogenic diets. Voluntary food intake was reduced dose dependently with the KE diet. Feeding the KE diet for up to 1 mo increased the number of mitochondria and doubled the electron transport chain proteins, uncoupling protein 1, and mitochondrial biogenesis-regulating proteins in the interscapular brown adipose tissue (IBAT). [F-18]-Fluorodeoxyglucose uptake in IBAT of the KE group was twice that in IBAT of the Ctrl group. Plasma leptin levels of the KE group were more than 2-fold those of the Ctrl group and were associated with increased sympathetic nervous system activity to IBAT. The KE group exhibited 14% greater resting energy expenditure, but the total energy expenditure measured over a 24-h period or body weights was not different. The quantitative insulin-sensitivity check index was 73% higher in the KE group. These results identify KE as a potential antiobesity supplement.-Srivastava, S., Kashiwaya, Y., King, M. T. Baxa, U., Tam, J., Niu, G., Chen, X., Clarke, K., Veech, R. L. Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet. FASEB J. 26, 2351-2362 (2012). www.fasebj.org	[Srivastava, Shireesh; Kashiwaya, Yoshihiro; King, M. Todd; Veech, Richard L.] NIAAA, Lab Metab Control, NIH, Rockville, MD 20852 USA; [Baxa, Ulrich] NCI, Electron Microscopy Lab, Adv Technol Program, SAIC Frederick Inc,Natl Inst Hlth, Frederick, MD 21701 USA; [Tam, Joseph] NIAAA, Lab Physiol Studies, NIH, Rockville, MD 20852 USA; [Niu, Gang; Chen, Xiaoyuan] Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD USA; [Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); University of Oxford	Veech, RL (corresponding author), NIAAA, Lab Metab Control, NIH, 5625 Fishers Ln,Room 2S-28, Rockville, MD 20852 USA.	rveech@mail.nih.gov	Chen, Xiaoyuan/D-1860-2014	Chen, Xiaoyuan/0000-0002-9622-0870	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000110] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/004/22659, PS/02/002/14893] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); British Heart Foundation(British Heart Foundation)		Balietti M, 2010, AGEING RES REV, V9, P273, DOI 10.1016/j.arr.2010.02.003; Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cha SH, 2006, P NATL ACAD SCI USA, V103, P15410, DOI 10.1073/pnas.0607334103; Cusin I, 1998, DIABETES, V47, P1014, DOI 10.2337/diabetes.47.7.1014; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dahlin M, 2005, EPILEPSY RES, V64, P115, DOI 10.1016/j.eplepsyres.2005.03.008; Dashti HM, 2007, MOL CELL BIOCHEM, V302, P249, DOI 10.1007/s11010-007-9448-z; ENDEMANN G, 1987, BIOCHEM CELL BIOL, V65, P989, DOI 10.1139/o87-129; Franko A, 2008, MOL CELL BIOL, V28, P2446, DOI 10.1128/MCB.00980-07; Fueger BJ, 2006, J NUCL MED, V47, P999; GEELEN MJH, 1983, FEBS LETT, V163, P269, DOI 10.1016/0014-5793(83)80833-3; Ghorbani M, 1997, BIOCHEM PHARMACOL, V54, P121, DOI 10.1016/S0006-2952(97)00162-7; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Henderson ST, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-31; Himms-Hagen J, 2001, Rev Endocr Metab Disord, V2, P395, DOI 10.1023/A:1011856617047; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kashiwaya Y, 2010, J BIOL CHEM, V285, P25950, DOI 10.1074/jbc.M110.138198; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; KOLANOWSKI J, 1994, METABOLISM, V43, P180, DOI 10.1016/0026-0495(94)90242-9; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Kwiterovich PO, 2003, JAMA-J AM MED ASSOC, V290, P912, DOI 10.1001/jama.290.7.912; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Murphy P, 2005, PEDIATR RES, V57, P353, DOI 10.1203/01.PDR.0000150804.18038.79; Nagashima K, 2011, METHODS MOL BIOL, V697, P83, DOI 10.1007/978-1-60327-198-1_8; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; OWEN OE, 1969, J CLIN INVEST, V48, P574, DOI 10.1172/JCI106016; Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, pE287, DOI 10.1152/ajpendo.00035.2008; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Rahmouni K, 2007, HYPERTENSION, V49, P647, DOI 10.1161/01.HYP.0000254827.59792.b2; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rim JS, 2002, J BIOL CHEM, V277, P34589, DOI 10.1074/jbc.M108866200; Rogovik AL, 2010, CAN FAM PHYSICIAN, V56, P540; ROTHWELL NJ, 1985, METABOLISM, V34, P474, DOI 10.1016/0026-0495(85)90214-8; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Samaha Frederick F, 2007, Curr Atheroscler Rep, V9, P441, DOI 10.1007/s11883-007-0059-7; SATO K, 1995, FASEB J, V9, P651, DOI 10.1096/fasebj.9.8.7768357; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Stephens M, 2011, CLIN ENDOCRINOL, V74, P661, DOI 10.1111/j.1365-2265.2011.04018.x; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; VanItallie TB, 2005, NEUROLOGY, V64, P728, DOI 10.1212/01.WNL.0000152046.11390.45; Veech RL, 2001, IUBMB LIFE, V51, P241; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Vernochet C, 2010, DRUG NEWS PERSPECT, V23, P409, DOI 10.1358/dnp.2010.23.7.1487083; Wolfgang MJ, 2007, P NATL ACAD SCI USA, V104, P19285, DOI 10.1073/pnas.0709778104; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	57	80	81	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2012	26	6					2351	2362		10.1096/fj.11-200410	http://dx.doi.org/10.1096/fj.11-200410			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22362892	Green Published			2022-12-25	WOS:000305017200013
J	Hayano, S; Kurosaka, H; Yanagita, T; Kalus, I; Milz, F; Ishihara, Y; Islam, MN; Kawanabe, N; Saito, M; Kamioka, H; Adachi, T; Dierks, T; Yamashiro, T				Hayano, Satoru; Kurosaka, Hiroshi; Yanagita, Takeshi; Kalus, Ina; Milz, Fabian; Ishihara, Yoshihito; Islam, Md. Nurul; Kawanabe, Noriaki; Saito, Masahiro; Kamioka, Hiroshi; Adachi, Taiji; Dierks, Thomas; Yamashiro, Takashi			Roles of Heparan Sulfate Sulfation in Dentinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONYCHO-DERMAL DYSPLASIA; CELL-SURFACE; TOOTH DEVELOPMENT; 6-O-ENDOSULFATASES SULF1; IN-VIVO; EXPRESSION; PROTEOGLYCANS; DSPP; MUTATION; GENE	Cell surface heparan sulfate (HS) is an essential regulator of cell signaling and development. HS traps signaling molecules, like Wnt in the glycosaminoglycan side chains of HS proteoglycans (HSPGs), and regulates their functions. Endosulfatases Sulf1 and Sulf2 are secreted at the cell surface to selectively remove 6-O-sulfate groups from HSPGs, thereby modifying the affinity of cell surface HSPGs for its ligands. This study provides molecular evidence for the functional roles of HSPG sulfation and desulfation in dentinogenesis. We show that odontogenic cells are highly sulfated on the cell surface and become desulfated during their differentiation to odontoblasts, which produce tooth dentin. Sulf1/Sulf2 double null mutant mice exhibit a thin dentin matrix and short roots combined with reduced expression of dentin sialophosphoprotein (Dspp) mRNA, encoding a dentin-specific extracellular matrix precursor protein, whereas single Sulf mutants do not show such defective phenotypes. In odontoblast cell lines, Dspp mRNA expression is potentiated by the activation of the Wnt canonical signaling pathway. In addition, pharmacological interference with HS sulfation promotes Dspp mRNA expression through activation of Wnt signaling. On the contrary, the silencing of Sulf suppresses the Wnt signaling pathway and subsequently Dspp mRNA expression. We also show that Wnt10a protein binds to cell surface HSPGs in odontoblasts, and interference with HS sulfation decreases the binding affinity of Wnt10a for HSPGs, which facilitates the binding of Wnt10a to its receptor and potentiates the Wnt signaling pathway, thereby up-regulating Dspp mRNA expression. These results demonstrate that Sulf-mediated desulfation of cellular HSPGs is an important modification that is critical for the activation of the Wnt signaling in odontoblasts and for production of the dentin matrix.	[Islam, Md. Nurul; Kawanabe, Noriaki; Kamioka, Hiroshi] Okayama Univ, Dept Orthodont, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan; [Kalus, Ina; Milz, Fabian; Dierks, Thomas] Univ Bielefeld, Dept Chem, D-33501 Bielefeld, Germany; [Saito, Masahiro] Tokyo Univ Sci, Fac Ind Sci & Technol, Tokyo 1628601, Japan; [Adachi, Taiji] Kyoto Univ, Dept Biomechan, Res Ctr Nano Med Engn, Inst Frontier Med Sci, Kyoto 6068507, Japan	Okayama University; University of Bielefeld; Tokyo University of Science; Kyoto University		yamataka@md.okayama-u.ac.jp	ISHIHARA, Yoshihito/B-2345-2011; Yamashiro, Takashi/Y-6411-2019; Dierks, Thomas/A-3596-2012; Adachi, Taiji/P-8981-2016; Kamioka, Hiroshi/B-2476-2011; Yamashiro, Takashi/S-6010-2019	ISHIHARA, Yoshihito/0000-0002-5999-8253; Dierks, Thomas/0000-0001-6426-1339; Adachi, Taiji/0000-0001-5280-4156; Yamashiro, Takashi/0000-0002-4419-9643; Kurosaka, Hiroshi/0000-0002-8956-5467	Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22792051, 24792284] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research program from the Japan Society for the Promotion of Science (to T. Y.).	Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Cardigan RA, 1997, J CARDIOTHOR VASC AN, V11, P329, DOI 10.1016/S1053-0770(97)90103-8; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Fritz T A, 2001, Methods Mol Biol, V171, P317; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Ida-Yonemochi H, 2011, MATRIX BIOL, V30, P379, DOI 10.1016/j.matbio.2011.08.001; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Langsdorf A, 2007, DEV BIOL, V311, P464, DOI 10.1016/j.ydbio.2007.08.053; Leteux C, 2001, J BIOL CHEM, V276, P12539, DOI 10.1074/jbc.M010291200; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679; Lohi M, 2010, DEV DYNAM, V239, P160, DOI 10.1002/dvdy.22047; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nawaz S, 2009, EUR J HUM GENET, V17, P1600, DOI 10.1038/ejhg.2009.81; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Qin C, 2002, J DENT RES, V81, P392, DOI 10.1177/154405910208100607; Rajpar MH, 2002, HUM MOL GENET, V11, P2559, DOI 10.1093/hmg/11.21.2559; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7; SHIELDS ED, 1973, ARCH ORAL BIOL, V18, P543, DOI 10.1016/0003-9969(73)90075-7; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Suomalainen M, 2010, DEV DYNAM, V239, P364, DOI 10.1002/dvdy.22106; Thesleff I, 1999, BONE, V25, P123, DOI 10.1016/S8756-3282(99)00119-2; THESLEFF I, 1991, J CRAN GENET DEV BIO, V11, P229; THESLEFF I, 1989, International Journal of Developmental Biology, V33, P91; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; Wu N, 2010, ARCH ORAL BIOL, V55, P426, DOI 10.1016/j.archoralbio.2010.03.011; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamashiro T, 2001, J DENT RES, V80, P461, DOI 10.1177/00220345010800021201; Yamashiro T, 2007, DIFFERENTIATION, V75, P452, DOI 10.1111/j.1432-0436.2006.00150.x; Yanagita T, 2007, FEBS J, V274, P1655, DOI 10.1111/j.1742-4658.2007.05709.x; Yip GW, 2002, DEVELOPMENT, V129, P2109; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	54	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12217	12229		10.1074/jbc.M111.332924	http://dx.doi.org/10.1074/jbc.M111.332924			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351753	Green Published, hybrid			2022-12-25	WOS:000302782200063
J	Li, HY; Dong, YY; Yang, J; Liu, XM; Wang, YF; Yao, N; Guan, LL; Wang, N; Wu, JY; Li, XK				Li, Haiyan; Dong, Yuanyuan; Yang, Jing; Liu, Xiuming; Wang, Yanfang; Yao, Na; Guan, Lili; Wang, Nan; Wu, Jinyu; Li, Xiaokun			De Novo Transcriptome of Safflower and the Identification of Putative Genes for Oleosin and the Biosynthesis of Flavonoids	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; CARTHAMUS-TINCTORIUS L.; EXPRESSION ANALYSIS; HYDROXYSAFFLOR YELLOW; OIL BODIES; TOOL; ASSOCIATION; ARABIDOPSIS; ANNOTATION; VALIDATION	Safflower (Carthamus tinctorius L.) is one of the most extensively used oil crops in the world. However, little is known about how its compounds are synthesized at the genetic level. In this study, Solexa-based deep sequencing on seed, leaf and petal of safflower produced a de novo transcriptome consisting of 153,769 unigenes. We annotated 82,916 of the unigenes with gene annotation and assigned functional terms and specific pathways to a subset of them. Metabolic pathway analysis revealed that 23 unigenes were predicted to be responsible for the biosynthesis of flavonoids and 8 were characterized as seed-specific oleosins. In addition, a large number of differentially expressed unigenes, for example, those annotated as participating in anthocyanin and chalcone synthesis, were predicted to be involved in flavonoid biosynthesis pathways. In conclusion, the de novo transcriptome investigation of the unique transcripts provided candidate gene resources for studying oleosin-coding genes and for investigating genes related to flavonoid biosynthesis and metabolism in safflower.	[Li, Haiyan; Dong, Yuanyuan; Yang, Jing; Liu, Xiuming; Wang, Yanfang; Yao, Na; Guan, Lili; Wang, Nan; Wu, Jinyu; Li, Xiaokun] Jilin Agr Univ, Minist Educ Engn Res Ctr Bioreactor & Pharmaceut, Changchun, Jilin, Peoples R China; [Li, Haiyan; Liu, Xiuming] Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Wu, Jinyu] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China	Jilin Agricultural University; Jilin Agricultural University; Wenzhou Medical University	Li, HY (corresponding author), Jilin Agr Univ, Minist Educ Engn Res Ctr Bioreactor & Pharmaceut, Changchun, Jilin, Peoples R China.	iamwujy@yahoo.com.cn; xiaokunli@163.net	yao, na/HDL-8772-2022		National High Technology Research and Development Program of China (863 Program) [2011AA100606]; Scientific Innovation of Colleges and Universities in China [70S018]; National Natural Science Foundation of China [30971804, 31101091, 31101172]; New Century Excellent Talents in University [NCET-08-0693]; Excellent Innovation Team Project of Jilin Province, China [20111815]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Scientific Innovation of Colleges and Universities in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Excellent Innovation Team Project of Jilin Province, China	This work was funded by grants from the National High Technology Research and Development Program of China (863 Program) (Grant No. 2011AA100606), the Important Projects in the Scientific Innovation of Colleges and Universities in China (Grant No. 70S018), the National Natural Science Foundation of China (Grant No. 30971804, 31101091, 31101172), the New Century Excellent Talents in University (Grant No. NCET-08-0693) and the Excellent Innovation Team Project of Jilin Province, China (Grant No. 20111815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKADA S, 1995, PLANT MOL BIOL, V29, P189, DOI 10.1007/BF00043645; Cazzato E, 2011, J SCI FOOD AGR; Chung KJ, 2008, PLANT CELL REP, V27, P29, DOI 10.1007/s00299-007-0440-6; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Giannoulia K, 2007, J PLANT PHYSIOL, V164, P104, DOI 10.1016/j.jplph.2006.03.016; Hemleben V, 2004, PLANT MOL BIOL, V55, P455, DOI 10.1007/s11103-004-1125-y; HRAZDINA G, 1982, PLANT PHYSIOL, V70, P506, DOI 10.1104/pp.70.2.506; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Katavic V, 2006, PROTEOMICS, V6, P4586, DOI 10.1002/pmic.200600020; Lacey DJ, 1998, BIOCHEM J, V334, P469, DOI 10.1042/bj3340469; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XZ, 2011, ANIM SCI J, V82, P441, DOI 10.1111/j.1740-0929.2010.00857.x; Li YJ, 2011, FEBS J, V278, P156, DOI 10.1111/j.1742-4658.2010.07941.x; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Pitakdantham W, 2010, Pak J Biol Sci, V13, P1000, DOI 10.3923/pjbs.2010.1000.1005; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Roh JS, 2004, BIOL PHARM BULL, V27, P1976, DOI 10.1248/bpb.27.1976; Rudolph CJ, 2010, GENETICS, V186, P473, DOI 10.1534/genetics.110.120691; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Simkin AJ, 2006, J PLANT PHYSIOL, V163, P691, DOI 10.1016/j.jplph.2005.11.008; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Thao NTP, 2011, ARCH PHARM RES, V34, P455, DOI 10.1007/s12272-011-0314-x; Vandana S, 2006, PLANT PHYSIOL BIOCH, V44, P714, DOI 10.1016/j.plaphy.2006.09.022; vanEldik GJ, 1997, PLANT J, V11, P105, DOI 10.1046/j.1365-313X.1997.11010105.x; Vega-Arreguin JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-299; Wenping H, 2011, GENOMICS; Wu CS, 2011, J PHARMACEUT BIOMED, V54, P186, DOI 10.1016/j.jpba.2010.07.010; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Ye SY, 2008, ARCH PHARM RES, V31, P1010, DOI 10.1007/s12272-001-1261-y; Zhang YB, 2011, EUR J PHARMACOL, V660, P438, DOI 10.1016/j.ejphar.2011.04.015	34	47	58	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30987	10.1371/journal.pone.0030987	http://dx.doi.org/10.1371/journal.pone.0030987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363528	Green Submitted, Green Published, gold			2022-12-25	WOS:000302873700018
J	Kos, A; Loohuis, NFMO; Wieczorek, ML; Glennon, JC; Martens, GJM; Kolk, SM; Aschrafi, A				Kos, Aron; Loohuis, Nikkie F. M. Olde; Wieczorek, Martha L.; Glennon, Jeffrey C.; Martens, Gerard J. M.; Kolk, Sharon M.; Aschrafi, Armaz			A Potential Regulatory Role for Intronic microRNA-338-3p for Its Host Gene Encoding Apoptosis-Associated Tyrosine Kinase	PLOS ONE			English	Article							EXPRESSION PROFILES; SYMPATHETIC NEURONS; AATYK; IDENTIFICATION; TARGETS; DIFFERENTIATION; TRANSLATION; AXONS	MicroRNAs (miRNAs) are important gene regulators that are abundantly expressed in both the developing and adult mammalian brain. These non-coding gene transcripts are involved in post-transcriptional regulatory processes by binding to specific target mRNAs. Approximately one third of known miRNA genes are located within intronic regions of protein coding and non-coding regions, and previous studies have suggested a role for intronic miRNAs as negative feedback regulators of their host genes. In the present study, we monitored the dynamic gene expression changes of the intronic miR-338-3p and miR-338-5p and their host gene Apoptosis-associated Tyrosine Kinase (AATK) during the maturation of rat hippocampal neurons. This revealed an uncorrelated expression pattern of mature miR-338 strands with their host gene. Sequence analysis of the 3' untranslated region (UTR) of rat AATK mRNA revealed the presence of two putative binding sites for miR-338-3p. Thus, miR-338-3p may have the capacity to modulate AATK mRNA levels in neurons. Transfection of miR338-3p mimics into rat B35 neuroblastoma cells resulted in a significant decrease of AATK mRNA levels, while the transfection of synthetic miR-338-5p mimics did not alter AATK levels. Our results point to a possible molecular mechanism by which miR-338-3p participates in the regulation of its host gene by modulating the levels of AATK mRNA, a kinase which plays a role during differentiation, apoptosis and possibly in neuronal degeneration.	[Kos, Aron; Loohuis, Nikkie F. M. Olde; Wieczorek, Martha L.; Glennon, Jeffrey C.; Aschrafi, Armaz] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Martens, Gerard J. M.; Kolk, Sharon M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Mol Anim Physiol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Kos, A (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands.	A.aschrafi@cns.umcn.nl	Kolk, Sharon M/A-9055-2011; Glennon, Jeffrey C/D-2379-2013; Glennon, Jeffrey/AAK-8394-2020; Aschrafi, Armaz/E-2202-2012; Martens, Gerard JM/D-1925-2010	Kolk, Sharon M/0000-0003-2116-5456; Glennon, Jeffrey C/0000-0002-2371-0422; Glennon, Jeffrey/0000-0002-2371-0422; Aschrafi, Armaz/0000-0003-4089-0960	Radboud University Nijmegen Medical Centre; FP7-Marie Curie International Reintegration	Radboud University Nijmegen Medical Centre; FP7-Marie Curie International Reintegration	This work was supported by a Donders Center for Neuroscience fellowship award of the Radboud University Nijmegen Medical Centre and a grant from FP7-Marie Curie International Reintegration to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aschrafi A, 2010, MOL CELL NEUROSCI, V43, P422, DOI 10.1016/j.mcn.2010.01.009; Aschrafi A, 2008, J NEUROSCI, V28, P12581, DOI 10.1523/JNEUROSCI.3338-08.2008; Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaozza E, 1997, ONCOGENE, V15, P3127, DOI 10.1038/sj.onc.1201575; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hughes JP, 2010, NEUROCHEM RES, V35, P588, DOI 10.1007/s11064-009-0103-9; Ivanovska I, 2008, CELL CYCLE, V7, P3137, DOI 10.4161/cc.7.20.6923; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Natera-Naranjo O, 2010, RNA, V16, P1516, DOI 10.1261/rna.1833310; Olde Loohuis NF, 2011, CELL MOL LIFE SCI; Raghunath M, 2000, MOL BRAIN RES, V77, P151, DOI 10.1016/S0169-328X(00)00048-6; Ragusa M, 2010, J MOL MED, V88, P1041, DOI 10.1007/s00109-010-0643-0; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smart F, 2007, J NEUROCHEM, V101, P1367, DOI 10.1111/j.1471-4159.2007.04521.x; Tomomura M, 2003, MOL BRAIN RES, V112, P103, DOI 10.1016/S0169-328X(03)00054-8; Tomomura M, 2001, ONCOGENE, V20, P1022, DOI 10.1038/sj.onc.1204210; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zhu YL, 2009, SCHIZOPHR RES, V109, P86, DOI 10.1016/j.schres.2009.01.022	37	61	68	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31022	10.1371/journal.pone.0031022	http://dx.doi.org/10.1371/journal.pone.0031022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363537	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600098
J	Liu, K; Guo, YH; Liu, HP; Bian, CB; Lam, R; Liu, YS; Mackenzie, F; Rojas, LA; Reinberg, D; Bedford, MT; Xu, RM; Min, JR				Liu, Ke; Guo, Yahong; Liu, Haiping; Bian, Chuanbing; Lam, Robert; Liu, Yongsong; Mackenzie, Farrell; Rojas, Luis Alejandro; Reinberg, Danny; Bedford, Mark T.; Xu, Rui-Ming; Min, Jinrong			Crystal Structure of TDRD3 and Methyl-Arginine Binding Characterization of TDRD3, SMN and SPF30	PLOS ONE			English	Article							TUDOR DOMAIN; HISTONE H3; X-RAY; ROYAL FAMILY; PROTEIN; RECOGNITION; COMPLEX; SITE; REFINEMENT; PRODUCT	SMN (Survival motor neuron protein) was characterized as a dimethyl-arginine binding protein over ten years ago. TDRD3 (Tudor domain-containing protein 3) and SPF30 (Splicing factor 30 kDa) were found to bind to various methyl-arginine proteins including Sm proteins as well later on. Recently, TDRD3 was shown to be a transcriptional coactivator, and its transcriptional activity is dependent on its ability to bind arginine-methylated histone marks. In this study, we systematically characterized the binding specificity and affinity of the Tudor domains of these three proteins quantitatively. Our results show that TDRD3 preferentially recognizes asymmetrical dimethylated arginine mark, and SMN is a very promiscuous effector molecule, which recognizes different arginine containing sequence motifs and preferentially binds symmetrical dimethylated arginine. SPF30 is the weakest methyl-arginine binder, which only binds the GAR motif sequences in our library. In addition, we also reported high-resolution crystal structures of the Tudor domain of TDRD3 in complex with two small molecules, which occupy the aromatic cage of TDRD3.	[Liu, Ke; Min, Jinrong] Huazhong Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China; [Liu, Ke; Guo, Yahong; Bian, Chuanbing; Lam, Robert; Liu, Yongsong; Mackenzie, Farrell; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Liu, Haiping; Xu, Rui-Ming] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Rojas, Luis Alejandro; Reinberg, Danny] NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA; [Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Div Sci Pk Res, Smithville, TX USA; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Central China Normal University; University of Toronto; Structural Genomics Consortium; Chinese Academy of Sciences; Institute of Biophysics, CAS; Howard Hughes Medical Institute; New York University; University of Texas System; UTMD Anderson Cancer Center; University of Toronto	Liu, K (corresponding author), Huazhong Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	rmxu@sun5.ibp.ac.cn; jr.min@utoronto.ca	xu, rui/GRX-5734-2022; Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; , KE/0000-0002-7082-262X; Rojas, Luis Alejandro/0000-0001-6445-1562; Reinberg, Danny/0000-0003-4288-2016	Structural Genomics Consortium [1097737]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institute; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; CCNU; National Institutes of Health [DK62248]; National Institute of Environmental Health Sciences [ES07784]; Natural Science Foundation of China [90919029, 3098801]; National Basic Research Program of China [2009CB825501, 2010CB944903]; Novo Nordisk-Chinese Academy of Sciences Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062248, R01DK062248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institute(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); CCNU; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Novo Nordisk-Chinese Academy of Sciences Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institute, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. KL is supported by a CCNU scholarship. MB is supported by National Institutes of Health grant number DK62248 and, in part, by institutional grant National Institute of Environmental Health Sciences ES07784. R-MX acknowledges the support from the Natural Science Foundation of China (grants 90919029 & 3098801), the National Basic Research Program of China (grants 2009CB825501 & 2010CB944903), and the Novo Nordisk-Chinese Academy of Sciences Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Cioaba MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013559; Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eryilmaz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007274; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Guo Y, 2009, NUCL ACIDS RES; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liu H, 2010, GENES DEV; Liu K, 2010, P NATL ACAD SCI USA, V107, P18398, DOI 10.1073/pnas.1013106107; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Siomi MC, 2010, GENE DEV, V24, P636, DOI 10.1101/gad.1899210; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Tripsianes K, 2011, NAT STRUCT MOL BIOL, V18, P1414, DOI 10.1038/nsmb.2185; Whitehead SE, 2002, J BIOL CHEM, V277, P48087, DOI 10.1074/jbc.M204551200; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001; Young PJ, 2003, MOL BRAIN RES, V119, P37, DOI 10.1016/j.molbrainres.2003.08.011	48	62	62	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30375	10.1371/journal.pone.0030375	http://dx.doi.org/10.1371/journal.pone.0030375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363433	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600027
J	Subramaniam, D; Ponnurangam, S; Ramamoorthy, P; Standing, D; Battafarano, RJ; Anant, S; Sharma, P				Subramaniam, Dharmalingam; Ponnurangam, Sivapriya; Ramamoorthy, Prabhu; Standing, David; Battafarano, Richard J.; Anant, Shrikant; Sharma, Prateek			Curcumin Induces Cell Death in Esophageal Cancer Cells through Modulating Notch Signaling	PLOS ONE			English	Article							FACTOR-KAPPA-B; EXPRESSION PROFILES; PROMOTES APOPTOSIS; COLORECTAL-CANCER; MIR-21 EXPRESSION; IN-VITRO; ADENOCARCINOMA; MICRORNAS; ACTIVATION; METASTASIS	Background: Curcumin inhibits the growth of esophageal cancer cell lines; however, the mechanism of action is not well understood. It is becoming increasingly clear that aberrant activation of Notch signaling has been associated with the development of esophageal cancer. Here, we have determined that curcumin inhibits esophageal cancer growth via a mechanism mediated through the Notch signaling pathway. Methodology/Principal Findings: In this study, we show that curcumin treatment resulted in a dose and time dependent inhibition of proliferation and colony formation in esophageal cancer cell lines. Furthermore, curcumin treatment induced apoptosis through caspase 3 activation, confirmed by an increase in the ratio of Bax to Bcl2. Cell cycle analysis demonstrated that curcumin treatment induced cell death and down regulated cyclin D1 levels. Curcumin treatment also resulted in reduced number and size of esophagospheres. Furthermore, curcumin treatment led to reduced Notch-1 activation, expression of Jagged-1 and its downstream target Hes-1. This reduction in Notch-1 activation was determined to be due to the down-regulation of critical components of the gamma-secretase complex proteins such as Presenilin 1 and Nicastrin. The combination of a known gamma-secretase inhibitor DAPT and curcumin further decreased proliferation and induced apoptosis in esophageal cancer cells. Finally, curcumin treatment down-regulate the expressions of Notch-1 specific microRNAs miR-21 and miR-34a, and upregulated tumor suppressor let-7a miRNA. Conclusion/Significance: Curcumin is a potent inhibitor of esophageal cancer growth that targets the Notch-1 activating gamma-secretase complex proteins. These data suggest that Notch signaling inhibition is a novel mechanism of action for curcumin during therapeutic intervention in esophageal cancers.	[Subramaniam, Dharmalingam; Ponnurangam, Sivapriya; Ramamoorthy, Prabhu; Standing, David; Anant, Shrikant] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Sharma, Prateek] Univ Kansas, Med Ctr, Div Gastroenterol & Hepatol, Kansas City, KS 66103 USA; [Subramaniam, Dharmalingam; Anant, Shrikant; Sharma, Prateek] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66103 USA; [Battafarano, Richard J.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University System of Maryland; University of Maryland Baltimore	Subramaniam, D (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA.	dsubramaniam@kumc.edu; psharma@kumc.edu	Anant, Shrikant/AAF-8020-2020		NIH; NATIONAL CANCER INSTITUTE [R01CA109269] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by NIH grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Ashworth T, 2009, CELL CYCLE, V8, P596, DOI 10.4161/cc.8.4.7728; Bansal A, 2011, AM J GASTROENTEROL, V106, P1055, DOI 10.1038/ajg.2011.37; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Barnas C, 1997, INT J CANCER, V71, P79, DOI 10.1002/(SICI)1097-0215(19970328)71:1<79::AID-IJC14>3.0.CO;2-4; Bosetti C, 2008, INT J CANCER, V122, P1118, DOI 10.1002/ijc.23232; Dawsey SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014080; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gong P, 2010, J BIOL CHEM, V285, P38042, DOI 10.1074/jbc.M110.132613; Hartojo W, 2010, TRANSL ONCOL, V3, P99, DOI 10.1593/tlo.09235; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hu YX, 2011, INT J CANCER, V128, P132, DOI 10.1002/ijc.25330; Katoh M, 2007, INT J ONCOL, V30, P247; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Lee ST, 2011, J NEURO-ONCOL, V102, P19, DOI 10.1007/s11060-010-0286-6; Li HL, 2009, STRUCTURE, V17, P326, DOI 10.1016/j.str.2009.01.007; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liao SK, 2011, J CELL BIOCHEM, V112, P1055, DOI 10.1002/jcb.23019; Masuda S, 2011, CANCER; Mendelson J, 2011, CANCER-AM CANCER SOC, V117, P3691, DOI 10.1002/cncr.25861; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Mudduluru G, 2011, BIOSCIENCE REP, V31, P185, DOI 10.1042/BSR20100065; O'Sullivan-Coyne G, 2009, BRIT J CANCER, V101, P1585, DOI 10.1038/sj.bjc.6605308; Peters JH, 2010, J GASTROINTEST SURG, V14, P81, DOI 10.1007/s11605-009-1011-7; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Saini S, 2011, CANC PREV RES PHILA; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sotillo E, 2011, ONCOGENE, V30, P2587, DOI 10.1038/onc.2010.634; Su CC, 2006, ANTICANCER RES, V26, P4379; Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272; Tian Fang, 2008, Ai Zheng, V27, P566; Tselepis C, 2003, GUT, V52, P174, DOI 10.1136/gut.52.2.174; Ushida J, 2000, JPN J CANCER RES, V91, P893, DOI 10.1111/j.1349-7006.2000.tb01031.x; VandenBoom TG, 2008, CURR GENOMICS, V9, P97, DOI 10.2174/138920208784139555; Wang ZW, 2010, CANCER LETT, V292, P141, DOI 10.1016/j.canlet.2009.11.012; Wang ZW, 2009, CANCER RES, V69, P2757, DOI 10.1158/0008-5472.CAN-08-3060; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Yang J, 2010, MED ONCOL, V27, P1114, DOI 10.1007/s12032-009-9344-3; Yao J, 2007, ORAL DIS, V13, P555, DOI 10.1111/j.1601-0825.2006.01334.x; Yu L, 2008, J PHARMACOL EXP THER, V327, P258, DOI 10.1124/jpet.108.141275; Zhang J, 2010, ONCOL REP, V24, P1217, DOI 10.3892/or_00000975	53	166	178	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30590	10.1371/journal.pone.0030590	http://dx.doi.org/10.1371/journal.pone.0030590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363450	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600038
J	Stark, FC; Gurnani, K; Sad, S; Krishnan, L				Stark, Felicity C.; Gurnani, Komal; Sad, Subash; Krishnan, Lakshmi			Lack of Functional Selectin Ligand Interactions Compromises Long Term Tumor Protection by CD8(+) T Cells	PLOS ONE			English	Article							P-SELECTIN; HOMEOSTATIC PROLIFERATION; LISTERIA-MONOCYTOGENES; FUC-TVII; MEMORY; MIGRATION; LYMPHOCYTES; EXPRESSION; TRAFFICKING; RECRUITMENT	Central memory CD8(+) T cells expressing the adhesion molecule CD62L (L-selectin) are potent mediators of anti-cancer immunity due to their ability to proliferate extensively upon antigen re-stimulation. The interaction of selectin with its ligands mediates leukocyte rolling along high endothelial venules. Mice deficient in alpha(1,3) Fucosyltransferase IV and VII (FtDKO) lack functional L, P and E selectin ligands. Thus, we addressed whether the lack of selectin ligand interactions alters tumor protection by CD8(+) T cells in FtDKO mice. Listeria monocytogenes-OVA (LM-OVA) infection evoked potent OVA-specific CD8(+) T cells that proliferated and contracted at similar kinetics and phenotype in FtDKO and wild-type mice. Additionally, OVA-specific CD8(+) T cells in both mouse strains exhibited similar phenotypic differentiation, in vivo cytolytic activity and IFN-gamma expression. However, FtDKO mice succumbed to B16-OVA tumors significantly earlier than wild-type mice. In contrast, FtDKO mice evoked strong recall memory CD8(+) T cell responses and protection to systemic LM-OVA re-challenge. The diminished tumor protection in FtDKO mice was not related to defective antigen presentation by dendritic cells or reduced proliferation of antigen-specific CD8(+) T cells. However, WT or FtDKO OVA-specific CD8(+) T cells showed significantly reduced ability to traffic to lymph nodes upon adoptive transfer into naive FtDKO recipients. Furthermore, FtDKO OVA-specific CD8(+) T cells displayed poor ability to infiltrate tumors growing in WT mice. These results reveal that selectin ligand expression on host endothelium as well CD8(+) T cells may be important for their efficient and continued extravasation into peripheral tumors.	[Stark, Felicity C.; Sad, Subash; Krishnan, Lakshmi] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Gurnani, Komal; Sad, Subash; Krishnan, Lakshmi] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Ottawa; National Research Council Canada	Stark, FC (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	Lakshmi.Krishnan@nrc-cnrc.gc.ca	Stark, Felicity/AAT-2342-2021	Stark, Felicity/0000-0002-7547-8493; Sad, Subash/0000-0002-2462-7137	Ontario Institute for Cancer Research [07-NOV-119]; Government of Ontario, Canada; National Research Council of Canada [65-OPS-481-e-0-1]; Ontario Graduate Student Scholarship	Ontario Institute for Cancer Research; Government of Ontario, Canada; National Research Council of Canada; Ontario Graduate Student Scholarship	This study was conducted in part with the support of the Ontario Institute for Cancer Research (Project # 07-NOV-119) through funding provided by the Government of Ontario, Canada. This project was also supported by funds from the National Research Council of Canada (Project # 65-OPS-481-e-0-1). FS was a recipient of Ontario Graduate Student Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Brinkman CC, 2008, J IMMUNOL, V181, P1814, DOI 10.4049/jimmunol.181.3.1814; Cai YH, 2006, J IMMUNOL, V176, P6568, DOI 10.4049/jimmunol.176.11.6568; Dudani R, 2002, J IMMUNOL, V168, P5737, DOI 10.4049/jimmunol.168.11.5737; EASTON EW, 1993, BLOOD, V81, P2978; Ehlers S, 2009, IMMUNOBIOLOGY, V214, P674, DOI 10.1016/j.imbio.2008.12.009; Erdmann I, 2002, J IMMUNOL, V168, P2139, DOI 10.4049/jimmunol.168.5.2139; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Ferguson AR, 2010, J IMMUNOL, V184, P4079, DOI 10.4049/jimmunol.0901903; Gunn GR, 2001, J IMMUNOL, V167, P6471, DOI 10.4049/jimmunol.167.11.6471; Harp JR, 2010, J IMMUNOL, V185, P5751, DOI 10.4049/jimmunol.1001878; Harp JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010973; Hinrichs CS, 2006, CURR OPIN IMMUNOL, V18, P363, DOI 10.1016/j.coi.2006.03.009; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Jones TR, 2003, J CLIN INVEST, V112, P1714, DOI 10.1172/JCI19391; Kershaw MH, 2002, HUM GENE THER, V13, P1971, DOI 10.1089/10430340260355374; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Klebanoff CA, 2011, IMMUNOL REV, V239, P27, DOI 10.1111/j.1600-065X.2010.00979.x; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Liu LH, 2010, VACCINE, V28, P3883, DOI 10.1016/j.vaccine.2010.03.041; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; Luangsay S, 2003, GASTROENTEROLOGY, V125, P491, DOI 10.1016/S0016-5085(03)00903-X; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Naito Y, 1998, CANCER RES, V58, P3491; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Patel KD, 2002, SEMIN IMMUNOL, V14, P73, DOI 10.1006/smim.2001.0344; Paterson Y, 2010, SEMIN IMMUNOL, V22, P183, DOI 10.1016/j.smim.2010.02.002; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Sad S, 2003, CRIT REV IMMUNOL, V23, P129, DOI 10.1615/CritRevImmunol.v23.i12.70; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sasaki K, 2008, J IMMUNOL, V181, P104, DOI 10.4049/jimmunol.181.1.104; Schuster K, 2009, EUR J IMMUNOL, V39, P2981, DOI 10.1002/eji.200939330; Smithson G, 2001, J EXP MED, V194, P601, DOI 10.1084/jem.194.5.601; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stark FC, 2009, CANCER RES, V69, P4327, DOI 10.1158/0008-5472.CAN-08-3160; Stekel DJ, 1998, SCAND J IMMUNOL, V47, P426; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Tangney M, 2010, CURR GENE THER, V10, P46, DOI 10.2174/156652310790945539; Wang XL, 2011, BLOOD, V117, P1888, DOI 10.1182/blood-2010-10-310599; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wirth TC, 2009, J IMMUNOL, V182, P6195, DOI 10.4049/jimmunol.0803315; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32211	10.1371/journal.pone.0032211	http://dx.doi.org/10.1371/journal.pone.0032211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359671	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200140
J	Veyrieras, JB; Gaffney, DJ; Pickrell, JK; Gilad, Y; Stephens, M; Pritchard, JK				Veyrieras, Jean-Baptiste; Gaffney, Daniel J.; Pickrell, Joseph K.; Gilad, Yoav; Stephens, Matthew; Pritchard, Jonathan K.			Exon-Specific QTLs Skew the Inferred Distribution of Expression QTLs Detected Using Gene Expression Array Data	PLOS ONE			English	Article							POPULATION; DISEASE; IMPACT; MAP	Mapping of expression quantitative trait loci (eQTLs) is an important technique for studying how genetic variation affects gene regulation in natural populations. In a previous study using Illumina expression data from human lymphoblastoid cell lines, we reported that cis-eQTLs are especially enriched around transcription start sites (TSSs) and immediately upstream of transcription end sites (TESs). In this paper, we revisit the distribution of eQTLs using additional data from Affymetrix exon arrays and from RNA sequencing. We confirm that most eQTLs lie close to the target genes; that transcribed regions are generally enriched for eQTLs; that eQTLs are more abundant in exons than introns; and that the peak density of eQTLs occurs at the TSS. However, we find that the intriguing TES peak is greatly reduced or absent in the Affymetrix and RNA-seq data. Instead our data suggest that the TES peak observed in the Illumina data is mainly due to exon-specific QTLs that affect 3' untranslated regions, where most of the Illumina probes are positioned. Nonetheless, we do observe an overall enrichment of eQTLs in exons versus introns in all three data sets, consistent with an important role for exonic sequences in gene regulation.	[Veyrieras, Jean-Baptiste; Gaffney, Daniel J.; Pickrell, Joseph K.; Gilad, Yoav; Stephens, Matthew; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Veyrieras, Jean-Baptiste] BioMiningLabs, Lyon, France; [Gaffney, Daniel J.; Pritchard, Jonathan K.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; Howard Hughes Medical Institute; University of Chicago	Veyrieras, JB (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	jb.veyrieras@gmail.com; gilad@uchicago.edu; mstephens@uchicago.edu; pritch@uchicago.edu		Gaffney, Daniel/0000-0002-1529-1862	National Institutes of Health [GM084996, MH084703, MH090951]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090951, R01MH084703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institutes of Health (GM084996, MH084703 and MH090951) and by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gaffney D, 2011, DISSECTING IN PRESS; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Listgarten J, 2010, P NATL ACAD SCI USA, V107, P16465, DOI 10.1073/pnas.1002425107; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mosteller F, 1977, JSAI WORKSH; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	31	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30629	10.1371/journal.pone.0030629	http://dx.doi.org/10.1371/journal.pone.0030629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359548	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200017
J	Boncoraglio, G; Kilner, RM				Boncoraglio, Giuseppe; Kilner, Rebecca M.			Female Burying Beetles Benefit from Male Desertion: Sexual Conflict and Counter-Adaptation over Parental Investment	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; PATERNAL CARE; SELECTION; EVOLUTION	Sexual conflict drives the coevolution of sexually antagonistic traits, such that an adaptation in one sex selects an opposing coevolutionary response from the other. Although many adaptations and counteradaptations have been identified in sexual conflict over mating interactions, few are known for sexual conflict over parental investment. Here we investigate a possible coevolutionary sequence triggered by mate desertion in the burying beetle Nicrophorus vespilloides, where males commonly leave before their offspring reach independence. Rather than suffer fitness costs as a consequence, our data suggest that females rely on the male's absence to recoup some of the costs of larval care, presumably because they are then free to feed themselves on the carcass employed for breeding. Consequently, forcing males to stay until the larvae disperse reduces components of female fitness to a greater extent than caring for young singlehandedly. Therefore we suggest that females may have co-evolved to anticipate desertion by their partners so that they now benefit from the male's absence.	[Boncoraglio, Giuseppe; Kilner, Rebecca M.] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Boncoraglio, G (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	gb406@cam.ac.uk	Kilner, Rebecca/B-2867-2012	Kilner, Rebecca/0000-0003-1159-0758	Marie Curie Intra-European Fellowship [PIEF-GA-2009-252120]	Marie Curie Intra-European Fellowship(European Commission)	This study was supported by Marie Curie Intra-European Fellowship PIEF-GA-2009-252120. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist Goran, 2005, pUnpaginated; BARTLETT J, 1988, BEHAV ECOL SOCIOBIOL, V23, P297, DOI 10.1007/BF00300576; Cotter SC, 2010, ECOL LETT, V13, P1114, DOI 10.1111/j.1461-0248.2010.01500.x; Cotter SC, 2011, FUNCT ECOL, V25, P652, DOI 10.1111/j.1365-2435.2010.01819.x; Creighton JC, 2009, AM NAT, V174, P673, DOI 10.1086/605963; Eggert AK, 1997, EVOLUTION SOCIAL BEH, P219; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Jenkins EV, 2000, ANIM BEHAV, V60, P443, DOI 10.1006/anbe.2000.1487; LAZARUS J, 1990, ANIM BEHAV, V39, P672, DOI 10.1016/S0003-3472(05)80378-1; Lessells CM, 2006, PHILOS T R SOC B, V361, P301, DOI 10.1098/rstb.2005.1795; Muller JK, 2007, BEHAV ECOL, V18, P196, DOI 10.1093/beheco/arl073; Muller JK, 1998, ECOL ENTOMOL, V23, P195, DOI 10.1046/j.1365-2311.1998.00119.x; Sakaluk SK, 1998, ETHOLOGY, V104, P553, DOI 10.1111/j.1439-0310.1998.tb00090.x; SCOTT MP, 1989, J INSECT BEHAV, V2, P133, DOI 10.1007/BF01053623; Smiseth PT, 2005, ANIM BEHAV, V69, P551, DOI 10.1016/j.anbehav.2004.06.004; Smiseth PT, 2003, P ROY SOC B-BIOL SCI, V270, P1773, DOI 10.1098/rspb.2003.2444; Szentirmai I, 2007, J EVOLUTION BIOL, V20, P1739, DOI 10.1111/j.1420-9101.2007.01392.x; TRUMBO ST, 1991, BEHAVIOUR, V117, P82, DOI 10.1163/156853991X00139; Trumbo ST, 2006, ANIM BEHAV, V72, P1159, DOI 10.1016/j.anbehav.2006.05.004; Ward RJS, 2009, BEHAV ECOL, V20, P1274, DOI 10.1093/beheco/arp132	22	54	55	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31713	10.1371/journal.pone.0031713	http://dx.doi.org/10.1371/journal.pone.0031713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355390	Green Published, gold, Green Submitted			2022-12-25	WOS:000302741300090
J	Chen, C; Deng, B; Qiao, M; Zheng, R; Chai, J; Ding, Y; Peng, J; Jiang, SW				Chen, Chen; Deng, Bing; Qiao, Mu; Zheng, Rong; Chai, Jin; Ding, Yi; Peng, Jian; Jiang, Siwen			Solexa Sequencing Identification of Conserved and Novel microRNAs in Backfat of Large White and Chinese Meishan Pigs	PLOS ONE			English	Article							ADIPOSE-TISSUE; BINDING-SITES; SMALL RNAS; EXPRESSION; CELL; ADIPOGENESIS; MECHANISM; MIR-122; MIRNAS; GROWTH	The domestic pig (Sus scrofa), an important species in animal production industry, is a right model for studying adipogenesis and fat deposition. In order to expand the repertoire of porcine miRNAs and further explore potential regulatory miRNAs which have influence on adipogenesis, high-throughput Solexa sequencing approach was adopted to identify miRNAs in backfat of Large White (lean type pig) and Meishan pigs (Chinese indigenous fatty pig). We identified 215 unique miRNAs comprising 75 known pre-miRNAs, of which 49 miRNA*s were first identified in our study, 73 miRNAs were overlapped in both libraries, and 140 were novelly predicted miRNAs, and 215 unique miRNAs were collectively corresponding to 235 independent genomic loci. Furthermore, we analyzed the sequence variations, seed edits and phylogenetic development of the miRNAs. 17 miRNAs were widely conserved from vertebrates to invertebrates, suggesting that these miRNAs may serve as potential evolutional biomarkers. 9 conserved miRNAs with significantly differential expressions were determined. The expression of miR-215, miR-135, miR-224 and miR-146b was higher in Large White pigs, opposite to the patterns shown by miR-1a, miR-133a, miR-122, miR-204 and miR-183. Almost all novel miRNAs could be considered pig-specific except ssc-miR-1343, miR-2320, miR-2326, miR-2411 and miR-2483 which had homologs in Bos taurus, among which ssc-miR-1343, miR-2320, miR-2411 and miR-2483 were validated in backfat tissue by stem-loop qPCR. Our results displayed a high level of concordance between the qPCR and Solexa sequencing method in 9 of 10 miRNAs comparisons except for miR-1a. Moreover, we found 2 miRNAs, miR-135 and miR-183, may exert impacts on porcine backfat development through WNT signaling pathway. In conclusion, our research develops porcine miRNAs and should be beneficial to study the adipogenesis and fat deposition of different pig breeds based on miRNAs.	[Chen, Chen; Deng, Bing; Qiao, Mu; Zheng, Rong; Chai, Jin; Ding, Yi; Jiang, Siwen] Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Wuhan, Peoples R China; [Chen, Chen; Deng, Bing; Qiao, Mu; Zheng, Rong; Chai, Jin; Ding, Yi; Jiang, Siwen] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Coll Anim Sci & Technol, Wuhan, Peoples R China; [Peng, Jian] Huazhong Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; Huazhong Agricultural University	Chen, C (corresponding author), Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Wuhan, Peoples R China.	pengjianhzau@163.com; jswhzau@163.com	Ding, Yi/U-3314-2019; Xie, Huangming/B-2260-2012	Deng, Bing/0000-0002-7391-7018	Chinese Ministry of Science and Technology; Major Projects of Genetically Modified Animals [2009ZX08009-161B, 2009ZX08009-151B]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Major Projects of Genetically Modified Animals	This research was supported by grants from the Chinese Ministry of Science and Technology, the Major Projects of Genetically Modified Animals (2009ZX08009-161B, 2009ZX08009-151B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar ALG, 2010, FEBS LETT, V584, P4426, DOI 10.1016/j.febslet.2010.09.050; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Borel C, 2008, MAMM GENOME, V19, P503, DOI 10.1007/s00335-008-9137-6; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jin WW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-29; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Meng YJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S12; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rathjen T, 2009, FEBS LETT, V583, P1422, DOI 10.1016/j.febslet.2009.03.048; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Sharbati-Tehrani S, 2008, BIOCHEM BIOPH RES CO, V375, P484, DOI 10.1016/j.bbrc.2008.08.048; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036	50	75	84	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31426	10.1371/journal.pone.0031426	http://dx.doi.org/10.1371/journal.pone.0031426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355364	gold, Green Published, Green Submitted			2022-12-25	WOS:000302741300064
J	Govind, K; Makinen, K; Savithri, HS				Govind, Kunduri; Makinen, Kristiina; Savithri, Handanahal S.			Sesbania Mosaic Virus (SeMV) Infectious Clone: Possible Mechanism of 3 ' and 5 ' End Repair and Role of Polyprotein Processing in Viral Replication	PLOS ONE			English	Article							COCKSFOOT-MOTTLE-VIRUS; COMPLETE NUCLEOTIDE-SEQUENCE; TRANSIENT EXPRESSION SYSTEM; NATIVELY UNFOLDED VPG; RNA VIRUSES; P1 PROTEIN; SERINE-PROTEASE; VECTORS; CDNA; DNA	Sesbania mosaic virus (SeMV) is a positive stranded RNA virus belonging to the genus Sobemovirus. Construction of an infectious clone is an essential step for deciphering the virus gene functions in vivo. Using Agrobacterium based transient expression system we show that SeMV icDNA is infectious on Sesbania grandiflora and Cyamopsis tetragonoloba plants. The efficiency of icDNA infection was found to be significantly high on Cyamopsis plants when compared to that on Sesbania grandiflora. The coat protein could be detected within 6 days post infiltration in the infiltrated leaves. Different species of viral RNA (double stranded and single stranded genomic and subgenomic RNA) could be detected upon northern analysis, suggesting that complete replication had taken place. Based on the analysis of the sequences at the genomic termini of progeny RNA from SeMV icDNA infiltrated leaves and those of its 3' and 5' terminal deletion mutants, we propose a possible mechanism for 3' and 5' end repair in vivo. Mutation of the cleavage sites in the polyproteins encoded by ORF 2 resulted in complete loss of infection by the icDNA, suggesting the importance of correct polyprotein processing at all the four cleavage sites for viral replication. Complementation analysis suggested that ORF 2 gene products can act in trans. However, the trans acting ability of ORF 2 gene products was abolished upon deletion of the N-terminal hydrophobic domain of polyprotein 2a and 2ab, suggesting that these products necessarily function at the replication site, where they are anchored to membranes.	[Govind, Kunduri; Savithri, Handanahal S.] Indian Inst Sci, Bangalore 560012, Karnataka, India; [Makinen, Kristiina] Univ Helsinki, Helsinki, Finland	Indian Institute of Science (IISC) - Bangalore; University of Helsinki	Govind, K (corresponding author), Indian Inst Sci, Bangalore 560012, Karnataka, India.	bchss@biochem.iisc.ernet.in	KUNDURI, GOVIND/K-5133-2019; Mäkinen, Kristiina M/C-8650-2012	KUNDURI, GOVIND/0000-0003-4170-965X; Mäkinen, Kristiina M/0000-0001-8233-8942	Indo-Finnish [BT/IN/Finland/18/HSS/2007]; Department of Biotechnology; Department of Science and technology; Council for Scientific and Industrial Research (CSIR); Academy of Finland [121622]	Indo-Finnish; Department of Biotechnology; Department of Science and technology(Department of Science & Technology (India)); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Academy of Finland(Academy of Finland)	We thank Indo-Finnish grant (BT/IN/Finland/18/HSS/2007), the Department of Biotechnology, the Department of Science and technology and the Council for Scientific and Industrial Research (CSIR) for financial support. Financial support from the Academy of Finland (grant 121622) for K.M. is gratefully acknowledged. K.Govind thanks CSIR for the senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai P, 2005, VIROLOGY, V338, P96, DOI 10.1016/j.virol.2005.05.013; Barr J, 2010, J GEN VIROL, V91, P1373, DOI 10.1099/vir.0.020818-0; Bendahmane A, 2000, PLANT J, V21, P73, DOI 10.1046/j.1365-313x.2000.00654.x; Bonneau C, 1998, VIROLOGY, V244, P79, DOI 10.1006/viro.1998.9100; BRUGIDOU C, 1995, VIROLOGY, V206, P108, DOI 10.1016/S0042-6822(95)80025-5; Chapman Sean N., 2008, V451, P477, DOI 10.1007/978-1-59745-102-4_32; Chowdhury SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015609; Chowdhury SR, 2011, FEBS J, V278, P257, DOI 10.1111/j.1742-4658.2010.07943.x; Citovsky V, 2007, CELL MICROBIOL, V9, P9, DOI 10.1111/j.1462-5822.2006.00830.x; DATLA RSS, 1992, GENE, V122, P383, DOI 10.1016/0378-1119(92)90232-E; Eskelin K, 2010, J VIROL METHODS, V164, P101, DOI 10.1016/j.jviromet.2009.12.006; Govind K, 2010, VIROLOGY, V401, P280, DOI 10.1016/j.virol.2010.02.025; HARMON SA, 1991, J VIROL, V65, P2757, DOI 10.1128/JVI.65.5.2757-2760.1991; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; KLUMP WM, 1990, J VIROL, V64, P1573, DOI 10.1128/JVI.64.4.1573-1583.1990; Lacombe S, 2010, PLANT J, V61, P371, DOI 10.1111/j.1365-313X.2009.04062.x; Lee LY, 2008, PLANT PHYSIOL, V146, P325, DOI 10.1104/pp.107.113001; Li XJ, 2007, J GEN VIROL, V88, P1620, DOI 10.1099/vir.0.82627-0; Liu Y, 2009, BBA-GENE REGUL MECH, V1789, P495, DOI 10.1016/j.bbagrm.2009.09.007; Lokesh GL, 2001, ARCH VIROL, V146, P209, DOI 10.1007/s007050170170; Makinen K, 2000, J GEN VIROL, V81, P2783, DOI 10.1099/0022-1317-81-11-2783; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; Meier M, 2007, ARCH VIROL, V152, P635, DOI 10.1007/s00705-006-0867-z; Meier M, 2006, VIRUS GENES, V32, P321, DOI 10.1007/s11262-005-6917-x; MILLER WA, 1995, CRIT REV PLANT SCI, V14, P179, DOI 10.1080/713608119; Nair S, 2008, VIROLOGY, V382, P83, DOI 10.1016/j.virol.2008.08.034; Nair S, 2010, FEBS LETT, V584, P571, DOI 10.1016/j.febslet.2009.12.003; Nair S, 2010, VIROLOGY, V396, P106, DOI 10.1016/j.virol.2009.09.025; Olspert A, 2011, FEBS LETT, V585, P2979, DOI 10.1016/j.febslet.2011.08.009; Olspert A, 2011, J GEN VIROL, V92, P445, DOI 10.1099/vir.0.026476-0; Ryabov Eugene V., 2008, V451, P491, DOI 10.1007/978-1-59745-102-4_33; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Sarmiento C, 2007, VIRUS RES, V123, P95, DOI 10.1016/j.virusres.2006.07.013; Satheshkumar PS, 2005, J BIOL CHEM, V280, P30291, DOI 10.1074/jbc.M504122200; Satheshkumar PS, 2004, VIROLOGY, V318, P429, DOI 10.1016/j.virol.2003.09.035; Sivakumaran K, 1998, VIROLOGY, V252, P376, DOI 10.1006/viro.1998.9489; SREENIVASULU P, 1982, CURR SCI INDIA, V51, P86; Tamm T, 2000, J VIROL, V74, P6231, DOI 10.1128/JVI.74.14.6231-6241.2000; VAN LAREBEKE N, 1974, NATURE, V252, P169, DOI 10.1038/252169a0; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6	41	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31190	10.1371/journal.pone.0031190	http://dx.doi.org/10.1371/journal.pone.0031190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355344	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000302741300044
J	Frolova, EG; Sopko, N; Blech, L; Popovic, ZB; Li, JB; Vasanji, A; Drumm, C; Krukovets, I; Jain, MK; Penn, MS; Plow, EF; Stenina, OI				Frolova, Ella G.; Sopko, Nikolai; Blech, Lauren; Popovic, Zoran B.; Li, Jianbo; Vasanji, Amit; Drumm, Carla; Krukovets, Irene; Jain, Mukesh K.; Penn, Marc S.; Plow, Edward F.; Stenina, Olga I.			Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload	FASEB JOURNAL			English	Article						heart hypertrophy; extracellular matrix; transverse aortic constriction	GROWTH-FACTOR-BETA; GENE-EXPRESSION; CARDIAC-HYPERTROPHY; ENDOTHELIAL-CELLS; HEART-FAILURE; UP-REGULATION; MICE; ANGIOGENESIS; TRANSITION; BONE	Thrombospondin-4 (TSP-4) expression increases dramatically in hypertrophic and failing hearts in rodent models and in humans. The aim of this study was to address the function of TSP-4 in the heart. TSP-4-knockout (Thbs4(-/-)) and wild-type (WT) mice were subjected to transverse aortic constriction (TAC) to increase left ventricle load. After 2 wk, Thbs4(-/-) mice had a significantly higher heart weight/body weight ratio than WT mice. The additional increase in the heart weight in TAC Thbs4(-/-) mice was due to increased deposition of extracellular matrix (ECM). The levels of interstitial collagens were higher in the knockout mice, but the size of cardiomyocytes and apoptosis in the myocardium was unaffected by TSP-4 deficiency, suggesting that increased reactive fibrosis was the primary cause of the higher heart weight. The increased ECM deposition in Thbs4(-/-) mice was accompanied by changes in functional parameters of the heart and decreased vessel density. The expression of inflammatory and fibrotic genes known to be influential in myocardial remodeling changed as a result of TSP-4 deficiency in vivo and as a result of incubation of cells with recombinant TSP-4 in vitro. Thus, TSP-4 is involved in regulating the adaptive responses of the heart to pressure overload, suggesting its important role in myocardial remodeling. Our study showed a direct influence of TSP-4 on heart function and to identify the mechanism of its effects on heart remodeling.-Frolova, E. G., Sopko, N., Blech, L., Popovic, Z. B., Li, J., Vasanji, A., Drumm, C., Krukovets, I., Jain, M. K., Penn, M. S., Plow, E. F., Stenina, O. I. Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload. FASEB J. 26, 2363-2373 (2012). www.fasebj.org	[Plow, Edward F.; Stenina, Olga I.] Case Western Reserve Univ, Sch Med, Cleveland Clin, Dept Mol Cardiol,Lerner Res Inst, Cleveland, OH 44195 USA; [Frolova, Ella G.; Blech, Lauren; Drumm, Carla; Krukovets, Irene; Plow, Edward F.; Stenina, Olga I.] Case Western Reserve Univ, Sch Med, Cleveland Clin, Joseph J Jacob Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA; [Sopko, Nikolai; Penn, Marc S.] Case Western Reserve Univ, Sch Med, Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Popovic, Zoran B.; Li, Jianbo] Case Western Reserve Univ, Sch Med, Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Vasanji, Amit] Case Western Reserve Univ, Sch Med, Cleveland Clin, Biomed Imaging & Anal Core, Cleveland, OH 44195 USA; [Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Cleveland Clin, Case Cardiovasc Res Inst, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Plow, EF (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland Clin, Dept Mol Cardiol,Lerner Res Inst, 9500 Euclid Ave,NB50, Cleveland, OH 44195 USA.	plowe@ccf.org; stenino@ccf.org	Sopko, Nikolai/AAL-2036-2020	Sopko, Nikolai/0000-0003-4913-0570; popovic, zoran/0000-0001-5692-2299; , Olga/0000-0002-1256-0545	U.S. National Institutes of Health [P50 HL077107, R01 DK067532]	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Drs. Judy Drazba and Satyamangla Prasad (Cleveland Clinic) for helpful discussions. This work was supported by U.S. National Institutes of Health grants (P50 HL077107 to E. F. P. and R01 DK067532 to O.I.S.).	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017; Bonnefoy A, 2008, CELL MOL LIFE SCI, V65, P713, DOI 10.1007/s00018-007-7487-y; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Bradshaw AD, 2009, CIRCULATION, V119, P269, DOI 10.1161/CIRCULATIONAHA.108.773424; Chatila Khaled, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P21; Cingolani OH, 2011, CIRC RES, V109, P1410, DOI 10.1161/CIRCRESAHA.111.256743; Collins KA, 2001, AM J PHYSIOL-HEART C, V280, pH1954, DOI 10.1152/ajpheart.2001.280.5.H1954; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Dorn GW, 2008, J MOL MED, V86, P1085, DOI 10.1007/s00109-008-0362-y; Frangogiannis NG, 2005, CIRCULATION, V111, P2935, DOI 10.1161/CIRCULATIONAHA.104.510354; Frolova EG, 2010, CIRC RES, V107, P1313, DOI 10.1161/CIRCRESAHA.110.232371; Gabrielsen A, 2007, J MOL CELL CARDIOL, V42, P870, DOI 10.1016/j.yjmcc.2006.12.016; Ghosh AK, 2010, CIRCULATION, V122, P1200, DOI 10.1161/CIRCULATIONAHA.110.955245; Hankenson KD, 2005, MATRIX BIOL, V24, P362, DOI 10.1016/j.matbio.2005.05.008; Hankenson KD, 2005, MOL CELL BIOL, V25, P5599, DOI 10.1128/MCB.25.13.5599-5606.2005; Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31; Krady MM, 2008, AM J PATHOL, V173, P879, DOI 10.2353/ajpath.2008.080128; Kyriakides TR, 2001, AM J PATHOL, V159, P1255, DOI 10.1016/S0002-9440(10)62512-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mirochnik Y, 2008, CURR DRUG TARGETS, V9, P851, DOI 10.2174/138945008785909347; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Mustonen E, 2008, BIOCHEM BIOPH RES CO, V373, P186, DOI 10.1016/j.bbrc.2008.05.164; Pluskota E, 2005, BLOOD, V106, P3970, DOI 10.1182/blood-2005-03-1292; Popovic ZB, 2005, J PHYSIOL-LONDON, V568, P255, DOI 10.1113/jphysiol.2005.090779; Qian XH, 1997, EXP CELL RES, V235, P403, DOI 10.1006/excr.1997.3681; ROBINSON TF, 1986, SCI AM, V254, P84, DOI 10.1038/scientificamerican0686-84; ROCKMAN HA, 1994, AM J PHYSIOL, V266, pH2468, DOI 10.1152/ajpheart.1994.266.6.H2468; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rysa J, 2005, HYPERTENSION, V45, P927, DOI 10.1161/01.HYP.0000161873.27088.4c; Salcedo L, 2011, INT J COLORECTAL DIS, V26, P1577, DOI 10.1007/s00384-011-1269-6; Schroen B, 2004, CIRC RES, V95, P515, DOI 10.1161/01.RES.0000141019.20332.3e; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26783; Sezaki S, 2005, EXP BIOL MED, V230, P621; Spinale FG, 2004, CIRC RES, V95, P446, DOI 10.1161/01.RES.0000142315.88477.42; Stenina OI, 2005, FASEB J, V19, P1893, DOI 10.1096/fj.05-3712fje; Stenina OI, 2003, CIRCULATION, V108, P1514, DOI 10.1161/01.CIR.0000089085.76320.4E; Tan FL, 2002, P NATL ACAD SCI USA, V99, P11387, DOI 10.1073/pnas.162370099; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; WEBER KT, 1993, CARDIOVASC RES, V27, P341, DOI 10.1093/cvr/27.3.341; Xia Y, 2009, HISTOCHEM CELL BIOL, V131, P471, DOI 10.1007/s00418-008-0541-5	42	98	102	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2363	2373		10.1096/fj.11-190728	http://dx.doi.org/10.1096/fj.11-190728			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22362893	Green Published			2022-12-25	WOS:000305017200014
J	Banno, A; Goult, BT; Lee, H; Bate, N; Critchley, DR; Ginsberg, MH				Banno, Asoka; Goult, Benjamin T.; Lee, HoSup; Bate, Neil; Critchley, David R.; Ginsberg, Mark H.			Subcellular Localization of Talin Is Regulated by Inter-domain Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VINCULIN BINDING-SITES; INTEGRIN ACTIVATION; CYTOPLASMIC DOMAIN; STRUCTURAL BASIS; HUMAN-PLATELETS; FERM DOMAIN; GPIIB-IIIA; ADHESION; ACTIN; ROD	Talin, which is composed of head (THD) and rod domains, plays an important role in cell adhesion events in diverse species including most metazoans and Dictyostelium discoideum. Talin is abundant in the cytosol; however, it mediates adhesion by associating with integrins in the plasma membrane where it forms a primary link between integrins and the actin cytoskeleton. Cells modulate the partitioning of talin between the plasma membrane and the cytosol to control cell adhesion. Here, we combine nuclear magnetic resonance spectroscopy (NMR) with subcellular fractionation to characterize two distinct THD-rod domain interactions that control the interaction of talin with the actin cytoskeleton or its localization to the plasma membrane. Aninteraction between a discrete vinculin-binding region of the rod (VBS1/2a; Tln1(482-787)), and the THD restrains talin from interacting with the plasma membrane. Furthermore, we show that vinculin binding to VBS1/2a results in talin recruitment to the plasma membrane. Thus, we have structurally defined specific inter-domain interactions between THD and the talin rod domain that regulate the subcellular localization of talin.	[Banno, Asoka; Lee, HoSup; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Goult, Benjamin T.; Bate, Neil; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of California System; University of California San Diego; University of Leicester	Ginsberg, MH (corresponding author), 9500 Gilman Dr,Mail Code 0726, La Jolla, CA 92093 USA.	mhginsberg@ucsd.edu	Goult, Benjamin T/B-3127-2009	Goult, Benjamin T/0000-0002-3438-2807	National Institutes of Health [U54 GM64346, HL078784, HL57900]; Tobacco-Related Disease Research Program Dissertation Fellowship Award; Wellcome Trust, Cancer Research UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057900, P01HL078784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program Dissertation Fellowship Award; Wellcome Trust, Cancer Research UK(Wellcome TrustCancer Research UK); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U54 GM64346 (to the Cell Migration Consortium), HL078784 and HL57900, a Tobacco-Related Disease Research Program Dissertation Fellowship Award, and the Wellcome Trust, Cancer Research UK.	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; BECKERLE MC, 1989, J CELL BIOL, V109, P3333, DOI 10.1083/jcb.109.6.3333; BERTAGNOLLI ME, 1993, J CELL SCI, V106, P1189; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hemmings L, 1996, J CELL SCI, V109, P2715; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kalli AC, 2010, STRUCTURE, V18, P1280, DOI 10.1016/j.str.2010.07.012; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kopp PM, 2010, EUR J CELL BIOL, V89, P661, DOI 10.1016/j.ejcb.2010.05.003; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Ohmori T, 2010, BIOCHEM BIOPH RES CO, V400, P323, DOI 10.1016/j.bbrc.2010.08.056; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; PAINTER RG, 1985, J CELL BIOCHEM, V27, P277, DOI 10.1002/jcb.240270309; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Ratnikov B, 2005, J CELL SCI, V118, P4921, DOI 10.1242/jcs.02682; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0; Ulmer TS, 2003, BIOCHEMISTRY-US, V42, P8307, DOI 10.1021/bi034384s; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	59	37	38	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13799	13812		10.1074/jbc.M112.341214	http://dx.doi.org/10.1074/jbc.M112.341214			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22351767	hybrid, Green Published			2022-12-25	WOS:000303996300035
J	Jacquot, A; Montigny, C; Hennrich, H; Barry, R; le Maire, M; Jaxel, C; Holthuis, J; Champeil, P; Lenoir, G				Jacquot, Aurore; Montigny, Cedric; Hennrich, Hanka; Barry, Raphaelle; le Maire, Marc; Jaxel, Christine; Holthuis, Joost; Champeil, Philippe; Lenoir, Guillaume			Phosphatidylserine Stimulation of Drs2p center dot Cdc50p Lipid Translocase Dephosphorylation Is Controlled by Phosphatidylinositol-4-phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; P-TYPE ATPASES; TRANSPORT ADENOSINE-TRIPHOSPHATASE; YEAST PLASMA-MEMBRANE; AMINOPHOSPHOLIPID TRANSPORT; PHOSPHOLIPID TRANSLOCATION; SUBCELLULAR-LOCALIZATION; P-4-ATPASE ATP8A2; PROTEIN-TRANSPORT; DIVALENT-CATION	Here, Drs2p, a yeast lipid translocase that belongs to the family of P-4-type ATPases, was overexpressed in the yeast Saccharomyces cerevisiae together with Cdc50p, its glycosylated partner, as a result of the design of a novel co-expression vector. The resulting high yield allowed us, using crude membranes or detergent-solubilized membranes, to measure the formation from [gamma-P-32]ATP of a P-32-labeled transient phosphoenzyme at the catalytic site of Drs2p. Formation of this phosphoenzyme could be detected only if Cdc50p was co-expressed with Drs2p but was not dependent on full glycosylation of Cdc50p. It was inhibited by orthovanadate and fluoride compounds. In crude membranes, the phosphoenzyme formed at steady state at 4 degrees C displayed ADP-insensitive but temperature-sensitive decay. Solubilizing concentrations of dodecyl maltoside left this decay rate almost unaltered, whereas several other detergents accelerated it. Unexpectedly, the dephosphorylation rate for the solubilized Drs2p center dot Cdc50p complex was inhibited by the addition of phosphatidylserine. Phosphatidylserine exerted its anticipated accelerating effect on the dephosphorylation of Drs2p center dot Cdc50p complex only in the additional presence of phosphatidylinositol-4-phosphate. These results explain why phosphatidylinositol-4-phosphate tightly controls Drs2p-catalyzed lipid transport and establish the functional relevance of the Drs2p center dot Cdc50p complex overexpressed here.	[Jacquot, Aurore; Montigny, Cedric; Barry, Raphaelle; le Maire, Marc; Jaxel, Christine; Champeil, Philippe; Lenoir, Guillaume] CEA, CNRS, UMR Syst Membranaires Photobiol Stress & Detoxica, F-91191 Gif Sur Yvette, France; [Jacquot, Aurore; Montigny, Cedric; Barry, Raphaelle; le Maire, Marc; Jaxel, Christine; Champeil, Philippe; Lenoir, Guillaume] CEA, Inst Biol & Technol Saclay iBiTec S, F-91191 Gif Sur Yvette, France; [Jacquot, Aurore; le Maire, Marc; Lenoir, Guillaume] Univ Paris 11, F-91405 Orsay, France; [Hennrich, Hanka; Holthuis, Joost] Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr & Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Utrecht University	Lenoir, G (corresponding author), CEA Saclay, iBiTec S, F-91191 Gif Sur Yvette, France.	guillaume.lenoir@cea.fr	MONTIGNY, Cédric/AAH-4216-2021; Holthuis, Joost/AAL-9157-2020; Lenoir, Guillaume/I-4002-2019	Lenoir, Guillaume/0000-0002-8759-5179; JAXEL, CHRISTINE/0000-0002-1387-4458; Holthuis, Joost/0000-0001-8912-1586	CNRS; Commissariat a l'Energie Atomique; Ministere de l'Enseignement Superieur et de la Recherche; Agence Nationale pour la Recherche	CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the CNRS and Commissariat a l'Energie Atomique, by a fellowship from the "Ministere de l'Enseignement Superieur et de la Recherche" (to A. J.), and by a grant from the Agence Nationale pour la Recherche (to C. M., C. J., and M. I. M.).	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Cardi D, 2010, METHODS MOL BIOL, V601, P247, DOI 10.1007/978-1-60761-344-2_15; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; de Meis L, 2003, J BIOL CHEM, V278, P41856, DOI 10.1074/jbc.M308280200; de Meis L, 2002, J MEMBRANE BIOL, V188, P1, DOI 10.1007/s00232-001-0171-5; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FUKUSHIMA Y, 1978, J BIOL CHEM, V253, P6853; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; Hauser H, 2000, BBA-BIOMEMBRANES, V1508, P164, DOI 10.1016/S0304-4157(00)00008-3; HOKIN LE, 1965, P NATL ACAD SCI USA, V54, P177, DOI 10.1073/pnas.54.1.177; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jidenko M, 2006, PROTEIN EXPRES PURIF, V48, P32, DOI 10.1016/j.pep.2006.03.001; Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; LUND S, 1989, J BIOL CHEM, V264, P4907; MACDONALD TL, 1988, TRENDS BIOCHEM SCI, V13, P15, DOI 10.1016/0968-0004(88)90012-6; MAKINOSE M, 1969, EUR J BIOCHEM, V10, P74; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Perret A, 1998, BIOCHEMISTRY-US, V37, P11412, DOI 10.1021/bi980908q; Picard M, 2006, J BIOL CHEM, V281, P3360, DOI 10.1074/jbc.M511385200; PICK U, 1982, J BIOL CHEM, V257, P6111; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; POMPON D, 1987, BIOCHEMISTRY-US, V26, P6429, DOI 10.1021/bi00394a020; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Puts CF, 2010, J PROTEOME RES, V9, P833, DOI 10.1021/pr900743b; ROSING J, 1980, J BIOL CHEM, V255, P274; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P8698; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Yamasaki K, 2002, J BIOL CHEM, V277, P13615, DOI 10.1074/jbc.M200625200; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	58	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13249	13261		10.1074/jbc.M111.313916	http://dx.doi.org/10.1074/jbc.M111.313916			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351780	Green Published, hybrid			2022-12-25	WOS:000302903700062
J	Carulli, S; Beck, K; Dayan, G; Boulesteix, S; Lortat-Jacob, H; Rousselle, P				Carulli, Sonia; Beck, Konrad; Dayan, Guila; Boulesteix, Sophie; Lortat-Jacob, Hugues; Rousselle, Patricia			Cell Surface Proteoglycans Syndecan-1 and-4 Bind Overlapping but Distinct Sites in Laminin alpha 3 LG45 Protein Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN ALPHA-3-BETA-1; KERATINOCYTE MIGRATION; SECONDARY STRUCTURE; BIOLOGICAL-ACTIVITY; EPITHELIAL-CELLS; HEPARAN-SULFATE; LAMA3 GENE; CHAIN; ADHESION; DYSTROGLYCAN	Keratinocyte migration during epidermal repair depends on interactions between cellular heparan sulfate proteoglycan receptors, syndecan-1 and -4, and the C-terminal globular domains (LG45) of the extracellular matrix protein laminin 332. This study investigates the molecular basis of the binding specificity of the syndecan-1 and -4 receptors expressed by human keratinocytes. We used site-directed mutagenesis to alter a recombinant LG45 protein by substituting the most critical basic residues with glutamine. All proteins were expressed in mammalian cells, purified, and characterized biochemically. We used in vitro binding assays, including surface plasmon resonance, to examine interactions between mutated LG45 and heparan sulfates, syndecan-1 and -4. We identify a major heparin binding domain on the outer edge of a beta-strand of LG45 surrounded by a track of converging low affinity residues. This domain harbors distinctive syndecan-1 and -4 binding-specific sequences. This is the first study to demonstrate a binding specificity of two proteoglycans produced by a single cell type. In addition, we found that although syndecan-1 interacts exclusively through its glycosaminoglycan chains, syndecan-4 binding relies on both its core protein and its heparan sulfate chains. These results suggest that LG45 may trigger different signals toward keratinocytes depending on its interaction with syndecan-1 or -4.	[Carulli, Sonia; Dayan, Guila; Boulesteix, Sophie; Rousselle, Patricia] Univ Lyon 1, Inst Biol & Chim Prot, FRE 3310, CNRS, F-69367 Lyon 07, France; [Beck, Konrad] Cardiff Univ, Sch Dent, Cardiff CF14 4XY, S Glam, Wales; [Lortat-Jacob, Hugues] Univ Grenoble 1, Commissariat Energie Atom, CNRS, Inst Biol Struct Jean Pierre Ebel,UMR 5075, F-38000 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Cardiff University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Rousselle, P (corresponding author), Univ Lyon 1, Inst Biol & Chim Prot, FRE 3310, CNRS, 7 Passage du Vercors, F-69367 Lyon 07, France.	patricia.rousselle@ibcp.fr	Rousselle, Patricia/CAF-3915-2022; Beck, Konrad/AAX-1351-2020; Rousselle, Patricia/J-5290-2019	Rousselle, Patricia/0000-0003-0275-4562; Beck, Konrad/0000-0001-5098-9484; Rousselle, Patricia/0000-0003-0275-4562	Agence Nationale de la Recherche [ANR-08-PCVI-0031, ANR-09-EBIO-023]; Association pour la Recherche sur le Cancer [1128]; Ligue Nationale Contre le Cancer; Rhone-Alpes region; Fondation pour la Recherche Medicale	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Rhone-Alpes region(Region Auvergne-Rhone-Alpes); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported in part by Agence Nationale de la Recherche Grants ANR-08-PCVI-0031 and ANR-09-EBIO-023, Association pour la Recherche sur le Cancer Grant 1128, and Ligue Nationale Contre le Cancer.; Recipient of a Ph.D. studentship from the Rhone-Alpes region (Program Cible) and from the Fondation pour la Recherche Medicale.	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Andac Z, 1999, J MOL BIOL, V287, P253, DOI 10.1006/jmbi.1999.2606; Araki E, 2009, MOL BIOL CELL, V20, P3012, DOI 10.1091/mbc.E08-09-0977; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Bachy S, 2008, J CELL PHYSIOL, V214, P238, DOI 10.1002/jcp.21184; Beck K, 1997, EUR J BIOCHEM, V247, P339, DOI 10.1111/j.1432-1033.1997.00339.x; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Decline F, 2003, CELL MOTIL CYTOSKEL, V54, P64, DOI 10.1002/cm.10086; Decline F, 2001, J CELL SCI, V114, P811; DeHauwer C, 1997, BIOCHEM BIOPH RES CO, V232, P267, DOI 10.1006/bbrc.1997.6291; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Echtermeyer F, 1999, J CELL SCI, V112, P3433; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Hintermann E, 2004, MATRIX BIOL, V23, P75, DOI 10.1016/j.matbio.2004.03.001; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200; Hozumi K, 2009, BIOCHEMISTRY-US, V48, P5375, DOI 10.1021/bi900542u; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lampe PD, 1998, J CELL BIOL, V143, P1735, DOI 10.1083/jcb.143.6.1735; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Mizushima H, 1997, CELL GROWTH DIFFER, V8, P979; Momota Y, 2005, J RECEPT SIG TRANSD, V25, P1, DOI 10.1081/RRS-200047870; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Nguyen BP, 2000, CURR OPIN CELL BIOL, V12, P554, DOI 10.1016/S0955-0674(00)00131-9; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rapraeger AC, 1998, CURR OPIN CELL BIOL, V10, P620, DOI 10.1016/S0955-0674(98)80038-0; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Rousselle P, 1997, J CELL BIOL, V138, P719, DOI 10.1083/jcb.138.3.719; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309; Sarrazin S, 2005, J BIOL CHEM, V280, P37558, DOI 10.1074/jbc.M507729200; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Sigle RO, 2004, J CELL SCI, V117, P4481, DOI 10.1242/jcs.01310; SONNENBERG A, 1993, J CELL SCI, V106, P1083; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Sulka B, 2009, J BIOL CHEM, V284, P10659, DOI 10.1074/jbc.M807643200; Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Tran M, 2008, CANCER RES, V68, P2885, DOI 10.1158/0008-5472.CAN-07-6160; Tsubota Y, 2005, J BIOL CHEM, V280, P14370, DOI 10.1074/jbc.M413051200; Tunggal L, 2002, AM J PATHOL, V160, P459, DOI 10.1016/S0002-9440(10)64865-1; Urushibata S, 2009, BIOCHEMISTRY-US, V48, P10522, DOI 10.1021/bi901421t; Utani A, 2003, J BIOL CHEM, V278, P34483, DOI 10.1074/jbc.M304827200; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Vives RR, 2004, J BIOL CHEM, V279, P54327, DOI 10.1074/jbc.M409760200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; Yamashita H, 2004, J MOL BIOL, V335, P1145, DOI 10.1016/j.jmb.2003.11.047; Zimmermann P, 1999, FASEB J, V13, pS91	62	42	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12204	12216		10.1074/jbc.M111.300061	http://dx.doi.org/10.1074/jbc.M111.300061			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351752	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000302782200062
J	Ghosh, D; Tsokos, GC; Kyttaris, VC				Ghosh, Debjani; Tsokos, George C.; Kyttaris, Vasileios C.			c-Jun and Ets2 Proteins Regulate Expression of Spleen Tyrosine Kinase in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISEASE; JNK; SYK; TRANSACTIVATION; TRANSCRIPTION; ACTIVATION; INHIBITOR; MEDIATE; GENE	Effector T cells and T cells from patients with systemic lupus erythematosus (SLE) express increased levels of the spleen tyrosine kinase (Syk). Syk binds to the T cell receptor (TCR)-CD3 complex and transduces the TCR-mediated signal in the cell more efficiently than the canonical CD3 zeta chain. The reasons for the increased expression of Syk are unclear. In the present study, we found that Syk is regulated by the transcription factor c-Jun in cooperation with Ets2. c-Jun and Ets2 bound to the SYK promoter in close proximity and increased the promoter activity in a specific manner. Disruption of c-Jun and Ets2 expression by siRNA resulted in decreased expression of Syk. Overexpression of c-Jun but not Ets2 resulted in increase in Syk protein. c-Jun and Ets2 co-immunoprecipitated and had an additive effect on Syk expression. c-Jun-driven SYK promoter activation showed a similar pattern in B cells; however, as expected, basal promoter activity was much higher in B cells as compared with T cells. Overexpression of c-Jun led to increase in intracytoplasmic calcium flux following TCR stimulation. Moreover, we found that SLE T cells had increased levels of c-Jun at baseline and phosphorylated c-Jun upon activation. Finally, disruption of c-Jun and Ets2 in SLE T cells resulted in a decrease in calcium flux upon TCR stimulation. In conclusion, c-Jun in cooperation with Ets2 increases the expression of Syk and contributes to Syk-mediated heightened calcium responses in SLE T cells.	[Ghosh, Debjani; Tsokos, George C.; Kyttaris, Vasileios C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kyttaris, VC (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol, 330 Brookline Ave,CLS 936, Boston, MA 02215 USA.	vkyttari@bidmc.harvard.edu	Kyttaris, Vasileios/AAR-4507-2020; tsokos, george C/O-3360-2013	Kyttaris, Vasileios/0000-0001-7652-3826; tsokos, george C/0000-0001-9589-2360	National Institutes of Health [RO1 AI42269, K23 AR055672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060849, K23AR055672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI42269 (to G. C. T.) and K23 AR055672 (to V. C. K.).	ADLER V, 1995, J BIOL CHEM, V270, P26071, DOI 10.1074/jbc.270.44.26071; Bahjat FR, 2008, ARTHRITIS RHEUM-US, V58, P1433, DOI 10.1002/art.23428; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; CROSS JC, 1993, P NATL ACAD SCI USA, V90, P8078, DOI 10.1073/pnas.90.17.8078; Deng GM, 2010, ARTHRITIS RHEUM-US, V62, P2086, DOI 10.1002/art.27452; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Ghosh D, 2012, ARTHRITIS RHEUM-US, V64, P799, DOI 10.1002/art.33375; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; Krishnan S, 2008, J IMMUNOL, V181, P8145, DOI 10.4049/jimmunol.181.11.8145; Manna PR, 2004, MOL ENDOCRINOL, V18, P558, DOI 10.1210/me.2003-0223; Manna PR, 2003, J MOL ENDOCRINOL, V30, P381, DOI 10.1677/jme.0.0300381; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Molad Y, 2010, ANN RHEUM DIS, V69, P175, DOI 10.1136/ard.2008.102780; Nambiar MP, 2003, ARTHRITIS RHEUM, V48, P1948, DOI 10.1002/art.11072; ROZEK D, 1993, MOL CELL BIOL, V13, P5490, DOI 10.1128/MCB.13.9.5490; Weinblatt ME, 2008, ARTHRITIS RHEUM-US, V58, P3309, DOI 10.1002/art.23992; Yang BS, 1996, MOL CELL BIOL, V16, P538	19	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11833	11841		10.1074/jbc.M111.333997	http://dx.doi.org/10.1074/jbc.M111.333997			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354960	hybrid, Green Published			2022-12-25	WOS:000302782200022
J	Bongfen, SE; Rodrigue-Gervais, IG; Berghout, J; Torre, S; Cingolani, P; Wiltshire, SA; Leiva-Torres, GA; Letourneau, L; Sladek, R; Blanchette, M; Lathrop, M; Behr, MA; Gruenheid, S; Vidal, SM; Saleh, M; Gros, P				Bongfen, Silayuv E.; Rodrigue-Gervais, Ian-Gael; Berghout, Joanne; Torre, Sabrina; Cingolani, Pablo; Wiltshire, Sean A.; Leiva-Torres, Gabriel A.; Letourneau, Louis; Sladek, Robert; Blanchette, Mathieu; Lathrop, Mark; Behr, Marcel A.; Gruenheid, Samantha; Vidal, Silvia M.; Saleh, Maya; Gros, Philippe			An N-Ethyl-N-Nitrosourea (ENU)-Induced Dominant Negative Mutation in the JAK3 Kinase Protects against Cerebral Malaria	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PLASMODIUM-BERGHEI ANKA; T-CELLS; JANUS KINASES; CITROBACTER-RODENTIUM; IFN-GAMMA; SUSCEPTIBILITY LOCUS; CYTOKINE PRODUCTION; INTERFERON-GAMMA; ENU MUTAGENESIS	Cerebral malaria (CM) is a lethal neurological complication of malaria. We implemented a genome-wide screen in mutagenized mice to identify host proteins involved in CM pathogenesis and whose inhibition may be of therapeutic value. One pedigree (P48) segregated a resistance trait whose CM-protective effect was fully penetrant, mapped to chromosome 8, and identified by genome sequencing as homozygosity for a mis-sense mutation (W81R) in the FERM domain of Janus-associated kinase 3 (Jak3). The causative effect of Jak3(W81R) was verified by complementation testing in Jak3(W81R/-) double heterozygotes that were fully protected against CM. Jak3(W81R) homozygotes showed defects in thymic development with depletion of CD8(+) T cell, B cell, and NK cell compartments, and defective T cell-dependent production of IFN-gamma. Adoptive transfer of normal splenocytes abrogates CM resistance in Jak3(W81R) homozygotes, an effect attributed to the CD8(+) T cells. Jak3(W81R) behaves as a dominant negative variant, with significant CM resistance of Jak3(W81R/+) heterozygotes, compared to CM-susceptible Jak3(+/+) and Jak3(+/-) controls. CM resistance in Jak3(W81R/+) heterozygotes occurs in presence of normal T, B and NK cell numbers. These findings highlight the pathological role of CD8(+) T cells and Jak3-dependent IFN-gamma-mediated Th1 responses in CM pathogenesis.	[Bongfen, Silayuv E.; Berghout, Joanne; Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Rodrigue-Gervais, Ian-Gael; Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ, Canada; [Torre, Sabrina; Wiltshire, Sean A.; Leiva-Torres, Gabriel A.; Letourneau, Louis; Sladek, Robert; Vidal, Silvia M.; Gros, Philippe] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Bongfen, Silayuv E.; Rodrigue-Gervais, Ian-Gael; Berghout, Joanne; Torre, Sabrina; Wiltshire, Sean A.; Leiva-Torres, Gabriel A.; Gruenheid, Samantha; Vidal, Silvia M.; Saleh, Maya; Gros, Philippe] McGill Univ, Complex Traits Grp, Montreal, PQ, Canada; [Cingolani, Pablo; Blanchette, Mathieu] McGill Univ, Sch Comp Sci, Montreal, PQ, Canada; [Lathrop, Mark] Ctr Natl Genotypage, Inst Genom, Evry, France; [Behr, Marcel A.; Gruenheid, Samantha] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Behr, Marcel A.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; CEA; UDICE-French Research Universities; Universite Paris Saclay; McGill University; McGill University	Bongfen, SE (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	philippe.gros@mcgill.ca	Berghout, Joanne/M-5493-2017; Sladek, Robert/R-2391-2019	Berghout, Joanne/0000-0002-9250-9159; Sladek, Robert/0000-0002-2730-1204; Leiva-Torres, Gabriel Andre/0000-0002-8144-1443; Saleh, Maya/0000-0003-1538-9146; Gruenheid, Samantha/0000-0002-0908-6715	Canadian Institutes of Health Research (CIHR) [216406]; European Union [HEALTH-F4-2008-201418]; Fonds De Recherche en Sante du Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); European Union(European Commission); Fonds De Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by research grants to PG, MS, SV, MB from the Canadian Institutes of Health Research (CIHR; 216406), to SG, and MAB from the CIHR, and to ML from the European Union Framework 7 Program READNA (HEALTH-F4-2008-201418). RS is supported by a salary award from the Fonds De Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; [Anonymous], 2004, AM J TRANSPLANT, V4, P51, DOI 10.1046/j.1600-6143.2003.00281.x; Bagot S, 2002, P NATL ACAD SCI USA, V99, P9919, DOI 10.1073/pnas.152215199; Balachandar S, 2011, EUR J CLIN MICROBIOL, V30, P483, DOI 10.1007/s10096-010-1122-9; Balling R, 2001, ANNU REV GENOM HUM G, V2, P463, DOI 10.1146/annurev.genom.2.1.463; Baptista FG, 2010, INFECT IMMUN, V78, P4033, DOI 10.1128/IAI.00079-10; Berghout J, 2010, GENES IMMUN, V11, P310, DOI 10.1038/gene.2009.79; Bongfen SE, 2009, TRENDS PARASITOL, V25, P417, DOI 10.1016/j.pt.2009.05.012; Cabrales P, 2011, J INFECT DIS; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Campino S, 2005, GENES IMMUN, V6, P416, DOI 10.1038/sj.gene.6364219; Chan ER, 2009, EXP HEMATOL, V37, P276, DOI 10.1016/j.exphem.2008.10.005; Cornejo MG, 2009, INT J BIOCHEM CELL B, V41, P2376, DOI 10.1016/j.biocel.2009.09.004; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; DEKOSSODO S, 1993, J IMMUNOL, V151, P4811; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; Fernandez L, 2009, MAMM GENOME, V20, P296, DOI 10.1007/s00335-009-9184-7; FINLEY R, 1983, J IMMUNOL, V131, P1522; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Franklin BS, 2011, P NATL ACAD SCI USA, V108, P3689, DOI 10.1073/pnas.1015406108; Frucht DM, 2001, GENES IMMUN, V2, P422, DOI 10.1038/sj.gene.6363802; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; GROS P, 1981, J IMMUNOL, V127, P2417; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hermsen C, 1997, PARASITOLOGY, V114, P7, DOI 10.1017/S0031182096008293; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Hong CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015333; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Kwiatkowski D, 2000, CURR OPIN GENET DEV, V10, P320, DOI 10.1016/S0959-437X(00)00087-3; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lackner P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-36; McCall MBB, 2010, EUR J IMMUNOL, V40, P3472, DOI 10.1002/eji.201040587; McQuillan JA, 2011, INT J PARASITOL, V41, P155, DOI 10.1016/j.ijpara.2010.08.003; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; Miller G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009137; Mitchell AJ, 2005, INFECT IMMUN, V73, P5645, DOI 10.1128/IAI.73.9.5645-5653.2005; Miu J, 2008, J IMMUNOL, V180, P1217, DOI 10.4049/jimmunol.180.2.1217; Morrell CN, 2011, INFECT IMMUN, V79, P1750, DOI 10.1128/IAI.00810-10; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Notorangelo LD, 2001, HUM MUTAT, V18, P255; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Ohno T, 2004, IMMUNOGENETICS, V56, P675, DOI 10.1007/s00251-004-0739-1; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Roberts JL, 2004, BLOOD, V103, P2009, DOI 10.1182/blood-2003-06-2104; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Rudin W, 1997, AM J PATHOL, V150, P257; Rudin W, 1997, EUR J IMMUNOL, V27, P810, DOI 10.1002/eji.1830270403; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Senaldi G, 1999, J IMMUNOL, V163, P6820; Simmons CP, 2003, INFECT IMMUN, V71, P5077, DOI 10.1128/IAI.71.9.5077-5086.2003; Simmons CP, 2002, J IMMUNOL, V168, P1804, DOI 10.4049/jimmunol.168.4.1804; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Weatherall DJ, 2008, BRIT J HAEMATOL, V141, P276, DOI 10.1111/j.1365-2141.2008.07085.x; WHO, 2010, GUID TREATM MAL, P37; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Yanez DM, 1996, J IMMUNOL, V157, P1620; Yanez DM, 1999, INFECT IMMUN, V67, P446; Zhou YJ, 2001, MOL CELL, V8, P959, DOI 10.1016/S1097-2765(01)00398-7	60	19	19	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31012	10.1371/journal.pone.0031012	http://dx.doi.org/10.1371/journal.pone.0031012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363534	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700021
J	Kidd, S; Spaeth, E; Watson, K; Burks, J; Lu, HB; Klopp, A; Andreeff, M; Marini, FC				Kidd, Shannon; Spaeth, Erika; Watson, Keri; Burks, Jared; Lu, Hongbo; Klopp, Ann; Andreeff, Michael; Marini, Frank C.			Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow-Derived Stroma	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL PROGENITOR CELLS; UMBILICAL-CORD BLOOD; BREAST-CANCER; IN-VIVO; MYOFIBROBLASTS CONTRIBUTE; MOUSE MODEL; ANGIOGENESIS; FIBROBLASTS; PERICYTE	To meet the requirements for rapid tumor growth, a complex array of non-neoplastic cells are recruited to the tumor microenvironment. These cells facilitate tumor development by providing matrices, cytokines, growth factors, as well as vascular networks for nutrient and waste exchange, however their precise origins remain unclear. Through multicolored tissue transplant procedures; we have quantitatively determined the contribution of bone marrow-derived and adipose-derived cells to stromal populations within syngeneic ovarian and breast murine tumors. Our results indicate that subpopulations of tumor-associated fibroblasts (TAFs) are recruited from two distinct sources. The majority of fibroblast specific protein (FSP) positive and fibroblast activation protein (FAP) positive TAFs originate from mesenchymal stem/stromal cells (MSC) located in bone marrow sources, whereas most vascular and fibrovascular stroma (pericytes, alpha-SMA(+) myofibroblasts, and endothelial cells) originates from neighboring adipose tissue. These results highlight the capacity for tumors to utilize multiple sources of structural cells in a systematic and discriminative manner.	[Kidd, Shannon; Spaeth, Erika; Watson, Keri; Burks, Jared; Lu, Hongbo; Andreeff, Michael; Marini, Frank C.] Univ Texas Houston, Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA; [Klopp, Ann] Univ Texas Houston, Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Kidd, S (corresponding author), Univ Texas Houston, Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA.	fmarini@wakehealth.edu	Marini, Frank C/L-8018-2016	Spaeth, Erika/0000-0002-5397-3493	National Cancer Institute [RC1CA146381, CA109451, P50CA083639, R01CA109451, R01NS06994, Ca-116199, CA55164, CA16672, CA49639]; Paul and Mary Haas Chair in Genetics; Rosalie B Hite Foundation; Susan G Komen Breast Cancer Foundation; Ovarian Cancer Research Fund; Army Department of Defense [BC083397]; NATIONAL CANCER INSTITUTE [P01CA055164, RC1CA146381, P01CA049639, P50CA116199, P30CA016672, R01CA109451, P50CA083639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069964] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Paul and Mary Haas Chair in Genetics; Rosalie B Hite Foundation; Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Ovarian Cancer Research Fund; Army Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by grants from the National Cancer Institute (RC1CA146381, CA109451, P50CA083639, R01CA109451, R01NS06994 and Ca-116199 for FCM, CA55164, CA16672, and CA49639 for Dr. Andreeff) and by the Paul and Mary Haas Chair in Genetics (Dr. Andreeff). Dr. Kidd is supported by the Rosalie B Hite Foundation. Dr. Marini is also supported in part by grants from the Susan G Komen Breast Cancer Foundation. Dr. Klopp is supported in part by the Ovarian Cancer Research Fund. Dr. Spaeth is supported in part by Army Department of Defense (BC083397). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bababeygy SR, 2008, STEM CELLS DEV, V17, P11, DOI 10.1089/scd.2007.0117; Bartsch K, 2009, TRANSPLANTATION, V87, P217, DOI 10.1097/TP.0b013e3181938998; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dickhut A, 2005, ANN HEMATOL, V84, P722, DOI 10.1007/s00277-005-1067-8; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Dome B, 2009, CRIT REV ONCOL HEMAT, V69, P108, DOI 10.1016/j.critrevonc.2008.06.009; Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]; Emura M, 2000, IN VITRO CELL DEV-AN, V36, P77; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Goon PKY, 2006, NEOPLASIA, V8, P79, DOI 10.1593/neo.05592; Gothert JR, 2004, BLOOD, V104, P1769, DOI 10.1182/blood-2003-11-3952; Grenier G, 2007, STEM CELLS, V25, P3101, DOI 10.1634/stemcells.2006-0795; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hutchinson L, 2011, STEM CELLS DEV, V20, P11, DOI 10.1089/scd.2010.0139; Ishii G, 2005, INT J CANCER, V117, P212, DOI 10.1002/ijc.21199; Ishii G, 2003, BIOCHEM BIOPH RES CO, V309, P232, DOI 10.1016/S0006-291X(03)01544-4; Jaster R, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-26; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kidd S, 2010, CYTOTHERAPY, V12, P615, DOI 10.3109/14653241003631815; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P599, DOI 10.14670/HH-17.599; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P677, DOI 10.1189/jlb.0506309; Larrivee B, 2005, J IMMUNOL, V175, P2890, DOI 10.4049/jimmunol.175.5.2890; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Manson JE, 2003, JAMA-J AM MED ASSOC, V289, P229, DOI 10.1001/jama.289.2.229; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Monsky WL, 2002, CLIN CANCER RES, V8, P1008; Muehlberg FL, 2009, CARCINOGENESIS, V30, P589, DOI 10.1093/carcin/bgp036; Nishitani Y, 2005, KIDNEY INT, V68, P1078, DOI 10.1111/j.1523-1755.2005.00500.x; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Reddy K, 2008, MOL CANCER RES, V6, P929, DOI 10.1158/1541-7786.MCR-07-2189; Rehman J, 2003, J AM COLL CARDIOL, V41, P1408, DOI 10.1016/S0735-1097(03)00231-6; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rose DP, 2007, ENDOCR REV, V28, P763, DOI 10.1210/er.2006-0019; Sangai T, 2005, INT J CANCER, V115, P885, DOI 10.1002/ijc.20969; Schneider M, 2008, J MOL MED, V86, P507, DOI 10.1007/s00109-007-0301-3; Short Brenton J., 2009, V482, P259, DOI 10.1007/978-1-59745-060-7_16; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Studeny M, 2001, BLOOD, V98, p696A; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com; Wang XM, 2005, HEPATOLOGY, V42, P935, DOI 10.1002/hep.20853; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Zhang Y, 2009, CANCER RES, V69, P5259, DOI 10.1158/0008-5472.CAN-08-3444; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	59	249	255	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30563	10.1371/journal.pone.0030563	http://dx.doi.org/10.1371/journal.pone.0030563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363446	gold, Green Published, Green Submitted			2022-12-25	WOS:000302871500012
J	Blondeau, B; Sahly, I; Massourides, E; Singh-Estivalet, A; Valtat, B; Dorchene, D; Jaisser, F; Breant, B; Tronche, F				Blondeau, Bertrand; Sahly, Iman; Massourides, Emmanuelle; Singh-Estivalet, Amrit; Valtat, Berengere; Dorchene, Delphine; Jaisser, Frederic; Breant, Bernadette; Tronche, Francois			Novel Transgenic Mice for Inducible Gene Overexpression in Pancreatic Cells Define Glucocorticoid Receptor-Mediated Regulations of Beta Cells	PLOS ONE			English	Article							EXPRESSION; BRAIN	Conditional gene deletion in specific cell populations has helped the understanding of pancreas development. Using this approach, we have shown that deleting the glucocorticoid receptor (GR) gene in pancreatic precursor cells leads to a doubled beta-cell mass. Here, we provide genetic tools that permit a temporally and spatially controlled expression of target genes in pancreatic cells using the Tetracycline inducible system. To efficiently target the Tetracycline transactivator (tTA) in specific cell populations, we generated Bacterial Artificial Chromosomes (BAC) transgenic mice expressing the improved Tetracycline transactivator (itTA) either in pancreatic progenitor cells expressing the transcription factor Pdx1 (BAC-Pdx1-itTA), or in beta cells expressing the insulin1 gene (BAC-Ins1-itTA). In the two transgenic models, itTA-mediated activation of reporter genes was efficient and subject to regulation by Doxycycline (Dox). The analysis of a tetracycline-regulated LacZ reporter gene shows that in BAC-Pdx1-itTA mice, itTA is expressed from embryonic (E) day 11.5 in all pancreatic precursor cells. In the adult pancreas, itTA is active in mature beta, delta cells and in few acinar cells. In BAC-Ins1-itTA mice tTA is active from E13.5 and is restricted to beta cells in fetal and adult pancreas. In both lines, tTA activity was suppressed by Dox treatment and re-induced after Dox removal. Using these transgenic lines, we overexpressed the GR in selective pancreatic cell populations and found that overexpression in precursor cells altered adult beta-cell fraction but not glucose tolerance. In contrast, GR overexpression in mature beta cells did not alter beta-cell fraction but impaired glucose tolerance with insufficient insulin secretion. In conclusion, these new itTA mouse models will allow fine-tuning of gene expression to investigate gene function in pancreatic biology and help us understand how glucocorticoid signaling affects on the long-term distinct aspects of beta-cell biology.	[Blondeau, Bertrand; Sahly, Iman; Singh-Estivalet, Amrit; Valtat, Berengere; Dorchene, Delphine; Jaisser, Frederic; Breant, Bernadette] INSERM, Ctr Rech Cordeliers, UMR S 872, Paris, France; [Blondeau, Bertrand; Sahly, Iman; Massourides, Emmanuelle; Singh-Estivalet, Amrit; Valtat, Berengere; Dorchene, Delphine; Jaisser, Frederic; Breant, Bernadette; Tronche, Francois] Univ Paris 06, Paris, France; [Massourides, Emmanuelle; Tronche, Francois] CNRS, Mol Genet Neurophysiol & Behav Team, UMR7224, Paris, France; [Massourides, Emmanuelle; Tronche, Francois] INSERM, U952, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Blondeau, B (corresponding author), INSERM, Ctr Rech Cordeliers, UMR S 872, Paris, France.	Bertrand.blondeau@crc.jussieu.fr	Jaisser, Frederic/P-4287-2017; TRONCHE, François/F-3895-2011	Jaisser, Frederic/0000-0001-9051-1901; Blondeau, Bertrand/0000-0002-1106-1509; Blondeau, Bertrand/0000-0001-8771-6631; Massourides, Emmanuelle/0000-0002-9829-5008	Univerisite Pierre et Marie Curie; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; European Union [Food-CT-2005-007036]; Agence Nationale de la Recherche [A05245DS]	Univerisite Pierre et Marie Curie; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	The authors thank E Casanova, N Copeland and R Sprengel for providing plasmids and bacterial strains used in this study. Financial support was provided by Univerisite Pierre et Marie Curie, The Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, the European Union Frame Program 6 Earnest program Food-CT-2005-007036 to B Breant and F Tronche and the Agence Nationale de la Recherche (Grant Gramsy No A05245DS) to B Breant and F Tronche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Blondeau B, 2001, AM J PHYSIOL-ENDOC M, V281, pE592, DOI 10.1152/ajpendo.2001.281.3.E592; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Gesina E, 2004, DIABETES, V53, P2322, DOI 10.2337/diabetes.53.9.2322; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Krestel HE, 2004, J NEUROSCI, V24, P10568, DOI 10.1523/JNEUROSCI.4579-03.2004; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Morozov A, 2003, BIOL PSYCHIAT, V54, P1125, DOI 10.1016/S0006-3223(03)00467-0; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Sahly I, 2007, MOL CELL NEUROSCI, V36, P27, DOI 10.1016/j.mcn.2007.05.005; Sainte-Marie Y, 2007, FASEB J, V21, P3133, DOI 10.1096/fj.07-8357com; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Stoffers DA, 1999, ENDOCRINOLOGY, V140, P5374, DOI 10.1210/en.140.11.5374; Turiault M, 2007, FEBS J, V274, P3568, DOI 10.1111/j.1742-4658.2007.05886.x; Valtat B, 2011, DIABETOLOGIA, V54, P350, DOI 10.1007/s00125-010-1898-2; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624	21	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30210	10.1371/journal.pone.0030210	http://dx.doi.org/10.1371/journal.pone.0030210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363422	gold, Green Published, Green Submitted			2022-12-25	WOS:000302853600016
J	Saudek, V				Saudek, Vladimir			Cystinosin, MPDU1, SWEETs and KDELR Belong to a Well-Defined Protein Family with Putative Function of Cargo Receptors Involved in Vesicle Trafficking	PLOS ONE			English	Article							CLEFT-LIP; SEQUENCE; TRANSLOCATION; GENE; PREDICTION; RETENTION; DOLICHOL; COMPLEX; DOMAIN; ERS1	Classification of proteins into families based on remote homology often helps prediction of their biological function. Here we describe prediction of protein cargo receptors involved in vesicle formation and protein trafficking. Hidden Markov model profile-to-profile searches in protein databases using endoplasmic reticulum lumen protein retaining receptors (KDEL, Erd2) as query reveal a large and diverse family of proteins with seven transmembrane helices and common topology and, most likely, similar function. Their coding genes exist in all eukaryota and in several prokaryota. Some are responsible for metabolic diseases (cystinosis, congenital disorder of glycosylation), others are candidate genes for genetic disorders (cleft lip and palate, certain forms of cancer) or solute uptake and efflux (SWEETs) and many have not yet been assigned a function. Comparison with the properties of KDEL receptors suggests that the family members could be involved in protein trafficking and serve as cargo receptors. This prediction sheds new light on a range of biologically, medically and agronomically important proteins and could open the way to discovering the function of many genes not yet annotated. Experimental testing is suggested.	Univ Cambridge Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Saudek, V (corresponding author), Univ Cambridge Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge, England.	vs317@cam.ac.uk			University of Cambridge Metabolic Research Labs, Institute of Metabolic Science	University of Cambridge Metabolic Research Labs, Institute of Metabolic Science	This work has been supported by University of Cambridge Metabolic Research Labs, Institute of Metabolic Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; Anantharaman V, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-34; Antignac C, 2010, ROLE CYSTINOSIN VESI; Baroni T, 2010, J CELL PHYSIOL, V222, P748, DOI 10.1002/jcp.22006; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Binda M, 2010, CELL CYCLE, V9, P221, DOI 10.4161/cc.9.2.10585; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Eddy Sean R, 2009, Genome Inform, V23, P205; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Frank CG, 2008, NATURE, V454, pE3, DOI 10.1038/nature07165; Gahl WA, 2002, NEW ENGL J MED, V347, P111, DOI 10.1056/NEJMra020552; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Gao XD, 2005, FEBS J, V272, P2497, DOI 10.1111/j.1742-4658.2005.04670.x; Gasnier B, 2010, MOL ANATOMY PHYSL HU; HARDWICK KG, 1990, EMBO J, V9, P623, DOI 10.1002/j.1460-2075.1990.tb08154.x; HARDWICK KG, 1990, NUCLEIC ACIDS RES, V18, P2177, DOI 10.1093/nar/18.8.2177; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hsu VW, 2009, FEBS LETT, V583, P3758, DOI 10.1016/j.febslet.2009.10.056; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Moriyama EN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r96; Nicholas KB, 2007, GENEDOC ANAL VISUALI; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Podar M, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-2; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Ponting CP, 2001, GENOME RES, V11, P1996, DOI 10.1101/gr.198701; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Sanyal S, 2010, P NATL ACAD SCI USA, V107, P11289, DOI 10.1073/pnas.1002408107; Schachter H, 2001, J CLIN INVEST, V108, P1579, DOI 10.1172/JCI200114498; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stokes AJ, 2005, J CELL BIOCHEM, V94, P669, DOI 10.1002/jcb.20331; Taub ML, 2011, BIOCHEM BIOPH RES CO, V407, P355, DOI 10.1016/j.bbrc.2011.03.022; TOWNSLEY FM, 1993, EMBO J, V12, P2821, DOI 10.1002/j.1460-2075.1993.tb05943.x; Wilmer MJ, 2010, AM J PHYSIOL-RENAL, V299, pF905, DOI 10.1152/ajprenal.00318.2010; Yoshiura K, 1998, GENOMICS, V54, P231, DOI 10.1006/geno.1998.5577; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061; Zhai YF, 2001, BBA-BIOMEMBRANES, V1511, P206, DOI 10.1016/S0005-2736(00)00389-8	49	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30876	10.1371/journal.pone.0030876	http://dx.doi.org/10.1371/journal.pone.0030876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363504	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600079
J	Velten, J; Cakir, C; Youn, E; Chen, JP; Cazzonelli, CI				Velten, Jeff; Cakir, Cahid; Youn, Eunseog; Chen, Junping; Cazzonelli, Christopher I.			Transgene Silencing and Transgene-Derived siRNA Production in Tobacco Plants Homozygous for an Introduced AtMYB90 Construct	PLOS ONE			English	Article							REDUCTASE CO-SUPPRESSION; SMALL RNAS; NITRATE REDUCTASE; ARABIDOPSIS-THALIANA; NITRITE REDUCTASE; GENE-EXPRESSION; MESSENGER-RNA; MECHANISM; MICRORNAS; PATHWAYS	Transgenic tobacco (Nicotiana tabacum) lines were engineered to ectopically over-express AtMYB90 (PAP2), an R2-R3 Myb gene associated with regulation of anthocyanin production in Arabidopsis thaliana. Independently transformed transgenic lines, Myb27 and Myb237, accumulated large quantities of anthocyanin, generating a dark purple phenotype in nearly all tissues. After self-fertilization, some progeny of the Myb27 line displayed an unexpected pigmentation pattern, with most leaves displaying large sectors of dramatically reduced anthocyanin production. The green-sectored 27Hmo plants were all found to be homozygous for the transgene and, despite a doubled transgene dosage, to have reduced levels of AtMYB90 mRNA. The observed reduction in anthocyanin pigmentation and AtMYB90 mRNA was phenotypically identical to the patterns seen in leaves systemically silenced for the AtMYB90 transgene, and was associated with the presence of AtMYB90-derived siRNA homologous to both strands of a portion of the AtMYB90 transcribed region. Activation of transgene silencing in the Myb27 line was triggered when the 35S::AtMYB90 transgene dosage was doubled, in both Myb27 homozygotes, and in plants containing one copy of each of the independently segregating Myb27 and Myb237 transgene loci. Mapping of sequenced siRNA molecules to the Myb27 TDNA (including flanking tobacco sequences) indicated that the 3' half of the AtMYB90 transcript is the primary target for siRNA associated silencing in both homozygous Myb27 plants and in systemically silenced tissues. The transgene within the Myb27 line was found to consist of a single, fully intact, copy of the AtMYB90 construct. Silencing appears to initiate in response to elevated levels of transgene mRNA (or an aberrant product thereof) present within a subset of leaf cells, followed by spread of the resulting small RNA to adjacent leaf tissues and subsequent amplification of siRNA production.	[Velten, Jeff; Cakir, Cahid; Chen, Junping] ARS, USDA, Lubbock, TX USA; [Youn, Eunseog] Texas Tech Univ, Dept Comp Sci, Lubbock, TX 79409 USA; [Cazzonelli, Christopher I.] Australian Natl Univ, Res Sch Biol, Ctr Excellence Plant Energy Biol, Australian Res Council, Canberra, ACT, Australia	United States Department of Agriculture (USDA); Texas Tech University System; Texas Tech University; Australian National University	Velten, J (corresponding author), ARS, USDA, Lubbock, TX USA.	Jeff.Velten@ars.usda.gov	Cazzonelli, Christopher I/A-5347-2010	Cazzonelli, Christopher I/0000-0003-3096-3193	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	Funding for this research is provided by the United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; BOERJAN W, 1994, PLANT CELL, V6, P1401, DOI 10.1105/tpc.6.10.1401; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; Cakir C, 2010, PHYSIOL MOL PLANT P, V74, P246, DOI 10.1016/j.pmpp.2010.04.001; Cazzonelli CI, 2004, PLANT MOL BIOL REP, V22, P347, DOI 10.1007/BF02772678; Chellappan Padmanabhan, 2009, V495, P121, DOI 10.1007/978-1-59745-477-3_11; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chinnusamy V, 2009, SCI CHINA SER C, V52, P331, DOI 10.1007/s11427-009-0052-1; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Choudhuri S, 2009, BIOCHEM BIOPH RES CO, V388, P177, DOI 10.1016/j.bbrc.2009.08.039; DE CARVALHO-NIEBEL F, 1995, PLANT CELL, V7, P347, DOI 10.2307/3869856; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; DEBORNE FD, 1994, MOL GEN GENET, V243, P613, DOI 10.1007/BF00279570; DECARVALHO F, 1992, EMBO J, V11, P2595, DOI 10.1002/j.1460-2075.1992.tb05324.x; DEHIO C, 1994, P NATL ACAD SCI USA, V91, P5538, DOI 10.1073/pnas.91.12.5538; Depicker A, 2005, ANNU PLANT REV, P1; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dunoyer P, 2006, NAT GENET, V38, P258, DOI 10.1038/ng1722; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Dunoyer P, 2009, TRENDS PLANT SCI, V14, P643, DOI 10.1016/j.tplants.2009.09.003; Eamens A, 2008, PLANT PHYSIOL, V147, P456, DOI 10.1104/pp.108.117275; Elmayan T, 1996, PLANT J, V9, P787, DOI 10.1046/j.1365-313X.1996.9060787.x; Fagard M, 2000, ANNU REV PLANT PHYS, V51, P167, DOI 10.1146/annurev.arplant.51.1.167; HART CM, 1992, MOL GEN GENET, V235, P179, DOI 10.1007/BF00279359; Kalantidis K, 2008, BIOL CELL, V100, P13, DOI 10.1042/BC20070079; Kasai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016895; Kooter JM, 1999, TRENDS PLANT SCI, V4, P340, DOI 10.1016/S1360-1385(99)01467-3; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Mallory AC, 2003, PLANT J, V35, P82, DOI 10.1046/j.1365-313X.2003.01785.x; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; Mitsuhara I, 2002, GENETICS, V160, P343; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Palauqui JC, 1996, PLANT PHYSIOL, V112, P1447, DOI 10.1104/pp.112.4.1447; PALAUQUI JC, 1995, PLANT MOL BIOL, V29, P149, DOI 10.1007/BF00019126; PEACH C, 1991, PLANT MOL BIOL, V17, P49, DOI 10.1007/BF00036805; Qin HX, 2003, PLANT MOL BIOL, V52, P217, DOI 10.1023/A:1023941123149; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Schubert D, 2004, PLANT CELL, V16, P2561, DOI 10.1105/tpc.104.024547; Stam M, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; VAUCHERET H, 1995, MOL GEN GENET, V248, P311, DOI 10.1007/BF02191598; Vaucheret H, 1998, PLANT J, V16, P651, DOI 10.1046/j.1365-313x.1998.00337.x; Vaucheret H, 2001, J CELL SCI, V114, P3083; Velten J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009917; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wielopolska A, 2005, PLANT BIOTECHNOL J, V3, P583, DOI 10.1111/j.1467-7652.2005.00149.x; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818	58	16	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30141	10.1371/journal.pone.0030141	http://dx.doi.org/10.1371/journal.pone.0030141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363419	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600014
J	Duttagupta, R; DiRienzo, S; Jiang, R; Bowers, J; Gollub, J; Kao, J; Kearney, K; Rudolph, D; Dawany, NB; Showe, MK; Stamato, T; Getts, RC; Jones, KW				Duttagupta, Radha; DiRienzo, Sharon; Jiang, Rong; Bowers, Jessica; Gollub, Jeremy; Kao, Jessica; Kearney, Keith; Rudolph, David; Dawany, Noor B.; Showe, Michael K.; Stamato, Tom; Getts, Robert C.; Jones, Keith W.			Genome-Wide Maps of Circulating miRNA Biomarkers for Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; MICRORNA; EXPRESSION; PROFILES; POLYMORPHISMS; DISTINGUISH; DISCOVERY; PLATELETS; AUTOPHAGY	Inflammatory Bowel Disease - comprised of Crohn's Disease and Ulcerative Colitis (UC) - is a complex, multi-factorial inflammatory disorder of the gastrointestinal tract. In this study we have explored the utility of naturally occurring circulating miRNAs as potential blood-based biomarkers for non-invasive prediction of UC incidences. Whole genome maps of circulating miRNAs in micro-vesicles, Peripheral Blood Mononuclear Cells and platelets have been constructed from a cohort of 20 UC patients and 20 normal individuals. Through Significance Analysis of Microarrays, a signature of 31 differentially expressed platelet-derived miRNAs has been identified and biomarker performance estimated through a non-probabilistic binary linear classification using Support Vector Machines. Through this approach, classifier measurements reveal a predictive score of 92.8% accuracy, 96.2% specificity and 89.5% sensitivity in distinguishing UC patients from normal individuals. Additionally, the platelet-derived biomarker signature can be validated at 88% accuracy through qPCR assays, and a majority of the miRNAs in this panel can be demonstrated to sub-stratify into 4 highly correlated intensity based clusters. Analysis of predicted targets of these biomarkers reveal an enrichment of pathways associated with cytoskeleton assembly, transport, membrane permeability and regulation of transcription factors engaged in a variety of regulatory cascades that are consistent with a cell-mediated immune response model of intestinal inflammation. Interestingly, comparison of the miRNA biomarker panel and genetic loci implicated in IBD through genome-wide association studies identifies a physical linkage between hsa-miR-941 and a UC susceptibility loci located on Chr 20. Taken together, analysis of these expression maps outlines a promising catalog of novel platelet-derived miRNA biomarkers of clinical utility and provides insight into the potential biological function of these candidates in disease pathogenesis.	[Duttagupta, Radha; Jiang, Rong; Gollub, Jeremy; Kao, Jessica; Jones, Keith W.] Affymetrix Inc, Appl Reasearch Grp, Santa Clara, CA USA; [Bowers, Jessica; Getts, Robert C.] Genisphere LLC, Res & Dev, Hatfield, PA USA; [DiRienzo, Sharon; Stamato, Tom] Lankenau Inst Med Res, Wynnewood, PA USA; [Kearney, Keith; Rudolph, David] Lankenau Med Ctr, Div Gastroenterol, Wynnewood, PA USA; [Dawany, Noor B.; Showe, Michael K.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	Affymetrix; Lankenau Medical Center; Lankenau Institute for Medical Research; Lankenau Medical Center; The Wistar Institute	Duttagupta, R (corresponding author), Affymetrix Inc, Appl Reasearch Grp, Santa Clara, CA USA.	Keith_Jones@affymetrix.com			Sharpe-Strumia Research Foundation of Bryn Mawr Hospital	Sharpe-Strumia Research Foundation of Bryn Mawr Hospital	Support for this work was provided by Sharpe-Strumia Research Foundation of Bryn Mawr Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bamias G, 2007, CURR OPIN GASTROEN, V23, P365, DOI 10.1097/MOG.0b013e3281c55eb2; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beniwal Poonam, 2010, Curr Gastroenterol Rep, V12, P479, DOI 10.1007/s11894-010-0145-9; Benjamini Y, 2001, ANN STAT, V29, P1165; Boni V, 2011, PHARMACOGENOMICS J, V11, P429, DOI 10.1038/tpj.2010.58; Borel C, 2008, MAMM GENOME, V19, P503, DOI 10.1007/s00335-008-9137-6; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Danese S, 2004, AM J GASTROENTEROL, V99, P938, DOI 10.1111/j.1572-0241.2004.04129.x; Danese S, 2011, AM J PHYSIOL-GASTR L, V300, pG716, DOI 10.1152/ajpgi.00472.2010; Elalamy I., 2008, EUR REV MED PHARMACO, V121, P843; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kwon JH, 2011, INFLAMMATORY BOWEL D; Landry P, 2009, NATURE STRUCTURAL MO; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Merrill AH, 1997, J NUTR, V127, pS830, DOI 10.1093/jn/127.5.830S; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Nikolaus S, 2007, GASTROENTEROLOGY, V133, P1670, DOI 10.1053/j.gastro.2007.09.001; Reid G, 2010, CRITICAL REV ONCOLOG; Roda G, 2010, INFLAMM BOWEL DIS, V16, P1239, DOI 10.1002/ibd.21212; Rybaczyk L, 2009, INFLAMM BOWEL DIS, V15, P971, DOI 10.1002/ibd.20893; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; SCHOEDON G, 1986, J INTERFERON RES, V6, P697, DOI 10.1089/jir.1986.6.697; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450	49	78	84	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31241	10.1371/journal.pone.0031241	http://dx.doi.org/10.1371/journal.pone.0031241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359580	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200049
J	Hu, RB; Chi, XY; Chai, GH; Kong, YZ; He, G; Wang, XY; Shi, DC; Zhang, DY; Zhou, GK				Hu, Ruibo; Chi, Xiaoyuan; Chai, Guohua; Kong, Yingzhen; He, Guo; Wang, Xiaoyu; Shi, Dachuan; Zhang, Dongyuan; Zhou, Gongke			Genome-Wide Identification, Evolutionary Expansion, and Expression Profile of Homeodomain-Leucine Zipper Gene Family in Poplar (Populus trichocarpa)	PLOS ONE			English	Article							MICRORNA-DIRECTED CLEAVAGE; CLASS IIIHD-ZIP; HD-ZIP; HOMEOBOX GENE; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTORS; WATER-DEFICIT; CELL-DIFFERENTIATION; LEAF DEVELOPMENT; MICROARRAY DATA	Background: Homeodomain-leucine zipper (HD-ZIP) proteins are plant-specific transcriptional factors known to play crucial roles in plant development. Although sequence phylogeny analysis of Populus HD-ZIPs was carried out in a previous study, no systematic analysis incorporating genome organization, gene structure, and expression compendium has been conducted in model tree species Populus thus far. Principal Findings: In this study, a comprehensive analysis of Populus HD-ZIP gene family was performed. Sixty-three full-length HD-ZIP genes were found in Populus genome. These Populus HD-ZIP genes were phylogenetically clustered into four distinct subfamilies (HD-ZIP I-IV) and predominately distributed across 17 linkage groups (LG). Fifty genes from 25 Populus paralogous pairs were located in the duplicated blocks of Populus genome and then preferentially retained during the sequential evolutionary courses. Genomic organization analyses indicated that purifying selection has played a pivotal role in the retention and maintenance of Populus HD-ZIP gene family. Microarray analysis has shown that 21 Populus paralogous pairs have been differentially expressed across different tissues and under various stresses, with five paralogous pairs showing nearly identical expression patterns, 13 paralogous pairs being partially redundant and three paralogous pairs diversifying significantly. Quantitative real-time RT-PCR (qRT-PCR) analysis performed on 16 selected Populus HD-ZIP genes in different tissues and under both drought and salinity stresses confirms their tissue-specific and stress-inducible expression patterns. Conclusions: Genomic organizations indicated that segmental duplications contributed significantly to the expansion of Populus HD-ZIP gene family. Exon/intron organization and conserved motif composition of Populus HD-ZIPs are highly conservative in the same subfamily, suggesting the members in the same subfamilies may also have conservative functionalities. Microarray and qRT-PCR analyses showed that 89% (56 out of 63) of Populus HD-ZIPs were duplicate genes that might have been retained by substantial subfunctionalization. Taken together, these observations may lay the foundation for future functional analysis of Populus HD-ZIP genes to unravel their biological roles.	[Hu, Ruibo; Chai, Guohua; He, Guo; Wang, Xiaoyu; Shi, Dachuan; Zhang, Dongyuan; Zhou, Gongke] Chinese Acad Sci, Qingdao Inst BioEnergy & BioProc Technol, Shandong Prov Key Lab Energy Genet, CAS Key Lab Biofuels, Qingdao, Shandong, Peoples R China; [Chi, Xiaoyuan] Shandong Peanut Res Inst, Qingdao, Shandong, Peoples R China; [Kong, Yingzhen] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; University System of Georgia; University of Georgia	Hu, RB (corresponding author), Chinese Acad Sci, Qingdao Inst BioEnergy & BioProc Technol, Shandong Prov Key Lab Energy Genet, CAS Key Lab Biofuels, Qingdao, Shandong, Peoples R China.	zhangdy@qibebt.ac.cn; zhougk@qibebt.ac.cn	zheng, yonghong/H-3700-2012; kong, yingzhen/AAB-1623-2022; Chai, Guohua/E-1270-2011; Hu, Ruibo/P-3471-2018	Chai, Guohua/0000-0002-2724-6516; Hu, Ruibo/0000-0001-6299-5320	National High-Tech Research and Development Program of China [2009AA10Z101, 2011AA100209]; National Basic Research Program of China [2012CB114501]; National Natural Science Foundation of China [30901157, 31000311]; Chinese Academy of Sciences; Qingdao Municipal Science and Technology Plan Project [11-2-4-8-(2)-jch]; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province [BS2011SW055]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Qingdao Municipal Science and Technology Plan Project; Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province	This study was supported by grants from the National High-Tech Research and Development Program of China ("863" program, 2009AA10Z101 and 2011AA100209), the National Basic Research Program of China ("973" program, 2012CB114501), the National Natural Science Foundation of China (30901157 and 31000311), the Program of 100 Distinguished Young Scientists of the Chinese Academy of Sciences, the Promotive Research Fund for Young and Middle-aged Scientists of Shandong Province (BS2011SW055), and the Qingdao Municipal Science and Technology Plan Project (11-2-4-8-(2)-jch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, DEVELOPMENT, V130, P635, DOI 10.1242/dev.00292; Agalou A, 2008, PLANT MOL BIOL, V66, P87, DOI 10.1007/s11103-007-9255-7; AOYAMA T, 1995, PLANT CELL, V7, P1773, DOI 10.1105/tpc.7.11.1773; Aso K, 1999, MOL BIOL EVOL, V16, P544, DOI 10.1093/oxfordjournals.molbev.a026135; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Barakat A, 2011, GENE, V479, P37, DOI 10.1016/j.gene.2011.02.008; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-26; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Carabelli M, 1996, P NATL ACAD SCI USA, V93, P3530, DOI 10.1073/pnas.93.8.3530; Chang S, 1993, PLANT MOL BIOL REP, V11, P113, DOI DOI 10.1007/BF02670468; Ciarbelli AR, 2008, PLANT MOL BIOL, V68, P465, DOI 10.1007/s11103-008-9383-8; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Cote CL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-273; Delarue M, 1998, PLANT J, V14, P603, DOI 10.1046/j.1365-313X.1998.00163.x; Dezar CA, 2011, J EXP BOT, V62, P1061, DOI 10.1093/jxb/erq339; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; Du JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017458; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Frank W, 1998, PLANT J, V15, P413, DOI 10.1046/j.1365-313X.1998.00222.x; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Green KA, 2005, PLANT CELL, V17, P691, DOI 10.1105/tpc.104.026179; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hanson J, 2001, PLANT MOL BIOL, V45, P247, DOI 10.1023/A:1006464907710; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Hjellstrom M, 2003, PLANT CELL ENVIRON, V26, P1127, DOI 10.1046/j.1365-3040.2003.01037.x; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Itoh JI, 2008, PLANT PHYSIOL, V147, P1960, DOI 10.1104/pp.108.118679; Johannesson H, 2003, PLANT MOL BIOL, V51, P719, DOI 10.1023/A:1022567625228; Johannesson H, 2001, PLANT MOL BIOL, V45, P63, DOI 10.1023/A:1006423324025; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim YK, 2007, PLANT CELL REP, V26, P1179, DOI 10.1007/s00299-007-0340-9; Kubo H, 1999, PLANT CELL, V11, P1217, DOI 10.1105/tpc.11.7.1217; Lee YH, 2001, BIOCHEM BIOPH RES CO, V284, P133, DOI 10.1006/bbrc.2001.4904; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Masucci JD, 1996, DEVELOPMENT, V122, P1253; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; McHale NA, 2004, PLANT CELL, V16, P1730, DOI 10.1105/tpc.021816; Mukherjee K, 2006, PLANT PHYSIOL, V140, P1142, DOI 10.1104/pp.105.073833; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Ohashi Y, 2002, PLANT J, V29, P359, DOI 10.1046/j.0960-7412.2001.01214.x; Ohashi-Ito K, 2003, PLANT CELL PHYSIOL, V44, P1350, DOI 10.1093/pcp/pcg164; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Prigge MJ, 2006, EVOL DEV, V8, P350, DOI 10.1111/j.1525-142X.2006.00107.x; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; Robischon M, 2011, PLANT PHYSIOL, V155, P1214, DOI 10.1104/pp.110.167007; RUBERTI I, 1991, EMBO J, V10, P1787, DOI 10.1002/j.1460-2075.1991.tb07703.x; Sawa S, 2002, PLANT J, V32, P1011, DOI 10.1046/j.1365-313X.2002.01488.x; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Sessa G, 1998, PLANT MOL BIOL, V38, P609, DOI 10.1023/A:1006016319613; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; Shen B, 2006, PLANT MOL BIOL, V60, P377, DOI 10.1007/s11103-005-4110-1; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Soderman E, 1999, PLANT MOL BIOL, V40, P1073, DOI 10.1023/A:1006267013170; Steindler C, 1999, DEVELOPMENT, V126, P4235; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tahir M, 2008, PLANT PHYSIOL BIOCH, V46, P1031, DOI 10.1016/j.plaphy.2008.08.001; Tamura K, 2011, MOL BIOL EVOL; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Tron AE, 2002, J BIOL CHEM, V277, P34800, DOI 10.1074/jbc.M203297200; Tuominen LK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-236; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vandepoele K, 2003, PLANT CELL, V15, P2192, DOI 10.1105/tpc.014019; Wang XF, 2006, BIOINFORMATICS, V22, P2955, DOI 10.1093/bioinformatics/btl525; Wang Y, 2003, DEV BIOL, V264, P228, DOI 10.1016/j.ydbio.2003.07.017; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan YA, 2009, P NATL ACAD SCI USA, V106, P22020, DOI 10.1073/pnas.0906869106; Zhong RQ, 1999, PLANT CELL, V11, P2139, DOI 10.1105/tpc.11.11.2139; Zhong R, 2007, PLANT SIGNAL BEHAV, V2, P351, DOI 10.4161/psb.2.5.4119; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087	89	62	74	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31149	10.1371/journal.pone.0031149	http://dx.doi.org/10.1371/journal.pone.0031149			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359569	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200038
J	Lu, YH; Fu, BJ; Feng, XM; Zeng, Y; Liu, Y; Chang, RY; Sun, G; Wu, BF				Lu, Yihe; Fu, Bojie; Feng, Xiaoming; Zeng, Yuan; Liu, Yu; Chang, Ruiying; Sun, Ge; Wu, Bingfang			A Policy-Driven Large Scale Ecological Restoration: Quantifying Ecosystem Services Changes in the Loess Plateau of China	PLOS ONE			English	Article							LAND CONVERSION PROGRAM; FOR-GREEN PROGRAM; ENVIRONMENTAL-CHANGES; GRAIN; VEGETATION; IMPACT; PRODUCTIVITY; METAANALYSIS; ENHANCEMENT; IMPROVEMENT	As one of the key tools for regulating human-ecosystem relations, environmental conservation policies can promote ecological rehabilitation across a variety of spatiotemporal scales. However, quantifying the ecological effects of such policies at the regional level is difficult. A case study was conducted at the regional level in the ecologically vulnerable region of the Loess Plateau, China, through the use of several methods including the Universal Soil Loss Equation (USLE), hydrological modeling and multivariate analysis. An assessment of the changes over the period of 2000-2008 in four key ecosystem services was undertaken to determine the effects of the Chinese government's ecological rehabilitation initiatives implemented in 1999. These ecosystem services included water regulation, soil conservation, carbon sequestration and grain production. Significant conversions of farmland to woodland and grassland were found to have resulted in enhanced soil conservation and carbon sequestration, but decreased regional water yield under a warming and drying climate trend. The total grain production increased in spite of a significant decline in farmland acreage. These trends have been attributed to the strong socioeconomic incentives embedded in the ecological rehabilitation policy. Although some positive policy results have been achieved over the last decade, large uncertainty remains regarding long-term policy effects on the sustainability of ecological rehabilitation performance and ecosystem service enhancement. To reduce such uncertainty, this study calls for an adaptive management approach to regional ecological rehabilitation policy to be adopted, with a focus on the dynamic interactions between people and their environments in a changing world.	[Lu, Yihe; Fu, Bojie; Feng, Xiaoming; Liu, Yu; Chang, Ruiying] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Zeng, Yuan; Wu, Bingfang] Chinese Acad Sci, Inst Remote Sensing Applicat, Beijing, Peoples R China; [Sun, Ge] US Forest Serv, USDA, So Res Stn, Raleigh, NC USA	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; United States Department of Agriculture (USDA); United States Forest Service	Lu, YH (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bfu@rcees.ac.cn	Sun, Ge/ABF-6673-2020; Fu, Bojie/B-1493-2009; Wu, Bingfang/AAD-7223-2022	chang, rui ying/0000-0002-0534-4502	National Basic Research Program of China [2009CB421104]; National Natural Science Foundation of China [40930528, 40971065]; State Forestry Administration [201004058]; CAS/SAFEA	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Forestry Administration; CAS/SAFEA(Chinese Academy of Sciences)	This work was financially supported by the National Basic Research Program of China (No. 2009CB421104), the National Natural Science Foundation of China (Nos. 40930528 and 40971065), the State Forestry Administration (No. 201004058), and the CAS/SAFEA International Partnership Program for Creative Research Teams of "Ecosystem Processes and Services." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T.G., 2008, SW HYDROL, V7, P18; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2001, J GEOGR SCI; [Anonymous], 2013, THE FUTURE OF NATURE, DOI DOI 10.12987/9780300188479-039; Aronson J, 2010, RESTOR ECOL, V18, P143, DOI 10.1111/j.1526-100X.2009.00638.x; Bai ZG, 2009, AMBIO, V38, P150, DOI 10.1579/0044-7447-38.3.150; Bennett MT, 2008, ECOL ECON, V65, P699, DOI 10.1016/j.ecolecon.2007.09.017; Cai C., 2000, J SOIL WATER CONSERV, V2, P19, DOI [10.13870/j.cnki.stbcxb.2000.02.005, DOI 10.13870/J.CNKI.STBCXB.2000.02.005, 10.3321/j.issn:1009-2242.2000.02.005]; Cao ShiXiong, 2007, Scientia Agricultura Sinica, V40, P972; Cao SX, 2009, LAND USE POLICY, V26, P1182, DOI 10.1016/j.landusepol.2009.02.006; Cao SX, 2009, J APPL ECOL, V46, P536, DOI 10.1111/j.1365-2664.2008.01605.x; Chang ZW, 2002, SOIL WATER CONSERVAT, V29, P39; Chen XG, 2009, FOREST ECOL MANAG, V258, P199, DOI 10.1016/j.foreco.2008.07.010; Ciesiolka CAA, 2006, J SOIL WATER CONSERV, V61, P223; Feng ZD, 2006, PALAEOGEOGR PALAEOCL, V241, P440, DOI 10.1016/j.palaeo.2006.04.009; Gilioli G, 2007, ECOHEALTH, V4, P428, DOI 10.1007/s10393-007-0128-y; Halle S, 2007, RESTOR ECOL, V15, P358, DOI 10.1111/j.1526-100X.2007.00226.x; HAMON W. R., 1964, Publ. Int. Ass. sci. Hydrol. Symp. gen. Assembly Berkeley, V63, P52; Harris JA, 2006, RESTOR ECOL, V14, P170, DOI 10.1111/j.1526-100X.2006.00136.x; Hu CX, 2006, INT J SUST DEV WORLD, V13, P211, DOI 10.1080/13504500609469673; Kinnell PIA, 2008, EARTH SURF PROC LAND, V33, P1627, DOI 10.1002/esp.1629; Kinnell PIA, 2010, J HYDROL, V385, P384, DOI 10.1016/j.jhydrol.2010.01.024; Li CB, 2010, ENVIRON MANAGE, V45, P476, DOI 10.1007/s00267-009-9369-6; Li L, 2010, J FOOD AGRIC ENVIRON, V8, P1185; [李奇睿 Li Qirui], 2010, [水土保持通报, Bulletin of Soil and Water Conservation], V30, P206; Li W, 2008, FOREST ECOL MANAG, V255, P2467, DOI 10.1016/j.foreco.2008.01.006; Li Y., 2009, FOR CONSTR, V5, P3, DOI [10.3969/j.issn.1006-6918.2009.05.001, DOI 10.3969/J.ISSN.1006-6918.2009.05.001]; Liu GC, 2007, SOIL WATER CONSERVAT, V34, P11; Liu ZR, 2006, SOIL WATER CONSERVAT, V27, P30; Lou XT, 2010, J ANHUI AGR SCI, V38, P6057; Peng H, 2007, J FOREST, V105, P409; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Shang X, 2010, REV PALAEOBOT PALYNO, V160, P46, DOI 10.1016/j.revpalbo.2010.01.004; Shi MJ, 2011, SUSTAIN SCI, V6, P135, DOI 10.1007/s11625-011-0133-5; Soil Survey Office of Shaanxi Province, 1992, SOIL SHAANX; Sun AZ, 2010, J GEOGR SCI, V20, P177, DOI 10.1007/s11442-010-0177-y; Sun G, 2011, ECOHYDROLOGY, V4, P245, DOI 10.1002/eco.194; Tattari S, 2001, PHYS CHEM EARTH PT B, V26, P27, DOI 10.1016/S1464-1909(01)85010-3; Uchida E, 2009, AM J AGR ECON, V91, P70, DOI 10.1111/j.1467-8276.2008.01184.x; WAHBA G, 1980, MON WEATHER REV, V108, P1122, DOI 10.1175/1520-0493(1980)108<1122:SNMMFV>2.0.CO;2; Wan YM, 1994, J SOIL WATER CONSERV, V8, P11; Wang C, 2007, J ENVIRON MANAGE, V85, P746, DOI 10.1016/j.jenvman.2006.04.025; Wang L, 2006, ENVIRON SCI POLICY, V9, P675, DOI 10.1016/j.envsci.2006.08.003; Wang YF, 2011, CATENA, V85, P58, DOI 10.1016/j.catena.2010.12.003; Xie C, 2009, FORESTRY EC, V31, P56; Xin ZB, 2008, SCI CHINA SER D, V51, P67, DOI 10.1007/s11430-007-0137-2; Xu ZG, 2004, INT FOREST REV, V6, P317, DOI 10.1505/ifor.6.3.317.59976; Yao SB, 2010, ENVIRON MANAGE, V45, P541, DOI 10.1007/s00267-009-9416-3; Yin RS, 2010, ENVIRON MANAGE, V45, P442, DOI 10.1007/s00267-009-9387-4; Yu DY, 2009, INT J REMOTE SENS, V30, P4851, DOI 10.1080/01431160802680552; Yu T, 2010, ESTUARINE COASTAL SH, V86, P345, DOI DOI 10.1016/J.ECSS.2009.05.014; Zhang K, 2004, SOIL TILL RES, V76, P157, DOI 10.1016/j.still.2003.09.007; Zhang K, 2010, QUATERN INT, V227, P38, DOI 10.1016/j.quaint.2010.04.019; Zhang Q, 2009, WATER RESOUR MANAG, V23, P1157, DOI 10.1007/s11269-008-9320-2; [张万昌 ZHANG WanChang], 2008, [生态学报, Acta Ecologica Sinica], V28, P2495; Zhang XP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006711; [周芸 Zhou Yun], 2005, [现代免疫学, Current Immunology], V25, P11; Zhu QK, 2009, J NW FORESTRY U, V24, P219; 方精云, 2007, [中国科学. D辑, 地球科学, Science in China. Series D, Earth Sciences], V37, P804	59	383	422	68	496	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31782	10.1371/journal.pone.0031782	http://dx.doi.org/10.1371/journal.pone.0031782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925XS	22359628	Green Published, gold			2022-12-25	WOS:000302796200097
J	Meisner, A; de Boer, W; Cornelissen, JHC; van der Putten, WH				Meisner, Annelein; de Boer, Wietse; Cornelissen, Johannes H. C.; van der Putten, Wim H.			Reciprocal Effects of Litter from Exotic and Congeneric Native Plant Species via Soil Nutrients	PLOS ONE			English	Article							SENECIO-JACOBAEA L; LEAF-LITTER; INVASIVE PLANTS; DECOMPOSITION RATES; TRAITS; ECOSYSTEM; IMPACTS; CARBON; CONSEQUENCES; ECOLOGY	Invasive exotic plant species are often expected to benefit exclusively from legacy effects of their litter inputs on soil processes and nutrient availability. However, there are relatively few experimental tests determining how litter of exotic plants affects their own growth conditions compared to congeneric native plant species. Here, we test how the legacy of litter from three exotic plant species affects their own performance in comparison to their congeneric natives that co-occur in the invaded habitat. We also analyzed litter effects on soil processes. In all three comparisons, soil with litter from exotic plant species had the highest respiration rates. In two out of the three exotic-native species comparisons, soil with litter from exotic plant species had higher inorganic nitrogen concentrations than their native congener, which was likely due to higher initial litter quality of the exotics. When litter from an exotic plant species had a positive effect on itself, it also had a positive effect on its native congener. We conclude that exotic plant species develop a legacy effect in soil from the invaded range through their litter inputs. This litter legacy effect results in altered soil processes that can promote both the exotic plant species and their native congener.	[Meisner, Annelein; van der Putten, Wim H.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [de Boer, Wietse] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [Cornelissen, Johannes H. C.] Vrije Univ VU Amsterdam, Fac Earth & Life Sci, Dept Ecol Sci, Amsterdam, Netherlands; [van der Putten, Wim H.] Wageningen Univ, Nematol Lab, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Vrije Universiteit Amsterdam; Wageningen University & Research	Meisner, A (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands.	A.Meisner@nioo.knaw.nl	van der Putten, Wim H/C-3707-2011; de Boer, Wietse/C-2737-2011; Meisner, Annelein/F-1778-2011; KNAW, NIOO-KNAW/A-4320-2012	van der Putten, Wim H/0000-0002-9341-4442; de Boer, Wietse/0000-0002-5380-2993; Meisner, Annelein/0000-0002-8053-5712; KNAW, NIOO-KNAW/0000-0002-3835-159X	Dutch Research Council [865.05.002]	Dutch Research Council	This study was funded by the Dutch Research Council ALW-Vici project (number 865.05.002) to WHV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Agrawal AA, 2005, ECOLOGY, V86, P2979, DOI 10.1890/05-0219; Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; Ashton IW, 2005, ECOL APPL, V15, P1263, DOI 10.1890/04-0741; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bardgett RD., 2005, THE BIOL OF SOIL, DOI [10.1093/acprof:oso/9780198525035.001.0001, DOI 10.1093/ACPROF:OSO/9780198525035.001.0001]; Barney JN, 2006, BIOL INVASIONS, V8, P703, DOI 10.1007/s10530-005-3174-9; BERENDSE F, 1994, J ECOL, V82, P187, DOI 10.2307/2261398; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Blumenthal D, 2009, P NATL ACAD SCI USA, V106, P7899, DOI 10.1073/pnas.0812607106; Cadisch G., 1997, DRIVEN NATURE PLANT; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; COLEMAN DC, 1983, ADV ECOL RES, V13, P1, DOI 10.1016/S0065-2504(08)60107-5; Cornelissen JHC, 1996, J ECOL, V84, P573, DOI 10.2307/2261479; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Dassonville N, 2008, OECOLOGIA, V157, P131, DOI 10.1007/s00442-008-1054-6; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; de Ridder-Duine AS, 2006, PEDOBIOLOGIA, V50, P293, DOI 10.1016/j.pedobi.2006.03.004; Dietz H, 2002, PLANT ECOL, V158, P171, DOI 10.1023/A:1015567316004; Dirkse G. M., 2007, FLORA NIJMEGEN KLEEF; Dorrepaal E, 2007, OECOLOGIA, V151, P251, DOI 10.1007/s00442-006-0580-3; Drenovsky RE, 2007, BIOL INVASIONS, V9, P107, DOI 10.1007/s10530-006-0007-4; Ehrenfeld JG, 2004, WEED TECHNOL, V18, P1232, DOI 10.1614/0890-037X(2004)018[1232:IOISFB]2.0.CO;2; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Engelkes T, 2008, NATURE, V456, P946, DOI 10.1038/nature07474; Eppinga MB, 2011, J ECOL, V99, P503, DOI 10.1111/j.1365-2745.2010.01781.x; FACELLI JM, 1993, OECOLOGIA, V95, P277, DOI 10.1007/BF00323500; Farrer EC, 2009, ECOL APPL, V19, P398, DOI 10.1890/08-0485.1; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Godoy O, 2010, OECOLOGIA, V162, P781, DOI 10.1007/s00442-009-1512-9; Guesewell S, 2006, FUNCT ECOL, V20, P575, DOI 10.1111/j.1365-2435.2006.01141.x; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; Hodkinson DJ, 1997, J APPL ECOL, V34, P1484, DOI 10.2307/2405264; Inderjit, 2011, ECOLOGY, V92, P316, DOI 10.1890/10-0400.1; Inderjit, 2010, TRENDS ECOL EVOL, V25, P512, DOI 10.1016/j.tree.2010.06.006; Koutika LS, 2007, BIOL FERT SOILS, V44, P331, DOI 10.1007/s00374-007-0210-1; Kurokawa H, 2010, FUNCT ECOL, V24, P513, DOI 10.1111/j.1365-2435.2009.01676.x; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lachmuth S, 2011, NEW PHYTOL, V192, P529, DOI 10.1111/j.1469-8137.2011.03808.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Meier CL, 2008, P NATL ACAD SCI USA, V105, P19780, DOI 10.1073/pnas.0805600105; Meisner A, 2011, J ECOL, V99, P1308, DOI 10.1111/j.1365-2745.2011.01858.x; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; Olsson PA, 2003, NEW PHYTOL, V159, P7, DOI 10.1046/j.1469-8137.2003.00810.x; Osono T, 2007, ECOL RES, V22, P955, DOI 10.1007/s11284-007-0390-z; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pelser P.B., 2006, COMPOSITAE NEWSLETTE, V44, P1; Penuelas J, 2007, GLOBAL CHANGE BIOL, V13, P2563, DOI 10.1111/j.1365-2486.2007.01464.x; Petsikos C, 2007, AGR ECOSYST ENVIRON, V120, P325, DOI 10.1016/j.agee.2006.10.019; Poorter Hendrik, 1997, P39, DOI 10.1016/B978-012083490-7/50003-7; Pysek Petr, 2007, V193, P97; Raizada P, 2008, P NATL A SCI INDIA B, V78, P288; Reinhart KO, 2003, ECOL LETT, V6, P1046, DOI 10.1046/j.1461-0248.2003.00539.x; Rothstein DE, 2004, ECOSYSTEMS, V7, P805, DOI 10.1007/s10021-004-0009-y; Scharfy D, 2011, NEW PHYTOL, V189, P818, DOI 10.1111/j.1469-8137.2010.03531.x; Sperry LJ, 2006, ECOLOGY, V87, P603, DOI 10.1890/05-0836; Strickland MS, 2010, GLOBAL CHANGE BIOL, V16, P1338, DOI 10.1111/j.1365-2486.2009.02042.x; STUCKEY RONALD L., 1966, SIDA CONTRIB BOT, V2, P361; Tamis W. L. M., 2005, GORTERIA, V6, P135; Tamis WLM, 2005, CLIMATIC CHANGE, V72, P37, DOI 10.1007/s10584-005-5287-7; Van der Meijden R., 2005, HEUKELS FLORA NEDERL; van der Wal A, 2007, PLANT SOIL, V301, P189, DOI 10.1007/s11104-007-9437-8; van Grunsven RHA, 2010, GLOBAL CHANGE BIOL, V16, P380, DOI 10.1111/j.1365-2486.2009.01996.x; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; Vila M, 2006, J BIOGEOGR, V33, P853, DOI 10.1111/j.1365-2699.2005.01430.x; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; WALKER LR, 1991, ECOLOGY, V72, P1449, DOI 10.2307/1941117; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 1998, J ECOL, V86, P405, DOI 10.1046/j.1365-2745.1998.00268.x; Wardle DA, 1995, AGR ECOSYST ENVIRON, V56, P19, DOI 10.1016/0167-8809(95)00636-2; WARDLE DA, 1987, NEW ZEAL J ECOL, V10, P67; Wolkovich EM, 2009, J VEG SCI, V20, P1121, DOI 10.1111/j.1654-1103.2009.01110.x; Yelenik SG, 2011, ECOLOGY, V92, P66, DOI 10.1890/10-0465.1	81	39	41	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31596	10.1371/journal.pone.0031596	http://dx.doi.org/10.1371/journal.pone.0031596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359604	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200073
J	Moreno, AA; Mukhtar, MS; Blanco, F; Boatwright, JL; Moreno, I; Jordan, MR; Chen, YI; Brandizzi, F; Dong, XN; Orellana, A; Pajerowska-Mukhtar, KM				Moreno, Adrian A.; Mukhtar, M. Shahid; Blanco, Francisca; Boatwright, Jon Lucas; Moreno, Ignacio; Jordan, Melissa R.; Chen, Yani; Brandizzi, Federica; Dong, Xinnian; Orellana, Ariel; Pajerowska-Mukhtar, Karolina M.			IRE1/bZIP60-Mediated Unfolded Protein Response Plays Distinct Roles in Plant Immunity and Abiotic Stress Responses	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SYSTEMIC ACQUIRED-RESISTANCE; PLASMA-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR XBP-1; ARABIDOPSIS-THALIANA; MESSENGER-RNA; DEFENSE RESPONSE; MAMMALIAN-CELLS; INNATE IMMUNITY; SALT STRESS	Endoplasmic reticulum (ER)-mediated protein secretion and quality control have been shown to play an important role in immune responses in both animals and plants. In mammals, the ER membrane-located IRE1 kinase/endoribonuclease, a key regulator of unfolded protein response (UPR), is required for plasma cell development to accommodate massive secretion of immunoglobulins. Plant cells can secrete the so-called pathogenesis-related (PR) proteins with antimicrobial activities upon pathogen challenge. However, whether IRE1 plays any role in plant immunity is not known. Arabidopsis thaliana has two copies of IRE1, IRE1a and IRE1b. Here, we show that both IRE1a and IRE1b are transcriptionally induced during chemically-induced ER stress, bacterial pathogen infection and treatment with the immune signal salicylic acid (SA). However, we found that IRE1a plays a predominant role in the secretion of PR proteins upon SA treatment. Consequently, the ire1a mutant plants show enhanced susceptibility to a bacterial pathogen and are deficient in establishing systemic acquired resistance (SAR), whereas ire1b is unaffected in these responses. We further demonstrate that the immune deficiency in ire1a is due to a defect in SA- and pathogen-triggered, IRE1-mediated cytoplasmic splicing of the bZIP60 mRNA, which encodes a transcription factor involved in the expression of UPR-responsive genes. Consistently, IRE1a is preferentially required for bZIP60 splicing upon pathogen infection, while IRE1b plays a major role in bZIP60 processing upon Tunicamycin (Tm)-induced stress. We also show that SA- dependent induction of UPR-responsive genes is altered in the bzip60 mutant resulting in a moderate susceptibility to a bacterial pathogen. These results indicate that the IRE1/bZIP60 branch of UPR is a part of the plant response to pathogens for which the two Arabidopsis IRE1 isoforms play only partially overlapping roles and that IRE1 has both bZIP60-dependent and bZIP60-independent functions in plant immunity.	[Moreno, Adrian A.; Blanco, Francisca; Moreno, Ignacio; Orellana, Ariel] Univ Andres Bello, FONDAP Ctr Genome Regulat, Nucleo Milenio Biotecnol Celular Vegetal, Ctr Biotecnol Vegetal,Fac Ciencias Biol, Santiago, Chile; [Mukhtar, M. Shahid; Boatwright, Jon Lucas; Jordan, Melissa R.; Pajerowska-Mukhtar, Karolina M.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Chen, Yani; Brandizzi, Federica] Michigan State Univ, DOE Plant Res Lab, E Lansing, MI 48824 USA; [Chen, Yani; Brandizzi, Federica] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Dong, Xinnian] Duke Univ, Dept Biol, Durham, NC USA	Universidad Andres Bello; University of Alabama System; University of Alabama Birmingham; Michigan State University; United States Department of Energy (DOE); Michigan State University; Duke University	Moreno, AA (corresponding author), Univ Andres Bello, FONDAP Ctr Genome Regulat, Nucleo Milenio Biotecnol Celular Vegetal, Ctr Biotecnol Vegetal,Fac Ciencias Biol, Santiago, Chile.	kmukhtar@uab.edu	Blanco-Herrera, Francisca/AAF-7105-2020; Orellana, Ariel/AAE-4866-2021; Moreno, Adrian/H-4956-2019; Orellana, Ariel/E-2166-2014	Blanco-Herrera, Francisca/0000-0002-7497-9907; Orellana, Ariel/0000-0002-9243-808X; Orellana, Ariel/0000-0002-9243-808X; Mukhtar, Shahid/0000-0002-1104-6931; Moreno, Adrian/0000-0001-5125-2927; Boatwright, Lucas/0000-0003-4371-2457	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1110954, 3100036]; ICM-PCB-MN [160-44F]; Basal Program [PFB-16]; Fondo de Financiamiento de Centros de Excelencia en Investigacion - Centro de Regulacion del Genoma; National Science Foundation [MCB-0519898]; National Aeronautics and Space Administration [NNH08ZTT003N NRA - 08-FSB_Prop-0052]; Hargitt Fellowship; University of Alabama Birmingham; Programa de Capital Humano Avanzado	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICM-PCB-MN; Basal Program(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Fondo de Financiamiento de Centros de Excelencia en Investigacion - Centro de Regulacion del Genoma; National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Hargitt Fellowship; University of Alabama Birmingham; Programa de Capital Humano Avanzado	This work was supported in part by Fondo Nacional de Desarrollo Cientifico y Tecnologico 1110954, Fondo Nacional de Desarrollo Cientifico y Tecnologico 3100036, ICM-PCB-MN 160-44F, Basal Program PFB-16, Fondo de Financiamiento de Centros de Excelencia en Investigacion - Centro de Regulacion del Genoma, a grant from National Science Foundation (MCB-0519898) to XD, a grant from National Aeronautics and Space Administration (NNH08ZTT003N NRA - 08-FSB_Prop-0052) to FB, the Hargitt Fellowship to KPM, University of Alabama Birmingham Gulf Oil Response Pilot Grants to MSM and KPM, University of Alabama Birmingham Faculty Development Grant to KPM and PhD fellowships from Programa de Capital Humano Avanzado to AAM and IM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Blanco F, 2009, PLANT MOL BIOL, V70, P79, DOI 10.1007/s11103-009-9458-1; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Durrant WE, 2007, P NATL ACAD SCI USA, V104, P4223, DOI 10.1073/pnas.0609357104; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Fujita M, 2007, BIOCHEM BIOPH RES CO, V364, P250, DOI 10.1016/j.bbrc.2007.09.124; Gao HB, 2008, P NATL ACAD SCI USA, V105, P16398, DOI 10.1073/pnas.0808463105; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Iwata Y, 2010, PLANT BIOTECHNOL, V27, P161, DOI 10.5511/plantbiotechnology.27.161; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaufman RJ, 2010, EMBO MOL MED, V2, P189, DOI 10.1002/emmm.201000076; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Lu DP, 2008, MOL GENET GENOMICS, V280, P199, DOI 10.1007/s00438-008-0356-z; Martinon F, 2011, CURR OPIN IMMUNOL, V23, P35, DOI 10.1016/j.coi.2010.10.016; Mitsuya Y, 2009, J PLANT PHYSIOL, V166, P626, DOI 10.1016/j.jplph.2008.08.006; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Mukhtar MS, 2009, CELL, V137, P804, DOI 10.1016/j.cell.2009.05.010; Nagashima Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00029; Nishimura MT, 2010, PLANT J, V61, P1053, DOI 10.1111/j.1365-313X.2010.04131.x; Noh SJ, 2002, BBA-GENE STRUCT EXPR, V1575, P130, DOI 10.1016/S0167-4781(02)00237-3; Pajerowska-Mukhtar KM, 2012, CURR BIOL, V22, P103, DOI 10.1016/j.cub.2011.12.015; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sasaki Y, 2001, DNA RES, V8, P153, DOI 10.1093/dnares/8.4.153; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schroder ME, 2007, IRE1 UCSD NATURE MOL, DOI [10.1038/mp.a003134.003101, DOI 10.1038/MP.A003134.003101]; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shang J, 2004, BIOCHEM BIOPH RES CO, V317, P390, DOI 10.1016/j.bbrc.2004.03.058; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Tateda C, 2008, J PLANT RES, V121, P603, DOI 10.1007/s10265-008-0185-5; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wang MY, 2011, METHOD ENZYMOL, V489, P319, DOI 10.1016/B978-0-12-385116-1.00018-2; Wang MY, 2010, PLANT MOL BIOL, V73, P467, DOI 10.1007/s11103-010-9633-4; Ye CM, 2011, PLANT PHYSIOL, V156, P741, DOI 10.1104/pp.111.174110; Yoshida H, 2007, ANTIOXID REDOX SIGN, V9, P2323, DOI 10.1089/ars.2007.1800; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	57	140	145	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31944	10.1371/journal.pone.0031944	http://dx.doi.org/10.1371/journal.pone.0031944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359644	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200113
J	Sebastian-Serrano, A; Sandonis, A; Cardozo, M; Rodriguez-Tornos, FM; Bovolenta, P; Nieto, M				Sebastian-Serrano, Alvaro; Sandonis, Africa; Cardozo, Marcos; Rodriguez-Tornos, Fernanda M.; Bovolenta, Paola; Nieto, Marta			P alpha x6 Expression in Postmitotic Neurons Mediates the Growth of Axons in Response to SFRP1	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-1; GANGLION-CELL AXONS; BINOCULAR VISION; PAX6 EXPRESSION; CEREBRAL-CORTEX; IN-VIVO; GUIDANCE; SPECIFICATION; RECEPTOR; PROLIFERATION	During development, the mechanisms that specify neuronal subclasses are coupled to those that determine their axonal response to guidance cues. Pax6 is a homedomain transcription factor required for the specification of a variety of neural precursors. After cell cycle exit, Pax6 expression is often shut down in the precursor progeny and most postmitotic neurons no longer express detectable levels of the protein. There are however exceptions and high Pax6 protein levels are found, for example, in postmitotic retinal ganglion cells (RGCs), dopaminergic neurons of the olfactory bulb and the limbic system in the telencephalon. The function of Pax6 in these differentiating neurons remains mostly elusive. Here, we demonstrate that Pax6 mediates the response of growing axons to SFRP1, a secreted molecule expressed in several Pax6-positive forebrain territories. Forced expression of Pax6 in cultured postmitotic cortical neurons, which do not normally express Pax6, was sufficient to increment axonal length. Growth was blocked by the addition of anti-SFRP1 antibodies, whereas exogenously added SFRP1 increased axonal growth of Pax6-transfected neurons but not that of control or untransfected cortical neurons. In the reverse scenario, shRNA-mediated knock-down of Pax6 in mouse retinal explants specifically abolished RGCs axonal growth induced by SFRP1, but had no effect on RGCs differentiation and it did not modify the effect of Shh or Netrin on axon growth. Taken together these results demonstrate that expression of Pax6 is necessary and sufficient to render postmitotic neurons competent to respond to SFRP1. These results reveal a novel and unexpected function of Pax6 in postmitotic neurons and situate Pax6 and SFRP1 as pair regulators of axonal connectivity.	[Sebastian-Serrano, Alvaro; Rodriguez-Tornos, Fernanda M.; Nieto, Marta] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Sandonis, Africa; Cardozo, Marcos; Bovolenta, Paola] Consejo Super Invest Cient UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Sandonis, Africa; Cardozo, Marcos; Bovolenta, Paola] CIBER Enfermedades Raras, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Sebastian-Serrano, A (corresponding author), CSIC, Ctr Nacl Biotecnol, Madrid, Spain.	mnlopez@cnb.csic.es	Sebastian-Serrano, Alvaro/Q-5982-2018; Nieto, Marta/F-1434-2013	Nieto, Marta/0000-0002-8349-8435; Cardozo, Marcos J/0000-0003-2246-2946; Bovolenta, Paola/0000-0002-1870-751X	(MICINN) Ministerio de Ciencia e Innovacion [SAF2008-00211, PIE-200820I166, BFU2007-61774]; Spanish Comunidad de Madrid [CCG08-CSIC/SAL-3464]	(MICINN) Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Comunidad de Madrid(Comunidad de Madrid)	This work was funded by the (MICINN) Ministerio de Ciencia e Innovacion grants (SAF2008-00211; PIE-200820I166; BFU2007-61774), and a grant from the Spanish Comunidad de Madrid CCG08-CSIC/SAL-3464. ASS from the MICINN (BES-2006-13901). FMR holds a fellowship from La Caixa foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Alvarez-Rodiguez R, 2007, J BIOL CHEM, V282, P37170, DOI 10.1074/jbc.M705414200; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Augustine C, 2001, MECH DEVELOP, V109, P395, DOI 10.1016/S0925-4773(01)00533-0; Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4; Baumer N, 2002, DEVELOPMENT, V129, P4535; BLACK MM, 1994, J NEUROSCI, V14, P857; Bovolenta P, 2005, J NEUROBIOL, V64, P405, DOI 10.1002/neu.20161; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Carcea I, 2010, J NEUROSCI, V30, P15317, DOI 10.1523/JNEUROSCI.1821-10.2010; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chuman Y, 2004, PEPTIDES, V25, P1831, DOI 10.1016/j.peptides.2004.07.010; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; de Iongh RU, 2006, FRONT BIOSCI-LANDMRK, V11, P2442, DOI 10.2741/1982; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Esteve P, 2003, J CELL SCI, V116, P2471, DOI 10.1242/jcs.00452; Estivill-Torrus G, 2002, DEVELOPMENT, V129, P455; Garcia-Frigola C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-103; Georgala PA, 2011, DEV NEUROBIOL; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Hsieh YW, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-32; Jones L, 2002, DEVELOPMENT, V129, P5041; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kim AS, 2001, MECH DEVELOP, V103, P167, DOI 10.1016/S0925-4773(01)00342-2; Lee R, 2008, J NEUROSCI, V28, P5910, DOI 10.1523/JNEUROSCI.0632-08.2008; Leimeister C, 1998, MECH DEVELOP, V75, P29, DOI 10.1016/S0925-4773(98)00072-0; Manuel M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-59; Mao WM, 2010, EXP EYE RES, V91, P552, DOI 10.1016/j.exer.2010.05.003; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Nikoletopoulou V, 2007, CELL STEM CELL, V1, P529, DOI 10.1016/j.stem.2007.08.011; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; Nural HF, 2004, J COMP NEUROL, V479, P399, DOI 10.1002/cne.20317; Osumi N, 1997, DEVELOPMENT, V124, P2961; Ouyang J, 2006, INVEST OPHTH VIS SCI, V47, P2397, DOI 10.1167/iovs.05-1083; Pak W, 2004, CELL, V119, P567, DOI 10.1016/j.cell.2004.10.026; Rodger J, 2006, NEUROSCIENCE, V142, P1043, DOI 10.1016/j.neuroscience.2006.07.057; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Sanchez-Camacho C, 2008, DEVELOPMENT, V135, P3531, DOI 10.1242/dev.023663; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Trevant B, 2008, J CELL PHYSIOL, V217, P113, DOI 10.1002/jcp.21482; Van Raay TJ, 2004, DEV NEUROSCI-BASEL, V26, P352, DOI 10.1159/000082277; Von Frowein J, 2002, MECH DEVELOP, V110, P249; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020	56	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31590	10.1371/journal.pone.0031590	http://dx.doi.org/10.1371/journal.pone.0031590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359602	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200071
J	Van Goor, D; Hyland, C; Schaefer, AW; Forscher, P				Van Goor, David; Hyland, Callen; Schaefer, Andrew W.; Forscher, Paul			The Role of Actin Turnover in Retrograde Actin Network Flow in Neuronal Growth Cones	PLOS ONE			English	Article							MYOSIN-II; F-ACTIN; BLEBBISTATIN INHIBITION; DEOXYRIBONUCLEASE-I; 2 POPULATIONS; LEADING-EDGE; LIM KINASE; POLYMERIZATION; FILAMENTS; COFILIN	The balance of actin filament polymerization and depolymerization maintains a steady state network treadmill in neuronal growth cones essential for motility and guidance. Here we have investigated the connection between depolymerization and treadmilling dynamics. We show that polymerization-competent barbed ends are concentrated at the leading edge and depolymerization is distributed throughout the peripheral domain. We found a high-to-low G-actin gradient between peripheral and central domains. Inhibiting turnover with jasplakinolide collapsed this gradient and lowered leading edge barbed end density. Ultrastructural analysis showed dramatic reduction of leading edge actin filament density and filament accumulation in central regions. Live cell imaging revealed that the leading edge retracted even as retrograde actin flow rate decreased exponentially. Inhibition of myosin II activity before jasplakinolide treatment lowered baseline retrograde flow rates and prevented leading edge retraction. Myosin II activity preferentially affected filopodial bundle disassembly distinct from the global effects of jasplakinolide on network turnover. We propose that growth cone retraction following turnover inhibition resulted from the persistence of myosin II contractility even as leading edge assembly rates decreased. The buildup of actin filaments in central regions combined with monomer depletion and reduced polymerization from barbed ends suggests a mechanism for the observed exponential decay in actin retrograde flow. Our results show that growth cone motility is critically dependent on continuous disassembly of the peripheral actin network.	[Van Goor, David; Hyland, Callen; Schaefer, Andrew W.; Forscher, Paul] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Van Goor, D (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	paul.forscher@yale.edu		Forscher, Paul/0000-0003-1988-5155	National Institutes of Health [RO1-NS28695, RO1 NS51786]; Nikon Partners-in-Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028695, R01NS051786] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nikon Partners-in-Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants RO1-NS28695 and RO1 NS51786 to P.F. and the Nikon Partners-in-Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2011, NEUROBIOL DIS, V41, P421, DOI 10.1016/j.nbd.2010.10.012; BRIDGMAN PC, 1989, J CELL BIOL, V108, P95, DOI 10.1083/jcb.108.1.95; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Chan AY, 1998, J CELL SCI, V111, P199; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Cramer LP, 2002, CELL MOTIL CYTOSKEL, V51, P27, DOI 10.1002/cm.10013; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Gallo G, 2002, J CELL BIOL, V158, P1219, DOI 10.1083/jcb.200204140; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; HEIDEMANN SR, 1990, J CELL BIOL, V111, P1949, DOI 10.1083/jcb.111.5.1949; Heidemann Steven R., 1995, Cell Biochemistry and Biophysics, V27, P135; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; JANSON LW, 1991, J CELL BIOL, V114, P1005, DOI 10.1083/jcb.114.5.1005; Ji L, 2005, J MICROSC-OXFORD, V220, P150, DOI 10.1111/j.1365-2818.2005.01522.x; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kiuchi T, 2011, J CELL BIOL, V193, P365, DOI 10.1083/jcb.201101035; KNOWLES GC, 1992, J HISTOCHEM CYTOCHEM, V40, P1605, DOI 10.1177/40.10.1527379; KOLEGA J, 1991, J CELL BIOL, V114, P993, DOI 10.1083/jcb.114.5.993; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Lorenz M, 2004, CELL MOTIL CYTOSKEL, V57, P207, DOI 10.1002/cm.10171; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Marsick BM, 2010, DEV NEUROBIOL, V70, P565, DOI 10.1002/dneu.20800; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Novak IL, 2008, BIOPHYS J, V95, P1627, DOI 10.1529/biophysj.108.130096; PODOLSKI JL, 1988, J BIOL CHEM, V263, P638; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ramamurthy B, 2004, BIOCHEMISTRY-US, V43, P14832, DOI 10.1021/bi0490284; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054; Thomann D, 2003, J MICROSC-OXFORD, V211, P230, DOI 10.1046/j.1365-2818.2003.01223.x; Thomann D, 2002, J MICROSC-OXFORD, V208, P49, DOI 10.1046/j.1365-2818.2002.01066.x; Tsuji T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004921; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; Vallotton P, 2003, BIOPHYS J, V85, P1289, DOI 10.1016/S0006-3495(03)74564-0; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; Visegrady B, 2004, FEBS LETT, V565, P163, DOI 10.1016/j.febslet.2004.03.096; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	59	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30959	10.1371/journal.pone.0030959	http://dx.doi.org/10.1371/journal.pone.0030959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359556	Green Published, gold, Green Submitted			2022-12-25	WOS:000302796200025
J	Xiang, Y; Qin, XQ; Liu, HJ; Tan, YR; Liu, C; Liu, CX				Xiang, Yang; Qin, Xiao-Qun; Liu, Hui-Jun; Tan, Yu-Rong; Liu, Chi; Liu, Cai-Xia			Identification of Transcription Factors Regulating CTNNAL1 Expression in Human Bronchial Epithelial Cells	PLOS ONE			English	Article							ALPHA-CATENIN; RECEPTOR GENE; PROTEIN; AP-2; AP-2-ALPHA; PATHWAY; BINDING; TARGET; ACTIVATION; INDUCTION	Adhesion molecules play important roles in airway hyperresponsiveness or airway inflammation. Our previous study indicated catenin alpha-like 1 (CTNNAL1), an alpha-catenin-related protein, was downregulated in asthma patients and animal model. In this study, we observed that the expression of CTNNAL1 was increased in lung tissue of the ozone-stressed Balb/c mice model and in acute ozone stressed human bronchial epithelial cells (HBEC). In order to identify the possible DNA-binding proteins regulating the transcription of CTNNAL1 gene in HBEC, we designed 8 oligo- nucleotide probes corresponding to various regions of the CTNNAL1 promoter in electrophoretic mobility shift assays (EMSA). We detected 5 putative transcription factors binding sites within CTNNAL1 promoter region that can recruit LEF-1, AP-2 alpha and CREB respectively by EMSA and antibody supershift assay. Chromatin immunoprecipitation (ChIP) assay verified that AP-2 alpha and LEF-1 could be recruited to the CTNNAL1 promoter. Therefore we further analyzed the functions of putative AP-2 and LEF-1 sites within CTNNAL1 promoter by site-directed mutagenesis of those sites within pGL3/FR/luc. We observed a reduction in human CTNNAL1 promoter activity of mutants of both AP-2 alpha and LEF-1 sites. Pre-treatment with ASOs targeting LEF-1 and AP-2 alpha yielded significant reduction of ozone-stress- induced CTNNAL1 expression. The activation of AP-2 alpha and LEF-1, followed by CTNNAL1 expression, showed a correlation during a 16-hour time course. Our data suggest that a robust transcriptional CTNNAL1 up-regulation occurs during acute ozone-induced stress and is mediated at least in part by ozone-induced recruitments of LEF-1 and AP-2 alpha to the human CTNNAL1 promoter.	[Xiang, Yang; Qin, Xiao-Qun; Liu, Hui-Jun; Tan, Yu-Rong; Liu, Chi; Liu, Cai-Xia] Cent S Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China	Central South University	Xiang, Y (corresponding author), Cent S Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China.	qinxiaoqun@mail.csu.edu.cn	Liu, Cai-Xia/AAL-2039-2020		National Natural Science Foundation of China [30800504, 30870917]; National Basic Research Program of China [2009CB522102]; Hunan College Innovation Program [10K079]; Natural Science Foundation of Hunan [09JJ3056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Hunan College Innovation Program; Natural Science Foundation of Hunan(Natural Science Foundation of Hunan Province)	This work was supported by grants #30800504, #30870917 from the National Natural Science Foundation of China, grant #2009CB522102 of National Basic Research Program of China (973 Program), grant #10K079 from the open fund of Hunan College Innovation Program, and grant #09JJ3056 from Natural Science Foundation of Hunan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Chen SY, 1999, ENDOCRINOLOGY, V140, P2100, DOI 10.1210/en.140.5.2100; Cheng YH, 2002, MOL CELL ENDOCRINOL, V191, P127, DOI 10.1016/S0303-7207(02)00081-3; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dutt P, 2004, CELL SIGNAL, V16, P201, DOI 10.1016/S0898-6568(03)00132-3; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Horsman S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-120; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; Janssens B, 1999, BBA-GENE STRUCT EXPR, V1447, P341, DOI 10.1016/S0167-4781(99)00170-0; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Li H, 2006, ONCOGENE, V25, P5405, DOI 10.1038/sj.onc.1209534; Park B, 2002, J BIOL CHEM, V277, P45361, DOI 10.1074/jbc.M202447200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Shimada T, 2007, INT J BIOCHEM CELL B, V39, P626, DOI 10.1016/j.biocel.2006.10.015; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Tan YR, 2007, BIOCHEM J, V405, P131, DOI 10.1042/BJ20061754; Wajapeyee N, 2006, J BIOL CHEM, V281, P16207, DOI 10.1074/jbc.M600539200; Wang HV, 2004, DEV DYNAM, V231, P128, DOI 10.1002/dvdy.20119; Wankhade S, 2000, J BIOL CHEM, V275, P29701, DOI 10.1074/jbc.M000931200; Wiesner C, 2008, ONCOGENE, V27, P2159, DOI 10.1038/sj.onc.1210863; WILLIAMS T, 1991, SCIENCE, V251, P1067, DOI 10.1126/science.1998122; Woltje M, 2000, J NEUROCHEM, V74, P1355, DOI 10.1046/j.1471-4159.2000.0741355.x; Xiang Y, 2008, J CELL BIOCHEM, V103, P920, DOI 10.1002/jcb.21461; Zhang JS, 1998, GENOMICS, V54, P149, DOI 10.1006/geno.1998.5458	28	11	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31158	10.1371/journal.pone.0031158	http://dx.doi.org/10.1371/journal.pone.0031158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359570	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200039
J	Xu, W; Chen, MH; Ge, NH; Xu, J				Xu, Wei; Chen, Minhui; Ge, Nanhai; Xu, Jun			Hemagglutinin from the H5N1 Virus Activates Janus Kinase 3 to Dysregulate Innate Immunity	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; AVIAN INFLUENZA-VIRUSES; EPITHELIAL-CELLS; ADHESION MOLECULES; HUMAN INFECTION; HUMANS; CORTICOSTEROIDS; TRACT; PROLIFERATION; PATHOGENESIS	Highly pathogenic avian influenza viruses (HPAIVs) cause severe disease in humans. There are no effective vaccines or antiviral therapies currently available to control fatal outbreaks due in part to the lack of understanding of virus-mediated immunopathology. In our study, we used hemagglutinin (HA) of H5N1 virus to investigate the related signaling pathways and their relationship to dysregulated innate immune reaction. We found the HA of H5N1 avian influenza triggered an abnormal innate immune signalling in the pulmonary epithelial cells, through an unusual process involving activation of Janus kinase 3 (JAK3) that is exclusively associated with gamma c chain and is essential for signaling via all gamma c cytokine receptors. By using a selective JAK3 inhibitor and JAK3 knockout mice, we have, for the first time, demonstrated the ability to target active JAK3 to counteract injury to the lungs and protect immunocytes from acute hypercytokinemia -induced destruction following the challenge of H5N1 HA in vitro and in vivo. On the basis of the present data, it appears that the efficacy of selective JAK3 inhibition is likely based on its ability to block multiple cytokines and protect against a superinflammatory response to pathogen-associated molecular patterns (PAMPs) attack. Our findings highlight the potential value of selective JAK3 inhibitor in treating the fatal immunopathology caused by H5N1 challenge.	[Xu, Wei; Chen, Minhui; Ge, Nanhai; Xu, Jun] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Xu, W (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	xufeili@vip.163.com			National Key Basic Research Program of China (973 Program) [2009CB522104]; National Natural Science Foundation of China [30230180, 30900576]; National High Technology Research and Development Program of China (863 Program) [2007AA022002]; China Postdoctoral Science Foundation [20100480734]; Yangcheng Scholars Research Program of Guangzhou Municipal Universities [10A024G]; Natural Science Foundation of Guangdong province, China [07117506]; Science and Technology Planning Project of Guangzhou City [2006Z3-E5081]; Science and Technology support program of Local Government in Guangzhou of China	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Yangcheng Scholars Research Program of Guangzhou Municipal Universities; Natural Science Foundation of Guangdong province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangzhou City; Science and Technology support program of Local Government in Guangzhou of China	This work was supported by grants from the National Key Basic Research Program of China (973 Program) (2009CB522104), the Key Program of National Natural Science Foundation of China (30230180), the National High Technology Research and Development Program of China (863 Program) (2007AA022002), the National Natural Science Foundation of China (30900576), the China Postdoctoral Science Foundation (20100480734), the Yangcheng Scholars Research Program of Guangzhou Municipal Universities (10A024G), the Key Program of Natural Science Foundation of Guangdong province, China (07117506), the Science and Technology Planning Project of Guangzhou City (2006Z3-E5081), and the Science and Technology support program of Local Government in Guangzhou of China (2009). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 2003, BIOORG MED CHEM LETT, V13, P3105, DOI 10.1016/S0960-894X(03)00657-7; Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Annane D, 2006, CRIT CARE MED, V34, P22, DOI 10.1097/01.CCM.0000194723.78632.62; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Cetkovic-Cyrlje M, 2004, CURR PHARM DESIGN, V10, P1767, DOI 10.2174/1381612043384529; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Gomersall CD, 2004, INTENS CARE MED, V30, P381, DOI 10.1007/s00134-003-2143-y; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hacker G, 2006, CELL CYCLE, V5, P2421, DOI 10.4161/cc.5.21.3397; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Herold S, 2006, J IMMUNOL, V177, P1817, DOI 10.4049/jimmunol.177.3.1817; Hiemstra PS, 2004, J LEUKOCYTE BIOL, V75, P3, DOI 10.1189/jlb.0903410; Hutchinson KL, 2001, J MED VIROL, V65, P561, DOI 10.1002/jmv.2073; Jaruga B, 2004, AM J PHYSIOL-GASTR L, V287, pG1044, DOI 10.1152/ajpgi.00184.2004; Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC; JORENS PG, 1992, CYTOKINE, V4, P592, DOI 10.1016/1043-4666(92)90025-M; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Lewandowski D, 2006, J IMMUNOL, V177, P479, DOI 10.4049/jimmunol.177.1.479; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Mer M, 1998, CHEST, V114, P426, DOI 10.1378/chest.114.2.426; Miyamoto T, 2002, AVIAN DIS, V46, P10, DOI 10.1637/0005-2086(2002)046[0010:LPRDET]2.0.CO;2; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nwe N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-16; O'Neill LAJ, 2008, NAT IMMUNOL, V9, P459, DOI 10.1038/ni0508-459; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Sandrock C, 2007, CRIT CARE, V11, DOI 10.1186/cc5675; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Swayne DE, 2000, REV SCI TECH OIE, V19, P463; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Wan XF, 2005, ARCH VIROL, V150, P1257, DOI 10.1007/s00705-004-0474-9; West K, 2009, CURR OPIN INVEST DR, V10, P491; WHO, 2010, CUM NUMB CONF HUM CA; Zhang ZF, 2009, HUM PATHOL, V40, P735, DOI 10.1016/j.humpath.2008.08.015; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	50	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31721	10.1371/journal.pone.0031721	http://dx.doi.org/10.1371/journal.pone.0031721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359619	Green Submitted, gold, Green Published			2022-12-25	WOS:000302796200088
J	Liang, Y; Arakawa, K; Ueta, K; Matsushita, Y; Kuriyama, C; Martin, T; Du, FY; Liu, Y; Xu, JN; Conway, B; Conway, J; Polidori, D; Ways, K; Demarest, K				Liang, Yin; Arakawa, Kenji; Ueta, Kiichiro; Matsushita, Yasuaki; Kuriyama, Chiaki; Martin, Tonya; Du, Fuyong; Liu, Yi; Xu, June; Conway, Bruce; Conway, Jamie; Polidori, David; Ways, Kirk; Demarest, Keith			Effect of Canagliflozin on Renal Threshold for Glucose, Glycemia, and Body Weight in Normal and Diabetic Animal Models	PLOS ONE			English	Article							SELECTIVE SGLT2 INHIBITOR; PROXIMAL TUBULAR CELLS; INSULIN-SECRETION; COTRANSPORTER; SODIUM; DAPAGLIFLOZIN; HYPERGLYCEMIA; TRANSPORTERS; T-1095; HOMEOSTASIS	Background: Canagliflozin is a sodium glucose co-transporter (SGLT) 2 inhibitor in clinical development for the treatment of type 2 diabetes mellitus (T2DM). Methods: C-14-alpha-methylglucoside uptake in Chinese hamster ovary-K cells expressing human, rat, or mouse SGLT2 or SGLT1; H-3-2-deoxy-D-glucose uptake in L6 myoblasts; and 2-electrode voltage clamp recording of oocytes expressing human SGLT3 were analyzed. Graded glucose infusions were performed to determine rate of urinary glucose excretion (UGE) at different blood glucose (BG) concentrations and the renal threshold for glucose excretion (RTG) in vehicle or canagliflozin-treated Zucker diabetic fatty (ZDF) rats. This study aimed to characterize the pharmacodynamic effects of canagliflozin in vitro and in preclinical models of T2DM and obesity. Results: Treatment with canagliflozin 1 mg/kg lowered RTG from 415 +/- 12 mg/dl to 94 +/- 10 mg/dl in ZDF rats while maintaining a threshold relationship between BG and UGE with virtually no UGE observed when BG was below RTG. Canagliflozin dose-dependently decreased BG concentrations in db/db mice treated acutely. In ZDF rats treated for 4 weeks, canagliflozin decreased glycated hemoglobin (HbA1c) and improved measures of insulin secretion. In obese animal models, canagliflozin increased UGE and decreased BG, body weight gain, epididymal fat, liver weight, and the respiratory exchange ratio. Conclusions: Canagliflozin lowered RTG and increased UGE, improved glycemic control and beta-cell function in rodent models of T2DM, and reduced body weight gain in rodent models of obesity.	[Liang, Yin; Martin, Tonya; Du, Fuyong; Xu, June; Conway, Bruce; Conway, Jamie; Demarest, Keith] Johnson & Johnson Pharmaceut Res & Dev LLC, Spring House, PA USA; [Arakawa, Kenji; Ueta, Kiichiro; Matsushita, Yasuaki; Kuriyama, Chiaki] Mitsubishi Tanabe Pharma Corp, Pharmacol Lab, Toda, Saitama, Japan; [Liu, Yi; Polidori, David] Johnson & Johnson Pharmaceut Res & Dev LLC, La Jolla, CA USA; [Ways, Kirk] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ USA	Johnson & Johnson; Johnson & Johnson USA; Mitsubishi Tanabe Pharma Corporation; Johnson & Johnson; Johnson & Johnson USA; Johnson & Johnson; Johnson & Johnson USA	Liang, Y (corresponding author), Johnson & Johnson Pharmaceut Res & Dev LLC, Spring House, PA USA.	yliang@its.jnj.com			Johnson & Johnson Pharmaceutical Research & Development, LLC; Janssen Global Services, LLC	Johnson & Johnson Pharmaceutical Research & Development, LLC(Johnson & JohnsonJohnson & Johnson USA); Janssen Global Services, LLC	Johnson & Johnson Pharmaceutical Research & Development, LLC. sponsored this study. Editorial assistance was provided by Phase Five Communications, Inc., and supported by Janssen Global Services, LLC. The authors are all employees of Johnson & Johnson Pharmaceutical Research & Development, LLC. or Mitsubishi Tanabe Pharma Corporation, and as such, designed the studies, participated in data collection and analysis, made the decision to publish, and prepared the manuscript.	Arakawa K, 2001, BRIT J PHARMACOL, V132, P578, DOI 10.1038/sj.bjp.0703829; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Bakris GL, 2009, KIDNEY INT, V75, P1272, DOI 10.1038/ki.2009.87; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Del Prato S, 2009, DIABETIC MED, V26, P1185, DOI 10.1111/j.1464-5491.2009.02847.x; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; FARBER SJ, 1951, J CLIN INVEST, V30, P125, DOI 10.1172/JCI102424; Freitas HS, 2008, ENDOCRINOLOGY, V149, P717, DOI 10.1210/en.2007-1088; Fujimori Y, 2009, EUR J PHARMACOL, V609, P148, DOI 10.1016/j.ejphar.2009.03.007; Grempler R, 2012, DIABETES OBES METAB, V14, P83, DOI 10.1111/j.1463-1326.2011.01517.x; Han SP, 2008, DIABETES, V57, P1723, DOI 10.2337/db07-1472; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kamran M, 1997, J AM SOC NEPHROL, V8, P943; Kloeckener-Gruissem B, 2008, AM J HUM GENET, V82, P772, DOI 10.1016/j.ajhg.2007.12.013; List JF, 2009, DIABETES CARE, V32, P650, DOI 10.2337/dc08-1863; Magni Lalo, 2007, J Diabetes Sci Technol, V1, P804; Mather A, 2010, NAT REV NEPHROL, V6, P307, DOI 10.1038/nrneph.2010.38; MOGENSEN CE, 1971, SCAND J CLIN LAB INV, V28, P101, DOI 10.3109/00365517109090668; Nair S, 2010, J CLIN ENDOCR METAB, V95, P34, DOI 10.1210/jc.2009-0473; Nomura S, 2010, J MED CHEM, V53, P6355, DOI 10.1021/jm100332n; Nunoi K, 2002, CLIN EXP PHARMACOL P, V29, P386, DOI 10.1046/j.1440-1681.2002.03671.x; Oku A, 2000, EUR J PHARMACOL, V391, P183, DOI 10.1016/S0014-2999(00)00016-9; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Rave K, 2006, NEPHROL DIAL TRANSPL, V21, P2166, DOI 10.1093/ndt/gfl175; Rosenstock J, 2010, DIABETES, V59, pA78; ROSSETTI L, 1987, J CLIN INVEST, V80, P1037, DOI 10.1172/JCI113157; Santer R, 2010, CLIN J AM SOC NEPHRO, V5, P133, DOI 10.2215/CJN.04010609; Sha S, 2011, DIABETES OBES METAB, V13, P669, DOI 10.1111/j.1463-1326.2011.01406.x; Ueta K, 2005, LIFE SCI, V76, P2655, DOI 10.1016/j.lfs.2004.09.038; Vallon V, 2011, J AM SOC NEPHROL, V22, P104, DOI 10.1681/ASN.2010030246; Vestri S, 2001, J MEMBRANE BIOL, V182, P105, DOI 10.1007/s00232-001-0036-y; Voss AA, 2007, MOL PHARMACOL, V71, P628, DOI 10.1124/mol.106.030288; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilding JPH, 2009, DIABETES CARE, V32, P1656, DOI 10.2337/dc09-0517; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wright EM, 1998, AM J PHYSIOL-GASTR L, V275, pG879, DOI 10.1152/ajpgi.1998.275.5.G879; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6	42	169	172	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30555	10.1371/journal.pone.0030555	http://dx.doi.org/10.1371/journal.pone.0030555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355316	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300016
J	Thompson, JD; Shibahara, G; Rajan, S; Pel, J; Marziali, A				Thompson, Jason D.; Shibahara, Gosuke; Rajan, Sweta; Pel, Joel; Marziali, Andre			Winnowing DNA for Rare Sequences: Highly Specific Sequence and Methylation Based Enrichment	PLOS ONE			English	Article							CHLAMYDIA-PNEUMONIAE; ELECTROPHORESIS; SENSITIVITY; MUTATIONS	Rare mutations in cell populations are known to be hallmarks of many diseases and cancers. Similarly, differential DNA methylation patterns arise in rare cell populations with diagnostic potential such as fetal cells circulating in maternal blood. Unfortunately, the frequency of alleles with diagnostic potential, relative to wild-type background sequence, is often well below the frequency of errors in currently available methods for sequence analysis, including very high throughput DNA sequencing. We demonstrate a DNA preparation and purification method that through non-linear electrophoretic separation in media containing oligonucleotide probes, achieves 10,000 fold enrichment of target DNA with single nucleotide specificity, and 100 fold enrichment of unmodified methylated DNA differing from the background by the methylation of a single cytosine residue.	[Thompson, Jason D.; Marziali, Andre] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada; [Shibahara, Gosuke; Rajan, Sweta; Pel, Joel; Marziali, Andre] Boreal Genom Inc, Vancouver, BC, Canada	University of British Columbia	Thompson, JD (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada.	andre@phas.ubc.ca			National Human Genome Research Institute (NHGRI) [R01 HG004873-01]; Genome British Columbia [SOF111]; National Research Council (NRC) [702024]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004873] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Genome British Columbia; National Research Council (NRC); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Human Genome Research Institute (NHGRI) Award Number R01 HG004873-01, Genome British Columbia Award Number SOF111, and National Research Council Industrial Research Assistance Program (NRC-IRAP) Project Number 702024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bau S, 2009, ANAL BIOANAL CHEM, V393, P171, DOI 10.1007/s00216-008-2460-7; Broemeling David J, 2008, JALA Charlottesv Va, V13, P40, DOI 10.1016/j.jala.2007.10.008; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Fischer C, 2001, LAB INVEST, V81, P827, DOI 10.1038/labinvest.3780292; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; Frumin LL, 2001, J BIOCHEM BIOPH METH, V48, P269, DOI 10.1016/S0165-022X(01)00161-0; Halperin A, 2004, BIOPHYS J, V86, P718, DOI 10.1016/S0006-3495(04)74150-8; Jeffreys AJ, 2003, GENOME RES, V13, P2316, DOI 10.1101/gr.1214603; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Lo YMD, 2007, NAT REV GENET, V8, P71, DOI 10.1038/nrg1982; Mahony JB, 2000, J CLIN MICROBIOL, V38, P2622, DOI 10.1128/JCM.38.7.2622-2627.2000; Marziall A, 2005, ELECTROPHORESIS, V26, P82, DOI 10.1002/elps.200406140; MONIA BP, 1992, J BIOL CHEM, V267, P19954; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Pel J, 2009, P NATL ACAD SCI USA, V106, P14796, DOI 10.1073/pnas.0907402106; SANGHVI YS, 1993, NUCLEIC ACIDS RES, V21, P3197, DOI 10.1093/nar/21.14.3197; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Smieja M, 2001, J CLIN MICROBIOL, V39, P1796, DOI 10.1128/JCM.39.5.1796-1801.2001; Sun XY, 2002, NAT BIOTECHNOL, V20, P186, DOI 10.1038/nbt0202-186; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Warmlander S, 2002, J BIOL CHEM, V277, P28491, DOI 10.1074/jbc.M202989200; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	26	18	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31597	10.1371/journal.pone.0031597	http://dx.doi.org/10.1371/journal.pone.0031597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355378	Green Published, gold			2022-12-25	WOS:000302741300078
J	Walker, AA; Weisman, S; Church, JS; Merritt, DJ; Mudie, ST; Sutherland, TD				Walker, Andrew A.; Weisman, Sarah; Church, Jeffrey S.; Merritt, David J.; Mudie, Stephen T.; Sutherland, Tara D.			Silk from Crickets: A New Twist on Spinning	PLOS ONE			English	Article							GRYLLACRIDIDS ORTHOPTERA; INSECT; FIBROIN; NEST; MORI; ULTRASTRUCTURE; RECOGNITION; SPINNERET; PROTEINS; SPIDERS	Raspy crickets (Orthoptera: Gryllacrididae) are unique among the orthopterans in producing silk, which is used to build shelters. This work studied the material composition and the fabrication of cricket silk for the first time. We examined silk-webs produced in captivity, which comprised cylindrical fibers and flat films. Spectra obtained from micro-Raman experiments indicated that the silk is composed of protein, primarily in a beta-sheet conformation, and that fibers and films are almost identical in terms of amino acid composition and secondary structure. The primary sequences of four silk proteins were identified through a mass spectrometry/cDNA library approach. The most abundant silk protein was large in size (300 and 220 kDa variants), rich in alanine, glycine and serine, and contained repetitive sequence motifs; these are features which are shared with several known beta-sheet forming silk proteins. Convergent evolution at the molecular level contrasts with development by crickets of a novel mechanism for silk fabrication. After secretion of cricket silk proteins by the labial glands they are fabricated into mature silk by the labium-hypopharynx, which is modified to allow the controlled formation of either fibers or films. Protein folding into beta-sheet structure during silk fabrication is not driven by shear forces, as is reported for other silks.	[Walker, Andrew A.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Merritt, David J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Mudie, Stephen T.] Australian Synchrotron, Clayton, Vic, Australia	Australian National University; University of Queensland	Walker, AA (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	Tara.Sutherland@csiro.au	Sutherland, Tara/B-5635-2009; Weisman, Sarah/B-5091-2009; Merritt, David J/D-2318-2010; Walker, Andrew/D-2665-2012	Merritt, David J/0000-0002-8573-7508; Walker, Andrew/0000-0003-1296-6593; Sutherland, Tara/0000-0001-5211-4593	Australian National University; Commonwealth Scientific and Industrial Research Organisation (CSIRO)	Australian National University(Australian National University); Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	Dr. Walker was supported by a PhD scholarship from Australian National University. Additional funding by the Commonwealth Scientific and Industrial Research Organisation (CSIRO). Part of this research was undertaken at the SAXS/WAXS beamline at the Australian Synchrotron, Victoria, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAI H, 1983, EXPERIENTIA, V39, P443, DOI 10.1007/BF01965158; Akai H, 1998, MICROSCOPIC ANATOMY; ASAKURA T, 1994, SILK PRODUCTION PROC, P1; Britton E. B, 1970, INSECTS AUSTR TXB ST; Church JS, 1997, BIOPOLYMERS, V42, P7, DOI 10.1002/(SICI)1097-0282(199707)42:1<7::AID-BIP2>3.0.CO;2-S; Clotuche G, 2009, MICROSC RES TECHNIQ, V72, P659, DOI 10.1002/jemt.20712; CODDINGTON JA, 1989, J ARACHNOL, V17, P71; Collin MA, 2009, INSECT BIOCHEM MOLEC, V39, P75, DOI 10.1016/j.ibmb.2008.10.004; COLONNACESARI F, 1975, J MOL BIOL, V95, P71, DOI 10.1016/0022-2836(75)90336-8; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Field L.H., 2001, BIOL WETAS KING CRIC; Frushour B.G., 1975, ADV INFRARED RAMAN S, V1, P35; Fu CJ, 2009, CHEM COMMUN, P6515, DOI 10.1039/b911049f; Hale RJ, 2000, AUST J ZOOL, V48, P643, DOI 10.1071/ZO00053; Hale Roderick J., 2001, P95, DOI 10.1079/9780851994086.0095; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; ISHAY JS, 1990, J MORPHOL, V203, P11, DOI 10.1002/jmor.1052030103; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Jost MC, 2006, MOL PHYLOGENET EVOL, V38, P510, DOI 10.1016/j.ympev.2005.10.004; Lockwood JA, 1996, AUST J ZOOL, V44, P129, DOI 10.1071/ZO9960129; Lucas F., 1968, Comprehensive Biochem, V26, P475; MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5; Maskell F. G., 1927, Transactions and Proceedings of the New Zealand Institute, V57, P637; Moriya M, 2008, POLYMER, V49, P5665, DOI 10.1016/j.polymer.2008.10.024; MORTON SR, 1983, AUST J ZOOL, V31, P557, DOI 10.1071/ZO9830557; NAGASHIMA T, 1991, Cytologia (Tokyo), V56, P679; Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w; Okada S, 2008, INT J BIOL MACROMOL, V43, P271, DOI 10.1016/j.ijbiomac.2008.06.007; RENTZ D C F, 1990, Invertebrate Taxonomy, V3, P1053; Rentz D. C. F., 1996, GRASSHOPPER COUNTRY; RENTZ DC, 1973, P ACAD NAT SCI PHILA, V125, P89; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rudall K. M., 1962, COMP BIOCH, P397; Sehnal F, 2008, PRION, V2, P145, DOI 10.4161/pri.2.4.7489; Sorensen GS, 2006, ARTHROPOD STRUCT DEV, V35, P3, DOI 10.1016/j.asd.2005.10.002; Sutherland TD, 2007, MOL BIOL EVOL, V24, P2424, DOI 10.1093/molbev/msm171; Sutherland TD, 2006, GENOME RES, V16, P1414, DOI 10.1101/gr.5052606; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6; Twardowshi J., 1994, RAMAN IR SPECTROSCOP; Vollrath F, 2006, SOFT MATTER, V2; Weisman S, 2008, BIOMACROMOLECULES, V9, P3065, DOI 10.1021/bm8005853; Weisman S, 2009, J STRUCT BIOL, V168, P467, DOI 10.1016/j.jsb.2009.07.002; WEYGOLDT P, 1966, SCIENCE, V153, P1647, DOI 10.1126/science.153.3744.1647; Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413	45	22	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30408	10.1371/journal.pone.0030408	http://dx.doi.org/10.1371/journal.pone.0030408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355311	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300011
J	Liu, CC; Garcia, A; Mahmmoud, YA; Hamilton, EJ; Galougahi, KK; Fry, NAS; Figtree, GA; Cornelius, F; Clarke, RJ; Rasmussen, HH				Liu, Chia-Chi; Garcia, Alvaro; Mahmmoud, Yasser A.; Hamilton, Elisha J.; Galougahi, Keyvan Karimi; Fry, Natasha A. S.; Figtree, Gemma A.; Cornelius, Flemming; Clarke, Ronald J.; Rasmussen, Helge H.			Susceptibility of beta 1 Na+-K+ Pump Subunit to Glutathionylation and Oxidative Inhibition Depends on Conformational State of Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-POTASSIUM PUMP; CRYSTAL-STRUCTURE; INTRACELLULAR NA+; ATPASE; ACTIVATION; SITES; IDENTIFICATION; PROTEINS	Glutathionylation of cysteine 46 of the beta 1 subunit of the Na+-K+ pump causes pump inhibition. However, the crystal structure, known in a state analogous to an E2.2K(+)center dot P-i configuration, indicates that the side chain of cysteine 46 is exposed to the lipid bulk phase of the membrane and not expected to be accessible to the cytosolic glutathione. We have examined whether glutathionylation depends on the conformational changes in the Na+-K+ pump cycle as described by the Albers-Post scheme. We measured beta 1 subunit glutathionylation and function of Na+-K+-ATPase in membrane fragments and in ventricular myocytes. Signals for glutathionylation in Na+-K+-ATPase-enriched membrane fragments suspended in solutions that preferentially induce E1ATP and E1Na(3) conformations were much larger than signals in solutions that induce the E2 conformation. Ouabain further reduced glutathionylation in E2 and eliminated an increase seen with exposure to the oxidant peroxynitrite (ONOO-). Inhibition of Na+-K+-ATPase activity after exposure to ONOO- was greater when the enzyme had been in the E1Na(3) than the E2 conformation. We exposed myocytes to different extracellular K+ concentrations to vary the membrane potential and hence voltage-dependent conformational poise. K+ concentrations expected to shift the poise toward E2 species reduced glutathionylation, and ouabain eliminated a ONOO--induced increase. Angiotensin II-induced NADPH oxidase-dependent Na+-K+ pump inhibition was eliminated by conditions expected to shift the poise toward the E2 species. We conclude that susceptibility of the beta 1 subunit to glutathionylation depends on the conformational poise of the Na+-K+ pump.	[Figtree, Gemma A.; Rasmussen, Helge H.] Royal N Shore Hosp, Dept Cardiol, St Leonards, NSW 2065, Australia; [Liu, Chia-Chi; Garcia, Alvaro; Hamilton, Elisha J.; Galougahi, Keyvan Karimi; Fry, Natasha A. S.; Figtree, Gemma A.; Rasmussen, Helge H.] Kolling Inst, N Shore Heart Res Grp, St Leonards, NSW 2065, Australia; [Clarke, Ronald J.] Univ Sydney, Sch Chem, Sydney, NSW 2000, Australia; [Mahmmoud, Yasser A.; Cornelius, Flemming] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; Aarhus University	Rasmussen, HH (corresponding author), Royal N Shore Hosp, Dept Cardiol, St Leonards, NSW 2065, Australia.	helge.rasmussen@sydney.edu.au	Clarke, Ronald J/L-5259-2016; Hamilton, Elisha/F-8187-2010; Cornelius, Flemming/C-1912-2019; Garcia, Alvaro/E-6573-2015	Clarke, Ronald J/0000-0002-0950-8017; Hamilton, Elisha/0000-0002-1892-352X; Cornelius, Flemming/0000-0003-1566-0020; Garcia, Alvaro/0000-0002-1159-4567; Rasmussen, Helge/0000-0003-2409-4083	North Shore Heart Research Foundation; National Health & Medical Research Council (Australia) [633252]; Medical Foundation; University of Sydney; Viertel Charitable Foundation; Danish Medical Research Council; Danish Agency for Science, Technology and Innovation	North Shore Heart Research Foundation; National Health & Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Medical Foundation; University of Sydney(University of Sydney); Viertel Charitable Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Agency for Science, Technology and Innovation	The work was supported in part by a grant from the North Shore Heart Research Foundation and by Project Grant 633252 from the National Health & Medical Research Council (Australia).; Supported by the Medical Foundation, University of Sydney, and the Viertel Charitable Foundation.; Supported by the Danish Medical Research Council and the Danish Agency for Science, Technology and Innovation.	Almeida Ana G, 2004, Rev Port Cardiol, V23, P1277; BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; Bar Shimon M, 1998, J BIOL CHEM, V273, P34190, DOI 10.1074/jbc.273.51.34190; Bibert S, 2011, J BIOL CHEM, V286, P18562, DOI 10.1074/jbc.M110.184101; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Buhagiar KA, 1999, AM J PHYSIOL-CELL PH, V277, pC461, DOI 10.1152/ajpcell.1999.277.3.C461; Clavreul N, 2006, FASEB J, V20, P518, DOI 10.1096/fj.05-4875fje; Cooper AJL, 2011, EXPERT OPIN DRUG MET, V7, P891, DOI 10.1517/17425255.2011.577738; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; Dempski RE, 2009, BBA-BIOENERGETICS, V1787, P714, DOI 10.1016/j.bbabio.2009.03.021; Durr KL, 2009, J BIOL CHEM, V284, P3842, DOI 10.1074/jbc.M808101200; Dufaitre-Patouraux L, 2004, DIABETES METAB, V30, P471, DOI 10.1016/S1262-3636(07)70145-3; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gatto C, 2007, J MEMBRANE BIOL, V216, P49, DOI 10.1007/s00232-007-9028-x; Hansen PS, 2007, AM J PHYSIOL-CELL PH, V292, pC1070, DOI 10.1152/ajpcell.00288.2006; Hansen PS, 2002, AM J PHYSIOL-CELL PH, V283, pC1511, DOI 10.1152/ajpcell.01343.2000; Hansen RE, 2005, BIOCHEMISTRY-US, V44, P5899, DOI 10.1021/bi0500372; Harada K, 2006, J PHYSIOL SCI, V56, P113, DOI 10.2170/physiolsci.RP001905; HIRANO Y, 1988, J PHYSIOL-LONDON, V395, P455, DOI 10.1113/jphysiol.1988.sp016929; HOOL LC, 1995, AM J PHYSIOL-CELL PH, V268, pC366, DOI 10.1152/ajpcell.1995.268.2.C366; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P53, DOI 10.1016/0005-2736(74)90293-4; JORGENSEN PL, 1986, BIOCHIM BIOPHYS ACTA, V860, P570, DOI 10.1016/0005-2736(86)90555-9; Klodos I, 2002, KIDNEY INT, V62, P2097, DOI 10.1046/j.1523-1755.2002.00654.x; Kong BY, 2004, BIOCHEMISTRY-US, V43, P2241, DOI 10.1021/bi0355443; LEE CO, 1975, J GEN PHYSIOL, V65, P695, DOI 10.1085/jgp.65.6.695; LUTSENKO S, 1994, J BIOL CHEM, V269, P4555; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; POST RL, 1965, J BIOL CHEM, V240, P1437; SAKMANN B, 1984, J PHYSIOL-LONDON, V347, P641, DOI 10.1113/jphysiol.1984.sp015088; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; STIMERS JR, 1990, J GEN PHYSIOL, V95, P77, DOI 10.1085/jgp.95.1.77; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; White CN, 2010, J BIOL CHEM, V285, P13712, DOI 10.1074/jbc.M109.090225; White CN, 2009, AM J PHYSIOL-CELL PH, V296, pC693, DOI 10.1152/ajpcell.00648.2008; William M, 2005, J PHYSIOL-LONDON, V565, P815, DOI 10.1113/jphysiol.2005.086447	40	38	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12353	12364		10.1074/jbc.M112.340893	http://dx.doi.org/10.1074/jbc.M112.340893			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354969	Green Published, hybrid			2022-12-25	WOS:000302782200075
J	Netz, DJA; Pierik, AJ; Stumpfig, M; Bill, E; Sharma, AK; Pallesen, LJ; Walden, WE; Lill, R				Netz, Daili J. A.; Pierik, Antonio J.; Stuempfig, Martin; Bill, Eckhard; Sharma, Anil K.; Pallesen, Leif J.; Walden, William E.; Lill, Roland			A Bridging [4Fe-4S] Cluster and Nucleotide Binding Are Essential for Function of the Cfd1-Nbp35 Complex as a Scaffold in Iron-Sulfur Protein Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RES; 2-HYDROXYGLUTARYL-COA DEHYDRATASE; ACIDAMINOCOCCUS-FERMENTANS; NBP35; BIOGENESIS; COMPONENT; BIOSYNTHESIS; TRAFFICKING; MECHANISMS; EUKARYOTES	The essential P-loop NTPases Cfd1 and Nbp35 of the cytosolic iron-sulfur (Fe-S) protein assembly machinery perform a scaffold function for Fe-S cluster synthesis. Both proteins contain a nucleotide binding motif of unknown function and a C-terminal motif with four conserved cysteine residues. The latter motif defines the Mrp/Nbp35 subclass of P-loop NTPases and is suspected to be involved in transient Fe-S cluster binding. To elucidate the function of these two motifs, we first created cysteine mutant proteins of Cfd1 and Nbp35 and investigated the consequences of these mutations by genetic, cell biological, biochemical, and spectroscopic approaches. The two central cysteine residues (CPXC) of the C-terminal motif were found to be crucial for cell viability, protein function, coordination of a labile [4Fe-4S] cluster, and Cfd1-Nbp35 hetero-tetramer formation. Surprisingly, the two proximal cysteine residues were dispensable for all these functions, despite their strict evolutionary conservation. Several lines of evidence suggest that the C-terminal CPXC motifs of Cfd1-Nbp35 coordinate a bridging [4Fe-4S] cluster. Upon mutation of the nucleotide binding motifs Fe-S clusters could no longer be assembled on these proteins unless wild-type copies of Cfd1 and Nbp35 were present in trans. This result indicated that Fe-S cluster loading on these scaffold proteins is a nucleotide-dependent step. We propose that the bridging coordination of the C-terminal Fe-S cluster may be ideal for its facile assembly, labile binding, and efficient transfer to target Fe-S apoproteins, a step facilitated by the cytosolic iron-sulfur (Fe-S) protein assembly proteins Nar1 and Cia1 in vivo.	[Netz, Daili J. A.; Pierik, Antonio J.; Stuempfig, Martin; Lill, Roland] Univ Marburg, Inst Zytobiol & Zytopathol, D-35032 Marburg, Germany; [Bill, Eckhard] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim An Der Ruhr, Germany; [Sharma, Anil K.; Pallesen, Leif J.; Walden, William E.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Sharma, Anil K.] MM Univ, Dept Biotechnol, Mullana Ambala 133207, India	Philipps University Marburg; Max Planck Society; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Maharishi Markandeshwar University	Lill, R (corresponding author), Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany.	Lill@staff.uni-marburg.de	Sharma, Anil K./AAP-1909-2020; Pierik, Antonio J/G-1108-2010	Sharma, Anil K./0000-0002-9768-1644; Pierik, Antonio J/0000-0002-1509-6370; Lill, Roland/0000-0002-8345-6518	National Institutes of Health [DK047281]; Deutsche Forschungsgemeinschaft [SFB 593, TR1, GRK 1216]; Rhon Klinikum AG; von Behring-Rontgen Stiftung; Max-Planck Gesellschaft; Fonds der chemischen Industrie; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rhon Klinikum AG; von Behring-Rontgen Stiftung; Max-Planck Gesellschaft(Max Planck Society); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK047281 (to W. E. W.). This work was also supported by Deutsche Forschungsgemeinschaft (SFB 593 and TR1, Gottfried-Wilhelm Leibniz program, and GRK 1216), Rhon Klinikum AG, von Behring-Rontgen Stiftung, Max-Planck Gesellschaft, and Fonds der chemischen Industrie (to R.L.).	Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Barthelme D, 2007, J BIOL CHEM, V282, P14598, DOI 10.1074/jbc.M700825200; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Boll M, 1997, EUR J BIOCHEM, V244, P840, DOI 10.1111/j.1432-1033.1997.00840.x; Bonomi F, 2008, BIOCHEMISTRY-US, V47, P12795, DOI 10.1021/bi801565j; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Bych K, 2008, J BIOL CHEM, V283, P35797, DOI 10.1074/jbc.M807303200; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Dutkiewicz R, 2006, J BIOL CHEM, V281, P7801, DOI 10.1074/jbc.M513301200; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HAGEN WR, 1985, FEBS LETT, V189, P250, DOI 10.1016/0014-5793(85)81033-4; HAGEN WR, 1992, ADV INORG CHEM, V38, P165, DOI 10.1016/S0898-8838(08)60064-1; Hans M, 2000, EUR J BIOCHEM, V267, P7082, DOI 10.1046/j.1432-1327.2000.01809.x; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Heinnickel M, 2006, BIOCHEMISTRY-US, V45, P6756, DOI 10.1021/bi060031s; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jeoung JH, 2010, J MOL BIOL, V396, P1165, DOI 10.1016/j.jmb.2009.12.062; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Krauss N, 1996, NAT STRUCT BIOL, V3, P965, DOI 10.1038/nsb1196-965; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Lee CC, 2009, P NATL ACAD SCI USA, V106, P18474, DOI 10.1073/pnas.0909149106; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; LINDAHL PA, 1985, J BIOL CHEM, V260, P1160; Locher KP, 2001, J MOL BIOL, V307, P297, DOI 10.1006/jmbi.2000.4496; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Seemann M, 2005, J BIOL INORG CHEM, V10, P131, DOI 10.1007/s00775-004-0619-z; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Shen G, 2007, J BIOL CHEM, V282, P31909, DOI 10.1074/jbc.M705554200; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Urzica E, 2009, BIOCHEMISTRY-US, V48, P4946, DOI 10.1021/bi900312x; Vitale G, 1996, GENE, V178, P97, DOI 10.1016/0378-1119(96)00341-1; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Zambelli B, 2009, PROTEINS, V74, P222, DOI 10.1002/prot.22205; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	57	75	77	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12365	12378		10.1074/jbc.M111.328914	http://dx.doi.org/10.1074/jbc.M111.328914			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22362766	Green Published, hybrid			2022-12-25	WOS:000302782200076
J	Olsen, JS; DiMaio, JTM; Doran, TM; Brown, C; Nilsson, BL; Dewhurst, S				Olsen, Joanna S.; DiMaio, John T. M.; Doran, Todd M.; Brown, Caitlin; Nilsson, Bradley L.; Dewhurst, Stephen			Seminal Plasma Accelerates Semen-derived Enhancer of Viral Infection (SEVI) Fibril Formation by the Prostatic Acid Phosphatase (PAP(248-286)) Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; AMYLOID FIBRILS; HIV-INFECTION; ALZHEIMERS-DISEASE; ZINC SALTS; IN-VITRO; TRANSMISSION; MECHANISM; KINETICS; INHIBITION	Amyloid fibrils contained in semen, known as SEVI, or semen-derived enhancer of viral infection, have been shown to increase the infectivity of HIV dramatically. However, previous work with these fibrils has suggested that extensive time and nonphysiologic levels of agitation are necessary to induce amyloid formation from the precursor peptide (a proteolytic cleavage product of prostatic acid phosphatase, PAP(248-286)). Here, we show that fibril formation by PAP(248-286) is accelerated dramatically in the presence of seminal plasma (SP) and that agitation is not required for fibrillization in this setting. Analysis of the effects of specific SP components on fibril formation by PAP(248-286) revealed that this effect is primarily due to the anionic buffer components of SP (notably inorganic phosphate and sodium bicarbonate). Divalent cations present in SP had little effect on the kinetics of fibril formation, but physiologic levels of Zn2+ strongly protected SEVI fibrils from degradation by seminal proteases. Taken together, these data suggest that in the in vivo environment, PAP(248-286) is likely to form fibrils efficiently, thus providing an explanation for the presence of SEVI in human semen.	[Dewhurst, Stephen] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Sch Med & Dent, Rochester, NY 14642 USA; [DiMaio, John T. M.; Doran, Todd M.; Nilsson, Bradley L.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Dewhurst, S (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Sch Med & Dent, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	stephen_dewhurst@urmc.rochester.edu	Nilsson, Bradley/P-3718-2016	Nilsson, Bradley/0000-0003-1193-3693; Dewhurst, Stephen/0000-0001-7729-7920	National Institutes of Health [R01AI084111, T32GM007356, T32DA007232]; Creative and Novel Ideas in HIV Research award; University of Rochester Developmental Center for AIDS [P30AI078498]; DuPont young professors award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094511, P30AI078498, R01AI084111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007232] Funding Source: NIH RePORTER; Division Of Chemistry [0840410] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creative and Novel Ideas in HIV Research award; University of Rochester Developmental Center for AIDS; DuPont young professors award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI084111 (to S. D.), T32GM007356 (to J. S. O.), and T32DA007232 (to J. S. O.). This work was also supported by a Creative and Novel Ideas in HIV Research award (to B. L. N.), by University of Rochester Developmental Center for AIDS Research Grant P30AI078498, and by a DuPont young professors award (to B. L. N.).	Alies B, 2011, J BIOL INORG CHEM, V16, P333, DOI 10.1007/s00775-010-0729-8; Arens M, 2000, J CLIN MICROBIOL, V38, P1758, DOI 10.1128/JCM.38.5.1758-1762.2000; Arnold F, 2012, J VIROL, V86, P1244, DOI 10.1128/JVI.06121-11; Balandya E, 2010, J IMMUNOL, V185, P7596, DOI 10.4049/jimmunol.1002846; Bourne N, 2005, ANTIMICROB AGENTS CH, V49, P1181, DOI 10.1128/AAC.49.3.1181-1183.2005; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Doncel GF, 2011, AM J REPROD IMMUNOL, V65, P292, DOI 10.1111/j.1600-0897.2010.00931.x; Easterhoff D, 2011, BIOPHYS J, V100, P1325, DOI 10.1016/j.bpj.2011.01.037; Fernandez-Romero JA, 2012, ANTIMICROB AGENTS CH, V56, P358, DOI 10.1128/AAC.05461-11; Goldblatt MW, 1935, BIOCHEM J, V29, P1346, DOI 10.1042/bj0291346; Haraguchi Y, 1999, ANTIVIR RES, V43, P123, DOI 10.1016/S0166-3542(99)00040-6; Harrison GA, 1933, BIOCHEM J, V27, P1152, DOI 10.1042/bj0271152; Huggins Charles, 1942, AMER JOUR PHYSIOL, V136, P467; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KAVANAGH JP, 1985, J REPROD FERTIL, V75, P35; Kenney J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015835; Kim KA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-55; KUMEL G, 1990, J GEN VIROL, V71, P2989, DOI 10.1099/0022-1317-71-12-2989; Lee CH, 1996, J PHARM SCI, V85, P649, DOI 10.1021/js9501573; Malm J, 2000, PROSTATE, V45, P132, DOI 10.1002/1097-0045(20001001)45:2<132::AID-PROS7>3.0.CO;2-3; Martellini JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016285; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; Morel B, 2010, BIOPHYS J, V99, P3801, DOI 10.1016/j.bpj.2010.10.039; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Neildez O, 1998, VIROLOGY, V243, P12, DOI 10.1006/viro.1997.9026; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Owen DH, 2005, J ANDROL, V26, P459, DOI 10.2164/jandrol.04104; Pfefferkorn CM, 2010, P NATL ACAD SCI USA, V107, P21447, DOI 10.1073/pnas.1006424107; Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Sabatte J, 2007, J VIROL, V81, P13723, DOI 10.1128/JVI.01079-07; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Ye ZQ, 2009, BIOCHEMISTRY-US, V48, P11582, DOI 10.1021/bi901709j; ZHANG ZY, 1991, BIOCHEMISTRY-US, V30, P8717, DOI 10.1021/bi00100a001; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832	39	39	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11842	11849		10.1074/jbc.M111.314336	http://dx.doi.org/10.1074/jbc.M111.314336			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354963	hybrid, Green Published			2022-12-25	WOS:000302782200023
J	Tanaka, K; Matsumoto, E; Higashimaki, Y; Katagiri, T; Sugimoto, T; Seino, S; Kaji, H				Tanaka, Ken-ichiro; Matsumoto, Erika; Higashimaki, Yoshiko; Katagiri, Takenobu; Sugimoto, Toshitsugu; Seino, Susumu; Kaji, Hiroshi			Role of Osteoglycin in the Linkage between Muscle and Bone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; ALKALINE-PHOSPHATASE ACTIVITY; MOLECULAR-CLONING; HIGH EXPRESSION; DIFFERENTIATION; IDENTIFICATION; GENES; SMAD3; MASS; MINERALIZATION	The interaction between muscle tissues and bone metabolism is incompletely understood. We hypothesized that there might be some humoral factors that are produced in muscle tissues and exhibit bone anabolic activity. We, therefore, performed comparative DNA microarray analysis between mouse myoblastic C2C12 cells transfected with either stable empty vector or ALK2 (R206H), the mutation that constitutively activates the bone morphogenetic protein (BMP) receptor, to search for muscle-derived bone anabolic factors. Twenty-five genes whose expression was decreased to <1/4, were identified; these included osteoglycin (OGN). Stable overexpression of OGN significantly decreased the levels of Runx2 and Osterix mRNA compared with those in cells transfected with vector alone in MC3T3-E1 cells. On the other hand, it significantly enhanced the levels of alkaline phosphatase (ALP), type I collagen (Col1), and osteocalcin (OCN) mRNA as well as beta-catenin and mineralization. A reduction in endogenous OGN level showed the opposite effects to those of OGN overexpression in MC3T3-E1 and mouse calvarial osteoblastic cells. Transient OGN overexpression significantly suppressed the levels of Runx2, Osterix, ALP, Col1, and OCN mRNA induced by BMP-2 in C2C12 cells. The conditioned medium from OGN-overexpressed and OGN-suppressed myoblastic cells enhanced and decreased, respectively, the levels of ALP, Col1, and beta-catenin in MC3T3-E1 cells. Moreover, OGNincreased Smad3/4-responsive transcriptional activity as well as Col1 mRNA levels independently of endogenous TGF-beta in these cells. In conclusion, this study suggests that OGN may be a crucial humoral bone anabolic factor that is produced by muscle tissues.	[Kaji, Hiroshi] Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, Osaka 5898511, Japan; [Tanaka, Ken-ichiro; Matsumoto, Erika; Higashimaki, Yoshiko; Seino, Susumu; Kaji, Hiroshi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Kobe, Hyogo 6500017, Japan; [Tanaka, Ken-ichiro; Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Izumo, Shimane 6938501, Japan; [Katagiri, Takenobu] Saitama Med Univ, Res Ctr Genom Med, Div Pathophysiol, Hidaka, Saitama 3501241, Japan; [Seino, Susumu; Kaji, Hiroshi] Kobe Univ, Grad Sch Med, Dept Physiol & Cellular Biol, Div Cellular & Mol Med, Kobe, Hyogo 6500017, Japan	Kindai University (Kinki University); Kobe University; Shimane University; Saitama Medical University; Kobe University	Kaji, H (corresponding author), Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, 377-2 Ohno Higashi, Osaka 5898511, Japan.	hkaji@med.kindai.ac.jp	Kaji, Hiroshi/AAI-5628-2020		Ministry of Education, Culture, Sports, and Science; Ministry of Science, Education, and Culture of Japan [21591179]; Grants-in-Aid for Scientific Research [21591179] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Science, Education, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from the Global COE Program F11 from the Ministry of Education, Culture, Sports, and Science and Grant-in-aid 21591179 from the Ministry of Science, Education, and Culture of Japan (to H. K).	Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Beecher N, 2005, INVEST OPHTH VIS SCI, V46, P4046, DOI 10.1167/iovs.05-0325; BENTZ H, 1989, J BIOL CHEM, V264, P20805; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Capozza RF, 2008, MENOPAUSE, V15, P905, DOI 10.1097/gme.0b013e318164ee85; Chan CY, 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/mcp.m110.004804; Chan XCY, 2007, J PROTEOME RES, V6, P698, DOI 10.1021/pr060448k; Cui XN, 2009, WORLD J GASTROENTERO, V15, P6117, DOI 10.3748/wjg.15.6117; Cui XN, 2008, ACTA BIOCH BIOPH SIN, V40, P349, DOI 10.1111/j.1745-7270.2008.00392.x; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Febbraio MA, 2004, DIABETES, V53, P1643, DOI 10.2337/diabetes.53.7.1643; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Ge GX, 2004, J BIOL CHEM, V279, P41626, DOI 10.1074/jbc.M406630200; Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hisa I, 2011, J BIOL CHEM, V286, P9787, DOI 10.1074/jbc.M110.179127; Inoue Y, 2009, J CELL BIOCHEM, V108, P285, DOI 10.1002/jcb.22252; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kampmann A, 2009, MOL CELL BIOCHEM, V322, P15, DOI 10.1007/s11010-008-9935-x; Kaplan FS, 2008, BEST PRACT RES CL RH, V22, P191, DOI 10.1016/j.berh.2007.11.007; Kapur S, 2010, J BIOL CHEM, V285, P37607, DOI 10.1074/jbc.M110.169714; Karsenty G, 2010, J CLIN ENDOCR METAB, V95, P4795, DOI 10.1210/jc.2010-1030; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Khosla S, 1996, J BONE MINER RES, V11, P857; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; MADISEN L, 1990, DNA CELL BIOL, V9, P303, DOI 10.1089/dna.1990.9.303; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Nakaoka D, 2001, OSTEOPOROSIS INT, V12, P548, DOI 10.1007/s001980170075; Osawa A, 2006, GENOMICS, V88, P52, DOI 10.1016/j.ygeno.2006.02.013; Patel MJ, 2007, J CELL BIOCHEM, V101, P587, DOI 10.1002/jcb.21218; Pedersen BK, 2009, J APPL PHYSIOL, V107, P1006, DOI 10.1152/japplphysiol.00734.2009; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; RICHARDS RR, 1991, J BONE JOINT SURG AM, V73A, P1323, DOI 10.2106/00004623-199173090-00006; Shanahan CM, 1997, ARTERIOSCL THROM VAS, V17, P2437, DOI 10.1161/01.ATV.17.11.2437; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sowa H, 2002, J BONE MINER RES, V17, P1190, DOI 10.1359/jbmr.2002.17.7.1190; Sowa H, 2004, J BIOL CHEM, V279, P40267, DOI 10.1074/jbc.M401312200; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Tasheva E, 2004, MOL VIS, V10, P758; Tasheva ES, 1999, J BIOL CHEM, V274, P18693, DOI 10.1074/jbc.274.26.18693; Tasheva ES, 2003, MOL VIS, V9, P277; Tasheva ES, 2002, BBA-GENE STRUCT EXPR, V1575, P123, DOI 10.1016/S0167-4781(02)00245-2; Tasheva ES, 2002, MOL VIS, V8, P407; Tu QS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.152405; Utvag SE, 2003, J ORTHOP TRAUMA, V17, P430, DOI 10.1097/00005131-200307000-00007; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Williamson RE, 2008, HEARING RES, V237, P57, DOI 10.1016/j.heares.2007.12.006; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606	53	85	91	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11616	11628		10.1074/jbc.M111.292193	http://dx.doi.org/10.1074/jbc.M111.292193			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351757	hybrid, Green Published			2022-12-25	WOS:000302782200002
J	Griebel, U; Oller, DK				Griebel, Ulrike; Oller, D. Kimbrough			Vocabulary Learning in a Yorkshire Terrier: Slow Mapping of Spoken Words	PLOS ONE			English	Article							LANGUAGE; DOG	Rapid vocabulary learning in children has been attributed to "fast mapping", with new words often claimed to be learned through a single presentation. As reported in 2004 in Science a border collie (Rico) not only learned to identify more than 200 words, but fast mapped the new words, remembering meanings after just one presentation. Our research tests the fast mapping interpretation of the Science paper based on Rico's results, while extending the demonstration of large vocabulary recognition to a lap dog. We tested a Yorkshire terrier (Bailey) with the same procedures as Rico, illustrating that Bailey accurately retrieved randomly selected toys from a set of 117 on voice command of the owner. Second we tested her retrieval based on two additional voices, one male, one female, with different accents that had never been involved in her training, again showing she was capable of recognition by voice command. Third, we did both exclusion-based training of new items (toys she had never seen before with names she had never heard before) embedded in a set of known items, with subsequent retention tests designed as in the Rico experiment. After Bailey succeeded on exclusion and retention tests, a crucial evaluation of true mapping tested items previously successfully retrieved in exclusion and retention, but now pitted against each other in a two-choice task. Bailey failed on the true mapping task repeatedly, illustrating that the claim of fast mapping in Rico had not been proven, because no true mapping task had ever been conducted with him. It appears that the task called retention in the Rico study only demonstrated success in retrieval by a process of extended exclusion.	[Griebel, Ulrike] Univ Memphis, Inst Intelligent Syst, Memphis, TN 38152 USA; [Oller, D. Kimbrough] Univ Memphis, Sch Commun Sci & Disorders, Memphis, TN 38152 USA; [Griebel, Ulrike; Oller, D. Kimbrough] Konrad Lorenz Inst Evolut & Cognit Res, Altenberg, Austria	University of Memphis; University of Memphis	Griebel, U (corresponding author), Univ Memphis, Inst Intelligent Syst, Memphis, TN 38152 USA.	ulrikegriebel@gmail.com	Oller, D. Kimbrough/G-1804-2010		Plough Foundation	Plough Foundation	This research was supported in part by the Plough Foundation, which supports Oller's Chair of Excellence at The University of Memphis (http://www.manta.com/c/mmcxph2/plough-foundation). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Colin, 1997, SPECIES MIND PHILOS; Bates E, 1995, HDB CHILD LANGUAGE, P96; Bekoff M, 1998, COGNITIVE ETHOLOGY C; Bloom P, 2004, SCIENCE, V304, P1605, DOI 10.1126/science.1099899; Carey S., 1982, LANG ACQUIS, P347; de Waal FBM, 2010, TRENDS COGN SCI, V14, P201, DOI 10.1016/j.tics.2010.03.003; Griffin Donald R., 2001, ANIMAL MINDS COGNITI; HERMAN LM, 1985, NEUROSCI BIOBEHAV R, V9, P667, DOI 10.1016/0149-7634(85)90013-2; HERMAN LM, 1984, COGNITION, V16, P129, DOI 10.1016/0010-0277(84)90003-9; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kastak CR, 2002, J EXP ANAL BEHAV, V78, P449, DOI 10.1901/jeab.2002.78-449; Markman EM, 2004, TRENDS COGN SCI, V8, P479, DOI 10.1016/j.tics.2004.09.007; MERVIS CB, 1994, CHILD DEV, V65, P1646, DOI 10.2307/1131285; Pepperberg IM, 2002, BRAIN BEHAV EVOLUT, V59, P54, DOI 10.1159/000063733; Pilley JW, 2011, BEHAV PROCESS, V86, P184, DOI 10.1016/j.beproc.2010.11.007; PREMACK D, 1971, SCIENCE, V172, P808, DOI 10.1126/science.172.3985.808; PREMACK D, 1985, COGNITION, V19, P207, DOI 10.1016/0010-0277(85)90036-8; Wilkinson KM, 2003, J APPL DEV PSYCHOL, V24, P739, DOI 10.1016/j.appdev.2003.09.006	18	40	40	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30182	10.1371/journal.pone.0030182	http://dx.doi.org/10.1371/journal.pone.0030182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363421	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600015
J	Loo, LWM; Cheng, I; Tiirikainen, M; Lum-Jones, A; Seifried, A; Dunklee, LM; Church, JM; Gryfe, R; Weisenberger, DJ; Haile, RW; Gallinger, S; Duggan, DJ; Thibodeau, SN; Casey, G; Le Marchand, L				Loo, Lenora W. M.; Cheng, Iona; Tiirikainen, Maarit; Lum-Jones, Annette; Seifried, Ann; Dunklee, Lucas M.; Church, James M.; Gryfe, Robert; Weisenberger, Daniel J.; Haile, Robert W.; Gallinger, Steven; Duggan, David J.; Thibodeau, Stephen N.; Casey, Graham; Le Marchand, Loic			cis-Expression QTL Analysis of Established Colorectal Cancer Risk Variants in Colon Tumors and Adjacent Normal Tissue	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN GENE-EXPRESSION; SUSCEPTIBILITY LOCI; MICROSATELLITE INSTABILITY; AURORA-A; IN-VIVO; HURP; ARC; CELLS; SCAN	Genome-wide association studies (GWAS) have identified 19 risk variants associated with colorectal cancer. As most of these risk variants reside outside the coding regions of genes, we conducted cis-expression quantitative trait loci (cis-eQTL) analyses to investigate possible regulatory functions on the expression of neighboring genes. Forty microsatellite stable and CpG island methylator phenotype-negative colorectal tumors and paired adjacent normal colon tissues were used for genome-wide SNP and gene expression profiling. We found that three risk variants (rs10795668, rs4444235 and rs9929218, using near perfect proxies rs706771, rs11623717 and rs2059252, respectively) were significantly associated (FDR q-value <= 0.05) with expression levels of nearby genes (<2 Mb up-or down-stream). We observed an association between the low colorectal cancer risk allele (A) for rs10795668 at 10p14 and increased expression of ATP5C1 (q = 0.024) and between the colorectal cancer high risk allele (C) for rs4444235 at 14q22.2 and increased expression of DLGAP5 (q = 0.041), both in tumor samples. The colorectal cancer low risk allele (A) for rs9929218 at 16q22.1 was associated with a significant decrease in expression of both NOL3 (q = 0.017) and DDX28 (q = 0.046) in the adjacent normal colon tissue samples. Of the four genes, DLGAP5 and NOL3 have been previously reported to play a role in colon carcinogenesis and ATP5C1 and DDX28 are mitochondrial proteins involved in cellular metabolism and division, respectively. The combination of GWAS findings, prior functional studies, and the cis-eQTL analyses described here suggest putative functional activities for three of the colorectal cancer GWAS identified risk loci as regulating the expression of neighboring genes.	[Loo, Lenora W. M.; Cheng, Iona; Tiirikainen, Maarit; Lum-Jones, Annette; Seifried, Ann; Dunklee, Lucas M.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Church, James M.] Cleveland Clin Fdn, Dept Colorectal Surg, Cleveland, OH 44195 USA; [Gryfe, Robert; Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Surg, Toronto, ON, Canada; [Weisenberger, Daniel J.] Univ So Calif, Keck Sch Med, Epigenome Ctr, Los Angeles, CA 90033 USA; [Haile, Robert W.; Casey, Graham] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Duggan, David J.] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ USA; [Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Cancer Research Center of Hawaii; University of Hawaii System; Cleveland Clinic Foundation; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Southern California; University of Southern California; Translational Genomics Research Institute; Mayo Clinic	Loo, LWM (corresponding author), Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA.	lloo@cc.hawaii.edu	Weisenberger, Daniel/AAA-8314-2020; Tirikainen, M/B-6954-2012; Gallinger, Steven/E-4575-2013; Gryfe, Robert/AAF-1870-2021	Weisenberger, Daniel/0000-0001-8303-2603; Tirikainen, M/0000-0002-8124-3818; 	National Cancer Institute, National Institutes of Health under RFA [CA-95-011]; University of Hawaii Colorectal Cancer Family Registry [U01 CA074806]; Mayo Clinic Cooperative Family Registry for Colon Cancer Studies [U01 CA074800]; Ontario Registry for Studies of Familial Colorectal Cancer [U01 CA074783]; University of Southern California Familial Colorectal Neoplasia Collaborative Group [U01 CA074799]; Colon Cancer Family Registry; Affymetrix Collaborations in Cancer Research Program;  [5U24 CA074806]; NATIONAL CANCER INSTITUTE [U01CA074799, U01CA074806, U01CA074800, K22CA095011, U01CA074783, P30CA071789, U24CA074806] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health under RFA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Hawaii Colorectal Cancer Family Registry; Mayo Clinic Cooperative Family Registry for Colon Cancer Studies; Ontario Registry for Studies of Familial Colorectal Cancer; University of Southern California Familial Colorectal Neoplasia Collaborative Group; Colon Cancer Family Registry; Affymetrix Collaborations in Cancer Research Program; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, National Institutes of Health under RFA # CA-95-011; and through cooperative agreements with the University of Hawaii Colorectal Cancer Family Registry (U01 CA074806), Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (U01 CA074800), Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783), the University of Southern California Familial Colorectal Neoplasia Collaborative Group (U01 CA074799), and members of the Colon Cancer Family Registry and P.I.s. In addition, this work was partly supported by grant 5U24 CA074806 and Affymetrix Collaborations in Cancer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassal S, 2001, GENOMICS, V77, P5, DOI 10.1006/geno.2001.6570; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Carvajal-Carmona LG, 2011, HUM MOL GENET, V20, P2879, DOI 10.1093/hmg/ddr190; Cheung VG, 2003, COLD SPRING HARB SYM, V68, P403, DOI 10.1101/sqb.2003.68.403; Cuezva JM, 2002, CANCER RES, V62, P6674; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Foo RSY, 2007, P NATL ACAD SCI USA, V104, P20826, DOI 10.1073/pnas.0710017104; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Funakoshi S, 2008, MOL CANCER RES, V6, P1478, DOI 10.1158/1541-7786.MCR-07-2161; Gudmundsson KO, 2007, STEM CELLS, V25, P1498, DOI 10.1634/stemcells.2005-0479; Heikaus S, 2008, APOPTOSIS, V13, P938, DOI 10.1007/s10495-008-0225-6; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lin F, 2008, CANCER BIOL THER, V7, P1669, DOI 10.4161/cbt.7.10.6660; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Mercier I, 2008, CELL CYCLE, V7, P1640, DOI 10.4161/cc.7.11.5979; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nakagawa Y, 1999, BRIT J CANCER, V80, P914, DOI 10.1038/sj.bjc.6690441; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pomerantz MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001204; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Prokunina-Olsson L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-96; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; WARBURG O, 1930, METABOLISM TUMORS; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Willers IM, 2010, BIOCHEM J, V426, P319, DOI 10.1042/BJ20091570; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Wu L, 2010, J BIOL CHEM, V285, P19235, DOI 10.1074/jbc.M110.114892; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	50	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30477	10.1371/journal.pone.0030477	http://dx.doi.org/10.1371/journal.pone.0030477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363440	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600032
J	Osycka-Salut, C; Gervasi, MG; Pereyra, E; Cella, M; Ribeiro, ML; Franchi, AM; Perez-Martinez, S				Osycka-Salut, Claudia; Gracia Gervasi, Maria; Pereyra, Elba; Cella, Maximiliano; Laura Ribeiro, Maria; Maria Franchi, Ana; Perez-Martinez, Silvina			Anandamide Induces Sperm Release from Oviductal Epithelia through Nitric Oxide Pathway in Bovines	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; BULL SPERM; ENDOCANNABINOID SYSTEM; PROMOTES CAPACITATION; CANNABINOID RECEPTOR; ACROSOME REACTION; SPERMATOZOA; SYNTHASE; BINDING; MOUSE	Mammalian spermatozoa are not able to fertilize an egg immediately upon ejaculation. They acquire this ability during their transit through the female genital tract in a process known as capacitation. The mammalian oviduct acts as a functional sperm reservoir providing a suitable environment that allows the maintenance of sperm fertilization competence until ovulation occurs. After ovulation, spermatozoa are gradually released from the oviductal reservoir in the caudal isthmus and ascend to the site of fertilization. Capacitating-related changes in sperm plasma membrane seem to be responsible for sperm release from oviductal epithelium. Anandamide is a lipid mediator that participates in the regulation of several female and male reproductive functions. Previously we have demonstrated that anandamide was capable to release spermatozoa from oviductal epithelia by induction of sperm capacitation in bovines. In the present work we studied whether anandamide might exert its effect by activating the nitric oxide (NO) pathway since this molecule has been described as a capacitating agent in spermatozoa from different species. First, we demonstrated that 1 mu M NOC-18, a NO donor, and 10 mM L-Arginine, NO synthase substrate, induced the release of spermatozoa from the oviductal epithelia. Then, we observed that the anandamide effect on sperm oviduct interaction was reversed by the addition of 1 mu M L-NAME, a NO synthase inhibitor, or 30 mu g/ml Hemoglobin, a NO scavenger. We also demonstrated that the induction of bull sperm capacitation by nanomolar concentrations of R(+)-methanandamide or anandamide was inhibited by adding L-NAME or Hemoglobin. To study whether anandamide is able to produce NO, we measured this compound in both sperm and oviductal cells. We observed that anandamide increased the levels of NO in spermatozoa, but not in oviductal cells. These findings suggest that anandamide regulates the sperm release from oviductal epithelia probably by activating the NO pathway during sperm capacitation.	[Osycka-Salut, Claudia; Gracia Gervasi, Maria; Pereyra, Elba; Cella, Maximiliano; Laura Ribeiro, Maria; Maria Franchi, Ana; Perez-Martinez, Silvina] Ctr Estudios Farmacol & Bot CEFYBO CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Osycka-Salut, C (corresponding author), Ctr Estudios Farmacol & Bot CEFYBO CONICET, Buenos Aires, DF, Argentina.	perezms@fmed.uba.ar		Osycka-Salut, Claudia Elena/0000-0002-8033-5155; Gervasi, Maria Gracia/0000-0002-5468-2700	National Research Council (CONICET)-Argentina [PIP 2008 2204]	National Research Council (CONICET)-Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by National Research Council (CONICET)-Argentina (PIP 2008 2204) to AF, MLR, and SPM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoako AA, 2010, J CHROMATOGR B, V878, P3231, DOI 10.1016/j.jchromb.2010.09.024; Aquila S, 2009, J CELL PHYSIOL, V221, P147, DOI 10.1002/jcp.21837; Bartlett SR, 1999, J PHYSIOL-LONDON, V521, P705, DOI 10.1111/j.1469-7793.1999.00705.x; Bosch P, 2001, THERIOGENOLOGY, V56, P247, DOI 10.1016/S0093-691X(01)00560-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Cella M, 2008, PLACENTA, V29, P699, DOI 10.1016/j.placenta.2008.05.003; CROSS NL, 1986, GAMETE RES, V15, P213, DOI 10.1002/mrd.1120150303; de Lamirande E, 2008, BBA-PROTEINS PROTEOM, V1784, P106, DOI 10.1016/j.bbapap.2007.08.024; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; El-Talatini MR, 2010, FERTIL STERIL, V93, P1989, DOI 10.1016/j.fertnstert.2008.12.033; Fazeli A, 1999, BIOL REPROD, V60, P879, DOI 10.1095/biolreprod60.4.879; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; FUKUI Y, 1990, THERIOGENOLOGY, V34, P579, DOI 10.1016/0093-691X(90)90013-J; GalantinoHomer HL, 1997, BIOL REPROD, V56, P707, DOI 10.1095/biolreprod56.3.707; Ghasemi M, 2007, BJU INT, V100, P1385, DOI 10.1111/j.1464-410X.2007.07180.x; Gervasi MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016993; Gervasi MG, 2009, REPRODUCTION, V137, P403, DOI 10.1530/REP-08-0204; Grisham MB, 1996, METHOD ENZYMOL, V268, P237; Gualtieri R, 2005, REPRODUCTION, V129, P51, DOI 10.1530/rep.1.00374; Herradon E, 2007, BRIT J PHARMACOL, V152, P699, DOI 10.1038/sj.bjp.0707404; Herrero MB, 1996, REPROD FERT DEVELOP, V8, P931, DOI 10.1071/RD9960931; Herrero MB, 1997, FEBS LETT, V411, P39, DOI 10.1016/S0014-5793(97)00570-X; Herrero MB, 2003, CURR PHARM DESIGN, V9, P419, DOI 10.2174/1381612033391720; Hou ML, 2008, ANIM REPROD SCI, V104, P56, DOI 10.1016/j.anireprosci.2007.01.006; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Hunter RHF, 2008, MOL REPROD DEV, V75, P167, DOI 10.1002/mrd.20776; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lapointe J, 2006, ENDOCRINOLOGY, V147, P5600, DOI 10.1210/en.2005-1548; LEE MA, 1987, FERTIL STERIL, V48, P649; Lefebvre R, 1996, BIOL REPROD, V54, P575, DOI 10.1095/biolreprod54.3.575; Maccarrone M, 2008, BRIT J PHARMACOL, V153, P189, DOI 10.1038/sj.bjp.0707444; Maccarrone M, 2005, J CELL SCI, V118, P4393, DOI 10.1242/jcs.02536; Martinez SP, 2000, J REPROD FERTIL, V118, P111, DOI 10.1530/reprod/118.1.111; Meiser H, 2003, ANAT HISTOL EMBRYOL, V32, P321, DOI 10.1111/j.1439-0264.2003.00459.x; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; O'Flaherty C, 2004, BBA-GEN SUBJECTS, V1674, P215, DOI 10.1016/j.bbagen.2004.06.020; PALMER RMJ, 1989, BIOCHEM BIOPH RES CO, V158, P348, DOI 10.1016/S0006-291X(89)80219-0; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; PARRISH JJ, 1989, GAMETE RES, V24, P403, DOI 10.1002/mrd.1120240407; Poblete LM, 2005, J PHYSIOL-LONDON, V568, P539, DOI 10.1113/jphysiol.2005.094292; Revah I, 2000, BIOL REPROD, V62, P1010, DOI 10.1095/biolreprod62.4.1010; Rodriguez PC, 2009, ANIM REPROD SCI, V110, P96, DOI 10.1016/j.anireprosci.2007.12.017; Rodriguez PC, 2005, ANIM REPROD SCI, V85, P231, DOI 10.1016/j.anireprosci.2004.05.018; Roessner C, 2010, ANDROLOGIA, V42, P132, DOI 10.1111/j.1439-0272.2009.01005.x; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Rosselli M, 1996, MOL HUM REPROD, V2, P607, DOI 10.1093/molehr/2.8.607; Schuel H, 2002, MOL REPROD DEV, V63, P376, DOI 10.1002/mrd.90021; Signorello MG, 2011, J CELL BIOCHEM, V112, P924, DOI 10.1002/jcb.23008; SMITH TT, 1991, J REPROD FERTIL, V91, P567, DOI 10.1530/jrf.0.0910567; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; Sun XF, 2008, MOL CELL ENDOCRINOL, V286, pS3, DOI 10.1016/j.mce.2008.01.002; Talevi R, 2001, BIOL REPROD, V64, P491, DOI 10.1095/biolreprod64.2.491; Tornblom SA, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-33; Vercelli CA, 2009, REPROD BIOMED ONLINE, V18, P824, DOI 10.1016/S1472-6483(10)60033-8; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Wang HB, 2005, PROSTAG OTH LIPID M, V77, P84, DOI 10.1016/j.prostaglandins.2004.09.013; WARD CR, 1984, DEV BIOL, V104, P287, DOI 10.1016/0012-1606(84)90084-8; Ye XQ, 2010, TRENDS ENDOCRIN MET, V21, P17, DOI 10.1016/j.tem.2009.08.003	61	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30671	10.1371/journal.pone.0030671	http://dx.doi.org/10.1371/journal.pone.0030671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363468	gold, Green Submitted, Green Published			2022-12-25	WOS:000302853600052
J	Belacortu, Y; Weiss, R; Kadener, S; Paricio, N				Belacortu, Yaiza; Weiss, Ron; Kadener, Sebastian; Paricio, Nuria			Transcriptional Activity and Nuclear Localization of Cabut, the Drosophila Ortholog of Vertebrate TGF-beta-Inducible Early-Response Gene (TIEG) Proteins	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR; OF-FUNCTION SCREEN; IMPORTIN-ALPHA; DORSAL CLOSURE; REPRESSOR DOMAINS; ZINC-FINGERS; CELL-GROWTH; SIGNALS NLS; OLI-NEU; BINDING	Background: Cabut (Cbt) is a C2H2-class zinc finger transcription factor involved in embryonic dorsal closure, epithelial regeneration and other developmental processes in Drosophila melanogaster. Cbt orthologs have been identified in other Drosophila species and insects as well as in vertebrates. Indeed, Cbt is the Drosophila ortholog of the group of vertebrate proteins encoded by the TGF-beta-inducible early-response genes (TIEGs), which belong to Sp1-like/Kruppel-like family of transcription factors. Several functional domains involved in transcriptional control and subcellular localization have been identified in the vertebrate TIEGs. However, little is known of whether these domains and functions are also conserved in the Cbt protein. Methodology/Principal Findings: To determine the transcriptional regulatory activity of the Drosophila Cbt protein, we performed Gal4-based luciferase assays in S2 cells and showed that Cbt is a transcriptional repressor and able to regulate its own expression. Truncated forms of Cbt were then generated to identify its functional domains. This analysis revealed a sequence similar to the mSin3A-interacting repressor domain found in vertebrate TIEGs, although located in a different part of the Cbt protein. Using beta-Galactosidase and eGFP fusion proteins, we also showed that Cbt contains the bipartite nuclear localization signal (NLS) previously identified in TIEG proteins, although it is non-functional in insect cells. Instead, a monopartite NLS, located at the amino terminus of the protein and conserved across insects, is functional in Drosophila S2 and Spodoptera exigua Sec301 cells. Last but not least, genetic interaction and immunohistochemical assays suggested that Cbt nuclear import is mediated by Importin-alpha 2. Conclusions/Significance: Our results constitute the first characterization of the molecular mechanisms of Cbt-mediated transcriptional control as well as of Cbt nuclear import, and demonstrate the existence of similarities and differences in both aspects of Cbt function between the insect and the vertebrate TIEG proteins.	[Belacortu, Yaiza; Paricio, Nuria] Univ Valencia, Dept Genet, Fac CC Biol, Burjassot, Spain; [Weiss, Ron; Kadener, Sebastian] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	University of Valencia; Hebrew University of Jerusalem	Belacortu, Y (corresponding author), Univ Valencia, Dept Genet, Fac CC Biol, Burjassot, Spain.	nuria.paricio@uv.es	Paricio, Nuria/K-2184-2014	Paricio, Nuria/0000-0001-7193-2532; BELACORTU, YAIZA/0000-0001-7342-2237	Gobierno de La Rioja; Ministerio de Educacion y Ciencia [BFU2004-00498, BFU2007-63213]; Conselleria d'Empresa, Universitat i Ciencia [PROMETEO/2010/081, ACOMP/2010/242]; Career Development Award (HFSP); Israel Science Foundation	Gobierno de La Rioja; Ministerio de Educacion y Ciencia(Spanish Government); Conselleria d'Empresa, Universitat i Ciencia; Career Development Award (HFSP); Israel Science Foundation(Israel Science Foundation)	YB was supported by a predoctoral fellowship from the Gobierno de La Rioja. This work was supported in part by grants from Ministerio de Educacion y Ciencia (BFU2004-00498 and BFU2007-63213) and Conselleria d'Empresa, Universitat i Ciencia (PROMETEO/2010/081 and ACOMP/2010/242) to NP, and by the Career Development Award (HFSP) and Israel Science Foundation personal grant to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Belacortu Y, 2011, GENE EXPR PATTERNS, V11, P190, DOI 10.1016/j.gep.2010.11.004; Bender H, 2004, J NEUROSCI RES, V75, P344, DOI 10.1002/jnr.10856; Blanco E, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-94; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown JL, 2005, NUCLEIC ACIDS RES, V33, P5181, DOI 10.1093/nar/gki827; Bulow MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015171; CARROLL SB, 1990, CELL, V60, P9, DOI 10.1016/0092-8674(90)90711-M; Chalaux E, 1999, FEBS LETT, V457, P478, DOI 10.1016/S0014-5793(99)01051-0; Chan CC, 2008, DEV BIOL, V318, P17, DOI 10.1016/j.ydbio.2008.02.050; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; Chen CL, 1999, MOL CELL BIOL, V19, P307; Chen GX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000026; Chen ZL, 2010, GENOMICS, V95, P111, DOI 10.1016/j.ygeno.2009.11.001; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Cook T, 2000, AM J PHYSIOL-GASTR L, V278, pG513, DOI 10.1152/ajpgi.2000.278.4.G513; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Dang DT, 2002, NUCLEIC ACIDS RES, V30, P2736, DOI 10.1093/nar/gkf400; Dockendorff TC, 1999, BIOL CHEM, V380, P1263, DOI 10.1515/BC.1999.161; Ellenrieder V, 2002, EMBO J, V21, P2451, DOI 10.1093/emboj/21.10.2451; Fernandez-Costa JM, 2010, MOL CELLS, V30, P65, DOI 10.1007/s10059-010-0089-9; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Giarre M, 2002, J STRUCT BIOL, V140, P279, DOI 10.1016/S1047-8477(02)00543-9; Gohla G, 2008, J CELL BIOCHEM, V104, P850, DOI 10.1002/jcb.21669; Gorjanacz M, 2002, DEV BIOL, V251, P271, DOI 10.1006/dbio.2002.0827; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Gray S, 1996, CURR OPIN CELL BIOL, V8, P358; Guertin DA, 2006, CURR BIOL, V16, P958, DOI 10.1016/j.cub.2006.03.084; HannaRose W, 1996, TRENDS GENET, V12, P229, DOI 10.1016/0168-9525(96)10022-6; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hirota T, 2010, GENES CELLS, V15, P111, DOI 10.1111/j.1365-2443.2009.01371.x; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kim J, 2010, BIOCHEM BIOPH RES CO, V401, P412, DOI 10.1016/j.bbrc.2010.09.068; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; KUSSEL P, 1995, J CELL BIOL, V129, P1491, DOI 10.1083/jcb.129.6.1491; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Mason DA, 2009, J MOL EVOL, V68, P351, DOI 10.1007/s00239-009-9215-8; Mason DA, 2003, GENETICS, V165, P1943; Mason DA, 2002, GENETICS, V161, P157; Mathe E, 2000, DEV BIOL, V223, P307, DOI 10.1006/dbio.2000.9743; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MILLER M, 1991, PHYSIOL REV, V71, P909, DOI 10.1152/physrev.1991.71.3.909; Minidorff EN, 2007, GENETICS, V176, P2247, DOI 10.1534/genetics.107.072819; Miyazaki K, 2001, MOL CELL BIOL, V21, P6651, DOI 10.1128/MCB.21.19.6651-6659.2001; Mosca TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015223; Mosca TJ, 2010, NAT NEUROSCI, V13, P935, DOI 10.1038/nn.2593; Munoz-Descalzo S, 2005, DEV BIOL, V287, P168, DOI 10.1016/j.ydbio.2005.08.048; Munoz-Descalzo S, 2007, DEV GENES EVOL, V217, P289, DOI 10.1007/s00427-007-0144-5; Munoz-Soriano V, 2011, FLY, V5, P88, DOI 10.4161/fly.5.2.15457; Murali T, 2011, NUCLEIC ACIDS RES, V39, pD736, DOI 10.1093/nar/gkq1092; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Noti JD, 2004, J BIOL CHEM, V279, P26948, DOI 10.1074/jbc.M310634200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Pang YP, 2003, FEBS LETT, V548, P108, DOI 10.1016/S0014-5793(03)00749-X; Perrimon N, 1999, CELL, V97, P13, DOI 10.1016/S0092-8674(00)80710-2; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; Ratan R, 2008, GENETICS, V178, P839, DOI 10.1534/genetics.107.081778; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RIHS HP, 1989, EMBO J, V8, P1479, DOI 10.1002/j.1460-2075.1989.tb03531.x; Rodriguez E, 2009, CELL RES, V19, P1041, DOI 10.1038/cr.2009.103; Rodriguez I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018418; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seetharam A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-276; Song CZ, 2003, J MOL BIOL, V329, P207, DOI 10.1016/S0022-2836(03)00429-7; Spain MM, 2010, J BIOL CHEM, V285, P27457, DOI 10.1074/jbc.M110.130245; Spittau B, 2007, J CELL BIOCHEM, V101, P712, DOI 10.1002/jcb.21228; Spittau B, 2012, CELL TISSUE RES, V347, P65, DOI 10.1007/s00441-011-1186-6; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; Subramaniam M, 2007, J CELL BIOCHEM, V102, P539, DOI 10.1002/jcb.21492; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; Tamanini F, 2005, METHOD ENZYMOL, V393, P418, DOI 10.1016/S0076-6879(05)93020-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOROK I, 1995, J CELL BIOL, V129, P1473, DOI 10.1083/jcb.129.6.1473; Tuncher A, 2005, J MOL BIOL, V352, P517, DOI 10.1016/j.jmb.2005.06.068; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Wang ZY, 2004, GENE, V325, P25, DOI 10.1016/j.gene.2003.09.045; Wong Li Chin, 2006, J Vis Exp, P52, DOI 10.3791/52; Yatsu J, 2008, INT J DEV BIOL, V52, P913, DOI 10.1387/ijdb.082576jy; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001; Zhao T, 2008, GENETICS, V178, P883, DOI 10.1534/genetics.107.082487	105	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32004	10.1371/journal.pone.0032004	http://dx.doi.org/10.1371/journal.pone.0032004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359651	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200120
J	Choo, YM; Lee, KS; Yoon, HJ; Qiu, YL; Wan, H; Sohn, MR; Sohn, HD; Jin, BR				Choo, Young Moo; Lee, Kwang Sik; Yoon, Hyung Joo; Qiu, Yuling; Wan, Hu; Sohn, Mi Ri; Sohn, Hung Dae; Jin, Byung Rae			Antifibrinolytic Role of a Bee Venom Serine Protease Inhibitor That Acts as a Plasmin Inhibitor	PLOS ONE			English	Article							PSEUDONAJA-TEXTILIS; BLOOD-COAGULATION; APROTININ; EVOLUTION; PURIFICATION; HEMOSTASIS; ENZYME	Bee venom is a rich source of pharmacologically active substances. In this study, we identified a bumblebee (Bombus ignitus) venom Kunitz-type serine protease inhibitor (Bi-KTI) that acts as a plasmin inhibitor. Bi-KTI showed no detectable inhibitory effect on factor Xa, thrombin, or tissue plasminogen activator. In contrast, Bi-KTI strongly inhibited plasmin, indicating that it acts as an antifibrinolytic agent; however, this inhibitory ability was two-fold weaker than that of aprotinin. The fibrin(ogen)olytic activities of B. ignitus venom serine protease (Bi-VSP) and plasmin in the presence of Bi-KTI indicate that Bi-KTI targets plasmin more specifically than Bi-VSP. These findings demonstrate a novel mechanism by which bumblebee venom affects the hemostatic system through the antifibrinolytic activity of Bi-KTI and through Bi-VSP-mediated fibrin(ogen) olytic activities, raising interest in Bi-KTI and Bi-VSP as potential clinical agents.	[Choo, Young Moo; Lee, Kwang Sik; Qiu, Yuling; Wan, Hu; Sohn, Mi Ri; Sohn, Hung Dae; Jin, Byung Rae] Dong A Univ, Coll Nat Resources & Life Sci, Pusan, South Korea; [Yoon, Hyung Joo] Natl Acad Agr Sci, Dept Agr Biol, Suwon, South Korea	Dong A University	Choo, YM (corresponding author), Dong A Univ, Coll Nat Resources & Life Sci, Pusan, South Korea.	brjin@dau.ac.kr	Wan, Hu/W-8453-2019	Wan, Hu/0000-0002-8123-3759	Rural Development Administration, Republic of Korea [200901OFT102966290]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the Agenda Project (200901OFT102966290) of the Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0; Choo YM, 2010, COMP BIOCHEM PHYS B, V156, P168, DOI 10.1016/j.cbpb.2010.03.007; Choo YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010393; DAVIS R, 1995, DRUGS, V49, P954, DOI 10.2165/00003495-199549060-00008; Flight S, 2005, PATHOPHYSIOL HAEMO T, V34, P188, DOI 10.1159/000092421; Flight SM, 2009, BRIT J HAEMATOL, V145, P207, DOI 10.1111/j.1365-2141.2009.07605.x; He JY, 2007, FEBS LETT, V581, P2965, DOI 10.1016/j.febslet.2007.05.047; HIDER RC, 1988, ENDEAVOUR, V12, P60, DOI 10.1016/0160-9327(88)90082-8; Kini RM, 2005, PATHOPHYSIOL HAEMO T, V34, P200, DOI 10.1159/000092424; Koh YS, 2001, TOXICON, V39, P555, DOI 10.1016/S0041-0101(00)00169-0; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Lu J, 2008, PEPTIDES, V29, P369, DOI 10.1016/j.peptides.2007.11.013; Masci PP, 2000, BLOOD COAGUL FIBRIN, V11, P385, DOI 10.1097/00001721-200006000-00011; Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X; Millers EKI, 2009, FEBS J, V276, P3163, DOI 10.1111/j.1742-4658.2009.07034.x; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; Qiu YL, 2011, TOXICOL APPL PHARM, V255, P207, DOI 10.1016/j.taap.2011.06.020; Roystone D, 1990, BLOOD COAGUL FIBRIN, V1, P53; Segal H, 2000, LANCET, V355, P1289, DOI 10.1016/S0140-6736(00)02105-X; SHAFQAT J, 1990, FEBS LETT, V275, P6, DOI 10.1016/0014-5793(90)81426-O; SIDDIQI AR, 1991, FEBS LETT, V294, P141, DOI 10.1016/0014-5793(91)81361-B; Sinauridze EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019969; Son DJ, 2007, PHARMACOL THERAPEUT, V115, P246, DOI 10.1016/j.pharmthera.2007.04.004; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; Xin Y, 2009, COMP BIOCHEM PHYS B, V154, P195, DOI 10.1016/j.cbpb.2009.06.003	25	60	66	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e32269	10.1371/journal.pone.0032269	http://dx.doi.org/10.1371/journal.pone.0032269			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359676	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200145
J	Gauglitz, GG; Zedler, S; von Spiegel, F; Fuhr, J; von Donnersmarck, GH; Faist, E				Gauglitz, Gerd G.; Zedler, Siegfried; von Spiegel, Felix; Fuhr, Jasmin; von Donnersmarck, Guido Henkel; Faist, Eugen			Functional Characterization of Cultured Keratinocytes after Acute Cutaneous Burn Injury	PLOS ONE			English	Article							HYPERTROPHIC SCAR FORMATION; NECROSIS-FACTOR-ALPHA; GROWTH FACTOR-ALPHA; STEM-CELL THERAPY; CLINICAL-APPLICATIONS; PEDIATRIC BURNS; SKIN; EXPRESSION; KELOIDS; RECEPTOR	Background: In addition to forming the epithelial barrier against the outside environment keratinocytes are immunologically active cells. In the treatment of severely burned skin, cryoconserved keratinocyte allografts gain in importance. It has been proposed that these allografts accelerate wound healing also due to the expression of a favourable - keratinocyte-derived - cytokine and growth factor milieu. Methods: In this study the morphology and cytokine expression profile of keratinocytes from skin after acute burn injury was compared to non-burned skin. Skin samples were obtained from patients after severe burn injury and healthy controls. Cells were cultured and secretion of selected inflammatory mediators was quantified using Bioplex Immunoassays. Immunohistochemistry was performed to analyse further functional and morphologic parameters. Results: Histology revealed increased terminal differentiation of keratinocytes (CK10, CK11) in allografts from non-burned skin compared to a higher portion of proliferative cells (CK5, vimentin) in acute burn injury. Increased levels of IL-1 alpha, IL-2, IL-4, IL-10, IFN-gamma and TNF alpha could be detected in culture media of burn injury skin cultures. Both culture groups contained large amounts of IL-1RA. IL-6 and GM-CSF were increased during the first 15 days of culture of burned skin compared to control skin. Levels of VEGF, FGF-basic, TGF-beta und G-CSF were high in both but not significantly different. Cryoconservation led to a diminished mediator synthesis except for higher levels of intracellular IL-1 alpha and IL-1 beta. Conclusion: Skin allografts from non-burned skin show a different secretion pattern of keratinocyte-derived cytokines and inflammatory mediators compared to keratinocytes after burn injury. As these secreted molecules exert auto- and paracrine effects and subsequently contribute to healing and barrier restoration after acute burn injury therapies affecting this specific cytokine/growth factor micromilieu could be beneficial in burned patients.	[Gauglitz, Gerd G.] Univ Munich, Dept Dermatol & Allergy, Munich, Germany; [Zedler, Siegfried; Faist, Eugen] Univ Munich, Dept Surg, Munich, Germany; [von Spiegel, Felix; Fuhr, Jasmin; von Donnersmarck, Guido Henkel] Community Hosp Bogenhausen, Dept Plast & Reconstruct Surg, Burn Unit, Munich, Germany	University of Munich; University of Munich; Munchen Klinik	Gauglitz, GG (corresponding author), Univ Munich, Dept Dermatol & Allergy, Munich, Germany.	gerd.gauglitz@med.uni-muenchen.de						Adriessen MP, 1998, J PATHOL, V186, P192, DOI 10.1002/(SICI)1096-9896(1998100)186:2<192::AID-PATH163>3.0.CO;2-X; Aktas G, 2000, HISTOCHEM CELL BIOL, V113, P227; ANTONIADES HN, 1993, AM J PATHOL, V142, P1099; Armour A, 2007, WOUND REPAIR REGEN, V15, pS6, DOI 10.1111/j.1524-475X.2007.00219.x; Atiyeh BS, 2005, WORLD J SURG, V29, P131, DOI 10.1007/s00268-004-1082-2; Bannasch H, 2003, CLIN PLAST SURG, V30, P573, DOI 10.1016/S0094-1298(03)00075-0; Barret JP, 2000, ANN SURG, V231, P869, DOI 10.1097/00000658-200006000-00011; Blome-Eberwein S, 2002, Burns, V28 Suppl 1, pS10; Bock O, 2005, ACTA DERM-VENEREOL, V85, P216, DOI 10.1080/00015550410025453; Boyce S T, 1996, Tissue Eng, V2, P255, DOI 10.1089/ten.1996.2.255; Branski LK, 2009, BURNS, V35, P171, DOI 10.1016/j.burns.2008.03.009; Corral CJ, 1999, ARCH SURG-CHICAGO, V134, P200, DOI 10.1001/archsurg.134.2.200; Garfein ES, 2003, CLIN PLAST SURG, V30, P485, DOI 10.1016/S0094-1298(03)00067-1; Gauglitz GG, 2011, MOL PHARMACEUT, V8, P1471, DOI 10.1021/mp2001457; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Hohlfeld J, 2005, LANCET, V366, P840, DOI 10.1016/S0140-6736(05)67107-3; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Kose O, 2008, DERMATOL SURG, V34, P336, DOI 10.1111/j.1524-4725.2007.34067.x; Lee TY, 1999, ANN PLAS SURG, V43, P179; Lu L, 2005, J AM COLL SURGEONS, V201, P391, DOI 10.1016/j.jamcollsurg.2005.03.032; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Muller M., 2007, TOTAL BURN CARE, V3, P177; Munster AM, 1996, ANN SURG, V224, P372, DOI 10.1097/00000658-199609000-00013; Nakae S, 2003, INT IMMUNOL, V15, P251, DOI 10.1093/intimm/dxg028; Nashan D, 1999, HAUTARZT, V50, P680, DOI 10.1007/s001050050981; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; Niessen FB, 2004, J PATHOL, V202, P121, DOI 10.1002/path.1502; OCONNOR NE, 1981, LANCET, V1, P75; Ohta Yukinori, 1994, Journal of Dermatology (Tokyo), V21, P301; ONO I, 1994, SCAND J PLAST RECONS, V28, P269, DOI 10.3109/02844319409022010; Pellegrini G, 1998, MED BIOL ENG COMPUT, V36, P778, DOI 10.1007/BF02518885; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021; PIERCE GF, 1989, J CELL BIOL, V109, P429, DOI 10.1083/jcb.109.1.429; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RICHARD JL, 1995, DIABETES CARE, V18, P64, DOI 10.2337/diacare.18.1.64; ROSENTHAL A, 1986, CELL, V46, P301, DOI 10.1016/0092-8674(86)90747-6; SCHULTZ GS, 1987, SCIENCE, V235, P350, DOI 10.1126/science.3492044; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Spiekstra SW, 2005, EXP DERMATOL, V14, P109, DOI 10.1111/j.0906-6705.2005.00226.x; Szulgit G, 2002, J INVEST DERMATOL, V118, P409, DOI 10.1046/j.0022-202x.2001.01680.x; Wood FM, 2006, BURNS, V32, P538, DOI 10.1016/j.burns.2006.02.025; WOOD LC, 1992, J CLIN INVEST, V90, P482, DOI 10.1172/JCI115884; Wood LC, 1996, J INVEST DERMATOL, V106, P397, DOI 10.1111/1523-1747.ep12343392; Xia W, 2004, WOUND REPAIR REGEN, V12, P546, DOI 10.1111/j.1067-1927.2004.012507.x; Zhang J Z, 1994, Exp Dermatol, V3, P164, DOI 10.1111/j.1600-0625.1994.tb00273.x	46	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e29942	10.1371/journal.pone.0029942	http://dx.doi.org/10.1371/journal.pone.0029942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359539	gold, Green Published, Green Submitted			2022-12-25	WOS:000302796200008
J	McRonald, FE; Risk, JM; Hodges, NJ				McRonald, Fiona E.; Risk, Janet M.; Hodges, Nikolas J.			Protection from Intracellular Oxidative Stress by Cytoglobin in Normal and Cancerous Oesophageal Cells	PLOS ONE			English	Article							DNA-DAMAGE; IN-VITRO; OVEREXPRESSION PROTECTS; HUMAN NEUROGLOBIN; LIGAND-BINDING; GLOBIN FAMILY; COMET ASSAY; TOC LOCUS; EXPRESSION; TYLOSIS	Cytoglobin is an intracellular globin of unknown function that is expressed mostly in cells of a myofibroblast lineage. Possible functions of cytoglobin include buffering of intracellular oxygen and detoxification of reactive oxygen species. Previous work in our laboratory has demonstrated that cytoglobin affords protection from oxidant-induced DNA damage when over expressed in vitro, but the importance of this in more physiologically relevant models of disease is unknown. Cytoglobin is a candidate for the tylosis with oesophageal cancer gene, and its expression is strongly down-regulated in non-cancerous oesophageal biopsies from patients with TOC compared with normal biopsies. Therefore, oesophageal cells provide an ideal experimental model to test our hypothesis that downregulation of cytoglobin expression sensitises cells to the damaging effects of reactive oxygen species, particularly oxidative DNA damage, and that this could potentially contribute to the TOC phenotype. In the current study, we tested this hypothesis by manipulating cytoglobin expression in both normal and oesophageal cancer cell lines, which have normal physiological and no expression of cytoglobin respectively. Our results show that, in agreement with previous findings, over expression of cytoglobin in cancer cell lines afforded protection from chemically-induced oxidative stress but this was only observed at non-physiological concentrations of cytoglobin. In addition, down regulation of cytoglobin in normal oesophageal cells had no effect on their sensitivity to oxidative stress as assessed by a number of end points. We therefore conclude that normal physiological concentrations of cytoglobin do not offer cytoprotection from reactive oxygen species, at least in the current experimental model.	[McRonald, Fiona E.; Hodges, Nikolas J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [McRonald, Fiona E.; Risk, Janet M.] Univ Liverpool, Sch Dent, Liverpool L69 3BX, Merseyside, England	University of Birmingham; University of Liverpool	McRonald, FE (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	n.hodges@bham.ac.uk		McRonald, Fiona/0000-0001-7226-9461; Risk, Janet/0000-0002-8770-7783; hodges, nikolas/0000-0002-3306-7688	Cancer Research UK [C7738/A10476]	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK project grant C7738/A10476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blank M, 2011, PLOS1; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; de Sanctis D, 2004, BIOCHEM BIOPH RES CO, V316, P1217, DOI 10.1016/j.bbrc.2004.03.007; Duez P, 2003, MUTAGENESIS, V18, P159, DOI 10.1093/mutage/18.2.159; Emara M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-33; Fang JY, 2011, RADIAT RES, V176, P198, DOI 10.1667/RR2517.1; Fordel E, 2004, BIOCHEM BIOPH RES CO, V319, P342, DOI 10.1016/j.bbrc.2004.05.010; Fordel E, 2007, FEBS J, V274, P1312, DOI 10.1111/j.1742-4658.2007.05679.x; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Gardner AM, 2010, J BIOL CHEM, V285, P23850, DOI 10.1074/jbc.M110.132340; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Guo X, 2007, BIOCHEM BIOPH RES CO, V364, P145, DOI 10.1016/j.bbrc.2007.09.108; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; He X, 2011, PROTEIN J, V30, P437, DOI 10.1007/s10930-011-9340-2; Hodges NJ, 2008, MUTAGENESIS, V23, P293, DOI 10.1093/mutage/gen013; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kelsell DP, 1996, HUM MOL GENET, V5, P857, DOI 10.1093/hmg/5.6.857; Langan JE, 2004, HUM GENET, V114, P534, DOI 10.1007/s00439-004-1100-3; Thuy LTT, 2011, AM J PATHOL, V179, P1050, DOI 10.1016/j.ajpath.2011.05.006; Lechauve C, 2010, FEBS J, V277, P2696, DOI [10.1111/j.1742-4658.2010.07686.x, 10.1111/j.1742-464X.2010.07686.x]; Lee AJ, 2005, CANCER EPIDEM BIOMAR, V14, P497, DOI 10.1158/1055-9965.EPI-04-0295; Li D, 2007, NEUROCHEM RES, V32, P1375, DOI 10.1007/s11064-007-9317-x; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Li WG, 2011, PROTEINS, V79, P115, DOI 10.1002/prot.22863; Makino M, 2006, ACTA CRYSTALLOGR D, V62, P671, DOI 10.1107/S0907444906013813; Man KNM, 2008, TOXICOL LETT, V183, P36, DOI 10.1016/j.toxlet.2008.09.015; Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z; McRonald FE, 2006, HUM MOL GENET, V15, P1271, DOI 10.1093/hmg/ddl042; Mimura I, 2010, AM J PHYSIOL-RENAL, V299, pF1120, DOI 10.1152/ajprenal.00145.2010; Nakatani K, 2004, LAB INVEST, V84, P91, DOI 10.1038/labinvest.3700013; Nishi H, 2011, AM J PATHOL, V178, P128, DOI 10.1016/j.ajpath.2010.11.011; NISHIHIRA T, 1979, GANN, V70, P575; Olive PL, 2005, CYTOM PART A, V66A, P1, DOI 10.1002/cyto.a.20154; Reeder BJ, 2011, BIOCHEM J, V434, P483, DOI 10.1042/BJ20101136; Ren Y, 2005, CLIN CANCER RES, V11, P6190, DOI 10.1158/1078-0432.CCR-04-2553; Risk JM, 2002, ONCOGENE, V21, P6395, DOI 10.1038/sj.onc.1205768; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Shahabi M, 2004, INT J ONCOL, V25, P389; Shaw RJ, 2009, BRIT J CANCER, V101, P139, DOI 10.1038/sj.bjc.6605121; Shigematsu A, 2008, HEMOGLOBIN, V32, P287, DOI 10.1080/03630260802017261; Shivapurkar N, 2008, CANCER RES, V68, P7448, DOI 10.1158/0008-5472.CAN-08-0565; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Stagner JI, 2009, ISLETS, V1, P50, DOI 10.4161/isl.1.1.8936; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; Sugimoto H, 2004, J MOL BIOL, V339, P873, DOI 10.1016/j.jmb.2004.04.024; Toyokuni S, 2008, IUBMB LIFE, V60, P441, DOI 10.1002/iub.61; Xinarianos G, 2006, HUM MOL GENET, V15, P2038, DOI 10.1093/hmg/ddl128; Xu R, 2006, MOL THER, V13, P1093, DOI 10.1016/j.ymthe.2005.11.027	50	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e30587	10.1371/journal.pone.0030587	http://dx.doi.org/10.1371/journal.pone.0030587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359545	Green Submitted, Green Published, gold			2022-12-25	WOS:000302796200014
J	Zhang, L; Wilson, DP				Zhang, Lei; Wilson, David P.			Trends in Notifiable Infectious Diseases in China: Implications for Surveillance and Population Health Policy	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; SEXUALLY-TRANSMITTED-DISEASES; FEMALE SEX WORKERS; HEPATITIS-B; DRUG-USERS; ANTIRETROVIRAL THERAPY; RESISTANT TUBERCULOSIS; SOUTHWESTERN CHINA; HEMORRHAGIC-FEVER; MEASLES VIRUSES	This study aimed to analyse trends in notifiable infectious diseases in China, in their historical context. Both English and Chinese literature was searched and diseases were categorised according to the type of disease or transmission route. Temporal trends of morbidity and mortality rates were calculated for eight major infectious diseases types. Strong government commitment to public health responses and improvements in quality of life has led to the eradication or containment of a wide range of infectious diseases in China. The overall infectious diseases burden experienced a dramatic drop during 1975-1995, but since then, it reverted and maintained a gradual upward trend to date. Most notifiable diseases are contained at a low endemic level; however, local small-scale outbreaks remain common. Tuberculosis, as a bacterial infection, has re-emerged since the 1990s and has become prevalent in the country. Sexually transmitted infections are in a rapid, exponential growth phase, spreading from core groups to the general population. Together human immunodeficiency virus (HIV), they account for 39% of all death cases due to infectious diseases in China in 2008. Zoonotic infections, such as severe acute respiratory syndrome (SARS), rabies and influenza, pose constant threats to Chinese residents and remain the most deadly disease type among the infected individuals. Therefore, second-generation surveillance of behavioural risks or vectors associated with pathogen transmission should be scaled up. It is necessary to implement public health interventions that target HIV and relevant coinfections, address transmission associated with highly mobile populations, and reduce the risk of cross-species transmission of zoonotic pathogens.	[Zhang, Lei; Wilson, David P.] Univ New S Wales, Fac Med, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Zhang, L (corresponding author), Univ New S Wales, Fac Med, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia.	lzhang@kirby.unsw.edu.au	Zhang, Lei/D-4039-2011; Wilson, David P/G-4614-2013	Zhang, Lei/0000-0003-2343-084X; 	Australian Government Department of Health and Ageing; Australian Research Council [FT0991990]; University of New South Wales	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian Research Council(Australian Research Council); University of New South Wales	This study was funded from the following sources: the Australian Government Department of Health and Ageing; Australian Research Council (FT0991990); the University of New South Wales. The views expressed in this publication do not necessarily represent the position of the Australian Government. The Kirby Institute is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinger Carmen, 2008, Promot Educ, V15, P24, DOI 10.1177/1025382307088095; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Bao YP, 2010, REV HIV HCV INFECT D; Beyrer C, 2003, JAMA-J AM MED ASSOC, V289, P1303, DOI 10.1001/jama.289.10.1303; Bi P, 2005, VECTOR-BORNE ZOONOT, V5, P95, DOI 10.1089/vbz.2005.5.95; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Chen XY, 2004, LANCET, V364, P417; Chen XY, 2002, B WORLD HEALTH ORGAN, V80, P430; Chiba Y, 2001, B WORLD HEALTH ORGAN, V79, P103; Chinese Ministry of Health, 2008, CHIN HLTH YB 2008; Choi KH, 2007, JAIDS-J ACQ IMM DEF, V45, P77, DOI 10.1097/QAI.0b013e3180415dd7; Ci W, 2000, CHINA J PREVENTIVE M, V34, P67; Cohen MS, 2000, SEX TRANSM DIS, V27, P143, DOI 10.1097/00007435-200003000-00004; Cong X, 2006, CHINESE J CONTROL EN, V21, P159; Cunningham AL, 2006, SEX TRANSM INFECT, V82, P164, DOI 10.1136/sti.2005.016899; Dong F, 2007, J CHIN MOD MED, V4, P598; Dong ZJ, 2005, CHINESE RURAL HLTH S, V09, P20; Fang LQ, 2009, EMERG INFECT DIS, V15, P2043, DOI 10.3201/eid1512.081078; Fang LQ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-77; Fang Y, 2008, J AGR FOOD CHEM, V56, P2079, DOI 10.1021/jf800150z; Fine PEM, 2009, J INFECT DIS, V200, P673, DOI 10.1086/605331; Flucount. org, 2010, WORLD LAB VER SWIN F; Guan P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-109; He Q, 2009, SEX TRANSM INFECT, DOI sti. 2009.035808; HIV/AIDS MoHPsRoCJUNPo, 2006, 2005 UPD HIV AIDS; Hu R, 2008, RABIES CHINA UPDATE; Hu RL, 2008, EPIDEMIOL INFECT, V136, P1556, DOI 10.1017/S0950268807000131; Jiang XY, 2008, SOUTH MED J, V101, P914, DOI 10.1097/SMJ.0b013e31817c13ab; Kretzschmar M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-108; Lam WK, 2003, RESPIROLOGY, V8, pS2, DOI 10.1046/j.1440-1843.2003.00516.x; Li B, 2006, J SE CHINA NATL DEFE, V8, P395; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Liu DH, 2008, INT J MED INFORM, V77, P630, DOI 10.1016/j.ijmedinf.2007.10.011; Liu HJ, 2006, AIDS PATIENT CARE ST, V20, P133, DOI 10.1089/apc.2006.20.133; Liu JJ, 2005, INT J TUBERC LUNG D, V9, P450; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008467; Meng SL, 2007, VIRUS RES, V124, P125, DOI 10.1016/j.virusres.2006.10.011; Miao Z, 2003, CHINESE J AIDS STD, V9, P54; Ministry of Health, 2006, 2006 YB CHIN HLTH ST; National Bureau of Statistics of China, 2010, 2010 YB CHIN HLTH ST; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Pirkle C, 2007, SEX TRANSM DIS, V34, P695, DOI 10.1097/01.olq.0000260989.70866.94; PURCELL RH, 1994, P NATL ACAD SCI USA, V91, P2401, DOI 10.1073/pnas.91.7.2401; Qian H, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P225; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Ruan YH, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000304695.54884.4f; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Ruan YH, 2006, SEX TRANSM DIS, V33, P719, DOI 10.1097/01.olq.0000218881.01437.99; Shang DQ, 2002, VET MICROBIOL, V90, P165, DOI 10.1016/S0378-1135(02)00252-3; Si H, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-113; Soriano V, 2006, J ANTIMICROB CHEMOTH, V57, P815, DOI 10.1093/jac/dkl068; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; State council AIDS working committee office and UN themem group on HIV/AIDS in China, 2004, JOINT ASS HIV AIDS P; Tang XC, 2005, EMERG INFECT DIS, V11, P1970, DOI 10.3201/eid1112.050271; Tarantola A, 2010, EUROSURVEILLANCE, V15, P8; Tedaldi E, 2008, CLIN INFECT DIS, V47, P1468, DOI 10.1086/593102; Tu G, 1999, CNINESE J BIOL; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; van den Berg T, 2009, REV SCI TECH OIE, V28, P93; Wang D, 2010, JPN J INFECT DIS, V63, P368; Wang KA, 1997, J INFECT DIS, V175, pS105, DOI 10.1093/infdis/175.Supplement_1.S105; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LX, 2003, J INFECT DIS, V187, pS252, DOI 10.1086/368045; Wang S, 1999, CHINA CHINESE J ENDE, V20, P7; WHO, 2008, CUM NUMB CONF RM HUM; World Health Organization, 1996, WHO EXP CONS RAB, P88; World Health Organization, 2005, GLOB RUB CONTR SURV; Wu NP, 2003, CHINESE MED J-PEKING, V116, P1318; Xiang B., 2003, MIGRATION HLTH CHINA, V17, P1; Xu JQ, 2006, CHINESE MED J-PEKING, V119, P1941, DOI 10.1097/00029330-200612010-00002; Xu ZY, 2008, J VIRAL HEPATITIS, V15, P33, DOI 10.1111/j.1365-2893.2008.01026.x; YANG BP, 1995, PEDIATR INFECT DIS J, V14, P308, DOI 10.1097/00006454-199504000-00011; Yang G. J., 2005, Parassitologia (Rome), V47, P127; Yang HH, 2001, J INFECT DIS, V183, P1775, DOI 10.1086/320729; Yang HH, 2001, B WORLD HEALTH ORGAN, V79, P625; Yu W L, 1989, Zhonghua Liu Xing Bing Xue Za Zhi, V10, P257; Ze W, 2001, EXPANDED PROGRAM IMM; Zeng G, 1997, CHINESE J EPIDEMIOLO, P18; Zhang C-h, 2009, FOREIGN MED SCI SECT, V30, P104; Zhang J, 2003, J CHINA AIDS STD, V9, P984; Zhang JP, 1999, CHINESE J ENDEMIOLOG, V20, P377; Zhang L, 2009, BUILD BETT INF DIS S; Zhang S, 2001, SHANGHHAI J PREVENTI, V12, P253; Zhang Sheng-Nian, 2002, Environ Health Prev Med, V7, P132, DOI 10.1265/ehpm.2002.132; Zhang Y, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-14; Zhang Y, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-120; Zhang YZ, 2006, VIRUS RES, V121, P179, DOI 10.1016/j.virusres.2006.05.010; Zhang YZ, 2005, EMERG INFECT DIS, V11, P1983; Zhao ZY, 2009, CHINESE MED J-PEKING, V122, P2241, DOI 10.3760/cma.j.issn.0366-6999.2009.19.010; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	92	55	69	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2012	7	2							e31076	10.1371/journal.pone.0031076	http://dx.doi.org/10.1371/journal.pone.0031076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925XS	22359565	Green Published, Green Submitted, gold			2022-12-25	WOS:000302796200034
J	Carlisle, AB; Kim, SL; Semmens, BX; Madigan, DJ; Jorgensen, SJ; Perle, CR; Anderson, SD; Chapple, TK; Kanive, PE; Block, BA				Carlisle, Aaron B.; Kim, Sora L.; Semmens, Brice X.; Madigan, Daniel J.; Jorgensen, Salvador J.; Perle, Christopher R.; Anderson, Scot D.; Chapple, Taylor K.; Kanive, Paul E.; Block, Barbara A.			Using Stable Isotope Analysis to Understand the Migration and Trophic Ecology of Northeastern Pacific White Sharks (Carcharodon carcharias)	PLOS ONE			English	Article							TUNA THUNNUS-OBESUS; CARBON ISOTOPES; COLLAGEN-SYNTHESIS; NITROGEN ISOTOPES; NATURAL-ABUNDANCE; GUADALUPE ISLAND; DIVING BEHAVIOR; FEEDING ECOLOGY; DIET; TURNOVER	The white shark (Carcharodon carcharias) is a wide-ranging apex predator in the northeastern Pacific (NEP). Electronic tagging has demonstrated that white sharks exhibit a regular migratory pattern, occurring at coastal sites during the late summer, autumn and early winter and moving offshore to oceanic habitats during the remainder of the year, although the purpose of these migrations remains unclear. The purpose of this study was to use stable isotope analysis (SIA) to provide insight into the trophic ecology and migratory behaviors of white sharks in the NEP. Between 2006 and 2009, 53 white sharks were biopsied in central California to obtain dermal and muscle tissues, which were analyzed for stable isotope values of carbon (delta C-13) and nitrogen (delta N-15). We developed a mixing model that directly incorporates movement data and tissue incorporation (turnover) rates to better estimate the relative importance of different focal areas to white shark diet and elucidate their migratory behavior. Mixing model results for muscle showed a relatively equal dietary contribution from coastal and offshore regions, indicating that white sharks forage in both areas. However, model results indicated that sharks foraged at a higher relative rate in coastal habitats. There was a negative relationship between shark length and muscle delta C-13 and delta N-15 values, which may indicate ontogenetic changes in habitat use related to onset of maturity. The isotopic composition of dermal tissue was consistent with a more rapid incorporation rate than muscle and may represent more recent foraging. Low offshore consumption rates suggest that it is unlikely that foraging is the primary purpose of the offshore migrations. These results demonstrate how SIA can provide insight into the trophic ecology and migratory behavior of marine predators, especially when coupled with electronic tagging data.	[Carlisle, Aaron B.; Madigan, Daniel J.; Jorgensen, Salvador J.; Perle, Christopher R.; Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Kim, Sora L.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Semmens, Brice X.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Jorgensen, Salvador J.] Monterey Bay Aquarium, Monterey, CA USA; [Anderson, Scot D.] Point Reyes Natl Seashore, Inverness, CA USA; [Chapple, Taylor K.] Univ Calif Davis, Davis, CA 95616 USA; [Chapple, Taylor K.] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Kanive, Paul E.] Montana State Univ, Bozeman, MT 59717 USA	Stanford University; University of California System; University of California Santa Cruz; University of California System; University of California San Diego; Scripps Institution of Oceanography; Monterey Bay Aquarium Research Institute; University of California System; University of California Davis; Max Planck Society; Montana State University System; Montana State University Bozeman	Carlisle, AB (corresponding author), Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.	aaroncar@stanford.edu		Carlisle, Aaron/0000-0003-0796-6564	Alfred P. Sloan Foundation; David and Lucile Packard Foundation; Gordon and Betty Moore Foundation; Monterey Bay Aquarium Foundation; Office of Naval Research; Stanford University's School of Humanities and Sciences	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Monterey Bay Aquarium Foundation; Office of Naval Research(Office of Naval Research); Stanford University's School of Humanities and Sciences	Funding was provided by the Alfred P. Sloan Foundation, the David and Lucile Packard Foundation, the Gordon and Betty Moore Foundation, Monterey Bay Aquarium Foundation, the Office of Naval Research, and Stanford University's School of Humanities and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsley DG, 1985, MEM S CALIF ACAD SCI, V9, P109; Anderson SD, 2003, CALIF FISH GAME, V89, P96; [Anonymous], 2020, ECONOMIST 0326; Babraj JA, 2005, AM J PHYSIOL-ENDOC M, V289, pE864, DOI 10.1152/ajpendo.00243.2005; BERGER WH, 1989, PRODUCTIVITY OCEAN P, P429; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bonfil R, 2010, AQUAT BIOL, V8, P115, DOI 10.3354/ab00217; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Bower JR, 2005, FISH RES, V76, P39, DOI 10.1016/j.fishres.2005.05.009; Bump JK, 2007, P ROY SOC B-BIOL SCI, V274, P2471, DOI 10.1098/rspb.2007.0700; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; Burton RK, 2001, OECOLOGIA, V128, P107, DOI 10.1007/s004420100631; Cailliet G.M., 1985, Memoirs of the Southern California Academy of Sciences, V9, P49; CAREY FG, 1982, COPEIA, P254; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Carlson JK, 2004, CRC MAR BIOL SER, P203; Casey J.G., 1985, Memoirs of the Southern California Academy of Sciences, V9, P2; Chapple TK, 2011, BIOL LETTERS, V7, P581, DOI 10.1098/rsbl.2011.0124; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Compagno LJV, 2001, SHARKS WORLD ANNOT; Dagorn L, 2000, MAR BIOL, V136, P361, DOI 10.1007/s002270050694; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dewar H, 2004, ENVIRON BIOL FISH, V70, P133, DOI 10.1023/B:EBFI.0000029343.54027.6a; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; DUNTON KH, 1989, MAR ECOL PROG SER, V56, P89, DOI 10.3354/meps056089; El-Harake WA, 1998, AM J PHYSIOL-ENDOC M, V274, pE586, DOI 10.1152/ajpendo.1998.274.4.E586; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Estrada JA, 2003, J MAR BIOL ASSOC UK, V83, P1347, DOI 10.1017/S0025315403008798; Evans DH, 2004, CRC MAR BIOL SER, P247; Fisk AT, 2002, ECOLOGY, V83, P2162, DOI 10.1890/0012-9658(2002)083[2162:UACASI]2.0.CO;2; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Francis MP, 1996, GREAT WHITE SHARKS, P157, DOI 10.1016/B978-012415031-7/50016-1; Francis TB, 2011, ECOL LETT, V14, P364, DOI 10.1111/j.1461-0248.2011.01597.x; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Fry B, 2006, STABLE ISOTOPES ECOL; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; GILMARTIN M, 1974, J EXP MAR BIOL ECOL, V16, P181, DOI 10.1016/0022-0981(74)90019-7; GOERICKE R, 1994, GLOBAL BIOGEOCHEM CY, V8, P85, DOI 10.1029/93GB03272; Goldman KJ, 1997, J COMP PHYSIOL B, V167, P423, DOI 10.1007/s003600050092; Gould P, 1997, CAN J ZOOL, V75, P549, DOI 10.1139/z97-068; Graham B.S., 2007, TROPHIC DYNAMICS MOV; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Graham BS, 2007, MAR BIOL, V150, P647, DOI 10.1007/s00227-006-0360-y; GRAHAM JB, 1990, J EXP BIOL, V151, P175; Hedges L.V., 1985, STAT METHODS META AN; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hobson KA, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P273, DOI 10.1007/978-90-481-3354-3_13; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; Ichii T, 2009, MAR ECOL PROG SER, V378, P1, DOI 10.3354/meps07873; Jacoby DMP, 2012, FISH FISH, V13, P399, DOI 10.1111/j.1467-2979.2011.00436.x; Jarman WM, 1996, ENVIRON SCI TECHNOL, V30, P654, DOI 10.1021/es950392n; Johnson SP, 2009, ECOL RES, V24, P855, DOI 10.1007/s11284-008-0559-0; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kerr LA, 2006, ENVIRON BIOL FISH, V77, P337, DOI 10.1007/s10641-006-9125-1; Kim S. L., 2011, ENVIRON BIOL FISH, DOI [10.1007/s10641-10011-19860-10649, DOI 10.1007/S10641-10011-19860-10649]; Kim SL, 2010, THESIS U CALIFORNIA; Kim SL, 2011, ENVIRON BIOL FISH, DOI [10.1007/s10641-10011-19919-10647, DOI 10.1007/S10641-10011-19919-10647]; Klimley A.P., 1985, Memoirs of the Southern California Academy of Sciences, V9, P15; LEBOEUF BJ, 1982, FISH B-NOAA, V80, P891; Logan J, 2006, OECOLOGIA, V147, P391, DOI 10.1007/s00442-005-0277-z; Logan JM, 2010, HYDROBIOLOGIA, V644, P231, DOI 10.1007/s10750-010-0120-3; Long DJ, 1996, GREAT WHITE SHARKS, P263, DOI 10.1016/B978-012415031-7/50025-2; Long DJ, 1996, GREAT WHITE SHARKS, P293, DOI 10.1016/B978-012415031-7/50028-8; MacAvoy SE, 2001, CAN J FISH AQUAT SCI, V58, P923, DOI 10.1139/cjfas-58-5-923; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Malcolm H., 2001, REV BIOL STATUS WHIT; Matsumoto Takayuki, 2008, Inter-American Tropical Tuna Commission Bulletin, V24, P3; McCosker J.E., 1985, Memoirs of the Southern California Academy of Sciences, V9, P123; McIntyre PB, 2006, OECOLOGIA, V148, P12, DOI 10.1007/s00442-005-0354-3; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Miller TW, 2008, LIMNOL OCEANOGR, V53, P1493, DOI 10.4319/lo.2008.53.4.1493; Mollet HF, 2000, FISH B-NOAA, V98, P299; Montoya JP, 2007, ECOL METHOD CONCEPT, P176, DOI 10.1002/9780470691854.ch7; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; MOTTA PJ, 1977, COPEIA, P454, DOI 10.2307/1443263; Musyl MK, 2003, FISH OCEANOGR, V12, P152, DOI 10.1046/j.1365-2419.2003.00229.x; Nardoto GB, 2006, SCI AGR, V63, P579, DOI 10.1590/S0103-90162006000600012; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Newsome SD, 2009, MAR ECOL PROG SER, V374, P229, DOI 10.3354/meps07747; Okamoto Hiroaki, 2003, Inter-American Tropical Tuna Commission Bulletin, V22, P221; Parry MP, 2008, MAR BIOL, V153; Parry MP, 2003, TROPHIC ECOLOGY 2 OM, P287; Pearcy WC, 1993, CAN J FISH AQUAT SCI, V50; PEARCY WG, 1983, DEEP-SEA RES, V30, P427, DOI 10.1016/0198-0149(83)90076-6; Perry RI, 1999, CAN J FISH AQUAT SCI, V56, P2477, DOI 10.1139/cjfas-56-12-2477; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2006, OECOLOGIA, V147, P195, DOI 10.1007/s00442-005-0292-0; Popp BN, 2007, TERR ECOL SER, V1, P173; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Pratt HL, 1996, GREAT WHITE SHARKS, P131, DOI 10.1016/B978-012415031-7/50014-8; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Ragen TJ, 1999, CONSERVATION MANAGEM, P223; RAU GH, 1983, ECOLOGY, V64, P1314, DOI 10.2307/1937843; Roper C.F.E., 1975, Smithsonian Contributions to Zoology, VNo. 209, P1; Rosenberg M.S., 2000, STAT SOFTWARE METAAN; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; SAINO T, 1987, DEEP-SEA RES, V34, P807, DOI 10.1016/0198-0149(87)90038-0; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347; Smith K, 2007, CURR OPIN CLIN NUTR, V10, P582, DOI 10.1097/MCO.0b013e328285d858; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Taylor L., 1985, Memoirs of the Southern California Academy of Sciences, V9, P41; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; THOMAS CJ, 1993, MAR ECOL PROG SER, V95, P19, DOI 10.3354/meps095019; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Topperoff AK, 1997, DIET HARBOR PROPOISE, P103; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; Waite AM, 2007, DEEP-SEA RES PT II, V54, P1055, DOI 10.1016/j.dsr2.2006.12.010; Wallman HL, 2006, ENVIRON BIOL FISH, V75, P259, DOI 10.1007/s10641-006-0025-1; Watanabe H, 2006, J FISH BIOL, V68, P1436, DOI 10.1111/j.0022-1112.2006.01027.x; Watanabe H, 2006, MAR ECOL PROG SER, V315, P187, DOI 10.3354/meps315187; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Weidel BC, 2011, CAN J FISH AQUAT SCI, V68, P387, DOI 10.1139/F10-158; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211; West JB, ISOCAPES UNDERSTANDI; Witteveen BH, 2009, MAR ECOL PROG SER, V393, P173, DOI 10.3354/meps08231; Witteveen BH, 2009, MAR ECOL PROG SER, V379, P299, DOI 10.3354/meps07900; Zhang HY, 2009, J EXP MAR BIOL ECOL, V381, pS80, DOI 10.1016/j.jembe.2009.07.014; Zuyev G, 2002, B MAR SCI, V71, P1019	131	120	121	0	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30492	10.1371/journal.pone.0030492	http://dx.doi.org/10.1371/journal.pone.0030492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355313	Green Published, gold			2022-12-25	WOS:000302741300013
J	Descamps, S; Jenouvrier, S; Gilchrist, HG; Forbes, MR				Descamps, Sebastien; Jenouvrier, Stephanie; Gilchrist, H. Grant; Forbes, Mark R.			Avian Cholera, a Threat to the Viability of an Arctic Seabird Colony?	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; LONG-LIVED BIRD; PASTEURELLA-MULTOCIDA; CLIMATE-CHANGE; POPULATION; VARIABILITY; DYNAMICS; SURVIVAL; BIODIVERSITY; EXTINCTION	Evidence that infectious diseases cause wildlife population extirpation or extinction remains anecdotal and it is unclear whether the impacts of a pathogen at the individual level can scale up to population level so drastically. Here, we quantify the response of a Common eider colony to emerging epidemics of avian cholera, one of the most important infectious diseases affecting wild waterfowl. We show that avian cholera has the potential to drive colony extinction, even over a very short period. Extinction depends on disease severity (the impact of the disease on adult female survival) and disease frequency (the number of annual epidemics per decade). In case of epidemics of high severity (i.e., causing > 30% mortality of breeding females), more than one outbreak per decade will be unsustainable for the colony and will likely lead to extinction within the next century; more than four outbreaks per decade will drive extinction to within 20 years. Such severity and frequency of avian cholera are already observed, and avian cholera might thus represent a significant threat to viability of breeding populations. However, this will depend on the mechanisms underlying avian cholera transmission, maintenance, and spread, which are currently only poorly known.	[Descamps, Sebastien] Norwegian Polar Res Inst, Tromso, Norway; [Descamps, Sebastien; Forbes, Mark R.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Jenouvrier, Stephanie] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Jenouvrier, Stephanie] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Gilchrist, H. Grant] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada	Norwegian Polar Institute; Carleton University; Woods Hole Oceanographic Institution; Centre National de la Recherche Scientifique (CNRS); Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	Descamps, S (corresponding author), Norwegian Polar Res Inst, Tromso, Norway.	sebastien.descamps@npolar.no	Forbes, Mark R/B-3575-2013	Forbes, Mark/0000-0002-2288-3209; jenouvrier, stephanie/0000-0003-3324-2383	Canadian Wildlife Service-Environment Canada; Nunavut Wildlife Management Board; Greenland Institute of Natural Resources; Polar Continental Shelf Project; Fonds Quebecois de la Recherche sur la Nature et les Technologies; Canadian Network of Centres of Excellence ArcticNet; Natural Sciences and Engineering Research Council of Canada; Department of Indian Affairs and Northern Canada	Canadian Wildlife Service-Environment Canada; Nunavut Wildlife Management Board; Greenland Institute of Natural Resources; Polar Continental Shelf Project(Natural Resources Canada); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT); Canadian Network of Centres of Excellence ArcticNet; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Department of Indian Affairs and Northern Canada	The study was supported by the Canadian Wildlife Service-Environment Canada (http://www.ec.gc.ca/), Nunavut Wildlife Management Board (http://www.nwmb.com/), Greenland Institute of Natural Resources (http://www.natur.gl/), Polar Continental Shelf Project (http://polar.nrcan.gc.ca/), Fonds Quebecois de la Recherche sur la Nature et les Technologies (http://www.fqrnt.gouv.qc.ca/), Canadian Network of Centres of Excellence ArcticNet (http://www.arcticnet.ulaval.ca/), Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/), and the Department of Indian Affairs and Northern Canada (http://www.ainc-inac.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchong JA, 2006, J WILDLIFE DIS, V42, P33, DOI 10.7589/0090-3558-42.1.33; Buttler EI, J WILDLIFE IN PRESS; Buttler EI, 2009, THESIS CARLETON U OT; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Cole RA, 1999, FIELD MANUAL WILDLIF, P48; COULSON JC, 1984, IBIS, V126, P525, DOI 10.1111/j.1474-919X.1984.tb02078.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Descamps S, 2011, J AVIAN BIOL, V42, P39, DOI 10.1111/j.1600-048X.2010.05196.x; Descamps S, 2010, OIKOS, V119, P1526, DOI 10.1111/j.1600-0706.2010.18508.x; Descamps S, 2009, BIOL LETTERS, V5, P278, DOI 10.1098/rsbl.2008.0704; Dobson A, 2009, ECOLOGY, V90, P920, DOI 10.1890/08-0736.1; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Friend M, 2001, AUK, V118, P290, DOI 10.1642/0004-8038(2001)118[0290:DEIBCF]2.0.CO;2; FRIEND M, 2006, 1285 US GEOL SURV; GORDUS AG, 1993, J WILDLIFE DIS, V29, P367, DOI 10.7589/0090-3558-29.2.367; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Kutz SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2571, DOI 10.1098/rspb.2005.3285; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Samuel MD, 2005, J WILDLIFE DIS, V41, P48, DOI 10.7589/0090-3558-41.1.48; Samuel Michael D., 2007, P239, DOI 10.1002/9780470344668.ch12; Sandercock BK, 2011, J ANIM ECOL, V80, P244, DOI 10.1111/j.1365-2656.2010.01769.x; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Waller LJ, 2007, AFR J MAR SCI, V29, P105, DOI 10.2989/AJMS.2007.29.1.9.74	33	46	48	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e29659	10.1371/journal.pone.0029659	http://dx.doi.org/10.1371/journal.pone.0029659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355304	Green Published, gold			2022-12-25	WOS:000302741300004
J	Ishikawa, K; Wan, L; Calzavacca, P; Bellomo, R; Bailey, M; May, CN				Ishikawa, Ken; Wan, Li; Calzavacca, Paolo; Bellomo, Rinaldo; Bailey, Michael; May, Clive N.			The Effects of Terlipressin on Regional Hemodynamics and Kidney Function in Experimental Hyperdynamic Sepsis	PLOS ONE			English	Article							RESISTANT SEPTIC SHOCK; ORGAN BLOOD-FLOW; VASOPRESSIN INFUSION; NOREPINEPHRINE; HEALTHY; HYPOTENSION; CHILDREN; SHEEP; RATS	Background and Aims: Although terlipressin (TP) may improve renal function in cirrhotic patients, its use in sepsis remains controversial due to concerns about regional ischemia. We investigated the effects of TP on regional hemodynamics and kidney function in experimental hyperdynamic sepsis. Methods: We studied thirteen merino ewes in a university physiology laboratory using a randomized controlled cross over design. We implanted flow probes around the pulmonary, circumflex coronary, superior mesenteric, renal and iliac arteries. We injected live Escherichia coli and induced hyperdynamic sepsis. We treated animals with either bolus vehicle or a single dose of TP (sTP = 1 mg). In a second group, after 1 mg of TP, two additional bolus injections (mTP) of 0.5 mg were given at 2 hourly intervals. Main Results: sTP (1 mg) significantly increased mean arterial pressure (MAP) (74 to 89 mmHg; P<0.0001) creatinine clearance (31 to 85 mL/min; P<0.0001) and urine output (24 to 307 mL/hr) (P<0.0001). However, it decreased CO (5.7 to 3.9 L/min; p<0.0001), coronary blood flow (CBF) (43 to 32 mL/min; p<0.0001) and mesenteric blood flow (MBF) (944 to 625 mL/min; p = 0.004) and increased blood lactate (2.1 to 4.0 mmol/L; p<0.0001). Extra doses of TP caused little additional effect. Conclusions: In hyperdynamic sepsis, bolus TP transiently improves MAP and renal function, but reduces CO, CBF and MBF, and increases blood lactate. Caution should be applied when prescribing bolus TP in septic patients at risk of coronary or mesenteric ischemia.	[Ishikawa, Ken; Wan, Li; Calzavacca, Paolo; May, Clive N.] Univ Melbourne, Howard Florey Inst, Parkville, Vic 3052, Australia; [Ishikawa, Ken; Wan, Li; Calzavacca, Paolo; Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Melbourne, Vic, Australia; [Ishikawa, Ken; Wan, Li; Calzavacca, Paolo; Bellomo, Rinaldo] Austin Hlth, Dept Med, Melbourne, Vic, Australia; [Bellomo, Rinaldo; Bailey, Michael] Monash Univ, Sch Epidemiol & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University	Ishikawa, K (corresponding author), Univ Melbourne, Howard Florey Inst, Parkville, Vic 3052, Australia.	rinaldo.bellomo@austin.org.au	Calzavacca, Paolo/AAN-1225-2020; Bailey, Michael J/A-4499-2012	Calzavacca, Paolo/0000-0001-8175-3693; Bailey, Michael J/0000-0002-5551-1401; Bellomo, Rinaldo/0000-0002-1650-8939	National Health Medical Research Council (NHMRC), Australia [454615]; Victorian Government; Iwate Medical University; NHMRC [566819]	National Health Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Iwate Medical University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a grant from the National Health Medical Research Council (NHMRC), Australia (454615) and the Victorian Government's Operational Infrastructure Support Program. KI was supported by a research fellowship from Iwate Medical University, and CNM was supported by an NHMRC Research Fellowship (566819). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese J, 2005, CRIT CARE MED, V33, P1897, DOI 10.1097/01.CCM.0000178182.37639.D6; Asfar P, 2003, CRIT CARE MED, V31, P215, DOI 10.1097/00003246-200301000-00033; Broking K, 2008, SHOCK, V29, P71; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Delmas A, 2005, CRIT CARE, V9, P212, DOI 10.1188/cc2945; Di Giantomasso D, 2006, ANAESTH INTENS CARE, V34, P427, DOI 10.1177/0310057X0603400408; Di Giantomasso D, 2005, INTENS CARE MED, V31, P454, DOI 10.1007/s00134-005-2580-x; Di Giantomasso D, 2003, INTENS CARE MED, V29, P1774, DOI 10.1007/s00134-003-1736-9; EDWARDS RM, 1989, AM J PHYSIOL, V256, pF274, DOI 10.1152/ajprenal.1989.256.2.F274; Escorsell A, 1997, J HEPATOL, V26, P621, DOI 10.1016/S0168-8278(97)80428-X; Gordon AC, 2010, INTENS CARE MED, V36, P83, DOI 10.1007/s00134-009-1687-x; Holmes CL, 2009, CURR OPIN CRIT CARE, V15, P398, DOI 10.1097/MCC.0b013e32832e96ef; Jing L, 2007, CRIT CARE, V11, DOI 10.1186/cc5717; Krishnagopalan Sreenandh, 2002, Curr Opin Crit Care, V8, P376, DOI 10.1097/00075198-200210000-00003; Lange M, 2008, INTENS CARE MED, V34, P821, DOI 10.1007/s00134-007-0946-y; Lange M, 2007, SHOCK, V28, P623, DOI 10.1097/shk.0b013e18050c78d; Leone M, 2004, SHOCK, V22, P314, DOI 10.1097/01.shk.0000136097.42048.bd; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Medel J, 2001, ANESTH ANALG, V93, P53; Michel F, 2007, AM J EMERG MED, V25, pe861; Morelli A, 2004, INTENS CARE MED, V30, P597, DOI 10.1007/s00134-003-2094-3; Morelli A, 2005, ANESTHESIOLOGY, V102, P12, DOI 10.1097/00000542-200501000-00006; Morelli A, 2009, EXPERT OPIN PHARMACO, V10, P2569, DOI 10.1517/14656560903257808; Morelli A, 2009, CRIT CARE, V13, DOI 10.1186/cc7990; Morelli A, 2008, BEST PRACT RES-CLIN, V22, P317, DOI 10.1016/j.bpa.2008.02.006; NILSSON G, 1990, DRUG EXP CLIN RES, V16, P307; Rajekar H, 2011, J GASTROEN HEPATOL, V26, P109, DOI 10.1111/j.1440-1746.2010.06583.x; Rodriguez-Nunez A, 2004, INTENS CARE MED, V30, P477, DOI 10.1007/s00134-003-2114-3; Rodriguez-Nunez A, 2006, CRIT CARE, V10, DOI 10.1186/cc3984; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Ryckwaert F, 2009, CRIT CARE MED, V37, P876, DOI 10.1097/CCM.0b013e31819b8199; Scharte M, 2001, CRIT CARE MED, V29, P1756, DOI 10.1097/00003246-200109000-00017; Singer M, 2008, BEST PRACT RES-CLIN, V22, P359, DOI 10.1016/j.bpa.2008.03.005; SOLOMON MA, 1994, AM J PHYSIOL, V266, pH757, DOI 10.1152/ajpheart.1994.266.2.H757; Stephan F, 1998, LANCET, V351, P1249, DOI 10.1016/S0140-6736(05)79315-6; Umgelter A, 2008, INTENS CARE MED, V34, P390, DOI 10.1007/s00134-007-0877-7; Wan L, 2009, CRIT CARE, V13, DOI 10.1186/cc8185; WEBB RL, 1986, AM J PHYSIOL, V251, pH1244, DOI 10.1152/ajpheart.1986.251.6.H1244	38	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e29693	10.1371/journal.pone.0029693	http://dx.doi.org/10.1371/journal.pone.0029693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355305	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300005
J	Kanju, PM; Parameshwaran, K; Sims-Robinson, C; Uthayathas, S; Josephson, EM; Rajakumar, N; Dhanasekaran, M; Suppiramaniam, V				Kanju, Patrick M.; Parameshwaran, Kodeeswaran; Sims-Robinson, Catrina; Uthayathas, Subramaniam; Josephson, Eleanor M.; Rajakumar, Nagalingam; Dhanasekaran, Muralikrishnan; Suppiramaniam, Vishnu			Selective Cholinergic Depletion in Medial Septum Leads to Impaired Long Term Potentiation and Glutamatergic Synaptic Currents in the Hippocampus	PLOS ONE			English	Article							192 IGG-SAPORIN; NICOTINIC ACETYLCHOLINE-RECEPTORS; WORKING-MEMORY; SPATIAL WORKING; BASAL FOREBRAIN; NMDA RECEPTORS; MUSCARINIC RECEPTORS; IMMUNOTOXIC LESIONS; STRATEGY SELECTION; RAT HIPPOCAMPUS	Cholinergic depletion in the medial septum (MS) is associated with impaired hippocampal-dependent learning and memory. Here we investigated whether long term potentiation (LTP) and synaptic currents, mediated by alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate (AMPA) and N-methyl-D-aspartate (NMDA) receptors in the CA1 hippocampal region, are affected following cholinergic lesions of the MS. Stereotaxic intra-medioseptal infusions of a selective immunotoxin, 192-saporin, against cholinergic neurons or sterile saline were made in adult rats. Four days after infusions, hippocampal slices were made and LTP, whole cell, and single channel (AMPA or NMDA receptor) currents were recorded. Results demonstrated impairment in the induction and expression of LTP in lesioned rats. Lesioned rats also showed decreases in synaptic currents from CA1 pyramidal cells and synaptosomal single channels of AMPA and NMDA receptors. Our results suggest that MS cholinergic afferents modulate LTP and glutamatergic currents in the CA1 region of the hippocampus, providing a potential synaptic mechanism for the learning and memory deficits observed in the rodent model of selective MS cholinergic lesioning.	[Kanju, Patrick M.; Parameshwaran, Kodeeswaran; Sims-Robinson, Catrina; Uthayathas, Subramaniam; Dhanasekaran, Muralikrishnan; Suppiramaniam, Vishnu] Auburn Univ, Dept Pharmacal Sci, Auburn, AL 36849 USA; [Kanju, Patrick M.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Parameshwaran, Kodeeswaran] Auburn Univ, Dept Pathobiol, Auburn, AL 36849 USA; [Sims-Robinson, Catrina] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Uthayathas, Subramaniam] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Josephson, Eleanor M.] Auburn Univ, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA; [Rajakumar, Nagalingam] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada	Auburn University System; Auburn University; Duke University; Auburn University System; Auburn University; University of Michigan System; University of Michigan; Emory University; Auburn University System; Auburn University; Western University (University of Western Ontario)	Kanju, PM (corresponding author), Auburn Univ, Dept Pharmacal Sci, Auburn, AL 36849 USA.	suppivd@auburn.edu	Uthayathas, subramaniam/GRY-0774-2022	Robinson, Catrina/0000-0003-4776-5839				Aigner Thomas G., 1995, Current Opinion in Neurobiology, V5, P155, DOI 10.1016/0959-4388(95)80021-2; AMARAL DG, 1985, J COMP NEUROL, V240, P37, DOI 10.1002/cne.902400104; AMBROSINGERSON J, 1993, P NATL ACAD SCI USA, V90, P7903, DOI 10.1073/pnas.90.16.7903; Andre JM, 2011, NEUROPHARMACOLOGY, V60, P617, DOI 10.1016/j.neuropharm.2010.12.004; ARAUJO DM, 1988, J NEUROCHEM, V50, P1914, DOI 10.1111/j.1471-4159.1988.tb02497.x; AUERBACH JM, 1994, J NEUROPHYSIOL, V72, P2034, DOI 10.1152/jn.1994.72.4.2034; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; BARTUS RT, 1985, PHARMACOL BIOCHEM BE, V23, P125, DOI 10.1016/0091-3057(85)90139-X; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Baxter MG, 1996, BEHAV NEUROSCI, V110, P460; BAXTER MG, 1995, BEHAV NEUROSCI, V109, P714, DOI 10.1037/0735-7044.109.4.714; Benfenati Fabio, 2007, Acta Biomed, V78 Suppl 1, P58; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BERGERSWEENEY J, 1994, J NEUROSCI, V14, P4507; Birthelmer A, 2003, BRAIN RES BULL, V59, P371, DOI 10.1016/S0361-9230(02)00930-9; Bizon JL, 2003, HIPPOCAMPUS, V13, P676, DOI 10.1002/hipo.10113; BLITZER RD, 1990, NEUROSCI LETT, V119, P207, DOI 10.1016/0304-3940(90)90835-W; Blokland A, 1995, BRAIN RES REV, V21, P285, DOI 10.1016/0165-0173(95)00016-X; Ciamei A, 2001, PSYCHOPHARMACOLOGY, V154, P126, DOI 10.1007/s002130000584; Cobb SR, 2005, J PHYSIOL-LONDON, V562, P81, DOI 10.1113/jphysiol.2004.076539; Daulatzai MA, 2010, J ALZHEIMERS DIS, V20, P355, DOI 10.3233/JAD-2010-1374; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Easton A, 2010, HIPPOCAMPUS; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; Fitz NF, 2008, BRAIN RES BULL, V77, P356, DOI 10.1016/j.brainresbull.2008.08.016; Fletcher BR, 2007, HIPPOCAMPUS, V17, P227, DOI 10.1002/hipo.20261; Frielingsdorf H, 2006, BEHAV BRAIN RES, V168, P37, DOI 10.1016/j.bbr.2005.10.008; Gibbs RB, 2007, NEUROBIOL LEARN MEM, V88, P19, DOI 10.1016/j.nlm.2007.03.007; GIVENS B, 1995, NEUROBIOL LEARN MEM, V63, P269, DOI 10.1006/nlme.1995.1031; Gould TJ, 2005, LEARN MEMORY, V12, P389, DOI 10.1101/lm.89105; HAGAN JJ, 1988, BEHAV BRAIN RES, V27, P9, DOI 10.1016/0166-4328(88)90105-2; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hefft S, 1999, J PHYSIOL-LONDON, V515, P769, DOI 10.1111/j.1469-7793.1999.769ab.x; HEPLER DJ, 1985, J NEUROSCI, V5, P866; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Holmes WR, 2006, J NEUROPHYSIOL, V96, P1478, DOI 10.1152/jn.00248.2006; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; Jafari-Sabet M, 2006, BEHAV BRAIN RES, V169, P120, DOI 10.1016/j.bbr.2005.12.011; Janis LS, 1998, BEHAV BRAIN RES, V90, P23; Johnson DA, 2002, BRAIN RES, V943, P132, DOI 10.1016/S0006-8993(02)02623-9; Johnson MW, 1997, J NEUROSCI METH, V77, P151, DOI 10.1016/S0165-0270(97)00120-9; Jonasson Z, 2004, EUR J NEUROSCI, V20, P3041, DOI 10.1111/j.1460-9568.2004.03739.x; Jouvenceau A, 1997, SYNAPSE, V26, P292, DOI 10.1002/(SICI)1098-2396(199707)26:3<292::AID-SYN10>3.0.CO;2-Y; JOUVENCEAU A, 1994, NEUROREPORT, V5, P1781, DOI 10.1097/00001756-199409080-00024; Kamsler A, 2010, P NATL ACAD SCI USA, V107, P1618, DOI 10.1073/pnas.0912540107; Kanju PM, 2008, EXP NEUROL, V214, P55, DOI 10.1016/j.expneurol.2008.07.010; KELSEY JE, 1988, BEHAV NEUROSCI, V102, P289; Kenney JW, 2008, MOL NEUROBIOL, V38, P101, DOI 10.1007/s12035-008-8037-9; Kirby BP, 2003, BEHAV BRAIN RES, V143, P41, DOI 10.1016/S0166-4328(03)00005-6; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Kuczewski N, 2005, EUR J NEUROSCI, V21, P1807, DOI 10.1111/j.1460-9568.2005.04014.x; Lauterborn JC, 2007, J NEUROSCI, V27, P10685, DOI 10.1523/JNEUROSCI.2624-07.2007; Lehmann O, 2003, EUR J NEUROSCI, V18, P651, DOI 10.1046/j.1460-9568.2003.02745.x; Levin ED, 1998, PHARMACOL BIOCHEM BE, V61, P335, DOI 10.1016/S0091-3057(98)00109-9; Levin ED, 2003, BRAIN RES BULL, V61, P489, DOI 10.1016/S0361-9230(03)00183-7; Lim CS, 2011, NEUROSCIENCE; Lin Y, 2006, P NATL ACAD SCI USA, V103, P19902, DOI 10.1073/pnas.0609924104; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Mansvelder HD, 2009, SEMIN CELL DEV BIOL, V20, P432, DOI 10.1016/j.semcdb.2009.01.007; MAREN S, 1993, P NATL ACAD SCI USA, V90, P9654, DOI 10.1073/pnas.90.20.9654; MARKOWSKA AL, 1995, J NEUROSCI, V15, P2063, DOI 10.1523/JNEUROSCI.15-03-02063.1995; Martin MA, 2007, BEHAV BRAIN RES, V183, P78, DOI 10.1016/j.bbr.2007.05.026; Matsuyama S, 2000, EUR J NEUROSCI, V12, P3741, DOI 10.1046/j.1460-9568.2000.00259.x; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; McMahan RW, 1997, HIPPOCAMPUS, V7, P130, DOI 10.1002/(SICI)1098-1063(1997)7:2<130::AID-HIPO2>3.0.CO;2-R; MHARZI M, 1992, BEHAV BRAIN RES, V49, P159, DOI 10.1016/S0166-4328(05)80160-3; MIYAMOTO M, 1987, BRAIN RES, V419, P19, DOI 10.1016/0006-8993(87)90564-6; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Moreira KM, 2005, BRAIN RES BULL, V67, P504, DOI 10.1016/j.brainresbull.2005.07.019; Morgan SL, 2001, J NEUROPHYSIOL, V86, P1289, DOI 10.1152/jn.2001.86.3.1289; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; Navakkode S, 2011, HIPPOCAMPUS; Ohno M, 1996, EUR J PHARMACOL, V312, P145, DOI 10.1016/0014-2999(96)00580-8; Ovsepian SV, 2004, EUR J NEUROSCI, V20, P1267, DOI 10.1111/j.1460-9568.2004.03582.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Figueredo LZP, 2008, BRAIN RES BULL, V77, P71, DOI 10.1016/j.brainresbull.2008.05.008; PITLER TA, 1992, J PHYSIOL-LONDON, V450, P127, DOI 10.1113/jphysiol.1992.sp019119; Pizzo DP, 1999, J NEUROSCI METH, V91, P9, DOI 10.1016/S0165-0270(99)00057-6; Placzek AN, 2009, ACTA PHARMACOL SIN, V30, P752, DOI 10.1038/aps.2009.39; Radcliffe KA, 1999, ANN NY ACAD SCI, V868, P591, DOI 10.1111/j.1749-6632.1999.tb11332.x; Rezayof A, 2010, LIFE SCI, V86, P260, DOI 10.1016/j.lfs.2009.12.008; Robinson H P, 1993, EXS, V63, P250; Salter MW, 2009, FRONT NEUROSCI, P123; Shen JM, 1996, BEHAV NEUROSCI, V110, P1181, DOI 10.1037/0735-7044.110.5.1181; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; TANG CM, 1991, SCIENCE, V254, P288, DOI 10.1126/science.1681589; Tsukada H, 2005, NEUROPSYCHOPHARMACOL, V30, P2144, DOI 10.1038/sj.npp.1300745; Vaglenova J, 2008, NEUROBIOL LEARN MEM, V90, P527, DOI 10.1016/j.nlm.2008.06.009; Vaithianathan H, 2005, CELL BIOCHEM BIOPHYS, V42, P75, DOI 10.1385/CBB:42:1:075; van der Staay FJ, 2006, HIPPOCAMPUS, V16, P1061, DOI 10.1002/hipo.20229; Walsh TJ, 1996, BRAIN RES, V726, P69, DOI 10.1016/S0006-8993(96)00271-5; Winters BD, 2004, BEHAV NEUROSCI, V118, P546, DOI 10.1037/0735-7044.118.3.546; Xu F, 2006, BRAIN RES, V1121, P22, DOI 10.1016/j.brainres.2006.08.129; Yamazaki Y, 2002, BRAIN RES, V946, P148, DOI 10.1016/S0006-8993(02)02935-9; Yamazaki Y, 2006, EUR J NEUROSCI, V23, P1819, DOI 10.1111/j.1460-9568.2006.04714.x; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062	101	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31073	10.1371/journal.pone.0031073	http://dx.doi.org/10.1371/journal.pone.0031073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355337	Green Submitted, gold, Green Published			2022-12-25	WOS:000302741300037
J	Lataillade, M; Chiarella, J; Yang, R; DeGrosky, M; Uy, J; Seekins, D; Simen, B; St John, E; Moreno, E; Kozal, M				Lataillade, Max; Chiarella, Jennifer; Yang, Rong; DeGrosky, Michelle; Uy, Jonathan; Seekins, Daniel; Simen, Birgitte; St John, Elizabeth; Moreno, Elizabeth; Kozal, Michael			Virologic Failures on Initial Boosted-PI Regimen Infrequently Possess Low-Level Variants with Major PI Resistance Mutations by Ultra-Deep Sequencing	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; VIRAL VARIANTS; STRATEGIES; IMPACT; HIV-1	Background: It is unknown whether HIV-positive patients experiencing virologic failure (VF) on boosted-PI (PI/r) regimens without drug resistant mutations (DRM) by standard genotyping harbor low-level PI resistant variants. CASTLE compared the efficacy of atazanavir/ritonavir (ATV/r) with lopinavir/ritonavir (LPV/r), each in combination with TVD in ARV-naive subjects. Objective: To determine if VF on an initial PI/r-based regimen possess low-level resistant variants that may affect a subsequent PI-containing regimen. Methods/Results: Patients experiencing VF on a Tenofovir/Emtricitabine+PI/r regimen were evaluated by ultra deep sequencing (UDS) for mutations classified/weighted by Stanford HIVdb. Samples were evaluated for variants to 0.4% levels. 36 VF subjects were evaluated by UDS; 24 had UDS for PI and RT DRMs. Of these 24, 19 (79.2%) had any DRM by UDS. The most common UDS-detected DRM were NRTI in 18 subjects: M184V/I (11), TAMs(7) & K65R(4); PI DRMs were detected in 9 subjects: M46I/V(5), F53L(2), I50V(1), D30N(1), and N88S(1). The remaining 12 subjects, all with VLs<10,000, had protease gene UDS, and 4 had low-level PI DRMs: F53L(2), L76V(1), I54S(1), G73S(1). Overall, 3/36(8.3%) subjects had DRMs identified with Stanford-HIVdb weights >12 for ATV or LPV: N88S (at 0.43% level-mutational load 1,828) in 1 subject on ATV; I50V (0.44%-mutational load 110) and L76V (0.52%-mutational load 20) in 1 subject each, both on LPV. All VF samples remained phenotypically susceptible to the treatment PI/r. Conclusion: Among persons experiencing VF without PI DRMs with standard genotyping on an initial PI/r regimen, low-level variants possessing major PI DRMs were present in a minority of cases, occurred in isolation, and did not result in phenotypic resistance. NRTI DRMs were detected in a high proportion of subjects. These data suggest that PIs may remain effective in subjects experiencing VF on a PI/r-based regimen when PI DRMs are not detected by standard or UDS genotyping.	[Lataillade, Max; Yang, Rong; DeGrosky, Michelle] Bristol Myers Squibb Co, Res & Dev, Wallingford, CT 06492 USA; [Lataillade, Max; Chiarella, Jennifer; Kozal, Michael] Yale Univ, Sch Med, New Haven, CT USA; [Lataillade, Max; Chiarella, Jennifer; Kozal, Michael] Vet Affairs Hlth Care Syst, New Haven, CT USA; [Uy, Jonathan; Seekins, Daniel] Bristol Myers Squibb Co, Res & Dev, Plainsboro, NJ USA; [Simen, Birgitte; St John, Elizabeth; Moreno, Elizabeth] 454 Life Sci Roche Co, Branford, CT USA	Bristol-Myers Squibb; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Bristol-Myers Squibb	Lataillade, M (corresponding author), Bristol Myers Squibb Co, Res & Dev, 5 Res Pkwy, Wallingford, CT 06492 USA.	Max.lataillade@BMS.com		Kozal, Michael/0000-0002-3100-8254; , Michael/0000-0002-7719-7396; Simen, Birgitte/0000-0003-0503-0973	Bristol-Myers Squibb, Global Clinical Research; Bristol Myers Squibb; Merck; Pfizer; Gilead; Abbott; Bristol-Myers Squibb; Stanford University	Bristol-Myers Squibb, Global Clinical Research; Bristol Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); Pfizer(Pfizer); Gilead(Gilead Sciences); Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); Stanford University(Stanford University)	Funds for this study were provided by Bristol-Myers Squibb, Global Clinical Research. The funders participated in study design and data collection.; The authors have read the journal's policy and have the following conflicts: Max Lataillade, Rong Yang, Michelle DeGrosky, Daniel Seekins, Jonathan Uy, and Donnie McGrath are employees of Bristol Myers Squibb, who funded this study. Yale University receives grant support from Merck, Pfizer, Gilead, Abbott and Bristol-Myers Squibb for studies that MJK serves as the principal investigator. Michael J. Kozal receives royalties from a patent owned by Stanford University for some HIV diagnostic tests. Elizabeth P. St. John and Birgitte B. Simen are employees of 454 Life Sciences-Roche Co. There are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The four patent numbers are: 5,631,128; 5,650,268; 5,856,086; and US RE38,352E.	Kozal MJ, 2007, HIV CLIN TRIALS, V8, P357, DOI 10.1310/hct0806-357; Lataillade M, 2008, J INT AIDS SOC S1, V11, pP180; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; MacArthur RD, 2006, LANCET, V368, P2125, DOI 10.1016/S0140-6736(06)69861-9; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Molina JM, 2008, 48 ANN ICAAC IDSA 46; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1, P1; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Shafer RW, 2009, J INFECT DIS, V199, P610, DOI 10.1086/596737; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Stenman J, 2003, BIOTECHNIQUES, V34, P172, DOI 10.2144/03341dd05; Synovate HIV Market Research, 2009, SYNOVATE HIV MARKET; Underwood MR, 2009, J INFECT DIS, V199, P84, DOI 10.1086/595296	14	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e30118	10.1371/journal.pone.0030118	http://dx.doi.org/10.1371/journal.pone.0030118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355307	Green Submitted, gold, Green Published			2022-12-25	WOS:000302741300007
J	Rigato, PO; Maciel, M; Goldoni, AL; Piubelli, OG; Orii, NM; Marques, ET; August, JT; Duarte, AJD; Sato, MN				Rigato, Paula Ordonhez; Maciel, Milton, Jr.; Goldoni, Adriana Leticia; Piubelli, Orlando Guerra; Orii, Noemia Mie; Marques, Ernesto Torres; August, Joseph Thomas; da Silva Duarte, Alberto Jose; Sato, Maria Notomi			Maternal LAMP/p55gagHIV-1 DNA Immunization Induces In Utero Priming and a Long-Lasting Immune Response in Vaccinated Neonates	PLOS ONE			English	Article							EARLY-LIFE; T-CELL; HYPERSENSITIVITY RESPONSE; ALLERGEN EXPOSURE; MEMBRANE-PROTEIN; II COMPARTMENT; TRANSMISSION; MICE; GAG; SENSITIZATION	Infants born to HIV-infected mothers are at high risk of becoming infected during gestation or the breastfeeding period. A search is thus warranted for vaccine formulations that will prevent mother-to-child HIV transmission. The LAMP/gag DNA chimeric vaccine encodes the HIV-1 p55gag fused to the lysosome-associated membrane protein-1 (LAMP-1) and has been shown to enhance anti-Gag antibody (Ab) and cellular immune responses in adult and neonatal mice; such a vaccine represents a new concept in antigen presentation. In this study, we evaluated the effect of LAMP/gag DNA immunization on neonates either before conception or during pregnancy. LAMP/gag immunization of BALB/c mice before conception by the intradermal route led to the transfer of anti-Gag IgG1 Ab through the placenta and via breastfeeding. Furthermore, there were an increased percentage of CD4+ CD25+ Foxp3+ T cells in the spleens of neonates. When offspring were immunized with LAMP/gag DNA, the anti-Gag Ab response and the Gag-specific IFN-gamma-secreting cells were decreased. Inhibition of anti-Gag Ab production and cellular responses were not observed six months after immunization, indicating that maternal immunization did not interfere with the long-lasting memory response in offspring. Injection of purified IgG in conjunction with LAMP/gag DNA immunization decreased humoral and cytotoxic T-cell responses. LAMP/gag DNA immunization by intradermal injection prior to conception promoted the transfer of Ab, leading to a diminished response to Gag without interfering with the development of anti-Gag T- and B-cell memory. Finally, we assessed responses after one intravenous injection of LAMP/gag DNA during the last five days of pregnancy. The intravenous injection led to in utero immunization. In conclusion, DNA vaccine enconding LAMP-1 with Gag and other HIV-1 antigens should be considered in the development of a protective vaccine for the maternal/fetal and newborn periods.	[Rigato, Paula Ordonhez; Goldoni, Adriana Leticia; Piubelli, Orlando Guerra; Orii, Noemia Mie; da Silva Duarte, Alberto Jose; Sato, Maria Notomi] Univ Sao Paulo, Sch Med, Lab Dermatol & Immunodeficiencies, Dept Dermatol,LIM 56, Sao Paulo, Brazil; [Maciel, Milton, Jr.] USN, Enter Dis Dept, Infect Dis Directorate, Med Res Ctr, Silver Spring, MD USA; [Marques, Ernesto Torres] Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [August, Joseph Thomas] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Universidade de Sao Paulo; United States Department of Defense; United States Navy; Johns Hopkins University	Rigato, PO (corresponding author), Univ Sao Paulo, Sch Med, Lab Dermatol & Immunodeficiencies, Dept Dermatol,LIM 56, Sao Paulo, Brazil.	marisato@usp.br	Sato, Maria N/C-2853-2012; Marques, Ernesto T. A/L-4967-2013; Sato, Maria N/C-1196-2012; Publica, Inct Saude/J-9544-2013; Goldoni, Adriana Leticia/I-1912-2012; Ordonhez Rigato, Paula/J-3618-2012; Marques, Ernesto/L-4514-2013	Marques, Ernesto T. A/0000-0003-3826-9358; Sato, Maria N/0000-0002-7911-1824; Goldoni, Adriana Leticia/0000-0002-4298-8526; Marques, Ernesto/0000-0003-3826-9358; RIGATO, PAULA ORDONHEZ/0000-0002-4416-3544	Ministerio da Saude do Brasil [914BRA1101]; Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP) [2004/14443-2]; Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo	Ministerio da Saude do Brasil; Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo	This work was supported by Ministerio da Saude do Brasil - Programa Nacional de HIV/AIDS/DST (914BRA1101), Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP n<SUP>o</SUP> 2004/14443-2) and Laboratorio de Investigacao Medica, Unidade 56 do Hospital das Clinicas da Faculdade de Medicina de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda LB, 2006, J IMMUNOL, V177, P2265, DOI 10.4049/jimmunol.177.4.2265; Becquet R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007397; BOGEN B, 1993, EMBO J, V12, P357, DOI 10.1002/j.1460-2075.1993.tb05664.x; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08; De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x; de Brito CA, 2009, IMMUNOTHERAPY-UK, V1, P883, DOI 10.2217/IMT.09.38; Fusaro AE, 2002, INT ARCH ALLERGY IMM, V127, P208, DOI 10.1159/000053865; Fusaro AE, 2007, IMMUNOLOGY, V122, P107, DOI 10.1111/j.1365-2567.2007.02618.x; Fusaro AE, 2009, IMMUNOLOGY, V128, pe541, DOI 10.1111/j.1365-2567.2008.03028.x; Gerdts V, 2000, NAT MED, V6, P929, DOI 10.1038/78699; Goldoni AL, 2011, IMMUNOBIOLOGY, V216, P505, DOI 10.1016/j.imbio.2010.08.007; Hassett DE, 1997, J VIROL, V71, P7881, DOI 10.1128/JVI.71.10.7881-7888.1997; Horwitz DA, 2008, EUR J IMMUNOL, V38, P912, DOI 10.1002/eji.200738109; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247; Lohman-Payne B, 2010, CLIN PERINATOL, V37, P787, DOI 10.1016/j.clp.2010.08.005; Manickan E, 1997, J CLIN INVEST, V100, P2371, DOI 10.1172/JCI119777; Marques ETA, 2003, J BIOL CHEM, V278, P37926, DOI 10.1074/jbc.M303336200; Okuda K, 2001, J IMMUNOL, V167, P5478, DOI 10.4049/jimmunol.167.9.5478; Rigato PO, 2010, VIROLOGY, V406, P37, DOI 10.1016/j.virol.2010.06.050; Rigato PO, 2009, IMMUNOTHERAPY-UK, V1, P141, DOI 10.2217/1750743X.1.1.141; Rinaldi M, 2006, VACCINE, V24, P4586, DOI 10.1016/j.vaccine.2005.08.030; Sedegah M, 2003, J IMMUNOL, V171, P3148, DOI 10.4049/jimmunol.171.6.3148; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Siegrist CA, 1998, EUR J IMMUNOL, V28, P4138, DOI 10.1002/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.0.CO;2-L; UNAIDS, 2010, AIDS EP UPD; Victor JR, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-11; Victor JR, 2003, J ALLERGY CLIN IMMUN, V111, P269, DOI 10.1067/mai.2003.39; Xin Ke-Qin, 2002, Biological Procedures Online, V3, P91, DOI 10.1251/bpo27; Xin KQ, 2003, J GENE MED, V5, P438, DOI 10.1002/jgm.356	33	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31608	10.1371/journal.pone.0031608	http://dx.doi.org/10.1371/journal.pone.0031608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355381	Green Submitted, Green Published, gold			2022-12-25	WOS:000302741300081
J	Yu, J; Zhang, YY; Zhang, XB; Rudic, RD; Bauer, PM; Altieri, DC; Sessa, WC				Yu, Jun; Zhang, Yuanyuan; Zhang, Xinbo; Rudic, R. Daniel; Bauer, Philip M.; Altieri, Dario C.; Sessa, William C.			Endothelium Derived Nitric Oxide Synthase Negatively Regulates the PDGF-Survivin Pathway during Flow-Dependent Vascular Remodeling	PLOS ONE			English	Article							BLOOD-FLOW; IN-VIVO; APOPTOSIS; CELLS; EXPRESSION; INHIBITION; CANCER; GENE; MIGRATION; INJURY	Chronic alterations in blood flow initiate structural changes in vessel lumen caliber to normalize shear stress. The loss of endothelial derived nitric oxide synthase (eNOS) in mice promotes abnormal flow dependent vascular remodeling, thus uncoupling mechanotransduction from adaptive vascular remodeling. However, the mechanisms of how the loss of eNOS promotes abnormal remodeling are not known. Here we show that abnormal flow-dependent remodeling in eNOS knockout mice (eNOS (-/-)) is associated with activation of the platelet derived growth factor (PDGF) signaling pathway leading to the induction of the inhibitor of apoptosis, survivin. Interfering with PDGF signaling or survivin function corrects the abnormal remodeling seen in eNOS (-/-) mice. Moreover, nitric oxide (NO) negatively regulates PDGF driven survivin expression and cellular proliferation in cultured vascular smooth muscle cells. Collectively, our data suggests that eNOS negatively regulates the PDGF-survivin axis to maintain proportional flow-dependent luminal remodeling and vascular quiescence.	[Yu, Jun; Zhang, Yuanyuan; Zhang, Xinbo; Rudic, R. Daniel; Bauer, Philip M.; Sessa, William C.] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Yu, Jun; Zhang, Yuanyuan; Zhang, Xinbo] Yale Univ, Sch Med, Internal Med Sect Cardiovasc Med, New Haven, CT USA; [Altieri, Dario C.] Wistar Inst Canc Ctr, Philadelphia, PA USA	Yale University; Yale University; The Wistar Institute	Yu, J (corresponding author), Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA.	jun.yu@yale.edu	Sessa, William C/B-6844-2011; zhang, yuanyuan/GYA-4428-2022; Rudic, Dan/B-3432-2016	Sessa, William C/0000-0001-5759-1938; Rudic, Dan/0000-0001-9122-3127	American Heart Association; NIH [HL64793, HL 61371, HL 64793, HL 081190, HL 096670, HL54131, CA78810, CA90917]; NATIONAL CANCER INSTITUTE [R01CA090917, R01CA078810] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089576, R01HL064793, R01HL081190, R01HL096670, R01HL054131, R37HL061371, R37HL054131, R01HL061371] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from American Heart Association to JY and grants from NIH (HL64793, HL 61371, HL 64793, HL 081190 and HL 096670 to WCS and HL54131, CA78810 and CA90917 to DCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Altieri DC, 1999, LAB INVEST, V79, P1327; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Blanc-Brude OP, 2002, NAT MED, V8, P987, DOI 10.1038/nm750; Chao JI, 2004, J BIOL CHEM, V279, P20267, DOI 10.1074/jbc.M312381200; Dai X, CIRC RES; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Gibbons GH, 1996, SCIENCE, V272, P689, DOI 10.1126/science.272.5262.689; Grossman D, 2001, P NATL ACAD SCI USA, V98, P635, DOI 10.1073/pnas.230450097; Gurjar MV, 1999, ARTERIOSCL THROM VAS, V19, P2871, DOI 10.1161/01.ATV.19.12.2871; Jacob A, 2002, AM J PHYSIOL-CELL PH, V283, pC704, DOI 10.1152/ajpcell.00110.2002; KAMIYA A, 1980, AM J PHYSIOL, V239, pH14, DOI 10.1152/ajpheart.1980.239.1.H14; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Kritz AB, 2008, MOL THER, V16, P1798, DOI 10.1038/mt.2008.188; LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904; LANGILLE BL, 1989, AM J PHYSIOL, V256, pH931, DOI 10.1152/ajpheart.1989.256.4.H931; Mondy JS, 1997, CIRC RES, V81, P320, DOI 10.1161/01.RES.81.3.320; Moroi M, 1998, J CLIN INVEST, V101, P1225, DOI 10.1172/JCI1293; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Ohashi H, 2004, CIRC RES, V94, P785, DOI 10.1161/01.RES.0000121103.03275.EC; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Rudic RD, 2000, CIRC RES, V86, P1160; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Rudic RD, 1999, AM J HUM GENET, V64, P673, DOI 10.1086/302304; Sandirasegarane L, 2000, AM J PHYSIOL-CELL PH, V279, pC225, DOI 10.1152/ajpcell.2000.279.1.C225; Sharma RV, 1999, AM J PHYSIOL-HEART C, V276, pH1450, DOI 10.1152/ajpheart.1999.276.5.H1450; Tran J, 1999, BIOCHEM BIOPH RES CO, V264, P781, DOI 10.1006/bbrc.1999.1589; Yamasaki Y, 2001, CIRC RES, V88, P630, DOI 10.1161/01.RES.88.6.630; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102	31	21	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2012	7	2							e31495	10.1371/journal.pone.0031495	http://dx.doi.org/10.1371/journal.pone.0031495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925DP	22355372	Green Published, Green Submitted, gold			2022-12-25	WOS:000302741300072
J	Zhang, JX; Han, BC; Wei, XN; Tan, CY; Chen, YZ; Jiang, YY				Zhang, Jingxian; Han, Bucong; Wei, Xiaona; Tan, Chunyan; Chen, Yuzong; Jiang, Yuyang			A Two-Step Target Binding and Selectivity Support Vector Machines Approach for Virtual Screening of Dopamine Receptor Subtype-Selective Ligands	PLOS ONE			English	Article							LARGE COMPOUND LIBRARIES; D-3 RECEPTOR; PARKINSONS-DISEASE; CURRENT PERSPECTIVES; MEDICINAL CHEMISTRY; RECENT PROGRESS; DRUG-DISCOVERY; FINGERPRINTS; QSAR; CLASSIFICATION	Target selective drugs, such as dopamine receptor (DR) subtype selective ligands, are developed for enhanced therapeutics and reduced side effects. In silico methods have been explored for searching DR selective ligands, but encountered difficulties associated with high subtype similarity and ligand structural diversity. Machine learning methods have shown promising potential in searching target selective compounds. Their target selective capability can be further enhanced. In this work, we introduced a new two-step support vector machines target-binding and selectivity screening method for searching DR subtype-selective ligands, which was tested together with three previously-used machine learning methods for searching D1, D2, D3 and D4 selective ligands. It correctly identified 50.6%-88.0% of the 21-408 subtype selective and 71.7%-81.0% of the 39-147 multi-subtype ligands. Its subtype selective ligand identification rates are significantly better than, and its multi-subtype ligand identification rates are comparable to the best rates of the previously used methods. Our method produced low false-hit rates in screening 13.56 M PubChem, 168,016 MDDR and 657,736 ChEMBLdb compounds. Molecular features important for subtype selectivity were extracted by using the recursive feature elimination feature selection method. These features are consistent with literature-reported features. Our method showed similar performance in searching estrogen receptor subtype selective ligands. Our study demonstrated the usefulness of the two-step target binding and selectivity screening method in searching subtype selective ligands from large compound libraries.	[Zhang, Jingxian; Tan, Chunyan; Chen, Yuzong; Jiang, Yuyang] Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518057, Guangdong, Peoples R China; [Zhang, Jingxian; Han, Bucong; Wei, Xiaona; Chen, Yuzong] Natl Univ Singapore, Ctr Computat Sci & Engn, Dept Pharm, Bioinformat & Drug Design Grp, Singapore 117548, Singapore; [Han, Bucong; Wei, Xiaona] Natl Univ Singapore, Singapore MIT Alliance, Singapore 117548, Singapore	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Zhang, JX (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518057, Guangdong, Peoples R China.	phacyz@nus.edu.sg; jiangyy@sz.tsinghua.edu.cn	Zhang, Jing/GWZ-7332-2022; jiang, yu/HGU-0029-2022; Tan, Chunyan/F-2785-2012	Tan, Chunyan/0000-0002-4263-2175; Chen, Yu Zong/0000-0002-5473-8022; Sarkar, Indra Neil/0000-0003-2054-7356	Academic Research Funds Singapore [R-148-000-081-112]; Ministry of Science and Technology; 863 Hi-Tech Program China [2007AA02Z160]; Key Special Project [009ZX09501-004]; Ministry of Science and Technology, China	Academic Research Funds Singapore(Ministry of Education, Singapore); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 863 Hi-Tech Program China(National High Technology Research and Development Program of China); Key Special Project; Ministry of Science and Technology, China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea)	The authors acknowledge the support from Academic Research Funds Singapore (R-148-000-081-112), Ministry of Science and Technology, 863 Hi-Tech Program China (2007AA02Z160), Key Special Project Grant 009ZX09501-004. Y.Z. Chen is supported by Academic Research Funds Singapore. Y.Y. Jiang is supported by the Ministry of Science and Technology, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albersen M, 2010, EXPERT OPIN EMERG DR, V15, P467, DOI 10.1517/14728214.2010.480973; Aloisi G, 2011, NEUROPHARMACOLOGY, V60, P439, DOI 10.1016/j.neuropharm.2010.10.018; Audouze K, 2004, J MED CHEM, V47, P3089, DOI 10.1021/jm031111m; Bellis LJ, 2011, BIOCHEM SOC T, V39, P1365, DOI 10.1042/BST0391365; Bender A, 2006, J CHEM INF MODEL, V46, P2445, DOI 10.1021/ci600197y; Boeckler F, 2006, PHARMACOL THERAPEUT, V112, P281, DOI 10.1016/j.pharmthera.2006.04.007; Bostrom J, 2006, J MED CHEM, V49, P6716, DOI 10.1021/jm060167o; Burbidge R, 2001, COMPUT CHEM, V26, P5, DOI 10.1016/S0097-8485(01)00094-8; Carro L, 2009, BIOORG MED CHEM LETT, V19, P6059, DOI 10.1016/j.bmcl.2009.09.041; Cha MY, 2003, BIOORGAN MED CHEM, V11, P1293, DOI 10.1016/S0968-0896(02)00617-X; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cho DI, 2010, ARCH PHARM RES, V33, P1521, DOI 10.1007/s12272-010-1005-8; Clark RD, 2009, J COMPUT AID MOL DES, V23, P765, DOI 10.1007/s10822-008-9227-2; Czerminski R, 2001, QUANT STRUCT-ACT REL, V20, P227, DOI 10.1002/1521-3838(200110)20:3<227::AID-QSAR227>3.0.CO;2-Y; Durrant JD, 2010, CURR OPIN PHARMACOL, V10, P770, DOI 10.1016/j.coph.2010.09.001; Ehrlich K, 2009, J MED CHEM, V52, P4923, DOI 10.1021/jm900690y; Enguehard-Gueiffier C, 2006, CURR MED CHEM, V13, P2981, DOI 10.2174/092986706778521841; Erhan D, 2006, J CHEM INF MODEL, V46, P626, DOI 10.1021/ci050367t; Givehchi A, 2006, J CHEM INF MODEL, V46, P1078, DOI 10.1021/ci0500233; Han LY, 2008, J MOL GRAPH MODEL, V26, P1276, DOI 10.1016/j.jmgm.2007.12.002; Heidbreder CA, 2010, ANN NY ACAD SCI, V1187, P4, DOI 10.1111/j.1749-6632.2009.05149.x; Herm L, 2009, BIOORGAN MED CHEM, V17, P4756, DOI 10.1016/j.bmc.2009.04.047; Horvath D, 2009, J CHEM INF MODEL, V49, P1762, DOI 10.1021/ci9000579; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Huber D, 2009, J MED CHEM, V52, P6860, DOI 10.1021/jm901120h; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jenner P, 2003, CURR OPIN NEUROL, V16, pS3, DOI 10.1097/00019052-200312001-00002; Johnson R, 1982, APPL MULTIVARIATE ST; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Li H, 2007, J PHARM SCI-US, V96, P2838, DOI 10.1002/jps.20985; Li ZR, 2007, BIOTECHNOL BIOENG, V97, P389, DOI 10.1002/bit.21214; Liu XH, 2009, J CHEM INF MODEL, V49, P2101, DOI 10.1021/ci900135u; Lober S, 2011, TRENDS PHARMACOL SCI, V32, P148, DOI 10.1016/j.tips.2010.12.003; Lober S, 2009, CHEMMEDCHEM, V4, P325, DOI 10.1002/cmdc.200800395; Lopez L, 2010, CHEMMEDCHEM, V5, P1300, DOI 10.1002/cmdc.201000101; Ma XH, 2010, MOL PHARMACEUT, V7, P1545, DOI 10.1021/mp100179t; Ma XH, 2009, COMB CHEM HIGH T SCR, V12, P344, DOI 10.2174/138620709788167944; Mahe P, 2009, COMB CHEM HIGH T SCR, V12, P409, DOI 10.2174/138620709788167926; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McCall RB, 2005, J PHARMACOL EXP THER, V314, P1248, DOI 10.1124/jpet.105.084202; Micheli F, 2011, CHEMMEDCHEM, V6, P1152, DOI 10.1002/cmdc.201000538; Michielan L, 2009, J CHEM INF MODEL, V49, P2588, DOI 10.1021/ci900299a; Mishra Nitish K., 2010, BMC Pharmacology, V10, P8, DOI 10.1186/1471-2210-10-8; Monge A, 2006, MOL DIVERS, V10, P389, DOI 10.1007/s11030-006-9033-5; Overington John, 2009, J Comput Aided Mol Des, V23, P195, DOI 10.1007/s10822-009-9260-9; Pilla M, 1999, NATURE, V400, P371, DOI 10.1038/43944; Quinlan J.R, 2014, C4 5 PROGRAMS MACHIN; Renner S, 2008, J CHEM INF MODEL, V48, P319, DOI 10.1021/ci7003626; Salama I, 2007, J MED CHEM, V50, P489, DOI 10.1021/jm0611152; Sato T, 2010, J CHEM INF MODEL, V50, P170, DOI 10.1021/ci900382e; Schietgat L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-2; Shi Z, 2012, J MOL GRAPH MODEL, V32, P49, DOI 10.1016/j.jmgm.2011.09.002; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; Simpson MM, 1999, MOL PHARMACOL, V56, P1116, DOI 10.1124/mol.56.6.1116; Singer C, 2007, MOVEMENT DISORD, V22, P476, DOI 10.1002/mds.21361; Sprous DG, 2010, CURR TOP MED CHEM, V10, P619, DOI 10.2174/156802610791111506; Sun HM, 2008, CURR MED CHEM, V15, P1018, DOI 10.2174/092986708784049630; Talevi A, 2009, CURR COMPUT-AID DRUG, V5, P23, DOI 10.2174/157340909787580854; Trotter MWB, 2001, MEAS CONTROL-UK, V34, P235, DOI 10.1177/002029400103400803; Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1; Tsoumakas G, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P667, DOI 10.1007/978-0-387-09823-4_34; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Verheij HJ, 2006, MOL DIVERS, V10, P377, DOI 10.1007/s11030-006-9040-6; Wang Q, 2010, J CHEM INF MODEL, V50, P1970, DOI 10.1021/ci1002747; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wester MJ, 2008, J CHEM INF MODEL, V48, P1311, DOI 10.1021/ci700342h; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Willett P, 2011, METHODS MOL BIOL, V672, P133, DOI 10.1007/978-1-60761-839-3_5; Xue Y, 2004, J CHEM INF COMP SCI, V44, P1630, DOI 10.1021/ci049869h; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Zeng CY, 2011, HYPERTENSION, V57, P11, DOI 10.1161/HYPERTENSIONAHA.110.157727; Zhang A, 2007, CHEM REV, V107, P274, DOI 10.1021/cr050263h; Zhang J, 2009, MED RES REV, V29, P272, DOI 10.1002/med.20130; Zhang ML, 2007, PATTERN RECOGN, V40, P2038, DOI 10.1016/j.patcog.2006.12.019	74	246	265	8	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39076	10.1371/journal.pone.0039076	http://dx.doi.org/10.1371/journal.pone.0039076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720033	Green Submitted, Green Published, gold			2022-12-25	WOS:000305350000037
J	Wu, SG; Wang, GT; Angert, ER; Wang, WW; Li, WX; Zou, H				Wu, Shangong; Wang, Guitang; Angert, Esther R.; Wang, Weiwei; Li, Wenxiang; Zou, Hong			Composition, Diversity, and Origin of the Bacterial Community in Grass Carp Intestine	PLOS ONE			English	Article							GUT MICROBIOTA; AEROMONAS-SALMONICIDA; PROBIOTIC ACTIVITY; RAINBOW-TROUT; MICROFLORA; RUMEN; FISH; IDENTIFICATION; AMPLIFICATION; FURUNCULOSIS	Gut microbiota has become an integral component of the host, and received increasing attention. However, for many domestic animals, information on the microbiota is insufficient and more effort should be exerted to manage the gastrointestinal bacterial community. Understanding the factors that influence the composition of microbial community in the host alimentary canal is essential to manage or improve the microbial community composition. In the present study, 16S rRNA gene sequence-based comparisons of the bacterial communities in the grass carp (Ctenopharyngodon idellus) intestinal contents and fish culture-associated environments are performed. The results show that the fish intestinal microbiota harbors many cellulose-decomposing bacteria, including sequences related to Anoxybacillus, Leuconostoc, Clostridium, Actinomyces, and Citrobacter. The most abundant bacterial operational taxonomic units (OTUs) in the grass carp intestinal content are those related to feed digestion. In addition, the potential pathogens and probiotics are important members of the intestinal microbiota. Further analyses show that grass carp intestine holds a core microbiota composed of Proteobacteria, Firmicutes, and Actinobacteria. The comparison analyses reveal that the bacterial community in the intestinal contents is most similar to those from the culture water and sediment. However, feed also plays significant influence on the composition of gut microbiota.	[Wu, Shangong; Wang, Guitang; Wang, Weiwei; Li, Wenxiang; Zou, Hong] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wu, Shangong; Wang, Guitang; Wang, Weiwei; Li, Wenxiang; Zou, Hong] Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Inst Hydrobiol, Wuhan, Peoples R China; [Angert, Esther R.] Cornell Univ, Dept Microbiol, Ithaca, NY USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Cornell University	Wu, SG (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	gtwang@ihb.ac.cn		Kuo, Ping-Chung/0000-0003-3019-1138; TENG, CHE-MING/0000-0002-9719-7334	National Basic Research Program of China [2009CB118705]; State Key Laboratory of Freshwater Ecology and Biotechnology [2011FB07]; earmarked fund for China Agriculture Research System [CARS-46-08]	National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); earmarked fund for China Agriculture Research System	The research was financially supported by grants from National Basic Research Program of China (No. 2009CB118705), the Open Fund of State Key Laboratory of Freshwater Ecology and Biotechnology (No. 2011FB07), and the earmarked fund for China Agriculture Research System (No. CARS-46-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; [Anonymous], 2008, FRESHWATER FISHERY; [Anonymous], [No title captured]; Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009; Berg R. D., 1992, Probiotics: the scientific basis., P55; Bjorksten B, 2006, CLIN EXP ALLERGY, V36, P1215, DOI 10.1111/j.1365-2222.2006.02579.x; CAHILL MM, 1990, MICROB ECOL, V19, P21, DOI 10.1007/BF02015051; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Cui Y., 1991, PROGR NATURAL SCI, V1, P449; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Gibson LF, 1998, AQUACULTURE, V169, P111, DOI 10.1016/S0044-8486(98)00369-X; Gibson LF, 1999, J APPL MICROBIOL, V85, p243S, DOI 10.1111/j.1365-2672.1998.tb05304.x; Han SF, 2010, AQUAC RES, V42, P47, DOI 10.1111/j.1365-2109.2010.02543.x; He Li, 2009, Chinese Journal of Applied and Environmental Biology, V15, P414, DOI 10.3724/SP.J.1145.2009.00414; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; HINEY MP, 1994, DIS AQUAT ORGAN, V19, P161, DOI 10.3354/dao019161; Irianto A, 2002, J FISH DIS, V25, P333, DOI 10.1046/j.1365-2761.2002.00375.x; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Kovach W., 1999, MVSP A MULTIVARIATE; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Li J.H., 2010, CHINA FISHERY STAT Y; Li SF, 1980, J FISH CHINA, V4, P275; Lodemel JB, 2001, AQUAC RES, V32, P935, DOI 10.1046/j.1365-2109.2001.00621.x; Luo Lin, 2001, Journal of Fisheries of China, V25, P232; MACKIE RI, 1990, J DAIRY SCI, V73, P2971, DOI 10.3168/jds.S0022-0302(90)78986-2; Ni D S, 1999, BIOL DIS GRASS CARP; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Pankratov T A, 2006, Dokl Biol Sci, V410, P428, DOI 10.1134/S0012496606050243; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Perumbakkam S, 2011, ANTON LEEUW INT J G, V99, P231, DOI 10.1007/s10482-010-9481-x; Pond MJ, 2006, AQUACULTURE, V261, P194, DOI 10.1016/j.aquaculture.2006.06.037; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qiu Y, 2010, CHINA FOOD, V19, P34; Raoult D, 2009, NAT REV MICROBIOL, V7, P616, DOI 10.1038/nrmicro2209; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Ringo E, 1998, AQUACULTURE, V160, P177, DOI 10.1016/S0044-8486(97)00299-8; Ringo E, 1999, AQUAC RES, V30, P73, DOI 10.1046/j.1365-2109.1999.00302.x; Ringo E, 2003, AQUACULTURE, V227, P395, DOI 10.1016/j.aquaculture.2003.05.001; Ringo E, 2006, AQUACULTURE, V261, P829, DOI 10.1016/j.aquaculture.2006.06.030; Roeselers G, 2011, ISME J, DOI [10.1038/ismej.2011.1038, DOI 10.1038/ISMEJ.2011.1038]; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; RUSSELL JB, 1981, J ANIM SCI, V53, P242, DOI 10.2527/jas1981.531242x; Saha S, 2006, AQUAC RES, V37, P380, DOI 10.1111/j.1365-2109.2006.01442.x; Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SIJPESTEIJN AK, 1951, J GEN MICROBIOL, V5, P869, DOI 10.1099/00221287-5-5-869; Song Xiao, 2009, Acta Hydrobiologica Sinica, V33, P709, DOI 10.3724/SP.J.1035.2009.40709; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Tan H, 2009, LETT APPL MICROBIOL, V49, P248, DOI 10.1111/j.1472-765X.2009.02649.x; Tomsic B, 2007, CARBOHYD POLYM, V69, P478, DOI 10.1016/j.carbpol.2007.01.003; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu SG, 2010, AQUACULTURE, V303, P1, DOI 10.1016/j.aquaculture.2009.12.025; XU BH, 1988, ACTA HYDROBIOL SIN, V12, P308; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yang WM, 2010, THESIS CAS WUHAN; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhou W., 1998, J HUAZHONG AGRIC UNI, V17, P252; Zu G, 2000, FRESHW FISH, V30, P35	63	431	489	19	218	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30440	10.1371/journal.pone.0030440	http://dx.doi.org/10.1371/journal.pone.0030440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22815798	gold, Green Submitted, Green Published			2022-12-25	WOS:000302871500008
J	Zhang, JB; Hanner, R				Zhang, Junbin; Hanner, Robert			Molecular Approach to the Identification of Fish in the South China Sea	PLOS ONE			English	Article							GENETIC-DIVERGENCE; MITOCHONDRIAL PSEUDOGENES; DNA BARCODES; REEF; POPULATIONS; EVOLUTION; DASCYLLUS; SYSTEM	Background: DNA barcoding is one means of establishing a rapid, accurate, and cost-effective system for the identification of species. It involves the use of short, standard gene targets to create sequence profiles of known species against sequences of unknowns that can be matched and subsequently identified. The Fish Barcode of Life (FISH-BOL) campaign has the primary goal of gathering DNA barcode records for all the world's fish species. As a contribution to FISH-BOL, we examined the degree to which DNA barcoding can discriminate marine fishes from the South China Sea. Methodology/Principal Findings: DNA barcodes of cytochrome oxidase subunit I (COI) were characterized using 1336 specimens that belong to 242 species fishes from the South China Sea. All specimen provenance data (including digital specimen images and geospatial coordinates of collection localities) and collateral sequence information were assembled using Barcode of Life Data System (BOLD; www.barcodinglife.org). Small intraspecific and large interspecific differences create distinct genetic boundaries among most species. In addition, the efficiency of two mitochondrial genes, 16S rRNA (16S) and cytochrome b (cytb), and one nuclear ribosomal gene, 18S rRNA (18S), was also evaluated for a few select groups of species. Conclusions/Significance: The present study provides evidence for the effectiveness of DNA barcoding as a tool for monitoring marine biodiversity. Open access data of fishes from the South China Sea can benefit relative applications in ecology and taxonomy.	[Zhang, Junbin] Shanghai Ocean Univ, Dept Aquaculture & Life Sci, Shanghai, Peoples R China; [Zhang, Junbin; Hanner, Robert] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Shanghai Ocean University; University of Guelph	Zhang, JB (corresponding author), Shanghai Ocean Univ, Dept Aquaculture & Life Sci, Shanghai, Peoples R China.	jb-zhang@shou.edu.cn	Zhang, Jing/GWZ-7332-2022; jiang, yu/HGU-0029-2022; Tan, Chunyan/F-2785-2012	Tan, Chunyan/0000-0002-4263-2175; Chen, Yu Zong/0000-0002-5473-8022; Sarkar, Indra Neil/0000-0003-2054-7356	Genome Canada (through the Ontario Genomics Institute); Chinese National Funding awards [40776089, U0633007]	Genome Canada (through the Ontario Genomics Institute)(Genome Canada); Chinese National Funding awards	This research was supported through funding to the Canadian Barcode of Life Network from Genome Canada (through the Ontario Genomics Institute) and by Chinese National Funding awards 40776089 and U0633007, which supported specimen collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Barbuto M, 2010, FOOD RES INT, V43, P376, DOI 10.1016/j.foodres.2009.10.009; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bernardi G, 2002, P ROY SOC B-BIOL SCI, V269, P599, DOI 10.1098/rspb.2001.1922; Bernardi G, 2001, MAR BIOL, V138, P457, DOI 10.1007/s002270000484; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Chakrabarty Prosanta, 2010, Marine Biodiversity, V40, P107, DOI 10.1007/s12526-010-0037-0; Chen JTF, 1986, SYNOPSIS VERTEBRATES; Chenoweth SF, 1997, J FISH BIOL, V50, P721, DOI 10.1006/jfbi.1996.0336; Comi G, 2005, FOOD CONTROL, V16, P37, DOI 10.1016/j.foodcont.2003.11.003; Cui ZX, 2010, ICHTHYOL RES, V57, P32, DOI 10.1007/s10228-009-0119-9; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Doyle JJ, 2000, PLANT MOL BIOL, V42, P1, DOI 10.1023/A:1006349518932; Dudgeon CL, 2000, MAR BIOL, V137, P1059, DOI 10.1007/s002270000403; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Greenstone MH, 2005, MOL ECOL, V14, P3247, DOI 10.1111/j.1365-294X.2005.02628.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HANNER R, 2005, PROPOSED STANDARDS B; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hellberg ME, 2002, B MAR SCI, V70, P273; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Liu Jing, 2002, Studia Marina Sinica, V44, P240; Lucy K, 2010, UNDERGRADUATE RES J; NEI M, 2000, MOL EVOLUTION PHYLOG; Neigel J, 2007, CORAL REEFS, V26, P487, DOI 10.1007/s00338-007-0248-4; Ornelas-Garcia Claudia Patricia, 2008, BMC Evol Biol, V8, P340, DOI 10.1186/1471-2148-8-340; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Parin NV, 2004, J ICHTHYOLOGY S1, V44, P33; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Piganeau G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016342; Planes S, 2001, EVOLUTION, V55, P2263; Rasmussen RS, 2009, J AGR FOOD CHEM, V57, P8379, DOI 10.1021/jf901618z; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rock J, 2008, ANTARCT SCI, V20, P253, DOI 10.1017/S0954102008001120; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Ruedas LA, 2000, MOL PHYLOGENET EVOL, V17, P129, DOI 10.1006/mpev.2000.0737; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Scheffer SJ, 2006, ANN ENTOMOL SOC AM, V99, P204, DOI 10.1603/0013-8746(2006)099[0204:DBATIL]2.0.CO;2; Shen SC, COASTAL FISHES TAIWA, P180; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sparks JS, 2005, CLADISTICS, V21, P305, DOI 10.1111/j.1096-0031.2005.00067.x; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Swartz ER, 2008, S AFR J SCI, V104, P293; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Tuckey JW, 1977, EXPLORATORY DATA ANA, P688; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Victor BC, 2009, ZOOTAXA, P24; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Xiao JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015067; Zhang JB, 2004, J EXP MAR BIOL ECOL, V298, P3, DOI 10.1016/S0022-0981(03)00341-1; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]	62	246	265	8	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30621	10.1371/journal.pone.0030621	http://dx.doi.org/10.1371/journal.pone.0030621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22720033	Green Published, Green Submitted, gold			2022-12-25	WOS:000302853600041
J	Zhang, L; Ren, G				Zhang, Lei; Ren, Gang			IPET and FETR: Experimental Approach for Studying Molecular Structure Dynamics by Cryo-Electron Tomography of a Single-Molecule Structure	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; NEGATIVE-STAINING PROTOCOL; APOLIPOPROTEIN-A-I; ELECTRON-MICROSCOPY; RADIATION-DAMAGE; 3-DIMENSIONAL RECONSTRUCTION; SCATTERING FACTORS; DIFFERENT SIZES; RESOLUTION; PROTEIN	The dynamic personalities and structural heterogeneity of proteins are essential for proper functioning. Structural determination of dynamic/heterogeneous proteins is limited by conventional approaches of X-ray and electron microscopy (EM) of single-particle reconstruction that require an average from thousands to millions different molecules. Cryo-electron tomography (cryoET) is an approach to determine three-dimensional (3D) reconstruction of a single and unique biological object such as bacteria and cells, by imaging the object from a series of tilting angles. However, cconventional reconstruction methods use large-size whole-micrographs that are limited by reconstruction resolution (lower than 20 A), especially for small and low-symmetric molecule (<400 kDa). In this study, we demonstrated the adverse effects from image distortion and the measuring tilt-errors (including tilt-axis and tilt-angle errors) both play a major role in limiting the reconstruction resolution. Therefore, we developed a "focused electron tomography reconstruction" (FETR) algorithm to improve the resolution by decreasing the reconstructing image size so that it contains only a single-instance protein. FETR can tolerate certain levels of image-distortion and measuring tilt-errors, and can also precisely determine the translational parameters via an iterative refinement process that contains a series of automatically generated dynamic filters and masks. To describe this method, a set of simulated cryoET images was employed; to validate this approach, the real experimental images from negative-staining and cryoET were used. Since this approach can obtain the structure of a single-instance molecule/particle, we named it individual-particle electron tomography (IPET) as a new robust strategy/approach that does not require a pre-given initial model, class averaging of multiple molecules or an extended ordered lattice, but can tolerate small tilt-errors for high-resolution single "snapshot" molecule structure determination. Thus, FETR/IPET provides a completely new opportunity for a single-molecule structure determination, and could be used to study the dynamic character and equilibrium fluctuation of macromolecules.	[Zhang, Lei; Ren, Gang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, L (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA.	gren@lbl.gov	Zhang, Lei/G-6427-2012; Ren, Gang/B-1567-2012	Zhang, Lei/0000-0002-4880-824X; Ren, Gang/0000-0002-8036-2321; Liu, Guangwei/0000-0002-6008-2891	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-05CH11231]; William Myron Keck Foundation [011808]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104427] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); William Myron Keck Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Office of Science, Office of Basic Energy Sciences of the United States Department of Energy (contract no. DE-AC02-05CH11231) and partially supported by the William Myron Keck Foundation (#011808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker LA, 2010, J STRUCT BIOL, V169, P431, DOI 10.1016/j.jsb.2009.11.014; Bammes BE, 2010, J STRUCT BIOL, V169, P331, DOI 10.1016/j.jsb.2009.11.001; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BRACEWELL RN, 1967, ASTROPHYS J, V150, P427, DOI 10.1086/149346; Cantele F, 2007, J STRUCT BIOL, V158, P59, DOI 10.1016/j.jsb.2006.10.015; Cardone G, 2007, VIROLOGY, V361, P426, DOI 10.1016/j.virol.2006.10.047; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Chen B, 2009, PROTEIN SCI, V18, P921, DOI 10.1002/pro.101; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Chen JZ, 2008, J STRUCT BIOL, V161, P92, DOI 10.1016/j.jsb.2007.09.017; CONWAY JF, 1993, J STRUCT BIOL, V111, P222, DOI 10.1006/jsbi.1993.1052; Cowley JM, 2006, INT TABLES CRYSTALLO, P262; CROWTHER RA, 1971, PHILOS T R SOC B, V261, P221, DOI 10.1098/rstb.1971.0054; Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004; Fernando KV, 2008, J STRUCT BIOL, V164, P49, DOI 10.1016/j.jsb.2008.06.012; Frank J, 2002, J STRUCT BIOL, V138, P85, DOI 10.1016/S1047-8477(02)00019-9; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Frey TG, 2006, ANNU REV BIOPH BIOM, V35, P199, DOI 10.1146/annurev.biophys.35.040405.102039; Fung JC, 1996, J STRUCT BIOL, V116, P181, DOI 10.1006/jsbi.1996.0029; Gil D, 2006, J STRUCT BIOL, V156, P546, DOI 10.1016/j.jsb.2006.07.012; GILBERT P, 1972, J THEOR BIOL, V36, P105, DOI 10.1016/0022-5193(72)90180-4; GLAESER RM, 1979, J MICROSC-OXFORD, V117, P77, DOI 10.1111/j.1365-2818.1979.tb00232.x; GLAESER RM, 1971, J ULTRA MOL STRUCT R, V36, P466, DOI 10.1016/S0022-5320(71)80118-1; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Grimm R, 1998, BIOPHYS J, V74, P1031, DOI 10.1016/S0006-3495(98)74028-7; HARRIS JR, 1994, MICRON, V25, P5; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; HERMAN GT, 1973, J THEOR BIOL, V42, P1, DOI 10.1016/0022-5193(73)90145-8; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hue F, 2005, J ELECTRON MICROSC, V54, P181, DOI 10.1093/jmicro/dfi042; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665; Jones MK, 2010, J BIOL CHEM, V285, P41161, DOI 10.1074/jbc.M110.187799; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; KLUG A, 1972, NATURE, V238, P435, DOI 10.1038/238435a0; KONING RI, 2009, ANN ANAT; Leschziner AE, 2006, J STRUCT BIOL, V153, P284, DOI 10.1016/j.jsb.2005.10.012; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mastronarde DN, 2008, J MICROSC-OXFORD, V230, P212, DOI 10.1111/j.1365-2818.2008.01977.x; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Milne JLS, 2009, NAT REV MICROBIOL, V7, P666, DOI 10.1038/nrmicro2183; Peng LM, 1996, ACTA CRYSTALLOGR A, V52, P456, DOI 10.1107/S010876739600089X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ren G, 2000, J MOL BIOL, V301, P369, DOI 10.1006/jmbi.2000.3949; Ren G, 1997, MICRON, V28, P459, DOI 10.1016/S0968-4328(97)00034-6; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; Ren G, 1996, ACTA PHYS SINICA, V45, P1344; Ren G, 2010, P NATL ACAD SCI USA, V107, P1059, DOI 10.1073/pnas.0908004107; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sandberg K, 2003, J STRUCT BIOL, V144, P61, DOI 10.1016/j.jsb.2003.09.013; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Schaffer B, 2006, ULTRAMICROSCOPY, V106, P1129, DOI 10.1016/j.ultramic.2006.04.028; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Stagg SM, 2006, J STRUCT BIOL, V155, P470, DOI 10.1016/j.jsb.2006.04.005; STOKROOS I, 1983, J BIOL BUCCALE, V11, P339; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; TAYLOR KA, 1976, J ULTRA MOL STRUCT R, V55, P448, DOI 10.1016/S0022-5320(76)80099-8; UNSER M, 1987, ULTRAMICROSCOPY, V23, P39, DOI 10.1016/0304-3991(87)90225-7; UNWIN PNT, 1975, J MOL BIOL, V94, P425, DOI 10.1016/0022-2836(75)90212-0; vanAntwerpen R, 1997, J LIPID RES, V38, P659; VANHEEL M, 1985, EMBO J, V4, P2389, DOI 10.1002/j.1460-2075.1985.tb03944.x; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Walz J, 1997, J STRUCT BIOL, V120, P387, DOI 10.1006/jsbi.1997.3934; Winkler H, 2007, J STRUCT BIOL, V157, P126, DOI 10.1016/j.jsb.2006.07.014; XIANG SB, 1993, ACTA CRYSTALLOGR D, V49, P193, DOI 10.1107/S0907444992008540; Zhang L, 2010, BIOPHYSICAL J, V98, p440a; Zhang L, 2010, BIOPHYSICAL J, V98, p441a; Zhang L, 2011, J LIPID RES, V52, P175, DOI 10.1194/jlr.D010959; Zhang L, 2010, J LIPID RES, V51, P1228, DOI 10.1194/jlr.D002493	77	104	106	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30249	10.1371/journal.pone.0030249	http://dx.doi.org/10.1371/journal.pone.0030249			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291925	Green Published, Green Submitted, gold			2022-12-25	WOS:000301639600008
J	Singh, A; Baranwal, V; Shankar, A; Kanwar, P; Ranjan, R; Yadav, S; Pandey, A; Kapoor, S; Pandey, GK				Singh, Amarjeet; Baranwal, Vinay; Shankar, Alka; Kanwar, Poonam; Ranjan, Rajeev; Yadav, Sandeep; Pandey, Amita; Kapoor, Sanjay; Pandey, Girdhar K.			Rice Phospholipase A Superfamily: Organization, Phylogenetic and Expression Analysis during Abiotic Stresses and Development	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; PATATIN-RELATED PHOSPHOLIPASES; LIPID ACYL HYDROLASE; GENE FAMILY; SHOOT GRAVITROPISM; PHOSPHATIDIC-ACID; DROUGHT STRESS; GUARD-CELL; REPRODUCTIVE DEVELOPMENT; SIGNAL-TRANSDUCTION	Background: Phospholipase A (PLA) is an important group of enzymes responsible for phospholipid hydrolysis in lipid signaling. PLAs have been implicated in abiotic stress signaling and developmental events in various plants species. Genome-wide analysis of PLA superfamily has been carried out in dicot plant Arabidopsis. A comprehensive genome-wide analysis of PLAs has not been presented yet in crop plant rice. Methodology/Principal Findings: A comprehensive bioinformatics analysis identified a total of 31 PLA encoding genes in the rice genome, which are divided into three classes; phospholipase A(1) (PLA(1)), patatin like phospholipases (pPLA) and low molecular weight secretory phospholipase A(2) (sPLA(2)) based on their sequences and phylogeny. A subset of 10 rice PLAs exhibited chromosomal duplication, emphasizing the role of duplication in the expansion of this gene family in rice. Microarray expression profiling revealed a number of PLA members expressing differentially and significantly under abiotic stresses and reproductive development. Comparative expression analysis with Arabidopsis PLAs revealed a high degree of functional conservation between the orthologs in two plant species, which also indicated the vital role of PLAs in stress signaling and plant development across different plant species. Moreover, sub-cellular localization of a few candidates suggests their differential localization and functional role in the lipid signaling. Conclusion/Significance: The comprehensive analysis and expression profiling would provide a critical platform for the functional characterization of the candidate PLA genes in crop plants.	[Singh, Amarjeet; Baranwal, Vinay; Shankar, Alka; Kanwar, Poonam; Ranjan, Rajeev; Yadav, Sandeep; Pandey, Amita; Kapoor, Sanjay; Pandey, Girdhar K.] Dept Plant Mol Biol, New Delhi, India		Singh, A (corresponding author), Dept Plant Mol Biol, Univ Delhi S Campus, New Delhi, India.	gkpandey@south.du.ac.in	Sharma, Prabhat/AAW-6558-2021; Ranjan, Rajeev/AAY-3243-2021	Ranjan, Rajeev/0000-0002-1344-4044; Kapoor, Sanjay/0000-0002-0283-1137; Pandey, Amita/0000-0001-8717-3227; SINGH, ASHUTOSH/0000-0002-0995-6696; Singh, Abhishek/0000-0001-6263-4410; SHARMA, PRABHAT/0000-0002-2638-2321; Kanwar, Poonam/0000-0002-9328-9274; PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924; Pallikadavath, Saseendran/0000-0002-2598-9949; Ogollah, Reuben/0000-0002-5777-4117	Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India	Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India	This work was supported by the Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Agarwal P, 2007, PLANT MOL BIOL, V65, P467, DOI 10.1007/s11103-007-9199-y; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bahn SC, 2003, FEBS LETT, V553, P113, DOI 10.1016/S0014-5793(03)00982-7; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Bargmann BO, 2006, CURR OPIN PLANT BIOL, V9, P515, DOI 10.1016/j.pbi.2006.07.011; Boss WF, 2008, ANNU PLANT REV, V33, P202, DOI 10.1111/b.9781405160025.2008.00008.x; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Chen GQ, 2011, CRIT REV PLANT SCI, V30, P239, DOI 10.1080/07352689.2011.572033; Clewley J P, 1997, Methods Mol Biol, V70, P119; Cusack BP, 2007, TRENDS GENET, V23, P270, DOI 10.1016/j.tig.2007.03.010; Dessen A, 2000, BBA-MOL CELL BIOL L, V1488, P40, DOI 10.1016/S1388-1981(00)00108-6; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Holk A, 2002, PLANT PHYSIOL, V130, P90, DOI 10.1104/pp.006288; Hong YY, 2008, PLANT CELL, V20, P803, DOI 10.1105/tpc.107.056390; Hong YY, 2009, PLANT J, V58, P376, DOI 10.1111/j.1365-313X.2009.03788.x; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang SS, 2001, PLANT PHYSIOL, V125, P573, DOI 10.1104/pp.125.2.573; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Kato T, 2002, PLANT CELL, V14, P33, DOI 10.1105/tpc.010215; Kim HJ, 2011, PLANT CELL, V23, P94, DOI 10.1105/tpc.110.074799; Laxalt AM, 2002, CURR OPIN PLANT BIOL, V5, P332, DOI 10.1016/S1369-5266(02)00268-6; Lee HY, 2005, PROG LIPID RES, V44, P52, DOI 10.1016/j.plipres.2004.10.002; Lee HY, 2003, PLANT CELL, V15, P1990, DOI 10.1105/tpc.014423; Lee OR, 2010, PLANT CELL, V22, P1812, DOI 10.1105/tpc.110.074211; Li MY, 2011, PLANT CELL, V23, P1107, DOI 10.1105/tpc.110.081240; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mansfeld J, 2006, BIOCHEMISTRY-US, V45, P5687, DOI 10.1021/bi052563z; Matos AR, 2008, PHYSIOL PLANTARUM, V134, P110, DOI 10.1111/j.1399-3054.2008.01123.x; Matos AR, 2009, PLANT PHYSIOL BIOCH, V47, P491, DOI 10.1016/j.plaphy.2009.02.011; Matos AR, 2001, FEBS LETT, V491, P188, DOI 10.1016/S0014-5793(01)02194-9; Matsui K, 2004, FEBS LETT, V569, P195, DOI 10.1016/j.febslet.2004.05.064; MAY C, 1998, BBA-LIPID LIPID MET, V1393, P267; Morita MT, 2002, PLANT CELL, V14, P47, DOI 10.1105/tpc.010216; Munnik T, 2001, FEBS LETT, V498, P172, DOI 10.1016/S0014-5793(01)02492-9; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Narusaka Y, 2003, PLANT CELL PHYSIOL, V44, P1246, DOI 10.1093/pcp/pcg138; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; O'Luanaigh N, 2002, MOL BIOL CELL, V13, P3730, DOI 10.1091/mbc.E02-04-0213; Paul RU, 1998, PLANT J, V16, P601, DOI 10.1046/j.1365-313x.1998.00333.x; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Rietz S, 2010, MOL PLANT, V3, P524, DOI 10.1093/mp/ssp109; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Ryu SB, 2004, TRENDS PLANT SCI, V9, P229, DOI 10.1016/j.tplants.2004.03.004; Scherer GFE, 2002, PLANT MOL BIOL, V49, P357, DOI 10.1023/A:1015290510483; Scherer GFE, 2010, TRENDS PLANT SCI, V15, P693, DOI 10.1016/j.tplants.2010.09.005; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Sirichandra C, 2009, J EXP BOT, V60, P1439, DOI 10.1093/jxb/ern340; Stahl U, 1998, PLANT PHYSIOL, V117, P197, DOI 10.1104/pp.117.1.197; Stahl U, 1999, PLANT MOL BIOL, V41, P481, DOI 10.1023/A:1006323405788; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P79, DOI 10.4161/psb.3.2.5303; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang XM, 2001, ANNU REV PLANT PHYS, V52, P211, DOI 10.1146/annurev.arplant.52.1.211; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	67	174	181	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30947	10.1371/journal.pone.0030947	http://dx.doi.org/10.1371/journal.pone.0030947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	23028594	Green Published, gold, Green Submitted			2022-12-25	WOS:000302853600094
J	Singh, A; Dey, AB; Mohan, A; Sharma, PK; Mitra, DK				Singh, Amar; Dey, Aparajita Ballave; Mohan, Anant; Sharma, Prabhat Kumar; Mitra, Dipendra Kumar			Foxp(3+) Regulatory T Cells among Tuberculosis Patients: Impact on Prognosis and Restoration of Antigen Specific IFN-gamma Producing T Cells	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PD-1 EXPRESSION; ACTIVE TUBERCULOSIS; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSES; TH1 RESPONSES; INFECTION; SUPPRESSION; EXPANSION; LIGANDS	CD(4+)CD(25+)Foxp(3+) Regulatory T cells (Treg) and programmed death-1 (PD-1) molecules have emerged as pivotal players in immune suppression of chronic diseases. However, their impact on the disease severity, therapeutic response and restoration of immune response in human tuberculosis remains unclear. Here, we describe the possible role of Treg cells, their M. tuberculosis driven expansion and contribution of PD-1 pathway to the suppressive function of Treg cells among pulmonary tuberculosis (PTB) patients. Multicolor flow cytometry, cell culture, cells sorting and ELISA were employed to execute the study. Our results showed significant increase in frequency of antigen-reactive Treg cells, which gradually declined during successful therapy and paralleled with decline of M. tuberculosis-specific IL-10 along with elevation of IFN-gamma production, and raising the IFN-gamma/IL-4 ratio. Interestingly, persistence of Treg cells tightly correlated with MDR tuberculosis. Also, we show that blocking PD-1/PD-L1 pathway abrogates Treg-mediated suppression, suggesting that the PD-1/PD-L1 pathway is required for Treg-mediated suppression of the antigen-specific T cells. Treg cells possibly play a role in dampening the effector immune response and abrogating PD-1 pathway on Treg cells significantly rescued protective T cell response, suggesting its importance in immune restoration among tuberculosis patients.	[Singh, Amar; Sharma, Prabhat Kumar; Mitra, Dipendra Kumar] All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India; [Dey, Aparajita Ballave; Mohan, Anant] All India Inst Med Sci, Dept Med, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Mitra, DK (corresponding author), All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India.	salilmitra1@yahoo.com	Sharma, Prabhat/AAW-6558-2021; Ranjan, Rajeev/AAY-3243-2021	Ranjan, Rajeev/0000-0002-1344-4044; Kapoor, Sanjay/0000-0002-0283-1137; Pandey, Amita/0000-0001-8717-3227; SINGH, ASHUTOSH/0000-0002-0995-6696; Singh, Abhishek/0000-0001-6263-4410; SHARMA, PRABHAT/0000-0002-2638-2321; Kanwar, Poonam/0000-0002-9328-9274; PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924; Pallikadavath, Saseendran/0000-0002-2598-9949; Ogollah, Reuben/0000-0002-5777-4117	Department of Biotechnology; Indian Council of Medical Research, Government of India, New Delhi, India	Department of Biotechnology; Indian Council of Medical Research, Government of India, New Delhi, India(Indian Council of Medical Research (ICMR))	The study was supported by the Department of Biotechnology and the Indian Council of Medical Research, Government of India, New Delhi, India. For this study the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez IB, 2010, J INFECT DIS, V202, P524, DOI 10.1086/654932; Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; Antas PRZ, 2007, AM J RESP CRIT CARE, V176, P214, DOI 10.1164/ajrccm.176.2.214; Aramaki O, 2004, TRANSPLANTATION, V77, P6, DOI 10.1097/01.TP.0000108637.65091.4B; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Burl S, 2007, CLIN EXP IMMUNOL, V149, P117, DOI 10.1111/j.1365-2249.2007.03399.x; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 1999, NAT MED, V5, P1365; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Green AM, 2010, J INFECT DIS, V202, P533, DOI 10.1086/654896; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Handzel ZT, 2007, ISR MED ASSOC J, V9, P479; Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; HUYGEN K, 1988, SCAND J IMMUNOL, V27, P187, DOI 10.1111/j.1365-3083.1988.tb02338.x; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Katara GK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001171; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Kitazawa Y, 2007, TRANSPLANTATION, V83, P774, DOI 10.1097/01.tp.0000256293.90270.e8; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Mitra DK, 2009, MICROBES INFECT, V11, P1122, DOI 10.1016/j.micinf.2009.08.006; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Raimondi G, 2006, J IMMUNOL, V176, P2808, DOI 10.4049/jimmunol.176.5.2808; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Sharma S, 2009, AM J RESP CRIT CARE, V179; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shen T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-279; TOOSSI Z, 1986, J EXP MED, V163, P1162, DOI 10.1084/jem.163.5.1162; TORRES M, 1994, CLIN EXP IMMUNOL, V96, P75, DOI 10.1111/j.1365-2249.1994.tb06233.x; Totsuka T, 2005, EUR J IMMUNOL, V35, P1773, DOI 10.1002/eji.200425109; Tousif S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019864; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	49	174	181	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44728	10.1371/journal.pone.0044728	http://dx.doi.org/10.1371/journal.pone.0044728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028594	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400035
